PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Levy, S; Elek, A; Grau-Bove, X; Menendez-Bravo, S; Iglesias, M; Tanay, A; Mass, T; Sebe-Pedros, A				Levy, Shani; Elek, Anamaria; Grau-Bove, Xavier; Menendez-Bravo, Simon; Iglesias, Marta; Tanay, Amos; Mass, Tali; Sebe-Pedros, Arnau			A stony coral cell atlas illuminates the molecular and cellular basis of coral symbiosis, calcification, and immunity	CELL			English	Article							ACROPORA-MILLEPORA; CLIMATE-CHANGE; EVOLUTION; GENOME; GENE; VISUALIZATION; DIVERSITY; ALGORITHM; RESPONSES; PROTEINS	Stony corals are colonial cnidarians that sustain the most biodiverse marine ecosystems on Earth: coral reefs. Despite their ecological importance, little is known about the cell types and molecular pathways that underpin the biology of reef-building corals. Using single-cell RNA sequencing, we define over 40 cell types across the life cycle of Stylophora pistillata. We discover specialized immune cells, and we uncover the developmental gene expression dynamics of calcium-carbonate skeleton formation. By simultaneously measuring the transcriptomes of coral cells and the algae within them, we characterize the metabolic programs involved in symbiosis in both partners. We also trace the evolution of these coral cell specializations by phylogenetic integration of multiple cnidarian cell type atlases. Overall, this study reveals the molecular and cellular basis of stony coral biology.	[Levy, Shani; Mass, Tali] Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-3498838 Haifa, Israel; [Levy, Shani; Mass, Tali] Univ Haifa, Leon H Charney Sch Marine Sci, Morris Kahn Marine Res Stn, Sdot Yam, Israel; [Elek, Anamaria; Grau-Bove, Xavier; Menendez-Bravo, Simon; Iglesias, Marta; Sebe-Pedros, Arnau] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain; [Elek, Anamaria; Grau-Bove, Xavier; Menendez-Bravo, Simon; Iglesias, Marta; Sebe-Pedros, Arnau] Univ Pompeu Fabra UPF, Barcelona, Spain; [Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Tanay, Amos] Weizmann Inst Sci, Dept Biol Regulat, IL-76100 Rehovot, Israel	University of Haifa; University of Haifa; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Weizmann Institute of Science; Weizmann Institute of Science	Mass, T (corresponding author), Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-3498838 Haifa, Israel.; Mass, T (corresponding author), Univ Haifa, Leon H Charney Sch Marine Sci, Morris Kahn Marine Res Stn, Sdot Yam, Israel.; Sebe-Pedros, A (corresponding author), Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain.; Sebe-Pedros, A (corresponding author), Univ Pompeu Fabra UPF, Barcelona, Spain.	tmass@univ.haifa.ac.il; arnau.sebe@crg.eu	Grau-Bové, Xavier/E-8223-2017; Levy, Shani/AAT-9429-2021; Sebe-Pedros, Arnau/B-9268-2011	Grau-Bové, Xavier/0000-0003-1978-5824; Mass, Tali/0000-0002-7298-290X; Levy, Shani/0000-0003-4857-8605; Sebe-Pedros, Arnau/0000-0002-9896-9746; Elek, Anamaria/0000-0002-3938-2494; Iglesias, Marta/0000-0003-1757-7343	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [851647, 755876]; Ministerio de Ciencia e Innovacion; Centro de Excelencia Severo Ochoa [SEV-2016-0571]; FPI Severo Ochoa PhD fellowship from the Ministerio de Ciencia e Innovacion; Juan de la Cierva fellowship from the Ministerio de Ciencia e Innovacion [FJC2018-036282-I]; European Union's H2020 research and innovation programme under Marie Sklodowska-Curie grant [754422]; European Research Council [724824]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Centro de Excelencia Severo Ochoa; FPI Severo Ochoa PhD fellowship from the Ministerio de Ciencia e Innovacion; Juan de la Cierva fellowship from the Ministerio de Ciencia e Innovacion; European Union's H2020 research and innovation programme under Marie Sklodowska-Curie grant; European Research Council(European Research Council (ERC)European Commission)	We thank Sebastian R. Najle, Jeana Drake, and Alex de Mendoza for critical comments on the manuscript; Cristina Peligero and Elad Chomsky for help with FACS-sorting experiments; Itay Kolsky, Maayan Neder, and Federica Scucchia for the help with collecting larvae from the wild; Hagai Nativ for the picture of S. pistillata adult colony in Figure 1A; and Yael Hertzog for the coral illustration in Figure 1G. Research in the A.S.-P. group was supported by the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme grant agreement 851647, the Ministerio de Ciencia e Innovacion, and the Centro de Excelencia Severo Ochoa (SEV-2016-0571). A.E. is supported by an FPI Severo Ochoa PhD fellowship from the Ministerio de Ciencia e Innovacion. X.G.-B. is supported by a Juan de la Cierva fellowship (FJC2018-036282-I) from the Ministerio de Ciencia e Innovacion. M.I. is supported by the European Union's H2020 research and innovation programme under Marie Sklodowska-Curie grant agreement 754422. T.M. acknowledges that this project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (755876). Research in the A.T. group was supported by the European Research Council (724824).	Akiva A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04285-7; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Aranda M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39734; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baumgarten S, 2015, P NATL ACAD SCI USA, V112, P11893, DOI 10.1073/pnas.1513318112; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; Bertucci A, 2015, MOL ECOL, V24, P4489, DOI 10.1111/mec.13328; Bertucci A, 2013, BIOORGAN MED CHEM, V21, P1437, DOI 10.1016/j.bmc.2012.10.024; Bhattacharya D, 2016, ELIFE, V5, DOI 10.7554/eLife.13288; Bolcun-Filas E, 2011, DEVELOPMENT, V138, P3319, DOI 10.1242/dev.067645; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Buitrago-Lopez C, 2020, GENOME BIOL EVOL, V12, P1911, DOI 10.1093/gbe/evaa184; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chang W, 2021, SHINY WEB APPL FRAME; Clavijo JM, 2018, BIOL REV, V93, P2006, DOI 10.1111/brv.12430; Cleves PA, 2020, TRENDS GENET, V36, P93, DOI 10.1016/j.tig.2019.11.001; Clevesa PA, 2018, P NATL ACAD SCI USA, V115, P5235, DOI 10.1073/pnas.1722151115; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; Derelle R, 2020, MOL BIOL EVOL, V37, P3389, DOI 10.1093/molbev/msaa159; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Dixon GB, 2015, SCIENCE, V348, P1460, DOI 10.1126/science.1261224; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drake JL, 2020, GLOBAL CHANGE BIOL, V26, P31, DOI 10.1111/gcb.14912; Drake JL, 2013, P NATL ACAD SCI USA, V110, P3788, DOI 10.1073/pnas.1301419110; Dunn CW, 2015, CURR OPIN GENET DEV, V35, P25, DOI 10.1016/j.gde.2015.08.006; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fincher CT, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1736; Fuller ZL, 2020, SCIENCE, V369, P268, DOI 10.1126/science.aba4674; Garcia-Castro H., 2020, BIORXIV, DOI [10.1101/2020.05.26.117234, DOI 10.1101/2020.05.26.117234]; Genikhovich G., 2009, COLD SPRING HARB PRO, V2009; Grover R, 2003, LIMNOL OCEANOGR, V48, P2266, DOI 10.4319/lo.2003.48.6.2266; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hambleton EA, 2019, ELIFE, V8, DOI 10.7554/eLife.43923; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hu MJ, 2020, NATURE, V582, P534, DOI 10.1038/s41586-020-2385-7; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Hughes TP, 2019, NATURE, V568, P387, DOI 10.1038/s41586-019-1081-y; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jacobovitz M., 2019, DINOFLAGEL LATE SYMB, DOI [10.1101/864579, DOI 10.1101/864579]; Jeon Y, 2019, GENOME BIOL EVOL, V11, P949, DOI 10.1093/gbe/evz043; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Kwong WK, 2019, NATURE, V568, P103, DOI 10.1038/s41586-019-1072-z; Ladner JT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-217; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Liew YJ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8028; Liew YJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006619; Liew YJ, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw152; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martinez S, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.566663; Mass T, 2013, CURR BIOL, V23, P1126, DOI 10.1016/j.cub.2013.05.007; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Mohamed A.R., 2019, BIORXIV; Morris LA, 2019, TRENDS MICROBIOL, V27, P678, DOI 10.1016/j.tim.2019.03.004; Musser J.M., 2019, PROFILING CELLULAR D, DOI [10.1101/758276, DOI 10.1101/758276]; Palmer CV, 2012, P ROY SOC B-BIOL SCI, V279, P4106, DOI 10.1098/rspb.2012.1477; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023992; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Parkinson JE, 2016, GENOME BIOL EVOL, V8, P665, DOI 10.1093/gbe/evw019; Picciani N, 2018, CURR BIOL, V28, P2413, DOI 10.1016/j.cub.2018.05.055; Putnam HM, 2017, CURR BIOL, V27, pR528, DOI 10.1016/j.cub.2017.04.047; Quattrini AM, 2020, NAT ECOL EVOL, V4, P1531, DOI 10.1038/s41559-020-01291-1; Radecker N, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022653118; Ramos-Silva P, 2013, MOL BIOL EVOL, V30, P2099, DOI 10.1093/molbev/mst109; Reaka-Kudla Marjorie L., 1997, P83; RINKEVICH B, 1979, MAR ECOL PROG SER, V1, P133, DOI 10.3354/meps001133; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosset SL, 2021, TRENDS MICROBIOL, V29, P320, DOI 10.1016/j.tim.2020.08.005; Sebe-Pedros A, 2018, NAT ECOL EVOL, V2, P1176, DOI 10.1038/s41559-018-0575-6; Sebe-Pedros A, 2018, CELL, V173, P1520, DOI 10.1016/j.cell.2018.05.019; Shinzato C, 2021, MOL BIOL EVOL, V38, P16, DOI 10.1093/molbev/msaa216; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Siebert S, 2019, SCIENCE, V365, P341, DOI 10.1126/science.aav9314; Sladitschek HL, 2020, CELL, V181, P922, DOI 10.1016/j.cell.2020.03.055; Steenwyk J.L., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.06.08.140384, DOI 10.1101/2020.06.08.140384]; Sully S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09238-2; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Torda G, 2017, NAT CLIM CHANGE, V7, P627, DOI 10.1038/NCLIMATE3374; Traylor-Knowles N., 2018, JOVE-J VIS EXP, V138; van Oppen MJH, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2019.0591; VANDERMEULEN JH, 1973, MAR BIOL, V23, P47, DOI 10.1007/BF00394111; Voolstra CR, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00068; Voolstra CR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17484-x; Walters BM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01690; Ying H, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1552-8; Zapata F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139068; Zhang DP, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-18; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zoccola D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09983	99	35	35	4	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2973	+		10.1016/j.cell.2021.04.005	http://dx.doi.org/10.1016/j.cell.2021.04.005		MAY 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33945788	hybrid, Green Published			2022-12-28	WOS:000656965600014
J	Yeager, M; Machiela, MJ; Kothiya, P; Dean, M; Bodelon, C; Suman, S; Wang, MY; Mirabello, L; Nelson, CW; Zhou, WY; Palmer, C; Ballew, B; Colli, LM; Freedman, ND; Dagnall, C; Hutchinson, A; Vij, V; Maruvka, Y; Hatch, M; Illienko, I; Belayev, Y; Nakamura, N; Chumak, V; Bakhanova, E; Belyi, D; Kryuchkov, V; Golovanov, I; Gudzenko, N; Cahoon, EK; Albert, P; Drozdovitch, V; Little, MP; Mabuchi, K; Stewart, C; Getz, G; Bazyka, D; de Gonzalez, AB; Chanock, SJ				Yeager, Meredith; Machiela, Mitchell J.; Kothiya, Prachi; Dean, Michael; Bodelon, Clara; Suman, Shalabh; Wang, Mingyi; Mirabello, Lisa; Nelson, Chase W.; Zhou, Weiyin; Palmer, Cameron; Ballew, Bari; Colli, Leandro M.; Freedman, Neal D.; Dagnall, Casey; Hutchinson, Amy; Vij, Vibha; Maruvka, Yosi; Hatch, Maureen; Illienko, Iryna; Belayev, Yuri; Nakamura, Nori; Chumak, Vadim; Bakhanova, Elena; Belyi, David; Kryuchkov, Victor; Golovanov, Ivan; Gudzenko, Natalia; Cahoon, Elizabeth K.; Albert, Paul; Drozdovitch, Vladimir; Little, Mark P.; Mabuchi, Kiyohiko; Stewart, Chip; Getz, Gad; Bazyka, Dimitry; de Gonzalez, Amy Berrington; Chanock, Stephen J.			Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident	SCIENCE			English	Article							DE-NOVO MUTATIONS; CLEANUP WORKERS; MATERNAL AGE; GERMLINE; CHILDREN; RATES; NUCLEOTIDE; PATTERNS; DAMAGE; LOCI	Effects of radiation exposure from the Chernobyl nuclear accident remain a topic of interest. We investigated germline de novo mutations (DNMs) in children born to parents employed as cleanup workers or exposed to occupational and environmental ionizing radiation after the accident. Whole-genome sequencing of 130 children (born 1987-2002) and their parents did not reveal an increase in the rates, distributions, or types of DNMs relative to the results of previous studies. We find no elevation in total DNMs, regardless of cumulative preconception gonadal paternal [mean = 365 milligrays (mGy), range = 0 to 4080 mGy] or maternal (mean = 19 mGy, range = 0 to 550 mGy) exposure to ionizing radiation. Thus, we conclude that, over this exposure range, evidence is lacking for a substantial effect on germline DNMs in humans, suggesting minimal impact from transgenerational genetic effects.	[Yeager, Meredith; Machiela, Mitchell J.; Kothiya, Prachi; Dean, Michael; Bodelon, Clara; Suman, Shalabh; Wang, Mingyi; Mirabello, Lisa; Zhou, Weiyin; Palmer, Cameron; Ballew, Bari; Colli, Leandro M.; Freedman, Neal D.; Dagnall, Casey; Hutchinson, Amy; Vij, Vibha; Hatch, Maureen; Cahoon, Elizabeth K.; Albert, Paul; Drozdovitch, Vladimir; Little, Mark P.; Mabuchi, Kiyohiko; de Gonzalez, Amy Berrington; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA; [Yeager, Meredith; Dean, Michael; Suman, Shalabh; Wang, Mingyi; Zhou, Weiyin; Palmer, Cameron; Ballew, Bari; Dagnall, Casey; Hutchinson, Amy] Frederick Natl Lab Canc Res, Canc Genom Res Lab, Frederick, MD 21701 USA; [Kothiya, Prachi] SymbioSeg LLC, Arlington, VA 20148 USA; [Nelson, Chase W.] Acad Sinica, Biodivers Res Ctr, Taipei 11529, Taiwan; [Nelson, Chase W.] Amer Museum Nat Hist, Inst Comparat Genom, New York, NY 10024 USA; [Colli, Leandro M.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Med Imaging Hematol & Oncol, BR-14049900 Ribeirao Preto, SP, Brazil; [Maruvka, Yosi; Stewart, Chip; Getz, Gad] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Maruvka, Yosi; Getz, Gad] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Illienko, Iryna; Belayev, Yuri; Chumak, Vadim; Bakhanova, Elena; Belyi, David; Gudzenko, Natalia; Bazyka, Dimitry] Natl Res Ctr Radiat Med, 53 Yu Illienka St, UA-04050 Kiev, Ukraine; [Nakamura, Nori] Radiat Effects Res Fdn, Dept Mol Biosci, Minami Ku, 5-2 Hijiyama Pk, Hiroshima 7320815, Japan; [Kryuchkov, Victor; Golovanov, Ivan] Bumasyan Fed Med & Biophys Ctr, 46 Zhivopisnaya St, Moscow 123182, Russia; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Harvard Med Sch, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Academia Sinica - Taiwan; American Museum of Natural History (AMNH); Universidade de Sao Paulo; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; National Academy of Medical Sciences of Ukraine; National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine; Radiation Effects Research Foundation - Japan; Burnazyan Federal Medical Biophysical Center; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Yeager, M; Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD 20892 USA.; Yeager, M (corresponding author), Frederick Natl Lab Canc Res, Canc Genom Res Lab, Frederick, MD 21701 USA.	yeagerm@mail.nih.gov; chanocks@mail.nih.gov	Colli, Leandro/A-3445-2009; Freedman, Neal David/B-9741-2015; Chumak, Vadim/N-6960-2015; Dean, Michael C/G-8172-2012; Machiela, Mitchell J/H-7335-2019; Berrington, Amy/L-7017-2017	Colli, Leandro/0000-0001-6928-1195; Freedman, Neal David/0000-0003-0074-1098; Chumak, Vadim/0000-0001-6045-9356; Dean, Michael C/0000-0003-2234-0631; Machiela, Mitchell J/0000-0001-6538-9705; Berrington, Amy/0000-0002-7332-8387; Suman, Shalabh/0000-0002-9144-1527; Drozdovitch, Vladimir/0000-0002-7952-379X; Gudzenko, Nataliya/0000-0003-2987-2382; Kothiyal, Prachi/0000-0002-5457-3029; Yeager, Meredith/0000-0003-3871-2225; Wang, Mingyi/0000-0001-9419-4384; Nelson, Chase/0000-0001-6287-1598	Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute; Gerstner Scholars Fellowship from the Gerstner Family Foundation at the American Museum of Natural History; Academia Sinica; National Cancer Institute, NIH [75N910D00024]; Japanese Ministry of Health, Labor and Welfare (MHLW); US Department of Energy (DOE)	Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute; Gerstner Scholars Fellowship from the Gerstner Family Foundation at the American Museum of Natural History; Academia Sinica(Academia Sinica - Taiwan); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japanese Ministry of Health, Labor and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); US Department of Energy (DOE)(United States Department of Energy (DOE))	This research was supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute. C.W.N. was supported by a Gerstner Scholars Fellowship from the Gerstner Family Foundation at the American Museum of Natural History and a postdoctoral research fellowship from Academia Sinica. This project has been funded in whole or in part with Federal funds from the National Cancer Institute, NIH, under contract no. 75N910D00024. The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, is a public interest foundation funded by the Japanese Ministry of Health, Labor and Welfare (MHLW) and the US Department of Energy (DOE). The opinions expressed by the authors are their own, and this material should not be interpreted as representing the official viewpoint of the National Cancer Institute of the US Department of Health and Human Services; US Department of Energy; or Japanese Ministry of Health, Labor and Welfare.	Adewoye AB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7684; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Costa EOA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23813-5; [Anonymous], 2020, LANCET, V395, P1012, DOI 10.1016/S0140-6736(20)30687-5; Bazyka D, 2020, AM J EPIDEMIOL, V189, P1451, DOI 10.1093/aje/kwaa095; Boice JD, 2020, HEALTH PHYS, V119, P494, DOI 10.1097/HP.0000000000001170; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cann HM, 2002, SCIENCE, V296, P261; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chumak V, 2021, J RADIOL PROT, V41, P764, DOI 10.1088/1361-6498/abf0f4; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Drake JW, 1998, GENETICS, V148, P1667; Dubrova YE, 1996, NATURE, V380, P683, DOI 10.1038/380683a0; Dubrova YE, 2002, AM J HUM GENET, V71, P801, DOI 10.1086/342729; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fucic A, 2008, MUTAT RES-REV MUTAT, V658, P111, DOI 10.1016/j.mrrev.2007.11.003; Gao ZY, 2019, P NATL ACAD SCI USA, V116, P9491, DOI 10.1073/pnas.1901259116; Goldmann JM, 2018, NAT GENET, V50, P487, DOI 10.1038/s41588-018-0071-6; Horai M, 2018, J HUM GENET, V63, P357, DOI 10.1038/s10038-017-0392-9; Jonsson H, 2017, NATURE, V549, P519, DOI 10.1038/nature24018; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kiuru A, 2003, RADIAT RES, V159, P651, DOI 10.1667/0033-7587(2003)159[0651:HMMATO]2.0.CO;2; Kodaira M, 2010, RADIAT RES, V173, P205, DOI 10.1667/RR1991.1; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kryuchkov V, 2009, HEALTH PHYS, V97, P275, DOI 10.1097/HP.0b013e3181ac9306; Little MP, 2013, MUTAT RES-REV MUTAT, V753, P50, DOI 10.1016/j.mrrev.2013.04.001; Livshits LA, 2001, RADIAT RES, V155, P74, DOI 10.1667/0033-7587(2001)155[0074:COCCWD]2.0.CO;2; Maruvka YE, 2017, NAT BIOTECHNOL, V35, P951, DOI 10.1038/nbt.3966; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Morton L, 2021, SCIENCE, V372; Morton LM, 2021, SCIENCE, V372, P705, DOI 10.1126/science.abg2538; Muller HJ, 1928, P NATL ACAD SCI USA, V14, P714, DOI 10.1073/pnas.14.9.714; Nachman MW, 2000, GENETICS, V156, P297; Nakamura N, 2013, ANNU REV GENET, V47, P33, DOI 10.1146/annurev-genet-111212-133501; National Research Council, 2006, US COMM HLTH EFF EXP; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; RUSSELL WL, 1977, P NATL ACAD SCI USA, V74, P3523, DOI 10.1073/pnas.74.8.3523; Slebos RJC, 2004, MUTAT RES-GEN TOX EN, V559, P143, DOI 10.1016/j.mrgentox.2004.01.003; Smith TCA, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007254; Tam V, 2019, NAT REV GENET, V20, P467, DOI 10.1038/s41576-019-0127-1; The Lancet, 2020, Lancet, V395, P537, DOI 10.1016/S0140-6736(20)30379-2; Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2; Weinberg HS, 2001, P ROY SOC B-BIOL SCI, V268, P1001, DOI 10.1098/rspb.2001.1650; Wong WSW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10486; Zhou WY, 2016, NAT GENET, V48, P563, DOI 10.1038/ng.3545	49	27	28	7	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					725	+		10.1126/science.abg2365	http://dx.doi.org/10.1126/science.abg2365			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33888597	Green Accepted, Bronze			2022-12-28	WOS:000651125300047
J	de Goede, OM; Nachun, DC; Ferraro, NM; Gloudemans, MJ; Rao, AS; Smail, C; Eulalio, TY; Aguet, F; Ng, B; Xu, JS; Barbeira, AN; Castel, SE; Kim-Hellmuth, S; Park, Y; Scott, AJ; Strober, BJ; Brown, CD; Wen, XQ; Hall, IM; Battle, A; Lappalainen, T; Im, HK; Ardlie, KG; Mostafavi, S; Quertermous, T; Kirkegaard, K; Montgomery, SB				de Goede, Olivia M.; Nachun, Daniel C.; Ferraro, Nicole M.; Gloudemans, Michael J.; Rao, Abhiram S.; Smail, Craig; Eulalio, Tiffany Y.; Aguet, Francois; Ng, Bernard; Xu, Jishu; Barbeira, Alvaro N.; Castel, Stephane E.; Kim-Hellmuth, Sarah; Park, YoSon; Scott, Alexandra J.; Strober, Benjamin J.; Brown, Christopher D.; Wen, Xiaoquan; Hall, Ira M.; Battle, Alexis; Lappalainen, Tuuli; Im, Hae Kyung; Ardlie, Kristin G.; Mostafavi, Sara; Quertermous, Thomas; Kirkegaard, Karla; Montgomery, Stephen B.		GTEx Consortium	Population-scale tissue transcriptomics maps long non-coding RNAs to complex disease	CELL			English	Article							EXPRESSION ANALYSIS; GENE; MECHANISMS; TOOL; ANNOTATION; LANDSCAPE; PACKAGE; STATES; MICE; GWAS	Long non-coding RNA (lncRNA) genes have well-established and important impacts on molecular and cellular functions. However, among the thousands of lncRNA genes, it is still a major challenge to identify the subset with disease or trait relevance. To systematically characterize these lncRNA genes, we used Genotype Tissue Expression (GTEx) project v8 genetic and multi-tissue transcriptomic data to profile the expression, genetic regulation, cellular contexts, and trait associations of 14,100 lncRNA genes across 49 tissues for 101 distinct complex genetic traits. Using these approaches, we identified 1,432 lncRNA gene-trait associations, 800 of which were not explained by stronger effects of neighboring protein-coding genes. This included associations between lncRNA quantitative trait loci and inflammatory bowel disease, type 1 and type 2 diabetes, and coronary artery disease, as well as rare variant associations to body mass index.	[de Goede, Olivia M.; Kirkegaard, Karla; Montgomery, Stephen B.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Nachun, Daniel C.; Montgomery, Stephen B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Ferraro, Nicole M.; Gloudemans, Michael J.; Smail, Craig; Eulalio, Tiffany Y.] Stanford Univ, Biomed Informat Training Program, Stanford, CA 94305 USA; [Rao, Abhiram S.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Smail, Craig] Childrens Mercy Res Inst, Genom Med Ctr, Kansas City, MO 64108 USA; [Aguet, Francois; Ardlie, Kristin G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ng, Bernard] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1Z4, Canada; [Ng, Bernard] Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Xu, Jishu] Rush Univ, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Barbeira, Alvaro N.; Im, Hae Kyung] Univ Chicago, Dept Med, Sect Genet Med, Chicago, IL 60637 USA; [Castel, Stephane E.; Kim-Hellmuth, Sarah; Lappalainen, Tuuli] New York Genome Ctr, New York, NY 10013 USA; [Castel, Stephane E.; Kim-Hellmuth, Sarah; Lappalainen, Tuuli] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Kim-Hellmuth, Sarah] Univ Hosp LMU Munich, Dr von Hauner Childrens Hosp, Dept Pediat, D-80337 Munich, Germany; [Park, YoSon] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Scott, Alexandra J.] Washington Univ, McDonnell Genome Inst, Sch Med, St Louis, MO 63108 USA; [Strober, Benjamin J.; Battle, Alexis] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Brown, Christopher D.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Wen, Xiaoquan] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Hall, Ira M.] Yale Univ, Dept Genet, Sch Med, New Haven, CT 06510 USA; [Battle, Alexis] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Mostafavi, Sara] Univ Washington, Paul G Allen Sch Comp Sci & Engn, Seattle, WA 98195 USA; [Quertermous, Thomas] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Quertermous, Thomas] Stanford Univ, Cardiovasc Inst, Stanford, CA 94305 USA; [Kirkegaard, Karla] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of British Columbia; Rush University; University of Chicago; Columbia University; University of Munich; University of Pennsylvania; Pennsylvania Medicine; Washington University (WUSTL); Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; Yale University; Johns Hopkins University; University of Washington; University of Washington Seattle; Stanford University; Stanford University; Stanford University	de Goede, OM; Montgomery, SB (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Montgomery, SB (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	odegoed@stanford.edu; smontgom@stanford.edu	Garrido-Martín, Diego/M-6770-2015	Garrido-Martín, Diego/0000-0002-4131-4458; Ng, Bernard/0000-0002-8688-3873; Trevanion, Stephen/0000-0002-4862-3333; Scott, Alexandra/0000-0002-1930-9265; Quertermous, Thomas/0000-0002-7645-9067; Snyder, Michael/0000-0003-0784-7987; Akey, Joshua/0000-0002-4411-1330; Eulalio, Tiffany/0000-0002-7084-9646; Kim-Hellmuth, Sarah/0000-0001-8791-5729	Common Fund of the Office of the Director of the National Institutes of Health (NIH); National Cancer Institute; National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Drug Abuse (NIDA); National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; Stanford graduate fellowship; Bio-X Stanford interdisciplinary graduate fellowship; National Science Foundation graduate research fellowship; NHLBI [R01HL135313-01, HHSN268201000029C]; National Library of Medicine (NLM) training grant [5T15LM007033-36]; NHGRI [5U41HG009494]; NIH [R01GM122924, 1K99HG009916-01, R01HG010067, R01MH109905, R01MH101822, R01MH106842, R01HL142028, UM1HG008901, R01GM124486, R01MH107666, P30DK020595, R01HL109512, R01HL134817, R33HL120757, R01HL139478, R01MH101814, R01HG008150, R01AG066490]; Marie-Sklodowska Curie fellowship H2020 grant [706636]; Mr. and Mrs. Spencer T. Olin fellowship for women in graduate study; Searle Scholar Program; Chan Zuckerberg Foundation-Human Cell Atlas Initiative; Stanford University School of Medicine; The NIH [R01HL142015, U01HG009431, U01HG009080]	Common Fund of the Office of the Director of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Stanford graduate fellowship(Stanford University); Bio-X Stanford interdisciplinary graduate fellowship; National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Library of Medicine (NLM) training grant; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie-Sklodowska Curie fellowship H2020 grant; Mr. and Mrs. Spencer T. Olin fellowship for women in graduate study; Searle Scholar Program; Chan Zuckerberg Foundation-Human Cell Atlas Initiative; Stanford University School of Medicine; The NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Montgomery and Kirkegaard labs for their feedback on this work. The GTEx project was supported by the Common Fund of the Office of the Director of the National Institutes of Health (NIH) and by the National Cancer Institute, the National Human Genome Research Institute (NHGRI), the National Heart, Lung, and Blood Institute (NHLBI), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke. We are thankful for support from a Stanford graduate fellowship and Bio-X Stanford interdisciplinary graduate fellowship (to O.M.d.G.); a National Science Foundation graduate research fellowship (to N.M.F.); NHLBI grant R01HL135313-01 (to A.S.R.); National Library of Medicine (NLM) training grant 5T15LM007033-36 (to T.Y.E.); NHLBI grant HHSN268201000029C and NHGRI grant 5U41HG009494 (to F.A. and K.G.A.); NIH grants R01GM122924 (to S.E.C. and T.L.) and 1K99HG009916-01 (to S.E.C.); Marie-Sk1odowska Curie fellowship H2020 grant 706636 (to S.K.-H.); NIH grant R01HG010067 (to Y.P.); a Mr. and Mrs. Spencer T. Olin fellowship for women in graduate study (to A.J.S.); NIH grant R01MH109905 (to A.B.); the Searle Scholar Program (to A.B.); NIH grant R01MH101822 (to C.D.B.); NIH grants R01MH106842, R01HL142028, UM1HG008901, and R01GM124486 (to T.L.); NIH grants R01MH107666 and P30DK020595 (H.K.I.); NIH grants R01HL109512, R01HL134817, R33HL120757, and R01HL139478 (to T.Q.); the Chan Zuckerberg Foundation-Human Cell Atlas Initiative (to T.Q.); Stanford University School of Medicine (to K.K.); and NIH grants R01MH101814 (NIH Common Fund; GTEx Program) (to A.B. and S.B.M.), R01HG008150 (NHGRI; Non-Coding Variants Program) (to A.B. and S.B.M.), and R01AG066490, R01HL142015, U01HG009431, and U01HG009080 (to S.B.M.).	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Allou L, 2021, NATURE, V592, P93, DOI 10.1038/s41586-021-03208-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbeira AN, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-020-02252-4; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Bomba L, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1212-4; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Castel SE, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02122-z; Castel SE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12817; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen HIH, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S14; Chiang C, 2017, NAT GENET, V49, P692, DOI 10.1038/ng.3834; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dougherty JD, 2010, NUCLEIC ACIDS RES, V38, P4218, DOI 10.1093/nar/gkq130; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Ferraro NM, 2020, SCIENCE, V369, P1334, DOI 10.1126/science.aaz5900; Gardner EJ, 2017, GENOME RES, V27, P1916, DOI 10.1101/gr.218032.116; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Han XP, 2018, CELL, V173, P1307, DOI 10.1016/j.cell.2018.05.012; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Heward JA, 2014, TRENDS IMMUNOL, V35, P408, DOI 10.1016/j.it.2014.07.005; Hon CC, 2017, NATURE, V543, P199, DOI 10.1038/nature21374; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jiang S, 2019, NUCLEIC ACIDS RES, V47, P7842, DOI 10.1093/nar/gkz621; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kerimov N., 2021, EQTL CATALOGUE COMPE, DOI [10.1101/2020.01.29.924266, DOI 10.1101/2020.01.29.924266]; Kornienko AE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0873-8; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lepik K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005766; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Li YI, 2018, NAT GENET, V50, P151, DOI 10.1038/s41588-017-0004-9; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Liu Y, 2018, NAT BIOTECHNOL, V36, P1203, DOI 10.1038/nbt.4283; Lu XC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03924; Mattioli K, 2019, GENOME RES, V29, P344, DOI 10.1101/gr.242222.118; Mele M, 2017, GENOME RES, V27, P27, DOI 10.1101/gr.214205.116; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mohammadi P, 2017, GENOME RES, V27, P1872, DOI 10.1101/gr.216747.116; Muhvic-Urek M, 2016, WORLD J GASTROENTERO, V22, P5655, DOI 10.3748/wjg.v22.i25.5655; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Ng B, 2017, NAT NEUROSCI, V20, P1418, DOI 10.1038/nn.4632; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Pabst O, 1999, DEVELOPMENT, V126, P2215; Pabst O, 2000, EMBO J, V19, P2015, DOI 10.1093/emboj/19.9.2015; Panousis NI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0467-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Roberts TC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0507; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robles EF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11889; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Storey J.D., 2020, QVALUE Q VALUE ESTIM; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Sultan M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-675; Tarlinton D, 2003, J IMMUNOL, V170, P4002, DOI 10.4049/jimmunol.170.8.4002; Urbut SM, 2019, NAT GENET, V51, P187, DOI 10.1038/s41588-018-0268-8; van de Geijn B, 2015, NAT METHODS, V12, P1061, DOI [10.1038/NMETH.3582, 10.1038/nmeth.3582]; van Dijk M, 2015, HUM MOL GENET, V24, P5475, DOI 10.1093/hmg/ddv274; Vojkovics D, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918757480; Vosa U., 2018, UNRAVELING POLYGENIC, DOI [10.1101/447367, DOI 10.1101/447367]; Walavalkar K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17325-y; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Wright CF, 2018, NAT REV GENET, V19, P253, DOI 10.1038/nrg.2017.116; Xia B, 2020, CELL, V180, P248, DOI 10.1016/j.cell.2019.12.015; Xu XX, 2014, J NEUROSCI, V34, P1420, DOI 10.1523/JNEUROSCI.4488-13.2014; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042; Yang L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r16; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Zerbino DR, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0621-5; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	97	28	28	4	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2633	+	e19	10.1016/j.cell.2021.03.050	http://dx.doi.org/10.1016/j.cell.2021.03.050		MAY 2021	35	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33864768	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000652830800010
J	Corcoran, TB; Myles, PS; Forbes, AB; Cheng, AC; Bach, LA; O'Loughlin, E; Leslie, K; Chan, MTV; Story, D; Short, TG; Martin, C; Coutts, P; Ho, KM				Corcoran, Tomas B.; Myles, Paul S.; Forbes, Andrew B.; Cheng, Allen C.; Bach, Leon A.; O'Loughlin, Edmond; Leslie, Kate; Chan, Matthew T., V; Story, David; Short, Timothy G.; Martin, Catherine; Coutts, Pauline; Ho, Kwok M.		PADDI Investigators; Australian New Zealand Coll Anaest; Australasian Soc Infect Dis Clinic	Dexamethasone and Surgical-Site Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Dexamethasone and Surgical-Site Infection In this trial involving patients undergoing noncardiac surgery, dexamethasone was noninferior to placebo with respect to the incidence of surgical-site infection within 30 days after surgery, including in patients with diabetes mellitus. Background The glucocorticoid dexamethasone prevents nausea and vomiting after surgery, but there is concern that it may increase the risk of surgical-site infection. Methods In this pragmatic, international, noninferiority trial, we randomly assigned 8880 adult patients who were undergoing nonurgent, noncardiac surgery of at least 2 hours' duration, with a skin incision length longer than 5 cm and a postoperative overnight hospital stay, to receive 8 mg of intravenous dexamethasone or matching placebo while under anesthesia. Randomization was stratified according to diabetes status and trial center. The primary outcome was surgical-site infection within 30 days after surgery. The prespecified noninferiority margin was 2.0 percentage points. Results A total of 8725 participants were included in the modified intention-to-treat population (4372 in the dexamethasone group and 4353 in the placebo group), of whom 13.2% (576 in the dexamethasone group and 572 in the placebo group) had diabetes mellitus. Of the 8678 patients included in the primary analysis, surgical-site infection occurred in 8.1% (354 of 4350 patients) assigned to dexamethasone and in 9.1% (394 of 4328) assigned to placebo (risk difference adjusted for diabetes status, -0.9 percentage points; 95.6% confidence interval [CI], -2.1 to 0.3; P<0.001 for noninferiority). The results for superficial, deep, and organ-space surgical-site infections and in patients with diabetes were similar to those of the primary analysis. Postoperative nausea and vomiting in the first 24 hours after surgery occurred in 42.2% of patients in the dexamethasone group and in 53.9% in the placebo group (risk ratio, 0.78; 95% CI, 0.75 to 0.82). Hyperglycemic events in patients without diabetes occurred in 22 of 3787 (0.6%) in the dexamethasone group and in 6 of 3776 (0.2%) in the placebo group. Conclusions Dexamethasone was noninferior to placebo with respect to the incidence of surgical-site infection within 30 days after nonurgent, noncardiac surgery. (Funded by the Australian National Health and Medical Research Council and others; PADDI Australian New Zealand Clinical Trials Registry number, .)	[Corcoran, Tomas B.; Coutts, Pauline; Ho, Kwok M.] Royal Perth Hosp, Perth, WA, Australia; [Corcoran, Tomas B.; O'Loughlin, Edmond; Ho, Kwok M.] Univ Western Australia, Nedlands, WA, Australia; [Ho, Kwok M.] Murdoch Univ, Murdoch, WA, Australia; [O'Loughlin, Edmond] Fiona Stanley Hosp, Perth, WA, Australia; [Myles, Paul S.; Cheng, Allen C.; Bach, Leon A.] Alfred Hosp, Melbourne, Vic, Australia; [Corcoran, Tomas B.; Myles, Paul S.; Forbes, Andrew B.; Cheng, Allen C.; Bach, Leon A.; Leslie, Kate; Martin, Catherine] Monash Univ, Clayton, Vic, Australia; [Leslie, Kate; Story, David] Univ Melbourne, Melbourne, Vic, Australia; [Leslie, Kate] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Chan, Matthew T., V] Chinese Univ Hong Kong, Hong Kong, Peoples R China; [Short, Timothy G.] Auckland City Hosp, Auckland, New Zealand; [Short, Timothy G.] Univ Auckland, Auckland, New Zealand	Royal Perth Hospital; University of Western Australia; University of Western Australia; Murdoch University; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; Royal Melbourne Hospital; Chinese University of Hong Kong; Auckland City Hospital; University of Auckland	Corcoran, TB (corresponding author), Royal Perth Hosp, Dept Anaesthesia & Pain Med, Wellington St, Perth, WA 6000, Australia.	tomas.corcoran@health.wa.gov.au	Chan, Matthew/J-2884-2013; Kennedy, Ross/AAK-1607-2021; Highton, David/K-9544-2017	Chan, Matthew/0000-0002-3574-7855; Highton, David/0000-0002-4608-4081; Corcoran, Tomas/0000-0002-5074-3334; Venkatesh, Bala/0000-0002-3234-5244				Abdelmalak BB, 2013, BRIT J ANAESTH, V111, P209, DOI 10.1093/bja/aet050; Abdelmalak B, 2010, CAN J ANESTH, V57, P1058, DOI 10.1007/s12630-010-9391-4; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; Bain CR, 2018, ANAESTHESIA, V73, P955, DOI 10.1111/anae.14306; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; Busti AJ, 2005, PHARMACOTHERAPY, V25, P1566, DOI 10.1592/phco.2005.25.11.1566; Corcoran TB, 2015, ANAESTH INTENS CARE, V43, P167, DOI 10.1177/0310057X1504300205; Corcoran TB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030402; de Oliveira GS, 2015, REGION ANESTH PAIN M, V40, P539, DOI 10.1097/AAP.0000000000000301; De Oliveira GS, 2013, ANESTH ANALG, V116, P58, DOI 10.1213/ANE.0b013e31826f0a0a; Dhatariya K, 2013, BRIT J ANAESTH, V110, P674, DOI 10.1093/bja/aet010; Dieleman JM, 2012, JAMA-J AM MED ASSOC, V308, P1761, DOI 10.1001/jama.2012.14144; FAUCI AS, 1976, ANN INTERN MED, V84, P304, DOI 10.7326/0003-4819-84-3-304; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Khan SA, 2013, ANESTH ANALG, V116, P966, DOI 10.1213/ANE.0b013e31828a73de; Kotagal M, 2015, ANN SURG, V261, P97, DOI 10.1097/SLA.0000000000000688; Kurz A, 2015, BRIT J ANAESTH, V115, P434, DOI 10.1093/bja/aev062; Myles PS, 2014, LANCET, V384, P1446, DOI 10.1016/S0140-6736(14)60893-X; Oray M, 2016, EXPERT OPIN DRUG SAF, V15, P457, DOI 10.1517/14740338.2016.1140743; Ravikumar R, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1455; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schweizer ML, 2014, JAMA SURG, V149, P575, DOI 10.1001/jamasurg.2013.4663; Stark PA, 2013, ANESTHESIOLOGY, V118, P1332, DOI 10.1097/ALN.0b013e318289b84b; Turan A, 2011, ANESTHESIOLOGY, V115, P457, DOI 10.1097/ALN.0b013e31822a2871	28	23	23	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1731	1741		10.1056/NEJMoa2028982	http://dx.doi.org/10.1056/NEJMoa2028982			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY1SU	33951362				2022-12-28	WOS:000647698500011
J	Syversen, SW; Goll, GL; Jorgensen, KK; Sandanger, O; Sexton, J; Olsen, IC; Gehin, JE; Warren, DJ; Brun, MK; Klaasen, RA; Karlsen, LN; Noraberg, G; Zettel, C; Ljosa, MKA; Haugen, AJ; Njalla, RJ; Bruun, TJ; Seeberg, KA; Michelsen, B; Strand, EK; Skorpe, S; Blomgren, IM; Bragnes, YH; Dotterud, CK; Thune, T; Ystrom, CM; Torp, R; Mielnik, P; Mork, C; Kvien, TK; Jahnsen, J; Bolstad, N; Haavardsholm, EA				Syversen, Silje Watterdal; Goll, Guro Lovik; Jorgensen, Kristin Kaasen; Sandanger, Oystein; Sexton, Joseph; Olsen, Inge Christoffer; Gehin, Johanna Elin; Warren, David John; Brun, Marthe Kirkesaether; Klaasen, Rolf Anton; Karlsen, Lars Normann; Noraberg, Geir; Zettel, Camilla; Ljosa, Maud Kristine Aga; Haugen, Anne Julsrud; Njalla, Rune Johan; Bruun, Trude Jannecke; Seeberg, Kathrine Aglen; Michelsen, Brigitte; Strand, Eldri Kveine; Skorpe, Svanaug; Blomgren, Ingrid Marianne; Bragnes, Yngvill Hovde; Dotterud, Christian Kvikne; Thune, Turid; Ystrom, Carl Magnus; Torp, Roald; Mielnik, Pawel; Mork, Cato; Kvien, Tore K.; Jahnsen, Jorgen; Bolstad, Nils; Haavardsholm, Espen A.			Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVITY SCORE ASDAS; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; PARALLEL-GROUP; DOUBLE-BLIND; EFFICACY; ASSOCIATION; MANAGEMENT; PSORIASIS; METHOTREXATE	Question Among patients with chronic immune-mediated inflammatory diseases initiating treatment with infliximab, does proactive therapeutic drug monitoring (TDM) improve clinical remission rates compared with standard therapy? Findings In this randomized clinical trial that included 411 patients, the proportion of patients who experienced disease remission after 30 weeks was 50.5% in the TDM group and 53.0% in the standard therapy group, a difference that was not statistically significant. Meaning These findings do not support routine use of proactive TDM during infliximab induction for improving disease remission rates. This randomized trial assesses the effect of therapeutic drug monitoring vs standard therapy on clinical remission at 30 weeks among patients with immune-mediated inflammatory diseases (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn disease, or psoriasis) initiating infliximab therapy. Importance Proactive therapeutic drug monitoring (TDM), defined as individualized drug dosing based on scheduled monitoring of serum drug levels, has been proposed as an alternative to standard therapy to maximize efficacy and safety of infliximab and other biological drugs. However, whether proactive TDM improves clinical outcomes when implemented at the time of drug initiation, compared with standard therapy, remains unclear. Objective To assess whether TDM during initiation of infliximab therapy improves treatment efficacy compared with standard infliximab therapy without TDM. Design, Setting, and Participants Randomized, parallel-group, open-label clinical trial of 411 adults with rheumatoid arthritis, spondyloarthritis, psoriatic arthritis, ulcerative colitis, Crohn disease, or psoriasis initiating infliximab therapy in 21 hospitals in Norway. Patients were recruited from March 1, 2017, to January 10, 2019. Final follow-up occurred on November 5, 2019. Interventions Patients were randomized 1:1 to receive proactive TDM with dose and interval adjustments based on scheduled monitoring of serum drug levels and antidrug antibodies (TDM group; n = 207) or standard infliximab therapy without drug and antibody level monitoring (standard therapy group; n = 204). Main Outcomes and Measures The primary end point was clinical remission at week 30. Results Among 411 randomized patients (mean age, 44.7 [SD, 14.9] years; 209 women [51%]), 398 (198 in the TDM group and 200 in the standard therapy group) received their randomized intervention and were included in the full analysis set. Clinical remission at week 30 was achieved in 100 (50.5%) of 198 and 106 (53.0%) of 200 patients in the TDM and standard therapy groups, respectively (adjusted difference, 1.5%; 95% CI, -8.2% to 11.1%; P = .78). Adverse events were reported in 135 patients (68%) and 139 patients (70%) in the TDM and standard therapy groups, respectively. Conclusions and Relevance Among patients with immune-mediated inflammatory diseases initiating treatment with infliximab, proactive therapeutic drug monitoring, compared with standard therapy, did not significantly improve clinical remission rates over 30 weeks. These findings do not support routine use of therapeutic drug monitoring during infliximab induction for improving disease remission rates.	[Syversen, Silje Watterdal; Goll, Guro Lovik; Sexton, Joseph; Brun, Marthe Kirkesaether; Kvien, Tore K.; Haavardsholm, Espen A.] Diakonhjemmet Hosp, Div Rheumatol & Res, POB 23 Vinderen, N-0319 Oslo, Norway; [Jorgensen, Kristin Kaasen; Jahnsen, Jorgen] Akershus Univ Hosp, Dept Gastroenterol, Lorenskog, Norway; [Sandanger, Oystein] Oslo Univ Hosp, Sect Dermatol, Oslo, Norway; [Olsen, Inge Christoffer] Oslo Univ Hosp, Dept Res Support Clin Trials, Oslo, Norway; [Gehin, Johanna Elin; Warren, David John; Klaasen, Rolf Anton; Bolstad, Nils] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Gehin, Johanna Elin; Brun, Marthe Kirkesaether; Kvien, Tore K.; Jahnsen, Jorgen; Haavardsholm, Espen A.] Univ Oslo, Fac Med, Oslo, Norway; [Karlsen, Lars Normann] Stavanger Univ Hosp, Dept Gastroenterol, Stavanger, Norway; [Noraberg, Geir] Hosp Southern Norway Trust, Dept Gastroenterol, Arendal, Norway; [Zettel, Camilla] Betanien Hosp, Dept Rheumatol, Skien, Norway; [Ljosa, Maud Kristine Aga] Alesund Hosp, Dept Rheumatol, Alesund, Norway; [Haugen, Anne Julsrud] Ostfold Hosp Trust, Dept Rheumatol, Moss, Norway; [Njalla, Rune Johan] Nordland Hosp Trust, Dept Rheumatol, Bodo, Norway; [Bruun, Trude Jannecke] Univ Hosp North Norway, Dept Rheumatol, Tromso, Norway; [Seeberg, Kathrine Aglen] Vestfold Hosp Trust, Dept Gastroenterol, Tonsberg, Norway; [Michelsen, Brigitte] Hosp Southern Norway Trust, Dept Med, Div Rheumatol, Kristiansand, Norway; [Strand, Eldri Kveine] Lillehammer Hosp Rheumat Dis, Lillehammer, Norway; [Skorpe, Svanaug] Haugesund Hosp Rheumat Dis, Haugesund, Norway; [Blomgren, Ingrid Marianne] Fonna Hosp Trust, Dept Gastroenterol, Haugesund, Norway; [Bragnes, Yngvill Hovde] Vestre Viken Hosp Trust, Dept Rheumatol, Drammen, Norway; [Dotterud, Christian Kvikne] Trondheim Reg & Univ Hosp, Dept Dermatol, St Olavs Hosp, Trondheim, Norway; [Thune, Turid] Haukeland Hosp, Dept Dermatol, Bergen, Norway; [Ystrom, Carl Magnus] Innlandet Hosp Trust, Dept Med, Elverum, Norway; [Torp, Roald] Innlandet Hosp Trust, Dept Med, Hamar, Norway; [Mielnik, Pawel] Forde Hosp Trust, Dept Neurol Rheumatol & Phys Med, Forde, Norway; [Mork, Cato] Akershus Dermatol Ctr, Lorenskog, Norway	Diakonhjemmet Hospital; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; Stavanger University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; Innlandet Hospital Trust; Innlandet Hospital Trust	Syversen, SW (corresponding author), Diakonhjemmet Hosp, Div Rheumatol & Res, POB 23 Vinderen, N-0319 Oslo, Norway.	s.w.syversen@gmail.com	Jahnsen, Jorgen/GRO-3253-2022	Jahnsen, Jorgen/0000-0002-0419-2914; Brun, Marthe/0000-0001-5148-9684				Adedokun OJ, 2014, GASTROENTEROLOGY, V147, P1296, DOI 10.1053/j.gastro.2014.08.035; Berth-Jones J, 2006, BRIT J DERMATOL, V155, P707, DOI 10.1111/j.1365-2133.2006.07389.x; Casteele NV, 2017, GASTROENTEROLOGY, V153, P835, DOI 10.1053/j.gastro.2017.07.031; Casteele NV, 2015, GUT, V64, P1539, DOI 10.1136/gutjnl-2014-307883; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Clair EWS, 2002, ARTHRITIS RHEUM, V46, P1451, DOI 10.1002/art.10302; Cornillie F, 2014, GUT, V63, P1721, DOI 10.1136/gutjnl-2012-304094; D'Haens G, 2007, GASTROENTEROLOGY, V132, P763, DOI 10.1053/j.gastro.2006.12.038; D'Haens G, 2018, GASTROENTEROLOGY, V154, P1343, DOI 10.1053/j.gastro.2018.01.004; England BR, 2019, ARTHRIT CARE RES, V71, P1540, DOI 10.1002/acr.24042; Feuerstein JD, 2017, GASTROENTEROLOGY, V153, P827, DOI 10.1053/j.gastro.2017.07.032; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Grossberg LB, 2018, INFLAMM BOWEL DIS, V24, P191, DOI 10.1093/ibd/izx023; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; HARVEY RF, 1980, LANCET, V1, P514; Jorgensen KK, 2017, LANCET, V389, P2304, DOI 10.1016/S0140-6736(17)30068-5; Kennedy NA, 2019, LANCET GASTROENTEROL, V4, P341, DOI 10.1016/S2468-1253(19)30012-3; Kobayashi T, 2016, J GASTROENTEROL, V51, P241, DOI 10.1007/s00535-015-1102-z; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Lukas C, 2009, ANN RHEUM DIS, V68, P18, DOI 10.1136/ard.2008.094870; Ma Christopher, 2019, Curr Treat Options Gastroenterol, V17, P127, DOI 10.1007/s11938-019-00222-9; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Medina F, 2017, THER DRUG MONIT, V39, P364, DOI 10.1097/FTD.0000000000000421; Mrowietz U, 2011, ARCH DERMATOL RES, V303, P1, DOI 10.1007/s00403-010-1080-1; Nencini F, 2018, J ALLER CL IMM-PRACT, V6, P2065, DOI 10.1016/j.jaip.2018.04.007; Papamichael K, 2019, EXPERT REV CLIN IMMU, V15, P837, DOI 10.1080/1744666X.2019.1630273; Papamichael K, 2016, CLIN GASTROENTEROL H, V14, P543, DOI 10.1016/j.cgh.2015.11.014; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ricciuto A, 2018, J CROHNS COLITIS, V12, P1302, DOI 10.1093/ecco-jcc/jjy109; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Steenholdt C, 2014, AM J GASTROENTEROL, V109, P1055, DOI 10.1038/ajg.2014.106; Syversen SW, 2020, TRIALS, V21, DOI 10.1186/s13063-019-3734-4; Teresa Jurado, 2017, Open Rheumatol J, V11, P75, DOI 10.2174/1874312901711010075; Thomas SS, 2015, BIODRUGS, V29, P241, DOI 10.1007/s40259-015-0134-5; Vande Casteele N, 2015, GASTROENTEROLOGY, V148, P1320, DOI 10.1053/j.gastro.2015.02.031; Vermeire S, 2010, CLIN GASTROENTEROL H, V8, P357, DOI 10.1016/j.cgh.2010.01.001; Verstockt B, 2018, ALIMENT PHARM THER, V48, P731, DOI 10.1111/apt.14943; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yoo DH, 2013, ANN RHEUM DIS, V72, P1613, DOI 10.1136/annrheumdis-2012-203090	41	45	45	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1744	1754		10.1001/jama.2021.4172	http://dx.doi.org/10.1001/jama.2021.4172			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944876	Green Published, Bronze			2022-12-28	WOS:000647831200015
J	Varner, CE				Varner, Catherine E.			In adults, NSAID use vs. nonuse in the past 4 mo was not linked to increased risk for COVID-19-related mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Varner, Catherine E.] Mt Sinai Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Varner, CE (corresponding author), Mt Sinai Hosp, Toronto, ON, Canada.							Lund LC, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003308; Vaja R, 2021, BRIT J CLIN PHARMACO, V87, P776, DOI 10.1111/bcp.14514; Yousefifard M, 2020, INT J CLIN PRACT, V74, DOI 10.1111/ijcp.13557	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC58	JC58		10.7326/ACPJ202105180-058	http://dx.doi.org/10.7326/ACPJ202105180-058			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939487				2022-12-28	WOS:000652604800013
J	Dyer, O				Dyer, Owen			Covid-19: Heavy use of oxygen brings new danger to world's hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2021	373								n1117	10.1136/bmj.n1117	http://dx.doi.org/10.1136/bmj.n1117			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UG4QI	33926865	Bronze			2022-12-28	WOS:000689238700001
J	Koren, D; Sparger, KA; Shailam, R; Sadow, PM				Koren, Dorit; Sparger, Katherine A.; Shailam, Randheer; Sadow, Peter M.			Case 13-2021: A Newborn Girl with a Neck Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								A Newborn Girl with a Neck Mass A newborn girl was admitted to the neonatal ICU after a planned cesarean section because of a neck mass, which was discovered on ultrasonography at 34 weeks 6 days of gestation. After birth, the mass measured 3.7 cm by 3.8 cm by 3.1 cm and displaced the internal jugular vein and carotid artery. A diagnostic procedure was performed.	[Koren, Dorit; Sparger, Katherine A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Shailam, Randheer] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Sadow, Peter M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Koren, Dorit; Sparger, Katherine A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Shailam, Randheer] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Koren, D (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.; Koren, D (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.							Adelchi Croce, 2014, BMC Res Notes, V7, P790, DOI 10.1186/1756-0500-7-790; Angell TE, 2017, CURR OPIN ENDOCRINOL, V24, P372, DOI 10.1097/MED.0000000000000354; Bae JS, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/289834; Chester J, 2008, J PEDIATR ENDOCR MET, V21, P479; Chou J, 2013, SURG RADIOL ANAT, V35, P875, DOI 10.1007/s00276-013-1115-3; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; Eng L., 2020, NEOREVIEWS, V21, P30; Feingold SB., 2010, NEOREVIEWS, V11, P640; Forghani N., 2008, NEOREVIEWS, V9, P66; FREUNDL K, 1978, BIOL NEONATE, V33, P217; Guan HX, 2020, THYROID, V30, P536, DOI 10.1089/thy.2019.0116; Jang EK, 2014, THYROID, V24, P1275, DOI 10.1089/thy.2014.0053; Kitahara CM, 2019, JAMA INTERN MED, V179, P1034, DOI 10.1001/jamainternmed.2019.0981; Kohn B, 2009, THYROID, V19, P187, DOI 10.1089/thy.2008.0302; Kraemer S, 2009, J PEDIATR ENDOCR MET, V22, P269; Lee Jeong Woo, 2018, Arch Craniofac Surg, V19, P243, DOI 10.7181/acfs.2018.02383; Marti JL, 2015, THYROID, V25, P681, DOI 10.1089/thy.2015.0067; Minakova Elena, 2020, Neoreviews, V21, pe716, DOI 10.1542/neo.21-11-e716; MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002; Panaitescu AM, 2018, ACTA ENDOCRINOL-BUCH, V14, P85, DOI 10.4183/aeb.2018.85; Salmeen KE, 2020, MATERNAL-FETAL AND NEONATAL ENDOCRINOLOGY: PHYSIOLOGY, PATHOPHYSIOLOGY, AND CLINICAL MANAGEMENT, P53, DOI 10.1016/B978-0-12-814823-5.00004-0; Steward DL, 2019, JAMA ONCOL, V5, P204, DOI 10.1001/jamaoncol.2018.4616; Stoppa-Vaucher S, 2011, THYROID, V21, P13, DOI 10.1089/thy.2010.0205; van der Kaay DCM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1878	24	0	0	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1647	1655		10.1056/NEJMcpc2100277	http://dx.doi.org/10.1056/NEJMcpc2100277			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1ND	33913642				2022-12-28	WOS:000645605800016
J	Murthy, S; Fontela, P; Berry, S				Murthy, Srinivas; Fontela, Patricia; Berry, Scott			Incorporating Adult Evidence Into Pediatric Research and Practice Bayesian Designs to Expedite Obtaining Child-Specific Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Murthy, Srinivas] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Fontela, Patricia] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Berry, Scott] Berry Associates, Austin, TX USA	University of British Columbia; McGill University	Murthy, S (corresponding author), Univ British Columbia, BC Childrens Hosp, 4500 Oak St, Vancouver, BC V6H 3V4, Canada.	Srinivas.murthy@cw.bc.ca		Murthy, Srinivas/0000-0002-9476-839X				Broglio KR, 2015, CONTEMP CLIN TRIALS, V44, P56, DOI 10.1016/j.cct.2015.07.003; Food and Drug Administration, 2020, INT FDA COMPL INN TR; Huff RA, 2017, PEDIATR RES, V82, P814, DOI 10.1038/pr.2017.163; Hwang TJ, 2020, JAMA PEDIATR, V174, P825, DOI 10.1001/jamapediatrics.2020.1888; Janiaud P, 2015, J CLIN EPIDEMIOL, V68, P1221, DOI 10.1016/j.jclinepi.2015.06.021; McGlothlin AE, 2018, JAMA-J AM MED ASSOC, V320, P2365, DOI 10.1001/jama.2018.17977; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Viele K, 2014, PHARM STAT, V13, P41, DOI 10.1002/pst.1589; Weiss SL, 2020, PEDIATR CRIT CARE ME, V21, pE52, DOI [10.1007/s00134-019-05878-6, 10.1097/PCC.0000000000002198]	9	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1937	1938		10.1001/jama.2020.25007	http://dx.doi.org/10.1001/jama.2020.25007		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	33900369				2022-12-28	WOS:000645631800001
J	O'Dowd, A				O'Dowd, Adrian			Why I ... crochet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[O'Dowd, Adrian] No Og, London, England										0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1018	10.1136/bmj.n1018	http://dx.doi.org/10.1136/bmj.n1018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903124	Bronze			2022-12-28	WOS:000678538700001
J	Casella, JF; Barton, BA; Kanter, J; Black, LV; Majumdar, S; Inati, A; Wali, Y; Drachtman, RA; Abboud, MR; Kilinc, Y; Fuh, BR; Al-Khabori, MK; Takemoto, CM; Salman, E; Sarnaik, SA; Shah, N; Morris, CR; Keates-Baleeiro, J; Raj, A; Alvarez, OA; Hsu, LL; Thompson, AA; Sisler, IY; Pace, BS; Noronha, SA; Lasky, JL; de Julian, EC; Godder, K; Thornburg, CD; Kamberos, NL; Nuss, R; Marsh, AM; Owen, WC; Schaefer, A; Tebbi, CK; Chantrain, CF; Cohen, DE; Karakas, Z; Piccone, CM; George, A; Fixler, JM; Singleton, TC; Moulton, T; Quinn, CT; Lobo, CLD; Almomen, AM; Goyal-Khemka, M; Maes, P; Emanuele, M; Gorney, RT; Padgett, CS; Parsley, E; Kronsberg, SS; Kato, GJ; Gladwin, MT				Casella, James F.; Barton, Bruce A.; Kanter, Julie; Black, L. Vandy; Majumdar, Suvankar; Inati, Adlette; Wali, Yasser; Drachtman, Richard A.; Abboud, Miguel R.; Kilinc, Yurdanur; Fuh, Beng R.; Al-Khabori, Murtadha K.; Takemoto, Clifford M.; Salman, Emad; Sarnaik, Sharada A.; Shah, Nirmish; Morris, Claudia R.; Keates-Baleeiro, Jennifer; Raj, Ashok; Alvarez, Ofelia A.; Hsu, Lewis L.; Thompson, Alexis A.; Sisler, India Y.; Pace, Betty S.; Noronha, Suzie A.; Lasky, Joseph L., III; de Julian, Elena Cela; Godder, Kamar; Thornburg, Courtney Dawn; Kamberos, Natalie L.; Nuss, Rachelle; Marsh, Anne M.; Owen, William C.; Schaefer, Anne; Tebbi, Cameron K.; Chantrain, Christophe F.; Cohen, Debra E.; Karakas, Zeynep; Piccone, Connie M.; George, Alex; Fixler, Jason M.; Singleton, Tammuella C.; Moulton, Thomas; Quinn, Charles T.; de Castro Lobo, Clarisse Lopes; Almomen, Abdulkareem M.; Goyal-Khemka, Meenakshi; Maes, Philip; Emanuele, Marty; Gorney, Rebecca T.; Padgett, Claire S.; Parsley, Ed; Kronsberg, Shari S.; Kato, Gregory J.; Gladwin, Mark T.			Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PURIFIED POLOXAMER-188; RATING-SCALE; ISCHEMIA/REPERFUSION	Key PointsQuestionCan poloxamer 188, an agent that is reported to reduce blood viscosity and cell-cell interactions, effectively reduce the duration of vaso-occlusive episodes (painful crises) in hospitalized patients with sickle cell disease? FindingsIn this randomized clinical trial that included 388 children and adults with sickle cell disease, treatment with poloxamer 188 vs placebo resulted in mean time to last dose of parenteral opioids during vaso-occlusive episodes of 81.8 vs 77.8 hours, a difference that was not statistically significant. MeaningAmong patients with sickle cell disease, poloxamer 188 did not significantly shorten the duration of painful vaso-occlusive episodes. ImportanceAlthough effective agents are available to prevent painful vaso-occlusive episodes of sickle cell disease (SCD), there are no disease-modifying therapies for ongoing painful vaso-occlusive episodes; treatment remains supportive. A previous phase 3 trial of poloxamer 188 reported shortened duration of painful vaso-occlusive episodes in SCD, particularly in children and participants treated with hydroxyurea. ObjectiveTo reassess the efficacy of poloxamer 188 for vaso-occlusive episodes. Design, Setting, and ParticipantsPhase 3, randomized, double-blind, placebo-controlled, multicenter, international trial conducted from May 2013 to February 2016 that included 66 hospitals in 12 countries and 60 cities; 388 individuals with SCD (hemoglobin SS, SC, S-beta(0) thalassemia, or S-beta(+) thalassemia disease) aged 4 to 65 years with acute moderate to severe pain typical of painful vaso-occlusive episodes requiring hospitalization were included. InterventionsA 1-hour 100-mg/kg loading dose of poloxamer 188 intravenously followed by a 12-hour to 48-hour 30-mg/kg/h continuous infusion (n=194) or placebo (n=194). Main Outcomes and MeasuresTime in hours from randomization to the last dose of parenteral opioids among all participants and among those younger than 16 years as a separate subgroup. ResultsOf 437 participants assessed for eligibility, 388 were randomized (mean age, 15.2 years; 176 [45.4%] female), the primary outcome was available for 384 (99.0%), 15-day follow-up contacts were available for 357 (92.0%), and 30-day follow-up contacts were available for 368 (94.8%). There was no significant difference between the groups for the mean time to last dose of parenteral opioids (81.8 h for the poloxamer 188 group vs 77.8 h for the placebo group; difference, 4.0 h [95% CI, -7.8 to 15.7]; geometric mean ratio, 1.2 [95% CI, 1.0-1.5]; P=.09). Based on a significant interaction of age and treatment (P=.01), there was a treatment difference in time from randomization to last administration of parenteral opioids for participants younger than 16 years (88.7 h in the poloxamer 188 group vs 71.9 h in the placebo group; difference, 16.8 h [95% CI, 1.7-32.0]; geometric mean ratio, 1.4 [95% CI, 1.1-1.8]; P=.008). Adverse events that were more common in the poloxamer 188 group than the placebo group included hyperbilirubinemia (12.7% vs 5.2%); those more common in the placebo group included hypoxia (12.0% vs 5.3%). Conclusions and RelevanceAmong children and adults with SCD, poloxamer 188 did not significantly shorten time to last dose of parenteral opioids during vaso-occlusive episodes. These findings do not support the use of poloxamer 188 for vaso-occlusive episodes. Trial RegistrationClinicalTrials.gov Identifier: NCT01737814 This phase 3 trial examines the effectiveness of poloxamer 188 in reducing the duration of painful vaso-occlusive episodes in children and adults with sickle cell disease compared with placebo.	[Casella, James F.; Takemoto, Clifford M.; Gorney, Rebecca T.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Barton, Bruce A.; Kronsberg, Shari S.] Univ Massachusetts, Sch Med, Worcester, MA 01605 USA; [Kanter, Julie] Univ South Carolina, Charleston, SC USA; [Kanter, Julie] Univ Alabama Birmingham, Birmingham, AL USA; [Black, L. Vandy] Lake Reg Med Ctr, Our Lady, Baton Rouge, LA USA; [Black, L. Vandy] Univ Florida, Coll Med, Gainesville, FL USA; [Majumdar, Suvankar] Univ Mississippi, Med Ctr, University, MS 38677 USA; [Majumdar, Suvankar] Natl Childrens Hosp, Washington, DC USA; [Inati, Adlette] Lebanese Amer Univ, Byblos & Beirut, Lebanon, NH USA; [Inati, Adlette] Nini Hosp, Tripoli, Lebanon; [Wali, Yasser; Al-Khabori, Murtadha K.] Sultan Qaboos Univ, Muscat, Oman; [Drachtman, Richard A.] Rutgers State Univ, New Brunswick, NJ USA; [Abboud, Miguel R.] Amer Univ Beirut, Med Ctr, Beirut, Lebanon; [Kilinc, Yurdanur] Cukurova Univ, Fac Med, Balcali Hosp, Adana, Turkey; [Fuh, Beng R.] East Carolina Univ, Greenville, NC 27858 USA; [Takemoto, Clifford M.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Salman, Emad] Golisano Childrens Hosp Southwest Florida, Ft Myers, FL USA; [Sarnaik, Sharada A.] Wayne State Univ, Sch Med, Detroit, MI USA; [Sarnaik, Sharada A.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Shah, Nirmish] Duke Univ, Sch Med, Durham, NC USA; [Morris, Claudia R.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Morris, Claudia R.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Keates-Baleeiro, Jennifer] Univ Tennessee, Thompson Childrens Hosp Erlanger, Chattanooga, TN USA; [Raj, Ashok] Univ Louisville, Norton Childrens Hosp, Louisville, KY USA; [Alvarez, Ofelia A.] Univ Miami, Miami, FL USA; [Hsu, Lewis L.] Univ Illinois, Chicago, IL USA; [Thompson, Alexis A.] Northwestern Univ, Ann & Robert H Lurie Childrens Hosp Chicago, Feinberg Sch Med, Evanston, IL USA; [Sisler, India Y.] Virginia Commonwealth Univ, Childrens Hosp Richmond, Richmond, KY USA; [Pace, Betty S.] Augusta Univ, Augusta, GA USA; [Noronha, Suzie A.] Univ Rochester, Sch Med & Dent, Golisano Childrens Hosp, Rochester, NY USA; [Lasky, Joseph L., III] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Lasky, Joseph L., III] Cure 4 Kids Fdn, Las Vegas, NV USA; [de Julian, Elena Cela] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Godder, Kamar] Nicklaus Childrens Hosp, Miami, FL USA; [Thornburg, Courtney Dawn] Rady Childrens Hosp San Diego, San Diego, CA USA; [Thornburg, Courtney Dawn] UC San Diego Sch Med, La Jolla, CA USA; [Kamberos, Natalie L.] Univ Iowa Childrens Hosp, Iowa City, IA USA; [Kamberos, Natalie L.] Loyola Univ Med Ctr, Maywood, IL 60153 USA; [Nuss, Rachelle] Univ Colorado, Childrens Hosp Colorado, Aurora, CO USA; [Marsh, Anne M.] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA; [Marsh, Anne M.] Univ Wisconsin Madison, Madison, NJ USA; [Owen, William C.] Childrens Hosp, Kings Daughters, Norfolk, VA USA; [Schaefer, Anne] Joe DiMaggio Childrens Hosp, Hollywood, FL USA; [Tebbi, Cameron K.] Tampa Gen Hosp, Tampa, FL 33606 USA; [Chantrain, Christophe F.] Clin MontLegia, CHC, Liege, Belgium; [Cohen, Debra E.] UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Cohen, Debra E.] Univ Florida, Studer Family Childrens Hosp Ascens Sacred Heart, Pensacola, FL USA; [Karakas, Zeynep] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Piccone, Connie M.] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Piccone, Connie M.] Carle Fdn Hosp, Urbana, IL USA; [George, Alex] Baylor Coll Med, Houston, TX 77030 USA; [George, Alex] Wake Forest Sch Med, Winston Salem, NC 27101 USA; [Fixler, Jason M.] Herman & Walter Samuelson Childrens Hosp Sinai, Baltimore, MD USA; [Singleton, Tammuella C.] Tulane Univ, New Orleans, LA 70118 USA; [Singleton, Tammuella C.] Mississippi Ctr Adv Med, Slidell, LA USA; [Moulton, Thomas] Bronx Lebanon Hosp Ctr, Bronx, NY USA; [Moulton, Thomas] Bayer Pharmaceut, Whippany, NJ USA; [Quinn, Charles T.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [de Castro Lobo, Clarisse Lopes] Inst Estadual Hematol Arthur Siqueira Cavalcanti, Rio De Janeiro, Brazil; [Almomen, Abdulkareem M.] King Khalid Univ Hosp KKUH, King Saud Univ Med City, Blood & Canc Ctr, Riyadh, Saudi Arabia; [Goyal-Khemka, Meenakshi] Phoenix Childrens Hosp, Phoenix, AZ USA; [Goyal-Khemka, Meenakshi] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Maes, Philip] Univ Hosp Antwerp UZA, Edegem, Belgium; [Emanuele, Marty] Visgenx, San Diego, CA USA; [Emanuele, Marty; Padgett, Claire S.; Parsley, Ed] Mast Therapeut Inc, San Diego, CA USA; [Padgett, Claire S.] Sanifit Therapeut, San Diego, CA USA; [Parsley, Ed] Biotechnol, San Diego, CA USA; [Kato, Gregory J.] CSL Behring, King Of Prussia, PA USA; [Kato, Gregory J.; Gladwin, Mark T.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Johns Hopkins University; University of Massachusetts System; University of Massachusetts Worcester; University of Alabama System; University of Alabama Birmingham; State University System of Florida; University of Florida; University of Mississippi; University of Mississippi Medical Center; Children's National Health System; Lebanese American University; Sultan Qaboos University; Rutgers State University New Brunswick; American University of Beirut; Cukurova University; University of North Carolina; East Carolina University; St Jude Children's Research Hospital; Wayne State University; Children's Hospital of Michigan; Duke University; Emory University; Children's Healthcare of Atlanta (CHOA); University of Tennessee System; University of Tennessee at Chattanooga; University of Louisville; University of Miami; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Virginia Commonwealth University; University System of Georgia; Augusta University; University of Rochester; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Complutense University of Madrid; General University Gregorio Maranon Hospital; Rady Childrens Hospital San Diego; University of Iowa; Loyola University Chicago; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Tampa General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; Istanbul University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Baylor College of Medicine; Wake Forest University; Tulane University; BronxCare Health System; Bayer AG; Bayer Healthcare Pharmaceuticals; Cincinnati Children's Hospital Medical Center; King Saud University; Phoenix Children's Hospital; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; University of Antwerp; CSL; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Casella, JF (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	jcasella@jhmi.edu	Tebbi, Cameron/AAY-4568-2021; Kato, Gregory J/I-7615-2014	Kato, Gregory J/0000-0003-4465-3217	Mast Therapeutics Inc	Mast Therapeutics Inc	This clinical trial was funded by Mast Therapeutics Inc (previously Adventrx Therapeutics Inc).	AdamsGraves P, 1997, BLOOD, V90, P2041, DOI 10.1182/blood.V90.5.2041; [Anonymous], TEST DIRECTORY JOHNS; Ballas SK, 2005, AM J HEMATOL, V79, P17, DOI 10.1002/ajh.20336; Ballas SK, 2004, HEMOGLOBIN, V28, P85, DOI 10.1081/HEM-120035919; Cooper TE, 2019, COCHRANE DB SYST REV, DOI [10.1002/14651858.CDO12187.pub2, 10.1002/14651858.CD012187.pub2]; Feaster DJ, 2011, AM J DRUG ALCOHOL AB, V37, P383, DOI 10.3109/00952990.2011.600386; Garra G, 2010, ACAD EMERG MED, V17, P50, DOI 10.1111/j.1553-2712.2009.00620.x; Gibbs WJ, 2004, ANN PHARMACOTHER, V38, P320, DOI 10.1345/aph.1D223; Hebbel RP, 2020, J CLIN INVEST, V130, P1062, DOI 10.1172/JCI133639; Hunter RL, 2010, ANN CLIN LAB SCI, V40, P115; Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099; Piel FB, 2017, NEW ENGL J MED, V376, P1561, DOI 10.1056/NEJMra1510865; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Sundd P, 2019, ANNU REV PATHOL-MECH, V14, P263, DOI 10.1146/annurev-pathmechdis-012418-012838; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Wagenmakers EJ, 2007, PSYCHOL REV, V114, P830, DOI 10.1037/0033-295X.114.3.830; Ware LJ, 2006, PAIN MANAG NURS, V7, P117, DOI 10.1016/j.pmn.2006.06.005	18	8	8	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1513	1523		10.1001/jama.2021.3414	http://dx.doi.org/10.1001/jama.2021.3414			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877274	Bronze, Green Published			2022-12-28	WOS:000642636500016
J	Kuehn, BM				Kuehn, Bridget M.			Preventable Vision Loss Affects Millions Globally	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1498	1498		10.1001/jama.2021.4494	http://dx.doi.org/10.1001/jama.2021.4494			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877268				2022-12-28	WOS:000642636500004
J	Kuehn, BM				Kuehn, Bridget M.			COVID-19 in Clinicians-More Cases in Women, More Deaths in Men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1498	1498		10.1001/jama.2021.5500	http://dx.doi.org/10.1001/jama.2021.5500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877266	Bronze			2022-12-28	WOS:000642636500006
J	Liu, J; Silver, DL				Liu, Jing; Silver, Debra L.			Founder cells shape brain evolution	CELL			English	Editorial Material							ORGANOIDS; MODELS	Humans have an extraordinarily expanded and complex cerebral cortex, relative to non-human primates. Yet the mechanisms underlying cortical differences across evolution are unclear. A new study by Benito-Kwiecinski et al. employs cerebral organoids derived across great apes to implicate neuroepithelial progenitor shape transitions in human cortical expansion.	[Liu, Jing; Silver, Debra L.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Silver, Debra L.] Duke Univ, Med Ctr, Dept Cell Biol, Duke Inst Brain Sci, Durham, NC 27710 USA; [Silver, Debra L.] Duke Univ, Med Ctr, Dept Neurobiol, Duke Inst Brain Sci, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Silver, DL (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Silver, DL (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Duke Inst Brain Sci, Durham, NC 27710 USA.; Silver, DL (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Duke Inst Brain Sci, Durham, NC 27710 USA.	debra.silver@duke.edu		Silver, Debra/0000-0001-9189-844X				Benito-Kwiecinski S, 2021, CELL, V184, P2084, DOI 10.1016/j.cell.2021.02.050; Bhaduri A, 2020, CELL STEM CELL, V27, P361, DOI 10.1016/j.stem.2020.08.013; Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Eze UC, 2021, NAT NEUROSCI, V24, P584, DOI 10.1038/s41593-020-00794-1; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Pollen AA, 2019, CELL, V176, P743, DOI 10.1016/j.cell.2019.01.017; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036	10	2	2	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2021	184	8					1965	1967		10.1016/j.cell.2021.03.045	http://dx.doi.org/10.1016/j.cell.2021.03.045		APR 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RN5JL	33861961	Bronze			2022-12-28	WOS:000640387300010
J	Griffin, GK; Wu, JY; Iracheta-Vellve, A; Patti, JC; Hsu, JF; Davis, T; Dele-Oni, D; Du, PP; Halawi, AG; Ishizuka, JJ; Kim, SY; Klaeger, S; Knudsen, NH; Miller, BC; Nguyen, TH; Olander, KE; Papanastasiou, M; Rachimi, S; Robitschek, EJ; Schneider, EM; Yeary, MD; Zimmer, MD; Jaffe, JD; Carr, SA; Doench, JG; Haining, WN; Yates, KB; Manguso, RT; Bernstein, BE				Griffin, Gabriel K.; Wu, Jingyi; Iracheta-Vellve, Arvin; Patti, James C.; Hsu, Jeffrey; Davis, Thomas; Dele-Oni, Deborah; Du, Peter P.; Halawi, Aya G.; Ishizuka, Jeffrey J.; Kim, Sarah Y.; Klaeger, Susan; Knudsen, Nelson H.; Miller, Brian C.; Nguyen, Tung H.; Olander, Kira E.; Papanastasiou, Malvina; Rachimi, Suzanna; Robitschek, Emily J.; Schneider, Emily M.; Yeary, Mitchell D.; Zimmer, Margaret D.; Jaffe, Jacob D.; Carr, Steven A.; Doench, John G.; Haining, W. Nicholas; Yates, Kathleen B.; Manguso, Robert T.; Bernstein, Bradley E.			Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity	NATURE			English	Article								A CRISPR-Cas9 screen of chromatin regulators in mouse tumour models treated with immune checkpoint blockade identifies SETDB1 as an epigenetic checkpoint protein that suppresses tumour-intrinsic immunogenicity. Epigenetic dysregulation is a defining feature of tumorigenesis that is implicated in immune escape(1,2). Here, to identify factors that modulate the immune sensitivity of cancer cells, we performed in vivo CRISPR-Cas9 screens targeting 936 chromatin regulators in mouse tumour models treated with immune checkpoint blockade. We identified the H3K9 methyltransferase SETDB1 and other members of the HUSH and KAP1 complexes as mediators of immune escape(3-5). We also found that amplification of SETDB1 (1q21.3) in human tumours is associated with immune exclusion and resistance to immune checkpoint blockade. SETDB1 represses broad domains, primarily within the open genome compartment. These domains are enriched for transposable elements (TEs) and immune clusters associated with segmental duplication events, a central mechanism of genome evolution(6). SETDB1 loss derepresses latent TE-derived regulatory elements, immunostimulatory genes, and TE-encoded retroviral antigens in these regions, and triggers TE-specific cytotoxic T cell responses in vivo. Our study establishes SETDB1 as an epigenetic checkpoint that suppresses tumour-intrinsic immunogenicity, and thus represents a candidate target for immunotherapy.	[Griffin, Gabriel K.; Wu, Jingyi; Iracheta-Vellve, Arvin; Patti, James C.; Hsu, Jeffrey; Davis, Thomas; Dele-Oni, Deborah; Du, Peter P.; Halawi, Aya G.; Kim, Sarah Y.; Klaeger, Susan; Knudsen, Nelson H.; Miller, Brian C.; Nguyen, Tung H.; Olander, Kira E.; Papanastasiou, Malvina; Rachimi, Suzanna; Robitschek, Emily J.; Schneider, Emily M.; Yeary, Mitchell D.; Zimmer, Margaret D.; Jaffe, Jacob D.; Carr, Steven A.; Doench, John G.; Haining, W. Nicholas; Yates, Kathleen B.; Manguso, Robert T.; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Griffin, Gabriel K.; Wu, Jingyi; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Griffin, Gabriel K.; Wu, Jingyi; Knudsen, Nelson H.; Yates, Kathleen B.; Manguso, Robert T.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Griffin, Gabriel K.; Wu, Jingyi; Ishizuka, Jeffrey J.; Knudsen, Nelson H.; Miller, Brian C.; Robitschek, Emily J.; Haining, W. Nicholas; Yates, Kathleen B.; Manguso, Robert T.; Bernstein, Bradley E.] Harvard Med Sch, Boston, MA 02115 USA; [Griffin, Gabriel K.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Ishizuka, Jeffrey J.; Miller, Brian C.; Robitschek, Emily J.; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Knudsen, Nelson H.; Yates, Kathleen B.; Manguso, Robert T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Miller, Brian C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Miller, Brian C.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Miller, Brian C.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Ishizuka, Jeffrey J.] Yale Canc Ctr, Dept Internal Med Oncol, New Haven, CT 06510 USA; [Ishizuka, Jeffrey J.] Yale Sch Med, New Haven, CT 06510 USA; [Jaffe, Jacob D.] Inzen Therapeut, Cambridge, MA 02139 USA; [Haining, W. Nicholas] Merck, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Yale University; Yale University; Merck & Company	Manguso, RT; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Manguso, RT; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Manguso, RT; Bernstein, BE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Manguso, RT (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	rmanguso@mgh.harvard.edu; bernstein.bradley@mgh.harvard.edu	Doench, John G/HCI-9570-2022; Iracheta-Vellve, Arvin/K-6140-2014	Doench, John G/0000-0002-3707-9889; Halawi, Aya/0000-0001-8275-4065; Papanastasiou, Malvina/0000-0003-3378-6612; Kim, Sarah/0000-0003-2290-6025; Iracheta-Vellve, Arvin/0000-0002-6635-3904; Miller, Brian/0000-0001-5931-4184; Klaeger, Susan/0000-0002-0074-5163; Zimmer, Margaret/0000-0002-3317-6569; Du, Peter/0000-0003-2652-0541; Rachimi, Suzanna/0000-0001-7294-8683; Hsu, Jeffrey/0000-0001-6065-4653; Patti, James C/0000-0002-1733-6702	Calico Life Sciences; Gene Regulation Observatory at the Broad Institute of MIT and Harvard; Damon-Runyon Cancer Research Foundation; National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium [NIH/NCI U24-CA210986, NIH/NCI U01 CA214125]; Wong Family Award; NCI/NIH Director's Fund [DP1CA216873]	Calico Life Sciences; Gene Regulation Observatory at the Broad Institute of MIT and Harvard; Damon-Runyon Cancer Research Foundation; National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium; Wong Family Award; NCI/NIH Director's Fund	This work was supported by funds from Calico Life Sciences, the Gene Regulation Observatory at the Broad Institute of MIT and Harvard, the Damon-Runyon Cancer Research Foundation (to G.K.G. and J.W.), the National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (NIH/NCI U24-CA210986 and NIH/NCI U01 CA214125 to S.A.C), the Wong Family Award (to B.C.M.), and the NCI/NIH Director's Fund (DP1CA216873 to B.E.B.). B.E.B. is the Bernard and Mildred Kayden Endowed MGH Research Institute Chair and an American Cancer Society Research Professor. The authors thank all members of the Bernstein and Manguso laboratories at MGH and the Broad Institute, E. Van Allen, N. Vokes, A. Sharpe, G. Poncet-Montange, D. McKinney, T. Sundberg, J. Growney, D. Stokoe and A. Firestone for thoughtful discussions and feedback. Graphics in Fig. 1a were created with Biorender.com using a paid license.	Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; Adoue V, 2019, IMMUNITY, V50, P629, DOI 10.1016/j.immuni.2019.01.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azazi D, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00863-8; Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Bonev B, 2017, CELL, V171, P557, DOI 10.1016/j.cell.2017.09.043; Braun DA, 2020, NAT MED, V26, P909, DOI 10.1038/s41591-020-0839-y; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burr ML, 2019, CANCER CELL, V36, P385, DOI 10.1016/j.ccell.2019.08.008; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Cuellar TL, 2017, J CELL BIOL, V216, P3535, DOI 10.1083/jcb.201612160; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Dennis MY, 2016, CURR OPIN GENET DEV, V41, P44, DOI 10.1016/j.gde.2016.08.001; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EVANS LH, 1990, J VIROL, V64, P6176, DOI 10.1128/JVI.64.12.6176-6183.1990; Galluzzi L, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat7807; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacobs FMJ, 2014, NATURE, V516, P242, DOI 10.1038/nature13760; Jiang Y, 2017, NAT GENET, V49, P1239, DOI 10.1038/ng.3906; Jones PA, 2019, NAT REV CANCER, V19, P151, DOI 10.1038/s41568-019-0109-9; Kershaw MH, 2001, CANCER RES, V61, P7920; Laumont CM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau5516; Lauren D., 2019, MINT CHIP3 LOW INPUT, DOI [10.17504/protocols.io.wbefaje, DOI 10.17504/PROTOCOLS.IO.WBEFAJE]; Li F, 2020, CANCER DISCOV, V10, P270, DOI 10.1158/2159-8290.CD-19-0780; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Mehdipour P, 2020, NATURE, V588, P169, DOI 10.1038/s41586-020-2844-1; Mertins P, 2018, NAT PROTOC, V13, P1632, DOI 10.1038/s41596-018-0006-9; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nakagawa S., 2016, DATABASE, V2016; Ntranos V, 2019, NAT METHODS, V16, P163, DOI 10.1038/s41592-018-0303-9; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Sarkizova S, 2020, NAT BIOTECHNOL, V38, P199, DOI 10.1038/s41587-019-0322-9; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sheng WQ, 2018, CELL, V174, P549, DOI 10.1016/j.cell.2018.05.052; Spranger S, 2018, ANNU REV CANC BIOL, V2, P213, DOI 10.1146/annurev-cancerbio-030617-050606; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi Y, 2008, J CLIN INVEST, V118, P1099, DOI 10.1172/JCI34409; Tchasovnikarova IA, 2015, SCIENCE, V348, P1481, DOI 10.1126/science.aaa7227; Topper MJ, 2020, NAT REV CLIN ONCOL, V17, P75, DOI 10.1038/s41571-019-0266-5; van Galen P, 2016, MOL CELL, V61, P170, DOI 10.1016/j.molcel.2015.11.003; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; WHITE HD, 1994, J VIROL, V68, P897, DOI 10.1128/JVI.68.2.897-904.1994; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0	58	63	65	23	62	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 8	2021	595	7866					309	+		10.1038/s41586-021-03520-4	http://dx.doi.org/10.1038/s41586-021-03520-4		MAY 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TE9OU	33953401	Green Accepted			2022-12-28	WOS:000647544800003
J	Kermode-Scott, B				Kermode-Scott, Barbara			Covid-19: Uptake of testing does not reflect chances of positive test, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Sundaram ME, 2021, CAN MED ASSOC J, V193, pE723, DOI 10.1503/cmaj.202608	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n1133	10.1136/bmj.n1133	http://dx.doi.org/10.1136/bmj.n1133			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947669	Bronze			2022-12-28	WOS:000649710200001
J	Stovitz, SD				Stovitz, Steven D.			In suspected SARS-CoV-2, rapid antigen detection tests had 67% to 73% sensitivity and 98% to 100% specificity	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stovitz, Steven D.] Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Stovitz, SD (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.		Stovitz, Steven/K-6329-2019	Stovitz, Steven/0000-0002-4168-9823				American Association for Clinical Chemistry, 2021, SARS COV 2 CYCL THRE; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848; Rao SN, 2020, INFECT DIS THER, V9, P573, DOI 10.1007/s40121-020-00324-3	4	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC56	JC56		10.7326/ACPJ202105180-056	http://dx.doi.org/10.7326/ACPJ202105180-056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939481				2022-12-28	WOS:000652604800011
J	Delorey, TM; Ziegler, CGK; Heimberg, G; Normand, R; Yang, YM; Segerstolpe, A; Abbondanza, D; Fleming, SJ; Subramanian, A; Montoro, DT; Jagadeesh, KA; Dey, KK; Sen, P; Slyper, M; Pita-Juarez, YH; Phillips, D; Biermann, J; Bloom-Ackermann, Z; Barkas, N; Ganna, A; Gomez, J; Melms, JC; Katsyv, I; Normandin, E; Naderi, P; Popov, YV; Raju, SS; Niezen, S; Tsai, LTY; Siddle, KJ; Sud, M; Tran, VM; Vellarikkal, SK; Wang, YP; Amir-Zilberstein, L; Atri, DS; Beechem, J; Brook, OR; Chen, JN; Divakar, P; Dorceus, P; Engreitz, JM; Essene, A; Fitzgerald, DM; Fropf, R; Gazal, S; Gould, J; Grzyb, J; Harvey, T; Hecht, J; Hether, T; Jane-Valbuena, J; Leney-Greene, M; Ma, H; McCabe, C; McLoughlin, DE; Miller, EM; Muus, C; Niemi, M; Padera, R; Pan, LL; Pant, D; Pe'er, C; Pfiffner-Borges, J; Pinto, CJ; Plaisted, J; Reeves, J; Ross, M; Rudy, M; Rueckert, EH; Siciliano, M; Sturm, A; Todres, E; Waghray, A; Warren, S; Zhang, ST; Zollinger, DR; Cosimi, L; Gupta, RM; Hacohen, N; Hibshoosh, H; Hide, W; Price, AL; Rajagopal, J; Tata, PR; Riedel, S; Szabo, G; Tickle, TL; Ellinor, PT; Hung, DB; Sabeti, PC; Novak, R; Rogers, R; Ingber, DE; Jiang, ZG; Juric, D; Babadi, M; Farhi, SL; Izar, B; Stone, JR; Vlachos, IS; Solomon, IH; Ashenberg, O; Porter, CBM; Li, B; Shalek, AK; Villani, AC; Rozenblatt-Rosen, O; Regev, A				Delorey, Toni M.; Ziegler, Carly G. K.; Heimberg, Graham; Normand, Rachelly; Yang, Yiming; Segerstolpe, Asa; Abbondanza, Domenic; Fleming, Stephen J.; Subramanian, Ayshwarya; Montoro, Daniel T.; Jagadeesh, Karthik A.; Dey, Kushal K.; Sen, Pritha; Slyper, Michal; Pita-Juarez, Yered H.; Phillips, Devan; Biermann, Jana; Bloom-Ackermann, Zohar; Barkas, Nikolaos; Ganna, Andrea; Gomez, James; Melms, Johannes C.; Katsyv, Igor; Normandin, Erica; Naderi, Pourya; Popov, Yury V.; Raju, Siddharth S.; Niezen, Sebastian; Tsai, Linus T. -Y.; Siddle, Katherine J.; Sud, Malika; Tran, Victoria M.; Vellarikkal, Shamsudheen K.; Wang, Yiping; Amir-Zilberstein, Liat; Atri, Deepak S.; Beechem, Joseph; Brook, Olga R.; Chen, Jonathan; Divakar, Prajan; Dorceus, Phylicia; Engreitz, Jesse M.; Essene, Adam; Fitzgerald, Donna M.; Fropf, Robin; Gazal, Steven; Gould, Joshua; Grzyb, John; Harvey, Tyler; Hecht, Jonathan; Hether, Tyler; Jane-Valbuena, Judit; Leney-Greene, Michael; Ma, Hui; McCabe, Cristin; McLoughlin, Daniel E.; Miller, Eric M.; Muus, Christoph; Niemi, Mari; Padera, Robert; Pan, Liuliu; Pant, Deepti; Pe'er, Carmel; Pfiffner-Borges, Jenna; Pinto, Christopher J.; Plaisted, Jacob; Reeves, Jason; Ross, Marty; Rudy, Melissa; Rueckert, Erroll H.; Siciliano, Michelle; Sturm, Alexander; Todres, Ellen; Waghray, Avinash; Warren, Sarah; Zhang, Shuting; Zollinger, Daniel R.; Cosimi, Lisa; Gupta, Rajat M.; Hacohen, Nir; Hibshoosh, Hanina; Hide, Winston; Price, Alkes L.; Rajagopal, Jayaraj; Tata, Purushothama Rao; Riedel, Stefan; Szabo, Gyongyi; Tickle, Timothy L.; Ellinor, Patrick T.; Hung, Deborah; Sabeti, Pardis C.; Novak, Richard; Rogers, Robert; Ingber, Donald E.; Jiang, Z. Gordon; Juric, Dejan; Babadi, Mehrtash; Farhi, Samouil L.; Izar, Benjamin; Stone, James R.; Vlachos, Ioannis S.; Solomon, Isaac H.; Ashenberg, Orr; Porter, Caroline B. M.; Li, Bo; Shalek, Alex K.; Villani, Alexandra-Chloe; Rozenblatt-Rosen, Orit; Regev, Aviv			COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets	NATURE			English	Article							SINGLE-CELL; T-CELLS; INFECTION; BLIMP-1	COVID-19, which is caused by SARS-CoV-2, can result in acute respiratory distress syndrome and multiple organ failure1-4, but little is known about its pathophysiology. Here we generated single-cell atlases of 24 lung, 16 kidney, 16 liver and 19 heart autopsy tissue samples and spatial atlases of 14 lung samples from donors who died of COVID-19. Integrated computational analysis uncovered substantial remodelling in the lung epithelial, immune and stromal compartments, with evidence of multiple paths of failed tissue regeneration, including defective alveolar type 2 differentiation and expansion of fibroblasts and putative TP63(+) intrapulmonary basal-like progenitor cells. Viral RNAs were enriched in mononuclear phagocytic and endothelial lung cells, which induced specific host programs. Spatial analysis in lung distinguished inflammatory host responses in lung regions with and without viral RNA. Analysis of the other tissue atlases showed transcriptional alterations in multiple cell types in heart tissue from donors with COVID-19, and mapped cell types and genes implicated with disease severity based on COVID-19 genome-wide association studies. Our foundational dataset elucidates the biological effect of severe SARS-CoV-2 infection across the body, a key step towards new treatments.	[Delorey, Toni M.; Heimberg, Graham; Yang, Yiming; Segerstolpe, Asa; Abbondanza, Domenic; Montoro, Daniel T.; Jagadeesh, Karthik A.; Slyper, Michal; Phillips, Devan; Sud, Malika; Amir-Zilberstein, Liat; Dorceus, Phylicia; Gould, Joshua; Harvey, Tyler; Jane-Valbuena, Judit; Ma, Hui; McCabe, Cristin; Pe'er, Carmel; Pfiffner-Borges, Jenna; Tickle, Timothy L.; Farhi, Samouil L.; Ashenberg, Orr; Porter, Caroline B. M.; Li, Bo; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Ziegler, Carly G. K.; Normand, Rachelly; Sen, Pritha; Pita-Juarez, Yered H.; Normandin, Erica; Raju, Siddharth S.; Tsai, Linus T. -Y.; Siddle, Katherine J.; Vellarikkal, Shamsudheen K.; Atri, Deepak S.; Chen, Jonathan; Engreitz, Jesse M.; Leney-Greene, Michael; Muus, Christoph; Rudy, Melissa; Gupta, Rajat M.; Hacohen, Nir; Szabo, Gyongyi; Sabeti, Pardis C.; Vlachos, Ioannis S.; Shalek, Alex K.; Villani, Alexandra-Chloe] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ziegler, Carly G. K.; Shalek, Alex K.] Harvard Med Sch, Program Hlth Sci & Technol, Boston, MA 02115 USA; [Ziegler, Carly G. K.; Shalek, Alex K.] MIT, Boston, MA 02215 USA; [Ziegler, Carly G. K.; Shalek, Alex K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ziegler, Carly G. K.; Shalek, Alex K.; Regev, Aviv] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Ziegler, Carly G. K.; Li, Bo; Shalek, Alex K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Ziegler, Carly G. K.; Shalek, Alex K.] Harvard Univ, Harvard Grad Program Biophys, Cambridge, MA 02138 USA; [Normand, Rachelly; Yang, Yiming; Sen, Pritha; Ma, Hui; Villani, Alexandra-Chloe] Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Hacohen, Nir; Villani, Alexandra-Chloe] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02115 USA; [Normand, Rachelly; Pita-Juarez, Yered H.; Normandin, Erica; Naderi, Pourya; Popov, Yury V.; Niezen, Sebastian; Tsai, Linus T. -Y.; Hecht, Jonathan; Hide, Winston; Riedel, Stefan; Szabo, Gyongyi; Jiang, Z. Gordon; Vlachos, Ioannis S.; Shalek, Alex K.] Harvard Med Sch, Boston, MA 02115 USA; [Normand, Rachelly] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Fleming, Stephen J.; Barkas, Nikolaos; Gould, Joshua; Tickle, Timothy L.; Babadi, Mehrtash] Broad Inst MIT & Harvard, Data Sci Platform, Cambridge, MA 02142 USA; [Fleming, Stephen J.; Babadi, Mehrtash] Broad Inst MIT & Harvard, Precis Cardiol Lab, Cambridge, MA 02142 USA; [Subramanian, Ayshwarya; Dey, Kushal K.; Price, Alkes L.] Harvard Univ, Dept Epidemiol, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Sen, Pritha] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Boston, MA 02114 USA; [Sen, Pritha; Pinto, Christopher J.; Juric, Dejan; Li, Bo; Villani, Alexandra-Chloe] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Pita-Juarez, Yered H.; Naderi, Pourya; Hecht, Jonathan; Hide, Winston; Riedel, Stefan; Vlachos, Ioannis S.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; [Pita-Juarez, Yered H.; Naderi, Pourya; Hide, Winston; Vlachos, Ioannis S.] Harvard Med Sch Initiat RNA Med, Boston, MA 02115 USA; [Pita-Juarez, Yered H.; Hide, Winston; Vlachos, Ioannis S.] Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA; [Biermann, Jana; Melms, Johannes C.; Wang, Yiping; Izar, Benjamin] Columbia Univ, Dept Med, Div Hematol Oncol, Irving Med Ctr, New York, NY USA; [Biermann, Jana; Melms, Johannes C.; Wang, Yiping; Izar, Benjamin] Columbia Ctr Translat Immunol, New York, NY USA; [Bloom-Ackermann, Zohar; Gomez, James; Tran, Victoria M.; Zhang, Shuting; Hung, Deborah] Broad Inst MIT & Harvard, Infect Dis & Microbiome Program, Cambridge, MA 02142 USA; [Ganna, Andrea; Niemi, Mari] Inst Mol Med Finland, Helsinki, Finland; [Ganna, Andrea] Harvard Med Sch, Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02115 USA; [Katsyv, Igor; Hibshoosh, Hanina] Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, New York, NY USA; [Popov, Yury V.; Niezen, Sebastian; Tsai, Linus T. -Y.; Essene, Adam; Pant, Deepti; Szabo, Gyongyi; Rogers, Robert; Jiang, Z. Gordon] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Popov, Yury V.; Niezen, Sebastian; Jiang, Z. Gordon] Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol Hepatol & Nutr, Boston, MA 02215 USA; [Raju, Siddharth S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Raju, Siddharth S.] Harvard Univ, Dept Organism & Evolutionary Biol, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Tsai, Linus T. -Y.; Essene, Adam; Pant, Deepti] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Tsai, Linus T. -Y.; Essene, Adam; Pant, Deepti] Funct Genom & Bioinformat Core Boston, Boston Nutr & Obes Res Ctr, Boston, MA USA; [Siddle, Katherine J.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolut Biol, Cambridge, MA 02138 USA; [Vellarikkal, Shamsudheen K.; Atri, Deepak S.; Gupta, Rajat M.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Vellarikkal, Shamsudheen K.; Atri, Deepak S.; Gupta, Rajat M.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Beechem, Joseph; Divakar, Prajan; Fropf, Robin; Hether, Tyler; Miller, Eric M.; Pan, Liuliu; Reeves, Jason; Ross, Marty; Rueckert, Erroll H.; Sturm, Alexander; Todres, Ellen; Warren, Sarah; Zollinger, Daniel R.] NanoString Technol Inc, Seattle, WA USA; [Brook, Olga R.] Beth Israel Deaconess Med Ctr, Dept Radiol, 330 Brookline Ave, Boston, MA 02215 USA; [Chen, Jonathan; Stone, James R.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA; [Engreitz, Jesse M.] Stanford Univ, Sch Med, Dept Genet & BASE Initiat, Stanford, CA 94305 USA; [Fitzgerald, Donna M.; Gazal, Steven; Rajagopal, Jayaraj; Juric, Dejan] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA USA; [McLoughlin, Daniel E.; Pinto, Christopher J.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Ctr Genet Epidemiol, Los Angeles, CA 90007 USA; [Grzyb, John; Padera, Robert; Plaisted, Jacob; Siciliano, Michelle; Solomon, Isaac H.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Muus, Christoph; Ingber, Donald E.] Harvard Univ, John Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Padera, Robert] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA; [Padera, Robert] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Waghray, Avinash; Shalek, Alex K.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Waghray, Avinash] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Cosimi, Lisa] Brigham & Womens Hosp, Dept Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Hacohen, Nir] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Tata, Purushothama Rao] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC USA; [Ellinor, Patrick T.] Broad Inst MIT & Harvard, Cardiovasc Dis Initiat, Cambridge, MA 02142 USA; [Hung, Deborah] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Hung, Deborah] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Hung, Deborah] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Sabeti, Pardis C.] Harvard Univ, Dept Immunol & Infect Dis, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Sabeti, Pardis C.; Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Sabeti, Pardis C.] Massachusetts Consortium Pathogen Readiness, Boston, MA USA; [Novak, Richard; Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Rogers, Robert] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ingber, Donald E.] Harvard Med Sch, Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Med Sch, Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Izar, Benjamin] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY USA; [Izar, Benjamin] Columbia Univ, Irving Med Ctr, Program Math Genom, York, NY USA; [Shalek, Alex K.] MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shalek, Alex K.] Harvard Med Sch, Program Immunol, Boston, MA 02115 USA; [Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Rozenblatt-Rosen, Orit; Regev, Aviv] Genentech Inc, San Francisco, CA 94080 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; Harvard University; Massachusetts General Hospital; University of Southern California; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Duke University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Roche Holding; Genentech	Rozenblatt-Rosen, O; Regev, A (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.; Vlachos, IS; Shalek, AK; Villani, AC (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Shalek, AK (corresponding author), Harvard Med Sch, Program Hlth Sci & Technol, Boston, MA 02115 USA.; Shalek, AK (corresponding author), MIT, Boston, MA 02215 USA.; Shalek, AK (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK; Regev, A (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), Harvard Univ, Harvard Grad Program Biophys, Cambridge, MA 02138 USA.; Villani, AC (corresponding author), Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA.; Villani, AC (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02115 USA.; Vlachos, IS; Shalek, AK (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Villani, AC (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Vlachos, IS (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA.; Vlachos, IS (corresponding author), Harvard Med Sch Initiat RNA Med, Boston, MA 02115 USA.; Vlachos, IS (corresponding author), Beth Israel Deaconess Med Ctr, Canc Res Inst, Boston, MA 02215 USA.; Shalek, AK (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Shalek, AK (corresponding author), MIT, Program Computat & Syst Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Shalek, AK (corresponding author), Harvard Med Sch, Program Immunol, Boston, MA 02115 USA.; Shalek, AK (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Rozenblatt-Rosen, O; Regev, A (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	ivlachos@bidmc.harvard.edu; shalek@mit.edu; avillani@mgh.harvard.edu; orit.r.rosen@gmail.com; aviv.regev.sc@gmail.com	Li, Bo/AAS-8773-2021; Sabeti, Pardis/GQH-8610-2022; Atri, Deepak/ADL-5644-2022; Riedel, Stefan/ABF-4206-2021; Rozenblatt-Rosen, Orit/HDN-4182-2022; Biermann, Jana/C-7710-2018; Vlachos, Ioannis/AFS-8859-2022; Gazal, Steven/AAK-3764-2020; Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022	Li, Bo/0000-0003-0668-1620; Atri, Deepak/0000-0001-8139-5419; Biermann, Jana/0000-0002-8907-4633; Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Vlachos, Ioannis/0000-0002-8849-808X; Niezen, Sebastian/0000-0002-9297-8828; Delorey, Toni/0000-0001-6614-3803; Niemi, Mari/0000-0003-0696-6175; Rudy, Melissa/0000-0003-0165-5669; Abbondanza, Domenic/0000-0002-7202-0225; Fleming, Stephen/0000-0002-1885-4405; Farhi, Samouil/0000-0003-1359-4568; Brook, Olga R/0000-0002-7074-8909; Popov, Yury V./0000-0001-7973-942X; Bloom-Ackermann, Zohar/0000-0001-9149-4218; McLoughlin, Daniel/0000-0002-3697-9623; Tata, Purushothama Rao/0000-0003-4837-0337; Phillips, Devan/0000-0002-9240-4912; Tsai, Linus/0000-0002-0134-6949; Yang, Yiming/0000-0002-0386-9428	Manton Foundation; Klarman Family Foundation; HHMI; Chan Zuckerberg Initiative; Human Tumor Atlas Network trans-network projects SARDANA (Shared Repositories, Data, Analysis and Access); DARPA [HR0011-20-2-0040]; US Food and Drug Administration [HHSF223201810172C]; National Institute of Health Director's New Innovator Award [DP2CA247831]; Massachusetts General Hospital (MGH) Transformative Scholar in Medicine Award; COVID-19 Clinical Trials Pilot grant from the Executive Committee on Research at MGH; Damon Runyon-Rachleff Innovation Award; NIH [R01AA0207440, U01AA026933]; National Institute of Health (NIH) [K08CA222663, R37CA258829, U54CA225088]; FastGrants; Burroughs Wellcome Fund Career Award for Medical Scientists; NIH/NCI Cancer Center at Columbia University [P30CA013696];  [U01 HG009379];  [R01 MH101244];  [R37 MH107649]	Manton Foundation; Klarman Family Foundation; HHMI(Howard Hughes Medical Institute); Chan Zuckerberg Initiative; Human Tumor Atlas Network trans-network projects SARDANA (Shared Repositories, Data, Analysis and Access); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US Food and Drug Administration; National Institute of Health Director's New Innovator Award; Massachusetts General Hospital (MGH) Transformative Scholar in Medicine Award; COVID-19 Clinical Trials Pilot grant from the Executive Committee on Research at MGH; Damon Runyon-Rachleff Innovation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FastGrants; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); NIH/NCI Cancer Center at Columbia University; ; ; 	We are deeply grateful to all donors and their families. This paper is part of the Human Cell Atlas (https://www.humancellatlas.org/publications/).We acknowledge the contribution of C. Kania, E. Kounaves, N. Lemelin, J. Susterich, J. Teixeira, C. Bernal, M. Berstein, A. Morris, J. N. Ray, A. Awley, A. Araujo and E. Figueroa who all assisted in performing the autopsies at the Massachusetts General Hospital. We thank A. Hupalowska and L. Gaffney for help with figure preparation. We thank M. Veregge, Z. Kramer and C. Jacobs for their contributions in the execution of experimental procedures, and D. Pouli who supported the creation of tissue annotation resources; 10x Genomics, Illumina, BD Biosciences, and NanoString for help and support with instruments and/or lab reagents and technical advice. Portions of this research were conducted on the Ithaca High Performance Computing system, Department of Pathology, BIDMC, and the O2 High Performance Compute Cluster at Harvard Medical School. This project has been funded in part with funds from the Manton Foundation, Klarman Family Foundation, HHMI, the Chan Zuckerberg Initiative and the Human Tumor Atlas Network trans-network projects SARDANA (Shared Repositories, Data, Analysis and Access). A.R. was an Investigator of the Howard Hughes Medical Institute. This project was also funded by DARPA grant HR0011-20-2-0040 (to D.E.I.) and the US Food and Drug Administration grant HHSF223201810172C (to P.C.S. and A.K.S.). A.-C.V. acknowledges funding support from the National Institute of Health Director's New Innovator Award (DP2CA247831), the Massachusetts General Hospital (MGH) Transformative Scholar in Medicine Award, a COVID-19 Clinical Trials Pilot grant from the Executive Committee on Research at MGH, and the Damon Runyon-Rachleff Innovation Award. G.S. acknowledges support from the NIH R01AA0207440 and U01AA026933 research grants. A.P. acknowledges funding from the following sources U01 HG009379, R01 MH101244, R37 MH107649. We thank all members of the Department of Pathology and Cell Biology at Columbia University Irving Medical Center who led the procurement of autopsy tissues used in this work. This work was supported by National Institute of Health (NIH) grants K08CA222663 (B.I.), R37CA258829 (B.I.), U54CA225088 (B.I.), FastGrants (B.I.) and the Burroughs Wellcome Fund Career Award for Medical Scientists (B.I.). This research was funded in part through the NIH/NCI Cancer Center Support Grant P30CA013696 at Columbia University and used the Molecular Pathology Shared Resource and its Tissue Bank.	Bian XW, 2020, NATL SCI REV, V7, P1414, DOI 10.1093/nsr/nwaa123; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Bosmuller H, 2020, VIRCHOWS ARCH, V477, P349, DOI 10.1007/s00428-020-02881-x; Brill B, 2019, TESTING DIFFERENTIAL; Butler D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21361-7; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Choi J, 2020, CELL STEM CELL, V27, P366, DOI 10.1016/j.stem.2020.06.020; Costa MFD, 2020, STEM CELL REP, V15, P1015, DOI 10.1016/j.stemcr.2020.09.006; Covid 19 Host Genetics Initiative, 2020, EUR J HUM GENET, V28, P715, DOI 10.1038/s41431-020-0636-6; Desai Niyati, 2020, medRxiv, DOI 10.1101/2020.07.30.20165241; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; FLEMING SJ, 2019, CELLBENDER REMOVE BA; Grant RA, 2021, NATURE, V590, P635, DOI 10.1038/s41586-020-03148-w; Grillo F, 2020, LANCET INFECT DIS, V21, pE72, DOI 10.1016/S1473-3099(20)30582-X; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; JAGADEESH KA, 2021, IDENTIFYING DIS CRIT; JOHNSON NF, 1980, THORAX, V35, P192, DOI 10.1136/thx.35.3.192; Kobayashi Y, 2020, NAT CELL BIOL, V22, P934, DOI 10.1038/s41556-020-0542-8; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Lemieux JE, 2021, SCIENCE, V371, P588, DOI 10.1126/science.abe3261; Li B, 2020, NAT METHODS, V17, P793, DOI 10.1038/s41592-020-0905-x; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; MELMS JC, 2021, NATURE; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muus C, 2021, NAT MED, V27, P546, DOI 10.1038/s41591-020-01227-z; PARK J, 2021, SYSTEMIC TISSUE CELL; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Ravindra Neal G, 2020, bioRxiv, DOI 10.1101/2020.05.06.081695; RENDEIRO AF, 2020, SPATIO TEMPORAL LAND; Schiller HB, 2019, AM J RESP CELL MOL, V61, P31, DOI 10.1165/rcmb.2018-0416TR; SCHUPP JC, 2020, INTEGRATED SINGLE CE; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Short KR, 2016, EUR RESPIR J, V47, P954, DOI 10.1183/13993003.01282-2015; Slyper M, 2020, NAT MED, V26, P792, DOI 10.1038/s41591-020-0844-1; SPERANZA E, 2020, SARS COV 2 INFECT DY; Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3; Su H, 2020, KIDNEY INT, V98, P219, DOI 10.1016/j.kint.2020.04.003; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; van de Sandt CE, 2017, AM J RESP CELL MOL, V57, P536, DOI 10.1165/rcmb.2016-0377OC; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Walsh KA, 2020, J INFECTION, V81, P357, DOI 10.1016/j.jinf.2020.06.067; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Xu JC, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01445-6; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yao XH, 2020, CELL RES, V30, P541, DOI 10.1038/s41422-020-0318-5; Younes M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5674; Yu HH, 2020, SCIENCE, V370, P1060, DOI 10.1126/science.aba5528; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	55	181	183	12	50	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 1	2021	595	7865					107	+		10.1038/s41586-021-03570-8	http://dx.doi.org/10.1038/s41586-021-03570-8		APR 2021	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC5EM	33915569	Bronze, Green Accepted			2022-12-28	WOS:000654894300001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: MHRA is concerned over use of rapid lateral flow devices for mass testing	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Griffin S, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n823; Halliday, 2021, GUARDIAN 0425; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n902; Iacobucci G, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3520; Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4950; Raffle AE, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1058	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1090	10.1136/bmj.n1090	http://dx.doi.org/10.1136/bmj.n1090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XF7FG	33910913				2022-12-28	WOS:000724233100001
J	Rubel, D				Rubel, Diana			Nanobody cytokine blockers in psoriasis	LANCET			English	Editorial Material									[Rubel, Diana] Australian Natl Univ, Canberra, ACT 2605, Australia	Australian National University	Rubel, D (corresponding author), Australian Natl Univ, Canberra, ACT 2605, Australia.	diana@wodendermatology.com.au						Jovcevska I, 2020, BIODRUGS, V34, P11, DOI 10.1007/s40259-019-00392-z; Papp KA, 2021, LANCET, V397, P1564, DOI 10.1016/S0140-6736(21)00440-2; Papp KA, 2018, J AM ACAD DERMATOL, V79, P277, DOI 10.1016/j.jaad.2018.03.037; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384	4	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1523	1524						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RR7QA	33894820				2022-12-28	WOS:000643286900004
J	Sato, T; Maeda, K; Nagataki, S; Yoshida, T; Grefenstette, B; Williams, BJ; Umeda, H; Ono, M; Hughes, JP				Sato, Toshiki; Maeda, Keiichi; Nagataki, Shigehiro; Yoshida, Takashi; Grefenstette, Brian; Williams, Brian J.; Umeda, Hideyuki; Ono, Masaomi; Hughes, John P.			High-entropy ejecta plumes in Cassiopeia A from neutrino-driven convection	NATURE			English	Article							CORE-COLLAPSE SUPERNOVAE; RAYLEIGH-TAYLOR INSTABILITIES; 3-DIMENSIONAL STRUCTURE; NUCLEOSYNTHESIS; TI-44; SIMULATIONS; EXPLOSIONS; REMNANT; ABUNDANCES; EVOLUTION	Recent multi-dimensional simulations suggest that high-entropy buoyant plumes help massive stars to explode(1,2). Outwardly protruding iron (Fe)-rich fingers of gas in the galactic supernova remnant(3,4) Cassiopeia A seem to match this picture. Detecting the signatures of specific elements synthesized in the high-entropy nuclear burning regime (that is, alpha-rich freeze out) would constitute strong substantiating evidence. Here we report observations of such elements-stable titanium (Ti) and chromium (Cr)-at a confidence level greater than 5 standard deviations in the shocked high-velocity Fe-rich ejecta of Cassiopeia A. We found that the observed Ti/Fe and Cr/Fe mass ratios require alpha-rich freeze out, providing evidence of the existence of the high-entropy ejecta plumes that boosted the shock wave at explosion. The metal composition of the plumes agrees well with predictions for strongly neutrino-processed proton-rich ejecta(2,5,6). These results support the operation of the convective supernova engine via neutrino heating in the supernova that produced Cassiopeia A.	[Sato, Toshiki] RIKEN, Wako, Saitama, Japan; [Sato, Toshiki; Williams, Brian J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Sato, Toshiki] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21228 USA; [Sato, Toshiki] Rikkyo Univ, Dept Phys, Tokyo, Japan; [Maeda, Keiichi] Kyoto Univ, Dept Astron, Kyoto, Japan; [Nagataki, Shigehiro; Ono, Masaomi] RIKEN Cluster Pioneering Res, Astrophys Big Bang Lab ABBL, Wako, Saitama, Japan; [Nagataki, Shigehiro; Ono, Masaomi] RIKEN Interdisciplinary Theoret & Math Sci Progra, Wako, Saitama, Japan; [Yoshida, Takashi; Umeda, Hideyuki] Univ Tokyo, Grad Sch Sci, Dept Astron, Tokyo, Japan; [Yoshida, Takashi] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto, Japan; [Grefenstette, Brian] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Hughes, John P.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ USA	RIKEN; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; Rikkyo University; Kyoto University; RIKEN; RIKEN; University of Tokyo; Kyoto University; California Institute of Technology; Rutgers State University New Brunswick	Sato, T (corresponding author), RIKEN, Wako, Saitama, Japan.; Sato, T (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.; Sato, T (corresponding author), Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21228 USA.; Sato, T (corresponding author), Rikkyo Univ, Dept Phys, Tokyo, Japan.	toshiki.sato@rikkyo.ac.jp	Nagataki, Shigehiro/N-7116-2015; Sato, Toshiki/Q-6281-2017	Nagataki, Shigehiro/0000-0002-7025-284X; Sato, Toshiki/0000-0001-9267-1693; ONO, Masaomi/0000-0002-0603-918X; Maeda, Keiichi/0000-0003-2611-7269	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP19K14739]; Special Postdoctoral Researchers Program; FY 2019 Incentive Research Projects in RIKEN; JSPS [JP18H05223, JP20H00174]; JSPS (grant KAKENHI) [19H00693]; RIKEN programme for Evolution of Matter in the Universe (r-EMU); Theoretical and Mathematical Sciences Program of RIKEN (iTHEMS); NASA [NNX15AK71G];  [JP17H01130];  [JP20H05249]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Special Postdoctoral Researchers Program; FY 2019 Incentive Research Projects in RIKEN; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS (grant KAKENHI); RIKEN programme for Evolution of Matter in the Universe (r-EMU); Theoretical and Mathematical Sciences Program of RIKEN (iTHEMS); NASA(National Aeronautics & Space Administration (NASA)); ; 	T.S. was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI grant number JP19K14739, the Special Postdoctoral Researchers Program, and FY 2019 Incentive Research Projects in RIKEN. K.M. was supported in part by Grants-in-Aid for the Scientific Research of JSPS (grant numbers JP18H05223 and JP20H00174). S.N. is partially supported by the Grants-in-Aid for the Scientific Research of JSPS (grant KAKENHI (A) 19H00693), the RIKEN programme for Evolution of Matter in the Universe (r-EMU), and the Theoretical and Mathematical Sciences Program of RIKEN (iTHEMS). J.PH. acknowledges support for X-ray studies of supernova remnants from NASA grant NNX15AK71G to Rutgers University. T.Y. is supported in part by a Grant-in-Aid for Scientific Research of Innovative Areas (JP20H05249). H.U. is supported in part by a Grant-in-Aid for Scientific Research (JP17H01130).	Aharonian F, 2018, PUBL ASTRON SOC JPN, V70, DOI 10.1093/pasj/psx156; Aharonian F, 2017, NATURE, V551, P478, DOI 10.1038/nature24301; Alarie A, 2014, MON NOT R ASTRON SOC, V441, P2996, DOI 10.1093/mnras/stu774; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; ARNETT D, 1989, ASTROPHYS J, V341, pL63, DOI 10.1086/185458; Barret D., P SPIE C SER, V10699, DOI [10.1117/12.2312409.short, DOI 10.1117/12.2312409.SHORT]; BETHE HA, 1985, ASTROPHYS J, V295, P14, DOI 10.1086/163343; Blondin JM, 2001, ASTROPHYS J, V557, P782, DOI 10.1086/321674; Bollig R., 2020, SELF CONSISTENT 3D S; Buras R, 2006, ASTRON ASTROPHYS, V447, P1049, DOI 10.1051/0004-6361:20053783; Burrows A, 2021, NATURE, V589, P29, DOI 10.1038/s41586-020-03059-w; BURROWS A, 1995, ASTROPHYS J, V450, P830, DOI 10.1086/176188; Burrows A, 2020, MON NOT R ASTRON SOC, V491, P2715, DOI 10.1093/mnras/stz3223; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; DeLaney T, 2010, ASTROPHYS J, V725, P2038, DOI 10.1088/0004-637X/725/2/2038; Fesen RA, 2001, ASTROPHYS J SUPPL S, V133, P161, DOI 10.1086/319181; Fesen RA, 2006, ASTROPHYS J, V645, P283, DOI 10.1086/504254; Fesen RA, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/1/17; Foster AR, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/128; Fruscione A, 2006, PROC SPIE, V6270, DOI 10.1117/12.671760; FRYXELL B, 1991, ASTROPHYS J, V367, P619, DOI 10.1086/169657; Gabler M, 2021, MON NOT R ASTRON SOC, V502, P3264, DOI 10.1093/mnras/stab116; Georgy C, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322178; Gotthelf EV, 2001, ASTROPHYS J, V552, pL39, DOI 10.1086/320250; Grefenstette BW, 2014, NATURE, V506, P339, DOI 10.1038/nature12997; Grefenstette BW, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/1/19; HACHISU I, 1990, ASTROPHYS J, V358, pL57, DOI 10.1086/185779; Hammer NJ, 2010, ASTROPHYS J, V714, P1371, DOI 10.1088/0004-637X/714/2/1371; HERANT M, 1991, ASTROPHYS J, V370, pL81, DOI 10.1086/185982; HERANT M, 1994, ASTROPHYS J, V435, P339, DOI 10.1086/174817; Hughes JP, 2000, ASTROPHYS J, V528, pL109, DOI 10.1086/312438; Hwang U, 2000, ASTROPHYS J, V537, pL119, DOI 10.1086/312776; Hwang U, 2003, ASTROPHYS J, V597, P362, DOI 10.1086/378269; Hwang U, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/130; IYUDIN AF, 1994, ASTRON ASTROPHYS, V284, pL1; Janka HT, 2007, PHYS REP, V442, P38, DOI 10.1016/j.physrep.2007.02.002; Janka HT, 2016, ANNU REV NUCL PART S, V66, P341, DOI 10.1146/annurev-nucl-102115-044747; Kaastra J. S., 1996, UV XRAY SPECTROSCOPY; Kifonidis K, 2003, ASTRON ASTROPHYS, V408, P621, DOI 10.1051/0004-6361:20030863; Kobayashi C, 2006, ASTROPHYS J, V653, P1145, DOI 10.1086/508914; Lattimer JM, 2001, ASTROPHYS J, V550, P426, DOI 10.1086/319702; LAWRENCE SS, 1995, ASTRON J, V109, P2635, DOI 10.1086/117477; LI HW, 1993, ASTROPHYS J, V419, P824, DOI 10.1086/173534; Maeda K, 2003, ASTROPHYS J, V598, P1163, DOI 10.1086/378948; Magkotsios G, 2010, ASTROPHYS J SUPPL S, V191, P66, DOI 10.1088/0067-0049/191/1/66; Milisavljevic D, 2015, SCIENCE, V347, P526, DOI 10.1126/science.1261949; Milisavljevic D, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/134; MULLER E, 1991, ASTRON ASTROPHYS, V251, P505; Nagataki S, 1999, ASTROPHYS J, V511, P341, DOI 10.1086/306663; Nagataki S, 1998, ASTROPHYS J, V492, pL45, DOI 10.1086/311089; Nakamura T, 2001, ASTROPHYS J, V555, P880, DOI 10.1086/321495; Ono M, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/161; Orlando S, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/1/22; Patnaude DJ, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/138; Patnaude DJ, 2011, ASTROPHYS J LETT, V729, DOI 10.1088/2041-8205/729/2/L28; REED JE, 1995, ASTROPHYS J, V440, P706, DOI 10.1086/175308; Renaud M, 2006, ASTROPHYS J, V647, pL41, DOI 10.1086/507300; Sato T, 2020, ASTROPHYS J, V893, DOI 10.3847/1538-4357/ab822a; Sato T, 2018, ASTROPHYS J, V853, DOI 10.3847/1538-4357/aaa021; Sato T, 2017, ASTROPHYS J, V836, DOI 10.3847/1538-4357/836/2/225; Takahashi K, 2019, ASTROPHYS J, V871, DOI 10.3847/1538-4357/aaf8a8; Takahashi K, 2018, ASTROPHYS J, V857, DOI 10.3847/1538-4357/aab95f; Takahashi K, 2016, MON NOT R ASTRON SOC, V456, P1320, DOI 10.1093/mnras/stv2649; Tashiro M., P SPIE C SER, V11444; Thorstensen JR, 2001, ASTRON J, V122, P297, DOI 10.1086/321138; Umeda H, 2005, ASTROPHYS J, V619, P427, DOI 10.1086/426097; Vance GS, 2020, ASTROPHYS J, V895, DOI 10.3847/1538-4357/ab8ade; Vartanyan D., MON NOT R ASTRON SOC, V477; Vink J, 2001, ASTROPHYS J, V560, pL79, DOI 10.1086/324172; Wanajo S, 2018, ASTROPHYS J, V852, DOI 10.3847/1538-4357/aa9d97; Wheeler JC, 2008, ASTROPHYS J, V677, P1091, DOI 10.1086/528366; Willingale R, 2002, ASTRON ASTROPHYS, V381, P1039, DOI 10.1051/0004-6361:20011614; Wongwathanarat A, 2017, ASTROPHYS J, V842, DOI 10.3847/1538-4357/aa72de; WOOSLEY SE, 1990, ASTROPHYS J, V356, P272, DOI 10.1086/168839; WOOSLEY SE, 1973, ASTROPHYS J SUPPL S, V26, P231, DOI 10.1086/190282; Yoshida T, 2008, ASTROPHYS J, V672, P1043, DOI 10.1086/523833; Yoshida T, 2019, ASTROPHYS J, V881, DOI 10.3847/1538-4357/ab2b9d	80	6	8	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					537	+		10.1038/s41586-021-03391-9	http://dx.doi.org/10.1038/s41586-021-03391-9			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6RQ	33883732	Green Submitted			2022-12-28	WOS:000687333900004
J	Beaver, JA; Pazdur, R				Beaver, Julia A.; Pazdur, Richard			"Dangling" Accelerated Approvals in Oncology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								"Dangling" Accelerated Approvals in Oncology The FDA recently reevaluated accelerated approvals for 35 oncology indications for anti-programmed death ligand 1 antibodies, revealing that for 10 indications, the required trials did not end up confirming benefit and yet their marketing authorization continued.	[Beaver, Julia A.; Pazdur, Richard] US FDA, Oncol Ctr Excellence, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Beaver, JA (corresponding author), US FDA, Oncol Ctr Excellence, Silver Spring, MD 20993 USA.							Beaver JA, 2018, JAMA ONCOL, V4, P849, DOI 10.1001/jamaoncol.2017.5618; Food and Drug Administration, 2021, FDA ONC DRUGS ADV CO; Food and Drug Administration DHHS, 2011, CDER DRUG BIOL ACC A	3	31	32	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18								10.1056/NEJMp2104846	http://dx.doi.org/10.1056/NEJMp2104846		APR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33882220				2022-12-28	WOS:000642260400001
J	Kar, P				Kar, Partha			Partha Kar: Changing the narrative around self-management	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n989	10.1136/bmj.n989	http://dx.doi.org/10.1136/bmj.n989			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883163	Bronze			2022-12-28	WOS:000642452700010
J	Taylor, L				Taylor, Luke			Covid-19: Spike in cases in Chile is blamed on people mixing after first vaccine shot	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Covid Chile, 2021, OVID CHILE CUALES SO; PAHO, 2021, PAHO DIR WARNS VACC; Tapia M., 2021, DESPUES 14 DIAS SEGU	3	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n1023	10.1136/bmj.n1023	http://dx.doi.org/10.1136/bmj.n1023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3BI	33879476	Bronze			2022-12-28	WOS:000643654700009
J	Arunachalam, PS; Walls, AC; Golden, N; Atyeo, C; Fischinger, S; Li, CF; Aye, P; Navarro, MJ; Lai, LL; Edara, VV; Roltgen, K; Rogers, K; Shirreff, L; Ferrell, DE; Wrenn, S; Pettie, D; Kraft, JC; Miranda, MC; Kepl, E; Sydeman, C; Brunette, N; Murphy, M; Fiala, B; Carter, L; White, AG; Trisal, M; Hsieh, CL; Russell-Lodrigue, K; Monjure, C; Dufour, J; Spencer, S; Doyle-Meyers, L; Bohm, RP; Maness, NJ; Roy, C; Plante, JA; Plante, KS; Zhu, A; Gorman, MJ; Shin, S; Shen, XY; Fontenot, J; Gupta, S; O'Hagan, DT; Van Der Most, R; Rappuoli, R; Coffman, RL; Novack, D; McLellan, JS; Subramaniam, S; Montefiori, D; Boyd, SD; Flynn, JL; Alter, G; Villinger, F; Kleanthous, H; Rappaport, J; Suthar, MS; King, NP; Veesler, D; Pulendran, B				Arunachalam, Prabhu S.; Walls, Alexandra C.; Golden, Nadia; Atyeo, Caroline; Fischinger, Stephanie; Li, Chunfeng; Aye, Pyone; Navarro, Mary Jane; Lai, Lilin; Edara, Venkata Viswanadh; Roltgen, Katharina; Rogers, Kenneth; Shirreff, Lisa; Ferrell, Douglas E.; Wrenn, Samuel; Pettie, Deleah; Kraft, John C.; Miranda, Marcos C.; Kepl, Elizabeth; Sydeman, Claire; Brunette, Natalie; Murphy, Michael; Fiala, Brooke; Carter, Lauren; White, Alexander G.; Trisal, Meera; Hsieh, Ching-Lin; Russell-Lodrigue, Kasi; Monjure, Christopher; Dufour, Jason; Spencer, Skye; Doyle-Meyers, Lara; Bohm, Rudolph P.; Maness, Nicholas J.; Roy, Chad; Plante, Jessica A.; Plante, Kenneth S.; Zhu, Alex; Gorman, Matthew J.; Shin, Sally; Shen, Xiaoying; Fontenot, Jane; Gupta, Shakti; O'Hagan, Derek T.; Van Der Most, Robbert; Rappuoli, Rino; Coffman, Robert L.; Novack, David; McLellan, Jason S.; Subramaniam, Shankar; Montefiori, David; Boyd, Scott D.; Flynn, JoAnne L.; Alter, Galit; Villinger, Francois; Kleanthous, Harry; Rappaport, Jay; Suthar, Mehul S.; King, Neil P.; Veesler, David; Pulendran, Bali			Adjuvanting a subunit COVID-19 vaccine to induce protective immunity	NATURE			English	Article							NEUTRALIZING ANTIBODY; RESPONSES	The development of a portfolio of COVID-19 vaccines to vaccinate the global population remains an urgent public health imperative(1). Here we demonstrate the capacity of a subunit vaccine, comprising the SARS-CoV-2 spike protein receptor-binding domain displayed on an I53-50 protein nanoparticle scaffold (hereafter designated RBD-NP), to stimulate robust and durable neutralizing-antibody responses and protection against SARS-CoV-2 in rhesus macaques. We evaluated five adjuvants including Essai O/W 1849101, a squalene-in-water emulsion; AS03, an alpha-tocopherol-containing oil-in-water emulsion; AS37, a Toll-like receptor 7 (TLR7) agonist adsorbed to alum; CpG1018-alum, a TLR9 agonist formulated in alum; and alum. RBD-NP immunization with AS03, CpG1018-alum, AS37 or alum induced substantial neutralizing-antibody and CD4 T cell responses, and conferred protection against SARS-CoV-2 infection in the pharynges, nares and bronchoalveolar lavage. The neutralizing-antibody response to live virus was maintained up to 180 days after vaccination with RBD-NP in AS03 (RBD-NP-AS03), and correlated with protection from infection. RBD-NP immunization cross-neutralized the B.1.1.7 SARS-CoV-2 variant efficiently but showed a reduced response against the B.1.351 variant. RBD-NP-AS03 produced a 4.5-fold reduction in neutralization of B.1.351 whereas the group immunized with RBD-NP-AS37 produced a 16-fold reduction in neutralization of B.1.351, suggesting differences in the breadth of the neutralizing-antibody response induced by these adjuvants. Furthermore, RBD-NP-AS03 was as immunogenic as a prefusion-stabilized spike immunogen (HexaPro) with AS03 adjuvant. These data highlight the efficacy of the adjuvanted RBD-NP vaccine in promoting protective immunity against SARS-CoV-2 and have led to phase I/II clinical trials of this vaccine (NCT04742738 and NCT04750343).	[Arunachalam, Prabhu S.; Li, Chunfeng; Trisal, Meera; Pulendran, Bali] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Walls, Alexandra C.; Navarro, Mary Jane; Wrenn, Samuel; Pettie, Deleah; Kraft, John C.; Miranda, Marcos C.; Kepl, Elizabeth; Sydeman, Claire; Brunette, Natalie; Murphy, Michael; Fiala, Brooke; Carter, Lauren; King, Neil P.; Veesler, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Golden, Nadia; Aye, Pyone; Russell-Lodrigue, Kasi; Monjure, Christopher; Dufour, Jason; Spencer, Skye; Doyle-Meyers, Lara; Bohm, Rudolph P.; Maness, Nicholas J.; Roy, Chad; Rappaport, Jay] Tulane Natl Primate Res Ctr, Covington, LA USA; [Atyeo, Caroline; Fischinger, Stephanie; Zhu, Alex; Gorman, Matthew J.; Shin, Sally; Alter, Galit] Ragon Inst MIT MGH & Harvard, Cambridge, MA USA; [Lai, Lilin; Edara, Venkata Viswanadh; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Atlanta, GA USA; [Roltgen, Katharina; Boyd, Scott D.; Pulendran, Bali] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Rogers, Kenneth; Shirreff, Lisa; Ferrell, Douglas E.; Fontenot, Jane; Villinger, Francois; King, Neil P.] Univ Louisiana Lafayette, New Iberia Res Ctr, New Iberia, LA USA; [Wrenn, Samuel; Pettie, Deleah; Kraft, John C.; Miranda, Marcos C.; Kepl, Elizabeth; Sydeman, Claire; Brunette, Natalie; Murphy, Michael; Fiala, Brooke; Carter, Lauren] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [White, Alexander G.; Flynn, JoAnne L.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [White, Alexander G.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA USA; [Hsieh, Ching-Lin; McLellan, Jason S.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Plante, Jessica A.; Plante, Kenneth S.] Univ Texas Med Branch, World Reference Ctr Emerging Viruses & Arboviruse, Galveston, TX 77555 USA; [Shen, Xiaoying; Montefiori, David] Duke Univ, Sch Med, Dept Surg, Durham, NC USA; [Gupta, Shakti; Subramaniam, Shankar] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [O'Hagan, Derek T.] GSK, Rockville, MD USA; [Van Der Most, Robbert] GSK, Rixensart, Belgium; [Rappuoli, Rino] GSK, Siena, Italy; [Coffman, Robert L.; Novack, David] Dynavax Technol Corp, Emeryville, CA USA; [Kleanthous, Harry] Bill & Melinda Gates Fdn, Seattle, WA USA; [Rappaport, Jay] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Pulendran, Bali] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; University of Washington; University of Washington Seattle; Tulane University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Stanford University; University of Louisiana Lafayette; New Iberia Research Center; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Medical Branch Galveston; Duke University; University of California System; University of California San Diego; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Bill & Melinda Gates Foundation; Tulane University; Stanford University	Pulendran, B (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Pulendran, B (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	bpulend@stanford.edu	Pulendran, Bali/AAW-9550-2021; Hsieh, Ching-Lin/ABA-6461-2021; Plante, Jessica/GRS-0172-2022; Veesler, David/HCH-3986-2022; O'Hagan, Derek/AAV-1850-2021	Plante, Jessica/0000-0002-4768-7458; Aye, Pyone Pyone/0000-0002-4764-3965; Shin, Sally/0000-0002-9306-2264; Pulendran, Bali/0000-0001-6517-4333; Fischinger, Stephanie/0000-0003-2307-3379; Spencer, Skye/0000-0001-9570-9634; li, chunfeng/0000-0001-8883-9078; Roltgen, Katharina/0000-0002-1582-1720; Brunette, Natalie/0000-0002-0558-5584; Walls, Alexandra/0000-0002-9636-8330; Edara, Venkata Viswanadh/0000-0001-9321-7839; Hsieh, Ching-Lin/0000-0002-3665-5717; Plante, Kenneth/0000-0002-7485-3167	Bill and Melinda Gates Foundation [INV -018417, INV-017592, OPP1156262]; Defense Threat Reduction Agency [HDTRA1-18-1-0001]; National Institute of General Medical Sciences [R01GM120553]; National Institute of Allergy and Infectious Diseases [DP1AI158186, HHSN272201700059C, R01-AI127521]; Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund; Fast Grants; NIAID-NIH [HHSN272201800004C]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pew Biomedical Scholars Award; Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund; Fast Grants; NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Bill and Melinda Gates Foundation INV018675 to B.P. and INV-017592 to J.S.M.; OPP1156262 to D.V. and N.P.K., a generous gift from the Audacious Project, a generous gift from J. Green and M. Halperin, a generous gift from the Hanauer family, the Defense Threat Reduction Agency (HDTRA1-18-1-0001 to N.P.K.), the National Institute of General Medical Sciences (R01GM120553 to D.V.), the National Institute of Allergy and Infectious Diseases (DP1AI158186 and HHSN272201700059C to D.V.; and R01-AI127521 to J.S.M.), a Pew Biomedical Scholars Award (D.V.), Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund (D.V.), Fast Grants (D.V.); Bill and Melinda Gates Foundation INV -018417 (J.L.F.); and NIAID-NIH Contract: HHSN272201800004C to D.M. We thank the staff at the New Iberia Research Center, UL Lafayette and the Tulane National Primate Research Center for conducting the animal studies; M. Pepper for coordination of human convalescent samples; and L. Stuart at the Bill and Melinda Gates Foundation for inputs and insights throughout the study; all the members of GSK, Dynavax and Seppic for critical reading of the manuscript. We acknowledge the generous help of Rashmi Ravichandran for protein production. The schematics were made using BioRender.	Ackerman ME, 2011, J IMMUNOL METHODS, V366, P8, DOI 10.1016/j.jim.2010.12.016; Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Arunachalam PS, 2020, NAT MED, V26, P932, DOI 10.1038/s41591-020-0858-8; Blair RV, 2021, AM J PATHOL, V191, P274, DOI 10.1016/j.ajpath.2020.10.016; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Brouwer PJM, 2021, CELL, V184, P1188, DOI 10.1016/j.cell.2021.01.035; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; Case James Brett, 2020, bioRxiv, DOI 10.1101/2020.05.18.102038; Cohet C, 2019, VACCINE, V37, P3006, DOI 10.1016/j.vaccine.2019.04.048; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Doherty M, 2016, VACCINE, V34, P6681, DOI 10.1016/j.vaccine.2016.11.015; Fischinger S, 2019, J IMMUNOL METHODS, V473, DOI 10.1016/j.jim.2019.07.002; Francica JR, 2017, BLOOD ADV, V1, P2329, DOI 10.1182/bloodadvances.2017011411; Giandhari, EMERGENCE RAPID SPRE; Hewitt JA, 2020, CELL HOST MICROBE, V28, P646, DOI 10.1016/j.chom.2020.09.016; Hsieh Ching-Lin, 2020, bioRxiv, DOI [10.1126/science.abd0826, 10.1101/2020.05.30.125484]; Karsten CB, 2019, J IMMUNOL METHODS, V471, P46, DOI 10.1016/j.jim.2019.05.006; Katzelnick LC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006862; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Liu Yang, 2021, N Engl J Med, DOI 10.1056/NEJMc2102017; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Millet Jean Kaoru, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.2035; Morel S, 2011, VACCINE, V29, P2461, DOI 10.1016/j.vaccine.2011.01.011; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Pollard AJ, 2021, NAT REV IMMUNOL, V21, P83, DOI 10.1038/s41577-020-00479-7; Pulendran B, 2021, NAT REV DRUG DISCOV, V20, P454, DOI 10.1038/s41573-021-00163-y; SADOFF J, NEW ENGL J MED; Suthar MS, 2020, CELL REP MED, V1, DOI [10.1016/j.xcrm.2020.100040, 10.1101/2020.05.03.20084442]; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1038/s41586-020-2608-y, 10.1101/2020.05.13.093195]; Vanderheiden Abigail, 2020, Curr Protoc Immunol, V131, pe116, DOI 10.1002/cpim.116; Vogel AB, 2021, NATURE, V592, P283, DOI 10.1038/s41586-021-03275-y; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walls Alexandra C, 2020, Cell, V183, P1367, DOI [10.1101/2020.08.11.247395, 10.1016/j.cell.2020.10.043]; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012; White A. G, J VIS EXP, V127; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004	48	111	115	16	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					253	+		10.1038/s41586-021-03530-2	http://dx.doi.org/10.1038/s41586-021-03530-2		APR 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ8YR	33873199	Bronze			2022-12-28	WOS:000650200200001
J	Reynolds, CJ; Pade, C; Gibbons, JM; Butler, DK; Otter, AD; Menacho, K; Fontana, M; Smit, A; Sackville-West, JE; Cutino-Moguel, T; Maini, MK; Chain, B; Noursadeghi, M; Brooks, T; Semper, A; Manisty, C; Treibel, TA; Moon, JC; Valdes, AM; McKnight, A; Altmann, DM; Boyton, R				Reynolds, Catherine J.; Pade, Corinna; Gibbons, Joseph M.; Butler, David K.; Otter, Ashley D.; Menacho, Katia; Fontana, Marianna; Smit, Angelique; Sackville-West, Jane E.; Cutino-Moguel, Teresa; Maini, Mala K.; Chain, Benjamin; Noursadeghi, Mahdad; Brooks, Tim; Semper, Amanda; Manisty, Charlotte; Treibel, Thomas A.; Moon, James C.; Valdes, Ana M.; McKnight, Aine; Altmann, Daniel M.; Boyton, Rosemary		UK COVIDsortium Immune Correlates; UK COVIDsortium Investigator	Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose	SCIENCE			English	Article							IMMUNITY	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine rollout has coincided with the spread of variants of concern. We investigated whether single-dose vaccination, with or without prior infection, confers cross-protective immunity to variants. We analyzed T and B cell responses after first-dose vaccination with the Pfizer/BioNTech messenger RNA vaccine BNT162b2 in health care workers (HCW) followed longitudinally, with or without prior Wuhan-Hu-1 SARS-CoV-2 infection. After one dose, individuals with prior infection showed enhanced T cell immunity, antibody-secreting memory B cell response to the spike protein, and neutralizing antibodies effective against variants B.1.1.7 and B.1.351. By comparison, HCW receiving one vaccine dose without prior infection showed reduced immunity against variants. B.1.1.7 and B.1.351 spike mutations resulted in increased, abrogated, or unchanged T cell responses, depending on human leukocyte antigen (HLA) polymorphisms. Single-dose vaccination with BNT162b2 in the context of prior infection with a heterologous variant substantially enhances neutralizing antibody responses against variants.	[Reynolds, Catherine J.; Butler, David K.; Boyton, Rosemary] Imperial Coll London, Dept Infect Dis, London, England; [Pade, Corinna; Gibbons, Joseph M.; McKnight, Aine] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Otter, Ashley D.; Brooks, Tim; Semper, Amanda] Publ Hlth England, Natl Infect Serv, Porton Down, England; [Menacho, Katia; Cutino-Moguel, Teresa; Manisty, Charlotte; Treibel, Thomas A.; Moon, James C.] Baits Hlth NHS Trust, St Bartholomews Hosp, London, England; [Fontana, Marianna; Smit, Angelique] Royal Free London NHS Fdn Trust, London, England; [Fontana, Marianna] UCL, Div Med, London, England; [Sackville-West, Jane E.] James Wigg Practice, London, England; [Maini, Mala K.; Chain, Benjamin; Noursadeghi, Mahdad] UCL, Div Infect & Immun, London, England; [Manisty, Charlotte; Treibel, Thomas A.; Moon, James C.] UCL, Inst Cardiovasc Sci, London, England; [Valdes, Ana M.] Nottingham City Hosp, Acad Rheumatol, Clin Sci, Nottingham, England; [Valdes, Ana M.] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham, England; [Valdes, Ana M.] Univ Nottingham, Nottingham, England; [Altmann, Daniel M.] Imperial Coll London, Dept Immunol & Inflammat, London, England; [Boyton, Rosemary] Royal Brompton & Harefield Hosp, Lung Div, London, England	Imperial College London; University of London; Queen Mary University London; Public Health England; Barts Health NHS Trust; University of London; Queen Mary University London; University of London; University College London; Royal Free London NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Nottingham University Hospital NHS Trust; University of Nottingham; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital	Boyton, R (corresponding author), Imperial Coll London, Dept Infect Dis, London, England.; Boyton, R (corresponding author), Royal Brompton & Harefield Hosp, Lung Div, London, England.	r.boyton@imperial.ac.uk	Moon, James/AAA-9905-2020; Sugimoto, Michelle Amantea/ABB-2024-2020; Gibbons, Joseph M/ABD-7726-2021; Temperton, Nigel James/M-1164-2019; Lin, Kai-Min/R-5480-2017	Moon, James/0000-0001-8071-1491; Sugimoto, Michelle Amantea/0000-0002-4527-6065; Gibbons, Joseph M/0000-0002-7238-2381; Temperton, Nigel James/0000-0002-7978-3815; Lin, Kai-Min/0000-0003-2109-1530; Butler, David/0000-0003-1882-8159; Treibel, Thomas/0000-0003-1560-7414; Otter, Ashley/0000-0002-8317-9194; Augusto, Joao/0000-0003-0040-5270; Valnarov-Boulter, Alexander/0000-0002-2591-914X; Manisty, Charlotte/0000-0003-0245-7090; McKnight, Aine/0000-0002-8113-817X; Davies, Rhodri/0000-0001-7630-7517; Kapil, Vikas/0000-0001-5778-6188; Menacho, Katia/0000-0001-5183-5655; Pade, Corinna/0000-0003-0626-2346; Di Genova, Cecilia/0000-0002-2121-0715; Noursadeghi, Mahdad/0000-0002-4774-0853; Swadling, Leo/0000-0002-0537-6715; Lee, Wing-Yiu/0000-0002-8524-3874; Schmidt, Nathalie/0000-0002-9841-8418; Valdes, Ana M./0000-0003-1141-4471; Hickling, Lauren Michaela/0000-0001-9864-4549; Reynolds, Catherine/0000-0002-1371-653X	Goldman Sachs; Citadel; Citadel Securities; Guy Foundation; GW Pharmaceuticals; Kusuma Trust; Jagclif Charitable Trust; UCLH Charity; MRC [MR/S019553/1, MR/R02622X/1, MR/V036939/1]; NIHR Imperial Biomedical Research Centre (BRC):ITMAT; Cystic Fibrosis Trust SRC [2019SRC015]; Horizon 2020 Marie Sklodowska-Curie Innovative Training Network (ITN) European Training Network [860325]; Rosetrees Trust; John Black Charitable Foundation; Medical College of St Bartholomew's Hospital Trust; University College London Hospitals (UCLH); Barts NIHR Biomedical Research Centres; British Heart Foundation (BHF) Accelerator Award [AA/18/6/34223]; BHF Intermediate Research Fellowship [FS/19/35/34374]; Wellcome Trust [207511/Z/17/Z, 214191/Z/18/Z]; NIHR Biomedical Research Funding; UKRI/NIHR UK-CIC; CRUK Immunology grant [26603]; UKRI/MRC COVID-19 Rapid response grant [COV0331 MR/V027883/1]	Goldman Sachs; Citadel; Citadel Securities; Guy Foundation; GW Pharmaceuticals; Kusuma Trust; Jagclif Charitable Trust; UCLH Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Imperial Biomedical Research Centre (BRC):ITMAT; Cystic Fibrosis Trust SRC; Horizon 2020 Marie Sklodowska-Curie Innovative Training Network (ITN) European Training Network; Rosetrees Trust(Rosetrees Trust); John Black Charitable Foundation; Medical College of St Bartholomew's Hospital Trust; University College London Hospitals (UCLH); Barts NIHR Biomedical Research Centres; British Heart Foundation (BHF) Accelerator Award; BHF Intermediate Research Fellowship; Wellcome Trust(Wellcome Trust); NIHR Biomedical Research Funding; UKRI/NIHR UK-CIC; CRUK Immunology grant; UKRI/MRC COVID-19 Rapid response grant	The COVIDsortium is supported by funding donated by individuals, charitable trusts, and corporations, including Goldman Sachs, Citadel, and Citadel Securities, the Guy Foundation, GW Pharmaceuticals, Kusuma Trust, and Jagclif Charitable Trust, and enabled by Barts Charity with support from UCLH Charity. Wider support is acknowledged on the COVIDsortium website (https://covid-consortium.com/).Institutional support from Barts Health NHS Trust and Royal Free NHS Foundation Trust facilitated study processes, in partnership with University College London and Queen Mary University of London. R.B. and D.M.A. are supported by MRC (MR/S019553/1, MR/R02622X/1, and MR/V036939/1), NIHR Imperial Biomedical Research Centre (BRC):ITMAT, Cystic Fibrosis Trust SRC (2019SRC015), and Horizon 2020 Marie Sklodowska-Curie Innovative Training Network (ITN) European Training Network (860325). A.M. is supported by Rosetrees Trust, the John Black Charitable Foundation, and Medical College of St Bartholomew's Hospital Trust. J.C.M., C.M., and T.A.T. are directly and indirectly supported by the University College London Hospitals (UCLH) and Barts NIHR Biomedical Research Centres and through a British Heart Foundation (BHF) Accelerator Award (AA/18/6/34223). T.A.T. is funded by a BHF Intermediate Research Fellowship (FS/19/35/34374). M.N. is supported by the Wellcome Trust (207511/Z/17/Z) and by NIHR Biomedical Research Funding to UCL and UCLH. M.K.M. is supported by UKRI/NIHR UK-CIC, a Wellcome Trust Investigator Award (214191/Z/18/Z), and a CRUK Immunology grant (26603). A.M.V., A.M., C.M., and J.C.M. were supported by UKRI/MRC COVID-19 Rapid response grant COV0331 MR/V027883/1. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Altmann DM, 2021, SCIENCE, V371, P1103, DOI 10.1126/science.abg7404; [Anonymous], 2021, NAT MED, V27, P183, DOI 10.1038/s41591-021-01261-5; [Anonymous], 2020, LANCET, V395, P1168, DOI 10.1016/S0140-6736(20)30822-9; [Anonymous], 2021, NAT MED, V27, P183; Augusto Joao B, 2020, Wellcome Open Res, V5, P179, DOI [10.12688/wellcomeopenres.16051.2, 10.12688/wellcomeopenres.16051.1]; Bertoletti A., 2021, OXF OPEN IMMUNOL, V2, DOI [10.1093/oxfimm/iqab006, DOI 10.1093/OXFIMM/IQAB006]; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; GISAID, TRACK VAR; Goel RR, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abi6950; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Manisty C, 2021, LANCET, V397, P1057, DOI 10.1016/S0140-6736(21)00501-8; Manisty C, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103259; Mascola J. R., 2021, JAMA-J AM MED ASSOC, V325, P1261; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Peng Y, 2020, NAT IMMUNOL, P1, DOI DOI 10.1038/s41590-020-0782-6; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Public Health England, 2021, COVID 19 LAB EV SER; Quigley KJ, 2015, AM J RESP CRIT CARE, V191, P1250, DOI 10.1164/rccm.201411-1995OC; Rambaut A., 2020, COVID 19 GENOMICS CO; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1; Reynolds C, 2015, J IMMUNOL, V194, P4814, DOI 10.4049/jimmunol.1402862; Reynolds CJ, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abf3698; Sahin U, 2020, NATURE, V586, P594, DOI 10.1038/s41586-020-2814-7; Shen XY, 2021, CELL HOST MICROBE, V29, P529, DOI 10.1016/j.chom.2021.03.002; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Treibel TA, 2020, LANCET, V395, P1608, DOI 10.1016/S0140-6736(20)31100-4; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang ZN, 2021, NAT PROD RES, DOI [10.1080/14786419.2021.1960326, 10.1038/s41586-021-03324-6]	30	146	147	4	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2021	372	6549					1418	+		10.1126/science.abh1282	http://dx.doi.org/10.1126/science.abh1282			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SY4KW	33931567	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000665860000043
J	Ota, M; Nagafuchi, Y; Hatano, H; Ishigaki, K; Terao, C; Takeshima, Y; Yanaoka, H; Kobayashi, S; Okubo, M; Shirai, H; Sugimori, Y; Maeda, J; Nakano, M; Yamada, S; Yoshida, R; Tsuchiya, H; Tsuchida, Y; Akizuki, S; Yoshifuji, H; Ohmura, K; Mimori, T; Yoshida, K; Kurosaka, D; Okada, M; Setoguchi, K; Kaneko, H; Ban, N; Yabuki, N; Matsuki, K; Mutoh, H; Oyama, S; Okazaki, M; Tsunoda, H; Iwasaki, Y; Sumitomo, S; Shoda, H; Kochi, Y; Okada, Y; Yamamoto, K; Okamura, T; Fujio, K				Ota, Mineto; Nagafuchi, Yasuo; Hatano, Hiroaki; Ishigaki, Kazuyoshi; Terao, Chikashi; Takeshima, Yusuke; Yanaoka, Haruyuki; Kobayashi, Satomi; Okubo, Mai; Shirai, Harumi; Sugimori, Yusuke; Maeda, Junko; Nakano, Masahiro; Yamada, Saeko; Yoshida, Ryochi; Tsuchiya, Haruka; Tsuchida, Yumi; Akizuki, Shuji; Yoshifuji, Hajime; Ohmura, Koichiro; Mimori, Tsuneyo; Yoshida, Ken; Kurosaka, Daitaro; Okada, Masato; Setoguchi, Keigo; Kaneko, Hiroshi; Ban, Nobuhiro; Yabuki, Nami; Matsuki, Kosuke; Mutoh, Hironori; Oyama, Sohei; Okazaki, Makoto; Tsunoda, Hiroyuki; Iwasaki, Yukiko; Sumitomo, Shuji; Shoda, Hirofumi; Kochi, Yuta; Okada, Yukinori; Yamamoto, Kazuhiko; Okamura, Tomohisa; Fujio, Keishi			Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases	CELL			English	Article							AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; PACKAGE; ASSOCIATION; LOCI; POLYMYOSITIS; INFLAMMATION; AUTOIMMUNITY; DISCOVERY	Genetic studies have revealed many variant loci that are associated with immune-mediated diseases. To elucidate the disease pathogenesis, it is essential to understand the function of these variants, especially under disease-associated conditions. Here, we performed a large-scale immune cell gene-expression analysis, together with whole-genome sequence analysis. Our dataset consists of 28 distinct immune cell subsets from 337 patients diagnosed with 10 categories of immune-mediated diseases and 79 healthy volunteers. Our dataset captured distinctive gene-expression profiles across immune cell types and diseases. Expression quantitative trait loci (eQTL) analysis revealed dynamic variations of eQTL effects in the context of immunological conditions, as well as cell types. These cell-type-specific and context-dependent eQTLs showed significant enrichment in immune disease-associated genetic variants, and they implicated the diseaserelevant cell types, genes, and environment. This atlas deepens our understanding of the immunogenetic functions of disease-associated variants under in vivo disease conditions.	[Ota, Mineto; Nagafuchi, Yasuo; Hatano, Hiroaki; Takeshima, Yusuke; Yanaoka, Haruyuki; Kobayashi, Satomi; Okubo, Mai; Shirai, Harumi; Sugimori, Yusuke; Maeda, Junko; Nakano, Masahiro; Yamada, Saeko; Yoshida, Ryochi; Tsuchiya, Haruka; Tsuchida, Yumi; Iwasaki, Yukiko; Sumitomo, Shuji; Shoda, Hirofumi; Yamamoto, Kazuhiko; Fujio, Keishi] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1130033, Japan; [Ota, Mineto; Nagafuchi, Yasuo; Takeshima, Yusuke; Okamura, Tomohisa] Univ Tokyo, Grad Sch Med, Dept Funct Genom & Immunol Dis, Tokyo 1130033, Japan; [Ishigaki, Kazuyoshi] Harvard Med Sch, Brigham & Womens Hosp, Ctr Data Sci, Boston, MA 02115 USA; [Terao, Chikashi] RIKEN, Lab Stat & Translat Genet, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Akizuki, Shuji; Yoshifuji, Hajime; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto 6068507, Japan; [Yoshida, Ken; Kurosaka, Daitaro] Jikei Univ, Dept Internal Med, Div Rheumatol, Sch Med, Tokyo 1058461, Japan; [Okada, Masato] St Lukes Int Hosp, Immunorheumatol Ctr, Tokyo 1048560, Japan; [Setoguchi, Keigo] Tokyo Metropolitan Komagome Hosp, Dept Med, Div Collagen Dis, Tokyo 1130021, Japan; [Kaneko, Hiroshi] Natl Ctr Global Hlth & Med, Div Rheumat Dis, Tokyo 1628655, Japan; [Ban, Nobuhiro; Yabuki, Nami; Matsuki, Kosuke; Mutoh, Hironori; Oyama, Sohei; Okazaki, Makoto; Tsunoda, Hiroyuki] Chugai Pharmaceut Co Ltd, Res Div, Kamakura, Kanagawa 2478530, Japan; [Kochi, Yuta] Tokyo Med & Dent Univ, Med Res Inst, Dept Genom Funct & Divers, Tokyo 1138510, Japan; [Kochi, Yuta; Yamamoto, Kazuhiko] RIKEN, Lab Autoimmune Dis, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan; [Okada, Yukinori] Osaka Univ, Dept Stat Genet, Grad Sch Med, Suita, Osaka 5650871, Japan	University of Tokyo; University of Tokyo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; RIKEN; Kyoto University; Jikei University; St. Luke's International Hospital; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; National Center for Global Health & Medicine - Japan; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Tokyo Medical & Dental University (TMDU); RIKEN; Osaka University	Fujio, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1130033, Japan.	otam-int@h.u-tokyo.ac.jp; fujiok-int@h.u-tokyo.ac.jp	Ishigaki, Kazuyoshi/ABF-6926-2021; Takeshima, Yusuke/AFV-4462-2022; Nagafuchi, Yasuo/Y-9083-2019; Ota, Mineto/AAX-1503-2021; Sumitomo, Shuji/N-3958-2018	Takeshima, Yusuke/0000-0001-8312-9309; Nagafuchi, Yasuo/0000-0002-1316-8035; Ota, Mineto/0000-0003-4552-8573; Kobayashi, Satomi/0000-0002-5454-1051; Sumitomo, Shuji/0000-0003-4980-2664; FUJIO, KEISHI/0000-0001-7276-5254	Chugai Pharmaceutical Co., Ltd., Tokyo, Japan; Center of Innovation Program from Japan Science and Technology Agency (JST) [JPMJCE1304]; Japan Agency for Medical Research and Development (AMED) [JP17ek0109103, 19ek0410047, JP20ek0410074]	Chugai Pharmaceutical Co., Ltd., Tokyo, Japan; Center of Innovation Program from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	The super-computing resource was provided by Human Genome Center, Institute of Medical Sciences, The University of Tokyo (http://sc.hgc.jp/shirokane.html).This study was supported by Chugai Pharmaceutical Co., Ltd., Tokyo, Japan; the Center of Innovation Program from Japan Science and Technology Agency (JST) (JPMJCE1304); and the Japan Agency for Medical Research and Development (AMED) (JP17ek0109103, 19ek0410047, and JP20ek0410074).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Akizuki S, 2019, ANN RHEUM DIS, V78, P509, DOI 10.1136/annrheumdis-2018-214116; Alasoo K, 2018, NAT GENET, V50, P424, DOI 10.1038/s41588-018-0046-7; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Calderon D, 2019, NAT GENET, V51, P1494, DOI 10.1038/s41588-019-0505-9; Chen L, 2016, CELL, V167, P1398, DOI 10.1016/j.cell.2016.10.026; Cho JH, 2015, NAT MED, V21, P730, DOI 10.1038/nm.3897; Chun S, 2017, NAT GENET, V49, P600, DOI 10.1038/ng.3795; Coetzee SG, 2015, BIOINFORMATICS, V31, P3847, DOI 10.1093/bioinformatics/btv470; Davenport EE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1560-8; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fort A, 2017, BIOINFORMATICS, V33, P1895, DOI 10.1093/bioinformatics/btx074; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Friedrich M, 2019, IMMUNITY, V50, P992, DOI 10.1016/j.immuni.2019.03.017; Fu B, 2017, SCI REP, V7, P1; Fujibayashi Takashi, 2004, Mod Rheumatol, V14, P425, DOI 10.3109/s10165-004-0338-x; G'Sell RT, 2015, ARTHRITIS RHEUMATOL, V67, P2292, DOI 10.1002/art.39245; Gamazon ER, 2018, NAT GENET, V50, P956, DOI 10.1038/s41588-018-0154-4; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; GRIGGS RC, 1995, ANN NEUROL, V38, P705, DOI 10.1002/ana.410380504; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoogendijk Jessica E, 2004, Neuromuscul Disord, V14, P337, DOI 10.1016/j.nmd.2004.02.006; Hormozdiari F, 2018, NAT GENET, V50, P1041, DOI 10.1038/s41588-018-0148-2; Hormozdiari F, 2016, AM J HUM GENET, V99, P1245, DOI 10.1016/j.ajhg.2016.10.003; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Ishigaki K, 2017, NAT GENET, V49, P1120, DOI 10.1038/ng.3885; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kadota K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-294; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Kim-Hellmuth S, 2020, SCIENCE, V369, P1332, DOI 10.1126/science.aaz8528; Kitching AR, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-0204-y; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lindley LE, 2015, DEVELOPMENT, V142, P893, DOI 10.1242/dev.110403; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Martin F, 2004, IMMUNITY, V20, P517, DOI 10.1016/S1074-7613(04)00112-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsuda S, 2017, J IMMUNOL, V199, P2316, DOI 10.4049/jimmunol.1700719; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Michalska A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01135; Miyagawa-Hayashino A, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1511-5; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ongen H, 2016, BIOINFORMATICS, V32, P1479, DOI 10.1093/bioinformatics/btv722; Park SH, 2017, NAT IMMUNOL, V18, P1104, DOI 10.1038/ni.3818; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saha Ashis, 2018, F1000Res, V7, P1860, DOI 10.12688/f1000research.17145.1; Satoh Y, 2013, IMMUNITY, V38, P1105, DOI 10.1016/j.immuni.2013.05.014; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; SILMAN AJ, 1990, LANCET, V335, P1078; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Sontheimer RD, 2002, J AM ACAD DERMATOL, V46, P626, DOI 10.1067/mjd.2002.120621; Sontheimer RD, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.94; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Sul JH, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003491; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Tadaka S, 2018, NUCLEIC ACIDS RES, V46, pD551, DOI 10.1093/nar/gkx978; Tawfik DM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66695-2; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Tsuchiya H., 2020, ANN RHEUM DIS ANNRHE; Urbut SM, 2019, NAT GENET, V51, P187, DOI 10.1038/s41588-018-0268-8; van Arensbergen J, 2019, NAT GENET, V51, P1160, DOI 10.1038/s41588-019-0455-2; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; van der Wijst MGP, 2018, NAT GENET, V50, P493, DOI 10.1038/s41588-018-0089-9; van Kempen TS, 2015, NAT REV RHEUMATOL, V11, P483, DOI 10.1038/nrrheum.2015.60; Vosa U., 2018, UNRAVELING POLYGENIC, DOI [10.1101/447367, DOI 10.1101/447367]; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; YAMAGUCHI M, 1992, J RHEUMATOL, V19, P424; Yee CS, 2011, RHEUMATOLOGY, V50, P982, DOI 10.1093/rheumatology/keq376; Zhang H, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0536-7; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	102	44	44	4	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					3006	+		10.1016/j.cell.2021.03.056	http://dx.doi.org/10.1016/j.cell.2021.03.056		MAY 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33930287				2022-12-28	WOS:000656965600016
J	Cui, YZ; Lyu, XH; Ding, L; Ke, L; Yang, DC; Pirouz, M; Qi, Y; Ong, J; Gao, G; Du, P; Gregory, RI				Cui, Yingzi; Lyu, Xuehui; Ding, Li; Ke, Lan; Yang, Dechang; Pirouz, Mehdi; Qi, Ye; Ong, Jennie; Gao, Ge; Du, Peng; Gregory, Richard, I			Global miRNA dosage control of embryonic germ layer specification	NATURE			English	Article							MICRORNA BIOGENESIS; ENRICHMENT ANALYSIS; MICROPROCESSOR; EXPRESSION; DGCR8; MOUSE; COMPLEX; DROSHA; DICER	MicroRNAs (miRNAs) have essential functions during embryonic development, and their dysregulation causes cancer(1,2). Altered global miRNA abundance is found in different tissues and tumours, which implies that precise control of miRNA dosage is important(1,3,4), but the underlying mechanism(s) of this control remain unknown. The protein complex Microprocessor, which comprises one DROSHA and two DGCR8 proteins, is essential for miRNA biogenesis(5-7). Here we identify a developmentally regulated miRNA dosage control mechanism that involves alternative transcription initiation (ATI) of DGCR8. ATI occurs downstream of a stem-loop in DGCR8 mRNA to bypass an autoregulatory feedback loop during mouse embryonic stem (mES) cell differentiation. Deletion ofthe stem-loop causes imbalanced DGCR8:DROSHA protein stoichiometry that drives irreversible Microprocessor aggregation, reduced primary miRNA processing, decreased mature miRNA abundance, and widespread de-repression of lipid metabolic mRNA targets. Although global miRNA dosage control is not essential for mES cells to exit from pluripotency, its dysregulation alters lipid metabolic pathways and interferes with embryonic development by disrupting germ layer specification in vitro and in vivo. This miRNA dosage control mechanism is conserved in humans. Our results identify a promoter switch that balances Microprocessor autoregulation and aggregation to precisely control global miRNA dosage and govern stem cell fate decisions during early embryonic development.	[Cui, Yingzi; Ding, Li; Ong, Jennie; Du, Peng] Peking Univ, Sch Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China; [Lyu, Xuehui; Qi, Ye; Ong, Jennie; Du, Peng] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Ke, Lan; Yang, Dechang; Gao, Ge] Peking Univ, Biomed Pioneering Innovat Ctr, Beijing Adv Innovat Ctr Genom, Beijing, Peoples R China; [Ke, Lan; Yang, Dechang; Gao, Ge] Peking Univ, Ctr Bioinformat, Sch Life Sci, Beijing, Peoples R China; [Ke, Lan; Yang, Dechang; Gao, Ge] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China; [Pirouz, Mehdi; Gregory, Richard, I] Boston Childrens Hosp, Div Hematol Oncol, Stem Cell Program, Boston, MA 02115 USA; [Pirouz, Mehdi; Gregory, Richard, I] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Gregory, Richard, I] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Gregory, Richard, I] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Gregory, Richard, I] Harvard Initiat RNA Med, Boston, MA 02115 USA	Peking University; Peking University; Peking University; Peking University; Peking University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School	Du, P (corresponding author), Peking Univ, Sch Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China.; Du, P (corresponding author), Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.; Gregory, RI (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Stem Cell Program, Boston, MA 02115 USA.; Gregory, RI (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Gregory, RI (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Gregory, RI (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.; Gregory, RI (corresponding author), Harvard Initiat RNA Med, Boston, MA 02115 USA.	pengdu@pku.edu.cn; rgregory@enders.tch.harvard.edu	ke, lan/AFP-9825-2022; Gao, Ge/F-3615-2012	Pirouz, Mehdi/0000-0002-7439-6066; Lyu, Xuehui/0000-0002-6185-1170; Gao, Ge/0000-0001-6470-8815	Natural Science Foundation of China [32050214, 32090012]; National Key Research and Development Program of China [2019YFA0110000]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [K01DK121861]; US National Institute of General Medical Sciences (NIGMS) [R01GM086386]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Kim, P. Li, Y. Qi, and X. Fu for discussions; the Biopolymer Facility at Harvard Medical School for RNA-seq and small RNA-seq Illumina high-throughput sequencing; the Core Facilities of the School of Life Sciences at Peking University, particularly S. Qin, C. Shan, L. Fu and S. Huang, for technical help with confocal imaging and radiolabelling assays; and the flow cytometry Core at National Center for Protein Sciences at Peking University, particularly H. Lyu and H. Yang, for technical help. Some work on protein purification was performed in N. Gao's laboratory (Peking University); we thank them for assistance. We thank J. Xiao's laboratory for providing the pFastBac-Dual vector, Sf21 cells and their assistance; H.-Y. Lee's laboratory and Y. Wang's laboratory for providing the K562 cells and DGCR8<SUP>-/-</SUP> cells, respectively; and F. Guo for providing the pFastBac-HTb-His<INF>6</INF>-DROSHA<SUP>390-1374</SUP> vector. This work was supported by grants to P.D. from the Natural Science Foundation of China (32050214 and 32090012) and the National Key Research and Development Program of China (2019YFA0110000), M.P. was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (K01DK121861), and a grant to R.I.G. from the US National Institute of General Medical Sciences (NIGMS) (R01GM086386).	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Case LB, 2019, SCIENCE, V363, P1093, DOI 10.1126/science.aau6313; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Du P, 2018, CELL STEM CELL, V22, P851, DOI 10.1016/j.stem.2018.04.021; Du P, 2015, CELL, V162, P885, DOI 10.1016/j.cell.2015.07.008; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Jiang S, 2019, NUCLEIC ACIDS RES, V47, P7842, DOI 10.1093/nar/gkz621; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kwon SC, 2016, CELL, V164, P81, DOI 10.1016/j.cell.2015.12.019; Lambo S, 2019, NATURE, V576, P274, DOI 10.1038/s41586-019-1815-x; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maharana S, 2018, SCIENCE, V360, P918, DOI 10.1126/science.aar7366; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Partin AC, 2020, MOL CELL, V78, P411, DOI 10.1016/j.molcel.2020.02.016; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Sladitschek HL, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20199043; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Triboulet R, 2009, RNA, V15, P1005, DOI 10.1261/rna.1591709; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Xie DQ, 2021, NAT CELL BIOL, V23, DOI 10.1038/s41556-020-00606-5; Yao X, 2018, JOVE-J VIS EXP, V133, P56844; Zhang B, 2014, ONCOGENE, V33, P3099, DOI 10.1038/onc.2013.281	37	15	15	15	59	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					602	+		10.1038/s41586-021-03524-0	http://dx.doi.org/10.1038/s41586-021-03524-0		MAY 2021	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IG	33953397	Green Accepted			2022-12-28	WOS:000647544800001
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Routes to recovery	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Downar J, 2017, CAN MED ASSOC J, V189, pE484, DOI 10.1503/cmaj.160775	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n1121	10.1136/bmj.n1121	http://dx.doi.org/10.1136/bmj.n1121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947742	Bronze			2022-12-28	WOS:000649710200010
J	Wheeler, DC; Stefansson, BV; Jongs, N				Wheeler, D. C.; Stefansson, B., V; Jongs, N.			In CKD, the effect of dapagliflozin on kidney outcomes did not vary by T2DM status or CKD cause	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC53	JC53		10.7326/ACPJ202105180-053	http://dx.doi.org/10.7326/ACPJ202105180-053			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939480				2022-12-28	WOS:000652604800008
J	Hinds, BJ				Hinds, Bruce J.			Engineering small-ion transporter channels	SCIENCE			English	Editorial Material									[Hinds, Bruce J.] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hinds, BJ (corresponding author), Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.	bjhinds@uw.edu						Gopinadhan K, 2019, SCIENCE, V363, P145, DOI 10.1126/science.aau6771; Harrell CC, 2004, J AM CHEM SOC, V126, P15646, DOI 10.1021/ja044948v; Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Kim S, 2018, NANOSCALE, V10, P20740, DOI 10.1039/c8nr05906c; Kopec W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13227-w; Majumder M, 2005, NATURE, V438, P44, DOI 10.1038/43844a; Majumder M, 2007, LANGMUIR, V23, P8624, DOI 10.1021/la700686k; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Shen YX, 2015, P NATL ACAD SCI USA, V112, P9810, DOI 10.1073/pnas.1508575112; Xue YH, 2021, SCIENCE, V372, P501, DOI 10.1126/science.abb5144	11	6	6	6	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					459	460		10.1126/science.abh2618	http://dx.doi.org/10.1126/science.abh2618			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926937				2022-12-28	WOS:000645554100023
J	Rosenstein, MG; Chang, SC; Sakowski, C; Markow, C; Teleki, S; Lang, L; Logan, J; Cape, V; Main, EK				Rosenstein, Melissa G.; Chang, Shen-Chih; Sakowski, Christa; Markow, Cathie; Teleki, Stephanie; Lang, Lance; Logan, Julia; Cape, Valerie; Main, Elliott K.			Hospital Quality Improvement Interventions, Statewide Policy Initiatives, and Rates of Cesarean Delivery for Nulliparous, Term, Singleton, Vertex Births in California	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROPHYLACTIC ANTICOAGULATION; COVID-19; TRIALS	Key PointsQuestionWhat were the rates of cesarean delivery for nulliparous, term, singleton, vertex (NTSV) births in California from 2014 to 2019 in the context of a mentor-led hospital collaborative intervention and statewide policy initiatives to reduce the rates of cesarean delivery? FindingsIn this observational study of 7574889 NTSV births that compared the rates of cesarean delivery between 2014 and 2019, the rates in California had a statistically significant decrease from 26.0% to 22.8% (relative risk, 0.88). The cesarean delivery rate for NTSV births in the US (excluding California) was 26.0% in both 2014 and 2019. MeaningBetween 2014 and 2019, the rates of cesarean delivery for NTSV births in California decreased over time in the setting of a coordinated hospital-level collaborative and statewide initiatives designed to support vaginal birth. ImportanceSafe reduction of the cesarean delivery rate is a national priority. ObjectiveTo evaluate the rates of cesarean delivery for nulliparous, term, singleton, vertex (NTSV) births in California in the context of a statewide multifaceted intervention designed to reduce the rates of cesarean delivery. Design, Setting, and ParticipantsObservational study of cesarean delivery rates from 2014 to 2019 among 7574889 NTSV births in the US and at 238 nonmilitary hospitals providing maternity services in California. From 2016 to 2019, California Maternal Quality Care Collaborative partnered with Smart Care California to implement multiple approaches to decrease the rates of cesarean delivery. Hospitals with rates of cesarean delivery greater than 23.9% for NTSV births were invited to join 1 of 3 cohorts for an 18-month quality improvement collaborative between July 2016 and June 2019. ExposuresWithin the collaborative, multidisciplinary teams implemented multiple strategies supported by mentorship, shared learning, and rapid-cycle data feedback. Partnerships among nonprofit organizations, state governmental agencies, purchasers, and health plans addressed the external environment through transparency, award programs, and incentives. Main Outcomes and MeasuresThe primary outcome was the change in cesarean delivery rates for NTSV births in California and a difference-in-differences analysis was performed to compare cesarean delivery rates for NTSV births in California vs the rates in the rest of the US. A mixed multivariable logistic regression model that adjusted for patient-level and hospital-level confounders also was used to assess the collaborative and the external statewide actions. The cesarean delivery rates for NTSV births at hospitals participating in the collaborative were compared with the rates from the nonparticipating hospitals and the rates in the participating hospitals prior to participation in the collaborative. ResultsA total of 7574889 NTSV births occurred in the US from 2014 to 2019, of which 914283 were at 238 hospitals in California. All California hospitals were exposed to the statewide actions to reduce the rates of cesarean delivery, including the 149 hospitals that had baseline rates of cesarean delivery greater than 23.9% for NTSV births, of which 91 (61%) participated in the quality improvement collaborative. The rate of cesarean delivery for NTSV births in California decreased from 26.0% (95% CI, 25.8%-26.2%) in 2014 to 22.8% (95% CI, 22.6%-23.1%) in 2019 (relative risk, 0.88; 95% CI, 0.87-0.89). The rate of cesarean delivery for NTSV births in the US (excluding California births) was 26.0% in both 2014 and 2019 (relative risk, 1.00; 95% CI, 0.996-1.005). The difference-in-differences analysis revealed that the reduction in the rate of cesarean delivery for NTSV births in California was 3.2% (95% CI, 1.7%-3.5%) higher than in the US (excluding California). Compared with the hospitals and the periods not exposed to the collaborative activities, and after adjusting for patient characteristics and time using a modified stepped-wedge analysis, exposure to collaborative activities was associated with a lower odds of cesarean delivery for NTSV births (24.4% vs 24.6%; adjusted odds ratio, 0.87 [95% CI, 0.85-0.89]). Conclusions and RelevanceIn this observational study of NTSV births in California from 2014 to 2019, the rates of cesarean delivery decreased over time in the setting of the implementation of a coordinated hospital-level collaborative and statewide initiatives designed to support vaginal birth. This population epidemiology study compares rates of cesarean delivery for nulliparous, term, singleton, vertex (NTSV) births in California before vs after a statewide intervention to reduce cesarean deliveries and compares trends in California with those in the US.	[Rosenstein, Melissa G.; Chang, Shen-Chih; Sakowski, Christa; Markow, Cathie; Cape, Valerie; Main, Elliott K.] Stanford Univ, Calif Maternal Qual Care Collaborat, Stanford, CA 94305 USA; [Rosenstein, Melissa G.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA; [Chang, Shen-Chih] Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA; [Teleki, Stephanie] Calif Hlth Care Fdn, Oakland, CA USA; [Lang, Lance] Covered Calif, Sacramento, CA USA; [Logan, Julia] Calif Dept Hlth Care Serv, Sacramento, CA USA; [Logan, Julia] Calif Publ Employees Retirement Syst, Sacramento, CA USA; [Main, Elliott K.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University; California Department of Health Care Services; Stanford University	Rosenstein, MG (corresponding author), Calif Maternal Qual Care Collaborat, Stanford Med Sch Off Bldg,1265 Welch Rd,MS 5415, Stanford, CA 94305 USA.	melissa.rosenstein@ucsf.edu						Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Al-Samkari H., 2020, RES PRACT THROMB HAE, P4; Al-Samkari H, 2020, BLOOD, V136, P489, DOI 10.1182/blood.2020006520; Barnes GD, 2020, J THROMB THROMBOLYS, V50, P72, DOI 10.1007/s11239-020-02138-z; Lemos ACB, 2020, THROMB RES, V196, P359, DOI 10.1016/j.thromres.2020.09.026; Bikdeli B, 2020, THROMB RES, V196, P638, DOI 10.1016/j.thromres.2020.09.033; Bikdeli B, 2020, THROMB RES, V196, P382, DOI 10.1016/j.thromres.2020.09.027; Bikdeli B, 2020, THROMB HAEMOSTASIS, V120, P1004, DOI 10.1055/s-0040-1713152; Bikdeli B, 2020, J AM COLL CARDIOL, V75, P2950, DOI 10.1016/j.jacc.2020.04.031; Bilaloglu S, 2020, JAMA-J AM MED ASSOC, V324, P799, DOI 10.1001/jama.2020.13372; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Cook D, 2011, NEW ENGL J MED, V364, P1305, DOI 10.1056/NEJMoa1014475; Cuker A, 2021, BLOOD ADV, V5, P872, DOI 10.1182/bloodadvances.2020003763; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Eck RJ, 2019, SEMIN THROMB HEMOST, V45, P810, DOI 10.1055/s-0039-1696965; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Hendren NS, 2021, CIRCULATION, V143, P135, DOI 10.1161/CIRCULATIONAHA.120.051936; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Jimenez D, 2021, CHEST, V159, P1182, DOI 10.1016/j.chest.2020.11.005; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.041, 10.1016/j.thromres.2020.04.013]; Levi M, 2020, LANCET HAEMATOL, V7, pE438, DOI 10.1016/S2352-3026(20)30145-9; Libby P, 2020, EUR HEART J, V41, P3038, DOI 10.1093/eurheartj/ehaa623; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Moores LK, 2020, CHEST, V158, P1143, DOI 10.1016/j.chest.2020.05.559; Pannucci CJ, 2018, PLAST RECONSTR SURG, V142, P239, DOI 10.1097/PRS.0000000000004517; Paranjpe I, 2020, J AM COLL CARDIOL, V76, P122, DOI 10.1016/j.jacc.2020.05.001; Piazza G, 2020, JAMA-J AM MED ASSOC, V324, P2548, DOI 10.1001/jama.2020.23422; Piazza G, 2020, J AM COLL CARDIOL, V76, P2060, DOI 10.1016/j.jacc.2020.08.070; Ramacciotti E, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620936350; Spyropoulos AC, 2020, BLOOD ADV, V4, P4028, DOI 10.1182/bloodadvances.2020002496; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Talasaz AH, 2021, J AM COLL CARDIOL, V77, P1903, DOI 10.1016/j.jacc.2021.02.035; Tomazini BM, 2020, JAMA-J AM MED ASSOC, V324, P1307, DOI 10.1001/jama.2020.17021; White D, 2020, J THROMB THROMBOLYS, V50, P287, DOI 10.1007/s11239-020-02145-0; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Yamakawa K, 2019, CLIN APPL THROMB-HEM, V25, DOI 10.1177/1076029619835055	37	9	9	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1631	1639		10.1001/jama.2021.3816	http://dx.doi.org/10.1001/jama.2021.3816			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904868	Green Published, Bronze			2022-12-28	WOS:000645617800020
J	van der Meij, A; Wermer, MJH				van der Meij, Anne; Wermer, Marieke J. H.			Vagus nerve stimulation: a potential new treatment for ischaemic stroke	LANCET			English	Editorial Material							REHABILITATION		[van der Meij, Anne; Wermer, Marieke J. H.] Leiden Univ, Dept Neurol, Med Ctr, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van der Meij, A (corresponding author), Leiden Univ, Dept Neurol, Med Ctr, NL-2333 ZA Leiden, Netherlands.	a.van_der_meij@lumc.nl						[Anonymous], 2019, LANCET NEUROL; Ay I, 2016, BRAIN STIMUL, V9, P166, DOI 10.1016/j.brs.2015.11.008; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Bornstein NM, 2019, LANCET, V394, P219, DOI 10.1016/S0140-6736(19)31192-4; Dawson J, 2021, LANCET, V397, P1545, DOI 10.1016/S0140-6736(21)00475-X; Dawson J, 2016, STROKE, V47, P143, DOI 10.1161/STROKEAHA.115.010477; Goadsby PJ, 2018, CEPHALALGIA, V38, P959, DOI 10.1177/0333102417744362; Khodaparast N, 2014, NEUROREHAB NEURAL RE, V28, P698, DOI 10.1177/1545968314521006; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Schroeder CF, 2019, NEUROLOGY, V93, pE518, DOI 10.1212/WNL.0000000000007857; Tassorelli C, 2018, NEUROLOGY, V91, pE364, DOI 10.1212/WNL.0000000000005857	11	5	5	3	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1520	1521						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RR7QA	33894818				2022-12-28	WOS:000643286900002
J	Essex, R; Talagala, I; Dada, O; Rao, M				Essex, Ryan; Talagala, Ishanka; Dada, Olamide; Rao, Mala			Clinical Excellence Awards-time for a fairer NHS rewards scheme	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; DISTINCTION AWARDS; PAY; PERFORMANCE; CONSULTANTS; ENGLAND; SYSTEM; WALES		[Essex, Ryan] Univ Greenwich, Old Royal Naval Coll, London SE10 9LS, England; [Talagala, Ishanka] Minist Hlth, Colombo 10, Sri Lanka; [Dada, Olamide] Cardiff Univ, Sch Med, Cardiff, Wales; [Rao, Mala] Imperial Coll London, Dept Primary Care & Publ Hlth, Ethn & Hlth Unit, London, England	University of Greenwich; Cardiff University; Imperial College London	Essex, R (corresponding author), Univ Greenwich, Old Royal Naval Coll, London SE10 9LS, England.	r.w.essex@gre.ac.uk	Essex, Ryan/O-2855-2019; Talagala, Ishanka/GNW-4551-2022	Essex, Ryan/0000-0003-3497-3137; Talagala, Ishanka/0000-0001-6351-2079				Abel P, 2006, J ROY SOC MED, V99, P487, DOI 10.1258/jrsm.99.10.487; Advisory Committee on Clinical Excellence Awards, 2017, ANN REP COV 2016 AW; Advisory Committee on Clinical Excellence Awards, 2019, GUID ASS NAT CLIN EX; Advisory Committee on Clinical Excellence Awards, 2003, GUID NHS CONS CLIN E; Advisory Committee on Clinical Excellence Awards, 2020, GUID APPL NAT CLIN E; Advisory Committee on Clinical Excellence Awards, 2019, 2019 ACCEA ANN REP C; Advisory Committee on Clinical Excellence Awards, 2016, ADV COMM CLIN EXC AW; Advisory Committee on Clinical Excellence Awards (ACCEA), 2018, ACCEA ANN REP COV 20; Alshamsan R, 2010, J HEALTH SERV RES PO, V15, P178, DOI 10.1258/jhsrp.2010.009113; [Anonymous], 2020, NHS WORKFORCE; Appleby J., 2018, WHAT IS ETHNICITY PA; Appleby J, 2018, GENDER PAY GAP ENGLI; Bloor K, 1998, BRIT MED J, V316, P569, DOI 10.1136/bmj.316.7131.569; British Medical Association, CONS WORKF SHORT SOL; British Medical Association, 2020, CONS AW SCH CLIN EXC; BRUGGEN P, 1982, BRIT MED J, V284, P1577, DOI 10.1136/bmj.284.6328.1577; Bucciol A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112631; Campbell JL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011958; Department of Health and Social Care, 2020, MEND GAP IND REV GEN; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Esmail A, 2003, BRIT MED J, V326, P687, DOI 10.1136/bmj.326.7391.687; Jha AK, 2013, JAMA-J AM MED ASSOC, V309, P347, DOI 10.1001/jama.2012.196646; Kalra V S, 2009, J Health Organ Manag, V23, P103; Lambert TW, 2004, BMJ-BRIT MED J, V328, P1347, DOI 10.1136/bmj.38062.639190.44; Mathes T, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011156.pub2; Mir F., 2021, BMJ-BRIT MED J; National Cost Collection for the NHS, 201819 NAT COST COLL; NHS, 2021, PRIM CAR COMM; NHS Employers, LOC CLIN EXC AW ARR; NHS Hospital and Community Health Service (HCHS) Monthly workforce statistics, 2020, NHS DIG; Pohler D, 2016, PERS PSYCHOL, V69, P395, DOI 10.1111/peps.12106; Review Body on Doctors' and Dentists' Remuneration, 2012, REV COMPENSATION LEV; Surash S., 2019, SURASH PEARCE REPORT	33	2	2	4	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2021	373								n876	10.1136/bmj.n876	http://dx.doi.org/10.1136/bmj.n876			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH9UK	33893141	Green Accepted			2022-12-28	WOS:000708014600001
J	Errickson, FC; Keller, K; Collins, WD; Srikrishnan, V; Anthoff, D				Errickson, Frank C.; Keller, Klaus; Collins, William D.; Srikrishnan, Vivek; Anthoff, David			Equity is more important for the social cost of methane than climate uncertainty	NATURE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; EMISSIONS; MODEL; CO2; SYSTEM; CYCLE; MITIGATION; BENEFITS; OCEAN; WELL	The social cost of methane (SC-CH4) measures the economic loss of welfare caused by emitting one tonne of methane into the atmosphere. This valuation may in turn be used in cost-benefit analyses or to inform climate policies(1-3). However, current SC-CH4 estimates have not included key scientific findings and observational constraints. Here we estimate the SC-CH4 by incorporating the recent upward revision of 25 per cent to calculations of the radiative forcing of methane(4), combined with calibrated reduced-form global climate models and an ensemble of integrated assessment models (IAMs). Our multi-model mean estimate for the SC-CH4 is US$933 per tonne of CH4 (5-95 per cent range, US$471-1,570 per tonne of CH4) under a high-emissions scenario (Representative Concentration Pathway (RCP) 8.5), a 22 per cent decrease compared to estimates based on the climate uncertainty framework used by the US federal government(5). Our ninety-fifth percentile estimate is 51 per cent lower than the corresponding figure from the US framework. Under a low-emissions scenario (RCP 2.6), our multi-model mean decreases to US$710 per tonne of CH4. Tightened equilibrium climate sensitivity estimates paired with the effect of previously neglected relationships between uncertain parameters of the climate model lower these estimates. We also show that our SC-CH4 estimates are sensitive to model combinations; for example, within one IAM, different methane cycle sub-models can induce variations of approximately 20 per cent in the estimated SC-CH4. But switching IAMs can more than double the estimated SC-CH4. Extending our results to account for societal concerns about equity produces SC-CH4 estimates that differ by more than an order of magnitude between low- and high-income regions. Our central equity-weighted estimate for the USA increases to US$8,290 per tonne of CH4 whereas our estimate for sub-Saharan Africa decreases to US$134 per tonne of CH4.	[Errickson, Frank C.] Princeton Univ, Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Errickson, Frank C.; Anthoff, David] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Keller, Klaus; Srikrishnan, Vivek] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Keller, Klaus] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Collins, William D.] Lawrence Berkeley Natl Lab, Climate & Ecol Sci Div, Berkeley, CA USA; [Collins, William D.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Srikrishnan, Vivek] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA	Princeton University; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Cornell University	Anthoff, D (corresponding author), Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA.	anthoff@berkeley.edu	Collins, William/J-3147-2014; Srikrishnan, Vivek/J-1966-2015	Collins, William/0000-0002-4463-9848; Srikrishnan, Vivek/0000-0003-0049-3805				Anthoff D., 2009, WP278 ESRI; Anthoff D, 2014, CLIMATE FRAMEWORK UN; Anthoff D, 2009, ECOL ECON, V68, P836, DOI 10.1016/j.ecolecon.2008.06.017; Carleton TA, 2016, SCIENCE, V353, DOI 10.1126/science.aad9837; Dennig F, 2015, P NATL ACAD SCI USA, V112, P15827, DOI 10.1073/pnas.1513967112; Diaz D, 2017, NAT CLIM CHANGE, V7, P774, DOI 10.1038/NCLIMATE3411; DLUGOKENCKY EJ, 1994, J GEOPHYS RES-ATMOS, V99, P17021, DOI 10.1029/94JD01245; EPA, 2016, REGULATORY IMPACT AN; Etheridge DM, 1998, J GEOPHYS RES-ATMOS, V103, P15979, DOI 10.1029/98JD00923; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Etminan M, 2016, GEOPHYS RES LETT, V43, P12614, DOI 10.1002/2016GL071930; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gilks W. R., 1996, MARKOV CHAIN MONTE C, P1, DOI DOI 10.1201/B14835; Gouretski V, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027834; Harmsen MJHM, 2015, CLIMATIC CHANGE, V133, P565, DOI 10.1007/s10584-015-1485-0; Hartin CA, 2015, GEOSCI MODEL DEV, V8, P939, DOI 10.5194/gmd-8-939-2015; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hof AF, 2012, CLIMATIC CHANGE, V113, P897, DOI 10.1007/s10584-011-0363-7; Hope C, 2005, CLIMATIC CHANGE, V68, P21, DOI 10.1007/s10584-005-1052-1; Hope CW, 2006, CLIM POLICY, V6, P537; Interagency working group on social cost of greenhouse gases US Government, 2016, ADD TECHN SUPP DOC S; Interagency Working Group on the Social Cost of Carbon United States Government, 2010, 12866 INT WORK GROUP; KEELING CD, 1976, TELLUS, V28, P538, DOI 10.1111/j.2153-3490.1976.tb00701.x; Koen C, 2005, MON NOT R ASTRON SOC, V361, P887, DOI 10.1111/j.1365-2966.2005.09213.x; Kriegler E, 2005, THESIS U POTSDAM; Le Quere C, 2018, EARTH SYST SCI DATA, V10, P2141, DOI 10.5194/essd-10-2141-2018; Marten AL, 2015, CLIM POLICY, V15, P272, DOI 10.1080/14693062.2014.912981; Marten AL, 2012, ENERG POLICY, V51, P957, DOI 10.1016/j.enpol.2012.09.073; Marten AL, 2011, ECONOMICS-KIEL, V5, DOI 10.5018/economics-ejournal.ja.2011-18; Matthey A., 2019, METHODENKONVENTION 3; McNeil BI, 2003, SCIENCE, V299, P235, DOI 10.1126/science.1077429; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M., 2010, RCP CONCENTRATION CA; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Meng XL, 1996, STAT SINICA, V6, P831; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; Natl Acad Sci Engn Med, 2017, VALUING CLIMATE DAMAGES: UPDATING ESTIMATION OF THE SOCIAL COST OF CARBON DIOXIDE, P1, DOI 10.17226/24651; Nordhaus W., 2013, DICE 2013R INTRO USE; Nordhaus W., 2011, 1826 COWL FDN; Page EA, 2008, ENVIRON POLIT, V17, P556, DOI 10.1080/09644010802193419; Reilly J, 1999, NATURE, V401, P549, DOI 10.1038/44069; Ricciuto DM, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002908; Roe GH, 2007, SCIENCE, V318, P629, DOI 10.1126/science.1144735; Ruckert KL, 2017, CLIMATIC CHANGE, V140, P349, DOI 10.1007/s10584-016-1858-z; Scovronick N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09499-x; Sherwood SC, 2020, REV GEOPHYS, V58, DOI 10.1029/2019RG000678; Shiell L, 2003, J ENVIRON ECON MANAG, V46, P38, DOI 10.1016/S0095-0696(02)00028-1; Shindell DT, 2017, FARADAY DISCUSS, V200, P429, DOI 10.1039/c7fd00009j; SMITH AFM, 1993, J ROY STAT SOC B MET, V55, P3; Smith CJ, 2018, GEOSCI MODEL DEV, V11, P2273, DOI 10.5194/gmd-11-2273-2018; Smith MR, 2018, NAT CLIM CHANGE, V8, P834, DOI 10.1038/s41558-018-0253-3; Swansea Bay University Heath Board, 2018, OUR ORG STRAT 2019 2; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; Tol, 2007, AGGREGATED CARBON CY; Tol RSJ, 2003, CLIMATIC CHANGE, V57, P71, DOI 10.1023/A:1022196517982; Urban NM, 2014, GEOPHYS RES LETT, V41, P2543, DOI 10.1002/2014GL059484; Urban NM, 2010, TELLUS A, V62, P737, DOI 10.1111/j.1600-0870.2010.00471.x; US Bureau of Labor Statistics, CPI INFL CALC; Vihola M, 2012, STAT COMPUT, V22, P997, DOI 10.1007/s11222-011-9269-5; Waldhoff S, 2014, ECONOMICS-KIEL, V8, DOI 10.5018/economics-ejournal.ja.2014-31; Weyant JR, 2006, ENERG J, P1; Wong TE, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aacb3d; ZELLNER A, 1964, J AM STAT ASSOC, V59, P763, DOI 10.2307/2283097	68	11	12	6	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					564	+		10.1038/s41586-021-03386-6	http://dx.doi.org/10.1038/s41586-021-03386-6			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	UD6SB	33883735				2022-12-28	WOS:000687335200001
J	Galli, M; Benenati, S; Capodanno, D; Franchi, F; Rollini, F; D'Amario, D; Porto, I; Angiolillo, DJ				Galli, Mattia; Benenati, Stefano; Capodanno, Davide; Franchi, Francesco; Rollini, Fabiana; D'Amario, Domenico; Porto, Italo; Angiolillo, Dominick J.			Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis	LANCET			English	Review							DRUG-ELUTING STENTS; PLATELET-FUNCTION; CYP2C19 GENOTYPE; OPEN-LABEL; CLOPIDOGREL; OUTCOMES; PCI; POLYMORPHISMS; IMPLANTATION; TICAGRELOR	Background Whether guided selection of antiplatelet therapy in patients undergoing percutaneous coronary intervention (PCI) is effective in improving outcomes compared with standard antiplatelet therapy remains controversial. We assessed the safety and efficacy of guided versus standard selection of antiplatelet therapy in patients undergoing PCI. Methods For this systematic review and meta-analysis, from Aug 20 to Oct 25, 2020, we searched MEDLINE (via PubMed), Cochrane, Embase, and Web of Science databases for randomised controlled trials and observational studies published in any language that compared guided antiplatelet therapy, by means of platelet function testing or genetic testing, versus standard antiplatelet therapy in patients undergoing PCI. Two reviewers independently assessed study eligibility, extracted the data, and assessed risk of bias. Risk ratios (RRs) and 95% CIs were used with random-effects or fixed-effect models according to the estimated heterogeneity among studies assessed by the I-2 index. Coprimary endpoints were trial-defined primary major adverse cardiovascular events and any bleeding. Key secondary endpoints were all-cause death, cardiovascular death, myocardial infarction, stroke, definite or probable stent thrombosis, and major and minor bleeding. This study is registered with PROSPERO (CRD42021215901). Findings 3656 potentially relevant articles were screened. Our analysis included 11 randomised controlled trials and three observational studies with data for 20 743 patients. Compared with standard therapy, guided selection of antiplatelet therapy was associated with a reduction in major adverse cardiovascular events (RR 0.78, 95% CI 0.63-0.95, p=0.015) and reduced bleeding, although not statistically significant (RR 0.88, 0.77-1.01, p=0.069). Cardiovascular death (RR 0.77, 95% CI 0.59-1.00, p=0.049), myocardial infarction (RR 0.76, 0.60-0.96, p=0.021), stent thrombosis (RR 0.64, 0.46-0.89, p=0.011), stroke (RR 0.66, 0.48-0.91, p=0.010), and minor bleeding (RR 0.78, 0.67-0.92, p=0.0030) were reduced with guided therapy compared with standard therapy. Risks of all-cause death and major bleeding did not differ between guided and standard approaches. Outcomes varied according to the strategy used, with an escalation approach associated with a significant reduction in ischaemic events without any trade-off in safety, and a de-escalation approach associated with a significant reduction in bleeding, without any trade-off in efficacy. Interpretation Guided selection of antiplatelet therapy improved both composite and individual efficacy outcomes with a favourable safety profile, driven by a reduction in minor bleeding, supporting the use of platelet function or genetic testing to optimise the choice of agent in patients undergoing PCI. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Galli, Mattia; D'Amario, Domenico] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Thorac Sci, Fdn Policlin Univ A Gemelli IRCCS, Rome, Italy; [Galli, Mattia; Franchi, Francesco; Rollini, Fabiana; Angiolillo, Dominick J.] Univ Florida, Div Cardiol, Coll Med, Jacksonville, FL 32209 USA; [Benenati, Stefano; Porto, Italo] Univ Genoa, Dept Internal Med & Med Specialties DIMI, Chair Cardiovasc Dis, Genoa, Italy; [Capodanno, Davide] Univ Catania, Azienda Osped Univ Policlin Gaspare Rodol San Mar, Catania, Italy; [Porto, Italo] San Martino Hosp, DICATOV Cardiothorack & Vasc Dept, IRCCS Oncol & Neurosci, Genoa, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; State University System of Florida; University of Florida; University of Genoa; University of Catania; University of Genoa; IRCCS AOU San Martino IST	Angiolillo, DJ (corresponding author), Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA.	dominick.angiolillo@jax.ufl.edu	Galli, Mattia/AAL-9666-2020; D'Amario, Domenico/L-3603-2018; Porto, Italo/V-5801-2019	Galli, Mattia/0000-0003-3909-182X; Porto, Italo/0000-0002-9854-5046; Benenati, Stefano/0000-0001-9669-4278	Fondazione Enrico ed Enrica Sovena (Rome, Italy)	Fondazione Enrico ed Enrica Sovena (Rome, Italy)	This work was not funded. MG is supported by a grant from Fondazione Enrico ed Enrica Sovena (Rome, Italy).	Angiolillo DJ, 2020, JACC-CARDIOVASC INTE, V13, P606, DOI 10.1016/j.jcin.2020.01.226; Angiolillo DJ, 2017, CIRCULATION, V136, P1955, DOI 10.1161/CIRCULATIONAHA.117.031164; Angiolillo DJ, 2017, LANCET, V390, P1718, DOI 10.1016/S0140-6736(17)32279-1; Aradi D, 2015, EUR HEART J, V36, P1762, DOI 10.1093/eurheartj/ehv104; Capodanno D, 2018, J AM COLL CARDIOL, V72, P2915, DOI 10.1016/j.jacc.2018.09.057; Cayla G, 2016, LANCET, V388, P2015, DOI 10.1016/S0140-6736(16)31323-X; Claassens DMF, 2019, NEW ENGL J MED, V381, P1621, DOI 10.1056/NEJMoa1907096; Collet JP, 2021, EUR HEART J, V42, P2020, DOI 10.1093/eurheartj/ehaa909; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Franchi Francesco, 2014, Curr Treat Options Cardiovasc Med, V16, P300, DOI 10.1007/s11936-014-0300-y; Hazarbasanov D, 2012, J THROMB THROMBOLYS, V34, P85, DOI 10.1007/s11239-012-0684-z; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Lee CH, 2018, AM J CARDIOL, V121, P423, DOI 10.1016/j.amjcard.2017.11.005; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1186/2046-4053-4-1, 10.1136/bmj.b2535]; Moon JY, 2018, EXPERT REV CLIN PHAR, V11, P151, DOI 10.1080/17512433.2017.1353909; Neumann FJ, 2019, EUR HEART J, V40, P79, DOI 10.1093/eurheartj/ehy855; Notarangelo FM, 2018, J AM COLL CARDIOL, V71, P1869, DOI 10.1016/j.jacc.2018.02.029; Pereira NL, 2020, JAMA-J AM MED ASSOC, V324, P761, DOI 10.1001/jama.2020.12443; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Richardson M, 2019, CLIN EPIDEMIOL GLOB, V7, P192, DOI 10.1016/j.cegh.2018.05.005; Sanchez-Ramos J, 2016, INT J CARDIOL, V225, P289, DOI 10.1016/j.ijcard.2016.09.088; Shen DL, 2016, J CARDIOVASC PHARM, V67, P232, DOI 10.1097/FJC.0000000000000337; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2019, JACC-CARDIOVASC INTE, V12, P1521, DOI 10.1016/j.jcin.2019.03.034; Sibbing D, 2017, LANCET, V390, P1747, DOI 10.1016/S0140-6736(17)32155-4; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026; Tuteja S, 2020, CIRC-GENOM PRECIS ME, V13, DOI 10.1161/CIRCGEN.119.002640; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Xie X, 2013, INT J CARDIOL, V168, P3736, DOI 10.1016/j.ijcard.2013.06.014; Zheng YY, 2020, EUR HEART J-CARD PHA, V6, P211, DOI 10.1093/ehjcvp/pvz059; Zhu HC, 2015, J GERIATR CARDIOL, V12, P23, DOI 10.11909/j.issn.1671-5411.2015.01.003	37	62	63	4	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1470	1483						14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN5FX	33865495				2022-12-28	WOS:000640378100024
J	Sacks, CA				Sacks, Chana A.			Orf	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material														Qiu, Cecil/0000-0003-2001-3864					0	1	1	3	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1552	1552		10.1056/NEJMicm2029641	http://dx.doi.org/10.1056/NEJMicm2029641		APR 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RQ6OT	33882630				2022-12-28	WOS:000641396300001
J	Torjesen, I				Torjesen, Ingrid			Covid-19: Risk of cerebral blood clots from disease is 10 times that from vaccination, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n931; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n774; Taquet M., CEREBRAL VENOUS THRO, DOI 10.1101/2021.04.27.21256153	4	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2021	373								n1005	10.1136/bmj.n1005	http://dx.doi.org/10.1136/bmj.n1005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RO8VU	33863757	Bronze			2022-12-28	WOS:000641319600013
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: US relaxes rules on mask wearing for fully vaccinated people	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Biden, 2021, **NON-TRADITIONAL**; Centers for Disease Control and Prevention, 2021, TWITTER; Centers for Disease Control and Prevention, 2021, YOUVE BEEN FULLY VAC; Stankiewicz K., 2021, CNBC COM 0428	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2021	373								n1115	10.1136/bmj.n1115	http://dx.doi.org/10.1136/bmj.n1115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UG4QI	33926894	Bronze			2022-12-28	WOS:000689238700004
J	Dluhy, LA; Abel, B; Dluhy, RG				Dluhy, Leonore A.; Abel, Brendan; Dluhy, Robert G.			Establishing Medical Civil Rights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dluhy, Leonore A.; Dluhy, Robert G.] Med Civil Rights Comm, Boston, MA 02110 USA; [Abel, Brendan] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA; [Dluhy, Robert G.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Abel, Brendan] Massachusetts Med Soc, Waltham, MA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dluhy, LA (corresponding author), Med Civil Rights Comm, Boston, MA 02110 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2021	385	6					490	491		10.1056/NEJMp2104468	http://dx.doi.org/10.1056/NEJMp2104468		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TZ7DN	33909960				2022-12-28	WOS:000645679400001
J	Stuart, B; Hounkpatin, H; Becque, T; Yao, GQ; Zhu, SH; Alonso-Coello, P; Altiner, A; Arroll, B; Bohning, D; Bostock, J; Bucher, HC; Chao, J; de la Poza, M; Francis, N; Gillespie, D; Hay, AD; Kenealy, T; Loffler, C; McCormick, DP; Mas-Dalmau, G; Munoz, L; Samuel, K; Moore, M; Little, P				Stuart, Beth; Hounkpatin, Hilda; Becque, Taeko; Yao, Guiqing; Zhu, Shihua; Alonso-Coello, Pablo; Altiner, Attila; Arroll, Bruce; Boehning, Dankmar; Bostock, Jennifer; Bucher, Heiner C.; Chao, Jennifer; de la Poza, Mariam; Francis, Nick; Gillespie, David; Hay, Alastair D.; Kenealy, Timothy; Loeffler, Christin; McCormick, David P.; Mas-Dalmau, Gemma; Munoz, Laura; Samuel, Kirsty; Moore, Michael; Little, Paul			Delayed antibiotic prescribing for respiratory tract infections: individual patient data meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE OTITIS-MEDIA; HEMOLYTIC STREPTOCOCCAL PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; ACUTE SORE THROAT; PARTICIPANT DATA; STRATEGIES; IMMEDIATE; COMPLICATIONS; PRESCRIPTION; THERAPY	OBJECTIvE To assess the overall effect of delayed antibiotic prescribing on average symptom severity for patients with respiratory tract infections in the community, and to identify any factors modifying this effect. DESIGN Systematic review and individual patient data meta-analysis. DATA SOURCES Cochrane Central Register of Controlled Trials, Ovid Medline, Ovid Embase, EBSCO CINAHL Plus, and Web of Science. ELIGIBILITY CRITERIA FOR STUDY SELECTION Randomised controlled trials and observational cohort studies in a community setting that allowed comparison between delayed versus no antibiotic prescribing, and delayed versus immediate antibiotic prescribing. MAIN OUTCOME MEASURES The primary outcome was the average symptom severity two to four days after the initial consultation measured on a seven item scale (ranging from normal to as bad as could be). Secondary outcomes were duration of illness after the initial consultation, complications resulting in admission to hospital or death, reconsultation with the same or worsening illness, and patient satisfaction rated on a Likert scale. RESULTS Data were obtained from nine randomised controlled trials and four observational studies, totalling 55 682 patients. No difference was found in follow-up symptom severity (seven point scale) for delayed versus immediate antibiotics (adjusted mean difference-0.003, 95% confidence interval-0.12 to 0.11) or delayed versus no antibiotics (0.02,-0.11 to 0.15). Symptom duration was slightly longer in those given delayed versus immediate antibiotics (11.4 v 10.9 days), but was similar for delayed versus no antibiotics. Complications resulting in hospital admission or death were lower with delayed versus no antibiotics (odds ratio 0.62, 95% confidence interval 0.30 to 1.27) and delayed versus immediate antibiotics (0.78, 0.53 to 1.13). A significant reduction in reconsultation rates (odds ratio 0.72, 95% confidence interval 0.60 to 0.87) and an increase in patient satisfaction (adjusted mean difference 0.09, 0.06 to 0.11) were observed in delayed versus no antibiotics. The effect of delayed versus immediate antibiotics and delayed versus no antibiotics was not modified by previous duration of illness, fever, comorbidity, or severity of symptoms. Children younger than 5 years had a slightly higher follow-up symptom severity with delayed antibiotics than with immediate antibiotics (adjusted mean difference 0.10, 95% confidence interval 0.03 to 0.18), but no increased severity was found in the older age group. CONCLUSIONS Delayed antibiotic prescribing is a safe and effective strategy for most patients, including those in higher risk subgroups. Delayed prescribing was associated with similar symptom duration as no antibiotic prescribing and is unlikely to lead to poorer symptom control than immediate antibiotic prescribing. Delayed prescribing could reduce reconsultation rates and is unlikely to be associated with an increase in symptoms or illness duration, except in young children. STUDY REGISTRATION PROSPERO CRD42018079400.	[Stuart, Beth; Hounkpatin, Hilda; Becque, Taeko; Zhu, Shihua; Francis, Nick; Moore, Michael; Little, Paul] Univ Southampton, Acad Unit Primary Care Populat Sci & Med Educ, Fac Med, Southampton SO16 5ST, Hants, England; [Yao, Guiqing] Univ Leicester, Coll Life Sci, Dept Hlth Sci, Biostat Res Grp, Leicester, Leics, England; [Alonso-Coello, Pablo] Inst Invest Biomed St Pau IIB St Pau CIBERESP, Iberoamer Cochrane Ctr, Barcelona, Spain; [Altiner, Attila; Loeffler, Christin] Rostock Univ, Inst Gen Practice, Med Ctr, Rostock, Germany; [Arroll, Bruce; Kenealy, Timothy] Univ Auckland, Dept Gen Practice & Primary Hlth Care, Auckland, New Zealand; [Boehning, Dankmar] Univ Southampton, Southampton Stat Sci Res Inst, Southampton, Hants, England; [Bostock, Jennifer] Kings Coll London, Div Hlth & Social Care Res, London, England; [Bucher, Heiner C.] Univ Hosp Basel, Basel Inst Clin Epidemiol & Biostat CEB, Basel, Switzerland; [Bucher, Heiner C.] Univ Basel, Basel, Switzerland; [Chao, Jennifer] SUNY Downstate, Pediat Emergency Med, Brooklyn, NY USA; [de la Poza, Mariam] Inst Catala Salut, Cap Doctor Carles Ribas, Foc 112, Barcelona, Spain; [Gillespie, David] Cardiff Univ, Coll Biomed & Life Sci, Ctr Trials Res, Sch Med, Cardiff, Wales; [Hay, Alastair D.] Univ Bristol, Ctr Acad Primary Care Populat Hlth Sci Bristol, Bristol Med Sch, Bristol, Avon, England; [McCormick, David P.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Mas-Dalmau, Gemma] Inst Invest Biomed St Pau IIB St Pau, Barcelona, Spain; [Munoz, Laura] Agencia Qualitat & Avaluacio Sanitaries Catalunya, Barcelona, Spain; [Samuel, Kirsty] Univ Leeds, Leeds Inst Hlth Sci, Aspire PPI Panel, Leeds, W Yorkshire, England	University of Southampton; University of Leicester; University of Rostock; University of Auckland; University of Southampton; University of London; King's College London; University of Basel; University of Basel; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Cardiff University; University of Bristol; University of Texas System; University of Texas Medical Branch Galveston; University of Leeds	Stuart, B (corresponding author), Univ Southampton, Acad Unit Primary Care Populat Sci & Med Educ, Fac Med, Southampton SO16 5ST, Hants, England.	bls1@soton.ac.uk	Francis, Nick/B-7413-2009; Moore, Michael/C-3447-2011	Francis, Nick/0000-0001-8939-7312; Hounkpatin, Hilda/0000-0002-1360-1791; Hay, Alastair/0000-0003-3012-375X; Bohning, Dankmar/0000-0003-0638-7106; Becque, Taeko/0000-0002-0362-3794; Stuart, Beth/0000-0001-5432-7437; Moore, Michael/0000-0002-5127-4509	NIHR Research for Patient Benefit (RfPB) Programme [PB-PG-0416-20005]	NIHR Research for Patient Benefit (RfPB) Programme	This work was funded by the NIHR Research for Patient Benefit (RfPB) Programme (grant No PB-PG-0416-20005). This funding supported the collation of the individual participant data, data management and analyses. The NIHR RfPB was not involved in any other aspect of the project, such as the design of the project's protocol and analysis plan, the collection and analyses. The funder had no input on the interpretation or publication of the study results.	Akl EA, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0083-6; [Anonymous], 1998, PATH LEAST RES MAIN; Arroll B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000247.pub2; Arroll B, 2002, J FAM PRACTICE, V51, P324; Bruyndonckx R, 2018, CLIN MICROBIOL INFEC, V24, P871, DOI 10.1016/j.cmi.2017.10.032; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Chao JH, 2008, PEDIATRICS, V121, pE1352, DOI 10.1542/peds.2007-2278; Cooke J, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2015-000086; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Abad MD, 2016, JAMA INTERN MED, V176, P21, DOI 10.1001/jamainternmed.2015.7088; Dowell J, 2001, BRIT J GEN PRACT, V51, P200; ELDAHER NT, 1991, PEDIATR INFECT DIS J, V10, P126, DOI 10.1097/00006454-199102000-00010; Faraoni D, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0265-3; Fiore DC, 2017, J FAM PRACTICE, V66, P730; Fischer T, 2009, PEDIATR EMERG CARE, V25, P575, DOI 10.1097/PEC.0b013e3181b91ff0; Francis NA, 2012, BRIT J GEN PRACT, V62, DOI [10.3399/bjgp12X654614, 10.3399/bjgp12X653561]; GERBER MA, 1990, J PEDIATR-US, V117, P853, DOI 10.1016/S0022-3476(05)80121-0; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Hay AD, 2016, LANCET RESP MED, V4, P902, DOI 10.1016/S2213-2600(16)30223-5; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hoye S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-34; Hungenberg M., 2019, EVID BASED PRACT, V22, P1, DOI [10.1097/EBP.0000000000000508, DOI 10.1097/EBP.0000000000000508]; Jehan F, 2020, NEW ENGL J MED, V383, P24, DOI 10.1056/NEJMoa1911998; Kavanagh KE, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-93; Lambert PC, 2002, J CLIN EPIDEMIOL, V55, P86, DOI 10.1016/S0895-4356(01)00414-0; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2148; Little P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1606; Little P, 2014, LANCET INFECT DIS, V14, P213, DOI 10.1016/S1473-3099(13)70294-9; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6867; Marchetti F, 2005, ARCH PEDIAT ADOL MED, V159, P679, DOI 10.1001/archpedi.159.7.679; Mas-Dalmau G, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-1323; McCormick DP, 2005, PEDIATRICS, V115, P1455, DOI 10.1542/peds.2004-1665; McDermott L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016903; Moore M, 2017, BRIT J GEN PRACT, V67, pE634, DOI 10.3399/bjgp17X692321; Moore M, 2013, BRIT J GEN PRACT, V63, P340, DOI 10.3399/bjgp13X668447; Mustafa RA, 2013, J CLIN EPIDEMIOL, V66, P736, DOI 10.1016/j.jclinepi.2013.02.004; National Institute for Health and Care Excellence, 2008, RESP TRACT INF SELF; OECD, 2018, STEMM SUP TID; PICHICHERO ME, 1987, PEDIATR INFECT DIS J, V6, P635, DOI 10.1097/00006454-198707000-00004; Pouwels KB, 2018, J ANTIMICROB CHEMOTH, V73, P19, DOI 10.1093/jac/dkx502; Public Health England, ENGL SURV PROGR ANT; Ridge KW, 2011, ANTIMICROBIAL RESIST; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schunemann HJ., 2019, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604.CH15; Siegel RM, 2003, PEDIATRICS, V112, P527, DOI 10.1542/peds.112.3.527; Smieszek T, 2018, J ANTIMICROB CHEMOTH, V73, P36, DOI 10.1093/jac/dkx500; Spinks A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000023.pub4; Spiro DM, 2006, JAMA-J AM MED ASSOC, V296, P1235, DOI 10.1001/jama.296.10.1235; Spurling GKP, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub5; Statacorp, 2017, STATA STAT SOFTWARE, DOI DOI 10.2307/2234838; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Stewart GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046042; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Stuart B, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026925; US Government Accountability Office, 1992, CROSS DES SYNTH NEW; van der Velden A, 2013, ANTIBIOTICS-BASEL, V2, P316, DOI 10.3390/antibiotics2020316; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; Wensaas KA, 2018, FAM PRACT, V35, P676, DOI 10.1093/fampra/cmy021; Williamson EJ, 2014, STAT MED, V33, P721, DOI 10.1002/sim.5991	67	17	17	4	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n808	10.1136/bmj.n808	http://dx.doi.org/10.1136/bmj.n808			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910882	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000656399900009
J	[Anonymous]				[Anonymous]			Financial Support of Medical Schools (Reprint of vol 130, pg 1225, 1946)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		GERMANN FEE, 1946, SCIENCE, V103, P68, DOI 10.1126/science.103.2664.68; 1946, JAMA, V130, P1225	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1685	1685		10.1001/jama.2020.17906	http://dx.doi.org/10.1001/jama.2020.17906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904880				2022-12-28	WOS:000645617800033
J	Rimmer, A				Rimmer, Abi			Sixty seconds on . . . smell training	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Huart C, 2021, INT FORUM ALLERGY RH, V11, P1041, DOI 10.1002/alr.22788; Vaira LA, 2020, J LARYNGOL OTOL, V134, P703, DOI 10.1017/S0022215120001826	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1080	10.1136/bmj.n1080	http://dx.doi.org/10.1136/bmj.n1080			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WT4PP	33903202				2022-12-28	WOS:000715848100001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Unusual blood clots are "very rare side effect" of Janssen vaccine, says EMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n931	2	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n1046	10.1136/bmj.n1046	http://dx.doi.org/10.1136/bmj.n1046			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883164	Bronze			2022-12-28	WOS:000642452700003
J	Jaklevic, MC				Jaklevic, Mary Chris			Breaks in Ankle Implant Are a Cause for Concern	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1499	1499		10.1001/jama.2021.5393	http://dx.doi.org/10.1001/jama.2021.5393			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877283				2022-12-28	WOS:000642636500009
J	Rimmer, A				Rimmer, Abi			Covid-19: NHS will take at least a year and a half to recover, doctors warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		O'Dowd A, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n995	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2021	373								n999	10.1136/bmj.n999	http://dx.doi.org/10.1136/bmj.n999			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RO8VU	33863761	Bronze			2022-12-28	WOS:000641319600006
J	Oliu-Barton, M; Pradelski, BSR; Aghion, P; Artus, P; Kickbusch, I; Lazarus, JV; Sridhar, D; Vanderslott, S				Oliu-Barton, Miquel; Pradelski, Bary S. R.; Aghion, Philippe; Artus, Patrick; Kickbusch, Ilona; Lazarus, Jeffrey V.; Sridhar, Devi; Vanderslott, Samantha			SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties	LANCET			English	Editorial Material									[Oliu-Barton, Miquel] Univ Paris Dauphine PSL, Paris, France; [Oliu-Barton, Miquel] Esade Ctr Econ Policy, Barcelona, Spain; [Pradelski, Bary S. R.] French Natl Ctr Sci Res CNRS, CS 40700, Grenoble 9, France; [Pradelski, Bary S. R.] Univ Oxford, Oxford Man Inst Quantitat Finance, Oxford, England; [Aghion, Philippe] Coll France, Paris, France; [Aghion, Philippe] London Sch Econ & Polit Sci, London, England; [Aghion, Philippe] INSEAD, Fontainebleau, France; [Artus, Patrick] Natixis, Paris, France; [Artus, Patrick] Paris Sch Econ, Paris, France; [Kickbusch, Ilona] Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland; [Lazarus, Jeffrey V.] Univ Barcelona, Barcelona Inst Global Hlth ISGlobal, Hosp Clin, Barcelona, Spain; [Sridhar, Devi] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Global Hlth Governance Programme, Edinburgh, Midlothian, Scotland; [Sridhar, Devi] Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Vanderslott, Samantha] Univ Oxford, Oxford Vaccine Grp, Ctr Clin Vaccinol & Trop Med, Oxford, England	UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine; Centre National de la Recherche Scientifique (CNRS); University of Oxford; UDICE-French Research Universities; PSL Research University Paris; College de France; University of London; London School Economics & Political Science; INSEAD Business School; Paris School of Economics; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Edinburgh; University of Edinburgh; University of Oxford	Pradelski, BSR (corresponding author), French Natl Ctr Sci Res CNRS, CS 40700, Grenoble 9, France.; Pradelski, BSR (corresponding author), Univ Oxford, Oxford Man Inst Quantitat Finance, Oxford, England.	bary.pradelski@cnrs.fr	Lazarus, Jeffrey V./R-6248-2018	Lazarus, Jeffrey V./0000-0001-9618-2299; Vanderslott, Samantha/0000-0001-8685-7758				Aschwanden C, 2021, NATURE, V591, P520, DOI 10.1038/d41586-021-00728-2; BAKER MG, 2020, BMJ-BRIT MED J, V371, DOI DOI 10.1136/BMJ.M4907; Bhattacharya S, 2010, LANCET, V375, P1602, DOI 10.1016/S0140-6736(10)60692-7; Blinken AJ, 2021, COMMUNICATION   0405; Bollyky TJ, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4088; Chetty R., 2020, 27431 NBER; Dorn F, 2020, MEDRXIV, DOI 10.1101/2020.08.14.20175224; Fontanet A, 2021, LANCET, V397, P952, DOI 10.1016/S0140-6736(21)00370-6; Freeman D, 2022, PSYCHOL MED, V52, P3127, DOI [10.1017/S0033291720005188, 10.1017/S0033291721002609]; Hale T, 2021, NAT HUM BEHAV, V5, P529, DOI 10.1038/s41562-021-01079-8; Moore S, 2021, LANCET INFECT DIS, V21, P793, DOI 10.1016/S1473-3099(21)00143-2; Oliu-Barton M, 2021, AIMING ZERO COVID 19; Pradelski B., 2020, EUROPE TIME COVID 19, V1, P83; Priesemann V, 2021, LANCET, V397, P469, DOI 10.1016/S0140-6736(21)00150-1; Priesemann V, 2021, LANCET, V397, P92, DOI 10.1016/S0140-6736(20)32625-8; Roser M., 2021, CORONAVIRUS PANDEMIC; Taquet M, 2021, LANCET PSYCHIAT, V8, P416, DOI 10.1016/S2215-0366(21)00084-5; Woloszko N., 2020, OECD EC DEP WORKING, V1634	18	61	63	5	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2021	397	10291					2234	2236		10.1016/S0140-6736(21)00978-8	http://dx.doi.org/10.1016/S0140-6736(21)00978-8		JUN 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SQ0SX	33932328	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000660072500007
J	Mackey, K; Kansagara, D; Vela, K				Mackey, Katherine; Kansagara, Devan; Vela, Kathryn			Update Alert 8: Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults	ANNALS OF INTERNAL MEDICINE			English	Letter									[Mackey, Katherine; Kansagara, Devan; Vela, Kathryn] VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Mackey, K (corresponding author), VA Portland Hlth Care Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.			Vela, Kathryn/0000-0003-0221-2800				Bengtson CD, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.630209; Cohen JB, 2021, LANCET RESP MED, V9, P275, DOI 10.1016/S2213-2600(20)30558-0; Lopes RD, 2021, JAMA-J AM MED ASSOC, V325, P254, DOI 10.1001/jama.2020.25864; Mackey K, 2021, ANN INTERN MED, V174, pW25, DOI 10.7326/L20-1446; Mackey K, 2020, ANN INTERN MED, V173, P195, DOI 10.7326/M20-1515	5	2	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN	2021	174	6					W54	W55		10.7326/L21-0223	http://dx.doi.org/10.7326/L21-0223			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TX0TN	33900794	Green Published			2022-12-28	WOS:000682804400004
J	Froehlich, TE				Froehlich, Tanya E.			Comparison of Medication Treatments for Preschool Children With ADHD A First Step Toward Addressing a Critical Gap	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METHYLPHENIDATE; ADOLESCENTS; SAFETY		[Froehlich, Tanya E.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Froehlich, TE (corresponding author), Cincinnati Childrens Hosp, Div Dev & Behav Pediat, 3333 Burnet Ave,MLC 4002, Cincinnati, OH 45229 USA.	tanya.froehlich@cchmc.org						Barbaresi WJ, 2020, J DEV BEHAV PEDIATR, V41, pS58, DOI 10.1097/DBP.0000000000000781; Becker SP, 2016, J DEV BEHAV PEDIATR, V37, P395, DOI 10.1097/DBP.0000000000000285; Blum NJ, 2018, J DEV BEHAV PEDIATR, V39, P531, DOI 10.1097/DBP.0000000000000585; Danielson ML, 2018, J CLIN CHILD ADOLESC, V47, P199, DOI 10.1080/15374416.2017.1417860; Davis D, 2019, PED AC SOC M 2019 AP; Froehlich TE, 2020, J CHILD ADOL PSYCHOP, V30, P137, DOI 10.1089/cap.2019.0125; Gilliam WS., 2005, PREKINDERGARTENERS L; Gleason MM, 2007, J AM ACAD CHILD PSY, V46, P1532, DOI 10.1097/chi.0b013e3181570d9e; Greenhill L, 2006, J AM ACAD CHILD PSY, V45, P1284, DOI 10.1097/01.chi.0000235077.32661.61; Harpin VA, 2005, ARCH DIS CHILD, V90, pI2, DOI 10.1136/adc.2004.059006; Harstad E, 2021, JAMA-J AM MED ASSOC, V325, P2067, DOI 10.1001/jama.2021.6118; Lee BJ, 1997, INF MENTAL HLTH J, V18, P300, DOI 10.1002/(SICI)1097-0355(199723)18:3<300::AID-IMHJ6>3.0.CO;2-Q; Mittal S, 2020, J CHILD ADOL PSYCHOP, V30, P81, DOI 10.1089/cap.2019.0105; Wigal T, 2006, J AM ACAD CHILD PSY, V45, P1294, DOI 10.1097/01.chi.0000235082.63156.27; Wolraich ML, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2528	15	2	2	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2049	2050		10.1001/jama.2021.5603	http://dx.doi.org/10.1001/jama.2021.5603		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	33946095				2022-12-28	WOS:000647843800001
J	Brodie, JF; Lieberman, S; Moehrenschlager, A; Redford, KH; Rodriguez, JP; Schwartz, M; Seddon, PJ; Watson, JEM				Brodie, Jedediah F.; Lieberman, Susan; Moehrenschlager, Axel; Redford, Kent H.; Rodriguez, Jon Paul; Schwartz, Mark; Seddon, Philip J.; Watson, James E. M.			Global policy for assisted colonization of species	SCIENCE			English	Editorial Material							TRANSLOCATION		[Brodie, Jedediah F.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Brodie, Jedediah F.] Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA; [Lieberman, Susan] Wildlife Conservat Soc, Bronx, NY USA; [Moehrenschlager, Axel] Calgary Zool Soc, Int Union Conservat Nat IUCN, Species Survival Commiss Conservat Translocat Spe, Calgary, AB, Canada; [Moehrenschlager, Axel] Calgary Zool Soc, Ctr Conservat Res, Calgary, AB, Canada; [Moehrenschlager, Axel] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC USA; [Moehrenschlager, Axel] Univ Oxford, Wildlife Conservat Res Unit, Oxford, England; [Redford, Kent H.] Archipelago Consulting, Portland, ME USA; [Redford, Kent H.] Univ New England, Dept Environm Studies, Biddeford, ME USA; [Redford, Kent H.] Griffith Univ, Nathan, Qld, Australia; [Rodriguez, Jon Paul] Venezuelan Inst Sci Invest IVIC & Provita, IUCN Species Survival Commiss, Caracas, Venezuela; [Schwartz, Mark] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Seddon, Philip J.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Watson, James E. M.] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld, Australia; [Watson, James E. M.] Univ Queensland, Ctr Biodivers & Conservat Sci, St Lucia, Qld, Australia; [Watson, James E. M.] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA	University of Montana System; University of Montana; University of Montana System; University of Montana; Wildlife Conservation Society; Clemson University; University of Oxford; University of New England - Maine; Griffith University; University of California System; University of California Davis; University of Otago; University of Queensland; University of Queensland; Wildlife Conservation Society	Brodie, JF (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.; Brodie, JF (corresponding author), Univ Montana, Wildlife Biol Program, Missoula, MT 59812 USA.	jedediah.brodie@umontana.edu	Watson, James Edward Maxwell/D-8779-2013; Schwartz, Mark/G-1066-2011; Rodriguez, Jon P/G-7224-2012; Rodriguez, Jon P/A-1491-2009; Seddon, Philip/G-8659-2011	Watson, James Edward Maxwell/0000-0003-4942-1984; Schwartz, Mark/0000-0002-3739-6542; Rodriguez, Jon P/0000-0001-5019-2870; Seddon, Philip/0000-0001-9076-9566				Butt N, 2021, CONSERV BIOL, V35, P775, DOI 10.1111/cobi.13643; CBD, 2020, POST 2020 DOC; CBD, 2000, CART PROT; CBD, 2011, NAG PROT; Essl F, 2019, BIOSCIENCE, V69, P908, DOI 10.1093/biosci/biz101; IUCN, 2013, GUID REINTR OTH CONS; Ramsar, 2002, 8 M C CONTR PART CON; Redford K.H., 2021, STRANGE NATURES CONS; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Roman-Palacios C, 2020, P NATL ACAD SCI USA, V117, P4211, DOI 10.1073/pnas.1913007117; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Schwartz MW, 2013, ANN NY ACAD SCI, V1286, P15, DOI 10.1111/nyas.12050; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x	14	14	14	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					456	458		10.1126/science.abg0532	http://dx.doi.org/10.1126/science.abg0532			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926936				2022-12-28	WOS:000645554100022
J	Pezo, V; Jaziri, F; Bourguignon, PY; Louis, D; Jacobs-Sera, D; Rozenski, J; Pochet, S; Herdewijn, P; Hatfull, GF; Kaminski, PA; Marliere, P				Pezo, Valerie; Jaziri, Faten; Bourguignon, Pierre-Yves; Louis, Dominique; Jacobs-Sera, Deborah; Rozenski, Jef; Pochet, Sylvie; Herdewijn, Piet; Hatfull, Graham F.; Kaminski, Pierre-Alexandre; Marliere, Philippe			Noncanonical DNA polymerization by aminoadenine-based siphoviruses	SCIENCE			English	Article							SOFTWARE; SYSTEM; RNA	Bacteriophage genomes harbor the broadest chemical diversity of nucleobases across all life forms. Certain DNA viruses that infect hosts as diverse as cyanobacteria, proteobacteria, and actinobacteria exhibit wholesale substitution of aminoadenine for adenine, thereby forming three hydrogen bonds with thymine and violating Watson-Crick pairing rules. Aminoadenine-encoded DNA polymerases, homologous to the Klenow fragment of bacterial DNA polymerase I that includes 3'-exonuclease but lacks 5'-exonuclease, were found to preferentially select for aminoadenine instead of adenine in deoxynucleoside triphosphate incorporation templated by thymine. Polymerase genes occur in synteny with genes for a biosynthesis enzyme that produces aminoadenine deoxynucleotides in a wide array of Siphoviridae bacteriophages. Congruent phylogenetic clustering of the polymerases and biosynthesis enzymes suggests that aminoadenine has propagated in DNA alongside adenine since archaic stages of evolution.	[Pezo, Valerie; Jaziri, Faten; Marliere, Philippe] Univ Paris Saclay, Univ Evry, Inst Francois Jacob, CEA,CNRS,Genom Metab,Genoscope, 2 Rue Gaston Cremieux, F-91057 Evry, France; [Bourguignon, Pierre-Yves] Werkstatt Potenzielle Genet, Naunynstr 30, D-10997 Berlin, Germany; [Bourguignon, Pierre-Yves; Marliere, Philippe] TESSSI, 81 Rue Reaumur, F-75002 Paris, France; [Louis, Dominique] Alderys, 86 Rue Paris, F-91400 Orsay, France; [Jacobs-Sera, Deborah; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, 4249 Fifth Ave, Pittsburgh, PA 15260 USA; [Rozenski, Jef; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst Biomed Res, Lab Med Chem, Herestr 49,Box 1041, B-3000 Leuven, Belgium; [Pochet, Sylvie] Inst Pasteur, Dept Chem & Biocatalysis, CNRS UMR3523, Organ Chem, 25-28 Rue Docteur Roux, F-75015 Paris, France; [Kaminski, Pierre-Alexandre] Inst Pasteur, CNRS URL3526, Dept Microbiol, Biol Gram Posit Pathogens, 25-28 Rue Docteur Roux, F-75015 Paris, France; [Jaziri, Faten] DNA Script, 67 Ave Fontainebleau, F-94270 Le Kremlin Bicetre, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Marliere, P (corresponding author), Univ Paris Saclay, Univ Evry, Inst Francois Jacob, CEA,CNRS,Genom Metab,Genoscope, 2 Rue Gaston Cremieux, F-91057 Evry, France.; Marliere, P (corresponding author), TESSSI, 81 Rue Reaumur, F-75002 Paris, France.	phmarliere@tesssi.eu		Kaminski, Pierre Alexandre/0000-0001-9841-6837; Herdewijn, Piet/0000-0003-3589-8503; Rozenski, Jef/0000-0001-9624-5536	European Research Council [ERC-2012-ADG-20120216/320683]; European Commission [BB/N01023X/1, ANR-15-SYNB-0003-04]	European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	The research received funding from the European Research Council (ERC-2012-ADG-20120216/320683) and from the European Commission (ERASynBio BB/N01023X/1 and ANR-15-SYNB-0003-04).	Bailly C, 1998, NUCLEIC ACIDS RES, V26, P4309, DOI 10.1093/nar/26.19.4309; Benner P, 2014, BIOINFORMATICS, V30, pI534, DOI 10.1093/bioinformatics/btu461; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; FATHI R, 1990, TETRAHEDRON LETT, V31, P319; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Harrison KJ, 2018, BIOINFORMATICS, V34, P1406, DOI 10.1093/bioinformatics/btx793; Herdewijn P, 2009, CHEM BIODIVERS, V6, P791, DOI 10.1002/cbdv.200900083; Hoshika S, 2019, SCIENCE, V363, P884, DOI 10.1126/science.aat0971; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KHUDYAKOV IY, 1978, VIROLOGY, V88, P8, DOI 10.1016/0042-6822(78)90104-6; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; KOVACS T, 1988, TETRAHEDRON LETT, V29, P4525, DOI 10.1016/S0040-4039(00)80537-7; Loh E, 2005, DNA REPAIR, V4, P1390, DOI 10.1016/j.dnarep.2005.09.006; Luo M, 2019, J AM CHEM SOC, V141, P10844, DOI 10.1021/jacs.9b04714; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Marliere P., 2003, Patent WO, Patent No. 03093461; Marliere P, 2011, ANGEW CHEM INT EDIT, V50, P7109, DOI 10.1002/anie.201100535; Mehta AP, 2016, J AM CHEM SOC, V138, P14230, DOI 10.1021/jacs.6b09661; O'Flaherty Derek K, 2014, Curr Protoc Nucleic Acid Chem, V59, DOI 10.1002/0471142700.nc0721s59; Pezo V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01359; Ravikumar A, 2014, NAT CHEM BIOL, V10, P175, DOI [10.1038/NCHEMBIO.1439, 10.1038/nchembio.1439]; Rich A., 1962, HORIZONS BIOCH, P103; Sheridan PP, 2003, GEOMICROBIOL J, V20, P1, DOI 10.1080/01490450303891; Sleiman D, 2021, SCIENCE, V372, P516, DOI 10.1126/science.abe6494; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; Weigele P, 2016, CHEM REV, V116, P12655, DOI 10.1021/acs.chemrev.6b00114; Wynne SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070892	29	25	28	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					520	+		10.1126/science.abe6542	http://dx.doi.org/10.1126/science.abe6542			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926956	Green Accepted			2022-12-28	WOS:000645554100049
J	Bienstock, JL; Eke, AC; Hueppchen, NA				Bienstock, Jessica L.; Eke, Ahizechukwu C.; Hueppchen, Nancy A.			Postpartum Hemorrhage	NEW ENGLAND JOURNAL OF MEDICINE			English	Review								Postpartum Hemorrhage The major causes of postpartum hemorrhage are uterine atony, lacerations, retained placenta or clots, and clotting factor deficiency. Uterine massage, oxytocin, and methylergonovine are the main treatments, along with blood transfusion and cardiovascular support.	[Bienstock, Jessica L.; Eke, Ahizechukwu C.; Hueppchen, Nancy A.] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, 600 N Wolfe St, Baltimore, MD 21287 USA	Johns Hopkins University	Bienstock, JL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, 600 N Wolfe St, Baltimore, MD 21287 USA.	jbienst@jhmi.edu		Eke, MD PhD, Ahizechukwu C./0000-0002-0070-9840				ALDERSON P, 2000, COCHRANE DB SYST REV, V2; [Anonymous], 2019, Obstet Gynecol, V134, pe150, DOI 10.1097/AOG.0000000000003564; [Anonymous], 2011, Obstet Gynecol, V117, P1472, DOI 10.1097/AOG.0b013e3182238c31; [Anonymous], 2009, WHO GUIDELINES MANAG; [Anonymous], 2007, MAK PREGN SAF; [Anonymous], 2017, BJOG-INT J OBSTET GY, V124, pe106, DOI DOI 10.1111/1471-0528.14178; Antonelli E, 2006, BJOG-INT J OBSTET GY, V113, P846, DOI 10.1111/j.1471-0528.2006.00965.x; Bakri YN, 2001, INT J GYNECOL OBSTET, V74, P139, DOI 10.1016/S0020-7292(01)00395-2; Begley CM, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub5; BLynch C, 1997, BRIT J OBSTET GYNAEC, V104, P372, DOI 10.1111/j.1471-0528.1997.tb11471.x; Borovac-Pinheiro A, 2018, AM J OBSTET GYNECOL, V219, P162, DOI 10.1016/j.ajog.2018.04.013; Bose P, 2006, BJOG-INT J OBSTET GY, V113, P919, DOI 10.1111/j.1471-0528.2006.01018.x; Butwick AJ, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.008; Carlan SJ, 1997, J CLIN ULTRASOUND, V25, P301, DOI 10.1002/(SICI)1097-0096(199707)25:6<301::AID-JCU3>3.0.CO;2-G; Carrillo AP, 2019, WOMENS HEALTH, V15, DOI 10.1177/1745506519878081; Centers for Disease Control and Prevention, PREGN MORT SURV SYST; Centers for Disease Control and Prevention, POSTPARTUM HEMORRHAG; Cho HY, 2015, INT J QUAL HEALTH C, V27, P459, DOI 10.1093/intqhc/mzv068; Cho JH, 2000, OBSTET GYNECOL, V96, P129, DOI 10.1016/S0029-7844(00)00852-8; Collins SL, 2019, AM J OBSTET GYNECOL, V220, P511, DOI 10.1016/j.ajog.2019.02.054; Committee on Practice Bulletins-Obstetrics, 2017, Obstet Gynecol, V130, pe168, DOI 10.1097/AOG.0000000000002351; D'Antonio F, 2014, ULTRASOUND OBST GYN, V44, P8, DOI 10.1002/uog.13327; Dahlke JD, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.023; Diaz V, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010980.pub2; Dildy GA, 2002, CLIN OBSTET GYNECOL, V45, P330, DOI 10.1097/00003081-200206000-00005; Dilla AJ, 2013, OBSTET GYNECOL, V122, P120, DOI 10.1097/AOG.0b013e3182941c78; Dobiesz VA., 2017, ROSENS EMERGENCY MED, V9, P2314; Doomah Yussriya Hanaa, 2019, Acta Inform Med, V27, P318, DOI 10.5455/aim.2019.27.318-326; El-Hamamy E, 2005, BJOG-INT J OBSTET GY, V112, P126, DOI 10.1111/j.1471-0528.2004.00259.x; Esike COU, 2020, OBSTET GYNECOL, V136, P466, DOI 10.1097/AOG.0000000000003947; Gallos ID, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011689.pub2; Gerdessen L, 2021, J CLIN MONIT COMPUT, V35, P245, DOI 10.1007/s10877-020-00579-8; Gipson MG, 2013, SEMIN INTERVENT RAD, V30, P333, DOI 10.1055/s-0033-1359726; Haultain FWN, 1901, BRIT MED J, V1901, P974; Hayman RG, 2002, OBSTET GYNECOL, V99, P502, DOI 10.1016/S0029-7844(01)01643-X; Hofmeyr GJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008020.pub2; Hofmeyr GJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006431.pub3; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Hu K, 2020, J MED DEVICES, V14, DOI 10.1115/1.4045965; Hunt BJ, 2015, BRIT J HAEMATOL, V170, P788, DOI 10.1111/bjh.13580; Huntington JL, 1928, AM J OBSTET GYNECOL, V15, P34, DOI 10.1016/S0002-9378(15)32679-X; Hussain SA, 2019, CUREUS, V11, DOI 10.7759/cureus.6456; Jauniaux ERM, 2019, BJOG-INT J OBSTET GY, V126, pE1, DOI 10.1111/1471-0528.15306; Jauniaux E, 2018, INT J GYNECOL OBSTET, V140, P274, DOI 10.1002/ijgo.12408; Joshi VM, 2007, BJOG-INT J OBSTET GY, V114, P356, DOI 10.1111/j.1471-0528.2006.01235.x; Joshi VM, 2004, BJOG-INT J OBSTET GY, V111, P279, DOI 10.1111/j.1471-0528.2004.00056.x; Lester F, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.054; Likis FE, 2015, MANAGEMENT POSTPARTU; Lu MC, 2009, J PERINATOL, V29, P422, DOI 10.1038/jp.2009.2; Malone DL, 2006, J TRAUMA, V60, pS91, DOI 10.1097/01.ta.0000199549.80731.e6; Marasinghe JP, 2011, ACTA OBSTET GYN SCAN, V90, P280, DOI 10.1111/j.1600-0412.2010.01048.x; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P378, DOI 10.1111/aogs.12077; McDonald SJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004074.pub3; McLucas B, 2016, MINIM INVASIV THER, V25, P1, DOI 10.3109/13645706.2015.1074082; Meher S, 2019, BEST PRACT RES CL OB, V61, P41, DOI 10.1016/j.bpobgyn.2019.04.003; Nyflot LT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175306; OLEARY JL, 1966, AM J OBSTET GYNECOL, V94, P920, DOI 10.1016/0002-9378(66)90026-3; Ouahba J, 2007, BJOG-INT J OBSTET GY, V114, P619, DOI 10.1111/j.1471-0528.2007.01272.x; Oyelese Y, 2007, OBSTET GYN CLIN N AM, V34, P421, DOI 10.1016/j.ogc.2007.06.007; Pacagnella RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057594; Pereira A, 2005, OBSTET GYNECOL, V106, P569, DOI 10.1097/01.AOG.0000168434.28222.d3; Porreco RP, 2010, CLIN OBSTET GYNECOL, V53, P182, DOI 10.1097/GRF.0b013e3181cc4139; Labarta FJR, 2016, EUR J OBSTET GYN R B, V206, P12, DOI 10.1016/j.ejogrb.2016.07.510; Saroja CSM, 2010, ARCH GYNECOL OBSTET, V281, P581, DOI 10.1007/s00404-009-1249-z; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sebghati M, 2017, WOMENS HEALTH, V13, P34, DOI 10.1177/1745505717716860; Shields LE, 2015, AM J OBSTET GYNECOL, V212, P272, DOI 10.1016/j.ajog.2014.07.012; Suarez S, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.11.1287; Toffaletti JG, 2019, ANESTH ANALG, V128, P414, DOI 10.1213/ANE.0000000000003499; Tuncalp O, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000494.pub4; Turan J, 2011, J WOMENS HEALTH, V20, P91, DOI 10.1089/jwh.2010.2081; Vijayaraghavan R, 2006, BJOG-INT J OBSTET GY, V113, P1100, DOI 10.1111/j.1471-0528.2006.01052.x; Vintejoux E, 2015, AUST NZ J OBSTET GYN, V55, P572, DOI 10.1111/ajo.12376; WATERS EG, 1952, AM J OBSTET GYNECOL, V64, P1143, DOI 10.1016/0002-9378(52)90377-3; Young PP, 2011, TRANSFUS MED REV, V25, P293, DOI 10.1016/j.tmrv.2011.04.002; Zheng J, 2011, BJOG-INT J OBSTET GY, V118, P370, DOI 10.1111/j.1471-0528.2010.02809.x; Zuckerwise LC, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.08.035	77	30	33	10	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1635	1645		10.1056/NEJMra1513247	http://dx.doi.org/10.1056/NEJMra1513247			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1ND	33913640				2022-12-28	WOS:000645605800014
J	Oliver, D				Oliver, David			David Oliver: Valuing the medical take	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Dobson R, 2007, BRIT MED J, V335, P632, DOI 10.1136/bmj.39349.486493.47; Fisher J, 2017, J ROY COLL PHYS EDIN, V47, P70, DOI 10.4997/JRCPE.2017.116; Gawande, 2007, NEW YORKER; OMahony S., 2021, MINISTRY BODIES; Royal College of Physicians, 2013, MED REG EMP UNS HER; Smith R., BMJ OPINION, V2021	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1066	10.1136/bmj.n1066	http://dx.doi.org/10.1136/bmj.n1066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910808	Bronze			2022-12-28	WOS:000656399900014
J	Slomski, A				Slomski, Anita			N-of-1 Trial Finds No Effect of Statins on Muscle Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1602	1602		10.1001/jama.2021.4801	http://dx.doi.org/10.1001/jama.2021.4801			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904872				2022-12-28	WOS:000645617800007
J	Wise, J				Wise, Jacqui			Covid-19: Countries rally to support India through "storm that has shaken the nation"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, STAT NSC SPOK EM HOM STAT NSC SPOK EM HOM; [Anonymous], 2021, INDEPENDENT; BMA, 2021, UK SUPP COUNTR EXP W UK SUPP COUNTR EXP W; Saxena A, 2021, THE INDIA EXPRESS	4	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1086	10.1136/bmj.n1086	http://dx.doi.org/10.1136/bmj.n1086			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903127	Bronze			2022-12-28	WOS:000678538700007
J	Yankova, E; Blackaby, W; Albertella, M; Rak, J; De Braekeleer, E; Tsagkogeorga, G; Pilka, ES; Aspris, D; Leggate, D; Hendrick, AG; Webster, NA; Andrews, B; Fosbeary, R; Guest, P; Irigoyen, N; Eleftheriou, M; Gozdecka, M; Dias, JML; Bannister, AJ; Vick, B; Jeremias, I; Vassiliou, GS; Rausch, O; Tzelepis, K; Kouzarides, T				Yankova, Eliza; Blackaby, Wesley; Albertella, Mark; Rak, Justyna; De Braekeleer, Etienne; Tsagkogeorga, Georgia; Pilka, Ewa S.; Aspris, Demetrios; Leggate, Dan; Hendrick, Alan G.; Webster, Natalie A.; Andrews, Byron; Fosbeary, Richard; Guest, Patrick; Irigoyen, Nerea; Eleftheriou, Maria; Gozdecka, Malgorzata; Dias, Joao M. L.; Bannister, Andrew J.; Vick, Binje; Jeremias, Irmela; Vassiliou, George S.; Rausch, Oliver; Tzelepis, Konstantinos; Kouzarides, Tony			Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia	NATURE			English	Article							METTL3-METTL14 COMPLEX; RNA; N-6-METHYLADENOSINE; CHROMATIN; METHYLTRANSFERASE; DIFFERENTIATION; TRANSLATION; DEMETHYLASE; REFINEMENT; ALIGNMENT	N-6-methyladenosine (m(6)A) is an abundant internal RNA modification(1,2) that is catalysed predominantly by the METTL3-METTL14 methyltransferase complex(3,4). The m(6)A methyltransferase METTL3 has been linked to the initiation and maintenance of acute myeloid leukaemia (AML), but the potential oftherapeutic applications targeting this enzyme remains unknown(5-7). Here we present the identification and characterization of STM2457, a highly potent and selective first-in-class catalytic inhibitor of METTL3, and a crystal structure of STM2457 in complex with METTL3-METTL14. Treatment of tumours with STM2457 leads to reduced AMLgrowth and an increase in differentiation and apoptosis. These cellular effects are accompanied by selective reduction of m(6)A levels on known leukaemogenic mRNAs and a decrease in their expression consistent with a translational defect. We demonstrate that pharmacological inhibition of METTL3 in vivo leads to impaired engraftment and prolonged survival in various mouse models of AML, specifically targeting key stem cell subpopulations of AML. Collectively, these results reveal the inhibition of METTL3 as a potential therapeutic strategy against AML, and provide proof of concept that the targeting of RNA-modifying enzymes represents a promising avenue for anticancer therapy.	[Yankova, Eliza; Tsagkogeorga, Georgia; Eleftheriou, Maria; Tzelepis, Konstantinos; Kouzarides, Tony] Univ Cambridge, Milner Therapeut Inst, Cambridge, England; [Yankova, Eliza; Rak, Justyna; De Braekeleer, Etienne; Aspris, Demetrios; Gozdecka, Malgorzata; Vassiliou, George S.; Tzelepis, Konstantinos] Wellcome Trust Sanger Inst, Haematol Canc Genet, Cambridge, England; [Yankova, Eliza; Blackaby, Wesley; Albertella, Mark; Tsagkogeorga, Georgia; Leggate, Dan; Hendrick, Alan G.; Webster, Natalie A.; Andrews, Byron; Fosbeary, Richard; Guest, Patrick; Rausch, Oliver] Storm Therapeut Ltd, Cambridge, England; [Rak, Justyna; De Braekeleer, Etienne; Vassiliou, George S.; Tzelepis, Konstantinos] Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England; [Pilka, Ewa S.] Evotec UK Ltd, Abingdon, Oxon, England; [Aspris, Demetrios; Vassiliou, George S.] Karaiskakio Fdn, Ctr Study Hematol Malignancies, Nicosia, Cyprus; [Irigoyen, Nerea] Univ Cambridge, Dept Pathol, Div Virol, Cambridge, England; [Dias, Joao M. L.] Univ Cambridge, Hutchison MRC Res Ctr, MRC Canc Unit, Cambridge, England; [Bannister, Andrew J.; Tzelepis, Konstantinos; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge, England; [Bannister, Andrew J.; Tzelepis, Konstantinos; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge, England; [Vick, Binje; Jeremias, Irmela] German Res Ctr Environm Hlth HMGU, Res Unit Apoptosis Hematopoiet Stem Cells, Helmholtz Zentrum Munchen, Munich, Germany; [Vick, Binje; Jeremias, Irmela] German Consortium Translat Canc Res DKTK, Munich, Germany; [Jeremias, Irmela] Ludwig Maximilians Univ Munchen, Dr von Hauner Childrens Hosp, Dept Pediat, Munich, Germany	University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Evotec; University of Cambridge; University of Cambridge; University of Cambridge; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); University of Munich	Tzelepis, K; Kouzarides, T (corresponding author), Univ Cambridge, Milner Therapeut Inst, Cambridge, England.; Tzelepis, K (corresponding author), Wellcome Trust Sanger Inst, Haematol Canc Genet, Cambridge, England.; Rausch, O (corresponding author), Storm Therapeut Ltd, Cambridge, England.; Tzelepis, K (corresponding author), Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England.; Tzelepis, K; Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.; Tzelepis, K; Kouzarides, T (corresponding author), Univ Cambridge, Dept Pathol, Cambridge, England.	oriver.rausch@stormtherapeutics.com; kt404@cam.ac.uk; t.kouzarides@gurdon.cam.ac.uk	Dias, Joao ML/D-2011-2013; Irigoyen, Nerea/CAJ-2485-2022	Dias, Joao ML/0000-0002-8451-3537; Irigoyen, Nerea/0000-0001-6346-3369; Yankova, Eliza/0000-0003-2913-0012; Albertella, Mark/0000-0003-4406-6135; Vick, Binje/0000-0003-1956-2778; Jeremias, Irmela/0000-0003-1773-7677; Vassiliou, George/0000-0003-4337-8022; Pilka, Ewa/0000-0002-0107-2597; Bannister, Andrew/0000-0002-6312-4436; Hendrick, Alan/0000-0002-8604-0462; Tzelepis, Konstantinos/0000-0002-4865-7648	Cancer Research UK [C6946/A14492, RG17001, C22324/A23015]; ERC [681524, 268569]; Wellcome Trust [092096]; Kay Kendall Leukaemia Fund project grant [RG88664]; Wellcome Trust Sir Henry Wellcome Fellowship [RG94424]; Leukaemia UK [G108148]; Cambridge-LMU Strategic Partnership Award	Cancer Research UK(Cancer Research UK); ERC(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Kay Kendall Leukaemia Fund project grant; Wellcome Trust Sir Henry Wellcome Fellowship; Leukaemia UK; Cambridge-LMU Strategic Partnership Award	T.K. was supported by grants from Cancer Research UK (grant reference RG17001) and ERC (project number 268569), in addition to benefiting from core support from the Wellcome Trust (Core Grant reference 092096), Cancer Research UK (grant reference C6946/A14492) and Kay Kendall Leukaemia Fund project grant (grant reference RG88664). K.T. was funded by a Wellcome Trust Sir Henry Wellcome Fellowship (grant reference RG94424). K.T and M.E. were funded by Leukaemia UK (G108148). I.J. was funded by ERC (Consolidator Grant 681524). I.J. and K.T. were funded by Cambridge-LMU Strategic Partnership Award. G.S.V. was funded by a Cancer Research UK Senior Cancer Fellowship (C22324/A23015). We thank B. L. Ng, J. Graham, S. Thompson and C. Hall for help with flow cytometry and the Cambridge Blood and Stem Cell Biobank for human AML and cord blood sample processing; the staff of the Sanger Institute Core Sequencing facility for sequencing and the staff of the Sanger Institute Research Support Facility for help with mouse experiments; D. Hardick, B. Thomas, Y. Ofir-Rosenfeld and A. Sapetschnig at Storm Therapeutics for comments and advice; and K. Danker, M. Ridgill, C. Hoareau and their colleagues at Evotec for drug discovery services and lead optimization support.	Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Choe J, 2018, NATURE, V561, P556, DOI 10.1038/s41586-018-0538-8; Cui XD, 2018, IEEE ACM T COMPUT BI, V15, P526, DOI 10.1109/TCBB.2015.2403355; Cui XD, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8367534; Daver N, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-00376-1; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; ELLISON RR, 1968, BLOOD, V32, P507, DOI 10.1182/blood.V32.4.507.507; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang Y, 2019, CANCER CELL, V35, P677, DOI 10.1016/j.ccell.2019.03.006; Iwasaki M, 2015, CELL STEM CELL, V17, P412, DOI 10.1016/j.stem.2015.08.008; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lee BH, 2007, CANCER CELL, V12, P367, DOI 10.1016/j.ccr.2007.08.031; Li FL, 2016, J BIOMOL SCREEN, V21, P290, DOI 10.1177/1087057115623264; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melnyk S, 2000, CLIN CHEM, V46, P265; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mikutis S, 2020, ACS CENTRAL SCI, V6, P2196, DOI 10.1021/acscentsci.0c01094; Moroz-Omori E. V., 2020, METTL3 INHIBITORS EP, DOI [10.1101/2020.09.25.311803, DOI 10.1101/2020.09.25.311803]; O'Connor Leigh, 2016, Yale Journal of Biology and Medicine, V89, P513; Panda AC, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2126; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ripperger T, 2015, BBA-GENE REGUL MECH, V1849, P1145, DOI 10.1016/j.bbagrm.2015.07.005; Schapira M, 2016, ACS CHEM BIOL, V11, P575, DOI 10.1021/acschembio.5b00781; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Tzelepis K, 2019, NAT STRUCT MOL BIOL, V26, P858, DOI 10.1038/s41594-019-0312-0; Tzelepis K, 2016, CELL REP, V17, P1193, DOI 10.1016/j.celrep.2016.09.079; Vick B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120925; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wlodek S, 2006, ACTA CRYSTALLOGR D, V62, P741, DOI 10.1107/S0907444906016076; Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	48	187	188	24	117	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					597	+		10.1038/s41586-021-03536-w	http://dx.doi.org/10.1038/s41586-021-03536-w		APR 2021	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IG	33902106	Green Submitted, Green Accepted			2022-12-28	WOS:000652171700003
J	Dang, VQ; Vuong, LN; Luu, TM; Pham, TD; Ho, TM; Ha, AN; Truong, BT; Phan, AK; Nguyen, DP; Pham, TN; Pham, QT; Wang, R; Norman, RJ; Mol, B				Dang, Vinh Q.; Vuong, Lan N.; Luu, Tam M.; Pham, Toan D.; Ho, Tuong M.; Ha, Anh N.; Truong, Binh T.; Phan, Anh K.; Nguyen, Dung P.; Pham, Thanh N.; Pham, Quan T.; Wang, Rui; Norman, Robert J.; Mol, Ben W.			Intracytoplasmic sperm injection versus conventional in-vitro fertilisation in couples with infertility in whom the male partner has normal total sperm count and motility: an open-label, randomised controlled trial	LANCET			English	Article							REPRODUCTIVE OUTCOMES; ICSI; WOMEN; IVF	Background The use of intracytoplasmic sperm injection has increased substantially worldwide, primarily in couples with non-male factor infertility. However, there is a paucity of evidence from randomised trials supporting this approach compared with conventional in-vitro fertilisation (IVF). We aimed to investigate whether intracytoplasmic sperm injection would result in a higher livebirth rate compared with conventional IVF. Methods This open-label, multicentre, randomised trial was done at two IVF centres in Ho Chi Minh City, Vietnam (IVFMD, My Duc Hospital and IVFAS, An Sinh Hospital). Eligible couples were aged at least 18 years and the male partner's sperm count and motility (progressive motility) were normal based on WHO 2010 criteria. Couples had to have undergone two or fewer previous conventional IVF or intracytoplasmic sperm injection attempts, have used an antagonist protocol for ovarian stimulation, and agree to have two or fewer embryos transferred. Couples were randomly assigned (1:1) to undergo either intracytoplasmic sperm injection or conventional IVF, using block randomisation with variable block size of 2, 4, or 8 and a telephone-based central randomisation method. The computer-generated randomisation list was prepared by an independent statistician who had no other involvement in the study. Embryologists and couples were not masked to study groups because of the type of interventions and differences in hospital fees, but clinicians performing embryo transfer were unaware of study group allocation. The primary outcome was livebirth after the first embryo transfer from the initiated cycle. Analyses were done on an intention-to-treat basis. The trial is registered with ClinicalTrials.gov, NCT03428919. Findings Between March 16, 2018, and Aug 12, 2019, we randomly assigned 1064 couples to intracytoplasmic sperm injection (n=532) or conventional IVF (n=532). Livebirth after the first embryo transfer from the initiated cycle occurred in 184 (35%) of 532 couples randomly assigned to intracytoplasmic sperm injection and in 166 (31%) of 532 couples randomly assigned to conventional IVF (absolute difference 3.4%, 95% CI -2.4 to 9.2; risk ratio [RR] 1.11, 95% CI 0.93 to 1.32; p=0.27). 29 (5%) couples in the intracytoplasmic sperm injection group and 34 (6%) couples in the conventional IVF group had fertilisation failure (absolute difference -0.9%, -4.0 to 2.1, RR 0.85, 95% CI 0.53 to 1.38; p=0.60). Interpretation In couples with infertility in whom the male partner has a normal total sperm count and motility, intracytoplasmic sperm injection did not improve the livebirth rate compared with conventional IVF. Our results challenge the value of the routine use of intracytoplasmic sperm injection in assisted reproduction techniques for this population. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Dang, Vinh Q.; Luu, Tam M.; Ha, Anh N.; Phan, Anh K.; Nguyen, Dung P.] My Duc Hosp, IVFMD, Ho Chi Minh City, Vietnam; [Dang, Vinh Q.; Vuong, Lan N.; Pham, Toan D.; Ho, Tuong M.; Pham, Quan T.] HOPE Res Ctr, Ho Chi Minh City, Vietnam; [Vuong, Lan N.] Univ Med & Pharm Ho Chi Minh City, Dept Obstet & Gynecol, Ho Chi Minh City, Vietnam; [Truong, Binh T.; Pham, Thanh N.] An Sinh Hosp, IVFAS, Ho Chi Minh City, Vietnam; [Wang, Rui; Mol, Ben W.] Monash Univ, Monash Hlth, Sch Clin Sci, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Norman, Robert J.] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Mol, Ben W.] Univ Aberdeen, Aberdeen Ctr Womens Hlth Res, Aberdeen, Scotland	HOPE Research Center, My Duc Hospital; HOPE Research Center, My Duc Hospital; Hochiminh City University of Medicine & Pharmacy; Monash University; Robinson Research Institute; University of Adelaide; University of Aberdeen	Dang, VQ (corresponding author), My Duc Hosp, IVFMD, Ho Chi Minh City, Vietnam.	bsvinh.dq@myduchospital.vn	Vinh, Dang Quang/N-6816-2019	Vinh, Dang Quang/0000-0001-5205-8210; Wang, Rui/0000-0002-6622-8134; Ho, Tuong/0000-0003-3528-7358	My Duc Hospital (Ho Chi Minh City, Vietnam); Merck Sharp and Dohme (MISP) [57508]	My Duc Hospital (Ho Chi Minh City, Vietnam); Merck Sharp and Dohme (MISP)	This study was funded by My Duc Hospital (Ho Chi Minh City, Vietnam), and partly supported by a grant from Merck Sharp and Dohme (MISP #57508). We thank Quynh N Nguyen for her administrative support and assistance in registering the trial. We also thank the couples who consented to participate in the study, the site staff who assisted with the trial, and the Data Safety Monitoring Committee for assistance with the safety data.	Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Apter S, 2017, REPROD BIOMED ONLINE, V35, P494, DOI [10.1016/j.rbmo.2017.06.015, 10.1093/hropen/hox011]; Bhattacharya S, 2001, LANCET, V357, P2075, DOI 10.1016/S0140-6736(00)05179-5; Bjorndahl L, 2016, HUM REPROD, V31, P227, DOI 10.1093/humrep/dev305; Boulet SL, 2015, JAMA-J AM MED ASSOC, V313, P255, DOI 10.1001/jama.2014.17985; de Mouzon J, 2020, HUM REPROD, V35, P1900, DOI 10.1093/humrep/deaa090; Deveneau NE, 2014, FERTIL STERIL, V102, P1584, DOI 10.1016/j.fertnstert.2014.09.016; Drakopoulos P, 2019, J ASSIST REPROD GEN, V36, P2067, DOI 10.1007/s10815-019-01563-1; European Association of Urology, 2020, SEX REPR HLTH; Evers JLH, 2016, HUM REPROD, V31, P1381, DOI 10.1093/humrep/dew092; Fan W, 2012, J ASSIST REPROD GEN, V29, P905, DOI 10.1007/s10815-012-9823-x; FLOERKEMEIER T, 2017, HUMAN REPROD OPEN, V2017, DOI DOI 10.1155/2017/8756432; Host Erik, 2001, Reprod Biomed Online, V3, P212; Iliodromiti S, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-93; Keyhan S, 2018, OBSTET GYNECOL, V131, P262, DOI 10.1097/AOG.0000000000002423; Kissin DM, 2015, HUM REPROD, V30, P454, DOI 10.1093/humrep/deu338; Li Z, 2018, HUM REPROD, V33, P1322, DOI 10.1093/humrep/dey118; Luke B, 2021, HUM REPROD, V36, P116, DOI 10.1093/humrep/deaa272; National Institute for Health and Care Excellence (NICE), 2013, FERT ASS TREATM PEOP; NGUYEN TKL, 2019, HUM REPROD OPEN, V2019, DOI DOI 10.1155/2019/9624374; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Penzias A, 2020, FERTIL STERIL, V114, P239, DOI 10.1016/j.fertnstert.2020.05.032; Sonntag B, 2020, HUM REPROD, V35, P968, DOI 10.1093/humrep/deaa021; Sunderam S, 2020, FERTIL STERIL, V113, P354, DOI 10.1016/j.fertnstert.2019.09.035; Supramaniam PR, 2020, HUM REPROD, V35, P583, DOI 10.1093/humrep/dez301; Tannus S, 2017, HUM REPROD, V32, P119, DOI 10.1093/humrep/dew298; Vuong LN, 2018, NEW ENGL J MED, V378, P137, DOI 10.1056/NEJMoa1703768; World Health Organization, 2010, WHO LAB MAN EX PROC; Wyns C, 2020, HUM REPROD OPEN, V2020, DOI 10.1093/hropen/hoaa032; Zagadailov P, 2018, OBSTET GYNECOL, V132, P310, DOI 10.1097/AOG.0000000000002730	30	20	20	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1554	1563						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR7QA	33894833				2022-12-28	WOS:000643286900021
J	Bhuyan, A				Bhuyan, Anoo			Covid-19: India looks to import oxygen as cases surge, overwhelming hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2021	373								n1061	10.1136/bmj.n1061	http://dx.doi.org/10.1136/bmj.n1061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0MU	33888471				2022-12-28	WOS:000708062500005
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Government race review "misused evidence," says Marmot	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Commission on Race and Ethnic Disparities, 2021, REP; Griffin S, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4842; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n911; Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m747	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2021	373								n1063	10.1136/bmj.n1063	http://dx.doi.org/10.1136/bmj.n1063			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0MU	33888469	Bronze			2022-12-28	WOS:000708062500007
J	Melancon, D; Gorissen, B; Garcia-Mora, CJ; Hoberman, C; Bertoldi, K				Melancon, David; Gorissen, Benjamin; Garcia-Mora, Carlos J.; Hoberman, Chuck; Bertoldi, Katia			Multistable inflatable origami structures at the metre scale	NATURE			English	Article							DEPLOYABLE STRUCTURES; DESIGN; STIFF	From stadium covers to solar sails, we rely on deployability for the design of large-scale structures that can quickly compress to a fraction of their size(1-4). Historically, two main strategies have been used to design deployable systems. The first and most frequently used approach involves mechanisms comprising interconnected bar elements, which can synchronously expand and retract(5-7), occasionally locking in place through bistable elements(8,9). The second strategy makes use of inflatable membranes that morph into target shapes by means of a single pressure input(10-12.) Neither strategy, however, can be readily used to provide an enclosed domain that is able to lock in place after deployment: the integration of a protective covering in linkage-based constructions is challenging and pneumatic systems require a constant applied pressure to keep their expanded shape(13-15). Here we draw inspiration from origami-the Japanese art of paper folding-to design rigid-walled deployable structures that are multistable and inflatable. Guided by geometric analyses and experiments, we create a library of bistable origami shapes that can be deployed through a single fluidic pressure input. We then combine these units to build functional structures at the metre scale, such as arches and emergency shelters, providing a direct route for building large-scale inflatable systems that lock in place after deployment and offer a robust enclosure through their stiff faces.	[Melancon, David; Gorissen, Benjamin; Garcia-Mora, Carlos J.; Bertoldi, Katia] Harvard Univ, JA Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Garcia-Mora, Carlos J.] Univ Seville, Dept Bldg Struct & Geotech Engn, Seville, Spain; [Hoberman, Chuck; Bertoldi, Katia] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Hoberman, Chuck] Hoberman Associates, New York, NY 10013 USA; [Hoberman, Chuck] Grad Sch Design, Cambridge, MA 02138 USA; [Bertoldi, Katia] Harvard Univ, Kavli Inst, Cambridge, MA 02138 USA	Harvard University; University of Sevilla; Harvard University; Harvard University	Bertoldi, K (corresponding author), Harvard Univ, JA Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Hoberman, C; Bertoldi, K (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.; Hoberman, C (corresponding author), Hoberman Associates, New York, NY 10013 USA.; Hoberman, C (corresponding author), Grad Sch Design, Cambridge, MA 02138 USA.; Bertoldi, K (corresponding author), Harvard Univ, Kavli Inst, Cambridge, MA 02138 USA.	choberman@gsd.harvard.edu; bertoldi@seas.harvard.edu		Gorissen, Benjamin/0000-0001-8275-7610	NSF through the Harvard University Materials Research Science and Engineering Center [DMR-1420570]; Fund for Scientific Research-Flanders (FWO); DMREF grant [DMR-1922321]	NSF through the Harvard University Materials Research Science and Engineering Center; Fund for Scientific Research-Flanders (FWO)(FWO); DMREF grant(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank E. Demaine, J. Ku, T. Tachi and Yunfang Yang for insightful discussions; S. Lindner-Liaw, M. Bhattacharya and M. Starkey for assistance in the fabrication of the centimetre-scale and large-scale structures; and A. E. Forte for his valuable comments and suggestions on the manuscript. This research was supported by NSF through the Harvard University Materials Research Science and Engineering Center grant number DMR-1420570 and DMREF grant number DMR-1922321, as well as the Fund for Scientific Research-Flanders (FWO).	Arnouts LIW, 2019, IASS 60TH ANNIVERSARY SYMPOSIUM (IASS SYMPOSIUM 2019) - 9TH INTERNATIONAL CONFERENCE ON TEXTILE COMPOSITES AND INFLATABLE STRUCTURES (STRUCTURAL MEMBRANES 2019), P1804; Block J, 2011, ACTA ASTRONAUT, V68, P984, DOI 10.1016/j.actaastro.2010.09.005; Cadogan D, 1999, ACTA ASTRONAUT, V44, P399, DOI 10.1016/S0094-5765(99)00103-4; Cai JG, 2015, J MECH DESIGN, V137, DOI 10.1115/1.4030158; Chen Y, 2016, P ROY SOC A-MATH PHY, V472, DOI 10.1098/rspa.2015.0846; CONNELLY R, 1979, MATH MAG, V52, P275, DOI DOI 10.1080/0025570X.1979.11976803; Connelly R., 1997, BEITRAGE ALGEBRA GEO, V38, P1, DOI [10.1038/scientificamerican0798-110, DOI 10.1038/SCIENTIFICAMERICAN0798-110]; Del Grosso AE, 2010, SMART MATER STRUCT, V19, DOI 10.1088/0964-1726/19/12/124011; Dolciani M. P., 1963, MODERN GEOMETRY STRU; Dudte LH, 2016, NAT MATER, V15, P583, DOI [10.1038/NMAT4540, 10.1038/nmat4540]; Faber JA, 2018, SCIENCE, V359, P1386, DOI 10.1126/science.aap7753; Filipov ET, 2015, P NATL ACAD SCI USA, V112, P12321, DOI 10.1073/pnas.1509465112; Garcia-Mora CJ, 2020, MECH MACH THEORY, V146, DOI 10.1016/j.mechmachtheory.2019.103720; Hanna BH, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/094009; Iniguez-Rabago A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13319-7; Kamrava S, 2017, SCI REP-UK, V7, DOI 10.1038/srep46046; Kim W, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aay3493; Li SG, 2017, P NATL ACAD SCI USA, V114, P13132, DOI 10.1073/pnas.1713450114; Liu K, 2017, P ROY SOC A-MATH PHY, V473, DOI 10.1098/rspa.2017.0348; Liu YJ, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/2/023001; Mackenzie D, 1998, SCIENCE, V279, P1637, DOI 10.1126/science.279.5357.1637; Martinez RV, 2012, ADV FUNCT MATER, V22, P1376, DOI 10.1002/adfm.201102978; Mira LA, 2014, AUTOMAT CONSTR, V43, P123, DOI 10.1016/j.autcon.2014.03.014; Miskin MZ, 2018, P NATL ACAD SCI USA, V115, P466, DOI 10.1073/pnas.1712889115; Onal CD, 2015, IEEE-ASME T MECH, V20, P2214, DOI 10.1109/TMECH.2014.2369854; Onal CD, 2013, IEEE-ASME T MECH, V18, P430, DOI 10.1109/TMECH.2012.2210239; Overvelde JTB, 2017, NATURE, V541, P347, DOI 10.1038/nature20824; Puig L, 2010, ACTA ASTRONAUT, V67, P12, DOI 10.1016/j.actaastro.2010.02.021; Reid A, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.013002; Rus D, 2018, NAT REV MATER, V3, P101, DOI 10.1038/s41578-018-0009-8; Seymour K., 2018, ORIGAMI 7, V3, P763; Siefert E, 2020, SOFT MATTER, V16, P7898, DOI 10.1039/d0sm01041c; Siefert E, 2019, NAT MATER, V18, P24, DOI 10.1038/s41563-018-0219-x; Silverberg JL, 2015, NAT MATER, V14, P389, DOI [10.1038/NMAT4232, 10.1038/nmat4232]; Silverberg JL, 2014, SCIENCE, V345, P647, DOI 10.1126/science.1252876; Skouras M, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2601097.2601166; Tachi T., 2011, ORIGAMI, V5; Thrall AP, 2012, ENG STRUCT, V37, P214, DOI 10.1016/j.engstruct.2011.12.031; Usevitch NS, 2020, SCI ROBOT, V5, DOI 10.1126/scirobotics.aaz0492; Waitukaitis S, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055503; Yasuda H, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.185502; You Z, 1997, INT J SOLIDS STRUCT, V34, P1825, DOI 10.1016/S0020-7683(96)00125-4; Zhao JS, 2009, MECH MACH THEORY, V44, P324, DOI 10.1016/j.mechmachtheory.2008.03.014; Zirbel SA, 2013, J MECH DESIGN, V135, DOI 10.1115/1.4025372	50	52	53	74	169	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					545	+		10.1038/s41586-021-03407-4	http://dx.doi.org/10.1038/s41586-021-03407-4			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6RQ	33883736	Green Accepted			2022-12-28	WOS:000687333900006
J	Dyer, C				Dyer, Clare			Covid-19: Government faces legal action over 102m pound contract for FFP3 masks	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n511; Iacobucci G, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4474	2	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n1040	10.1136/bmj.n1040	http://dx.doi.org/10.1136/bmj.n1040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883105	Bronze			2022-12-28	WOS:000642452700008
J	Kamran, H; Jneid, H; Kayani, WT; Virani, SS; Levine, GN; Nambi, V; Khalid, U				Kamran, Hassan; Jneid, Hani; Kayani, Waleed T.; Virani, Salim S.; Levine, Glenn N.; Nambi, Vijay; Khalid, Umair			Oral Antiplatelet Therapy After Acute Coronary Syndrome: A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ARTERY-DISEASE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; RECEPTOR ANTAGONIST; FOCUSED UPDATE; CLOPIDOGREL; PRASUGREL; ASPIRIN; TICAGRELOR; VORAPAXAR	This narrative review summarizes oral antiplatelet therapy and specifically addresses the effects of dual antiplatelet therapy for patients with acute coronary syndrome who have not taken anticoagulants. ImportanceAcute coronary syndrome (ACS) is a major cause of morbidity and mortality in the United States with an annual incidence of approximately 1 million. Dual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) reduces cardiovascular event rates after ACS. ObservationsIn 2016, the updated guidelines from the American College of Cardiology/American Heart Association (ACC/AHA) recommended aspirin plus a P2Y12 inhibitor for at least 12 months for patients with ACS. Since these recommendations were published, new randomized clinical trials have studied different regimens and durations of antiplatelet therapy. Recommendations vary according to the risk of bleeding. If bleeding risk is low, prolonged DAPT may be considered, although the optimal duration of prolonged DAPT beyond 1 year is not well established. If bleeding risk is high, shorter duration (ie, 3-6 months) of DAPT may be reasonable. A high risk of bleeding traditionally is defined as a 1-year risk of serious bleeding (either fatal or associated with a >= 3-g/dL drop in hemoglobin) of at least 4% or a risk of an intracranial hemorrhage of at least 1%. Patients at higher risk are 65 years old or older; have low body weight (BMI <18.5), diabetes, or prior bleeding; or take oral anticoagulants. The newest P2Y12 inhibitors, prasugrel and ticagrelor, are more potent, with high on-treatment residual platelet reactivity of about 3% vs 30% to 40% with clopidogrel and act within 30 minutes compared with 2 hours for clopidogrel. Clinicians should avoid prescribing prasugrel to patients with a history of stroke or transient ischemic attack because of an increased risk of cerebrovascular events (6.5% vs 1.2% with clopidogrel, P=.002) and should avoid prescribing it to patients older than 75 years or who weigh less than 60 kg. The ISAR-REACT-5 trial found that prasugrel reduced rates of death, myocardial infarction, or stroke at 1 year compared with ticagrelor among patients with ACS undergoing percutaneous coronary intervention (9.3% vs 6.9%, P=.006) with no significant difference in bleeding. Recent trials suggested that discontinuing aspirin rather than the P2Y12 inhibitor may be associated with better outcomes. Conclusions and RelevanceDual antiplatelet therapy reduces rates of cardiovascular events in patients with acute coronary syndrome. Specific combinations and duration of dual antiplatelet therapy should be based on patient characteristics-risk of bleeding myocardial ischemia.	[Kamran, Hassan; Jneid, Hani; Kayani, Waleed T.; Virani, Salim S.; Levine, Glenn N.; Nambi, Vijay; Khalid, Umair] Baylor Coll Med, Dept Med, Sect Cardiol, Houston, TX 77030 USA; [Jneid, Hani; Virani, Salim S.; Levine, Glenn N.; Nambi, Vijay; Khalid, Umair] Michael E DeBakey VA Med Ctr, Dept Med, Sect Cardiol, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Khalid, U (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd Mail Code 111B, Houston, TX 77030 USA.; Khalid, U (corresponding author), Baylor Coll Med, 2002 Holcombe Blvd Mail Code 111B, Houston, TX 77030 USA.	mukhalid@bcm.edu						Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; [Anonymous], 2009, EFFIENT PRASUGREL PR; [Anonymous], 2011, BRILINTA TICAGRELOR; Badimon L, 2012, EUR HEART J-ACUTE CA, V1, P60, DOI 10.1177/2048872612441582; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bittl JA, 2016, CIRCULATION, V134, pE156, DOI 10.1161/CIR.0000000000000405; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Brilakis ES, 2013, JAMA-J AM MED ASSOC, V310, P189, DOI 10.1001/jama.2013.7086; Cannon CP, 2007, J AM COLL CARDIOL, V50, P1844, DOI 10.1016/j.jacc.2007.07.053; Cannon CP, 2010, LANCET, V375, P283, DOI 10.1016/S0140-6736(09)62191-7; Chaabane C, 2013, CARDIOVASC RES, V99, P353, DOI 10.1093/cvr/cvt115; Collet J.P, 2020, EUR HEART J; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Cornelissen A, 2019, J CELL MOL MED, V23, P39, DOI 10.1111/jcmm.13936; Cowled P., 2011, MECH VASCULAR DIS RE, P18; Dobesh PP, 2014, PHARMACOTHERAPY, V34, P1077, DOI 10.1002/phar.1477; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Kim BK, 2020, JAMA-J AM MED ASSOC, V323, P2407, DOI 10.1001/jama.2020.7580; Lee DH, 2018, EUR CARDIOL REV, V13, P54, DOI 10.15420/ecr.2018:8:2; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Maree AO, 2005, J AM COLL CARDIOL, V46, P1258, DOI 10.1016/j.jacc.2005.06.058; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Mason PJ, 2005, J AM COLL CARDIOL, V46, P986, DOI 10.1016/j.jacc.2004.08.070; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehran R, 2019, NEW ENGL J MED, V381, P2032, DOI 10.1056/NEJMoa1908419; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2014, CIRCULATION, V129, P2136, DOI 10.1161/CIRCULATIONAHA.113.007524; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Norgard NB, 2009, VASC HEALTH RISK MAN, V5, P873; O'Donoghue ML, 2020, CIRCULATION, V142, P538, DOI 10.1161/CIRCULATIONAHA.120.046251; Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050; Palmerini T, 2019, CIRC-CARDIOVASC INTE, V12, DOI 10.1161/CIRCINTERVENTIONS.118.007541; Palmerini T, 2017, EUR HEART J, V38, P1034, DOI 10.1093/eurheartj/ehw627; Parodi G, 2015, EUR HEART J-ACUTE CA, V4, P555, DOI 10.1177/2048872614554108; Reynolds HR, 2021, CIRCULATION, V143, P624, DOI 10.1161/CIRCULATIONAHA.120.052008; Riesmeyer JS, 2012, J CLIN PHARMACOL, V52, P789, DOI 10.1177/0091270011406280; Roe MT, 2013, CIRCULATION, V128, P823, DOI 10.1161/CIRCULATIONAHA.113.002303; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sangkuhl K, 2010, PHARMACOGENET GENOM, V20, P463, DOI 10.1097/FPC.0b013e3283385420; Santos-Gallego CG, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0401-9; Schupke S, 2019, NEW ENGL J MED, V381, P1524, DOI 10.1056/NEJMoa1908973; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tada T, 2013, JACC-CARDIOVASC INTE, V6, P1267, DOI 10.1016/j.jcin.2013.06.015; Tamis-Holland JE, 2019, CIRCULATION, V139, pE891, DOI 10.1161/CIR.0000000000000670; Tran H, 2004, JAMA-J AM MED ASSOC, V292, P1867, DOI 10.1001/jama.292.15.1867; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wallentin L, 2009, EUR HEART J, V30, P1964, DOI 10.1093/eurheartj/ehp296; Watanabe H, 2019, JAMA-J AM MED ASSOC, V321, P2414, DOI 10.1001/jama.2019.8145; Wei J, 2019, JAMA-J AM MED ASSOC, V322, P2334, DOI 10.1001/jama.2019.15736; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2010, CIRCULATION, V122, P394, DOI 10.1161/CIRCULATIONAHA.109.921502; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; 1988, LANCET, V12, pA3, DOI DOI 10.1016/0735-1097(88)92635-6	65	20	22	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1545	1555		10.1001/jama.2021.0716	http://dx.doi.org/10.1001/jama.2021.0716			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877270				2022-12-28	WOS:000642636500020
J	Mahase, E				Mahase, Elisabeth			Covid-19: Government's shielding scheme failed thousands of clinically extremely vulnerable people, say MPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		House of Commons Committee of Public Accounts, 2021, COVID 19 SUPP VULN L	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n1033	10.1136/bmj.n1033	http://dx.doi.org/10.1136/bmj.n1033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3BI	33879475	Bronze			2022-12-28	WOS:000643654700005
J	Iacobucci, G				Iacobucci, Gareth			Birmingham council sets up task force to tackle high rate of infant mortality	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Salway S, 2020, COMMUNITIES PREFER C; Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2020	372								n1015	10.1136/bmj.n1015	http://dx.doi.org/10.1136/bmj.n1015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ2MU	33875445				2022-12-28	WOS:000642254900001
J	Qaseem, A; Etxeandia-Ikobaltzeta, I; Mustafa, RA; Kansagara, D; Fitterman, N; Wilt, TJ				Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar; Mustafa, Reem A.; Kansagara, Devan; Fitterman, Nick; Wilt, Timothy J.		Amer Coll Phys	Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE RESPIRATORY-FAILURE; ACUTE HEART-FAILURE; CARDIAC ULTRASOUND; LUNG ULTRASOUND; DIAGNOSTIC-ACCURACY; INTERNAL-MEDICINE; CHEST ULTRASOUND; MANAGEMENT	Description: The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings to improve the diagnostic, treatment, and health outcomes of those with suspected congestive heart failure, pneumonia, pulmonary embolism, pleural effusion, or pneumothorax. Methods: The ACP Clinical Guidelines Committee based this guideline on a systematic review on the benefits, harms, and diagnostic test accuracy of POCUS; patient values and preferences; and costs of POCUS. The systematic review evaluated health outcomes, diagnostic timeliness, treatment decisions, and test accuracy. The critical health, diagnostic, and treatment outcomes evaluated were in-hospital mortality, time to diagnosis, and time to treatment. The important outcomes evaluated were intensive care unit admissions, correctness of diagnosis, disease-specific outcomes, hospital readmissions, length of hospital stay, and quality of life. The critical test accuracy outcomes included false-positive results for suspected pneumonia, pneumothorax, and pulmonary embolism and false-negative results for suspected congestive heart failure, pneumonia, pneumothorax, and pulmonary embolism. Important test accuracy outcomes included false-positive results for suspected congestive heart failure and false-negative and false-positive results for suspected pleural effusion. This guideline was developed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method. Target Audience and Patient Population: The target audience is all clinicians, and the target patient population is adult patients with acute dyspnea in ED or inpatient settings. Recommendation: ACP suggests that clinicians may use point-of-care ultrasonography in addition to the standard diagnostic pathway when there is diagnostic uncertainty in patients with acute dyspnea in emergency department or inpatient settings (conditional recommendation; low-certainty evidence).	[Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Mustafa, Reem A.] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA; [Kansagara, Devan] Portland VA Med Ctr, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Fitterman, Nick] Northwell Hlth, Huntington, WV USA; [Wilt, Timothy J.] Minneapolis VA Med Ctr, Minneapolis, MN USA; [Etxeandia-Ikobaltzeta, Itziar] 1 Santa Margarita Hosp St,Ground Floor 2,Off 1, Gipuzkoa 20303, Spain; [Mustafa, Reem A.] 3901 Rainbow Blvd,MS3002, Kansas City, KS 66160 USA; [Fitterman, Nick] Northwell Hlth, 270 Pk Ave, Huntington, NY 11743 USA; [Wilt, Timothy J.] VA Med Ctr 111-0, Minneapolis, MN 55417 USA	American College of Physicians; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Northwell Health	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022; ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022	ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Qaseem, Amir/0000-0001-6866-7985	ACP	ACP	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	[Anonymous], 2015, GRADEPRO GDT GRADEPR; Baker K, 2020, EMERG MED AUSTRALAS, V32, P45, DOI 10.1111/1742-6723.13333; Buessler A, 2020, CHEST, V157, P99, DOI 10.1016/j.chest.2019.07.017; Carlino MV, 2018, ECHOCARDIOGR-J CARD, V35, P785, DOI 10.1111/echo.13851; Colclough A, 2017, HERZ, V42, P255, DOI 10.1007/s00059-016-4531-4; De Carvalho H, 2021, EUR J EMERG MED, V28, P29, DOI 10.1097/MEJ.0000000000000732; Filipiak-Strzecka D, 2018, INT J CARDIOVAS IMAG, V34, P1595, DOI 10.1007/s10554-018-1382-5; Filopei J, 2014, J HOSP MED, V9, P594, DOI 10.1002/jhm.2219; Gartlehner G, 2021, ANN INTERN MED, V174, P967, DOI 10.7326/M20-5504; Higgins JPT, 2016, COCHRANE DB SYST REV, V10, P29; Kajimoto K, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-49; Kobal SL, 2005, AM J CARDIOL, V96, P1002, DOI 10.1016/j.amjcard.2005.05.060; Laursen CB, 2014, LANCET RESP MED, V2, P638, DOI 10.1016/S2213-2600(14)70135-3; Laursen CB, 2013, CHEST, V144, P1868, DOI 10.1378/chest.13-0882; Mantuani D, 2016, WEST J EMERG MED, V17, P46, DOI 10.5811/westjem.2015.11.28525; Narula J, 2018, JAMA CARDIOL, V3, P346, DOI 10.1001/jamacardio.2018.0001; Panoulas VF, 2013, EUR HEART J-CARD IMG, V14, P323, DOI 10.1093/ehjci/jes140; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Perrone T, 2017, EUR J INTERN MED, V46, P61, DOI 10.1016/j.ejim.2017.07.034; Pirozzi C, 2014, CRIT ULTRASOUND J, V6, DOI 10.1186/2036-7902-6-5; Pivetta E, 2019, EUR J HEART FAIL, V21, P754, DOI 10.1002/ejhf.1379; Qaseem A, 2019, ANN INTERN MED, V171, P354, DOI 10.7326/M18-3279; Qaseem A, 2019, ANN INTERN MED, V170, P863, DOI 10.7326/M18-3290; Rui, NATL HOSP AMBULATORY; Sartini S, 2017, INTERN EMERG MED, V12, P861, DOI 10.1007/s11739-016-1498-3; Schunemann H, GRADE HDB; Sen S, 2017, J CRIT CARE, V40, P58, DOI 10.1016/j.jcrc.2017.03.007; Sforza A, 2017, CARDIOVASC ULTRASOUN, V15, DOI 10.1186/s12947-017-0105-8; Silva S, 2013, CHEST, V144, P859, DOI 10.1378/chest.13-0167; Vourvouri EC, 2005, HEART, V91, P171, DOI 10.1136/hrt.2003.028225; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zanobetti M, 2017, CHEST, V151, P1295, DOI 10.1016/j.chest.2017.02.003	32	25	24	1	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					985	+		10.7326/M20-7844	http://dx.doi.org/10.7326/M20-7844			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33900792				2022-12-28	WOS:000675809000025
J	Mendel, M; Delaney, K; Pandey, RR; Chen, KM; Wenda, JM; Vagbo, CB; Steiner, FA; Homolka, D; Pillai, RS				Mendel, Mateusz; Delaney, Kamila; Pandey, Radha Raman; Chen, Kuan-Ming; Wenda, Joanna M.; Vagbo, Cathrine Broberg; Steiner, Florian A.; Homolka, David; Pillai, Ramesh S.			Splice site m(6)A methylation prevents binding of U2AF35 to inhibit RNA splicing	CELL			English	Article							PRE-MESSENGER-RNA; YTH DOMAIN; MECHANISTIC INSIGHTS; SEX DETERMINATION; STRUCTURAL BASIS; NUCLEAR-RNA; U6 SNRNA; RECOGNITION; SEQUENCES; REVEALS	The N-6-methyladenosine (m(6)A) RNA modification is used widely to alter the fate of mRNAs. Here we demonstrate that the C. elegans writer METT-10 (the ortholog of mouse METTL16) deposits an m(6)A mark on the 3' splice site (AG) of the S-adenosylmethionine (SAM) synthetase pre-mRNA, which inhibits its proper splicing and protein production. The mechanism is triggered by a rich diet and acts as an m(6)A-mediated switch to stop SAM production and regulate its homeostasis. Although the mammalian SAM synthetase pre-mRNA is not regulated via this mechanism, we show that splicing inhibition by 3' splice site m(6)A is conserved in mammals. The modification functions by physically preventing the essential splicing factor U2AF35 from recognizing the 3' splice site. We propose that use of splice-site m(6)A is an ancient mechanism for splicing regulation.	[Mendel, Mateusz; Delaney, Kamila; Pandey, Radha Raman; Chen, Kuan-Ming; Wenda, Joanna M.; Steiner, Florian A.; Homolka, David; Pillai, Ramesh S.] Univ Geneva, Sci 3, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland; [Vagbo, Cathrine Broberg] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Prote & Mod Expt Core PROMEC, Trondheim, Norway; [Vagbo, Cathrine Broberg] St Olavs Hosp, Trondheim, Norway	University of Geneva; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Homolka, D; Pillai, RS (corresponding author), Univ Geneva, Sci 3, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	david.homolka@unige.ch; ramesh.pillai@unige.ch	Pandey, Radha Raman/AAQ-8593-2020	Pandey, Radha Raman/0000-0002-4439-8386; Wenda, Joanna/0000-0002-7312-6777; Delaney, Kamila/0000-0002-1006-9146; Steiner, Florian/0000-0002-0514-5060	NIH Office of Research Infrastructure Programs [P40 OD010440]; Boehringer Ingelheim Fonds PhD fellowship; Novartis Foundation for Medical-Biological Research [19B138]; Swiss National Science Foundation (ERC) [CRETP3_166923, 310030B_185386, CRSII5_183524]; NCCR RNA Disease [51NF40_182880]; Republic and Canton of Geneva	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim); Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Swiss National Science Foundation (ERC); NCCR RNA Disease; Republic and Canton of Geneva	Wethank theCaenorhabditisGeneticsCenter (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for some worm strains. Wethank Markus Stoffel for transgenicmouse lines. We thank Sebastian Fica for providing b-globin and MINX splicing constructs, Wojtek Galej for discussions, and Pascal Gos and Marina Berti for assistance with experiments. We thank the following facilities: the iGE3 Genomics Platform, University of Geneva; the Metabolomics Platform, University of Lausanne; and theEMBL Genomics core facility. M.M. is grateful for a Boehringer Ingelheim Fonds PhD fellowship and thanks the Novartis Foundation for Medical-Biological Research (19B138) for salary support. This work was supported by grants to R.S.P. from the Swiss National Science Foundation (ERC Transfer Grant CRETP3_166923, Project Grant 310030B_185386, andSinergia GrantCRSII5_183524andfunding from the NCCR RNA & Disease 51NF40_182880). Work in the Pillai lab is supported by the Republic and Canton of Geneva.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aoyama T, 2020, NUCLEIC ACIDS RES, V48, P5157, DOI 10.1093/nar/gkaa227; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bartosovic M, 2017, NUCLEIC ACIDS RES, V45, P11356, DOI 10.1093/nar/gkx778; Batey RT, 2011, WIRES RNA, V2, P299, DOI 10.1002/wrna.63; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Blumenthal T., 1997, C ELEGANS; Breaker RR, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032797; BRENNER S, 1974, GENETICS, V77, P71; Brown JA, 2016, P NATL ACAD SCI USA, V113, P14013, DOI 10.1073/pnas.1614759113; CANTONI GL, 1975, ANNU REV BIOCHEM, V44, P435, DOI 10.1146/annurev.bi.44.070175.002251; Chevalier C, 2020, CELL METAB, V32, P575, DOI 10.1016/j.cmet.2020.08.012; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DESROSIERS RC, 1975, BIOCHEMISTRY-US, V14, P4367, DOI 10.1021/bi00691a004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dorsett M, 2009, GENETICS, V183, P233, DOI 10.1534/genetics.109.105270; Doxtader KA, 2018, MOL CELL, V71, P1001, DOI 10.1016/j.molcel.2018.07.025; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fica SM, 2017, NAT STRUCT MOL BIOL, V24, P791, DOI 10.1038/nsmb.3463; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Galej WP, 2018, BIOCHEM SOC T, V46, P1407, DOI 10.1042/BST20170240; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; Herzel L, 2017, NAT REV MOL CELL BIO, V18, P637, DOI 10.1038/nrm.2017.63; Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Ivanova I, 2017, MOL CELL, V67, P1059, DOI 10.1016/j.molcel.2017.08.003; Jain D, 2018, ELIFE, V7, DOI 10.7554/eLife.30919; Jalili V, 2018, BIOINFORMATICS, V34, P2338, DOI 10.1093/bioinformatics/bty119; Kan LJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15737; Kasowitz SD, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007412; Kastner B, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a032417; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lasman L, 2020, GENE DEV, V34, P1373, DOI 10.1101/gad.340695.120; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li FD, 2014, CELL RES, V24, P1490, DOI 10.1038/cr.2014.153; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mayeda A, 1999, METH MOL B, V118, P315; Mendel M, 2018, MOL CELL, V71, P986, DOI 10.1016/j.molcel.2018.08.004; Soares LMM, 2006, SCIENCE, V312, P1961, DOI 10.1126/science.1128659; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mon H, 2012, RNA BIOL, V9, P40, DOI 10.4161/rna.9.1.18084; Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; PADGETT RA, 1984, SCIENCE, V225, P898, DOI 10.1126/science.6206566; Pandey RR, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108038; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; R Development Core Team, 2009, R LANG ENV STAT COMP; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Revtovich AV, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008011; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Rudner DZ, 1996, P NATL ACAD SCI USA, V93, P10333, DOI 10.1073/pnas.93.19.10333; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; SCHIBLER U, 1977, J MOL BIOL, V115, P695, DOI 10.1016/0022-2836(77)90110-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047; Sendinc E, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00186-6; Shi YG, 2017, NAT REV MOL CELL BIO, V18, P655, DOI 10.1038/nrm.2017.86; Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Sickmier EA, 2006, MOL CELL, V23, P49, DOI 10.1016/j.molcel.2006.05.025; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sun HZ, 2019, BIOL REPROD, V100, P601, DOI 10.1093/biolre/ioy194; Theler D, 2014, NUCLEIC ACIDS RES, V42, P13911, DOI 10.1093/nar/gku1116; Valcarcel J, 1996, SCIENCE, V273, P1706, DOI 10.1126/science.273.5282.1706; van Delft P, 2017, CHEMBIOCHEM, V18, P979, DOI 10.1002/cbic.201700093; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wojtas MN, 2017, MOL CELL, V68, P374, DOI 10.1016/j.molcel.2017.09.021; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yoshida H, 2015, GENE DEV, V29, P1649, DOI 10.1101/gad.267104.115; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zhang XH, 2020, RNA, V26, P150, DOI 10.1261/rna.072983.119; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zhou KI, 2019, MOL CELL, V76, P70, DOI 10.1016/j.molcel.2019.07.005; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597; Zorio DAR, 1999, RNA, V5, P487, DOI 10.1017/S1355838299982225; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	103	36	36	8	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 10	2021	184	12					3125	+	e25	10.1016/j.cell.2021.03.062	http://dx.doi.org/10.1016/j.cell.2021.03.062		JUN 2021	43	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SP9WV	33930289	hybrid, Green Published			2022-12-28	WOS:000660014300007
J	Jiao, CL; Sharma, S; Dugar, G; Peeck, NL; Bischler, T; Wimmer, F; Yu, YY; Barquist, L; Schoen, C; Kurzai, O; Sharma, CM; Beisel, CL				Jiao, Chunlei; Sharma, Sahil; Dugar, Gaurav; Peeck, Natalia L.; Bischler, Thorsten; Wimmer, Franziska; Yu, Yanying; Barquist, Lars; Schoen, Christoph; Kurzai, Oliver; Sharma, Cynthia M.; Beisel, Chase L.			Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9	SCIENCE			English	Article							NUCLEIC-ACID DETECTION; CRISPR; DIVERSITY; REVEALS; BINDING	CRISPR-Cas systems recognize foreign genetic material using CRISPR RNAs (crRNAs). In type II systems, a trans-activating crRNA (tracrRNA) hybridizes to crRNAs to drive their processing and utilization by Cas9. While analyzing Cas9-RNA complexes from Campylobacter jejuni, we discovered tracrRNA hybridizing to cellular RNAs, leading to formation of "noncanonical" crRNAs capable of guiding DNA targeting by Cas9. Our discovery inspired the engineering of reprogrammed tracrRNAs that link the presence of any RNA of interest to DNA targeting with different Cas9 orthologs. This capability became the basis for a multiplexable diagnostic platform termed LEOPARD (leveraging engineered tracrRNAs and on-target DNAs for parallel RNA detection). LEOPARD allowed simultaneous detection of RNAs from different viruses in one test and distinguished severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its D614G (Asp(614)-> Gly) variant with single-base resolution in patient samples.	[Jiao, Chunlei; Peeck, Natalia L.; Wimmer, Franziska; Yu, Yanying; Barquist, Lars; Beisel, Chase L.] Helmholtz Inst RNA Based Infect Res HIRI, Helmholtz Ctr Infect Res HZI, D-97080 Wurzburg, Germany; [Sharma, Sahil; Dugar, Gaurav; Sharma, Cynthia M.] Univ Wurzburg, Inst Mol Infect Biol, Mol Infect Biol 2, D-97080 Wurzburg, Germany; [Bischler, Thorsten] Univ Wurzburg, Core Unit Syst Med, D-97080 Wurzburg, Germany; [Barquist, Lars; Beisel, Chase L.] Univ Wurzburg, Med Fac, D-97080 Wurzburg, Germany; [Schoen, Christoph; Kurzai, Oliver] Univ Wurzburg, Inst Hyg & Microbiol, D-97080 Wurzburg, Germany; [Kurzai, Oliver] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Dugar, Gaurav] Univ Amsterdam, Swammerdam Inst Far Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	Helmholtz Association; Helmholtz-Center for Infection Research; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Hans Knoll Institute (HKI); University of Amsterdam	Beisel, CL (corresponding author), Helmholtz Inst RNA Based Infect Res HIRI, Helmholtz Ctr Infect Res HZI, D-97080 Wurzburg, Germany.; Sharma, CM (corresponding author), Univ Wurzburg, Inst Mol Infect Biol, Mol Infect Biol 2, D-97080 Wurzburg, Germany.; Beisel, CL (corresponding author), Univ Wurzburg, Med Fac, D-97080 Wurzburg, Germany.	cythia.sharma@uni-wuerzburg.de; chase.beisel@helmholtz-hiri.de	Sharma, Sahil/ABG-2932-2020; Sharma, Cynthia/D-2869-2013; Barquist, Lars/H-6529-2019; Schoen, Christoph/G-9837-2013	Sharma, Sahil/0000-0003-4067-5419; Barquist, Lars/0000-0003-4732-2667; Peeck, Natalia Luise/0000-0002-8480-9784; Schoen, Christoph/0000-0003-2222-1085; Sharma, Cynthia Mira/0000-0002-2321-9705; Dugar, Gaurav/0000-0002-5678-3679; Jiao, Chunlei/0000-0001-5173-2058; Kurzai, Oliver/0000-0002-7277-2646; Bischler, Thorsten/0000-0001-9288-9481; Yu, Yanying/0000-0002-2247-5782	Deutsche Forschungsgemeinschaft Interdisciplinary Center for Clinical Research Wurzburg (IZKF) project Z-6 Free State of Bavaria for COVID-19 research at the IHM [SH 580/9-1, BE 6703/1-1]	Deutsche Forschungsgemeinschaft Interdisciplinary Center for Clinical Research Wurzburg (IZKF) project Z-6 Free State of Bavaria for COVID-19 research at the IHM	Support was provided by Deutsche Forschungsgemeinschaft SH 580/9-1 (C.M.S.) and BE 6703/1-1 (C.L.B.) Interdisciplinary Center for Clinical Research Wurzburg (IZKF) project Z-6 Free State of Bavaria for COVID-19 research at the IHM.	Ackerman CM, 2020, NATURE, V582, P277, DOI 10.1038/s41586-020-2279-8; Afroz T, 2014, MOL MICROBIOL, V93, P1093, DOI 10.1111/mmi.12695; Altuvia Y, 2018, NUCLEIC ACIDS RES, V46, P10530, DOI 10.1093/nar/gky816; [Anonymous], NUCLEIC ACIDS RES; [Anonymous], NAT REV MICROBIOL; [Anonymous], CELL; [Anonymous], MOL CELL; [Anonymous], RNA BIOL; [Anonymous], NAT BIOTECHNOL; [Anonymous], MOL CELL; [Anonymous], NATURE; [Anonymous], MOL CELL; [Anonymous], P NATL ACAD SCI USA; [Anonymous], SCIENCE; Anzalone AV, 2020, NAT BIOTECHNOL, V38, P824, DOI 10.1038/s41587-020-0561-9; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barquist L., 2021, PERL SCRIPT EVALUATI; Barquist L., 2021, PERL SCRIPT EVALUATI; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bischler T., 2021, PEAKACHU PEAK CALLIN; Bischler T., 2021, PEAKACHU PEAK CALLIN, DOI [10.5281/ZENODO.4669966, DOI 10.5281/ZENODO.4669966]; Boyle EA, 2017, P NATL ACAD SCI USA, V114, P5461, DOI 10.1073/pnas.1700557114; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dugar G, 2018, MOL CELL, V69, P893, DOI 10.1016/j.molcel.2018.01.032; Dugar G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11667; Dugar G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003495; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Forstner KU, 2014, BIOINFORMATICS, V30, P3421, DOI 10.1093/bioinformatics/btu533; Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179; Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321; Hanna RE, 2020, NAT BIOTECHNOL, V38, P813, DOI 10.1038/s41587-020-0490-7; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hummel KB, 2006, J VIROL METHODS, V132, P166, DOI 10.1016/j.jviromet.2005.10.006; Jacobsen T, 2020, NUCLEIC ACIDS RES, V48, P5624, DOI 10.1093/nar/gkaa272; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung C, 2017, CELL, V170, P35, DOI 10.1016/j.cell.2017.05.044; Karvelis T, 2013, RNA BIOL, V10, P841, DOI 10.4161/rna.24203; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Leenay RT, 2017, J MOL BIOL, V429, P177, DOI 10.1016/j.jmb.2016.11.024; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Liao CY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10747-3; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Makarova KS, 2020, NAT REV MICROBIOL, V18, P67, DOI 10.1038/s41579-019-0299-x; Marshall R, 2018, MOL CELL, V69, P146, DOI 10.1016/j.molcel.2017.12.007; Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836; Ratner HK, 2019, MOL CELL, V75, P498, DOI 10.1016/j.molcel.2019.05.029; Reis AC, 2019, NAT BIOTECHNOL, V37, P1294, DOI 10.1038/s41587-019-0286-9; Scott T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52616-5; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; Strecker J, 2019, SCIENCE, V365, P48, DOI 10.1126/science.aax9181; Wessels HH, 2020, NAT BIOTECHNOL, V38, P722, DOI 10.1038/s41587-020-0456-9; Workman RE, 2021, CELL, V184, P675, DOI 10.1016/j.cell.2020.12.017; Wu Xuebing, 2014, Quant Biol, V2, P59; Yamada M, 2017, MOL CELL, V65, P1109, DOI 10.1016/j.molcel.2017.02.007; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	66	34	34	18	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2021	372	6545					941	+		10.1126/science.abe7106	http://dx.doi.org/10.1126/science.abe7106			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK7YO	33906967	Green Published			2022-12-28	WOS:000656432400041
J	Dorman, SE; Nahid, P; Kurbatova, EV; Phillips, PPJ; Bryant, K; Dooley, KE; Engle, M; Goldberg, SV; Phan, HTT; Hakim, J; Johnson, JL; Lourens, M; Martinson, NA; Muzanyi, G; Narunsky, K; Nerette, S; Nguyen, NV; Pham, TH; Pierre, S; Purfield, AE; Samaneka, W; Savic, RM; Sanne, I; Scott, NA; Shenje, J; Sizemore, E; Vernon, A; Waja, Z; Weiner, M; Swindells, S; Chaisson, RE				Dorman, S. E.; Nahid, P.; Kurbatova, E., V; Phillips, P. P. J.; Bryant, K.; Dooley, K. E.; Engle, M.; Goldberg, S., V; Phan, H. T. T.; Hakim, J.; Johnson, J. L.; Lourens, M.; Martinson, N. A.; Muzanyi, G.; Narunsky, K.; Nerette, S.; Nguyen, N., V; Pham, T. H.; Pierre, S.; Purfield, A. E.; Samaneka, W.; Savic, R. M.; Sanne, I; Scott, N. A.; Shenje, J.; Sizemore, E.; Vernon, A.; Waja, Z.; Weiner, M.; Swindells, S.; Chaisson, R. E.		AIDS Clinical Trials Grp; Tb Trials Consortium	Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Short-Course Treatment of Tuberculosis In this phase 3 trial for the treatment of tuberculosis, a 4-month rifapentine-based regimen containing moxifloxacin was noninferior to a standard 6-month regimen. Background Rifapentine-based regimens have potent antimycobacterial activity that may allow for a shorter course in patients with drug-susceptible pulmonary tuberculosis. Methods In an open-label, phase 3, randomized, controlled trial involving persons with newly diagnosed pulmonary tuberculosis from 13 countries, we compared two 4-month rifapentine-based regimens with a standard 6-month regimen consisting of rifampin, isoniazid, pyrazinamide, and ethambutol (control) using a noninferiority margin of 6.6 percentage points. In one 4-month regimen, rifampin was replaced with rifapentine; in the other, rifampin was replaced with rifapentine and ethambutol with moxifloxacin. The primary efficacy outcome was survival free of tuberculosis at 12 months. Results Among 2516 participants who had undergone randomization, 2343 had a culture positive for Mycobacterium tuberculosis that was not resistant to isoniazid, rifampin, or fluoroquinolones (microbiologically eligible population; 768 in the control group, 791 in the rifapentine-moxifloxacin group, and 784 in the rifapentine group), of whom 194 were coinfected with human immunodeficiency virus and 1703 had cavitation on chest radiography. A total of 2234 participants could be assessed for the primary outcome (assessable population; 726 in the control group, 756 in the rifapentine-moxifloxacin group, and 752 in the rifapentine group). Rifapentine with moxifloxacin was noninferior to the control in the microbiologically eligible population (15.5% vs. 14.6% had an unfavorable outcome; difference, 1.0 percentage point; 95% confidence interval [CI], -2.6 to 4.5) and in the assessable population (11.6% vs. 9.6%; difference, 2.0 percentage points; 95% CI, -1.1 to 5.1). Noninferiority was shown in the secondary and sensitivity analyses. Rifapentine without moxifloxacin was not shown to be noninferior to the control in either population (17.7% vs. 14.6% with an unfavorable outcome in the microbiologically eligible population; difference, 3.0 percentage points [95% CI, -0.6 to 6.6]; and 14.2% vs. 9.6% in the assessable population; difference, 4.4 percentage points [95% CI, 1.2 to 7.7]). Adverse events of grade 3 or higher occurred during the on-treatment period in 19.3% of participants in the control group, 18.8% in the rifapentine-moxifloxacin group, and 14.3% in the rifapentine group. Conclusions The efficacy of a 4-month rifapentine-based regimen containing moxifloxacin was noninferior to the standard 6-month regimen in the treatment of tuberculosis. (Funded by the Centers for Disease Control and Prevention and others; Study 31/A5349 ClinicalTrials.gov number, .)	[Dorman, S. E.] Med Univ South Carolina, Charleston, SC 29425 USA; [Nahid, P.; Phillips, P. P. J.; Savic, R. M.] Univ Calif San Francisco, UCSF Ctr TB, 1001 Potrero Ave 5K1, San Francisco, CA 94110 USA; [Nahid, P.; Phillips, P. P. J.; Phan, H. T. T.; Nguyen, N., V; Pham, T. H.; Savic, R. M.] Vietnam Natl TB Program Univ California San Franc, Hanoi, Vietnam; [Nguyen, N., V; Pham, T. H.] Natl Lung Hosp, Hanoi, Vietnam; [Kurbatova, E., V; Bryant, K.; Goldberg, S., V; Purfield, A. E.; Scott, N. A.; Sizemore, E.; Vernon, A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Engle, M.; Weiner, M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Engle, M.; Weiner, M.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Hakim, J.; Samaneka, W.] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Johnson, J. L.] Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA; [Johnson, J. L.; Muzanyi, G.] Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda; [Lourens, M.] TASK, Cape Town, South Africa; [Narunsky, K.] Univ Cape Town, Lung Inst, Cape Town, South Africa; [Shenje, J.] South African TB Vaccine Initiat, Cape Town, South Africa; [Martinson, N. A.; Waja, Z.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Sanne, I] Wits Hlth Consortium, Johannesburg, South Africa; [Dooley, K. E.; Martinson, N. A.; Chaisson, R. E.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Purfield, A. E.] US Publ Hlth Serv Commissioned Corps, Rockville, MD USA; [Nerette, S.; Pierre, S.] Haitian Grp Study Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Swindells, S.] Univ Nebraska Med Ctr, Omaha, NE USA	Medical University of South Carolina; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Zimbabwe; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; University of Cape Town; University of Cape Town; University of Witwatersrand; University of Witwatersrand; Johns Hopkins University; United States Public Health Service; University of Nebraska System; University of Nebraska Medical Center	Nahid, P (corresponding author), Univ Calif San Francisco, UCSF Ctr TB, 1001 Potrero Ave 5K1, San Francisco, CA 94110 USA.	pnahid@ucsf.edu		Pierre, Samuel/0000-0001-8063-8773; Borisov, Andrey/0000-0001-9124-8877				Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; [Anonymous], 2017, GUIDELINES TREATMENT; [Anonymous], 2010, COMMON TERMINOLOGY C; Blakemore R, 2011, AM J RESP CRIT CARE, V184, P1076, DOI 10.1164/rccm.201103-0536OC; Bonnett LJ, 2017, CLIN INFECT DIS, V65, P46, DOI 10.1093/cid/cix247; Burman WJ, 2006, AM J RESP CRIT CARE, V174, P331, DOI 10.1164/rccm.200603-360OC; Burman WJ, 2001, CLIN PHARMACOKINET, V40, P327, DOI 10.2165/00003088-200140050-00002; CAPELLE P, 1972, GUT, V13, P366, DOI 10.1136/gut.13.5.366; Conde MB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154778; Conde MB, 2009, LANCET, V373, P1183, DOI 10.1016/S0140-6736(09)60333-0; Dorman SE, 2020, CONTEMP CLIN TRIALS, V90, DOI 10.1016/j.cct.2020.105938; Dorman SE, 2015, AM J RESP CRIT CARE, V191, P333, DOI 10.1164/rccm.201410-1843OC; Dorman SE, 2009, AM J RESP CRIT CARE, V180, P273, DOI 10.1164/rccm.200901-0078OC; FOX W, 1981, BRIT J DIS CHEST, V75, P331, DOI 10.1016/0007-0971(81)90022-X; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P2827, DOI 10.1128/JCM.00138-11; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Jayaram R, 2003, ANTIMICROB AGENTS CH, V47, P2118, DOI 10.1128/AAC.47.7.2118-2124.2003; Ji BH, 1998, ANTIMICROB AGENTS CH, V42, P2066, DOI 10.1128/AAC.42.8.2066; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Koch A, 2018, CURR OPIN PHARMACOL, V42, P7, DOI 10.1016/j.coph.2018.05.013; Lumb R, 2013, LAB DIAGNOSIS TUBERC, P3; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Mohamed K, 2011, PHARM STAT, V10, P461, DOI 10.1002/pst.520; Nahid P, 2016, CLIN INFECT DIS, V63, P853, DOI 10.1093/cid/ciw566; Nuermberger EL, 2004, AM J RESP CRIT CARE, V170, P1131, DOI 10.1164/rccm.200407-885OC; Nuermberger EL, 2004, AM J RESP CRIT CARE, V169, P421, DOI 10.1164/rccm.200310-1380OC; Nunn AJ, 2010, INT J TUBERC LUNG D, V14, P241; Owens RC, 2005, CLIN INFECT DIS, V41, pS144, DOI 10.1086/428055; Peloquin CA, 1999, CHEST, V115, P12, DOI 10.1378/chest.115.1.12; Reuben A, 2004, HEPATOLOGY, V39, P574, DOI 10.1002/hep.20081; Rodriguez JC, 2002, INT J ANTIMICROB AG, V20, P464, DOI 10.1016/S0924-8579(02)00239-X; Rosenthal IM, 2008, AM J RESP CRIT CARE, V178, P989, DOI 10.1164/rccm.200807-1029OC; Rosenthal IM, 2007, PLOS MED, V4, P1931, DOI 10.1371/journal.pmed.0040344; Rosenthal IM, 2005, AM J RESP CRIT CARE, V172, P1457, DOI 10.1164/rccm.200507-1072OC; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Savic RM, 2017, CLIN PHARMACOL THER, V102, P321, DOI 10.1002/cpt.634; SOARES JF, 1983, COMMUN STAT-THEOR M, V12, P2017, DOI 10.1080/03610928308828586; Svensson EM, 2018, CLIN INFECT DIS, V67, P34, DOI 10.1093/cid/ciy026; Witney AA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0834-4; Xie YL, 2017, NEW ENGL J MED, V377, P1043, DOI 10.1056/NEJMoa1614915; Zvada SP, 2010, ANTIMICROB AGENTS CH, V54, P3390, DOI 10.1128/AAC.00345-10	42	111	114	5	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1705	1718		10.1056/NEJMoa2033400	http://dx.doi.org/10.1056/NEJMoa2033400			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY1SU	33951360	Bronze, Green Accepted			2022-12-28	WOS:000647698500009
J	Pal, H				Pal, Hemraj			In recently detoxified alcohol-dependent adults, acamprosate increases abstinence maintenance and reduces dropout	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pal, Hemraj] Essex Partnership Univ Fdn NHS Trust, Colchester, Essex, England		Pal, H (corresponding author), Essex Partnership Univ Fdn NHS Trust, Colchester, Essex, England.							*AM PSYCH ASS, 2018, AM J PSYCHIAT, DOI DOI 10.1176/APPI; Lingford-Hughes AR, 2012, J PSYCHOPHARMACOL, V26, P899, DOI 10.1177/0269881112444324; National Institute for Health and Clinical Excellence, ALC US DIS DIAGN ASS	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC51	JC51	m3934	10.7326/ACPJ202105180-051	http://dx.doi.org/10.7326/ACPJ202105180-051			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939485				2022-12-28	WOS:000652604800006
J	Bogati, B				Bogati, Bikash			Driving for a difference	SCIENCE			English	Editorial Material								I was in the second year of my Ph.D. program when a colleague asked what I would do if I had an extra hour every day. Without much deliberation, I said I would use it to help others. The question haunted me. Like many graduate students, I was overwhelmed with research, teaching, coursework, and some attempt at a personal life. Still, I asked myself, "Do I really need a 25th hour to help other people-or do I need to make better use of the 24 hours I have?" A short time later, I started to volunteer for an organization that provides transportation for senior citizens and people with disabilities. To my surprise, adding this activity to my busy life was just what I needed to calm the chaos I was feeling as a first-generation international graduate student.	[Bogati, Bikash] Univ Tennessee, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Bogati, B (corresponding author), Univ Tennessee, Knoxville, TN 37996 USA.		Bogati, Bikash/ABE-7321-2021	Bogati, Bikash/0000-0002-9069-6632					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					534	534		10.1126/science.372.6541.534	http://dx.doi.org/10.1126/science.372.6541.534			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926957				2022-12-28	WOS:000645554100051
J	Chen, XF; Wang, Q; Cheng, ZY; Zhu, ML; Zhou, H; Jiang, P; Zhou, LL; Xue, QQ; Yuan, FP; Zhu, J; Wu, XL; Ma, E				Chen, Xuefei; Wang, Qi; Cheng, Zhiying; Zhu, Mingliu; Zhou, Hao; Jiang, Ping; Zhou, Lingling; Xue, Qiqi; Yuan, Fuping; Zhu, Jing; Wu, Xiaolei; Ma, En			Direct observation of chemical short-range order in a medium-entropy alloy	NATURE			English	Article								Direct experimental evidence of chemical short-range atomic-scale ordering (CSRO) in a VCoNi medium-entropy alloy is provided via diffraction and electron microscopy, analysed from specific crystallographic directions. Complex concentrated solutions of multiple principal elements are being widely investigated as high- or medium-entropy alloys (HEAs or MEAs)(1-11), often assuming that these materials have the high configurational entropy of an ideal solution. However, enthalpic interactions among constituent elements are also expected at normal temperatures, resulting in various degrees of local chemical order(12-22). Of the local chemical orders that can develop, chemical short-range order (CSRO) is arguably the most difficult to decipher and firm evidence of CSRO in these materials has been missing thus far(16,22). Here we discover that, using an appropriate zone axis, micro/nanobeam diffraction, together with atomic-resolution imaging and chemical mapping via transmission electron microscopy, can explicitly reveal CSRO in a face-centred-cubic VCoNi concentrated solution. Our complementary suite of tools provides concrete information about the degree/extent of CSRO, atomic packing configuration and preferential occupancy of neighbouring lattice planes/sites by chemical species. Modelling of the CSRO order parameters and pair correlations over the nearest atomic shells indicates that the CSRO originates from the nearest-neighbour preference towards unlike (V-Co and V-Ni) pairs and avoidance of V-V pairs. Our findings offer a way of identifying CSRO in concentrated solution alloys. We also use atomic strain mapping to demonstrate the dislocation interactions enhanced by the CSROs, clarifying the effects of these CSROs on plasticity mechanisms and mechanical properties upon deformation.	[Chen, Xuefei; Zhu, Mingliu; Jiang, Ping; Zhou, Lingling; Xue, Qiqi; Yuan, Fuping; Wu, Xiaolei] Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing, Peoples R China; [Chen, Xuefei; Zhou, Lingling; Xue, Qiqi; Yuan, Fuping; Wu, Xiaolei] Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China; [Wang, Qi] Sci & Technol Surface Phys & Chem Lab, Jiangyou, Peoples R China; [Cheng, Zhiying; Zhu, Jing] Tsinghua Univ, Sch Mat Sci & Engn, Natl Ctr Electron Microscopy Beijing, Beijing, Peoples R China; [Zhou, Hao] Nanjing Univ Sci & Technol, Sch Mat Sci & Engn, Nano & Heterogeneous Mat Ctr, Nanjing, Peoples R China; [Ma, En] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Ctr Alloy Innovat & Design CAID, Xian, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University; Nanjing University of Science & Technology; Xi'an Jiaotong University	Wu, XL (corresponding author), Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing, Peoples R China.; Wu, XL (corresponding author), Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China.; Zhu, J (corresponding author), Tsinghua Univ, Sch Mat Sci & Engn, Natl Ctr Electron Microscopy Beijing, Beijing, Peoples R China.; Ma, E (corresponding author), Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Ctr Alloy Innovat & Design CAID, Xian, Peoples R China.	jzhu@tsinghua.edu.cn; xlwu@imech.ac.cn; maen@xjtu.edu.cn	Qi, Wang/HDM-5801-2022; wu, xiaolei/A-4968-2010	Wu, Xiaolei/0000-0001-8270-7621; Zhou, Lingling/0000-0002-2274-6749; Wang, Qi/0000-0003-3418-8809; Zhu, Jing/0000-0002-2175-9476				Ding J, 2018, P NATL ACAD SCI USA, V115, P8919, DOI 10.1073/pnas.1808660115; Ding QQ, 2019, NATURE, V574, P223, DOI 10.1038/s41586-019-1617-1; Fernandez-Caballero A, 2017, J PHASE EQUILIB DIFF, V38, P391, DOI 10.1007/s11669-017-0582-3; George EP, 2020, ACTA MATER, V188, P435, DOI 10.1016/j.actamat.2019.12.015; George EP, 2019, NAT REV MATER, V4, P515, DOI 10.1038/s41578-019-0121-4; Gludovatz B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10602; Hytch MJ, 1998, ULTRAMICROSCOPY, V74, P131, DOI 10.1016/S0304-3991(98)00035-7; Jian WR, 2020, ACTA MATER, V199, P352, DOI 10.1016/j.actamat.2020.08.044; Kuwano N, 1999, B MATER SCI, V22, P697, DOI 10.1007/BF02749988; Lei ZF, 2018, NATURE, V563, P546, DOI 10.1038/s41586-018-0685-y; Li QJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11464-7; Li ZM, 2016, NATURE, V534, P227, DOI 10.1038/nature17981; LIU CT, 1973, METALL TRANS, V4, P1743, DOI 10.1007/BF02666205; Ma E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13311-1; Ma Y, 2018, SCRIPTA MATER, V144, P64, DOI 10.1016/j.scriptamat.2017.09.049; Miracle DB, 2017, ACTA MATER, V122, P448, DOI 10.1016/j.actamat.2016.08.081; Oh HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10012-7; Singh P, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.224204; Sohn SS, 2020, ACTA MATER, V194, P106, DOI 10.1016/j.actamat.2020.03.048; Sohn SS, 2019, ADV MATER, V31, DOI 10.1002/adma.201807142; Tamm A, 2015, ACTA MATER, V99, P307, DOI 10.1016/j.actamat.2015.08.015; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Tendeloo G, 1998, PHASE TRANSIT, V67, P101, DOI 10.1080/01411599808219190; VANTENDELOO G, 1986, SCRIPTA METALL MATER, V20, P335, DOI 10.1016/0036-9748(86)90153-5; Warren B, 1990, XRAY DIFFRACTION, P253; Wei SL, 2018, J MATER RES, V33, P2924, DOI 10.1557/jmr.2018.306; Williams DB, 2009, SPRINGER, P407, DOI DOI 10.1295/KOBUNSHI.43.94; Yang T, 2018, SCIENCE, V362, P933, DOI 10.1126/science.aas8815; Ye YF, 2016, MATER TODAY, V19, P349, DOI 10.1016/j.mattod.2015.11.026; Yin BL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16083-1; Zhang FX, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.205501; Zhang RP, 2020, NATURE, V581, P283, DOI 10.1038/s41586-020-2275-z; ZUNGER A, 1990, PHYS REV LETT, V65, P353, DOI 10.1103/PhysRevLett.65.353; ZUNGER A, 1994, NATO ADV SCI INST SE, V319, P361	34	111	113	107	400	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					712	+		10.1038/s41586-021-03428-z	http://dx.doi.org/10.1038/s41586-021-03428-z			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911276				2022-12-28	WOS:000645368900011
J	Schumacher, B; Pothof, J; Vijg, J; Hoeijmakers, JHJ				Schumacher, Bjoern; Pothof, Joris; Vijg, Jan; Hoeijmakers, Jan H. J.			The central role of DNA damage in the ageing process	NATURE			English	Review								Ageing is a complex, multifaceted process leading to widespread functional decline that affects every organ and tissue, but it remains unknown whether ageing has a unifying causal mechanism or is grounded in multiple sources. Phenotypically, the ageing process is associated with a wide variety of features at the molecular, cellular and physiological level-for example, genomic and epigenomic alterations, loss of proteostasis, declining overall cellular and subcellular function and deregulation of signalling systems. However, the relative importance, mechanistic interrelationships and hierarchical order of these features of ageing have not been clarified. Here we synthesize accumulating evidence that DNA damage affects most, if not all, aspects of the ageing phenotype, making it a potentially unifying cause of ageing. Targeting DNA damage and its mechanistic links with the ageing phenotype will provide a logical rationale for developing unified interventions to counteract age-related dysfunction and disease. This Review examines the evidence showing that DNA damage is associated with ageing phenotypes, suggesting that it may have a central role as the cause of ageing.	[Schumacher, Bjoern; Hoeijmakers, Jan H. J.] Univ Cologne, Med Fac, Inst Genome Stabil Ageing & Dis, Cologne, Germany; [Schumacher, Bjoern; Hoeijmakers, Jan H. J.] Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Pothof, Joris; Hoeijmakers, Jan H. J.] Erasmus MC, Dept Mol Genet, Rotterdam, Netherlands; [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Vijg, Jan] Shanghai Jiao Tong Univ, Ctr Single Cell Omics, Sch Publ Hearth, Sch Med, Shanghai, Peoples R China; [Hoeijmakers, Jan H. J.] Princess Maxima Ctr Pediat Oncol, Oncode Inst, Utrecht, Netherlands	University of Cologne; University of Cologne; Erasmus University Rotterdam; Erasmus MC; Yeshiva University; Albert Einstein College of Medicine; Shanghai Jiao Tong University	Schumacher, B (corresponding author), Univ Cologne, Med Fac, Inst Genome Stabil Ageing & Dis, Cologne, Germany.; Schumacher, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne CMMC, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.	bjoern.schumacher@uni-koern.de	Schumacher, Björn/I-4829-2013; Hoeijmakers, Jan/AAX-6972-2021	Schumacher, Björn/0000-0001-6097-5238; vijg, jan/0000-0002-8457-9595	NHLBI NIH HHS [U01 HL145560] Funding Source: Medline; NIA NIH HHS [P01 AG047200, U19 AG056278, P30 AG038072] Funding Source: Medline; NIEHS NIH HHS [U01 ES029519] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Adamowicz M, 2016, CELL REP, V16, P2068, DOI 10.1016/j.celrep.2016.07.038; Alexander P, 1967, Symp Soc Exp Biol, V21, P29; Alves-Fernandes DK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133153; Alyodawi K, 2019, J CACHEXIA SARCOPENI, V10, P662, DOI 10.1002/jcsm.12404; Ameur A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002028; Andriani GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35218; [Anonymous], 2019, GENETICS, DOI DOI 10.1534/genetics.119.302422; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Barzilai A, 2017, MECH AGEING DEV, V161, P4, DOI 10.1016/j.mad.2016.03.011; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Brazhnik K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax2659; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Bucholtz N, 2013, DNA REPAIR, V12, P811, DOI 10.1016/j.dnarep.2013.07.005; Charlesworth B, 2000, GENETICS, V156, P927; Childs BG, 2016, SCIENCE, V354, P472, DOI 10.1126/science.aaf6659; Day FR, 2015, NAT GENET, V47, P1294, DOI 10.1038/ng.3412; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921; Demanelis K, 2020, SCIENCE, V369, P1333, DOI 10.1126/science.aaz6876; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dominick G, 2017, AGING CELL, V16, P52, DOI 10.1111/acel.12525; Edifizi D, 2017, CELL REP, V20, P2026, DOI 10.1016/j.celrep.2017.08.028; Ermolaeva MA, 2013, NATURE, V501, P416, DOI 10.1038/nature12452; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Franco I, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1892-z; Franco I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03244-6; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Gao R, 2019, ELIFE, V8, DOI 10.7554/eLife.42988; Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; GENSLER HL, 1981, Q REV BIOL, V56, P279, DOI 10.1086/412317; Gonzalo S, 2017, AGEING RES REV, V33, P18, DOI 10.1016/j.arr.2016.06.007; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HART RW, 1974, P NATL ACAD SCI USA, V71, P2169, DOI 10.1073/pnas.71.6.2169; Hauer MH, 2017, GENE DEV, V31, P2204, DOI 10.1101/gad.307702.117; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; HENSHAW PS, 1947, RADIOLOGY, V49, P349, DOI 10.1148/49.3.349; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Hu Z, 2014, GENE DEV, V28, P396, DOI 10.1101/gad.233221.113; Ito T, 2018, CELL REP, V22, P3480, DOI 10.1016/j.celrep.2018.03.002; Jans J, 2005, CURR BIOL, V15, P105, DOI 10.1016/j.cub.2005.01.001; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jeon OH, 2017, NAT MED, V23, P775, DOI 10.1038/nm.4324; Johnson SC, 2015, AGING CELL, V14, P809, DOI 10.1111/acel.12362; Jones L, 2017, LANCET NEUROL, V16, P88, DOI 10.1016/S1474-4422(16)30350-7; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kauppila TES, 2017, CELL METAB, V25, P57, DOI 10.1016/j.cmet.2016.09.017; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kotsantis P, 2018, CANCER DISCOV, V8, P537, DOI 10.1158/2159-8290.CD-17-1461; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Laven JSE, 2016, MATURITAS, V92, P15, DOI 10.1016/j.maturitas.2016.07.006; Leandro GS, 2013, INT J MOL SCI, V14, P12380, DOI 10.3390/ijms140612380; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu L, 2018, CELL STEM CELL, V23, P544, DOI 10.1016/j.stem.2018.08.019; Lodato MA, 2018, SCIENCE, V359, P555, DOI 10.1126/science.aao4426; Lopes AFC, 2020, NUCLEIC ACIDS RES, V48, P10973, DOI 10.1093/nar/gkaa795; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Lubberts S, 2020, CRIT REV ONCOL HEMAT, V151, DOI 10.1016/j.critrevonc.2020.102963; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Ma YX, 2018, BBA-MOL CELL RES, V1865, P1293, DOI 10.1016/j.bbamcr.2018.06.011; Martinez P, 2017, J CELL BIOL, V216, P875, DOI 10.1083/jcb.201610111; Matsumura H, 2016, SCIENCE, V351, DOI 10.1126/science.aad4395; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McCay CM, 1939, J NUTR, V18, P1; McNeely T, 2020, HUM GENET, V139, P309, DOI 10.1007/s00439-019-02047-z; Mingard C, 2020, CHEM SOC REV, V49, P7354, DOI 10.1039/d0cs00647e; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Mori T, 2019, DNA REPAIR, V80, P52, DOI 10.1016/j.dnarep.2019.04.004; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Mueller MM, 2014, NAT CELL BIOL, V16, P1168, DOI 10.1038/ncb3071; Nakazawa Y, 2020, CELL, V180, P1228, DOI 10.1016/j.cell.2020.02.010; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2018, ANNU REV BIOCHEM, V87, P295, DOI 10.1146/annurev-biochem-062917-012239; O'Hara R, 2019, GENOME RES, V29, P1878, DOI 10.1101/gr.250480.119; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Obulesu M, 2010, INT J NEUROSCI, V120, P397, DOI 10.3109/00207450903411133; Ou HL, 2019, DEV CELL, V50, P167, DOI 10.1016/j.devcel.2019.06.012; Prasad R, 2017, PHOTOCHEM PHOTOBIOL, V93, P930, DOI 10.1111/php.12687; Robin JD, 2014, GENE DEV, V28, P2464, DOI 10.1101/gad.251041.114; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Russo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33222; Sacramento EK, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209596; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schumacher B., 2017, MYSTERY HUMAN AGING; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Sepe S, 2016, CELL REP, V15, P1866, DOI 10.1016/j.celrep.2016.04.071; Sepe S, 2013, DNA REPAIR, V12, P568, DOI 10.1016/j.dnarep.2013.04.009; Shaposhnikov M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15299; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; TAKADA K, 1986, CLIN NEUROPATHOL, V5, P64; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Tian X, 2019, CELL, V177, P622, DOI 10.1016/j.cell.2019.03.043; Traube FR, 2019, NAT PROTOC, V14, P283, DOI 10.1038/s41596-018-0094-6; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Houten B, 2000, MUTAT RES-DNA REPAIR, V460, P81, DOI 10.1016/S0921-8777(00)00018-5; Vermeij WP, 2016, NATURE, V537, P427, DOI 10.1038/nature19329; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Vijg J., 2007, AGING GENOME; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wang SY, 2020, NAT STRUCT MOL BIOL, V27, P1165, DOI 10.1038/s41594-020-00513-1; Wei YN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0608-2; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wu CL, 2013, ONCOGENE, V32, P2682, DOI 10.1038/onc.2012.279; Yizhak K, 2019, SCIENCE, V364, P970, DOI 10.1126/science.aaw0726; Zhang L, 2019, P NATL ACAD SCI USA, V116, P9014, DOI 10.1073/pnas.1902510116; Zhang L, 2018, ANNU REV GENET, V52, P397, DOI 10.1146/annurev-genet-120417-031501; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869	125	100	100	27	110	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					695	703		10.1038/s41586-021-03307-7	http://dx.doi.org/10.1038/s41586-021-03307-7			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911272				2022-12-28	WOS:000645368900008
J	Goldfarb, JL; Kreps, S; Brownstein, JS; Kriner, DL				Goldfarb, Jillian L.; Kreps, Sarah; Brownstein, John S.; Kriner, Douglas L.			Beyond the First Dose - Covid-19 Vaccine Follow-through and Continued Protective Measures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldfarb, Jillian L.] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14850 USA; [Kreps, Sarah; Kriner, Douglas L.] Cornell Univ, Dept Govt, Ithaca, NY USA; [Brownstein, John S.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Brownstein, John S.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA	Cornell University; Cornell University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Goldfarb, JL (corresponding author), Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY 14850 USA.							Guidry JPD, 2021, AM J INFECT CONTROL, V49, P137, DOI 10.1016/j.ajic.2020.11.018; Kramer DB, 2021, NEW ENGL J MED, V384, pe62, DOI 10.1056/NEJMp2102146; Malina D, 2021, NEW ENGL J MED, V384, DOI 10.1056/NEJMms2033790; Southwell BG, 2020, HEALTH COMMUN, V35, P1707, DOI 10.1080/10410236.2020.1837462; SteelFisher GK, 2021, NEW ENGL J MED, V384, P1483, DOI 10.1056/NEJMp2100351	5	10	10	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2021	385	2					101	103		10.1056/NEJMp2104527	http://dx.doi.org/10.1056/NEJMp2104527		APR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TH8TR	33909962	Bronze			2022-12-28	WOS:000645679200001
J	Papp, KA; Weinberg, MA; Morris, A; Reich, K				Papp, Kim A.; Weinberg, Mark A.; Morris, Alun; Reich, Kristian			IL17A/F nanobody sonelokimab in patients with plaque psoriasis: a multicentre, randomised, placebo-controlled, phase 2b study	LANCET			English	Article							DOUBLE-BLIND; BIMEKIZUMAB; MODERATE; SECUKINUMAB; USTEKINUMAB; BRODALUMAB; ANTIBODIES; IXEKIZUMAB; EFFICACY; SAFETY	Background Sonelokimab (also known as M1095) is a novel trivalent nanobody comprised of monovalent camelid-derived (ie, from the Camelidae family of mammals, such as camels, llamas, and alpacas) nanobodies specific to human interleukin (IL)-17A, IL-17F, and human serum albumin. Nanobodies are a novel class of proprietary therapeutic proteins based on single-domain, camelid, heavy-chain-only antibodies. We assessed the efficacy, safety, and tolerability of sonelokimab across four dosage regimens compared with placebo in patients with plaque-type psoriasis. Secukinumab served as an active control. Methods This multicentre, randomised, placebo-controlled, phase 2b trial was done at 41 clinics and research sites in Bulgaria, Canada, Czech Republic, Germany, Hungary, Poland, and the USA. Participants (aged 18-75 years) with stable moderate to severe plaque-type psoriasis (defined as an Investigator's Global Assessment [IGA] score of >= 3, a body surface area involvement of >= 10%, and a Psoriasis Area and Severity Index score of >= 12) for more than 6 months before randomisation, who were candidates for systemic biological therapy were included. Participants previously treated with more than two biologics or any therapy targeting IL-17 were excluded. Randomisation was stratified by weight (<= 90 kg or >90 kg) and previous use of biologics. Investigators, participants, and vendors remained masked for the duration of the study, with the exception of each site's study drug administrator (who did not complete any other assessments in the study) and a study monitor who only assessed drug preparation, administration, and accountability. The study sponsor remained masked until all week 24 data were clean and locked. Participants were randomly assigned (1: 1:1:1:1:1) using a centralised interactive response technology system to one of six parallel treatment groups: placebo group, sonelokimab 30 mg group, sonelokimab 60 mg group, sonelokimab 120 mg normal load group, sonelokimab 120 mg augmented load group, or secukinumab 300 mg group. All participants underwent a 4-week screening period, a 12-week placebo-controlled induction period, a 12-week dose maintenance or escalation period, and a 24-week response assessment or dose-holding period. During the placebo-controlled induction period (weeks 0-12), participants received either placebo (at weeks 0, 1, 2, 3, 4, 6, 8, and 10), sonelokimab 30 mg, 60 mg, or 120 mg normal load (at weeks 0, 2, 4, and 8), sonelokimab 120 mg augmented load (at weeks 0, 2, 4, 6, 8, and 10), or secukinumab 300 mg (at weeks 0, 1, 2, 3, 4, and 8), with placebo given at weeks 1, 3, 6, and 10 in the sonelokimab 30 mg, 60 mg, and 120 mg normal load groups, at weeks 1 and 3 in the sonelokimab 120 mg augmented load group, and at weeks 6 and 10 in the secukinumab 300 mg group. During the dose maintenance or escalation period (weeks 12-24), participants assigned to the placebo group received sonelokimab 120 mg (at weeks 12, 14, 16, and then every 4 weeks); those assigned to sonelokimab 30 mg or 60 mg groups with an IGA score of more than 1 were escalated to 120 mg and then every 4 weeks, and those with an IGA score of 1 or less stayed on the assigned dose at week 12 and then every 4 weeks; those assigned to the sonelokimab 120 mg groups received sonelokimab 120 mg at week 12 and then every 8 weeks (normal load group) or every 4 weeks (augmented load); and those assigned to the secukinumab 300 mg group received secukinumab 300 mg at week 12 and then every 4 weeks. During this period, placebo was given at week 14 in all groups, except in participants who initially received placebo, and at week 16 in the sonelokimab 120 mg normal load group. In the response assessment with dose-holding period (weeks 24-48), participants in the sonelokimab 30 mg or 60 mg groups who had dose escalation to 120 mg remained on the same regimen regardless of the IGA score at week 24. Participants in the secukinumab 300 mg group also remained on the same regimen regardless of IGA score at week 24. Participants in the sonelokimab 30 mg and 60 mg groups without dose escalation, and all participants in the two sonelokimab 120 mg groups (including placebo rollover patients) were eligible to stop the study drug at week 24. Those participants with an IGA score of 0 at week 24 received placebo; these participants resumed the previous dose of sonelokimab every 4 weeks when they had an IGA score of 1 or more (assessed every 4 weeks). Participants in these groups with an IGA score of 1 or more at week 24 continued on the same dosage. All study treatments were administered as subcutaneous injections. The final dose in all groups was given at week 44. The primary outcome was the proportion of participants in the sonelokimab groups with an IGA of clear or almost clear (score 0 or 1) at week 12 compared with the placebo group. The primary outcome and safety outcomes were assessed on an intention-to-treat basis. The study was not powered for formal comparisons between sonelokimab and secukinumab groups. This trial is registered with ClinicalTrials.gov, NCT03384745. Findings Between Aug 15, 2018, and March 27, 2019, 383 patients were assessed for eligibility, 313 of whom were enrolled and randomly assigned to the placebo group (n=52), the sonelokimab 30 mg group ( n=52), the sonelokimab 60 mg group (n=52), the sonelokimab 120 mg normal load group (n=53), the sonelokimab 120 mg augmented load group (n=51), or the secukinumab 300 mg group (n=53). Baseline characteristics of participants were similar among the groups. At week 12, none ( 0.0% [95% CI 0.0-6.8]) of the 52 participants in the placebo group had an IGA score of 0 or 1 versus 25 (48.1% [34.0-62.4], p<0.0001) of 52 participants in the sonelokimab 30 mg group, 44 (84.6% [71.9-93.1], p<0.0001) of 52 participants in the sonelokimab 60 mg group, 41 (77.4% [63.8-87.7], p<0.0001) of 53 participants in the sonelokimab 120 mg normal load group, 45 (88.2% [76.1-95.6], p<0.0001) of 51 participants in the sonelokimab 120 mg augmented load group, and 41 (77.4% [63.8-87.7], p<0.0001) of 53 participants in the secukinumab 300 mg group. During the placebo-controlled induction period, 155 (49.5%) of 313 participants had one or more mostly mild to moderate adverse event; the most frequent adverse events in all participants on sonelokimab during weeks 0-12 were nasopharyngitis (28 [13.5%] of 208 participants), pruritus (14 [6.7%] participants), and upper respiratory tract infection (nine [4.3%] participants). One patient from all sonelokimab-containing groups had Crohn's disease that developed during weeks 12-52. Over 52 weeks, sonelokimab safety was similar to secukinumab, with the possible exception of manageable Candida infections (one [1.9%] of 53 participants in the secukinumab group had a Candida infection vs 19 [17.4%] of 257 participants in all sonelokimab-containing groups). Interpretation Treatment with sonelokimab doses of 120 mg or less showed significant clinical benefit over placebo, with rapid onset of treatment effect, durable improvements, and an acceptable safety profile. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Papp, Kim A.] Prob Med Res, Waterloo, ON N2J 1C4, Canada; [Weinberg, Mark A.] Avillion, Northbrook, IL USA; [Morris, Alun] Avillion, London, England; [Reich, Kristian] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Papp, KA (corresponding author), Prob Med Res, Waterloo, ON N2J 1C4, Canada.	kapapp@probitymedical.com			Avillion; ClinBAY (Limassol, Cyprus)	Avillion; ClinBAY (Limassol, Cyprus)	This study was funded by Avillion. The authors thank the patients who took part in this study and their families. We also thank Giorgio Massimini, Aida Aydemir, and Eric Jacobson of Merck Healthcare (Darmstadt, Germany), for helping with the trial design. Statistical support was provided by Natacha Gallot from ClinBAY (Limassol, Cyprus). Writing and editing assistance, including preparation of a draft manuscript under the direction and guidance of the authors, incorporation of author feedback, and submission of the manuscript, was provided by Leonard Lionnet (PhD) of Kay Square Scientific (Newtown Square, PA, USA). This support was funded by Avillion.	Ablynx, 2019, UND NAN; Belanger K, 2019, ANTIBODIES, V8, DOI 10.3390/antib8020027; Eli Lilly and Company, 2020, HIGHL PRESCR INF TAL; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238, DOI 10.1159/000250839; Glatt S, 2018, ANN RHEUM DIS, V77, P523, DOI 10.1136/annrheumdis-2017-212127; Goepfert A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08360-9; Gordon KB, 2016, NEW ENGL J MED, V375, P345, DOI 10.1056/NEJMoa1512711; Gordon KB, 2021, LANCET, V397, P475, DOI 10.1016/S0140-6736(21)00126-4; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Jovcevska I, 2020, BIODRUGS, V34, P11, DOI 10.1007/s40259-019-00392-z; Konning D, 2017, CURR OPIN STRUC BIOL, V45, P10, DOI 10.1016/j.sbi.2016.10.019; Kolbinger F, 2017, J ALLERGY CLIN IMMUN, V3; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Langley RGB, 2015, J DERMATOL TREAT, V26, P23, DOI 10.3109/09546634.2013.865009; Lebwohl M, 2015, NEW ENGL J MED, V373, P1318, DOI 10.1056/NEJMoa1503824; Monin L, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028522; Papp KA, 2018, J AM ACAD DERMATOL, V79, P277, DOI 10.1016/j.jaad.2018.03.037; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Paul C, 2018, BRIT J DERMATOL, V178, P1003, DOI 10.1111/bjd.16497; Reich K, 2021, LANCET, V397, P487, DOI 10.1016/S0140-6736(21)00125-2; Ritchlin CT, 2020, LANCET, V395, P427, DOI 10.1016/S0140-6736(19)33161-7; Scully M, 2019, NEW ENGL J MED, V380, P335, DOI 10.1056/NEJMoa1806311; Spadiut O, 2014, TRENDS BIOTECHNOL, V32, P54, DOI 10.1016/j.tibtech.2013.10.002; Svecova D, 2019, J AM ACAD DERMATOL, V81, P196, DOI 10.1016/j.jaad.2019.03.056; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; Weisman S, 2003, J Dermatolog Treat, V14, P158, DOI 10.1080/09546630310013360; Wu YP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00469; Yang EY, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01182	28	32	33	2	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1564	1575						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR7QA	33894834				2022-12-28	WOS:000643286900022
J	Silvin, A; Ginhoux, F				Silvin, Aymeric; Ginhoux, Florent			Expanding cell-to-cell interactions	SCIENCE			English	Editorial Material									[Silvin, Aymeric] Gustave Roussy Canc Campus, INSERM, U1015, F-94800 Villejuif, France; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University	Silvin, A (corresponding author), Gustave Roussy Canc Campus, INSERM, U1015, F-94800 Villejuif, France.	aymeric.silvin@gustaveroussy.fr; florent_ginhoux@immunol.a-star.edu.sg						Clark IC, 2021, SCIENCE, V372, P360, DOI 10.1126/science.abf1230; Eng CHL, 2019, NATURE, V568, P235, DOI 10.1038/s41586-019-1049-y; Hartmann K, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0735-1; Joshi AU, 2019, NAT NEUROSCI, V22, P1635, DOI 10.1038/s41593-019-0486-0; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Medaglia C, 2017, SCIENCE, V358, P1622, DOI 10.1126/science.aao4277; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0	9	0	0	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					342	+		10.1126/science.abh2810	http://dx.doi.org/10.1126/science.abh2810			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888626				2022-12-28	WOS:000645009800020
J	McDermott, MM; Newman, AB				McDermott, Mary M.; Newman, Anne B.			Remote Research and Clinical Trial Integrity During and After the Coronavirus Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERIPHERAL ARTERY-DISEASE; EXERCISE		[McDermott, Mary M.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McDermott, MM (corresponding author), 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	mdm608@northwestern.edu			NIA [P30AG059988, P30AG024827]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported, in part, by grants P30AG059988 and P30AG024827 from the NIA.	Befort CA, 2021, JAMA-J AM MED ASSOC, V325, P363, DOI 10.1001/jama.2020.25855; Corcoran MP, 2016, GERONTOLOGIST, V56, P669, DOI 10.1093/geront/gnv018; Depner CM, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz254; Lenze EJ, 2020, JAMA-J AM MED ASSOC, V324, P2292, DOI 10.1001/jama.2020.22760; McDermott MM, 2021, JAMA-J AM MED ASSOC, V325, P1266, DOI 10.1001/jama.2021.2536; McDermott MM, 2020, JAMA-J AM MED ASSOC, V323, P2135, DOI 10.1001/jama.2020.4689; McDermott MM, 2018, JAMA-J AM MED ASSOC, V319, P1665, DOI 10.1001/jama.2018.3275; Richterman A, 2020, JAMA-J AM MED ASSOC, V324, P2155, DOI 10.1001/jama.2020.21399; Sedrak MS, 2021, CA-CANCER J CLIN, V71, P78, DOI 10.3322/caac.21638; Xue JZ, 2020, NAT REV DRUG DISCOV, V19, P662, DOI 10.1038/d41573-020-00150-9	10	34	34	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 18	2021	325	19					1935	1936		10.1001/jama.2021.4609	http://dx.doi.org/10.1001/jama.2021.4609		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF3QY	33885728	Bronze			2022-12-28	WOS:000642580800001
J	Davies, M				Davies, Marika			Championing transgender rights: specialty doctor Kate Nambiar	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n983	10.1136/bmj.n983	http://dx.doi.org/10.1136/bmj.n983			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883171	Bronze			2022-12-28	WOS:000642452700002
J	McKay, SL; Tobolowsky, FA; Moritz, ED; Hatfield, KM; Bhatnagar, A; LaVoie, SP; Jackson, DA; Lecy, KD; Bryant-Genevier, J; Campbell, D; Freeman, B; Gilbert, SE; Folster, JM; Medrzycki, M; Shewmaker, PL; Bankamp, B; Radford, KW; Anderson, R; Bowen, MD; Negley, J; Reddy, SC; Jernigan, JA; Brown, AC; McDonald, LC; Kutty, PK				McKay, Susannah L.; Tobolowsky, Farrell A.; Moritz, Erin D.; Hatfield, Kelly M.; Bhatnagar, Amelia; LaVoie, Stephen P.; Jackson, David A.; Lecy, K. Danielle; Bryant-Genevier, Jonathan; Campbell, Davina; Freeman, Brandi; Gilbert, Sarah E.; Folster, Jennifer M.; Medrzycki, Magdalena; Shewmaker, Patricia L.; Bankamp, Bettina; Radford, Kay W.; Anderson, Raydel; Bowen, Michael D.; Negley, Jeanne; Reddy, Sujan C.; Jernigan, John A.; Brown, Allison C.; McDonald, L. Clifford; Kutty, Preeta K.		CDC Infection Prevention Control T; CDC COVID-19 Surge Lab Grp	Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak	ANNALS OF INTERNAL MEDICINE			English	Article							RISK	Background: To address high COVID-19 burden in U.S. nursing homes, rapid SARS-CoV-2 antigen tests have been widely distributed in those facilities. However, performance data are lacking, especially in asymptomatic people. Objective: To evaluate the performance of SARS-CoV-2 antigen testing when used for facility-wide testing during a nursing home outbreak. Design: A prospective evaluation involving 3 facility-wide rounds of testing where paired respiratory specimens were collected to evaluate the performance of the BinaxNOW antigen test compared with virus culture and real-time reverse transcription polymerase chain reaction (RT-PCR). Early and late infection were defined using changes in RT-PCR cycle threshold values and prior test results. Setting: A nursing home with an ongoing SARS-CoV-2 outbreak. Participants: 532 paired specimens collected from 234 available residents and staff. Measurements: Percentage of positive agreement (PPA) and percentage of negative agreement (PNA) for BinaxNOW compared with RT-PCR and virus culture. Results: BinaxNOW PPA with virus culture, used for detection of replication-competent virus, was 95%. However, the overall PPA of antigen testing with RT-PCR was 69%, and PNA was 98%. When only the first positive test result was analyzed for each participant, PPA of antigen testing with RT-PCR was 82% among 45 symptomatic people and 52% among 343 asymptomatic people. Compared with RT-PCR and virus culture, the BinaxNOW test performed well in early infection (86% and 95%, respectively) and poorly in late infection (51% and no recovered virus, respectively). Limitation: Accurate symptom ascertainment was challenging in nursing home residents; test performance may not be representative of testing done by nonlaboratory staff. Conclusion: Despite lower positive agreement compared with RT-PCR, antigen test positivity had higher agreement with shedding of replication-competent virus. These results suggest that antigen testing could be a useful tool to rapidly identify contagious people at risk for transmitting SARS-CoV-2 during nascent outbreaks and help reduce COVID-19 burden in nursing homes.	[McKay, Susannah L.; Tobolowsky, Farrell A.; Moritz, Erin D.; Hatfield, Kelly M.; Bhatnagar, Amelia; LaVoie, Stephen P.; Jackson, David A.; Bryant-Genevier, Jonathan; Campbell, Davina; Freeman, Brandi; Gilbert, Sarah E.; Folster, Jennifer M.; Medrzycki, Magdalena; Shewmaker, Patricia L.; Bankamp, Bettina; Radford, Kay W.; Anderson, Raydel; Bowen, Michael D.; Reddy, Sujan C.; Jernigan, John A.; Brown, Allison C.; McDonald, L. Clifford; Kutty, Preeta K.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Lecy, K. Danielle] Ctr Dis Control & Prevent, Anchorage, AK USA; [Negley, Jeanne] Georgia Dept Publ Hlth, 2 Peachtree St NW 14-225, Atlanta, GA 30303 USA; [McKay, Susannah L.; Tobolowsky, Farrell A.; Moritz, Erin D.; Hatfield, Kelly M.; Bhatnagar, Amelia; LaVoie, Stephen P.; Jackson, David A.; Lecy, K. Danielle; Bryant-Genevier, Jonathan; Campbell, Davina; Freeman, Brandi; Gilbert, Sarah E.; Folster, Jennifer M.; Medrzycki, Magdalena; Shewmaker, Patricia L.; Bankamp, Bettina; Radford, Kay W.; Anderson, Raydel; Bowen, Michael D.; Reddy, Sujan C.; Jernigan, John A.; Brown, Allison C.; McDonald, L. Clifford; Kutty, Preeta K.] 1600 Clifton Rd NE, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	McKay, SL (corresponding author), 1600 Clifton Rd NE, Atlanta, GA 30333 USA.	nra2@cdc.gov	Brown, Allison Cory/ABB-3230-2021; LaVoie, Stephen/L-6919-2017	Brown, Allison Cory/0000-0003-0011-0309; Katz, Eric/0000-0002-4444-8902; Jenkins, Brent/0000-0003-2907-660X; Bhatnagar, Amelia/0000-0003-3859-0328; Gilbert, Sarah/0000-0002-0775-1195; Moritz, Erin/0000-0001-7449-1955; Currie, Dustin/0000-0003-2061-2672; Jernigan, John/0000-0001-8163-925X; LaVoie, Stephen/0000-0002-6478-8453; Jackson, David/0000-0002-7528-121X				Abbott, 2020, BINAXNOW COVID 19 AG; [Anonymous], 2011, RES INVESTIGATIONS G; [Anonymous], 2018, PROTECTION HUMAN SUB; [Anonymous], 2018, RECORDS MAINTAINED I; [Anonymous], 1981, INSTITUTIONAL REV BO; Arons MM, 2020, NEW ENGL J MED, V382, P2081, DOI 10.1056/NEJMoa2008457; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; CDC, SARS COV 2 ANT TEST; CDC, 2020, DUR IS PREC AD COVID; CDC, TEST GUID NURS HOM; CDC, 2020, SYMPT COR; CDC, INT GUID ANT TEST SA; Centers for Medicare & Medicaid Services, 2020, COVID 19 NURS HOM DA; COVID 19 Investigation, 2020, NAT MED, V26, P861, DOI 10.1038/s41591-020-0877-5; Gniazdowski V, 2021, CLIN INFECT DIS, V73, pE860, DOI 10.1093/cid/ciaa1616; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Kissler SM., 2020, MEDRXIV, DOI [10.1101/2020.10.21.20217042, DOI 10.1101/2020.10.21.20217042]; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Larremore DB, 2021, SCI ADV, V7, DOI [10.1126/sciadv.abd5393, 10.1101/2020.06.22.20136309]; Manabe YCC, 2020, ANTIGEN BASED TESTIN, DOI [10.1101/2020.10.02.20205708, DOI 10.1101/2020.10.02.20205708]; McGarry BE, 2021, JAMA INTERN MED, V181, P556, DOI 10.1001/jamainternmed.2020.7330; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Perera RAPM, 2020, EMERG INFECT DIS, V26, P2701, DOI 10.3201/eid2611.203219; Peto T., 2021, COVID 19 RAPID ANTIG, DOI [10.1101/2021.01.13.21249563, DOI 10.1101/2021.01.13.21249563]; Pilarowski G, 2021, CLIN INFECT DIS, V73, pE3098, DOI 10.1093/cid/ciaa1890; Pray IW, 2021, MMWR-MORBID MORTAL W, V69, P1642, DOI 10.15585/mmwr.mm695152a3; S. Food and Drug Administration, 2020, IND EUAS MOL DIAGN T; See I, 2021, CLIN INFECT DIS, V73, pE792, DOI 10.1093/cid/ciab110; Shi SM, 2020, J AM MED DIR ASSOC, V21, P1378, DOI 10.1016/j.jamda.2020.08.027; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Taylor J, 2020, MMWR-MORBID MORTAL W, V69, P1288, DOI 10.15585/mmwr.mm6937a3; U.S. Department of Health & Human Services, 2020, COR COVID 19 TEST; U.S. Food and Drug Administration, 2020, IND EUAS ANT DIAGN T; U.S. Food and Drug Administration, 2007, FDA DOCKET NO 2003D0; U.S. Food and Drug Administration, 2000, POT FALS POS RES ANT; White EM, 2020, JAMA INTERN MED, V180, P1709, DOI 10.1001/jamainternmed.2020.5664; Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI 10.1159/000505601	37	30	29	3	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					945	+		10.7326/M21-0422	http://dx.doi.org/10.7326/M21-0422			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33900791	Green Published			2022-12-28	WOS:000675809000021
J	Mahase, E				Mahase, Elisabeth			Covid-19: Vaccines will be tested against variants of concern after 29m pound funding boost from UK government	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1164; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1116; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n597	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2021	373								n1163	10.1136/bmj.n1163	http://dx.doi.org/10.1136/bmj.n1163			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YV	33952439	Bronze			2022-12-28	WOS:000651241700012
J	Sharma, P; Ramesh, V				Sharma, Prateek; Ramesh, V			Hypopigmented atrophic plaques in a young woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sharma, Prateek; Ramesh, V] Safdarjang Hosp, Dept Dermatol, New Delhi, India	Vardhman Mahavir Medical College & Safdarjung Hospital	Sharma, P (corresponding author), Safdarjang Hosp, Dept Dermatol, New Delhi, India.	prateeiik@gmail.com						Al-Niaimi F, 2013, BRIT J DERMATOL, V168, P643, DOI 10.1111/bjd.12014; Birenbaum DL, 2007, J REPROD MED, V52, P28; Funaro Deana, 2004, Dermatol Ther, V17, P28, DOI 10.1111/j.1396-0296.2004.04004.x; Kizer WS, 2003, SOUTH MED J, V96, P9, DOI 10.1097/00007611-200301000-00004; Leibovitz A, 2000, ARCH GERONTOL GERIAT, V31, P1, DOI 10.1016/S0167-4943(00)00059-5; Lewis FM, 2018, BRIT J DERMATOL, V178, P839, DOI 10.1111/bjd.16241; Powell JJ, 1999, LANCET, V353, P1777, DOI 10.1016/S0140-6736(98)08228-2; Walkden Valerie, 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P551	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n1012	10.1136/bmj.n1012	http://dx.doi.org/10.1136/bmj.n1012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952444				2022-12-28	WOS:000651241900012
J	Harstad, E; Shults, J; Barbaresi, W; Bax, A; Cacia, J; Deavenport-Saman, A; Friedman, S; LaRosa, A; Loe, IM; Mittal, S; Tulio, S; Vanderbilt, D; Blum, NJ				Harstad, Elizabeth; Shults, Justine; Barbaresi, William; Bax, Ami; Cacia, Jaclyn; Deavenport-Saman, Alexis; Friedman, Sandra; LaRosa, Angela; Loe, Irene M.; Mittal, Shruti; Tulio, Shelby; Vanderbilt, Douglas; Blum, Nathan J.			alpha(2)-Adrenergic Agonists or Stimulants for Preschool-Age Children With Attention-Deficit/Hyperactivity Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								This retrospective review uses data from health records of preschool-age children with attention-deficit/hyperactivity disorder (ADHD) treated in developmental-behavioral pediatric practices to examine the improvements and adverse effects associated with the use of alpha(2)-adrenergic agonists vs stimulants for initial ADHD medication treatment. Importance Attention-deficit/hyperactivity disorder (ADHD) is diagnosed in approximately 2.4% of preschool-age children. Stimulants are recommended as first-line medication treatment. However, up to 25% of preschool-age children with ADHD are treated with alpha(2)-adrenergic agonist medications, despite minimal evidence about their efficacy or adverse effects in this age range. Objective To determine the frequency of reported improvement in ADHD symptoms and adverse effects associated with alpha(2)-adrenergic agonists and stimulant medication for initial ADHD medication treatment in preschool-age children. Design, Setting, and Participants Retrospective electronic health record review. Data were obtained from health records of children seen at 7 outpatient developmental-behavioral pediatric practices in the Developmental Behavioral Pediatrics Research Network in the US. Data were abstracted for 497 consecutive children who were younger than 72 months when treatment with an alpha(2)-adrenergic agonist or stimulant medication was initiated by a developmental-behavioral pediatrician for ADHD and were treated between January 1, 2013, and July 1, 2017. Follow-up was complete on February 27, 2019. Exposures alpha(2)-Adrenergic agonist vs stimulant medication as initial ADHD medication treatment. Main Outcomes and Measures Reported improvement in ADHD symptoms and adverse effects. Results Data were abstracted from electronic health records of 497 preschool-age children with ADHD receiving alpha(2)-adrenergic agonists or stimulants. Median child age was 62 months at ADHD medication initiation, and 409 children (82%) were males. For initial ADHD medication treatment, alpha(2)-adrenergic agonists were prescribed to 175 children (35%; median length of alpha(2)-adrenergic agonist use, 136 days) and stimulants were prescribed to 322 children (65%; median length of stimulant use, 133 days). Improvement was reported in 66% (95% CI, 57.5%-73.9%) of children who initiated alpha(2)-adrenergic agonists and 78% (95% CI, 72.4%-83.4%) of children who initiated stimulants. Only daytime sleepiness was more common for those receiving alpha(2)-adrenergic agonists vs stimulants (38% vs 3%); several adverse effects were reported more commonly for those receiving stimulants vs alpha(2)-adrenergic agonists, including moodiness/irritability (50% vs 29%), appetite suppression (38% vs 7%), and difficulty sleeping (21% vs 11%). Conclusions and Relevance In this retrospective review of health records of preschool-age children with ADHD treated in developmental-behavioral pediatric practices, improvement was noted in the majority of children who received alpha(2)-adrenergic agonists or stimulants, with differing adverse effect profiles between medication classes. Further research, including from randomized clinical trials, is needed to assess comparative effectiveness of alpha(2)-adrenergic agonists vs stimulants. Question For preschool-age children with attention-deficit/hyperactivity disorder initiating alpha(2)-adrenergic agonist or stimulant medications in developmental-behavioral pediatric practices, what improvements and adverse effects were noted? Findings In this retrospective review of health records of 497 children, improvement was noted in 115 of 175 children (66%) who received alpha(2)-adrenergic agonists and 251 of 322 children (78%) who received stimulants, with differences in adverse effect profiles noted between medication classes. Meaning Further research from randomized clinical trials is needed to assess comparative effectiveness of alpha(2)-adrenergic agonists vs stimulants for preschool-age children with ADHD.	[Harstad, Elizabeth; Barbaresi, William] Boston Childrens Hosp, Div Dev Med, 300 Longwood Ave, Boston, MA 02115 USA; [Shults, Justine; Cacia, Jaclyn; Tulio, Shelby] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Shults, Justine; Blum, Nathan J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bax, Ami] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Deavenport-Saman, Alexis; Vanderbilt, Douglas] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA; [Deavenport-Saman, Alexis] Childrens Hosp Los Angeles, Div Gen Pediat, Los Angeles, CA 90027 USA; [Friedman, Sandra] Univ Colorado, Sch Med, Childrens Hosp Colorado, Aurora, CO USA; [LaRosa, Angela] Med Univ South Carolina, Charleston, SC 29425 USA; [Loe, Irene M.] Stanford Univ, Stanford, CA 94305 USA; [Mittal, Shruti] Atrium Hlth, Concord, NC USA; [Blum, Nathan J.] Childrens Hosp Philadelphia, Div Dev & Behav Pediat, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Southern California; Children's Hospital Los Angeles; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of South Carolina; Stanford University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Harstad, E (corresponding author), Boston Childrens Hosp, Div Dev Med, 300 Longwood Ave, Boston, MA 02115 USA.	elizabeth.harstad@childrens.harvard.edu	Deavenport-Saman, Alexis/I-3673-2019	Deavenport-Saman, Alexis/0000-0002-8715-7531	Maternal and Child Health Bureau, Health Resources and Services Administration, US Department of Health and Human Services [UA3MC20218]	Maternal and Child Health Bureau, Health Resources and Services Administration, US Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	DBPNet is supported by cooperative agreement UA3MC20218 from the Maternal and Child Health Bureau, Health Resources and Services Administration, US Department of Health and Human Services.	Barbaresi WJ, 2020, J DEV BEHAV PEDIATR, V41, pS35, DOI 10.1097/DBP.0000000000000770; Barbaresi WJ, 2006, J DEV BEHAV PEDIATR, V27, P1, DOI 10.1097/00004703-200602000-00001; Blum NJ, 2018, J DEV BEHAV PEDIATR, V39, P531, DOI 10.1097/DBP.0000000000000585; Blum NJ, 2012, J DEV BEHAV PEDIATR, V33, P78, DOI 10.1097/DBP.0b013e31823e05bb; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cortese S, 2018, LANCET PSYCHIAT, V5, P727, DOI 10.1016/S2215-0366(18)30269-4; Danielson ML, 2018, J CLIN CHILD ADOLESC, V47, P199, DOI 10.1080/15374416.2017.1417860; Davis DW, 2020, J CHILD ADOL PSYCHOP, V30, P448, DOI 10.1089/cap.2020.0015; Greenhill L, 2006, J AM ACAD CHILD PSY, V45, P1284, DOI 10.1097/01.chi.0000235077.32661.61; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Harstad E, 2016, J DEV BEHAV PEDIATR, V37, P541, DOI 10.1097/DBP.0000000000000329; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUNT RD, 1995, J AM ACAD CHILD PSY, V34, P50, DOI 10.1097/00004583-199501000-00013; Kraemer HC, 2015, JAMA PSYCHIAT, V72, P961, DOI 10.1001/jamapsychiatry.2015.1178; LaVange LM, 2001, STAT MED, V20, P2609, DOI 10.1002/sim.732; Lee BJ, 1997, INF MENTAL HLTH J, V18, P300, DOI 10.1002/(SICI)1097-0355(199723)18:3<300::AID-IMHJ6>3.0.CO;2-Q; Mittal S, 2020, J CHILD ADOL PSYCHOP, V30, P81, DOI 10.1089/cap.2019.0105; Nair V, 2009, J TROP PEDIATRICS, V55, P116, DOI 10.1093/tropej/fmn117; Panther Shannon G, 2017, J Pediatr Pharmacol Ther, V22, P423, DOI 10.5863/1551-6776-22.6.423; Posner K, 2007, J CHILD ADOL PSYCHOP, V17, P547, DOI 10.1089/cap.2007.0075; Spira EG, 2005, J CHILD PSYCHOL PSYC, V46, P755, DOI 10.1111/j.1469-7610.2005.01466.x; Stein MA, 2015, CNS DRUGS, V29, P953, DOI 10.1007/s40263-015-0291-6; Wigal T, 2006, J AM ACAD CHILD PSY, V45, P1294, DOI 10.1097/01.chi.0000235082.63156.27; Wilens TE, 2015, J AM ACAD CHILD PSY, V54, P916, DOI 10.1016/j.jaac.2015.08.016; Wolraich ML, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2528; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	26	7	7	8	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2067	2075		10.1001/jama.2021.6118	http://dx.doi.org/10.1001/jama.2021.6118		MAY 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	33946100	Green Published, Bronze			2022-12-28	WOS:000647843800002
J	Lillegraven, S; Sundlisaeter, NP; Aga, AB; Sexton, J; Olsen, IC; Fremstad, H; Spada, C; Madland, TM; Hoili, CA; Bakland, G; Lexberg, A; Hansen, IJW; Hansen, IM; Haukeland, H; Ljosa, MKA; Moholt, E; Uhlig, T; Solomon, DH; van der Heijde, D; Kvien, TK; Haavardsholm, EA				Lillegraven, Siri; Sundlisaeter, Nina Paulshus; Aga, Anna-Birgitte; Sexton, Joseph; Olsen, Inge C.; Fremstad, Hallvard; Spada, Cristina; Madland, Tor Magne; Hoili, Christian A.; Bakland, Gunnstein; Lexberg, Ase; Hansen, Inger Johanne Widding; Hansen, Inger Myrnes; Haukeland, Hilde; Ljosa, Maud-Kristine Aga; Moholt, Ellen; Uhlig, Till; Solomon, Daniel H.; van der Heijde, Desiree; Kvien, Tore K.; Haavardsholm, Espen A.			Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission The ARCTIC REWIND Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLLEGE-OF-RHEUMATOLOGY; AMERICAN-COLLEGE; SUSTAINED REMISSION; 28-JOINT COUNTS; ACTIVITY INDEX; ETANERCEPT; DEFINITION; VALIDATION; CRITERIA; LEAGUE	This randomized trial compares the effects of half-dose conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) vs stable-dose csDMARDs on the risk of flares in patients with rheumatoid arthritis in sustained remission. Importance Sustained remission has become an achievable goal for patients with rheumatoid arthritis (RA) receiving conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), but how to best treat patients in clinical remission remains unclear. Objective To assess the effect of tapering of csDMARDs, compared with continuing csDMARDs without tapering, on the risk of flares in patients with RA in sustained remission. Design, Setting, and Participants ARCTIC REWIND was a multicenter, randomized, parallel, open-label noninferiority study conducted in 10 Norwegian hospital-based rheumatology practices. A total of 160 patients with RA in remission for 12 months who were receiving stable csDMARD therapy were enrolled between June 2013 and June 2018, and the final visit occurred in June 2019. Interventions Patients were randomly assigned to half-dose csDMARDs (n = 80) or stable-dose csDMARDs (n = 80). Main Outcomes and Measures The primary end point was the proportion of patients with a disease flare between baseline and the 12-month follow-up, defined as a combination of Disease Activity Score (DAS) greater than 1.6 (threshold for RA remission), an increase in DAS score of 0.6 units or more, and at least 2 swollen joints. A disease flare could also be recorded if both the patient and investigator agreed that a clinically significant flare had occurred. A risk difference of 20% was defined as the noninferiority margin. Results Of 160 enrolled patients (mean [SD] age, 55.1 [11.9] years; 66% female), 156 received the allocated therapy, of which 155 without any major protocol violations were included in the primary analysis population (77 receiving half-dose and 78 receiving stable-dose csDMARDs). Flare occurred in 19 patients (25%) in the half-dose csDMARD group compared with 5 (6%) in the stable-dose csDMARD group (risk difference, 18% [95% CI, 7%-29%]). Adverse events occurred in 34 patients (44%) in the half-dose group and 42 (54%) in the stable-dose group, none leading to study discontinuation. No deaths occurred. Conclusions and Relevance Among patients with RA in remission taking csDMARD therapy, treatment with half-dose vs stable-dose csDMARDs did not demonstrate noninferiority for the percentage of patients with disease flares over 12 months, and there were significantly fewer flares in the stable-dose group. These findings do not support treatment with half-dose therapy. Question In patients with rheumatoid arthritis in remission taking conventional synthetic disease-modifying antirheumatic drugs (csDMARDs), is reducing the csDMARDs to half dose noninferior to stable csDMARD dosage for the outcome of rheumatoid arthritis flares? Findings In this randomized clinical trial that included 160 patients with rheumatoid arthritis in remission taking csDMARD therapy, treatment with half-dose vs stable-dose csDMARDs resulted in disease flares in 25% vs 6% over 12 months; this did not meet the noninferiority criterion of a 20% difference. There were significantly fewer patients with flares in the stable-dose group. Meaning These findings do not support the use of half-dose treatment in patients with rheumatoid arthritis in remission taking csDMARDs.	[Lillegraven, Siri; Sundlisaeter, Nina Paulshus; Aga, Anna-Birgitte; Sexton, Joseph; Moholt, Ellen; Uhlig, Till; van der Heijde, Desiree; Kvien, Tore K.; Haavardsholm, Espen A.] Diakonhjemmet Hosp, Div Rheumatol & Res, POB 23 Vinderen, N-0319 Oslo, Norway; [Olsen, Inge C.] Oslo Univ Hosp, Clin Trial Unit, Oslo, Norway; [Fremstad, Hallvard; Ljosa, Maud-Kristine Aga] Helse More & Romsdal HF, Dept Rheumatol, Alesund Hosp, Alesund, Norway; [Spada, Cristina] Revmatismesykehuset AS, Lillehammer, Norway; [Madland, Tor Magne] Haukeland Hosp, Dept Rheumatol, Bergen, Norway; [Hoili, Christian A.] Hosp Ostfold HF, Dept Rheumatol, Moss, Norway; [Bakland, Gunnstein] Univ Hosp North Norway, Dept Rheumatol, Tromso, Norway; [Lexberg, Ase] Vestre Viken HF, Dept Rheumatol, Drammen Hosp, Drammen, Norway; [Hansen, Inger Johanne Widding] Sorlandet Hosp HF, Dept Rheumatol, Kristiansand, Norway; [Hansen, Inger Myrnes] Helgelandssykehuset Mo I Rana, Dept Rheumatol, Mo I Rana, Norway; [Haukeland, Hilde] Martina Hansens Hosp, Dept Rheumatol, Baerum, Norway; [Uhlig, Till; Kvien, Tore K.; Haavardsholm, Espen A.] Univ Oslo, Fac Med, Oslo, Norway; [Solomon, Daniel H.] Brigham & Womens Hosp, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [van der Heijde, Desiree] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands	Diakonhjemmet Hospital; University of Oslo; University of Bergen; Haukeland University Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; Harvard University; Brigham & Women's Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Lillegraven, S (corresponding author), Diakonhjemmet Hosp, Div Rheumatol & Res, POB 23 Vinderen, N-0319 Oslo, Norway.	siri.lillegraven@gmail.com	van der Heijde, Désirée/I-6774-2019	van der Heijde, Désirée/0000-0002-5781-158X; Aga, Anna-Birgitte/0000-0003-0234-4993				Aga AB, 2015, ANN RHEUM DIS, V74, P381, DOI 10.1136/annrheumdis-2013-204020; Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Combe B, 2013, J RHEUMATOL, V40, P1650, DOI 10.3899/jrheum.121515; Emery P, 2014, NEW ENGL J MED, V371, P1781, DOI 10.1056/NEJMoa1316133; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Fransen J, 2004, RHEUMATOLOGY, V43, P1252, DOI 10.1093/rheumatology/keh297; Fries JF, 2009, J RHEUMATOL, V36, P2061, DOI 10.3899/jrheum.090358; Gossec L, 2011, ANN RHEUM DIS, V70, P935, DOI 10.1136/ard.2010.142901; Haavardsholm EA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4205; Hammer HB, 2011, ANN RHEUM DIS, V70, P1995, DOI 10.1136/ard.2011.152926; Haschka J, 2016, ANN RHEUM DIS, V75, P45, DOI 10.1136/annrheumdis-2014-206439; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P315, DOI 10.1136/ard.2010.136556; Kuijper TM, 2016, ANN RHEUM DIS, V75, P2119, DOI 10.1136/annrheumdis-2016-209272; Kvien TK, 2005, CLIN EXP RHEUMATOL, V23, pS188; Landewe R, 2006, ANN RHEUM DIS, V65, P637, DOI 10.1136/ard.2005.039859; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Prevoo MLL, 1996, BRIT J RHEUMATOL, V35, P1101; RITCHIE DM, 1968, Q J MED, V37, P393; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Smolen JS, 2020, ANN RHEUM DIS, V79, P685, DOI 10.1136/annrheumdis-2019-216655; Smolen JS, 2014, LANCET, V383, P321, DOI 10.1016/S0140-6736(13)61751-1; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Solomon DH, 2020, ANN INTERN MED, V172, P369, DOI 10.7326/M19-3369; tenWolde S, 1996, LANCET, V347, P347, DOI 10.1016/S0140-6736(96)90535-8; US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER) :, 2016, NON CLIN TRIALS EST; US Department of Heath and Human Services Food and Drug Administration, 1999, GUID IND CLIN DEV PR; van der Heijde D, 1999, J RHEUMATOL, V26, P743; van Herwaarden N, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1389; van Mulligen E, 2019, ANN RHEUM DIS, V78, P746, DOI 10.1136/annrheumdis-2018-214970; van Vollenhoven RF, 2016, ANN RHEUM DIS, V75, P52, DOI 10.1136/annrheumdis-2014-205726; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	36	8	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1755	1764		10.1001/jama.2021.4542	http://dx.doi.org/10.1001/jama.2021.4542			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944875	Green Published, Bronze			2022-12-28	WOS:000647831200016
J	Tatum, M				Tatum, Megan			Outcry over persecution of health workers in Myanmar	LANCET			English	Editorial Material																			0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1609	1609						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33933195				2022-12-28	WOS:000645510600009
J	Dyer, C				Dyer, Clare			Spire Healthcare pleads guilty to failing to tell four patients about poor treatment	BMJ-BRITISH MEDICAL JOURNAL			English	News Item								Sarah Dronsfield, the CQC's head of hospital inspection, said, "All care providers have a duty to be open and transparent with patients and their loved ones, particularly when something goes wrong, and this case sends a clear message that we will not hesitate to take action when that does not happen. The patients under the charge of Mr Walsh received neither a prompt apology nor full explanation for the poor care they received. Spire Hospital Leeds was not transparent or open with regards to what happened." Alison Dickinson, group clinical director at Spire Healthcare, said the group had invested significantly in training and strengthened the systems for ensuring that patients were told in a transparent and timely way when things went wrong. She added, "We regret that we missed opportunities to inform four patients of failings in the care provided by their consultant, Mike Walsh. We investigated those incidents, apologised to the four patients, and offered each of them the opportunity to discuss their concerns, but we fully accept that we did not do this as promptly as we should have done. We fell short of the requirements regarding duty of candour as well as the high standards that we set for ourselves and that patients should be able to expect from us." The case is only the second prosecution brought by the CQC for breach of the duty of candour. Last September University Hospitals Plymouth NHS Trust pleaded guilty to failing to provide an apology or timely explanation to the relatives of a 91 year old woman who died after her oesophagus was perforated during an endoscopy.1										Dyer C, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3737	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2021	373								n1129	10.1136/bmj.n1129	http://dx.doi.org/10.1136/bmj.n1129			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QM	33931397				2022-12-28	WOS:000649708000006
J	Grossman, D; Galdieri, D				Grossman, Dan; Galdieri, Dado			THE SENTINELS	SCIENCE			English	Editorial Material																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					450	455		10.1126/science.372.6541.450	http://dx.doi.org/10.1126/science.372.6541.450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926935				2022-12-28	WOS:000645554100021
J	Coomarasamy, A; Dhillon-Smith, RK; Papadopoulou, A; Al-Memar, M; Brewin, J; Abrahams, VM; Maheshwari, A; Christiansen, OB; Stephenson, MD; Goddijn, M; Oladapo, OT; Wijeyaratne, CN; Bick, D; Shehata, H; Small, R; Bennett, PR; Regan, L; Rai, R; Bourne, T; Kaur, R; Pickering, O; Brosens, JJ; Devall, AJ; Gallos, ID; Quenby, S				Coomarasamy, Arri; Dhillon-Smith, Rima K.; Papadopoulou, Argyro; Al-Memar, Maya; Brewin, Jane; Abrahams, Vikki M.; Maheshwari, Abha; Christiansen, Ole B.; Stephenson, Mary D.; Goddijn, Mariette; Oladapo, Olufemi T.; Wijeyaratne, Chandrika N.; Bick, Debra; Shehata, Hassan; Small, Rachel; Bennett, Phillip R.; Regan, Lesley; Rai, Raj; Bourne, Tom; Kaur, Rajinder; Pickering, Oonagh; Brosens, Jan J.; Devall, Adam J.; Gallos, Ioannis D.; Quenby, Siobhan			Recurrent miscarriage: evidence to accelerate action	LANCET			English	Review							IN-VITRO FERTILIZATION; POLYCYSTIC-OVARY-SYNDROME; ANTIBODY-POSITIVE WOMEN; PREGNANT-WOMEN; LEVOTHYROXINE TREATMENT; SUBCLINICAL HYPOTHYROIDISM; CHROMOSOME ANALYSIS; RANDOMIZED-TRIAL; THYROID-DISEASE; THROMBOPHILIA	Women who have had repeated miscarriages often have uncertainties about the cause, the likelihood of recurrence, the investigations they need, and the treatments that might help. Health-care policy makers and providers have uncertainties about the optimal ways to organise and provide care. For this Series paper, we have developed recommendations for practice from literature reviews, appraisal of guidelines, and a UK-wide consensus conference that was held in December, 2019. Caregivers should individualise care according to the clinical needs and preferences of women and their partners. We define a minimum set of investigations and treatments to be offered to couples who have had recurrent miscarriages, and urge health-care policy makers and providers to make them universally available. The essential investigations include measurements of lupus anticoagulant, anticardiolipin antibodies, thyroid function, and a transvaginal pelvic ultrasound scan. The key treatments to consider are first trimester progesterone administration, levothyroxine in women with subclinical hypothyroidism, and the combination of aspirin and heparin in women with antiphospholipid antibodies. Appropriate screening and care for mental health issues and future obstetric risks, particularly preterm birth, fetal growth restriction, and stillbirth, will need to be incorporated into the care pathway for couples with a history of recurrent miscarriage. We suggest health-care services structure care using a graded model in which women are offered online health-care advice and support, care in a nurse or midwifery-led clinic, and care in a medical consultant-led clinic, according to clinical needs.	[Coomarasamy, Arri; Dhillon-Smith, Rima K.; Papadopoulou, Argyro; Kaur, Rajinder; Pickering, Oonagh; Devall, Adam J.; Gallos, Ioannis D.] Univ Birmingham, Tommys Natl Ctr Miscarriage Res, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Al-Memar, Maya; Bennett, Phillip R.; Regan, Lesley; Rai, Raj; Bourne, Tom] Imperial Coll London, Tommys Natl Ctr Miscarriage Res, London, England; [Brewin, Jane] Tommys Char, Laurence Pountney Hill, London, England; [Abrahams, Vikki M.] Yale Univ, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA; [Maheshwari, Abha] Aberdeen Ctr Reprod Med, Aberdeen, Scotland; [Christiansen, Ole B.] Aalborg Univ Hosp, Dept Obstet & Gynaecol, Ctr Recurrent Pregnancy Loss Western Denmark, Aalborg, Denmark; [Stephenson, Mary D.] Univ Illinois, Dept Obstet & Gynecol, Recurrent Pregnancy Loss Program, Chicago, IL 60612 USA; [Goddijn, Mariette] Univ Amsterdam, Amsterdam UMC, Ctr Reprod Med, Amsterdam, Netherlands; [Oladapo, Olufemi T.] WHO, Dept Sexual & Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland; [Wijeyaratne, Chandrika N.] Univ Colombo, Dept Reprod Med, Colombo, Sri Lanka; [Bick, Debra] Univ Warwick, Warwick Clin Trials Unit, Warwick, England; [Shehata, Hassan] Epsom & St Helier Univ Hosp NHS Trust, Epsom Gen Hosp, Epsom, Surrey, England; [Small, Rachel] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [Brosens, Jan J.; Quenby, Siobhan] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Warwick, England; [Brosens, Jan J.; Quenby, Siobhan] Univ Hosp Coventry & Warwickshire NHS Trust, Tommys Natl Ctr Miscarriage Res, Coventry, W Midlands, England	University of Birmingham; Imperial College London; Yale University; Aalborg University; Aalborg University Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Amsterdam; The World Bank; United Nations Population Fund; World Health Organization; University of Colombo; University of Warwick; Heart of England NHS Foundation Trust; University of Birmingham; University of Warwick; University of Warwick	Coomarasamy, A (corresponding author), Univ Birmingham, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.	a.coomarasamy@bham.ac.uk	Devall, Adam/AAC-9646-2022; Bourne, Tom/I-6478-2012; Kaur, Rajinder/GRR-3195-2022; Papadopoulou, Argyro/AAR-1380-2020	Bourne, Tom/0000-0003-1421-6059; Papadopoulou, Argyro/0000-0001-9409-8608; Quenby, Siobhan/0000-0003-3221-5471; Goddijn, Mariette/0000-0001-9928-9673; Bennett, Phillip/0000-0002-6253-4919; Gallos, Ioannis/0000-0002-2766-358X	Tommy's Charity; Wellcome Trust Investigator Award [212233/Z/18/Z]	Tommy's Charity; Wellcome Trust Investigator Award(Wellcome Trust)	The Tommy's Charity funds the Tommy's National Centre for Miscarriage Research. JJB holds a Wellcome Trust Investigator Award (212233/Z/18/Z). The funders had no role in the writing of the article or in the decision to submit the paper for publication.	Achilli C, 2018, FERTIL STERIL, V110, P1089, DOI 10.1016/j.fertnstert.2018.07.004; Aleman A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003576.pub2; Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; Alfirevic Z, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008991.pub3; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Areia AL, 2016, ARCH GYNECOL OBSTET, V293, P81, DOI 10.1007/s00404-015-3782-2; Atik RB, 2018, HUM REPROD OPEN, V2018, DOI 10.1093/hropen/hoy004; Balen AH, 2016, HUM REPROD UPDATE, V22, P687, DOI 10.1093/humupd/dmw025; BALEN AH, 1993, HUM REPROD, V8, P959, DOI 10.1093/oxfordjournals.humrep.a138174; Balogun OO, 2016, COCHRANE DB SYST REV; Boelig RC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010607.pub2; Brenner B, 2000, CURR OPIN HEMATOL, V7, P290, DOI 10.1097/00062752-200009000-00006; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Brown HC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002856.pub3; Carp H, 2015, GYNECOL ENDOCRINOL, V31, P422, DOI 10.3109/09513590.2015.1006618; Chen HX, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008883.pub2; Coleman T, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078.pub2; Coomarasamy A, 2019, NEW ENGL J MED, V380, P1815, DOI 10.1056/NEJMoa1813730; Coomarasamy A, 2015, NEW ENGL J MED, V373, P2141, DOI 10.1056/NEJMoa1504927; Coomarasamy A, 2020, AM J OBSTET GYNECOL, V223, P167, DOI 10.1016/j.ajog.2019.12.006; COULAM CB, 1995, AM J REPROD IMMUNOL, V33, P40, DOI 10.1111/j.1600-0897.1995.tb01136.x; Cui WY, 2010, B WORLD HEALTH ORGAN, V88, P881, DOI 10.2471/BLT.10.011210; de Jong PG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004734.pub4; De-Regil LM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007950.pub2; Dhillon-Smith RK, 2019, NEW ENGL J MED, V380, P1316, DOI 10.1056/NEJMoa1812537; Dong AC, 2020, FERTIL STERIL, V113, P587, DOI 10.1016/j.fertnstert.2019.11.003; Duhig K, 2016, OBSTET MED, V9, P113, DOI 10.1177/1753495X16648495; Earl R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008633.pub3; Egerup P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141588; Franssen MTM, 2006, BMJ-BRIT MED J, V332, P759, DOI 10.1136/bmj.38735.459144.2F; Franssen MTM, 2005, BMJ-BRIT MED J, V331, P137, DOI 10.1136/bmj.38498.669595.8F; Fukui A, 1999, AM J REPROD IMMUNOL, V41, P413; Furber CM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009334.pub2; Gonzalez R, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011444.pub3; Haas DM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003511.pub2; HAMILTONFAIRLEY D, 1992, BRIT J OBSTET GYNAEC, V99, P128, DOI 10.1111/j.1471-0528.1992.tb14470.x; Hamulyak EN, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012852.pub2; Iews M, 2018, REPROD BIOMED ONLINE, V36, P677, DOI 10.1016/j.rbmo.2018.03.005; Inagaki N, 2003, HUM REPROD, V18, P608, DOI 10.1093/humrep/deg139; Keats EC, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub6; Kim CH, 2011, FERTIL STERIL, V95, P1650, DOI 10.1016/j.fertnstert.2010.12.004; KWAK JYH, 1995, AM J REPROD IMMUNOL, V34, P93, DOI 10.1111/j.1600-0897.1995.tb00924.x; Ledee-Bataille N, 2005, FERTIL STERIL, V83, P598, DOI 10.1016/j.fertnstert.2004.11.021; Lensen SF, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011424.pub2; Li L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010568.pub2; Lim CED, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009278.pub2; Lovvik TS, 2019, LANCET DIABETES ENDO, V7, P256, DOI 10.1016/S2213-8587(19)30002-6; Matsubayashi H, 2001, FERTIL STERIL, V76, P694, DOI 10.1016/S0015-0282(01)02009-X; Morley LC, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub6; Morley LC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008611.pub2; Musters AM, 2011, FERTIL STERIL, V95, P2153, DOI 10.1016/j.fertnstert.2010.12.022; National Institute for Health and Clinical Excellence, 2019, ECT PREGN MISC DIAGN; Nazarpour S, 2018, J CLIN ENDOCR METAB, V103, P926, DOI 10.1210/jc.2017-01850; Nazarpour S, 2017, EUR J ENDOCRINOL, V176, P253, DOI 10.1530/EJE-16-0548; Negro R, 2005, HUM REPROD, V20, P1529, DOI 10.1093/humrep/deh843; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Negro R, 2016, J CLIN ENDOCR METAB, V101, P3685, DOI 10.1210/jc.2016-1803; Ogasawara M, 2000, FERTIL STERIL, V73, P300, DOI 10.1016/S0015-0282(99)00495-1; Oon VJH, 2000, HUM REPROD UPDATE, V6, P519, DOI 10.1093/humupd/6.5.519; Palomba S, 2009, FERTIL STERIL, V92, P1646, DOI 10.1016/j.fertnstert.2008.08.087; Prager S, 2018, OBSTET GYNECOL, V132, pE197, DOI 10.1097/AOG.0000000000002899; Prior M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016571; Rao M, 2019, HUM REPROD UPDATE, V25, P344, DOI 10.1093/humupd/dmz003; Reid SM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007752.pub3; Rikken JFW, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008576.pub4; RUUTIANINEN K, 1991, CURR OPIN OBSTET GYN, V3, P326; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Sharpe A, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013505; Smith PP, 2019, BJOG-INT J OBSTET GY, V126, P176, DOI 10.1111/1471-0528.15528; Stagnaro-Green A, 2012, NAT REV ENDOCRINOL, V8, P650, DOI 10.1038/nrendo.2012.171; Stern C, 2003, FERTIL STERIL, V80, P376, DOI 10.1016/S0015-0282(03)00610-1; Thangaratinam S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2616; van Dijk MM, 2020, HUM REPROD UPDATE, V26, P356, DOI 10.1093/humupd/dmz048; Wang HN, 2017, JAMA-J AM MED ASSOC, V318, P2190, DOI 10.1001/jama.2017.18249; Wong LF, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000112.pub3; Yang GY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-320; Zhang TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001732	77	23	25	7	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1675	1682		10.1016/S0140-6736(21)00681-4	http://dx.doi.org/10.1016/S0140-6736(21)00681-4		APR 2021	8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV0EH	33915096	Green Submitted			2022-12-28	WOS:000645510600028
J	Pierrat, V; Marchand-Martin, L; Marret, S; Arnaud, C; Benhammou, V; Cambonie, G; Debillon, T; Dufourg, MN; Gire, C; Goffinet, F; Kaminski, M; Lapillonne, A; Morgan, AS; Roze, JC; Twilhaar, S; Charles, MA; Ancel, PW				Pierrat, Veronique; Marchand-Martin, Laetitia; Marret, Stephane; Arnaud, Catherine; Benhammou, Valerie; Cambonie, Gilles; Debillon, Thierry; Dufourg, Marie-Noelle; Gire, Catherine; Goffinet, Francois; Kaminski, Monique; Lapillonne, Alexandre; Morgan, Andrei Scott; Roze, Jean-Christophe; Twilhaar, Sabrina; Charles, Marie-Aline; Ancel, Pierre-Wes		EPIPAGE-2 Writing Grp	Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; DEVELOPMENTAL COORDINATION DISORDER; BEHAVIORAL-PROBLEMS; EARLY-TERM; DIFFICULTIES; CARE; DISABILITIES; PERFORMANCE; GESTATION; STRENGTHS	OBJECTIVES To describe neurodevelopment at age 5 among children born preterm. DESIGN Population based cohort study, EPIPAGE-2. SETTING France, 2011. PARTICIPANTS 4441 children aged 51/2 born at 24-26, 27-31, and 32-34 weeks MAIN OUTCOME MEASURES Severe/moderate neurodevelopmental disabilities, defined as severe/moderate cerebral palsy (Gross Motor Function Classification System (GMFCS) 22), or unilateral or bilateral blindness or deafness, or full scale intelligence quotient less than minus two standard deviations (Wechsler Preschool and Primary Scale of Intelligence, 4th edition). Mild neurodevelopmental disabilities, defined as mild cerebral palsy (GMFCS-1), or visual disability 23.2/10 and <5/10, or hearing loss <40 dB, or full scale intelligence quotient (minus two to minus one standard deviation) or developmental coordination disorders (Movement Assessment Battery for Children, 2nd edition, total score less than or equal to the fifth centile), or behavioural difficulties (strengths and difficulties questionnaire, total score greater than or equal to the 90th centile), school assistance (mainstream class with support or special school), complex developmental interventions, and parents' concerns about development. The distributions of the scores in contemporary term born children were used as reference. Results are given after multiple imputation as percentages of outcome measures with exact binomial 95% confidence intervals. RESULTS Among 4441 participants, 3083 (69.4%) children were assessed. Rates of severe/moderate neurodevelopmental disabilities were 28% (95% confidence interval 23.4% to 32.2%), 19% (16.8% to 20.7%), and 12% (9.2% to 14.0%) and of mild disabilities were 38.5% (33.7% to 43.4%), 36% (33.4% to 38.1%), and 34% (30.2% to 37.4%) at 2426, 27-31, and 32-34 weeks, respectively. Assistance at school was used by 27% (22.9% to 31.7%), 14% (12.1% to 15.9%), and 7% (4.4% to 9.0%) of children at 24-26, 27-31, and 32-34 weeks, respectively. About half of the children born at 24-26 weeks (52% (46.4% to 57.3%)) received at least one developmental intervention which decreased to 26% (21.8% to 29.4%) for those born at 32-34 weeks. Behaviour was the concern most commonly reported by parents. Rates of neurodevelopment disabilities increased as gestational age decreased and were higher in families with low socioeconomic status. CONCLUSIONS In this large cohort of children born preterm, rates of severe/moderate neurodevelopmental disabilities remained high in each gestational age group. Proportions of children receiving school assistance or complex developmental interventions might have a significant impact on educational and health organisations. Parental concerns about behaviour warrant attention.	[Pierrat, Veronique; Marchand-Martin, Laetitia; Benhammou, Valerie; Goffinet, Francois; Kaminski, Monique; Morgan, Andrei Scott; Twilhaar, Sabrina; Ancel, Pierre-Wes] Univ Paris, INRAE, INSERM, EPOPe,CRESS,Obstetr Perinatal & Pediat Epidemiol, F-75004 Paris, France; [Pierrat, Veronique] Jeanne Flandre Hosp, Dept Neonatal Med, CHU Lille, Lille, France; [Marret, Stephane] Rouen Univ Hosp, Dept Neonatal Med Intens Care & Neuropediat, Rouen, France; [Marret, Stephane] Normandy Univ, Inst Biomed Res & Innovat, Perinatal Handicap, Neovasc Team,INSERM U1254, Rouen, France; [Arnaud, Catherine] SPHERE Team, INSERM U1027, Paris, France; [Arnaud, Catherine] Toulouse 3 Univ Paul Sabatier, Toulouse, France; [Arnaud, Catherine] Univ Hosp Toulouse, Clin Epidemiol Unit, Toulouse, France; [Cambonie, Gilles] Montpellier Univ Hosp, Dept Neonatal Med, Montpellier, France; [Debillon, Thierry; Charles, Marie-Aline] Grenoble Alps Univ Hosp, Neonatal Intens Care Unit, Grenoble, France; [Debillon, Thierry] Grenoble Alps Univ, CNRS, UMR 5525 Tech Evaluat & Modelisat Act Sante, Tech Ingn Med & Complexite Informat Math & Applic, Grenoble, France; [Dufourg, Marie-Noelle] French Inst Med Res & Hlth, French Inst Demog Studies, ELFE Joint Unit, French Blood Agcy, Paris, France; [Gire, Catherine] North Hosp, AP HM, Dept Neonatol, Marseille, France; [Goffinet, Francois] Federat Hosp Univ Prematur, AP HP, Ctr Univ Paris, Port Royal Matern, Paris, France; [Lapillonne, Alexandre] Univ Paris, Univ Hosp Necker Enfants Malad, AP HP, Paris, France; [Morgan, Andrei Scott] UCL, UCL Elizabeth Garrett Anderson Inst Womens Hlth, London, England; [Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Roze, Jean-Christophe] Nantes Univ Hosp, Clin Invest Ctr CIC004, Clin Epidemiol, Nantes, France; [Charles, Marie-Aline] Univ Paris, INRAE, INSERM, Team Early Life Res Later Hlth,UMR 1153, Villejuif, France; [Ancel, Pierre-Wes] Clin Invest Ctr P1419, AP HP, Paris, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Montpellier; CHU de Montpellier; CHU Grenoble Alpes; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Pierrat, V (corresponding author), Tenon Hosp, U1153, Equipe EPOPe, 4 Rue Chine, F-75020 Paris, France.	veronique.pierrat@inserm.fr	Twilhaar, Sabrina/D-1863-2019; Boileau, Pascal/AAG-9683-2021; Charles, Marie Aline/F-8567-2017; EGO, Anne/G-7071-2011; ARNAUD, Catherine/AAC-5646-2019	Twilhaar, Sabrina/0000-0001-7912-9883; Boileau, Pascal/0000-0001-9755-6467; Charles, Marie Aline/0000-0003-4025-4390; EGO, Anne/0000-0002-1025-910X; ARNAUD, Catherine/0000-0002-4002-802X; GOFFINET, Francois/0000-0001-9643-0299; Roze, Jean-Christophe/0000-0003-3367-512X; Marret, Stephane/0000-0002-2858-148X; CAMBONIE, GILLES/0000-0002-1360-7915; Marchand-Martin, Laetitia/0000-0002-8036-8387	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Research Agency through the French EQUIPEX programme of investments in the future [ANR-11-EQPX-0038]; PREMUP Foundation; Foundation of France [11779]; Foundation for Medical Research [SPF20160936356]; hospital clinical research programme Epinutri [DGOS13-040]; National Institute of Health and Medical Research (INSERM); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA)	French Institute of Public Health Research/Institute of Public Health; French Health Ministry; National Research Agency through the French EQUIPEX programme of investments in the future; PREMUP Foundation; Foundation of France(Fondation de France); Foundation for Medical Research; hospital clinical research programme Epinutri; National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); National Institute of Cancer; National Solidarity Fund for Autonomy (CNSA)	This project has been funded with support from the French Institute of Public Health Research/Institute of Public Health, and its partners. Partners include the French Health Ministry, National Institute of Health and Medical Research (INSERM), National Institute of Cancer, and National Solidarity Fund for Autonomy (CNSA); National Research Agency through the French EQUIPEX programme of investments in the future (reference ANR-11-EQPX-0038); PREMUP Foundation; Foundation of France (reference 11779); Foundation for Medical Research (SPF20160936356); and hospital clinical research programme Epinutri (DGOS13-040). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allotey J, 2018, BJOG-INT J OBSTET GY, V125, P16, DOI 10.1111/1471-0528.14832; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Ancel PY, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-97; Blank R, 2019, DEV MED CHILD NEUROL, V61, P242, DOI 10.1111/dmcn.14132; Bolk J, 2018, JAMA PEDIATR, V172, P765, DOI 10.1001/jamapediatrics.2018.1394; Brenner M, 2018, EUR J PEDIATR, V177, P1641, DOI 10.1007/s00431-018-3216-9; Brown, 2013, ENCY AUTISM SPECTRUM, P1925, DOI [10.1007/978-1-4419-1698-3_1922, DOI 10.1007/978-1-4419-1698-3_1922, 10.1007/978-1-4419-1698- 3_1922]; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Chan E, 2016, CHILD CARE HLTH DEV, V42, P297, DOI 10.1111/cch.12320; Charles MA, 2020, INT J EPIDEMIOL, V49, P368, DOI 10.1093/ije/dyz227; Cheong JLY, 2020, SEMIN FETAL NEONAT M, V25, DOI 10.1016/j.siny.2020.101114; Cheong JLY, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-4086; Costeloe Kate L, 2012, BMJ, V345, pe7976, DOI 10.1136/bmj.e7976; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Ding S, 2020, ARCH DIS CHILD-FETAL, V105, P510, DOI 10.1136/archdischild-2019-318144; Ego A, 2016, J GYNECOL OBST BIO R, V45, P155, DOI 10.1016/j.jgyn.2015.08.009; Gale, BMJ PAEDIAT OPEN; Ghassabian A, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4372; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; HAS, NEURODEVELOPMENTAL D; Holsti L, 2002, J DEV BEHAV PEDIATR, V23, P9, DOI 10.1097/00004703-200202000-00002; Jaworski M, 2018, J PEDIATR-US, V200, P58, DOI 10.1016/j.jpeds.2018.03.006; Johnson S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029720; Johnson S, 2018, J PEDIATR-US, V193, P85, DOI 10.1016/j.jpeds.2017.10.002; Johnson S, 2017, ARCH DIS CHILD, V102, P97, DOI 10.1136/archdischild-2015-309581; Johnson S, 2016, EARLY HUM DEV, V103, P69, DOI 10.1016/j.earlhumdev.2016.07.009; Johnson S, 2015, DEV MED CHILD NEUROL, V57, P571, DOI 10.1111/dmcn.12683; Koldewijn K, 2018, POSTDISCHARGE RESPON; Kuo DZ, 2014, HEALTH AFFAIR, V33, P2190, DOI 10.1377/hlthaff.2014.0273; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Mills IS, 2018, J PAEDIATR CHILD H, V54, P74, DOI 10.1111/jpc.13668; NICE, NICE GUID 2017; Pearson Clinical & Talent Assessment, WPPSI 4 WECHSL INT S; Pierrat V, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3448; Potijk MR, 2016, ARCH DIS CHILD, V101, P217, DOI 10.1136/archdischild-2015-308958; Potijk MR, 2013, J PEDIATR-US, V163, P1289, DOI 10.1016/j.jpeds.2013.07.001; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Quigley MA, 2012, ARCH DIS CHILD-FETAL, V97, pF167, DOI 10.1136/archdischild-2011-300888; Roberts G, 2011, DEV MED CHILD NEUROL, V53, P55, DOI 10.1111/j.1469-8749.2010.03779.x; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI [10.1002/9780470316696, DOI 10.1002/9780470316696]; Saigal S, 2003, PEDIATRICS, V112, P943, DOI 10.1542/peds.112.4.943; Saurel-Cubizolles MJ, 2020, DEV MED CHILD NEUROL, V62, P1182, DOI 10.1111/dmcn.14587; Serenius F, 2016, JAMA PEDIATR, V170, P954, DOI 10.1001/jamapediatrics.2016.1210; Squarza C, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01257; Squires J, 2009, AGES STAGES QUESTION; Webbe JWH, 2020, ARCH DIS CHILD-FETAL, V105, pF425, DOI 10.1136/archdischild-2019-317501; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; World Health Organization, 2021, VIS IMP BLINDN; Zanlonghi X., 1999, J FRANCAIS ORTHOPT, V31, P199; Zeitlin J, 2020, ARCH DIS CHILD-FETAL, V105, P538, DOI 10.1136/archdischild-2019-317991	53	36	36	8	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n741	10.1136/bmj.n741	http://dx.doi.org/10.1136/bmj.n741			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SK7MH	33910920	Green Published, hybrid			2022-12-28	WOS:000656399900005
J	Krist, AH; Davidson, KW; Mangione, CM; Cabana, M; Caughey, AB; Davis, EM; Donahue, KE; Doubeni, CA; Kubik, M; Li, L; Ogedegbe, G; Pbert, L; Silverstein, M; Stevermer, J; Tseng, CW; Wong, JB				Krist, Alex H.; Davidson, Karina W.; Mangione, Carol M.; Cabana, Michael; Caughey, Aaron B.; Davis, Esa M.; Donahue, Katrina E.; Doubeni, Chyke A.; Kubik, Martha; Li, Li; Ogedegbe, Gbenga; Pbert, Lori; Silverstein, Michael; Stevermer, James; Tseng, Chien-Wen; Wong, John B.		Us Preventive Serv Task Force	Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BRAIN INSULIN-RESISTANCE; DIABETES-MELLITUS; RISK; DEMENTIA; GLUCOSE; METAANALYSIS; DISEASE; COHORT; SENSITIVITY; ASSOCIATION	ImportanceHypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardial infarction, stroke, and chronic kidney disease. ObjectiveTo reaffirm its 2015 recommendation, the US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for hypertension in adults, the accuracy of office blood pressure measurement for initial screening, and the accuracy of various confirmatory blood pressure measurement methods. PopulationAdults 18 years or older without known hypertension. Evidence AssessmentUsing a reaffirmation deliberation process, the USPSTF concludes with high certainty that screening for hypertension in adults has substantial net benefit. RecommendationThe USPSTF recommends screening for hypertension in adults 18 years or older with office blood pressure measurement. The USPSTF recommends obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment. (A recommendation) This 2021 US Preventive Services Task Force Reaffirmation Recommendation Statement recommends screening for hypertension in adults 18 years or older with office blood pressure measurement and obtaining blood pressure measurements outside of the clinical setting for diagnostic confirmation before starting treatment (A recommendation).	[Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, One Capitol Sq,830 E Main St,Sixth Floor, Richmond, VA 23219 USA; [Davidson, Karina W.] Northwell Hlth, Feinstein Inst Med Res, Manhasset, NY USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Cabana, Michael] Albert Einstein Coll Med, New York, NY USA; [Caughey, Aaron B.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Davis, Esa M.] Univ Pittsburgh, Pittsburgh, PA USA; [Donahue, Katrina E.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Doubeni, Chyke A.] Mayo Clin, Rochester, MN USA; [Kubik, Martha] George Mason Univ, Fairfax, VA 22030 USA; [Li, Li] Univ Virginia, Charlottesville, VA USA; [Ogedegbe, Gbenga] NYU, New York, NY USA; [Pbert, Lori] Univ Massachusetts, Sch Med, Worcester, MA USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Stevermer, James] Univ Missouri, Columbia, MO 65211 USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Wong, John B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Virginia Commonwealth University; Northwell Health; University of California System; University of California Los Angeles; Yeshiva University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic; George Mason University; University of Virginia; New York University; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Missouri System; University of Missouri Columbia; University of Hawaii System; Pacific Health Research & Education Institute; Tufts University	Krist, AH (corresponding author), Virginia Commonwealth Univ, One Capitol Sq,830 E Main St,Sixth Floor, Richmond, VA 23219 USA.	chair@uspstf.net	Davidson, Karina/GWC-0996-2022	Davidson, Karina/0000-0002-9162-477X; Wong, John/0000-0003-4203-9010				Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Batty GD, 2014, EPIDEMIOLOGY, V25, P932, DOI 10.1097/EDE.0000000000000184; Beeri MS, 2020, LANCET DIABETES ENDO, V8, P736, DOI 10.1016/S2213-8587(20)30267-9; Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Crane PK, 2013, NEW ENGL J MED, V369, P540, DOI [10.1056/NEJMoa1215740, 10.1056/NEJMc1311765]; Cunnane SC, 2020, NAT REV DRUG DISCOV, V19, P609, DOI 10.1038/s41573-020-0072-x; Diabetes UK, FACTS STATS REVISED; Hamed SA, 2017, EXPERT REV CLIN PHAR, V10, P409, DOI 10.1080/17512433.2017.1293521; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Huo XX, 2016, LANCET DIABETES ENDO, V4, P115, DOI 10.1016/S2213-8587(15)00508-2; Kellar D, 2020, LANCET NEUROL, V19, P758, DOI 10.1016/S1474-4422(20)30231-3; Kivimaki M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1495; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Livingston G, 2020, LANCET, V396, P413, DOI 10.1016/S0140-6736(20)30367-6; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McMillan JM, 2018, BMJ OPEN DIAB RES CA, V6, DOI 10.1136/bmjdrc-2018-000563; Rawlings AM, 2019, DIABETES CARE, V42, P1248, DOI 10.2337/dc19-0120; Rawlings AM, 2014, ANN INTERN MED, V161, P785, DOI 10.7326/M14-0737; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sattar N, 2019, CIRCULATION, V139, P2228, DOI 10.1161/CIRCULATIONAHA.118.037885; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Sommerlad A, 2018, ALZHEIMERS DEMENT, V14, P933, DOI 10.1016/j.jalz.2018.02.012; Standl E, 2019, EUR J PREV CARDIOL, V26, P7, DOI 10.1177/2047487319881021; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Tuligenga RH, 2014, LANCET DIABETES ENDO, V2, P228, DOI 10.1016/S2213-8587(13)70192-X; van Sloten TT, 2020, LANCET DIABETES ENDO, V8, P325, DOI 10.1016/S2213-8587(19)30405-X; Wang ZD, 2020, ALZHEIMERS DEMENT, V16, P316, DOI 10.1016/j.jalz.2019.09.003; Wilkinson T, 2018, ALZHEIMERS DEMENT, V14, P1038, DOI 10.1016/j.jalz.2018.02.016; Willette AA, 2015, JAMA NEUROL, V72, P1013, DOI 10.1001/jamaneurol.2015.0613; Xu WL, 2009, DIABETES, V58, P71, DOI 10.2337/db08-0586; Xue M, 2019, AGEING RES REV, V55, DOI 10.1016/j.arr.2019.100944; Yaffe K, 2013, JAMA INTERN MED, V173, P1300, DOI 10.1001/jamainternmed.2013.6176; Zhang JY, 2017, DIABETES RES CLIN PR, V124, P41, DOI 10.1016/j.diabres.2016.10.024	40	44	44	6	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1650	1656		10.1001/jama.2021.4987	http://dx.doi.org/10.1001/jama.2021.4987			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904861	Bronze			2022-12-28	WOS:000645617800022
J	Bartoszko, JJ; Siemieniuk, RAC; Kum, E; Qasim, A; Zeraatkar, D; Ge, L; Han, MA; Sadeghirad, B; Agarwal, A; Agoritsas, T; Chu, DK; Couban, R; Darzi, AJ; Devji, T; Ghadimi, M; Honarmand, K; Izcovich, A; Khamis, A; Lamontagne, F; Loeb, M; Marcucci, M; McLeod, SL; Motaghi, S; Murthy, S; Mustafa, RA; Neary, JD; Pardo-Hernandez, H; Rada, G; Rochwerg, B; Switzer, C; Tendal, B; Thabane, L; Vandvik, PO; Vernooij, RWM; Viteri-Garcia, A; Wang, Y; Yao, L; Ye, ZK; Guyatt, GH; Brignardello-Petersen, R				Bartoszko, Jessica J.; Siemieniuk, Reed A. C.; Kum, Elena; Qasim, Anila; Zeraatkar, Dena; Ge, Long; Han, Mi Ah; Sadeghirad, Behnam; Agarwal, Arnav; Agoritsas, Thomas; Chu, Derek K.; Couban, Rachel; Darzi, Andrea J.; Devji, Tahira; Ghadimi, Maryam; Honarmand, Kimia; Izcovich, Ariel; Khamis, Assem; Lamontagne, Francois; Loeb, Mark; Marcucci, Maura; McLeod, Shelley L.; Motaghi, Sharhzad; Murthy, Srinivas; Mustafa, Reem A.; Neary, John D.; Pardo-Hernandez, Hector; Rada, Gabriel; Rochwerg, Bram; Switzer, Charlotte; Tendal, Britta; Thabane, Lehana; Vandvik, Per O.; Vernooij, Robin W. M.; Viteri-Garcia, Andres; Wang, Ying; Yao, Liang; Ye, Zhikang; Guyatt, Gordon H.; Brignardello-Petersen, Romina			Prophylaxis against covid-19: living systematic review and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							IVERMECTIN	OBJECTIVE To determine and compare the effects of drug prophylaxis on SARS-CoV-2 infection and covid-19. DESIGN Living systematic review and network meta-analysis. DATA SOURCES World Health Organization covid-19 database, a comprehensive multilingual source of global covid-19 literature to 25 March 2021, and six additional Chinese databases to 20 February 2021. STUDY SELECTION Randomised trials of people at risk of covid-19 who were assigned to receive prophylaxis or no prophylaxis (standard care or placebo). Pairs of reviewers independently screened potentially eligible articles. METHODS Random effects bayesian network meta-analysis was performed after duplicate data abstraction. Included studies were assessed for risk of bias using a modification of the Cochrane risk of bias 2.0 tool, and certainty of evidence was assessed using the grading of recommendations assessment, development, and evaluation (GRADE) approach. RESULTS The first iteration of this living network meta-analysis includes nine randomised trials-six of hydroxychloroquine (n=6059 participants), one of ivermectin combined with iota-carrageenan (n=234), and two of ivermectin alone (n=540), all compared with standard care or placebo. Two trials (one of ramipril and one of bromhexine hydrochloride) did not meet the sample size requirements for network meta-analysis. Hydroxychloroquine has trivial to no effect on admission to hospital (risk difference 1 fewer per 1000 participants, 95% credible interval 3 fewer to 4 more; high certainty evidence) or mortality (1 fewer per 1000, 2 fewer to 3 more; high certainty). Hydroxychloroquine probably does not reduce the risk of laboratory confirmed SARS-CoV-2 infection (2 more per 1000, 18 fewer to 28 more; moderate certainty), probably increases adverse effects leading to drug discontinuation (19 more per 1000, 1 fewer to 70 more; moderate certainty), and may have trivial to no effect on suspected, probable, or laboratory confirmed SARS-CoV-2 infection (15 fewer per 1000, 64 fewer to 41 more; low certainty). Owing to serious risk of bias and very serious imprecision, and thus very low certainty of evidence, the effects of ivermectin combined with iota-carrageenan on laboratory confirmed covid-19 (52 fewer per 1000, 58 fewer to 37 fewer), ivermectin alone on laboratory confirmed infection (50 fewer per 1000, 59 fewer to 16 fewer) and suspected, probable, or laboratory confirmed infection (159 fewer per 1000, 165 fewer to 144 fewer) remain very uncertain. CONCLUSIONS Hydroxychloroquine prophylaxis has trivial to no effect on hospital admission and mortality, probably increases adverse effects, and probably does not reduce the risk of SARS-CoV-2 infection. Because of serious risk of bias and very serious imprecision, it is highly uncertain whether ivermectin combined with iota-carrageenan and ivermectin alone reduce the risk of SARS-CoV-2 infection.	[Bartoszko, Jessica J.; Kum, Elena; Qasim, Anila; Zeraatkar, Dena; Sadeghirad, Behnam; Agarwal, Arnav; Agoritsas, Thomas; Chu, Derek K.; Darzi, Andrea J.; Devji, Tahira; Ghadimi, Maryam; Loeb, Mark; Marcucci, Maura; Motaghi, Sharhzad; Rochwerg, Bram; Switzer, Charlotte; Thabane, Lehana; Wang, Ying; Yao, Liang; Ye, Zhikang; Guyatt, Gordon H.; Brignardello-Petersen, Romina] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Ge, Long] Lanzhou Univ, Sch Publ Hlth, Evidence Based Social Sci Res Ctr, Lanzhou, Gansu, Peoples R China; [Han, Mi Ah] Chosun Univ, Dept Prevent Med, Coll Med, Gwangju, South Korea; [Sadeghirad, Behnam; Couban, Rachel] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Agarwal, Arnav] Univ Toronto, Dept Med, Toronto, ON, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Chu, Derek K.; Loeb, Mark; Marcucci, Maura; Neary, John D.; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Honarmand, Kimia] Western Univ, Dept Med, London, ON, Canada; [Izcovich, Ariel] Hosp Aleman, Serv Clin Med, Buenos Aires, DF, Argentina; [Khamis, Assem] Hull York Med Sch, Wolfson Palliat Care Res Ctr, York, N Yorkshire, England; [Lamontagne, Francois] CHU Sherbrooke, Dept Med, Sherbrooke, PQ, Canada; [Lamontagne, Francois] CHU Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [McLeod, Shelley L.] Sinai Hlth, Schwartz Reisman Emergency Med Inst, Toronto, ON, Canada; [McLeod, Shelley L.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Murthy, Srinivas] Univ British Columbia, Dept Pediat, Fac Med, Vancouver, BC, Canada; [Mustafa, Reem A.] Univ Kansas, Med Ctr, Dept Med, Kansas City, MO USA; [Pardo-Hernandez, Hector] St Pau Biomed Res Inst IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain; [Pardo-Hernandez, Hector] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Rada, Gabriel; Viteri-Garcia, Andres] Epistemonikos Fdn, Santiago, Chile; [Rada, Gabriel] Pontificia Univ Catolica Chile, Cochrane Chile Associated Ctr, C Evidence Ctr, Santiago, Chile; [Tendal, Britta] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic, Australia; [Vandvik, Per O.] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Vernooij, Robin W. M.] Univ Med Ctr Utrecht, Dept Nephrol & Hypertens, Utrecht, Netherlands; [Vernooij, Robin W. M.] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Viteri-Garcia, Andres] Univ UTE, Fac Ciencias Salud Eugenio Espejo, Ctr Invest Salud Publ & Epidemiol Clin CISPEC, Quito, Ecuador	McMaster University; Lanzhou University; Chosun University; McMaster University; University of Toronto; University of Geneva; University of Geneva; McMaster University; Western University (University of Western Ontario); Hospital Aleman; University of Buenos Aires; University of Hull; University of York - UK; University of Sherbrooke; University of Sherbrooke; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of British Columbia; University of Kansas; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pontificia Universidad Catolica de Chile; Monash University; University of Oslo; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Siemieniuk, RAC (corresponding author), McMaster Univ, Med Ctr, 1280 Main St West 2C Area, Hamilton, ON L8S 4K1, Canada.	reed.siemieniuk@medportal.ca	T, E/HII-8943-2022; Zeraatkar, Dena/GNM-9600-2022; Agarwal, Arnav/J-1553-2014; Couban, Rachel/AAV-1568-2021; Sadeghirad, Behnam/A-1772-2009; McLeod, Shelley/AAE-9636-2019	Agarwal, Arnav/0000-0002-0931-7851; Couban, Rachel/0000-0001-8672-2845; Sadeghirad, Behnam/0000-0001-9422-5232; McLeod, Shelley/0000-0003-2686-6307; Lamontagne, Francois/0000-0002-0360-3427; Chu, Derek/0000-0001-8269-4496; Wang, Ying/0000-0002-2296-1991; Murthy, Srinivas/0000-0002-9476-839X; Izcovich, Ariel/0000-0001-9053-4396; Kum, Elena/0000-0002-6548-2632; Qasim, Anila/0000-0001-9658-0078; Yao, Liang/0000-0003-4068-3136; Siemieniuk, Reed/0000-0002-3725-3031	Canadian Institutes of Health Research [CIHR-IRSC:0579001321, MM1-174897]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institutes of Health Research (grant CIHR-IRSC:0579001321; grant MM1-174897).	Abella BS, 2021, JAMA INTERN MED, V181, P195, DOI 10.1001/jamainternmed.2020.6319; Ahmed S, 2021, META ANAL RANDOMIZED; Amat-Santos IJ, 2020, J AM COLL CARDIOL, V76, P268, DOI 10.1016/j.jacc.2020.05.040; [Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], LIV EV RESP COVID 19; [Anonymous], COV SYST REV SOFTW, DOI DOI 10.1177/002221949903200203; Barnabas RV, 2021, ANN INTERN MED, V174, P344, DOI 10.7326/M20-6519; Boulware DR, 2020, NEW ENGL J MED, V383, P517, DOI 10.1056/NEJMoa2016638; Brignardello-Petersen R, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3900; Brignardello-Petersen R, 2018, J CLIN EPIDEMIOL, V93, P36, DOI 10.1016/j.jclinepi.2017.10.005; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Elgazzar Ahmed., 2020, RES SQ, DOI [10.21203/rs.3.rs-100956/v3, DOI 10.21203/RS.3.RS-100956/V2, DOI 10.21203/RS.3.RS-100956/V3]; Elliott JH, 2017, J CLIN EPIDEMIOL, V91, P23, DOI 10.1016/j.jclinepi.2017.08.010; gemtc, 2020, GEMTC NETW MET AN US; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P407, DOI 10.1016/j.jclinepi.2010.07.017; Hutton B, 2015, ANN INTERN MED, V162, P777, DOI 10.7326/M14-2385; Johns Hopkins University, 2020, CORONAVIRUS RESOURCE; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Krakower DS, 2015, CURR HIV-AIDS REP, V12, P127, DOI 10.1007/s11904-014-0253-5; Lamontagne F, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n526; Lamontagne F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3379; Lewis K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244778; Lofgren Sarah M, 2020, medRxiv, DOI 10.1101/2020.07.16.20155531; Marshall IJ, 2018, RES SYNTH METHODS, V9, P602, DOI 10.1002/jrsm.1287; Marti-Soler H, 2020, BMC INFECT DIS, DOI [10.21203/rs.3.rs-72132/v1, DOI 10.21203/RS.3.RS-72132/V1]; Mitja O, 2021, NEW ENGL J MED, V384, P417, DOI 10.1056/NEJMoa2021801; Norwegian Institute of Public Health, NIPH SYST LIV MAP CO; Padhy BM, 2020, J PHARM PHARM SCI, V23, P462, DOI 10.18433/jpps31457; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Rajasingham Radha, 2021, Clin Infect Dis, V72, pe835, DOI [10.1101/2020.09.18.20197327, 10.1093/cid/ciaa1571]; Rover C, 2020, J STAT SOFTW, V93, P1, DOI 10.18637/jss.v093.i06; Schandelmaier S, 2020, CAN MED ASSOC J, V192, pE901, DOI 10.1503/cmaj.200077; Shoumann WM, 2021, J CLIN DIAGN RES, V15, pOC27, DOI 10.7860/JCDR/2021/46795.14529; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Siemieniuk RAC, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2980; The COVID-NMA initiative, LIV MAPP LIV SYST RE; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V41, P145, DOI DOI 10.1056/NEJMcp2009249; ToroHuamanchumo CJ, 20212021012621250420, V2021; Turner RM, 2015, STAT MED, V34, P984, DOI 10.1002/sim.6381; Vakhrushev AD, 20212021030321252855, V2021; van Valkenhoef G, 2016, RES SYNTH METHODS, V7, P80, DOI 10.1002/jrsm.1167; Vandvik PO, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0596-4; World Health Organization (WHO), GLOB RES COR DIS COV	43	42	43	4	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n949	10.1136/bmj.n949	http://dx.doi.org/10.1136/bmj.n949			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903131	Green Published, hybrid			2022-12-28	WOS:000678538700011
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: US authorises Johnson and Johnson vaccine again, ending pause in rollout	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, NEW YORK TIMES; Fox M., 2021, CNN 0423 CNN 0423; Sax P, 2021, NEJM J WATCH; Society of Hematology, 2021, COV 19 RES HEM DIAGN COV 19 RES HEM DIAGN; US Food and Drug Administration, 2021, FDA CDC LIFT REC PAU FDA CDC LIFT REC PAU; Wen LS, 2021, WASH POST	6	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1079	10.1136/bmj.n1079	http://dx.doi.org/10.1136/bmj.n1079			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903130	Bronze			2022-12-28	WOS:000678538700005
J	Negin, J; Alpers, P; Nassar, N; Hemenway, D				Negin, Joel; Alpers, Philip; Nassar, Natasha; Hemenway, David			Australian Firearm Regulation at 25-Successes, Ongoing Challenges, and Lessons for the World	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Australian Firearm Regulation at 25 A 1996 mass shooting in Australia launched one of the world's most powerful natural experiments in firearm-injury prevention. This experience provides important lessons for the United States and other jurisdictions with high rates of gun violence.	[Negin, Joel; Alpers, Philip] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [Nassar, Natasha] Univ Sydney, Childrens Hosp Westmead, Sch Clin, Fac Med & Hlth, Sydney, NSW, Australia; [Hemenway, David] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	University of Sydney; University of Sydney; Harvard University; Harvard T.H. Chan School of Public Health	Negin, J (corresponding author), Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia.			Negin, Joel/0000-0002-2016-311X				Chapman S, 2006, INJURY PREV, V12, P365, DOI 10.1136/ip.2006.013714; Chapman S, 2016, JAMA-J AM MED ASSOC, V316, P291, DOI 10.1001/jama.2016.8752; Jones M, 2018, ANN INTERN MED, V169, P62, DOI 10.7326/M18-0503; Naghavi M, 2018, JAMA-J AM MED ASSOC, V320, P792, DOI 10.1001/jama.2018.10060; Spencer CM, 2020, TRAUMA VIOLENCE ABUS, V21, P527, DOI 10.1177/1524838018781101	5	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1581	1583		10.1056/NEJMp2102574	http://dx.doi.org/10.1056/NEJMp2102574		APR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV1ND	33909963				2022-12-28	WOS:000643861900001
J	Klein, KN; Zhao, PA; Lyu, XW; Sasaki, T; Bartlett, DA; Singh, AM; Tasan, I; Zhang, M; Watts, LP; Hiraga, S; Natsume, T; Zhou, XM; Baslan, T; Leung, D; Kanemaki, MT; Donaldson, AD; Zhao, HM; Dalton, S; Corces, VG; Gilbert, DM				Klein, Kyle N.; Zhao, Peiyao A.; Lyu, Xiaowen; Sasaki, Takayo; Bartlett, Daniel A.; Singh, Amar M.; Tasan, Ipek; Zhang, Meng; Watts, Lotte P.; Hiraga, Shin-ichiro; Natsume, Toyoaki; Zhou, Xuemeng; Baslan, Timour; Leung, Danny; Kanemaki, Masato T.; Donaldson, Anne D.; Zhao, Huimin; Dalton, Stephen; Corces, Victor G.; Gilbert, David M.			Replication timing maintains the global epigenetic state in human cells	SCIENCE			English	Article							BIOCONDUCTOR PACKAGE; DNA	The temporal order of DNA replication [replication timing (RT)] is correlated with chromatin modifications and three-dimensional genome architecture; however, causal links have not been established, largely because of an inability to manipulate the global RT program. We show that loss of RIF1 causes near-complete elimination of the RT program by increasing heterogeneity between individual cells. RT changes are coupled with widespread alterations in chromatin modifications and genome compartmentalization. Conditional depletion of RIF1 causes replication-dependent disruption of histone modifications and alterations in genome architecture. These effects were magnified with successive cycles of altered RT. These results support models in which the timing of chromatin replication and thus assembly plays a key role in maintaining the global epigenetic state.	[Klein, Kyle N.; Zhao, Peiyao A.; Sasaki, Takayo; Bartlett, Daniel A.; Gilbert, David M.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Lyu, Xiaowen; Corces, Victor G.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA 30322 USA; [Lyu, Xiaowen] Xiamen Univ, Sch Med, State Key Lab Cellular Stress Biol, Fujian Prov Key Lab Reprod Hlth Res, Xiamen, Peoples R China; [Sasaki, Takayo; Gilbert, David M.] San Diego Biomed Res Inst, La Jolla, CA 92121 USA; [Singh, Amar M.; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Tasan, Ipek; Zhang, Meng; Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Watts, Lotte P.; Hiraga, Shin-ichiro; Donaldson, Anne D.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Natsume, Toyoaki; Kanemaki, Masato T.] Natl Inst Genet, Dept Chromosome Sci, Res Org Informat & Syst ROIS, Yata 1111, Mishima, Shizuoka 4118540, Japan; [Natsume, Toyoaki; Kanemaki, Masato T.] Grad Univ Adv Studies SOKENDAI, Dept Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan; [Zhou, Xuemeng; Leung, Danny] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Baslan, Timour] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA	State University System of Florida; Florida State University; Emory University; Xiamen University; University System of Georgia; University of Georgia; University of Illinois System; University of Illinois Urbana-Champaign; University of Aberdeen; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Hong Kong University of Science & Technology; Memorial Sloan Kettering Cancer Center	Gilbert, DM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Gilbert, DM (corresponding author), San Diego Biomed Res Inst, La Jolla, CA 92121 USA.	gilbert@sdbri.org	Hiraga, Shin-ichiro/C-6596-2008; Natsume, Toyoaki/S-1936-2018	Hiraga, Shin-ichiro/0000-0002-8722-3869; Leung, Danny Chi Yeu/0000-0002-2472-894X; Zhang, Meng/0000-0002-4076-6276; Zhao, Peiyao/0000-0002-4763-9544; Klein, Kyle/0000-0002-7713-2787; Tasan, Ipek/0000-0002-4375-4051; Natsume, Toyoaki/0000-0002-3544-4491; Bartlett, Daniel/0000-0003-3197-2438; Dalton, Stephen/0000-0002-3450-1263; Lyu, Xiaowen/0000-0002-8317-1141; Kanemaki, Masato/0000-0002-7657-1649; Corces, Victor/0000-0001-5140-4337; Watts, Lotte/0000-0002-1364-4345	NIH [GM083337, GM035463, GM085354]; Hong Kong Research Grant Council [ECS 26104216]; William C. and Joyce C. O'Neil Charitable Trust, Memorial Sloan Kettering Single Cell Sequencing Initiative	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong Research Grant Council(Hong Kong Research Grants Council); William C. and Joyce C. O'Neil Charitable Trust, Memorial Sloan Kettering Single Cell Sequencing Initiative	This work was supported by NIH grant GM083337 to D.M.G., GM035463 to V.G.C., and GM085354 to D.M.G., S.D., and V.G.C. D.L. is supported by the Hong Kong Research Grant Council (ECS 26104216). T.B. is supported by the William C. and Joyce C. O'Neil Charitable Trust, Memorial Sloan Kettering Single Cell Sequencing Initiative.	Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Buonomo SBC, 2017, ADV EXP MED BIOL, V1042, P259, DOI 10.1007/978-981-10-6955-0_12; Dileep V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02800-w; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Escobar TM, 2019, CELL, V179, P953, DOI 10.1016/j.cell.2019.10.009; Foti R, 2016, MOL CELL, V61, P260, DOI 10.1016/j.molcel.2015.12.001; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Jiang QH, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108315; Lajoie BR, 2015, METHODS, V72, P65, DOI 10.1016/j.ymeth.2014.10.031; Lande-Diner L, 2009, MOL CELL, V34, P767, DOI 10.1016/j.molcel.2009.05.027; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li PS, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx884; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lun ATL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0683-0; Lyu XW, 2018, MOL CELL, V71, P940, DOI 10.1016/j.molcel.2018.07.012; Marchal C, 2018, NAT PROTOC, V13, P819, DOI 10.1038/nprot.2017.148; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reveron-Gomez N, 2018, MOL CELL, V72, P239, DOI 10.1016/j.molcel.2018.08.010; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Seller CA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005687; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Stovner EB, 2019, BIOINFORMATICS, V35, P4392, DOI 10.1093/bioinformatics/btz232; Yoshida K, 2014, MOL CELL, V54, P691, DOI 10.1016/j.molcel.2014.04.032; Zhang JM, 2002, NATURE, V420, P198, DOI 10.1038/nature01150; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao P. A., 2021, **DROPPED REF**; Zhao PA, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-01983-8	35	30	30	7	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					371	+		10.1126/science.aba5545	http://dx.doi.org/10.1126/science.aba5545			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888635	Green Accepted, Green Submitted			2022-12-28	WOS:000645009800036
J	Dyer, O				Dyer, Owen			Covid-19: Canada relaxes age limits on AstraZeneca vaccine as Ontario cases surge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n1053	10.1136/bmj.n1053	http://dx.doi.org/10.1136/bmj.n1053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3DF	33883124	Bronze			2022-12-28	WOS:000643659700003
J	Perkel, JM				Perkel, Jeffrey M.			REACTIVE, REPRODUCIBLE, COLLABORATIVE: COMPUTATIONAL NOTEBOOKS EVOLVE	NATURE			English	Editorial Material						Computational biology and bioinformatics; Computer science; Software		A new breed of notebooks is taking data visualization and collaborative functionality to the next level, with spreadsheet simplicity.						Perkel, Jeffrey/0000-0001-5699-1008				Pimentel Joao Felipe, 2019, 2019 IEEE/ACM 16th International Conference on Mining Software Repositories (MSR), P507, DOI 10.1109/MSR.2019.00077	1	6	6	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					156	157		10.1038/d41586-021-01174-w	http://dx.doi.org/10.1038/d41586-021-01174-w			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RW5JM	33941927				2022-12-28	WOS:000646558500001
J	Rimmer, A				Rimmer, Abi			Excited delirium: what's the evidence for its use in medicine?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		American College of Physicians, 2009, WHIT PAP REP EXC DEL; [Anonymous], 2013, Emerg Med J, V30, P958, DOI 10.1136/emermed-2013-203139.1; Council on Psychiatry and Law, 2020, POS STAT US TERM EXC; Forensic Science Regulator, 2020, GUID US EXC DEL CAUS; Hoffman L., 2009, EMERG MED NEWS; Karnowski S., 2021, AP NEWS         0413; Linder LM, 2018, PHARMACOTHERAPY, V38, P139, DOI 10.1002/phar.2060; Royal College of Emergency Medicine, 2016, GUID MAN EXC DEL AC; Sassoon AM, 2020, FLORIDA TODAY; Strommer EMF, 2020, FORENSIC SCI MED PAT, V16, P680, DOI 10.1007/s12024-020-00291-8	10	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n1156	10.1136/bmj.n1156	http://dx.doi.org/10.1136/bmj.n1156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952574				2022-12-28	WOS:000651241900003
J	Wang, NE; Matlow, R; Shapiro, A				Wang, N. Ewen; Matlow, Ryan; Shapiro, Alan			When Undoing Is Not Enough - Repairing Harms Inflicted on Immigrant Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wang, N. Ewen] Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA 94305 USA; [Matlow, Ryan] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Shapiro, Alan] Montefiore Med Ctr, Div Acad Gen Pediat, Dept Pediat, New York, NY USA; [Shapiro, Alan] Albert Einstein Coll Med, New York, NY USA; [Shapiro, Alan] Terra Firma Healthcare & Justice Immigrant Childr, New York, NY USA	Stanford University; Stanford University; Montefiore Medical Center; Yeshiva University	Wang, NE (corresponding author), Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA 94305 USA.							[Anonymous], 2019, FAM CAS MAN PROGR WH; Linton JM, 2018, CHILD YOUTH SERV REV, V92, P122, DOI 10.1016/j.childyouth.2018.03.043; Linton JM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2017-0483; Oberg C, 2021, PEDIATRICS, V147, DOI 10.1542/peds.2020-012930; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663	5	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2021	384	25								10.1056/NEJMp2103956	http://dx.doi.org/10.1056/NEJMp2103956		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UA7NI	33951356				2022-12-28	WOS:000647809300001
J	Jatoi, I; Kemp, Z				Jatoi, Ismail; Kemp, Zoe			Risk-Reducing Mastectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER		[Jatoi, Ismail] Univ Texas Hlth Sci Ctr San Antonio, Div Surg Oncol & Endocrine Surg, 7703 Floyd Curl Dr,Mail Code 7738, San Antonio, TX 78229 USA; [Kemp, Zoe] Royal Marsden Hosp, NHS Trust, Dept Canc Genet, London, England; [Kemp, Zoe] Royal Marsden Hosp, NHS Trust, Dept Breast Med Oncol, London, England	University of Texas System; University of Texas Health San Antonio; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Jatoi, I (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Surg Oncol & Endocrine Surg, 7703 Floyd Curl Dr,Mail Code 7738, San Antonio, TX 78229 USA.	jatoi@uthscsa.edu						Carbine NE, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002748.pub4; Grobmyer SR, 2019, BJS OPEN, V3, P169, DOI 10.1002/bjs5.50117; Kuchenbaecker KB, 2017, JAMA-J AM MED ASSOC, V317, P2402, DOI 10.1001/jama.2017.7112; Moskowitz CS, 2014, J CLIN ONCOL, V32, P2217, DOI 10.1200/JCO.2013.54.4601; Tung NM, 2020, J CLIN ONCOL, V38, P2080, DOI 10.1200/JCO.20.00299; West AH, 2018, FAM CANCER, V17, P495, DOI 10.1007/s10689-018-0070-x; Yadav Siddhartha, 2019, Am Soc Clin Oncol Educ Book, V39, P61, DOI 10.1200/EDBK_238987	7	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1781	1782		10.1001/jama.2020.22414	http://dx.doi.org/10.1001/jama.2020.22414			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944884				2022-12-28	WOS:000647831200019
J	Schultz, R; Beroza, GC; Ellsworth, WL				Schultz, Ryan; Beroza, Gregory C.; Ellsworth, William L.			A risk-based approach for managing hydraulic fracturing-induced seismicity	SCIENCE			English	Article							EARTHQUAKES; SYSTEM; SHALE	Risks from induced earthquakes are a growing concern that needs effective management. For hydraulic fracturing of the Eagle Ford shale in southern Texas, we developed a risk-informed strategy for choosing red-light thresholds that require immediate well shut-in. We used a combination of datasets to simulate spatially heterogeneous nuisance and damage impacts. Simulated impacts are greater in the northeast of the play and smaller in the southwest. This heterogeneity is driven by concentrations of population density. Spatially varying red-light thresholds normalized on these impacts [moment magnitude (M-w) 2.0 to 5.0] are fairer and safer than a single threshold applied over a broad area. Sensitivity tests indicate that the forecast maximum magnitude is the most influential parameter. Our method provides a guideline for traffic light protocols and managing induced seismicity risks.	[Schultz, Ryan; Beroza, Gregory C.; Ellsworth, William L.] Stanford Univ, Dept Geophys, Stanford, CA 94305 USA	Stanford University	Schultz, R (corresponding author), Stanford Univ, Dept Geophys, Stanford, CA 94305 USA.	rjs10@stanford.edu		Schultz, Ryan/0000-0002-1796-9622	Stanford Center for Induced and Triggered Seismicity	Stanford Center for Induced and Triggered Seismicity	This work was supported by the Stanford Center for Induced and Triggered Seismicity.	Atkinson GM, 2016, SEISMOL RES LETT, V87, P631, DOI 10.1785/0220150263; Baird BW, 2020, EARTHQ SPECTRA, V36, P1995, DOI 10.1177/8755293020935138; Baisch S, 2019, SEISMOL RES LETT, V90, P1145, DOI 10.1785/0220180337; Bommer JJ, 2006, ENG GEOL, V83, P287, DOI 10.1016/j.enggeo.2005.11.002; Chase RE, 2019, EARTHQ ENG STRUCT D, V48, P1365, DOI 10.1002/eqe.3189; Cremen G, 2020, NAT HAZARD EARTH SYS, V20, P2701, DOI 10.5194/nhess-20-2701-2020; Douglas J, 2014, PURE APPL GEOPHYS, V171, P1847, DOI 10.1007/s00024-013-0765-8; Ellsworth WL, 2013, SCIENCE, V341, P142, DOI 10.1126/science.1225942; Fasola SL, 2019, GEOPHYS RES LETT, V46, P12958, DOI 10.1029/2019GL085167; Federal Emergency Management Agency (FEMA), 2015, MULT LOSS EST METH T; Frohlich C, 2013, EARTH PLANET SC LETT, V379, P56, DOI 10.1016/j.epsl.2013.07.025; Ghofrani H, 2019, SEISMOL RES LETT, V90, P1420, DOI 10.1785/0220180285; Heath DC, 2020, EARTHQ SPECTRA, V36, P1570, DOI 10.1177/8755293020911137; Jaiswal K, 2010, EARTHQ SPECTRA, V26, P1017, DOI 10.1193/1.3480331; Langenbruch C, 2020, GEOPHYS RES LETT, V47, DOI 10.1029/2019GL085878; Lei XL, 2019, SEISMOL RES LETT, V90, P1099, DOI 10.1785/0220190029; Mignan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13585-9; Mignan A, 2015, GEOTHERMICS, V53, P133, DOI 10.1016/j.geothermics.2014.05.007; Park J, 2016, COMPUT GEOSCI-UK, V97, P15, DOI 10.1016/j.cageo.2016.08.021; Pawley S, 2018, GEOPHYS RES LETT, V45, P1786, DOI 10.1002/2017GL076100; Rose A.N., 2019, LANDSCAN 2018 HIGH R; Savvaidis A, 2019, SEISMOL RES LETT, V90, P1702, DOI 10.1785/0220180350; Schultz R, 2018, SCIENCE, V359, P304, DOI 10.1126/science.aao0159; Schultz R, 2021, EARTHQ SPECTRA, V37, P789, DOI 10.1177/8755293020988025; Schultz R, 2020, B SEISMOL SOC AM, V110, P2411, DOI 10.1785/0120200016; Schultz R, 2020, REV GEOPHYS, V58, DOI 10.1029/2019RG000695; Smith Don C., 2015, OIL GAS NATURAL RESO, V1, P81; US Energy Information Administration, 2014, UPD EIA EAGL FORD PL; van der Elst NJ, 2016, J GEOPHYS RES-SOL EA, V121, P4575, DOI 10.1002/2016JB012818; Verdon JP, 2021, J SEISMOL, V25, P301, DOI 10.1007/s10950-020-09966-9; Wald DJ, 2011, ANN GEOPHYS-ITALY, V54, P688, DOI 10.4401/ag-5354; Zalachoris G, 2019, EARTHQ SPECTRA, V35, P1, DOI 10.1193/022618EQS047M; Zoback MD, 2012, EARTH MAGAZINE, P38	33	8	8	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					504	+		10.1126/science.abg5451	http://dx.doi.org/10.1126/science.abg5451			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926953				2022-12-28	WOS:000645554100045
J	Theofanopoulou, C; Gedman, G; Cahill, JA; Boeckx, C; Jarvis, ED				Theofanopoulou, Constantina; Gedman, Gregory; Cahill, James A.; Boeckx, Cedric; Jarvis, Erich D.			Universal nomenclature for oxytocin-vasotocin ligand and receptor families	NATURE			English	Article								Oxytocin (OXT; hereafter OT) and arginine vasopressin or vasotocin (AVP or VT; hereafter VT) are neurotransmitter ligands that function through specific receptors to control diverse functions(1,2). Here we performed genomic analyses on 35 species that span all major vertebrate lineages, including newly generated high-contiguity assemblies from the Vertebrate Genomes Project(3,4). Our findings support the claim(5) that OT (also known as OXT) and VT (also known as AVP) are adjacent paralogous genes that have resulted from a local duplication, which we infer was through DNA transposable elements near the origin of vertebrates and in which VT retained more of the parental sequence. We identified six major oxytocin-vasotocin receptors among vertebrates. We propose that all six of these receptors arose from a single receptor that was shared with the common ancestor of invertebrates, through a combination of whole-genome and large segmental duplications. We propose a universal nomenclature based on evolutionary relationships for the genes that encode these receptors, in which the genes are given the same orthologous names across vertebrates and paralogous names relative to each other. This nomenclature avoids confusion due to differential naming in the pre-genomic era and incomplete genome assemblies, furthers our understanding of the evolution of these genes, aids in the translation of findings across species and serves as a model for other gene families. A revised, universal nomenclature for the vertebrate genes that encode the oxytocin and vasopressin-vasotocin ligands and receptors will improve our understanding of gene evolution and facilitate the translation of findings across species.	[Theofanopoulou, Constantina; Gedman, Gregory; Cahill, James A.; Jarvis, Erich D.] Rockefeller Univ, Lab Neurogenet Language, 1230 York Ave, New York, NY 10021 USA; [Theofanopoulou, Constantina; Boeckx, Cedric] Univ Barcelona, Sect Gen Linguist, Barcelona, Spain; [Theofanopoulou, Constantina; Boeckx, Cedric] Univ Barcelona, Inst Complex Syst, Barcelona, Spain; [Boeckx, Cedric] ICREA, Barcelona, Spain; [Jarvis, Erich D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Rockefeller University; University of Barcelona; University of Barcelona; ICREA; Howard Hughes Medical Institute	Theofanopoulou, C; Jarvis, ED (corresponding author), Rockefeller Univ, Lab Neurogenet Language, 1230 York Ave, New York, NY 10021 USA.; Theofanopoulou, C (corresponding author), Univ Barcelona, Sect Gen Linguist, Barcelona, Spain.; Theofanopoulou, C (corresponding author), Univ Barcelona, Inst Complex Syst, Barcelona, Spain.; Jarvis, ED (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	ktheofanop@rockefeller.edu; ejarvis@rockefeller.edu	Boeckx, Cedric a/F-4781-2016	Theofanopoulou, Constantina/0000-0003-2014-7563; Cahill, James/0000-0002-7145-0215; Boeckx, Cedric/0000-0001-8882-9718				ACHER R, 1988, BIOCHIMIE, V70, P1197, DOI 10.1016/0300-9084(88)90185-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Buechi HB, 2017, GEN COMP ENDOCR, V246, P309, DOI 10.1016/j.ygcen.2017.01.007; Daza DO, 2012, GEN COMP ENDOCR, V175, P135, DOI 10.1016/j.ygcen.2011.10.011; Garrison JL, 2012, SCIENCE, V338, P540, DOI 10.1126/science.1226201; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Green RE, 2014, SCIENCE, V346, P1335, DOI 10.1126/science.1254449; Gwee PC, 2008, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-47; Haug-Baltzell A, 2017, BIOINFORMATICS, V33, P2197, DOI 10.1093/bioinformatics/btx144; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Hoyle CHV, 1999, BRAIN RES, V848, P1, DOI 10.1016/S0006-8993(99)01975-7; Hubley R, 2016, NUCLEIC ACIDS RES, V44, pD81, DOI 10.1093/nar/gkv1272; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jebb D, 2020, NATURE, V583, P578, DOI 10.1038/s41586-020-2486-3; Kawada T, 2008, PEPTIDES, V29, P1672, DOI 10.1016/j.peptides.2008.05.030; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kiezun Adam, 2012, BMC Res Notes, V5, P92, DOI 10.1186/1756-0500-5-92; Knobloch HS, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00031; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Liutkeviciute Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep39177; Lovell PV, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0565-1; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Mayasich SA, 2016, GEN COMP ENDOCR, V226, P88, DOI 10.1016/j.ygcen.2016.01.001; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Miyashita T, 2019, P NATL ACAD SCI USA, V116, P2146, DOI 10.1073/pnas.1814794116; Morgenstern B, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-6; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nakatani Y, 2017, BIOINFORMATICS, V33, pI369, DOI 10.1093/bioinformatics/btx259; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rayko E, 2006, GENE, V365, P41, DOI 10.1016/j.gene.2005.09.038; Rhie A, 2021, NATURE, V592, P737, DOI 10.1038/s41586-021-03451-0; Roch GJ, 2014, MOL BIOL EVOL, V31, P765, DOI 10.1093/molbev/mst269; Smith JJ, 2018, NAT GENET, V50, P270, DOI 10.1038/s41588-017-0036-1; Smith JJ, 2015, GENOME RES, V25, P1081, DOI 10.1101/gr.184135.114; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Song ZM, 2018, FRONT NEUROENDOCRIN, V51, P14, DOI 10.1016/j.yfrne.2017.10.004; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yachdav G, 2016, BIOINFORMATICS, V32, P3501, DOI 10.1093/bioinformatics/btw474; Yamaguchi Y, 2012, GEN COMP ENDOCR, V178, P519, DOI 10.1016/j.ygcen.2012.07.008; Yun S, 2015, MOL BIOL EVOL, V32, P2803, DOI 10.1093/molbev/msv179; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang HX, 2017, P NATL ACAD SCI USA, V114, P9146, DOI 10.1073/pnas.1704457114	47	25	25	0	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					747	+		10.1038/s41586-020-03040-7	http://dx.doi.org/10.1038/s41586-020-03040-7			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911268	hybrid, Green Published			2022-12-28	WOS:000645368900017
J	Price, A				Price, Amy			Why I wear a mask indoors and out COMMENT	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Price, Amy] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Price, A (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	aprice@bmj.com						Centers for Disease Control and Prevention, STORE WASH MASKS; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Price A, ADDRESSING COVID 19; Romero-Severson EO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236776; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0022968; World Health Organization, 2020, ADVICE USE MASKS CON; Zhao M, 2020, NANO LETT, V20, P5544, DOI 10.1021/acs.nanolett.0c02211	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1055	10.1136/bmj.n1055	http://dx.doi.org/10.1136/bmj.n1055			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910888	Bronze			2022-12-28	WOS:000656399900002
J	Shen, CS; Mao, CY; Xu, CJ; Jin, N; Zhang, HB; Shen, DD; Shen, QY; Wang, XM; Hou, TJ; Chen, Z; Rondard, P; Pin, JP; Zhang, Y; Liu, JF				Shen, Cangsong; Mao, Chunyou; Xu, Chanjuan; Jin, Nan; Zhang, Huibing; Shen, Dan-Dan; Shen, Qingya; Wang, Xiaomei; Hou, Tingjun; Chen, Zhong; Rondard, Philippe; Pin, Jean-Philippe; Zhang, Yan; Liu, Jianfeng			Structural basis of GABA(B) receptor-G(i) protein coupling	NATURE			English	Article							CRYO-EM STRUCTURE; 2ND INTRACELLULAR LOOP; ACTIVATION; SUBUNIT; VISUALIZATION; RECOGNITION; SYSTEM; GB2	G-protein-coupled receptors (GPCRs) have central roles in intercellular communication(1,2). Structural studies have revealed how GPCRs can activate G proteins. However, whether this mechanism is conserved among all classes of GPCR remains unknown. Here we report the structure of the class-C heterodimeric GABA(B) receptor, which is activated by the inhibitory transmitter GABA, in its active form complexed with G(i1) protein. We found that a single G protein interacts with the GB2 subunit of the GABA(B) receptor at a site that mainly involves intracellular loop 2 on the side of the transmembrane domain. This is in contrast to the G protein binding in a central cavity, as has been observed with other classes of GPCR. This binding mode results from the active form of the transmembrane domain of this GABA(B) receptor being different from that of other GPCRs, as it shows no outside movement of transmembrane helix 6. Our work also provides details of the inter- and intra-subunit changes that link agonist binding to G-protein activation in this heterodimeric complex.	[Shen, Cangsong; Xu, Chanjuan; Jin, Nan; Wang, Xiaomei; Liu, Jianfeng] Huazhong Univ Sci & Technol HUST, Int Res Ctr Sensory Biol & Technol MOST, Coll Life Sci & Technol, ZJU HUST Joint Lab Cellular Signaling,Key Lab Mol, Wuhan, Peoples R China; [Shen, Cangsong; Mao, Chunyou; Jin, Nan; Zhang, Huibing; Shen, Dan-Dan; Shen, Qingya; Zhang, Yan] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Biophys, Hangzhou, Peoples R China; [Shen, Cangsong; Mao, Chunyou; Jin, Nan; Zhang, Huibing; Shen, Dan-Dan; Shen, Qingya; Zhang, Yan] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Pathol, Hangzhou, Peoples R China; [Shen, Cangsong; Mao, Chunyou; Jin, Nan; Zhang, Huibing; Shen, Dan-Dan; Shen, Qingya; Zhang, Yan] Zhejiang Univ, Med Ctr, Liangzhu Lab, Hangzhou, Peoples R China; [Mao, Chunyou; Zhang, Huibing; Shen, Dan-Dan; Shen, Qingya; Zhang, Yan] Zhejiang Prov Key Lab Immun & Inflammatory Dis, Hangzhou, Peoples R China; [Xu, Chanjuan; Liu, Jianfeng] Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China; [Hou, Tingjun] Zhejiang Univ, Coll Pharmaceut Sci, Innovat Inst Artificial Intelligence Med, Hangzhou, Peoples R China; [Chen, Zhong] Zhejiang Chinese Med Univ, Key Lab Neuropharmacol & Translat Med Zhejiang P, Hangzhou, Peoples R China; [Rondard, Philippe; Pin, Jean-Philippe] Univ Montpellier, CNRS, INSERM, Inst Genom Fonct, F-34094 Montpellier, France; [Zhang, Yan] Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine In, Sch Med, Hangzhou, Peoples R China	Huazhong University of Science & Technology; Zhejiang University; Zhejiang University; Zhejiang University; Guangzhou Regenerative Medicine & Health Guangdong Laboratory (Bioisland Laboratory); Zhejiang University; Zhejiang Chinese Medical University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Zhejiang University	Liu, JF (corresponding author), Huazhong Univ Sci & Technol HUST, Int Res Ctr Sensory Biol & Technol MOST, Coll Life Sci & Technol, ZJU HUST Joint Lab Cellular Signaling,Key Lab Mol, Wuhan, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Biophys, Hangzhou, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Pathol, Hangzhou, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Univ, Med Ctr, Liangzhu Lab, Hangzhou, Peoples R China.; Zhang, Y (corresponding author), Zhejiang Prov Key Lab Immun & Inflammatory Dis, Hangzhou, Peoples R China.; Liu, JF (corresponding author), Guangzhou Regenerat Med & Hlth Guangdong Lab, Bioland Lab, Guangzhou, Peoples R China.; Pin, JP (corresponding author), Univ Montpellier, CNRS, INSERM, Inst Genom Fonct, F-34094 Montpellier, France.; Zhang, Y (corresponding author), Zhejiang Univ, MOE Frontier Sci Ctr Brain Res & Brain Machine In, Sch Med, Hangzhou, Peoples R China.	jean-philippe.pin@igf.cnrs.fr; zhang_yan@zju.edu.cn; jfliu@mail.hust.edu.cn	Hou, Tingjun/C-7492-2011; Zhang, Yan/V-8007-2019	Hou, Tingjun/0000-0001-7227-2580; Zhang, Yan/0000-0003-2189-0244; Shen, Qingya/0000-0001-6602-7116; Xu, Chanjuan/0000-0002-5640-1896; Mao, Chunyou/0000-0001-5349-8592	Ministry of Science and Technology [2019YFA050880, 2018YFA0507003]; National Natural Science Foundation of China [81922071, 81720108031, 81872945, 31721002]; Zhejiang Province Natural Science Fund for Excellent Young Scholars [LR19H31000]; Fondation pour la Recherche Medicale [DEQ20170336747]; Agence Nationale pour la Recherche [ANR 18-CE11-0004-01]; Centre National de la Recherche Scientifique (CNRS) [07030, 1403]; Institut National de la Sante et de la Recherche Medicale (INSERM); Program Hubert Curien (PHC) Cai Yuanpei from the Ministere Francais des Affaires Etrangeres	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Fund for Excellent Young Scholars; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Program Hubert Curien (PHC) Cai Yuanpei from the Ministere Francais des Affaires Etrangeres	The cryo-EM data were collected at the Cryo-Electron Microscopy Center of Zhejiang University with the technical support from S. Chang. Protein purification were performed at the Protein Facilities (Zhejiang University School of Medicine) with the support of C. Ma. This project was supported by Ministry of Science and Technology (2019YFA050880 to Y.Z., 2018YFA0507003 to J.L.), the National Natural Science Foundation of China Grant (81922071 to Y.Z. and 81720108031, 81872945, 31721002 to J.L.), Zhejiang Province Natural Science Fund for Excellent Young Scholars (LR19H31000 to YZ.); the Fondation pour la Recherche Medicale (DEQ20170336747, to J.-P.P.) and the Agence Nationale pour la Recherche (ANR 18-CE11-0004-01 to J.-P.P.). J.-P.P. and P.R. were supported by the Centre National de la Recherche Scientifique (CNRS, PICS no. 07030; PRC no. 1403), the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Program Hubert Curien (PHC) Cai Yuanpei from the Ministere Francais des Affaires Etrangeres.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Chun L, 2012, ACTA PHARMACOL SIN, V33, P312, DOI 10.1038/aps.2011.186; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Grushevskyi EO, 2019, P NATL ACAD SCI USA, V116, P10150, DOI 10.1073/pnas.1900261116; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Havlickova M, 2003, J BIOL CHEM, V278, P35063, DOI 10.1074/jbc.M306555200; Havlickova M, 2002, MOL PHARMACOL, V62, P343, DOI 10.1124/mol.62.2.343; Heymann JB, 2018, J STRUCT BIOL, V204, P90, DOI 10.1016/j.jsb.2018.07.003; Hilger D, 2020, SCIENCE, V369, P523, DOI 10.1126/science.aba3373; Hlavackova V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002720; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kato HE, 2019, NATURE, V572, P80, DOI 10.1038/s41586-019-1337-6; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Koek W, 2013, J PHARMACOL EXP THER, V344, P553, DOI 10.1124/jpet.112.202226; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Mao CY, 2020, CELL RES, V30, P564, DOI 10.1038/s41422-020-0350-5; Papasergi-Scott MM, 2020, NATURE, V584, P310, DOI 10.1038/s41586-020-2469-4; Park J, 2020, NATURE, V584, P304, DOI 10.1038/s41586-020-2452-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pin JP, 2016, NATURE, V540, P60, DOI 10.1038/nature20566; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Qi XF, 2019, NATURE, V571, P279, DOI 10.1038/s41586-019-1286-0; Qiao AN, 2020, SCIENCE, V367, P1346, DOI 10.1126/science.aaz5346; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scheres SHW, 2016, METHOD ENZYMOL, V579, P125, DOI 10.1016/bs.mie.2016.04.012; Schorb M, 2019, NAT METHODS, V16, P471, DOI 10.1038/s41592-019-0396-9; Shaye H, 2020, NATURE, V584, P298, DOI 10.1038/s41586-020-2408-4; Tu HJ, 2010, J NEUROSCI, V30, P749, DOI 10.1523/JNEUROSCI.2343-09.2010; Velazhahan V, 2021, NATURE, V589, P148, DOI 10.1038/s41586-020-2994-1; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xing CR, 2020, CELL, V180, P645, DOI 10.1016/j.cell.2020.01.007; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	46	24	25	18	79	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 24	2021	594	7864					594	+		10.1038/s41586-021-03507-1	http://dx.doi.org/10.1038/s41586-021-03507-1		APR 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX5MA	33911284	hybrid, Green Published			2022-12-28	WOS:000645221300003
J	Chen, MM; Mott, N; Clark, SJ; Harper, DM; Shuman, AG; Prince, MEP; Dossett, LA				Chen, Michelle M.; Mott, Nicole; Clark, Sarah J.; Harper, Diane M.; Shuman, Andrew G.; Prince, Mark E. P.; Dossett, Lesly A.			HPV Vaccination Among Young Adults in the US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							UNITED-STATES		[Chen, Michelle M.; Shuman, Andrew G.; Prince, Mark E. P.] Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA; [Mott, Nicole] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Clark, Sarah J.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Harper, Diane M.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Dossett, Lesly A.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chen, MM (corresponding author), Dept Otolaryngol Head & Neck Surg, 1500 E Med Ctr Dr,SPC 5312, Ann Arbor, MI 48109 USA.	mche@med.umich.edu	Harper, Diane/I-2180-2014; Chen, Michelle/N-9056-2013	Harper, Diane/0000-0001-7648-883X; Chen, Michelle/0000-0002-6988-5658; Mott, Nicole/0000-0003-4834-3400	postdoctoral Ruth L. Kirschstein National Research Service Award (National Institutes of Health)	postdoctoral Ruth L. Kirschstein National Research Service Award (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr Chen is supported by the postdoctoral Ruth L. Kirschstein National Research Service Award (National Institutes of Health).	Callahan ST, 2010, J ADOLESCENT HEALTH, V46, P407, DOI 10.1016/j.jadohealth.2009.09.010; Centers for Disease Control and Prevention, 2019, NAT HLTH INT SURV; Elam-Evans LD, 2020, MMWR-MORBID MORTAL W, V69, P1109, DOI 10.15585/mmwr.mm6933a1; Meites E, 2019, MMWR-MORBID MORTAL W, V68, P698, DOI [10.15585/mmwr.mm6832a3, 10.1111/ajt.15633]; Rolnick SJ, 2013, VACCINE, V31, P3928, DOI 10.1016/j.vaccine.2013.06.041; Senkomago V, 2019, MMWR-MORBID MORTAL W, V68, P724, DOI 10.15585/mmwr.mm6833a3	6	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1673	1674		10.1001/jama.2021.0725	http://dx.doi.org/10.1001/jama.2021.0725			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904878	Bronze, Green Published			2022-12-28	WOS:000645617800025
J	Delre, C; Jiang, YF; Kang, P; Kwon, J; Hall, A; Jayapurna, I; Ruan, ZY; Ma, L; Zolkin, K; Li, T; Scown, CD; Ritchie, RO; Russell, TP; Xu, T				Delre, Christopher; Jiang, Yufeng; Kang, Philjun; Kwon, Junpyo; Hall, Aaron; Jayapurna, Ivan; Ruan, Zhiyuan; Ma, Le; Zolkin, Kyle; Li, Tim; Scown, Corinne D.; Ritchie, Robert O.; Russell, Thomas P.; Xu, Ting			Near-complete depolymerization of polyesters with nano-dispersed enzymes	NATURE			English	Article							ENZYMATIC DEGRADATION; LIPASE; DECRYSTALLIZATION; CRYSTALLIZATION; CRYSTALLINITY; PROCESSIVITY; HYDROLYSIS	Successfully interfacing enzymes and biomachinery with polymers affords on-demand modification and/or programmable degradation during the manufacture, utilization and disposal of plastics, but requires controlled biocatalysis in solid matrices with macromolecular substrates(1-7). Embedding enzyme microparticles speeds up polyester degradation, but compromises host properties and unintentionally acceleratesthe formation of microplastics with partial polymer degradation(6,8,9). Here we showthat by nanoscopically dispersing enzymes with deep active sites, semi-crystalline polyesters can be degraded primarilyvia chain-end-mediated processive depolymerization with programmable latency and material integrity, akin to polyadenylation-induced messenger RNA decay(10). It is also feasible to achieve processivity with enzymes that have surface-exposed active sites by engineering enzyme-protectant-polymer complexes. Poly(caprolactone) and poly(lactic acid) containing less than 2 weight per cent enzymes are depolymerized in days, with up to 98 per cent polymer-to-small-molecule conversion in standard soil composts and household tap water, completely eliminating current needsto separate and landfill their products in compost facilities. Furthermore, oxidases embedded in polyolefins retain their activities. However, hydrocarbon polymers do not closely associate with enzymes, as their polyester counterparts do, and the reactive radicals that are generated cannot chemically modify the macromolecular host. This study provides molecularguidance towards enzyme-polymer pairing and the selection of enzyme protectants to modulate substrate selectivity and optimize biocatalytic pathways. The results also highlight the need for in-depth research in solid-state enzymology, especially in multi-step enzymatic cascades, to tackle chemically dormant substrates without creating secondary environmental contamination and/or biosafety concerns.	[Delre, Christopher; Jiang, Yufeng; Hall, Aaron; Jayapurna, Ivan; Ruan, Zhiyuan; Ma, Le; Zolkin, Kyle; Li, Tim; Ritchie, Robert O.; Xu, Ting] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Delre, Christopher; Jiang, Yufeng; Kwon, Junpyo; Ma, Le; Ritchie, Robert O.; Russell, Thomas P.; Xu, Ting] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Kang, Philjun; Xu, Ting] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kwon, Junpyo; Ritchie, Robert O.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Scown, Corinne D.] Lawrence Berkeley Natl Lab, Energy Anal & Environm Impacts Div, Berkeley, CA USA; [Russell, Thomas P.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Massachusetts System; University of Massachusetts Amherst	Xu, T (corresponding author), Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA.; Xu, T (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Xu, T (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	tingxu@berkeley.edu	Russell, Thomas Paul/ADL-3689-2022	Russell, Thomas Paul/0000-0001-6384-5826; Hall, Aaron/0000-0002-7739-201X; Ruan, Zhiyuan/0000-0001-9083-7952; Jayapurna, Ivan/0000-0003-1070-1014; DelRe, Christopher/0000-0002-1671-5807; Li, Tim/0000-0001-8008-5881	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division (DOE-BES-MSE), through the Organic-Inorganic Nanocomposites programme [DE-AC02-05-CH11231, KC3104]; DOE-BES-MSE through the Adaptive Interfacial Assemblies Towards Structuring Liquids KCTR16 programme (tensiometry studies on RHP/enzyme/polymer complexation) [DE-AC02-05-CH11231]; Berkeley Lab; US Department of Defense, Army Research Office [W911NF-13-1-0232]; National Defense Science and Engineering Graduate (NDSEG) Fellowship (Bioremediation); Bakar Fellowship at University of California Berkeley; US Department of Energy, Office of Science, Office of Basic Energy Science [DE-AC02-05CH11231]	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division (DOE-BES-MSE), through the Organic-Inorganic Nanocomposites programme(United States Department of Energy (DOE)); DOE-BES-MSE through the Adaptive Interfacial Assemblies Towards Structuring Liquids KCTR16 programme (tensiometry studies on RHP/enzyme/polymer complexation); Berkeley Lab; US Department of Defense, Army Research Office(United States Department of Defense); National Defense Science and Engineering Graduate (NDSEG) Fellowship (Bioremediation); Bakar Fellowship at University of California Berkeley; US Department of Energy, Office of Science, Office of Basic Energy Science(United States Department of Energy (DOE))	This work was primarily supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division (DOE-BES-MSE) under contract DE-AC02-05-CH11231, through the Organic-Inorganic Nanocomposites KC3104 programme (enzyme-plastic composite design and degradation mechanism; C.D., L.M., A.H., I.J., R.O.R., T.X.). Y.J. and T.P.R. acknowledge support from DOE-BES-MSE under the same contract number, through the Adaptive Interfacial Assemblies Towards Structuring Liquids KCTR16 programme (tensiometry studies on RHP/enzyme/polymer complexation). C.D.S. acknowledges Laboratory Directed Research and Development funding from Berkeley Lab (integration with organic waste infrastructure). The US Department of Defense, Army Research Office supported Z.R. (lipase stabilization) under contract W911NF-13-1-0232. C.D. was partially supported by a National Defense Science and Engineering Graduate (NDSEG) Fellowship (Bioremediation). T.X. also acknowledges support from a Bakar Fellowship at University of California Berkeley (compost tests). Scattering studies at the Advanced Light Source were supported by the US Department of Energy, Office of Science, Office of Basic Energy Science under contract DE-AC02-05CH11231.	Ajioka M, 1998, POLYM DEGRAD STABIL, V59, P137, DOI 10.1016/S0141-3910(97)00165-1; Arnold FH, 2018, ANGEW CHEM INT EDIT, V57, P4143, DOI 10.1002/anie.201708408; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; BORNSCHEUER U, 1994, BBA-GEN SUBJECTS, V1201, P55, DOI 10.1016/0304-4165(94)90151-1; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; Christensen PR, 2019, NAT CHEM, V11, P442, DOI 10.1038/s41557-019-0249-2; DelRe C, 2018, ACS APPL MATER INTER, V10, P44216, DOI 10.1021/acsami.8b18484; FLORY PJ, 1978, NATURE, V272, P226, DOI 10.1038/272226a0; Ganesh M, 2009, MACROMOLECULES, V42, P6836, DOI 10.1021/ma901481h; Haider TP, 2019, ANGEW CHEM INT EDIT, V58, P50, DOI 10.1002/anie.201805766; Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x; Hobbs SR, 2019, ADV MATER SCI ENG, V2019, DOI 10.1155/2019/4715904; Horn SJ, 2006, P NATL ACAD SCI USA, V103, P18089, DOI 10.1073/pnas.0608909103; Huang QY, 2020, BIOMACROMOLECULES, V21, P3301, DOI 10.1021/acs.biomac.0c00759; Iiyoshi Y, 1998, J WOOD SCI, V44, P222, DOI 10.1007/BF00521967; Ivleva NP, 2017, ANGEW CHEM INT EDIT, V56, P1720, DOI 10.1002/anie.201606957; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jiang T, 2020, NATURE, V577, P216, DOI 10.1038/s41586-019-1881-0; Khan I, 2019, ACS OMEGA, V4, P2844, DOI 10.1021/acsomega.8b02642; Klibanov AM, 2001, NATURE, V409, P241, DOI 10.1038/35051719; Kuchler A, 2016, NAT NANOTECHNOL, V11, P409, DOI 10.1038/nnano.2016.54; Li SM, 1999, MACROMOLECULES, V32, P4454, DOI 10.1021/ma990117b; Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k; Nordahl SL, 2020, ENVIRON SCI TECHNOL, V54, P9200, DOI 10.1021/acs.est.0c00364; Panganiban B, 2018, SCIENCE, V359, P1239, DOI 10.1126/science.aao0335; Payne CM, 2011, J PHYS CHEM LETT, V2, P1546, DOI 10.1021/jz2005122; Pleiss J, 1998, CHEM PHYS LIPIDS, V93, P67, DOI 10.1016/S0009-3084(98)00030-9; Radi R, 2018, P NATL ACAD SCI USA, V115, P5839, DOI 10.1073/pnas.1804932115; Roohi, 2017, CURR PHARM BIOTECHNO, V18, P429, DOI 10.2174/1389201018666170523165742; Ru JK, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00442; Satchwel AJ, 2018, ENVIRON SCI TECHNOL, V52, P13663, DOI 10.1021/acs.est.8b04481; Schneiderman DK, 2017, MACROMOLECULES, V50, P3733, DOI 10.1021/acs.macromol.7b00293; Smith AAA, 2019, ACS MACRO LETT, V8, P36, DOI 10.1021/acsmacrolett.8b00813; Tennakoon A, 2020, NAT CATAL, V3, P893, DOI 10.1038/s41929-020-00519-4; TOKIWA Y, 1977, NATURE, V270, P76, DOI 10.1038/270076a0; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Tournier V, 2020, NATURE, V580, P216, DOI 10.1038/s41586-020-2149-4; VARMANAIR M, 1991, J POLYM SCI POL PHYS, V29, P1107, DOI 10.1002/polb.1991.090290909; Wei R, 2020, NAT CATAL, V3, P867, DOI 10.1038/s41929-020-00521-w; Wurm A, 2012, MACROMOLECULES, V45, P3816, DOI 10.1021/ma300363b; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; Yang J, 2014, ENVIRON SCI TECHNOL, V48, P13776, DOI 10.1021/es504038a; YANG Z, 1995, J AM CHEM SOC, V117, P4843, DOI 10.1021/ja00122a014	43	55	56	121	377	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					558	+		10.1038/s41586-021-03408-3	http://dx.doi.org/10.1038/s41586-021-03408-3			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TS1OW	33883730	Green Submitted			2022-12-28	WOS:000679428400001
J	Wilkinson, E				Wilkinson, Emma			What the new Health Security Agency means for public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2021, BMJ BRIT MED J; Department of Health and Social Care, 2021, NEW OFF HLTH PROM DR; Iacobucci G, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3257; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Senthilingam M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n411	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n996	10.1136/bmj.n996	http://dx.doi.org/10.1136/bmj.n996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883162	Bronze			2022-12-28	WOS:000642452700007
J	Dyer, C				Dyer, Clare			Midlands trust told to take urgent action over care of young people with mental health needs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1616	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n1020	10.1136/bmj.n1020	http://dx.doi.org/10.1136/bmj.n1020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RS3BI	33879456				2022-12-28	WOS:000643654700007
J	Dyer, O				Dyer, Owen			Covid-19: US reports low rate of new infections in people already vaccinated	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Kustin T, 2021, NAT MED, V27, P1379, DOI 10.1038/s41591-021-01413-7	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2021	373								n1000	10.1136/bmj.n1000	http://dx.doi.org/10.1136/bmj.n1000			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RO8VU	33863709	Bronze			2022-12-28	WOS:000641319600003
J	Bourdenx, M; Martin-Segura, A; Scrivo, A; Rodriguez-Navarro, JA; Kaushik, S; Tasset, I; Diaz, A; Storm, NJ; Xin, QS; Juste, YR; Stevenson, E; Luengo, E; Clement, CC; Choi, SJ; Krogan, NJ; Mosharov, EV; Santambrogio, L; Grueninger, F; Collin, L; Swaney, DL; Sulzer, D; Gavathiotis, E; Cuervo, AM				Bourdenx, Mathieu; Martin-Segura, Adrian; Scrivo, Aurora; Rodriguez-Navarro, Jose A.; Kaushik, Susmita; Tasset, Inmaculada; Diaz, Antonio; Storm, Nadia J.; Xin, Qisheng; Juste, Yves R.; Stevenson, Erica; Luengo, Enrique; Clement, Cristina C.; Choi, Se Joon; Krogan, Nevan J.; Mosharov, Eugene, V; Santambrogio, Laura; Grueninger, Fiona; Collin, Ludovic; Swaney, Danielle L.; Sulzer, David; Gavathiotis, Evripidis; Cuervo, Ana Maria			Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome	CELL			English	Article							REGIONAL VULNERABILITY; SELECTIVE AUTOPHAGY; ALPHA-SYNUCLEIN; LAMP-2 GENE; TAU; NEURODEGENERATION; DEGRADATION; AGGREGATION; HOMEOSTASIS; EXPRESSION	Components of the proteostasis network malfunction in aging, and reduced protein quality control in neurons has been proposed to promote neurodegeneration. Here, we investigate the role of chaperone-mediated autophagy (CMA), a selective autophagy shown to degrade neurodegeneration-related proteins, in neuronal proteostasis. Using mouse models with systemic and neuronal-specific CMA blockage, we demonstrate that loss of neuronal CMA leads to altered neuronal function, selective changes in the neuronal metastable proteome, and proteotoxicity, all reminiscent of brain aging. Imposing CMA loss on a mouse model of Alzheimer's disease (AD) has synergistic negative effects on the proteome at risk of aggregation, thus increasing neuronal disease vulnerability and accelerating disease progression. Conversely, chemical enhancement of CMA ameliorates pathology in two different AD experimental mouse models. We conclude that functional CMA is essential for neuronal proteostasis through the maintenance of a subset of the proteome with a higher risk of misfolding than the general proteome.	[Bourdenx, Mathieu; Martin-Segura, Adrian; Scrivo, Aurora; Rodriguez-Navarro, Jose A.; Kaushik, Susmita; Tasset, Inmaculada; Diaz, Antonio; Storm, Nadia J.; Xin, Qisheng; Juste, Yves R.; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Bourdenx, Mathieu; Martin-Segura, Adrian; Scrivo, Aurora; Rodriguez-Navarro, Jose A.; Kaushik, Susmita; Tasset, Inmaculada; Diaz, Antonio; Storm, Nadia J.; Xin, Qisheng; Juste, Yves R.; Gavathiotis, Evripidis; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Med, Inst Aging Studies, Bronx, NY 10461 USA; [Xin, Qisheng; Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA; [Stevenson, Erica; Krogan, Nevan J.; Swaney, Danielle L.] Univ Calif San Francisco, Dept Cellular Mol Pharmacol, Sch Med, San Francisco, CA 94158 USA; [Stevenson, Erica; Krogan, Nevan J.; Swaney, Danielle L.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Stevenson, Erica; Krogan, Nevan J.; Swaney, Danielle L.] David Gladstone Inst, San Francisco, CA 94158 USA; [Luengo, Enrique] Univ Autonoma Madrid, Sch Med, Inst Teofilo Hernando Drug Discovery, Dept Pharmacol, Madrid 28049, Spain; [Clement, Cristina C.; Santambrogio, Laura] Weill Cornell Med, Dept Radiat Oncol, Englander Inst Precis Med, New York, NY 10021 USA; [Choi, Se Joon; Mosharov, Eugene, V; Sulzer, David] Columbia Univ, New York State Psychiat Inst, Dept Psychiat, Med Ctr, New York, NY 10461 USA; [Grueninger, Fiona; Collin, Ludovic] Roche Innovat Ctr Basel, Neuro Immunol, Roche Pharma Res & Early Dev pRED, CH-4070 Basel, Switzerland; [Sulzer, David] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA; [Sulzer, David] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY 10032 USA; [Gavathiotis, Evripidis] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Bourdenx, Mathieu] Univ Bordeaux, Inst Malad Neurodegenerat, CNRS, Bordeaux, France; [Rodriguez-Navarro, Jose A.] Hosp Univ Ramon y Cajal, Inst Ramon y Cajal Invest Sanitarias IRYCIS, Neurobiol Dept, Madrid, Spain; [Storm, Nadia J.] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Autonomous University of Madrid; Cornell University; Columbia University; New York State Psychiatry Institute; Roche Holding; Columbia University; Columbia University; Yeshiva University; Albert Einstein College of Medicine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Hospital Universitario Ramon y Cajal; University of Copenhagen	Bourdenx, M; Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.; Bourdenx, M; Gavathiotis, E; Cuervo, AM (corresponding author), Albert Einstein Coll Med, Dept Med, Inst Aging Studies, Bronx, NY 10461 USA.; Gavathiotis, E (corresponding author), Albert Einstein Coll Med, Dept Biochem, New York, NY 10461 USA.; Gavathiotis, E (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.; Bourdenx, M (corresponding author), Univ Bordeaux, Inst Malad Neurodegenerat, CNRS, Bordeaux, France.	mathieu.bourdenx@u-bordeaux.fr; evripidis.gavathiotis@einsteinmed.org; ana-maria.cuervo@einsteinmed.org	Martín-Segura, Adrián/ABA-1890-2020; Kaushik, Susmita/GVS-3186-2022; Clement, Cristina/ABG-4525-2021; Scrivo, Aurora/ABA-4113-2021	Martín-Segura, Adrián/0000-0001-9369-0589; Kaushik, Susmita/0000-0002-6096-5387; Clement, Cristina/0000-0003-1464-407X; Bourdenx, Mathieu/0000-0002-9799-9222; Scrivo, Aurora/0000-0001-7511-035X; Gavathiotis, Evripidis/0000-0001-6319-8331; Juste, Yves-Robert/0000-0002-7237-2327	National Institutes of Health [AG054108, AG021904, AG017617, AG038072, AG031782, NS100717, NS095435, P30 CA013330, 1S10OD016305, T32 GM007491]; JPB Foundation; Rainwater Charitable Foundation; Michael J. Fox Foundation; Backus Foundation; Ramon Areces; MINECO [SAF78666R]; Fulbright MINECC; EMBO; Danish Council DFF; Fundacion Tatiana Perez de Guzman el Bueno;  [CP13-00234]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Rainwater Charitable Foundation; Michael J. Fox Foundation; Backus Foundation; Ramon Areces; MINECO(Spanish Government); Fulbright MINECC; EMBO(European Molecular Biology Organization (EMBO)); Danish Council DFF; Fundacion Tatiana Perez de Guzman el Bueno; 	We appreciated help from Dr. Y. Cooper with the CMA activation score, Dr. P. Kirchner with dataset handling, Dr. J.J. Bravo-Cordero with actin cytoskeleton analysis, Dr. A.R. Saez with confocal microscopy, Dr. E. Bejarano with immunoblotting, and Dr. L. Ozmen with breeding design. This work was supported by the National Institutes of Health (grants AG054108, AG021904, AG017617, and AG038072 to A.M.C.; grant AG031782 to A.M.C., L.S., and E.G.; grant NS100717 to A.M.C. and N.J.K.; grant NS095435 to D.S.; and grants P30 CA013330 and 1S10OD016305 [for chemical synthesis] and T32 GM007491 [for support to Y.R.J.]). This work was also supported by the JPB Foundation (to A.M.C. and D.S.), the Rainwater Charitable Foundation (to A.M.C. and E.G.), the Michael J. Fox Foundation (to A.M.C. and E.G.), the Backus Foundation (to A.M.C.), Ramon Areces (fellowship to A.M.-S.), MINECO (grant SAF78666R to J.A.R.-N.), Charles H. Revson (fellowship CP13-00234 to J.A.R.-N.), Fulbright MINECC (fellowship to I.T.), EMBO (fellowship to N.J.S.), the Danish Council DFF (fellowship to N.J.S.), and Fundacion Tatiana Perez de Guzman el Bueno (fellowship to E.L.).	Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Alvarez-Erviti L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.73; Anguiano J, 2013, NAT CHEM BIOL, V9, P374, DOI 10.1038/nchembio.1230; ANIENTO F, 1993, J BIOL CHEM, V268, P10463; Bai B, 2020, NEURON, V106, P700, DOI 10.1016/j.neuron.2020.04.031; Bourdenx M, 2017, PROG NEUROBIOL, V155, P171, DOI 10.1016/j.pneurobio.2015.07.003; Caballero B, 2018, AGING CELL, V17, DOI 10.1111/acel.12692; CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Choi M, 2014, BIOINFORMATICS, V30, P2524, DOI 10.1093/bioinformatics/btu305; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; Ciryam P, 2013, CELL REP, V5, P781, DOI 10.1016/j.celrep.2013.09.043; Colas J, 2020, NEURAL PLAST, V2020, DOI 10.1155/2020/9369815; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Crameri F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19160-7; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Dong S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14164-4; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Esteban-Martinez L, 2017, EMBO J, V36, P1688, DOI 10.15252/embj.201695916; Fan XY, 2018, CELL RES, V28, P730, DOI 10.1038/s41422-018-0053-3; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; Freer R, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600947; Fu HJ, 2019, NAT NEUROSCI, V22, P47, DOI 10.1038/s41593-018-0298-7; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; Grubman A, 2019, NAT NEUROSCI, V22, P2087, DOI 10.1038/s41593-019-0539-4; Grueninger F, 2010, NEUROBIOL DIS, V37, P294, DOI 10.1016/j.nbd.2009.09.004; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hernandez I, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat3005; HIRANO A, 1994, NEUROPATH APPL NEURO, V20, P3, DOI 10.1111/j.1365-2990.1994.tb00951.x; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Johnson ECB, 2020, NAT MED, V26, P769, DOI 10.1038/s41591-020-0815-6; Kaufman SK, 2016, NEURON, V92, P796, DOI 10.1016/j.neuron.2016.09.055; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kins S, 2001, J BIOL CHEM, V276, P38193; Kirchner P, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000301; Koga H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1393; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kundra R, 2017, P NATL ACAD SCI USA, V114, pE5703, DOI 10.1073/pnas.1618417114; Leger M, 2013, NAT PROTOC, V8, P2531, DOI 10.1038/nprot.2013.155; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marx V, 2019, NAT METHODS, V16, P809, DOI 10.1038/s41592-019-0540-6; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Miedel CJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55523; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Murphy KE, 2015, MOVEMENT DISORD, V30, P1639, DOI 10.1002/mds.26141; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Pang SC, 2012, NEUROSCI LETT, V526, P63, DOI 10.1016/j.neulet.2012.07.044; Pascovici D, 2016, PROTEOMICS, V16, P2448, DOI 10.1002/pmic.201600044; Pennington ZT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56408-9; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Plaisier SB, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq636; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rothaug M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-014-0182-y; Salvador N, 2000, J BIOL CHEM, V275, P27447; Schneider JL, 2015, AGING CELL, V14, P249, DOI 10.1111/acel.12310; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Scrivo A, 2018, LANCET NEUROL, V17, P802, DOI 10.1016/S1474-4422(18)30238-2; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021050; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Valdor R, 2014, NAT IMMUNOL, V15, P1046, DOI 10.1038/ni.3003; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vidoni C, 2016, MED RES REV, V36, P845, DOI 10.1002/med.21394; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang XJ, 2013, BRAIN RES, V1518, P9, DOI 10.1016/j.brainres.2013.04.042; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xilouri M, 2016, AUTOPHAGY, V12, P2230, DOI 10.1080/15548627.2016.1214777; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yu A, 2014, P NATL ACAD SCI USA, V111, pE1481, DOI 10.1073/pnas.1321811111; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851	97	68	70	31	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2696	+		10.1016/j.cell.2021.03.048	http://dx.doi.org/10.1016/j.cell.2021.03.048		MAY 2021	44	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33891876	Green Accepted, Bronze			2022-12-28	WOS:000652830800014
J	Himmelstein, DU; Woolhandler, S				Himmelstein, David U.; Woolhandler, Steffie			Recovering from Trump: Biden's first 100 days	LANCET			English	Editorial Material									[Himmelstein, David U.; Woolhandler, Steffie] CUNY Hunter Coll, New York, NY 10035 USA; [Woolhandler, Steffie] Cambridge Hlth Alliance, Cambridge, MA USA; [Woolhandler, Steffie] Harvard Med Sch, Cambridge, MA USA	City University of New York (CUNY) System; Hunter College (CUNY); Harvard University; Cambridge Health Alliance	Himmelstein, DU (corresponding author), CUNY Hunter Coll, New York, NY 10035 USA.	dhimmels@hunter.cuny.edu						Ahmad FB., 2021, NATL HLTH STAT REPOR; [Anonymous], 2021, FED REG; Belluck P, 2021, NY TIMES; Congressional Budget Office's Single-Payer Health Care Systems Team, 2020, CBO AN COSTS PROP SI; Congressional Research Service, 2021, US INT FOOD ASS; Congressional Research Service, 2019, FOR AID INTR US PROG; Cooper Helene, 2021, NY TIMES; Dickman S, 2021, INT J HEALTH SERV, V51, P371, DOI 10.1177/0020731420980682; Gupta A., 2021, 28474 NBER; Health Outcomes and Data Analytics Unit, 2021, DAT REP ACC DRUG OV; Henney JE, 2019, NEW ENGL J MED, V381, P597, DOI 10.1056/NEJMp1908305; Human Rights Watch, 2021, Q A US TITL 42 POL E; Jakes L., 2020, NEWYORK TIMES   0405; Jordan Miriam, 2021, NY TIMES; Khatri UG, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34878; Lesniewski Niels, 2021, ROLL CALL; Marr C., 2021, HOUSE COVID RELIEF B; McDermott D, 2020, HLTH INSURER FINANCI; Navarro V, 2021, INT J HEALTH SERV, V51, P125, DOI 10.1177/0020731421994841; Office of the Director of National Intelligence, 2021, ANN THREAT ASS US IN; Siegel R., 2021, WASHINGTON POST; TheWhite House, 2021, SUMM PRES DISCR FUND; TheWhite House, 2021, FACT SHEET AM JOBS P; Walker Mark, 2021, NY TIMES; White House, 2021, BACKGR PRESS CALL SE; WHO, ACC COVID 19 TOOLS F; Woolhandler S, 2021, LANCET, V397, P705, DOI 10.1016/S0140-6736(20)32545-9; Zhu JM, 2021, NEW ENGL J MED, V384, P981, DOI 10.1056/NEJMp2032115	28	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1787	1791		10.1016/S0140-6736(21)00979-X	http://dx.doi.org/10.1016/S0140-6736(21)00979-X		MAY 2021	6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD0HD	33933187	Green Published, Bronze			2022-12-28	WOS:000651041900006
J	Ackels, T; Erskine, A; Dasgupta, D; Marin, AC; Warner, TPA; Tootoonian, S; Fukunaga, I; Harris, JJ; Schaefer, AT				Ackels, Tobias; Erskine, Andrew; Dasgupta, Debanjan; Marin, Alina Cristina; Warner, Tom P. A.; Tootoonian, Sina; Fukunaga, Izumi; Harris, Julia J.; Schaefer, Andreas T.			Fast odour dynamics are encoded in the olfactory system and guide behaviour	NATURE			English	Article							INFORMATION; DISCRIMINATION; PLUMES; SNIFF; TIME; PERCEPTION; NEURONS; SPEED	Odours are transported in turbulent plumes, which result in rapid concentration fluctuations(1,2) that contain rich information about the olfactory scenery, such as the composition and location of an odour source(2-4). However, it is unclear whether the mammalian olfactory system can use the underlying temporal structure to extract information about the environment. Here we show that ten-millisecond odour pulse patterns produce distinct responses in olfactory receptor neurons. In operant conditioning experiments, mice discriminated temporal correlations of rapidly fluctuating odours at frequencies of up to 40 Hz. In imaging and electrophysiological recordings, such correlation information could be readily extracted from the activity of mitral and tufted cells-the output neurons of the olfactory bulb. Furthermore, temporal correlation of odour concentrations5 reliably predicted whether odorants emerged from the same or different sources in naturalistic environments with complex airflow. Experiments in which mice were trained on such tasks and probed using synthetic correlated stimuli at different frequencies suggest that mice can use the temporal structure of odours to extract information about space. Thus, the mammalian olfactory system has access to unexpectedly fast temporal features in odour stimuli. This endows animals with the capacity to overcome key behavioural challenges such as odour source separation(5), figure-ground segregation6 and odour localization(7) by extracting information about space from temporal odour dynamics.	[Ackels, Tobias; Erskine, Andrew; Dasgupta, Debanjan; Marin, Alina Cristina; Warner, Tom P. A.; Tootoonian, Sina; Fukunaga, Izumi; Harris, Julia J.; Schaefer, Andreas T.] Francis Crick Inst, Sensory Circuits & Neurotechnol Lab, London, England; [Ackels, Tobias; Erskine, Andrew; Dasgupta, Debanjan; Tootoonian, Sina; Harris, Julia J.; Schaefer, Andreas T.] UCL, Dept Neurosci Physiol & Pharmacol, London, England	Francis Crick Institute; University of London; University College London	Schaefer, AT (corresponding author), Francis Crick Inst, Sensory Circuits & Neurotechnol Lab, London, England.; Schaefer, AT (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, London, England.	andreas.schaefer@crick.ac.uk	Ackels, Tobias/AAU-7528-2021	Harris, Julia Jade/0000-0002-2118-7674; Schaefer, Andreas/0000-0002-4677-8788; Fukunaga, Izumi/0000-0003-1860-5377; Dasgupta, Debanjan/0000-0002-9093-301X; Ackels, Tobias/0000-0002-4964-1162	Francis Crick Institute; Cancer Research UK [FC001153]; UK Medical Research Council [FC001153, MC_UP_1202/5]; Wellcome Trust [FC001153]; Wellcome Trust Investigator grant [110174/Z/15/Z]; BIF doctoral fellowship; DFG postdoctoral fellowship	Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Investigator grant(Wellcome Trust); BIF doctoral fellowship; DFG postdoctoral fellowship(German Research Foundation (DFG))	We thank the animal facilities at the National Institute for Medical Research and the Francis Crick Institute for animal care and technical assistance, the mechanical and electronic workshops in MPI Heidelberg (N. Neef, K. Schmidt, M. Lukat, R. Roedel, C. Kieser) and London (A. Ling, A. Hurst, M. Stopps) for support during development and construction, the Aurora Scientific team for suggestions for adapting the miniPID, T. Margrie for discussion, V. Murthy for discussions and suggestions on the OSN imaging experiments, and A. Fleischmann, K. Franks, F. Guillemot, M. Hausser, F. Iacaruso, R. Jordan, J. Kohl, T. Mrsic-Flogel, V. Pachnis, A. Silver, and P. Znamenskiy for comments on earlier versions of the manuscript. We thank the members of the Odor2Action NeuroNex network, in particular J. Victor, J. Crimaldi, B. Smith, M. Schmucker, and J. Verhagen for discussions. This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001153), the UK Medical Research Council (FC001153), and the Wellcome Trust (FC001153); by the UK Medical Research Council (grant reference MC_UP_1202/5); a Wellcome Trust Investigator grant to A.T.S. (110174/Z/15/Z), a BIF doctoral fellowship to A.C.M., and a DFG postdoctoral fellowship to T.A.	Abeles M, 2004, SCIENCE, V304, P523, DOI 10.1126/science.1097725; Abraham NM, 2010, NEURON, V65, P399, DOI 10.1016/j.neuron.2010.01.009; Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Baker TC, 1998, NATURE, V393, P530, DOI 10.1038/31131; Bressel OC, 2016, J COMP NEUROL, V524, P199, DOI 10.1002/cne.23835; BROWN JL, 1973, ANNU REV PSYCHOL, V24, P151, DOI 10.1146/annurev.ps.24.020173.001055; Burton SD, 2017, J NEUROPHYSIOL, V118, P2034, DOI 10.1152/jn.00109.2017; Carr Catherine E., 1996, Advances in Psychology, V115, P27; Catania KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2444; Celani A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041015; Crimaldi JP, 2001, EXP FLUIDS, V31, P90, DOI 10.1007/s003480000263; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; Erskine A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211571; FACKRELL JE, 1982, J FLUID MECH, V117, P1, DOI 10.1017/S0022112082001499; Fukunaga I, 2014, NAT NEUROSCI, V17, P1208, DOI 10.1038/nn.3760; Geffen MN, 2009, NEURON, V61, P570, DOI 10.1016/j.neuron.2009.01.021; Ghatpande AS, 2011, J PHYSIOL-LONDON, V589, P2261, DOI 10.1113/jphysiol.2010.203687; Haddad R, 2013, NAT NEUROSCI, V16, P949, DOI 10.1038/nn.3407; HOPFIELD JJ, 1991, P NATL ACAD SCI USA, V88, P6462, DOI 10.1073/pnas.88.15.6462; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Jordan R, 2018, NEURON, V98, P1214, DOI 10.1016/j.neuron.2018.05.016; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Li A, 2014, J NEUROSCI, V34, P16058, DOI 10.1523/JNEUROSCI.3382-14.2014; Lopes G, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00007; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; MOORE PA, 1991, BIOL BULL, V181, P408, DOI 10.2307/1542361; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; MYLNE KR, 1991, Q J ROY METEOR SOC, V117, P177, DOI 10.1002/qj.49711749709; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Park IM, 2014, J NEUROSCI, V34, P941, DOI 10.1523/JNEUROSCI.2204-13.2014; Raiser G, 2017, CHEM SENSES, V42, P141, DOI 10.1093/chemse/bjw114; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Rebello MR, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002021; Riffell JA, 2014, SCIENCE, V344, P1515, DOI 10.1126/science.1251041; Rokni D, 2014, NAT NEUROSCI, V17, P1225, DOI 10.1038/nn.3775; Schmuker M, 2016, SENSOR ACTUAT B-CHEM, V235, P636, DOI 10.1016/j.snb.2016.05.098; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Stierle JS, 2013, J NEUROSCI, V33, P6060, DOI 10.1523/JNEUROSCI.5838-12.2013; Szyszka P, 2014, P NATL ACAD SCI USA, V111, P16925, DOI 10.1073/pnas.1412051111; Szyszka P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036096; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Wadhwa N, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461966; WESTHEIMER G, 1977, VISION RES, V17, P887, DOI 10.1016/0042-6989(77)90062-1	50	21	21	8	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					558	+		10.1038/s41586-021-03514-2	http://dx.doi.org/10.1038/s41586-021-03514-2		MAY 2021	34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IB	33953395	Green Submitted, Green Accepted			2022-12-28	WOS:000647555000008
J	Masuda, R; Kaneko, Y; Tokura, Y; Takahashi, Y				Masuda, Ryoji; Kaneko, Yoshio; Tokura, Yoshinori; Takahashi, Youtarou			Electric field control of natural optical activity in a multiferroic helimagnet	SCIENCE			English	Article							CUPRIC OXIDE; ELECTROMAGNONS; DYNAMICS; DRIVEN; CUO	Controlling the chiral degree of freedom in matter has long been an important issue for many fields of science. The spin-spiral order, which exhibits a strong magnetoelectric coupling, gives rise to chirality irrespective of the atomic arrangement of matter. Here, we report the resonantly enhanced natural optical activity on the electrically active magnetic excitation, that is, electromagnon, in multiferroic cupric oxide. The electric field control of the natural optical activity is demonstrated through magnetically induced chirality endowed with magnetoelectric coupling. These optical properties inherent to multiferroics may lead to optical devices based on the control of chirality.	[Masuda, Ryoji; Tokura, Yoshinori; Takahashi, Youtarou] Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; [Masuda, Ryoji; Tokura, Yoshinori; Takahashi, Youtarou] Univ Tokyo, Quantum Phase Elect Ctr QPEC, Tokyo 1138656, Japan; [Kaneko, Yoshio; Tokura, Yoshinori; Takahashi, Youtarou] RIKEN Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan; [Tokura, Yoshinori] Univ Tokyo, Tokyo Coll, Tokyo 1138656, Japan	University of Tokyo; University of Tokyo; RIKEN; University of Tokyo	Takahashi, Y (corresponding author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.; Takahashi, Y (corresponding author), Univ Tokyo, Quantum Phase Elect Ctr QPEC, Tokyo 1138656, Japan.; Takahashi, Y (corresponding author), RIKEN Ctr Emergent Matter Sci CEMS, Wako, Saitama 3510198, Japan.	youtarou-takahashi@ap.t.u-tokyo.ac.jp	Takahashi, Youtarou/F-1542-2014; Tokura, Yoshinori/C-7352-2009	Takahashi, Youtarou/0000-0003-3630-9782; Tokura, Yoshinori/0000-0002-2732-4983; Kaneko, Yoshio/0000-0002-3510-1739	JST [JPMJPR1423, JPMJCR16F1]; JSPS KAKENHI [17K19050, 17H04845]	JST(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JST grants JPMJPR1423 and JPMJCR16F1 and JSPS KAKENHI grants 17K19050 and 17H04845.	AIN M, 1992, J PHYS-CONDENS MAT, V4, P5327, DOI 10.1088/0953-8984/4/23/009; ASBRINK S, 1970, ACTA CRYSTALL B-STRU, VB 26, P8, DOI 10.1107/S0567740870001838; Babkevich P, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.134428; Barron L. D., 2004, MOL LIGHT SCATTERING, V2nd; Bordacs S, 2012, NAT PHYS, V8, P734, DOI [10.1038/NPHYS2387, 10.1038/nphys2387]; BROWN PJ, 1991, J PHYS-CONDENS MAT, V3, P4281, DOI 10.1088/0953-8984/3/23/016; Cao K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.197201; Fert A, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.31; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Hoffmann T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.124714; Jones SPP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4787; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Katsura H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.027203; Kezsmarki I, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.057403; Kibayashi S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5583; Kimura T, 2008, NAT MATER, V7, P291, DOI 10.1038/nmat2125; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kubacka T, 2014, SCIENCE, V343, P1333, DOI 10.1126/science.1242862; Kuzmenko AM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.174407; Landau LD., 1984, ELECTRODYNAMICS CONT; Masuda R., 2021, HARVARD DATAVERSE, DOI [10.7910/DVN/6X8OYQ, DOI 10.7910/DVN/6X8OYQ]; Matsukura F, 2015, NAT NANOTECHNOL, V10, P209, DOI [10.1038/NNANO.2015.22, 10.1038/nnano.2015.22]; Mostovoy M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067601; Nagaosa N, 2013, NAT NANOTECHNOL, V8, P899, DOI [10.1038/nnano.2013.243, 10.1038/NNANO.2013.243]; Pasteur L., 1848, ANN CHIM PHYS, V24, P442; Pimenov A, 2006, NAT PHYS, V2, P97, DOI 10.1038/nphys212; Raybould TA, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.035119; Saito M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117402; Saito M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.013705; Scagnoli V, 2011, SCIENCE, V332, P696, DOI 10.1126/science.1201061; Sergienko IA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094434; Shuvaev A, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.227201; Stein J, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.177201; Takahashi Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.037204; Takahashi Y, 2012, NAT PHYS, V8, P121, DOI [10.1038/NPHYS2161, 10.1038/nphys2161]; Tokura Y, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/7/076501; Wagniere GH., 2007, CHIRALITY UNIVERSAL; YANG BX, 1989, PHYS REV B, V39, P4343, DOI 10.1103/PhysRevB.39.4343	38	10	10	6	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					496	+		10.1126/science.aaz4312	http://dx.doi.org/10.1126/science.aaz4312			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926951				2022-12-28	WOS:000645554100043
J	Dean, N				Dean, Natalie			Hospital admissions due to COVID-19 in Scotland after one dose of vaccine	LANCET			English	Editorial Material									[Dean, Natalie] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Dean, N (corresponding author), Univ Florida, Dept Biostat, Gainesville, FL 32611 USA.	nataliedean@ufl.edu						Bernal J.L., 2021, EARLY EFFECTIVENESS, DOI [DOI 10.1101/2021.03.01.21252652, DOI 10.1016/j.autrev.2020.102524]; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Franke MF, 2017, VACCINE, V35, P5819, DOI 10.1016/j.vaccine.2017.09.025; Joint Committee on Vaccination and Immunisation, 2020, OPT COVID 19 VACC PR; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Vasileiou E, 2021, LANCET, V397, P1646, DOI 10.1016/S0140-6736(21)00677-2; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1	7	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1601	1603		10.1016/S0140-6736(21)00765-0	http://dx.doi.org/10.1016/S0140-6736(21)00765-0		APR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33901421	Green Published, Bronze			2022-12-28	WOS:000645510600005
J	Gareth, I				Gareth, Iacobucci			Sixty seconds on ... concussion in football	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bretzin AC, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.8191; Pym M., 2021, BBC 0426	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2021	373								n1119	10.1136/bmj.n1119	http://dx.doi.org/10.1136/bmj.n1119			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UG4QI	33926890				2022-12-28	WOS:000689238700003
J	Slomski, A				Slomski, Anita			Low-Income African American Women With Hypertension and Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1602	1602		10.1001/jama.2021.5861	http://dx.doi.org/10.1001/jama.2021.5861			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904870				2022-12-28	WOS:000645617800006
J	Saffran, L				Saffran, Lise			Public health storytelling practice	LANCET			English	Editorial Material									[Saffran, Lise] Univ Missouri, Sch Hlth Profess, Columbia, MO 65211 USA; [Saffran, Lise] Hlth Humanities Consortium, Chicago, IL USA	University of Missouri System; University of Missouri Columbia	Saffran, L (corresponding author), Univ Missouri, Sch Hlth Profess, Columbia, MO 65211 USA.; Saffran, L (corresponding author), Hlth Humanities Consortium, Chicago, IL USA.	saffranl@health.missouri.edu							0	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1536	1537						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RR7QA	33894824				2022-12-28	WOS:000643286900011
J	Steffens, L; Pettinato, E; Steiner, TM; Mall, A; Konig, S; Eisenreich, W; Berg, IA				Steffens, Lydia; Pettinato, Eugenio; Steiner, Thomas M.; Mall, Achim; Koenig, Simone; Eisenreich, Wolfgang; Berg, Ivan A.			High CO2 levels drive the TCA cycle backwards towards autotrophy	NATURE			English	Article								In the deltaproteobacterium Hippea maritima, the tricarboxylic acid (TCA) cycle can be reversed by high partial pressures of CO2 for the autotrophic fixation of carbon. It has recently been shown that in anaerobic microorganisms the tricarboxylic acid (TCA) cycle, including the seemingly irreversible citrate synthase reaction, can be reversed and used for autotrophic fixation of carbon(1,2). This reversed oxidative TCA cycle requires ferredoxin-dependent 2-oxoglutarate synthase instead of the NAD-dependent dehydrogenase as well as extremely high levels of citrate synthase (more than 7% of the proteins in the cell). In this pathway, citrate synthase replaces ATP-citrate lyase of the reductive TCA cycle, which leads to the spending of one ATP-equivalent less per one turn of the cycle. Here we show, using the thermophilic sulfur-reducing deltaproteobacterium Hippea maritima, that this route is driven by high partial pressures of CO2. These high partial pressures are especially important for the removal of the product acetyl coenzyme A (acetyl-CoA) through reductive carboxylation to pyruvate, which is catalysed by pyruvate synthase. The reversed oxidative TCA cycle may have been functioning in autotrophic CO2 fixation in a primordial atmosphere that is assumed to have been rich in CO2.	[Steffens, Lydia; Pettinato, Eugenio; Berg, Ivan A.] Univ Munster, Inst Mol Microbiol & Biotechnol, Munster, Germany; [Steiner, Thomas M.; Eisenreich, Wolfgang] Tech Univ Munich, Dept Chem, Bavarian NMR Ctr Struct Membrane Biochem, Garching, Germany; [Mall, Achim] Univ Bergen, KG Jebsen Ctr Deep Sea Res, Bergen, Norway; [Mall, Achim] Univ Bergen, Dept Biol Sci, Bergen, Norway; [Koenig, Simone] Univ Munster, Med Fac, Interdisciplinary Ctr Clin Res, Core Unit Prote, Munster, Germany	University of Munster; Technical University of Munich; University of Bergen; University of Bergen; University of Munster	Berg, IA (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, Munster, Germany.; Eisenreich, W (corresponding author), Tech Univ Munich, Dept Chem, Bavarian NMR Ctr Struct Membrane Biochem, Garching, Germany.	wolfgang.eisenreich@mytum.de; ivan.berg@uni-muenster.de	Eisenreich, Wolfgang/A-1258-2013	Eisenreich, Wolfgang/0000-0002-9832-8279; Pettinato, Eugenio/0000-0002-3174-020X; Steffens, Lydia/0000-0002-0546-2736	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [BE 4822/5-1, 364653263-TRR 235]; Hans-Fischer Gesellschaft (Munich)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Hans-Fischer Gesellschaft (Munich)	We thank G. Fuchs for discussions during this work and for critical reading of the manuscript, W. Schulz for his help with cloning of citrate synthase genes, A. M. Berg and D. Ackermann for technical assistance and A. Probst for the help with bioinformatics analysis. This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project-ID BE 4822/5-1 to I.A.B. and Project-ID 364653263-TRR 235 to W.E. as well as the Hans-Fischer Gesellschaft (Munich) to W.E.	Ahmed Zeeshan, 2014, Database (Oxford), V2014, DOI 10.1093/database/bau077; Ajo-Franklin J, 2019, GEOPHYS MONOGR SER, V238, P187; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berg IA, 2011, APPL ENVIRON MICROB, V77, P1925, DOI 10.1128/AEM.02473-10; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; BERGMEYER HU, 1975, Z KLIN CHEM KLIN BIO, V13, P507; Bisswanger H., 2008, ENZYME KINETICS PRIN; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Dahle H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01570; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Distler U, 2016, NAT PROTOC, V11, P795, DOI 10.1038/nprot.2016.042; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Flamholz A, 2012, NUCLEIC ACIDS RES, V40, pD770, DOI 10.1093/nar/gkr874; FLINT DH, 1994, ARCH BIOCHEM BIOPHYS, V311, P509, DOI 10.1006/abbi.1994.1269; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Furdui C, 2000, J BIOL CHEM, V275, P28494, DOI 10.1074/jbc.M003291200; German C. R., 2006, TREATISE GEOCHEMISTR, P18; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Greene A. C., 2014, PROKARYOTES, P135, DOI DOI 10.1007/978-3-642-39044-9_312.; GUYNN RW, 1973, J BIOL CHEM, V248, P6957; Hua ZS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05284-4; Hugler M, 2007, ENVIRON MICROBIOL, V9, P81, DOI 10.1111/j.1462-2920.2006.01118.x; Konneke M, 2014, P NATL ACAD SCI USA, V111, P8239, DOI 10.1073/pnas.1402028111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lupton J, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001152; Mall A, 2018, SCIENCE, V359, P563, DOI 10.1126/science.aao2410; Martin WF, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00817; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Miroshnichenko ML, 1999, INT J SYST BACTERIOL, V49, P1033, DOI 10.1099/00207713-49-3-1033; Noor E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003483; Nunoura T, 2018, SCIENCE, V359, P559, DOI 10.1126/science.aao3407; OBZHIROV AI, 1992, GEO-MAR LETT, V12, P54, DOI 10.1007/BF02092109; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Probst AJ, 2020, ISME J, V14, P1547, DOI 10.1038/s41396-020-0624-4; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; SCHAUDER R, 1987, ARCH MICROBIOL, V148, P218, DOI 10.1007/BF00414815; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Slobodkin A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110849; Song Y, 2020, P NATL ACAD SCI USA, V117, P7516, DOI 10.1073/pnas.1912289117; Spieck E, 2020, ISME J, V14, P364, DOI 10.1038/s41396-019-0530-9; Supek F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-182; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; TRUEPER H G, 1964, Antonie Van Leeuwenhoek, V30, P225; Wildschutz L, 2019, J AUTOIMMUN, V100, P75, DOI 10.1016/j.jaut.2019.03.004; Witt A, 2019, FEBS J, V286, P4494, DOI 10.1111/febs.14981; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z; Zhang T, 2020, ISME J, V14, P2078, DOI 10.1038/s41396-020-0673-8; Zhao W., 2008, THESIS U GEORGIA ATH	52	30	31	26	133	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					784	+		10.1038/s41586-021-03456-9	http://dx.doi.org/10.1038/s41586-021-03456-9		APR 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33883741				2022-12-28	WOS:000642083200001
J	Xia, SY; Zhang, ZB; Magupalli, VG; Pablo, JL; Dong, Y; Vora, SM; Wang, LF; Fu, TM; Jacobson, MP; Greka, A; Lieberman, J; Ruan, JB; Wu, H				Xia, Shiyu; Zhang, Zhibin; Magupalli, Venkat Giri; Pablo, Juan Lorenzo; Dong, Ying; Vora, Setu M.; Wang, Longfei; Fu, Tian-Min; Jacobson, Matthew P.; Greka, Anna; Lieberman, Judy; Ruan, Jianbin; Wu, Hao			Gasdermin D pore structure reveals preferential release of mature interleukin-1	NATURE			English	Article							MEMBRANE; GSDMD; PYROPTOSIS; CASPASE-11; SECRETION	As organelles of the innate immune system, inflammasomes activate caspase-1 and other inflammatory caspases that cleave gasdermin D (GSDMD). Caspase-1 also cleaves inactive precursors of the interleukin (IL)-1 family to generate mature cytokines such as IL-1 beta and IL-18. Cleaved GSDMD formstransmembrane pores to enable the release of IL-1 and to drive cell lysisthrough pyroptosis(1-9). Here we report cryo-electron microscopy structures of the pore and the prepore of GSDMD. These structures reveal the different conformations ofthe two states, as well as extensive membrane-binding elements including a hydrophobic anchor and three positively charged patches. The GSDMD pore conduit is predominantly negatively charged. By contrast, IL-1 precursors have an acidic domain that is proteolytically removed by caspase-1(10). When permeabilized by GSDMD pores, unlysed liposomes release positively charged and neutral cargoes faster than negatively charged cargoes of similar sizes, and the pores favour the passage of IL-1 beta and IL-18 over that of their precursors. Consistent with these findings, living-but not pyroptotic-macrophages preferentially release mature IL-1 beta upon perforation by GSDMD. Mutation of the acidic residues of GSDMD compromises this preference, hindering intracellular retention ofthe precursor and secretion ofthe mature cytokine. The GSDMD pore therefore mediates IL-1 release by electrostatic filtering, which suggests the importance of charge in addition to size in the transport of cargoes across this large channel.	[Xia, Shiyu; Zhang, Zhibin; Magupalli, Venkat Giri; Dong, Ying; Vora, Setu M.; Wang, Longfei; Fu, Tian-Min; Lieberman, Judy; Ruan, Jianbin; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Xia, Shiyu; Magupalli, Venkat Giri; Dong, Ying; Vora, Setu M.; Wang, Longfei; Fu, Tian-Min; Ruan, Jianbin; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhang, Zhibin; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Pablo, Juan Lorenzo; Greka, Anna] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Pablo, Juan Lorenzo; Greka, Anna] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Fu, Tian-Min] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Fu, Tian-Min] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Jacobson, Matthew P.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA USA; [Ruan, Jianbin] Univ Connecticut, Dept Immunol, Hlth Ctr, Farmington, CT 06032 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of California System; University of California San Francisco; University of Connecticut	Ruan, JB; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Ruan, JB; Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Ruan, JB (corresponding author), Univ Connecticut, Dept Immunol, Hlth Ctr, Farmington, CT 06032 USA.	ruan@uchc.edu; wu@crystal.harvard.edu	Jacobson, Matthew/Y-5161-2018	Jacobson, Matthew/0000-0001-6262-655X; Xia, Shiyu/0000-0001-9024-0689; Magupalli, Venkat/0000-0003-4638-3062; Greka, Anna/0000-0001-5697-7791; Zhang, Zhibin/0000-0003-1349-2713	US National Institutes of Health [R01AI139914, DP1HD087988, R01AI124491, R01CA240955, R01DK095045, R01DK099465, 5T32HL066987-18]; Charles A. King Trust	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust	We thank B. Honig, T. Rapoport, F. Shao, J. Kagan, D. Golenbock, S. Blacklow, A. Kruse and M. Liao for discussions. For structural data collection, we thank R. Walsh, S. Sterling, S. Rawson and Z. Li at the Harvard Cryo-EM Center for Structural Biology and K. Song, K. Lee and C. Xu at the Cryo-EM Core Facility at University of Massachusetts Medical School. This work was supported by US National Institutes of Health grants R01AI139914 (H.W. and J.L.), DP1HD087988 (H.W.), R01AI124491 (H.W.), R01CA240955 (J.L.), R01DK095045 (A.G.), R01DK099465 (A.G.) and 5T32HL066987-18 (T.-M.F.). S.X. received an Albert J. Ryan fellowship. J.R. and Z.Z. received postdoctoral fellowships from the Charles A. King Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batista SJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17491-z; Burgener SS, 2019, CELL REP, V27, P3646, DOI 10.1016/j.celrep.2019.05.065; Chen KW, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6676; Davis MA, 2019, P NATL ACAD SCI USA, V116, P5061, DOI 10.1073/pnas.1818598116; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Kayagaki N, 2021, NATURE, V591, P131, DOI 10.1038/s41586-021-03218-7; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lee IH, 2015, P NATL ACAD SCI USA, V112, P15892, DOI 10.1073/pnas.1518765113; Liu X, 2021, NAT REV DRUG DISCOV, V20, P384, DOI 10.1038/s41573-021-00154-z; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Liu ZH, 2019, IMMUNITY, V51, P43, DOI 10.1016/j.immuni.2019.04.017; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Monteleone M, 2018, CELL REP, V24, P1425, DOI 10.1016/j.celrep.2018.07.027; Mulvihill E, 2018, EMBO J, V37, DOI 10.15252/embj.201798321; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Sborgi L, 2016, EMBO J, V35, P1766, DOI 10.15252/embj.201694696; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Tapia VS, 2019, J BIOL CHEM, V294, P8325, DOI 10.1074/jbc.RA119.008009; van Pee K, 2017, ELIFE, V6, DOI 10.7554/eLife.23644; Wang QY, 2020, NATURE, V579, P421, DOI 10.1038/s41586-020-2079-1; Xia SY, 2019, METHOD ENZYMOL, V625, P95, DOI 10.1016/bs.mie.2019.04.024; Zhang ZB, 2020, NATURE, V579, P415, DOI 10.1038/s41586-020-2071-9; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	42	112	115	12	64	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					607	+		10.1038/s41586-021-03478-3	http://dx.doi.org/10.1038/s41586-021-03478-3		APR 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IG	33883744	Green Accepted			2022-12-28	WOS:000642083200002
J	Glied, S				Glied, Sherry			Price Transparency-Promise and Peril	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Glied, Sherry] NYU, Robert F Wagner Grad Sch Publ Serv, 295 Lafayette St, New York, NY 10012 USA	New York University	Glied, S (corresponding author), NYU, Robert F Wagner Grad Sch Publ Serv, 295 Lafayette St, New York, NY 10012 USA.	sherry.glied@nyu.edu							0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1496	1497		10.1001/jama.2021.4640	http://dx.doi.org/10.1001/jama.2021.4640			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877280	Bronze			2022-12-28	WOS:000642636500003
J	Pagel, C				Pagel, Christina			There is a real danger that covid-19 will become entrenched as a disease of poverty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Pagel, Christina] UCL, Clin Operat Res Unit, London, England	University of London; University College London	Pagel, C (corresponding author), UCL, Clin Operat Res Unit, London, England.	c.pagel@ucl.ac.uk						[Anonymous], 2021, SPI M O SUMMARY FURT; [Anonymous], 2021, NHS COV 19 VACC COV; [Anonymous], 2021, GUARDIAN; Cevik M, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n224; Gray S, 2021, BMJ OPINION; ICNARC, COV 19 REP; Lintern S., INDEPENDENT; Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006; Riley S, 2021, PREPRINT, DOI 10.1101/2021.03.03.21252856v1; Riley S, 2021, REACT 1 ROUND 10 REP; Smith LE, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n608; Tolhurst A., 2021, DIDO HARDING ADMITS; Triggle N., 2021, COVID UNDER 30S OFFE; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	14	3	3	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2021	372								n986	10.1136/bmj.n986	http://dx.doi.org/10.1136/bmj.n986			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IH	33875555	Green Submitted, Bronze			2022-12-28	WOS:000642451400006
J	Wang, H; Chen, YC; Lin, YL; Abesig, J; Wu, IXY; Tam, W				Wang, Huan; Chen, Yancong; Lin, Yali; Abesig, Julius; Wu, Irene X. Y.; Tam, Wilson			The methodological quality of individual participant data meta-analysis on intervention effects: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED-TRIALS; SEARCH STRATEGIES; DATA-RETRIEVAL; PATIENT DATA; ONE-STAGE; IPD; DESIGN	OBJECTIVE To assess the methodological quality of individual participant data (IPD) meta-analysis and to identify areas for improvement. DESIGN Systematic review. DATA SOURCES Medline, Embase, and Cochrane Database of Systematic Reviews. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Systematic reviews with IPD meta-analyses of randomised controlled trials on intervention effects published in English. RESULTS 323 IPD meta-analyses covering 21 clinical areas and published between 1991 and 2019 were included: 270 (84%) were non-Cochrane reviews and 269 (84%) were published in journals with a high impact factor (top quarter). The IPD meta-analyses showed low compliance in using a satisfactory technique to assess the risk of bias of the included randomised controlled trials (43%, 95% confidence interval 38% to 48%), accounting for risk of bias when interpreting results (40%, 34% to 45%), providing a list of excluded studies with justifications (32%, 27% to 37%), establishing an a priori protocol (31%, 26% to 36%), prespecifying methods for assessing both the overall effects (44%, 39% to 50%) and the participant-intervention interactions (31%, 26% to 36%), assessing and considering the potential of publication bias (31%, 26% to 36%), and conducting a comprehensive literature search (19%, 15% to 23%). Up to 126 (39%) IPD meta-analyses failed to obtain IPD from 90% or more of eligible participants or trials, among which only 60 (48%) provided reasons and 21 (17%) undertook certain strategies to account for the unavailable IPD. CONCLUSIONS The methodological quality of IPD meta-analyses is unsatisfactory. Future IPD meta-analyses need to establish an a priori protocol with prespecified data syntheses plan, comprehensively search the literature, critically appraise included randomised controlled trials with appropriate technique, account for risk of bias during data analyses and interpretation, and account for unavailable IPD.	[Wang, Huan; Chen, Yancong; Lin, Yali; Abesig, Julius; Wu, Irene X. Y.] Cent South Univ, Xiangya Sch Publ Hlth, 5-F,238 Shang Ma Yuan Ling Alley, Changsha, Hunan, Peoples R China; [Tam, Wilson] Natl Univ Singapore, Alice Lee Ctr Nursing Studies, Singapore, Singapore	Central South University; National University of Singapore	Wu, IXY (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, 5-F,238 Shang Ma Yuan Ling Alley, Changsha, Hunan, Peoples R China.	irenexywu@csu.edu.cn	Tam, Wilson/K-1664-2019; ABESIG, JULIUS/AAV-7956-2020; Tam, Wilson/H-5890-2019	ABESIG, JULIUS/0000-0002-0061-8244; Wu, Irene XY/0000-0003-3772-2376; Lin, Yali/0000-0002-6847-9666; wang, huan/0000-0001-7337-9005; Tam, Wilson/0000-0003-0641-3060	High-level Talents Introduction Plan from Central South University [502045003]; National Natural Science Foundation of China [81973709]	High-level Talents Introduction Plan from Central South University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the High-level Talents Introduction Plan from Central South University (No 502045003) and the National Natural Science Foundation of China (No 81973709). The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Abo-Zaid G, 2013, J CLIN EPIDEMIOL, V66, P865, DOI 10.1016/j.jclinepi.2012.12.017; Abo-Zaid G, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-56; Ahmed I, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7762; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Burke DL, 2017, STAT MED, V36, P855, DOI 10.1002/sim.7141; Churuangsuk C, 2018, OBES REV, V19, P1700, DOI 10.1111/obr.12744; Cochrane, 2020, COCHRANE LIB; Debray TPA, 2015, RES SYNTH METHODS, V6, P293, DOI 10.1002/jrsm.1160; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Fisher DJ, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j573; Gao Y, 2020, J CLIN EPIDEMIOL, V119, P36, DOI 10.1016/j.jclinepi.2019.11.012; Hua HR, 2017, STAT MED, V36, P772, DOI 10.1002/sim.7171; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Luo YN, 2018, COMPLEMENT THER CLIN, V33, P197, DOI 10.1016/j.ctcp.2018.10.002; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2003, Health Technol Assess, V7, P1; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Murad M Hassan, 2016, Evid Based Med, V21, P125, DOI 10.1136/ebmed-2016-110401; Nevitt SJ, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1390; OXMAN AD, 1995, JAMA-J AM MED ASSOC, V274, P845, DOI 10.1001/jama.274.10.845; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Simmonds M, 2015, CONTEMP CLIN TRIALS, V45, P76, DOI 10.1016/j.cct.2015.06.012; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Stewart LA, 2002, EVAL HEALTH PROF, V25, P76, DOI 10.1177/0163278702025001006; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stewart L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-7; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Tierney JF, 2015, J CLIN EPIDEMIOL, V68, P1325, DOI 10.1016/j.jclinepi.2015.05.024; Tierney JF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001855; Tsoi AKN, 2020, BONE, V139, DOI 10.1016/j.bone.2020.115541; Vale CL, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1088; Wilczynski NL, 2007, J CLIN EPIDEMIOL, V60, P29, DOI 10.1016/j.jclinepi.2006.04.001; Wu IXY, 2021, J CLIN EPIDEMIOL, V130, P59, DOI 10.1016/j.jclinepi.2020.10.011; Wu IXY, 2020, THER ADV MUSCULOSKEL, V12, DOI 10.1177/1759720X20959967; Wu IXY, 2020, ANN AM THORAC SOC, V17, P949, DOI 10.1513/AnnalsATS.202003-187OC; Yan PJ, 2019, J CLIN EPIDEMIOL, V109, P20, DOI 10.1016/j.jclinepi.2018.12.013	39	6	6	5	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2021	372								n736	10.1136/bmj.n736	http://dx.doi.org/10.1136/bmj.n736			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IH	33875446	Green Published, hybrid			2022-12-28	WOS:000642451400001
J	Mathur, R; Rentsch, CT; Morton, CE; Hulme, WJ; Schultze, A; MacKenna, B; Eggo, RM; Bhaskaran, K; Wong, AYS; Williamson, EJ; Forbes, H; Wing, K; McDonald, HI; Bates, C; Bacon, S; Walker, AJ; Evans, D; Inglesby, P; Mehrkar, A; Curtis, HJ; DeVito, NJ; Croker, R; Drysdale, H; Cockburn, J; Parry, J; Hester, F; Harper, S; Douglas, IJ; Tomlinson, L; Evans, SJW; Grieve, R; Harrison, D; Rowan, K; Khunti, K; Chaturvedi, N; Smeeth, L; Ben Goldacre				Mathur, Rohini; Rentsch, Christopher T.; Morton, Caroline E.; Hulme, William J.; Schultze, Anna; MacKenna, Brian; Eggo, Rosalind M.; Bhaskaran, Krishnan; Wong, Angel Y. S.; Williamson, Elizabeth J.; Forbes, Harriet; Wing, Kevin; McDonald, Helen, I; Bates, Chris; Bacon, Seb; Walker, Alex J.; Evans, David; Inglesby, Peter; Mehrkar, Amir; Curtis, Helen J.; DeVito, Nicholas J.; Croker, Richard; Drysdale, Henry; Cockburn, Jonathan; Parry, John; Hester, Frank; Harper, Sam; Douglas, Ian J.; Tomlinson, Laurie; Evans, Stephen J. W.; Grieve, Richard; Harrison, David; Rowan, Kathy; Khunti, Kamlesh; Chaturvedi, Nishi; Smeeth, Liam; Ben Goldacre		OpenSAFELY Collaborative	Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform	LANCET			English	Article							RACE	Background COVID-19 has disproportionately affected minority ethnic populations in the UK. Our aim was to quantify ethnic differences in SARS-CoV-2 infection and COVID-19 outcomes during the first and second waves of the COVID-19 pandemic in England. Methods We conducted an observational cohort study of adults (aged >= 18 years) registered with primary care practices in England for whom electronic health records were available through the OpenSAFELY platform, and who had at least 1 year of continuous registration at the start of each study period (Feb 1 to Aug 3, 2020 [wave 1], and Sept 1 to Dec 31, 2020 [wave 2]). Individual-level primary care data were linked to data from other sources on the outcomes of interest: SARS-CoV-2 testing and positive test results and COVID-19-related hospital admissions, intensive care unit (ICU) admissions, and death. The exposure was self-reported ethnicity as captured on the primary care record, grouped into five high-level census categories (White, South Asian, Black, other, and mixed) and 16 subcategories across these five categories, as well as an unknown ethnicity category. We used multivariable Cox regression to examine ethnic differences in the outcomes of interest. Models were adjusted for age, sex, deprivation, clinical factors and comorbidities, and household size, with stratification by geographical region. Findings Of 17 288 532 adults included in the study (excluding care home residents), 10 877 978 (62.9%) were White, 1 025 319 (5.9%) were South Asian, 340 912 (2. 0%) were Black, 170 484 (1.0%) were of mixed ethnicity, 320 788 (1.9%) were of other ethnicity, and 4 553 051 (26.3%) were of unknown ethnicity. In wave 1, the likelihood of being tested for SARS-CoV-2 infection was slightly higher in the South Asian group (adjusted hazard ratio 1.08 [95% CI 1.07-1.09]), Black group (1.08 [1.06-1 .09]), and mixed ethnicity group (1. 04 [1. 02-1.05]) and was decreased in the other ethnicity group (0.77 [0.76-0.78]) relative to the White group. The risk of testing positive for SARS-CoV-2 infection was higher in the South Asian group (1.99 [1.94-2.04]), Black group (1.69 [1.62-1. 77]), mixed ethnicity group (1.49 [1.39-1. 59]), and other ethnicity group (1. 20 [1 .14-1.28]). Compared with the White group, the four remaining high-level ethnic groups had an increased risk of COVID-19-related hospitalisation (South Asian group 1.48 [1 .41-1.55], Black group 1.78 [1.67-1.90], mixed ethnicity group 1.63 [1. 45-1.83], other ethnicity group 1.54 [1.41-1.69]), COVID-19-related ICU admission (2.18 [1.92-2.48], 3.12 [2. 65-3.67], 2.96 [2. 26-3.87], 3.18 [2.58-3.93]), and death (1.26 [1.15-1 .37], 1.51 [1.31-1.71], 1.41 [1.11-1.81], 1.22 [1.00-1.48]). In wave 2, the risks of hospitalisation, ICU admission, and death relative to the White group were increased in the South Asian group but attenuated for the Black group compared with these risks in wave 1. Disaggregation into 16 ethnicity groups showed important heterogeneity within the five broader categories. Interpretation Some minority ethnic populations in England have excess risks of testing positive for SARS-CoV-2 and of adverse COVID-19 outcomes compared with the White population, even after accounting for differences in sociodemographic, clinical, and household characteristics. Causes are likely to be multifactorial, and delineating the exact mechanisms is crucial. Tackling ethnic inequalities will require action across many fronts, including reducing structural inequalities, addressing barriers to equitable care, and improving uptake of testing and vaccination. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Mathur, Rohini; Rentsch, Christopher T.; Schultze, Anna; Bhaskaran, Krishnan; Wong, Angel Y. S.; Forbes, Harriet; Douglas, Ian J.; Tomlinson, Laurie; Smeeth, Liam] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Williamson, Elizabeth J.; Evans, Stephen J. W.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Eggo, Rosalind M.; McDonald, Helen, I] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Grieve, Richard] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Morton, Caroline E.; Hulme, William J.; MacKenna, Brian; Wing, Kevin; Bacon, Seb; Walker, Alex J.; Evans, David; Inglesby, Peter; Mehrkar, Amir; Curtis, Helen J.; DeVito, Nicholas J.; Croker, Richard; Drysdale, Henry; Ben Goldacre] Univ Oxford, DataLab, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [McDonald, Helen, I] Natl Inst Hlth Res, Hlth Protect Res Unit Immunisat, London, England; [Bates, Chris; Cockburn, Jonathan; Parry, John; Hester, Frank; Harper, Sam] TPP, Leeds, W Yorkshire, England; [Harrison, David; Rowan, Kathy] Intens Care Natl Audit & Res Ctr, London, England; [Khunti, Kamlesh] Univ Leicester, Diabet Res Ctr, Leicester, Leics, England; [Chaturvedi, Nishi] UCL, Med Res Council Unit Lifelong Hlth & Ageing, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Intensive Care National Audit & Research Centre; University of Leicester; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London	Mathur, R (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England.	Rohini.mathur@lshtm.ac.uk	/ABC-9527-2021; DeVito, Nicholas J./Q-5952-2017; Harrison, David A/O-4355-2018; Smeeth, Liam/X-5862-2018; Wing, Kevin/I-7807-2015	DeVito, Nicholas J./0000-0001-8286-1995; Harrison, David A/0000-0002-9002-9098; Smeeth, Liam/0000-0002-9168-6022; McDonald, Helen/0000-0003-0576-2015; Bhaskaran, Krishnan/0000-0001-5364-8757; Wing, Kevin/0000-0003-2335-9641; Tomlinson, Laurie/0000-0001-8848-9493; Forbes, Harriet/0000-0001-6888-2212; Khunti, Kamlesh/0000-0003-2343-7099; Evans, Stephen/0000-0002-1474-2596; Rowan, Kathryn/0000-0001-8217-5602; Grieve, Richard/0000-0001-8899-1301; Hulme, William/0000-0002-9162-4999	UK Medical Research Council (MRC) [MR/V015737/1]; Wellcome Trust [201375/Z/16/Z]; NIHR Oxford Biomedical Research Centre; NIHR Applied Research Collaboration Oxford and Thames Valley; Mohn-Westlake Foundation; NHS England; Health Foundation; BG's grants; GlaxoSmithKline; Sir Henry Dale fellowship - Wellcome; Sir Henry Dale fellowship - Royal Society; Public Health England; LSHTM; British Heart Foundation; MRC; NIHR; Health Data Research UK; UK Research and Innovation fellowship	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Applied Research Collaboration Oxford and Thames Valley; Mohn-Westlake Foundation; NHS England; Health Foundation; BG's grants; GlaxoSmithKline(GlaxoSmithKline); Sir Henry Dale fellowship - Wellcome; Sir Henry Dale fellowship - Royal Society; Public Health England; LSHTM; British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Health Data Research UK; UK Research and Innovation fellowship	This work was supported by the UK Medical Research Council (MRC; grant number MR/V015737/1). RM holds a fellowship funded by the Wellcome Trust (201375/Z/16/Z). BG's work on better use of data in health care more broadly is currently funded in part by the NIHR Oxford Biomedical Research Centre, the NIHR Applied Research Collaboration Oxford and Thames Valley, the Mohn-Westlake Foundation, NHS England, and the Health Foundation; all DataLab staff are supported by BG's grants on this work. AS is employed by LSHTM on a fellowship sponsored by GlaxoSmithKline. KB holds a Sir Henry Dale fellowship jointly funded by Wellcome and the Royal Society. HIM is funded by the NIHR Health Protection Research Unit in Immunisation, a partnership between Public Health England and LSHTM. AYSW holds a fellowship from the British Heart Foundation. EJW holds grants from the MRC. IJD holds grants from the NIHR and GlaxoSmithKline. HF holds a UK Research and Innovation fellowship. RME is funded by Health Data Research UK and the MRC. The views expressed are those of the authors and not necessarily those of the NIHR, NHS England, Public Health England, or the Department of Health and Social Care. TPP provided technical expertise and infrastructure within their data centre pro bono in the context of a national emergency. The authors are very grateful for all the support received from the TPP Technical Operations team throughout this work, and for generous assistance from the information governance and database teams at NHS England and NHSX.	Aldridge Robert W, 2020, Wellcome Open Res, V5, P88, DOI [10.12688/wellcomeopenres.15922.2, 10.12688/wellcomeopenres.15922.1]; Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Apea V. J., 2020, ETHNICITY OUTCOMES P, DOI [10.1101/2020.06.10.20127621, DOI 10.1101/2020.06.10.20127621]; Asimakopoulou K, 2020, HEALTH EXPECT, V23, P1502, DOI 10.1111/hex.13134; Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0; Bear L, A RIGHT TO CARE THE; Bhala N, 2020, LANCET, V395, P1673, DOI 10.1016/S0140-6736(20)31102-8; Bhopal RS, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002515; Bhopal RS, 2013, MIGRATION ETHNICITY, P33; Cabinet Office, 2020, OV HOUS; Chen JT, 2021, J PUBLIC HEALTH MAN, V27, pS43, DOI 10.1097/PHH.0000000000001263; Christie B, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e475; Griffith GJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19478-2; Harrison EM., 2020, PREPRINT, DOI [10.2139/ssrn.3618215, DOI 10.2139/SSRN.3618215]; Hawkins D, 2020, AM J IND MED, V63, P817, DOI 10.1002/ajim.23145; Iacobucci G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2264; Kabarriti R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19795; Kaur J., 2020, CORONAVIRUS COVID 19; Kenway P, 2020, ACCOUNTING FOR THE V; Khunti K, 2020, J PUBLIC HLTH OXF; Lassale C, 2020, MEDRXIV; Pirtle WNL, 2020, HEALTH EDUC BEHAV, V47, P504, DOI 10.1177/1090198120922942; Lau B, 2009, AM J EPIDEMIOL, V170, P244, DOI 10.1093/aje/kwp107; Lee C, 2009, SOC SCI MED, V68, P1183, DOI 10.1016/j.socscimed.2008.12.036; London Health Observatory, 2003, MISS REC CAS REC ETH; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2506; Mathur R, 2013, NCRM WORKING PAPER S; Ministry of Housing Communities and Local Government, 2015, ENGLISH INDICES OF D; Morris S, 2020, CORONAVIRUS RECORD E; Munoz-Price LS, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21892; Nafilyan V, 2020, MEDRXIV, DOI [10.1101/2020.11.27.20238147, DOI 10.1101/2020.11.27.20238147]; Office for National Statistics, 2018, ETHNICITY FACTS AND; OpenSAFELY, COVID 19 TEST RESULT; Ortiz-Fernandez L, 2020, GENES IMMUN, V21, P269, DOI 10.1038/s41435-020-0107-7; Oshi M, 2020, CANCERS, V12, DOI 10.3390/cancers12020444; Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404; Public Health England, 2020, BEYOND THE DATA UNDE; Raisi-Estabragh Z, 2020, J PUBLIC HEALTH-UK, V42, P451, DOI 10.1093/pubmed/fdaa095; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4921; Rentsch CT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003379; Rubin-Miller, 2020, COVID 19 RACIAL DISP; SAGE,, 2020, FACTORS INFLUENCING; SAGE publishing group (SAGE), 2020, DRIV HIGH COVID 19 I; Sapey E, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000644; Scientific Pandemic Influenza Group on Behaviours Environmental and Modelling Group, SPI B EMG MHCLG HOUS; Scott AP, 2013, J EPIDEMIOL COMMUN H, V67, P743, DOI 10.1136/jech-2012-202265; Smith CW., 2014, CENSUS ANALYSIS WHAT; Tapper J., 2021, LOW PAID SHUN COVID; Trades Union Congress, 2020, BME WORKERS HAVE BEE; UK Department of Health and Social Care, 2020, CORONAVIRUS COVID 19; Ward H., 2020, ANTIBODY PREVALENCE, DOI [10.1101/2020.08.12.20173690, DOI 10.1101/2020.08.12.20173690]; Warden J, 1999, BRIT MED J, V318, P625, DOI 10.1136/bmj.318.7184.625; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yehia BR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18039	55	136	137	6	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1711	1724		10.1016/S0140-6736(21)00634-6	http://dx.doi.org/10.1016/S0140-6736(21)00634-6		MAY 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33939953	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000647813600026
J	Rafla-Yuan, E; Chhabra, DK; Mensah, MO				Rafla-Yuan, Eric; Chhabra, Divya K.; Mensah, Michael O.			Decoupling Crisis Response from Policing - A Step Toward Equitable Psychiatric Emergency Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MATTER; RACE		[Rafla-Yuan, Eric] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Mensah, Michael O.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Chhabra, Divya K.] Columbia Univ, Dept Psychiat, Vagelos Coll Phys & Surg, New York, NY USA; [Chhabra, Divya K.] Weill Cornell Med, Dept Psychiat, New York, NY USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; Columbia University; Cornell University	Rafla-Yuan, E (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.			Rafla-Yuan, Eric/0000-0002-7505-0550				Abrego L., 2016, J MIGRATION HUMAN SE, V5, P694, DOI DOI 10.1177/233150241700500308; Acierno LJ, 2007, CLIN CARDIOL, V30, P52, DOI 10.1002/clc.20042; [Anonymous], 2021, MENT HLTH MOB CRIS S; [Anonymous], 2020, STRAT OUTR ENG COMM; Bailey ZD, 2021, NEW ENGL J MED, V384, P768, DOI 10.1056/NEJMms2025396; Balfour ME, 2020, COPS CLIN BOTH COLLA; Bor J, 2018, LANCET, V392, P302, DOI [10.1016/S0140-6736(18)31130-9, 10.1016/s0140-6736(18)31130-9]; Cacho Lisa M., 2012, SOCIAL DEATH RACIALI; CAROLINE NL, 1977, JAMA-J AM MED ASSOC, V237, P43, DOI 10.1001/jama.237.1.43; Committee on Trauma and Committee on Shock Division of Medical Sciences National Academy of Sciences National Research Council, 1966, ACC DEATH DIS NEGL D; Edgerly Dennis, 2013, JEMS, V38, P46; Edwards F, 2019, P NATL ACAD SCI USA, V116, P16793, DOI 10.1073/pnas.1821204116; Edwards ML, 2019, J HIST MED ALL SCI, V74, P440, DOI 10.1093/jhmas/jrz041; Elinson Zusha, 2018, WALL STREET J; Engel RS, 2020, CRIMINOL PUBLIC POL, V19, P721, DOI 10.1111/1745-9133.12467; Gross Jenny, 2020, NY TIMES; Hogan MF, 2021, PSYCHIAT SERV, V72, P169, DOI 10.1176/appi.ps.202000114; Hong M, 2020, ABC7            1130; Hong Nicole, 2021, NY TIMES; Johnson O, 2019, SOC SCI MED, V220, P226, DOI 10.1016/j.socscimed.2018.11.024; Kawachi I, 2005, HEALTH AFFAIR, V24, P343, DOI 10.1377/hlthaff.24.2.343; Kindy K., 2020, WASHINGTON POST; Lamb HR, 2002, PSYCHIATR SERV, V53, P1266, DOI 10.1176/appi.ps.53.10.1266; Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P393, DOI 10.1007/s40615-020-00738-2; Lord R, 2020, PUBLIC SOURCE   1207; Mallory C., 2015, DISCRIMINATION HARAS; McLeod MN, 2020, J RACIAL ETHN HEALTH, V7, P10, DOI 10.1007/s40615-019-00629-1; Miller Ryan W., 2020, US TODAY; Monk EP, 2020, SOC SCI MED, V266, DOI [10.1016/j.socscimed.2020.113340, 10.1016/j.scoscimed.2020.113340]; Nir SM, 2021, NY TIMES; Noulekoun F, 2021, FORESTS, V12, DOI 10.3390/f12030276; Raji M., 2020, TEXAS OBSERVER  0604; Reaves BA, 2017, SHERIFF DEPUTY, V69, P44; Riggins A., 2019, SAN DIEGO UNION TRIB; Salhi BA, 2021, NEW ENGL J MED, V384, P201, DOI 10.1056/NEJMp2023874; Schumaker E, 2020, ABC NEWS; Skiba RJ, 2014, EQUITY EXCELL EDUC, V47, P546, DOI 10.1080/10665684.2014.958965; Stonington SD, 2018, NEW ENGL J MED, V379, P1958, DOI 10.1056/NEJMms1814262	38	7	7	3	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1769	1773		10.1056/NEJMms2035710	http://dx.doi.org/10.1056/NEJMms2035710			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33951369	Bronze			2022-12-28	WOS:000647698500018
J	Mahase, E				Mahase, Elisabeth			Covid-19: Public health response should be "local by default," say leaders	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3248; Iacobucci G, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1113; Mahase E, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1033; UCL, 2021, HLTH PUBL	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n1161	10.1136/bmj.n1161	http://dx.doi.org/10.1136/bmj.n1161			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952441	Bronze			2022-12-28	WOS:000651241900010
J	Rimmer, A				Rimmer, Abi			I'm missing out on training, what should I do?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		NHS Employers, 2016, TERMS CONDITIONS SER	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n1104	10.1136/bmj.n1104	http://dx.doi.org/10.1136/bmj.n1104			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947772	Bronze			2022-12-28	WOS:000649710200006
J	Griffin, TP; Dinneen, SF				Griffin, Tomas P.; Dinneen, Sean F.			In men who are overweight or obese, adding testosterone therapy reduced glucose intolerance/T2DM	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Griffin, Tomas P.; Dinneen, Sean F.] Galway Univ Hosp, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Griffin, TP (corresponding author), Galway Univ Hosp, Galway, Ireland.			Dinneen, Sean/0000-0002-6636-0493				Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS15, DOI 10.2337/dc21-S002; Bayer AG., TESTOSTERONE THERAPY; Bogdanet D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113451	3	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC54	JC54		10.7326/ACPJ202105180-054	http://dx.doi.org/10.7326/ACPJ202105180-054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939479				2022-12-28	WOS:000652604800009
J	Thiagarajan, K				Thiagarajan, Kamala			NEWS ANALYSIS Why is India having a covid-19 surge?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ahmad A., 2021, INDIA FUND CAPACITY; [Anonymous], 2021, INDIA RECEIVE 1 BATC; [Anonymous], 2021, COVID 19 INDIA SWOT; [Anonymous], 2021, INDIA WILL NEED 500; Bellman E, 2021, WALL STREET J; Chaba AA, 2021, INDIAN EXPRESS; Gupta Mohak, 2021, Int J Infect Dis, V103, P579, DOI 10.1016/j.ijid.2020.11.206; Malani A, 2021, LANCET GLOB HEALTH, V9, pE110, DOI 10.1016/S2214-109X(20)30467-8; Mukherjee A, 2021, EPIDEMIOL INFECT, V149, DOI 10.1017/S0950268821000662; Our World in Data, DAIL COV 19 TESTS; Public Health England, 2021, CONF CAS COVID 19 VA; Pulla P, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2859; Sebastian M., 2021, LIVE LAW; THIAGARAJAN K, 2021, BMJ, V373; Thiagarajan K, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n196	15	44	44	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2021	373								n1124	10.1136/bmj.n1124	http://dx.doi.org/10.1136/bmj.n1124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QM	33931413	Bronze			2022-12-28	WOS:000649708000002
J	[Anonymous]				[Anonymous]			BMJ Editorial Scholar	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2021	373								n1099	10.1136/bmj.n1099	http://dx.doi.org/10.1136/bmj.n1099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UG4PM	33926895				2022-12-28	WOS:000689236500001
J	Stokoe, E				Stokoe, Elizabeth			The sense of a conversational ending	NATURE			English	Editorial Material						Psychology; Sociology		How we feel about the duration of our conversations has rarely been studied. New research has asked people about the lengths of their conversations, and whether they end when they want them to. Study investigates how people feel about the duration of conversations.	[Stokoe, Elizabeth] Loughborough Univ, Sch Social Sci & Humanities, Loughborough LE11 3TU, Leics, England	Loughborough University	Stokoe, E (corresponding author), Loughborough Univ, Sch Social Sci & Humanities, Loughborough LE11 3TU, Leics, England.	e.h.stokoe@lboro.ac.uk						Baumeister RF, 2007, PERSPECT PSYCHOL SCI, V2, P396, DOI 10.1111/j.1745-6916.2007.00051.x; Huma B, 2020, RES LANG SOC INTERAC, V53, P271, DOI 10.1080/08351813.2020.1739432; Mastroianni AM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2011809118; Mehl MR, 2017, CURR DIR PSYCHOL SCI, V26, P184, DOI 10.1177/0963721416680611; Patterson A, 2009, BRIT J SOC PSYCHOL, V48, P447, DOI 10.1348/014466608X369467; Schegloff E.A., 1973, SEMIOTICA, V8, P289, DOI [10.1515/semi.1973.8.4.289, DOI 10.1515/SEMI.1973.8.4.289]; SCHEGLOFF EA, 1987, SOC PSYCHOL QUART, V50, P101, DOI 10.2307/2786745; Schegloff EA, 1997, J NARRAT LIFE HIST, V7, P97, DOI 10.1075/jnlh.7.1-4.11nar; Stivers T, 2008, RES LANG SOC INTERAC, V41, P31, DOI 10.1080/08351810701691123; Stokoe E, 2020, DISCOURSE STUD, V22, P87, DOI 10.1177/1461445619887537; Stokoe E, 2016, BRIT J GEN PRACT, V66, pE779, DOI 10.3399/bjgp16X686653; Stokoe E, 2013, RES LANG SOC INTERAC, V46, P165, DOI 10.1080/08351813.2013.780341	12	0	0	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					347	349		10.1038/d41586-021-01074-z	http://dx.doi.org/10.1038/d41586-021-01074-z		APR 2021	3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SD6EJ	33911242				2022-12-28	WOS:000645224800004
J	Mahase, E				Mahase, Elisabeth			Covid-19: Wider use of FFP3 masks may be needed because of airborne transmission, say scientific advisers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, 2020, COV 19 GUID MAINT SE COV 19 GUID MAINT SE; SAGE, 2021, MASKS HEALTHC WORK M MASKS HEALTHC WORK M; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n30	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1089	10.1136/bmj.n1089	http://dx.doi.org/10.1136/bmj.n1089			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903128	Bronze			2022-12-28	WOS:000678538700008
J	Ritchie, PDL; Clarke, JJ; Cox, PM; Huntingford, C				Ritchie, Paul D. L.; Clarke, Joseph J.; Cox, Peter M.; Huntingford, Chris			Overshooting tipping point thresholds in a changing climate	NATURE			English	Review							TRANSITIONS; TIME	Palaeorecords suggest that the climate system has tipping points, where small changes in forcing cause substantial and irreversible alteration to Earth system components called tipping elements. As atmospheric greenhouse gas concentrations continue to rise as a result of fossil fuel burning, human activity could also trigger tipping, and the impacts would be difficult to adapt to. Previous studies report low global warming thresholds above pre-industrial conditions for key tipping elements such as ice-sheet melt. If so, high contemporary rates of warming imply that exceeding these thresholds is almost inevitable, which is widely assumed to mean that we are now committed to suffering these tipping events. Here we show that this assumption may be flawed, especially for slow-onset tipping elements (such as the collapse of the Atlantic Meridional Overturning Circulation) in our rapidly changing climate. Recently developed theory indicates that a threshold may be temporarily exceeded without prompting a change of system state, if the overshoot time is short compared to the effective timescale of the tipping element. To demonstrate this, we consider transparently simple models of tipping elements with prescribed thresholds, driven by global warming trajectories that peak before returning to stabilize at a global warming level of 1.5 degrees Celsius above the pre-industrial level. These results highlight the importance of accounting for timescales when assessing risks associated with overshooting tipping point thresholds.	[Ritchie, Paul D. L.; Clarke, Joseph J.; Cox, Peter M.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Huntingford, Chris] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England	University of Exeter; UK Centre for Ecology & Hydrology (UKCEH)	Ritchie, PDL (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England.	Paul.Ritchie@exeter.ac.uk	Ritchie, Paul/ABF-7004-2021; Huntingford, Christopher/A-4307-2008; Cox, Peter Michae;/B-3299-2012	Huntingford, Christopher/0000-0002-5941-7770; Cox, Peter Michae;/0000-0002-0679-2219; Clarke, Joseph/0000-0002-6250-1543; Ritchie, Paul/0000-0002-7649-2991	European Research Council [742472]; European Union [821003]; Natural Environment Research Council National Capability Fund	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Natural Environment Research Council National Capability Fund	This work was supported by the European Research Council 'Emergent Constraints on Climate-Land feedbacks in the Earth System (ECCLES)' project, grant agreement number 742472 (P.D.L.R., J.J.C. and P.M.C.). P.M.C. was also supported by the European Union's Framework Programme Horizon 2020 for Research and Innovation under grant agreement number 821003, Climate-Carbon Interactions in the Current Century (4C) project. C.H. acknowledges the Natural Environment Research Council National Capability Fund awarded to the UK Centre for Ecology and Hydrology.	Alkhayuon H, 2019, P ROY SOC A-MATH PHY, V475, DOI 10.1098/rspa.2019.0051; CESSI P, 1994, J PHYS OCEANOGR, V24, P1911, DOI 10.1175/1520-0485(1994)024<1911:ASBMOS>2.0.CO;2; Cox PM, 2004, THEOR APPL CLIMATOL, V78, P137, DOI 10.1007/s00704-004-0049-4; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dekker MM, 2018, EARTH SYST DYNAM, V9, P1243, DOI 10.5194/esd-9-1243-2018; Dijkstra HA, 2013, NONLINEAR CLIMATE DYNAMICS, P1, DOI 10.1017/CBO9781139034135; Ditlevsen PD, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044486; Drijfhout S, 2015, P NATL ACAD SCI USA, V112, pE5777, DOI 10.1073/pnas.1511451112; Herald CM, 2013, J CONTEMP WAT RES ED, V152, P14, DOI 10.1111/j.1936-704X.2013.03162.x; Hughes TP, 2013, TRENDS ECOL EVOL, V28, P149, DOI 10.1016/j.tree.2012.08.022; Huntingford C, 2017, EARTH SYST DYNAM, V8, P617, DOI 10.5194/esd-8-617-2017; Jackson LC, 2018, GEOPHYS RES LETT, V45, P8547, DOI 10.1029/2018GL078104; Kaszas B, 2019, CHAOS, V29, DOI 10.1063/1.5108837; Kriegler E, 2009, P NATL ACAD SCI USA, V106, P5041, DOI 10.1073/pnas.0809117106; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2019, NATURE, V575, P592, DOI 10.1038/d41586-019-03595-0; Lenton TM, 2013, ANNU REV ENV RESOUR, V38, P1, DOI 10.1146/annurev-environ-102511-084654; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; Levermann A, 2009, P NATL ACAD SCI USA, V106, P20572, DOI 10.1073/pnas.0901414106; Lucarini V, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.158701; Medeiros ES, 2017, SCI REP-UK, V7, DOI 10.1038/srep42351; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; NORTH GR, 1984, J ATMOS SCI, V41, P3390, DOI 10.1175/1520-0469(1984)041<3390:TSICII>2.0.CO;2; O'Keeffe PE, 2020, SIAM J APPL DYN SYST, V19, P2371, DOI 10.1137/19M1242884; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Raftery AE, 2017, NAT CLIM CHANGE, V7, P637, DOI [10.1038/nclimate3352, 10.1038/NCLIMATE3352]; Ritchie P, 2019, P ROY SOC A-MATH PHY, V475, DOI 10.1098/rspa.2018.0504; Robinson A, 2012, NAT CLIM CHANGE, V2, P429, DOI 10.1038/NCLIMATE1449; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schellnhuber HJ, 2016, NAT CLIM CHANGE, V6, P649, DOI 10.1038/nclimate3013; Steffen W, 2018, P NATL ACAD SCI USA, V115, P8252, DOI 10.1073/pnas.1810141115; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Tong D, 2019, NATURE, V572, P373, DOI 10.1038/s41586-019-1364-3; Walker G, 2006, NATURE, V441, P802, DOI 10.1038/441802a; Wernecke H, 2018, J PHYS COMMUN, V2, DOI 10.1088/2399-6528/aac33c; Winkelmann R, 2020, IN PRESS, P1, DOI [10.5194/esd-2020-18, DOI 10.5194/ESD-2020-18]; Zickfeld K, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022771	38	26	26	21	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					517	523		10.1038/s41586-021-03263-2	http://dx.doi.org/10.1038/s41586-021-03263-2			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6RQ	33883733	Green Accepted			2022-12-28	WOS:000687333900001
J	Kmietowicz, Z				Kmietowicz, Zosia			Covid-19: Failed response in Brazil has led to humanitarian catastrophe, says MSF	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2021	373								n1002	10.1136/bmj.n1002	http://dx.doi.org/10.1136/bmj.n1002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RO8VU	33863702	Bronze			2022-12-28	WOS:000641319600009
J	Dufourt, J; Bellec, M; Trullo, A; Dejean, M; De Rossi, S; Favard, C; Lagha, M				Dufourt, Jeremy; Bellec, Maelle; Trullo, Antonio; Dejean, Matthieu; De Rossi, Sylvain; Favard, Cyril; Lagha, Mounia			Imaging translation dynamics in live embryos reveals spatial heterogeneities	SCIENCE			English	Article							RNA LOCALIZATION; GENE-EXPRESSION; DROSOPHILA; PLATFORM; PROTEIN; TRANSCRIPTS; DIFFUSION; NETWORK; CELLS	Much is known about the factors involved in the translation of messenger RNA (mRNA) into protein; however, this multistep process has not been imaged in living multicellular organisms. Here, we deploy the SunTag method to visualize and quantify the timing, location, and kinetics of the translation of single mRNAs in living Drosophila embryos. By focusing on the translation of the conserved major epithelial-mesenchymal transition-inducing transcription factor Twist, we identify spatial heterogeneity in mRNA translation efficiency and reveal the existence of translation factories, where clustered mRNAs are cotranslated preferentially at basal perinuclear regions. Observing the location and dynamics of mRNA translation in a living multicellular organism opens avenues for understanding gene regulation during development.	[Dufourt, Jeremy; Bellec, Maelle; Trullo, Antonio; Dejean, Matthieu; Lagha, Mounia] Univ Montpellier, Inst Genet Mol Montpellier, CNRS UMR 5535, F-34293 Montpellier 5, France; [De Rossi, Sylvain] Univ Montpellier, INSERM, CNRS, MRI,BioCampus Montpellier, Montpellier, France; [Favard, Cyril] Univ Montpellier, Inst Rech Infectiol Montpellier, CNRS, UMR 9004, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Dufourt, J; Lagha, M (corresponding author), Univ Montpellier, Inst Genet Mol Montpellier, CNRS UMR 5535, F-34293 Montpellier 5, France.	jeremy.dufourt@igmm.cnrs.fr; mounia.lagha@igmm.cnrs.fr	Favard, Cyril/P-6392-2016; Lagha, Mounia/T-7351-2018	Favard, Cyril/0000-0002-8304-2980; Bellec, Maelle/0000-0002-9029-0042; Dufourt, Jeremy/0000-0003-4043-7250; Trullo, Antonio/0000-0001-7560-3859; Lagha, Mounia/0000-0002-7082-1950; DEJEAN, Matthieu/0000-0003-4175-1954	FRM fellowship; HFSP-CDA grant; CNRS; INSERM; ERC SyncDev starting grant	FRM fellowship(Fondation pour la Recherche Medicale); HFSP-CDA grant; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ERC SyncDev starting grant	M.B. is a recipient of an FRM fellowship. This work was supported by the ERC SyncDev starting grant and a HFSP-CDA grant to M. L. M.L., J.D., and C.F. are sponsored by CNRS. S.D.R. is sponsored by INSERM.	Becker K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07455-9; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bullock SL, 2004, DEVELOPMENT, V131, P4251, DOI 10.1242/dev.01289; Castanon I, 2001, DEVELOPMENT, V128, P3145; Chang L, 2006, J CELL BIOL, V172, P747, DOI 10.1083/jcb.200511033; Chin A, 2017, BBA-GEN SUBJECTS, V1861, P2956, DOI 10.1016/j.bbagen.2017.06.011; Chouaib R, 2020, DEV CELL, V54, P773, DOI 10.1016/j.devcel.2020.07.010; DAVIS I, 1991, CELL, V67, P927, DOI 10.1016/0092-8674(91)90366-7; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Dufourt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07613-z; Eichhorn SW, 2016, ELIFE, V5, DOI 10.7554/eLife.16955; Ferraro T, 2016, CURR BIOL, V26, P212, DOI 10.1016/j.cub.2015.11.058; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Morisaki T, 2016, SCIENCE, V352, P1425, DOI 10.1126/science.aaf0899; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Muller P, 2014, BIOINFORMATICS, V30, P2532, DOI 10.1093/bioinformatics/btu328; Normanno D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8357; PETERSEN NO, 1986, BIOPHYS J, V49, P809, DOI 10.1016/S0006-3495(86)83709-2; Pichon X, 2016, J CELL BIOL, V214, P769, DOI 10.1083/jcb.201605024; Qian H, 1991, BIOPHYS J, V60, P910, DOI 10.1016/S0006-3495(91)82125-7; Rappaz Benjamin, 2013, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0427s59; Sandler JE, 2016, GENETICS, V202, P1575, DOI 10.1534/genetics.116.186783; Sandmann T, 2007, GENE DEV, V21, P436, DOI 10.1101/gad.1509007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tantale K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12248; Tarantino N, 2014, J CELL BIOL, V204, P231, DOI 10.1083/jcb.201307172; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wang C, 2016, CELL, V165, P990, DOI 10.1016/j.cell.2016.04.040; Widengren J, 1999, CHEM PHYS, V250, P171, DOI 10.1016/S0301-0104(99)00255-4; Wu B, 2016, SCIENCE, V352, P1430, DOI 10.1126/science.aaf1084; Yan XW, 2016, CELL, V165, P976, DOI 10.1016/j.cell.2016.04.034	37	11	12	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 21	2021	372	6544					840	+		10.1126/science.abc3483	http://dx.doi.org/10.1126/science.abc3483			64	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SH2WJ	33927056	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000653997000042
J	Goyal, RK				Goyal, Raj K.			Gastric Emptying Abnormalities in Diabetes Mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review								Gastric Emptying Abnormalities in Diabetes Persistent gastric emptying problems require diagnosis and management. Postprandial dyspepsia and impaired plasma glucose regulation are commonly thought to be due to delayed emptying but can also be due to rapid emptying. Therapy must address whether emptying is delayed or rapid.	[Goyal, Raj K.] Vet Affairs Boston Healthcare Syst, Dept Med, Div Gastroenterol, 2B101 OREA Bldg,1400 VFW Pkwy, West Roxbury, MA 02132 USA; [Goyal, Raj K.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02215 USA; [Goyal, Raj K.] Harvard Med Sch, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Goyal, RK (corresponding author), Vet Affairs Boston Healthcare Syst, Dept Med, Div Gastroenterol, 2B101 OREA Bldg,1400 VFW Pkwy, West Roxbury, MA 02132 USA.	raj_goyal@hms.harvard.edu						Addula M, 2018, EXPERT REV CLIN IMMU, V14, P831, DOI 10.1080/1744666X.2018.1524756; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; BARNETT JL, 1988, GASTROENTEROLOGY, V94, P739, DOI 10.1016/0016-5085(88)90248-X; Berg P, 2016, DIGEST DIS SCI, V61, P11, DOI 10.1007/s10620-015-3839-x; Bernard CE, 2014, NEUROGASTROENT MOTIL, V26, P1275, DOI 10.1111/nmo.12389; Bharucha AE, 2015, GASTROENTEROLOGY, V149, P330, DOI 10.1053/j.gastro.2015.05.007; Bharucha AE, 2015, CLIN GASTROENTEROL H, V13, P466, DOI 10.1016/j.cgh.2014.06.034; Bharucha AE, 2009, CLIN ENDOCRINOL, V70, P415, DOI 10.1111/j.1365-2265.2008.03351.x; Bhetwal BP, 2013, J MUSCLE RES CELL M, V34, P137, DOI 10.1007/s10974-013-9341-1; Borg MJ, 2019, DIABETES OBES METAB, V21, P640, DOI 10.1111/dom.13567; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Camilleri M, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0038-z; Camilleri M, 2017, GASTROENTEROLOGY, V153, P1240, DOI 10.1053/j.gastro.2017.07.035; Chang J, 2013, DIABETIC MED, V30, pE185, DOI 10.1111/dme.12147; Chedid V, 2019, AM J GASTROENTEROL, V114, P143, DOI 10.1038/s41395-018-0234-1; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Cherian D, 2010, CLIN GASTROENTEROL H, V8, P676, DOI 10.1016/j.cgh.2010.04.027; Chiba Y, 2010, J PHARMACOL SCI, V114, P264, DOI 10.1254/jphs.10R10FM; Choi KM, 2007, NEUROGASTROENT MOTIL, V19, P585, DOI 10.1111/j.1365-2982.2007.00936.x; Cipriani G, 2018, GASTROENTEROLOGY, V154, P2122, DOI 10.1053/j.gastro.2018.02.027; Coleski R, 2009, NEUROGASTROENT MOTIL, V21, P492, DOI 10.1111/j.1365-2982.2008.01235.x; Eisenman ST, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12984; FELDMAN M, 1984, GASTROENTEROLOGY, V87, P895; Fosso Chimi L, 2018, Gastroenterol Hepatol (N Y), V14, P140; FRANK JW, 1995, GASTROENTEROLOGY, V109, P755, DOI 10.1016/0016-5085(95)90382-8; Goyal RK, 2019, J DIABETES COMPLICAT, V33, DOI 10.1016/j.jdiacomp.2019.107414; Goyal RK, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13546; Grover M, 2019, GUT, V68, P2238, DOI 10.1136/gutjnl-2019-318712; Grover M, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0379-1; Grover M, 2011, GASTROENTEROLOGY, V140, P1575, DOI 10.1053/j.gastro.2011.01.046; Halmos KC, 2015, NEUROSCIENCE, V306, P115, DOI 10.1016/j.neuroscience.2015.08.023; HASLER WL, 1995, GASTROENTEROLOGY, V108, P727, DOI 10.1016/0016-5085(95)90445-X; Hayashi Y, 2017, GASTROENTEROLOGY, V153, P521, DOI 10.1053/j.gastro.2017.04.020; He XD, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00001; Holst JJ, 2016, DIABETES CARE, V39, P884, DOI 10.2337/dc16-0351; Horvath VJ, 2006, GASTROENTEROLOGY, V130, P759, DOI 10.1053/j.gastro.2005.12.027; Horvath VJ, 2005, DIABETES, V54, P1528, DOI 10.2337/diabetes.54.5.1528; Janssen P, 2013, AM J GASTROENTEROL, V108, P1382, DOI 10.1038/ajg.2013.118; Joshi Sachindra R, 2012, Mol Cell Pharmacol, V4, P1; KASSANDER P, 1958, ANN INTERN MED, V48, P797, DOI 10.7326/0003-4819-48-4-797; Kirkham P, 2007, BIOCHEM SOC T, V35, P284, DOI 10.1042/BST0350284; Koch KL, 2014, EXP BRAIN RES, V232, P2553, DOI 10.1007/s00221-014-4007-9; Krishnasamy S, 2018, DIABETES THER, V9, pS1, DOI 10.1007/s13300-018-0454-9; Kumar A, 2008, NEUROGASTROENT MOTIL, V20, P635, DOI 10.1111/j.1365-2982.2008.01081.x; Lacy BE, 2018, AM J GASTROENTEROL, V113, P216, DOI 10.1038/ajg.2017.458; Lamy CM, 2014, CELL METAB, V19, P527, DOI 10.1016/j.cmet.2014.02.003; Litvin M, 2013, J CLIN INVEST, V123, P1922, DOI 10.1172/JCI69796; Lupoli R, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071559; Lutz TA, 2018, DIABETES, V67, P805, DOI 10.2337/db17-1347; Mahavadi S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178574; Marathe CS, 2015, J CLIN ENDOCR METAB, V100, P3565, DOI 10.1210/JC.2015-2482; Mashimo H, 2000, GASTROENTEROLOGY, V119, P766, DOI 10.1053/gast.2000.16509; Meier JJ, 2015, DIABETES CARE, V38, P1263, DOI 10.2337/dc14-1984; Neshatian L, 2015, NEUROGASTROENT MOTIL, V27, P7, DOI 10.1111/nmo.12418; O'Grady G, 2012, GASTROENTEROLOGY, V143, P589, DOI 10.1053/j.gastro.2012.05.036; Park SY, 2017, AM J GASTROENTEROL, V112, P1689, DOI 10.1038/ajg.2017.264; Pasricha PJ, 2015, GASTROENTEROL CLIN N, V44, P1, DOI 10.1016/j.gtc.2014.11.001; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Rayner CK, 2019, GASTROENTEROLOGY, V156, P1555, DOI 10.1053/j.gastro.2019.03.030; Revicki DA, 2012, NEUROGASTROENT MOTIL, V24, P456, DOI 10.1111/j.1365-2982.2012.01879.x; Riddle MC, 2017, DIABETES CARE, V40, P291, DOI 10.2337/dc16-2380; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Singh J, 2016, AM J PHYSIOL-GASTR L, V311, pG964, DOI 10.1152/ajpgi.00290.2016; Singh J, 2015, AM J PHYSIOL-GASTR L, V309, pG292, DOI 10.1152/ajpgi.00125.2015; Solway J, 1998, AM J RESP CRIT CARE, V158, pS100, DOI 10.1164/ajrccm.158.supplement_2.13tac500; Stanghellini V, 2014, GUT, V63, P1972, DOI 10.1136/gutjnl-2013-306084; Taborsky GJ, 2012, ENDOCRINOLOGY, V153, P1055, DOI 10.1210/en.2011-2040; Tack J, 2020, GASTROENTEROLOGY, V158, P1841, DOI 10.1053/j.gastro.2019.06.049; Talley NJ, 2015, NEW ENGL J MED, V373, P1853, DOI 10.1056/NEJMra1501505; Hien TT, 2016, J BIOL CHEM, V291, P3552, DOI 10.1074/jbc.M115.654384; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Vijayvargiya P, 2019, GASTROENTEROLOGY, V156, P1650, DOI 10.1053/j.gastro.2019.01.249; Watson LE, 2019, J CLIN ENDOCR METAB, V104, P3311, DOI 10.1210/jc.2018-02736; Wauters L, 2020, GUT, V69, P591, DOI 10.1136/gutjnl-2019-318536; Zhou SY, 2011, AM J PHYSIOL-GASTR L, V300, pG394, DOI 10.1152/ajpgi.00493.2010	76	6	6	3	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1742	1751		10.1056/NEJMra2020927	http://dx.doi.org/10.1056/NEJMra2020927			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY1SU	33951363				2022-12-28	WOS:000647698500012
J	Kelsey, MD; Granger, CB				Kelsey, Michelle D.; Granger, Christopher B.			LOW-HARM score predicted mortality in patients hospitalized with COVID-19 in Mexico	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kelsey, Michelle D.; Granger, Christopher B.] Duke Univ, Durham, NC 27708 USA	Duke University	Kelsey, MD (corresponding author), Duke Univ, Durham, NC 27708 USA.							Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	2	0	0	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC59	JC59		10.7326/ACPJ202105180-059	http://dx.doi.org/10.7326/ACPJ202105180-059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939489				2022-12-28	WOS:000652604800014
J	Strong, NM; Badgett, RG				Strong, Nora M.; Badgett, Robert G.			Saliva and nasopharyngeal samples have similar sensitivity for detecting SARS-CoV-2	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Strong, Nora M.; Badgett, Robert G.] Univ Kansas, Sch Med, Wichita, KS 67214 USA	University of Kansas; University of Kansas Medical Center	Strong, NM (corresponding author), Univ Kansas, Sch Med, Wichita, KS 67214 USA.							Butler-Laporte G, 2021, JAMA INTERN MED, V181, P353, DOI 10.1001/jamainternmed.2020.8876; Kohn MA, 2013, ACAD EMERG MED, V20, P1194, DOI 10.1111/acem.12255; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Zhen W, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00743-20	4	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC55	JC55		10.7326/ACPJ202105180-055	http://dx.doi.org/10.7326/ACPJ202105180-055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939482				2022-12-28	WOS:000652604800010
J	Bush, MB; Nascimento, MN; Akesson, CM; Cardenes-Sandi, GM; Maezumi, SY; Behling, H; Correa-Metrio, A; Church, W; Huisman, SN; Kelly, T; Mayle, FE; McMichael, CNH				Bush, M. B.; Nascimento, M. N.; Akesson, C. M.; Cardenes-Sandi, G. M.; Maezumi, S. Y.; Behling, H.; Correa-Metrio, A.; Church, W.; Huisman, S. N.; Kelly, T.; Mayle, F. E.; McMichael, C. N. H.			Widespread reforestation before European influence on Amazonia	SCIENCE			English	Article							HOLOCENE ENVIRONMENTAL-CHANGES; CLIMATE-CHANGE; HUMAN OCCUPATION; ATMOSPHERIC CO2; RECORD; VEGETATION; HISTORY; POLLEN; AMERICA; REGION	An estimated 90 to 95% of Indigenous people in Amazonia died after European contact. This population collapse is postulated to have caused decreases in atmospheric carbon dioxide concentrations at around 1610 CE, as a result of a wave of land abandonment in the wake of disease, slavery, and warfare, whereby the attendant reversion to forest substantially increased terrestrial carbon sequestration. On the basis of 39 Amazonian fossil pollen records, we show that there was no synchronous reforestation event associated with such an atmospheric carbon dioxide response after European arrival in Amazonia. Instead, we find that, at most sites, land abandonment and forest regrowth began about 300 to 600 years before European arrival. Pre-European pandemics, social strife, or environmental change may have contributed to these early site abandonments and ecological shifts.	[Bush, M. B.; Nascimento, M. N.; Akesson, C. M.] Florida Inst Technol, Inst Global Ecol, Melbourne, FL 32901 USA; [Nascimento, M. N.; Maezumi, S. Y.; Huisman, S. N.; McMichael, C. N. H.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Ecosyst & Landscape Dynam, Amsterdam, Netherlands; [Cardenes-Sandi, G. M.] Univ Costa Rica, Escuela Centroamer Geol, San Jose, Costa Rica; [Behling, H.] Univ Goettingen, Dept Palynol & Climate Dynam, Gottingen, Germany; [Correa-Metrio, A.] Univ Nacl Autonoma Mexico, Inst Geol, Ciudad De Mexico, Mexico; [Church, W.] Columbus State Univ, Dept Earth & Space Sci, Columbus, GA USA; [Kelly, T.] Queen Mary Univ London, Sch Geog, London, England; [Mayle, F. E.] Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England; [Akesson, C. M.] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland	Florida Institute of Technology; University of Amsterdam; Universidad Costa Rica; University of Gottingen; Universidad Nacional Autonoma de Mexico; University System of Georgia; Columbus State University; University of London; Queen Mary University London; University of Reading; University of St Andrews	Bush, MB (corresponding author), Florida Inst Technol, Inst Global Ecol, Melbourne, FL 32901 USA.; McMichael, CNH (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Ecosyst & Landscape Dynam, Amsterdam, Netherlands.	mbush@fit.edu; c.n.h.momichael@uva.nl	Church, Warren B/HCI-3537-2022	Correa-Metrio, Alexander/0000-0002-1278-2746; Church, Warren/0000-0001-8003-4195; McMichael, Crystal/0000-0002-1064-1499; Akesson, Christine/0000-0002-1442-7019; Bush, Mark/0000-0001-6894-8613; Maezumi, S. Yoshi/0000-0002-4333-1972; Huisman, Seringe/0000-0003-3250-7255; Nascimento, Majoi/0000-0003-4009-4905	National Science Foundation [EAR1338694, BCS0926973]; National Aeronautics and Space Administration [NNX14AD31G]; European Research Council [ERC 2019 StG 853394]; Florida Institute of Technology postdoctoral award; NERC	National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); European Research Council(European Research Council (ERC)European Commission); Florida Institute of Technology postdoctoral award; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Ecuadorian work was conducted under Ecuadorian Collection Permit 08-2017-IC. M.B.B. acknowledges funding from the National Science Foundation (grants EAR1338694 and BCS0926973) and the National Aeronautics and Space Administration (grant NNX14AD31G). C.N.H.M. and M.N.N. acknowledge funding from the European Research Council (ERC 2019 StG 853394). M.N.N. also acknowledges a Florida Institute of Technology postdoctoral award. T.K. acknowledges a NERC-funded PhD studentship.	Absy M. L., 1979, THESIS U AMSTERDAM; Acuna C, 1698, RELATION GREAT RIVER; Akesson C., 2019, THESIS MELBOURNE FL; Akesson CM, 2021, J ECOL, V109, P432, DOI 10.1111/1365-2745.13501; Arkush E, 2013, J ARCHAEOL RES, V21, P307, DOI 10.1007/s10814-013-9065-1; Arroyo-Kalin M, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2019.0715; Arroyo-Kalin M, 2017, ARCHAEOL INT, V20, P122, DOI 10.5334/ai-367; Behling H, 1999, PALAEOGEOGR PALAEOCL, V145, P193, DOI 10.1016/S0031-0182(98)00105-9; Behling H, 2000, QUATERNARY RES, V53, P369, DOI 10.1006/qres.1999.2117; Behling H, 2001, PALAEOGEOGR PALAEOCL, V173, P87, DOI 10.1016/S0031-0182(01)00321-2; Behling H, 2001, VEG HIST ARCHAEOBOT, V10, P175, DOI 10.1007/PL00006929; Bird BW, 2011, P NATL ACAD SCI USA, V108, P8583, DOI 10.1073/pnas.1003719108; Burbridge RE, 2004, QUATERNARY RES, V61, P215, DOI 10.1016/j.yqres.2003.12.004; Bush MB, 2007, J BIOGEOGR, V34, P1342, DOI 10.1111/j.1365-2699.2007.01704.x; Bush MB, 2016, QUATERNARY SCI REV, V141, P52, DOI 10.1016/j.quascirev.2016.03.022; Bush MB, 2007, FRONT ECOL ENVIRON, V5, P457, DOI 10.1890/070018; Bush MB, 2007, PHILOS T R SOC B, V362, P209, DOI 10.1098/rstb.2006.1980; Bush MB, 2017, GLOBAL CHANGE BIOL, V23, P3181, DOI 10.1111/gcb.13608; Bush MB, 2002, PALAEOGEOGR PALAEOCL, V177, P5, DOI 10.1016/S0031-0182(01)00348-0; Cardenes-Sandi G. M., 2011, THESIS U COSTA RICA; Carson JF, 2014, P NATL ACAD SCI USA, V111, P10497, DOI 10.1073/pnas.1321770111; Church WB, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P903, DOI 10.1007/978-0-387-74907-5_45; Cochrane Mark A., 2009, P1, DOI 10.1007/978-3-540-77381-8_1; COLINVAUX PA, 1988, REV PALAEOBOT PALYNO, V55, P73, DOI 10.1016/0034-6667(88)90054-1; Cook N. D, 1998, NEW APPROACHES AM SE; de Paula Moraes C., 2012, AMAZONICA, V4, P122, DOI DOI 10.18542/AMAZONICA.V4I1.884; de Souza JG, 2019, NAT ECOL EVOL, V3, P1007, DOI 10.1038/s41559-019-0924-0; De Toledo MB, 2007, J BIOGEOGR, V34, P1313, DOI 10.1111/j.1365-2699.2006.01606.x; De Toledo MB., 2004, THESIS FLORIDA I TEC; Fehren-Schmitz L, 2014, P NATL ACAD SCI USA, V111, P9443, DOI 10.1073/pnas.1403466111; FROST I, 1988, ECOLOGY, V69, P66, DOI 10.2307/1943161; Hermanowski B, 2012, QUATERNARY RES, V77, P138, DOI 10.1016/j.yqres.2011.10.009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kelly TJ, 2018, J QUATERNARY SCI, V33, P369, DOI 10.1002/jqs.3019; Kelly TJ, 2017, PALAEOGEOGR PALAEOCL, V468, P129, DOI 10.1016/j.palaeo.2016.11.039; Koch A, 2019, QUATERNARY SCI REV, V207, P13, DOI 10.1016/j.quascirev.2018.12.004; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Meure CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026152; Maezumi SY, 2018, NAT PLANTS, V4, P540, DOI 10.1038/s41477-018-0205-y; Martin PA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2236; Mayle FE, 2000, SCIENCE, V290, P2291, DOI 10.1126/science.290.5500.2291; McMichael CH, 2012, SCIENCE, V336, P1429, DOI 10.1126/science.1219982; Medina J.T., 1934, DISCOVERY AMAZON ACC; Mesquita RCG, 2001, J ECOL, V89, P528, DOI 10.1046/j.1365-2745.2001.00583.x; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Nascimento MN, 2019, J BIOGEOGR, V46, P2389, DOI 10.1111/jbi.13704; Nelson EA, 2020, INT J PALEOPATHOL, V29, P128, DOI 10.1016/j.ijpp.2019.12.006; Nevle RJ, 2011, HOLOCENE, V21, P853, DOI 10.1177/0959683611404578; ORTLOFF CR, 1993, J ARCHAEOL SCI, V20, P195, DOI 10.1006/jasc.1993.1014; REEVE ME, 1993, ETHNOHISTORY, V41, P106, DOI 10.2307/3536980; Rodgers JC, 1996, PALAEOGEOGR PALAEOCL, V124, P53, DOI 10.1016/0031-0182(96)00004-1; Roucoux KH, 2013, PALAEOGEOGR PALAEOCL, V374, P242, DOI 10.1016/j.palaeo.2013.01.023; Sa ND, 2016, ACTA BOT BRAS, V30, P473, DOI 10.1590/0102-33062016abb0250; SMITH NJH, 1999, AMAZON RIVER FOREST; Urrego DH, 2013, J BIOGEOGR, V40, P521, DOI 10.1111/jbi.12016; Wang W, 2017, CELL BIOL TOXICOL, V33, P207, DOI 10.1007/s10565-017-9396-7; Weng CY, 2002, REV PALAEOBOT PALYNO, V120, P73, DOI 10.1016/S0034-6667(01)00148-8; Whitney BS, 2019, HOLOCENE, V29, P262, DOI 10.1177/0959683618810394; Zalasiewicz J, 2015, ANTHROPOCENE REV, V2, P117, DOI 10.1177/2053019615587056	59	16	16	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					484	+		10.1126/science.abf3870	http://dx.doi.org/10.1126/science.abf3870			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926948	Green Accepted			2022-12-28	WOS:000645554100040
J	Coomarasamy, A; Gallos, ID; Papadopoulou, A; Dhillon-Smith, RK; Al-Memar, M; Brewin, J; Christiansen, OB; Stephenson, MD; Oladapo, OT; Wijeyaratne, CN; Small, R; Bennett, PR; Regan, L; Goddijn, M; Devall, AJ; Bourne, T; Brosens, JJ; Quenby, S				Coomarasamy, Arri; Gallos, Ioannis D.; Papadopoulou, Argyro; Dhillon-Smith, Rima K.; Al-Memar, Maya; Brewin, Jane; Christiansen, Ole B.; Stephenson, Mary D.; Oladapo, Olufemi T.; Wijeyaratne, Chandrika N.; Small, Rachel; Bennett, Phillip R.; Regan, Lesley; Goddijn, Mariette; Devall, Adam J.; Bourne, Tom; Brosens, Jan J.; Quenby, Siobhan			Sporadic miscarriage: evidence to provide effective care	LANCET			English	Review							PREGNANCY ASSESSMENT UNIT; EMERGENCY-DEPARTMENT; RANDOMIZED-TRIAL; VAGINAL PROGESTERONE; MANAGEMENT; WOMEN; ULTRASOUND; IMPACT; ABORTION; DYDROGESTERONE	The physical and psychological effect of miscarriage is commonly underappreciated. The journey from diagnosis of miscarriage, through clinical management, to supportive aftercare can be challenging for women, their partners, and caregivers. Diagnostic challenges can lead to delayed or ineffective care and increased anxiety. Inaccurate diagnosis of a miscarriage can result in the unintended termination of a wanted pregnancy. Uncertainty about the therapeutic effects of interventions can lead to suboptimal care, with variations across facilities and countries. For this Series paper, we have developed recommendations for practice from a literature review, appraisal of guidelines, and expert group discussions. The recommendations are grouped into three categories: (1) diagnosis of miscarriage, (2) prevention of miscarriage in women with early pregnancy bleeding, and (3) management of miscarriage. We recommend that every country reports annual aggregate miscarriage data, similarly to the reporting of stillbirth. Early pregnancy services need to focus on providing an effective ultrasound service, as it is central to the diagnosis of miscarriage, and be able to provide expectant management of miscarriage, medical management with mifepristone and misoprostol, and surgical management with manual vacuum aspiration. Women with the dual risk factors of early pregnancy bleeding and a history of previous miscarriage can be recommended vaginal micronised progesterone to improve the prospects of livebirth. We urge health-care funders and providers to invest in early pregnancy care, with specific focus on training for clinical nurse specialists and doctors to provide comprehensive miscarriage care within the setting of dedicated early pregnancy units.	[Coomarasamy, Arri; Gallos, Ioannis D.; Papadopoulou, Argyro; Dhillon-Smith, Rima K.; Devall, Adam J.] Univ Birmingham, Inst Metab & Syst Res, Tommys Natl Ctr Miscarriage Res, Birmingham, W Midlands, England; [Al-Memar, Maya; Bennett, Phillip R.; Regan, Lesley; Bourne, Tom] Imperial Coll London, Tommys Natl Ctr Miscarriage Res, London, England; [Brewin, Jane] Tommys Char, Laurence Pountney Hill, London, England; [Christiansen, Ole B.] Aalborg Univ Hosp, Dept Obstet & Gynaecol, Ctr Recurrent Pregnancy Loss Western Denmark, Aalborg, Denmark; [Stephenson, Mary D.] Univ Illinois, Dept Obstet & Gynecol, Recurrent Pregnancy Loss Program, Chicago, IL 60612 USA; [Oladapo, Olufemi T.] WHO, Dept Sexual & Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland; [Wijeyaratne, Chandrika N.] Univ Colombo, Dept Reprod Med, Colombo, Sri Lanka; [Small, Rachel] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Heartlands Hosp, Birmingham, W Midlands, England; [Goddijn, Mariette] Univ Amsterdam, Amsterdam UMC, Ctr Reprod Med, Amsterdam, Netherlands; [Bourne, Tom] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Brosens, Jan J.; Quenby, Siobhan] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Warwick, England; [Brosens, Jan J.; Quenby, Siobhan] Univ Hosp Coventry & Warwickshire NHS Trust, Tommys Natl Ctr Miscarriage Res, Coventry, W Midlands, England	University of Birmingham; Imperial College London; Aalborg University; Aalborg University Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; The World Bank; United Nations Population Fund; World Health Organization; University of Colombo; Heart of England NHS Foundation Trust; University of Birmingham; University of Amsterdam; KU Leuven; University of Warwick; University of Warwick	Gallos, ID (corresponding author), Univ Birmingham, Inst Metab & Syst Res, Birmingham B15 2TT, W Midlands, England.	i.d.gallos@bham.ac.uk	Papadopoulou, Argyro/AAR-1380-2020; Devall, Adam/AAC-9646-2022; Bourne, Tom/I-6478-2012	Papadopoulou, Argyro/0000-0001-9409-8608; Bourne, Tom/0000-0003-1421-6059; Bennett, Phillip/0000-0002-6253-4919; Gallos, Ioannis/0000-0002-2766-358X; Goddijn, Mariette/0000-0001-9928-9673; Quenby, Siobhan/0000-0003-3221-5471	Tommy's Charity; Wellcome Trust Investigator Award [212233/Z/18/Z]	Tommy's Charity; Wellcome Trust Investigator Award(Wellcome Trust)	The Tommy's Charity funds the Tommy's National Centre for Miscarriage Research. JJB holds a Wellcome Trust Investigator Award (212233/Z/18/Z). The funders had no role in the writing of the Series paper, or in the decision to submit the paper for publication.	Akhter P, 2007, IRISH J MED SCI, V176, P23, DOI 10.1007/s11845-007-0013-2; Aleman A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003576.pub2; Axelsen SM, 1995, EUR J OBSTET GYN R B, V63, P131, DOI 10.1016/0301-2115(95)02236-8; BATZOFIN JH, 1984, OBSTET GYNECOL, V63, P515; Bignardi T, 2010, ULTRASOUND OBST GYN, V35, P344, DOI 10.1002/uog.7523; BIGRIGG MA, 1991, BRIT MED J, V302, P577, DOI 10.1136/bmj.302.6776.577; Bottomley C, 2009, BEST PRACT RES CL OB, V23, P463, DOI 10.1016/j.bpobgyn.2009.02.004; Brownlea S, 2005, AUST NZ J OBSTET GYN, V45, P108, DOI 10.1111/j.1479-828X.2005.00351.x; Carp H, 2012, GYNECOL ENDOCRINOL, V28, P983, DOI 10.3109/09513590.2012.702875; CATES W, 1985, LANCET, V2, P596; Chen JL, 2016, INT IMMUNOPHARMACOL, V40, P347, DOI 10.1016/j.intimp.2016.09.018; Cleeve A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149172; Coomarasamy A, 2019, NEW ENGL J MED, V380, P1815, DOI 10.1056/NEJMoa1813730; Coomarasamy A, 2015, NEW ENGL J MED, V373, P2141, DOI 10.1056/NEJMoa1504927; Coomarasamy A, 2020, AM J OBSTET GYNECOL, V223, P167, DOI 10.1016/j.ajog.2019.12.006; Coomarasamy Arri, 2011, BMJ, V342, pd1914, DOI 10.1136/bmj.d1914; Devaseelan P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007422.pub2; Di Renzo GC, 2012, GYNECOL ENDOCRINOL, V28, P925, DOI 10.3109/09513590.2012.730576; Doubilet PM, 2013, NEW ENGL J MED, V369, P1443, DOI 10.1056/NEJMra1302417; Duley L, 2005, COCHRANE DATABASE SY, V3; El-Zibdeh MY, 2009, MATURITAS, V65, pS43, DOI 10.1016/j.maturitas.2009.11.013; Elson J, 2004, CURR OPIN OBSTET GYN, V16, P339, DOI 10.1097/01.gco.0000136501.81614.05; French JI, 1999, OBSTET GYNECOL, V93, P715, DOI 10.1016/S0029-7844(98)00557-2; Gallos ID, 2017, COCHRANE DB SYST REV, V3, DOI [DOI 10.1002/14651858.CD012602, 10.1002/14651858.CD012602]; Guha S, 2013, HUM REPROD, V28, P2905, DOI 10.1093/humrep/det342; Iyoke CA, 2014, NIGER J CLIN PRACT, V17, P419, DOI 10.4103/1119-3077.134003; Jackson E, 2011, REPROD HEALTH MATTER, V19, P133, DOI 10.1016/S0968-8080(11)37563-5; Jeve Y, 2011, ULTRASOUND OBST GYN, V38, P489, DOI 10.1002/uog.10108; Kiemtore S, 2017, INT J GYNECOL OBSTET, V136, P215, DOI 10.1002/ijgo.12031; Kongnyuy EJ, 2007, TROP DOCT, V37, P70, DOI 10.1258/004947507780609310; Lane BF, 2013, ULTRASOUND Q, V29, P91, DOI 10.1097/RUQ.0b013e31829158c2; Ledger WL, 2016, FERTIL STERIL, V105, P417, DOI 10.1016/j.fertnstert.2015.11.002; Lee HJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3616875; Lissauer D, 2019, NEW ENGL J MED, V380, P1012, DOI 10.1056/NEJMoa1808817; May W, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001779.pub2; Melese T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166287; Morin L, 2016, J OBSTET GYNAECOL CA, V38, P982, DOI 10.1016/j.jogc.2016.06.001; National Collaborating Centre for Women's and Children's Health (UK), 2012, ECTOPIC PREGNANCY MI; O'Rourke D, 2009, AUST NZ J OBSTET GYN, V49, P110, DOI 10.1111/j.1479-828X.2009.00954.x; Ogwulu CBO, 2020, BJOG-INT J OBSTET GY, V127, P757, DOI 10.1111/1471-0528.16068; Palagiano A, 2004, ANN NY ACAD SCI, V1034, P200, DOI 10.1196/annals.1335.022; Pandian RU, 2009, MATURITAS, V65, pS47, DOI 10.1016/j.maturitas.2009.11.016; Pexsters A, 2011, ULTRASOUND OBST GYN, V38, P510, DOI 10.1002/uog.8884; Ramin K D, 1995, Infect Dis Obstet Gynecol, V2, P213, DOI 10.1155/S1064744995000044; Rhone SA, 2012, J OBSTET GYNAECOL CA, V34, P243, DOI 10.1016/S1701-2163(16)35184-2; Rovner P, 2018, J ULTRAS MED, V37, P1533, DOI 10.1002/jum.14474; Sayasneh A, 2012, ULTRASOUND OBST GYN, V40, P145, DOI 10.1002/uog.11184; Schouwink M H, 2000, Early Pregnancy, V4, P203; SEERAS R, 1989, East African Medical Journal, V66, P607; SIPILA P, 1992, BRIT J OBSTET GYNAEC, V99, P959, DOI 10.1111/j.1471-0528.1992.tb13697.x; Smith LFP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3827; Titapant Vitaya, 2012, Journal of the Medical Association of Thailand, V95, P1372; Tomic V, 2011, GYNECOL ENDOCRINOL, V27, P1010, DOI 10.3109/09513590.2011.569791; Tunde-Byass M, 2009, J OBSTET GYNAECOL CA, V31, P841, DOI 10.1016/S1701-2163(16)34302-X; van den Berg MMJ, 2015, REPROD BIOMED ONLINE, V31, P192, DOI 10.1016/j.rbmo.2015.04.008; Volgsten H, 2018, ACTA OBSTET GYN SCAN, V97, P1491, DOI 10.1111/aogs.13432; Wahabi HA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005943.pub5; Wendt K, 2014, EMERG MED J, V31, pE50, DOI 10.1136/emermed-2013-202887; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; Yang J, 2005, PAEDIATR PERINAT EP, V19, P276, DOI 10.1111/j.1365-3016.2005.00655.x; Zaqout M, 2015, PEDIATR CARDIOL, V36, P1483, DOI 10.1007/s00246-015-1190-9	61	12	12	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1668	1674		10.1016/S0140-6736(21)00683-8	http://dx.doi.org/10.1016/S0140-6736(21)00683-8		APR 2021	7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV0EH	33915095	Green Submitted, Green Published			2022-12-28	WOS:000645510600027
J	Pruss, KM; Sonnenburg, JL				Pruss, Kali M.; Sonnenburg, Justin L.			C. difficile exploits a host metabolite produced during toxin-mediated disease	NATURE			English	Article								Several enteric pathogens can gain specific metabolic advantages over other members of the microbiota by inducing host pathology and inflammation. The pathogen Clostridium difficile is responsible for a toxin-mediated colitis that causes 450,000 infections and 15,000 deaths in the United States each year(1); however, the molecular mechanisms by which C. difficile benefits from this pathology remain unclear. To understand how the metabolism of C. difficile adapts to the inflammatory conditions that its toxins induce, here we use RNA sequencing to define, in a mouse model, the metabolic states of wild-type C. difficile and of an isogenic mutant that lacks toxins. By combining bacterial and mouse genetics, we demonstrate that C. difficile uses sorbitol derived from both diet and host. Host-derived sorbitol is produced by the enzyme aldose reductase, which is expressed by diverse immune cells and is upregulated during inflammation-including during toxin-mediated disease induced by C. difficile. This work highlights a mechanism by which C. difficile can use a host-derived nutrient that is generated during toxin-induced disease by an enzyme that has not previously been associated with infection.	[Pruss, Kali M.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University	Sonnenburg, JL (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	jsonnenburg@stanford.edu			NIDDK [R01-DK08502510]; Chan Zuckerberg Biohub; Ford Foundation Pre-Doctoral Fellowship; NSF Graduate Research Fellowship	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chan Zuckerberg Biohub; Ford Foundation Pre-Doctoral Fellowship; NSF Graduate Research Fellowship(National Science Foundation (NSF))	We thank S. Higginbottom for assistance with all mouse experiments. A. Chien assisted with the development of the GC-MS protocol; S. Kuehne and N. Minton provided the toxin-mutant C. difficile strains; A. Shen provided reagents for the generation of new C. difficile mutants; A. Bhatnagar and D. Mosely provided the aldose reductase knockout mice; and D. Davis shared protocols and advice regarding the development of the streptozotocin model of hyperglycaemia. This study was supported by R01-DK08502510 (with thanks to B. Karp for service and support at NIDDK) and the Chan Zuckerberg Biohub, and a Ford Foundation Pre-Doctoral Fellowship and NSF Graduate Research Fellowship to K.M.P. We thank all members of the Sonnenburg laboratory, who provided feedback throughout the development of the project.	Antunes A, 2012, NUCLEIC ACIDS RES, V40, P10701, DOI 10.1093/nar/gks864; Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins J, 2018, NATURE, V553, P291, DOI 10.1038/nature25178; D'Auria KM, 2013, INFECT IMMUN, V81, P3814, DOI 10.1128/IAI.00869-13; Di Rienzi SC, 2020, ADV NUTR, V11, P616, DOI 10.1093/advances/nmz118; El Feghaly RE, 2013, CLIN INFECT DIS, V56, P1713, DOI 10.1093/cid/cit147; Faber F, 2016, NATURE, V534, P697, DOI 10.1038/nature18597; Ge SX, 2020, BIOINFORMATICS, V36, P2628, DOI 10.1093/bioinformatics/btz931; Hassan SA, 2013, J ROY COLL PHYS EDIN, V43, P103, DOI 10.4997/JRCPE.2013.203; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Hryckowian AJ, 2018, NAT MICROBIOL, V3, P662, DOI 10.1038/s41564-018-0150-6; Hryckowian AJ, 2017, CURR OPIN MICROBIOL, V35, P42, DOI 10.1016/j.mib.2016.11.006; KARASAWA T, 1995, MICROBIOL-UK, V141, P371, DOI 10.1099/13500872-141-2-371; Kashima K, 1998, ENDOCRINOLOGY, V139, P3404, DOI 10.1210/en.139.8.3404; Kuehne SA, 2014, J INFECT DIS, V209, P83, DOI 10.1093/infdis/jit426; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kumar N, 2019, NAT GENET, V51, P1315, DOI 10.1038/s41588-019-0478-8; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Lopez CA, 2016, SCIENCE, V353, P1249, DOI 10.1126/science.aag3042; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McKenzie AT, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0349-1; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Minton NP, 2016, ANAEROBE, V41, P104, DOI 10.1016/j.anaerobe.2016.05.011; Moing A, 2000, DEV CROP SCI, V26, P337; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Ng YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056051; Pal PB, 2017, ENDOCRINOLOGY, V158, P3661, DOI 10.1210/en.2017-00294; R Core Team, 2018, R LANG ENV STAT COMP; Ramana Kota V, 2011, Biomol Concepts, V2, P103; Rivera-Chavez F, 2019, NATURE, V572, P244, DOI 10.1038/s41586-019-1453-3; Rivera-Chavez F, 2015, ANNU REV MICROBIOL, V69, P31, DOI 10.1146/annurev-micro-091014-104108; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Shakov R, 2011, AM J INFECT CONTROL, V39, P194, DOI 10.1016/j.ajic.2010.08.017; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; SVENSATER G, 1992, ORAL MICROBIOL IMMUN, V7, P148, DOI 10.1111/j.1399-302X.1992.tb00528.x; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062081; Tang WH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00087; Thompson LR, 2017, NATURE, V551, P457, DOI 10.1038/nature24621; Whitaker WR, 2017, CELL, V169, P538, DOI 10.1016/j.cell.2017.03.041; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; YAMADA M, 1987, J BIOL CHEM, V262, P5455	44	18	19	1	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					261	+		10.1038/s41586-021-03502-6	http://dx.doi.org/10.1038/s41586-021-03502-6		APR 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33911281	Green Accepted			2022-12-28	WOS:000645221300004
J	Zhang, X; Nottingham, KG; Patel, C; Alegre-Requena, JV; Levy, JN; Paton, RS; McNally, A				Zhang, Xuan; Nottingham, Kyle G.; Patel, Chirag; Alegre-Requena, Juan V.; Levy, Jeffrey N.; Paton, Robert S.; McNally, Andrew			Phosphorus-mediated sp(2)-sp(3) couplings for C-H fluoroalkylation of azines	NATURE			English	Article							TRIFLUOROMETHYLATION REACTIONS; FLUORINE; FUNCTIONALIZATION; PHARMACEUTICALS; SUBSTITUTION; HETEROARENES	Fluoroalkyl groups profoundly affect the physical properties of pharmaceuticals and influence almost all metrics associated with their pharmacokinetic and pharmacodynamic profile(1-4). Drug candidates increasingly contain trifluoromethyl (CF3) and difluoromethyl (CF2H) groups, and the same trend in agrochemical development shows that the effect of fluoroalkylation translates across human, insect and plant life(5,6). New fluoroalkylation reactions have undoubtedly stimulated this shift; however, methods that directly convert C-H bonds into C-CF2X groups (where X is F or H) in complex drug-like molecules are rare(7-13). Pyridines are the most common aromatic heterocycles in pharmaceuticals(14), but only one approach-via fluoroalkyl radicals-is viable for achieving pyridyl C-H fluoroalkylation in the elaborate structures encountered during drug development(15-17). Here we develop a set of bench-stable fluoroalkylphosphines that directly convert the C-H bonds in pyridine building blocks, drug-like fragments and pharmaceuticals into fluoroalkyl derivatives. No preinstalled functional groups or directing groups are required. The reaction tolerates a variety of sterically and electronically distinct pyridines, and is exclusively selective for the 4-position in most cases. The reaction proceeds through initial formation of phosphonium salts followed by sp(2)-sp(3) coupling of phosphorus ligands-an underdeveloped manifold for forming C-C bonds.	[Zhang, Xuan; Nottingham, Kyle G.; Patel, Chirag; Alegre-Requena, Juan V.; Levy, Jeffrey N.; Paton, Robert S.; McNally, Andrew] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA	Colorado State University	Paton, RS; McNally, A (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	robert.paton@colostate.edu; andy.mcnally@colostate.edu	Paton, Robert/A-4564-2010; Alegre-Requena, Juan V./AFQ-0674-2022; Alegre-Requena, Juan V./GRR-1595-2022	Paton, Robert/0000-0002-0104-4166; Alegre-Requena, Juan V./0000-0002-0769-7168; Zhang, Xuan/0000-0002-7679-7963; McNally, Andrew/0000-0002-8651-1631	National Science Foundation (NSF) [1753087]; NSF [ACI-1532235, ACI-1532236]; Extreme Science and Engineering Discovery Environment (XSEDE) [TG-CHE180056, TG-CHE200033]	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Extreme Science and Engineering Discovery Environment (XSEDE)	This work was supported by the National Science Foundation (NSF) under grant number 1753087. We acknowledge the Rocky Mountain Advanced Computing Consortium (RMACC) Summit supercomputer, supported by the NSF (grants ACI-1532235 and ACI-1532236), and the Extreme Science and Engineering Discovery Environment (XSEDE) (allocations TG-CHE180056 and TG-CHE200033). We thank M. J. Gaunt for help in preparing the manuscript. We dedicate this paper to the memory of Robert M. Williams.	Alonso C, 2015, CHEM REV, V115, P1847, DOI 10.1021/cr500368h; ANDERS E, 1987, TETRAHEDRON LETT, V28, P2675, DOI 10.1016/S0040-4039(00)96178-1; Barata-Vallejo S, 2019, MOLECULES, V24, DOI 10.3390/molecules24244483; Barata-Vallejo S, 2014, CHEM-EUR J, V20, P16806, DOI 10.1002/chem.201404005; Barbe G, 2008, J AM CHEM SOC, V130, P18, DOI 10.1021/ja077463q; Beatty JW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8919; Boyle BT, 2019, J AM CHEM SOC, V141, P15441, DOI 10.1021/jacs.9b08504; Burriss A, 2018, PEST MANAG SCI, V74, P1228, DOI 10.1002/ps.4806; Dolewski RD, 2018, J AM CHEM SOC, V140, P8020, DOI 10.1021/jacs.8b04530; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fasano V, 2018, CHEM COMMUN, V54, P662, DOI 10.1039/c7cc09128a; Finet J.-P., 1998, LIGAND COUPLING REAC, V18, P159; Fujimoto H, 2020, J AM CHEM SOC, V142, P17323, DOI 10.1021/jacs.0c08928; Fujiwara Y, 2012, NATURE, V492, P95, DOI 10.1038/nature11680; Fujiwara Y, 2012, J AM CHEM SOC, V134, P1494, DOI 10.1021/ja211422g; Gibbs MA, 2003, CLIN PHARMACOKINET, V42, P969, DOI 10.2165/00003088-200342110-00003; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hilton MC, 2018, SCIENCE, V362, P799, DOI 10.1126/science.aas8961; Hilton MC, 2016, J AM CHEM SOC, V138, P13806, DOI 10.1021/jacs.6b08662; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108; Krishnamurti V, 2019, ORG LETT, V21, P1526, DOI 10.1021/acs.orglett.9b00381; Lemos A, 2019, ADV SYNTH CATAL, V361, P1500, DOI 10.1002/adsc.201801121; Levy JN, 2020, J AM CHEM SOC, V142, P11295, DOI 10.1021/jacs.0c04674; Lim S, 2020, J AM CHEM SOC, V142, P16188, DOI 10.1021/jacs.0c07580; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Nagase M, 2016, J AM CHEM SOC, V138, P6103, DOI 10.1021/jacs.6b01753; Nagib DA, 2011, NATURE, V480, P224, DOI 10.1038/nature10647; O'Hara F, 2013, J AM CHEM SOC, V135, P12122, DOI 10.1021/ja406223k; Postigo A, 2019, LATE-STAGE FLUORINATION OF BIOACTIVE MOLECULES AND BIOLOGICALLY-RELEVANT SUBSTRATES, P1, DOI 10.1016/C2016-0-03574-X; UCHIDA Y, 1989, TETRAHEDRON LETT, V30, P567, DOI 10.1016/S0040-4039(00)95256-0; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; Ye F, 2019, ANGEW CHEM INT EDIT, V58, P14615, DOI 10.1002/anie.201906672; Yerien DE, 2017, CHEM-EUR J, V23, P14676, DOI 10.1002/chem.201702311; Zafrani Y, 2017, J MED CHEM, V60, P797, DOI 10.1021/acs.jmedchem.6b01691; Zhou Y, 2016, CHEM REV, V116, P422, DOI 10.1021/acs.chemrev.5b00392	36	34	34	12	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					217	+		10.1038/s41586-021-03567-3	http://dx.doi.org/10.1038/s41586-021-03567-3		APR 2021	7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ8YR	33910228				2022-12-28	WOS:000657239100001
J	Rimmer, A				Rimmer, Abi			Beauty services firm backtracks on NHS staff ban	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gmel GE, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.625835	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2021	372								n1009	10.1136/bmj.n1009	http://dx.doi.org/10.1136/bmj.n1009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IH	33875520	Bronze			2022-12-28	WOS:000642451400003
J	Jack, B				Jack, Belinda			Pandemic reading: poetry, looking and seeing	LANCET			English	Editorial Material									[Jack, Belinda] Univ Oxford, Christ Church, Oxford OX1 1DP, England	University of Oxford	Jack, B (corresponding author), Univ Oxford, Christ Church, Oxford OX1 1DP, England.	belinda.jack@chch.ox.ac.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1438	1439						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33865487				2022-12-28	WOS:000640378100012
J	Chow, EJ; O'Halloran, A; Rolfes, MA; Reed, C; Garg, S				Chow, Eric J.; O'Halloran, Alissa; Rolfes, Melissa A.; Reed, Carrie; Garg, Shikha			Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults Response	ANNALS OF INTERNAL MEDICINE			English	Letter									[Chow, Eric J.; O'Halloran, Alissa; Rolfes, Melissa A.; Reed, Carrie; Garg, Shikha] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Chow, EJ (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.		Chow, Eric J./T-6061-2019	Chow, Eric J./0000-0003-3349-9330				Schattner A, 2020, PATIENT EDUC COUNS, V103, P1052, DOI 10.1016/j.pec.2019.12.008	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					583	+		10.7326/L21-0018	http://dx.doi.org/10.7326/L21-0018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RU1WZ	33872522				2022-12-28	WOS:000644942400012
J	Khan, MS; Ali, SAM; Adelaine, A; Karan, A				Khan, Mishal S.; Ali, Sameen A. Mohsin; Adelaine, Addy; Karan, Abraar			Rethinking vaccine hesitancy among minority groups	LANCET			English	Editorial Material							PAKISTAN		[Khan, Mishal S.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England; [Khan, Mishal S.] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Khan, Mishal S.] Aga Khan Univ, Dept Pathol, Karachi, Pakistan; [Ali, Sameen A. Mohsin] Lahore Univ Management Sci, Dept Humanities & Social Sci, Lahore, Pakistan; [Adelaine, Addy] Ladders4Action, Weston Super Mare, England; [Karan, Abraar] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Karan, Abraar] Harvard Med Sch, Boston, MA 02115 USA	University of London; London School of Hygiene & Tropical Medicine; Aga Khan University; Aga Khan University; Lahore University of Management Sciences; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Khan, MS (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London WC1H 9SH, England.; Khan, MS (corresponding author), Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan.; Khan, MS (corresponding author), Aga Khan Univ, Dept Pathol, Karachi, Pakistan.	mishal.khan@lshtm.ac.uk	Karan, Abraar/AAD-7967-2022; Adelaine, Addy/G-2501-2017	Adelaine, Addy/0000-0003-0729-3259; Ali, Sameen/0000-0003-1062-2105				Ali S., 2021, J BEHAV PUBLIC ADM, V4, P1, DOI [10.30636/jbpa.41.184, DOI 10.30636/JBPA.41.184]; Boyd R., 2021, NY TIMES; Commission on Race and Ethnic Disparities, 2021, REP COMM RAC ETHN DI; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Jamal D, 2020, VACCINE, V38, P4747, DOI 10.1016/j.vaccine.2020.05.018; Kaiser Family Foundation, 2021, LAT DAT COVID 19 VAC; Kama-Kieghe S., 2021, GP ONLINE; Khan YH, 2020, AM J TROP MED HYG, V103, P603, DOI 10.4269/ajtmh.20-0654; Lenzer J, 2007, BRIT MED J, V334, P1181, DOI 10.1136/bmj.39237.658171.DB; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Michelson A., 2021, BUSINESS INSIDER; Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008; Royal Society of Arts M C, 2021, ETHN MIN TWIC LIK FA; WHO, 2020, CALL ACT MAN INF; Women and Equalities Committee, 2021, GOV FAIL BAM COMM YO	15	18	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 22	2021	397	10288					1863	1865		10.1016/S0140-6736(21)00938-7	http://dx.doi.org/10.1016/S0140-6736(21)00938-7		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SF1XN	33894143	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000652556000004
J	Dong, CY; Ly, C; Dunlap, LE; Vargas, MV; Sun, JQ; Hwang, IW; Azinfar, A; Oh, WC; Wetsel, WC; Olson, DE; Tian, L				Dong, Chunyang; Ly, Calvin; Dunlap, Lee E.; Vargas, Maxemiliano V.; Sun, Junqing; Hwang, In-Wook; Azinfar, Arya; Oh, Won Chan; Wetsel, William C.; Olson, David E.; Tian, Lin			Psychedelic-inspired drug discovery using an engineered biosensor	CELL			English	Article							AGONIST-DIRECTED TRAFFICKING; SEROTONIN 2A RECEPTOR; 5-HT2A; COMPLEX; SYNAPTOGENESIS; IDENTIFICATION; CHEMISTRY; PROTEINS; LIGANDS; MICE	Ligands can induce G protein-coupled receptors (GPCRs) to adopt a myriad of conformations, many of which play critical roles in determining the activation of specific signaling cascades associated with distinct functional and behavioral consequences. For example, the 5-hydroxytryptamine 2A receptor (5-HT2AR) is the target of classic hallucinogens, atypical antipsychotics, and psychoplastogens. However, currently available methods are inadequate for directly assessing 5-HT2AR conformation both in vitro and in vivo. Here, we developed psychLight, a genetically encoded fluorescent sensor based on the 5-HT2AR structure. PsychLight detects behaviorally relevant serotonin release and correctly predicts the hallucinogenic behavioral effects of structurally similar 5-HT2AR ligands. We further used psychLight to identify a non-hallucinogenic psychedelic analog, which produced rapid-onset and long-lasting antidepressant-like effects after a single administration. The advent of psychLight will enable in vivo detection of serotonin dynamics, early identification of designer drugs of abuse, and the development of 5-HT2AR-dependent non-hallucinogenic therapeutics.	[Dong, Chunyang] Univ Calif Davis, Grad Program Biochem Mol Cellular Dev Biol, Davis, CA 95616 USA; [Ly, Calvin; Dunlap, Lee E.; Azinfar, Arya; Olson, David E.] Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA; [Vargas, Maxemiliano V.] Univ Calif Davis, Neurosci Grad Program, Davis, CA 95618 USA; [Hwang, In-Wook; Oh, Won Chan] Univ Colorado, Dept Pharmacol, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Wetsel, William C.] Duke Univ, Med Ctr, Mouse Behav & Neuroendocrine Anal Core Facil, Durham, NC 27710 USA; [Dong, Chunyang; Sun, Junqing; Olson, David E.; Tian, Lin] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95618 USA; [Olson, David E.; Tian, Lin] Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95618 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Duke University; Duke University; Duke University; University of California System; University of California Davis; University of California System; University of California Davis	Olson, DE (corresponding author), Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA.; Olson, DE; Tian, L (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95618 USA.; Olson, DE; Tian, L (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95618 USA.	deolson@ucdavis.edu; lintian@ucdavis.edu		HWANG, INWOOK/0000-0003-4317-3465; Dong, Chunyang/0000-0002-4820-4454	Biological Analysis Core of the UC Davis MIND Institute Intellectual and Development Disabilities Research Center [U54 HD079125]; National Insitute of Health [R01GM128997, DP2MH107056, U01NS090604, U01NS013522, U01NS103571, R01MH101214, R01MH12478, R21MH126073]; Hellman Fellowship; Human Frontier Fellowship; Rita Allen Investigator Award; UC Davis; National Institute Healthy training grants [T32GM113770, 5T32GM099608]; Brain and Behavior Research Foundation NARSAD Young Investigator Award; Brain Research Foundation Seed Grant	Biological Analysis Core of the UC Davis MIND Institute Intellectual and Development Disabilities Research Center; National Insitute of Health; Hellman Fellowship; Human Frontier Fellowship; Rita Allen Investigator Award; UC Davis; National Institute Healthy training grants; Brain and Behavior Research Foundation NARSAD Young Investigator Award; Brain Research Foundation Seed Grant	We thank Dr. Yiyang Gong for helping out with d0 analysis. We also thank Mr. Christopher Means and Dr. Ramona Rodriguiz for conducting and analyzing the sucrose preference experiment. We also thank Kyle Puhger and Dr. Brian Wiltgen for providing critical suggestions on fiber-photometry data analysis. We thank Drs. Michael Bruchas (University of Washington), Henry Lester (Cal-Tech), and Bruce Cohen (CalTech) for providing critical suggestions on pA2 analysis. Some graphic components were created with BioRender.com. This project used the Biological Analysis Core of the UC Davis MIND Institute Intellectual and Development Disabilities Research Center (U54 HD079125). Several of the drugs used in this study were provided by the NIDA Drug Supply Program. This work was supported by funds from the National Insitute of Health (R01GM128997 to D.E.O.; DP2MH107056, U01NS090604, U01NS013522, U01NS103571, and R01MH101214 to L.T.; and R01MH12478 and R21MH126073 to W.C.O.), a Hellman Fellowship (to D.E.O.), Human Frontier Fellowship (to L.T.), Rita Allen Investigator Award (to L.T.), UC Davis STAIR and STAIR Plus grants (to D.E.O. and L.T.), two National Institute Healthy training grants (T32GM113770 to C.L. and 5T32GM099608 to M.V.V.), Brain and Behavior Research Foundation NARSAD Young Investigator Award (to W.C.O.), and a Brain Research Foundation Seed Grant (to W.C.O.).	Aghajanian GK, 1999, NEUROPSYCHOPHARMACOL, V21, pS16; Benes H, 2006, J NEURAL TRANSM, V113, P87, DOI 10.1007/s00702-005-0386-1; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; Blair JB, 2000, J MED CHEM, V43, P4701, DOI 10.1021/jm000339w; Broussard GJ, 2018, NEUROMETHODS, V130, P117, DOI 10.1007/978-1-4939-7228-9_5; Cameron LP, 2021, NATURE, V589, P474, DOI 10.1038/s41586-020-3008-z; Cameron LP, 2019, ACS CHEM NEUROSCI, V10, P3261, DOI 10.1021/acschemneuro.8b00692; Cameron LP, 2018, ACS CHEM NEUROSCI, V9, P1582, DOI 10.1021/acschemneuro.8b00134; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chi TY, 2020, J NEUROL SCI, V411, DOI 10.1016/j.jns.2020.116715; Cussac D, 2008, EUR J PHARMACOL, V594, P32, DOI 10.1016/j.ejphar.2008.07.040; Dunlap LE, 2020, J MED CHEM, V63, P1142, DOI 10.1021/acs.jmedchem.9b01404; Dunlap LE, 2018, ACS CHEM NEUROSCI, V9, P2408, DOI 10.1021/acschemneuro.8b00155; Ebersole BJ, 2003, MOL PHARMACOL, V63, P36, DOI 10.1124/mol.63.1.36; Fribourg M, 2011, CELL, V147, P1011, DOI 10.1016/j.cell.2011.09.055; Fukui M, 2007, J NEUROSCI, V27, P10520, DOI 10.1523/JNEUROSCI.4388-06.2007; GLENNON RA, 1983, EUR J PHARMACOL, V86, P453, DOI 10.1016/0014-2999(83)90196-6; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Halberstadt AL, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107933; Hanks JB, 2013, ACS CHEM NEUROSCI, V4, P33, DOI 10.1021/cn300138m; Hascoet M., 2009, FORCED SWIMMING TEST, P85; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Huot P, 2011, J NEUROSCI, V31, P7190, DOI 10.1523/JNEUROSCI.1171-11.2011; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; KALIR A, 1963, J MED CHEM, V6, P716, DOI 10.1021/jm00342a019; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kim K, 2020, CELL, V182, P1574, DOI 10.1016/j.cell.2020.08.024; Ko KW, 2016, NAT NEUROSCI, V19, P826, DOI 10.1038/nn.4293; Kwon HB, 2012, NAT NEUROSCI, V15, P1667, DOI 10.1038/nn.3256; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Ly C, 2018, CELL REP, V23, P3170, DOI 10.1016/j.celrep.2018.05.022; Marzaro G, 2009, GREEN CHEM, V11, P774, DOI 10.1039/b900750d; Nenajdenko VG, 2001, TETRAHEDRON-ASYMMETR, V12, P2517, DOI 10.1016/S0957-4166(01)00442-6; Oh WC, 2016, SCIENCE, V353, P1037, DOI 10.1126/science.aaf5206; Olsen RHJ, 2020, NAT CHEM BIOL, V16, P841, DOI 10.1038/s41589-020-0535-8; Olson DE, 2021, ACS PHARMACOL TRANSL, V4, P563, DOI 10.1021/acsptsci.0c00192; Olson DE, 2018, J EXP NEUROSCI, V12, DOI 10.1177/1179069518800508; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; Preller KH, 2018, ELIFE, V7, DOI 10.7554/eLife.35082; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Rabin RA, 2002, PHARMACOL BIOCHEM BE, V72, P29, DOI 10.1016/S0091-3057(01)00720-1; Ren J, 2018, CELL, V175, P472, DOI 10.1016/j.cell.2018.07.043; Roth BL, 2017, NAT CHEM BIOL, V13, P1143, DOI 10.1038/nchembio.2490; Schmid CL, 2008, P NATL ACAD SCI USA, V105, P1079, DOI 10.1073/pnas.0708862105; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Shonberg J, 2014, MED RES REV, V34, P1286, DOI 10.1002/med.21318; Somei M, 2001, CHEM PHARM BULL, V49, P87, DOI 10.1248/cpb.49.87; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Talluri SK, 2007, TETRAHEDRON, V63, P9758, DOI 10.1016/j.tet.2007.07.012; Tandon N, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.3073; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Tombari RJ, 2019, ACS CHEM BIOL, V14, P1866, DOI 10.1021/acschembio.9b00548; Unger EK, 2020, CELL, V183, P1986, DOI 10.1016/j.cell.2020.11.040; Wacker D, 2017, CELL, V168, P377, DOI 10.1016/j.cell.2016.12.033; Wan JX, 2021, NAT NEUROSCI, V24, P746, DOI 10.1038/s41593-021-00823-7; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Yaden DB, 2021, ACS PHARMACOL TRANSL, V4, P568, DOI 10.1021/acsptsci.0c00194; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	62	35	35	5	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2779	+		10.1016/j.cell.2021.03.043	http://dx.doi.org/10.1016/j.cell.2021.03.043		MAY 2021	32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33915107	Bronze, Green Accepted			2022-12-28	WOS:000652830800019
J	Horby, PW; Landray, MJ				Horby, Peter W.; Landray, Martin J.		Recovery Collaborative Grp	Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial	LANCET			English	Article							CORONAVIRUS DISEASE 2019; OUTCOMES	Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein >= 75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg-800 mg (depending on weight) given intravenously. A second dose could be given 12-24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0.85; 95% CI 0.76-0.94; p=0.0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1.22; 1.12-1.33; p<0.0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0.84; 95% CI 0.77-0.92; p<0.0001). Interpretation In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Copyright (C) 2021 Published by Elsevier Ltd. All rights reserved.	[Horby, Peter W.; Landray, Martin J.] RECOVERY Cent Coordinating Off, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England	University of Oxford	Horby, PW; Landray, MJ (corresponding author), RECOVERY Cent Coordinating Off, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.		Shanahan, Thomas/AAP-3822-2020; Tso, Simon/N-2422-2014; mcgrath, brendan a/D-7202-2013; Caplin, Ben/AAH-1641-2019; Fawke, Joe/ABA-9407-2021; Darton, Thomas/H-2816-2017; Dosanjh, Davinder/ABD-8895-2021; Chan, Xin Hui S/ABA-5004-2021; Evans, D Gareth/AAB-4308-2022; Ahmed, Naseer/C-8119-2019; Tageldin, Amr/CAF-8726-2022; Pessoa-Amorim, Guilherme/AAV-4151-2021; Wu, Henry H.L./B-9400-2019; Gkrania-Klotsas, Effrossyni/AAT-8424-2021; Rivera-Ortega, Pilar/X-7083-2019; Payne, Brendan/I-1233-2016; Kudsk-Iversen, Soren/Y-9391-2018; Faust, Saul/J-9779-2014; Gibbison, Ben/J-6611-2014; Porter, Joanna/C-7162-2009; Skene, Imogen/D-6153-2018; moon, james/F-1031-2014; Llewelyn, Martin/A-7194-2011; Montgomery, Hugh/C-2592-2008; Pearse, Rupert/H-5426-2011	Shanahan, Thomas/0000-0001-5613-2545; Tso, Simon/0000-0001-9221-7618; mcgrath, brendan a/0000-0003-3048-3480; Caplin, Ben/0000-0001-9544-164X; Fawke, Joe/0000-0002-5267-7107; Darton, Thomas/0000-0003-2209-9956; Dosanjh, Davinder/0000-0002-9169-5607; Chan, Xin Hui S/0000-0002-9941-6975; Evans, D Gareth/0000-0002-8482-5784; Ahmed, Naseer/0000-0002-0960-1123; Pessoa-Amorim, Guilherme/0000-0002-4050-6191; Wu, Henry H.L./0000-0002-4561-0844; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; Rivera-Ortega, Pilar/0000-0002-7960-8822; Soiza, Roy/0000-0002-1397-4272; Newman, Tom/0000-0002-7987-9948; Rokadiya, Sakib/0000-0003-2955-4907; Welters, Ingeborg/0000-0002-3408-8798; Roehr, Charles Christoph/0000-0001-7965-4637; Brankin-Frisby, Thomas/0000-0003-2184-8580; Spears, Mark/0000-0003-4381-5819; Behrouzi, Roya/0000-0002-1978-6539; Esmail, Hanif/0000-0002-4278-9316; Montgomery, Alan/0000-0003-0450-1606; Pastika, Libor/0000-0001-6892-6553; Payne, Brendan/0000-0002-3101-3512; Lowsby, Richard/0000-0001-9940-191X; Drysdale, Simon/0000-0002-6350-6557; Kudsk-Iversen, Soren/0000-0002-7112-3548; Collini, Paul/0000-0001-6696-6826; Lim, Ivy/0000-0001-9848-8769; Gorick, Hugh/0000-0003-3089-9830; Foley, Paul/0000-0002-4856-832X; mumford, andrew/0000-0002-5523-511X; Ramasamy, Maheshi Nirmala/0000-0002-2119-951X; Dobbie, Laurence J./0000-0003-1908-848X; Cole, Joby/0000-0002-5258-5835; Gregory, Katherine/0000-0002-0610-5386; brightling, chris/0000-0002-9345-4903; Rowan, Kathryn/0000-0001-8217-5602; So, Beng/0000-0003-4356-532X; Puxty, Kathryn/0000-0002-5742-6171; Welch, Hugh/0000-0001-6906-2718; Mishra, Eleanor/0000-0002-5903-3005; Colton, Hayley/0000-0002-3287-4103; Iliodromiti, Stamatina/0000-0001-6453-6654; Archer, Ann/0000-0002-4185-4454; Hum, Ryan Malcolm/0000-0003-0801-6974; Razvi, Salman/0000-0002-9047-1556; Ricketts, William/0000-0002-0475-0744; Iftikhar, Hina/0000-0003-2138-1415; King, Scott/0000-0001-6821-9234; Graham, Jonathan/0000-0002-3227-5928; Faust, Saul/0000-0003-3410-7642; O'Sullivan, Eoin/0000-0002-7709-6595; De Sousa, Paulo/0000-0003-3011-4116; Chaudhuri, Nazia/0000-0003-3325-6996; Gibbison, Ben/0000-0003-3635-6212; Hannah, Jennifer/0000-0002-3491-6653; Vallabhaneni, Pramodh/0000-0002-4887-8651; Barnett-Vanes, Ashton/0000-0002-8088-1068; Nigel, Brunskill/0000-0002-7109-7108; imray, chris/0000-0001-8451-4102; Parekh, Dhruv/0000-0002-1508-8362; Bassett, John/0000-0002-8815-6012; Lim, Wei Shen/0000-0002-7694-3051; de Vere, Natasha/0000-0001-9593-6925; Underwood, Jonathan/0000-0001-6963-2821; Gibani, Malick/0000-0003-1781-0053; Mazzella, Andrea/0000-0003-1560-7465; Lewis, Joseph/0000-0002-3837-5188; Cooper, Jamie/0000-0003-3812-7026; Shah, Pallav/0000-0002-9052-4638; Forton, Julian/0000-0002-0580-0432; Taynton, Thomas/0000-0001-7771-9564; de Silva, Thushan/0000-0002-6498-9212; Campbell, Mark/0000-0002-9759-0232; Burton, Ben/0000-0001-9579-9078; Dhaliwal, Kevin/0000-0002-3925-3174; Sahdev, Nikhil/0000-0003-2291-5044; Glaysher, Sharon/0000-0002-9584-0621; Pfeffer, Paul/0000-0003-0369-2885; Brannigan, Jamie/0000-0003-1697-403X; Kametas, Nicholas/0000-0002-7992-6038; Orton, Christopher/0000-0002-9167-5462; Ireland, Aidan Taeke/0000-0001-9513-2302; Graham-Brown, Matthew/0000-0002-6197-180X; Barker, Joseph/0000-0002-5483-9608; Gorog, Diana/0000-0002-9286-1451; Scott, Alex/0000-0001-6719-0417; kumar, vimal/0000-0002-3801-995X; Al-Shahi Salman, Rustam/0000-0002-2108-9222; Ustianowski, Andrew/0000-0002-6134-7855; Burden, Christy/0000-0001-6409-5238; Porter, Joanna/0000-0002-7307-169X; Kapil, Vikas/0000-0001-5778-6188; Milligan, Iain D/0000-0002-6501-5524; Lillie, Patrick/0000-0002-4811-4774; Peters, Mark/0000-0003-3653-4808; Gupta-Wright, Ankur/0000-0002-5150-2970; Barrett, Amy/0000-0001-8671-8803; Smith, Christopher/0000-0001-7369-2034; Green, Christopher/0000-0002-1984-4014; Nadeem, Iftikhar/0000-0002-8644-925X; Whittaker, Elizabeth/0000-0002-7944-8793; Skene, Imogen/0000-0001-5215-2899; Hoggett, Lee/0000-0003-1135-6232; Jethwa, Kishan/0000-0003-1715-9256; Linares, Christian Alexander/0000-0002-2473-8873; Hawcutt, Dan/0000-0002-8120-6507; Mentzer, Alexander/0000-0002-4502-2209; Hormis, Anil/0000-0001-5510-7639; Denis, Emmanuelle/0000-0001-8463-1341; Murray, Clare/0000-0002-8961-8055; Cathie, Katrina/0000-0001-5074-0769; Downey, Damian/0000-0002-6471-549X; vatish, manu/0000-0002-6012-2574; Mahaveer, Ajit/0000-0001-9786-6860; Kelly, Dominic/0000-0002-6063-8896; Christides, Alexander/0000-0002-9476-9827; Dixon, Giles/0000-0001-9787-0739; Murray, Eleanor/0000-0002-4837-4840; Adams, Richard/0000-0003-3915-7243; Hodson, Kenneth/0000-0003-3091-6952; Islim, Abdurrahman/0000-0001-9621-043X; Chapman, Laura/0000-0001-6174-9435; Aujayeb, Avinash/0000-0002-0859-5550; Dark, Paul/0000-0003-3309-0164; Peto, Leon/0000-0002-4100-2163; McKnight, Gerard/0000-0003-1546-7853; Haynes, Richard/0000-0002-1179-0023; Lord, Robert/0000-0001-9008-2502; Pathan, Nazima/0000-0001-7656-9453; Noba, Lyrics/0000-0002-5389-7937; moon, james/0000-0001-8071-1491; Mutch, Callum/0000-0001-9788-0179; Tridente, Ascanio/0000-0003-1500-447X; Merrick, Blair/0000-0002-6061-6064; Bancroft, Elizabeth/0000-0002-5482-5660; Cavazza, Anna/0000-0003-3720-0463; Linden, Dermot/0000-0003-0552-1115; Llewelyn, Martin/0000-0002-6811-1124; Emberson, Jonathan/0000-0001-7792-9422; Montgomery, Hugh/0000-0001-8797-5019; Rickman, Hannah/0000-0002-3502-0744; Hodgson, Luke/0000-0002-8278-9513; maskell, nick/0000-0002-1276-6500; Willis, Joanna/0000-0003-3260-4311; Harwood, Catherine/0000-0002-1375-0965; Adamali, Huzaifa/0000-0002-8230-175X; Crocombe, Dominic/0000-0002-1401-6930; Sarkar, Rahuldeb/0000-0002-4343-8526; Patel, Manish/0000-0003-3012-7507; Hartshorn, Stuart/0000-0003-0419-1564; Parmar, Chetan/0000-0002-1238-6524; Bhagani, Sanjay/0000-0003-2557-4337; Naisbitt, Michael/0000-0003-1560-6235; Baillie, John Kenneth/0000-0001-5258-793X; Jhanji, Shaman/0000-0002-1116-628X; Bibby, Anna/0000-0001-7386-7754; Bukhari, Marwan/0000-0003-4311-5222; Barnacle, James/0000-0003-1316-6205; Pearse, Rupert/0000-0002-4373-5934; Hinshaw, Kim/0000-0003-0468-4326; Buch, Maya/0000-0002-8962-5642; Last, Anna/0000-0001-8730-9323; Quenby, Siobhan/0000-0003-3221-5471; Landray, Martin/0000-0001-6646-827X; Dey, Vishal/0000-0002-5108-4158; Vidler, Jennifer/0000-0003-2996-3014; Bachar, Roudi/0000-0001-8113-7110; Macleod, Mary Joan/0000-0003-2115-8184; Ripley, David/0000-0001-8460-9873; Shelley, Ben/0000-0001-6771-9659; CARTER, Michael/0000-0003-3403-4746; Jajbhay, Danyal/0000-0002-3475-9651; Abu-Arafeh, Ahmad/0000-0003-2464-3871; Ali, Mohammad/0000-0002-4765-615X	UK Research and Innovation (Medical Research Council); National Institute of Health Research	UK Research and Innovation (Medical Research Council); National Institute of Health Research(National Institute for Health Research (NIHR))	UK Research and Innovation (Medical Research Council) and National Institute of Health Research.	Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Del Valle D.M., 2020, NAT MED, V26, P1636, DOI DOI 10.1038/s41591-020-1051-9; Dorward DA, 2021, AM J RESP CRIT CARE, V203, P192, DOI 10.1164/rccm.202008-3265OC; Early Breast Cancer Trialists' Collaborative Group, 1990, TREATMENT EARLY BREA; Escadafal C, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002396; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Hermine O, 2021, JAMA INTERN MED, V181, P32, DOI 10.1001/jamainternmed.2020.6820; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Lescure FX, 2021, LANCET RESP MED, V9, P522, DOI 10.1016/S2213-2600(21)00099-0; Murthy S, 2021, LANCET RESP MED, V9, P438, DOI 10.1016/S2213-2600(21)00127-2; National Institutes of Health, 2021, COR DIS 2019 COVID 1; Oberhoffer M, 1999, CRIT CARE MED, V27, P1814, DOI 10.1097/00003246-199909000-00018; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Rosas I., 2020, TOCILIZUMAB HOSPITAL, DOI [10.1101/2020.08.27.20183442, DOI 10.1101/2020.08.27.20183442]; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Salama C, 2021, NEW ENGL J MED, V384, P20, DOI 10.1056/NEJMoa2030340; Salvarani C, 2021, JAMA INTERN MED, V181, P24, DOI 10.1001/jamainternmed.2020.6615; Soin AS, 2021, LANCET RESP MED, V9, P511, DOI 10.1016/S2213-2600(21)00081-3; Sterne JAC, 2020, JAMA-J AM MED ASSOC, V324, P1330, DOI 10.1001/jama.2020.17023; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; Veiga VC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n84; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wang L, 2020, J INFECTION, V80, P639, DOI 10.1016/j.jinf.2020.03.019; Yuan Q, 2020, INFECT DIS-NOR, V71, P2027, DOI [DOI 10.1093/CID/CIAA344, DOI 10.1093/cid/ciaa344]; Zhou L, 2020, NEW ENGL J MED, DOI [10.1056/NEJMoa2002032, DOI 10.1056/NEJMOA2002032, 10.1097/CM90000000000000824.]	28	888	897	9	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1637	1645						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV0EH	33933206	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000645510600024
J	Silberner, J				Silberner, Joanne			How Joe Biden has changed US healthcare in just 100 days	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												joanne.silberner@gmail.com						Godlee F, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3703; Kates J., KFF 2021; Keith K, 2021, HEALTH AFFAIR, V40, P696, DOI 10.1377/hlthaff.2021.00597; Lenzer j, BMJ-BRIT MED J, V372, pN744; Rovner J., 2021, KAISER HLTH NEWS; Silberner J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n142; Tanne Jh, BMJ-BRIT MED J, V373, pN940	7	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2021	373								n1081	10.1136/bmj.n1081	http://dx.doi.org/10.1136/bmj.n1081			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UG4TJ	33926911				2022-12-28	WOS:000689246600004
J	Kuehn, BM				Kuehn, Bridget M.			Israel's Real-life Evidence That Vaccine Can Prevent Severe COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1603	1603		10.1001/jama.2021.5617	http://dx.doi.org/10.1001/jama.2021.5617			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904859	Bronze			2022-12-28	WOS:000645617800011
J	Kuehn, BM				Kuehn, Bridget M.			More Severe Obesity Leads to More Severe COVID-19 in Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	8	9	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1603	1603		10.1001/jama.2021.4853	http://dx.doi.org/10.1001/jama.2021.4853			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904860	Bronze			2022-12-28	WOS:000645617800010
J	Shen, BY; Chen, X; Wang, HQ; Xiong, H; Bosch, EGT; Lazic, I; Cai, DL; Qian, WZ; Jin, SF; Liu, X; Han, Y; Wei, F				Shen, Boyuan; Chen, Xiao; Wang, Huiqiu; Xiong, Hao; Bosch, Eric G. T.; Lazic, Ivan; Cai, Dali; Qian, Weizhong; Jin, Shifeng; Liu, Xin; Han, Yu; Wei, Fei			A single-molecule van der Waals compass	NATURE			English	Article							POWDER NEUTRON; NMR METHOD; ZEOLITE; ZSM-5; STEM; OPTIMIZATION; DIFFRACTION; CRYSTAL; XYLENE	Single-molecule imaging is challenging but highly beneficial for investigating intermolecular interactions at the molecular level(1-6). Van der Waals interactions at the sub-nanometre scale strongly influence various molecular behaviours under confinement conditions(7-11). Inspired by the traditional compass(12), here we use a para-xylene molecule as a rotating pointer to detect the host-guest van der Waals interactions in the straight channel of the MFI-type zeolite framework. We use integrated differential phase contrast scanning transmission electron microscopy(13-15) to achieve real-space imaging of a single para-xylene molecule in each channel. A good correlation between the orientation of the single-molecule pointer and the atomic structure of the channel is established by combining the results of calculations and imaging studies. The orientations of para-xylene help us to identify changes in the van der Waals interactions, which are related to the channel geometry in both spatial and temporal dimensions. This work not only provides a visible and sensitive means to investigate host-guest van der Waals interactions in porous materials at the molecular level, but also encourages the further study of other single-molecule behaviours using electron microscopy techniques.	[Shen, Boyuan; Chen, Xiao; Wang, Huiqiu; Xiong, Hao; Cai, Dali; Qian, Weizhong; Wei, Fei] Tsinghua Univ, Dept Chem Engn, Beijing Key Lab Green Chem React Engn & Technol, Beijing, Peoples R China; [Bosch, Eric G. T.; Lazic, Ivan] Thermo Fisher Sci, Mat & Struct Anal, Eindhoven, Netherlands; [Jin, Shifeng] Chinese Acad Sci, Res & Dev Ctr Funct Crystals, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Liu, Xin] Dalian Univ Technol, Sch Chem, Dalian, Peoples R China; [Liu, Xin; Han, Yu] King Abdullah Univ Sci & Technol, Adv Membranes & Porous Mat Ctr, Phys Sci & Engn Div, Thuwal, Saudi Arabia; [Han, Yu] Chongqing Univ, Multiscale Porous Mat Ctr, Sch Chem & Chem Engn, Inst Adv Interdisciplinary Studies, Chongqing, Peoples R China	Tsinghua University; Thermo Fisher Scientific; Chinese Academy of Sciences; Dalian University of Technology; King Abdullah University of Science & Technology; Chongqing University	Chen, X; Wei, F (corresponding author), Tsinghua Univ, Dept Chem Engn, Beijing Key Lab Green Chem React Engn & Technol, Beijing, Peoples R China.	chenx123@tsinghua.edu.cn; wf-dce@mail.tsinghua.edu.cn	Liu, Xin/G-3303-2012; Han, Yu/N-2036-2015; Han, Yu/GZA-9220-2022; Wang, Huiqiu/B-5082-2019	Liu, Xin/0000-0002-4422-4108; Han, Yu/0000-0003-1462-1118; CHEN, XIAO/0000-0003-1104-6146; Wang, Huiqiu/0000-0002-3707-5095; Xiong, Hao/0000-0001-5479-7754; Lazic, Ivan/0000-0001-5238-952X	National Key Research and Development Program of China [2018YFB0604801]; National Natural Science Foundation of China [21771029, 202013981, 22005170]; National Key R&D Program of China [2017YFB0602204]; King Abdullah University of Science and Technology [FCC/1/1974-16-01]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	We thank Q. Zhang and W. Gao for discussions. This work was supported by the National Key Research and Development Program of China (2018YFB0604801), the National Natural Science Foundation of China (21771029, 202013981 and 22005170) and the National Key R&D Program of China (2017YFB0602204). Y.H. thanks the Center Applied Research Fund (FCC/1/1974-16-01) from King Abdullah University of Science and Technology. We thank the Tsinghua National Laboratory for Information Science and Technology for assistance with the energy simulation.	Albers BJ, 2009, NAT NANOTECHNOL, V4, P307, DOI [10.1038/nnano.2009.57, 10.1038/NNANO.2009.57]; Allen LJ, 2015, ULTRAMICROSCOPY, V151, P11, DOI 10.1016/j.ultramic.2014.10.011; Aradhya SV, 2012, NAT MATER, V11, P872, DOI [10.1038/NMAT3403, 10.1038/nmat3403]; Beguin L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263201; Bereciartua PJ, 2017, SCIENCE, V358, P1068, DOI 10.1126/science.aao0092; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Boronat M, 2019, ACS CATAL, V9, P1539, DOI 10.1021/acscatal.8b04317; Bosch EGT, 2019, ULTRAMICROSCOPY, V207, DOI 10.1016/j.ultramic.2019.112831; Bosch EGT, 2015, ULTRAMICROSCOPY, V156, P59, DOI 10.1016/j.ultramic.2015.02.004; CARLSON JB, 1975, SCIENCE, V189, P753, DOI 10.1126/science.189.4205.753; Chen QL, 2020, ADV MATER, V32, DOI 10.1002/adma.201907619; de Graaf S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay4312; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Fyfe CA, 2005, J AM CHEM SOC, V127, P7543, DOI 10.1021/ja0432822; Fyfe CA, 2008, MICROPOR MESOPOR MAT, V112, P299, DOI 10.1016/j.micromeso.2007.10.026; Fyfe CA, 2006, J AM CHEM SOC, V128, P11860, DOI 10.1021/ja060744y; Gao WP, 2019, NATURE, V575, P480, DOI 10.1038/s41586-019-1649-6; Goyal R, 2000, J PHYS CHEM B, V104, P2878, DOI 10.1021/jp992984o; Grimme S, 2004, J COMPUT CHEM, V25, P1463, DOI 10.1002/jcc.20078; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Gross L, 2010, NAT CHEM, V2, P821, DOI [10.1038/NCHEM.765, 10.1038/nchem.765]; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P107, DOI 10.1016/B978-0-12-375182-9.10006-5; Kawai S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11559; Kirkland E. J., 2020, ADV COMPUTING ELECT, V3rd; KOKOTAILO GT, 1978, NATURE, V272, P437, DOI 10.1038/272437a0; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; Lazic I., 2016, MICROSC MICROANAL, V22, P36, DOI [10.1017/S1431927616001033, DOI 10.1017/S1431927616001033]; Lazic I, 2017, ADV IMAG ELECT PHYS, V199, P75, DOI 10.1016/bs.aiep.2017.01.006; Lazic I, 2016, ULTRAMICROSCOPY, V160, P265, DOI 10.1016/j.ultramic.2015.10.011; LeBeau JM, 2010, ULTRAMICROSCOPY, V110, P118, DOI 10.1016/j.ultramic.2009.10.001; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Margenau H, 1939, REV MOD PHYS, V11, P0001, DOI 10.1103/RevModPhys.11.1; Perdew JP, 1997, PHYS REV LETT, V78, P1396, DOI 10.1103/PhysRevLett.78.1396; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440; Shen BY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16531-y; Shen BY, 2020, ADV MATER, V32, DOI 10.1002/adma.201906103; Song DS, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201903843; TAYLOR JC, 1987, J CHEM SOC CHEM COMM, P1186, DOI 10.1039/c39870001186; VANKONINGSVELD H, 1989, ACTA CRYSTALLOGR B, V45, P423, DOI 10.1107/S0108768189004519; Yucelen E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20377-2; Zhang J, 2013, SCIENCE, V342, P611, DOI 10.1126/science.1242603	45	29	29	54	202	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					541	+		10.1038/s41586-021-03429-y	http://dx.doi.org/10.1038/s41586-021-03429-y			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6RQ	33883731	Green Submitted			2022-12-28	WOS:000687333900005
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Does it matter who owns general practice?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						Bostock N., 2017, GP 1103; Cowling TE, 2017, J ROY SOC MED, V110, P440, DOI 10.1177/0141076817738499; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n519; Kollewe J., 2021, GUARDIAN; Smith M., 2021, MIRROR	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n1026	10.1136/bmj.n1026	http://dx.doi.org/10.1136/bmj.n1026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883173	Bronze			2022-12-28	WOS:000642452700001
J	Colby, K				Colby, Kathryn			Update on Corneal Transplant in 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Colby, Kathryn] New York Univ Grossman Sch Med, Dept Ophthalmol, 222 E 41st St, New York, NY 10017 USA		Colby, K (corresponding author), New York Univ Grossman Sch Med, Dept Ophthalmol, 222 E 41st St, New York, NY 10017 USA.	kathryn.colby@nyulangone.org						[Anonymous], 2019, 2018 EYEB STAT REP; Borkar DS, 2016, CORNEA, V35, P1267, DOI 10.1097/ICO.0000000000000915; Cordoba A, 2020, CORNEA, V39, P529, DOI 10.1097/ICO.0000000000002246; Hos D, 2019, PROG RETIN EYE RES, V73, DOI 10.1016/j.preteyeres.2019.07.001; Kinoshita S, 2018, NEW ENGL J MED, V378, P995, DOI 10.1056/NEJMoa1712770; Macsai MS, 2019, CORNEA, V38, P529, DOI 10.1097/ICO.0000000000001883; Palioura S, 2017, CORNEA, V36, P21, DOI 10.1097/ICO.0000000000001039; Sarnicola C, 2019, EYE CONTACT LENS, V45, P1, DOI 10.1097/ICL.0000000000000469; Wajnsztajn D, 2021, AM J OPHTHALMOL, V226, P68, DOI 10.1016/j.ajo.2021.02.003	9	3	3	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 11	2021	325	18					1886	1887		10.1001/jama.2020.17382	http://dx.doi.org/10.1001/jama.2020.17382		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB7YR	33871550				2022-12-28	WOS:000642584100001
J	Prkachin, Y				Prkachin, Yvan			The Reign of the Ventilator: Acute Respiratory Distress Syndrome, COVID-19, and Technological Imperatives in Intensive Care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LUNG; COPENHAGEN; ARDS; POLIOMYELITIS; EPIDEMIC; PRESSURE; INJURY	In the early phase of the COVID-19 pandemic, a dispute arose as to whether the disease caused a typical or atypical version of acute respiratory distress syndrome (ARDS). This essay recounts the emergence of ARDS and places it in the context of the technological transformation of modern hospital care-particularly the emergence of intensive care after the 1952 Copenhagen polio epidemic. The polio epidemic seemed to show the value of manual positive-pressure ventilation, leading to the proliferation of mechanical ventilators and the expansion of intensive care units in the 1960s. This created the conditions of possibility for ARDS to be described and institutionalized within modern intensive care. Yet the centrality of the ventilator to descriptions and definitions of ARDS quickly made it difficult to conceive of the disorder outside the framework of mechanical ventilation and blood gas levels, or to acknowledge the degree to which the ventilator was a source of iatrogenic injury and complications. Moreover, the imperative to understand and treat ARDS with mechanical ventilation set the stage for the early confusion about whether patients with COVID-19 should receive mechanical ventilation. This history offers many crucial lessons about how new technologies can lead to new and valuable therapies but can also subtly shape and constrain medical thinking. Moreover, ventilators not only changed how respiratory disorders were conceived; they also brought new forms of respiratory illness into existence.	[Prkachin, Yvan] Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Prkachin, Y (corresponding author), Harvard Univ, Hist Sci Dept, 1 Oxford St, Cambridge, MA 02138 USA.	yvanprkachin@fas.harvard.edu						[Anonymous], 1967, Minn Med, V50, P1693; [Anonymous], 1968, HARTFORD COURAN 0416, P14; ASHBAUGH DG, 1967, LANCET, V2, P319; Astrup P., 1986, JAMA-J AM MED ASSOC, V257, P389, DOI [10.1001/jama.1987.03390030119036, DOI 10.1001/JAMA.1987.03390030119036]; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Berthelsen PG, 2003, ACTA ANAESTH SCAND, V47, P1190, DOI 10.1046/j.1399-6576.2003.00256.x; Chiu A, 2020, WASH POST; Downes, 1990, CLIN APPL VENTILATOR, P1; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Fan E, 2018, JAMA-J AM MED ASSOC, V319, P698, DOI 10.1001/jama.2017.21907; GATTINONI L, 1986, INTENS CARE MED, V12, P137; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Gattinoni L, 1986, J Thorac Imaging, V1, P25, DOI 10.1097/00005382-198607000-00005; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE; Hilberman M, 1975, Crit Care Med, V3, P159; Kallet RH, 2009, RESP CARE, V54, P912, DOI 10.4187/002013209793800330; Kinney JM, 1977, MANUAL SURGICAL THER, P3; Kyle-Sidell C, 2020, NYC ICU DOES COVID 1; Lassen H, 1956, MANAGEMENT LIFE THRE; LASSEN HCA, 1953, LANCET, V264, P37; MARKEL H, 1994, ARCH PEDIAT ADOL MED, V148, P1174, DOI 10.1001/archpedi.1994.02170110060009; Monagle W J, 1970, Mod Hosp, V115, P74; Morris MJ, 2006, MIL MED, V171, P1039, DOI 10.7205/MILMED.171.11.1039; MURRAY JF, 1975, AM REV RESPIR DIS, V111, P716; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; Petty, 2003, SNOWDR PULM C; PETTY TL, 1988, CLIN CHEST MED, V9, P1; PETTY TL, 1988, AM REV RESPIR DIS, V138, P724, DOI 10.1164/ajrccm/138.3.724; PETTY TL, 1975, AM REV RESPIR DIS, V111, P713; Petty TL, 2001, AM J RESP CRIT CARE, V163, P602, DOI 10.1164/ajrccm.163.3.16331; PETTY TL, 1988, AM REV RESPIR DIS, V138, P475, DOI 10.1164/ajrccm/138.2.475; Pontoppidan H, 2004, ANESTHESIOLOGY, V101, P1015, DOI 10.1097/00000542-200410000-00028; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reiser S J, 1992, Int J Technol Assess Health Care, V8, P382; Reisner-Senelar L, 2011, INTENS CARE MED, V37, P1084, DOI 10.1007/s00134-011-2235-z; Rothman D., 1997, BEGINNINGS COUNT TEC; Russell, 1979, TECHNOLOGY HOSP MEDI; Sanger DE, 2020, NEW YORK TIMES; Slutsky AS, 2015, AM J RESP CRIT CARE, V191, P1106, DOI 10.1164/rccm.201503-0421PP; Smallman-Raynor M. R., 2006, POLIOMYELITIS EMERGE; Somerson S J, 1992, AANA J, V60, P83; Stevens R., 1999, SICKNESS WEALTH AM H; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; West JB, 2005, J APPL PHYSIOL, V99, P424, DOI 10.1152/japplphysiol.00184.2005; Whyte J, 2020, MEDSCAPE; Williams M., 2020, CBC NEWS 0417; Ziehr DR, 2020, AM J RESP CRIT CARE, V201, P1560, DOI 10.1164/rccm.202004-1163LE	49	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG	2021	174	8					1145	+		10.7326/M21-0270	http://dx.doi.org/10.7326/M21-0270			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP3IW	33939486	Green Published			2022-12-28	WOS:000695277800026
J	Tully, J; Bhugra, D; Lewis, SJ; Drennan, G; Markham, S				Tully, John; Bhugra, Dinesh; Lewis, Stephanie J.; Drennan, Gerard; Markham, Sarah			Is PTSD overdiagnosed?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTTRAUMATIC-STRESS-DISORDER; PRIMARY-CARE; PREVALENCE; TRAUMA; DSM-5		[Tully, John] Univ Nottingham, Fac Med & Hlth Sci, Nottingham, England; [Bhugra, Dinesh; Lewis, Stephanie J.; Markham, Sarah] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Lewis, Stephanie J.; Drennan, Gerard] South London & Maudsley NHS Fdn Trust, London, England	University of Nottingham; University of London; King's College London; South London & Maudsley NHS Trust	Tully, J (corresponding author), Univ Nottingham, Fac Med & Hlth Sci, Nottingham, England.	John.Tully@nottingham.ac.uk; stephanie.j.lewis@kcl.ac.uk						American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2018, BBC NEWS JUN; Anton C, 2016, YOUR WORKPLACE GIVES; Bzdok D, 2018, BIOL PSYCHIAT-COGN N, V3, P223, DOI 10.1016/j.bpsc.2017.11.007; Carey PD, 2003, J NERV MENT DIS, V191, P230, DOI 10.1097/00005053-200304000-00003; Chamberlain SR, 2021, BJPSYCH OPEN, V7, DOI 10.1192/bjo.2021.3; Chandan JS, 2020, LANCET PUBLIC HEALTH, V5, pE309, DOI 10.1016/S2468-2667(20)30112-2; Ehlers A, 2009, LONDON J PRIM CARE, V2, P36, DOI 10.1080/17571472.2009.11493240; Greenberg N, 2021, OCCUP MED-OXFORD, V71, P62, DOI 10.1093/occmed/kqaa220; Haslam N, 2020, PSYCHOL MED, V50, P1418, DOI 10.1017/S003329172000183X; Haslam N, 2016, PSYCHOL INQ, V27, P1, DOI 10.1080/1047840X.2016.1082418; Hiller RM, 2016, J CHILD PSYCHOL PSYC, V57, P884, DOI 10.1111/jcpp.12566; Hoge CW, 2014, LANCET PSYCHIAT, V1, P269, DOI 10.1016/S2215-0366(14)70235-4; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Koenen KC, 2017, PSYCHOL MED, V47, P2260, DOI 10.1017/S0033291717000708; Lewis Stephanie J, 2019, Lancet Psychiatry, V6, P247, DOI 10.1016/S2215-0366(19)30031-8; Liebschutz J, 2007, J GEN INTERN MED, V22, P719, DOI 10.1007/s11606-007-0161-0; Ministry of Defence, 2019, UK ARM FORC MENT HLT; Morina N, 2014, CLIN PSYCHOL REV, V34, P249, DOI 10.1016/j.cpr.2014.03.002; National Institute for Health and Care Excellence, 2018, POSTTR STRESS DIS; Nichter B, 2020, J PSYCHIATR RES, V121, P56, DOI 10.1016/j.jpsychires.2019.11.008; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Stein DJ, 2014, DEPRESS ANXIETY, V31, P494, DOI 10.1002/da.22279; Stevelink SAM, 2018, BRIT J PSYCHIAT, V213, P690, DOI 10.1192/bjp.2018.175; Summerfield D, 2001, BRIT MED J, V322, P95, DOI 10.1136/bmj.322.7278.95; UK Office for National Statistics, 2020, DOM AB COR COVID 19; World Health Organization, 2018, TOP 10 CAUS DEATH; World Health Organization, 2020, IMP COVID 19 MENT NE; Yildiz PD, 2017, J AFFECT DISORDERS, V208, P634, DOI 10.1016/j.jad.2016.10.009	29	5	5	4	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n787	10.1136/bmj.n787	http://dx.doi.org/10.1136/bmj.n787			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD2YX	33952508				2022-12-28	WOS:000651241900004
J	Bhuyan, A				Bhuyan, Anoo			Experts criticise India's complacency over COVID-19	LANCET			English	Editorial Material																			0	24	25	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1611	1612						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33933197	Bronze, Green Published			2022-12-28	WOS:000645510600011
J	See, I; Su, JR; Lale, A; Woo, EJ; Guh, AY; Shimabukuro, TT; Streiff, MB; Rao, AK; Wheeler, AP; Beavers, SF; Durbin, AP; Edwards, K; Miller, E; Harrington, TA; Mba-Jonas, A; Nair, N; Nguyen, DT; Talaat, KR; Urrutia, VC; Walker, SC; Creech, CB; Clark, TA; DeStefano, F; Broder, KR				See, Isaac; Su, John R.; Lale, Allison; Woo, Emily Jane; Guh, Alice Y.; Shimabukuro, Tom T.; Streiff, Michael B.; Rao, Agam K.; Wheeler, Allison P.; Beavers, Suzanne F.; Durbin, Anna P.; Edwards, Kathryn; Miller, Elaine; Harrington, Theresa A.; Mba-Jonas, Adamma; Nair, Narayan; Nguyen, Duong T.; Talaat, Kawsar R.; Urrutia, Victor C.; Walker, Shannon C.; Creech, C. Buddy; Clark, Thomas A.; DeStefano, Frank; Broder, Karen R.			US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPARIN-INDUCED THROMBOCYTOPENIA; UNITED-STATES; DIAGNOSIS; SAFETY; ASSAYS	IMPORTANCE Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and serious condition, has been described in Europe following receipt of the ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca), which uses a chimpanzee adenoviral vector. A mechanism similar to autoimmune heparin-induced thrombocytopenia (HIT) has been proposed. In the US, the Ad26.COV2.S COVID-19 vaccine (Janssen/Johnson & Johnson), which uses a human adenoviral vector, received Emergency Use Authorization (EUA) on February 27, 2021. By April 12, 2021, approximately 7 million Ad26.COV2.S vaccine doses had been given in the US, and 6 cases of CVST with thrombocytopenia had been identified among the recipients, resulting in a temporary national pause in vaccination with this product on April 13, 2021. OBJECTIVE To describe reports of CVST with thrombocytopenia following Ad26.COV2.S vaccine receipt. DESIGN, SETTING, AND PARTICIPANTS Case series of 12 US patients with CVST and thrombocytopenia following use of Ad26.COV2.S vaccine under EUA reported to the Vaccine Adverse Event Reporting System (VAERS) from March 2 to April 21, 2021 (with follow-up reported through April 21, 2021). EXPOSURES Receipt of Ad26.COV2.S vaccine. MAIN OUTCOMES AND MEASURES Clinical course, imaging, laboratory tests, and outcomes after CVST diagnosis obtained from VAERS reports, medical record review, and discussion with clinicians. RESULTS Patients' ages ranged from 18 to younger than 60 years; all were White women, reported from 11 states. Seven patients had at least 1 CVST risk factor, including obesity (n = 6), hypothyroidism (n = 1), and oral contraceptive use (n = 1); none had documented prior heparin exposure. Time from Ad26.COV2.S vaccination to symptom onset ranged from 6 to 15 days. Eleven patients initially presented with headache; 1 patient initially presented with back pain and later developed headache. Of the 12 patients with CVST, 7 also had intracerebral hemorrhage; 8 had non-CVST thromboses. After diagnosis of CVST, 6 patients initially received heparin treatment. Platelet nadir ranged from 9 x10(3)/mu L to 127 x10(3)/mu L. All 11 patients tested for the heparin-platelet factor 4 HIT antibody by enzyme-linked immunosorbent assay (ELISA) screening had positive results. All patients were hospitalized (10 in an intensive care unit [ICU]). As of April 21, 2021, outcomes were death (n = 3), continued ICU care (n = 3), continued non-ICU hospitalization (n = 2), and discharged home (n = 4). CONCLUSIONS AND RELEVANCE The initial 12 US cases of CVST with thrombocytopenia after Ad26.COV2.S vaccination represent serious events. This case series may inform clinical guidance as Ad26.COV2.S vaccination resumes in the US as well as investigations into the potential relationship between Ad26.COV2.S vaccine and CVST with thrombocytopenia.	[See, Isaac; Su, John R.; Lale, Allison; Guh, Alice Y.; Shimabukuro, Tom T.; Rao, Agam K.; Beavers, Suzanne F.; Miller, Elaine; Harrington, Theresa A.; Nguyen, Duong T.; Clark, Thomas A.; DeStefano, Frank; Broder, Karen R.] Ctr Dis Control & Prevent, COVID 19 Response Team, 1600 Clifton Rd,HT 16-3, Atlanta, GA 30329 USA; [Woo, Emily Jane; Mba-Jonas, Adamma; Nair, Narayan] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Streiff, Michael B.; Durbin, Anna P.; Talaat, Kawsar R.; Urrutia, Victor C.] Johns Hopkins Univ, Baltimore, MD USA; [Wheeler, Allison P.; Edwards, Kathryn; Walker, Shannon C.; Creech, C. Buddy] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); Johns Hopkins University; Vanderbilt University	See, I (corresponding author), Ctr Dis Control & Prevent, COVID 19 Response Team, 1600 Clifton Rd,HT 16-3, Atlanta, GA 30329 USA.	isee@cdc.gov	Urrutia, Victor/AAH-6683-2021	Urrutia, Victor/0000-0002-4995-6949; Walker, Shannon/0000-0003-4390-3931	Centers for Disease Control and Prevention (CDC) Clinical Immunization Safety Assessment (CISA) [200-2012-53664, 200-2012-50430]	Centers for Disease Control and Prevention (CDC) Clinical Immunization Safety Assessment (CISA)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention (CDC) Clinical Immunization Safety Assessment (CISA) Project contracts 200-2012-53664 to Johns Hopkins University and 200-2012-50430 to Vanderbilt University Medical Center.	American Heart Association, CVST BLOOD CLOTS POT; American Society of Hemoatology, VACC IND IMM THROMB; Brighton Collaboration, INT CAS DEF THROMB T; CDC, INT CLIN CONS US COV; CDC Health Alert Network, CAS CER VEN SIN THRO; Centers for Disease Control and Prevention, CLIN IMM SAF ASS CIS; Centers for Disease Control and Prevention, COVID DAT TRACK COVI; de Bruijn SFTM, 2001, J NEUROL NEUROSUR PS, V70, P105, DOI 10.1136/jnnp.70.1.105; European Medicines Agency, COVID 19 VACC ASTRAZ; Food and Drug Administration, 2021, FDA BRIEF DOC JANSS; Food and Drug Administration, FACT SHEET HEALTHC P; Greinacher A, 2017, J THROMB HAEMOST, V15, P2099, DOI 10.1111/jth.13813; Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840; Idiculla PS, 2020, EUR NEUROL, V83, P369, DOI 10.1159/000509802; MacNeil JR, 2021, MMWR-MORBID MORTAL W, V70, P651, DOI 10.15585/mmwr.mm7017e4; Minet V, 2017, MOLECULES, V22, DOI 10.3390/molecules22040617; Muir KL, 2021, NEW ENGL J MED, V384, P1964, DOI 10.1056/NEJMc2105869; Nwajei F, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.105412; Onwuemene O, 2016, HEMATOL-AM SOC HEMAT, P262, DOI 10.1182/asheducation-2016.1.262; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Romano SD, 2021, MMWR-MORBID MORTAL W, V70, P560, DOI [10.15585/mmwr.mm7015e2, 10.15585/mmwr.mm7015e2externalicon]; Sadoff J, 2021, NEW ENGL J MED, V384, P1965, DOI 10.1056/NEJMc2106075; Sahu KK, 2020, J BLOOD MED, V11, P267, DOI 10.2147/JBM.S232648; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882; Scully M, 2021, NEW ENGL J MED, V384, P2202, DOI 10.1056/NEJMoa2105385; Shay DK, 2021, MMWR-MORBID MORTAL W, V70, P680, DOI 10.15585/mmwr.mm7018e2; US Food and Drug Administration, JANSS COVID 19 VACC; Warkentin TE, 2014, BLOOD, V123, P3651, DOI 10.1182/blood-2014-01-549741; World Health Organization, GLOB ADV COMM VACC S	30	296	301	5	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2021	325	24					2448	2456		10.1001/jama.2021.7517	http://dx.doi.org/10.1001/jama.2021.7517		APR 2021	9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD7ZK	33929487	Bronze, Green Published			2022-12-28	WOS:000645632000002
J	Vasileiou, E; Simpson, CR; Shi, T; Kerr, S; Agrawal, U; Akbari, A; Bedston, S; Beggs, J; Bradley, D; Chuter, A; de Lusignan, S; Docherty, AB; Ford, D; Hobbs, FDR; Joy, M; Katikireddi, SV; Marple, J; McCowan, C; McGagh, D; McMenamin, J; Moore, E; Murray, JLK; Pan, JF; Ritchie, L; Shah, SA; Stock, S; Torabi, F; Tsang, RSM; Wood, R; Woolhouse, M; Robertson, C; Sheikh, A				Vasileiou, Eleftheria; Simpson, Colin R.; Shi, Ting; Kerr, Steven; Agrawal, Utkarsh; Akbari, Ashley; Bedston, Stuart; Beggs, Jillian; Bradley, Declan; Chuter, Antony; de Lusignan, Simon; Docherty, Annemarie B.; Ford, David; Hobbs, F. D. Richard; Joy, Mark; Katikireddi, Srinivasa Vittal; Marple, James; McCowan, Colin; McGagh, Dylan; McMenamin, Jim; Moore, Emily; Murray, Josephine L. K.; Pan, Jiafeng; Ritchie, Lewis; Shah, Syed Ahmar; Stock, Sarah; Torabi, Fatemeh; Tsang, Ruby S. M.; Wood, Rachael; Woolhouse, Mark; Robertson, Chris; Sheikh, Aziz			Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study	LANCET			English	Article							INFLUENZA VACCINE	Background The BNT162b2 mRNA (Pfizer-BioNTech) and ChAdOx1 nCoV-19 (Oxford-AstraZeneca) COVID-19 vaccines have shown high efficacy against disease in phase 3 clinical trials and are now being used in national vaccination programmes in the UK and several other countries. Studying the real-world effects of these vaccines is an urgent requirement. The aim of our study was to investigate the association between the mass roll-out of the first doses of these COVID-19 vaccines and hospital admissions for COVID-19. Methods We did a prospective cohort study using the Early Pandemic Evaluation and Enhanced Surveillance of COVID-19-EAVE II-database comprising linked vaccination, primary care, real-time reverse transcription-PCR testing, and hospital admission patient records for 5.4 million people in Scotland (about 99% of the population) registered at 940 general practices. Individuals who had previously tested positive were excluded from the analysis. A time-dependent Cox model and Poisson regression models with inverse propensity weights were fitted to estimate effectiveness against COVID-19 hospital admission (defined as 1-adjusted rate ratio) following the first dose of vaccine. Findings Between Dec 8, 2020, and Feb 22, 2021, a total of 1 331 993 people were vaccinated over the study period. The mean age of those vaccinated was 65.0 years (SD 16.2). The first dose of the BNT162b2 mRNA vaccine was associated with a vaccine effect of 91% (95% CI 85-94) for reduced COVID-19 hospital admission at 28-34 days post-vaccination. Vaccine effect at the same time interval for the ChAdOx1 vaccine was 88% (95% CI 75-94). Results of combined vaccine effects against hospital admission due to COVID-19 were similar when restricting the analysis to those aged 80 years and older (83%, 95% CI 72-89 at 28-34 days post-vaccination). Interpretation Mass roll-out of the first doses of the BNT162b2 mRNA and ChAdOx1 vaccines was associated with substantial reductions in the risk of hospital admission due to COVID-19 in Scotland. There remains the possibility that some of the observed effects might have been due to residual confounding. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Vasileiou, Eleftheria; Simpson, Colin R.; Kerr, Steven; Chuter, Antony; Docherty, Annemarie B.; Shah, Syed Ahmar; Stock, Sarah; Woolhouse, Mark; Sheikh, Aziz] Univ Edinburgh, Usher Inst, Edinburgh EH8 9AG, Midlothian, Scotland; [Marple, James] Univ Edinburgh, Royal Infirm Edinburgh, NHS Lothian, Edinburgh, Midlothian, Scotland; [Marple, James] Univ Edinburgh, Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Simpson, Colin R.] Victoria Univ Wellington, Wellington Fac Hlth, Sch Hlth, Wellington, New Zealand; [Agrawal, Utkarsh; McCowan, Colin] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland; [Akbari, Ashley; Bedston, Stuart; Torabi, Fatemeh] Swansea Univ, Sch Med, Populat Data Sci, Swansea, W Glam, Wales; [Ford, David] Swansea Univ, Coll Med, Hlth Informat, Hlth Informat Grp, Swansea, W Glam, Wales; [Beggs, Jillian; Chuter, Antony] Hlth Data Res Hub Resp Hlth, Edinburgh, Midlothian, Scotland; [Bradley, Declan] Publ Hlth Agcy, Belfast, Antrim, North Ireland; [Bradley, Declan] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [de Lusignan, Simon; Hobbs, F. D. Richard; Joy, Mark; McGagh, Dylan; Tsang, Ruby S. M.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Katikireddi, Srinivasa Vittal] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [McMenamin, Jim; Moore, Emily; Murray, Josephine L. K.; Robertson, Chris] Publ Hlth Scotland, Glasgow, Lanark, Scotland; [Wood, Rachael] Publ Hlth Scotland, Clin & Publ Hlth Intelligence Team, Edinburgh, Midlothian, Scotland; [Pan, Jiafeng; Robertson, Chris] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Ritchie, Lewis] Univ Aberdeen, Sch Med & Dent, Acad Primary Care, Aberdeen, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; Victoria University Wellington; University of St Andrews; Swansea University; Swansea University; Queens University Belfast; University of Oxford; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Strathclyde; University of Aberdeen	Sheikh, A (corresponding author), Univ Edinburgh, Usher Inst, Edinburgh EH8 9AG, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Simpson, Colin R/L-7180-2014; Tsang, Ruby S. M./D-5111-2014; Bradley, Declan/AFN-7904-2022; Bradley, Declan T/AFO-1353-2022; Chuter, Antony/GNO-9976-2022	Simpson, Colin R/0000-0002-5194-8083; Tsang, Ruby S. M./0000-0002-2520-526X; Chuter, Antony/0000-0002-0646-5939; Ford, David/0000-0001-6551-721X; Torabi, Fatemeh/0000-0002-5853-4625; Wood, Rachael/0000-0003-4453-623X; Beggs, Jillian/0000-0002-7591-3256; Akbari, Ashley/0000-0003-0814-0801; Murray, Josephine-Louise/0000-0002-1511-7944; Shi, Ting/0000-0002-4101-4535; Bradley, Declan/0000-0003-1468-1823; Moore, Emily/0000-0002-9634-3299; Katikireddi, Srinivasa/0000-0001-6593-9092; Vasileiou, Eleftheria/0000-0001-6850-7578; Agrawal, Utkarsh/0000-0001-5181-6120; Pan, Jiafeng/0000-0001-5993-3209; McCowan, Colin/0000-0002-9466-833X	Medical Research Council [MR/R008345/1, MC_UU_00022/2]; BREATHE-The Health Data Research Hub for Respiratory Health through UK Research and Innovation Industrial Strategy Challenge Fund [MC_PC_19004]; Public Health Scotland; National Institutes of Health Research (NIHR) School for Primary Care Research; NIHR Collaboration for Leadership in Applied Health Research and Care Oxford; NIHR Oxford Biomedical Research Centre; NRS Senior Clinical Fellowship [SCAF/15/02]; Scottish Government Chief Scientist Office [SPHSU13]; Scottish Government's director-general of Health and Social Care	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BREATHE-The Health Data Research Hub for Respiratory Health through UK Research and Innovation Industrial Strategy Challenge Fund; Public Health Scotland; National Institutes of Health Research (NIHR) School for Primary Care Research; NIHR Collaboration for Leadership in Applied Health Research and Care Oxford; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); NRS Senior Clinical Fellowship; Scottish Government Chief Scientist Office; Scottish Government's director-general of Health and Social Care	EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE-The Health Data Research Hub for Respiratory Health (MC_PC_19004), which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and the Scottish Government's director-general of Health and Social Care. FDRH acknowledges part support from the National Institutes of Health Research (NIHR) School for Primary Care Research, the NIHR Collaboration for Leadership in Applied Health Research and Care Oxford, and the NIHR Oxford Biomedical Research Centre. We thank Dave Kelly from Albasoft for his support with making primary care data available, and James Pickett, Wendy Inglis-Humphrey, Vicky Hammersley, Maria Georgiou, and Laura Gonzalez Rienda for their support with project management and administration. SVK acknowledges funding from an NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and Scottish Government Chief Scientist Office (SPHSU13).	Aran D, 2021, MEDRXIV, DOI [DOI 10.1101/2021.02.05.21251139, 10.1101/2021.02.05.21251139]; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Krammer F, 2021, NEW ENGL J MED, V384, P1372, DOI 10.1056/NEJMc2101667; Lipsitch M, 2020, SCIENCE, V370, P763, DOI 10.1126/science.abe5938; Lopalco PL, 2015, VACCINE, V33, P1541, DOI 10.1016/j.vaccine.2014.10.047; National Services Scotland, 2020, NAT DAT CAT RAP PREL; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Saadat S, 2021, JAMA-J AM MED ASSOC, V325, P1467, DOI 10.1001/jama.2021.3341; Simpson Colin R, 2020, BMJ Open, V10, pe039097, DOI 10.1136/bmjopen-2020-039097; Simpson CR, 2019, LANCET INFECT DIS, V19, pE295, DOI 10.1016/S1473-3099(18)30786-2; social study, 2021, ESTIMATING REAL WORL; UK Government, 2020, COVID 19 TEST DAT ME; UK Government, 2020, JOINT COMM VACC IMM; UK Government, 2021, COR UK	21	318	319	10	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1646	1657		10.1016/S0140-6736(21)00677-2	http://dx.doi.org/10.1016/S0140-6736(21)00677-2		APR 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV0EH	33901420	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000645510600025
J	Duan, HB; Zhou, S; Jiang, KJ; Bertram, C; Harmsen, M; Kriegler, E; van Vuuren, DP; Wang, SY; Fujimori, S; Tavoni, M; Ming, X; Keramidas, K; Iyer, G; Edmonds, J				Duan, Hongbo; Zhou, Sheng; Jiang, Kejun; Bertram, Christoph; Harmsen, Mathijs; Kriegler, Elmar; van Vuuren, Detlef P.; Wang, Shouyang; Fujimori, Shinichiro; Tavoni, Massimo; Ming, Xi; Keramidas, Kimon; Iyer, Gokul; Edmonds, James			Assessing China's efforts to pursue the 1.5 degrees C warming limit	SCIENCE			English	Article							2 DEGREES-C; CLIMATE-CHANGE; INTEGRATED ASSESSMENT; CO2 EMISSIONS; SOCIAL COST; ENERGY; UNCERTAINTY; SCENARIOS; TRANSITION; SCIENCE	Given the increasing interest in keeping global warming below 1.5 degrees C, a key question is what this would mean for China's emission pathway, energy restructuring, and decarbonization. By conducting a multimodel study, we find that the 1.5 degrees C-consistent goal would require China to reduce its carbon emissions and energy consumption by more than 90 and 39%, respectively, compared with the "no policy" case. Negative emission technologies play an important role in achieving near-zero emissions, with captured carbon accounting on average for 20% of the total reductions in 2050. Our multimodel comparisons reveal large differences in necessary emission reductions across sectors, whereas what is consistent is that the power sector is required to achieve full decarbonization by 2050. The cross-model averages indicate that China's accumulated policy costs may amount to 2.8 to 5.7% of its gross domestic product by 2050, given the 1.5 degrees C warming limit.	[Duan, Hongbo; Wang, Shouyang; Ming, Xi] Univ Chinese Acad Sci, Sch Econ & Management, Beijing 100190, Peoples R China; [Zhou, Sheng] Tsinghua Univ, Inst Energy Environm & Econ, Beijing 100084, Peoples R China; [Jiang, Kejun] Chinese Acad Macroecon Res, Energy Res Inst, Beijing 100038, Peoples R China; [Bertram, Christoph; Kriegler, Elmar] Leibniz Assoc, Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Harmsen, Mathijs; van Vuuren, Detlef P.] Netherlands Environm Assessment Agcy PBL, Postbus 30314, The Hague, Netherlands; [Harmsen, Mathijs; van Vuuren, Detlef P.] Univ Utrecht, Copernicus Inst Sustainable Dev, POB 80125, NL-3508 TC Utrecht, Netherlands; [Kriegler, Elmar] Univ Potsdam, Fac Econ & Social Sci, D-14482 Potsdam, Germany; [Wang, Shouyang] Chinese Acad Sci, Acad Math & Syst Sci, Beijing 100190, Peoples R China; [Fujimori, Shinichiro] Kyoto Univ, Dept Environm Engn, Kyoto 6158540, Japan; [Fujimori, Shinichiro] Natl Inst Environm Studies, Ctr Social & Environm Syst Res, Tsukuba, Ibaraki 3058506, Japan; [Fujimori, Shinichiro] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Tavoni, Massimo] Politecn Milan, Dept Management Econ & Ind Engn, I-20123 Milan, Italy; [Tavoni, Massimo] Fdn Ctr Euromediterraneo Cambiamenti Climat, RFF CMCC European Inst Econ & Environm, I-20123 Milan, Italy; [Keramidas, Kimon] European Commiss, Joint Res Ctr JRC, E-41092 Seville, Spain; [Iyer, Gokul; Edmonds, James] Univ Maryland, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Iyer, Gokul; Edmonds, James] Pacific Northwest Natl Lab, College Pk, MD 20740 USA	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University; Potsdam Institut fur Klimafolgenforschung; Utrecht University; University of Potsdam; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Kyoto University; National Institute for Environmental Studies - Japan; International Institute for Applied Systems Analysis (IIASA); Polytechnic University of Milan; Centro Euro-Mediterraneo sui Cambiamenti Climatici (CMCC); University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Duan, HB; Wang, SY (corresponding author), Univ Chinese Acad Sci, Sch Econ & Management, Beijing 100190, Peoples R China.; Zhou, S (corresponding author), Tsinghua Univ, Inst Energy Environm & Econ, Beijing 100084, Peoples R China.; van Vuuren, DP (corresponding author), Netherlands Environm Assessment Agcy PBL, Postbus 30314, The Hague, Netherlands.; van Vuuren, DP (corresponding author), Univ Utrecht, Copernicus Inst Sustainable Dev, POB 80125, NL-3508 TC Utrecht, Netherlands.; Wang, SY (corresponding author), Chinese Acad Sci, Acad Math & Syst Sci, Beijing 100190, Peoples R China.	hbduan@ucas.ac.cn; zhshinet@tsinghua.edu.cn; detlef.vanvuurert@pbl.nl; sywang@amss.ac.cn	Fujimori, Shinichiro/A-1288-2015	Fujimori, Shinichiro/0000-0001-7897-1796; Wang, Shouyang/0000-0001-5773-998X; Bertram, Christoph/0000-0002-0933-4395; zhou, sheng/0000-0001-9182-6235; Duan, Hongbo/0000-0001-5143-4413	National Natural Science Foundation of China [71874177, 72022019, 71874096, 71988101]; National Key Research and Development Program of China [2020YFA0608603]; Environment Research and Technology Development Fund of the Environmental Restoration and Conservation Agency of Japan [JPMEERF20202002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Environment Research and Technology Development Fund of the Environmental Restoration and Conservation Agency of Japan	H.D., S.Z., and S.W. acknowledge financial support from the National Natural Science Foundation of China (71874177, 72022019, 71874096, and 71988101) and the National Key Research and Development Program of China (2020YFA0608603). S.F. acknowledges funding from The Environment Research and Technology Development Fund (JPMEERF20202002) of the Environmental Restoration and Conservation Agency of Japan. The results and conclusions in this research are those of the authors and do not necessarily represent the official position of the granting organizations.	Akimoto K., 2014, CONTRIBUTION WORKING; Aldy J, 2016, NAT CLIM CHANGE, V6, P1000, DOI [10.1038/nclimate3106, 10.1038/NCLIMATE3106]; Ang BW, 2005, ENERG POLICY, V33, P867, DOI 10.1016/j.enpol.2003.10.010; [Anonymous], 2015, STAT CVF CHAIR PHIL; Bows-Larkin A, 2014, CARBON MANAG, V5, P193, DOI 10.1080/17583004.2014.913859; Cai YY, 2016, NAT CLIM CHANGE, V6, P520, DOI [10.1038/nclimate2964, 10.1038/NCLIMATE2964]; Calvin K, 2012, ENERG ECON, V34, pS251, DOI 10.1016/j.eneco.2012.09.003; China Coal-Control Project (CCCP), 2018, EN SCEN AN FEAS ACH; Climate Vulnerable Forum, 2015, STAT CVF CHAIR PHIL; Creutzig F, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.140; Davis SJ, 2018, SCIENCE, V360, P1419, DOI 10.1126/science.aas9793; Diffenbaugh NS, 2019, P NATL ACAD SCI USA, V116, P9808, DOI 10.1073/pnas.1816020116; Duan HB, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf8f9; Duan HB, 2018, ENERG ECON, V70, P45, DOI 10.1016/j.eneco.2017.12.022; Fujimori S, 2017, GLOBAL ENVIRON CHANG, V42, P268, DOI 10.1016/j.gloenvcha.2016.06.009; Gillingham K, 2018, J ASSOC ENVIRON RESO, V5, P791, DOI 10.1086/698910; Golub A, 2014, ENVIRON MODEL ASSESS, V19, P99, DOI 10.1007/s10666-013-9386-y; Hare WL, 2011, REG ENVIRON CHANGE, V11, pS1, DOI 10.1007/s10113-010-0195-4; Hoegh-Guldberg O, 2019, SCIENCE, V365, P1263, DOI 10.1126/science.aaw6974; Hof AF, 2017, ENVIRON SCI POLICY, V71, P30, DOI 10.1016/j.envsci.2017.02.008; Hwang IC, 2017, RESOUR ENERGY ECON, V48, P1, DOI 10.1016/j.reseneeco.2017.01.001; IPCC, SPEC REP GLOB WARM 1; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jiang KJ, 2012, CARBON MANAG, V3, P333, DOI 10.4155/CMT.12.42; Jordan A, 2013, CLIM POLICY, V13, P751, DOI 10.1080/14693062.2013.835705; Keramidas K., 2017, POLES JRC MODEL DOCU, DOI [10.2760/225347, DOI 10.2760/225347]; Kriegler E, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0457; Luderer G, 2018, NAT CLIM CHANGE, V8, P626, DOI 10.1038/s41558-018-0198-6; Luderer G, 2017, ENERG ECON, V64, P542, DOI 10.1016/j.eneco.2017.03.027; Mach KJ, 2017, ANNU REV ENV RESOUR, V42, P569, DOI 10.1146/annurev-environ-102016-061007; Marcucci A, 2017, CLIMATIC CHANGE, V144, P181, DOI 10.1007/s10584-017-2051-8; Masson-Delmotte V., 2018, SPECIAL REPORT GLOBA; Mejean A, 2019, ENERG EFFIC, V12, P441, DOI 10.1007/s12053-018-9682-0; Millar RJ, 2017, NAT GEOSCI, V10, P741, DOI 10.1038/NGEO3031; Mora C, 2018, NAT CLIM CHANGE, V8, P1062, DOI 10.1038/s41558-018-0315-6; Nieto J, 2018, ECOL ECON, V146, P69, DOI 10.1016/j.ecolecon.2017.10.007; Nordhaus WD, 2017, P NATL ACAD SCI USA, V114, P1518, DOI 10.1073/pnas.1609244114; Otto FEL, 2015, NAT CLIM CHANGE, V5, P917, DOI 10.1038/NCLIMATE2716; Peters GP, 2016, NAT CLIM CHANGE, V6, P646, DOI 10.1038/nclimate3000; Pretis F, 2018, PHILOS T R SOC A, V376, DOI 10.1098/rsta.2016.0460; Raupach MR, 2014, NAT CLIM CHANGE, V4, P873, DOI 10.1038/NCLIMATE2384; Rogelj J, 2018, NAT CLIM CHANGE, V8, P325, DOI 10.1038/s41558-018-0091-3; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Samir KC, 2017, GLOBAL ENVIRON CHANG, V42, P181, DOI 10.1016/j.gloenvcha.2014.06.004; Sanderson BM, 2017, EARTH SYST DYNAM, V8, P827, DOI 10.5194/esd-8-827-2017; Schleussner CF, 2016, NAT CLIM CHANGE, V6, P827, DOI 10.1038/NCLIMATE3096; Stevanovic M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501452; Sugiyama M, 2019, ENERGY, V167, P1120, DOI 10.1016/j.energy.2018.10.091; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UN DEP EC; van Vuuren DP, 2018, NAT CLIM CHANGE, V8, P391, DOI 10.1038/s41558-018-0119-8; Vrontisi Z, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab53e; Warren R, 2018, CLIMATIC CHANGE, V147, P395, DOI 10.1007/s10584-018-2158-6; Zhou S, 2018, ENERGY STRATEG REV, V20, P113, DOI 10.1016/j.esr.2018.02.001	54	107	118	168	630	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					378	+		10.1126/science.aba8767	http://dx.doi.org/10.1126/science.aba8767			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888636	Green Published			2022-12-28	WOS:000645009800037
J	Osseward, PJ; Amin, ND; Moore, JD; Temple, BA; Barriga, BK; Bachmann, LC; Jr, FB; Gullo, M; Clark, RC; Driscoll, SP; Pfaff, SL; Hayashi, M				Osseward, Peter J.; Amin, Neal D.; Moore, Jeffrey D.; Temple, Benjamin A.; Barriga, Bianca K.; Bachmann, Lukas C.; Jr, Fernando Beltran; Gullo, Miriam; Clark, Robert C.; Driscoll, Shawn P.; Pfaff, Samuel L.; Hayashi, Marito			Conserved genetic signatures parcellate cardinal spinal neuron classes into local and projection subsets	SCIENCE			English	Article							CELL-TYPE; CORD; CIRCUITS; ORIGIN; ORGANIZATION; DIVERSITY; EVOLUTION; IDENTITY; DEFINES; ADULT	Motor and sensory functions of the spinal cord are mediated by populations of cardinal neurons arising from separate progenitor lineages. However, each cardinal class is composed of multiple neuronal types with distinct molecular, anatomical, and physiological features, and there is not a unifying logic that systematically accounts for this diversity. We reasoned that the expansion of new neuronal types occurred in a stepwise manner analogous to animal speciation, and we explored this by defining transcriptomic relationships using a top-down approach. We uncovered orderly genetic tiers that sequentially divide groups of neurons by their motor-sensory, local-long range, and excitatory-inhibitory features. The genetic signatures defining neuronal projections were tied to neuronal birth date and conserved across cardinal classes. Thus, the intersection of cardinal class with projection markers provides a unifying taxonomic solution for systematically identifying distinct functional subsets.	[Osseward, Peter J.; Amin, Neal D.; Temple, Benjamin A.; Barriga, Bianca K.; Bachmann, Lukas C.; Jr, Fernando Beltran; Gullo, Miriam; Clark, Robert C.; Driscoll, Shawn P.; Pfaff, Samuel L.; Hayashi, Marito] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Osseward, Peter J.; Temple, Benjamin A.] Univ Calif San Diego, Neurosci Grad Program, 9500 Gilman Dr, La Jolla, CA 92037 USA; [Moore, Jeffrey D.] Harvard Univ, Howard Hughes Med Inst, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Barriga, Bianca K.] Univ Calif San Diego, Biol Sci Grad Program, 9500 Gilman Dr, La Jolla, CA 92037 USA; [Amin, Neal D.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Hayashi, Marito] Harvard Med Sch, Dept Cell Biol, Howard Hughes Med Inst, Boston, MA 02115 USA	Salk Institute; University of California System; University of California San Diego; Harvard University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Stanford University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.	pfaff@salk.edu		Amin, Neal/0000-0003-2027-1329; Beltran Jr, Fernando/0000-0002-5607-1399; Osseward, Peter/0000-0001-7010-1374	Christopher and Dana Reeve Foundation; NIMH T32 Training Grant [T32MH019938]; NIH-NICHD [K99 HD096512]; UCSD Cell and Molecular Genetics Training Program [T32 GM007240]; Timken-Sturgis Foundation; Japanese Ministry of Education, Culture, Sports, Science, and Technology Long-Term Student Support Program; Howard Hughes Medical Institute; Sol Goldman Charitable Trust; National Institutes of Health [1 U19 NS112959-01]	Christopher and Dana Reeve Foundation; NIMH T32 Training Grant; NIH-NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UCSD Cell and Molecular Genetics Training Program; Timken-Sturgis Foundation; Japanese Ministry of Education, Culture, Sports, Science, and Technology Long-Term Student Support Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sol Goldman Charitable Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	P.J.O. was supported by the Christopher and Dana Reeve Foundation. N.D.A. is supported by the NIMH T32 Training Grant T32MH019938 J.D.M. is supported by NIH-NICHD K99 HD096512. B.K.B. is supported by the UCSD Cell and Molecular Genetics Training Program (T32 GM007240) and the Timken-Sturgis Foundation. M.H. was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology Long-Term Student Support Program and the Timken-Sturgis Foundation. S.L.P. is a Benjamin H. Lewis chair in neuroscience. This research was supported by funding from the Howard Hughes Medical Institute, the Christopher and Dana Reeve Foundation, the Sol Goldman Charitable Trust, and National Institutes of Health (1 U19 NS112959-01).	Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Arendt D, 2019, CURR OPIN NEUROBIOL, V56, P144, DOI 10.1016/j.conb.2019.01.022; Arendt D, 2016, NAT REV GENET, V17, P744, DOI 10.1038/nrg.2016.127; Azim E, 2014, NATURE, V508, P357, DOI 10.1038/nature13021; Baek M, 2019, CELL REP, V27, P2620, DOI 10.1016/j.celrep.2019.04.113; Bikoff JB, 2016, CELL, V165, P207, DOI 10.1016/j.cell.2016.01.027; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Bui TV, 2013, NEURON, V78, P191, DOI 10.1016/j.neuron.2013.02.007; Delile J, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.173807; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Doe CQ, 2017, ANNU REV CELL DEV BI, V33, P219, DOI 10.1146/annurev-cellbio-111315-125210; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gabitto MI, 2016, CELL, V165, P220, DOI 10.1016/j.cell.2016.01.026; Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586; Hantman AW, 2010, NAT NEUROSCI, V13, P1233, DOI 10.1038/nn.2637; Haring M, 2018, NAT NEUROSCI, V21, P869, DOI 10.1038/s41593-018-0141-1; Hayashi M, 2018, NEURON, V97, P869, DOI 10.1016/j.neuron.2018.01.023; Henry AM, 2012, MAMM GENOME, V23, P539, DOI 10.1007/s00335-012-9406-2; Hilde KL, 2016, NEURON, V91, P763, DOI 10.1016/j.neuron.2016.07.014; Hobert O, 2019, CURR OPIN NEUROBIOL, V56, P97, DOI 10.1016/j.conb.2018.12.006; Jiang J, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00075; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; Koch SC, 2018, ANNU REV PHYSIOL, V80, P189, DOI 10.1146/annurev-physiol-022516-034303; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; Lai HC, 2016, DEVELOPMENT, V143, P3434, DOI 10.1242/dev.139592; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Levine AJ, 2014, NAT NEUROSCI, V17, P586, DOI 10.1038/nn.3675; Lu DC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00025; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; Nishida K, 2017, EUR J NEUROSCI, V46, P2608, DOI 10.1111/ejn.13736; Osseward PJ, 2019, CURR OPIN NEUROBIOL, V56, P175, DOI 10.1016/j.conb.2019.03.003; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Pivetta C, 2014, CELL, V156, P537, DOI 10.1016/j.cell.2013.12.014; Roome RB, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108425; Ruder L, 2016, NEURON, V92, P1063, DOI 10.1016/j.neuron.2016.10.032; Sathyamurthy A, 2018, CELL REP, V22, P2216, DOI 10.1016/j.celrep.2018.02.003; Saxena A, 2012, BIOTECHNIQUES, V52, P381, DOI 10.2144/0000113878; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Sternfeld MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21540; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tambalo M, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.184143; Tasic B, 2018, NATURE, V563, P72, DOI 10.1038/s41586-018-0654-5; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; Wilke SA, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-9; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Yuengert R, 2015, CELL REP, V13, P1258, DOI 10.1016/j.celrep.2015.09.064; Zeng HK, 2017, NAT REV NEUROSCI, V18, P530, DOI 10.1038/nrn.2017.85; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhang ZZ, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113055	52	13	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					385	+		10.1126/science.abe0690	http://dx.doi.org/10.1126/science.abe0690			77	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888637	Green Accepted			2022-12-28	WOS:000645009800038
J	Warren, RB; Blauvelt, A; Bagel, J; Papp, KA; Yamauchi, P; Armstrong, A; Langley, RG; Vanvoorden, V; De Cuyper, D; Cioffi, C; Peterson, L; Cross, N; Reich, K				Warren, R. B.; Blauvelt, A.; Bagel, J.; Papp, K. A.; Yamauchi, P.; Armstrong, A.; Langley, R. G.; Vanvoorden, V.; De Cuyper, D.; Cioffi, C.; Peterson, L.; Cross, N.; Reich, K.			Bimekizumab versus Adalimumab in Plaque Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY; DOUBLE-BLIND; EFFICACY; MODERATE; SAFETY; MULTICENTER; IL-17A	BACKGROUND Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits interleukin17A and interleukin-17F. The efficacy and safety of bimekizumab as compared with the tumor necrosis factor inhibitor adalimumab in patients with moderateto-severe plaque psoriasis have not been extensively examined. METHODS We randomly assigned patients with moderate-to-severe plaque psoriasis in a 1:1:1 ratio to receive subcutaneous bimekizumab at a dose of 320 mg every 4 weeks for 56 weeks; bimekizumab at a dose of 320 mg every 4 weeks for 16 weeks, then every 8 weeks for weeks 16 to 56; or subcutaneous adalimumab at a dose of 40 mg every 2 weeks for 24 weeks, followed by bimekizumab at a dose of 320 mg every 4 weeks to week 56. The primary end points were a 90% or greater reduction from baseline in the Psoriasis Area and Severity Index (PASI) score (PASI 90 response; PASI scores range from 0 to 72, with higher scores indicating worse disease) and an Investigator's Global Assessment (IGA) score of 0 or 1, signifying clear or almost clear skin (scores range from 0 [clear skin] to 4 [severe disease]), at week 16. The analysis of the primary end points tested noninferiority at a margin of -10 percentage points and then tested for superiority. RESULTS A total of 614 patients were screened, and 478 were enrolled; 158 patients were assigned to receive bimekizumab every 4 weeks, 161 to receive bimekizumab every 4 weeks and then every 8 weeks, and 159 to receive adalimumab. The mean age of the patients was 44.9 years; the mean PASI score at baseline was 19.8. At week 16, a total of 275 of 319 patients (86.2%) who received bimekizumab (both dose groups combined) and 75 of 159 (47.2%) who received adalimumab had a PASI 90 response (adjusted risk difference, 39.3 percentage points; 95% confidence interval [CI], 30.9 to 47.7; P<0.001 for noninferiority and superiority). A total of 272 of 319 patients (85.3%) who received bimekizumab and 91 of 159 (57.2%) who received adalimumab had an IGA score of 0 or 1 (adjusted risk difference, 28.2 percentage points; 95% CI, 19.7 to 36.7; P<0.001 for noninferiority and superiority). The most common adverse events with bimekizumab were upper respiratory tract infections, oral candidiasis (predominantly mild or moderate as recorded by the investigator), hypertension, and diarrhea. CONCLUSIONS In this 56-week trial, bimekizumab was noninferior and superior to adalimumab through 16 weeks in reducing symptoms and signs of plaque psoriasis but was associated with a higher frequency of oral candidiasis and diarrhea. Longer and larger trials are required to determine the efficacy and safety of bimekizumab as compared with other agents in the treatment of plaque psoriasis.	[Warren, R. B.] Univ Manchester, Dermatol Ctr, Salford Royal NHS Fdn Trust, Manchester Natl Inst Hlth Res Biomed Res Ctr, Manchester M13 9PL, Lancs, England; [Blauvelt, A.] Oregon Med Res Ctr, Portland, OR USA; [Bagel, J.] Psoriasis Treatment Ctr Cent New Jersey, East Windsor, NJ USA; [Papp, K. A.] Prob Med Res & K Papp Clin Res, Waterloo, ON, Canada; [Langley, R. G.] Dalhousie Univ, Halifax, NS, Canada; [Yamauchi, P.] Dermatol Inst & Skin Care Ctr, Santa Monica, CA USA; [Yamauchi, P.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA; [Armstrong, A.] Univ Southern Calif, Dept Dermatol, Keck Sch Med, Los Angeles, CA 90007 USA; [Vanvoorden, V.; De Cuyper, D.] UCB Pharma, Brussels, Belgium; [Cioffi, C.; Peterson, L.; Cross, N.] UCB Pharma, Raleigh, NC USA; [Reich, K.] Univ Med Ctr Hamburg Eppendorf, Ctr Translat Res Inflammatory Skin Dis, Inst Hlth Serv Res Dermatol & Nursing, Hamburg, Germany	Salford Royal NHS Foundation Trust; University of Manchester; Dalhousie University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; UCB Pharma SA; UCB Pharma SA; University of Hamburg; University Medical Center Hamburg-Eppendorf	Warren, RB (corresponding author), Univ Manchester, Dermatol Ctr, Salford Royal NHS Fdn Trust, Manchester Natl Inst Hlth Res Biomed Res Ctr, Manchester M13 9PL, Lancs, England.	richard.warren@manchester.ac.uk		Peterson, Luke/0000-0003-2581-5655				Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Brembilla NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01682; Glatt S, 2018, ANN RHEUM DIS, V77, P523, DOI 10.1136/annrheumdis-2017-212127; Glatt S, 2017, BRIT J CLIN PHARMACO, V83, P991, DOI 10.1111/bcp.13185; Gordon KB, 2021, LANCET, V397, P475, DOI 10.1016/S0140-6736(21)00126-4; Hawkes JE, 2018, J IMMUNOL, V201, P1605, DOI 10.4049/jimmunol.1800013; Papp KA, 2018, J AM ACAD DERMATOL, V79, P277, DOI 10.1016/j.jaad.2018.03.037; Prignano F, 2021, EXPERT OPIN BIOL TH, V21, P75, DOI 10.1080/14712598.2020.1812576; Reich K, 2021, NEW ENGL J MED, V385, P142, DOI 10.1056/NEJMoa2102383; Reich K, 2021, LANCET, V397, P487, DOI 10.1016/S0140-6736(21)00125-2; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042; Sbidian E, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011535.pub3; Warren RB, 2020, DERMATOLOGY THER, V10, P73, DOI 10.1007/s13555-019-00337-y; Yost John, 2009, F1000 Med Rep, V1, DOI 10.3410/M1-30	14	37	37	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2021	385	2					130	141		10.1056/NEJMoa2102388	http://dx.doi.org/10.1056/NEJMoa2102388		APR 2021	12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH8TR	33891379	Bronze			2022-12-28	WOS:000643852700001
J	Mahase, E				Mahase, Elisabeth			Covid-19: Lateral flow tests in care homes failed to stop outbreaks, finds study	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], SARS COV 2 INFECTIVI, DOI [10.1101/2021.03.31.21254687v1.full.pdf, DOI 10.1101/2021.03.31.21254687V1.FULL.PDF]; [Anonymous], 2021, SSRN; [Anonymous], 2021, BBC; Griffin S, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n823; Halliday J., 2021, GUARDIAN; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n902; Thacker PD, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n490	7	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n1025	10.1136/bmj.n1025	http://dx.doi.org/10.1136/bmj.n1025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3BI	33879467	Bronze			2022-12-28	WOS:000643654700008
J	Aggarwal, NK				Aggarwal, Neil K.			Advancing President Biden's Equity Agenda - Lessons from Disparities Work	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH	Advancing President Biden's Equity Agenda On his first day in office, President Biden signed an executive order on advancing racial equity and supporting underserved communities. This policy presents an opportunity to implement lessons from health disparities research that target systemic racism.	[Aggarwal, Neil K.] Columbia Univ, New York, NY 10027 USA; [Aggarwal, Neil K.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Aggarwal, NK (corresponding author), Columbia Univ, New York, NY 10027 USA.; Aggarwal, NK (corresponding author), New York State Psychiat Inst & Hosp, New York, NY 10032 USA.							[Anonymous], 2017, J HEADACHE PAIN, V18, P111; Bailey ZD, 2017, LANCET, V389, P1453, DOI 10.1016/S0140-6736(17)30569-X; Bey GS, 2019, J RACIAL ETHN HEALTH, V6, P117, DOI 10.1007/s40615-018-0507-9; Executive Office of the President, 2021, 13985 WHIT HOUS; Harris AP, 2020, UCLA LAW REV, V67, P758	5	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1481	1483		10.1056/NEJMp2101439	http://dx.doi.org/10.1056/NEJMp2101439		APR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RQ6OT	33882629	Bronze			2022-12-28	WOS:000641395300001
J	Chisholm, RL				Chisholm, Rex L.			Is genetic ancestry a tool to combat health disparities?	CELL			English	Editorial Material								The use of race and ethnicity in medicine has become a matter of intense debate. Currently the social construct of race and ethnicity is far from precise, serving as a poor proxy for ancestry. In this issue of Cell, Belbin et al. provide an interesting framework for better characterizing population substructure in a diverse urban environment.	[Chisholm, Rex L.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Chisholm, Rex L.] Northwestern Univ, Dept Cell & Dev Biol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Chisholm, RL (corresponding author), Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA.; Chisholm, RL (corresponding author), Northwestern Univ, Dept Cell & Dev Biol, Feinberg Sch Med, Chicago, IL 60611 USA.	r-chisholm@northwestern.edu	Chisholm, Rex/B-3418-2009	Chisholm, Rex/0000-0002-5638-3990				Belbin GM, 2021, CELL, V184, P2068, DOI 10.1016/j.cell.2021.03.034; Cheng CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032840; Collins TC, 2003, ARCH INTERN MED, V163, P1469, DOI 10.1001/archinte.163.12.1469; Green ED, 2020, NATURE, V586, P683, DOI 10.1038/s41586-020-2817-4; Lackland DT, 2014, AM J MED SCI, V348, P135, DOI 10.1097/MAJ.0000000000000308; Malina D, 2021, NEW ENGL J MED, V384, P474, DOI 10.1056/NEJMms2029562; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740	7	2	2	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2021	184	8					1964	1965		10.1016/j.cell.2021.03.038	http://dx.doi.org/10.1016/j.cell.2021.03.038		APR 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RN5JL	33861960	Bronze			2022-12-28	WOS:000640387300009
J	Csibi, A; Fendt, SM; Li, CG; Poulogiannis, G; Choo, AY; Chapski, DJ; Jeong, SM; Dempsey, JM; Parkhitko, A; Morrison, T; Henske, EP; Haigis, MC; Cantley, LC; Stephanopoulos, G; Yu, J; Blenis, J				Csibi, Alfred; Fendt, Sarah-Maria; Li, Chenggang; Poulogiannis, George; Choo, Andrew Y.; Chapski, Douglas J.; Jeong, Seung Min; Dempsey, Jamie M.; Parkhitko, Andrey; Morrison, Tasha; Henske, Elizabeth P.; Haigis, Marcia C.; Cantley, Lewis C.; Stephanopoulos, Gregory; Yu, Jane; Blenis, John			The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4 (vol 153, pg 840, 2013)	CELL			English	Correction												john_blenis@hms.harvard.edu	Poulogiannis, George/AAY-2210-2021	Fendt, Sarah-Maria/0000-0001-6018-9296				Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023	1	3	3	7	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2021	184	8					2256	2256		10.1016/j.cell.2021.03.059	http://dx.doi.org/10.1016/j.cell.2021.03.059		APR 2021	1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RN5JL	33861966	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000640387300030
J	Schattner, A				Schattner, Ami			Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults	ANNALS OF INTERNAL MEDICINE			English	Letter							RISK		[Schattner, Ami] Hebrew Univ & Hadassah, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Schattner, A (corresponding author), Hebrew Univ & Hadassah, Jerusalem, Israel.			Chow, Eric/0000-0003-3349-9330				Chow EJ, 2020, ANN INTERN MED, V173, P605, DOI 10.7326/M20-1509; O'Halloran AC, 2016, AM J PREV MED, V50, pE15, DOI 10.1016/j.amepre.2015.06.008; Schattner A, 2020, PATIENT EDUC COUNS, V103, P1052, DOI 10.1016/j.pec.2019.12.008; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747	4	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					583	583		10.7326/L21-0017	http://dx.doi.org/10.7326/L21-0017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RU1WZ	33872521				2022-12-28	WOS:000644942400011
J	Kim, B; Kanai, MI; Oh, Y; Kyung, M; Kim, EK; Jang, IH; Lee, JH; Kim, SG; Suh, GSB; Lee, WJ				Kim, Boram; Kanai, Makoto I.; Oh, Yangkyun; Kyung, Minsoo; Kim, Eun-Kyoung; Jang, In-Hwan; Lee, Ji-Hoon; Kim, Sang-Gyu; Suh, Greg S. B.; Lee, Won-Jae			Response of the microbiome-gut-brain axis in Drosophila to amino acid deficit	NATURE			English	Article							UNCHARGED TRANSFER-RNA; EXPRESSION; HOMEOSTASIS; PHYSIOLOGY; INDUCTION; MUTUALISM; RESOURCE; GCN2	YYY A balanced intake of macronutrients-protein, carbohydrate and fat-is essential for the well-being of organisms. An adequate calorific intake but with insufficient protein consumption can lead to several ailments, including kwashiorkor(1). Taste receptors (T1R1-T1R3)(2) can detect amino acids in the environment, and cellular sensors (Gcn2 and Tor)(3) monitor the levels of amino acids in the cell. When deprived of dietary protein, animals select a food source that contains a greater proportion of protein or essential amino acids (EAAs)(4). This suggests that food selection is geared towards achieving the target amount of a particular macronutrient with assistance of the EAA-specific hunger-driven response, which is poorly understood. Here we show in Drosophila that a microbiome-gut-brain axis detects a deficit of EAAs and stimulates a compensatory appetite for EAAs. We found that the neuropeptide CNMamide (CNMa)(5) was highly induced in enterocytes of the anterior midgut during protein deprivation. Silencing of the CNMa-CNMa receptor axis blocked the EAA-specific hunger-driven response in deprived flies. Furthermore, gnotobiotic flies bearing an EAA-producing symbiotic microbiome exhibited a reduced appetite for EAAs. By contrast, gnotobiotic flies with a mutant microbiome that did not produce leucine or other EAAs showed higher expression of CNMa and a greater compensatory appetite for EAAs. We propose that gut enterocytes sense the levels of diet- and microbiome-derived EAAs and communicate the EAA-deprived condition to the brain through CNMa.	[Kim, Boram; Kyung, Minsoo; Kim, Eun-Kyoung; Jang, In-Hwan; Lee, Ji-Hoon; Lee, Won-Jae] Seoul Natl Univ, Natl Creat Res Initiat Ctr Hologenom, Seoul, South Korea; [Kim, Boram; Kyung, Minsoo; Kim, Eun-Kyoung; Jang, In-Hwan; Lee, Ji-Hoon; Lee, Won-Jae] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Kim, Boram; Kim, Sang-Gyu; Suh, Greg S. B.] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Kanai, Makoto I.; Oh, Yangkyun; Suh, Greg S. B.] NYU, Grossman Sch Med, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10012 USA; [Suh, Greg S. B.] Korea Adv Inst Sci & Technol, KAIST Inst, Daejeon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); New York University; Korea Advanced Institute of Science & Technology (KAIST)	Lee, WJ (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Hologenom, Seoul, South Korea.; Lee, WJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.; Suh, GSB (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea.; Suh, GSB (corresponding author), NYU, Grossman Sch Med, Skirball Inst Biomol Med, Dept Cell Biol, New York, NY 10012 USA.; Suh, GSB (corresponding author), Korea Adv Inst Sci & Technol, KAIST Inst, Daejeon, South Korea.	seongbaesuh@kaist.ac.kr; lwj@snu.ac.kr		Oh, Yangkyun/0000-0003-4070-7601; Kim, Sang-Gyu/0000-0003-2574-3233; Suh, Greg/0000-0003-4381-658X; KIM, Boram/0000-0002-4786-6675	Samsung Science and Technology Foundation [SSTF-BA-1401-15]; National Research Foundation of Korea [NRF-2020R1A2C2009865]; NIH [R01DK116294, R01DK106636]; National Creative Research Initiative programs of the National Research Foundation of South Korea [2015R1A3A2033475]; National Research Foundation of South Korea [NRF-2020R1I1A1A01072255]	Samsung Science and Technology Foundation(Samsung); National Research Foundation of Korea(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Creative Research Initiative programs of the National Research Foundation of South Korea(National Research Foundation of Korea); National Research Foundation of South Korea(National Research Foundation of Korea)	We thank the W.-J.L. and G.S.B.S. laboratory members for discussion and critical reading of the manuscript, and we thank the KAIST Biocore center (operator: J. Kim). This work is supported by grants from the Samsung Science and Technology Foundation (project number: SSTF-BA-1802-11) and the National Research Foundation of Korea (NRF-2020R1A2C2009865); by NIH R01 grants (R01DK116294 and R01DK106636, which have been transferred to H. Don Ryoo at New York University) to G.S.B.S; and by grants from National Creative Research Initiative programs of the National Research Foundation of South Korea (2015R1A3A2033475) and the Samsung Science and Technology Foundation (project number: SSTF-BA-1401-15) to W.-J.L. B.K. is supported by the National Research Foundation of South Korea (NRF-2020R1I1A1A01072255).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Bjordal M, 2014, CELL, V156, P510, DOI 10.1016/j.cell.2013.12.024; Bouche V, 2016, AUTOPHAGY, V12, P484, DOI 10.1080/15548627.2015.1134081; Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001; Croset V, 2016, SCI REP-UK, V6, DOI 10.1038/srep34871; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Dus M, 2013, NAT NEUROSCI, V16, P526, DOI 10.1038/nn.3372; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Erkosar B, 2013, CELL HOST MICROBE, V13, P8, DOI 10.1016/j.chom.2012.12.004; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Ganguly A, 2017, CELL REP, V18, P737, DOI 10.1016/j.celrep.2016.12.071; Gribble FM, 2019, NAT REV ENDOCRINOL, V15, P226, DOI 10.1038/s41574-019-0168-8; Gribble FM, 2016, ANNU REV PHYSIOL, V78, P277, DOI 10.1146/annurev-physiol-021115-105439; Hadjieconomou D, 2020, NATURE, V587, P455, DOI 10.1038/s41586-020-2866-8; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hill CM, 2018, FRONT NEUROENDOCRIN, V51, P125, DOI 10.1016/j.yfrne.2018.06.002; Jung SH, 2014, FEBS LETT, V588, P2037, DOI 10.1016/j.febslet.2014.04.028; Katzen F, 1999, APPL ENVIRON MICROB, V65, P278; Kiela PR, 2016, BEST PRACT RES CL GA, V30, P145, DOI 10.1016/j.bpg.2016.02.007; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Leitao-Goncalves R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000862; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Liu QL, 2017, SCIENCE, V356, P534, DOI 10.1126/science.aal3245; De Sousa-Coelho AL, 2012, BIOCHEM J, V443, P165, DOI 10.1042/BJ20111748; Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; Redhai S, 2020, NATURE, V580, P263, DOI 10.1038/s41586-020-2111-5; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Semba RD, 2016, EBIOMEDICINE, V6, P246, DOI 10.1016/j.ebiom.2016.02.030; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Simpson SJ, 2005, OBES REV, V6, P133, DOI 10.1111/j.1467-789X.2005.00178.x; Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033; Sun JH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14161; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tasanapak K, 2013, J MICROBIOL, V51, P783, DOI 10.1007/s12275-013-2619-6; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Wang PP, 2020, NEURON, V108, P640, DOI 10.1016/j.neuron.2020.08.017; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Yang Z, 2018, CELL RES, V28, P1013, DOI 10.1038/s41422-018-0084-9; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Zhang YM, 2018, AUTOPHAGY, V14, P1959, DOI 10.1080/15548627.2018.1493044	48	17	17	15	70	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					570	+		10.1038/s41586-021-03522-2	http://dx.doi.org/10.1038/s41586-021-03522-2		MAY 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IB	33953396				2022-12-28	WOS:000647544800002
J	Wensien, M; von Pappenheim, FR; Funk, LM; Kloskowski, P; Curth, U; Diederichsen, U; Uranga, J; Ye, J; Fang, P; Pan, KT; Urlaub, H; Mata, RA; Sautner, V; Tittmann, K				Wensien, Marie; von Pappenheim, Fabian Rabe; Funk, Lisa-Marie; Kloskowski, Patrick; Curth, Ute; Diederichsen, Ulf; Uranga, Jon; Ye, Jin; Fang, Pan; Pan, Kuan-Ting; Urlaub, Henning; Mata, Ricardo A.; Sautner, Viktor; Tittmann, Kai			A lysine-cysteine redox switch with an NOS bridge regulates enzyme function	NATURE			English	Article							NEISSERIA-GONORRHOEAE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; OXIDATIVE STRESS; STRUCTURAL BASIS; DISULFIDE BONDS; F6P ALDOLASE; PROTEIN; TRANSALDOLASE; ULTRACENTRIFUGATION	Disulfide bonds between cysteine residues areimportant post-translational modifications in proteins that have critical roles for protein structure and stability, as redox-active catalytic groups in enzymes or allosteric redox switches that govern protein function(1-4). In addition to forming disulfide bridges, cysteine residues are susceptible to oxidation by reactive oxygen species, and are thus central not only to the scavenging of these but also to cellular signalling and communication in biological as well as pathological contexts(5,6). Oxidized cysteine species are highly reactive and may form covalent conjugates with, for example, tyrosines in the active sites of some redox enzymes(7,8). However, to our knowledge, regulatory switches with covalent crosslinks other than disulfides have not previously been demonstrated. Here we report the discovery of a covalent crosslink between a cysteine and a lysine residue with a NOS bridge that serves as an allosteric redox switch in the transaldolase enzyme of Neisseria gonorrhoeae, the pathogen that causes gonorrhoea. X-ray structure analysis of the protein in the oxidized and reduced state reveals a loaded-spring mechanism that involves a structural relaxation upon redox activation, which is propagated from the allosteric redox switch at the protein surface to the active site in the protein interior. This relaxation leads to a reconfiguration of key catalytic residues and elicits an increase in enzymatic activity of several orders of magnitude. The redox switch is highly conserved in related transaldolases from other members of the Neisseriaceae; for example, it is present in the transaldolase of Neisseria meningitides (a pathogen that is the primary cause of meningitis and septicaemia in children). We surveyed the Protein Data Bank and found that the NOS bridge exists in diverse protein families across all domains of life (including Homo sapiens) and that it is often located at catalytic or regulatory hotspots. Our findings will inform strategies for the design of proteins and peptides, as well as the development of new classes of drugs and antibodies that target the lysine-cysteine redox switch(9,10).	[Wensien, Marie; von Pappenheim, Fabian Rabe; Funk, Lisa-Marie; Kloskowski, Patrick; Sautner, Viktor; Tittmann, Kai] Georg August Univ Gottingen, Dept Mol Enzymol, Gottingen Ctr Mol Biosci, Gottingen, Germany; [Wensien, Marie; von Pappenheim, Fabian Rabe; Funk, Lisa-Marie; Kloskowski, Patrick; Sautner, Viktor; Tittmann, Kai] Max Planck Inst Biophys Chem, Dept Struct Dynam, Gottingen, Germany; [Curth, Ute] Hannover Med Sch, Inst Biophys Chem, Hannover, Germany; [Diederichsen, Ulf] Georg August Univ Gottingen, Inst Organ & Biomol Chem, Gottingen, Germany; [Uranga, Jon; Ye, Jin; Mata, Ricardo A.] Georg August Univ Gottingen, Inst Phys Chem, Gottingen, Germany; [Fang, Pan; Pan, Kuan-Ting; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Res Grp, Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt, Gottingen, Germany	University of Gottingen; Max Planck Society; Hannover Medical School; University of Gottingen; University of Gottingen; Max Planck Society; University of Gottingen	Tittmann, K (corresponding author), Georg August Univ Gottingen, Dept Mol Enzymol, Gottingen Ctr Mol Biosci, Gottingen, Germany.; Tittmann, K (corresponding author), Max Planck Inst Biophys Chem, Dept Struct Dynam, Gottingen, Germany.	ktittma@gwdg.de	Uranga, Jon/ABC-3945-2021; Mata, Ricardo A./AAC-4850-2020	Uranga, Jon/0000-0002-1256-6656; Mata, Ricardo A./0000-0002-2720-3364; Pan, Kuan-Ting/0000-0001-6974-5324; Rabe von Pappenheim, Fabian/0000-0002-3925-8127; Wensien, Marie/0000-0003-4111-6918; Funk, Lisa-Marie/0000-0003-2443-691X	Max-Planck Society; DFG-funded Gottingen Graduate Center for Neurosciences, Biophysics and Molecular Biosciences GGNB	Max-Planck Society(Max Planck SocietyFoundation CELLEX); DFG-funded Gottingen Graduate Center for Neurosciences, Biophysics and Molecular Biosciences GGNB	This study was supported by the Max-Planck Society and the DFG-funded Gottingen Graduate Center for Neurosciences, Biophysics and Molecular Biosciences GGNB. We acknowledge access to beamline P14 at DESY/EMBL (Hamburg), and thank G. Bourenkov and T. Schneider for local support. We thank G. Bourenkov, A. Pearson, H. Stark, R. Kluger and M. Alcarazo for discussion; and A. Linden for help with the mass spectrometry experiments.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akter S, 2018, NAT CHEM BIOL, V14, P995, DOI 10.1038/s41589-018-0116-2; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Callaway E, 2020, NATURE, V588, P203, DOI 10.1038/d41586-020-03348-4; Chevillard S, 1998, ONCOGENE, V16, P3083, DOI 10.1038/sj.onc.1202096; Chiu J, 2019, J BIOL CHEM, V294, P2949, DOI 10.1074/jbc.REV118.005604; Dai S, 2019, NATURE, V573, P609, DOI 10.1038/s41586-019-1581-9; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Firbank SJ, 2001, P NATL ACAD SCI USA, V98, P12932, DOI 10.1073/pnas.231463798; Frisch M. J., 2009, GAUSSIAN 09 REVISION; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Hogg PJ, 2003, TRENDS BIOCHEM SCI, V28, P210, DOI 10.1016/S0968-0004(03)00057-4; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kirby AJ, 2006, J AM CHEM SOC, V128, P12374, DOI 10.1021/ja065147q; KOVACIC P, 1961, J AM CHEM SOC, V83, P221, DOI 10.1021/ja01462a043; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lehwess-Litzmann A, 2011, NAT CHEM BIOL, V7, P678, DOI [10.1038/NCHEMBIO.633, 10.1038/nchembio.633]; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Ludtke S, 2013, NAT CHEM, V5, P762, DOI [10.1038/NCHEM.1728, 10.1038/nchem.1728]; MATSUMURA M, 1989, SCIENCE, V243, P792, DOI 10.1126/science.2916125; Mesecar AD, 1997, SCIENCE, V277, P202, DOI 10.1126/science.277.5323.202; Muller YA, 2020, J BIOL CHEM, V295, P3189, DOI 10.1074/jbc.RA119.011546; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Neumann P, 2014, CURR OPIN STRUC BIOL, V29, P122, DOI 10.1016/j.sbi.2014.11.001; Nussinov R, 2015, ANNU REV PHARMACOL, V55, P249, DOI 10.1146/annurev-pharmtox-010814-124401; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; von Pappenheim FR, 2020, NAT CHEM BIOL, V16, P1237, DOI 10.1038/s41589-020-0628-4; Rappoport D, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3484283; Ruszkowski M, 2016, PROTEIN SCI, V25, P1734, DOI 10.1002/pro.2958; Sautner V, 2015, BIOCHEMISTRY-US, V54, P4475, DOI 10.1021/acs.biochem.5b00283; Schorken U, 2001, EUR J BIOCHEM, V268, P2408, DOI 10.1046/j.1432-1327.2001.02128.x; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Seib KL, 2006, MICROBIOL MOL BIOL R, V70, P344, DOI 10.1128/MMBR.00044-05; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Tittmann K, 2014, BIOORG CHEM, V57, P263, DOI 10.1016/j.bioorg.2014.09.001; Tsolas O, 1975, Methods Enzymol, V42, P290; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Wang JM, 2019, PROTEIN SCI, V28, P472, DOI 10.1002/pro.3568; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wi T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002344; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wong CP, 2018, ANGEW CHEM INT EDIT, V57, P560, DOI 10.1002/anie.201710682	57	26	26	5	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					460	+		10.1038/s41586-021-03513-3	http://dx.doi.org/10.1038/s41586-021-03513-3		MAY 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33953398	Green Published			2022-12-28	WOS:000647555000003
J	Voelker, R				Voelker, Rebecca			Cell-Based Gene Therapy Is New Option for Multiple Myeloma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1713	1713		10.1001/jama.2021.6401	http://dx.doi.org/10.1001/jama.2021.6401			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944887				2022-12-28	WOS:000647831200004
J	Salwa, J; Robertson, C				Salwa, Jacqueline; Robertson, Christopher			Designing an Independent Public Health Agency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Salwa, Jacqueline] Harvard Law Sch, Cambridge, MA 02138 USA; [Robertson, Christopher] Boston Univ, Sch Law, Boston, MA 02215 USA	Harvard University; Boston University	Salwa, J (corresponding author), Harvard Law Sch, Cambridge, MA 02138 USA.			Robertson, Christopher/0000-0001-6188-8005				Adib D., 2020, ABC NEWS; Califf RM, 2019, HEALTH AFFAIR, V38, P84, DOI 10.1377/hlthaff.2018.05185; Gravelle JG., 2014, FEDERAL PROPOSALS TA	3	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1684	1687		10.1056/NEJMp2033970	http://dx.doi.org/10.1056/NEJMp2033970		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33951378				2022-12-28	WOS:000646647200001
J	Sleiman, D; Garcia, PS; Lagune, M; Loc'h, J; Haouz, A; Taib, N; Rothlisberger, P; Gribaldo, S; Marliere, P; Kaminski, PA				Sleiman, Dona; Garcia, Pierre Simon; Lagune, Marion; Loc'h, Jerome; Haouz, Ahmed; Taib, Najwa; Rothlisberger, Pascal; Gribaldo, Simonetta; Marliere, Philippe; Kaminski, Pierre Alexandre			A third purine biosynthetic pathway encoded by aminoadenine-based viral DNA genomes	SCIENCE			English	Article							ADENYLOSUCCINATE SYNTHETASE; RECOGNITION	Cells have two purine pathways that synthesize adenine and guanine ribonucleotides from phosphoribose via inosylate. A chemical hybrid between adenine and guanine, 2-aminoadenine (Z), replaces adenine in the DNA of the cyanobacterial virus S-2L. We show that S-2L and Vibrio phage PhiVC8 encode a third purine pathway catalyzed by PurZ, a distant paralog of succinoadenylate synthase (PurA), the enzyme condensing aspartate and inosylate in the adenine pathway. PurZ condenses aspartate with deoxyguanylate into dSMP (N6-succino-2-amino-2'-deoxyadenylate), which undergoes defumarylation and phosphorylation to give dZTP (2-amino-2'-deoxyadenosine-5'-triphosphate), a substrate for the phage DNA polymerase. Crystallography and phylogenetics analyses indicate a close relationship between phage PurZ and archaeal PurA enzymes. Our work elucidates the biocatalytic innovation that remodeled a DNA building block beyond canonical molecular biology.	[Sleiman, Dona; Lagune, Marion; Kaminski, Pierre Alexandre] Inst Pasteur, CNRS UMR 2001, Biol Gram Posit Pathogens, Paris, France; [Garcia, Pierre Simon; Taib, Najwa; Gribaldo, Simonetta] Inst Pasteur, Evolutionary Biol Microbial Cell, CNRS UMR 2001, Paris, France; [Garcia, Pierre Simon] Inst Pasteur, Stress Adaptat & Metab, CNRS UMR 2001, Paris, France; [Loc'h, Jerome] Inst Pasteur, Struct Dynam Macromol, CNRS UMR 3528, Paris, France; [Haouz, Ahmed] Inst Pasteur, C2RT, Crystallog Platform, CNRS UMR 3528, Paris, France; [Taib, Najwa] Inst Pasteur, Hub Bioinformat & Biostat, Paris, France; [Rothlisberger, Pascal] Inst Pasteur, Bioorgan Chem Nucle Acids, CNRS UMR 3523, Paris, France; [Marliere, Philippe] Univ Paris Saclay, Univ Evry, Inst Francois Jacob, CNRS,CEA,Genom Metab,Genoscope, Evry, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Kaminski, PA (corresponding author), Inst Pasteur, CNRS UMR 2001, Biol Gram Posit Pathogens, Paris, France.	pierre-alexandre.kaminski@pasteur.fr	gribaldo, simonetta/AAW-4377-2020	gribaldo, simonetta/0000-0002-7662-021X; Sleiman, Dona/0000-0002-4005-6514; Lagune, Marion/0000-0001-9600-5719; Kaminski, Pierre Alexandre/0000-0001-9841-6837; HAOUZ, Ahmed/0000-0003-1196-1635; Taib, Najwa/0000-0002-1422-043X	ERASynBio "TNA episome"; ERACoBioTech "Iron Plug'n Play" fellowship; French National Agency [ANR-16-CE02-0005-01]; French government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases [ANR-10-LABX-62-IBEID]	ERASynBio "TNA episome"; ERACoBioTech "Iron Plug'n Play" fellowship; French National Agency(French National Research Agency (ANR)); French government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases(French National Research Agency (ANR))	D.S. and P.S.G. were supported by an ERASynBio "TNA episome" and by an ERACoBioTech "Iron Plug'n Play" fellowship, respectively. S.G. acknowledges funding from the French National Agency for research grant Archaevol (ANR-16-CE02-0005-01). This study was funded from the French government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (grant no. ANR-10-LABX-62-IBEID).	Agarwal K C, 1978, Methods Enzymol, V51, P483; Bailly C, 1998, NUCLEIC ACIDS RES, V26, P4309, DOI 10.1093/nar/26.19.4309; Bouyoub A, 1996, J MOL BIOL, V261, P144, DOI 10.1006/jmbi.1996.0448; Callahan MP, 2011, P NATL ACAD SCI USA, V108, P13995, DOI 10.1073/pnas.1106493108; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Eddy Sean R, 2009, Genome Inform, V23, P205; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia P, 2021, SUP DATA DATASET FIG; Garcia P, 2021, **DATA OBJECT**, DOI [10.6084/m9.figshare.14134922.v1, DOI 10.6084/M9.FIGSHARE.14134922.V1]; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; KHUDYAKOV IY, 1978, VIROLOGY, V88, P8, DOI 10.1016/0042-6822(78)90104-6; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mehrotra S, 2007, BIOCHEMISTRY-US, V46, P12821, DOI 10.1021/bi701009y; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pezo V, 2021, SCIENCE, V372, P520, DOI 10.1126/science.abe6542; Raman J, 2004, MOL BIOCHEM PARASIT, V138, P1, DOI 10.1016/j.molbiopara.2004.06.013; Solis-Sanchez A, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0490-x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SZEKERES M, 1987, FEBS LETT, V222, P89, DOI 10.1016/0014-5793(87)80197-7; Val ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002472; Wang WY, 1997, J BIOL CHEM, V272, P7078, DOI 10.1074/jbc.272.11.7078	28	27	31	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					516	+		10.1126/science.abe6494	http://dx.doi.org/10.1126/science.abe6494			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926955				2022-12-28	WOS:000645554100048
J	Rhie, A; McCarthy, SA; Fedrigo, O; Damas, J; Formenti, G; Koren, S; Uliano-Silva, M; Chow, W; Fungtammasan, A; Kim, J; Lee, C; Ko, BJ; Chaisson, M; Gedman, GL; Cantin, LJ; Thibaud-Nissen, F; Haggerty, L; Bista, I; Smith, M; Haase, B; Mountcastle, J; Winkler, S; Paez, S; Howard, J; Vernes, SC; Lama, TM; Grutzner, F; Warren, WC; Balakrishnan, CN; Burt, D; George, JM; Biegler, MT; Iorns, D; Digby, A; Eason, D; Robertson, B; Edwards, T; Wilkinson, M; Turner, G; Meyer, A; Kautt, AF; Franchini, P; Detrich, HW; Svardal, H; Wagner, M; Naylor, GJP; Pippel, M; Malinsky, M; Mooney, M; Simbirsky, M; Hannigan, BT; Pesout, T; Houck, M; Misuraca, A; Kingan, SB; Hall, R; Kronenberg, Z; Sovi, I; Dunn, C; Ning, Z; Hastie, A; Lee, J; Selvaraj, S; Green, RE; Putnam, NH; Gut, I; Ghurye, J; Garrison, E; Sims, Y; Collins, J; Pelan, S; Torrance, J; Tracey, A; Wood, J; Dagnew, RE; Guan, D; London, SE; Clayton, DF; Mello, CV; Friedrich, SR; Lovell, PV; Osipova, E; Al-Ajli, FO; Secomandi, S; Kim, H; Theofanopoulou, C; Hiller, M; Zhou, Y; Harris, RS; Makova, KD; Medvedev, P; Hoffman, J; Masterson, P; Clark, K; Martin, F; Howe, K; Flicek, P; Walenz, BP; Kwak, W; Clawson, H; Diekhans, M; Nassar, L; Paten, B; Kraus, RHS; Crawford, AJ; Gilbert, MTP; Zhang, G; Venkatesh, B; Murphy, RW; Koepfli, KP; Shapiro, B; Johnson, WE; Di Palma, F; Marques-Bonet, T; Teeling, EC; Warnow, T; Graves, JM; Ryder, OA; Haussler, D; O'Brien, SJ; Korlach, J; Lewin, HA; Howe, K; Myers, EW; Durbin, R; Phillippy, AM; Jarvis, ED				Rhie, Arang; McCarthy, Shane A.; Fedrigo, Olivier; Damas, Joana; Formenti, Giulio; Koren, Sergey; Uliano-Silva, Marcela; Chow, William; Fungtammasan, Arkarachai; Kim, Juwan; Lee, Chul; Ko, Byung June; Chaisson, Mark; Gedman, Gregory L.; Cantin, Lindsey J.; Thibaud-Nissen, Francoise; Haggerty, Leanne; Bista, Iliana; Smith, Michelle; Haase, Bettina; Mountcastle, Jacquelyn; Winkler, Sylke; Paez, Sadye; Howard, Jason; Vernes, Sonja C.; Lama, Tanya M.; Grutzner, Frank; Warren, Wesley C.; Balakrishnan, Christopher N.; Burt, Dave; George, Julia M.; Biegler, Matthew T.; Iorns, David; Digby, Andrew; Eason, Daryl; Robertson, Bruce; Edwards, Taylor; Wilkinson, Mark; Turner, George; Meyer, Axel; Kautt, Andreas F.; Franchini, Paolo; Detrich, H. William; Svardal, Hannes; Wagner, Maximilian; Naylor, Gavin J. P.; Pippel, Martin; Malinsky, Milan; Mooney, Mark; Simbirsky, Maria; Hannigan, Brett T.; Pesout, Trevor; Houck, Marlys; Misuraca, Ann; Kingan, Sarah B.; Hall, Richard; Kronenberg, Zev; Sovi, Ivan; Dunn, Christopher; Ning, Zemin; Hastie, Alex; Lee, Joyce; Selvaraj, Siddarth; Green, Richard E.; Putnam, Nicholas H.; Gut, Ivo; Ghurye, Jay; Garrison, Erik; Sims, Ying; Collins, Joanna; Pelan, Sarah; Torrance, James; Tracey, Alan; Wood, Jonathan; Dagnew, Robel E.; Guan, Dengfeng; London, Sarah E.; Clayton, David F.; Mello, Claudio, V; Friedrich, Samantha R.; Lovell, Peter, V; Osipova, Ekaterina; Al-Ajli, Farooq O.; Secomandi, Simona; Kim, Heebal; Theofanopoulou, Constantina; Hiller, Michael; Zhou, Yang; Harris, Robert S.; Makova, Kateryna D.; Medvedev, Paul; Hoffman, Jinna; Masterson, Patrick; Clark, Karen; Martin, Fergal; Howe, Kevin; Flicek, Paul; Walenz, Brian P.; Kwak, Woori; Clawson, Hiram; Diekhans, Mark; Nassar, Luis; Paten, Benedict; Kraus, Robert H. S.; Crawford, Andrew J.; Gilbert, M. Thomas P.; Zhang, Guojie; Venkatesh, Byrappa; Murphy, Robert W.; Koepfli, Klaus-Peter; Shapiro, Beth; Johnson, Warren E.; Di Palma, Federica; Marques-Bonet, Tomas; Teeling, Emma C.; Warnow, Tandy; Graves, Jennifer Marshall; Ryder, Oliver A.; Haussler, David; O'Brien, Stephen J.; Korlach, Jonas; Lewin, Harris A.; Howe, Kerstin; Myers, Eugene W.; Durbin, Richard; Phillippy, Adam M.; Jarvis, Erich D.			Towards complete and error-free genome assemblies of all vertebrate species	NATURE			English	Article							LONG-READ; MITOCHONDRIAL GENOME; CHROMOSOME; EVOLUTION; SEQUENCE; DUPLICATION; QUALITY; REARRANGEMENT; RECEPTORS; INSIGHTS	The Vertebrate Genome Project has used an optimized pipeline to generate high-quality genome assemblies for sixteen species (representing all major vertebrate classes), which have led to new biological insights. High-quality and complete reference genome assemblies are fundamental for the application of genomics to biology, disease, and biodiversity conservation. However, such assemblies are available for only a few non-microbial species(1-4). To address this issue, the international Genome 10K (G10K) consortium(5,6) has worked over a five-year period to evaluate and develop cost-effective methods for assembling highly accurate and nearly complete reference genomes. Here we present lessons learned from generating assemblies for 16 species that represent six major vertebrate lineages. We confirm that long-read sequencing technologies are essential for maximizing genome quality, and that unresolved complex repeats and haplotype heterozygosity are major sources of assembly error when not handled correctly. Our assemblies correct substantial errors, add missing sequence in some of the best historical reference genomes, and reveal biological discoveries. These include the identification of many false gene duplications, increases in gene sizes, chromosome rearrangements that are specific to lineages, a repeated independent chromosome breakpoint in bat genomes, and a canonical GC-rich pattern in protein-coding genes and their regulatory regions. Adopting these lessons, we have embarked on the Vertebrate Genomes Project (VGP), an international effort to generate high-quality, complete reference genomes for all of the roughly 70,000 extant vertebrate species and to help to enable a new era of discovery across the life sciences.	[Rhie, Arang; Koren, Sergey; Walenz, Brian P.; Phillippy, Adam M.] NIH, NHGRI, Computat & Stat Genom Branch, Genome Informat Sect, Bldg 10, Bethesda, MD 20892 USA; [McCarthy, Shane A.; Bista, Iliana; Guan, Dengfeng; Durbin, Richard] Univ Cambridge, Dept Genet, Cambridge, England; [McCarthy, Shane A.; Chow, William; Bista, Iliana; Smith, Michelle; Malinsky, Milan; Ning, Zemin; Sims, Ying; Collins, Joanna; Pelan, Sarah; Torrance, James; Tracey, Alan; Wood, Jonathan; Howe, Kerstin; Durbin, Richard] Wellcome Sanger Inst, Cambridge, England; [Fedrigo, Olivier; Formenti, Giulio; Haase, Bettina; Mountcastle, Jacquelyn; Paez, Sadye; Jarvis, Erich D.] Rockefeller Univ, Vertebrate Genome Lab, 1230 York Ave, New York, NY 10021 USA; [Damas, Joana; Lewin, Harris A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Formenti, Giulio; Gedman, Gregory L.; Cantin, Lindsey J.; Paez, Sadye; Biegler, Matthew T.; Theofanopoulou, Constantina; Jarvis, Erich D.] Rockefeller Univ, Lab Neurogenet Language, 1230 York Ave, New York, NY 10021 USA; [Uliano-Silva, Marcela] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Genet, Berlin, Germany; [Uliano-Silva, Marcela] Berlin Ctr Genom Biodivers Res, Berlin, Germany; [Fungtammasan, Arkarachai; Simbirsky, Maria; Hannigan, Brett T.] DNAnexus Inc, Mountain View, CA USA; [Kim, Juwan; Lee, Chul; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Ko, Byung June; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Ko, Byung June; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Chaisson, Mark; Dagnew, Robel E.] Univ Southern Calif, Los Angeles, CA 90007 USA; [Thibaud-Nissen, Francoise; Hoffman, Jinna; Masterson, Patrick; Clark, Karen] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA; [Haggerty, Leanne; Martin, Fergal; Howe, Kevin; Flicek, Paul] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Hinxton, England; [Winkler, Sylke; Pippel, Martin; Osipova, Ekaterina; Myers, Eugene W.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Winkler, Sylke] DRESDEN Concept Genome Ctr, Dresden, Germany; [Howard, Jason] Novogene, Durham, NC USA; [Vernes, Sonja C.] Max Planck Inst Psycholinguist, Neurogenet Vocal Commun Grp, Nijmegen, Netherlands; [Vernes, Sonja C.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Vernes, Sonja C.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Lama, Tanya M.] Univ Massachusetts, Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA; [Grutzner, Frank] Univ Adelaide, Sch Biol Sci, Environm Inst, Adelaide, SA, Australia; [Warren, Wesley C.] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA; [Balakrishnan, Christopher N.] East Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Burt, Dave] Univ Queensland, UQ Genom, Brisbane, Qld, Australia; [George, Julia M.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Iorns, David] Genet Rescue Fdn, Wellington, New Zealand; [Digby, Andrew; Eason, Daryl] Kakapo Recovery, Dept Conservat, Invercargill, New Zealand; [Robertson, Bruce] Univ Otago, Dept Zool, Dunedin, New Zealand; [Edwards, Taylor] Univ Arizona Genet Core, Tucson, AZ USA; [Wilkinson, Mark] Nat Hist Museum, Dept Life Sci, London, England; [Turner, George] Bangor Univ, Sch Nat Sci, Bangor, Gwynedd, Wales; [Meyer, Axel; Kautt, Andreas F.; Franchini, Paolo; Kraus, Robert H. S.] Univ Konstanz, Dept Biol, Constance, Germany; [Kautt, Andreas F.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Detrich, H. William] Northeastern Univ, Marine Sci Ctr, Dept Marine & Environm Sci, Nahant, MA 01908 USA; [Svardal, Hannes] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Svardal, Hannes] Nat Biodivers Ctr, Leiden, Netherlands; [Wagner, Maximilian] Karl Franzens Univ Graz, Inst Biol, Graz, Austria; [Naylor, Gavin J. P.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Pippel, Martin; Osipova, Ekaterina; Myers, Eugene W.] Ctr Syst Biol, Dresden, Germany; [Malinsky, Milan] Univ Basel, Zool Inst, Basel, Switzerland; [Mooney, Mark] Tagbio, San Francisco, CA USA; [Pesout, Trevor; Green, Richard E.; Garrison, Erik; Clawson, Hiram; Diekhans, Mark; Nassar, Luis; Paten, Benedict; Haussler, David] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Houck, Marlys; Misuraca, Ann; Ryder, Oliver A.] San Diego Zoo Global, Escondido, CA USA; [Kingan, Sarah B.; Hall, Richard; Kronenberg, Zev; Sovi, Ivan; Dunn, Christopher; Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA; [Sovi, Ivan] Digital BioL, Ivanic Grad, Croatia; [Hastie, Alex; Lee, Joyce] Bionano Genom, San Diego, CA USA; [Selvaraj, Siddarth] Arima Genom, San Diego, CA USA; [Green, Richard E.; Ghurye, Jay] Dovetail Genom, Santa Cruz, CA USA; [Gut, Ivo] Barcelona Inst Sci & Technol, Ctr Genom Regulat, CNAG CRG, Barcelona, Spain; [Gut, Ivo] Univ Pompeu Fabra, Barcelona, Spain; [Ghurye, Jay] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Guan, Dengfeng] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin, Peoples R China; [London, Sarah E.] Univ Chicago, Dept Psychol, Inst Mind & Biol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Clayton, David F.] Clemson Univ, Dept Genet & Biochem, Clemson, SC USA; [Mello, Claudio, V; Friedrich, Samantha R.; Lovell, Peter, V] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Osipova, Ekaterina] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Al-Ajli, Farooq O.] Monash Univ Malaysia Genom Facil, Sch Sci, Selangor Darul Ehsan, Malaysia; [Al-Ajli, Farooq O.] Monash Univ Malaysia, Trop Med & Biol Multidisciplinary Platform, Selangor Darul Ehsan, Malaysia; [Al-Ajli, Farooq O.] Qatar Falcon Genome Project, Doha, Qatar; [Secomandi, Simona] Univ Milan, Dept Biosci, Milan, Italy; [Kim, Heebal; Kwak, Woori] eGnome Inc, Seoul, South Korea; [Hiller, Michael] LOEWE Ctr Translat Biodivers Genom, Frankfurt, Germany; [Hiller, Michael] Senckenberg Res Inst, Frankfurt, Germany; [Hiller, Michael] Goethe Univ, Fac Biosci, Frankfurt, Germany; [Zhou, Yang] BGI Shenzhen, Shenzhen, Peoples R China; [Harris, Robert S.; Makova, Kateryna D.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Makova, Kateryna D.; Medvedev, Paul] Penn State Univ, Ctr Med Genom, University Pk, PA 16802 USA; [Makova, Kateryna D.; Medvedev, Paul] Penn State Univ, Ctr Computat Biol & Bioinformat, University Pk, PA 16802 USA; [Medvedev, Paul] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Medvedev, Paul] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Kwak, Woori] Hoonygen, Seoul, South Korea; [Kraus, Robert H. S.] Max Planck Inst Anim Behav, Dept Migrat, Radolfzell am Bodensee, Germany; [Crawford, Andrew J.] Univ Andes, Dept Biol Sci, Bogota, Colombia; [Gilbert, M. Thomas P.] Univ Copenhagen, Ctr Evolutionary Hologen, Globe Inst, Copenhagen, Denmark; [Gilbert, M. Thomas P.] Univ Museum, NTNU, Trondheim, Norway; [Zhang, Guojie] BGI Shenzhen, China Natl Genebank, Shenzhen, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Villum Ctr Biodivers Genom, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark; [Zhang, Guojie] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Zhang, Guojie] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China; [Venkatesh, Byrappa] Inst Mol & Cell Biol, Biopolis, ASTAR, Singapore, Singapore; [Murphy, Robert W.] Royal Ontario Museum, Ctr Biodivers, Toronto, ON, Canada; [Koepfli, Klaus-Peter; Johnson, Warren E.] Smithsonian Conservat Biol Inst, Ctr Species Survival, Natl Zool Pk, Washington, DC USA; [Shapiro, Beth; Haussler, David] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Shapiro, Beth; Jarvis, Erich D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Johnson, Warren E.] Smithsonian Inst, Museum Support Ctr MRC 534, Walter Reed Biosystemat Unit, Suitland, MD USA; [Johnson, Warren E.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Di Palma, Federica] Univ East Anglia, Earlham Inst, Dept Biol Sci, Norwich, Norfolk, England; [Marques-Bonet, Tomas] Inst Evolutionary Biol UPF, PRBB, CSIC, Barcelona, Spain; [Marques-Bonet, Tomas] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Marques-Bonet, Tomas] Barcelona Inst Sci & Technol BIST, Ctr Genom Regulat CRG, Barcelona, Spain; [Marques-Bonet, Tomas] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont, Barcelona, Spain; [Teeling, Emma C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin, Ireland; [Warnow, Tandy] Univ Illinois, Dept Comp Sci, 1304 W Springfield Ave, Urbana, IL 61801 USA; [Graves, Jennifer Marshall] Trobe Univ, Sch Life Sci, Victoria, Australia; [Ryder, Oliver A.] Univ Calif San Diego, Dept Evolut Behav & Ecol, La Jolla, CA 92093 USA; [O'Brien, Stephen J.] ITMO Univ, Lab Genom Divers Ctr Comp Technol, St Petersburg, Russia; [O'Brien, Stephen J.] Nova Southeastern Univ, Guy Harvey Oceanog Ctr, Halmos Coll Nat Sci & Oceanog, Ft Lauderdale, FL 33314 USA; [Lewin, Harris A.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Lewin, Harris A.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA; [Myers, Eugene W.] Tech Univ Dresden, Fac Comp Sci, Dresden, Germany	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Cambridge; Wellcome Trust Sanger Institute; Rockefeller University; University of California System; University of California Davis; Rockefeller University; Leibniz Institut fur Zoo und Wildtierforschung; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Southern California; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); European Molecular Biology Laboratory (EMBL); Max Planck Society; Max Planck Society; Radboud University Nijmegen; University of St Andrews; University of Massachusetts System; University of Massachusetts Amherst; University of Adelaide; University of Missouri System; University of Missouri Columbia; University of North Carolina; East Carolina University; University of Queensland; Clemson University; University of Otago; University of Arizona; Natural History Museum London; Bangor University; University of Konstanz; Harvard University; Northeastern University; University of Antwerp; Naturalis Biodiversity Center; University of Graz; State University System of Florida; University of Florida; University of Basel; University of California System; University of California Santa Cruz; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University System of Maryland; University of Maryland College Park; Harbin Institute of Technology; University of Chicago; Clemson University; Oregon Health & Science University; Max Planck Society; Monash University; Monash University Sunway; University of Milan; Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; Beijing Genomics Institute (BGI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Max Planck Society; Universidad de los Andes (Colombia); University of Copenhagen; Beijing Genomics Institute (BGI); University of Copenhagen; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Royal Ontario Museum; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of California System; University of California Santa Cruz; Howard Hughes Medical Institute; Smithsonian Institution; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; University of East Anglia; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); University College Dublin; University of Illinois System; University of Illinois Urbana-Champaign; La Trobe University; University of California System; University of California San Diego; ITMO University; Nova Southeastern University; University of California System; University of California Davis; University of California System; University of California Davis; Technische Universitat Dresden	Phillippy, AM (corresponding author), NIH, NHGRI, Computat & Stat Genom Branch, Genome Informat Sect, Bldg 10, Bethesda, MD 20892 USA.; Durbin, R (corresponding author), Univ Cambridge, Dept Genet, Cambridge, England.; Howe, K; Durbin, R (corresponding author), Wellcome Sanger Inst, Cambridge, England.; Jarvis, ED (corresponding author), Rockefeller Univ, Vertebrate Genome Lab, 1230 York Ave, New York, NY 10021 USA.; Jarvis, ED (corresponding author), Rockefeller Univ, Lab Neurogenet Language, 1230 York Ave, New York, NY 10021 USA.; Myers, EW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.; Myers, EW (corresponding author), Ctr Syst Biol, Dresden, Germany.; Jarvis, ED (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Myers, EW (corresponding author), Tech Univ Dresden, Fac Comp Sci, Dresden, Germany.	kj2@sanger.ac.uk; gene@mpi-cbg.de; rd109@cam.ac.uk; adam.phillippy@nih.gov; ejarvis@rockefeller.edu	Formenti, Giulio/GRX-8689-2022; Zhang, Guojie/J-7273-2019; Kim, Heebal/A-8889-2016; Pippel, Martin/AGA-8156-2022; Phillippy, Adam M/U-5731-2018; Damas, Joana/AHE-6278-2022; Meyer, Axel/C-9826-2009; Fungtammasan, Arkarachai/I-9847-2019; LEWIN, HARRIS/HGC-6543-2022; Gut, Ivo/ABF-3188-2020; Biegler, Matthew/AAW-2452-2021; Crawford, Andrew J./G-6365-2012; Bista, Iliana/GXM-7439-2022; Rhie, Arang/AAP-8907-2021; Grutzner, Frank/ABB-2820-2021; Bista, Iliana/AFM-5294-2022; Vernes, Sonja/E-8454-2012; Gilbert, Marcus/A-8936-2013; George, Julia/B-2169-2008; Johnson, Warren/D-4149-2016	Formenti, Giulio/0000-0002-7554-5991; Zhang, Guojie/0000-0001-6860-1521; Kim, Heebal/0000-0003-3064-1303; Pippel, Martin/0000-0002-8134-5929; Phillippy, Adam M/0000-0003-2983-8934; Damas, Joana/0000-0003-4857-2510; Meyer, Axel/0000-0002-0888-8193; Fungtammasan, Arkarachai/0000-0003-2398-0358; LEWIN, HARRIS/0000-0002-1043-7287; Gut, Ivo/0000-0001-7219-632X; Biegler, Matthew/0000-0003-4331-9890; Crawford, Andrew J./0000-0003-3153-6898; Rhie, Arang/0000-0002-9809-8127; Grutzner, Frank/0000-0002-3088-7314; Edwards, Taylor/0000-0002-7235-6175; Vernes, Sonja/0000-0003-0305-4584; Gilbert, Marcus/0000-0002-5805-7195; Howe, Kevin/0000-0002-1751-9226; Flicek, Paul/0000-0002-3897-7955; Green, Richard/0000-0003-0516-5827; Uliano da Silva, Marcela/0000-0001-6723-4715; Martin, Fergal/0000-0002-1672-050X; Ning, Zemin/0000-0003-4359-776X; Fedrigo, Olivier/0000-0002-6450-7551; Zhou, Yang/0000-0003-1247-5049; Digby, Andrew/0000-0002-1870-8811; Friedrich, Samantha/0000-0003-0570-6080; Teeling, Emma/0000-0002-3309-1346; Chow, William/0000-0002-9056-201X; Howard, Jason/0000-0003-3265-5127; Haggerty, Leanne/0000-0001-8843-3596; Venkatesh, Byrappa/0000-0003-3620-0277; Bista, Iliana/0000-0002-6155-3093; Secomandi, Simona/0000-0001-8597-6034; George, Julia/0000-0001-6194-6914; Mello, Claudio/0000-0002-9826-8421; Johnson, Warren/0000-0002-5954-186X	UKRI [MR/T021985/1] Funding Source: UKRI	UKRI		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Arima Genomics Inc., AR GEN MAPP PIP; Becak M. L., 1973, CHROMOSOME ATLAS FIS, V2; Bionano Genomics Inc., BION SOFTW DOWNL; Bishara A, 2015, GENOME RES, V25, P1570, DOI 10.1101/gr.191189.115; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Brandl K, 2012, P NATL ACAD SCI USA, V109, P12650, DOI 10.1073/pnas.1210366109; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cataldo I, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00027; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chow W, 2016, BIOINFORMATICS, V32, P2508, DOI 10.1093/bioinformatics/btw159; Damas J, 2020, P NATL ACAD SCI USA, V117, P22311, DOI 10.1073/pnas.2010146117; Daza DO, 2020, GENOME BIOL EVOL, V12, P993, DOI 10.1093/gbe/evz274; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Dussex N., CELL GENOM; English AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047768; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Farre M, 2016, GENOME BIOL EVOL, V8, P2442, DOI 10.1093/gbe/evw166; Formenti G., GENOME BIOL; Garrison E, 2012, HAPLOTYPE BASED VARI; Ghurye J, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007273; Guan D., ASSET; Guan DF, 2020, BIOINFORMATICS, V36, P2896, DOI 10.1093/bioinformatics/btaa025; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; Harry E., PRETEXTVIEW; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Howe K., 2021, GIGASCIENCE, V10; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Jain C, 2018, BIOINFORMATICS, V34, P748, DOI 10.1093/bioinformatics/bty597; Japundzic-Zigon N, 2020, CURR NEUROPHARMACOL, V18, P14, DOI 10.2174/1570159X17666190717150501; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jarvis ED, 2013, J COMP NEUROL, V521, P3614, DOI 10.1002/cne.23404; Jebb D, 2020, NATURE, V583, P578, DOI 10.1038/s41586-020-2486-3; Jenjaroenpun P, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky014; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r28; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kerpedjiev P, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1486-1; Kim J., 2021, FALS GENE CHROMOSOME, DOI [10.1101/2021.04.09.438906, DOI 10.1101/2021.04.09.438906]; Kim J, 2017, P NATL ACAD SCI USA, V114, pE5379, DOI 10.1073/pnas.1702012114; Ko BJ., 2021, WIDESPREAD FALSE GEN, DOI [10.1101/2021.04.09.438957, DOI 10.1101/2021.04.09.438957]; Koepfli KP, 2015, ANNU REV ANIM BIOSCI, V3, P57, DOI 10.1146/annurev-animal-090414-014900; Kolesnikov AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P1424, DOI 10.1134/S0006297912130020; Kolmogorov M, 2014, BIOINFORMATICS, V30, P302, DOI 10.1093/bioinformatics/btu280; Koren S., 2018, NAT BIOTECHNOL; Koren S, 2019, NAT BIOTECHNOL, V37, P127, DOI 10.1038/s41587-018-0005-y; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Koren S, 2015, CURR OPIN MICROBIOL, V23, P110, DOI 10.1016/j.mib.2014.11.014; Korlach J, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix085; Kronenberg ZN, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20536-y; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lemaire S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1869-y; Lewin HA, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz086; Lewin HA, 2018, P NATL ACAD SCI USA, V115, P4325, DOI 10.1073/pnas.1720115115; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S., 2014, GENOME BIOL, V15; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin B, 2017, CELL SYST, V5, P25, DOI 10.1016/j.cels.2017.06.014; Logsdon GA, 2021, NATURE, V593, P101, DOI 10.1038/s41586-021-03420-7; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Malmstrom M, 2016, NAT GENET, V48, P1204, DOI 10.1038/ng.3645; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miga KH, 2020, NATURE, V585, P79, DOI 10.1038/s41586-020-2547-7; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Nattestad M., DOT; Ning Z., SCAFF10X; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Pfenning AR, 2014, SCIENCE, V346, P1333, DOI 10.1126/science.1256846; Rhie A, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02134-9; Roach MJ, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2485-7; Robinson Richard, 2008, PLoS Biol, V6, pe77, DOI 10.1371/journal.pbio.0060077; Rodriguez-Agudo D, 2019, J LIPID RES, V60, P1087, DOI 10.1194/jlr.M091967; Schneider VA, 2017, GENOME RES, V27, P849, DOI 10.1101/gr.213611.116; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Soorni A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3412-9; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; Suzuki A, 2016, NAT CELL BIOL, V18, P382, DOI 10.1038/ncb3323; Tarailo-Graovac M, 2009, CURRENT PROTOCOLS BI, V25; Teeling EC, 2018, ANNU REV ANIM BIOSCI, V6, P23, DOI 10.1146/annurev-animal-022516-022811; Theofanopoulou C, 2021, NATURE, V592, P747, DOI 10.1038/s41586-020-03040-7; Tomaszkiewicz M, 2017, TRENDS GENET, V33, P266, DOI 10.1016/j.tig.2017.01.008; Tse D., 2013, BMC BIOINFORMATICS, V14; Tyson JR, 2018, GENOME RES, V28, P266, DOI 10.1101/gr.221184.117; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vollger MR, 2019, NAT METHODS, V16, P88, DOI 10.1038/s41592-018-0236-3; Vurture GW, 2017, BIOINFORMATICS, V33, P2202, DOI 10.1093/bioinformatics/btx153; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Warren WC, 2017, G3-GENES GENOM GENET, V7, P109, DOI 10.1534/g3.116.035923; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weisenfeld NI, 2017, GENOME RES, V27, P757, DOI 10.1101/gr.214874.116; Yin Z-T, 2019, BMC GENOMICS, V20; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhang LG, 2004, P NATL ACAD SCI USA, V101, P16855, DOI 10.1073/pnas.0407821101; Zhao HH, 2016, MITOCHONDRIAL DNA A, V27, P1005, DOI 10.3109/19401736.2014.926526; Zhou Y, 2021, NATURE, V592, P756, DOI 10.1038/s41586-020-03039-0	108	203	205	29	86	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					737	+		10.1038/s41586-021-03451-0	http://dx.doi.org/10.1038/s41586-021-03451-0			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911273	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000645368900016
J	Liu, Y; Makarova, KS; Huang, WC; Wolf, YI; Nikolskaya, AN; Zhang, XX; Cai, MW; Zhang, CJ; Xu, W; Luo, ZH; Cheng, L; Koonin, EV; Li, M				Liu, Yang; Makarova, Kira S.; Huang, Wen-Cong; Wolf, Yuri I.; Nikolskaya, Anastasia N.; Zhang, Xinxu; Cai, Mingwei; Zhang, Cui-Jing; Xu, Wei; Luo, Zhuhua; Cheng, Lei; Koonin, Eugene V.; Li, Meng			Expanded diversity of Asgard archaea and their relationships with eukaryotes	NATURE			English	Article							ORIGIN; ALIGNMENT; SOFTWARE; TREE; DOMAINS; FIELD	Asgard is a recently discovered superphylum of archaea that appears to include the closest archaeal relatives of eukaryotes(1-5). Debate continues as to whether the archaeal ancestor of eukaryotes belongs within the Asgard superphylum or whether this ancestor is a sister group to all other archaea (that is, a two-domain versus a three-domain tree of life)(6-8). Here we present a comparative analysis of 162 complete or nearly complete genomes of Asgard archaea, including 75 metagenome-assembled genomes that-to our knowledge-have not previously been reported. Our results substantially expand the phylogenetic diversity of Asgard and lead us to propose six additional phyla that include a deep branch that we have provisionally named Wukongarchaeota. Our phylogenomic analysis does not resolve unequivocally the evolutionary relationship between eukaryotes and Asgard archaea, but instead-depending on the choice of species and conserved genes used to build the phylogeny-supports either the origin of eukaryotes from within Asgard (as a sister group to the expanded Heimdallarchaeota-Wukongarchaeota branch) or a deeper branch for the eukaryote ancestor within archaea. Our comprehensive protein domain analysis using the 162 Asgard genomes results in a major expansion of the set of eukaryotic signature proteins. The Asgard eukaryotic signature proteins show variable phyletic distributions and domain architectures, which is suggestive of dynamic evolution through horizontal gene transfer, gene loss, gene duplication and domain shuffling. The phylogenomics of the Asgard archaea points to the accumulation of the components of the mobile archaeal `eukaryome' in the archaeal ancestor of eukaryotes (within or outside Asgard) through extensive horizontal gene transfer.	[Liu, Yang; Huang, Wen-Cong; Zhang, Xinxu; Cai, Mingwei; Zhang, Cui-Jing; Li, Meng] Shenzhen Univ, Inst Adv Study, Shenzhen Key Lab Marine Microbiome Engn, Shenzhen, Peoples R China; [Makarova, Kira S.; Wolf, Yuri I.; Nikolskaya, Anastasia N.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Xu, Wei; Luo, Zhuhua] Third Inst Oceanog, Minist Nat Resources, Key Lab Marine Biogenet Resources, Xiamen, Peoples R China; [Cheng, Lei] Minist Agr, Biogas Inst, Key Lab Dev & Applicat Rural Renewable Energy, Chengdu, Peoples R China	Shenzhen University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Ministry of Natural Resources of the People's Republic of China; Chinese Academy of Agricultural Sciences; Biogas Institute of Ministry of Agriculture, CAAS; Ministry of Agriculture & Rural Affairs	Li, M (corresponding author), Shenzhen Univ, Inst Adv Study, Shenzhen Key Lab Marine Microbiome Engn, Shenzhen, Peoples R China.; Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	koonin@ncbi.nlm.nih.gov; limeng848@szu.edu.cn	Li, Meng/K-3172-2012; Huang, Wen-Cong/ABF-1208-2021; Liu, Yang/AIE-3290-2022	Li, Meng/0000-0001-8675-0758; Liu, Yang/0000-0002-1109-0756; Luo, Zhuhua/0000-0002-7553-8628; Huang, Wen-Cong/0000-0002-1328-4087; Zhang, Cui-Jing/0000-0003-0904-5531	National Natural Science Foundation of China [91851105, 31970105, 92051102, 31700430, 91951102, 41776170, 92051108]; Innovation Team Project of Universities in Guangdong Province [2020KCXTD023]; Shenzhen Science and Technology Program [JCYJ20200109105010363, JCYJ20190808152403587]; Scientific Research Foundation of Third Institute of Oceanography, MNR [2019022]; China Ocean Mineral Resources R&D Association (COMRA) Program [DY135-B2-09]; National Key Basic Research Program of China ('973'-Program) [2015CB755903]; Intramural Research Program of the National Institutes of Health of the USA (National Library of Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Team Project of Universities in Guangdong Province; Shenzhen Science and Technology Program; Scientific Research Foundation of Third Institute of Oceanography, MNR; China Ocean Mineral Resources R&D Association (COMRA) Program; National Key Basic Research Program of China ('973'-Program)(National Basic Research Program of China); Intramural Research Program of the National Institutes of Health of the USA (National Library of Medicine)	We thank P. Forterre and T. Williams for critical reading of the manuscript and helpful suggestions; J. Chen, H. Li, P. Du and D. Zou for support with sampling and preliminary analysis of Changjiang estuary sediments; Z. Zhou and J.-D. Gu for support with sampling and preliminary analysis of Mai Po Nature Reserve sediments; S. Zheng and F. Liu for support with sampling and preliminary analysis of Rongcheng Swan Lake Nature Reserve sediments; and the crew and scientific team of RV Xiangyanghong 09, the pilots and the supporting team of Jiaolong manned submersible in the 37th Dayang Cruise for the sampling. M.L., Y.L., X.Z., W.X., Z.L. and L.C. are supported by National Natural Science Foundation of China (grant no. 91851105, 31970105, 92051102, 31700430, 91951102, 41776170 and 92051108), the Innovation Team Project of Universities in Guangdong Province (no. 2020KCXTD023), the Shenzhen Science and Technology Program (grant no. JCYJ20200109105010363 and JCYJ20190808152403587), the Scientific Research Foundation of Third Institute of Oceanography, MNR (2019022), the China Ocean Mineral Resources R&D Association (COMRA) Program (DY135-B2-09) and the National Key Basic Research Program of China (`973'-Program, 2015CB755903). K.S.M., Y.I.W., A.N. and E.V.K. are supported by the Intramural Research Program of the National Institutes of Health of the USA (National Library of Medicine).	Akil C, 2020, P NATL ACAD SCI USA, V117, P19904, DOI [10.1073/pnas.200199049167117, 10.1073/pnas.2009167117]; Akil C, 2018, NATURE, V562, P439, DOI 10.1038/s41586-018-0548-6; Balasingam N, 2020, BIOCHEM CELL BIOL, V98, P1, DOI 10.1139/bcb-2018-0353; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai MW, 2020, SCI CHINA LIFE SCI, V63, P886, DOI 10.1007/s11427-020-1679-1; Cheng L, 2008, FEMS MICROBIOL LETT, V285, P65, DOI 10.1111/j.1574-6968.2008.01212.x; Christ L, 2017, TRENDS BIOCHEM SCI, V42, P42, DOI 10.1016/j.tibs.2016.08.016; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Da Cunha V, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007215; Da Cunha V, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006810; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Esterman ES, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab015; Forterre P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00717; Garrido ND, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00108; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Imachi H, 2020, NATURE, V577, P519, DOI 10.1038/s41586-019-1916-6; Kang DWD, 2019, PEERJ, V7, DOI 10.7717/peerj.7359; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klinger CM, 2016, MOL BIOL EVOL, V33, P1528, DOI 10.1093/molbev/msw034; Koonin EV, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016188; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Liu Y, 2018, ISME J, V12, P1021, DOI 10.1038/s41396-018-0060-x; Lombard J, 2012, NAT REV MICROBIOL, V10, P507, DOI 10.1038/nrmicro2815; Lopez-Garcia P, 2020, NAT MICROBIOL, V5, P655, DOI 10.1038/s41564-020-0710-4; Lopez-Garcia P, 2020, CELL, V181, P232, DOI 10.1016/j.cell.2020.03.058; Lu ZY, 2020, MBIO, V11, DOI 10.1128/mBio.00417-20; MacLeod F, 2019, AIMS MICROBIOL, V5, P48, DOI 10.3934/microbiol.2019.1.48; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Nayfach S, 2021, NAT BIOTECHNOL, V39, P499, DOI 10.1038/s41587-020-0718-6; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; R Core Team, 2021, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rinke C, 2021, RESOLVING WIDESPREAD, DOI [10.1101/2020.03.01.972265: 2020.03.01.972265, DOI 10.1101/2020.03.01.972265]; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shen K, 2018, NATURE, V556, P64, DOI 10.1038/nature26158; Sieber CMK, 2018, NAT MICROBIOL, V3, P836, DOI 10.1038/s41564-018-0171-1; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sondergaard D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34212; Spang A, 2019, NAT MICROBIOL, V4, P1138, DOI 10.1038/s41564-019-0406-9; Spang A, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007080; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988; Su MY, 2020, NATURE, V585, P251, DOI 10.1038/s41586-020-2633-x; SWOFFORD DL, 1987, MATH BIOSCI, V87, P199, DOI 10.1016/0025-5564(87)90074-5; Uritskiy GV, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0541-1; Williams TA, 2020, NAT ECOL EVOL, V4, P138, DOI 10.1038/s41559-019-1040-x; Williams TA, 2013, NATURE, V504, P231, DOI 10.1038/nature12779; Yang Mingzhang, 2020, Curr Protoc Bioinformatics, V69, pe90, DOI 10.1002/cpbi.90; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Zaremba-Niedzwiedzka K, 2017, NATURE, V541, P353, DOI 10.1038/nature21031; Zhang JW, 2021, ISME J, V15, P1826, DOI 10.1038/s41396-020-00890-x; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	67	49	50	30	151	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					553	+		10.1038/s41586-021-03494-3	http://dx.doi.org/10.1038/s41586-021-03494-3		APR 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IB	33911286				2022-12-28	WOS:000645221300002
J	Mann, K; Deny, S; Ganguli, S; Clandinin, TR				Mann, Kevin; Deny, Stephane; Ganguli, Surya; Clandinin, Thomas R.			Coupling of activity, metabolism and behaviour across the Drosophila brain	NATURE			English	Article								Coordinated activity across networks of neurons is a hallmark of both resting and active behavioural states in many species(1-5). These global patterns alter energy metabolism over seconds to hours, which underpins the widespread use of oxygen consumption and glucose uptake as proxies of neural activity(6,7). However, whether changes in neural activity are causally related to metabolic flux in intact circuits on the timescales associated with behaviour is unclear. Here we combine two-photon microscopy of the fly brain with sensors that enable the simultaneous measurement of neural activity and metabolic flux, across both resting and active behavioural states. We demonstrate that neural activity drives changes in metabolic flux, creating a tight coupling between these signals that can be measured across brain networks. Using local optogenetic perturbation, we demonstrate that even transient increases in neural activity result in rapid and persistent increases in cytosolic ATP, which suggests that neuronal metabolism predictively allocates resources to anticipate the energy demands of future activity. Finally, our studies reveal that the initiation of even minimal behavioural movements causes large-scale changes in the pattern of neural activity and energy metabolism, which reveals a widespread engagement of the brain. As the relationship between neural activity and energy metabolism is probably evolutionarily ancient and highly conserved, our studies provide a critical foundation for using metabolic proxies to capture changes in neural activity.	[Mann, Kevin; Ganguli, Surya; Clandinin, Thomas R.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Deny, Stephane; Ganguli, Surya] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Ganguli, S; Clandinin, TR (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.; Ganguli, S (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	sganguli@stanford.edu; trc@stanford.edu		Ganguli, Surya/0000-0002-9264-7551; Deny, Stephane/0000-0003-4707-128X	Simons foundation; NSF Career Award [1845166]; Stanford Wu Tsai neuroscience institute	Simons foundation; NSF Career Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Stanford Wu Tsai neuroscience institute	We thank C. Gallen for providing discussion and support. This work was supported by the Simons foundation (T.R.C. and S.G.), an NSF Career Award 1845166 (S.G.) and the Stanford Wu Tsai neuroscience institute (K.M.)	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Aimon S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006732; Bidaye SS, 2014, SCIENCE, V344, P97, DOI 10.1126/science.1249964; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cong L, 2017, ELIFE, V6, DOI 10.7554/eLife.28158; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Gonzalez-Gutierrez A., 2019, MONOCARBOXYLATE TRAN, DOI [10.1101/610196, DOI 10.1101/610196]; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; HORWITZ B, 1992, NATO ADV SCI I D-BEH, V68, P189; Ito K, 2014, NEURON, V81, P755, DOI 10.1016/j.neuron.2013.12.017; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Lemon WC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8924; Liska A, 2015, NEUROIMAGE, V115, P281, DOI 10.1016/j.neuroimage.2015.04.033; Lobas MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08441-5; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Mann K, 2017, CURR BIOL, V27, P2389, DOI 10.1016/j.cub.2017.06.076; Migault G, 2018, CURR BIOL, V28, P3723, DOI 10.1016/j.cub.2018.10.017; Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36; Mitra A, 2018, NEURON, V98, P297, DOI 10.1016/j.neuron.2018.03.015; Namiki S, 2018, ELIFE, V7, DOI 10.7554/eLife.34272; Nguyen JP, 2016, P NATL ACAD SCI USA, V113, pE1074, DOI 10.1073/pnas.1507110112; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Palva JM, 2012, NEUROIMAGE, V62, P2201, DOI 10.1016/j.neuroimage.2012.02.060; Passow S, 2015, HUM BRAIN MAPP, V36, P2027, DOI 10.1002/hbm.22753; Placais PY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15510; Power JD, 2014, NEURON, V84, P681, DOI 10.1016/j.neuron.2014.09.007; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; San Martin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085780; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Sokoloff L., 1989, NEUROMETHODS CARBOHY, P155; Steinmetz NA, 2019, NATURE, V576, P266, DOI 10.1038/s41586-019-1787-x; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P579, DOI 10.3758/BF03196615; WEISSMAN MB, 1988, REV MOD PHYS, V60, P537, DOI 10.1103/RevModPhys.60.537	40	20	20	3	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					244	+		10.1038/s41586-021-03497-0	http://dx.doi.org/10.1038/s41586-021-03497-0		APR 2021	18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33911283				2022-12-28	WOS:000645221300001
J	Buguzi, S				Buguzi, Syriacus			Covid-19: Counting the cost of denial in Tanzania	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												six.buguzi@gmail.com						[Anonymous], 2021, WIZARA YA AFYA TANZA; [Anonymous], 2021, ZITTO MWAMIRUYAGWA K; Tanzania Communications Regulatory Authority, 2020, EL POST COMM ACT; WHO, 2021, WHO DIR GEN STAT TAN	4	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2021	373								n1052	10.1136/bmj.n1052	http://dx.doi.org/10.1136/bmj.n1052			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RW1QM	33906903	Bronze			2022-12-28	WOS:000646297900004
J	Burki, T				Burki, Talha			The death penalty continues unabated globally	LANCET			English	Editorial Material																			0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1531	1532						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RR7QA	33894822				2022-12-28	WOS:000643286900008
J	Reich, K; Warren, RB; Lebwohl, M; Gooderham, M; Strober, B; Langley, RG; Paul, C; De Cuyper, D; Vanvoorden, V; Madden, C; Cioffi, C; Peterson, L; Blauvelt, A				Reich, Kristian; Warren, Richard B.; Lebwohl, Mark; Gooderham, Melinda; Strober, Bruce; Langley, Richard G.; Paul, Carle; De Cuyper, Dirk; Vanvoorden, Veerle; Madden, Cynthia; Cioffi, Christopher; Peterson, Luke; Blauvelt, Andrew			Bimekizumab versus Secukinumab in Plaque Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; MODERATE; MULTICENTER; EFFICACY; SAFETY	BACKGROUND Bimekizumab is a monoclonal IgG1 antibody that selectively inhibits both interleukin-17A and interleukin-17F. The efficacy and safety of bimekizumab as compared with secukinumab, which selectively inhibits interleukin-17A alone, in patients with moderate-to-severe plaque psoriasis have not been extensively examined. METHODS In this phase 3b trial, we randomly assigned patients with moderate-to-severe plaque psoriasis, in a 1:1 ratio, to receive bimekizumab subcutaneously at a dose of 320 mg every 4 weeks or secukinumab subcutaneously at a dose of 300 mg weekly to week 4, followed by every 4 weeks to week 48. At week 16, patients receiving bimekizumab underwent rerandomization, in a 1:2 ratio, to receive maintenance dosing every 4 weeks or every 8 weeks to week 48. The primary end point was 100% reduction from baseline in the Psoriasis Area and Severity Index (PASI) score at week 16. The primary analysis was first tested for the noninferiority of bimekizumab to secukinumab at a margin of -10 percentage points and then tested for superiority. RESULTS A total of 1005 patients were screened and 743 were enrolled; 373 patients were assigned to receive bimekizumab and 370 to receive secukinumab. At week 16, a total of 230 patients (61.7%) in the bimekizumab group and 181 (48.9%) in the secukinumab group had a 100% reduction from baseline in the PASI score (PASI 100) (adjusted risk difference, 12.7 percentage points; 95% confidence interval [CI], 5.8 to 19.6); bimekizumab was shown to be noninferior and superior to secukinumab (P<0.001 for noninferiority and superiority). At week 48, a total of 250 patients (67.0%) treated with bimekizumab had a PASI 100 response, as compared with 171 patients (46.2%) treated with secukinumab (adjusted risk difference, 20.9 percentage points; 95% CI, 14.1 to 27.7; P<0.001). At the week 4 time point, 265 patients (71.0%) in the bimekizumab group had 75% or greater reduction from baseline in the PASI score, as compared with 175 patients (47.3%) in the secukinumab group (adjusted risk difference, 23.7; 95% CI, 17.0 to 30.4; P<0.001). Oral candidiasis occurred more often with bimekizumab (72 patients, 19.3%) than with secukinumab (11 patients, 3.0%). CONCLUSIONS In patients with moderate-to-severe psoriasis, treatment with bimekizumab resulted in greater skin clearance than treatment with secukinumab over 16 and 48 weeks but was associated with oral candidiasis (predominantly mild or moderate as recorded by the investigator). Longer and larger trials are required to determine the comparative effect and risks of interleukin-17 inhibitors in psoriasis.	[Reich, Kristian] Univ Med Ctr Hamburg Eppendorf, Ctr Translat Res Inflammatory Skin Dis, Hamburg, Germany; [Warren, Richard B.] Univ Manchester, Dermatol Ctr, Salford Royal NHS Fdn Trust, Manchester NIHR Biomed Res Ctr, Manchester, Lancs, England; [Lebwohl, Mark] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Gooderham, Melinda] SKiN Ctr Dermatol, Prob Med Res, Peterborough, ON, Canada; [Gooderham, Melinda] Queens Univ, Kingston, ON, Canada; [Langley, Richard G.] Dalhousie Univ, Halifax, NS, Canada; [Strober, Bruce] Yale Univ, New Haven, CT USA; [Strober, Bruce] Cent Connecticut Dermatol Res, Cromwell, CT USA; [Paul, Carle] Paul Sabatier Univ, Toulouse, France; [De Cuyper, Dirk; Vanvoorden, Veerle] UCB Pharma, Brussels, Belgium; [Madden, Cynthia; Cioffi, Christopher; Peterson, Luke] UCB Pharma, Raleigh, NC USA; [Blauvelt, Andrew] Oregon Med Res Ctr, Portland, OR USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Salford Royal NHS Foundation Trust; University of Manchester; Icahn School of Medicine at Mount Sinai; Queens University - Canada; Dalhousie University; Yale University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UCB Pharma SA; UCB Pharma SA	Reich, K (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Martinistr 52, D-20246 Hamburg, Germany.	k.reich@uke.de		Paul, Carle/0000-0003-0165-5263; Peterson, Luke/0000-0003-2581-5655	UCB Pharma; Manchester National Institute for Health Research Biomedical Research Centre	UCB Pharma(UCB Pharma SA); Manchester National Institute for Health Research Biomedical Research Centre	Supported by UCB Pharma. Dr. Warren receives support from the Manchester National Institute for Health Research Biomedical Research Centre.	Adams R, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01894; Blauvelt A, 2020, J AM ACAD DERMATOL, V83, P1367, DOI 10.1016/j.jaad.2020.05.105; Blauvelt A, 2018, CLIN REV ALLERG IMMU, V55, P379, DOI 10.1007/s12016-018-8702-3; Chiricozzi A, 2019, PSORIASIS-TARGETS TH, V9, P29, DOI 10.2147/PTT.S179283; Conti HR, 2015, J IMMUNOL, V195, P780, DOI 10.4049/jimmunol.1500909; Fala Loretta, 2016, Am Health Drug Benefits, V9, P60; Fieldhouse KA., 2020, DRUGS CONTEXT, V9; Fujita H, 2021, J DERMATOL, V48, P175, DOI 10.1111/1346-8138.15655; Glatt S, 2018, ANN RHEUM DIS, V77, P523, DOI 10.1136/annrheumdis-2017-212127; Gordon KB, 2021, LANCET, V397, P475, DOI 10.1016/S0140-6736(21)00126-4; Hansen RB, 2016, EXPERT REV CLIN IMMU, V12, P1027, DOI 10.1080/1744666X.2016.1224658; Hohenberger M, 2018, J DERMATOL TREAT, V29, P13, DOI 10.1080/09546634.2017.1329511; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Kolbinger F, 2017, J ALLERGY CLIN IMMUN, V139, P923, DOI 10.1016/j.jaci.2016.06.038; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Papp KA, 2018, J AM ACAD DERMATOL, V79, P277, DOI 10.1016/j.jaad.2018.03.037; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Reich K, 2021, LANCET, V397, P487, DOI 10.1016/S0140-6736(21)00125-2; Thaci D, 2015, J AM ACAD DERMATOL, V73, P400, DOI 10.1016/j.jaad.2015.05.013; Warren RB, 2021, NEW ENGL J MED, V385, P130, DOI 10.1056/NEJMoa2102388; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799	21	50	50	5	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2021	385	2					142	152		10.1056/NEJMoa2102383	http://dx.doi.org/10.1056/NEJMoa2102383		APR 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TH8TR	33891380	Bronze			2022-12-28	WOS:000643851000001
J	Dyer, C				Dyer, Clare			Government and medical educators must act to reduce deaths from air pollution, says coroner	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Barlow P., 2021, REGULATION 28 REPORT; Dyer C, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4902	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2021	373								n1062	10.1136/bmj.n1062	http://dx.doi.org/10.1136/bmj.n1062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0MU	33888526				2022-12-28	WOS:000708062500006
J	Thiagarajan, K				Thiagarajan, Kamala			What do we know about India's Covaxin vaccine?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												kamala.thiagarajan@gmail.com						[Anonymous], 2021, NEW INDIAN EXPRESS; [Anonymous], 2021, DNA INDIA; [Anonymous], 2021, NEW VAR COR 50 MOR I; [Anonymous], 2020, COVID 19 POSTPANDEMI; [Anonymous], 2021, WIRE; Baraniuk C, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n912; Bharat Biotech, 2021, BHAR BIOT ANN PHAS 3; Dey S., 2021, TIMES INDIA; Ella R, 2020, SAFETY IMMUNOGENICIT, DOI [10.1101/2020:12.2120248643v1, DOI 10.1101/2020:12.2120248643V1]; Ella R, 2021, LANCET INFECT DIS, V21, P637, DOI [10.1016/S1473-3099(21)00070-0, 10.1016/S1473-3099(20)30942-7]; Kay C., 2020, BLOOMBERG; Robertson S., 2020, NEWS MED LIFE SCI; Sapkal GN, 2021, NEUTRALIZATION UK VA, DOI [10.1101/2021.01.26426986v1, DOI 10.1101/2021.01.26426986V1]; Sharma N., 2020, EC TIMES; Thiagarajan K, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n196	15	26	27	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n997	10.1136/bmj.n997	http://dx.doi.org/10.1136/bmj.n997			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3BI	33879478	Bronze			2022-12-28	WOS:000643654700001
J	Rickard, CM; Marsh, NM; Larsen, EN; McGrail, MR; Graves, N; Runnegar, N; Webster, J; Corley, A; McMillan, D; Gowardman, JR; Long, DA; Fraser, JF; Gill, FJ; Young, J; Murgo, M; Alexandrou, E; Abu Choudhury, M; Chan, RJ; Gavin, NC; Daud, A; Palermo, A; Regli, A; Playford, EG				Rickard, Claire M.; Marsh, Nicole M.; Larsen, Emily N.; McGrail, Matthew R.; Graves, Nicholas; Runnegar, Naomi; Webster, Joan; Corley, Amanda; McMillan, David; Gowardman, John R.; Long, Debbie A.; Fraser, John F.; Gill, Fenella J.; Young, Jeanine; Murgo, Marghie; Alexandrou, Evan; Abu Choudhury, Md; Chan, Raymond J.; Gavin, Nicole C.; Daud, Azlina; Palermo, Annamaria; Regli, Adrian; Playford, E. Geoffrey			Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial	LANCET			English	Article							INTRAVENOUS ADMINISTRATION SETS; CARE-ASSOCIATED INFECTIONS; INTRAVASCULAR DEVICES; COLONIZATION; GUIDELINES; PREVENTION; MANAGEMENT; HOSPITALS; ADULTS; RISK	Background The optimal duration of infusion set use to prevent life-threatening catheter-related bloodstream infection (CRBSI) is unclear. We aimed to compare the effectiveness and costs of 7-day (intervention) versus 4-day (control) infusion set replacement to prevent CRBSI in patients with central venous access devices (tunnelled cuffed, non-tunnelled, peripherally inserted, and totally implanted) and peripheral arterial catheters. Methods We did a randomised, controlled, assessor-masked trial at ten Australian hospitals. Our hypothesis was CRBSI equivalence for central venous access devices and non-inferiority for peripheral arterial catheters (both 2% margin). Adults and children with expected greater than 24 h central venous access device-peripheral arterial catheter use were randomly assigned (1:1; stratified by hospital, catheter type, and intensive care unit or ward) by a centralised, web-based service (concealed before allocation) to infusion set replacement every 7 days, or 4 days. This included crystalloids, non-lipid parenteral nutrition, and medication infusions. Patients and clinicians were not masked, but the primary outcome (CRBSI) was adjudicated by masked infectious diseases physicians. The analysis was modified intention to treat (mITT). This study is registered with the Australian New Zealand Clinical Trials Registry ACTRN12610000505000 and is complete. Findings Between May 30, 2011, and Dec, 9, 2016, from 6007 patients assessed, we assigned 2944 patients to 7-day (n=1463) or 4-day (n=1481) infusion set replacement, with 2941 in the mITT analysis. For central venous access devices, 20 (1.78%) of 1124 patients (7-day group) and 16 (1.46%) of 1097 patients (4-day group) had CRBSI (absolute risk difference [ARD] 0.32%, 95% CI -0.73 to 1.37). For peripheral arterial catheters, one (0.28%) of 357 patients in the 7-day group and none of 363 patients in the 4-day group had CRBSI (ARD 0.28%, -0.27% to 0.83%). There were no treatment-related adverse events. Interpretation Infusion set use can be safely extended to 7 days with resultant cost and workload reductions. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Rickard, Claire M.; Marsh, Nicole M.; McGrail, Matthew R.; Runnegar, Naomi; Corley, Amanda; Gowardman, John R.; Fraser, John F.; Gavin, Nicole C.; Playford, E. Geoffrey] Univ Queensland, UQ Ctr Clin Res, Sch Nursing Midwifery & Social Work, Rural Clin Sch,Sch Med, Brisbane, Qld, Australia; [Rickard, Claire M.; Marsh, Nicole M.; Larsen, Emily N.; Webster, Joan; Corley, Amanda; Long, Debbie A.; Fraser, John F.; Gill, Fenella J.; Alexandrou, Evan; Abu Choudhury, Md; Chan, Raymond J.; Gavin, Nicole C.] Griffith Univ, Sch Nursing & Midwifery & Alliance Vasc Access Te, Menzies Hlth Inst Queensland, Nathan, Qld, Australia; [Rickard, Claire M.; Marsh, Nicole M.; Larsen, Emily N.; Webster, Joan; Corley, Amanda; Gowardman, John R.; Gavin, Nicole C.] Royal Brisbane & Womens Hosp, Nursing & Midwifery Res Ctr, Herston Infect Dis Inst, Canc Care Serv & Intens Care Serv, Herston, Qld, Australia; [Rickard, Claire M.; Runnegar, Naomi; Chan, Raymond J.; Playford, E. Geoffrey] Princess Alexandra Hosp, Infect Management Serv, Nursing Practice Dev Unit, Woolloongabba, Qld, Australia; [Rickard, Claire M.; Corley, Amanda; Fraser, John F.] Prince Charles Hosp, Crit Care Res Grp, Chermside, Qld, Australia; [Long, Debbie A.; Chan, Raymond J.; Gavin, Nicole C.] Queensland Univ Technol, Canc & Palliat Care Outcomes Ctr, Sch Nursing, Kelvin Grove, Qld, Australia; [Graves, Nicholas] Duke Natl Univ Singapore, Med Sch, Hlth Serv & Syst Res, Singapore, Singapore; [McMillan, David; Young, Jeanine] Univ Sunshine Coast, Sch Hlth & Sports Sci, Sch Nursing Midwifery & Paramed, Sippy Downs, Qld, Australia; [McMillan, David; Young, Jeanine] Univ Sunshine Coast, INFLAME Biomed Res Cluster, Sippy Downs, Qld, Australia; [Long, Debbie A.] Queensland Childrens Hosp, Paediat Intens Care Unit, South Brisbane, Qld, Australia; [Gill, Fenella J.] Curtin Univ, Sch Nursing Midwifery & Paramed, Kent St, Bentley, WA, Australia; [Gill, Fenella J.] Child & Adolescent Hlth Serv, Perth Childrens Hosp, Nedlands, WA, Australia; [Murgo, Marghie] Australian Commiss Safety & Qual Healthcare, Partnering Consumers, Sydney, NSW, Australia; [Alexandrou, Evan] Western Sydney Univ, Sch Nursing & Midwifery, Penrith, NSW, Australia; [Alexandrou, Evan] Ctr Appl Nursing Res, Liverpool, NSW, Australia; [Alexandrou, Evan] Ingham Inst Appl Med Res, Liverpool, NSW, Australia; [Alexandrou, Evan] Liverpool Hosp, Dept Intens Care, Liverpool, NSW, Australia; [Alexandrou, Evan] Univ New South Wales, South Western Sydney Clin Sch, Liverpool, NSW, Australia; [Daud, Azlina] Int Islamic Univ Malaysia, Fac Nursing, Jalan Sultan Ahmad Shah,Kuantan Campus, Kuantan, Pahang, Malaysia; [Palermo, Annamaria; Regli, Adrian] St John God Murdoch Hosp, Intens Care Unit, Murdoch, WA, Australia; [Regli, Adrian] Univ Western Australia, Med Sch, Sterling Highway, Crawley, WA, Australia; [Regli, Adrian] Notre Dame Univ, Med Sch, Henry Rd, Fremantle, WA, Australia	University of Queensland; Griffith University; Royal Brisbane & Women's Hospital; Prince Charles Hospital; Queensland University of Technology (QUT); National University of Singapore; University of the Sunshine Coast; University of the Sunshine Coast; Curtin University; Western Sydney University; Ingham Institute for Applied Medical Research; Liverpool Hospital; University of New South Wales Sydney; International Islamic University Malaysia; St John of God Health Care; University of Western Australia; University of Notre Dame Australia	Rickard, CM (corresponding author), Univ Queensland, UQ Ctr Clin Res, Sch Nursing Midwifery & Social Work, Rural Clin Sch,Sch Med, Brisbane, Qld, Australia.	c.rickard@uq.edu.au	Runnegar, Naomi J/N-2911-2016; Runnegar, Naomi/ABF-6386-2021; Larsen, Emily N/O-7291-2014; Gill, Fenella J/O-5572-2018; Long, Debbie/L-2036-2016; Rickard, Claire M./C-3440-2008; Gavin, Nicole/R-2095-2016; Chan, Raymond/K-8415-2019; Young, Jeanine/G-2528-2010	Runnegar, Naomi J/0000-0003-1196-4131; Runnegar, Naomi/0000-0003-1196-4131; Gill, Fenella J/0000-0003-4697-9640; Long, Debbie/0000-0002-0984-9559; Rickard, Claire M./0000-0002-6341-7415; Marsh, Nicole/0000-0002-5779-1304; Gavin, Nicole/0000-0002-0828-9852; Murgo, Margherita/0000-0002-3879-7268; Chan, Raymond/0000-0003-0248-7046; Choudhury, Nahid/0000-0002-6527-4876; Young, Jeanine/0000-0003-3849-3392; Fraser, John/0000-0002-7012-2519	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council.	Bell T, 2017, INFECT DIS CLIN N AM, V31, P551, DOI 10.1016/j.idc.2017.05.007; Centers for Disease Control, 1971, MMWR-MORBID M      S, V20, P81; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chou EH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227752; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Rosenthal VD, 2020, AM J INFECT CONTROL, V48, P281, DOI 10.1016/j.ajic.2019.08.015; Fortun J, 2008, ENFERM INFEC MICR CL, V26, P168, DOI 10.1157/13116754; Gorski Lisa A, 2021, J Infus Nurs, V44, pS1, DOI 10.1097/NAN.0000000000000396; Kassar R, 2009, MEDICINE, V88, P279, DOI 10.1097/MD.0b013e3181b7c64a; Larsen EN, 2019, INFECT CONT HOSP EP, V40, P1100, DOI 10.1017/ice.2019.205; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Macias AE, 2008, AM J INFECT CONTROL, V36, P48, DOI 10.1016/j.ajic.2007.02.003; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; National Healthcare Safety Network, 2017, BLOODSTR INF EV CENT; National Institute for Health and Care Excellence, 2020, PER CAR AD NG180, P1; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; Prowle JR, 2011, CRIT CARE, V15, DOI 10.1186/cc10114; Queensland Health, WAG RAT NURS STREAM; Raad I, 2001, INFECT CONT HOSP EP, V22, P136, DOI 10.1086/501879; RADD I, 1993, J INFECT DIS, V168, P400, DOI 10.1093/infdis/168.2.400; Rickard CM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007257; Rickard CM, 2009, J CLIN NURS, V18, P3022, DOI 10.1111/j.1365-2702.2009.02870.x; Rickard CM, 2004, INFECT CONT HOSP EP, V25, P650, DOI 10.1086/502456; Sengul T, 2020, AM J INFECT CONTROL, V48, P275, DOI 10.1016/j.ajic.2019.08.020; Si Damin, 2016, Med J Aust, V204, P276; The Joint Commission, 2012, PREV CENTR LIN ASS B; Tuffaha HW, 2019, AUST HEALTH REV, V43, P511, DOI 10.1071/AH18102; Ullman AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003588.pub3; Wisniewski Andrea, 2020, J Extra Corpor Technol, V52, P135, DOI 10.1182/ject-1900023; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	31	11	13	4	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1447	1458						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RN5FX	33865494				2022-12-28	WOS:000640378100022
J	Luyckx, VA; Harris, DCH; Varghese, C; Jha, V				Luyckx, Valerie A.; Harris, David C. H.; Varghese, Cherian; Jha, Vivekanand			Bringing equity in access to quality dialysis	LANCET			English	Editorial Material							KIDNEY-DISEASE; CARE		[Luyckx, Valerie A.] Harvard Med Sch, Div Renal, Brigham & Womens Hosp, Boston, MA 02115 USA; [Luyckx, Valerie A.] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa; [Harris, David C. H.] Univ Sydney, Westmead Inst Med Res, Ctr Transplantat & Renal Res, Sydney, NSW, Australia; [Varghese, Cherian] WHO, Geneva, Switzerland; [Jha, Vivekanand] George Inst Global Hlth, New Delhi, India; [Jha, Vivekanand] Univ New South Wales, Fac Med, Sydney, NSW, Australia; [Jha, Vivekanand] Imperial Coll London, Sch Publ Hlth, London, England; [Jha, Vivekanand] Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Manipal, India	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Cape Town; University of Sydney; Westmead Institute for Medical Research; World Health Organization; University of New South Wales Sydney; Imperial College London; Manipal Academy of Higher Education (MAHE)	Jha, V (corresponding author), George Inst Global Hlth, New Delhi, India.; Jha, V (corresponding author), Univ New South Wales, Fac Med, Sydney, NSW, Australia.; Jha, V (corresponding author), Imperial Coll London, Sch Publ Hlth, London, England.; Jha, V (corresponding author), Manipal Acad Higher Educ, Prasanna Sch Publ Hlth, Manipal, India.	vjha@georgeinstitute.org.in	Luyckx, Valerie/J-9747-2019	Luyckx, Valerie/0000-0001-7066-8135; Jha, Vivekanand/0000-0002-8015-9470				Afiatin, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177436; Bikbov B, 2020, LANCET, V395, P709, DOI 10.1016/S0140-6736(20)30045-3; Harris DCH, 2020, KIDNEY INT, V98, P1062, DOI 10.1016/j.kint.2020.07.022; International Society of Nephrology, 2021, ISN FRAM DEV DIAL PR; International Society of Nephrology, 2019, GLOBAL KIDNEY HLTH A; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; Manyazewal T, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0221-9; Pike Eva, 2017, J Clin Med Res, V9, P104, DOI 10.14740/jocmr2817w; Ramachandran R, 2020, KIDNEY INT, V98, P238, DOI 10.1016/j.kint.2020.04.019; Shroff R, 2021, PERITON DIALYSIS INT, V41, P137, DOI 10.1177/0896860821995385; Tonelli M, 2020, KIDNEY INT SUPPL, V10, pE19, DOI 10.1016/j.kisu.2019.11.002; Vanholder R, 2017, NAT REV NEPHROL, V13, P393, DOI 10.1038/nrneph.2017.63; Voorhoeve A, 2017, HEALTH SYST REFORM, V3, P301, DOI 10.1080/23288604.2017.1324938; World Health Organization (WHO), 2014, MAK FAIR CHOIC PATH	14	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2021	398	10294					10	11		10.1016/S0140-6736(21)00732-7	http://dx.doi.org/10.1016/S0140-6736(21)00732-7		JUL 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TC9PM	33865498				2022-12-28	WOS:000668969500009
J	Morton, LM; Karyadi, DM; Stewart, C; Bogdanova, TI; Dawson, ET; Steinberg, MK; Dai, JQ; Hartley, SW; Schonfeld, SJ; Sampson, JN; Maruvka, YE; Kapoor, V; Ramsden, DA; Carvajal-Garcia, J; Perou, CM; Parker, JS; Krznaric, M; Yeager, M; Boland, JF; Hutchinson, A; Hicks, BD; Dagnall, CL; Gastier-Foster, JM; Bowen, J; Lee, O; Machiela, MJ; Cahoon, EK; Brenner, AV; Mabuchi, K; Drozdovitch, V; Masiuk, S; Chepurny, M; Zurnadzhy, LY; Hatch, M; de Gonzalez, AB; Thomas, GA; Tronko, MD; Getz, G; Chanock, SJ				Morton, Lindsay M.; Karyadi, Danielle M.; Stewart, Chip; Bogdanova, Tetiana, I; Dawson, Eric T.; Steinberg, Mia K.; Dai, Jieqiong; Hartley, Stephen W.; Schonfeld, Sara J.; Sampson, Joshua N.; Maruvka, Yosef E.; Kapoor, Vidushi; Ramsden, Dale A.; Carvajal-Garcia, Juan; Perou, Charles M.; Parker, Joel S.; Krznaric, Marko; Yeager, Meredith; Boland, Joseph F.; Hutchinson, Amy; Hicks, Belynda D.; Dagnall, Casey L.; Gastier-Foster, Julie M.; Bowen, Jay; Lee, Olivia; Machiela, Mitchell J.; Cahoon, Elizabeth K.; Brenner, Alina, V; Mabuchi, Kiyohiko; Drozdovitch, Vladimir; Masiuk, Sergii; Chepurny, Mykola; Zurnadzhy, Liudmyla Yu; Hatch, Maureen; de Gonzalez, Amy Berrington; Thomas, Gerry A.; Tronko, Mykola D.; Getz, Gad; Chanock, Stephen J.			Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident	SCIENCE			English	Article							MUTATIONAL SIGNATURES; CANCER RISK; IONIZING-RADIATION; EXTERNAL RADIATION; POOLED ANALYSIS; DISCOVERY; EXPOSURE; PROGRAM; FUSION; AGE	The 1986 Chernobyl nuclear power plant accident increased papillary thyroid carcinoma (PTC) incidence in surrounding regions, particularly for radioactive iodine (I-131)-exposed children. We analyzed genomic, transcriptomic, and epigenomic characteristics of 440 PTCs from Ukraine (from 359 individuals with estimated childhood I-131 exposure and 81 unexposed children born after 1986). PTCs displayed radiation dose-dependent enrichment of fusion drivers, nearly all in the mitogen-activated protein kinase pathway, and increases in small deletions and simple/balanced structural variants that were clonal and bore hallmarks of nonhomologous end-joining repair. Radiation-related genomic alterations were more pronounced for individuals who were younger at exposure. Transcriptomic and epigenomic features were strongly associated with driver events but not radiation dose. Our results point to DNA double-strand breaks as early carcinogenic events that subsequently enable PTC growth after environmental radiation exposure.	[Morton, Lindsay M.; Schonfeld, Sara J.; Cahoon, Elizabeth K.; Mabuchi, Kiyohiko; Drozdovitch, Vladimir; Hatch, Maureen; de Gonzalez, Amy Berrington] NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Karyadi, Danielle M.; Dawson, Eric T.; Hartley, Stephen W.; Lee, Olivia; Chanock, Stephen J.] NCI, Lab Genet Susceptibil, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Stewart, Chip; Maruvka, Yosef E.; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Bogdanova, Tetiana, I; Zurnadzhy, Liudmyla Yu] Natl Acad Med Sci Ukraine, Lab Morphol Endocrine Syst, VP Komisarenko Inst Endocrinol & Metab, UA-04114 Kiev, Ukraine; [Dawson, Eric T.] Nvidia Corp, Santa Clara, CA 95051 USA; [Steinberg, Mia K.; Dai, Jieqiong; Kapoor, Vidushi; Yeager, Meredith; Boland, Joseph F.; Hutchinson, Amy; Hicks, Belynda D.; Dagnall, Casey L.] Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Bethesda, MD 20892 USA; [Sampson, Joshua N.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Ramsden, Dale A.] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Carvajal-Garcia, Juan] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Perou, Charles M.; Parker, Joel S.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Krznaric, Marko; Thomas, Gerry A.] Imperial Coll London, Charing Cross Hosp, Dept Surg & Canc, London W6 8RF, England; [Gastier-Foster, Julie M.; Bowen, Jay] Nationwide Childrens Hosp, Biospecimen Core Resource, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pathol, Coll Med, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pediat, Coll Med, Columbus, OH 43210 USA; [Machiela, Mitchell J.] NCI, Integrat Tumor Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brenner, Alina, V] Radiat Effects Res Fdn, Hiroshima 7320815, Japan; [Masiuk, Sergii; Chepurny, Mykola] Natl Acad Med Sci Ukraine, Inst Radiat Hyg & Epidemiol, Radiol Protect Lab, Natl Res Ctr Radiat Med, UA-04050 Kiev, Ukraine; [Tronko, Mykola D.] Natl Acad Med Sci Ukraine, Dept Fundamental & Appl Problems Endocrinol, VP Komisarenko Inst Endocrinol & Metab, UA-04114 Kiev, Ukraine; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc Res & Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Harvard Med Sch, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Academy of Medical Sciences of Ukraine; V. P. Komissarenko Institute of Endocrinology & Metabolism of the National Academy of Medical Science of Ukraine; Nvidia Corporation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Imperial College London; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radiation Effects Research Foundation - Japan; National Academy of Medical Sciences of Ukraine; National Research Center for Radiation Medicine of National Academy of Medical Sciences of Ukraine; National Academy of Medical Sciences of Ukraine; V. P. Komissarenko Institute of Endocrinology & Metabolism of the National Academy of Medical Science of Ukraine; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Morton, LM (corresponding author), NCI, Radiat Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.; Chanock, SJ (corresponding author), NCI, Lab Genet Susceptibil, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	mortonli@mail.nih.gov; chanocks@mail.nih.gov	Machiela, Mitchell J/H-7335-2019; Perou, Charles M/H-9934-2014; Morton, Lindsay/AAE-7495-2022; Berrington, Amy/L-7017-2017	Machiela, Mitchell J/0000-0001-6538-9705; Perou, Charles M/0000-0001-9827-2247; Morton, Lindsay/0000-0001-9767-2310; Berrington, Amy/0000-0002-7332-8387; Stewart, Chip/0000-0003-2245-9552; Chepurny, Mykola/0000-0001-9852-0669; Schonfeld, Sara/0000-0002-4368-4647; Karyadi, Danielle/0000-0003-4164-5625; , Mia/0000-0001-7642-5265; Lee, Olivia/0000-0001-5389-6267; Bowen, Jay/0000-0001-6861-9043; Carvajal-Garcia, Juan/0000-0001-7257-3674; Maruvka, Yosef/0000-0002-8918-9887; Drozdovitch, Vladimir/0000-0002-7952-379X	Intramural Program of the National Cancer Institute, National Institutes of Health; National Cancer Institute [U24CA082102]	Intramural Program of the National Cancer Institute, National Institutes of Health; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Intramural Program of the National Cancer Institute, National Institutes of Health. The Chernobyl Tissue Bank is supported by the National Cancer Institute (U24CA082102).	1000 Genomes Project Consortium, 2015, Nature, V526, P68, DOI 10.1038/nature15393; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Barnard Stephen, 2013, Genome Integr, V4, P1, DOI 10.1186/2041-9414-4-1; Behjati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12605; Benelli M, 2012, BIOINFORMATICS, V28, P3232, DOI 10.1093/bioinformatics/bts617; Benjamin D S. T., 2019, BIORXIV, DOI [10.1101/861054, DOI 10.1101/861054, 10.1101/861054v1]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birger C., 2017, BIORXIV209494; Bogdanova TI, 2021, THYROID, V31, P1322, DOI 10.1089/thy.2020.0308; Calabrese C, 2020, NATURE, V578, P129, DOI 10.1038/s41586-020-1970-0; Campbell PJ, 2020, NATURE, V578, P82, DOI 10.1038/s41586-020-1969-6; Cann HM, 2002, SCIENCE, V296, P261; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Carvajal-Garcia J, 2020, P NATL ACAD SCI USA, V117, P8476, DOI 10.1073/pnas.1921791117; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; de Gonzalez Amy Berrington, 2020, Journal of the National Cancer Institute Monographs, P97, DOI 10.1093/jncimonographs/lgaa009; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; Drost J, 2018, NAT REV CANCER, V18, P407, DOI 10.1038/s41568-018-0007-6; Drost J, 2017, SCIENCE, V358, P234, DOI 10.1126/science.aao3130; Efanov AA, 2018, JNCI-J NATL CANCER I, V110, P371, DOI 10.1093/jnci/djx209; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Fortin JP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0503-2; Furukawa K, 2013, INT J CANCER, V132, P1222, DOI 10.1002/ijc.27749; Gadalla SM, 2016, BIOL BLOOD MARROW TR, V22, P2276, DOI 10.1016/j.bbmt.2016.09.012; Ganly I, 2018, CANCER CELL, V34, P256, DOI 10.1016/j.ccell.2018.07.002; Goh VST, 2019, INT J RADIAT BIOL, V95, P1668, DOI 10.1080/09553002.2019.1664788; Gopa RK, 2018, CANCER CELL, V34, P242, DOI 10.1016/j.ccell.2018.06.013; Gudmundsson J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14517; Haas B, 2017, BIORXIV120295; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Hauptmann Michael, 2020, Journal of the National Cancer Institute Monographs, P188, DOI 10.1093/jncimonographs/lgaa010; Hess J, 2011, P NATL ACAD SCI USA, V108, P9595, DOI 10.1073/pnas.1017137108; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hubley R., 2013, REPEATMASKER OPEN 40; IARC, 2012, IARC MON EV CARC R C, V100c, P219; Imielinski M, 2017, CELL, V168, P460, DOI 10.1016/j.cell.2016.12.025; Interactive RadioEpidemiological Program Information,, 2020, VERS 5 7; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jin YM, 2019, G3-GENES GENOM GENET, V9, P2447, DOI 10.1534/g3.118.200925; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Kim S, 2018, NAT METHODS, V15, P591, DOI 10.1038/s41592-018-0051-x; Kocher DC, 2008, HEALTH PHYS, V95, P119, DOI 10.1097/01.HP.0000291191.49583.f7; Kumar S, 2016, SCI REP-UK, V6, DOI 10.1038/srep21597; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H., 2013, ARXIV13033997, DOI DOI 10.48550/ARXIV.1303.3997; Li YL, 2020, NATURE, V578, P112, DOI 10.1038/s41586-019-1913-9; Liang JL, 2018, J PATHOL, V244, P215, DOI 10.1002/path.5005; Likhtarov I, 2013, RADIAT PROT DOSIM, V156, P407, DOI 10.1093/rpd/nct096; Likhtarov I, 2011, HEALTH PHYS, V100, P583, DOI 10.1097/HP.0b013e3181ff391a; LIKHTAROV I, 2014, HEALTH PHYS, V106, DOI DOI 10.1097/HP.0B013-31829F3096; Liu QJ, 2014, MUTAT RES-GEN TOX EN, V759, P1, DOI 10.1016/j.mrgentox.2013.07.016; Liu S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1234; LiVolsi VA, 2011, CLIN ONCOL-UK, V23, P261, DOI 10.1016/j.clon.2011.01.160; Liyanarachchi S, 2020, P NATL ACAD SCI USA, V117, P5997, DOI 10.1073/pnas.1919976117; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maruvka YE, 2017, NAT BIOTECHNOL, V35, P951, DOI 10.1038/nbt.3966; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; NRC, 2006, HLTH RISKS EXP LOW L, V7; Panebianco F, 2017, P NATL ACAD SCI USA, V114, P2307, DOI 10.1073/pnas.1614265114; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; RON E, 1995, RADIAT RES, V141, P259, DOI 10.2307/3579003; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schlumberger M, 2021, NAT REV ENDOCRINOL, V17, P176, DOI 10.1038/s41574-020-00448-z; Sehl ME, 2020, NPJ BREAST CANCER, V6, DOI 10.1038/s41523-020-0161-3; Selmansberger M, 2015, ONCOGENE, V34, P3917, DOI 10.1038/onc.2014.311; Selmansberger M, 2015, CARCINOGENESIS, V36, P748, DOI 10.1093/carcin/bgv043; Shilnikova N., 2015, EPICURE RISK REGRESS; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor-Weiner A, 2018, NAT METHODS, V15, P531, DOI 10.1038/s41592-018-0036-9; Thomas GA, 2012, J RADIOL PROT, V32, pN77, DOI 10.1088/0952-4746/32/1/N77; Thomas GA, 2000, SCIENCE, V289, P2283; Tian Y, 2017, BIOINFORMATICS, V33, P3982, DOI 10.1093/bioinformatics/btx513; Tong J., 2020, RAD MED PROTECTION, V1, P15; Tronko M, 2017, INT J CANCER, V141, P1585, DOI 10.1002/ijc.30857; Tufano RP, 2012, MEDICINE, V91, P274, DOI 10.1097/MD.0b013e31826a9c71; Turner C, 2003, HUM GENET, V112, P303, DOI 10.1007/s00439-002-0892-2; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR),, 2010, SOURC EFF ION RAD UI; UNSCEAR, 2008, EFFECTS IONIZING RAD, VI; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; Veiga LHS, 2016, RADIAT RES, V185, P473, DOI 10.1667/RR14213.1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Williams ED, 2004, BRIT J CANCER, V90, P2219, DOI 10.1038/sj.bjc.6601860; Zhao BL, 2020, NAT REV MOL CELL BIO, V21, P765, DOI 10.1038/s41580-020-00297-8	104	27	27	8	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					705	+	abg2538	10.1126/science.abg2538	http://dx.doi.org/10.1126/science.abg2538			55	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33888599	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000651125300042
J	Padma, TV				Padma, T. V.			Indian government should heed its scientists on COVID	NATURE			English	Editorial Material												tvpadma_10@yahoo.co.in							0	6	6	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					9	9		10.1038/d41586-021-01140-6	http://dx.doi.org/10.1038/d41586-021-01140-6			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RZ1BQ	33931770				2022-12-28	WOS:000648334100001
J	Rahimi, K				Rahimi, Kazem		Blood Pressure Lowering Treatment	Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis	LANCET			English	Article							MILLION ADULTS; TASK-FORCE; RISK; HYPERTENSION; MANAGEMENT; MEDICINE; OUTCOMES	Background The effects of pharmacological blood pressure lowering at normal or high-normal blood pressure ranges in people with or without pre-existing cardiovascular disease remains uncertain. We analysed individual participant data from randomised trials to investigate the effects of blood pressure lowering treatment on the risk of major cardiovascular events by baseline levels of systolic blood pressure. Methods We did a meta-analysis of individual participant-level data from 48 randomised trials of pharmacological blood pressure lowering medications versus placebo or other classes of blood pressure-lowering medications, or between more versus less intensive treatment regimens, which had at least 1000 persons-years of follow-up in each group. Trials exclusively done with participants with heart failure or short-term interventions in participants with acute myocardial infarction or other acute settings were excluded. Data from 51 studies published between 1972 and 2013 were obtained by the Blood Pressure Lowering Treatment Trialists' Collaboration (Oxford University, Oxford, UK). We pooled the data to investigate the stratified effects of blood pressure-lowering treatment in participants with and without prevalent cardiovascular disease (ie, any reports of stroke, myocardial infarction, or ischaemic heart disease before randomisation), overall and across seven systolic blood pressure categories (ranging from <120 to >= 170 mm Hg). The primary outcome was a major cardiovascular event (defined as a composite of fatal and non-fatal stroke, fatal or non-fatal myocardial infarction or ischaemic heart disease, or heart failure causing death or requiring admission to hospital), analysed as per intention to treat. Findings Data for 344 716 participants from 48 randomised clinical trials were available for this analysis. Pre-randomisation mean systolic/diastolic blood pressures were 146/84 mm Hg in participants with previous cardiovascular disease (n=157 728) and 157/89 mm Hg in participants without previous cardiovascular disease (n=186 988). There was substantial spread in participants' blood pressure at baseline, with 31 239 (19.8%) of participants with previous cardiovascular disease and 14 928 (8.0%) of individuals without previous cardiovascular disease having a systolic blood pressure of less than 130 mm Hg. The relative effects of blood pressure-lowering treatment were proportional to the intensity of systolic blood pressure reduction. After a median 4.15 years' follow-up (Q1-Q3 2.97-4.96), 42 324 participants (12.3%) had at least one major cardiovascular event. In participants without previous cardiovascular disease at baseline, the incidence rate for developing a major cardiovascular event per 1000 person-years was 31.9 (95% CI 31.3-32.5) in the comparator group and 25.9 (25.4-26.4) in the intervention group. In participants with previous cardiovascular disease at baseline, the corresponding rates were 39.7 (95% CI 39.0-40.5) and 36.0 (95% CI 35.3-36.7), in the comparator and intervention groups, respectively. Hazard ratios (HR) associated with a reduction of systolic blood pressure by 5 mm Hg for a major cardiovascular event were 0.91, 95% CI 0.89-0.94 for partipants without previous cardiovascular disease and 0.89, 0.86-0.92, for those with previous cardiovascular disease. In stratified analyses, there was no reliable evidence of heterogeneity of treatment effects on major cardiovascular events by baseline cardiovascular disease status or systolic blood pressure categories. Interpretation In this large-scale analysis of randomised trials, a 5 mm Hg reduction of systolic blood pressure reduced the risk of major cardiovascular events by about 10%, irrespective of previous diagnoses of cardiovascular disease, and even at normal or high-normal blood pressure values. These findings suggest that a fixed degree of pharmacological blood pressure lowering is similarly effective for primary and secondary prevention of major cardiovascular disease, even at blood pressure levels currently not considered for treatment. Physicians communicating the indication for blood pressure lowering treatment to their patients should emphasise its importance on reducing cardiovascular risk rather than focusing on blood pressure reduction itself. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.	[Rahimi, Kazem] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford OX1 2BQ, England	University of Oxford	Rahimi, K (corresponding author), Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford OX1 2BQ, England.	kazem.rahimi@wrh.ox.ac.uk	Rahimi, Kazem/AAA-4250-2022; Asselbergs, Folkert W./ABD-6752-2021; Canoy, Dexter/L-6440-2013; Sundstrom, Johan/A-6286-2009	Asselbergs, Folkert W./0000-0002-1692-8669; Neal, Bruce/0000-0002-0490-7465; Chalmers, John/0000-0002-9931-0580; Yusuf, Salim/0000-0003-4776-5601; Canoy, Dexter/0000-0003-4493-9901; Reid, Christopher/0000-0001-9173-3944; Gupta, Ajay/0000-0001-5807-8503; MacMahon, Stephen/0000-0003-2064-7699; Pepine, Carl/0000-0002-6011-681X; Woodward, Mark/0000-0001-9800-5296; Rodgers, Anthony/0000-0003-1282-1896; Pinho-Gomes, Ana-Catarina/0000-0001-9895-1493; Sundstrom, Johan/0000-0003-2247-8454; Copland, Emma/0000-0001-9280-5241	BHF [PG/18/65/33872, FS/19/36/34346]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre; Oxford Martin School; US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	BHF(British Heart Foundation); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Oxford Martin School; US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the BHF (PG/18/65/33872 and FS/19/36/34346), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, and the Oxford Martin School. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health and Social Care. This manuscript was prepared using ACCORD, ALLHAT, PEACE, and SHEP studies' research materials obtained from the US National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and Data Repository Information Coordinating Centre and does not necessarily reflect the opinions or views of the ACCORD, ALLHAT, PEACE, and SHEP investigators, or the NHLBI. The AASK study was done by AASK investigators and supported by the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The data from the AASK study reported here were supplied by the NIDDK central repositories. This manuscript was not prepared in collaboration with the investigators of the AASK study and does not necessarily reflect the opinions or views of AASK, the NIDDK central repositories, or the NIDDK. We acknowledge the original depositors of the Australian National Blood Pressure Study data and the Australian Data Archive, and declare that those who carried out the original analysis and collection of the data bear no responsibility for the further analysis or interpretation of the data.	Bohm M, 2017, LANCET, V389, P2226, DOI 10.1016/S0140-6736(17)30754-7; Brunstrom M, 2018, JAMA INTERN MED, V178, P28, DOI 10.1001/jamainternmed.2017.6015; Canoy D, 2018, BMJ EVID-BASED MED, V23, P189, DOI 10.1136/bmjebm-2018-110934; Emdin CA, 2017, INT J EPIDEMIOL, V46, P162, DOI 10.1093/ije/dyw053; Emdin CA, 2015, J AM COLL CARDIOL, V66, P1552, DOI 10.1016/j.jacc.2015.07.059; Emdin CA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4865; Emdin CA, 2015, EUROPACE, V17, P701, DOI 10.1093/europace/euv021; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Herrett E, 2019, LANCET, V394, P663, DOI 10.1016/S0140-6736(19)31359-5; HOMMEL G, 1988, BIOMETRIKA, V75, P383, DOI 10.2307/2336190; Karmali KN, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002538; Kent DM, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4245; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li YK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62922-y; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Messerli FH, 2009, J AM COLL CARDIOL, V54, P279, DOI [10.1016/j.jacc.2009.03.053, 10.1016/j.jacc.2009.05.073]; Nazarzadeh M, 2020, EUR HEART J, V41, P1942, DOI DOI 10.1093/eurheartj/ehaa355; Nazarzadeh M, 2019, JAMA CARDIOL, V4, P788, DOI 10.1001/jamacardio.2019.2202; New Zealand Ministry of Health, 2018, CARD DIS RISK ASS MA; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rahimi K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028698; Rahimi K, 2018, EUR HEART J, V39, P3596, DOI 10.1093/eurheartj/ehy486; Rahimi K, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002404; Rahimi Kazem, 2017, Evid Based Med, V22, P73, DOI 10.1136/ebmed-2016-110648; Rahimi K, 2015, CIRC RES, V116, P925, DOI 10.1161/CIRCRESAHA.116.304723; Rahimi K, 2013, CIRCULATION, V128, P2283, DOI 10.1161/CIRCULATIONAHA.113.006218; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Smith CT, 2007, CLIN TRIALS, V4, P621, DOI 10.1177/1740774507085276; Solares JRA, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012129; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sterne JAC, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4898; Sundstrom J, 2015, ANN INTERN MED, V162, P184, DOI 10.7326/M14-0773; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Suzuki H, 2005, HYPERTENS RES, V28, P307, DOI 10.1291/hypres.28.307; UK National Institute for Health and Care Excellence, 2019, HYP AD DIAGN MAN NIC; Vidal-Petiot E, 2016, LANCET, V388, P2142, DOI 10.1016/S0140-6736(16)31326-5; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Williams B, 2018, J HYPERTENS, V39, P3021, DOI 10.1097/HJH.0000000000001940; Yuan Q, 2020, INFECT DIS-NOR, V71, P2027, DOI [DOI 10.1093/CID/CIAA344, DOI 10.1093/cid/ciaa344]	41	126	125	13	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1625	1636						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV0EH	33933205	Green Published, hybrid			2022-12-28	WOS:000645510600023
J	Wu, K				Wu, Ken			Losing Touch	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Losing Touch In providing surrogate incubators for babies who were born too soon, we in the NICU place painful restrictions on the most basic of human relationships, the one between parents and their child, as medical demands require parents and baby to lose touch with one another.	[Wu, Ken] Imperial Coll Healthcare NHS Trust, Queen Charlottes & Chelsea Hosp, London, England	Imperial College London	Wu, K (corresponding author), Imperial Coll Healthcare NHS Trust, Queen Charlottes & Chelsea Hosp, London, England.								0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1687	1689		10.1056/NEJMp2033590	http://dx.doi.org/10.1056/NEJMp2033590		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33951375				2022-12-28	WOS:000646649900001
J	Choe, H; Farzan, M				Choe, Hyeryun; Farzan, Michael			How SARS-CoV-2 first adapted in humans	SCIENCE			English	Editorial Material									[Choe, Hyeryun; Farzan, Michael] Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA	Scripps Research Institute	Choe, H (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, Jupiter, FL 33458 USA.	hchoe@scripps.edu; mfarzan@scripps.edu						Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Juraszek J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20321-x; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Mellet J, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010039; Plante JA, 2021, NATURE, V592, P116, DOI 10.1038/s41586-020-2895-3; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Weissman D., 2021, CELL HOST MICROBE, V29, pE4, DOI DOI 10.1016/j.chom.2020.11.012; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhang J., 2021, SCIENCE, V372, P525, DOI DOI 10.1126/science.abf2303; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zhou B, 2021, NATURE, V592, P122, DOI 10.1038/s41586-021-03361-1	15	11	11	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					466	467		10.1126/science.abi4711	http://dx.doi.org/10.1126/science.abi4711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926942				2022-12-28	WOS:000645554100028
J	Mahase, E				Mahase, Elisabeth			Covid-19: Booster vaccine to be rolled out in autumn as UK secures 60m more Pfizer doses	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n664	1	15	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2021	373								n1116	10.1136/bmj.n1116	http://dx.doi.org/10.1136/bmj.n1116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UG4QI	33926905	Bronze			2022-12-28	WOS:000689238700002
J	Rosch, B; Gentner, TX; Eyselein, J; Langer, J; Elsen, H; Harder, S				Roesch, B.; Gentner, T. X.; Eyselein, J.; Langer, J.; Elsen, H.; Harder, S.			Strongly reducing magnesium(0) complexes	NATURE			English	Article								Strongly reducing beta-diketiminate complexes containing magnesium in its zero oxidation state are reported, among which is a compound with a linear triatomic Mg-Mg-Mg core. A complex of a metal in its zero oxidation state can be considered a stabilized, but highly reactive, form of a single metal atom. Such complexes are common for the more noble transition metals. Although rare examples are known for electronegative late-main-group p-block metals or semimetals(1-6), it is a challenge to isolate early-main-group s-block metals in their zero oxidation state(7-11). This is directly related to their very low electronegativity and strong tendency to oxidize. Here we present examples of zero-oxidation-state magnesium (that is, magnesium(0)) complexes that are stabilized by superbulky, monoanionic, beta-diketiminate ligands. Whereas the reactivity of an organomagnesium compound is typically defined by the nucleophilicity of its organic groups and the electrophilicity of Mg2+ cations, the Mg-0 complexes reported here feature electron-rich Mg centres that are nucleophilic and strongly reducing. The latter property is exemplified by the ability to reduce Na+ to Na-0. We also present a complex with a linear Mg-3 core that formally could be described as a Mg-I-Mg-0-Mg-I unit. Such multinuclear mixed-valence Mg-n clusters are discussed as fleeting intermediates during the early stages of Grignard reagent formation. Their remarkably strong reducing power implies a rich reactivity and application as specialized reducing agents.	[Roesch, B.; Gentner, T. X.; Eyselein, J.; Langer, J.; Elsen, H.; Harder, S.] Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Erlangen, Germany	University of Erlangen Nuremberg	Harder, S (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Chem & Pharm, Erlangen, Germany.	sjoerd.harder@fau.de	; Langer, Jens/F-3495-2010	Mai, Jonathan/0000-0003-0766-3918; Langer, Jens/0000-0002-2895-4979				Arrowsmith M, 2016, NAT CHEM, V8, P890, DOI [10.1038/NCHEM.2542, 10.1038/nchem.2542]; Arrowsmith M, 2014, INORG CHEM, V53, P10543, DOI 10.1021/ic501638v; BADER RFW, 1991, CHEM REV, V91, P893, DOI 10.1021/cr00005a013; Bakewell C, 2018, CHEM SCI, V9, P2348, DOI 10.1039/c7sc05059c; Bakewell C, 2016, J AM CHEM SOC, V138, P12763, DOI 10.1021/jacs.6b08104; BECKE AD, 1993, J CHEM PHYS, V98, P1372, DOI 10.1063/1.464304; Braunschweig H, 2012, SCIENCE, V336, P1420, DOI 10.1126/science.1221138; Camp C, 2016, DALTON T, V45, P14462, DOI 10.1039/c6dt02013e; CAO WL, 1987, CHEM PHYS LETT, V141, P380, DOI 10.1016/0009-2614(87)85044-3; Chase MW, 1998, J PHYS CHEM REF DATA, V9, DOI [10.18434/T42S31, DOI 10.18434/T42S31]; Clegg W, 2011, EUR J INORG CHEM, P721, DOI 10.1002/ejic.201000983; Couchman SA, 2013, DALTON T, V42, P11375, DOI 10.1039/c3dt50563d; Cui CM, 2000, ANGEW CHEM INT EDIT, V39, P4274, DOI 10.1002/1521-3773(20001201)39:23<4274::AID-ANIE4274>3.0.CO;2-K; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; DYE JL, 1974, J AM CHEM SOC, V96, P608, DOI 10.1021/ja00809a060; ERIKSSON LA, 1995, J CHEM PHYS, V103, P1050, DOI 10.1063/1.469815; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Garst G.F., 2000, GRIGNARD REAGENTS NE, P185; Gentner T.X., 2020, ANGEW CHEM INT EDIT, V59, P2; Gentner TX, 2019, ANGEW CHEM INT EDIT, V58, P607, DOI 10.1002/anie.201812051; GLAUNSINGER WS, 1978, NATURE, V271, P414, DOI 10.1038/271414a0; Green SP, 2007, SCIENCE, V318, P1754, DOI 10.1126/science.1150856; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Hicks J, 2018, ORGANOMETALLICS, V37, P4810, DOI 10.1021/acs.organomet.8b00803; Hicks J, 2018, NATURE, V557, P92, DOI 10.1038/s41586-018-0037-y; Hicks J, 2015, ANGEW CHEM INT EDIT, V54, P10000, DOI 10.1002/anie.201504818; IMIZU Y, 1984, INORG CHEM, V23, P3602, DOI 10.1021/ic00190a034; Jones C, 2020, COMMUN CHEM, V3, DOI 10.1038/s42004-020-00408-8; Jones C, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0059; Jones C, 2012, CHEM COMMUN, V48, P9855, DOI 10.1039/c2cc35228a; Jones DDL, 2021, ANGEW CHEM INT EDIT, V60, P7087, DOI 10.1002/anie.202017126; Keith T. A., 2017, AIMALL VERSION 17012; Kohn A, 2001, PHYS CHEM CHEM PHYS, V3, P711, DOI 10.1039/b007869g; Kruczynski T, 2016, CHEM SCI, V7, P1543, DOI 10.1039/c5sc03914b; LAMBERT C, 1994, ANGEW CHEM INT EDIT, V33, P1129, DOI 10.1002/anie.199411291; Li Y, 2013, J AM CHEM SOC, V135, P12422, DOI 10.1021/ja406112u; Mondal KC, 2013, ANGEW CHEM INT EDIT, V52, P2963, DOI 10.1002/anie.201208307; Perdew J., 1991, ELECT STRUCTURE SOLI; Platts JA, 2011, J PHYS CHEM A, V115, P194, DOI 10.1021/jp109547w; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Rigaku Oxford Diffraction, 2018, CRYSALISPRO SOFTWARE; Rosch B, 2020, CHEM COMMUN, V56, P11402, DOI 10.1039/d0cc05200k; Sheldrick GM, 2015, ACTA CRYSTALLOGR A, V71, P3, DOI 10.1107/S2053273314026370; Sidiropoulos A, 2009, ANGEW CHEM INT EDIT, V48, P9701, DOI 10.1002/anie.200905495; SLATER JC, 1964, J CHEM PHYS, V41, P3199, DOI 10.1063/1.1725697; Tjurina LA, 2004, ORGANOMETALLICS, V23, P1349, DOI 10.1021/om030633x; Velazquez A, 2007, ORGANOMETALLICS, V26, P4731, DOI 10.1021/om700477b; Wang Q, 2019, ANGEW CHEM INT EDIT, V58, P17365, DOI 10.1002/anie.201908572; Wang YZ, 2008, SCIENCE, V321, P1069, DOI 10.1126/science.1160768; Weigend F, 2005, PHYS CHEM CHEM PHYS, V7, P3297, DOI 10.1039/b508541a; Wu X, 2018, SCIENCE, V361, P912, DOI 10.1126/science.aau0839	51	35	35	15	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					717	+		10.1038/s41586-021-03401-w	http://dx.doi.org/10.1038/s41586-021-03401-w			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911274				2022-12-28	WOS:000645368900012
J	Sentilhes, L; Senat, MV; Le Lous, M; Winer, N; Rozenberg, P; Kayem, G; Verspyck, E; Fuchs, F; Azria, E; Gallot, D; Korb, D; Desbriere, R; Le Ray, C; Chauleur, C; de Marcillac, F; Perrotin, F; Parant, O; Salomon, LJ; Gauchotte, E; Bretelle, F; Sananes, N; Bohec, C; Mottet, N; Legendre, G; Letouzey, V; Haddad, B; Vardon, D; Madar, H; Mattuizzi, A; Daniel, V; Regueme, S; Roussillon, C; Benard, A; Georget, A; Darsonval, A; Deneux-Tharaux, C				Sentilhes, Loic; Senat, Marie V.; Le Lous, Maela; Winer, Norbert; Rozenberg, Patrick; Kayem, Gilles; Verspyck, Eric; Fuchs, Florent; Azria, Elie; Gallot, Denis; Korb, Diane; Desbriere, Raoul; Le Ray, Camille; Chauleur, Celine; de Marcillac, Fanny; Perrotin, Franck; Parant, Olivier; Salomon, Laurent J.; Gauchotte, Emilie; Bretelle, Florence; Sananes, Nicolas; Bohec, Caroline; Mottet, Nicolas; Legendre, Guillaume; Letouzey, Vincent; Haddad, Bassam; Vardon, Delphine; Madar, Hugo; Mattuizzi, Aurelien; Daniel, Valerie; Regueme, Sophie; Roussillon, Caroline; Benard, Antoine; Georget, Aurore; Darsonval, Astrid; Deneux-Tharaux, Catherine			Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Prophylactic administration of tranexamic acid has been associated with reduced postpartum blood loss after cesarean delivery in several small trials, but evidence of its benefit in this clinical context remains inconclusive. Methods In a multicenter, double-blind, randomized, controlled trial, we assigned women undergoing cesarean delivery before or during labor at 34 or more gestational weeks to receive an intravenously administered prophylactic uterotonic agent and either tranexamic acid (1 g) or placebo. The primary outcome was postpartum hemorrhage, defined as a calculated estimated blood loss greater than 1000 ml or receipt of a red-cell transfusion within 2 days after delivery. Secondary outcomes included gravimetrically estimated blood loss, provider-assessed clinically significant postpartum hemorrhage, use of additional uterotonic agents, and postpartum blood transfusion. Results Of the 4551 women who underwent randomization, 4431 underwent cesarean delivery, 4153 (93.7%) of whom had primary outcome data available. The primary outcome occurred in 556 of 2086 women (26.7%) in the tranexamic acid group and in 653 of 2067 (31.6%) in the placebo group (adjusted risk ratio, 0.84; 95% confidence interval [CI], 0.75 to 0.94; P=0.003). There were no significant between-group differences in mean gravimetrically estimated blood loss or in the percentage of women with provider-assessed clinically significant postpartum hemorrhage, use of additional uterotonic agents, or postpartum blood transfusion. Thromboembolic events in the 3 months after delivery occurred in 0.4% of women (8 of 2049) who received tranexamic acid and in 0.1% of women (2 of 2056) who received placebo (adjusted risk ratio, 4.01; 95% CI, 0.85 to 18.92; P=0.08). Conclusions Among women who underwent cesarean delivery and received prophylactic uterotonic agents, tranexamic acid treatment resulted in a significantly lower incidence of calculated estimated blood loss greater than 1000 ml or red-cell transfusion by day 2 than placebo, but it did not result in a lower incidence of hemorrhage-related secondary clinical outcomes. (Funded by the French Ministry of Health; TRAAP2 ClinicalTrials.gov number, NCT03431805.) Blood-Loss Prevention after Cesarean Delivery In this trial involving women undergoing cesarean delivery (all of whom received prophylactic uterotonic medication), tranexamic acid treatment resulted in a significantly lower incidence of estimated blood loss greater than 1000 ml or red-cell transfusion by day 2 than placebo, but it did not reduce the risk of hemorrhage-related secondary clinical outcomes.	[Sentilhes, Loic; Madar, Hugo; Mattuizzi, Aurelien] Bordeaux Univ Hosp, Dept Obstet & Gynecol, Pl Amelie Raba Leon, F-33076 Bordeaux, France; [Regueme, Sophie] Bordeaux Univ Hosp, Dept Clin Res & Innovat, Bordeaux, France; [Roussillon, Caroline] Bordeaux Univ Hosp, Euclid French Clin Res Infrastruct Network F CRIN, Dept Clin Res & Innovat, Bordeaux, France; [Benard, Antoine; Georget, Aurore] CHU Bordeaux, Publ Hlth Dept, Clin Epidemiol Unit, Bordeaux, France; [Senat, Marie V.] Bicetre Univ Hosp, Dept Obstet & Gynecol, Paris, France; [Kayem, Gilles] Trousseau Hosp, Dept Obstet & Gynecol, Paris, France; [Korb, Diane] Robert Debre Hosp, Dept Obstet & Gynecol, Paris, France; [Le Ray, Camille] Cochin Hosp, Port Royal Matern Unit, Paris, France; [Salomon, Laurent J.] Necker Enfants Malades Hosp, Dept Obstet & Gynecol, Paris, France; [Kayem, Gilles; Azria, Elie; Le Ray, Camille; Deneux-Tharaux, Catherine] Univ Paris, Obstetr Perinatal & Pediat Epidemiol Res Team EPO, Ctr Res Epidemiol & Stat Sorbonne,INSERM,AP HP, Inst Natl Rech Agron INRA,Univ Hosp Dept Pregnanc, Paris, France; [Azria, Elie] Paris Descartes Univ, Paris St Joseph Hosp, Matern Unit, Paris, France; [Le Lous, Maela] Rennes Univ Hosp, Dept Obstet & Gynecol, Rennes, France; [Winer, Norbert] Univ Nantes, Ctr Invest Clin Mere Enfant, Inst Malad Appareil Digestif, Univ Med Ctr Nantes,Dept Obstet & Gynecol,Univ Ho, Nantes, France; [Winer, Norbert] Univ Nantes, Physiol Nutr Adaptat, INRA, Unite Mixte Rech UMR 1280,Inst Malad Appareil Dig, Nantes, France; [Winer, Norbert] Ctr Rech Nutr Humaine Ouest, Nantes, France; [Rozenberg, Patrick] Poissy St Germain Hosp, Dept Obstet & Gynecol, Poissy, France; [Verspyck, Eric] Rouen Univ Hosp, Dept Obstet & Gynecol, Rouen, France; [Fuchs, Florent] Montpellier Univ Hosp, Dept Obstet & Gynecol, Montpellier, France; [Fuchs, Florent] INSERM, Reprod & Child Dev, Ctr Res Epidemiol & Populat Hlth, Unite 1018, Villejuif, France; [Gallot, Denis] Clermont Ferrand Univ Hosp, Dept Obstet & Gynecol, Clermont Ferrand, France; [Desbriere, Raoul] St Joseph Hosp, Dept Obstet & Gynecol, Marseille, France; [Bretelle, Florence] Aix Marseille Univ, Dept Obstet & Gynecol, AP HM, Marseille, France; [Chauleur, Celine] St Etienne Univ Hosp, Dept Obstet & Gynecol, St Etienne, France; [de Marcillac, Fanny] Univ Hosp Strasbourg, Dept Obstet & Gynecol, Strasbourg, France; [Perrotin, Franck] Tours Univ Hosp, Dept Obstet & Gynecol, Tours, France; [Parant, Olivier] Toulouse Univ Hosp, Dept Obstet & Gynecol, Toulouse, France; [Gauchotte, Emilie] Nancy Univ Hosp, Dept Obstet & Gynecol, Nancy, France; [Sananes, Nicolas] Ctr Medicochirurg & Obstetr, Dept Obstet & Gynecol, Schiltigheim, France; [Bohec, Caroline] Francois Mitterrand Hosp, Dept Obstet & Gynecol, Pau, France; [Mottet, Nicolas] Besancon Univ Hosp, Dept Obstet & Gynecol, Besancon, France; [Legendre, Guillaume] Angers Univ Hosp, Dept Obstet & Gynecol, Angers, France; [Daniel, Valerie; Darsonval, Astrid] Angers Univ Hosp, Dept Pharm, Angers, France; [Letouzey, Vincent] Caremeau Univ Hosp, Dept Obstet & Gynecol, Nimes, France; [Haddad, Bassam] Univ Paris Est Creteil, Dept Obstet & Gynecol & Reprod Med, Ctr Hosp Intercommunal Creteil, Creteil, France; [Vardon, Delphine] Caen Univ Hosp, Dept Obstet & Gynecol, Caen, France; [Daniel, Valerie; Darsonval, Astrid] Brest Univ Hosp, PPRIGO Prod Pharmaceut Rech Inst Grand Ouest, Brest, France	CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; INRAE; Nantes Universite; CHU de Rouen; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Clermont Ferrand; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU de St Etienne; CHU Strasbourg; CHU Tours; CHU de Toulouse; CHU de Nancy; Universite de Franche-Comte; CHU Besancon; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite de Montpellier; CHU de Nimes; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Brest	Sentilhes, L (corresponding author), Bordeaux Univ Hosp, Dept Obstet & Gynecol, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	loicsentilhes@hotmail.com	EGO, Anne/G-7071-2011	EGO, Anne/0000-0002-1025-910X; Le Ray, Camille/0000-0003-0891-1063				Alam A, 2015, TRANSFUS MED REV, V29, P231, DOI 10.1016/j.tmrv.2015.07.002; [Anonymous], 2009, POSTPARTUM HAEMORRHA; [Anonymous], 2017, WHO REC TRAN AC TREA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carvalho JCA, 2004, OBSTET GYNECOL, V104, P1005, DOI 10.1097/01.AOG.0000142709.04450.bd; Committee on Practice Bulletins-Obstetrics, 2017, Obstet Gynecol, V130, pe168, DOI 10.1097/AOG.0000000000002351; Gai MY, 2004, EUR J OBSTET GYN R B, V112, P154, DOI 10.1016/S0301-2115(03)00287-2; Gallos I, 2019, HEALTH TECHNOL ASSES, V23, pVII, DOI 10.3310/hta23090; Gayet-Ageron A, 2018, LANCET, V391, P125, DOI 10.1016/S0140-6736(17)32455-8; Guedeney N, 1998, EUR PSYCHIAT, V13, P83, DOI 10.1016/S0924-9338(98)80023-0; HALT-IT Trial Collaborators, 2020, LANCET, V395, P1927, DOI 10.1016/S0140-6736(20)30848-5; Kamel H, 2014, NEW ENGL J MED, V370, P1307, DOI 10.1056/NEJMoa1311485; Ker K, 2016, BJOG-INT J OBSTET GY, V123, P1745, DOI 10.1111/1471-0528.14267; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Li CB, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005653; Maged AM, 2015, INT J GYNECOL OBSTET, V131, P265, DOI 10.1016/j.ijgo.2015.05.027; Meher S, 2019, BJOG-INT J OBSTET GY, V126, P83, DOI 10.1111/1471-0528.15335; Misme H, 2016, J GYNECOL OBST BIO R, V45, P71, DOI 10.1016/j.jgyn.2015.01.004; Movafegh A, 2011, INT J GYNECOL OBSTET, V115, P224, DOI 10.1016/j.ijgo.2011.07.015; Myles PS, 2017, NEW ENGL J MED, V376, P136, DOI 10.1056/NEJMoa1606424; Novikova N, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007872.pub3; Roberts I, 2019, LANCET, V394, P1713, DOI 10.1016/S0140-6736(19)32233-0; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sentilhes L, 2017, BJOG-INT J OBSTET GY, V124, P718, DOI 10.1111/1471-0528.14305; Sentilhes L, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-019-2718-4; Sentilhes L, 2019, EXPERT REV HEMATOL, V12, P753, DOI 10.1080/17474086.2019.1642744; Sentilhes L, 2018, NEW ENGL J MED, V379, P731, DOI 10.1056/NEJMoa1800942; Sentilhes L, 2016, EXPERT REV HEMATOL, V9, P1043, DOI 10.1080/17474086.2016.1245135; Sentilhes L, 2016, ACTA OBSTET GYN SCAN, V95, P836, DOI 10.1111/aogs.12864; Sentilhes L, 2016, EUR J OBSTET GYN R B, V198, P12, DOI 10.1016/j.ejogrb.2015.12.012; Sentilhes L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0573-5; Sentithes L, 2015, BRIT J ANAESTH, V114, P576, DOI 10.1093/bja/aeu448; Shakur H, 2017, LANCET, V389, P2105, DOI 10.1016/S0140-6736(17)30638-4; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sheehan SR, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4661; Shook PR, 2003, ANESTHESIOLOGY, V98, P1; Simonazzi G, 2016, ACTA OBSTET GYN SCAN, V95, P28, DOI 10.1111/aogs.12798; Sivakumar H, 2016, BRIT J ANAESTH, V117, P431, DOI 10.1093/bja/aew170; Xu JJ, 2013, ARCH GYNECOL OBSTET, V287, P463, DOI 10.1007/s00404-012-2593-y	39	43	44	5	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1623	1634		10.1056/NEJMoa2028788	http://dx.doi.org/10.1056/NEJMoa2028788			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1ND	33913639	Bronze			2022-12-28	WOS:000645605800013
J	Zhang, WJ; Bado, IL; Hu, JY; Wan, YW; Wu, L; Wang, H; Gao, Y; Jeong, HH; Xu, Z; Hao, XX; Lege, BM; Al-Ouran, R; Li, L; Li, JS; Yu, LQ; Singh, S; Lo, HC; Niu, MC; Liu, J; Jiang, WY; Li, Y; Wong, STC; Cheng, CH; Liu, ZD; Zhang, XHF				Zhang, Weijie; Bado, Igor L.; Hu, Jingyuan; Wan, Ying-Wooi; Wu, Ling; Wang, Hai; Gao, Yang; Jeong, Hyun-Hwan; Xu, Zhan; Hao, Xiaoxin; Lege, Bree M.; Al-Ouran, Rami; Li, Lucian; Li, Jiasong; Yu, Liqun; Singh, Swarnima; Lo, Hin Ching; Niu, Muchun; Liu, Jun; Jiang, Weiyu; Li, Yi; Wong, Stephen T. C.; Cheng, Chonghui; Liu, Zhandong; Zhang, Xiang H-F			The bone microenvironment invigorates metastatic seeds for further dissemination	CELL			English	Article							EVOLUTIONARY HISTORY; OSTEOGENIC NICHE; CLINICAL-COURSE; CANCER-CELLS; TGF-BETA; PLASTICITY; ANGIOGENESIS; DISCOVERY; FEATURES	Metastasis has been considered as the terminal step of tumor progression. However, recent genomic studies suggest that many metastases are initiated by further spread of other metastases. Nevertheless, the corresponding pre-clinical models are lacking, and underlying mechanisms are elusive. Using several approaches, including parabiosis and an evolving barcode system, we demonstrated that the bone microenvironment facilitates breast and prostate cancer cells to further metastasize and establish multi-organ secondary metastases. We uncovered that this metastasis-promoting effect is driven by epigenetic reprogramming that confers stem cell-like properties on cancer cells disseminated from bone lesions. Furthermore, we discovered that enhanced EZH2 activity mediates the increased stemness and metastasis capacity. The same findings also apply to single cell-derived populations, indicating mechanisms distinct from clonal selection. Taken together, our work revealed an unappreciated role of the bone microenvironment in metastasis evolution and elucidated an epigenomic reprogramming process driving terminal-stage, multi-organ metastases.	[Zhang, Weijie; Bado, Igor L.; Wu, Ling; Wang, Hai; Gao, Yang; Xu, Zhan; Hao, Xiaoxin; Lege, Bree M.; Yu, Liqun; Singh, Swarnima; Lo, Hin Ching; Liu, Jun; Jiang, Weiyu; Li, Yi; Cheng, Chonghui; Zhang, Xiang H-F] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Zhang, Weijie; Bado, Igor L.; Wu, Ling; Wang, Hai; Gao, Yang; Xu, Zhan; Hao, Xiaoxin; Yu, Liqun; Singh, Swarnima; Lo, Hin Ching; Liu, Jun; Jiang, Weiyu; Li, Yi; Wong, Stephen T. C.; Zhang, Xiang H-F] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Zhang, Weijie; Bado, Igor L.; Wu, Ling; Wang, Hai; Gao, Yang; Xu, Zhan; Hao, Xiaoxin; Yu, Liqun; Singh, Swarnima; Lo, Hin Ching; Liu, Jun; Jiang, Weiyu; Li, Yi; Wong, Stephen T. C.; Zhang, Xiang H-F] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hu, Jingyuan; Wan, Ying-Wooi; Jeong, Hyun-Hwan; Al-Ouran, Rami; Li, Lucian; Liu, Zhandong] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Hu, Jingyuan] Baylor Coll Med, Quantitat & Computat Biosci Program, Houston, TX 77030 USA; [Wan, Ying-Wooi; Jeong, Hyun-Hwan; Lege, Bree M.; Cheng, Chonghui; Liu, Zhandong] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Al-Ouran, Rami; Li, Lucian] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Li, Jiasong; Wong, Stephen T. C.] Houston Methodist Canc Ctr, Dept Syst Med, Houston, TX 77030 USA; [Li, Jiasong; Wong, Stephen T. C.] Houston Methodist Canc Ctr, Bioengn & Translat Biophoton Lab, Houston, TX 77030 USA; [Niu, Muchun] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Zhang, Xiang H-F] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine	Zhang, XHF (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA.; Zhang, XHF (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.; Zhang, XHF (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.; Zhang, XHF (corresponding author), Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA.	xiangz@bcm.edu	Zhang, Weijie/AFS-0002-2022; Bado, Igor/AAY-1214-2021; Li, Yi/A-7635-2009; Jeong, Hyun-Hwan/W-1585-2018	Bado, Igor/0000-0001-8855-4750; jiang, weiyu/0000-0001-6199-4289; Hao, Xiaoxin/0000-0001-8763-3529; Li, Yi/0000-0002-9976-518X; Jeong, Hyun-Hwan/0000-0001-5090-2422; Zhang, Xiang/0000-0002-5674-8670; Zhang, Weijie/0000-0002-6462-6067	US Department of Defense [DAMD W81XWH-16-1-0073, DAMD W81XWH-20-1-0375]; NCI [CA183878, CA227904, CA221946, CA251950, U01CA252553]; Breast Cancer Research Foundation; McNair Foundation; CPRIT Training Grant [RP160283]; John S. Dunn Research Foundation; T.T. and W.F. Chao Center for BRAIN; CPRIT Scholar Award [RR160009]; NIH [1S10OD016167]; CPRIT Core Facility Support Award [CPRIT-RP180672]	US Department of Defense(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; McNair Foundation; CPRIT Training Grant; John S. Dunn Research Foundation; T.T. and W.F. Chao Center for BRAIN; CPRIT Scholar Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT Core Facility Support Award	We would like to thank Zhang Laboratory members Dr. Lin Tian and Dr. Reza Kalhor for insightful discussion. Thanks also go to Epizyme (Cambridge, MA) for providing the EZH2 inhibitor EPZ-011989. We also acknowledge the Pathology Core of Lester and Sue Smith Breast Center, the Optical Imaging & Vital Microscopy (OiVM) core, the Genomic and RNA profiling core at Baylor College of Medicine, and Small Animal Imaging Facility (SAIF) core at Texas Children Hospital. X.H.-F.Z. is supported by US Department of Defense (DAMD W81XWH-16-1-0073 and DAMD W81XWH-20-1-0375), NCI (CA183878, CA227904, CA221946, and CA251950), the Breast Cancer Research Foundation, and McNair Foundation. S.S. is a recipient of CPRIT Training Grant (RP160283). S.T.C.W. and Jiasong Li are supported in part by NCI (U01CA252553), the John S. Dunn Research Foundation, and T.T. and W.F. Chao Center for BRAIN. C.C. is supported by the CPRIT Scholar Award (RR160009). This project was supported by the RNA In Situ Hybridization Core with a Shared Instrumentation grant from the NIH (1S10OD016167), the Cytometry and Cell Sorting Core with funding from the CPRIT Core Facility Support Award (CPRIT-RP180672), and the expert assistance of Dr. Cecilia Ljungberg and Joel M. Sederstrom at Baylor College of Medicine.	Aceto N, 2018, MOL CANCER RES, V16, P720, DOI 10.1158/1541-7786.MCR-17-0480; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alix-Panabieres C, 2007, CLIN CHEM, V53, P537, DOI 10.1373/clinchem.2006.079509; Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Bado IL, 2021, DEV CELL, V56, P1100, DOI 10.1016/j.devcel.2021.03.008; Balic M, 2006, CLIN CANCER RES, V12, P5615, DOI 10.1158/1078-0432.CCR-06-0169; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Barger CJ, 2019, CANCERS, V11, DOI 10.3390/cancers11020251; Beeman N., 2000, METHODS MAMMARY GLAN, P259; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Boyce BF, 1999, ENDOCR-RELAT CANCER, V6, P333, DOI 10.1677/erc.0.0060333; Brown D., 2017, NAT COMMUN, V8, P25; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; COLEMAN RE, 1987, BRIT J CANCER, V55, P61, DOI 10.1038/bjc.1987.13; Coleman RE, 1998, BRIT J CANCER, V77, P336, DOI 10.1038/bjc.1998.52; Coleman RE, 2008, CLIN CANCER RES, V14, P6387, DOI 10.1158/1078-0432.CCR-08-1572; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Deroose CM, 2007, J NUCL MED, V48, P295; Disibio G, 2008, ARCH PATHOL LAB MED, V132, P931, DOI 10.1043/1543-2165(2008)132[931:MPOCRF]2.0.CO;2; Echeverria GV, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07406-4; Esposito M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031252; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Gupta PB, 2019, CELL STEM CELL, V24, P65, DOI 10.1016/j.stem.2018.11.011; Hirukawa A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04864-8; Hu J., 2020, TRACEQC R PACKAGE QU, DOI 2020.06.05.137141; Juarez P, 2011, BONE, V48, P23, DOI 10.1016/j.bone.2010.08.004; Kalhor R, 2018, SCIENCE, V361, P893, DOI 10.1126/science.aat9804; Kalhor R, 2017, NAT METHODS, V14, P195, DOI [10.1038/nmeth.4108, 10.1038/NMETH.4108]; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kottakis F, 2011, MOL CELL, V43, P285, DOI 10.1016/j.molcel.2011.06.020; Ku SY, 2017, SCIENCE, V355, P78, DOI 10.1126/science.aah4199; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Ma AQ, 2020, NAT CHEM BIOL, V16, P214, DOI 10.1038/s41589-019-0421-4; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Price TT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad4059; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Ullah I, 2018, J CLIN INVEST, V128, P1355, DOI 10.1172/JCI96149; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wang H, 2018, CANCER CELL, V34, P823, DOI 10.1016/j.ccell.2018.10.002; Wang H, 2015, CANCER CELL, V27, P193, DOI 10.1016/j.ccell.2014.11.017; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yue Z, 2019, CELL REP, V28, P966, DOI 10.1016/j.celrep.2019.06.065; Zhang L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz5387; Zhang X.H.F, J VIS EXP 2016, V2016, P1; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036	59	45	45	5	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2021	184	9					2471	+		10.1016/j.cell.2021.03.011	http://dx.doi.org/10.1016/j.cell.2021.03.011		APR 2021	36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RV7SH	33878291	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000646027900021
J	Yang, CT; Zhou, Y; Marcus, S; Formenti, G; Bergeron, LA; Song, ZZ; Bi, XP; Bergman, J; Rousselle, MMC; Zhou, CR; Zhou, L; Deng, Y; Fang, MQ; Xie, D; Zhu, YZ; Tan, SJ; Mountcastle, J; Haase, B; Balacco, J; Wood, J; Chow, W; Rhie, A; Pippel, M; Fabiszak, MM; Koren, S; Fedrigo, O; Freiwald, WA; Howe, K; Yang, HM; Phillippy, AM; Schierup, MH; Jarvis, ED; Zhang, GJ				Yang, Chentao; Zhou, Yang; Marcus, Stephanie; Formenti, Giulio; Bergeron, Lucie A.; Song, Zhenzhen; Bi, Xupeng; Bergman, Juraj; Rousselle, Marjolaine Marie C.; Zhou, Chengran; Zhou, Long; Deng, Yuan; Fang, Miaoquan; Xie, Duo; Zhu, Yuanzhen; Tan, Shangjin; Mountcastle, Jacquelyn; Haase, Bettina; Balacco, Jennifer; Wood, Jonathan; Chow, William; Rhie, Arang; Pippel, Martin; Fabiszak, Margaret M.; Koren, Sergey; Fedrigo, Olivier; Freiwald, Winrich A.; Howe, Kerstin; Yang, Huanming; Phillippy, Adam M.; Schierup, Mikkel Heide; Jarvis, Erich D.; Zhang, Guojie			Evolutionary and biomedical insights from a marmoset diploid genome assembly	NATURE			English	Article							COMMON MARMOSET; NEUROSCIENCE RESEARCH; Y-CHROMOSOMES; MUTATION-RATE; ALIGNMENT; BEHAVIOR; SUPPRESSION; EXPRESSION; PATTERNS; BIOLOGY	The accurate and complete assembly of both haplotype sequences of a diploid organism is essential to understanding the role of variation in genome functions, phenotypes and diseases(1). Here, using a trio-binning approach, we present a high-quality, diploid reference genome, with both haplotypes assembled independently at the chromosome level, for the common marmoset (Callithrix jacchus), an primate model system that is widely used in biomedical research(2,3). The full spectrum of heterozygosity between the two haplotypes involves 1.36% of the genome-much higher than the 0.13% indicated by the standard estimation based on single-nucleotide heterozygosity alone. The de novo mutation rate is 0.43 x 10(-8) per site per generation, and the paternal inherited genome acquired twice as many mutations as the maternal. Our diploid assembly enabled us to discover a recent expansion of the sex-differentiation region and unique evolutionary changes in the marmoset Y chromosome. In addition, we identified many genes with signatures of positive selection that might have contributed to the evolution of Callithrix biological features. Brain-related genes were highly conserved between marmosets and humans, although several genes experienced lineage-specific copy number variations or diversifying selection, with implications for the use of marmosets as a model system.	[Yang, Chentao; Zhou, Yang; Bi, Xupeng; Zhou, Chengran; Zhou, Long; Deng, Yuan; Fang, Miaoquan; Xie, Duo; Zhu, Yuanzhen; Tan, Shangjin; Yang, Huanming] BGI Shenzhen, Shenzhen, Peoples R China; [Yang, Chentao; Bergeron, Lucie A.; Deng, Yuan; Zhang, Guojie] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Villum Ctr Biodivers Genom, Copenhagen, Denmark; [Marcus, Stephanie; Formenti, Giulio; Jarvis, Erich D.] Rockefeller Univ, Lab Neurogenet Language, New York, NY USA; [Formenti, Giulio; Mountcastle, Jacquelyn; Haase, Bettina; Balacco, Jennifer; Fedrigo, Olivier; Jarvis, Erich D.] Rockefeller Univ, Vertebrate Genome Lab, New York, NY USA; [Song, Zhenzhen; Yang, Huanming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Bergman, Juraj; Rousselle, Marjolaine Marie C.; Schierup, Mikkel Heide] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Wood, Jonathan; Chow, William; Howe, Kerstin] Wellcome Sanger Inst, Hinxton, England; [Rhie, Arang; Koren, Sergey; Phillippy, Adam M.] Natl Human Genome Res Inst, Computat & Stat Gen Branch, Genome Informat Sect, NIH, Bethesda, MD USA; [Pippel, Martin] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Pippel, Martin] Ctr Syst Biol, Dresden, Germany; [Fabiszak, Margaret M.; Freiwald, Winrich A.] Rockefeller Univ, Lab Neural Syst, New York, NY USA; [Freiwald, Winrich A.] Rockefeller Univ, Ctr Brains Minds & Machines CBMM, New York, NY USA; [Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou, Peoples R China; [Yang, Huanming] BGI Shenzhen, Guangdong Prov Acad Workstat BGI Synthet Genom, Shenzhen, Peoples R China; [Jarvis, Erich D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Zhang, Guojie] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhang, Guojie] BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China; [Zhang, Guojie] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Peoples R China	Beijing Genomics Institute (BGI); University of Copenhagen; Rockefeller University; Rockefeller University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Aarhus University; Wellcome Trust Sanger Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Max Planck Society; Rockefeller University; Rockefeller University; Beijing Genomics Institute (BGI); Howard Hughes Medical Institute; Chinese Academy of Sciences; Kunming Institute of Zoology; Beijing Genomics Institute (BGI); Chinese Academy of Sciences	Zhang, GJ (corresponding author), Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Villum Ctr Biodivers Genom, Copenhagen, Denmark.; Zhang, GJ (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.; Zhang, GJ (corresponding author), BGI Shenzhen, China Natl GeneBank, Shenzhen, Peoples R China.; Zhang, GJ (corresponding author), Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Peoples R China.	guojie.zhang@bio.ku.dk	Pippel, Martin/AGA-8156-2022; Phillippy, Adam M/U-5731-2018; YANG, Chentao/A-6192-2019; Formenti, Giulio/GRX-8689-2022; Zhang, Guojie/J-7273-2019	Pippel, Martin/0000-0002-8134-5929; Phillippy, Adam M/0000-0003-2983-8934; YANG, Chentao/0000-0003-3447-2316; Formenti, Giulio/0000-0002-7554-5991; Zhang, Guojie/0000-0001-6860-1521; Bergman, Juraj/0000-0002-9415-2747; Zhou, Yang/0000-0003-1247-5049; Chow, William/0000-0002-9056-201X; Bergeron, Lucie/0000-0003-1877-1690; Zhu, Yuanzhen/0000-0001-5426-4704	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB31020000]; National Key R&D Program of China (MOST) [2018YFC1406901]; International Partnership Program of the Chinese Academy of Sciences [152453KYSB20170002]; Carlsberg Foundation [CF16-0663]; Villum Foundation [25900]; Howard Hughes Medical Institute; Intramural Research Program of the National Human Genome Research Institute, the National Institutes of Health (NIH); Korea Health Technology R&D Project through the Korea Health Industry Development Institute [HI17C2098]; NIH National Institute of General Medical Sciences [T32GM007739]; NIH National Institute of Mental Health F30 [MH112351]; Guangdong Provincial Academician Workstation of BGI Synthetic Genomics [2017B090904014]; Rockefeller University	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China (MOST); International Partnership Program of the Chinese Academy of Sciences; Carlsberg Foundation(Carlsberg Foundation); Villum Foundation(Villum Fonden); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural Research Program of the National Human Genome Research Institute, the National Institutes of Health (NIH); Korea Health Technology R&D Project through the Korea Health Industry Development Institute; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Institute of Mental Health F30; Guangdong Provincial Academician Workstation of BGI Synthetic Genomics; Rockefeller University	This work was supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB31020000); the National Key R&D Program of China (MOST) grant 2018YFC1406901; the International Partnership Program of the Chinese Academy of Sciences (no. 152453KYSB20170002); the Carlsberg Foundation (CF16-0663); the Villum Foundation (no. 25900) to G.Z.; Howard Hughes Medical Institute and Rockefeller University start-up funds to E.D.J.; the Intramural Research Program of the National Human Genome Research Institute, the National Institutes of Health (NIH) (A.R., A.M.P. and S.K.); the Korea Health Technology R&D Project through the Korea Health Industry Development Institute HI17C2098 (A.R.); the NIH National Institute of General Medical Sciences (no. T32GM007739) and an NIH National Institute of Mental Health F30 (no. MH112351) (M.M.F.); and the Guangdong Provincial Academician Workstation of BGI Synthetic Genomics (no. 2017B090904014) (H.Y.).	Abbott DH, 2003, COMPARATIVE MED, V53, P339; Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Aleman F, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00148; Anton E, 2010, J HUM GENET, V55, P541, DOI 10.1038/jhg.2010.67; Bachtrog D, 2006, CURR OPIN GENET DEV, V16, P578, DOI 10.1016/j.gde.2006.10.007; Bailey MT, 2002, COMP BIOCHEM PHYS A, V133, P379, DOI 10.1016/S1095-6433(02)00174-5; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; BENIRSCHKE K, 1962, SCIENCE, V138, P513, DOI 10.1126/science.138.3539.513; Binkley N, 1998, J BONE MINER RES, V13, P1775, DOI 10.1359/jbmr.1998.13.11.1775; Bishara A, 2015, GENOME RES, V25, P1570, DOI 10.1101/gr.191189.115; Chakraborty M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12884-1; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Chintalapati M, 2020, CURR OPIN GENET DEV, V62, P58, DOI 10.1016/j.gde.2020.05.028; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chomez P, 2000, DEVELOPMENT, V127, P1489; Chow W, 2016, BIOINFORMATICS, V32, P2508, DOI 10.1093/bioinformatics/btw159; Colman RJ, 1997, J BONE MINER RES, V12, pF466; Cortez D, 2014, NATURE, V508, P488, DOI 10.1038/nature13151; Formenti G., 2020, COMPLETE VERTEBRATE, DOI [10.1101/2020.06.30.177956, DOI 10.1101/2020.06.30.177956]; Garrison E., 2012, ARXIV12073907; Ghurye J, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007273; Goel M, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1911-0; Goldmann JM, 2016, NAT GENET, V48, P935, DOI 10.1038/ng.3597; Guan DF, 2020, BIOINFORMATICS, V36, P2896, DOI 10.1093/bioinformatics/btaa025; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hinch AG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004503; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Hughes JF, 2015, ANNU REV GENET, V49, P507, DOI 10.1146/annurev-genet-112414-055311; Iseki S, 1999, DEVELOPMENT, V126, P5611; Jordan DM, 2015, NATURE, V524, P225, DOI 10.1038/nature14497; Kishi N, 2014, DEV GROWTH DIFFER, V56, P53, DOI 10.1111/dgd.12109; Koren S, 2018, NAT BIOTECHNOL, V36, P1174, DOI 10.1038/nbt.4277; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lam ET, 2012, NAT BIOTECHNOL, V30, P771, DOI 10.1038/nbt.2303; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loytynoja A, 2014, METHODS MOL BIOL, V1079, P155, DOI 10.1007/978-1-62703-646-7_10; Lucotte EA, 2018, GENETICS, V209, P907, DOI 10.1534/genetics.118.300826; Ludlage E, 2003, COMPARATIVE MED, V53, P369; Malukiewicz J., 2020, PREPRINT, DOI [10.1101/708255, DOI 10.1101/708255]; Millar MR, 2000, INT J ANDROL, V23, P266, DOI 10.1046/j.1365-2605.2000.00236.x; MOORE HDM, 1985, AM J ANAT, V172, P265, DOI 10.1002/aja.1001720402; Mueller JL, 2013, NAT GENET, V45, P1083, DOI 10.1038/ng.2705; Mujoomdar ML, 2011, REPRODUCTION, V141, P343, DOI 10.1530/REP-10-0451; Nattestad M, 2016, BIOINFORMATICS, V32, P3021, DOI 10.1093/bioinformatics/btw369; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Okano H, 2012, SEMIN FETAL NEONAT M, V17, P336, DOI 10.1016/j.siny.2012.07.002; Pfeifer SP, 2017, EVOLUTION, V71, P2858, DOI 10.1111/evo.13383; Plaza-Diaz J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02203-3; Power ML, 2010, DEV PRIMATOL-PROG PR, P25, DOI 10.1007/978-1-4419-6661-2_2; Raudsepp T, 2015, CYTOGENET GENOME RES, V147, P81, DOI 10.1159/000443157; Rhie A, 2021, NATURE, V592, P737, DOI 10.1038/s41586-021-03451-0; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saleem AN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000985; Saltzman W, 1997, ANN NY ACAD SCI, V807, P567, DOI 10.1111/j.1749-6632.1997.tb51970.x; Sato K, 2015, SCI REP, V2015, P5; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Sherlock JK, 1996, GENOMICS, V33, P214, DOI 10.1006/geno.1996.0186; Son A, 2019, J ENDOCRINOL, V242, P241, DOI 10.1530/JOE-19-0123; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Storz JF, 2018, CURR OPIN STRUC BIOL, V50, P18, DOI 10.1016/j.sbi.2017.10.009; Sweeney Carolyn, 2012, Chimerism, V3, P43, DOI 10.4161/chim.20729; Thomas GWC, 2018, CURR BIOL, V28, P3193, DOI 10.1016/j.cub.2018.08.050; Tillgren V, 2015, J BIOL CHEM, V290, P918, DOI 10.1074/jbc.M114.593541; Turroni F, 2018, TRENDS MICROBIOL, V26, P339, DOI 10.1016/j.tim.2017.10.001; Vollger MR, 2019, NAT METHODS, V16, P88, DOI 10.1038/s41592-018-0236-3; Wahab F, 2015, CURR BIOL, V25, pR780, DOI 10.1016/j.cub.2015.06.042; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weisenfeld NI, 2017, GENOME RES, V27, P757, DOI 10.1101/gr.214874.116; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; Wisniewski JR, 2015, J PROTEOME RES, V14, P353, DOI 10.1021/pr500833v; Wood AR, 2011, HUM MOL GENET, V20, P4082, DOI 10.1093/hmg/ddr328; Worley KC, 2014, NAT GENET, V46, P850, DOI 10.1038/ng.3042; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang ZB, 2020, REPROD DOMEST ANIM, V55, P1145, DOI 10.1111/rda.13753	78	9	9	14	51	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					227	+		10.1038/s41586-021-03535-x	http://dx.doi.org/10.1038/s41586-021-03535-x		APR 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ8YR	33910227	Green Published, hybrid			2022-12-28	WOS:000652171600001
J	Kar, P				Kar, Partha			Partha Kar: "Phir Bhi Dil Hai Hindustani"-the anguish of the Indian diaspora	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2021	373								n1094	10.1136/bmj.n1094	http://dx.doi.org/10.1136/bmj.n1094			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QQ	33906836	Bronze			2022-12-28	WOS:000649708400001
J	Slomski, A				Slomski, Anita			Relugolix Combination Therapy for Uterine Fibroids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1602	1602		10.1001/jama.2021.5857	http://dx.doi.org/10.1001/jama.2021.5857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904871				2022-12-28	WOS:000645617800008
J	Sharif, A				Sharif, Adnan			Why journals should stop publishing transplantation research from China	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sharif, Adnan] Univ Hosp Birmingham, Queen Elizabeth Hosp, Dept Nephrol & Transplantat, Birmingham, W Midlands, England; [Sharif, Adnan] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Sharif, A (corresponding author), Univ Hosp Birmingham, Queen Elizabeth Hosp, Dept Nephrol & Transplantat, Birmingham, W Midlands, England.; Sharif, A (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.	adnan.sharif@uhb.nhs.uk						Akabayashi A, 2018, TRANSPL P, V50, P1209, DOI 10.1016/j.transproceed.2018.02.078; [Anonymous], 2016, EXPR CONC REG PERS C EXPR CONC REG PERS C; Australian Department of Foreign Affairs and Trade, 2019, COUNTR INF REP PEOPL COUNTR INF REP PEOPL; Australian House of Representatives Joint Standing Committee on Foreign Affairs Defence and Trade, 2018, COMPASSION NOT COMME; China Tribunal, 2020, FIN JUDG SUMM REP FIN JUDG SUMM REP; Cyranoski D, 2019, NATURE, V570, P425, DOI 10.1038/d41586-019-01890-4; Dai SP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h239; Dandan N., 2018, 6 TONE 0316 6 TONE 0316; Dyer O, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l5220; Fan RP, 2019, J MED PHILOS, V44, P534, DOI 10.1093/jmp/jhz022; Kilgour D, 2016, BLOODY HARVEST SLAUG; Martin DE, 2019, TRANSPLANT DIRECT, V5, DOI 10.1097/TXD.0000000000000872; Matas D, 2006, INDEPENDENT INVESTIG; Optimisa Research, NHSBT ORG DON 2013 R NHSBT ORG DON 2013 R; Pan XT, 2021, TRANSPL P, V53, P513, DOI 10.1016/j.transproceed.2020.09.017; Robertson M, 2020, ORGAN PROCUREMENT EX, DOI [10.2139/ssrn.3598791, DOI 10.2139/SSRN.3598791]; Robertson MP, 2019, BMC MED ETHICS, V20, DOI 10.1186/s12910-019-0406-6; Rogers W, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024473; Sharif A, 2014, AM J TRANSPLANT, V14, P2246, DOI 10.1111/ajt.12871; Statista, NUMB PEOPL REG DON T NUMB PEOPL REG DON T; Tibell A, 2007, TRANSPLANTATION, V84, P292, DOI 10.1097/01.tp.0000275181.33071.07; Wu YJ, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009951	22	0	0	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1069	10.1136/bmj.n1069	http://dx.doi.org/10.1136/bmj.n1069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903097				2022-12-28	WOS:000678538700003
J	Miller, A; Schneider, J				Miller, Adam; Schneider, Jeremy			Pacemaker-Associated Superior Vena Cava Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Miller, Adam; Schneider, Jeremy] Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Miller, A (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	adm005@health.ucsd.edu							0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					E63	E63		10.1056/NEJMicm2031975	http://dx.doi.org/10.1056/NEJMicm2031975		APR 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV1ND	33909964				2022-12-28	WOS:000643863900001
J	Zylke, J				Zylke, Jody			Poloxamer 188 for Sickle Cell Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jody.zylke@jamanetwork.org						Bauchner H, 2021, JAMA-J AM MED ASSOC, V325, P751, DOI 10.1001/jama.2020.25952; Casella JF, 2021, JAMA-J AM MED ASSOC, V325, P1513, DOI 10.1001/jama.2021.3414; Orringer EP, 2001, JAMA-J AM MED ASSOC, V286, P2099, DOI 10.1001/jama.286.17.2099	3	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1524	1524		10.1001/jama.2021.3399	http://dx.doi.org/10.1001/jama.2021.3399			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877286	Bronze			2022-12-28	WOS:000642636500017
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... dog bites	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Pet Food Manufacturers Association, 2019, PFMA REL ITS NEW TOP; Pet Food Manufacturers Association, 2021, NEW PET POP 2021; Tulloch JSP, 2021, BMJ PAEDIATR OPEN, V5, DOI 10.1136/bmjpo-2021-001040	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2021	372								n1006	10.1136/bmj.n1006	http://dx.doi.org/10.1136/bmj.n1006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IH	33875447				2022-12-28	WOS:000642451400005
J	Powell, K; Subbarao, K				Powell, Kendall; Subbarao, Kanta			Where I work Kendall Powell	NATURE			English	Editorial Material						Careers; SARS-CoV-2; Virology; Infection		Virologist Kanta Subbarao stalks respiratory viruses around the world and in the culture dish. Virologist Kanta Subbarao stalks respiratory viruses around the world and in the culture dish.	[Subbarao, Kanta] Peter Doherty Inst Infect & Immun, World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia	World Health Organization	Subbarao, K (corresponding author), Peter Doherty Inst Infect & Immun, World Hlth Org Collaborating Ctr Reference & Res, Melbourne, Vic, Australia.								0	0	0	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					160	160		10.1038/d41586-021-01175-9	http://dx.doi.org/10.1038/d41586-021-01175-9			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RW5JM	33941925				2022-12-28	WOS:000646558500002
J	Fernando, SM; Qureshi, D; Sood, MM; Pugliese, M; Talarico, R; Myran, DT; Herridge, MS; Needham, DM; Rochwerg, B; Cook, DJ; Wunsch, H; Fowler, RA; Scales, DC; Bienvenu, OJ; Rowan, KM; Kisilewicz, M; Thompson, LH; Tanuseputro, P; Kyeremanteng, K				Fernando, Shannon M.; Qureshi, Danial; Sood, Manish M.; Pugliese, Michael; Talarico, Robert; Myran, Daniel T.; Herridge, Margaret S.; Needham, Dale M.; Rochwerg, Bram; Cook, Deborah J.; Wunsch, Hannah; Fowler, Robert A.; Scales, Damon C.; Bienvenu, O. Joseph; Rowan, Kathryn M.; Kisilewicz, Magdalena; Thompson, Laura H.; Tanuseputro, Peter; Kyeremanteng, Kwadwo			Suicide and self-harm in adult survivors of critical illness: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; CARE-UNIT ADMISSIONS; INTENSIVE-CARE; OUTCOMES; PREDICTION; MORBIDITY; MORTALITY; CONSENSUS; ICU	OBJECTIVE To analyse the association between survival from critical illness and suicide or self-harm after hospital discharge. DESIGN Population based cohort study using linked and validated provincial databases. SETTING Ontario, Canada between January 2009 and December 2017 (inclusive). PARTICIPANTS Consecutive adult intensive care unit (ICU) survivors (a18 years) were included. Linked administrative databases were used to compare ICU hospital survivors with hospital survivors who never required ICU admission (non-ICU hospital survivors). Patients were categorised based on their index hospital admission (ICU or non-ICU) during the study period. MAIN OUTCOME MEASURES The primary outcome was the composite of death by suicide (as noted in provincial death records) and deliberate self-harm events after discharge. Each outcome was also assessed independently. Incidence of suicide was evaluated while accounting for competing risk of death from other causes. Analyses were conducted by using overlap propensity score weighted, cause specific Cox proportional hazard models. RESULTS 423 060 consecutive ICU survivors (mean age 61.7 years, 39% women) were identified. During the study period, the crude incidence (per 100 000 person years) of suicide, self-harm, and the composite of suicide or self-harm among ICU survivors was 41.4, 327.9, and 361.0, respectively, compared with 16.8, 177.3, and 191.6 in non-ICU hospital survivors. Analysis using weighted models showed that ICU survivors (v non-ICU hospital survivors) had a higher risk of suicide (adjusted hazards ratio 1.22, 95% confidence interval 1.11 to 1.33) and self-harm (1.15, 1.12 to 1.19). Among ICU survivors, several factors were associated with suicide or self-harm: previous depression or anxiety (5.69, 5.38 to 6.02), previous post-traumatic stress disorder (1.87, 1.64 to 2.13), invasive mechanical ventilation (1.45, 1.38 to 1.54), and renal replacement therapy (1.35, 1.17 to 1.56). CONCLUSIONS Survivors of critical illness have increased risk of suicide and self-harm, and these outcomes were associated with pre-existing psychiatric illness and receipt of invasive life support. Knowledge of these prognostic factors might allow for earlier intervention to potentially reduce this important public health problem.	[Fernando, Shannon M.; Kyeremanteng, Kwadwo] Univ Ottawa, Div Crit Care, Dept Med, Ottawa, ON, Canada; [Fernando, Shannon M.] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada; [Qureshi, Danial; Sood, Manish M.; Pugliese, Michael; Talarico, Robert; Myran, Daniel T.; Wunsch, Hannah; Fowler, Robert A.; Scales, Damon C.; Tanuseputro, Peter] ICES, Toronto, ON, Canada; [Qureshi, Danial; Sood, Manish M.; Pugliese, Michael; Talarico, Robert; Myran, Daniel T.; Thompson, Laura H.; Tanuseputro, Peter; Kyeremanteng, Kwadwo] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Qureshi, Danial; Sood, Manish M.; Tanuseputro, Peter] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [Qureshi, Danial; Tanuseputro, Peter] Bruyere Res Inst, Ottawa, ON, Canada; [Sood, Manish M.] Univ Ottawa, Div Nephrol, Dept Med, Ottawa, ON, Canada; [Myran, Daniel T.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Herridge, Margaret S.; Wunsch, Hannah; Fowler, Robert A.; Scales, Damon C.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Herridge, Margaret S.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Herridge, Margaret S.; Wunsch, Hannah; Fowler, Robert A.; Scales, Damon C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Needham, Dale M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Needham, Dale M.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Rochwerg, Bram; Cook, Deborah J.] McMaster Univ, Div Crit Care, Dept Med, Hamilton, ON, Canada; [Cook, Deborah J.; Wunsch, Hannah] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Wunsch, Hannah; Fowler, Robert A.; Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Scales, Damon C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Bienvenu, O. Joseph] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr, Napier House, London, England; [Kisilewicz, Magdalena] Queensway Carleton Hosp, Dept Crit Care, Ottawa, ON, Canada; [Tanuseputro, Peter] Univ Ottawa, Dept Med, Div Palliat Care, Ottawa, ON, Canada; [Tanuseputro, Peter; Kyeremanteng, Kwadwo] Inst Savoir Montfort, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Johns Hopkins University; Johns Hopkins University; McMaster University; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Johns Hopkins University; Intensive Care National Audit & Research Centre; University of Ottawa	Fernando, SM (corresponding author), Ottawa Hosp, Dept Crit Care, Gen Campus,501 Smyth Rd, Ottawa, ON K1H 8M2, Canada.	sfernando@qmed.ca		Thompson, Laura Hilary/0000-0003-3792-9772; Herridge, Margaret/0000-0002-2903-1631; Qureshi, Danial/0000-0001-5703-2220; Rowan, Kathryn/0000-0001-8217-5602	Institut du Savoir Montfort, Hopital Montfort, Ottawa (Canada); ICES - Ontario Ministry of Health and Longterm Care (MOHLTC)	Institut du Savoir Montfort, Hopital Montfort, Ottawa (Canada); ICES - Ontario Ministry of Health and Longterm Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	Funded by the Institut du Savoir Montfort, Hopital Montfort, Ottawa (Canada) . This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and Longterm Care (MOHLTC) . The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data or information compiled and provided by the Canadian Institute for Health Information (CIHI) . However, the analyses, conclusions, and opinions and statements expressed in the material are those of the authors, and not necessarily those of CIHI.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Amartey A, TECHNICAL APPENDIX; Azoulay E, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1887-7; Barak Y, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.5634; Bayoumi Imaan, 2020, CMAJ Open, V8, pE455, DOI 10.9778/cmajo.20190153; Brooks R, 1997, INTENS CARE MED, V23, P581, DOI 10.1007/s001340050376; Chan MKY, 2016, BRIT J PSYCHIAT, V209, P279, DOI 10.1192/bjp.bp.115.170050; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Fernando SM, 2019, INTENS CARE MED, V45, P1580, DOI 10.1007/s00134-019-05766-z; Flaatten H, 2001, INTENS CARE MED, V27, P1005, DOI 10.1007/s001340100960; Gatov E, 2018, CAN J PSYCHIAT, V63, P152, DOI 10.1177/0706743717737033; Hatch R, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03354-y; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Jensen JF, 2015, INTENS CARE MED, V41, P763, DOI 10.1007/s00134-015-3689-1; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Lederer DJ, 2019, ANN AM THORAC SOC, V16, P22, DOI 10.1513/AnnalsATS.201808-564PS; Leisman DE, 2020, CRIT CARE MED, V48, P623, DOI 10.1097/CCM.0000000000004246; Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283; Mikkelsen ME, 2020, CRIT CARE MED, V48, P1670, DOI 10.1097/CCM.0000000000004586; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Neufeld KJ, 2020, CHEST, V158, P999, DOI 10.1016/j.chest.2020.03.059; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Prince E, 2018, CRIT CARE CLIN, V34, P599, DOI 10.1016/j.ccc.2018.06.006; Riley RD, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001380; Roberts DJ, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4104; Sareen J, 2020, CRIT CARE MED, V48, pE675, DOI 10.1097/CCM.0000000000004413; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Sisti D, 2018, JAMA-J AM MED ASSOC, V320, P1633, DOI 10.1001/jama.2018.13083; Sivanathan L, 2019, INTENS CARE MED, V45, P1550, DOI 10.1007/s00134-019-05752-5; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Talarico R, CMAJ; Thomas LE, 2020, JAMA-J AM MED ASSOC, V323, P2417, DOI 10.1001/jama.2020.7819; Turecki G, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0121-0; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Walkup JT, 2012, PHARMACOEPIDEM DR S, V21, P174, DOI 10.1002/pds.2335; Wunsch H, 2020, AM J RESP CRIT CARE, V202, P568, DOI 10.1164/rccm.201912-2503OC; Wunsch H, 2014, JAMA-J AM MED ASSOC, V311, P1133, DOI 10.1001/jama.2014.2137; Zimmerman JE, 2013, CRIT CARE, V17, DOI 10.1186/cc12695	41	14	14	7	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n973	10.1136/bmj.n973	http://dx.doi.org/10.1136/bmj.n973			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952509	hybrid, Green Published			2022-12-28	WOS:000651241900008
J	Ratzan, S; Schneider, EC; Hatch, H; Cacchione, J				Ratzan, Scott; Schneider, Eric C.; Hatch, Hilary; Cacchione, Joseph			Missing the Point - How Primary Care Can Overcome Covid-19 Vaccine "Hesitancy"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ratzan, Scott] CUNY, Grad Sch Publ Hlth, New York, NY 10021 USA; [Schneider, Eric C.] Commonwealth Fund, New York, NY USA; [Hatch, Hilary] Phreesia Inc, New York, NY USA; [Cacchione, Joseph] Ascens Hlth, St Louis, MO USA	City University of New York (CUNY) System; Commonwealth Fund	Ratzan, S (corresponding author), CUNY, Grad Sch Publ Hlth, New York, NY 10021 USA.							[Anonymous], 2021, EXPANDING COVID 19 V; Jackson DN, 2019, AM J HEALTH PROMOT, V33, P1187, DOI 10.1177/0890117119861280; Norcross JC, 2011, J CLIN PSYCHOL, V67, P143, DOI 10.1002/jclp.20758; Stanley-Becker I, 2021, WASH POST; Vanderpool RC, 2020, AM J PUBLIC HEALTH, V110, pS284, DOI 10.2105/AJPH.2020.305906	5	27	27	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2021	384	25								10.1056/NEJMp2106137	http://dx.doi.org/10.1056/NEJMp2106137		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UA7NI	33951377	Bronze			2022-12-28	WOS:000647808900001
J	Dyer, C				Dyer, Clare			Hospital doctor who took 41 pound 000 in salary payments after contract ended loses appeal against erasure	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n1146	10.1136/bmj.n1146	http://dx.doi.org/10.1136/bmj.n1146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947653				2022-12-28	WOS:000649710200008
J	Obuobi, S; Vela, MB; Callender, B				Obuobi, Shirlene; Vela, Monica B.; Callender, Brian			Comics as anti-racist education and advocacy	LANCET			English	Editorial Material									[Obuobi, Shirlene; Vela, Monica B.; Callender, Brian] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Callender, Brian] Univ Chicago, Stevanovich Inst Format Knowledge, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Obuobi, S (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	shirlene.obuobi@uchospitals.edu							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1615	1617						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33933198	Green Published			2022-12-28	WOS:000645510600013
J	Kwakkenbos, L; Imran, M; McCall, SJ; McCord, KA; Frobert, O; Hemkens, LG; Zwarenstein, M; Relton, C; Rice, DB; Langan, SM; Benchimol, EI; Thabane, L; Campbell, MK; Sampson, M; Erlinge, D; Verkooijen, HM; Moher, D; Boutron, I; Ravaud, P; Nicholl, J; Uher, R; Sauve, M; Fletcher, J; Torgerson, D; Gale, C; Juszczak, E; Thombs, BD				Kwakkenbos, Linda; Imran, Mahrukh; McCall, Stephen J.; McCord, Kimberly A.; Frobert, Ole; Hemkens, Lars G.; Zwarenstein, Merrick; Relton, Clare; Rice, Danielle B.; Langan, Sinead M.; Benchimol, Eric, I; Thabane, Lehana; Campbell, Marion K.; Sampson, Margaret; Erlinge, David; Verkooijen, Helena M.; Moher, David; Boutron, Isabelle; Ravaud, Philippe; Nicholl, Jon; Uher, Rudolf; Sauve, Maureen; Fletcher, John; Torgerson, David; Gale, Chris; Juszczak, Edmund; Thombs, Brett D.			CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; IMPROVING ADHERENCE; THROMBUS ASPIRATION; CLINICAL-TRIAL; GUIDELINES; STATEMENT; SERVICES; REGISTRY; RISK; INTERVENTION	Randomised controlled trials are increasingly conducted as embedded, nested, or using cohorts or routinely collected data, including registries, electronic health records, and administrative databases, to assess if participants are eligible for the trial and to facilitate recruitment, to deliver an embedded intervention, to collect trial outcome data, or a combination of these purposes. This report presents the Consolidated Standards of Reporting Trials (CONSORT) extension for randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE). The extension was developed to look at the unique characteristics of trials conducted with these types of data with the goal of improving reporting quality in the long term by setting standards early in the process of uptake of these trial designs. The extension was developed with a sequential approach, including a Delphi survey, a consensus meeting, and piloting of the checklist. The checklist was informed by the CONSORT 2010 statement and two reporting guidelines for observational studies, the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement and the REporting of studies Conducted using Observational Routinely collected Data (RECORD) statement. The extension includes eight items modified from the CONSORT 2010 statement and five new items. Reporting items with explanations and examples are provided, including key aspects of trials conducted using cohorts or routinely collected data that require specific reporting considerations.	[Kwakkenbos, Linda] Radboud Univ Nijmegen, Behav Sci Inst, Clin Psychol, Nijmegen, Netherlands; [Imran, Mahrukh; Rice, Danielle B.; Thombs, Brett D.] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [McCall, Stephen J.; Juszczak, Edmund] Univ Oxford, Nuffield Dept Populat Hlth, Natl Perinatal Epidemiol Unit, Clin Trials Unit, Oxford, England; [McCall, Stephen J.] Amer Univ Beirut, Ctr Res Populat & Hlth, Fac Hlth Sci, Ras Beirut, Lebanon; [McCord, Kimberly A.; Hemkens, Lars G.] Univ Basel, Univ Hosp Basel, Basel Inst Clin Epidemiol & Biostat, Dept Clin Res, Basel, Switzerland; [Frobert, Ole] Orebro Univ, Dept Cardiol, Fac Hlth, Orebro, Sweden; [Hemkens, Lars G.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA USA; [Hemkens, Lars G.] Berlin Inst Hlth, Meta Res Innovat Ctr Berlin METRIC B, Berlin, Germany; [Zwarenstein, Merrick] Western Univ, Dept Family Med, London, ON, Canada; [Zwarenstein, Merrick; Benchimol, Eric, I] ICES, Toronto, ON, Canada; [Relton, Clare] Queen Mary Univ, Barts Inst Populat Hlth Sci, Ctr Clin Trials & Methodol, London, England; [Rice, Danielle B.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Langan, Sinead M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Benchimol, Eric, I] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Benchimol, Eric, I] Hosp Sick Children, SickKids Res Inst, Div Gastroenterol Hepatol & Nutr, Toronto, ON, Canada; [Benchimol, Eric, I] Hosp Sick Children, SickKids Res Inst, Child Hlth Evaluat Sci, Toronto, ON, Canada; [Thabane, Lehana] McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada; [Campbell, Marion K.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Sampson, Margaret] Childrens Hosp Eastern Ontario, Lib Serv, Ottawa, ON, Canada; [Erlinge, David] Lund Univ, Clin Sci, Dept Cardiol, Lund, Sweden; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Verkooijen, Helena M.] Univ Utrecht, Utrecht, Netherlands; [Moher, David] Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada; [Boutron, Isabelle; Ravaud, Philippe] Univ Paris, Ctr Res Epidemiol & Stat CRESS, INSERM, INRA, Paris, France; [Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, Paris, France; [Nicholl, Jon] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Uher, Rudolf] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Sauve, Maureen] Scleroderma Soc Ontario, Hamilton, ON, Canada; [Sauve, Maureen] Scleroderma Canada, Hamilton, ON, Canada; [Fletcher, John] BMJ, London, England; [Torgerson, David] Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England; [Gale, Chris] Imperial Coll London, Sch Publ Hlth, Neonatal Med, Fac Med, Chelsea & Westminster Campus, London, England; [Juszczak, Edmund] Univ Nottingham, Nottingham Clin Trials Unit, Univ Pk, Nottingham, England; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada	Radboud University Nijmegen; Lady Davis Institute; McGill University; University of Oxford; American University of Beirut; University of Basel; Orebro University; Stanford University; Berlin Institute of Health; Western University (University of Western Ontario); University of Toronto; University of London; Queen Mary University London; McGill University; University of London; London School of Hygiene & Tropical Medicine; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Aberdeen; University of Ottawa; Children's Hospital of Eastern Ontario; Lund University; Utrecht University; Utrecht University Medical Center; Utrecht University; University of Ottawa; Ottawa Hospital Research Institute; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Sheffield; Dalhousie University; University of York - UK; Imperial College London; University of Nottingham; McGill University; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Uher, Rudolf/A-5477-2008; Kwakkenbos, Linda/GXH-2756-2022; Benchimol, Eric Ian/A-7711-2010; Cord, Kimberly Mc/ABG-4905-2021; Gale, Chris/F-1833-2010	Uher, Rudolf/0000-0002-2998-0546; Kwakkenbos, Linda/0000-0002-1573-4504; Benchimol, Eric Ian/0000-0001-8855-3598; Cord, Kimberly Mc/0000-0002-2147-3160; Langan, Sinead/0000-0002-7022-7441; McCall, Stephen/0000-0003-0078-7010; Gale, Chris/0000-0003-0707-876X; Frobert, Ole/0000-0002-5846-345X; Campbell, Marion/0000-0001-5386-4097	Canadian Institutes of Health Research [PJT-156172, PCS-161863]; United Kingdom National Institute of Health Research (NIHR) Clinical TrialsUnit Support Funding; Vanier CIHR Graduate Scholarship; Wellcome Senior Clinical Fellowship in Science [205039/Z/16/Z]; Canadian Institutes of Health Research; Career Enhancement Program of the Canadian Child Health Clinician Scientist Program; Canada Research Chairs Program [231397]; UK Medical Research Council; Tier 1 Canada Research Chair; University Research Chair (uOttawa); Canadian Association of Gastroenterology; Crohn's and Colitis Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); United Kingdom National Institute of Health Research (NIHR) Clinical TrialsUnit Support Funding; Vanier CIHR Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Wellcome Senior Clinical Fellowship in Science; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Career Enhancement Program of the Canadian Child Health Clinician Scientist Program; Canada Research Chairs Program(Canada Research Chairs); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Tier 1 Canada Research Chair(Canada Research Chairs); University Research Chair (uOttawa); Canadian Association of Gastroenterology; Crohn's and Colitis Canada	The development of the CONSORT extension for randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) was funded by grants from the Canadian Institutes of Health Research (PI BDT, Co-Is OF, CR, LK, and EJ, No PJT-156172; PI BDT, Co-I LK, No PCS-161863) and from the United Kingdom National Institute of Health Research (NIHR) Clinical TrialsUnit Support Funding (PI EJ, Co-PI CG, supported salary of SJM) . The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care. DBR was supported by a Vanier CIHR Graduate Scholarship. SML was supported by a Wellcome Senior Clinical Fellowship in Science (205039/Z/16/Z) . EIB was supported by a New Investigator Award from the Canadian Institutes of Health Research, Canadian Association of Gastroenterology, and Crohn's and Colitis Canada. He was also supported by the Career Enhancement Program of the Canadian Child Health Clinician Scientist Program. DM was supported by a University Research Chair (uOttawa) . RU was supported by the Canada Research Chairs Program (Award No 231397) . CG was supported by the UK Medical Research Council through a Clinician Scientist Fellowship. BDT was supported by a Tier 1 Canada Research Chair.	Altman DG, 2013, AM J GASTROENTEROL, V108, P1231, DOI 10.1038/ajg.2012.457; Anderson GL, 2016, CLIN TRIALS, V13, P519, DOI 10.1177/1740774516656579; [Anonymous], 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18430; [Anonymous], 2021, REP GUID DEV; [Anonymous], 1999, EPIDEMIOLOGIC METHOD; Asberg S, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2313-9; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Berkhout C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192155; Bohensky MA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-346; Bradley CJ, 2010, HEALTH SERV RES, V45, P1468, DOI 10.1111/j.1475-6773.2010.01142.x; Burbach JPM, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0586-4; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Carrier ME, 2018, J SCLERODERMA RELAT, V3, P91, DOI 10.5301/jsrd.5000263; Clinical Trials Transformation Initiative, CTTI REC REG TRIALS; Cobo E, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6783; Cockayne S, 2017, HEALTH TECHNOL ASSES, V21, P1, DOI 10.3310/hta21240; Courtright KR, 2016, ANN AM THORAC SOC, V13, P1629, DOI 10.1513/AnnalsATS.201604-308OT; Dapp U, 2011, J GERONTOL A-BIOL, V66, P591, DOI 10.1093/gerona/glr021; Dregan A, 2014, STROKE, V45, P2066, DOI 10.1161/STROKEAHA.114.005713; Eldridge SM, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5239; Erlinge D, 2017, NEW ENGL J MED, V377, P1132, DOI 10.1056/NEJMoa1706443; Erlinge D, 2016, AM HEART J, V175, P36, DOI 10.1016/j.ahj.2016.02.007; Evans I, 2011, TESTING TREATMENTS B; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Funk Michele Jonsson, 2014, Curr Epidemiol Rep, V1, P175; Gale C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-033543; Harron K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085278; Harron K, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech-2012-201376; Hemkens LG, 2016, J CLIN EPIDEMIOL, V79, P104, DOI 10.1016/j.jclinepi.2016.06.005; Hemkens LG, 2017, JAMA INTERN MED, V177, P176, DOI 10.1001/jamainternmed.2016.8040; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1055/s-0041-111066, 10.1136/bmj.g1687]; Hofmann R, 2017, NEW ENGL J MED, V377, P1240, DOI 10.1056/NEJMoa1706222; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Imran M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2021-049093; James S, 2015, NAT REV CARDIOL, V12, P312, DOI 10.1038/nrcardio.2015.33; James S, 2012, HEART, V98, P1329, DOI 10.1136/heartjnl-2012-301727; Juszczak E, 2019, JAMA-J AM MED ASSOC, V321, P1610, DOI 10.1001/jama.2019.3087; Kwakkenbos L, 2018, RES INTEGR PEER REV, V3, DOI 10.1186/s41073-018-0053-3; Kwakkenbos L, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-025266; Lagerqvist B, 2014, NEW ENGL J MED, V371, P1111, DOI 10.1056/NEJMoa1405707; Lariscy JT, 2011, J AGING HEALTH, V23, P1263, DOI 10.1177/0898264311421369; Levine DA, 2011, ARCH INTERN MED, V171, P1910, DOI 10.1001/archinternmed.2011.498; Liebschutz JM, 2017, JAMA INTERN MED, V177, P1265, DOI 10.1001/jamainternmed.2017.2468; Lowery JT, 2014, CANCER EPIDEM BIOMAR, V23, P601, DOI 10.1158/1055-9965.EPI-13-1085; Marino M, 2016, AM J PREV MED, V50, P161, DOI 10.1016/j.amepre.2015.07.032; Mc Cord KA, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2394-5; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Neumann L, 2017, J NUTR HEALTH AGING, V21, P1016, DOI 10.1007/s12603-017-0932-1; O'Connor PJ, 2011, ANN FAM MED, V9, P12, DOI 10.1370/afm.1196; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Shlomo N, 2019, DATA DRIVEN POLICY I, DOI [10.1007/978-3-319-78461-8_4, DOI 10.1007/978-3-319-78461-8_4]; Silbernagel G, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003776; Stewart JC, 2014, PSYCHOSOM MED, V76, P29, DOI 10.1097/PSY.0000000000000022; Torgerson DJ, 2008, DESIGNING RANDOMISED TRIALS IN HEALTH, EDUCATION AND THE SOCIAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1057/9780230583993; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; van Velzen P, 2017, LANCET RESP MED, V5, P492, DOI 10.1016/S2213-2600(17)30165-0; Vollmer WM, 2014, AM J MANAG CARE, V20, pSP502; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Young-Afat DA, 2016, EPIDEMIOLOGY, V27, P389, DOI 10.1097/EDE.0000000000000435; Zeiger RS, 2014, J ALLER CL IMM-PRACT, V2, P445, DOI 10.1016/j.jaip.2014.01.018; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	66	26	29	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2021	373								n857	10.1136/bmj.n857	http://dx.doi.org/10.1136/bmj.n857			20	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	UG4TJ	33926904	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000689246600003
J	Quenby, S; Gallos, ID; Dhillon-Smith, RK; Podesek, M; Stephenson, MD; Fisher, J; Brosens, JJ; Brewin, J; Ramhorst, R; Lucas, ES; McCoy, RC; Anderson, R; Daher, S; Regan, L; Al-Memar, M; Bourne, T; MacIntyre, DA; Rai, R; Christiansen, OB; Sugiura-Ogasawara, M; Odendaal, J; Devall, AJ; Bennett, PR; Petrou, S; Coomarasamy, A				Quenby, Siobhan; Gallos, Ioannis D.; Dhillon-Smith, Rima K.; Podesek, Marcelina; Stephenson, Mary D.; Fisher, Joanne; Brosens, Jan J.; Brewin, Jane; Ramhorst, Rosanna; Lucas, Emma S.; McCoy, Rajiv C.; Anderson, Robert; Daher, Shahd; Regan, Lesley; Al-Memar, Maya; Bourne, Tom; MacIntyre, David A.; Rai, Raj; Christiansen, Ole B.; Sugiura-Ogasawara, Mayumi; Odendaal, Joshua; Devall, Adam J.; Bennett, Phillip R.; Petrou, Stavros; Coomarasamy, Arri			Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss	LANCET			English	Review							1ST TRIMESTER; RISK-FACTORS; SPONTANEOUS-ABORTION; 1ST-TRIMESTER MISCARRIAGE; RECURRENT MISCARRIAGES; MATERNAL AGE; LIVE BIRTH; CHROMOSOME-ABNORMALITIES; THREATENED MISCARRIAGE; REPRODUCTIVE HEALTH	Miscarriage is generally defined as the loss of a pregnancy before viability. An estimated 23 million miscarriages occur every year worldwide, translating to 44 pregnancy losses each minute. The pooled risk of miscarriage is 15.3% (95% CI 12.5-18.7%) of all recognised pregnancies. The population prevalence of women who have had one miscarriage is 10.8% (10.3-11.4%), two miscarriages is 1.9% (1.8-2.1%), and three or more miscarriages is 0.7% (0.5-0.8%). Risk factors for miscarriage include very young or older female age (younger than 20 years and older than 35 years), older male age (older than 40 years), very low or very high body-mass index, Black ethnicity, previous miscarriages, smoking, alcohol, stress, working night shifts, air pollution, and exposure to pesticides. The consequences of miscarriage are both physical, such as bleeding or infection, and psychological. Psychological consequences include increases in the risk of anxiety, depression, post-traumatic stress disorder, and suicide. Miscarriage, and especially recurrent miscarriage, is also a sentinel risk marker for obstetric complications, including preterm birth, fetal growth restriction, placental abruption, and stillbirth in future pregnancies, and a predictor of longer-term health problems, such as cardiovascular disease and venous thromboembolism. The costs of miscarriage affect individuals, health-care systems, and society. The short-term national economic cost of miscarriage is estimated to be 471 pound million per year in the UK. As recurrent miscarriage is a sentinel marker for various obstetric risks in future pregnancies, women should receive care in preconception and obstetric clinics specialising in patients at high risk. As psychological morbidity is common after pregnancy loss, effective screening instruments and treatment options for mental health consequences of miscarriage need to be available. We recommend that miscarriage data are gathered and reported to facilitate comparison of rates among countries, to accelerate research, and to improve patient care and policy development.	[Quenby, Siobhan; Brosens, Jan J.; Lucas, Emma S.; Odendaal, Joshua] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Warwick, England; [Fisher, Joanne] Univ Warwick, Warwick Clin Trials Unit, Warwick, England; [Quenby, Siobhan; Brosens, Jan J.; Lucas, Emma S.; Odendaal, Joshua] Univ Hosp Coventry & Warwickshire NHS Trust, Tommys Natl Ctr Miscarriage Res, Coventry CV2 2DX, W Midlands, England; [Gallos, Ioannis D.; Dhillon-Smith, Rima K.; Podesek, Marcelina; Devall, Adam J.; Coomarasamy, Arri] Univ Birmingham, Tommys Natl Ctr Miscarriage Res, Inst Metab & Syst Res, Birmingham, W Midlands, England; [Stephenson, Mary D.] Univ Illinois, Dept Obstet & Gynecol, Recurrent Pregnancy Loss Program, Chicago, IL 60612 USA; [Brewin, Jane] Tommys Char, Laurence Pountney Hill, London, England; [Ramhorst, Rosanna] Univ Buenos Aires, CONICET, Inst Quim Biol, Fac Ciencias Exactas & Nat IQUIBICEN, Buenos Aires, DF, Argentina; [McCoy, Rajiv C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Anderson, Robert; Daher, Shahd; Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Regan, Lesley; Al-Memar, Maya; Bourne, Tom; MacIntyre, David A.; Rai, Raj; Bennett, Phillip R.] Imperial Coll London, Tommys Natl Ctr Miscarriage Res, London, England; [Christiansen, Ole B.] Aalborg Univ Hosp, Dept Obstet & Gynaecol, Ctr Recurrent Pregnancy Loss Western Denmark, Aalborg, Denmark; [Sugiura-Ogasawara, Mayumi] Nagoya City Univ, Grad Sch Med Sci, Dept Obstet & Gynecol, Nagoya, Aichi, Japan	University of Warwick; University of Warwick; University of Warwick; University of Birmingham; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Johns Hopkins University; University of Oxford; Imperial College London; Aalborg University; Aalborg University Hospital; Nagoya City University	Quenby, S (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Tommys Natl Ctr Miscarriage Res, Coventry CV2 2DX, W Midlands, England.	s.quenby@warwick.ac.uk	Devall, Adam/AAC-9646-2022; McCoy, Rajiv/AEW-9951-2022; Petrou, Stavros/ABD-8323-2021; Bourne, Tom/I-6478-2012	McCoy, Rajiv/0000-0003-0615-146X; Petrou, Stavros/0000-0003-3121-6050; Bourne, Tom/0000-0003-1421-6059; Quenby, Siobhan/0000-0003-3221-5471; Bennett, Phillip/0000-0002-6253-4919; Gallos, Ioannis/0000-0002-2766-358X; MacIntyre, David/0000-0002-4186-5567	Tommy's Charity; Wellcome Trust Investigator Award [212233/Z/18/Z]	Tommy's Charity; Wellcome Trust Investigator Award(Wellcome Trust)	The Tommy's Charity funds the Tommy's National Centre for Miscarriage Research. JJB holds a Wellcome Trust Investigator Award (212233/Z/18/Z). The funders had no role in the writing of the article or in the decision to submit the paper for publication. We would like to acknowledge Hannah Noordali for her input to the literature search that was done for this manuscript.	Adolfsson A, 2006, ACTA OBSTET GYN SCAN, V85, P741, DOI 10.1080/00016340600627022; Ahlborg G, 1996, INT J EPIDEMIOL, V25, P783, DOI 10.1093/ije/25.4.783; Al-Memar M, 2020, BJOG-INT J OBSTET GY, V127, P264, DOI 10.1111/1471-0528.15972; Al-Memar M, 2019, ULTRASOUND OBST GYN, V54, P530, DOI 10.1002/uog.20262; Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P1103, DOI 10.1016/j.fertnstert.2012.06.048; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Antoniotti GS, 2018, HUM REPROD, V33, P654, DOI 10.1093/humrep/dey029; Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101, DOI 10.1016/S1472-6483(10)60300-8; ARMSTRONG BG, 1992, AM J PUBLIC HEALTH, V82, P85, DOI 10.2105/AJPH.82.1.85; Atik RB, 2018, HUM REPROD OPEN, V2018, DOI 10.1093/hropen/hoy004; Avalos LA, 2014, SUBST USE MISUSE, V49, P1437, DOI 10.3109/10826084.2014.912228; Baba S, 2011, HUM REPROD, V26, P466, DOI 10.1093/humrep/deq343; Badawy A, 2009, FERTIL STERIL, V91, P838, DOI 10.1016/j.fertnstert.2008.01.016; Banno C, 2020, J HUM GENET, V65, P155, DOI 10.1038/s10038-019-0694-1; Bardos J, 2015, OBSTET GYNECOL, V125, P1313, DOI 10.1097/AOG.0000000000000859; Betts D, 2014, MIDWIFERY, V30, P650, DOI 10.1016/j.midw.2013.12.011; BIGRIGG MA, 1991, BRIT MED J, V302, P577, DOI 10.1136/bmj.302.6776.577; Boyles SH, 2000, HEALTH PSYCHOL, V19, P510; Brier N, 1999, OBSTET GYNECOL, V93, P151, DOI 10.1016/S0029-7844(98)00294-4; Brigham SA, 1999, HUM REPROD, V14, P2868, DOI 10.1093/humrep/14.11.2868; Bukowski R, 2001, AM J OBSTET GYNECOL, V185, P463, DOI 10.1067/mob.2001.115865; Burkhardt T, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.01.011; Campbell S, 2011, AUST NZ J PUBL HEAL, V35, P343, DOI 10.1111/j.1753-6405.2011.00729.x; Campillo IS, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0682-1; Carranza-Lira S, 2000, Med Sci Monit, V6, P759; Chan YY, 2011, ULTRASOUND OBST GYN, V38, P371, DOI 10.1002/uog.10056; Chatenoud L, 1998, ANN EPIDEMIOL, V8, P520, DOI 10.1016/S1047-2797(98)00017-9; CHRISTIANSEN OB, 1992, BRIT J OBSTET GYNAEC, V99, P408, DOI 10.1111/j.1471-0528.1992.tb13759.x; Clifford K, 1997, HUM REPROD, V12, P387, DOI 10.1093/humrep/12.2.387; Coomarasamy A, 2020, AM J OBSTET GYNECOL, V223, P167, DOI 10.1016/j.ajog.2019.12.006; Coomarasamy A, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20410; Nava AC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210449; Dalton VK, 2006, OBSTET GYNECOL, V108, P103, DOI 10.1097/01.AOG.0000223206.64144.68; Dalton VK, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.08.031; DeFranco E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120594; Doubilet PM, 2013, NEW ENGL J MED, V369, P1443, DOI 10.1056/NEJMra1302417; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; Farooq Fariha, 2011, J Ayub Med Coll Abbottabad, V23, P28; Farren J, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.10.102; Feichtinger M, 2018, J ASSIST REPROD GEN, V35, P1401, DOI 10.1007/s10815-018-1226-1; FENSTER L, 1995, AM J EPIDEMIOL, V142, P1176, DOI 10.1093/oxfordjournals.aje.a117576; Gaskins AJ, 2019, HUM REPROD, V34, P1809, DOI 10.1093/humrep/dez111; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041; Graziosi GCM, 2005, HUM REPROD, V20, P1067, DOI 10.1093/humrep/deh709; Gunnarsdottir J, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.01.041; Hardy K, 2016, AM J MED GENET A, V170, P2671, DOI 10.1002/ajmg.a.37795; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; Health and Social Care Information Centre, NHS MAT STAT 2011 12; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HIMMELBERGER DU, 1978, AM J EPIDEMIOL, V108, P470, DOI 10.1093/oxfordjournals.aje.a112645; Hughes J, 1996, BRIT J OBSTET GYNAEC, V103, P1217, DOI 10.1111/j.1471-0528.1996.tb09632.x; Kaandorp SP, 2014, HUM REPROD, V29, P1146, DOI 10.1093/humrep/deu052; Kakita-Kobayashi M, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa049; Kersting Anette, 2012, Dialogues Clin Neurosci, V14, P187; KLINE J, 1980, LANCET, V2, P176, DOI 10.1016/S0140-6736(80)90062-8; Kling C, 2018, ARCH GYNECOL OBSTET, V297, P205, DOI 10.1007/s00404-017-4532-4; Kolte AM, 2015, HUM REPROD, V30, P495, DOI 10.1093/humrep/deu299; Kolte AM, 2014, HUM REPROD, V29, P931, DOI 10.1093/humrep/deu042; Leiser CL, 2019, FERTIL STERIL, V111, P341, DOI 10.1016/j.fertnstert.2018.10.028; Lemmers M, 2018, ACTA OBSTET GYN SCAN, V97, P294, DOI 10.1111/aogs.13283; Leviton A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091152; Li XY, 2017, ENVIRON POLLUT, V227, P596, DOI 10.1016/j.envpol.2017.03.055; Li XL, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0181-5; Linnakaari R, 2019, HUM REPROD, V34, P2120, DOI 10.1093/humrep/dez211; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; Lucas ES, 2016, STEM CELLS, V34, P346, DOI 10.1002/stem.2222; Lund M, 2012, OBSTET GYNECOL, V119, P37, DOI 10.1097/AOG.0b013e31823c0413; Lynch CD, 2018, HUM REPROD, V33, P728, DOI 10.1093/humrep/dey030; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; MacWilliams K, 2016, J EMERG NURS, V42, P504, DOI 10.1016/j.jen.2016.05.011; Magnus MC, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l869; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Nagy S, 2003, OBSTET GYNECOL, V102, P94, DOI 10.1016/S0029-7844(03)00403-4; Naidoo S, 2011, SCAND J WORK ENV HEA, V37, P227, DOI 10.5271/sjweh.3133; Nelson DB, 2003, ANN EPIDEMIOL, V13, P223, DOI 10.1016/S1047-2797(02)00419-2; Nguyen BT, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.05.028; Nielsen HS, 2010, HUM REPROD, V25, P1543, DOI 10.1093/humrep/deq091; Niinimaki M, 2009, BJOG-INT J OBSTET GY, V116, P984, DOI 10.1111/j.1471-0528.2009.02161.x; Nilsson SF, 2014, BJOG-INT J OBSTET GY, V121, P1375, DOI 10.1111/1471-0528.12694; PARAZZINI F, 1994, HUM REPROD, V9, P1950, DOI 10.1093/oxfordjournals.humrep.a138365; Pathak R, 2010, CLIN BIOCHEM, V43, P131, DOI 10.1016/j.clinbiochem.2009.09.019; Petrou S, 2006, BJOG-INT J OBSTET GY, V113, P879, DOI 10.1111/j.1471-0528.2006.00998.x; Petrou S, 2009, VALUE HEALTH, V12, P551, DOI 10.1111/j.1524-4733.2008.00459.x; Philipp T, 2002, AM J MED GENET, V111, P43, DOI 10.1002/ajmg.10476; Pineles BL, 2014, AM J EPIDEMIOL, V179, P807, DOI 10.1093/aje/kwt334; Prior M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016571; Ralph SG, 1999, BRIT MED J, V319, P220, DOI 10.1136/bmj.319.7204.220; Rausch M, 2012, FERTIL STERIL, V97, P355, DOI 10.1016/j.fertnstert.2011.11.044; RCOG, 2011, INV TREATM COUPL REC; Robinson L, 2012, HUM REPROD, V27, P2908, DOI 10.1093/humrep/des261; Roepke ER, 2017, ACTA OBSTET GYN SCAN, V96, P1365, DOI 10.1111/aogs.13210; Rossen LM, 2018, PAEDIATR PERINAT EP, V32, P19, DOI 10.1111/ppe.12417; Saraswat L, 2010, BJOG-INT J OBSTET GY, V117, P245, DOI 10.1111/j.1471-0528.2009.02427.x; Savva GM, 2010, PRENATAL DIAG, V30, P57, DOI 10.1002/pd.2403; Schenker MB, 1997, J OCCUP ENVIRON MED, V39, P556, DOI 10.1097/00043764-199706000-00011; Shi Xiao-Bo, 2008, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V33, P518; SIMPSON JL, 1990, AM J MED GENET, V35, P165, DOI 10.1002/ajmg.1320350205; Stephenson MD, 2002, HUM REPROD, V17, P446, DOI 10.1093/humrep/17.2.446; Sugiura-Ogasawara M, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13072; Tasnim N, 2014, JCPSP-J COLL PHYSICI, V24, P815, DOI 11.2014/JCPSP.815819; Tasnim N, 2011, J PAK MED ASSOC, V61, P149; Toth B, 2018, GEBURTSH FRAUENHEILK, V78, P364, DOI 10.1055/a-0586-4568; Turco MY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.163428; Ugurlu EN, 2009, FERTIL STERIL, V91, P1657, DOI 10.1016/j.fertnstert.2008.02.002; van den Berg MMJ, 2015, REPROD BIOMED ONLINE, V31, P192, DOI 10.1016/j.rbmo.2015.04.008; van Oppenraaij RHF, 2009, HUM REPROD UPDATE, V15, P409, DOI 10.1093/humupd/dmp009; Wainstock T, 2013, PSYCHOSOM MED, V75, P228, DOI 10.1097/PSY.0b013e318280f5f3; Wall KM, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.05.034; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; Xu GL, 2014, FERTIL STERIL, V101, P1663, DOI 10.1016/j.fertnstert.2014.02.013; You JHS, 2005, HUM REPROD, V20, P2873, DOI 10.1093/humrep/dei163; Zeitlin J, 2000, BRIT J OBSTET GYNAEC, V107, P750, DOI 10.1111/j.1471-0528.2000.tb13336.x; Zhang LQ, 2019, NAT SUSTAIN, V2, P1011, DOI 10.1038/s41893-019-0387-y	114	122	128	39	109	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1658	1667		10.1016/S0140-6736(21)00682-6	http://dx.doi.org/10.1016/S0140-6736(21)00682-6		APR 2021	10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33915094	Green Submitted			2022-12-28	WOS:000645510600026
J	Song, ZR; Lillehaugen, T; Wallace, J				Song, Zirui; Lillehaugen, Timothy; Wallace, Jacob			Out-of-Network Laboratory Test Spending, Utilization, and Prices in the US	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Song, Zirui; Lillehaugen, Timothy] Harvard Med Sch, Boston, MA 02115 USA; [Lillehaugen, Timothy] IBM Watson Hlth, Cambridge, MA USA; [Wallace, Jacob] Yale Sch Publ Hlth, New Haven, CT USA	Harvard University; Harvard Medical School; Yale University	Song, ZR (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180A Longwood Ave, Boston, MA 02115 USA.	song@hcp.med.harvard.edu		Wallace, Jacob/0000-0003-4533-5253	National Institutes of Health Director's Early Independence Award [DP5-OD024564]	National Institutes of Health Director's Early Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Director's Early Independence Award DP5-OD024564 (to Dr Song).	American Society of Addiction Medicine, 2017, APPR US DRUG TEST CL; Centers for Medicare & Medicaid Services (CMS) HHS; Centers for Disease Control Prevention (CDC) HHS; Office for Civil Rights (OCR) HHS, 2014, FED REGISTER, V79, P7289, DOI DOI 10.1201/B17548-8; IBM Watson Health, 2018, IBM MARK RES DAT LIF; Schulte F, 2017, LIQUID GOLD PAIN DOC; Song ZR, 2020, HEALTH AFFAIR, V39, P1032, DOI 10.1377/hlthaff.2019.01776; Song ZR, 2021, J GEN INTERN MED, V36, P232, DOI 10.1007/s11606-020-05665-w	6	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1674	1676		10.1001/jama.2021.0720	http://dx.doi.org/10.1001/jama.2021.0720			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904879	Green Published, Bronze			2022-12-28	WOS:000645617800026
J	Walker, KF; Plumb, J; Gray, J; Thornton, JG; Avery, AJ; Daniels, JP				Walker, Kate F.; Plumb, Jane; Gray, Jim; Thornton, Jim G.; Avery, Anthony J.; Daniels, Jane P.			Should all pregnant women be offered testing for group B streptococcus?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVENTION; DISEASE; STRATEGIES		[Walker, Kate F.; Thornton, Jim G.; Avery, Anthony J.; Daniels, Jane P.] Univ Nottingham, Nottingham, England; [Plumb, Jane] Grp B Strep Support, Haywards Heath, England; [Gray, Jim] Birmingham Womens & Childrens NHS Fdn Trust, Birmingham, W Midlands, England	University of Nottingham	Walker, KF (corresponding author), Univ Nottingham, Nottingham, England.	kate.walker@nottingham.ac.uk		Walker, Kate F./0000-0001-5794-7324				[Anonymous], 2020, OBSTET GYNECOL, V135, pE51, DOI [10.1097/AOG.0000000000003335, 10.1097/AOG.0000000000003668]; Australian Government Depart of Health, 2019, PREGN CAR GUID GROUP PREGN CAR GUID GROUP, V394; Bevan D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024324; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; da Silva HD, 2019, J INFECT PUBLIC HEAL, V12, P479, DOI 10.1016/j.jiph.2019.03.004; Hasperhoven GF, 2020, BJOG-INT J OBSTET GY, V127, P680, DOI 10.1111/1471-0528.16085; Heath PGT, 2004, LANCET, V363, P292, DOI 10.1016/S0140-6736(03)15389-5; Huang J, 2019, PEDIATR NEONATOL, V60, P487, DOI 10.1016/j.pedneo.2019.07.001; Hughes RG, 2017, BJOG-INT J OBSTET GY, V124, pE280, DOI 10.1111/1471-0528.14821; Kaambwa B, 2010, BJOG-INT J OBSTET GY, V117, P1616, DOI 10.1111/j.1471-0528.2010.02752.x; Le Doare K, 2017, CLIN INFECT DIS, V65, pS143, DOI 10.1093/cid/cix654; Li QY, 2020, PEDIATR INFECT DIS J, V39, P740, DOI 10.1097/INF.0000000000002674; Money D, 2016, J OBSTET GYNAECOL CA, V38, pS326, DOI 10.1016/j.jogc.2016.09.042; O'Sullivan C, 2016, ARCH DIS CHILD, V101, pA2, DOI DOI 10.1136/ARCHDISCHILD-2016-310863.3; O'Sullivan CP, 2019, LANCET INFECT DIS, V19, P83, DOI 10.1016/S1473-3099(18)30555-3; Ohlsson A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007467.pub4; Schrag SJ, 2002, NEW ENGL J MED, V347, P233, DOI 10.1056/NEJMoa020205; Schrag SJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2013; Seedat F, 2016, UNIVERSAL ANTENATAL; Seedat F, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1432-3; World Health Organization, 2015, WHO REC PREV TRE MAT	21	1	1	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n882	10.1136/bmj.n882	http://dx.doi.org/10.1136/bmj.n882			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903125	Green Accepted			2022-12-28	WOS:000678538700009
J	Lane, R				Lane, Richard			Faith Osier: inspirational immunologist	LANCET			English	Biographical-Item																		OSIER F, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1533	1533						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR7QA	33894823				2022-12-28	WOS:000643286900009
J	Mascharak, S; DesJardins-Park, HE; Davitt, MF; Griffin, M; Borrelli, MR; Moore, AL; Chen, K; Duoto, B; Chinta, M; Foster, DS; Shen, AH; Januszyk, M; Kwon, SH; Wernig, G; Wan, DC; Lorenz, HP; Gurtner, GC; Longaker, MT				Mascharak, Shamik; DesJardins-Park, Heather E.; Davitt, Michael F.; Griffin, Michelle; Borrelli, Mimi R.; Moore, Alessandra L.; Chen, Kellen; Duoto, Bryan; Chinta, Malini; Foster, Deshka S.; Shen, Abra H.; Januszyk, Michael; Kwon, Sun Hyung; Wernig, Gerlinde; Wan, Derrick C.; Lorenz, H. Peter; Gurtner, Geoffrey C.; Longaker, Michael T.			Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring	SCIENCE			English	Article							FOCAL ADHESION; BASIC SCIENCE; HETEROGENEITY; MYOFIBROBLAST; HEURISTICS; SURGERY; DEVICE; TAZ; YAP	Skin scarring, the end result of adult wound healing, is detrimental to tissue form and function. Engrailed-1 lineage-positive fibroblasts (EPFs) are known to function in scarring, but Engrailed-1 lineage-negative fibroblasts (ENFs) remain poorly characterized. Using cell transplantation and transgenic mouse models, we identified a dermal ENF subpopulation that gives rise to postnatally derived EPFs by activating Engrailed-1 expression during adult wound healing. By studying ENF responses to substrate mechanics, we found that mechanical tension drives Engrailed-1 activation via canonical mechanotransduction signaling. Finally, we showed that blocking mechanotransduction signaling with either verteporfin, an inhibitor of Yes-associated protein (YAP), or fibroblast-specific transgenic YAP knockout prevents Engrailed-1 activation and promotes wound regeneration by ENFs, with recovery of skin appendages, ultrastructure, and mechanical strength. This finding suggests that there are two possible outcomes to postnatal wound healing: a fibrotic response (EPF-mediated) and a regenerative response (ENF-mediated).	[Mascharak, Shamik; DesJardins-Park, Heather E.; Davitt, Michael F.; Griffin, Michelle; Borrelli, Mimi R.; Moore, Alessandra L.; Chen, Kellen; Duoto, Bryan; Chinta, Malini; Foster, Deshka S.; Shen, Abra H.; Januszyk, Michael; Kwon, Sun Hyung; Wan, Derrick C.; Lorenz, H. Peter; Gurtner, Geoffrey C.; Longaker, Michael T.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Sch Med, Stanford, CA 94305 USA; [Mascharak, Shamik; DesJardins-Park, Heather E.; Wernig, Gerlinde; Longaker, Michael T.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Wernig, Gerlinde] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Gurtner, GC; Longaker, MT (corresponding author), Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Sch Med, Stanford, CA 94305 USA.; Longaker, MT (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	ggurtner@stanford.edu; longaker@stanford.edu		Talbott, Heather/0000-0003-0250-925X; Wan, Derrick/0000-0003-4666-1683; Moore, Alessandra/0000-0001-7815-178X; Chen, Kellen/0000-0002-7023-7850; Davitt, Michael/0000-0003-4684-501X; Foster, Deshka S/0000-0001-8372-4722	Hagey Laboratory for Pediatric Regenerative Medicine; Gunn/Olivier Research Fund; Stinehart/Reed Award; NIH [R01-GM136659, R01-GM116892, R01-DE027346, U24-DE026914]	Hagey Laboratory for Pediatric Regenerative Medicine; Gunn/Olivier Research Fund; Stinehart/Reed Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by the Hagey Laboratory for Pediatric Regenerative Medicine (M.T.L., D. C.W., G.C.G., and H.P.L.); the Gunn/Olivier Research Fund, the Stinehart/Reed Award, and NIH grant R01-GM136659 (M.T.L.); and NIH grants R01-GM116892 (H.P.L. and M.T.L.), R01-DE027346 (D.C.W. and M.T.L.), and U24-DE026914 (D.C.W., G.C.G., and M.T.L.).	Aarabi S, 2007, FASEB J, V21, P3250, DOI 10.1096/fj.07-8218com; Alsamman S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay8798; Barnes LA, 2018, ADV WOUND CARE, V7, P47, DOI 10.1089/wound.2016.0709; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Salzer MC, 2018, CELL, V175, P1575, DOI 10.1016/j.cell.2018.10.012; Correa-Gallegos D, 2019, NATURE, V576, P287, DOI 10.1038/s41586-019-1794-y; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; desJardins-Park HE, 2020, PRS-GLOB OPEN, V8, DOI 10.1097/GOX.0000000000002927; Driskell RR, 2015, TRENDS CELL BIOL, V25, P92, DOI 10.1016/j.tcb.2014.10.001; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Eva KW, 2005, MED EDUC, V39, P870, DOI 10.1111/j.1365-2929.2005.02258.x; Griffin MF, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.044164; Guerrero-Juarez CF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08247-x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Jiang DS, 2018, NAT CELL BIOL, V20, P422, DOI 10.1038/s41556-018-0073-8; Leavitt T, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108356; Lim AF, 2014, PLAST RECONSTR SURG, V133, P398, DOI 10.1097/01.prs.0000436526.64046.d0; Liu F, 2015, AM J PHYSIOL-LUNG C, V308, pL344, DOI 10.1152/ajplung.00300.2014; Longaker MT, 2014, PLAST RECONSTR SURG, V134, P536, DOI 10.1097/PRS.0000000000000417; Lynch MD, 2018, J CLIN INVEST, V128, P26, DOI 10.1172/JCI93555; Marsh E, 2018, CELL, V175, P1620, DOI 10.1016/j.cell.2018.10.013; Marshall CD, 2018, ADV WOUND CARE, V7, P29, DOI 10.1089/wound.2016.0696; Mascharak S., 2020, DIVERGING MOL SIGNAT; Mascharak S, 2020, TRENDS MOL MED, V26, P1101, DOI 10.1016/j.molmed.2020.07.008; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Philippeos C, 2018, J INVEST DERMATOL, V138, P811, DOI 10.1016/j.jid.2018.01.016; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shook BA, 2018, SCIENCE, V362, P909, DOI 10.1126/science.aar2971; Stauffer W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33592-8; Sun BK, 2014, SCIENCE, V346, P941, DOI 10.1126/science.1253836; Tabib T, 2018, J INVEST DERMATOL, V138, P802, DOI 10.1016/j.jid.2017.09.045; Totaro A, 2018, TRENDS CELL BIOL, V28, P560, DOI 10.1016/j.tcb.2018.03.001; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Walmsley GG, 2015, PLAST RECONSTR SURG, V135, P907, DOI 10.1097/PRS.0000000000000972; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574	42	118	118	60	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					362	+	eaba2374	10.1126/science.aba2374	http://dx.doi.org/10.1126/science.aba2374			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888614	Green Accepted			2022-12-28	WOS:000645009800034
J	Al-Aly, Z; Xie, Y; Bowe, B				Al-Aly, Ziyad; Xie, Yan; Bowe, Benjamin			High-dimensional characterization of post-acute sequelae of COVID-19	NATURE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; PROTON PUMP INHIBITORS; ALL-CAUSE MORTALITY; KIDNEY OUTCOMES; RISK; SCORE; CONSEQUENCES	The acute clinical manifestations of COVID-19 have been well characterized(1,2), but the post-acute sequelae of this disease have not been comprehensively described. Here we use the national healthcare databases of the US Department of Veterans Affairs to systematically and comprehensively identify 6-month incident sequelae-including diagnoses, medication use and laboratory abnormalities-in patients with COVID-19 who survived for at least 30 days after diagnosis. We show that beyond the first 30 days of illness, people with COVID-19 exhibit a higher risk of death and use of health resources. Our high-dimensional approach identifies incident sequelae in the respiratory system, as well as several other sequelae that include nervous system and neurocognitive disorders, mental health disorders, metabolic disorders, cardiovascular disorders, gastrointestinal disorders, malaise, fatigue, musculoskeletal pain and anaemia. We show increased incident use of several therapeutic agents-including pain medications (opioids and non-opioids) as well as antidepressant, anxiolytic, antihypertensive and oral hypoglycaemic agents-as well as evidence of laboratory abnormalities in several organ systems. Our analysis of an array of prespecified outcomes reveals a risk gradient that increases according to the severity of the acute COVID-19 infection (that is, whether patients were not hospitalized, hospitalized or admitted to intensive care). Our findings show that a substantial burden of health loss that spans pulmonary and several extrapulmonary organ systems is experienced by patients who survive after the acute phase of COVID-19. These results will help to inform health system planning and the development of multidisciplinary care strategies to reduce chronic health loss among individuals with COVID-19.	[Al-Aly, Ziyad; Xie, Yan; Bowe, Benjamin] VA St Louis Hlth Care Syst, Res & Dev Serv, Clin Epidemiol Ctr, St Louis, MO 63125 USA; [Al-Aly, Ziyad; Xie, Yan; Bowe, Benjamin] Vet Res & Educ Fdn St Louis, St Louis, MO 63103 USA; [Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Nephrol Sect, Med Serv, St Louis, MO 63125 USA; [Al-Aly, Ziyad] Washington Univ, Dept Med, Sch Med, St Louis, MO 63130 USA; [Al-Aly, Ziyad] Washington Univ St Louis, Inst Publ Hlth, St Louis, MO 63130 USA; [Xie, Yan; Bowe, Benjamin] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidmiol & Biostat, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Saint Louis University	Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Res & Dev Serv, Clin Epidemiol Ctr, St Louis, MO 63125 USA.; Al-Aly, Z (corresponding author), Vet Res & Educ Fdn St Louis, St Louis, MO 63103 USA.; Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Nephrol Sect, Med Serv, St Louis, MO 63125 USA.; Al-Aly, Z (corresponding author), Washington Univ, Dept Med, Sch Med, St Louis, MO 63130 USA.; Al-Aly, Z (corresponding author), Washington Univ St Louis, Inst Publ Hlth, St Louis, MO 63130 USA.	zalaly@gmail.com	Al-Aly, Ziyad/S-4439-2016	Al-Aly, Ziyad/0000-0002-2600-0434; Xie, Yan/0000-0002-2457-9382	United States Department of Veterans Affairs; Institute for Public Health at Washington University in Saint Louis; American Society of Nephrology and KidneyCure fellowship awards	United States Department of Veterans Affairs(US Department of Veterans Affairs); Institute for Public Health at Washington University in Saint Louis; American Society of Nephrology and KidneyCure fellowship awards	This study used data from the VA COVID-19 Shared Data Resource. M. Cai developed the data visualization and A. K. Gibson provided technical and editorial assistance. This research was funded by the United States Department of Veterans Affairs and the Institute for Public Health at Washington University in Saint Louis (for Z.A.-A.), and two American Society of Nephrology and KidneyCure fellowship awards (for Y.X. and B.B.). The funders of this study had no role in study design; collection, analysis and interpretation of data; writing the report; and the decision to submit the report for publication. This research project was reviewed and approved by the Institutional Review Board of the Department of Veterans Affairs Saint Louis Health Care System.	Advisory Group of the British Society for Immunology, 2020, LONG TERM IMM HLTH C; Aubert Carole E, 2020, Mayo Clin Proc Innov Qual Outcomes, V4, P40, DOI 10.1016/j.mayocpiqo.2019.09.002; Bowe B, 2021, CLIN J AM SOC NEPHRO, V16, P14, DOI 10.2215/CJN.09610620; Bowe B, 2018, LANCET PLANET HEALTH, V2, pE301, DOI 10.1016/s2542-5196(18)30140-2; Bowe B, 2016, CLIN J AM SOC NEPHRO, V11, P1784, DOI 10.2215/CJN.00730116; Bowe B, 2016, KIDNEY INT, V89, P886, DOI 10.1016/j.kint.2015.12.034; del Rio C, 2020, JAMA-J AM MED ASSOC, V324, P1723, DOI 10.1001/jama.2020.19719; Figueroa JD, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2377; Greene M, 2014, J AM GERIATR SOC, V62, P447, DOI 10.1111/jgs.12695; Kind AJH, 2018, NEW ENGL J MED, V378, P2456, DOI 10.1056/NEJMp1802313; Knipe Duleeka, 2020, Wellcome Open Res, V5, P82, DOI [10.12688/wellcomeopenres.15870.2, 10.12688/wellcomeopenres.15870.1]; Li F, 2019, ANN APPL STAT, V13, P2389, DOI 10.1214/19-AOAS1282; Li F, 2018, J AM STAT ASSOC, V113, P390, DOI 10.1080/01621459.2016.1260466; Lipsitch M, 2010, EPIDEMIOLOGY, V21, P383, DOI 10.1097/EDE.0b013e3181d61eeb; Mahase E, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1515; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Olvey EL, 2010, CLIN PHARMACOL THER, V87, P48, DOI 10.1038/clpt.2009.198; Raker EJ, 2020, P NATL ACAD SCI USA, V117, P12595, DOI 10.1073/pnas.2006706117; Shi X, 2020, CURR EPIDEMIOL REP, V7, P190, DOI 10.1007/s40471-020-00243-4; Thomas LE, 2020, JAMA-J AM MED ASSOC, V323, P2417, DOI 10.1001/jama.2020.7819; Townsend E, 2020, LANCET PSYCHIAT, V7, P1014, DOI 10.1016/S2215-0366(20)30457-0; Vincent BM, 2018, HEALTH SERV OUTCOME, V18, P143, DOI 10.1007/s10742-018-0178-3; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wei YG, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6258; Xie Y, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4677; Xie Y, 2020, DIABETES CARE, V43, P2785, DOI 10.2337/dc20-1231; Xie Y, 2020, DIABETES CARE, V43, P2859, DOI 10.2337/dc20-1890; Xie Y, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1580; Xie Y, 2018, KIDNEY INT, V93, P741, DOI 10.1016/j.kint.2017.08.033; Xie Y, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015735; Xie Y, 2017, KIDNEY INT, V91, P1482, DOI 10.1016/j.kint.2016.12.021; Xie Y, 2016, J AM SOC NEPHROL, V27, P3153, DOI 10.1681/ASN.2015121377	33	351	356	44	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					259	+		10.1038/s41586-021-03553-9	http://dx.doi.org/10.1038/s41586-021-03553-9		APR 2021	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ8YR	33887749	Bronze, Green Submitted			2022-12-28	WOS:000652171800001
J	Yo, JH; Gandhi, S				Yo, Jennifer H.; Gandhi, Shital			Striae and an Adrenal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yo, Jennifer H.; Gandhi, Shital] Mt Sinai Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Yo, JH (corresponding author), Mt Sinai Hosp, Toronto, ON, Canada.	jennifer.yo@monashhealth.org		Yo, Jennifer/0000-0002-0618-1813					0	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					E57	E57		10.1056/NEJMicm2024730	http://dx.doi.org/10.1056/NEJMicm2024730			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RQ6OT	33882208				2022-12-28	WOS:000642536700001
J	Rimmer, A				Rimmer, Abi			Invest to staff the NHS properly, healthcare leaders warn prime minister	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n1059	10.1136/bmj.n1059	http://dx.doi.org/10.1136/bmj.n1059			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3DF	33883204				2022-12-28	WOS:000643659700001
J	Ferry, G				Ferry, Georgina			Mary Susan Malahlela: practising medicine under apartheid	LANCET			English	Editorial Material												mgf@georginaferry.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1437	1437						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33865486				2022-12-28	WOS:000640378100011
J	Jeraj, S				Jeraj, Samir			Doing the work to end health inequalities caused by systemic racism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sa.jeraj@gmail.com						Adams A, 2014, SOC SCI MED, V116, P161, DOI 10.1016/j.socscimed.2014.07.004; Cook T., 2020, HEALTH SERV J; Pham TM, 2018, CLIN EPIDEMIOL, V10, P949, DOI 10.2147/CLEP.S152647; Race Equality Foundation, 2013, BLACK MIN ETHN COMM; UCL, 2018, LIK DEM HIGH BLACK; UK All-Party Parliamentary Group on Dementia, 2013, UK ALL PARTY PARLIAM	6	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2021	373								n821	10.1136/bmj.n821	http://dx.doi.org/10.1136/bmj.n821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RO8VU	33863708	Bronze			2022-12-28	WOS:000641319600004
J	Lee, AYY				Lee, Agnes Y. Y.			Inpatient Notes: Direct Oral Anticoagulants in Patients With Cancer-What Hospitalists Need to Know	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lee, Agnes Y. Y.] Univ British Columbia, Vancouver, BC, Canada; [Lee, Agnes Y. Y.] Vancouver Coastal Hlth Author, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	Lee, AYY (corresponding author), Diamond Hlth Care Ctr, 2775 Laurel St,10th Floor, Vancouver, BC V5Z 1M9, Canada.	alee14@bccancer.bc.ca						Bannow BTS, 2018, J THROMB HAEMOST, V16, P1246, DOI 10.1111/jth.14015; Key NS, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.01461; Martin KA, 2017, AM J MED, V130, P517, DOI 10.1016/j.amjmed.2016.12.033; Mulder FI, 2020, BLOOD, V136, P1433, DOI 10.1182/blood.2020005819; Short NJ, 2014, ONCOLOGIST, V19, P82, DOI 10.1634/theoncologist.2013-0239	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					HO2	HO3		10.7326/M21-0807	http://dx.doi.org/10.7326/M21-0807			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RU1WZ	33872545				2022-12-28	WOS:000644942400017
J	Newton, SL; Yeh, JSJ				Newton, Shauna L.; Yeh, James Song-Jeng			Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults	ANNALS OF INTERNAL MEDICINE			English	Letter									[Newton, Shauna L.; Yeh, James Song-Jeng] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Yeh, James Song-Jeng] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Newton, SL (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.			Yeh, James/0000-0003-3549-6096				Armstrong PW, 1998, CIRCULATION, V98, P1860, DOI 10.1161/01.CIR.98.18.1860; Chow EJ, 2020, ANN INTERN MED, V173, P605, DOI 10.7326/M20-1509; Clar C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005050.pub3; DeFilippis AP, 2019, CIRCULATION, V140, P1661, DOI 10.1161/CIRCULATIONAHA.119.040631; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR	2021	174	4					582	583		10.7326/L21-0016	http://dx.doi.org/10.7326/L21-0016			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RU1WZ	33872524				2022-12-28	WOS:000644942400010
J	Hamid, AA; Frank, MJ; Moore, CI				Hamid, Arif A.; Frank, Michael J.; Moore, Christopher, I			Wave-like dopamine dynamics as a mechanism for spatiotemporal credit assignment	CELL			English	Article							GOAL-DIRECTED ACTION; BASAL GANGLIA; MIDBRAIN DOPAMINE; STRIATAL DOPAMINE; CHOLINERGIC INTERNEURONS; DORSAL STRIATUM; REWARD; PREDICTION; NEURONS; SIGNALS	Significant evidence supports the view that dopamine shapes learning by encoding reward prediction errors. However, it is unknown whether striatal targets receive tailored dopamine dynamics based on regional functional specialization. Here, we report wave-like spatiotemporal activity patterns in dopamine axons and release across the dorsal striatum. These waves switch between activational motifs and organize dopamine transients into localized clusters within functionally related striatal subregions. Notably, wave trajectories were tailored to task demands, propagating from dorsomedial to dorsolateral striatum when rewards are contingent on animal behavior and in the opponent direction when rewards are independent of behavioral responses. We propose a computational architecture in which striatal dopamine waves are sculpted by inference about agency and provide a mechanism to direct credit assignment to specialized striatal subregions. Supporting model predictions, dorsomedial dopamine activity during reward-pursuit signaled the extent of instrumental control and interacted with reward waves to predict future behavioral adjustments.	[Hamid, Arif A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Frank, Michael J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Moore, Christopher, I] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA	Brown University; Brown University; Brown University	Hamid, AA (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.; Frank, MJ (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.; Moore, CI (corresponding author), Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA.	arifhamid.DA@gmail.com; michael_frank@brown.edu; christopher_moore@brown.edu		Moore, Christopher/0000-0003-4534-1602; Hamid, Arif/0000-0001-7403-0067; Frank, Michael/0000-0001-8451-0523	HHMI Hanna Gray Fellowship; NIH [R01MH080066]; NSF [1460604]; Carney Institute for Brain Sciences at Brown University; Dean's office at Brown University	HHMI Hanna Gray Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Carney Institute for Brain Sciences at Brown University; Dean's office at Brown University	We thank Matthew Nassar, Joshua Berke, Peter Dayan, and Theresa Desrochers for valuable discussion of the project and feedback on an earlier version of the manuscript and members of the Frank and Moore laboratories for feedback at various stages of the project. We also thank Ines Belghiti and Aneri Soni for help with adapting the MoE model implementation to the tone task. GCaMP6f and jRGECO1a were developed and made available by the HHMI Janelia GENIE Project. dLight was developed and made available by Lin Tian. This work was supported by HHMI Hanna Gray Fellowship to A.A.H.; NIH R01MH080066 and NSF grant 1460604 to M.J.F.; and awards from Carney Institute for Brain Sciences and Dean's office at Brown University to C.I.M.	Adrover MF, 2020, J NEUROSCI, V40, P7510, DOI 10.1523/JNEUROSCI.1327-20.2020; Afrashteh N, 2017, NEUROIMAGE, V153, P58, DOI 10.1016/j.neuroimage.2017.03.034; Aoki S, 2019, ELIFE, V8, DOI 10.7554/eLife.49995; Badre D, 2012, CEREB CORTEX, V22, P527, DOI 10.1093/cercor/bhr117; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Balleine BW, 2015, CURR OPIN BEHAV SCI, V5, P1, DOI 10.1016/j.cobeha.2015.06.001; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Barbera G, 2016, NEURON, V92, P202, DOI 10.1016/j.neuron.2016.08.037; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berke JD, 2018, NAT NEUROSCI, V21, P787, DOI 10.1038/s41593-018-0152-y; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bradfield LA, 2013, NEURON, V79, P153, DOI 10.1016/j.neuron.2013.04.039; Brodnik ZD, 2019, ACS CHEM NEUROSCI, V10, P1978, DOI 10.1021/acschemneuro.8b00268; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Brown J, 1999, J NEUROSCI, V19, P10502; Bruhn A., 2002, Pattern Recognition. 24th DAGM Symposium. Proceedings (Lecture Notes in Computr Science Vol.2449), P454; Cachope R, 2012, CELL REP, V2, P33, DOI 10.1016/j.celrep.2012.05.011; Chang YH, 2004, ADV NEUR IN, V16, P807; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collins AGE, 2014, PSYCHOL REV, V121, P337, DOI 10.1037/a0037015; Collins AGE, 2013, PSYCHOL REV, V120, P190, DOI 10.1037/a0030852; Corbit LH, 2010, EUR J NEUROSCI, V31, P1312, DOI 10.1111/j.1460-9568.2010.07153.x; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; Dabney W, 2020, NATURE, V577, P671, DOI 10.1038/s41586-019-1924-6; Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Engelhard B, 2019, NATURE, V570, P509, DOI 10.1038/s41586-019-1261-9; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Frank MJ, 2012, CEREB CORTEX, V22, P509, DOI 10.1093/cercor/bhr114; Frank MJ, 2011, CURR OPIN NEUROBIOL, V21, P381, DOI 10.1016/j.conb.2011.02.013; Franklin NT, 2015, ELIFE, V4, DOI 10.7554/eLife.12029; Gardner MPH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1645; Gershman SJ, 2015, CURR OPIN BEHAV SCI, V5, P43, DOI 10.1016/j.cobeha.2015.07.007; Gershman SJ, 2014, NEURAL COMPUT, V26, P467, DOI 10.1162/NECO_a_00559; Gershman SJ, 2009, J NEUROSCI, V29, P13524, DOI 10.1523/JNEUROSCI.2469-09.2009; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Guru A., 2020, BIORXIV; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hamid AA, 2016, NAT NEUROSCI, V19, P117, DOI 10.1038/nn.4173; Hazy TE, 2010, NEUROSCI BIOBEHAV R, V34, P701, DOI 10.1016/j.neubiorev.2009.11.019; Hintiryan H, 2016, NAT NEUROSCI, V19, P1100, DOI 10.1038/nn.4332; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holly EN, 2020, STRIATAL LOW THRESHO, DOI [10.1101/2020.08.03.235044, DOI 10.1101/2020.08.03.235044]; Hooks BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05780-7; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Hunnicutt BJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19103; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Iino Y, 2020, NATURE, V579, P555, DOI 10.1038/s41586-020-2115-1; Joshua M, 2009, NEURON, V62, P695, DOI 10.1016/j.neuron.2009.04.026; Kasanetz F, 2008, P NATL ACAD SCI USA, V105, P8124, DOI 10.1073/pnas.0711113105; Kim HF, 2015, BRAIN, V138, P1776, DOI 10.1093/brain/awv134; Kim HGR, 2020, CELL, V183, P1600, DOI 10.1016/j.cell.2020.11.013; Kim Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029766; Klaus A, 2017, NEURON, V96, P949, DOI 10.1016/j.neuron.2017.10.031; Kosillo P, 2016, CEREB CORTEX, V26, P4160, DOI 10.1093/cercor/bhw252; Kramer PF, 2020, ELIFE, V9, DOI 10.7554/eLife.55729; Lau B, 2005, J EXP ANAL BEHAV, V84, P555, DOI 10.1901/jeab.2005.110-04; Lee J, 2020, NAT NEUROSCI, V23, P1388, DOI 10.1038/s41593-020-00712-5; Lerner TN, 2015, CELL, V162, P635, DOI 10.1016/j.cell.2015.07.014; Li W, 2011, BIOCHEM PHARMACOL, V82, P977, DOI 10.1016/j.bcp.2011.06.006; Liu C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/6/065604; Liu CL, 2018, CELL, V172, P706, DOI 10.1016/j.cell.2018.01.008; Lloyd K, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004622; Lopes EF, 2019, J NEUROSCI, V39, P1058, DOI 10.1523/JNEUROSCI.2028-18.2018; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Ludvig EA, 2008, NEURAL COMPUT, V20, P3034, DOI 10.1162/neco.2008.11-07-654; Mackevicius EL, 2019, ELIFE, V8, DOI 10.7554/eLife.38471; Mandelbaum G, 2019, NEURON, V102, P636, DOI 10.1016/j.neuron.2019.02.035; Marquand AF, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0146; Martin A, 2019, CELL REP, V29, P4320, DOI 10.1016/j.celrep.2019.11.096; Matamales M, 2020, SCIENCE, V367, P549, DOI 10.1126/science.aaz5751; Matsuda W, 2009, J NEUROSCI, V29, P444, DOI 10.1523/JNEUROSCI.4029-08.2009; Mello GBM, 2015, CURR BIOL, V25, P1113, DOI 10.1016/j.cub.2015.02.036; Menegas W, 2017, ELIFE, V6, DOI 10.7554/eLife.21886; Mohajerani MH, 2013, NAT NEUROSCI, V16, P1426, DOI 10.1038/nn.3499; Mohebi A, 2019, NATURE, V570, P65, DOI 10.1038/s41586-019-1235-y; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Morita K, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00036; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Muller L, 2018, NAT REV NEUROSCI, V19, P255, DOI 10.1038/nrn.2018.20; Muller L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4675; O'Reilly RC, 2006, NEURAL COMPUT, V18, P283, DOI 10.1162/089976606775093909; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Parker JG, 2018, NATURE, V557, P177, DOI 10.1038/s41586-018-0090-6; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; Peter S., 2017, ADV NEURAL INFORM PR, P3675; Piray P, 2017, CEREB CORTEX, V27, P485, DOI 10.1093/cercor/bhv243; Pissadaki EK, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00013; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Rehani R, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0351-18.2018; Schoenbaum G, 2013, NEURON, V79, P3, DOI 10.1016/j.neuron.2013.06.033; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schultz W, 2016, NAT REV NEUROSCI, V17, P183, DOI 10.1038/nrn.2015.26; Sharpe MJ, 2018, NAT NEUROSCI, V21, P1493, DOI 10.1038/s41593-018-0202-5; Shin JH, 2020, P NATL ACAD SCI USA, V117, P27004, DOI 10.1073/pnas.2010361117; Shindou T, 2019, EUR J NEUROSCI, V49, P726, DOI 10.1111/ejn.13921; Shnitko TA, 2015, ACS CHEM NEUROSCI, V6, P147, DOI 10.1021/cn500251j; Singh SP, 1996, MACH LEARN, V22, P123, DOI 10.1007/BF00114726; Soares S, 2016, SCIENCE, V354, P1273, DOI 10.1126/science.aah5234; Stanley G, 2020, NEURON, V105, P688, DOI 10.1016/j.neuron.2019.11.004; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Thorn CA, 2010, NEURON, V66, P781, DOI 10.1016/j.neuron.2010.04.036; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Townsend RG, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006643; Wien T.U., 1994, COMPUTING DISCRETE F, V64, P636; Wunderlich K, 2012, NEURON, V75, P418, DOI 10.1016/j.neuron.2012.03.042; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Zimdars, 2003, P 20 INT C MACH LEAR, P656	119	25	25	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2733	+		10.1016/j.cell.2021.03.046	http://dx.doi.org/10.1016/j.cell.2021.03.046		MAY 2021	33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33861952	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000652830800016
J	Becerril, S; Fruhbeck, G				Becerril, Sara; Fruehbeck, Gema			Cagrilintide plus semaglutide for obesity management	LANCET			English	Editorial Material									[Becerril, Sara; Fruehbeck, Gema] Univ Navarra, Univ Navarra Clin, Metab Res Lab, Dept Endocrinol & Nutr,IdiSNA,CIBEROBN, Pamplona 31008, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Navarra	Fruhbeck, G (corresponding author), Univ Navarra, Univ Navarra Clin, Metab Res Lab, Dept Endocrinol & Nutr,IdiSNA,CIBEROBN, Pamplona 31008, Spain.	gfruhbeck@unav.es						Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS111, DOI 10.2337/dc21-S009; Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3; Enebo LB, 2021, LANCET, V397, P1736, DOI 10.1016/S0140-6736(21)00845-X; Fletcher MM, 2021, J PHARMACOL EXP THER, V377, DOI 10.1124/jpet.121.000567; Kalyani RR, 2021, NEW ENGL J MED, V384, P1248, DOI 10.1056/NEJMcp2000280; Mathiesen DS, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.617400; Ryan D, 2021, LANCET DIABETES ENDO, V9, P252, DOI 10.1016/S2213-8587(21)00081-4; Tak YJ, 2021, CURR OBES REP, V10, P14, DOI 10.1007/s13679-020-00422-w; Zhang ZY, 2021, HYPERTENSION, V77, P788, DOI 10.1161/HYPERTENSIONAHA.120.12858	9	7	7	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1687	1689		10.1016/S0140-6736(21)00944-2	http://dx.doi.org/10.1016/S0140-6736(21)00944-2		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33894837				2022-12-28	WOS:000647813600004
J	Hall, VJ; Foulkes, S; Saei, A; Andrews, N; Oguti, B; Charlett, A; Wellington, E; Stowe, J; Gillson, N; Atti, A; Islam, J; Karagiannis, I; Munro, K; Khawam, J; Chand, MA; Brown, CS; Ramsay, M; Lopez-Bernal, J; Hopkins, S				Hall, Victoria Jane; Foulkes, Sarah; Saei, Ayoub; Andrews, Nick; Oguti, Blanche; Charlett, Andre; Wellington, Edgar; Stowe, Julia; Gillson, Natalie; Atti, Ana; Islam, Jasmin; Karagiannis, Ioannis; Munro, Katie; Khawam, Jameel; Chand, Meera A.; Brown, Colin S.; Ramsay, Mary; Lopez-Bernal, Jamie; Hopkins, Susan		SIREN Study Grp	COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study	LANCET			English	Article								Background BNT162b2 mRNA and ChAdOx1 nCOV-19 adenoviral vector vaccines have been rapidly rolled out in the UK from December, 2020. We aimed to determine the factors associated with vaccine coverage for both vaccines and documented the vaccine effectiveness of the BNT162b2 mRNA vaccine in a cohort of health-care workers undergoing regular asymptomatic testing. Methods The SIREN study is a prospective cohort study among staff (aged >= 18 years) working in publicly-funded hospitals in the UK. Participants were assigned into either the positive cohort (antibody positive or history of infection [indicated by previous positivity of antibody or PCR tests]) or the negative cohort (antibody negative with no previous positive test) at the beginning of the follow-up period. Baseline risk factors were collected at enrolment, symptom status was collected every 2 weeks, and vaccination status was collected through linkage to the National Immunisations Management System and questionnaires. Participants had fortnightly asymptomatic SARS-CoV-2 PCR testing and monthly antibody testing, and all tests (including symptomatic testing) outside SIREN were captured. Data cutoff for this analysis was Feb 5, 2021. The follow-up period was Dec 7, 2020, to Feb 5, 2021. The primary outcomes were vaccinated participants (binary ever vacinated variable; indicated by at least one vaccine dose recorded by at least one of the two vaccination data sources) for the vaccine coverage analysis and SARS-CoV-2 infection confirmed by a PCR test for the vaccine effectiveness analysis. We did a mixed-effect logistic regression analysis to identify factors associated with vaccine coverage. We used a piecewise exponential hazard mixed-effects model (shared frailty-type model) using a Poisson distribution to calculate hazard ratios to compare time-to-infection in unvaccinated and vaccinated participants and estimate the impact of the BNT162b2 vaccine on all PCR-positive infections (asymptomatic and symptomatic). This study is registered with ISRCTN, number ISRCTN11041050, and is ongoing. Findings 23 324 participants from 104 sites (all in England) met the inclusion criteria for this analysis and were enrolled. Included participants had a median age of 46.1 years (IQR 36.0-54.1) and 19 692 (84%) were female; 8203 (35%) were assigned to the positive cohort at the start of the analysis period, and 15 121 (65%) assigned to the negative cohort. Total follow-up time was 2 calendar months and 1 106 905 person-days (396 318 vaccinated and 710 587 unvaccinated). Vaccine coverage was 89% on Feb 5, 2021, 94% of whom had BNT162b2 vaccine. Significantly lower coverage was associated with previous infection, gender, age, ethnicity, job role, and Index of Multiple Deprivation score. During follow-up, there were 977 new infections in the unvaccinated cohort, an incidence density of 14 infections per 10 000 person-days; the vaccinated cohort had 71 new infections 21 days or more after their first dose (incidence density of eight infections per 10 000 person-days) and nine infections 7 days after the second dose (incidence density four infections per 10 000 person-days). In the unvaccinated cohort, 543 (56%) participants had typical COVID-19 symptoms and 140 (14%) were asymptomatic on or 14 days before their PCR positive test date, compared with 29 (36%) with typical COVID-19 symptoms and 15 (19%) asymptomatic in the vaccinated cohort. A single dose of BNT162b2 vaccine showed vaccine effectiveness of 70% (95% CI 55-85) 21 days after first dose and 85% (74-96) 7 days after two doses in the study population. Interpretation Our findings show that the BNT162b2 vaccine can prevent both symptomatic and asymptomatic infection in working-age adults. This cohort was vaccinated when the dominant variant in circulation was B1.1.7 and shows effectiveness against this variant. Copyright Crown copyright (C) 2021 Published by Elsevier Ltd. All rights reserved.	[Hall, Victoria Jane; Foulkes, Sarah; Saei, Ayoub; Andrews, Nick; Oguti, Blanche; Charlett, Andre; Wellington, Edgar; Stowe, Julia; Gillson, Natalie; Atti, Ana; Islam, Jasmin; Karagiannis, Ioannis; Munro, Katie; Khawam, Jameel; Chand, Meera A.; Brown, Colin S.; Ramsay, Mary; Lopez-Bernal, Jamie; Hopkins, Susan] Publ Hlth England Colindale, 61 Colindale Ave, London NW9 5EQ, England; [Hall, Victoria Jane; Hopkins, Susan] Univ Oxford, Unit Healthcare Associated Infect & Antimicrobial, Natl Inst Hlth Res Hlth Protect Res NIHR, Oxford, England; [Oguti, Blanche] Univ Oxford, Oxford Vaccine Grp, Oxford, England; [Charlett, Andre] Univ Bristol, NIHR Hlth Protect Res Unit Behav Sci & Evaluat, Bristol, Avon, England; [Andrews, Nick; Charlett, Andre; Ramsay, Mary] London Sch Hyg & Trop Med, NIHR Hlth Protect Res Unit Immunisat, London, England; [Chand, Meera A.] Guys & St Thomass Hosp NHS Trust, London, England	Public Health England; University of Oxford; University of Oxford; University of Bristol; University of London; London School of Hygiene & Tropical Medicine	Hopkins, S (corresponding author), Publ Hlth England Colindale, 61 Colindale Ave, London NW9 5EQ, England.	susan.hopkins@phe.gov.uk	Payne, Brendan/I-1233-2016; Eyre, David/P-6887-2016	Payne, Brendan/0000-0002-3101-3512; Stewart, Sally/0000-0002-9014-8601; Parmar, Chetan/0000-0002-1238-6524; Lackenby, Angie/0000-0002-1557-0415; Islam, Jasmin/0000-0003-0005-014X; Kirwan, Peter/0000-0001-6904-0500; Brown, Colin/0000-0003-4776-3403; Eyre, David/0000-0001-5095-6367; Stowe, Julia/0000-0002-3999-6461; Atti, Ana/0000-0001-6768-6586; Heeney, Jonathan/0000-0003-2702-1621; Foulkes, Sarah/0000-0001-7241-6345; Lopez Bernal, Jamie/0000-0002-1301-5653; Arenas-Pinto, Alejandro/0000-0002-3368-5005; Dunachie, Susanna/0000-0001-5665-6293; Planche, Timothy/0000-0002-0263-0888; klenerman, paul/0000-0003-4307-9161; Patel, Manish/0000-0003-3012-7507; Crosby-Nwaobi, Roxanne/0000-0001-7828-9228; Birch, Sarah/0000-0002-0711-3740; Cole, Michelle/0000-0002-6707-6910; Game, Frances/0000-0002-5294-4789; Laugharne, Richard/0000-0001-9916-343X; Robotham, Julie/0000-0003-2515-4084; Osborne, Jane/0000-0001-9529-7748; Hall, Victoria/0000-0001-8744-4277; Rokadiya, Sakib/0000-0003-2955-4907; Hopkins, Susan/0000-0001-5179-5702; Otter, Ashley/0000-0002-8317-9194	UK Department of Health and Social Care; PHE [NIHR200915]; Scottish government; Welsh government; Northern Irish government; National Institute for Health Research (NIHR); NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford	UK Department of Health and Social Care; PHE; Scottish government; Welsh government; Northern Irish government; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford	This study was funded by the UK Department of Health and Social Care and PHE, with contributions from the Scottish, Welsh, and Northern Irish governments. Funding is also provided by the National Institute for Health Research (NIHR) as an Urgent Public Health Priority Study. SH and VJH are supported by the NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with PHE (NIHR200915). We thank all staff supporting study delivery at participating sites and all participants for their ongoing commitment and contributions to this study. We also thank the PHE COVID-19 Vaccine Coverage team and the COVID-19 data store team for their support establishing linkage to the National Immunisation Management System, and all colleagues from PHE, NHS England & Improvement, and NHS Digital involved in developing the National Immunisation Management System.	Abu Jabal K, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.6.2100096; Aiello A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02247; Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; [Anonymous], **DATA OBJECT**; Chodick G., 2021, EFFECTIVENESS 1 DOSE, DOI [10.1101/2021.01.27.21250612, DOI 10.1101/2021.01.27.21250612, 10.1101/2021.01.27.21250612v1]; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Department of Health and Social Care, 2021, OPTIMISING COVID 19; Department of Health and Social Care, 2021, UK COVID 19 VACC UPT; Emary KRW, 2021, LANCET, V397, P1351, DOI 10.1016/S0140-6736(21)00628-0; Galanis PA, 2020, INTENTION HLTH CARE, DOI 10.1101/2020.12.08.20246041; HOLFORD TR, 1976, BIOMETRICS, V32, P587, DOI 10.2307/2529747; HOLFORD TR, 1980, BIOMETRICS, V36, P299, DOI 10.2307/2529982; Israeli Ministry of Health, 2021, VACC SAF EFF; Martin CA, 2021, ASS DEMOGRAPHIC OCCU, DOI [10.1101/2021.02.11.21251548, DOI 10.1101/2021.02.11.21251548]; Medicines and Healthcare Regulatory Authority, 2020, MHRA GUID COR COVID; Morton CE, 2021, TRENDS REGIONAL VARI, DOI [10.1101/2021.01.25.21250356, DOI 10.1101/2021.01.25.21250356]; Peto T., 2021, COVID 19 RAPID ANTIG, DOI [10.1101/2021.01.13.21249563, DOI 10.1101/2021.01.13.21249563]; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Public Health England, 2021, COVID 19 GREEN BOOK; Public Health England, 2021, TECHNICAL BRIEFING 6; Shah Divyang, 2009, Indian J Occup Environ Med, V13, P77, DOI 10.4103/0019-5278.55123; Sharma O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.585354; UN-FAO, 2021, CORONAVIRUS COVID 19; UNICEF, 2022, WHO COR COVID 19 DAS; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wallace S, 2020, SIREN PROTOCOL IMPAC, DOI [10.1101/2020.12.15.20247981, DOI 10.1101/2020.12.15.20247981]; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	28	384	390	15	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1725	1735		10.1016/S0140-6736(21)00790-X	http://dx.doi.org/10.1016/S0140-6736(21)00790-X		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3KF	33901423	Green Published, Bronze			2022-12-28	WOS:000647813600027
J	Reinhart, E; Dawes, D; Maybank, A				Reinhart, Eric; Dawes, Daniel; Maybank, Aletha			Structural medicine: towards an economy of care	LANCET			English	Editorial Material							HEALTH-CARE; STATES		[Reinhart, Eric] World Bank, Data & Evidence Justice Reform, 1818 H St NW, Washington, DC 20433 USA; [Reinhart, Eric] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Reinhart, Eric] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Reinhart, Eric] Chicago Ctr Psychoanal, Chicago, IL 60601 USA; [Dawes, Daniel] Morehouse Sch Med, Satcher Hlth Leadership Inst, Atlanta, GA 30310 USA; [Maybank, Aletha] Amer Med Assoc, Ctr Hlth Equ, 515 N State St, Chicago, IL 60610 USA	The World Bank; Harvard University; University of Chicago; Morehouse School of Medicine; American Medical Association	Reinhart, E (corresponding author), World Bank, Data & Evidence Justice Reform, 1818 H St NW, Washington, DC 20433 USA.; Reinhart, E (corresponding author), Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA.; Reinhart, E (corresponding author), Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA.; Reinhart, E (corresponding author), Chicago Ctr Psychoanal, Chicago, IL 60601 USA.	reinhar@fas.harvard.edu						Alesina A., 2006, HORIZONS STRATEGIQUE, V2, P51; Arno P, 2020, HLTH AFF BLOG   0325; Artiga S., 2020, COVID 19 RISKS IMPAC; Batalova J., 2020, IMMIGRANT HLTH CARE; Bidadanure JU, 2019, ANNU REV POLIT SCI, V22, P481, DOI 10.1146/annurev-polisci-050317-070954; Boesch D., 2021, WOMEN LOSE ALL JOBS; Bradley E., 2013, AM HLTH CARE PARADOX; Chen YX, 2021, ELECTRON J DIFFER EQ; Cohen Patricia, 2020, NEW YORK TIMES; Dawes Daniel E., 2020, POLITICAL DETERMINAN; Dubay L., 2020, RISK EXPOSURE CORONA; Galvani AP, 2020, LANCET, V395, P524, DOI 10.1016/S0140-6736(19)33019-3; Gonsalves Gregg, 2020, BOSTON REV; Hughes MM, 2020, MMWR-MORBID MORTAL W, V69, P1364, DOI 10.15585/mmwr.mm6938a3; Kaiser Family Foundation, 2021, LAT DAT COVID 19 VAC; Lopez L, 2021, JAMA-J AM MED ASSOC, V325, P719, DOI 10.1001/jama.2020.26443; Metzl JM, 2020, JAMA-J AM MED ASSOC, V324, P231, DOI 10.1001/jama.2020.9289; Neate R., 2020, GUARDIAN        1007; O'Brien F, 2020, BLOOMBERG       0618; Reinhart E., 2021, BOSTON REV; Reinhart E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2878; Shaefer HL, 2013, SOC SERV REV, V87, P250, DOI 10.1086/671012; Witters D., 2020, GALLUP          0901; World Bank Group, 2020, POV SHAR PROSP 2020; Wrigley-Field E, 2020, P NATL ACAD SCI USA, V117, P21854, DOI 10.1073/pnas.2014750117	25	1	1	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1691	1693		10.1016/S0140-6736(21)00937-5	http://dx.doi.org/10.1016/S0140-6736(21)00937-5		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33891895	Bronze, Green Published			2022-12-28	WOS:000647813600006
J	Hyde, R				Hyde, Rob			Controversy surrounds Merkel's new lockdown powers	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1610	1610						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33933196	Green Published			2022-12-28	WOS:000645510600010
J	Hugonnet, R; McNabb, R; Berthier, E; Menounos, B; Nuth, C; Girod, L; Farinotti, D; Huss, M; Dussaillant, I; Brun, F; Kaab, A				Hugonnet, Romain; McNabb, Robert; Berthier, Etienne; Menounos, Brian; Nuth, Christopher; Girod, Luc; Farinotti, Daniel; Huss, Matthias; Dussaillant, Ines; Brun, Fanny; Kaab, Andreas			Accelerated global glacier mass loss in the early twenty-first century	NATURE			English	Article							SEA-LEVEL RISE; DIGITAL ELEVATION MODELS; COMPLETE INVENTORY; NEPAL HIMALAYA; CLIMATE-CHANGE; VOLUME CHANGE; ICE-SHEET; SURFACE; BALANCE; UNCERTAINTY	Glaciers distinct from the Greenland and Antarctic ice sheets are shrinking rapidly, altering regional hydrology(1), raising global sea level(2) and elevating natural hazards(3). Yet, owing to the scarcity of constrained mass loss observations, glacier evolution during the satellite era is known only partially, as a geographic and temporal patchwork(4,5). Here we reveal the accelerated, albeit contrasting, patterns of glacier mass loss during the early twenty-first century. Using largely untapped satellite archives, we chart surface elevation changes at a high spatiotemporal resolution over all of Earth's glaciers. We extensively validate our estimates against independent, high-precision measurements and present a globally complete and consistent estimate of glacier mass change. We show that during 2000-2019, glaciers lost a mass of 267 +/- 16 gigatonnes per year, equivalent to 21 +/- 3 per cent of the observed sea-level rise(6). We identify a mass loss acceleration of 48 +/- 16 gigatonnes per year per decade, explaining 6 to 19 per cent of the observed acceleration of sea-level rise. Particularly, thinning rates of glaciers outside ice sheet peripheries doubled over the past two decades. Glaciers currently lose more mass, and at similar or larger acceleration rates, than the Greenland or Antarctic ice sheets taken separately(7-9). By uncovering the patterns of mass change in many regions, we find contrasting glacier fluctuations that agree with the decadal variability in precipitation and temperature. These include a North Atlantic anomaly of decelerated mass loss, a strongly accelerated loss from northwestern American glaciers, and the apparent end of the Karakoram anomaly of mass gain(10). We anticipate our highly resolved estimates to advance the understanding of drivers that govern the distribution of glacier change, and to extend our capabilities of predicting these changes at all scales. Predictions robustly benchmarked against observations are critically needed to design adaptive policies for the local- and regional-scale management of water resources and cryospheric risks, as well as for the global-scale mitigation of sea-level rise. Analysis of satellite stereo imagery uncovers two decades of mass change for all of Earth's glaciers, revealing accelerated glacier shrinkage and regionally contrasting changes consistent with decadal climate variability.	[Hugonnet, Romain; Berthier, Etienne; Dussaillant, Ines] Univ Toulouse, UPS, CNRS, CNES,IRD,LEGOS, Toulouse, France; [Hugonnet, Romain; Farinotti, Daniel; Huss, Matthias] Swiss Fed Inst Technol, Lab Hydraul Hydrol & Glaciol VAW, Zurich, Switzerland; [Hugonnet, Romain; Farinotti, Daniel; Huss, Matthias] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland; [McNabb, Robert] Ulster Univ, Sch Geog & Environm Sci, Coleraine, Londonderry, North Ireland; [McNabb, Robert; Nuth, Christopher; Girod, Luc; Kaab, Andreas] Univ Oslo, Dept Geosci, Oslo, Norway; [Menounos, Brian] Univ Northern British Columbia, Geog Earth & Environm Sci, Prince George, BC, Canada; [Menounos, Brian] Hakai Inst, Campbell River, BC, Canada; [Nuth, Christopher] Norwegian Def Res Estab, Kjeller, Norway; [Huss, Matthias] Univ Fribourg, Dept Geosci, Fribourg, Switzerland; [Dussaillant, Ines] Univ Zurich, Dept Geog, Zurich, Switzerland; [Brun, Fanny] Univ Grenoble Alpes, Grenoble INP, CNRS, IGE,IRD, Grenoble, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Ulster University; University of Oslo; University of Northern British Columbia; Hakai Institute; Norwegian Defence Research Establishment; University of Fribourg; University of Zurich; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Recherche pour le Developpement (IRD)	Hugonnet, R (corresponding author), Univ Toulouse, UPS, CNRS, CNES,IRD,LEGOS, Toulouse, France.; Hugonnet, R (corresponding author), Swiss Fed Inst Technol, Lab Hydraul Hydrol & Glaciol VAW, Zurich, Switzerland.; Hugonnet, R (corresponding author), Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland.	romain.hugonnet@gmail.com	Berthier, Etienne/B-8900-2009	Berthier, Etienne/0000-0001-5978-9155; McNabb, Robert/0000-0003-0016-493X; Girod, Luc/0000-0003-3627-5885; Farinotti, Daniel/0000-0003-3417-4570; Hugonnet, Romain/0000-0002-0955-1306				Ablain M, 2019, EARTH SYST SCI DATA, V11, P1189, DOI 10.5194/essd-11-1189-2019; Alexandrov O., ICEBRIDGE DMS L3 AME; Aoalgeirsdottir G, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.523646; Bamber JL, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aac2f0; Barros VR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1133; Bauder A, 2007, ANN GLACIOL-SER, V46, P145, DOI 10.3189/172756407782871701; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Berthier E, 2010, NAT GEOSCI, V3, P92, DOI 10.1038/NGEO737; Berthier E, 2016, FRONT EARTH SC-SWITZ, V4, DOI 10.3389/feart.2016.00063; Berthier E, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051755; Bevis M, 2019, P NATL ACAD SCI USA, V116, P1934, DOI 10.1073/pnas.1806562116; Beyer RA, 2018, EARTH SPACE SCI, V5, P537, DOI 10.1029/2018EA000409; Blazquez A, 2018, GEOPHYS J INT, V215, P415, DOI 10.1093/gji/ggy293; Bolch T, 2010, REMOTE SENS ENVIRON, V114, P127, DOI 10.1016/j.rse.2009.08.015; Braun M. H., 2019, NAT CLIM CHANGE; Brun F, 2017, NAT GEOSCI, V10, P668, DOI [10.1038/NGEO2999, 10.1038/ngeo2999]; Cauvy-Fraunie S, 2019, NAT ECOL EVOL, V3, P1675, DOI 10.1038/s41559-019-1042-8; Cazenave A, 2018, EARTH SYST SCI DATA, V10, P1551, DOI 10.5194/essd-10-1551-2018; Ciraci E., 2020, GEOPHYS RES LETT, V47, P226; Cogley JG, 1998, J GLACIOL, V44, P315, DOI 10.3189/S0022143000002641; Cressie N. A. C., 1993, STAT SPATIAL DATA, V4, P613; Davaze L, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.00149; Dehecq A, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.566802; Dehecq A, 2016, IEEE J-STARS, V9, P3870, DOI 10.1109/JSTARS.2016.2581482; Dimarzio J., 2014, GLAS ICESAT L2 GLOBA; Dunse T, 2015, CRYOSPHERE, V9, P197, DOI 10.5194/tc-9-197-2015; Dussaillant I, 2019, NAT GEOSCI, V12, P803, DOI 10.1038/s41561-019-0432-5; Dussaillant I, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00008; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Gardelle J, 2012, J GLACIOL, V58, P419, DOI 10.3189/2012JoG11J175; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Garreaud RD, 2020, INT J CLIMATOL, V40, P421, DOI 10.1002/joc.6219; Girod L, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070704; Glacier Monitoring Switzerland, 2018, SWISS GLACIER VOLUME; Graler B, 2016, R J, V8, P204; Granshaw FD, 2006, J GLACIOL, V52, P251, DOI 10.3189/172756506781828782; Harding DJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023471; Hersbach H., 2016, ECMWF NEWSLETTER NO, V147, P7, DOI DOI 10.5194/TC-14-957-2020; Hohle J, 2009, ISPRS J PHOTOGRAMM, V64, P398, DOI 10.1016/j.isprsjprs.2009.02.003; Howat IM, 2014, CRYOSPHERE, V8, P1509, DOI 10.5194/tc-8-1509-2014; Howat IM, 2019, CRYOSPHERE, V13, P665, DOI 10.5194/tc-13-665-2019; Howat IM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034496; Huss M, 2013, CRYOSPHERE, V7, P877, DOI 10.5194/tc-7-877-2013; Huss M, 2018, NAT CLIM CHANGE, V8, P135, DOI 10.1038/s41558-017-0049-x; Immerzeel WW, 2020, NATURE, V577, P364, DOI 10.1038/s41586-019-1822-y; Journel A. G., 1978, MINING GEOSTATISTICS; Kaab A, 2012, NATURE, V488, P495, DOI 10.1038/nature11324; Kulp SA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12808-z; Lacroix P, 2016, EARTH PLANETS SPACE, V68, DOI 10.1186/s40623-016-0423-3; Larsen C., ICEBRIDGE UAF LIDAR; Larsen CF, 2015, GEOPHYS RES LETT, V42, P5902, DOI 10.1002/2015GL064349; Malicke M., 2019, SCIKIT GSTAT 0 2 6 S, DOI [10.5281/ZENODO.3531816, DOI 10.5281/ZENODO.3531816]; Marzeion B, 2014, SCIENCE, V345, P919, DOI 10.1126/science.1254702; McMillan M, 2014, GEOPHYS RES LETT, V41, P8902, DOI 10.1002/2014GL062255; McNabb R, 2019, CRYOSPHERE, V13, P895, DOI 10.5194/tc-13-895-2019; Menounos B, 2019, GEOPHYS RES LETT, V46, P200, DOI 10.1029/2018GL080942; Meredith M., 2019, IPCC SPECIAL REPORT; NASA/METI/AIST/Japan Spacesystems & U.S./Japan ASTER Science Team, 2001, ASTER LEV 1A DAT SET, DOI [10.5067/ASTER/AST_L1A.003, DOI 10.5067/ASTER/AST_L1A.003]; Nerem RS, 2018, P NATL ACAD SCI USA, V115, P2022, DOI 10.1073/pnas.1717312115; Noh MJ, 2017, ISPRS J PHOTOGRAMM, V129, P55, DOI 10.1016/j.isprsjprs.2017.04.019; Nuimura T, 2012, J GLACIOL, V58, P648, DOI 10.3189/2012JoG11J061; Nuth C, 2011, CRYOSPHERE, V5, P271, DOI 10.5194/tc-5-271-2011; Nuth C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41117-0; Parkes D, 2018, NATURE, V563, P551, DOI 10.1038/s41586-018-0687-9; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pelto B, 2019, CRYOSPHERE, V13, P1709, DOI 10.5194/tc-13-1709-2019; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Porter C., 2018, **DATA OBJECT**, DOI 10.7910/DVN/OHHUKH; Pritchard HD, 2019, NATURE, V569, P649, DOI 10.1038/s41586-019-1240-1; Raper SCB, 2006, NATURE, V439, P311, DOI 10.1038/nature04448; Rastner P, 2012, CRYOSPHERE, V6, P1483, DOI 10.5194/tc-6-1483-2012; RGI Consortium, TECHNICAL REPORT; Rizzoli P, 2017, ISPRS J PHOTOGRAMM, V132, P119, DOI 10.1016/j.isprsjprs.2017.08.008; Rolstad C, 2009, J GLACIOL, V55, P666, DOI 10.3189/002214309789470950; Rupnik E., 2017, OPEN GEOSPAT DATA SO, V2, DOI [DOI 10.1186/S40965-017-0027-2, 10.1186/s40965-017-0027-2]; Sakakibara D, 2013, ANN GLACIOL, V54, P131, DOI 10.3189/2013AoG63A236; Schiefer E, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030780; Schuler TV, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.00156; Shean DE, 2020, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00363; Shean DE, 2016, ISPRS J PHOTOGRAMM, V116, P101, DOI 10.1016/j.isprsjprs.2016.03.012; Shepherd A, 2020, NATURE, V579, P233, DOI 10.1038/s41586-019-1855-2; Shepherd A, 2018, NATURE, V558, P219, DOI 10.1038/s41586-018-0179-y; Skliris N, 2016, SCI REP-UK, V6, DOI 10.1038/srep38752; Smith B, 2020, SCIENCE, V368, P1239, DOI 10.1126/science.aaz5845; Sorensen LS, 2018, EARTH PLANET SC LETT, V495, P234, DOI 10.1016/j.epsl.2018.05.015; Stoffel M, 2012, PROG PHYS GEOG, V36, P421, DOI 10.1177/0309133312441010; Tielidze LG, 2018, CRYOSPHERE, V12, P81, DOI 10.5194/tc-12-81-2018; Toutin T, 2002, IEEE T GEOSCI REMOTE, V40, P2241, DOI 10.1109/TGRS.2002.802878; Vassilaki DI, 2020, ISPRS J PHOTOGRAMM, V160, P33, DOI 10.1016/j.isprsjprs.2019.11.015; Velicogna I., 2020, GEOPHYS RES LETT, V47, pL11501; Wagnon P, 2013, CRYOSPHERE, V7, P1769, DOI 10.5194/tc-7-1769-2013; Wales DJ, 1997, J PHYS CHEM A, V101, P5111, DOI 10.1021/jp970984n; Wang D, 2015, REMOTE SENS-BASEL, V7, P10117, DOI 10.3390/rs70810117; Webster R., 2007, STAT PRACTICE; Williams C. K., 2006, ADAPT COMPUT MACH LE, V2; Willis MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053136; World Glacier Monitoring Service (WGMS), 2019, FLUCT GLAC DAT, DOI 10.5904/wgms-fog-2019-12.; Wouters B, 2019, FRONT EARTH SC-SWITZ, V7, DOI 10.3389/feart.2019.00096; Zemp M, 2019, NATURE, V568, P382, DOI 10.1038/s41586-019-1071-0	100	223	230	76	214	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					726	+		10.1038/s41586-021-03436-z	http://dx.doi.org/10.1038/s41586-021-03436-z			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911269	Green Accepted, Green Submitted			2022-12-28	WOS:000645368900014
J	Liu, JA; Pearson, DG; Wang, LH; Mather, KA; Kjarsgaard, BA; Schaeffer, AJ; Irvine, GJ; Kopylova, MG; Armstrong, JP				Liu, Jingao; Pearson, D. Graham; Wang, Lawrence Hongliang; Mather, Kathy A.; Kjarsgaard, Bruce A.; Schaeffer, Andrew J.; Irvine, Gordon J.; Kopylova, Maya G.; Armstrong, John P.			Plume-driven recratonization of deep continental lithospheric mantle	NATURE			English	Article								Upwelling of mantle plumes is proposed as a mechanism for craton healing after substantial disruption of their roots, enabling them to return to their original lithospheric thickness. Cratons are Earth's ancient continental land masses that remain stable for billions of years. The mantle roots of cratons are renowned as being long-lived, stable features of Earth's continents, but there is also evidence of their disruption in the recent(1-6) and more distant(7-9) past. Despite periods of lithospheric thinning during the Proterozoic and Phanerozoic eons, the lithosphere beneath many cratons seems to always 'heal', returning to a thickness of 150 to 200 kilometres(10-12); similar lithospheric thicknesses are thought to have existed since Archaean times(3,13-15). Although numerous studies have focused on the mechanism for lithospheric destruction(2,5,13,16-19), the mechanisms that recratonize the lithosphere beneath cratons and thus sustain them are not well understood. Here we study kimberlite-borne mantle xenoliths and seismology across a transect of the cratonic lithosphere of Arctic Canada, which includes a region affected by the Mackenzie plume event 1.27 billion years ago(20). We demonstrate the important role of plume upwelling in the destruction and recratonization of roughly 200-kilometre-thick cratonic lithospheric mantle in the northern portion of the Slave craton. Using numerical modelling, we show how new, buoyant melt residues produced by the Mackenzie plume event are captured in a region of thinned lithosphere between two thick cratonic blocks. Our results identify a process by which cratons heal and return to their original lithospheric thickness after substantial disruption of their roots. This process may be widespread in the history of cratons and may contribute to how cratonic mantle becomes a patchwork of mantle peridotites of different age and origin.	[Liu, Jingao] China Univ Geosci Beijing, State Key Lab GeoL Proc & Mineral Resources, Beijing, Peoples R China; [Liu, Jingao; Pearson, D. Graham] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada; [Wang, Lawrence Hongliang] Inst Energy Technol, Dept Environm Anal, Oslo, Norway; [Mather, Kathy A.; Irvine, Gordon J.] Univ Durham, Dept Earth Sci, Durham, England; [Kjarsgaard, Bruce A.] Geological Survey Canada, Ottawa, ON, Canada; [Schaeffer, Andrew J.] Geological Survey Canada, Sidney, BC, Canada; [Kopylova, Maya G.] Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC, Canada; [Armstrong, John P.] Lucara Diamond Corp, Vancouver, BC, Canada	China University of Geosciences; University of Alberta; Durham University; University of British Columbia	Liu, JA (corresponding author), China Univ Geosci Beijing, State Key Lab GeoL Proc & Mineral Resources, Beijing, Peoples R China.; Liu, JA (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB, Canada.	jingao@cugb.edu.cn	Liu, Jingao/S-3552-2018; Liu, Jingao/L-7122-2019	Liu, Jingao/0000-0002-8800-5898; Liu, Jingao/0000-0002-8800-5898; Pearson, Graham/0000-0001-5974-4192				[Anonymous], 1999, P 7 INT KIMB C; Armstrong J. P., 2012, 10 INT KIMB C, DOI [10.29173/ikc3723, DOI 10.29173/IKC3723]; Aulbach S, 2004, CHEM GEOL, V208, P61, DOI 10.1016/j.chemgeo.2004.04.006; Aulbach S, 2012, LITHOS, V149, P16, DOI 10.1016/j.lithos.2012.02.011; Bleeker W, 2002, GEOL SOC SPEC PUBL, V199, P151, DOI 10.1144/GSL.SP.2002.199.01.09; Boyd F.R., 1987, MAGMATIC PROCESSES P, VVolume 1, P13; Carlson RW, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000156; Carlson RW, 2004, LITHOS, V77, P453, DOI 10.1016/j.lithos.2004.03.030; CHRISTENSEN UR, 1985, J GEOPHYS RES-SOLID, V90, P291, DOI 10.1029/JB090iB12p10291; Day HW, 2012, AM MINERAL, V97, P52, DOI 10.2138/am.2011.3763; Day JMD, 2008, J PETROL, V49, P1255, DOI 10.1093/petrology/egn024; Ernst RE, 2008, PRECAMBRIAN RES, V160, P159, DOI 10.1016/j.precamres.2007.04.019; ERNST RE, 1992, NATURE, V356, P511, DOI 10.1038/356511a0; Feng M, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004449; Fishwick S, 2008, PRECAMBRIAN RES, V166, P111, DOI 10.1016/j.precamres.2007.04.026; Foley SF, 2008, NAT GEOSCI, V1, P503, DOI 10.1038/ngeo261; French JE, 2008, PRECAMBRIAN RES, V160, P308, DOI 10.1016/j.precamres.2007.08.005; Geissler WH, 2010, GEOPHYS J INT, V181, P604, DOI 10.1111/j.1365-246X.2010.04548.x; Griffin WL, 2009, J PETROL, V50, P1185, DOI 10.1093/petrology/egn033; Griffin WL, 1998, GEODYNAMICS, V27, P107; Griffin WL, 2003, PRECAMBRIAN RES, V127, P19, DOI 10.1016/S0301-9268(03)00180-3; Grutter HS, 2009, LITHOS, V112, P1167, DOI 10.1016/j.lithos.2009.03.023; Hanson RE, 1998, GEOLOGY, V26, P1143, DOI 10.1130/0091-7613(1998)026<1143:UPZAFT>2.3.CO;2; Hanson RE, 2004, SCIENCE, V304, P1126, DOI 10.1126/science.1096329; Harris GA, 2018, MINER PETROL, V112, P57, DOI 10.1007/s00710-018-0609-4; Heaman LM, 2003, LITHOS, V71, P153, DOI 10.1016/j.lithos.2003.07.005; HEAMAN LM, 1992, EARTH PLANET SC LETT, V109, P117, DOI 10.1016/0012-821X(92)90078-A; Heaman LM, 2002, GEOLOGY, V30, P507, DOI 10.1130/0091-7613(2002)030<0507:EEOHFS>2.0.CO;2; HOFFMAN PF, 1988, ANNU REV EARTH PL SC, V16, P543, DOI 10.1146/annurev.ea.16.050188.002551; Holland HD, 2014, TREATISE GEOCHEMISTR, P169; Hu JS, 2018, NAT GEOSCI, V11, P203, DOI 10.1038/s41561-018-0064-1; James DE, 2002, GEOL SOC SPEC PUBL, V199, P1, DOI 10.1144/GSL.SP.2002.199.01.01; James DE, 2001, GEOPHYS RES LETT, V28, P2485, DOI 10.1029/2000GL012578; Jessell MW, 2016, PRECAMBRIAN RES, V274, P3, DOI 10.1016/j.precamres.2015.08.010; Katz RF, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000433; KENNEDY CS, 1976, J GEOPHYS RES, V81, P2467, DOI 10.1029/JB081i014p02467; King SD, 2010, GEOPHYS J INT, V180, P73, DOI 10.1111/j.1365-246X.2009.04413.x; Kjarsgaard B. A., 1995, Decade of North American Geology, VP1, P557; Kopylova MG, 2019, J PETROL, V60, P1991, DOI 10.1093/petrology/egz061; Kopylova MG, 2000, EARTH PLANET SC LETT, V181, P71, DOI 10.1016/S0012-821X(00)00187-4; Lebedev S, 2005, GEOPHYS J INT, V162, P951, DOI 10.1111/j.1365-246X.2005.02708.x; Lebedev S, 2008, GEOPHYS J INT, V173, P505, DOI 10.1111/j.1365-246X.2008.03721.x; LECHEMINANT AN, 1989, EARTH PLANET SC LETT, V96, P38, DOI 10.1016/0012-821X(89)90122-2; Lee CTA, 2011, ANNU REV EARTH PL SC, V39, P59, DOI 10.1146/annurev-earth-040610-133505; Liu JG, 2018, GEOCHIM COSMOCHIM AC, V239, P284, DOI 10.1016/j.gca.2018.08.010; Liu JA, 2016, PRECAMBRIAN RES, V272, P168, DOI 10.1016/j.precamres.2015.11.001; Liu JG, 2014, CHEM GEOL, V363, P301, DOI 10.1016/j.chemgeo.2013.11.008; Luguet A, 2008, CHEM GEOL, V248, P342, DOI 10.1016/j.chemgeo.2007.10.013; Mackinder A, 2019, CAN J EARTH SCI, V56, P738, DOI 10.1139/cjes-2018-0083; Mather KA, 2011, LITHOS, V125, P729, DOI 10.1016/j.lithos.2011.04.003; Maurya S, 2016, J GEOPHYS RES-SOL EA, V121, P7450, DOI 10.1002/2016JB012948; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; Menzies M.A., 1993, GEOL SOC SPEC PUBL, V76, P71, DOI 10.1144/GSL.SP.1993.076.01.04; MORESI LN, 1995, PHYS FLUIDS, V7, P2154, DOI 10.1063/1.868465; Ootes L, 2020, LITHOS, V354, DOI 10.1016/j.lithos.2019.105220; Ottley CJ, 2003, PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES, P221, DOI 10.1039/9781847551689-00221; Peace AL, 2017, GEOSCI CAN, V44, P91, DOI 10.12789/geocanj.2017.44.120; Pearson D. G., 2014, TREAT GEOCHEM, V3, P255, DOI DOI 10.1016/B978-0-08-095975-7.00205-9; Pearson DG, 2000, CHEM GEOL, V165, P87, DOI 10.1016/S0009-2541(99)00161-8; Perchuk AL, 2020, NATURE, V586, P395, DOI 10.1038/s41586-020-2806-7; Pidgeon RT, 2003, AUST J EARTH SCI, V50, P769, DOI 10.1111/j.1440-0952.2003.01024.x; Puchkov VN, 2013, LITHOS, V174, P109, DOI 10.1016/j.lithos.2012.08.021; Reis NJ, 2013, LITHOS, V174, P175, DOI 10.1016/j.lithos.2012.10.014; Rudnick R.L., 1999, MANTLE PETROLOGY FIE, V6, P3; Rudnick RL, 2009, LITHOS, V112, P1083, DOI 10.1016/j.lithos.2009.04.042; Schaeffer AJ, 2014, EARTH PLANET SC LETT, V402, P26, DOI 10.1016/j.epsl.2014.05.014; Schaeffer AJ, 2013, GEOPHYS J INT, V194, P417, DOI 10.1093/gji/ggt095; Schmidberger SS, 2007, EARTH PLANET SC LETT, V254, P55, DOI 10.1016/j.epsl.2006.11.020; Schutt DL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2003JB002950; Shellnutt JG, 2018, PRECAMBRIAN RES, V308, P58, DOI 10.1016/j.precamres.2018.01.021; Shirey S, 2019, DIAMONDS MANTLE GEOD, P89; Sleep NH, 1997, J GEOPHYS RES-SOL EA, V102, P10001, DOI 10.1029/97JB00551; Smit KV, 2014, J PETROL, V55, P1829, DOI 10.1093/petrology/egu043; Snyder DB, 2017, TECTONOPHYSICS, V694, P464, DOI 10.1016/j.tecto.2016.11.032; Stachel T, 1998, EARTH PLANET SC LETT, V159, P1, DOI 10.1016/S0012-821X(98)00064-8; Stachel T, 2018, MINER PETROL, V112, P325, DOI 10.1007/s00710-018-0574-y; Stark JC, 2018, PRECAMBRIAN RES, V316, P291, DOI 10.1016/j.precamres.2018.08.014; Steinberger B, 2018, TECTONOPHYSICS, V746, P325, DOI 10.1016/j.tecto.2016.08.001; THOMPSON RN, 1991, J GEOL SOC LONDON, V148, P973, DOI 10.1144/gsjgs.148.6.0973; van Hunen J, 2005, EARTH PLANET SC LETT, V238, P146, DOI 10.1016/j.epsl.2005.07.006; Wang HL, 2015, GEOCHEM GEOPHY GEOSY, V16, P1156, DOI 10.1002/2015GC005784; Wang XC, 2014, PRECAMBRIAN RES, V241, P85, DOI 10.1016/j.precamres.2013.11.008; Westerlund KJ, 2006, CONTRIB MINERAL PETR, V152, P275, DOI 10.1007/s00410-006-0101-8; Wingate MTD, 2004, GEOLOGY, V32, P105, DOI 10.1130/G20171.1; Wittig N, 2008, EARTH PLANET SC LETT, V274, P24, DOI 10.1016/j.epsl.2008.06.034; Wu FY, 2019, ANNU REV EARTH PL SC, V47, P173, DOI 10.1146/annurev-earth-053018-060342; Youbi N, 2013, PRECAMBRIAN RES, V236, P106, DOI 10.1016/j.precamres.2013.07.003; Zhong SJ, 2000, J GEOPHYS RES-SOL EA, V105, P11063, DOI 10.1029/2000JB900003	89	22	22	13	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					732	+		10.1038/s41586-021-03395-5	http://dx.doi.org/10.1038/s41586-021-03395-5			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911271				2022-12-28	WOS:000645368900015
J	Melms, JC; Biermann, J; Huang, HC; Wang, YP; Nair, A; Tagore, S; Katsyv, I; Rendeiro, AF; Amin, AD; Schapiro, D; Frangieh, CJ; Luoma, AM; Filliol, A; Fang, YS; Ravichandran, H; Clausi, MG; Alba, GA; Rogava, M; Chen, SW; Ho, PT; Montoro, DT; Kornberg, AE; Han, AS; Bakhoum, MF; Anandasabapathy, N; Suarez-Farinas, M; Bakhoum, SF; Bram, Y; Borczuk, A; Guo, XZV; Lefkowitch, JH; Marboe, C; Lagana, SM; Del Portillo, A; Zorn, E; Markowitz, GS; Schwabe, RF; Schwartz, RE; Elemento, O; Saqi, A; Hibshoosh, H; Que, JW; Izar, B				Melms, Johannes C.; Biermann, Jana; Huang, Huachao; Wang, Yiping; Nair, Ajay; Tagore, Somnath; Katsyv, Igor; Rendeiro, Andre F.; Amin, Amit Dipak; Schapiro, Denis; Frangieh, Chris J.; Luoma, Adrienne M.; Filliol, Aveline; Fang, Yinshan; Ravichandran, Hiranmayi; Clausi, Mariano G.; Alba, George A.; Rogava, Meri; Chen, Sean W.; Ho, Patricia; Montoro, Daniel T.; Kornberg, Adam E.; Han, Arnold S.; Bakhoum, Mathieu F.; Anandasabapathy, Niroshana; Suarez-Farinas, Mayte; Bakhoum, Samuel F.; Bram, Yaron; Borczuk, Alain; Guo, Xinzheng V.; Lefkowitch, Jay H.; Marboe, Charles; Lagana, Stephen M.; Del Portillo, Armando; Zorn, Emmanuel; Markowitz, Glen S.; Schwabe, Robert F.; Schwartz, Robert E.; Elemento, Olivier; Saqi, Anjali; Hibshoosh, Hanina; Que, Jianwen; Izar, Benjamin			A molecular single-cell lung atlas of lethal COVID-19	NATURE			English	Article							TUFT CELLS; INFERENCE; IMMUNITY	Respiratory failure is the leading cause of death in patients with severe SARS-CoV-2 infection(1,2), but the host response at the lung tissue level is poorly understood. Here we performed single-nucleus RNA sequencing of about 116,000 nuclei from the lungs of nineteen individuals who died of COVID-19 and underwent rapid autopsy and seven control individuals. Integrated analyses identified substantial alterations in cellular composition, transcriptional cell states, and cell-to-cell interactions, thereby providing insight into the biology of lethal COVID-19. The lungs from individuals with COVID-19 were highly inflamed, with dense infiltration of aberrantly activated monocyte-derived macrophages and alveolar macrophages, but had impaired T cell responses. Monocyte/macrophage-derived interleukin-1 beta and epithelial cell-derived interleukin-6 were unique features of SARS-CoV-2 infection compared to other viral and bacterial causes of pneumonia. Alveolar type 2 cells adopted an inflammation-associated transient progenitor cell state and failed to undergo full transition into alveolar type 1 cells, resulting in impaired lung regeneration. Furthermore, we identified expansion of recently described CTHRC1(+) pathological fibroblasts(3) contributing to rapidly ensuing pulmonary fibrosis in COVID-19. Inference of protein activity and ligand-receptor interactions identified putative drug targets to disrupt deleterious circuits. This atlas enables the dissection of lethal COVID-19, may inform our understanding of long-term complications of COVID-19 survivors, and provides an important resource for therapeutic development.	[Melms, Johannes C.; Biermann, Jana; Wang, Yiping; Amin, Amit Dipak; Rogava, Meri; Chen, Sean W.; Ho, Patricia; Izar, Benjamin] Columbia Univ, Dept Med, Div Hematol Oncol, Irving Med Ctr, New York, NY 10027 USA; [Melms, Johannes C.; Biermann, Jana; Wang, Yiping; Amin, Amit Dipak; Rogava, Meri; Chen, Sean W.; Ho, Patricia; Kornberg, Adam E.; Han, Arnold S.; Zorn, Emmanuel; Izar, Benjamin] Columbia Univ, Irving Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA; [Huang, Huachao; Fang, Yinshan; Que, Jianwen] Columbia Univ, Irving Med Ctr, Columbia Ctr Human Dev, New York, NY 10027 USA; [Huang, Huachao; Fang, Yinshan; Que, Jianwen] Columbia Univ, Irving Med Ctr, Div Digest & Liver Dis, New York, NY 10027 USA; [Huang, Huachao; Nair, Ajay; Filliol, Aveline; Fang, Yinshan; Schwabe, Robert F.; Que, Jianwen] Columbia Univ, Dept Med, Irving Med Ctr, New York, NY 10027 USA; [Tagore, Somnath] Columbia Univ, Dept Syst Biol, Irving Med Ctr, New York, NY USA; [Katsyv, Igor; Lefkowitch, Jay H.; Marboe, Charles; Lagana, Stephen M.; Del Portillo, Armando; Markowitz, Glen S.; Saqi, Anjali; Hibshoosh, Hanina] Columbia Univ, Dept Pathol & Cell Biol, Irving Med Ctr, New York, NY USA; [Rendeiro, Andre F.; Elemento, Olivier] Weill Cornell Med, Inst Computat Biomed, New York, NY USA; [Rendeiro, Andre F.; Ravichandran, Hiranmayi; Anandasabapathy, Niroshana; Elemento, Olivier] Weill Cornell Med, Caryl & Israel Englander Inst Precis Med, New York, NY USA; [Schapiro, Denis] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA; [Schapiro, Denis; Frangieh, Chris J.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA; [Frangieh, Chris J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Luoma, Adrienne M.] Dana Farber Canc Ctr, Dept Canc Immunol & Virol, Boston, MA USA; [Ravichandran, Hiranmayi] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA; [Ravichandran, Hiranmayi; Elemento, Olivier] Weill Cornell Med, WorldQuant Initiat Quantitat Predict, New York, NY USA; [Clausi, Mariano G.; Guo, Xinzheng V.] Columbia Univ, Irving Med Ctr, Human Immune Monitoring Core, New York, NY USA; [Alba, George A.] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care, Boston, MA 02114 USA; [Montoro, Daniel T.] Broad Inst MIT & Harvard, Cell Circuits, Cambridge, MA 02142 USA; [Montoro, Daniel T.] Harvard Med Sch, Syst Biol, Boston, MA 02115 USA; [Bakhoum, Mathieu F.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Anandasabapathy, Niroshana] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA; [Anandasabapathy, Niroshana] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY USA; [Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Bakhoum, Samuel F.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Bram, Yaron; Schwartz, Robert E.] Weill Cornell Med, Dept Med, Div Gastroenterol & Hepatol, New York, NY USA; [Borczuk, Alain] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Borczuk, Alain] Weill Cornell Med, Dept Med, New York, NY USA; [Schwabe, Robert F.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Que, Jianwen; Izar, Benjamin] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY 10027 USA; [Izar, Benjamin] Columbia Univ, Program Math Genom, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Cornell University; Cornell University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Cornell University; Cornell University; Columbia University; NewYork-Presbyterian Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Cornell University; Cornell University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Izar, B (corresponding author), Columbia Univ, Dept Med, Div Hematol Oncol, Irving Med Ctr, New York, NY 10027 USA.; Izar, B (corresponding author), Columbia Univ, Irving Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA.; Que, JW (corresponding author), Columbia Univ, Irving Med Ctr, Columbia Ctr Human Dev, New York, NY 10027 USA.; Que, JW (corresponding author), Columbia Univ, Irving Med Ctr, Div Digest & Liver Dis, New York, NY 10027 USA.; Que, JW (corresponding author), Columbia Univ, Dept Med, Irving Med Ctr, New York, NY 10027 USA.; Que, JW; Izar, B (corresponding author), Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY 10027 USA.; Izar, B (corresponding author), Columbia Univ, Program Math Genom, New York, NY 10027 USA.	jq2240@cumc.columbia.edu; bi2175@cumc.columbia.edu	Guo, Xinzheng Victor/ABG-2980-2021; Filliol, Aveline/AAD-8683-2019; BORCZUK, alain/AHA-5172-2022; Biermann, Jana/C-7710-2018; Fang, Yinshan/AAU-4250-2021; Rendeiro, André F./AAC-4747-2019; Tagore, Somnath/HCI-5816-2022; Schwabe, Robert/AAY-6506-2021	Guo, Xinzheng Victor/0000-0003-0499-9870; Filliol, Aveline/0000-0002-1345-8147; Biermann, Jana/0000-0002-8907-4633; Rendeiro, André F./0000-0001-9362-5373; Amin, Amit Dipak/0000-0002-2613-2082; Ravichandran, Hiranmayi/0000-0001-8671-7667; Schapiro, Denis/0000-0002-9391-5722; Nair, Ajay/0000-0003-4521-5614	National Institute of Health (NIH) National Cancer Institute (NCI) [K08CA222663, R37CA258829, U54CA225088]; FastGrant; Burroughs Wellcome Fund Career Award for Medical Scientists; Louis V. Gerstner, Jr. Scholars Program; Department of Defense (DoD) Discovery Award [W81XWH-21-1-0196]; NCI [T32CA203702]; Volastra; Janssen; Eli Lilly research grants; NIH [UL1TR002384, R01CA194547, NCI R01CA234614, NIAID R01AI107301, NIDDK R01DK121072, RO3DK117252, S10RR027050]; Leukemia and Lymphoma Society [SCOR 7012-16, SCOR 7021-20, SCOR 180078-02]; Irma Hirschl Trust Research Award; Damon Runyon Cancer Research Foundation [DRQ-03-20]; NIH/NCI Cancer Center at Columbia University Genetically Modified Mouse Model Shared Resource, Molecular Pathology Shared Resource and its Tissue Bank [P30CA013696];  [R01HL152293];  [R01HL132996]	National Institute of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FastGrant; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Louis V. Gerstner, Jr. Scholars Program; Department of Defense (DoD) Discovery Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Volastra; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Eli Lilly research grants; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Irma Hirschl Trust Research Award; Damon Runyon Cancer Research Foundation; NIH/NCI Cancer Center at Columbia University Genetically Modified Mouse Model Shared Resource, Molecular Pathology Shared Resource and its Tissue Bank; ; 	We are grateful to all donors and their families. This work is part of the Human Cell Atlas (www.humancellatlas.org/publications).We thank J. Bhattacharya, I. Tabas, A. Tall and S. Roth for discussions. B.I. is supported by National Institute of Health (NIH) National Cancer Institute (NCI) grants K08CA222663, R37CA258829 and U54CA225088, a FastGrant, the Burroughs Wellcome Fund Career Award for Medical Scientists and the Louis V. Gerstner, Jr. Scholars Program. J.Q. is supported by R01HL152293 and R01HL132996. H. Huang is supported by the Department of Defense (DoD) Discovery Award W81XWH-21-1-0196. A.R. is supported by an NCI T32CA203702 grant. O.E. is supported by Volastra, Janssen and Eli Lilly research grants, NIH grants UL1TR002384, R01CA194547, and Leukemia and Lymphoma Society SCOR 7012-16, SCOR 7021-20 and SCOR 180078-02 grants. R.E.S. is supported by NIH grants NCI R01CA234614, NIAID R01AI107301, NIDDK R01DK121072 and RO3DK117252, and is an Irma Hirschl Trust Research Award Scholar. D.S. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRQ-03-20). This research was funded in part through the NIH Support Grant S10RR027050 for flow cytometry analysis and the NIH/NCI Cancer Center Support Grant P30CA013696 at Columbia University Genetically Modified Mouse Model Shared Resource, Molecular Pathology Shared Resource and its Tissue Bank.	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Alvarez MJ, 2018, NAT GENET, V50, P979, DOI 10.1038/s41588-018-0138-4; Alvarez MJ, 2016, NAT GENET, V48, P838, DOI 10.1038/ng.3593; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; BANGE EM, 2021, CD8 T CELLS COMPENSA; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Choi J, 2020, CELL STEM CELL, V27, P366, DOI 10.1016/j.stem.2020.06.020; Cui L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16466-4; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; De Michele S, 2020, AM J CLIN PATHOL, V154, P748, DOI 10.1093/ajcp/aqaa156; DELOREY TM, 2021, COVID19 TISSUE ATLAS; Deprez M, 2020, AM J RESP CRIT CARE, V202, P1636, DOI 10.1164/rccm.201911-2199OC; Ding HX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03843-3; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Doran AC, 2020, NAT REV IMMUNOL, V20, P254, DOI 10.1038/s41577-019-0240-6; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Federico A, 2020, BIOINFORMATICS, V36, P1307, DOI 10.1093/bioinformatics/btz700; Fleming SJ, 2019, BIORXIV, DOI 10.1101/791699v1.abstract; Franzen O, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz046; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hewitson JP, 2020, J IMMUNOL, V204, P2949, DOI 10.4049/jimmunol.1900940; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Kobayashi Y, 2020, NAT CELL BIOL, V22, P934, DOI 10.1038/s41556-020-0542-8; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Lachmann A, 2016, BIOINFORMATICS, V32, P2233, DOI 10.1093/bioinformatics/btw216; Lefebvre C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.31; Little DR, 2019, P NATL ACAD SCI USA, V116, P20545, DOI 10.1073/pnas.1906663116; Mould KJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126556; Muus C, 2021, NAT MED, V27, P546, DOI 10.1038/s41591-020-01227-z; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2011400, 10.1056/NEJMc2013400]; Rendeiro A. F., NATURE; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Slyper M, 2020, NAT MED, V26, P792, DOI 10.1038/s41591-020-0844-1; Strunz M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17358-3; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tsukui T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15647-5; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang HW, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0148-0; Westphalen CB, 2014, J CLIN INVEST, V124, P1283, DOI 10.1172/JCI73434; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Younes M, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5674; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhang Z, 2017, P NATL ACAD SCI USA, V114, P3903, DOI 10.1073/pnas.1621177114; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Ziegler CGK, 2020, CELL, V181, P1016, DOI 10.1016/j.cell.2020.04.035	58	119	120	24	98	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 1	2021	595	7865					114	+		10.1038/s41586-021-03569-1	http://dx.doi.org/10.1038/s41586-021-03569-1		APR 2021	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TC5EM	33915568	Bronze, Green Accepted			2022-12-28	WOS:000654894300002
J	Norman, M; Naver, L; Soderling, J; Ahlberg, M; Askling, HH; Aronsson, B; Bystrom, E; Jonsson, J; Sengpiel, V; Ludvigsson, JF; Hakansson, S; Stephansson, O				Norman, Mikael; Naver, Lars; Soderling, Jonas; Ahlberg, Mia; Askling, Helena Hervius; Aronsson, Bernice; Bystrom, Emma; Jonsson, Jerker; Sengpiel, Verena; Ludvigsson, Jonas F.; Hakansson, Stellan; Stephansson, Olof			Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COVID-19	IMPORTANCE The outcomes of newborn infants of women testing positive for SARS-CoV-2 in pregnancy is unclear. OBJECTIVE To evaluate neonatal outcomes in relation to maternal SARS-CoV-2 test positivity in pregnancy. DESIGN, SETTING, AND PARTICIPANTS Nationwide, prospective cohort study based on linkage of the Swedish Pregnancy Register, the Neonatal Quality Register, and the Register for Communicable Diseases. Ninety-two percent of all live births in Sweden between March 11, 2020, and January 31, 2021, were investigated for neonatal outcomes by March 8, 2021. Infants with malformations were excluded. Infants of women who tested positive for SARS-CoV-2 were matched, directly and using propensity scores, on maternal characteristics with up to 4 comparator infants. EXPOSURES Maternal test positivity for SARS-CoV-2 in pregnancy. MAIN OUTCOMES AND MEASURES In-hospital mortality; neonatal resuscitation; admission for neonatal care; respiratory, circulatory, neurologic, infectious, gastrointestinal, metabolic, and hematologic disorders and their treatments; length of hospital stay; breastfeeding; and infant test positivity for SARS-CoV-2. RESULTS Of 88 159 infants (49.0% girls), 2323 (1.6%) were delivered by mothers who tested positive for SARS-CoV-2. The mean gestational age of infants of SARS-CoV-2-positive mothers was 39.2 (SD, 2.2) weeks vs 39.6 (SD, 1.8) weeks for comparator infants, and the proportions of preterm infants (gestational age <37 weeks) were 205/2323 (8.8%) among infants of SARS-CoV-2-positive mothers and 4719/85 836 (5.5%) among comparator infants. After matching on maternal characteristics, maternal SARS-CoV-2 test positivity was significantly associated with admission for neonatal care (11.7% vs 8.4%; odds ratio [OR], 1.47; 95% CI, 1.26-1.70) and with neonatal morbidities such as respiratory distress syndrome (1.2% vs 0.5%; OR, 2.40; 95% CI, 1.50-3.84), any neonatal respiratory disorder (2.8% vs 2.0%; OR, 1.42; 95% CI, 1.07-1.90), and hyperbilirubinemia (3.6% vs 2.5%; OR, 1.47; 95% CI, 1.13-1.90). Mortality (0.30% vs 0.12%; OR, 2.55; 95% CI, 0.99-6.57), breastfeeding rates at discharge (94.4% vs 95.1%; OR, 0.84; 95% CI, 0.67-1.05), and length of stay in neonatal care (median, 6 days in both groups; difference, 0 days; 95% CI, -2 to 7 days) did not differ significantly between the groups. Twenty-one infants (0.90%) of SARS-CoV-2-positive mothers tested positive for SARS-CoV-2 in the neonatal period; 12 did not have neonatal morbidity, 9 had diagnoses with unclear relation to SARS-CoV-2, and none had congenital pneumonia. CONCLUSIONS AND RELEVANCE In a nationwide cohort of infants in Sweden, maternal SARS-CoV-2 infection in pregnancy was significantly associated with small increases in some neonatal morbidities. Given the small numbers of events for many of the outcomes and the large number of statistical comparisons, the findings should be interpreted as exploratory.	[Norman, Mikael; Naver, Lars] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Norman, Mikael; Naver, Lars] Karolinska Univ Hosp, Dept Neonatal Med, Stockholm, Sweden; [Norman, Mikael; Hakansson, Stellan] Swedish Neonatal Qual Register, Stockholm, Sweden; [Soderling, Jonas; Ahlberg, Mia; Stephansson, Olof] Karolinska Inst, Dept Med, Clin Epidemiol Div, Stockholm, Sweden; [Ahlberg, Mia; Stephansson, Olof] Karolinska Univ Hosp, Dept Womens Hlth, Stockholm, Sweden; [Askling, Helena Hervius] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden; [Aronsson, Bernice; Bystrom, Emma; Jonsson, Jerker] Publ Hlth Agcy Sweden, Stockholm, Sweden; [Sengpiel, Verena] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden; [Sengpiel, Verena] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden; [Ludvigsson, Jonas F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden; [Hakansson, Stellan] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Public Health Agency of Sweden; Sahlgrenska University Hospital; University of Gothenburg; Karolinska Institutet; Orebro University; Umea University	Norman, M (corresponding author), Karolinska Inst, Novum, Dept Clin Sci Intervent & Technol, Div Pediat, Blickagangen 6A, SE-14157 Stockholm, Sweden.	mikael.norman@ki.se	Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602; Stephansson, Olof/0000-0003-1528-4563; Jonsson, Jerker/0000-0003-1383-6176; Naver, Lars/0000-0001-6027-0211	Swedish Society of Medicine [2020-937944]; NordForsk [105545]; Region Stockholm [ALF2020-0443]; Karolinska Institutet [ALF2020-0443]; Childhood Foundation of the Swedish Order of Freemasons; Swedish government (Ministry of Health and Social Affairs); Regional Health Care Providers (County Councils)	Swedish Society of Medicine; NordForsk; Region Stockholm; Karolinska Institutet(Karolinska Institutet); Childhood Foundation of the Swedish Order of Freemasons; Swedish government (Ministry of Health and Social Affairs); Regional Health Care Providers (County Councils)	This study was supported by grants from the Swedish Society of Medicine (2020-937944) and NordForsk (105545), by grants from a regional agreement on clinical research between Region Stockholm and Karolinska Institutet (ALF2020-0443), and by the Childhood Foundation of the Swedish Order of Freemasons. The Swedish Neonatal Quality Register and the Swedish Pregnancy Register are funded by the Swedish government (Ministry of Health and Social Affairs) and the body of Regional Health Care Providers (County Councils).	Ahlberg M, 2020, JAMA-J AM MED ASSOC, V324, P1782, DOI 10.1001/jama.2020.19124; Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Chambers C, 2020, JAMA-J AM MED ASSOC, V324, P1347, DOI 10.1001/jama.2020.15580; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107; Dumitriu D, 2021, JAMA PEDIATR, V175, P157, DOI 10.1001/jamapediatrics.2020.4298; Etminan M, 2020, CHEST, V158, pS21, DOI 10.1016/j.chest.2020.03.011; GroSS Rudiger, 2020, Lancet, V395, P1757, DOI 10.1016/S0140-6736(20)31181-8; Hessami K, 2022, J MATERN-FETAL NEO M, V35, P2936, DOI 10.1080/14767058.2020.1806817; Hu XL, 2021, NEONATOLOGY, V117, P592, DOI 10.1159/000509141; Juan J, 2020, ULTRASOUND OBST GYN, V56, P15, DOI 10.1002/uog.22088; Knight M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2107; Kyle MH, 2020, SEMIN PERINATOL, V44, DOI 10.1016/j.semperi.2020.151286; Laptook AR, 2002, CLIN PERINATOL, V29, P623, DOI 10.1016/S0095-5108(02)00057-X; Lavizzari A, 2021, PEDIATR RES, V89, P940, DOI 10.1038/s41390-020-0976-5; Lee K, 2009, GLOB INST, P1; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P2459, DOI 10.1111/apa.15582; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Morens DM, 2010, CRIT CARE MED, V38, pE10, DOI 10.1097/CCM.0b013e3181ceb25b; Norman M, 2019, ACTA PAEDIATR, V108, P1411, DOI 10.1111/apa.14823; Oncel MY, 2021, EUR J PEDIATR, V180, P733, DOI 10.1007/s00431-020-03767-5; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Penfield CA, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100133; Pettirosso E, 2020, AUST NZ J OBSTET GYN, V60, P640, DOI 10.1111/ajo.13204; Poon LC, 2020, INT J GYNECOL OBSTET, V149, P273, DOI 10.1002/ijgo.13156; Raschetti R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18982-9; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shah PKS, 2020, ACTA OBSTET GYN SCAN, V99, P565, DOI 10.1111/aogs.13870; Stephansson O, 2018, ACTA OBSTET GYN SCAN, V97, P466, DOI 10.1111/aogs.13266; Tam PCK, 2021, CLIN INFECT DIS, V72, P128, DOI 10.1093/cid/ciaa673; Vivanti AJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17436-6; Wei M, 2020, JAMA-J AM MED ASSOC, V323, P1313, DOI 10.1001/jama.2020.2131; Wu Y, 2020, BJOG-INT J OBSTET GY, V127, P1109, DOI 10.1111/1471-0528.16276; Yan J, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.014; Yeo KT, 2020, ACTA PAEDIATR, V109, P2192, DOI 10.1111/apa.15495; Yoon SH, 2020, EUR REV MED PHARMACO, V24, P7804, DOI 10.26355/eurrev_202007_22285; Zaigham M, 2020, ACTA OBSTET GYN SCAN, V99, P823, DOI 10.1111/aogs.13867; Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878; Zhang L, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03026-3; Zimmermann P, 2020, PEDIATR INFECT DIS J, V39, P469, DOI 10.1097/INF.0000000000002700	41	56	58	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	2021	325	20					2076	2086		10.1001/jama.2021.5775	http://dx.doi.org/10.1001/jama.2021.5775		APR 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ6MR	33914014	Bronze, Green Published			2022-12-28	WOS:000645643100002
J	Pouchain, D				Pouchain, Denis			Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. An individual participant-level data meta-analysis	EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE			French	Editorial Material						hypertension; cardiovascular risk; meta-analysis	ADULTS					denis.pouchain@free.fr	Rahimi, Kazem/AAA-4250-2022; Asselbergs, Folkert W./ABD-6752-2021; Canoy, Dexter/L-6440-2013; Sundstrom, Johan/A-6286-2009	Asselbergs, Folkert W./0000-0002-1692-8669; Neal, Bruce/0000-0002-0490-7465; Chalmers, John/0000-0002-9931-0580; Yusuf, Salim/0000-0003-4776-5601; Canoy, Dexter/0000-0003-4493-9901; Reid, Christopher/0000-0001-9173-3944; Gupta, Ajay/0000-0001-5807-8503; MacMahon, Stephen/0000-0003-2064-7699; Pepine, Carl/0000-0002-6011-681X; Woodward, Mark/0000-0001-9800-5296; Rodgers, Anthony/0000-0003-1282-1896; Pinho-Gomes, Ana-Catarina/0000-0001-9895-1493; Sundstrom, Johan/0000-0003-2247-8454; Copland, Emma/0000-0001-9280-5241				Diao D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006742.pub2; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Ferru, 2002, REV PRATICIEN MED GE, V16, P177; Kobuko Y, 2021, LANCET; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Musini VM, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008276.pub2; Pouchain D., 2016, EXERCER, V126, P171; Rahimi K, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028698; Vidal-Petiot E, 2016, LANCET, V388, P2142, DOI 10.1016/S0140-6736(16)31326-5; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177	12	126	125	13	29	COLL NATL GENERALISTES ENSEIGNANTS	MONTREUIL SOUS BOIS	3, RUE PARMENTIER, MONTREUIL SOUS BOIS, 93100, FRANCE	0998-3953	1961-9138		EXERCER	Exercer	JUN	2021		174					262	264		10.1016/S0140-6736(21)00590-0	http://dx.doi.org/10.1016/S0140-6736(21)00590-0		APR 2021	3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	TB2FP	33933205	hybrid, Green Published			2022-12-28	WOS:000667761300005
J	Ren, AA; Snellings, DA; Su, YRS; Hong, CC; Castro, M; Tang, AT; Detter, MR; Hobson, N; Girard, R; Romanos, S; Lightle, R; Moore, T; Shenkar, R; Benavides, C; Beaman, MM; Muller-Fielitz, H; Chen, M; Mericko, P; Yang, JS; Sung, DC; Lawton, MT; Ruppert, JM; Schwaninger, M; Korbelin, J; Potente, M; Awad, IA; Marchuk, DA; Kahn, ML				Ren, Aileen A.; Snellings, Daniel A.; Su, Yourong S.; Hong, Courtney C.; Castro, Marco; Tang, Alan T.; Detter, Matthew R.; Hobson, Nicholas; Girard, Romuald; Romanos, Sharbel; Lightle, Rhonda; Moore, Thomas; Shenkar, Robert; Benavides, Christian; Beaman, M. Makenzie; Mueller-Fielitz, Helge; Chen, Mei; Mericko, Patricia; Yang, Jisheng; Sung, Derek C.; Lawton, Michael T.; Ruppert, J. Michael; Schwaninger, Markus; Koerbelin, Jakob; Potente, Michael; Awad, Issam A.; Marchuk, Douglas A.; Kahn, Mark L.			PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism	NATURE			English	Article							SOMATIC MUTATIONS; MALFORMATIONS; PROGRESSION; PROLIFERATION; ANGIOGENESIS; PATHWAYS; GENES; KLF4	Vascular malformations are thought to be monogenic disorders that result in dysregulated growth of blood vessels. In the brain, cerebral cavernous malformations (CCMs) arise owing to inactivation of the endothelial CCM protein complex, which is required to dampen the activity of the kinase MEKK3(1-4). Environmental factors can explain differences in the natural history of CCMs between individuals(5), but why single CCMs often exhibit sudden, rapid growth, culminating in strokes or seizures, is unknown. Here we show that growth of CCMs requires increased signalling through the phosphatidylinositol-3-kinase (PI3K)-mTOR pathway as well as loss of function of the CCM complex. We identify somatic gain-of-function mutations in PIK3CA and loss-of-function mutations in the CCM complex in the same cells in a majority of human CCMs. Using mouse models, we show that growth of CCMs requires both PI3K gain of function and CCM loss of function in endothelial cells, and that both CCM loss of function and increased expression of the transcription factor KLF4 (a downstream effector of MEKK3) augment mTOR signalling in endothelial cells. Consistent with these findings, the mTORC1 inhibitor rapamycin effectively blocks the formation of CCMs in mouse models. We establish a three-hit mechanism analogous to cancer, in which aggressive vascular malformations arise through the loss of vascular 'suppressor genes' that constrain vessel growth and gain of a vascular 'oncogene' that stimulates excess vessel growth. These findings suggest that aggressive CCMs could be treated using clinically approved mTORC1 inhibitors.	[Ren, Aileen A.; Hong, Courtney C.; Tang, Alan T.; Chen, Mei; Mericko, Patricia; Yang, Jisheng; Sung, Derek C.; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Ren, Aileen A.; Hong, Courtney C.; Tang, Alan T.; Chen, Mei; Mericko, Patricia; Yang, Jisheng; Sung, Derek C.; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Snellings, Daniel A.; Detter, Matthew R.; Benavides, Christian; Beaman, M. Makenzie; Marchuk, Douglas A.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA; [Su, Yourong S.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Castro, Marco; Potente, Michael] Max Planck Inst Heart & Lung Res, Angiogenesis & Metab Lab, Bad Nauheim, Germany; [Hobson, Nicholas; Girard, Romuald; Romanos, Sharbel; Lightle, Rhonda; Moore, Thomas; Shenkar, Robert; Awad, Issam A.] Univ Chicago Med & Biol Sci, Sect Neurosurg, Dept Surg, Neurovasc Surg Program, Chicago, IL USA; [Lawton, Michael T.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Ruppert, J. Michael] West Virginia Univ, Canc Inst, Morgantown, WV 26506 USA; [Mueller-Fielitz, Helge; Schwaninger, Markus] Univ Lubeck, Inst Expt & Clin Pharmacol & Toxicol, Ctr Brain Behav & Metab, Lubeck, Germany; [Koerbelin, Jakob] Univ Med Ctr Hamburg Eppendorf, Dept Oncol Hematol & Bone Marrow Transplantat, Hamburg, Germany; [Potente, Michael] Humboldt Univ, Berlin Inst Hlth BIH, Berlin, Germany; [Potente, Michael] Humboldt Univ, Charite Univ Med Berlin, Freie Univ Berlin, Berlin, Germany; [Potente, Michael] Max Delbruck Ctr Mol Med MDC, Berlin, Germany	University of Pennsylvania; University of Pennsylvania; Duke University; University of Pennsylvania; Max Planck Society; Barrow Neurological Institute; West Virginia University; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; Berlin Institute of Health; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kahn, ML (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.; Kahn, ML (corresponding author), Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA.; Marchuk, DA (corresponding author), Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC USA.	douglas.marchuk@duke.edu; markkahn@pennmedicine.upenn.edu		Detter, Matthew/0000-0003-1207-2565; Snellings, Daniel/0000-0003-0615-9111; Korbelin, Jakob/0000-0002-5435-7182; Muller-Fielitz, Helge/0000-0003-2815-4426; Ren, Aileen/0000-0002-1116-900X; Castro, Marco/0000-0001-7851-7446; Marchuk, Douglas/0000-0002-3110-6671; Romanos, Sharbel/0000-0002-0719-6355; Potente, Michael/0000-0002-5689-0036	National Institute of Health [R01HL094326, R01NS100949, P01NS092521]; Leducq Foundation; AHA-Allen foundation [T32 HL007150, F31HL152738, F31NS115256, F30NS100252]; European Research Council (ERC) Synergy grant [2019-WATCH-810331]; ERC Consolidator grant [EMERGE-773047]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); AHA-Allen foundation; European Research Council (ERC) Synergy grant(European Research Council (ERC)); ERC Consolidator grant(European Research Council (ERC))	We thank the members of the Kahn laboratory for thoughtful comments and advice; A. Alliance for enrolling patients; the University of Chicago PaleoCT core facility for its expertise in imaging and image quantification; the Penn CDB Microscopy Core for support with microscopy; Duke University School of Medicine for use of the Sequencing and Genomic Technologies Shared Resource for library preparation and sequencing; and K. Wood (Duke University) for providing the cell-line DNA used as a positive control in the ddPCR assay design. Flow cytometry was performed in the Duke Human Vaccine Institute Research Flow Cytometry Shared Resource Facility. These studies were supported by National Institute of Health grants R01HL094326 and R01NS100949 (to M.L.K.), P01NS092521 (M.L.K., D.A.M. and I.A.A.) the Leducq Foundation (M.L.K. and M.P.), the AHA-Allen foundation (M.L.K.), T32 HL007150 (A.A.R.), F31HL152738 (D.A.S.), F31NS115256 (C.C.H.) and F30NS100252 (A.T.T.); European Research Council (ERC) Synergy grant-2019-WATCH-810331 (to M.S.); and ERC Consolidator grant EMERGE-773047 (to M.	Abdulrauf SI, 1999, NEUROSURGERY, V44, P41, DOI 10.1097/00006123-199901000-00020; Adams DM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3257; Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Akers AL, 2009, HUM MOL GENET, V18, P919, DOI 10.1093/hmg/ddn430; Awad IA, 2019, J NEUROSURG, V131, P1, DOI 10.3171/2019.3.JNS181724; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Castel P, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1164; Castillo SD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9982; Castro M, 2019, CIRC RES, V124, P1240, DOI 10.1161/CIRCRESAHA.118.314300; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Cuttano R, 2016, EMBO MOL MED, V8, P6, DOI 10.15252/emmm.201505433; Detter MR, 2018, CIRC RES, V123, P1143, DOI 10.1161/CIRCRESAHA.118.313970; Dogruluk T, 2015, CANCER RES, V75, P5341, DOI 10.1158/0008-5472.CAN-15-1654; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Fisher OS, 2014, CELL MOL LIFE SCI, V71, P1881, DOI 10.1007/s00018-013-1532-9; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Gault J, 2005, STROKE, V36, P872, DOI 10.1161/01.STR.0000157586.20479.fd; Hong CC, 2020, J EXP MED, V217, DOI 10.1084/jem.20200140; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Korbelin J, 2016, EMBO MOL MED, V8, P609, DOI 10.15252/emmm.201506078; Limaye N, 2015, AM J HUM GENET, V97, P914, DOI 10.1016/j.ajhg.2015.11.011; Lissbrant IF, 2003, BIOL REPROD, V68, P1107, DOI 10.1095/biolreprod.102.008284; Lopez-Ramirez MA, 2017, J EXP MED, V214, P3331, DOI 10.1084/jem.20171178; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Malinyerno M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10707-x; Marchi S, 2015, EMBO MOL MED, V7, P1403, DOI 10.15252/emmm.201505316; Martelotto L. G., 2020, FRANKENSTEIN PROTOCO, DOI 10.17504/protocols.io.3fkgjkw; McDonald DA, 2014, HUM MOL GENET, V23, P4357, DOI 10.1093/hmg/ddu153; Otten C, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201809155; OZEKI M, 2019, ORPHANET J RARE DIS, V14; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Porter PJ, 1997, J NEUROSURG, V87, P190, DOI 10.3171/jns.1997.87.2.0190; Ramirez-Zamora A, 2009, ARQ NEURO-PSIQUIAT, V67, P917, DOI 10.1590/S0004-282X2009000500030; Renz M, 2015, DEV CELL, V32, P181, DOI 10.1016/j.devcel.2014.12.016; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; Rodriguez-Laguna L, 2019, J EXP MED, V216, P407, DOI 10.1084/jem.20181353; Salman RAS, 2012, LANCET NEUROL, V11, P217, DOI 10.1016/S1474-4422(12)70004-2; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Storck SE, 2016, J CLIN INVEST, V126, P123, DOI 10.1172/JCI81108; Tan WH, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048934; Tang AT, 2017, NATURE, V545, P305, DOI 10.1038/nature22075; Triana P, 2017, EUR J PEDIATR SURG, V27, P86, DOI 10.1055/s-0036-1593383; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Venot Q, 2018, NATURE, V558, P540, DOI 10.1038/s41586-018-0217-9; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Xu LW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47297-z; Zhou ZN, 2016, NATURE, V532, P122, DOI 10.1038/nature17178	50	40	41	7	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 10	2021	594	7862					271	+		10.1038/s41586-021-03562-8	http://dx.doi.org/10.1038/s41586-021-03562-8		APR 2021	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SQ8YR	33910229	Green Accepted			2022-12-28	WOS:000654894200001
J	Fair, MA; Johnson, SB				Fair, Malika A.; Johnson, Sherese B.			Addressing racial inequities in medicine	SCIENCE			English	Editorial Material								The COVID-19 pandemic highlights the need to dismantle structural racism that perpetuates health inequities.	[Fair, Malika A.; Johnson, Sherese B.] Assoc Amer Med Coll, Washington, DC 20001 USA; [Fair, Malika A.] George Washington Univ, Sch Med & Hlth Sci, Dept Emergency Med, Washington, DC 20052 USA	Association of American Medical Colleges; George Washington University	Fair, MA (corresponding author), Assoc Amer Med Coll, Washington, DC 20001 USA.; Fair, MA (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Emergency Med, Washington, DC 20052 USA.	mfair@aamc.org; sjohnson@aamc.org						Agency for Healthcare Research and Quality,, 2020, 2019 NAT HEALTHC QUA; Ahmed S, 2021, J GEN INTERN MED, V36, P464, DOI 10.1007/s11606-020-06280-5; Amutah BAC, 2021, NEW ENGL J MED, V384, P872, DOI 10.1056/NEJMms2025768; Egede LE, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2023616; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P1517, DOI 10.15585/mmwr.mm6942e1; Hardeman RR, 2020, HEALTH SERV RES, V55, P777, DOI 10.1111/1475-6773.13558; Hoffman KM, 2016, P NATL ACAD SCI USA, V113, P4296, DOI 10.1073/pnas.1516047113; Institute of Medicine (US) Committee on Quality of Health Care in America, 2001, CROSSING QUALITY CHA; Mackey K, 2021, ANN INTERN MED, V174, P362, DOI 10.7326/M20-6306; Singu S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00406; Teo BW, 2018, ADV CHRONIC KIDNEY D, V25, P41, DOI 10.1053/j.ackd.2017.10.005; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; White Coats for Black Lives, 2019, RAC JUST REP CARD; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	15	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					348	349		10.1126/science.abf6738	http://dx.doi.org/10.1126/science.abf6738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888630				2022-12-28	WOS:000645009800024
J	Gilani, A; Juraschek, SP; Belanger, MJ; Vowles, JE; Wannamethee, SG				Gilani, Artaza; Juraschek, Stephen P.; Belanger, Matthew J.; Vowles, Julie E.; Wannamethee, S. Goya			Postural hypotension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE-MEASUREMENTS; ORTHOSTATIC HYPOTENSION; DIAGNOSIS; MANAGEMENT; METAANALYSIS; RISK; HYPERTENSION; PREVENTION; PREVALENCE; STATEMENT		[Gilani, Artaza; Wannamethee, S. Goya] UCL, Sch Med, UCL Res Dept Primary Care & Populat Hlth, Royal Free Hosp Campus, London NW3 2PF, England; [Juraschek, Stephen P.; Belanger, Matthew J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gen Med, Sect Res, Boston, MA 02115 USA; [Vowles, Julie E.] Hillingdon Hosp NHS Fdn Trust, Uxbridge UB8 3NN, Middx, England	University of London; University College London; UCL Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gilani, A (corresponding author), UCL, Sch Med, UCL Res Dept Primary Care & Populat Hlth, Royal Free Hosp Campus, London NW3 2PF, England.	artaza.gilani@ucl.ac.uk		Gilani, Artaza/0000-0002-5385-8524	National Institute for Health Research (NIHR) School for Primary Care Research - National Heart, Lung, and Blood Institute	National Institute for Health Research (NIHR) School for Primary Care Research - National Heart, Lung, and Blood Institute	AG was funded by the National Institute for Health Research (NIHR) School for Primary Care Research. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. SPJ is funded by the National Heart, Lung, and Blood Institute.	Arbogast SD, 2009, AM J MED, V122, P574, DOI 10.1016/j.amjmed.2008.10.040; Aung AK, 2012, OCHSNER J, V12, P35; Benvenuto LJ, 2011, AM J HYPERTENS, V24, P135, DOI 10.1038/ajh.2010.146; Biaggioni I., 2018, AM J HYPERTENS, V31, P1255, DOI DOI 10.1093/AJH/HPY089; Breeuwsma AC, 2017, HYPERTENS RES, V40, P765, DOI 10.1038/hr.2017.39; Briggs R, 2018, HYPERTENSION, V71, P946, DOI 10.1161/HYPERTENSIONAHA.117.10542; Cooke J, 2009, QJM-INT J MED, V102, P335, DOI 10.1093/qjmed/hcp020; Cremer A, 2019, J HYPERTENS, V37, P923, DOI 10.1097/HJH.0000000000001986; de Boer IH, 2017, DIABETES CARE, V40, P1273, DOI 10.2337/dci17-0026; Excellence NIfHaC, 2010, TRANS LOSS CONSC BLA; Freeman R, 2020, HYPERTENSION, V75, P1325, DOI 10.1161/HYPERTENSIONAHA.119.13619; Freeman R, 2018, J AM COLL CARDIOL, V72, P1294, DOI 10.1016/j.jacc.2018.05.079; Freeman R, 2011, AUTON NEUROSCI-BASIC, V161, P46, DOI 10.1016/j.autneu.2011.02.004; Gibbons CH, 2006, NEUROLOGY, V67, P28, DOI 10.1212/01.wnl.0000223828.28215.0b; Gibbons CH, 2017, J NEUROL, V264, P1567, DOI 10.1007/s00415-016-8375-x; Joseph A, 2017, NEPHROL THER, V13, pS55, DOI 10.1016/j.nephro.2017.01.003; Juraschek SP, 2021, ANN INTERN MED, V174, P58, DOI 10.7326/M20-4298; Magkas N, 2019, J CLIN HYPERTENS, V21, P426, DOI 10.1111/jch.13491; Milazzo V, 2012, J HYPERTENS, V1, P2167, DOI DOI 10.4172/2167-1095.1000104; Mills PB, 2015, ARCH PHYS MED REHAB, V96, P366, DOI 10.1016/j.apmr.2014.09.028; Min M, 2019, J CLIN HYPERTENS, V21, P1221, DOI 10.1111/jch.13613; Min M, 2018, INT J GERIATR PSYCH, V33, P1541, DOI 10.1002/gps.4964; Mol A, 2019, J AM MED DIR ASSOC, V20, P589, DOI 10.1016/j.jamda.2018.11.003; Mol A, 2018, AGEING RES REV, V48, P122, DOI 10.1016/j.arr.2018.10.007; Muntner P, 2019, HYPERTENSION, V73, pE35, DOI 10.1161/HYP.0000000000000087; Narkiewicz K, 2000, CIRCULATION, V101, P398, DOI 10.1161/01.CIR.101.4.398; National Heart Foundation of Australia, 2016, GUID DIAGN MAN HYP A; National Institute for Health and Care Excellence, 2015, ORTH HYP AUT DYSF MI; National Institute for Health and Care Excellence, 2013, POST HYP AD FLUDR; National Institute for Health and Care Excellence, 2019, HYPERTENSION ADULTS; Nerenberg KA, 2018, CAN J CARDIOL, V34, P506, DOI 10.1016/j.cjca.2018.02.022; Ong ACL, 2013, INT J CLIN PRACT, V67, P633, DOI 10.1111/ijcp.12122; Parsaik AK, 2013, J GEN INTERN MED, V28, P1496, DOI 10.1007/s11606-013-2520-3; Peeters LEJ, 2019, EXPERT OPIN DRUG MET, V15, P287, DOI 10.1080/17425255.2019.1588249; Ricci F, 2015, EUR HEART J, V36, P1609, DOI 10.1093/eurheartj/ehv093; Royal College of Physicians, 2017, MEAS LYING STAND BLO; Saedon NI, 2020, J GERONTOL A-BIOL, V75, P117, DOI 10.1093/gerona/gly188; Shaw BH, 2017, J HYPERTENS, V35, P1019, DOI 10.1097/HJH.0000000000001265; Strassheim V, 2016, J HYPERTENS, V34, P1933, DOI 10.1097/HJH.0000000000001043; Subbarayan S, 2019, J AM MED DIR ASSOC, V20, P1065, DOI 10.1016/j.jamda.2019.03.032; Sutton R, 2017, J ARRYTHM, V33, P545, DOI 10.1016/j.joa.2017.03.007; Sutton Richard, 2014, Glob Cardiol Sci Pract, V2014, P1, DOI 10.5339/gcsp.2014.18; Trahair LG, 2014, J AM MED DIR ASSOC, V15, P394, DOI 10.1016/j.jamda.2014.01.011; Velseboer DC, 2011, PARKINSONISM RELAT D, V17, P724, DOI 10.1016/j.parkreldis.2011.04.016; Weiss A, 2002, ARCH INTERN MED, V162, P2369, DOI 10.1001/archinte.162.20.2369; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Williams B., 2018, EUR HEART J, V39, P3021, DOI [10.1093/eurheartj/ehy339, DOI 10.1093/EURHEARTJ/EHY339]; Wright JT, 2015, NEW ENGL J MED, V373, P2103, DOI 10.1056/NEJMoa1511939; Zhou Y, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000008004	49	2	2	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2021	373								n922	10.1136/bmj.n922	http://dx.doi.org/10.1136/bmj.n922			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WH9UK	33893162				2022-12-28	WOS:000708014600002
J	Pohl, S; Ulitzsch, E; von Davier, M				Pohl, Steffi; Ulitzsch, Esther; von Davier, Matthias			Reframing rankings in educational assessments	SCIENCE			English	Editorial Material							SPEED; MODEL		[Pohl, Steffi] Free Univ Berlin, Berlin, Germany; [Ulitzsch, Esther] Leibniz Inst Sci & Math Educ, Kiel, Germany; [von Davier, Matthias] Boston Coll, Chestnut Hill, MA 02167 USA	Free University of Berlin; Leibniz Institut fur die Padagogik der Naturwissenschaften und Mathematik an der Universitat Kiel (IPN); Boston College	Pohl, S (corresponding author), Free Univ Berlin, Berlin, Germany.	steffi.pohl@fu-berlin.de	Ulitzsch, Esther/AAO-7967-2021	Ulitzsch, Esther/0000-0002-9267-8542; von Davier, Matthias/0000-0003-1298-9701	German Research Foundation (DFG) [PO 1655/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) under grant PO 1655/3-1.We thank T. Gotz, S.Krumm, M. Brunner, T.Asalti, and anonymous reviewers for helpful comments.	[Anonymous], [No title captured]; Bezirhan U, 2021, EDUC PSYCHOL MEAS, V81, P363, DOI 10.1177/0013164420950556; Carpenter B, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i01; Fox JP, 2016, MULTIVAR BEHAV RES, V51, P540, DOI 10.1080/00273171.2016.1171128; Gelman A, 1996, STAT SINICA, V6, P733; Gelman A, 2011, CH CRC HANDB MOD STA, P163; Hitt C, 2016, ECON EDUC REV, V52, P105, DOI 10.1016/j.econedurev.2016.02.001; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Neal RM, 2011, CH CRC HANDB MOD STA, P113; O'Muircheartaigh C, 1999, J ROY STAT SOC A STA, V162, P177, DOI 10.1111/1467-985X.00129; Pohl S, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01988; R Core Team, 2017, R LANG ENV STAT COMP; Rose N, 2017, PSYCHOMETRIKA, V82, P795, DOI 10.1007/s11336-016-9544-7; Singer JD, 2018, SCIENCE, V360, P38, DOI 10.1126/science.aar4952; Ulitzsch E, 2020, BRIT J MATH STAT PSY, V73, P83, DOI 10.1111/bmsp.12188; Ulitzsch E, 2020, EDUC PSYCHOL MEAS, V80, P522, DOI 10.1177/0013164419878241; Ulitzsch E, 2020, MULTIVAR BEHAV RES, V55, P425, DOI 10.1080/00273171.2019.1643699; van der Linden WJ, 2007, PSYCHOMETRIKA, V72, P287, DOI 10.1007/s11336-006-1478-z; Wang C, 2015, BRIT J MATH STAT PSY, V68, P456, DOI 10.1111/bmsp.12054; Woodward R, 2009, GLOB INST, V35, P1	20	6	6	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					338	+		10.1126/science.abd3300	http://dx.doi.org/10.1126/science.abd3300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888624				2022-12-28	WOS:000645009800018
J	Kuehn, BM				Kuehn, Bridget M.			Costly Hearing Loss Requires Greater Global Attention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1498	1498		10.1001/jama.2021.5498	http://dx.doi.org/10.1001/jama.2021.5498			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877267				2022-12-28	WOS:000642636500005
J	Dyer, C				Dyer, Clare			Covid-19: Irish GP who refused to vaccinate patients is suspended	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2021	373								n987	10.1136/bmj.n987	http://dx.doi.org/10.1136/bmj.n987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RO8VU	33863787	Bronze			2022-12-28	WOS:000641319600010
J	Greely, HT; Farahany, NA				Greely, Henry T.; Farahany, Nita A.			Advancing the ethical dialogue about monkey/human chimeric embryos	CELL			English	Editorial Material								In this issue of Cell, Tan et al. report the first injection of human stem cells into in vitro non-human primate blastocysts with significant survival of the human cells, raising new scientific possibilities but also important ethical issues.	[Greely, Henry T.] Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA; [Farahany, Nita A.] Duke Univ, Initiat Sci & Soc, Durham, NC 27708 USA	Stanford University; Duke University	Greely, HT (corresponding author), Stanford Univ, Ctr Law & Biosci, Stanford, CA 94305 USA.; Farahany, NA (corresponding author), Duke Univ, Initiat Sci & Soc, Durham, NC 27708 USA.	hgreely@stanford.edu; farahany@duke.edu	Farahany, Nita/AGH-5500-2022	Farahany, Nita/0000-0003-4808-6256				Greely HT, 2007, AM J BIOETHICS, V7, P27, DOI 10.1080/15265160701290371; Greely HT, 2021, AM J BIOETHICS, V21, P34, DOI 10.1080/15265161.2020.1845853; ISSCR, 2016, GUID STEM CELL RES C; Ma HX, 2019, SCIENCE, V366, P836, DOI 10.1126/science.aax7890; NAS (National Academies of Sciences Engineering and Medicine), 2021, EM FIELD HUM NEUR OR, DOI [10.17226/26078, DOI 10.17226/26078]; National Institutes of Health (NIH), 2009, GUID HUM STEM CELL R GUID HUM STEM CELL R; NRC (National Research Council) and IOM, 2010, FIN REP NAT AC HUM E; Robert JS, 2003, AM J BIOETHICS, V3, P1, DOI 10.1162/15265160360706417; Tan T, 2021, CELL, V184, P2020, DOI 10.1016/j.cell.2021.03.020; Wu J, 2016, NATURE, V540, P51, DOI 10.1038/nature20573	10	2	3	4	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2021	184	8					1962	1963		10.1016/j.cell.2021.03.044	http://dx.doi.org/10.1016/j.cell.2021.03.044		APR 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RN5JL	33861959	Bronze			2022-12-28	WOS:000640387300008
J	Voss, WN; Hou, YXJ; Johnson, NV; Delidakis, G; Kim, JE; Javanmardi, K; Horton, AP; Bartzoka, F; Paresi, CJ; Tanno, Y; Chou, CW; Abbasi, SA; Pickens, W; George, K; Boutz, DR; Towers, DM; McDaniel, JR; Billick, D; Goike, J; Rowe, L; Batra, D; Pohl, J; Lee, J; Gangappa, S; Sambhara, S; Gadush, M; Wang, NS; Person, MD; Iverson, BL; Gollihar, JD; Dye, JM; Herbert, AS; Finkelstein, IJ; Baric, RS; McLellan, JS; Georgiou, G; Lavinder, JJ; Ippolito, GC				Voss, William N.; Hou, Yixuan J.; Johnson, Nicole, V; Delidakis, George; Kim, Jin Eyun; Javanmardi, Kamyab; Horton, Andrew P.; Bartzoka, Foteini; Paresi, Chelsea J.; Tanno, Yuri; Chou, Chia-Wei; Abbasi, Shawn A.; Pickens, Whitney; George, Katia; Boutz, Daniel R.; Towers, Dalton M.; McDaniel, Jonathan R.; Billick, Daniel; Goike, Jule; Rowe, Lori; Batra, Dhwani; Pohl, Jan; Lee, Justin; Gangappa, Shivaprakash; Sambhara, Suryaprakash; Gadush, Michelle; Wang, Nianshuang; Person, Maria D.; Iverson, Brent L.; Gollihar, Jimmy D.; Dye, John M.; Herbert, Andrew S.; Finkelstein, Ilya J.; Baric, Ralph S.; McLellan, Jason S.; Georgiou, George; Lavinder, Jason J.; Ippolito, Gregory C.			Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes	SCIENCE			English	Article							ANTIBODY; REPERTOIRE; SOFTWARE; MEMORY	The molecular composition and binding epitopes of the immunoglobulin G (IgG) antibodies that circulate in blood plasma after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are unknown. Proteomic deconvolution of the IgG repertoire to the spike glycoprotein in convalescent subjects revealed that the response is directed predominantly (>80%) against epitopes residing outside the receptor binding domain (RBD). In one subject, just four IgG lineages accounted for 93.5% of the response, including an amino (N)-terminal domain (NTD)-directed antibody that was protective against lethal viral challenge. Genetic, structural, and functional characterization of a multidonor class of "public" antibodies revealed an NTD epitope that is recurrently mutated among emerging SARS-CoV-2 variants of concern. These data show that "public" NTD-directed and other non-RBD plasma antibodies are prevalent and have implications for SARS-CoV-2 protection and antibody escape.	[Voss, William N.; Johnson, Nicole, V; Javanmardi, Kamyab; Horton, Andrew P.; Bartzoka, Foteini; Chou, Chia-Wei; Pickens, Whitney; George, Katia; Boutz, Daniel R.; Billick, Daniel; Goike, Jule; Wang, Nianshuang; Gollihar, Jimmy D.; Finkelstein, Ilya J.; McLellan, Jason S.; Georgiou, George; Lavinder, Jason J.; Ippolito, Gregory C.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Hou, Yixuan J.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Delidakis, George; Tanno, Yuri; Towers, Dalton M.; Georgiou, George; Lavinder, Jason J.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Kim, Jin Eyun; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Paresi, Chelsea J.; Iverson, Brent L.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Abbasi, Shawn A.; Dye, John M.; Herbert, Andrew S.] US Army Med Res Inst Infect Dis, Frederick, MD USA; [Boutz, Daniel R.; Gollihar, Jimmy D.] Univ Texas Austin, CCDC Army Res Lab South, Austin, TX 78712 USA; [McDaniel, Jonathan R.] Pfizer, Biomed Design, Cambridge, MA USA; [Rowe, Lori; Batra, Dhwani; Pohl, Jan; Lee, Justin] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Div Sci Resources, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Rowe, Lori] Tulane Natl Primate Res Ctr, Dept Microbiol, 18703 Three Rivers Rd, Covington, LA USA; [Gangappa, Shivaprakash; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Immunol & Pathogenesis Branch, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Gadush, Michelle; Person, Maria D.] Univ Texas Austin, Ctr Biomed Res Support, Austin, TX 78712 USA; [Gollihar, Jimmy D.; Ippolito, Gregory C.] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston Methodist Res Inst, Houston, TX 77030 USA; [Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Georgiou, George; Ippolito, Gregory C.] Univ Texas Austin, Dept Oncol, Dell Med Sch, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; University of Texas System; University of Texas Austin; Pfizer; Centers for Disease Control & Prevention - USA; Tulane University; Centers for Disease Control & Prevention - USA; University of Texas System; University of Texas Austin; The Methodist Hospital System; The Methodist Hospital - Houston; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin	Lavinder, JJ; Ippolito, GC (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.; Lavinder, JJ (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Ippolito, GC (corresponding author), Houston Methodist Hosp, Dept Pathol & Genom Med, Houston Methodist Res Inst, Houston, TX 77030 USA.; Ippolito, GC (corresponding author), Univ Texas Austin, Dept Oncol, Dell Med Sch, Austin, TX 78712 USA.	jlavinder@utexas.edu; gci@utexas.edu	Ippolito, Gregory C./AAR-2930-2021	Ippolito, Gregory C./0000-0002-7565-7002; Paresi, Chelsea/0000-0002-2405-8085; Chou, Chia-Wei/0000-0001-9618-338X; Kim, Jin Eyun/0000-0002-6297-3292; Gollihar, Jimmy/0000-0003-3957-2092; Hou, Yixuan/0000-0002-8323-7243; Pickens, Whitney/0000-0001-6100-8231; George, Katia/0000-0001-8511-7918; Horton, Andrew/0000-0002-0272-4411; Johnson, Nicole/0000-0003-4351-125X; Javanmardi, Kamyab/0000-0002-6449-6709	Military Infectious Diseases Research Program [14066041]; NIH [P41-GM103311]; University of Texas College of Natural Sciences; Cancer Prevention and Research Institute of Texas (CPRIT) [RR160023]; Clayton Foundation; National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (NIAID) [R01-AI127521]; Welch Foundation [F-0003-19620604, F-1016]; NIH NCI COVID-19 SeroNet grant [U54-CA260543]; UT System Proteomics Network pilot funding; NIH NIAID [75N93019C00050]	Military Infectious Diseases Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas College of Natural Sciences; Cancer Prevention and Research Institute of Texas (CPRIT); Clayton Foundation; National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NIH NCI COVID-19 SeroNet grant; UT System Proteomics Network pilot funding; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for USAMRIID was provided through the CARES Act with programmatic oversight from the Military Infectious Diseases Research Program-project 14066041. Opinions, conclusions, interpretations, and recommendations are those of the authors and are not necessarily endorsed by the U.S. Army. The mention of trade names or commercial products does not constitute endorsement or recommendation for use by the Department of the Army or the Department of Defense. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of Centers for Disease Control and Prevention. Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311. The Sauer Structural Biology Laboratory is supported by the University of Texas College of Natural Sciences and by award RR160023 from the Cancer Prevention and Research Institute of Texas (CPRIT). This research was funded in part by the Clayton Foundation (C.J.P., B.L.I., G.G.) and a National Institutes of Health (NIH)-National Institute of Allergy and Infectious Diseases (NIAID) grant awarded to J.S.M. (R01-AI127521), as well as by Welch Foundation grant nos. F-0003-19620604 (J.S.M.) and F-1016 (I.J.F.); NIH NCI COVID-19 SeroNet grant U54-CA260543 (R.S.B.); UT System Proteomics Network pilot funding (J.J.L, M.D.P.); and in part with federal funds under a contract from the NIH NIAID, contract no. 75N93019C00050 (G.G., J.J.L., G.C.I.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andreano Emanuele, 2020, bioRxiv, DOI 10.1101/2020.12.28.424451; Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Chi XY, 2020, SCIENCE, V369, P650, DOI 10.1126/science.abc6952; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Choonhan Y, 2017, COSMIC2 SCI GATEWAY; Croll TI, 2018, ACTA CRYSTALLOGR D, V74, P519, DOI 10.1107/S2059798318002425; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; Dunbar J, 2016, NUCLEIC ACIDS RES, V44, pW474, DOI 10.1093/nar/gkw361; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Henderson R, 2020, NAT STRUCT MOL BIOL, V27, P925, DOI [10.1101/2020.05.18.102087, 10.1038/s41594-020-0479-4]; Hou YXJ, 2020, CELL, V182, P429, DOI 10.1016/j.cell.2020.05.042; Hsieh Ching-Lin, 2020, bioRxiv, DOI [10.1126/science.abd0826, 10.1101/2020.05.30.125484]; Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497; Javanmardi K., 2021, RAPID CHARACTERIZATI; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Lavinder JJ, 2015, CURR OPIN CHEM BIOL, V24, P112, DOI 10.1016/j.cbpa.2014.11.007; Lefranc MP, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8090319; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Liu L, 2022, IEEE T KNOWL DATA EN, V34, P2293, DOI [10.1109/TKDE.2020.3004939, 10.1101/2020.06.17.153486]; McCarthy KR, 2021, SCIENCE, V371, P1139, DOI 10.1126/science.abf6950; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Nielsen Sandra C A, 2020, Res Sq, DOI 10.21203/rs.3.rs-27220/v1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Resende P.C., 2021, ONGOING EVOLUTION VA; Ripperger TJ, 2020, IMMUNITY, V53, P925, DOI 10.1016/j.immuni.2020.10.004; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Salazar Eric, 2020, medRxiv, DOI 10.1101/2020.05.08.20095471; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, JAMA INTERN MED, V180, P1356, DOI 10.1001/jamainternmed.2020.4616; Zost Seth J, 2020, bioRxiv, DOI 10.1101/2020.05.22.111005	54	86	87	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2021	372	6546					1108	+		10.1126/science.abg5268	http://dx.doi.org/10.1126/science.abg5268			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM5NE	33947773	Green Published, Green Submitted			2022-12-28	WOS:000657651200053
J	Powell, EE; Wong, VWS; Rinella, M				Powell, Elizabeth E.; Wong, Vincent Wai-Sun; Rinella, Mary			Non-alcoholic fatty liver disease	LANCET			English	Review							FIBROSIS STAGE; CARDIOVASCULAR OUTCOMES; PROSPECTIVE DERIVATION; NONINVASIVE FIBROSIS; DIABETES-MELLITUS; PHYSICAL-ACTIVITY; NATURAL-HISTORY; STEATOHEPATITIS; PROGRESSION; STEATOSIS	Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of 25% and is a leading cause of cirrhosis and hepatocellular carcinoma. NAFLD encompasses a disease continuum from steatosis with or without mild inflammation (non-alcoholic fatty liver), to non-alcoholic steatohepatitis (NASH), which is characterised by necroinflammation and faster fibrosis progression than non-alcoholic fatty liver. NAFLD has a bidirectional association with components of the metabolic syndrome, and type 2 diabetes increases the risk of cirrhosis and related complications. Although the leading causes of death in people with NAFLD are cardiovascular disease and extrahepatic malignancy, advanced liver fibrosis is a key prognostic marker for liver-related outcomes and overall mortality, and can be assessed with combinations of non-invasive tests. Patients with cirrhosis should be screened for hepatocellular carcinoma and oesophageal varices. There is currently no approved therapy for NAFLD, although several drugs are in advanced stages of development. Because of the complex pathophysiology and substantial heterogeneity of disease phenotypes, combination treatment is likely to be required for many patients with NAFLD. Healthy lifestyle and weight reduction remain crucial to the prevention and treatment of NAFLD.	[Powell, Elizabeth E.] Univ Queensland, Translat Res Inst, Fac Med, Ctr Liver Dis Res, Brisbane, Qld, Australia; [Powell, Elizabeth E.] Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia; [Wong, Vincent Wai-Sun] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Wong, Vincent Wai-Sun] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China; [Rinella, Mary] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Queensland; Chinese University of Hong Kong; Chinese University of Hong Kong; Northwestern University; Feinberg School of Medicine	Powell, EE (corresponding author), Princess Alexandra Hosp, Dept Gastroenterol & Hepatol, Brisbane, Qld 4102, Australia.	e.powell@uq.edu.au						Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Albhaisi S, 2019, PHARM MED, V33, P451, DOI 10.1007/s40290-019-00305-z; Alexander M, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1103-x; Allen AM, 2019, J HEPATOL, V71, P1229, DOI 10.1016/j.jhep.2019.08.018; Allen AM, 2018, HEPATOLOGY, V68, P2230, DOI 10.1002/hep.30094; Allen AM, 2018, HEPATOLOGY, V67, P1726, DOI 10.1002/hep.29546; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; [Anonymous], 2020, INTERCEPT RECEIVES C; Anstee QM, 2019, HEPATOLOGY, V70, P1521, DOI 10.1002/hep.30842; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Armstrong MJ, 2016, LANCET, V387, P679, DOI 10.1016/S0140-6736(15)00803-X; Aron-Wisnewsky J, 2020, GASTROENTEROLOGY, V158, P1881, DOI 10.1053/j.gastro.2020.01.049; Azzu V, 2020, GASTROENTEROLOGY, V158, P1899, DOI 10.1053/j.gastro.2019.12.054; Bedossa P, 2014, HEPATOLOGY, V60, P565, DOI 10.1002/hep.27173; Belfort R, 2006, NEW ENGL J MED, V355, P2297, DOI 10.1056/NEJMoa060326; Brain D, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05233-2; Bril F, 2019, DIABETES CARE, V42, P1481, DOI 10.2337/dc19-0167; Bril F, 2015, LIVER INT, V35, P2139, DOI 10.1111/liv.12840; Carlsson B, 2020, ALIMENT PHARM THER, V51, P1305, DOI 10.1111/apt.15738; Caussy C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09455-9; Caussy C, 2018, HEPATOLOGY, V68, P763, DOI 10.1002/hep.29797; Cefalu WT, 2019, DIABETES CARE, V42, pS34, DOI 10.2337/dc19-S004; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Chalmers J, 2020, FRONTLINE GASTROENTE, V11, P86, DOI 10.1136/flgastro-2019-101177; Cusi K, 2020, LIVER INT, V40, P82, DOI 10.1111/liv.14350; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Daniels SJ, 2019, HEPATOLOGY, V69, P1075, DOI 10.1002/hep.30163; Davison BA, 2020, J HEPATOL, V73, P1322, DOI 10.1016/j.jhep.2020.06.025; Davyduke T, 2019, HEPATOL COMMUN, V3, P1322, DOI 10.1002/hep4.1411; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; EASL, 2016, DIABETOLOGIA, V59, P1121, DOI 10.1007/s00125-016-3902-y; Eddowes PJ, 2019, GASTROENTEROLOGY, V156, P1717, DOI 10.1053/j.gastro.2019.01.042; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; El-Gohary M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208798; Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039; Eslam M, 2020, GASTROENTEROLOGY, V158, P1999, DOI 10.1053/j.gastro.2019.11.312; Eslam M, 2020, NAT REV GASTRO HEPAT, V17, P40, DOI 10.1038/s41575-019-0212-0; Estes C, 2020, ALIMENT PHARM THER, V51, P801, DOI 10.1111/apt.15673; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Friedman SL, 2018, NAT MED, V24, P908, DOI 10.1038/s41591-018-0104-9; Gerage AM, 2018, J GASTROEN HEPATOL, V33, P741, DOI 10.1111/jgh.13965; Ghorpade DS, 2018, NATURE, V555, P673, DOI 10.1038/nature26138; Hagstrom H, 2020, GASTROENTEROLOGY, V158, P200, DOI 10.1053/j.gastro.2019.09.008; Haldar D, 2019, J HEPATOL, V71, P313, DOI 10.1016/j.jhep.2019.04.011; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Harrison SA, 2020, LANCET GASTROENTEROL, V5, P970, DOI 10.1016/S2468-1253(20)30252-1; Harrison SA, 2021, GASTROENTEROLOGY, V160, P219, DOI 10.1053/j.gastro.2020.08.004; Harrison SA, 2020, J HEPATOL, V73, P26, DOI 10.1016/j.jhep.2020.02.027; Harrison SA, 2019, LANCET, V394, P2012, DOI 10.1016/S0140-6736(19)32517-6; Hsiang JC, 2020, CLIN GASTROENTEROL H, V18, P2168, DOI 10.1016/j.cgh.2020.05.021; Jarvis H, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003100; Kanwal F, 2020, HEPATOLOGY, V71, P808, DOI 10.1002/hep.31014; Kanwal F, 2018, GASTROENTEROLOGY, V155, P1828, DOI 10.1053/j.gastro.2018.08.024; Kleiner DE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12565; Krawczyk M, 2020, GASTROENTEROLOGY, V158, P1865, DOI 10.1053/j.gastro.2020.01.053; Kushner RF, 2020, OBESITY, V28, P1050, DOI 10.1002/oby.22794; Kwak MS, 2017, LIVER INT, V37, P919, DOI 10.1111/liv.13332; Lassailly G, 2020, GASTROENTEROLOGY, V159, P1290, DOI 10.1053/j.gastro.2020.06.006; Lazarus JV, 2020, NAT REV GASTRO HEPAT, V17, P377, DOI 10.1038/s41575-020-0315-7; Lazarus JV, 2020, J HEPATOL, V72, P14, DOI 10.1016/j.jhep.2019.08.027; Lazo Mariana, 2011, BMJ, V343, pd6891, DOI 10.1136/bmj.d6891; Lee BW, 2020, DIABETES METAB J, V44, P382, DOI 10.4093/dmj.2020.0010; Lee HW, 2020, HEPATOLOGY, V72, P1230, DOI 10.1002/hep.31142; Lefere S, 2019, JHEP REP, V1, P30, DOI 10.1016/j.jhepr.2019.02.004; Liu K, 2017, AM J GASTROENTEROL, V112, P1812, DOI 10.1038/ajg.2017.389; Liu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47687-3; Loomba R, 2021, HEPATOLOGY, V73, P625, DOI 10.1002/hep.31622; Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Ma JT, 2018, GASTROENTEROLOGY, V155, P107, DOI 10.1053/j.gastro.2018.03.038; Mahady SE, 2017, CLIN GASTROENTEROL H, V15, P1453, DOI 10.1016/j.cgh.2017.02.031; Marchesini G, 2019, J HEPATOL, V71, P1073, DOI 10.1016/j.jhep.2019.09.020; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; McSweeney L, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2020.100099; Meffert PJ, 2018, J HEPATOL, V68, P858, DOI 10.1016/j.jhep.2017.11.038; National Institute for Health and Care Excellence, 2016, NON FATT LIV DIS NAF; Neuschwander-Tetri BA, 2020, GASTROENTEROLOGY, V158, P1984, DOI 10.1053/j.gastro.2020.01.051; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Newsome PN, 2021, NEW ENGL J MED, V384, P1113, DOI 10.1056/NEJMoa2028395; Newsome PN, 2020, LANCET GASTROENTEROL, V5, P362, DOI 10.1016/S2468-1253(19)30383-8; Nobili V, 2009, GASTROENTEROLOGY, V136, P160, DOI 10.1053/j.gastro.2008.09.013; O'Neil PM, 2018, LANCET, V392, P637, DOI 10.1016/S0140-6736(18)31773-2; Paik JM, 2020, HEPATOLOGY, V72, P1605, DOI 10.1002/hep.31173; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Park CC, 2017, GASTROENTEROLOGY, V152, P598, DOI 10.1053/j.gastro.2016.10.026; Patel PJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006761; Petta S, 2018, J HEPATOL, V69, P18, DOI [10.1016/j.jhep.2018.02.015, 10.1016/j.jhep.2018.05.019]; Pitisuttithum P, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01240-z; Pockros PJ, 2019, LIVER INT, V39, P2082, DOI 10.1111/liv.14209; Polyzos SA, 2019, METABOLISM, V92, P82, DOI 10.1016/j.metabol.2018.11.014; POWELL EE, 1990, HEPATOLOGY, V11, P74, DOI 10.1002/hep.1840110114; Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rinella ME, 2020, J HEPATOL, V73, P9, DOI 10.1016/j.jhep.2020.04.034; Rinella ME, 2019, HEPATOLOGY, V70, P1424, DOI 10.1002/hep.30782; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rowe IA, 2018, LANCET GASTROENTEROL, V3, P66, DOI 10.1016/S2468-1253(17)30142-5; Sanyal AJ, 2006, HEPATOLOGY, V43, P682, DOI 10.1002/hep.21103; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Shili-Masmoudi S, 2020, LIVER INT, V40, P581, DOI 10.1111/liv.14301; Siddiqui MS, 2019, CLIN GASTROENTEROL H, V17, P156, DOI 10.1016/j.cgh.2018.04.043; Siddiqui MS, 2015, CLIN GASTROENTEROL H, V13, P1000, DOI 10.1016/j.cgh.2014.10.008; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Srivastava A, 2019, J HEPATOL, V71, P371, DOI 10.1016/j.jhep.2019.03.033; Stender S, 2017, NAT GENET, V49, P842, DOI 10.1038/ng.3855; Sung KC, 2016, J HEPATOL, V65, P791, DOI 10.1016/j.jhep.2016.05.026; Targher G, 2020, GUT, V69, P1545, DOI 10.1136/gutjnl-2020-321611; Targher G, 2020, GUT, V69, P1691, DOI 10.1136/gutjnl-2020-320622; Taylor RS, 2020, GASTROENTEROLOGY, V158, P1611, DOI 10.1053/j.gastro.2020.01.043; THALER H, 1962, VIRCHOWS ARCH A, V335, P180, DOI 10.1007/BF02438705; Tsochatzis EA, 2018, LANCET GASTROENTEROL, V3, P509, DOI 10.1016/S2468-1253(18)30077-3; Unalp-Arida A, 2020, HEPATOLOGY, V71, P820, DOI 10.1002/hep.31032; Vilar-Gomez E, 2020, HEPATOLOGY, V71, P495, DOI 10.1002/hep.30368; Vilar-Gomez E, 2018, GASTROENTEROLOGY, V155, P443, DOI 10.1053/j.gastro.2018.04.034; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Vittorio J, 2020, F1000 RES, V9, P9; Wai JW, 2020, J GASTROENTEROL, V55, P731, DOI 10.1007/s00535-020-01686-8; Wei JL, 2015, AM J GASTROENTEROL, V110, P1306, DOI 10.1038/ajg.2015.235; Wong RJ, 2015, GASTROENTEROLOGY, V148, P547, DOI 10.1053/j.gastro.2014.11.039; Wong RJ, 2014, HEPATOLOGY, V59, P2188, DOI 10.1002/hep.26986; Wong VWS, 2009, ALIMENT PHARM THER, V29, P387, DOI 10.1111/j.1365-2036.2008.03896.x; Wong VWS, 2019, GUT, V68, P2057, DOI 10.1136/gutjnl-2018-317334; Wong VWS, 2018, NAT REV GASTRO HEPAT, V15, P461, DOI 10.1038/s41575-018-0014-9; Wong VWS, 2018, J GASTROEN HEPATOL, V33, P70, DOI 10.1111/jgh.13857; Wu SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33386; Ye Q, 2020, LANCET GASTROENTEROL, V5, P739, DOI 10.1016/S2468-1253(20)30077-7; Younossi Z, 2018, J HEPATOL, V69, P1365, DOI 10.1016/j.jhep.2018.08.013; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2021, HEPATOLOGY, V73, P1194, DOI 10.1002/hep.31420; Younossi ZM, 2019, LANCET, V394, P2184, DOI 10.1016/S0140-6736(19)33041-7; Younossi ZM, 2020, DIABETES CARE, V43, P283, DOI 10.2337/dc19-1113; Younossi ZM, 2019, J HEPATOL, V71, P793, DOI 10.1016/j.jhep.2019.06.021; Younossi ZM, 2019, HEPATOLOGY, V69, P564, DOI 10.1002/hep.30254; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	142	247	251	142	279	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2021	397	10290					2212	2224		10.1016/S0140-6736(20)32511-3	http://dx.doi.org/10.1016/S0140-6736(20)32511-3		JUN 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SM8DI	33894145				2022-12-28	WOS:000657828600027
J	Hsieh, TS; Lopez, VA; Black, MH; Osinski, A; Pawlowski, K; Tomchick, DR; Liou, J; Tagliabracci, VS				Hsieh, Ting-Sung; Lopez, Victor A.; Black, Miles H.; Osinski, Adam; Pawlowski, Krzysztof; Tomchick, Diana R.; Liou, Jen; Tagliabracci, Vincent S.			Dynamic remodeling of host membranes by self-organizing bacterial effectors	SCIENCE			English	Article							PHOSPHATIDYLINOSITOL 3-PHOSPHATE; SYSTEM; IDENTIFICATION; LOCALIZATION; OSCILLATIONS; RECOGNITION; DIVISION; FEATURES; REVEALS; MODEL	During infection, intracellular bacterial pathogens translocate a variety of effectors into host cells that modify host membrane trafficking for their benefit. We found a self-organizing system consisting of a bacterial phosphoinositide kinase and its opposing phosphatase that formed spatiotemporal patterns, including traveling waves, to remodel host cellular membranes. The Legionella effector MavQ, a phosphatidylinositol (PI) 3-kinase, was targeted to the endoplasmic reticulum (ER). MavQ and the Legionella PI 3-phosphatase SidP, even in the absence of other bacterial components, drove rapid PI 3-phosphate turnover on the ER and spontaneously formed traveling waves that spread along ER subdomains inducing vesicle and tubule budding. Thus, bacteria can exploit a self-organizing membrane-targeting mechanism to hijack host cellular structures for survival.	[Hsieh, Ting-Sung; Lopez, Victor A.; Black, Miles H.; Osinski, Adam; Pawlowski, Krzysztof; Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Pawlowski, Krzysztof] Warsaw Univ Life Sci, Inst Biol, Dept Biochem & Microbiol, PL-02776 Warsaw, Poland; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Tomchick, Diana R.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Liou, Jen] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Tagliabracci, Vincent S.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Warsaw University of Life Sciences; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.; Tagliabracci, VS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	vincent.tagliabracci@utsouthwestern.edu	Tomchick, Diana/HGV-2018-2022; Pawlowski, Krzysztof/C-2949-2013	Pawlowski, Krzysztof/0000-0002-5367-0935; Tagliabracci, Vincent/0000-0002-9735-4678; Tomchick, Diana/0000-0002-7529-4643; Osinski, Adam Krzysztof/0000-0003-0010-0733; Lopez, Victor Antonio/0000-0003-1618-5786; Black, Miles/0000-0002-2864-1710; Hsieh, Ting-Sung/0000-0003-2792-0168				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Borek D, 2003, ACTA CRYSTALLOGR D, V59, P2031, DOI 10.1107/S0907444903020924; Borek D, 2013, J SYNCHROTRON RADIAT, V20, P37, DOI 10.1107/S0909049512048807; Borek D, 2010, ACTA CRYSTALLOGR D, V66, P426, DOI 10.1107/S0907444909040177; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Chatfield Christa H, 2013, Methods Mol Biol, V954, P151, DOI 10.1007/978-1-62703-161-5_7; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELORENZO V, 1993, J BACTERIOL, V175, P6902, DOI 10.1128/jb.175.21.6902-6907.1993; Dong N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.236; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Halatek J, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0107; Hammond GRV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139957; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hansen SD, 2019, P NATL ACAD SCI USA, V116, P15013, DOI 10.1073/pnas.1901744116; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hsu FS, 2012, P NATL ACAD SCI USA, V109, P13567, DOI 10.1073/pnas.1207903109; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Ledvina H. E, CELL HOST MICROBE, V24; Ledvina HE, 2018, CELL HOST MICROBE, V24, P285, DOI 10.1016/j.chom.2018.07.003; Leslie A. G. W., 1991, CCP4 STUDY WEEKEND, P80; Li G, 2021, EMBO REP, V22, DOI 10.15252/embr.202051163; Li XR, 2013, P NATL ACAD SCI USA, V110, P21165, DOI 10.1073/pnas.1311864110; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; Mesmin B, 2017, EMBO J, V36, P3156, DOI 10.15252/embj.201796687; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Reddick LE, 2012, JOVE-J VIS EXP, DOI 10.3791/3650; Renard HF, 2018, TRENDS CELL BIOL, V28, P274, DOI 10.1016/j.tcb.2017.12.001; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sexton JA, 2005, MOL MICROBIOL, V57, P70, DOI 10.1111/j.1365-2958.2005.04667.x; Steiner B, 2018, INT J MED MICROBIOL, V308, P49, DOI 10.1016/j.ijmm.2017.08.004; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Toulabi L, 2013, J BIOL CHEM, V288, P24518, DOI 10.1074/jbc.M113.474239; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Urbanus ML, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167381; Weber S, 2014, MBIO, V5, DOI 10.1128/mBio.00839-13; Xiong D, 2016, NAT CHEM BIOL, V12, P159, DOI [10.1038/NCHEMBIO.2000, 10.1038/nchembio.2000]; Xu D, 2014, BIOINFORMATICS, V30, P660, DOI 10.1093/bioinformatics/btt578	57	6	6	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2021	372	6545					935	+		10.1126/science.aay8118	http://dx.doi.org/10.1126/science.aay8118			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK7YO	33927055	Green Accepted, Bronze			2022-12-28	WOS:000656432400040
J	Mohamed, F; Raal, FJ				Mohamed, Farzahna; Raal, Frederick J.			Hyperpigmentation from Addison's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mohamed, Farzahna; Raal, Frederick J.] Univ Witwatersrand, Johannesburg, South Africa	University of Witwatersrand	Mohamed, F (corresponding author), Univ Witwatersrand, Johannesburg, South Africa.	farzahna.mohamed@yahoo.com	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1752	1752		10.1056/NEJMicm2018221	http://dx.doi.org/10.1056/NEJMicm2018221			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33951364				2022-12-28	WOS:000647698500013
J	Calhoun, A				Calhoun, Amanda			The Pathophysiology of Racial Disparities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Calhoun, Amanda] Yale Child Study Ctr, New Haven, CT 06519 USA	Yale University	Calhoun, A (corresponding author), Yale Child Study Ctr, New Haven, CT 06519 USA.							Geiger H.J., 2003, UNEQUAL TREATMENT CO; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Mikati I, 2018, AM J PUBLIC HEALTH, V108, P480, DOI [10.2105/AJPH.2017.304297, 10.2105/ajph.2017.304297]; Owens DC, 2019, AM J PUBLIC HEALTH, V109, P1342, DOI 10.2105/AJPH.2019.305243	4	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20								10.1056/NEJMpv2105339	http://dx.doi.org/10.1056/NEJMpv2105339		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SJ4AW	33951379	Bronze			2022-12-28	WOS:000647809500001
J	Peyton, MA				Peyton, Margo A.			The Silent Mutation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Peyton, Margo A.] Johns Hopkins Sch Med, 733 N Broadway, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Peyton, MA (corresponding author), Johns Hopkins Sch Med, 733 N Broadway, Baltimore, MD 21205 USA.	mpeyton6@jhmi.edu						Comfort N, 2006, J HIST MED ALL SCI, V61, P415, DOI 10.1093/jhmas/jrl001; Sacks O., 1984, A LEG TO STAND ON; Sontag S., 1978, ILLNESS METAPHOR	3	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1721	1722		10.1001/jama.2021.5484	http://dx.doi.org/10.1001/jama.2021.5484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944872				2022-12-28	WOS:000647831200010
J	Agirman, G; Hsiao, EY				Agirman, Gulistan; Hsiao, Elaine Y.			SnapShot: The microbiota-gut-brain axis	CELL			English	Editorial Material									[Agirman, Gulistan; Hsiao, Elaine Y.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Agirman, G (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA.			Agirman, Gulistan/0000-0003-3379-9632				Benakis C, 2020, CURR OPIN NEUROBIOL, V61, P1, DOI 10.1016/j.conb.2019.11.009; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Erny D, 2017, IMMUNOLOGY, V150, P7, DOI 10.1111/imm.12645; Foster JA, 2017, NEUROBIOL STRESS, V7, P124, DOI 10.1016/j.ynstr.2017.03.001; Jameson KG, 2020, MOL CELL, V78, P577, DOI 10.1016/j.molcel.2020.03.006; Joly A, 2021, TRENDS MICROBIOL, V29, P686, DOI 10.1016/j.tim.2020.11.007; Pronovost GN, 2019, IMMUNITY, V50, P18, DOI 10.1016/j.immuni.2018.11.016; Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015; Vuong HE, 2017, ANNU REV NEUROSCI, V40, P21, DOI 10.1146/annurev-neuro-072116-031347	9	31	33	14	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2021	184	9					2524	2525		10.1016/j.cell.2021.03.022	http://dx.doi.org/10.1016/j.cell.2021.03.022		APR 2021	2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RV7SH	33930299	Bronze			2022-12-28	WOS:000646027900027
J	Eckardt, KU; Agarwal, R; Aswad, A; Awad, A; Block, GA; Bacci, MR; Farag, YMK; Fishbane, S; Hubert, H; Jardine, A; Khawaja, Z; Koury, MJ; Maroni, BJ; Matsushita, K; McCullough, PA; Lewis, EF; Luo, WL; Parfrey, PS; Pergola, P; Sarnak, MJ; Spinowitz, B; Tumlin, J; Vargo, DL; Walters, KA; Winkelmayer, WC; Wittes, J; Zwiech, R; Chertow, GM				Eckardt, Kai-Uwe; Agarwal, Rajiv; Aswad, Ahmad; Awad, Ahmed; Block, Geoffrey A.; Bacci, Marcelo R.; Farag, Youssef M. K.; Fishbane, Steven; Hubert, Harold; Jardine, Alan; Khawaja, Zeeshan; Koury, Mark J.; Maroni, Bradley J.; Matsushita, Kunihiro; McCullough, Peter A.; Lewis, Eldrin F.; Luo, Wenli; Parfrey, Patrick S.; Pergola, Pablo; Sarnak, Mark J.; Spinowitz, Bruce; Tumlin, James; Vargo, Dennis L.; Walters, Kimberly A.; Winkelmayer, Wolfgang C.; Wittes, Janet; Zwiech, Rafal; Chertow, Glenn M.			Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, a class of compounds that stimulate endogenous erythropoietin production. Methods We conducted two randomized, open-label, noninferiority phase 3 trials to evaluate the safety and efficacy of vadadustat, as compared with darbepoetin alfa, in patients with anemia and incident or prevalent dialysis-dependent chronic kidney disease (DD-CKD). The primary safety end point, assessed in a time-to-event analysis, was the first occurrence of a major adverse cardiovascular event (MACE, a composite of death from any cause, a nonfatal myocardial infarction, or a nonfatal stroke), pooled across the trials (noninferiority margin, 1.25). A key secondary safety end point was the first occurrence of a MACE plus hospitalization for either heart failure or a thromboembolic event. The primary and key secondary efficacy end points were the mean change in hemoglobin from baseline to weeks 24 to 36 and from baseline to weeks 40 to 52, respectively, in each trial (noninferiority margin, -0.75 g per deciliter). Results A total of 3923 patients were randomly assigned in a 1:1 ratio to receive vadadustat or darbepoetin alfa: 369 in the incident DD-CKD trial and 3554 in the prevalent DD-CKD trial. In the pooled analysis, a first MACE occurred in 355 patients (18.2%) in the vadadustat group and in 377 patients (19.3%) in the darbepoetin alfa group (hazard ratio, 0.96; 95% confidence interval [CI], 0.83 to 1.11). The mean differences between the groups in the change in hemoglobin concentration were -0.31 g per deciliter (95% CI, -0.53 to -0.10) at weeks 24 to 36 and -0.07 g per deciliter (95% CI, -0.34 to 0.19) at weeks 40 to 52 in the incident DD-CKD trial and -0.17 g per deciliter (95% CI, -0.23 to -0.10) and -0.18 g per deciliter (95% CI, -0.25 to -0.12), respectively, in the prevalent DD-CKD trial. The incidence of serious adverse events in the vadadustat group was 49.7% in the incident DD-CKD trial and 55.0% in the prevalent DD-CKD trial, and the incidences in the darbepoetin alfa group were 56.5% and 58.3%, respectively. Conclusions Among patients with anemia and CKD who were undergoing dialysis, vadadustat was noninferior to darbepoetin alfa with respect to cardiovascular safety and correction and maintenance of hemoglobin concentrations. (Funded by Akebia Therapeutics and Otsuka Pharmaceutical; INNO(2)VATE ClinicalTrials.gov numbers, NCT02865850 and NCT02892149.) Vadadustat for Anemia in Patients Undergoing Dialysis Two randomized, open-label, noninferiority phase 3 trials compared the prolyl hydroxylase inhibitor vadadustat with darbepoetin alfa in patients with incident or prevalent chronic kidney disease who were undergoing dialysis. Vadadustat was noninferior to darbepoetin alfa with respect to cardiovascular safety and correction and maintenance of hemoglobin concentrations.	[Eckardt, Kai-Uwe] Charite, Dept Nephrol & Med Intens Care, Charitepl 1, D-10117 Berlin, Germany; [Agarwal, Rajiv] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Aswad, Ahmad] Gonzalez MD & Aswad MD Hlth Care Serv, Miami, FL USA; [Awad, Ahmed] Clin Res Consultants, Kansas City, MO USA; [Block, Geoffrey A.] US Renal Care, Plano, TX USA; [McCullough, Peter A.] Baylor Univ, Med Ctr, Baylor Heart & Vasc Hosp, Baylor Heart & Vasc Inst, Dallas, TX USA; [Pergola, Pablo] Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, Renal Associates, San Antonio, TX 78229 USA; [Winkelmayer, Wolfgang C.] Baylor Coll Med, Sect Nephrol, Houston, TX 77030 USA; [Bacci, Marcelo R.] Praxis Med Res, Sao Paulo, Brazil; [Bacci, Marcelo R.] Fac Med ABC, Div Gen Practice, Dept Med, Sao Paulo, Brazil; [Farag, Youssef M. K.; Khawaja, Zeeshan; Maroni, Bradley J.; Luo, Wenli; Vargo, Dennis L.] Akebia Therapeut, Cambridge, MA USA; [Sarnak, Mark J.] Tufts Univ, Sch Med, Div Nephrol, Tufts Med Ctr, Boston, MA 02111 USA; [Fishbane, Steven] Hofstra Northwell Sch Med, Div Nephrol, Dept Med, Great Neck, NY USA; [Spinowitz, Bruce] New York Presbyterian, Div Nephrol, Queens, NY USA; [Hubert, Harold] Nephrol Associates, Augusta, GA USA; [Tumlin, James] Emory Univ, Sch Med, Atlanta, GA USA; [Jardine, Alan] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Koury, Mark J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Matsushita, Kunihiro] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Lewis, Eldrin F.; Chertow, Glenn M.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Parfrey, Patrick S.] Mem Univ, Dept Med, St John, NF, Canada; [Walters, Kimberly A.; Wittes, Janet] Stat Collaborat, Washington, DC USA; [Zwiech, Rafal] Med Univ Lodz, Barlicki Mem Teaching Hosp 1, Dialysis Dept, Dept Kidney Transplantat, Lodz, Poland	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Indiana University System; Indiana University Bloomington; Baylor University; Baylor University Medical Center; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Faculdade de Medicina do ABC; Tufts Medical Center; Tufts University; Northwell Health; Emory University; University of Glasgow; Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stanford University; Memorial University Newfoundland; Medical University Lodz	Eckardt, KU (corresponding author), Charite, Dept Nephrol & Med Intens Care, Charitepl 1, D-10117 Berlin, Germany.	nephro-intensiv@charite.de	Matsushita, Kunihiro/AAJ-5817-2020; Block, Geoffrey/AAV-8070-2021; Bacci, Marcelo R/K-8728-2012	Matsushita, Kunihiro/0000-0002-7179-718X; Block, Geoffrey/0000-0002-4646-7074; Bacci, Marcelo R/0000-0001-8578-8404; Chertow, Glenn/0000-0002-7599-0534; Jardine, Alan/0000-0001-5815-9370				Babitt JL, 2012, J AM SOC NEPHROL, V23, P1631, DOI 10.1681/ASN.2011111078; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Chen N, 2019, NEW ENGL J MED, V381, P1011, DOI 10.1056/NEJMoa1901713; Chertow GM, 2021, NEW ENGL J MED, V384, P1589, DOI 10.1056/NEJMoa2035938; Eckardt K-U., 2020, NEPHROL DIAL TRANSPL; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Haase VH, 2019, NEPHROL DIAL TRANSPL, V34, P90, DOI 10.1093/ndt/gfy055; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koury MJ, 2015, NAT REV NEPHROL, V11, P394, DOI 10.1038/nrneph.2015.82; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Luo W., 2020, NEPHROL DIAL TRANSPL; Macdougall IC, 2007, NEPHROL DIAL TRANSPL, V22, P2, DOI 10.1093/ndt/gfm160; Martin ER, 2017, AM J NEPHROL, V45, P380, DOI 10.1159/000464476; Maxwell PH, 2016, NAT REV NEPHROL, V12, P157, DOI 10.1038/nrneph.2015.193; Mix TCH, 2005, AM HEART J, V149, P408, DOI 10.1016/j.ahj.2004.09.047; Pergola PE, 2016, KIDNEY INT, V90, P1115, DOI 10.1016/j.kint.2016.07.019; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Schodel J, 2019, NAT REV NEPHROL, V15, P641, DOI 10.1038/s41581-019-0182-z; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Sugahara M, 2017, KIDNEY INT, V92, DOI 10.1016/j.kint.2017.02.035	23	53	57	5	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1601	1612		10.1056/NEJMoa2025956	http://dx.doi.org/10.1056/NEJMoa2025956			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1ND	33913638	Bronze			2022-12-28	WOS:000645605800011
J	Greenhalgh, T; Jimenez, JL; Prather, KA; Tufekci, Z; Fisman, D; Schooley, R				Greenhalgh, Trisha; Jimenez, Jose L.; Prather, Kimberly A.; Tufekci, Zeynep; Fisman, David; Schooley, Robert			Ten scientific reasons in support of airborne transmission of SARS-CoV-2	LANCET			English	Editorial Material									[Greenhalgh, Trisha] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Jimenez, Jose L.] Univ Colorado, Dept Chem, Boulder, CO 80309 USA; [Jimenez, Jose L.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Prather, Kimberly A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Tufekci, Zeynep] Univ N Carolina, Sch Informat & Lib Sci, Chapel Hill, NC 27515 USA; [Fisman, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Schooley, Robert] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis & Global Publ Hlth, La Jolla, CA 92093 USA	University of Oxford; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of California System; University of California San Diego	Greenhalgh, T (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	trish.greenhalgh@phc.ox.ac.uk	Prather, Kim/A-3892-2008; Greenhalgh, Trisha/B-1825-2015; Jimenez, Jose L/A-5294-2008	Prather, Kim/0000-0003-3048-9890; Greenhalgh, Trisha/0000-0003-2369-8088; Jimenez, Jose L/0000-0001-6203-1847				Bulfone TC, 2021, J INFECT DIS, V223, P550, DOI 10.1093/infdis/jiaa742; Chen WZ, 2020, BUILD ENVIRON, V176, DOI 10.1016/j.buildenv.2020.106859; Eichler N, 2021, EMERG INFECT DIS, V27, P1274, DOI 10.3201/eid2705.210514; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.3, 10.12688/wellcomeopenres.15842.1]; Fennelly KP, 2020, LANCET RESP MED, V8, P914, DOI 10.1016/S2213-2600(20)30323-4; GELFAND HM, 1971, AM J EPIDEMIOL, V93, P234, DOI 10.1093/oxfordjournals.aje.a121251; Goldman E, 2020, LANCET INFECT DIS, V20, P892, DOI 10.1016/S1473-3099(20)30561-2; Guerra FM, 2017, LANCET INFECT DIS, V17, pE420, DOI 10.1016/S1473-3099(17)30307-9; Heneghan C.J., 2021, F1000RESEARCH, V10, DOI [10.12688/f1000research.52091.1, DOI 10.12688/F1000RESEARCH.52091.1]; Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057; Klompas M, 2021, ANN INTERN MED, V174, P794, DOI 10.7326/M20-7567; Kutter JS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21918-6; Laxminarayan Ramanan, 2020, Science, V370, P691, DOI 10.1126/science.abd7672; Lednicky JA, 2021, INT J INFECT DIS, V108, P212, DOI 10.1016/j.ijid.2021.04.063; Lednickya JA, 2020, INT J INFECT DIS, V100, P476, DOI [10.1016/j.ijid.2020.09.025, 10.1101/2020.08.03.20167395]; Lewis D, 2021, NATURE, V590, P544, DOI 10.1038/d41586-021-00460-x; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Nissen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76442-2; Pan M, 2019, J APPL MICROBIOL, V127, P1596, DOI 10.1111/jam.14278; Petersen E, 2020, LANCET INFECT DIS, V20, pE238, DOI 10.1016/S1473-3099(20)30484-9; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; Schijven J, 2021, ENVIRON HEALTH PERSP, V129, DOI 10.1289/EHP7886; Sun KY, 2021, SCIENCE, V371, P254, DOI 10.1126/science.abe2424; Tang JW, 2021, J HOSP INFECT, V110, P89, DOI 10.1016/j.jhin.2020.12.022; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]	25	356	363	20	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1603	1605		10.1016/S0140-6736(21)00869-2	http://dx.doi.org/10.1016/S0140-6736(21)00869-2		APR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33865497	Green Published, Bronze			2022-12-28	WOS:000645510600006
J	Wagner, M; Meyer, B; Setvin, M; Schmid, M; Diebold, U				Wagner, Margareta; Meyer, Bernd; Setvin, Martin; Schmid, Michael; Diebold, Ulrike			Direct assessment of the acidity of individual surface hydroxyls	NATURE			English	Article								The state of deprotonation/protonation of surfaces has far-ranging implications in chemistry, from acid-base catalysis(1) and the electrocatalytic and photocatalytic splitting of water(2), to the behaviour of minerals(3) and biochemistry(4). An entity's acidity is described by its proton affinity and its acid dissociation constant pK(a) (the negative logarithm of the equilibrium constant of the proton transfer reaction in solution). The acidity of individual sites is difficult to assess for solids, compared with molecules. For mineral surfaces, the acidity is estimated by semi-empirical concepts, such as bond-order valence sums(5), and increasingly modelled with first-principles molecular dynamics simulations(6,7). At present, such predictions cannot be tested-experimental measures, such as the point of zero charge(8), integrate over the whole surface or, in some cases, individual crystal facets(9). Here we assess the acidity of individual hydroxyl groups on In2O3(111)-a model oxide with four different types of surface oxygen atom. We probe the strength of their hydrogen bonds with the tip of a non-contact atomic force microscope and find quantitative agreement with density functional theory calculations. By relating the results to known proton affinities of gas-phase molecules, we determine the proton affinity of the different surface sites of In2O3 with atomic precision. Measurements on hydroxylated titanium dioxide and zirconium oxide extend our method to other oxides. Non-contact atomic force microscopy measurements are used to probe the hydrogen bond strength of individual surface hydroxyl groups and determine their acidity with atomic precision.	[Wagner, Margareta; Setvin, Martin; Schmid, Michael; Diebold, Ulrike] TU Wien, Inst Appl Phys, Vienna, Austria; [Wagner, Margareta] Brno Univ Technol, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Meyer, Bernd] Friedrich Alexander Univ Erlangen Nurnberg, Interdisciplinary Ctr Mol Mat, Erlangen, Germany; [Meyer, Bernd] Friedrich Alexander Univ Erlangen Nurnberg, Comp Chem Ctr, Erlangen, Germany; [Setvin, Martin] Charles Univ Prague, Fac Math & Phys, Dept Surface & Plasma Sci, Prague, Czech Republic	Technische Universitat Wien; Brno University of Technology; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Charles University Prague	Diebold, U (corresponding author), TU Wien, Inst Appl Phys, Vienna, Austria.	diebold@iap.tuwien.ac.at	Setvin, Martin/G-4879-2016	Setvin, Martin/0000-0002-1210-7740; Schmid, Michael/0000-0003-3373-9357; Diebold, Ulrike/0000-0003-0319-5256; Wagner, Margareta/0000-0001-9414-1696				Brown GE, 2012, GEOCHEM PERSPECT, V1, P483, DOI 10.7185/geochempersp.1.4; Bullard JW, 2006, LANGMUIR, V22, P10264, DOI 10.1021/la061900h; Capdevila-Cortada M, 2016, APPL CATAL B-ENVIRON, V197, P299, DOI 10.1016/j.apcatb.2016.02.035; Cheng J, 2010, J CHEM THEORY COMPUT, V6, P880, DOI 10.1021/ct100013q; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Giessibl FJ, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5052264; Gittus OR, 2018, J PHYS CHEM LETT, V9, P5574, DOI 10.1021/acs.jpclett.8b01870; Gorte RJ, 1997, TOP CATAL, V4, P57, DOI 10.1023/A:1019167601251; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Gross L, 2009, SCIENCE, V324, P1428, DOI 10.1126/science.1172273; Hagleitner DR, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.115441; Hapala P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085421; Hiemstra T, 1996, J COLLOID INTERF SCI, V184, P680, DOI 10.1006/jcis.1996.0666; Huber F, 2017, REV SCI INSTRUM, V88, DOI 10.1063/1.4993737; Hunter EPL, 1998, J PHYS CHEM REF DATA, V27, P413, DOI 10.1063/1.556018; Kosmulski M, 2009, ADV COLLOID INTERFAC, V152, P14, DOI 10.1016/j.cis.2009.08.003; Kowalski PM, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115410; KRAMER GJ, 1993, NATURE, V363, P529, DOI 10.1038/363529a0; Lackner P, 2018, J MATER CHEM A, V6, P17587, DOI 10.1039/c8ta04137g; Lantz MA, 2001, SCIENCE, V291, P2580, DOI 10.1126/science.1057824; Larrazabal GO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03980-9; Mallard, 2018, NIST CHEM WEBBOOK; Martin O., 2016, ANGEW CHEM, V128, P6369, DOI [10.1002/ange.201600943, DOI 10.1002/ANGE.201600943]; Onoda J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15155; Peng JB, 2018, NATURE, V557, P701, DOI 10.1038/s41586-018-0122-2; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Seh ZW, 2017, SCIENCE, V355, DOI 10.1126/science.aad4998; Setvin M, 2018, SCIENCE, V359, P572, DOI 10.1126/science.aar2287; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Sokolovic I, 2020, P NATL ACAD SCI USA, V117, P14827, DOI 10.1073/pnas.1922452117; Stetsovych O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8265; Stubian M, 2020, REV SCI INSTRUM, V91, DOI 10.1063/5.0011097; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Sugimoto Y, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106803; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Wagner M, 2017, ACS NANO, V11, P11531, DOI 10.1021/acsnano.7b06387; Wagner M, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.206101; Wagner M, 2014, ADV MATER INTERFACES, V1, DOI 10.1002/admi.201400289; Yurtsever A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.125416	41	25	25	33	149	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					722	+		10.1038/s41586-021-03432-3	http://dx.doi.org/10.1038/s41586-021-03432-3			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911267	Green Published			2022-12-28	WOS:000645368900013
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: India should stop mass gatherings and consider postponing elections, doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Wise J, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n1086	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1102	10.1136/bmj.n1102	http://dx.doi.org/10.1136/bmj.n1102			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910883	Bronze			2022-12-28	WOS:000656399900001
J	Javid, B; Bassler, D; Bryant, MB; Cevik, M; Tufekci, Z; Baral, S				Javid, Babak; Bassler, Dirk; Bryant, Manuel B.; Cevik, Muge; Tufekci, Zeynep; Baral, Stefan			Should masks be worn outdoors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC TRUST; HEALTH; STATE		[Javid, Babak] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA; [Bassler, Dirk; Bryant, Manuel B.] Univ Hosp Zurich, Dept Neonatol, Zurich, Switzerland; [Bassler, Dirk; Bryant, Manuel B.] Univ Zurich, Zurich, Switzerland; [Cevik, Muge] Univ St Andrews, Sch Med, Div Infect & Global Hlth Res, St Andrews, Fife, Scotland; [Tufekci, Zeynep] Univ N Carolina, Sch Informat, Chapel Hill, NC 27515 USA; [Tufekci, Zeynep] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27515 USA; [Baral, Stefan] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	University of California System; University of California San Francisco; University of Zurich; University Zurich Hospital; University of Zurich; University of St Andrews; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Javid, B (corresponding author), Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA.; Cevik, M (corresponding author), Univ St Andrews, Sch Med, Div Infect & Global Hlth Res, St Andrews, Fife, Scotland.	babak.javid@ucsf.edu; mc349@st-andrews.ac.uk	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Cevik, Muge/0000-0003-1133-3874				Bargain O, 2020, J PUBLIC ECON, V192, DOI 10.1016/j.jpubeco.2020.104316; Belosi F, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110603; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; de Bruin WB, 2020, J RISK UNCERTAINTY, V61, P177, DOI 10.1007/s11166-020-09336-3; Bulfone TC, 2021, J INFECT DIS, V223, P550, DOI 10.1093/infdis/jiaa742; Clair R, 2021, HUM SOC SCI COMMUN, V8, DOI 10.1057/s41599-021-00710-3; Dave D, 2021, SOUTH ECON J, V87, P769, DOI 10.1002/soej.12475; Duffy B., 2020, ACCEPTING SUFFERING; Firestone MJ, 2020, MMWR-MORBID MORTAL W, V69, P1771, DOI 10.15585/mmwr.mm6947e1; Foad A., 2020, RAPID SCOPING REV EV, DOI [DOI 10.1101/2020.09.04.20188417, 10.1101/2020.09.04.20188417]; Guy GP, 2021, MMWR-MORBID MORTAL W, V70, P350, DOI 10.15585/mmwr.mm7010e3externalicon; Holt Lunstad J, 2020, SOCIAL ISOLATION HLT; Leclerc Quentin J, 2020, Wellcome Open Res, V5, P83, DOI [10.12688/wellcomeopenres.15889.1, 10.12688/wellcomeopenres.15889.2]; Liu Y, 2020, LANCET, V395, pE47, DOI 10.1016/S0140-6736(20)30462-1; Neyman G, 2021, J PUBLIC HEALTH-UK, V43, P225, DOI 10.1093/pubmed/fdaa212; Nishiura H., 2020, MEDRXIV, DOI 10.1101/2020.02.28.20029272; Scheuch G, 2020, J AEROSOL MED PULM D, V33, P230, DOI 10.1089/jamp.2020.1616; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; van der Westhuizen HM, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3021; Waltenburg MA, 2021, EMERG INFECT DIS, V27, P243, DOI 10.3201/eid2701.203821; Wong F, 2020, P NATL ACAD SCI USA, V117, P29416, DOI 10.1073/pnas.2018490117; Worden Lee, 2020, medRxiv, DOI 10.1101/2020.06.09.20125831; Wynne B, 2006, COMMUNITY GENET, V9, P211, DOI 10.1159/000092659	23	2	2	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1036	10.1136/bmj.n1036	http://dx.doi.org/10.1136/bmj.n1036			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910914	Bronze, Green Accepted			2022-12-28	WOS:000656399900007
J	Rubin, R				Rubin, Rita			Vaccination Priorities Delay Shots for Higher-Risk People of Color	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1601	1601		10.1001/jama.2021.5115	http://dx.doi.org/10.1001/jama.2021.5115			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904885				2022-12-28	WOS:000645617800004
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK launches antivirals taskforce to deliver home treatments by autumn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, PFIZ IN PHAS 1 STUD PFIZ IN PHAS 1 STUD; [Anonymous], 2021, MERCK RIDG BIOTH PRO; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Department for Business Energy and Industrial Strategy, 2020, UK VACC TASKF 2020 A; Dyer O, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m626; Hayden FG, 2018, NEW ENGL J MED, V379, P913, DOI 10.1056/NEJMoa1716197; Horby PW, 2020, LANCET, V396, P1345, DOI 10.1016/S0140-6736(20)32013-4; Hsu J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4457; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; National Institute for Health Research, FAV BE INV POSS COVI FAV BE INV POSS COVI; Public Health England, 2014, US ANT TREATM PROPH; Tamiflu campaign, BMJ-BRIT MED J	12	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1077	10.1136/bmj.n1077	http://dx.doi.org/10.1136/bmj.n1077			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903129	Bronze			2022-12-28	WOS:000678538700004
J	Ruzycki, SM; Franceschet, S; Brown, A				Ruzycki, Shannon M.; Franceschet, Susan; Brown, Allison			Making medical leadership more diverse	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AFFIRMATIVE-ACTION; GENDER QUOTAS; FACULTY; STUDENTS; WOMEN; DISCRIMINATION; REPRESENTATION; ADVANCEMENT; HARASSMENT		[Ruzycki, Shannon M.; Brown, Allison] Univ Calgary, Cumming Sch Med, Div Gen Internal Med, Dept Med, Calgary, AB, Canada; [Ruzycki, Shannon M.; Brown, Allison] Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada; [Franceschet, Susan] Univ Calgary, Dept Polit Sci, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Ruzycki, SM (corresponding author), Univ Calgary, Cumming Sch Med, Div Gen Internal Med, Dept Med, Calgary, AB, Canada.; Ruzycki, SM (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med, Calgary, AB, Canada.	Shannon.Ruzycki@ucalgary.ca						AAMC, UND REPR MED DEF 200; Ambasta A, 2019, J GEN INTERN MED, V34, P2123, DOI 10.1007/s11606-019-05124-1; Antwi-Boasiako KB, 2004, J INSTR PSYCHOL, V31, P269; Association of American Colleges, 2020, DIV MED FACTS FIG 20; Association of Faculties of Medicine of Canada, 2018, CAN MED ED STAT 2018; Beaman L, 2009, Q J ECON, V124, P1497, DOI 10.1162/qjec.2009.124.4.1497; Bertrand M, 2019, REV ECON STUD, V86, P191, DOI 10.1093/restud/rdy032; Besley T, 2017, AM ECON REV, V107, P2204, DOI 10.1257/aer.20160080; Blake Valarie, 2012, Virtual Mentor, V14, P1003, DOI 10.1001/virtualmentor.2012.14.12.hlaw1-1212; Canadian Medical Association, CMA BOARD DIR 2019; Clayton A, 2019, AM J POLIT SCI, V63, P113, DOI 10.1111/ajps.12391; Cohen JJ, 2003, JAMA-J AM MED ASSOC, V289, P1143, DOI 10.1001/jama.289.9.1143; Devine PG, 2017, J EXP SOC PSYCHOL, V73, P211, DOI 10.1016/j.jesp.2017.07.002; Dhir A., 2016, CHALLENGING BOARDROO; Dobbin F, 2015, AM SOCIOL REV, V80, P1014, DOI 10.1177/0003122415596416; Dossa F, 2019, JAMA SURG, V154, P1134, DOI 10.1001/jamasurg.2019.3769; Eaton AA, 2020, SEX ROLES, V82, P127, DOI 10.1007/s11199-019-01052-w; Fitzsousa E, 2019, J GEN INTERN MED, V34, P2738, DOI 10.1007/s11606-019-05138-9; Gawad Nada, 2020, CMAJ Open, V8, pE34, DOI 10.9778/cmajo.20190090; Greenwood BN, 2020, P NATL ACAD SCI USA, V117, P21194, DOI 10.1073/pnas.1913405117; Guevara JP, 2013, JAMA-J AM MED ASSOC, V310, P2297, DOI 10.1001/jama.2013.282116; Halley MC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4926; Helitzer DL, 2017, J WOMENS HEALTH, V26, P540, DOI 10.1089/jwh.2016.6019; Hempenstall A, 2019, MED J AUSTRALIA, V211, P475, DOI 10.5694/mja2.50388; Herron RC., 2010, SUPERFICIALLY SIMILA; Hiatt Mark D., 2003, J AM PHYS SURG, V8, P37; Hu YY, 2019, NEW ENGL J MED, V381, P1741, DOI 10.1056/NEJMsa1903759; Hughes MM, 2017, ANNU REV SOCIOL, V43, P331, DOI 10.1146/annurev-soc-060116-053324; Institute for Democracy and Electoral Assistance, GEND QUOT DAT 2013; Johnson PA, 2018, SEXUAL HARASSMENT OF WOMEN: CLIMATE, CULTURE, AND CONSEQUENCES IN ACADEMIC SCIENCES, ENGINEERING, AND MEDICINE, P1, DOI 10.17226/24994; Kalev A, 2006, AM SOCIOL REV, V71, P589, DOI 10.1177/000312240607100404; Kelly R., 2016, ALL WOMEN SHORTLISTS, P5057; Klein R, 2019, J GEN INTERN MED, V34, P712, DOI 10.1007/s11606-019-04884-0; Krook ML, 2016, POLIT GROUPS IDENTIT, V4, P268, DOI 10.1080/21565503.2016.1151797; Lab D., 2021, DENSITYDESIGN; Ladher N., 2020, BMJ OPINION; Lakhan Shaheen Emmanuel, 2003, BMC Med Educ, V3, P6, DOI 10.1186/1472-6920-3-6; Maille C, 2015, EUR J AM STUD, V10, DOI 10.4000/ejas.10502; Mansbridge J, 1999, J POLIT, V61, P628, DOI 10.2307/2647821; Mayfield Jacob J, 2017, MedEdPORTAL, V13, P10634, DOI 10.15766/mep_2374-8265.10634; Meeks LM, 2016, JAMA-J AM MED ASSOC, V316, P2271, DOI 10.1001/jama.2016.10544; Rice VM, 2021, JAMA-J AM MED ASSOC, V325, P23, DOI 10.1001/jama.2020.21576; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; Ovseiko PV, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3975; Pantea MC, 2015, BRIT J SOCIOL EDUC, V36, P896, DOI 10.1080/01425692.2013.869172; Patra K, 2020, NFL; Pattani R, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1032-8; Phillips A., 1998, XENOPHON S; Phillips SP, 2019, ECLINICALMEDICINE, V7, P15, DOI 10.1016/j.eclinm.2019.01.008; Price EG, 2005, J GEN INTERN MED, V20, P565, DOI 10.1111/j.1525-1497.2005.0127.x; Rund J., 2020, BLOOMBERG LAW 0904; Ruzycki SM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.15165; Ruzycki SM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.2103; Ruzycki SM., BMJ LEAD, V2021, DOI [10.1136/leader-2020-000231, DOI 10.1136/LEADER-2020-000231]; SCHALLER JG, 1990, JAMA-J AM MED ASSOC, V264, P1854, DOI 10.1001/jama.264.14.1854; Sensoy O, 2017, HARVARD EDUC REV, V87, P557, DOI 10.17763/1943-5045-87.4.557; Somani AA, 2013, WM MARY L REV, V54; Spector ND, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-2149; Spector ND, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.6484; The five business benefits of a diverse team, 2019, MANAGER; Yasukawa K, 2014, TOHOKU J EXP MED, V232, P35, DOI 10.1620/tjem.232.35	61	6	6	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n945	10.1136/bmj.n945	http://dx.doi.org/10.1136/bmj.n945			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	TQ8OY	33903170				2022-12-28	WOS:000678538700010
J	Dyer, O				Dyer, Owen			Myanmar coup regime targets striking doctors with bullets, arrests, and erasures	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, IRRAWADDY; [Anonymous], 2021, WAVE NEW WARRANTS AR; Soe ZW, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00457-8	3	2	2	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2021	373								n1076	10.1136/bmj.n1076	http://dx.doi.org/10.1136/bmj.n1076			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0KR	33893072				2022-12-28	WOS:000708057000015
J	Konieczny, P; Naik, S				Konieczny, Piotr; Naik, Shruti			Healing without scarring	SCIENCE			English	Editorial Material							SKIN	A gene regulatory circuit directs tissue regeneration and limits fibrosis.	[Konieczny, Piotr; Naik, Shruti] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Konieczny, Piotr; Naik, Shruti] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Konieczny, Piotr; Naik, Shruti] NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA	New York University; New York University; New York University	Naik, S (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.; Naik, S (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.; Naik, S (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA.	shruti.naik@nyulangone.org	Konieczny, Piotr/F-8842-2015	Konieczny, Piotr/0000-0003-4114-349X				Alsamman S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay8798; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Gokey JJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122490; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Harn HIC, 2019, EXP DERMATOL, V28, P464, DOI 10.1111/exd.13460; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Mascharak S, 2021, SCIENCE, V372, P362, DOI 10.1126/science.aba2374; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151	11	6	6	10	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					346	347		10.1126/science.abi5770	http://dx.doi.org/10.1126/science.abi5770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888629				2022-12-28	WOS:000645009800023
J	Mason, M; Arukumar, P; Feinglass, J				Mason, Maryann; Arukumar, Ponni; Feinglass, Joe			The Pandemic Stay-at-Home Order and Opioid-Involved Overdose Fatalities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mason, Maryann] Northwestern Univ, Buehler Ctr Hlth Policy & Econ, Feinberg Sch Med, 420 E Super St,Ninth Floor, Chicago, IL 60611 USA; [Arukumar, Ponni] Cook Cty Med Examiners Off, Chicago, IL USA; [Feinglass, Joe] Northwestern Univ, Div Gen Internal Med & Geriatr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Mason, M (corresponding author), Northwestern Univ, Buehler Ctr Hlth Policy & Econ, Feinberg Sch Med, 420 E Super St,Ninth Floor, Chicago, IL 60611 USA.	maryann-mason@northwestern.edu						Alegria M, 2021, HEALTH AFFAIR, V40, P226, DOI 10.1377/hlthaff.2020.01472; [Anonymous], 2020, OP DAT DASHB; Centers for Disease Control and Prevention (CDC), 2020, INCR FAT DRUG OV US; Cook County Government, 2020, MED EX CAS ARCH; Englander H, 2020, J HOSP MED, V15, P628, DOI 10.12788/jhm.3485; Feinglass J, 2022, PUBLIC HEALTH REP, V137, P291, DOI 10.1177/0033354921994901; Larochelle MR, 2019, DRUG ALCOHOL DEPEN, V204, DOI 10.1016/j.drugalcdep.2019.06.039; Mason M, 2021, MMWR-MORBID MORTAL W, V70, P362, DOI 10.15585/mmwr.mm7010a3externalicon; Potier C, 2014, DRUG ALCOHOL DEPEN, V145, P48, DOI 10.1016/j.drugalcdep.2014.10.012	9	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2021	325	24					2495	2496		10.1001/jama.2021.6700	http://dx.doi.org/10.1001/jama.2021.6700		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD7ZK	33890982	Bronze			2022-12-28	WOS:000642581800001
J	[Anonymous]				[Anonymous]			Seven days in medicine: 14-20 April	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, 2021, 2020 ANT AG CLIN PRE	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2021	373								n1011	10.1136/bmj.n1011	http://dx.doi.org/10.1136/bmj.n1011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0MU	33888466				2022-12-28	WOS:000708062500001
J	Cuchet, P; Valette, X				Cuchet, Pierre; Valette, Xavier			Radiation pneumonitis and chemotherapy in a patient with multiple myeloma	LANCET			English	Editorial Material									[Valette, Xavier] Ctr Hosp Univ Caen Normandie, Serv Reanimat Med, Caen, France; [Cuchet, Pierre] Ctr Hosp Univ Caen Normandie, Serv Pneumol, F-14000 Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Cuchet, P (corresponding author), Ctr Hosp Univ Caen Normandie, Serv Pneumol, F-14000 Caen, France.	pierrecuchet91@gmail.com							0	1	1	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1484	1484						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33865496				2022-12-28	WOS:000640378100025
J	Nau, C; Navarro, RA; Chevez, SG; Hogan, T; Ironside, KR; Ludwig, SM; Ngo-Metzger, Q; Mourra, NR; Young, DR; Sangha, N; Turner, BP; Li, I; Padilla, A; Chen, AY; Hong, V; Yau, V; Tartof, S				Nau, Claudia; Navarro, Ronald A.; Chevez, Shari G.; Hogan, TiffanyA.; Ironside, Kristen R.; Ludwig, Stacey M.; Ngo-Metzger, Quyen; Mourra, Natalie R.; Young, Deborah Rohm; Sangha, Navdeep; Turner, Branden P.; Li, Iona (Xia); Padilla, Ariadna; Chen, Aiyu; Hong, Vennis; Yau, Vincent; Tartof, Sara			COVID-19 Inequities Across Multiple Racial and Ethnic Groups: Results From an Integrated Health Care Organization	ANNALS OF INTERNAL MEDICINE			English	Letter									[Nau, Claudia; Chevez, Shari G.; Young, Deborah Rohm; Li, Iona (Xia); Padilla, Ariadna; Chen, Aiyu; Hong, Vennis; Tartof, Sara] Kaiser Permanente Southern Calif, 100 South Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA; [Navarro, Ronald A.] Kaiser Permanente Southern Calif, South Bay Med Ctr, Harbor City, CA USA; [Hogan, TiffanyA.; Ironside, Kristen R.; Ludwig, Stacey M.; Mourra, Natalie R.] Kaiser Permanente Southern Calif, Los Angeles Med Ctr, Los Angeles, CA USA; [Ngo-Metzger, Quyen] Kaiser Permanente Sch Med, Pasadena, CA USA; [Turner, Branden P.] Kaiser Permanente Southern Calif, West Los Angeles Med Ctr, Los Angeles, CA USA; [Yau, Vincent] Genentech Inc, San Francisco, CA USA	Kaiser Permanente; Kaiser Permanente; Kaiser Permanente; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Kaiser Permanente; Kaiser Permanente; Roche Holding; Genentech	Nau, C (corresponding author), Kaiser Permanente Southern Calif, 100 South Los Robles Ave,2nd Floor, Pasadena, CA 91101 USA.	claudia.l.nau@kp.org	Navarro, Ronald A/AAE-1422-2019	Navarro, Ronald A/0000-0003-1869-6440; Hogan, Tiffany/0000-0002-9453-9167; Bruxvoort, Katia/0000-0001-8277-2431; Tartof, Sara/0000-0003-2336-8476	Roche-Genentech	Roche-Genentech(Roche HoldingGenentech)	By Roche-Genentech. However, the study was solely done at KPSC. The funder did not contribute to the design, conduct, or analysis of this study or tomanuscript development, writing, or review.	Escobar GJ, 2021, ANN INTERN MED, V174, P786, DOI 10.7326/M20-6979; Koebnick Corinna, 2012, Perm J, V16, P37; Lopez L, 2021, JAMA-J AM MED ASSOC, V325, P719, DOI 10.1001/jama.2020.26443; Tartof SY, 2020, ANN INTERN MED, V173, P773, DOI 10.7326/M20-3742	4	10	10	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG	2021	174	8					1183	+		10.7326/M20-8283	http://dx.doi.org/10.7326/M20-8283			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UP3IW	33872046	Green Published			2022-12-28	WOS:000695277800038
J	Gartlehner, G; Wagner, G; Affengruber, L; Chapman, A; Dobrescu, A; Klerings, I; Kaminski-Hartenthaler, A; Spiel, AO				Gartlehner, Gerald; Wagner, Gernot; Affengruber, Lisa; Chapman, Andrea; Dobrescu, Andreea; Klerings, Irma; Kaminski-Hartenthaler, Angela; Spiel, Alexander O.			Point-of-Care Ultrasonography in Patients With Acute Dyspnea: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							ACUTE HEART-FAILURE; INFERIOR VENA-CAVA; CHEST-X-RAY; LUNG ULTRASOUND; CARDIAC ULTRASOUND; EMERGENCY-DEPARTMENT; DIAGNOSTIC-ACCURACY; NATRIURETIC PEPTIDE; INTERNAL-MEDICINE; PNEUMONIA	Background: Dyspnea is a common and often debilitating symptom with a complex diagnostic work-up. Purpose: To evaluate the benefits, harms, and diagnostic test accuracy of point-of-care ultrasonography (POCUS) in patients with acute dyspnea. (PROSPERO: CRD42019126419) Data Sources: Searches of multiple electronic databases without language limitations (January 2004 to August 2020) and reference lists of pertinent articles and reviews. Study Selection: Five randomized controlled trials (RCTs) and 44 prospective cohort-type studies in patients with acute dyspnea evaluated POCUS as a diagnostic tool to determine the underlying cause of dyspnea. Two investigators independently screened the literature for inclusion. Data Extraction: Data abstraction by a single investigator was confirmed by a second investigator; 2 investigators independently rated risk of bias and determined certainty of evidence. Data Synthesis: Point-of-care ultrasonography, when added to a standard diagnostic pathway, led to statistically significantly more correct diagnoses in patients with dyspnea than the standard diagnostic pathway alone. In-hospital mortality and length of hospital stay did not differ significantly between patients who did or did not receive POCUS in addition to standard diagnostic tests. Finally, POCUS consistently improved the sensitivities of standard diagnostic pathways to detect congestive heart failure, pneumonia, pulmonary embolism, pleural effusion, or pneumothorax; specificities increased in most but not all studies. Limitations: Most studies assessed diagnostic test accuracy, which has limited utility for clinical decision making. Studies rarely reported on the proportion of indeterminate sonography results, and no evidence is available on adverse health outcomes of false-positive or false-negative POCUS results. Conclusion: Point-of-care ultrasonography can improve the correctness of diagnosis in patients with acute dyspnea.	[Gartlehner, Gerald; Wagner, Gernot; Affengruber, Lisa; Chapman, Andrea; Dobrescu, Andreea; Klerings, Irma; Kaminski-Hartenthaler, Angela] Danube Univ Krems, Dept Evidence Based Med & Evaluat, Dr Karl Dorrek Str, A-3500 Krems An Der Donau, Austria; [Spiel, Alexander O.] Med Univ Vienna, Dept Emergency Med, Spitalgasse 23, A-1090 Vienna, Austria	Danube University Krems; Medical University of Vienna	Gartlehner, G (corresponding author), Danube Univ Krems, Dept Evidence Based Med & Evaluat, Dr Karl Dorrek Str, A-3500 Krems An Der Donau, Austria.	gerald.gartlehner@donau-uni.ac.at		Chapman, Andrea/0000-0002-1010-7800; Affengruber, Lisa/0000-0002-7721-8732; Klerings, Irma/0000-0001-6644-9845	American College of Physicians	American College of Physicians	By the American College of Physicians.	Alldred SK, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009925; Alrajab S, 2013, CRIT CARE, V17, DOI 10.1186/cc13016; Alzahrani SA, 2017, CRIT ULTRASOUND J, V9, DOI 10.1186/s13089-017-0059-y; Anderson KL, 2013, AM J EMERG MED, V31, P1208, DOI 10.1016/j.ajem.2013.05.007; Andrews JC, 2013, J CLIN EPIDEMIOL, V66, P726, DOI 10.1016/j.jclinepi.2013.02.003; Arques S, 2008, INT J CARDIOL, V124, P400, DOI 10.1016/j.ijcard.2006.12.084; Baker K, 2020, EMERG MED AUSTRALAS, V32, P45, DOI 10.1111/1742-6723.13333; Baker Kylie, 2013, Australas J Ultrasound Med, V16, P183, DOI 10.1002/j.2205-0140.2013.tb00245.x; Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Bitar Z, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0100-x; Bossuyt PM, 2006, BRIT MED J, V332, P1089, DOI 10.1136/bmj.332.7549.1089; Bourcier JE, 2014, AM J EMERG MED, V32, P115, DOI 10.1016/j.ajem.2013.10.003; Brass P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011447; Brass P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006962.pub2; Buda N, 2020, ULTRASOUND Q, V36, P111, DOI 10.1097/RUQ.0000000000000499; Buessler A, 2020, CHEST, V157, P99, DOI 10.1016/j.chest.2019.07.017; Carlino MV, 2018, ECHOCARDIOGR-J CARD, V35, P785, DOI 10.1111/echo.13851; Chiem AT, 2015, ACAD EMERG MED, V22, P564, DOI 10.1111/acem.12651; Cibinel GA, 2012, INTERN EMERG MED, V7, P65, DOI 10.1007/s11739-011-0709-1; Colclough A, 2017, HERZ, V42, P255, DOI 10.1007/s00059-016-4531-4; Corradi F, 2015, BIOMED RES INT, V2015; Cortellaro F, 2012, EMERG MED J, V29, P19, DOI 10.1136/emj.2010.101584; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Dwyer KH, 2018, AM J EMERG MED, V36, P1145, DOI 10.1016/j.ajem.2017.11.033; Fields JM, 2017, J AM SOC ECHOCARDIOG, V30, P714, DOI 10.1016/j.echo.2017.03.004; Filipiak-Strzecka D, 2018, INT J CARDIOVAS IMAG, V34, P1595, DOI 10.1007/s10554-018-1382-5; Filopei J, 2014, J HOSP MED, V9, P594, DOI 10.1002/jhm.2219; Gaber HR, 2019, CLIN EXP EMERG MED, V6, P226, DOI 10.15441/ceem.18.072; Gallard E, 2015, AM J EMERG MED, V33, P352, DOI 10.1016/j.ajem.2014.12.003; Glockner E, 2016, ULTRASOUND INT OPEN, V2, pE90, DOI 10.1055/s-0042-108343; Glockner E, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56080379; Higgins JPT, 2016, COCHRANE DB SYST REV, V10, P29; Kajimoto K, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-49; Kobal SL, 2005, AM J CARDIOL, V96, P1002, DOI 10.1016/j.amjcard.2005.05.060; Koh Y, 2018, J THORAC DIS, V10, P6221, DOI 10.21037/jtd.2018.10.30; Lahham S, 2019, J ULTRAS MED, V38, P695, DOI 10.1002/jum.14753; Laursen CB, 2014, LANCET RESP MED, V2, P638, DOI 10.1016/S2213-2600(14)70135-3; Laursen CB, 2013, CHEST, V144, P1868, DOI 10.1378/chest.13-0882; Le Bastard Q., 2020, EUR J EMERG MED, V17, P17; Leeflang MMG, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-82; Liteplo AS, 2009, ACAD EMERG MED, V16, P201, DOI 10.1111/j.1553-2712.2008.00347.x; Llamas-Alvarez AM, 2017, CHEST, V151, P374, DOI 10.1016/j.chest.2016.10.039; Mantuani D, 2016, WEST J EMERG MED, V17, P46, DOI 10.5811/westjem.2015.11.28525; Maw AM, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0703; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; Miller JB, 2012, AM J EMERG MED, V30, P778, DOI 10.1016/j.ajem.2011.04.008; Moore CL, 2011, NEW ENGL J MED, V364, P749, DOI 10.1056/NEJMra0909487; Mulherin SA, 2002, ANN INTERN MED, V137, P598, DOI 10.7326/0003-4819-137-7-200210010-00011; Narula J, 2018, JAMA CARDIOL, V3, P346, DOI 10.1001/jamacardio.2018.0001; Nazerian P, 2010, ACAD EMERG MED, V17, P18, DOI 10.1111/j.1553-2712.2009.00630.x; Ohman J, 2019, EUR J EMERG MED, V26, P112, DOI 10.1097/MEJ.0000000000000499; Orso D, 2018, EUR J EMERG MED, V25, P312, DOI 10.1097/MEJ.0000000000000517; Pagano A, 2015, INTERN EMERG MED, V10, P851, DOI 10.1007/s11739-015-1297-2; Panoulas VF, 2013, EUR HEART J-CARD IMG, V14, P323, DOI 10.1093/ehjci/jes140; Parlamento S, 2009, AM J EMERG MED, V27, P379, DOI 10.1016/j.ajem.2008.03.009; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Perrone T, 2017, EUR J INTERN MED, V46, P61, DOI 10.1016/j.ejim.2017.07.034; Pirozzi C, 2014, CRIT ULTRASOUND J, V6, DOI 10.1186/2036-7902-6-5; Pivetta E, 2019, EUR J HEART FAIL, V21, P754, DOI 10.1002/ejhf.1379; Pivetta E, 2015, CHEST, V148, P202, DOI 10.1378/chest.14-2608; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rover C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0091-1; Rui, NATL HOSP AMBULATORY; Russell FM, 2017, J EMERG MED, V52, P839, DOI 10.1016/j.jemermed.2017.02.003; Russell FM, 2015, ACAD EMERG MED, V22, P182, DOI 10.1111/acem.12570; Sartini S, 2017, INTERN EMERG MED, V12, P861, DOI 10.1007/s11739-016-1498-3; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Sen S, 2017, J CRIT CARE, V40, P58, DOI 10.1016/j.jcrc.2017.03.007; Sforza A, 2017, CARDIOVASC ULTRASOUN, V15, DOI 10.1186/s12947-017-0105-8; Silva S, 2013, CHEST, V144, P859, DOI 10.1378/chest.13-0167; Staub LJ, 2019, J EMERG MED, V56, P53, DOI 10.1016/j.jemermed.2018.09.009; Testa A, 2012, CRIT CARE, V16, DOI 10.1186/cc11201; Tzadok B, 2018, ISR MED ASSOC J, V20, P308; Vitturi N, 2011, J Ultrasound, V14, P147, DOI 10.1016/j.jus.2011.06.009; Vourvouri EC, 2005, HEART, V91, P171, DOI 10.1136/hrt.2003.028225; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wooten WM, 2019, J ULTRAS MED, V38, P967, DOI 10.1002/jum.14781; Xia Y, 2016, J THORAC DIS, V8, P2822, DOI 10.21037/jtd.2016.09.38; Ye X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130066; Yousefifard M, 2016, EMERGENCY, V4, P1; Zanobetti M, 2017, CHEST, V151, P1295, DOI 10.1016/j.chest.2017.02.003	81	10	10	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					967	+		10.7326/M20-5504	http://dx.doi.org/10.7326/M20-5504			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33900798				2022-12-28	WOS:000675809000023
J	Enebo, LB; Berthelsen, KK; Kankam, M; Lund, MT; Rubino, DM; Satylganova, A; Lau, DCW				Enebo, Lone B.; Berthelsen, Kasper K.; Kankam, Martin; Lund, Michael T.; Rubino, Domenica M.; Satylganova, Altynai; Lau, David C. W.			Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial	LANCET			English	Article							OBESITY; OVERWEIGHT; AMYLIN; CARE	Background Cagrilintide, a long-acting amylin analogue, and semaglutide 2.4 mg, a glucagon-like peptide-1 analogue, are both being investigated as options for weight management. We aimed to determine the safety, tolerability, pharmacokinetics, and pharmacodynamics of this drug combination. Methods In this randomised, placebo-controlled, multiple-ascending dose, phase 1b trial, individuals aged 18-55 years with a body-mass index 27.0-39.9 kg/m(2) and who were otherwise healthy were recruited from a single centre in the USA. The trial included six sequential overlapping cohorts, and in each cohort eligible participants were randomly assigned (3:1) to once-weekly subcutaneous cagrilintide (0.16, 0.30, 0.60, 1.2, 2.4, or 4.5 mg) or matched placebo, in combination with once-weekly subcutaneous semaglutide 2.4 mg, without lifestyle interventions. In each cohort, the doses of cagrilintide and semaglutide were co-escalated in 4-week intervals to the desired dose over 16 weeks, participants were treated at the target dose for 4 weeks, and then followed up for 5 weeks. Participants, investigators, and the sponsor were masked to treatment assignment. The primary endpoint was number of treatment-emergent adverse events from baseline to end of follow-up. Secondary pharmacokinetic endpoints assessed from day of last dose (week 19) to end of treatment (week 20) were area under the plasma concentration- time curve from 0 to 168 h (AUC(0-168 h)) and maximum concentration [C-max] of cagrilintide and semaglutide; exploratory pharmacokinetic endpoints were half-life, time to C-max [t(max)], plasma clearance, and volume of distribution of cagrilintide and semaglutide; and exploratory pharmacodynamic endpoints were changes in bodyweight, glycaemic parameters, and hormones. Safety, pharmacokinetic, and pharmacodynamic endpoints were assessed in all participants who were exposed to at least one dose of study drug. This study is registered with ClinicalTrials.gov, NCT03600480, and is now complete. Findings Between July 25, 2018, and Dec 17, 2019, 285 individuals were screened and 96 were randomly assigned to cagrilintide (0.16-2 .4 mg group n=12; 4.5 mg group n= 11) or placebo (n=24), in combination with semaglutide 2.4 mg, of whom 95 were exposed to treatment (one patient in 0.60 mg cagrilintide group was not exposed) and included in the safety and full analysis datasets. The mean age was 40.6 years (SD 9.2), 56 (59%) of 95 participants were men and 51 (54%) were Black or African American. Of 566 adverse events reported in 92 participants (69 [97%] of 71 participants assigned to 0.16-4 .5 mg cagrilintide and 23 [96%] of 24 assigned to placebo), 207 (37%) were gastrointestinal disorders. Most adverse events were mild to moderate in severity and the proportion of participants with one or more adverse event was similar across treatment groups. Exposure was proportional to cagrilintide dose and did not affect semaglutide exposure or elimination. AUC(0-168 h) ranged from 926 nmol x h/L to 24 271 nmol x h/L, and C-max ranged from 6.14 nmol/L to 170 nmol/L with cagrilintide 0.16-4.5 mg. AUC 0- 168 h ranged from 12 757 nmol x h/L to 15 305 nmol x h/L, and C-max ranged from 96.4 nmol/L to 120 nmol/L with semaglutide 2.4 mg. Cagrilintide 0.16-4.5 mg had a half-life of 159- 195 h, with a median t(max) of 24-72 h. Semaglutide 2.4 mg had a half-life of 145-165 h, with a median t(max) of 12-24 h. Plasma clearance and volume of distribution for both cagrilintide and semaglutide were similar across treatment groups. At week 20, mean percentage bodyweight reductions were greater with cagrilintide 1.2 and 2.4 mg than with placebo (15.7% [SE 1.6] for cagrilintide 1 .2 mg and 17 .1% [1.5] for cagrilintide 2. 4 mg vs 9.8% [1.2] for pooled placebo cohorts 1-5; estimated treatment difference of -6.0% [95% CI -9.9 to -2 .0] for cagrilintide 1.2 mg and -7.4% [-11.2 to -3.5] for cagrilintide 2. 4 mg vs pooled placebo), and with cagrilintide 4.5 mg than with matched placebo (15.4% [1.3] vs 8.0% [2.2]; estimated treatment difference -7.4% [-12 .8 to -2.1]), all in combination with semaglutide 2.4 mg. Glycaemic parameters improved in all treatment groups, independently of cagrilintide dose. Changes in hormones were similar across treatment groups. Interpretation Concomitant treatment with cagrilintide and semaglutide 2.4 mg was well tolerated with an acceptable safety profile. Future larger and longer trials are needed to fully assess the efficacy and safety of this treatment combination. Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Enebo, Lone B.; Berthelsen, Kasper K.; Lund, Michael T.; Satylganova, Altynai] Novo Nordisk AS, Soborg, Denmark; [Kankam, Martin] Altasci Clin Kansas, Overland Pk, KS USA; [Rubino, Domenica M.] Washington Ctr Weight Management, Arlington, VA USA; [Lau, David C. W.] Univ Calgary, Cumming Sch Med, Julia McFarlane Diabet Res Ctr, Calgary, AB, Canada; [Lau, David C. W.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada	Novo Nordisk; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Enebo, LB (corresponding author), Novo Nordisk AS, Soborg, Denmark.	lobe@novonordisk.com			Novo Nordisk A/S - Novo Nordisk A/S	Novo Nordisk A/S - Novo Nordisk A/S	This study was funded by Novo Nordisk A/S. We thank all participants, investigators, and trial staff who were involved in the conduct of the trial. We also thank Diana Marouco of Axis, a division of Spirit Medical Communications Group, for medical writing and editorial assistance, funded by Novo Nordisk A/S.	A.S. Novo Nordisk, 2019, OZEMPIC SEMAGLUTIDE; Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Bessesen DH, 2018, LANCET DIABETES ENDO, V6, P237, DOI 10.1016/S2213-8587(17)30236-X; Blundell J, 2017, DIABETES OBES METAB, V19, P1242, DOI 10.1111/dom.12932; Boyle CN, 2018, MOL METAB, V8, P203, DOI 10.1016/j.molmet.2017.11.009; Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3; Caterson ID, 2019, DIABETES OBES METAB, V21, P1914, DOI 10.1111/dom.13752; Cefalu WT, 2015, DIABETES CARE, V38, P1567, DOI 10.2337/dc15-1081; Cooper ME, 1997, NEPHROL DIAL TRANSPL, V12, P8, DOI 10.1093/ndt/12.1.8; Dahl K, 2020, OB WEEK VIRT M NOV 2; Davies M, 2021, LANCET, V397, P971, DOI 10.1016/S0140-6736(21)00213-0; Friedrichsen M, 2021, DIABETES OBES METAB, V23, P754, DOI 10.1111/dom.14280; Gabery S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133429; Garvey WT, 2016, ENDOCR PRACT, V22, P1, DOI 10.4158/EP161365.GL; Gesundheit N, 2012, Int J Obes Suppl, V2, pS39; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Kruse T, 2020, OBESITY WEEK; Kushner RF, 2020, OBESITY, V28, P1050, DOI 10.1002/oby.22794; McGowan B, 2020, OBESITY WEEK; Nauck MA, 2019, EUR J ENDOCRINOL, V181, pR211, DOI 10.1530/EJE-19-0566; O'Neil PM, 2018, LANCET, V392, P637, DOI 10.1016/S0140-6736(18)31773-2; Raun K, 2020, OB WEEK VIRT M NOV 2; Ryan DH, 2017, CURR OBES REP, V6, P187, DOI 10.1007/s13679-017-0262-y; Shi FH, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00576; Wadden TA, 2021, JAMA-J AM MED ASSOC, V325, P1403, DOI 10.1001/jama.2021.1831; WHO, 2021, INT NONPR NAM PHARM; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183; Wilding JPH, 2017, J PSYCHOPHARMACOL, V31, P1503, DOI 10.1177/0269881117737401; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415	29	68	68	11	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1736	1748		10.1016/S0140-6736(21)00845-X	http://dx.doi.org/10.1016/S0140-6736(21)00845-X		MAY 2021	13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3KF	33894838				2022-12-28	WOS:000647813600028
J	Dyer, C				Dyer, Clare			Covid-19: Students overlooked for vaccine in favour of family members at Dublin hospital	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Brian K., 2021, EXTERNAL REV    0401	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n1136	10.1136/bmj.n1136	http://dx.doi.org/10.1136/bmj.n1136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947689	Bronze			2022-12-28	WOS:000649710200004
J	Carmody, RN; Sarkar, A; Reese, AT				Carmody, Rachel N.; Sarkar, Amar; Reese, Aspen T.			Gut microbiota through an evolutionary lens	SCIENCE			English	Editorial Material									[Carmody, Rachel N.; Sarkar, Amar] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Reese, Aspen T.] Univ Calif San Diego, Div Biol Sci, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	Harvard University; University of California System; University of California San Diego	Carmody, RN (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	carmody@fas.harvard.edu; areese@ucsd.edu						Ayeni FA, 2018, CELL REP, V23, P3056, DOI 10.1016/j.celrep.2018.05.018; Bello MGD, 2018, SCIENCE, V362, P33, DOI 10.1126/science.aau8816; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; Groussin M, 2021, CELL, V184, P2053, DOI 10.1016/j.cell.2021.02.052; Jasienska G, 2017, LANCET, V390, P510, DOI [10.1016/S0140-6736(17)30573-1, 10.1016/s0140-6736(17)30573-1]; Kimura I, 2020, SCIENCE, V367, P1002, DOI 10.1126/science.aaw8429; Ley RE, 2016, NAT REV GASTRO HEPAT, V13, P69, DOI 10.1038/nrgastro.2016.4; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834; Sonnenburg ED, 2019, NAT REV MICROBIOL, V17, P383, DOI 10.1038/s41579-019-0191-8; Sonnenburg JL, 2019, SCIENCE, V366, P444, DOI 10.1126/science.aaw9255; Warinner C, 2017, ANNU REV GENOM HUM G, V18, P321, DOI 10.1146/annurev-genom-091416-035526	15	9	9	5	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					462	463		10.1126/science.abf0590	http://dx.doi.org/10.1126/science.abf0590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926939	Green Published			2022-12-28	WOS:000645554100025
J	Li, M; Gong, LY; Cheng, FY; Yu, HY; Zhao, DH; Wang, R; Wang, T; Zhang, SJ; Zhou, J; Shmakov, SA; Koonin, EV; Xiang, H				Li, Ming; Gong, Luyao; Cheng, Feiyue; Yu, Haiying; Zhao, Dahe; Wang, Rui; Wang, Tian; Zhang, Shengjie; Zhou, Jian; Shmakov, Sergey A.; Koonin, Eugene, V; Xiang, Hua			Toxin-antitoxin RNA pairs safeguard CRISPR-Cas systems	SCIENCE			English	Article							EVOLUTIONARY CLASSIFICATION; GENE-EXPRESSION; IN-VIVO; SEQUENCE; INTERFERENCE; TERMINATION; ADAPTATION; ARCHAEA; CODONS; BURST	CRISPR-Cas systems provide RNA-guided adaptive immunity in prokaryotes. We report that the multisubunit CRISPR effector Cascade transcriptionally regulates a toxin-antitoxin RNA pair, CreTA. CreT (Cascade-repressed toxin) is a bacteriostatic RNA that sequesters the rare arginine tRNA(UCU) (transfer RNA with anticodon UCU). CreA is a CRISPR RNA-resembling antitoxin RNA, which requires Cas6 for maturation. The partial complementarity between CreA and the creT promoter directs Cascade to repress toxin transcription. Thus, CreA becomes antitoxic only in the presence of Cascade. In CreTA-deleted cells, cascade genes become susceptible to disruption by transposable elements. We uncover several CreTA analogs associated with diverse archaeal and bacterial CRISPR-cas loci. Thus, toxin-antitoxin RNA pairs can safeguard CRISPR immunity by making cells addicted to CRISPR-Cas, which highlights the multifunctionality of Cas proteins and the intricate mechanisms of CRISPR-Cas regulation.	[Li, Ming; Gong, Luyao; Cheng, Feiyue; Yu, Haiying; Zhao, Dahe; Wang, Rui; Zhang, Shengjie; Zhou, Jian; Xiang, Hua] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Li, Ming] Chinese Acad Sci, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China; [Li, Ming; Gong, Luyao; Cheng, Feiyue; Wang, Rui; Zhang, Shengjie; Xiang, Hua] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Wang, Tian] Sichuan Normal Univ, Coll Life Sci, Chengdu, Peoples R China; [Shmakov, Sergey A.; Koonin, Eugene, V] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Xiang, Hua] Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China; [Wang, Rui] Chengdu Med Coll, Noncoding RNA & Drug Discovery Key Lab Sichuan Pr, Chengdu, Sichuan, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Sichuan Normal University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Chinese Academy of Sciences; Chengdu Medical College	Li, M; Xiang, H (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China.; Li, M (corresponding author), Chinese Acad Sci, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.; Li, M; Xiang, H (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China.; Xiang, H (corresponding author), Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China.	lim_im@im.ac.cn; xiangh@im.ac.cn		Wang, Rui/0000-0003-2127-2251; Li, Ming/0000-0002-0634-8396; Zhang, Shengjie/0000-0001-6988-2791; Cheng, Feiyue/0000-0002-8096-4680	Strategic Priority Research Program of the Chinese Academy of Sciences [XDA24020101]; National Key R&D Program of China [2020YFA0906800]; National Natural Science Foundation of China [31771381, 32022003, 31970544, 91751201]; National Transgenic Science and Technology Program [2019ZX08010-001, 2019ZX08010-003]; Youth Innovation Promotion Association of CAS [2020090]; Young Elite Scientists Sponsorship Program by CAST [2017QNRC001]; Intramural Research Program of the National Institutes of Health (National Library of Medicine)	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Science and Technology Program; Youth Innovation Promotion Association of CAS; Young Elite Scientists Sponsorship Program by CAST; Intramural Research Program of the National Institutes of Health (National Library of Medicine)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	H.X. is supported by the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA24020101), the National Key R&D Program of China (2020YFA0906800), and the National Natural Science Foundation of China (91751201). M.L. is supported by the National Natural Science Foundation of China (31771381, 32022003, and 31970544), the National Transgenic Science and Technology Program (2019ZX08010-001 and 2019ZX08010-003), the Youth Innovation Promotion Association of CAS (2020090), and the Young Elite Scientists Sponsorship Program by CAST (2017QNRC001). S.A.S. and E.V.K. are supported by the Intramural Research Program of the National Institutes of Health (National Library of Medicine).	Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bikard D, 2012, CELL HOST MICROBE, V12, P177, DOI 10.1016/j.chom.2012.06.003; Boudry P, 2015, MBIO, V6, DOI 10.1128/mBio.01112-15; Brenneis M, 2007, PLOS GENET, V3, P2450, DOI 10.1371/journal.pgen.0030229; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cai SF, 2015, APPL ENVIRON MICROB, V81, P373, DOI 10.1128/AEM.02878-14; CHEN GFT, 1990, NUCLEIC ACIDS RES, V18, P1465, DOI 10.1093/nar/18.6.1465; CHEN GFT, 1994, GENE DEV, V8, P2641, DOI 10.1101/gad.8.21.2641; Dar D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.143, 10.1038/nmicrobiol.2016.143]; Faure G, 2019, RNA BIOL, V16, P435, DOI 10.1080/15476286.2018.1493331; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fraikin N, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00763-19; Gong LY, 2019, NUCLEIC ACIDS RES, V47, P5880, DOI 10.1093/nar/gkz244; Hering O, 2009, MOL MICROBIOL, V71, P1451, DOI 10.1111/j.1365-2958.2009.06615.x; Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032; Huber M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11999-9; Iranzo J, 2017, P NATL ACAD SCI USA, V114, pE5616, DOI 10.1073/pnas.1704925114; Jiang WY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003844; Koonin EV, 2020, NAT REV GENET, V21, P119, DOI 10.1038/s41576-019-0172-9; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Koonin EV, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600186; Li M, 2014, NUCLEIC ACIDS RES, V42, P7226, DOI 10.1093/nar/gku389; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Lin JZ, 2020, NUCLEIC ACIDS RES, V48, P10470, DOI 10.1093/nar/gkaa749; Liu HL, 2011, J GENET GENOMICS, V38, P261, DOI 10.1016/j.jgg.2011.05.003; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Luo ML, 2015, NUCLEIC ACIDS RES, V43, P674, DOI 10.1093/nar/gku971; Makarova KS, 2020, NAT REV MICROBIOL, V18, P67, DOI 10.1038/s41579-019-0299-x; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Mann M, 2017, NUCLEIC ACIDS RES, V45, pW435, DOI 10.1093/nar/gkx279; Meeske AJ, 2019, NATURE, V570, P241, DOI 10.1038/s41586-019-1257-5; Osakabe K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01366-6; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; PFEIFER F, 1990, NUCLEIC ACIDS RES, V18, P6921, DOI 10.1093/nar/18.23.6921; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Ratner HK, 2019, MOL CELL, V75, P498, DOI 10.1016/j.molcel.2019.05.029; Reuter CJ, 2004, APPL ENVIRON MICROB, V70, P7530, DOI 10.1128/AEM.70.12.7530-7538.2004; Rostol JT, 2019, NAT MICROBIOL, V4, P656, DOI 10.1038/s41564-018-0353-x; Sartorius-Neef S, 2004, MOL MICROBIOL, V51, P579, DOI 10.1046/j.1365-2958.2003.03858.x; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Song S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01895; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; van Sluijs L, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz047; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; Walker Julie E, 2020, Metab Eng Commun, V10, pe00116, DOI 10.1016/j.mec.2019.e00116; Walling LR, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1506; Wang R, 2016, NUCLEIC ACIDS RES, V44, P4266, DOI 10.1093/nar/gkw260; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Workman RE, 2021, CELL, V184, P675, DOI 10.1016/j.cell.2020.12.017; Yu H., 2021, ZENODO; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	53	19	22	17	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					481	+	eabe5601	10.1126/science.abe5601	http://dx.doi.org/10.1126/science.abe5601			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926924				2022-12-28	WOS:000645554100037
J	Dalglish, SL; Costello, A; Clark, H; Coll-Seck, A				Dalglish, Sarah L.; Costello, Anthony; Clark, Helen; Coll-Seck, Awa			Children in All Policies 2030: a new initiative to implement the recommendations of the WHO-UNICEF-Lancet Commission	LANCET			English	Editorial Material							EMERGENCE		[Dalglish, Sarah L.; Costello, Anthony] UCL, London WC1H 9BT, England; [Clark, Helen] Helen Clark Fdn, Auckland, New Zealand; [Clark, Helen] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Coll-Seck, Awa] Senegal Presidency, Dakar, Senegal	University of London; University College London	Dalglish, SL (corresponding author), UCL, London WC1H 9BT, England.	s.dalglish@ucl.ac.uk						Clark H, 2020, LANCET, V395, P605, DOI 10.1016/S0140-6736(19)32540-1; Crutchfield L.R., 2018, CHANGE HAPPENS WHY S; Daphi P, 2022, SOC MOVEMENT STUD, V21, P8, DOI 10.1080/14742837.2019.1676223; Deitelhoff N, 2012, CAMB REV INT AFF, V25, P345, DOI 10.1080/09557571.2012.710580; Eaton L, 2021, B WORLD HEALTH ORGAN, V99, P6, DOI 10.2471/BLT.21.020121; Gram L, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003302; IEA, 2021, STEEP DROP EARL 2020; Keck ME., 2014, ACTIVISTS BORDERS AD; Richardson D., 2020, SUPPORTING FAMILIES; Shiffman J, 2016, HEALTH POLICY PLANN, V31, P3, DOI 10.1093/heapol/czu046; Shiffman J, 2016, HEALTH POLICY PLANN, V31, P1, DOI 10.1093/heapol/czw019; United Nations Development Programme, 2021, PEOPL CLIM VOT RES; Wasi P., 2000, HUMAN RESOURCES HLTH, V4, P106; WHO-UNICEF-Lancet Commissioners, 2020, LANCET, V396, P298, DOI 10.1016/S0140-6736(20)31481-1	14	2	2	3	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1605	1607		10.1016/S0140-6736(21)00718-2	http://dx.doi.org/10.1016/S0140-6736(21)00718-2		APR 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33891894	Bronze			2022-12-28	WOS:000645510600007
J	Mello, MM; Riley, T				Mello, Michelle M.; Riley, Trish			To Address Drug Affordability, Grab the Low-hanging Fruit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Mello, Michelle M.] Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Dept Med, Stanford Hlth Policy, Stanford, CA 94305 USA; [Mello, Michelle M.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Riley, Trish] Natl Acad State Hlth Policy, Portland, ME USA	Stanford University; Stanford University; Stanford University	Mello, MM (corresponding author), Stanford Law Sch, 559 Nathan Abbott Way, Stanford, CA 94305 USA.; Mello, MM (corresponding author), Stanford Sch Med, Dept Hlth Res & Policy, 559 Nathan Abbott Way, Stanford, CA 94305 USA.	mmello@law.stanford.edu		Mello, Michelle/0000-0003-2877-4270				Alpern JD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13595; Anderson-Cook A, 2020, MEDICARE D, DOI DOI 10.1377/HBLOG20200204.864372/FULL/; Conti RM, 2018, J PHARM POLICY PRACT, V11, DOI 10.1186/s40545-018-0156-8; Deb C, 2020, JAMA-J AM MED ASSOC, V323, P826, DOI 10.1001/jama.2020.0359; Gavulic KA, 2021, J HEALTH POLIT POLIC, V46, P599, DOI 10.1215/03616878-8970810; Hernandez I, 2020, JAMA-J AM MED ASSOC, V323, P854, DOI 10.1001/jama.2020.1012; Hernandez I, 2019, HEALTH AFFAIR, V38, P76, DOI 10.1377/hlthaff.2018.05147	7	2	2	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1599	1600		10.1001/jama.2021.4619	http://dx.doi.org/10.1001/jama.2021.4619			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904881	Bronze			2022-12-28	WOS:000645617800002
J	Rissman, L				Rissman, Lauren			Becoming a Mother and Gaining Perspective	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Rissman, Lauren] Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago	Rissman, L (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA.	lrissman@luriechildrens.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1611	1612		10.1001/jama.2021.5160	http://dx.doi.org/10.1001/jama.2021.5160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904864				2022-12-28	WOS:000645617800015
J	Rubin, R				Rubin, Rita			NIH Launches Program to Investigate COVID-19 in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1601	1601		10.1001/jama.2021.5880	http://dx.doi.org/10.1001/jama.2021.5880			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904884	Bronze			2022-12-28	WOS:000645617800005
J	Sibbing, D; Kastrati, A				Sibbing, Dirk; Kastrati, Adnan			Guided P2Y(12) inhibitor therapy after percutaneous coronary intervention	LANCET			English	Editorial Material							ANTIPLATELET TREATMENT; CLOPIDOGREL; STANDARD		[Sibbing, Dirk] Privatklin Lauterbacher Muhle Ostersee, Iffeldorf, Germany; [Sibbing, Dirk] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Dept Cardiol, D-80636 Munich, Germany; [Sibbing, Dirk; Kastrati, Adnan] German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany; [Kastrati, Adnan] Tech Univ Munich, Dept Cardiol, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; German Heart Centre Munich; Technical University of Munich	Sibbing, D (corresponding author), Privatklin Lauterbacher Muhle Ostersee, Iffeldorf, Germany.; Sibbing, D (corresponding author), Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Dept Cardiol, D-80636 Munich, Germany.; Sibbing, D (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany.	dirk@sibbing.net						Claassens DMF, 2019, NEW ENGL J MED, V381, P1621, DOI 10.1056/NEJMoa1907096; Collet JP, 2021, EUR HEART J, V42, P2020, DOI 10.1093/eurheartj/ehaa909; Galli M, 2021, LANCET, V397, P1470, DOI 10.1016/S0140-6736(21)00533-X; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Pereira NL, 2020, JAMA-J AM MED ASSOC, V324, P761, DOI 10.1001/jama.2020.12443; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Roberts JD, 2012, LANCET, V379, P1705, DOI 10.1016/S0140-6736(12)60161-5; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2019, JACC-CARDIOVASC INTE, V12, P1521, DOI 10.1016/j.jcin.2019.03.034; Sibbing D, 2017, LANCET, V390, P1747, DOI 10.1016/S0140-6736(17)32155-4; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026	12	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1423	1425						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33865482				2022-12-28	WOS:000640378100004
J	Copp, T; Doust, J; McCaffery, K; Hersch, J; Jansen, J				Copp, Tessa; Doust, Jenny; McCaffery, Kirsten; Hersch, Jolyn; Jansen, Jesse			Polycystic ovary syndrome: why widening the diagnostic criteria may be harming women	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY; PREVALENCE		[Copp, Tessa; McCaffery, Kirsten; Hersch, Jolyn; Jansen, Jesse] Univ Sydney, Sydney, NSW, Australia; [Doust, Jenny] Univ Queensland, Brisbane, Qld, Australia; [Jansen, Jesse] Maastricht Univ, Maastricht, Netherlands	University of Sydney; University of Queensland; Maastricht University	Copp, T (corresponding author), Univ Sydney, Sydney, NSW, Australia.	tessa.copp@sydney.edu.au	Hersch, Jolyn/H-7153-2013; Doust, Jenny/AGI-8773-2022	Hersch, Jolyn/0000-0001-5225-6639; Doust, Jenny/0000-0002-4024-9308				Australian Government National Health and Medical Research Council, 2018, INT EV BAS GUID ASS; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Copp T, 2020, HUM REPROD, V35, P660, DOI 10.1093/humrep/deaa005; Copp T, 2019, HUM REPROD OPEN, V2019, DOI 10.1093/hropen/hoz026; Copp T, 2020, HUM REPROD, V35, P394, DOI 10.1093/humrep/dez274; Dontje ML, 2016, PREV MED, V83, P56, DOI 10.1016/j.ypmed.2015.11.030; Doust J, 2017, JAMA INTERN MED, V177, P1020, DOI 10.1001/jamainternmed.2017.1302; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; French DP, 2017, ANN BEHAV MED, V51, P718, DOI 10.1007/s12160-017-9895-z; Jones GL, 2011, JOGNN-J OBST GYN NEO, V40, P577, DOI 10.1111/j.1552-6909.2011.01279.x; Lauritsen MP, 2014, HUM REPROD, V29, P791, DOI 10.1093/humrep/det469; Lizneva D, 2016, FERTIL STERIL, V106, P6, DOI 10.1016/j.fertnstert.2016.05.003; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Soares JM, 2019, REV BRAS GINECOL OBS, V41, P361, DOI [10.1055/s-0039-1693530, 10.1055/s-0039-1688959]	14	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 16	2021	373								n700	10.1136/bmj.n700	http://dx.doi.org/10.1136/bmj.n700			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RO8VU	33863701				2022-12-28	WOS:000641319600011
J	Mansfield, KP; Naik, S				Mansfield, Kody Paul; Naik, Shruti			Neu(ronal) custodians of cutaneous immunity	CELL			English	Editorial Material							MAST-CELLS	Sensory neurons have surfaced as key instigators of skin inflammation. In this issue of Cell, Zhang et al. define an anti-inflammatory Langerhans cell (LC)-neuron-mast cell (MC) circuit that underlies skin immune homeostasis. They uncover a role for LCs in maintaining innervation of MrgprD(+) nonpeptidergic neurons that restrain MC activation via glutamate secretion.	[Mansfield, Kody Paul; Naik, Shruti] New York Univ Langone Hlth, Dept Med, Ronald O Perelman Dept Dermatol, Dept Pathol, 550 First Ave, New York, NY 10016 USA; [Mansfield, Kody Paul; Naik, Shruti] New York Univ Langone Hlth, Perlmutter Canc Ctr, 550 First Ave, New York, NY 10016 USA	New York University; New York University	Naik, S (corresponding author), New York Univ Langone Hlth, Dept Med, Ronald O Perelman Dept Dermatol, Dept Pathol, 550 First Ave, New York, NY 10016 USA.; Naik, S (corresponding author), New York Univ Langone Hlth, Perlmutter Canc Ctr, 550 First Ave, New York, NY 10016 USA.	shruti.naik@nyulangone.org						Doss ALN, 2014, NEUROSCI LETT, V578, P55, DOI 10.1016/j.neulet.2014.06.036; Galli SJ, 2020, ANNU REV IMMUNOL, V38, P49, DOI 10.1146/annurev-immunol-071719-094903; Kaplan DH, 2017, NAT IMMUNOL, V18, P1068, DOI 10.1038/ni.3815; Sa-Nunes A, 2020, TRENDS PARASITOL, V36, P655, DOI 10.1016/j.pt.2020.05.003; Serhan N, 2019, NAT IMMUNOL, V20, P1435, DOI 10.1038/s41590-019-0493-z; Tamari M, 2021, ANNU REV IMMUNOL, V39, P369, DOI 10.1146/annurev-immunol-101719-113805; Zhang SQ, 2021, CELL, V184, P2151, DOI 10.1016/j.cell.2021.03.002	7	0	0	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2021	184	8					1968	1970		10.1016/j.cell.2021.03.040	http://dx.doi.org/10.1016/j.cell.2021.03.040		APR 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RN5JL	33861962	Bronze			2022-12-28	WOS:000640387300011
J	Clemente, F; Unterlander, M; Dolgova, O; Amorim, CEG; Coroado-Santos, F; Neuenschwander, S; Ganiatsou, E; Davalos, DIC; Anchieri, L; Michaud, F; Winkelbach, L; Blocher, J; Cardenas, YOA; da Mota, BS; Kalliga, E; Souleles, A; Kontopoulos, I; Karamitrou-Mentessidi, G; Philaniotou, O; Sampson, A; Theodorou, D; Tsipopoulou, M; Akamatis, I; Halstead, P; Kotsakis, K; Urem-Kotsou, D; Panagiotopoulos, D; Ziota, C; Triantaphyllou, S; Delaneau, O; Jensen, JD; Moreno-Mayar, JV; Burger, J; Sousa, VC; Lao, O; Malaspinas, AS; Papageorgopoulou, C				Clemente, Florian; Unterlaender, Martina; Dolgova, Olga; Amorim, Carlos Eduardo G.; Coroado-Santos, Francisco; Neuenschwander, Samuel; Ganiatsou, Elissavet; Davalos, Diana I. Cruz; Anchieri, Lucas; Michaud, Frederic; Winkelbach, Laura; Bloecher, Jens; Cardenas, Yami Ommar Arizmendi; da Mota, Barbara Sousa; Kalliga, Eleni; Souleles, Angelos; Kontopoulos, Ioannis; Karamitrou-Mentessidi, Georgia; Philaniotou, Olga; Sampson, Adamantios; Theodorou, Dimitra; Tsipopoulou, Metaxia; Akamatis, Ioannis; Halstead, Paul; Kotsakis, Kostas; Urem-Kotsou, Dushka; Panagiotopoulos, Diamantis; Ziota, Christina; Triantaphyllou, Sevasti; Delaneau, Olivier; Jensen, Jeffrey D.; Victor Moreno-Mayar, J.; Burger, Joachim; Sousa, Vitor C.; Lao, Oscar; Malaspinas, Anna-Sapfo; Papageorgopoulou, Christina			The genomic history of the Aegean palatial civilizations	CELL			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; LACTASE-PERSISTENCE PHENOTYPE; INDO-EUROPEAN LANGUAGES; SKIN COLOR PREDICTION; ANCIENT NEAR-EAST; BRONZE-AGE; SEQUENCE ALIGNMENT; TERRITORIAL CHARACTERISTICS; PHYLOGENETIC ANALYSIS; POPULATION-STRUCTURE	The Cycladic, the Minoan, and the Helladic (Mycenaean) cultures define the Bronze Age (BA) of Greece. Urbanism, complex social structures, craft and agricultural specialization, and the earliest forms of writing characterize this iconic period. We sequenced six Early to Middle BA whole genomes, along with 11 mitochondrial genomes, sampled from the three BA cultures of the Aegean Sea. The Early BA (EBA) genomes are homogeneous and derive most of their ancestry from Neolithic Aegeans, contrary to earlier hypotheses that the Neolithic- EBA cultural transition was due to massive population turnover. EBA Aegeans were shaped by relatively small-scale migration from East of the Aegean, as evidenced by the Caucasus-related ancestry also detected in Anatolians. In contrast, Middle BA (MBA) individuals of northern Greece differ from EBA populations in showing similar to 50% Pontic-Caspian Steppe-related ancestry, dated at ca. 2,600-2,000 BCE. Such gene flow events during the MBA contributed toward shaping present-day Greek genomes.	[Clemente, Florian; Amorim, Carlos Eduardo G.; Neuenschwander, Samuel; Davalos, Diana I. Cruz; Anchieri, Lucas; Michaud, Frederic; Cardenas, Yami Ommar Arizmendi; da Mota, Barbara Sousa; Delaneau, Olivier; Victor Moreno-Mayar, J.; Malaspinas, Anna-Sapfo] Univ Lausanne, Dept Computat Biol, CH-1015 Lausanne, Switzerland; [Clemente, Florian; Amorim, Carlos Eduardo G.; Neuenschwander, Samuel; Davalos, Diana I. Cruz; Anchieri, Lucas; Michaud, Frederic; Cardenas, Yami Ommar Arizmendi; da Mota, Barbara Sousa; Delaneau, Olivier; Victor Moreno-Mayar, J.; Malaspinas, Anna-Sapfo] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Unterlaender, Martina; Ganiatsou, Elissavet; Kalliga, Eleni; Souleles, Angelos; Papageorgopoulou, Christina] Democritus Univ Thrace, Dept Hist & Ethnol, Lab Phys Anthropol, Komotini 69100, Greece; [Unterlaender, Martina; Winkelbach, Laura; Bloecher, Jens; Burger, Joachim] Johannes Gutenberg Univ Mainz, Inst Organism & Mol Evolut, Palaeogenet Grp, D-55099 Mainz, Germany; [Dolgova, Olga; Lao, Oscar] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, CNAG CRG, Baldiri Reixac 4, Barcelona 08028, Spain; [Coroado-Santos, Francisco; Sousa, Vitor C.] Univ Lisbon, Ctr Ecol Evolut & Environm Changes, Fac Sci, CE3C, P-1749016 Lisbon, Portugal; [Neuenschwander, Samuel] Swiss Inst Bioinformat, Vital IT, CH-1015 Lausanne, Switzerland; [Kontopoulos, Ioannis; Victor Moreno-Mayar, J.] Univ Copenhagen, Ctr GeoGenet, GLOBE Inst, DK-1350 Copenhagen, Denmark; [Karamitrou-Mentessidi, Georgia; Philaniotou, Olga; Tsipopoulou, Metaxia] Hellen Minist Culture & Sports, Ephor Emerita Antiqu, Athens 10682, Greece; [Sampson, Adamantios] Univ Aegean, Dept Mediterranean Studies, Rhodes 85132, Greece; [Theodorou, Dimitra] Hellen Minist Culture & Sports, Ephorate Antiqu Kozani, Kozani 50004, Greece; [Akamatis, Ioannis; Kotsakis, Kostas; Triantaphyllou, Sevasti] Aristotle Univ Thessaloniki, Dept Hist & Archaeol, Thessaloniki 54124, Greece; [Halstead, Paul] Univ Sheffield, Dept Archaeol, Minalloy House,10-16 Regent St, Sheffield S1 3NJ, S Yorkshire, England; [Urem-Kotsou, Dushka] Democritus Univ Thrace, Dept Hist & Ethnol, Komotini 69100, Greece; [Panagiotopoulos, Diamantis] Heidelberg Univ, Inst Class Archaeol, Marstallhof 4, D-69117 Heidelberg, Germany; [Ziota, Christina] Hellen Minist Culture & Sports, Ephorate Antiqu Florina, Florina 53100, Greece; [Jensen, Jeffrey D.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Victor Moreno-Mayar, J.] Natl Inst Genom Med INMEGEN, Mexico City 14610, DF, Mexico; [Lao, Oscar] Univ Pompeu Fabra UPF, Barcelona, Spain; [Unterlaender, Martina] Fed Criminal Police Off, D-65173 Wiesbaden, Germany	University of Lausanne; Swiss Institute of Bioinformatics; Democritus University of Thrace; Johannes Gutenberg University of Mainz; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universidade de Lisboa; Swiss Institute of Bioinformatics; University of Copenhagen; University of Aegean; Aristotle University of Thessaloniki; University of Sheffield; Democritus University of Thrace; Ruprecht Karls University Heidelberg; Arizona State University; Arizona State University-Tempe; Instituto Nacional de Medicina Genomica; Pompeu Fabra University	Malaspinas, AS (corresponding author), Univ Lausanne, Dept Computat Biol, CH-1015 Lausanne, Switzerland.; Malaspinas, AS (corresponding author), Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.; Papageorgopoulou, C (corresponding author), Democritus Univ Thrace, Dept Hist & Ethnol, Lab Phys Anthropol, Komotini 69100, Greece.	annasapfo.malaspinas@unil.ch; cpapage@he.duth.gr	Sousa, Vitor C/P-1871-2016; Moreno-Mayar, J. Víctor/AAB-3732-2022; /AAR-2792-2021; Lao, Oscar/N-9930-2017; Jensen, Jeffrey/S-1084-2016	Sousa, Vitor C/0000-0003-3575-0875; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Malaspinas, Anna-Sapfo/0000-0003-1001-7511; Panagiotopoulos, Diamantis/0000-0002-9232-1797; Neuenschwander, Samuel/0000-0002-4080-5546; Dolgova, Olga/0000-0001-5231-9388; Cruz Davalos, Diana Ivette/0000-0002-5309-6937; Lao, Oscar/0000-0002-8525-9649; Kontopoulos, Ioannis/0000-0001-5591-8917; papageorgopoulou, Christina/0000-0002-4145-950X; Jensen, Jeffrey/0000-0002-4786-8064	FCT [01/SAICT/2016 022153]; FEDER [01/SAICT/2016 022153]; European Union; General Secretariat of Research and Innovation-GSRI; Ministry of Development & Investments in Greece; Federal Ministry of Education and Research-BMBF in Germany under the Bilateral Cooperation Program Greece -Germany 2017 [BIOMUSE-0195]; Spanish Ministry of Science and Innovation; Centro de Excelencia Severo Ochoa; CERCA Programme/Generalitat de Catalunya; Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III; Generalitat de Catalunya through Departament de Salut and Departament d'Empresa i Coneixement; European Regional Development Fund by the Spanish Ministry of Science and Innovation; Secretaria d'Universitats i Recerca, Departament d'Empresa i Coneixement of the Generalitat de Catalunya; Swiss National Science Foundation (SFNS); European Research Council (ERC) grant; EU Social Fund; Greek national funds research funding program ARISTEIA II [3461]; Greek-German bilateral cooperation program 2017 (General Secreteriat for Research and Innovation, Ministry of Development and Investments, Greece) - Operational Programme "Competitiveness, Entrepreneurship and Innovation'' (NSRF 2014-2020) [BIOMUSE-0195]; European Union (EU Social Fund); Greek-German bilateral cooperation program 2017 (Federal Ministry of Education and Research - BMBF, Germany) - Operational Programme "Competitiveness, Entrepreneurship and Innovation'' (NSRF 2014-2020) [BIOMUSE-0195]; European Union (European Regional Development Fund); research initiative GeneRED; Greek State Scholarships Foundation (IKY); SNSF [PP00P3_176977]; Portuguese Foundation for Science and Technology (FCT-Fundacao para a Ciencia e Tecnologia) [UIDB/00329/2020, CEECIND/02391/2017]; Ramon y Cajal grant from the Spanish Ministerio de Economia y Competitividad (MEIC) [RYC-2013-14797]; (MEIC/FEDER) grant [PGC2018-098574-B-I00]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya [GRC 2017 SGR 937]; National Institutes of Health grants [R01GM135899, R35GM139383]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); European Union(European Commission); General Secretariat of Research and Innovation-GSRI; Ministry of Development & Investments in Greece; Federal Ministry of Education and Research-BMBF in Germany under the Bilateral Cooperation Program Greece -Germany 2017; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centro de Excelencia Severo Ochoa; CERCA Programme/Generalitat de Catalunya; Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III(Spanish Government); Generalitat de Catalunya through Departament de Salut and Departament d'Empresa i Coneixement; European Regional Development Fund by the Spanish Ministry of Science and Innovation; Secretaria d'Universitats i Recerca, Departament d'Empresa i Coneixement of the Generalitat de Catalunya(Generalitat de Catalunya); Swiss National Science Foundation (SFNS)(Swiss National Science Foundation (SNSF)); European Research Council (ERC) grant(European Research Council (ERC)); EU Social Fund; Greek national funds research funding program ARISTEIA II; Greek-German bilateral cooperation program 2017 (General Secreteriat for Research and Innovation, Ministry of Development and Investments, Greece) - Operational Programme "Competitiveness, Entrepreneurship and Innovation'' (NSRF 2014-2020); European Union (EU Social Fund); Greek-German bilateral cooperation program 2017 (Federal Ministry of Education and Research - BMBF, Germany) - Operational Programme "Competitiveness, Entrepreneurship and Innovation'' (NSRF 2014-2020)(Federal Ministry of Education & Research (BMBF)); European Union (European Regional Development Fund)(European Commission); research initiative GeneRED; Greek State Scholarships Foundation (IKY); SNSF(Swiss National Science Foundation (SNSF)); Portuguese Foundation for Science and Technology (FCT-Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); Ramon y Cajal grant from the Spanish Ministerio de Economia y Competitividad (MEIC); (MEIC/FEDER) grant; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya(Generalitat de Catalunya); National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank the Lausanne Genomics Technologies Facility (GTF) for performing sequencing and the former Vital-IT platform of the SIB Swiss Institute of Bioinformatics (SIB) and the DCSR for maintaining the computer infrastructure at UNIL. We thank the INCD (https://incd.pt/) for use of their computing infrastructure, which is funded by FCT and FEDER (01/SAICT/2016 022153).C.P., E.G., A.S., L.W., and J. Burger acknowledge the support of the European Union and the General Secretariat of Research and Innovation-GSRI, Ministry of Development & Investments in Greece, and the Federal Ministry of Education and Research-BMBF in Germany under the Bilateral Cooperation Program Greece -Germany 2017 (project BIOMUSE-0195). O.L. and O. Dolgova acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, Centro de Excelencia Severo Ochoa, CERCA Programme/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d'Empresa i Coneixement, as well as co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de Espana (POPE) 2014-2020, and by the Secretaria d'Universitats i Recerca, Departament d'Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014-2020. We would also like to thank David Reich and his lab for making ancient and modern data available; Iosif Lazaridis for help with qpWave/qpAdm; Aggeliki Georgiadou for help with editing the supplementary information; Iago Maceda for advice on whole genome sequence dataset building; and Julia Santiago, Alexandre Reymond, Eske Willerslev, Johannes Krause, and Morten Allentoft for helpful discussions. We thank Theodoros Pitsios (Anthropology Museum, National and Kapodistrian University of Athens) for providing samples from the osteological material of Agios Kosmas archaeological site. We thank the three anonymous reviewers for their constructive comments, which helped us to improve the manuscript. F.C., C.E.G.A., S.N., D.I.C.D., L.A., B.S.d.M., Y.O.A.C., F.M., J.V.M.-M., and A.-S.M. were supported by the Swiss National Science Foundation (SFNS) and a European Research Council (ERC) grant to A.-S.M. M.U., S.T., D.U.-K., and C.P. were co-financed by the EU Social Fund and the Greek national funds research funding program ARISTEIA II (project-3461). C.P., E.G., A.S., L.W., and J. Burger were co-financed by the Greek-German bilateral cooperation program 2017 (General Secreteriat for Research and Innovation, Ministry of Development and Investments, Greece, and Federal Ministry of Education and Research -BMBF, Germany) project BIOMUSE-0195 funded by the Operational Programme ``Competitiveness, Entrepreneurship and Innovation'' (NSRF 2014-2020) and co-financed by Greece and the European Union (EU Social Fund and European Regional Development Fund). J. Blocher was funded in part by the research initiative GeneRED. E.K. was funded by the Greek State Scholarships Foundation (IKY). O. Delaneau is funded by a SNSF (project grant PP00P3_176977). V.C.S. was supported by Portuguese Foundation for Science and Technology (FCT-Fundacao para a Ciencia e Tecnologia) through funds granted to cE3c (UIDB/00329/2020) and individual grant CEECIND/02391/2017. O.L.; was supported by a Ramon y Cajal grant from the Spanish Ministerio de Economia y Competitividad (MEIC) (RYC-2013-14797), a PGC2018-098574-B-I00 (MEIC/FEDER) grant, and the support of Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya (GRC 2017 SGR 937). O. Dolgova was supported by a PGC2018-098574-B-I00 (MEIC/FEDER) grant. J.D.J. was funded by National Institutes of Health grants R01GM135899 and R35GM139383.	Aeschbacher S, 2012, GENETICS, V192, P1027, DOI 10.1534/genetics.112.143164; Akamatis I., 2009, KERMATIA FILIAS STUD, P193; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andreou S, 1996, AM J ARCHAEOL, V100, P537, DOI 10.2307/507028; Andreou S., 2012, OXFORD HDB BRONZE AG, P643; Andrews S., 2010, FASTQC QUALITY CONTR; Anthony DW, 2007, HORSE, THE WHEEL, AND LANGUAGE: HOW BRONZE-AGE RIDERS FROM THE EURASIAN STEPPES SHAPED THE MODERN WORLD, P1; ANTHONY DW, 1995, ANTIQUITY, V69, P554, DOI 10.1017/S0003598X00081941; Antonio ML, 2019, SCIENCE, V366, P708, DOI 10.1126/science.aay6826; Bartonek Antonin, 2003, HDB MYKENISCHEN GRIE; Beaumont MA, 2002, GENETICS, V162, P2025; Beaumont MA, 2019, ANNU REV STAT APPL, V6, P379, DOI 10.1146/annurev-statistics-030718-105212; Beekes R.S., 2011, COMP INDO EUROPEAN L; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Bellwood P, 2001, ANNU REV ANTHROPOL, V30, P181, DOI 10.1146/annurev.anthro.30.1.181; Bellwood P, 2007, CAMB ARCHAEOL J, V17, P87, DOI 10.1017/S0959774307000078; Bellwood Peter, 2003, EXAMINING FARMING LA; Ben Halima Y, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0573-3; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bintliff J., 2018, COMMUNITIES TRANSITI, P249; Birchal A., 1973, BRONZE AGE MIGRATION, P51; Blegen C.W., 1928, AM J ARCHAEOLOGY, V32, P146; Bock C, 2007, PLOS COMPUT BIOL, V3, P1055, DOI 10.1371/journal.pcbi.0030110; Bogucki, 1984, OXFORD J ARCHAEOL, V3, P15, DOI [10.1111/j.1468-0092.1984.tb00113.x, DOI 10.1111/J.1468-0092.1984.TB00113.X]; Bouckaert R, 2012, SCIENCE, V337, P957, DOI 10.1126/science.1219669; BOUCKAERT REMCO, 2013, SCIENCE, V342, P1446; Boyadzhiev Yavor., 2016, HUMAN FACE RADIOCARB, P157; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Broodbank C., 2002, ISLAND ARCHAEOLOGY E; Broodbank C, 2008, CAMBRIDGE COMPANION TO THE AEGEAN BRONZE AGE, P47; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Broushaki F, 2016, SCIENCE, V353, P499, DOI 10.1126/science.aaf7943; Brown T., 2011, BIOMOLECULAR ARCHAEO, P190; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; CARRUBA O, 1995, ATHENAEUM, V83, P5; Casillas S, 2017, GENETICS, V205, P1003, DOI 10.1534/genetics.116.196493; Caskey J.L., 1966, GREECE AEGEAN ISLAND; Caskey J.L., 1971, CAMBRIDGE ANCIENT 2, VI, P771; CASKEY JL, 1966, HESPERIA, V35, P363, DOI 10.2307/147565; CASKEY JL, 1960, HESPERIA, V29, P285, DOI 10.2307/147199; Cassidy LM, 2016, P NATL ACAD SCI USA, V113, P368, DOI 10.1073/pnas.1518445113; Ceballos FC, 2018, NAT REV GENET, V19, P220, DOI 10.1038/nrg.2017.109; Chadwick J.L., 1975, CAMBRIDGE ANCIENT HI, P805; Chadwick J.L., 2014, DECIPHERMENT LINEAR; Chaitanya L, 2018, FORENSIC SCI INT-GEN, V35, P123, DOI 10.1016/j.fsigen.2018.04.004; Chang W, 2015, LANGUAGE, V91, P194, DOI 10.1353/lan.2015.0005; Chapman J., 2006, EUR J ARCHAEOL, V9, P159, DOI [DOI 10.1177/1461957107086121, 10.1177/1461957107086121]; Cheer SM, 1997, AM J HUM BIOL, V9, P233, DOI 10.1002/(SICI)1520-6300(1997)9:2<233::AID-AJHB10>3.0.CO;2-N; Childe V.G., 1950, TOWN PLAN REV, V21, P3; Childe V.G., 1915, J HELL STUD, V35, P196; Childe VG, 1942, MAN, V42, P98, DOI 10.2307/2791711; Choleva M, 2012, HESPERIA, V81, P343, DOI 10.2972/hesperia.81.3.0343; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cline, 2012, OXFORD HDB BRONZE AG, P11, DOI DOI 10.1093/OXFORDHB/9780199873609.013.0002; Cline E.H., 2012, OXFORD HDB BRONZE AG; Coleman J.E., 2018, COMMUNITIES TRANSITI, P33; Coleman JE, 2000, J INDO-EUR STUD, V28, P101; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cox M.A., 2008, HDB DATA VISUALIZATI, P315; Csillery K, 2010, TRENDS ECOL EVOL, V25, P410, DOI 10.1016/j.tree.2010.04.001; Damgaard PD, 2018, SCIENCE, V360, P1422, DOI 10.1126/science.aar7711; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Demacopoulou K., 1990, KYKLADIKOS POLITISMO, P115; Demoule J.P., 2017, BALKAN DIALOGUES, P52; DEMOULE JP, 1993, J WORLD PREHIST, V7, P355, DOI 10.1007/BF00997801; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Dickinson O., 2016, ARCHAEOLOGY GREECE R, P3; Douka K, 2017, ANTIQUITY, V91, P304, DOI 10.15184/aqy.2017.29; Doumas C., 1977, STUDIES MEDITERRANEA, P144; Doumas C., 2010, CRETAN OFFERINGS STU, P101; Drews Robert, 1988, COMING GREEKS INDO E; Driessen J., 2008, COMPANION LINEAR B M, P69; Duhoux Y, 1998, J INDO-EUR STUD, V26, P1; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Durham W.H., 1991, COEVOLUTION GENES CU, P154; Edwards I.E.S., 1973, CAMBRIDGE ANCIENT HI; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Eupedia, 2018, DISTR EUR MIT DNA MT; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; Ewing GB, 2016, MOL ECOL, V25, P135, DOI 10.1111/mec.13390; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Excoffier L, 2011, BIOINFORMATICS, V27, P1332, DOI 10.1093/bioinformatics/btr124; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fernandes DM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33067-w; Fernandes DM, 2020, NAT ECOL EVOL, V4, P334, DOI 10.1038/s41559-020-1102-0; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Fick A., 1905, VORGRIECHISCHE ORTSN; Forsen J., 2012, OXFORD HDB BRONZE AG, P99; Fortson B.W., 2010, INDO EUROPEAN LANGUA; Foundoulakis E., 1985, ARCH EUBOEAN STUDIES, P249; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Fu QM, 2016, NATURE, V534, P200, DOI 10.1038/nature17993; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Furnee E.J., 1979, VORGRIECHISCH KARTVE; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gamba C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6257; Gamkrelidze T. V., 1995, INDO EUROPEAN INDO E; GAMKRELIDZE TV, 1985, J INDO-EUR STUD, V13, P3; GAMKRELIDZE TV, 1983, SOV ANTHROPOL ARCH, V22, P51, DOI 10.2753/AAE1061-1959220151; Gerbault P, 2013, HUM HERED, V76, P154, DOI 10.1159/000360136; Gerbault P, 2011, PHILOS T R SOC B, V366, P863, DOI 10.1098/rstb.2010.0268; Giannopoulos T.G., 2012, GREEKS WHENCE MAINST; GILMAN A, 1981, CURR ANTHROPOL, V22, P1, DOI 10.1086/202600; Gimbutas M., 1973, BEGINNING BRONZE AGE; Gimbutas M., 1997, J INDO EUROPEAN STUD, DOI DOI 10.1073/pnas.1813608115; Gimbutas MA, 1956, PREHISTORY E EUROPE; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Goldberg A, 2017, P NATL ACAD SCI USA, V114, P2657, DOI 10.1073/pnas.1616392114; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2011, PHILOS T R SOC B, V366, P1090, DOI 10.1098/rstb.2010.0378; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gunther T, 2015, P NATL ACAD SCI USA, V112, P11917, DOI 10.1073/pnas.1509851112; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Halstead P., 2005, ARCHAEOLOGICAL REPOR, P66; Harding A.F., 2000, EUROPEAN SOC BRONZE; Harris RB, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007859; HARRISON GG, 1975, AM ANTHROPOL, V77, P812, DOI 10.1525/aa.1975.77.4.02a00050; Heaton J, 2015, J MACH LEARN RES, V16, P1243; Heubeck A., 1961, PRAEGRAECA SPRACHLIC; Hoban S, 2012, NAT REV GENET, V13, P110, DOI 10.1038/nrg3130; Hofmanova Z, 2016, P NATL ACAD SCI USA, V113, P6886, DOI 10.1073/pnas.1523951113; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hood M.S.F., 1963, J HELL STUD, V83, P199; Hughey JR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2871; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jensen JD, 2019, EVOLUTION, V73, P111, DOI 10.1111/evo.13650; Jiang B, 2017, STAT SINICA, V27, P1595, DOI 10.5705/ss.202015.0340; Johri P, 2020, GENETICS, V215, P173, DOI 10.1534/genetics.119.303002; Jones ER, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9912; Kahveci T., 2006, CRC COMPUTER INFORM, V9, P43; Karamitrou-Mentessidi G., 2016, AEMTH 30; Karamitrou-Mentessidi G., 2012, AEMTH 26, P47; Karamitrou-Mentessidi G., 2013, AEMTH 27, P121; Karamitrou-Mentessidi G., 2015, EURASIAN PREHIST, V12, P47; Karnava A., 1999, CRETAN HIEROGLYPHIC; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kilinc GM, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.2064; Kilinc GM, 2016, CURR BIOL, V26, P2659, DOI 10.1016/j.cub.2016.07.057; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Kontopoulos I, 2019, ARCHAEOL ANTHROP SCI, V11, P5213, DOI 10.1007/s12520-019-00853-0; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Kotsakis K., 2016, AEMTH 30; Kotsakis K., 2008, ESCAPING LABYRINTH C, P49; Kotsakis K., 2018, COMMUNITIES TRANSITI, P12; KOTSAKIS K., 2004, ARCHEOLOGIKO ERGO ST, V16, P407; Kouka O., 2013, FRITZ THYSSEN STIFTU, P120; Kouka O., 2011, COOKING POTS DRINKIN, P43; Kouka O, 2002, SIEDLUNGSORGANISATIO; Kretschmer P., 1896, EINLEITUNG GESCH GRI; Kristiansen K, 2016, HUMAN MOBILITY TECHN, P154, DOI DOI 10.1017/9781316536063; Kruschke J., 2014, DOING BAYESIAN DATA, DOI DOI 10.1016/B978-0-12-405888-0.09999-2; Kuchay RAH, 2013, GENES NUTR, V8, P145, DOI 10.1007/s12263-012-0305-7; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lacan M, 2011, P NATL ACAD SCI USA, V108, P18255, DOI 10.1073/pnas.1113061108; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Laroche E., 1957, MNHMHS XAPIN GE DENK, P1; Lawson DJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05257-7; Lazaridis I, 2017, NATURE, V548, P214, DOI 10.1038/nature23310; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lespez L, 2016, QUATERNARY RES, V85, P227, DOI 10.1016/j.yqres.2016.02.002; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-22; Lifran EV, 2009, AUST J DAIRY TECHNOL, V64, P89; Lipson M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005550; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Lorente-Galdos B, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1684-5; Lukic S, 2012, GENETICS, V192, P619, DOI 10.1534/genetics.112.141846; Malaspinas AS, 2014, BIOINFORMATICS, V30, P2962, DOI 10.1093/bioinformatics/btu410; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; Mallory Joseph P., 1997, ENCY INDOEUROPEAN CU; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; Malmstrom H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-89; Maniatis Y, 2011, RADIOCARBON, V53, P461, DOI 10.1017/S0033822200034597; Maniatis Y., 2012, P INT C CENT RES PRE, P22; Manning S.W., 1995, ABSOLUTE CHRONOLOGY; Maran J., 1998, KULTURWANDEL GRIECHI, V3; Maran J., 2005, AEGEAN BALTIC SEAS; Marcus JH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14523-6; Mathieson I, 2018, NATURE, V555, P197, DOI 10.1038/nature25778; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; McCracken R D, 1971, J Trop Pediatr Environ Child Health, V17, P7; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; MELLAART J, 1958, AM J ARCHAEOL, V62, P9, DOI 10.2307/500459; Mendizabal I, 2012, CURR BIOL, V22, P2342, DOI 10.1016/j.cub.2012.10.039; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Middleton G.D., 2019, OXFORD CLASSICAL DIC; Middleton G.D., 2020, COLLAPSE TRANSFORMAT; Milka E, 2010, AGHIOS KOSMAS EARLY, P347; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Molder Felix, 2021, F1000Res, V10, P33, DOI 10.12688/f1000research.29032.1; Mondal M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08089-7; Moreno-Mayar JV, 2020, BIOINFORMATICS, V36, P828, DOI 10.1093/bioinformatics/btz660; Moreno-Mayar JV, 2018, SCIENCE, V362, DOI 10.1126/science.aav2621; Morin E, 2008, P NATL ACAD SCI USA, V105, P48, DOI 10.1073/pnas.0709372104; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; Nikita E., 2017, PETRAS SITEIA PRE PR, P325; Oakley R., 1972, BR J SOCIOL, V24, P125; Olalde I, 2019, SCIENCE, V363, P1230, DOI 10.1126/science.aav4040; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Olalde I, 2015, MOL BIOL EVOL, V32, P3132, DOI 10.1093/molbev/msv181; OLIVIER JP, 1986, WORLD ARCHAEOL, V17, P377, DOI 10.1080/00438243.1986.9979977; Omrak A, 2016, CURR BIOL, V26, P270, DOI 10.1016/j.cub.2015.12.019; Orlando L, 2015, NAT REV GENET, V16, P395, DOI 10.1038/nrg3935; Ozdogan M., 2006, AEGEAN MARMARA BLACK, P21; Palmer L.R., 1961, MYCENAEANS MINOANS A; Panagiotopoulos D., 2012, P ARCH SOC ATH, P185; Panagiotopoulos D., 2016, P ARCH SOC ATH, P171; Panagiotopoulos D., 2015, P ARCH SOC ATH, P525; Papadatos Y., 2008, ESCAPING LABYRINTH C, V8, P261; Papadatos Y., 2007, MEDITERRANEAN CROSSR, P419; Papadatos Y, 2013, AM J ARCHAEOL, V117, P353; Papathanasopoulos G., 1962, ARCHAIOLOGIKON DELT, V174, P104; Papavasileiou G., 1959, ANCIENT TOMBS EUBOEA; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Parlama L., 1992, ARCHAEOLOGIA, V42, P16; Parpola A, 2008, J INDO-EUR STUD MONO, P1; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Perles C., 2001, FIRST FARMING COMMUN; Perles C, 2013, ANTIQUITY, V87, P1001, DOI 10.1017/S0003598X00049826; Peter BM, 2016, GENETICS, V202, P1485, DOI 10.1534/genetics.115.183913; Philaniotou O., 2008, MCDONALD I MONOGRAPH, P195; Philaniotou O., 2017, EARLY CYCLADIC SCULP, P263; Philaniotou O., 2017, EARLY CYCLADIC SCULP, P171; Philaniotou O., 2006, TINOS ARCHAEOLOGY AE; Plantinga TS, 2012, EUR J HUM GENET, V20, P778, DOI 10.1038/ejhg.2011.254; Poplin R., 2018, BIORXIV, DOI DOI 10.1101/201178; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Pudlo P, 2016, BIOINFORMATICS, V32, P859, DOI 10.1093/bioinformatics/btv684; Pullen D, 2008, CAMBRIDGE COMPANION TO THE AEGEAN BRONZE AGE, P19; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2018, R LANG ENV STAT COMP; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Rahmstorf Lorenz, 2015, TOOLS TEXTILES CONTE, V21, P1; Ramsey CB, 2017, RADIOCARBON, V59, P1809, DOI 10.1017/RDC.2017.108; Rascovan N, 2019, CELL, V176, P295, DOI 10.1016/j.cell.2018.11.005; Rasmussen S, 2015, CELL, V163, P571, DOI 10.1016/j.cell.2015.10.009; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Renaud G, 2017, BIOINFORMATICS, V33, P577, DOI 10.1093/bioinformatics/btw670; RENFREW C, 1989, SCI AM, V261, P106, DOI 10.1038/scientificamerican1089-106; Renfrew C, 2000, CAMB ARCHAEOL J, V10, P7, DOI 10.1017/S0959774300000019; Renfrew C., 1988, ARCHAEOLOGY LANGUAGE; Renfrew C., 2014, CAMBRIDGE WORLD PREH, V3; Renfrew C., 2011, EMERGENCE CIVILISATI; Renfrew C., 2018, COMMUNITIES TRANSITI, P3; Renfrew Colin, 1972, EMERGENCE CIVILISATI; Ringe Don., 2006, PROTO INDO EUROPEAN; Rubinacci S, 2021, NAT GENET, V53, DOI 10.1038/s41588-020-00756-0; RUTTER J, 1983, AM J ARCHAEOL, V87, P69, DOI 10.2307/504665; Rutter J., 1979, CERAMIC CHANGE AEGEA; Rutter J.B., 2001, AEGEAN PREHISTORY, P148; RUTTER JB, 1993, AM J ARCHAEOL, V97, P745, DOI 10.2307/506720; Saholu V, 2008, AEGEAN NEOLITHIC CHA, P483; Sampson A., 1988, MANIKA 2 EARLY BRONZ; Sampson A., 1981, NEOLITHIC EARLY BRON; Sampson A., 1991, ARCHAEOMETRY, P709; Sampson A., 1985, MANIKA I EARLY HELLA; Schachermeyr F., 1955, PRAHISTORISCHE KULTU; Scheu A, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0203-2; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schroeder H, 2015, P NATL ACAD SCI USA, V112, P3669, DOI 10.1073/pnas.1421784112; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Shelmerdine CW, 2008, CAMBRIDGE COMPANION TO THE AEGEAN BRONZE AGE, P1, DOI 10.1017/CCOL9780521814447; Shelton K., 2012, OXFORD HDB BRONZE AG, P139; Shelton K., 2010, POLITICAL EC AEGEAN, P184; Sherratt Andrew, 1981, PLOUGH PASTORALISM A; Sisson SA., 2018, HDB APPROXIMATE BAYE; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Sxahoglu V., 2005, AGE OXF J ARCHAEOL, V24, P339; Szecsenyi-Nagy A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0339; Tavare S, 1997, GENETICS, V145, P505; Televantou C.A., 2008, MCDONALD I MONOGRAPH, P43; Theocharis D., 1959, ALPHARHOCHIEPSILON O, V6, P279; Theocharis D., 1973, NEOLITHIC GREECE; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Todorova K., 1995, MONOGRAPHS WORLD ARC, P79; Tomkins P., 2012, OXFORD HDB BRONZE AG, P66; Treuil R., 1989, CIVILISATIONS EGEENN; Triantaphyllou S., 2011, P 11TH INT CRET C RE, P203; Triantaphyllou S., 2001, BRIT ARCHAEOLOGICAL; Triantaphyllou S., 2008, ESCAPING LABYRINTH C; Triantaphyllou S., 2017, PRE PROTO PALATIAL C, P271; Triantaphyllou S, 2015, ANNU BRIT SCH ATHENS, V110, P3, DOI 10.1017/S0068245415000064; Tsartsidou G, 2020, ARCHAEOL ANTHROP SCI, V12, DOI 10.1007/s12520-020-01161-8; Tsipopoulou M., 2002, MONUMENTS MINOS RETH, P133; Tsipopoulou M., 2008, ARCHAEOLOGICAL WORK; Tsipopoulou M., 2012, MONOGRAPHS DANISH I, P117; Tsipopoulou M., 2012, ARCHAEOL WORK CRETE, VI, P121; Tsipopoulou M., 1999, MELETEMATA STUDIES A, P847; Tsipopoulou M., 2017, MONOGRAPHS DANISH I, P57; Tsirtsoni Z., 2016, HUMAN FACE RADIOCARB, P13; Tsountas Ch, 1897, MYCENAEAN AGE STUDY; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Veeramah KR, 2018, P NATL ACAD SCI USA, V115, P3494, DOI 10.1073/pnas.1719880115; Ventris M., 1953, J HELLENIC STUDIES J, V73, P84; Ventris M., 1953, DOCUMENTS MYCENAEAN; Ventris M., 1956, DOCUMENTS MYCENAEAN; Verdugo MP, 2019, SCIENCE, V365, P173, DOI 10.1126/science.aav1002; Voutsaki S., 2012, OXFORD HDB BRONZE AG, P53; W Dorpfeld, 1935, TWILIGHT EARLY HELLA; Wace A.J.B., 1957, DOCUMENTS MYCENAEAN, pxvii; Wace A.J.B., 1916, BSA, V22, P175; Wakeley J., 2008, COALESCENT THEORY IN; Walsh S, 2017, HUM GENET, V136, P847, DOI 10.1007/s00439-017-1808-5; Walsh S, 2014, FORENSIC SCI INT-GEN, V9, P150, DOI 10.1016/j.fsigen.2013.12.006; Walsh S, 2013, FORENSIC SCI INT-GEN, V7, P98, DOI 10.1016/j.fsigen.2012.07.005; Walsh S, 2011, FORENSIC SCI INT-GEN, V5, P170, DOI 10.1016/j.fsigen.2010.02.004; Walter H., 1981, VORGESCHICHTLICHE ST, V1; Weiss H., 2000, ENV DISASTER ARCHAEO, P75; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Weninger B, 2009, DOC PRAEHIST, V36, P7, DOI 10.4312/dp.36.2; Whittle A., 1997, MOVING MOVING NEOLIT; Wiener M.H., 2013, AM J ARCHAEOL, V117, P581; Wilson D, 2008, CAMBRIDGE COMPANION TO THE AEGEAN BRONZE AGE, P77; Windler A, 2013, J ARCHAEOL SCI, V40, P204, DOI 10.1016/j.jas.2012.08.017; Wollstein A, 2010, CURR BIOL, V20, P1983, DOI 10.1016/j.cub.2010.10.040; Wright JC, 2008, CAMBRIDGE COMPANION TO THE AEGEAN BRONZE AGE, P230; Xanthoudides S., 1924, VAULTED TOMBS MESARA; Xu LD, 2010, SCAND J GASTROENTERO, V45, P168, DOI 10.3109/00365520903414176; Yakar J., 2012, OXFORD HDB ANCIENT A; Yengo L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11724-6; Zapheiropoulou P., 2008, MCDONALD I MONOGRAPH; Ziota C., 2007, TAFIKES PRAKTIKES KA; Ziota C., 2004, SPATIAL ANAL FUNERAR, P38	351	12	13	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2565	+	e21	10.1016/j.cell.2021.03.039	http://dx.doi.org/10.1016/j.cell.2021.03.039		MAY 2021	43	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33930288	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000652830800005
J	Vinuales, J; Moon, S; Le Moli, G; Burci, GL				Vinuales, Jorge; Moon, Suerie; Le Moli, Ginevra; Burci, Gian-Luca			A global pandemic treaty should aim for deep prevention	LANCET			English	Editorial Material							ONE HEALTH		[Vinuales, Jorge; Le Moli, Ginevra] Univ Cambridge, Cambridge Ctr Environm Energy & Nat Resources Gov, Cambridge CB23QZ, England; [Vinuales, Jorge; Moon, Suerie; Burci, Gian-Luca] Grad Inst Int & Dev Studies, Geneva, Switzerland; [Le Moli, Ginevra] Leiden Univ, Grotius Ctr Int Legal Studies, Leiden, Netherlands	University of Cambridge; Leiden University; Leiden University - Excl LUMC	Vinuales, J (corresponding author), Univ Cambridge, Cambridge Ctr Environm Energy & Nat Resources Gov, Cambridge CB23QZ, England.; Vinuales, J (corresponding author), Grad Inst Int & Dev Studies, Geneva, Switzerland.	jev32@cam.ac.uk		Moon, Suerie/0000-0001-8504-1212; Le Moli, Ginevra/0000-0001-7678-1446				Amuasi JH, 2020, LANCET, V395, P1543, DOI 10.1016/S0140-6736(20)31028-X; Bainimarama JV, 2021, WHO; European Council, 2021, PENINSULA 1014; Gibb R, 2020, NATURE, V584, P398, DOI 10.1038/s41586-020-2562-8; Intergovernmental Platform on Biodiversity and Ecosystem Services, 2020, IPBES WORKSH REP BIO; Kluge H, 2021, LANCET, V397, P1689, DOI 10.1016/S0140-6736(21)00709-1; OIE WHO UNEP, 2021, RED PUBL HLTH RISKS; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Pan-European Commission on Health and Sustainable Development, 2021, RETH POL PRIOR LIGHT; Waugh C, 2020, LANCET, V396, P1882, DOI 10.1016/S0140-6736(20)32387-4; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775	11	10	10	4	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1791	1792		10.1016/S0140-6736(21)00948-X	http://dx.doi.org/10.1016/S0140-6736(21)00948-X		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD0HD	33932327	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000651041900007
J	Mao, YF; Catacchio, CR; Hillier, LW; Porubsky, D; Li, RY; Sulovari, A; Fernandes, JD; Montinaro, F; Gordon, DS; Storer, JM; Haukness, M; Fiddes, IT; Murali, SC; Dishuck, PC; Hsieh, PH; Harvey, WT; Audano, PA; Mercuri, L; Piccolo, I; Antonacci, F; Munson, KM; Lewis, AP; Baker, C; Underwood, JG; Hoekzema, K; Huang, TH; Sorensen, M; Walker, JA; Hoffman, J; Thibaud-Nissen, F; Salama, SR; Pang, AWC; Lee, JY; Hastie, AR; Paten, B; Batzer, MA; Diekhans, M; Ventura, M; Eichler, EE				Mao, Yafei; Catacchio, Claudia R.; Hillier, LaDeana W.; Porubsky, David; Li, Ruiyang; Sulovari, Arvis; Fernandes, Jason D.; Montinaro, Francesco; Gordon, David S.; Storer, Jessica M.; Haukness, Marina; Fiddes, Ian T.; Murali, Shwetha Canchi; Dishuck, Philip C.; Hsieh, PingHsun; Harvey, William T.; Audano, Peter A.; Mercuri, Ludovica; Piccolo, Ilaria; Antonacci, Francesca; Munson, Katherine M.; Lewis, Alexandra P.; Baker, Carl; Underwood, Jason G.; Hoekzema, Kendra; Huang, Tzu-Hsueh; Sorensen, Melanie; Walker, Jerilyn A.; Hoffman, Jinna; Thibaud-Nissen, Francoise; Salama, Sofie R.; Pang, Andy W. C.; Lee, Joyce; Hastie, Alex R.; Paten, Benedict; Batzer, Mark A.; Diekhans, Mark; Ventura, Mario; Eichler, Evan E.			A high-quality bonobo genome refines the analysis of hominid evolution	NATURE			English	Article							SEGMENTAL DUPLICATIONS; DIVERSITY; CHIMPANZEE	The divergence of chimpanzee and bonobo provides one of the few examples of recent hominid speciation(1,2). Here we describe a fully annotated, high-quality bonobo genome assembly, which was constructed without guidance from reference genomes by applying a multiplatform genomics approach. We generate a bonobo genome assembly in which more than 98% of genes are completely annotated and 99% of the gaps are closed, including the resolution of about half of the segmental duplications and almost all of the full-length mobile elements. We compare the bonobo genome to those of other great apes(1,3-5) and identify more than 5,569 fixed structural variants that specifically distinguish the bonobo and chimpanzee lineages. We focus on genes that have been lost, changed in structure or expanded in the last few million years of bonobo evolution. We produce a high-resolution map of incomplete lineage sorting and estimate that around 5.1% of the human genome is genetically closer to chimpanzee or bonobo and that more than 36.5% of the genome shows incomplete lineage sorting if we consider a deeper phylogeny including gorilla and orangutan. We also show that 26% of the segments of incomplete lineage sorting between human and chimpanzee or human and bonobo are non-randomly distributed and that genes within these clustered segments show significant excess of amino acid replacement compared to the rest of the genome.	[Mao, Yafei; Hillier, LaDeana W.; Porubsky, David; Li, Ruiyang; Sulovari, Arvis; Gordon, David S.; Murali, Shwetha Canchi; Dishuck, Philip C.; Hsieh, PingHsun; Harvey, William T.; Audano, Peter A.; Munson, Katherine M.; Lewis, Alexandra P.; Baker, Carl; Hoekzema, Kendra; Huang, Tzu-Hsueh; Sorensen, Melanie; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Catacchio, Claudia R.; Montinaro, Francesco; Mercuri, Ludovica; Piccolo, Ilaria; Antonacci, Francesca; Ventura, Mario] Univ Bari, Dept Biol, Bari, Italy; [Fernandes, Jason D.; Haukness, Marina; Fiddes, Ian T.; Salama, Sofie R.; Paten, Benedict; Diekhans, Mark] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Montinaro, Francesco] Estonian Bioctr, Inst Genom, Tartu, Estonia; [Gordon, David S.; Murali, Shwetha Canchi; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Storer, Jessica M.] Inst Syst Biol, Seattle, WA USA; [Underwood, Jason G.] Pacific Biosci PacBio Calif, Menlo Pk, CA USA; [Walker, Jerilyn A.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Hoffman, Jinna; Thibaud-Nissen, Francoise] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Salama, Sofie R.] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA; [Pang, Andy W. C.; Lee, Joyce; Hastie, Alex R.] Bionano Genom, San Diego, CA USA	University of Washington; University of Washington Seattle; Universita degli Studi di Bari Aldo Moro; University of California System; University of California Santa Cruz; Estonian Biocentre; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB); Louisiana State University System; Louisiana State University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Ventura, M (corresponding author), Univ Bari, Dept Biol, Bari, Italy.; Eichler, EE (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	mario.ventura@uniba.it; eee@gs.washington.edu	Montinaro, Francesco/HDM-8551-2022	Sorensen, Melanie/0000-0002-1525-9707; Porubsky, David/0000-0001-8414-8966; Piccolo, Ilaria/0000-0002-2592-6382; Munson, Katherine/0000-0001-8413-6498; Sulovari, Arvis/0000-0003-4354-9020	National Institutes of Health (NIH) [HG002385, 1U24HG009081, 2010-RBFR103CE3, R01 GM59290, 2U41HG007234, U01HG010961, U41HG010972, R01HG010485, U01HL137183, 5U54HG007990]; NHGRI [RO1 HG002939, 5T32HG008345-04, R01HG010329-01]; European Regional Development Fund [2014-2020.4.01.16-0030]; Intramural Research Program of the National Library of Medicine, National Institutes of Health; NIH Pathway to Independence Award (NHGRI) [K99HG011041]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); European Regional Development Fund(European Commission); Intramural Research Program of the National Library of Medicine, National Institutes of Health; NIH Pathway to Independence Award (NHGRI)	We thank L. Carbone and O. Ryder for providing the Mhudiblu bonobo cell line; R. Gage and C. Marchetto for the preparation of the RNA sequence and access to bonobo induced pluripotent stem cell lines; A. Rhie for assistance with Merqury analysis; and T. Brown for manuscript proofreading and editing. The silhouettes of the bonobo and gorilla in Fig. 3 and Extended Data Fig. 2 (and, additionally, the human silhouette in Extended Data Fig. 2) are downloaded from phylopic.org under a Public Domain Dedication 1.0 licence. The silhouette of the chimpanzee in Fig. 3 and Extended Data Fig. 2 is downloaded from phylopic.org under a Creative Commons Attribution 3.0 Unported licence (https://creativecommons.org/licenses/by/3.0/, credit to T. M. Keesey and T. Hisgett). This work was supported, in part, by National Institutes of Health (NIH) grants HG002385 and 1U24HG009081 to E.E.E.;Futuro in Ricerca 2010-RBFR103CE3 to M.V.; R01 GM59290 to M.A.B.; 2U41HG007234 to M.D. and B.P.; U01HG010961, U41HG010972, R01HG010485, U01HL137183 and 5U54HG007990 to B.P.; Arian Smit's NHGRI grant RO1 HG002939 to J.M.S.; 5T32HG008345-04 to B.P.; R01HG010329-01 to S.R.S.; and European Regional Development Fund 2014-2020.4.01.16-0030 to F.M. E.E.E. is an investigator of the Howard Hughes Medical Institute. The work of J.H. and F.T.-N. was supported by the Intramural Research Program of the National Library of Medicine, National Institutes of Health. P.H. is supported by an NIH Pathway to Independence Award (NHGRI, K99HG011041).	Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; CHEN S, 2019, NAT METHODS, V20; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; Falconer E, 2012, NAT METHODS, V9, P1107, DOI [10.1038/NMETH.2206, 10.1038/nmeth.2206]; Fiddes IT, 2018, GENOME RES, V28, P1029, DOI 10.1101/gr.233460.117; Formenti G, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02336-9; Gallo A, 2017, HUM GENET, V136, P1265, DOI 10.1007/s00439-017-1837-0; Garrison E, 2012, HAPLOTYPE BASED VARI; Ghareghani M, 2018, BIOINFORMATICS, V34, P115, DOI 10.1093/bioinformatics/bty290; Gordon D, 2016, SCIENCE, V352, DOI 10.1126/science.aae0344; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Kronenberg ZN, 2018, SCIENCE, V360, P1085, DOI 10.1126/science.aar6343; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Logsdon GA, 2020, NAT REV GENET, V21, P597, DOI 10.1038/s41576-020-0236-x; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Marchetto MC, 2019, ELIFE, V8, DOI 10.7554/eLife.37527; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Pavlidis P, 2017, J BIOL RES-THESSALON, V24, DOI 10.1186/s40709-017-0064-0; Porubsky D, 2021, NAT BIOTECHNOL, V39, P302, DOI 10.1038/s41587-020-0719-5; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Sanders AD, 2016, GENOME RES, V26, P1575, DOI 10.1101/gr.201160.115; Savva YA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-252; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Sedlazeck FJ, 2018, NAT METHODS, V15, P461, DOI 10.1038/s41592-018-0001-7; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Sudmant PH, 2013, GENOME RES, V23, P1373, DOI 10.1101/gr.158543.113; Takemoto H, 2015, EVOL ANTHROPOL, V24, P170, DOI 10.1002/evan.21456; Ventura M, 2011, GENOME RES, V21, P1640, DOI 10.1101/gr.124461.111; Vollger MR, 2020, ANN HUM GENET, V84, P125, DOI 10.1111/ahg.12364; Vollger MR, 2019, NAT METHODS, V16, P88, DOI 10.1038/s41592-018-0236-3; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; 2020, NATURE, V583, P699	39	6	6	10	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					77	+		10.1038/s41586-021-03519-x	http://dx.doi.org/10.1038/s41586-021-03519-x		MAY 2021	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	33953399	Green Published, hybrid			2022-12-28	WOS:000647544800004
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: Biden aims for 70% of Americans to have at least one vaccination by 4 July	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Alabdullah B, 2021, CRYPTOGRAPHY-BASEL, V5, DOI 10.3390/cryptography5010004; Anderson M., 2021, BECKERS HOSP REV; [Anonymous], 2021, NY TIMES; Centers for Disease Control and Prevention, 2021, COV 19 VACC US; Mandavilli A., 2021, NY TIMES; Romo Vanessa., 2021, NATL PUBLIC RADIO	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n1155	10.1136/bmj.n1155	http://dx.doi.org/10.1136/bmj.n1155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952576	Bronze			2022-12-28	WOS:000651241900015
J	Joshi, PH; de Lemos, JA				Joshi, Parag H.; de Lemos, James A.			Diagnosis and Management of Stable Angina A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-ARTERY-DISEASE; COMPUTED-TOMOGRAPHY ANGIOGRAPHY; ISCHEMIC-HEART-DISEASE; ASSOCIATION TASK-FORCE; CT ANGIOGRAPHY; PROGNOSTIC VALUE; CHEST-PAIN; CARDIOVASCULAR EVENTS; PRETEST PROBABILITY; PRACTICE GUIDELINES	This narrative review discusses diagnostic tests and medical therapies for stable angina that have evolved over the last decade with more clarity regarding the role for revascularization. Importance Nearly 10 million US adults experience stable angina, which occurs when myocardial oxygen supply does not meet demand, resulting in myocardial ischemia. Stable angina is associated with an average annual risk of 3% to 4% for myocardial infarction or death. Diagnostic tests and medical therapies for stable angina have evolved over the last decade with a better understanding of the optimal use of coronary revascularization. Observations Coronary computed tomographic angiography is a first-line diagnostic test in the evaluation of patients with stable angina due to higher sensitivity and comparable specificity compared with imaging-based stress testing. Moreover, coronary computed tomographic angiography allows detection of nonobstructive atherosclerosis that would not be identified with other noninvasive imaging modalities, improving risk assessment and potentially triggering more appropriate allocation of preventive therapies. Novel therapies treating lipids (proprotein convertase subtilisin/kexin type 9 inhibitors, ezetimibe, and icosapent ethyl) and type 2 diabetes (sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists) have improved cardiovascular outcomes in patients with stable ischemic heart disease when added to usual care. Randomized clinical trials showed no improvement in the rates of mortality or myocardial infarction with revascularization (largely by percutaneous coronary intervention) compared with optimal medical therapy alone, even in the setting of moderate to severe ischemia. In contrast, revascularization provides a meaningful benefit on angina and quality of life compared with antianginal therapies. Measures of the effect of angina on a patient's quality of life should be integrated into the clinic encounter to assist with the decision to proceed with revascularization. Conclusions and Relevance For patients with stable angina, emphasis should be placed on optimizing lifestyle factors and preventive medications such as lipid-lowering and antiplatelet agents to reduce the risk for cardiovascular events and death. Antianginal medications, such as beta-blockers, nitrates, or calcium channel blockers, should be initiated to improve angina symptoms. Revascularization with percutaneous coronary intervention should be reserved for patients in whom angina symptoms negatively influence quality of life, generally after a trial of antianginal medical therapy. Shared decision-making with an informed patient is important for effective treatment of stable angina.	[Joshi, Parag H.; de Lemos, James A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, 5909 Harry Hines Blvd, Dallas, TX 76390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	de Lemos, JA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, 5909 Harry Hines Blvd, Dallas, TX 76390 USA.	james.delemos@utsouthwestern.edu	de Lemos, James/ABD-6669-2021					Adamson PD, 2019, J AM COLL CARDIOL, V74, P2058, DOI 10.1016/j.jacc.2019.07.085; Ahmad Y, 2020, EUR HEART J, V41, P3228; Ahmed HM, 2015, MAYO CLIN PROC, V90, P346, DOI 10.1016/j.mayocp.2014.12.013; Al-Lamee R, 2018, CIRCULATION, V138, P1780, DOI 10.1161/CIRCULATIONAHA.118.033801; Al-Lamee R, 2018, LANCET, V391, P31, DOI 10.1016/S0140-6736(17)32714-9; Al-Lamee RK, 2019, CIRCULATION, V140, P1971, DOI 10.1161/CIRCULATIONAHA.119.042918; Alkhouli M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.21326; AlTurki A, 2019, AM J CARDIOL, V124, P1869, DOI 10.1016/j.amjcard.2019.09.011; Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2645, DOI [10.1016/j.jacc.2014.09.016, 10.1016/j.jacc.2014.09.017]; Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; Arnold SV, 2020, CIRCULATION, V141, pE779, DOI 10.1161/CIR.0000000000000766; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bangalore S, 2020, CIRCULATION, V142, P841, DOI 10.1161/CIRCULATIONAHA.120.048194; Belsey J, 2015, EUR J PREV CARDIOL, V22, P837, DOI 10.1177/2047487314533217; Beltrame JF, 2009, ARCH INTERN MED, V169, P1491, DOI 10.1001/archinternmed.2009.295; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bittencourt MS, 2016, CIRCULATION, V134, P201, DOI 10.1161/CIRCULATIONAHA.116.023396; Bittencourt MS, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004419; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031; Cannon CP, 2015, NEW ENGL J MED, V373, P1476, DOI 10.1056/NEJMc1509363; Celeng C, 2019, JACC-CARDIOVASC IMAG, V12, P1316, DOI 10.1016/j.jcmg.2018.07.022; Chan PS, 2014, CIRC-CARDIOVASC QUAL, V7, P640, DOI 10.1161/CIRCOUTCOMES.114.000967; Chow CK, 2010, CIRCULATION, V121, P750, DOI 10.1161/CIRCULATIONAHA.109.891523; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Connolly SJ, 2018, LANCET, V391, P205, DOI 10.1016/S0140-6736(17)32458-3; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Curfman G, 2020, JAMA-J AM MED ASSOC, V324, P2280, DOI 10.1001/jama.2020.22898; Dagenais GR, 2002, CAN J CARDIOL, V18, P941; Das SR, 2018, J AM COLL CARDIOL, V72, P3200, DOI 10.1016/j.jacc.2018.09.020; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Dinu M, 2018, EUR J CLIN NUTR, V72, P30, DOI 10.1038/ejcn.2017.58; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Eisen A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004080; EMOND M, 1994, CIRCULATION, V90, P2645, DOI 10.1161/01.CIR.90.6.2645; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Fairbairn TA, 2018, EUR HEART J, V39, P3701, DOI 10.1093/eurheartj/ehy530; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gallone G, 2020, JACC-CARDIOVASC INTE, V13, P1, DOI 10.1016/j.jcin.2019.08.055; Genders TSS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3485; Genders TSS, 2011, EUR HEART J, V32, P1316, DOI 10.1093/eurheartj/ehr014; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Glaser R, 2005, CIRCULATION, V111, P143, DOI 10.1161/01.CIR.0000150335.01285.12; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Head SJ, 2018, LANCET, V391, P939, DOI 10.1016/S0140-6736(18)30423-9; Hemingway H, 2006, JAMA-J AM MED ASSOC, V295, P1404, DOI 10.1001/jama.295.12.1404; Hemingway H, 2008, CIRCULATION, V117, P1526, DOI 10.1161/CIRCULATIONAHA.107.720953; Heran BS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001800.pub2, 10.1002/14651858.CD001800.pub3]; Hoffmann U, 2017, CIRCULATION, V135, P2320, DOI 10.1161/CIRCULATIONAHA.116.024360; Hulten EA, 2011, J AM COLL CARDIOL, V57, P1237, DOI 10.1016/j.jacc.2010.10.011; Karady J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.28312; Knuuti J, 2018, EUR HEART J, V39, P3322, DOI 10.1093/eurheartj/ehy267; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Kreatsoulas C, 2013, JAMA INTERN MED, V173, P829, DOI 10.1001/jamainternmed.2013.229; Kristensen SL, 2019, LANCET DIABETES ENDO, V7, P776, DOI 10.1016/S2213-8587(19)30249-9; Levin DC, 2019, J AM COLL RADIOL, V16, P147, DOI 10.1016/j.jacr.2018.07.022; Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Libby P, 2019, CIRC RES, V124, P150, DOI 10.1161/CIRCRESAHA.118.311098; Liberale L, 2020, EUR HEART J, DOI [DOI 10.1177/2047487314525529, 10.1093/eurheartj/ehz961, DOI 10.1093/eurheartj/ehz961]; Lu MT, 2017, J CARDIOVASC COMPUT, V11, P373, DOI 10.1016/j.jcct.2017.08.005; Mackay MH, 2011, EUR HEART J, V32, P3107, DOI 10.1093/eurheartj/ehr358; Mahmoudi M, 2020, CARDIOVASC REVASCULA, V21, P890, DOI 10.1016/j.carrev.2019.12.009; Majithia A, 2019, ARTERIOSCL THROM VAS, V39, P546, DOI 10.1161/ATVBAHA.118.310955; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; Maron DJ, 2020, NEW ENGL J MED, V382, P1395, DOI 10.1056/NEJMoa1915922; Martinez-Gonzalez MA, 2019, CIRC RES, V124, P779, DOI 10.1161/CIRCRESAHA.118.313348; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Merz CNB, 2017, CIRCULATION, V135, P1075, DOI 10.1161/CIRCULATIONAHA.116.024534; Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576; Min JK, 2015, JACC-CARDIOVASC IMAG, V8, P1209, DOI 10.1016/j.jcmg.2015.08.006; Min JK, 2011, J AM COLL CARDIOL, V58, P849, DOI 10.1016/j.jacc.2011.02.074; Moholdt T, 2018, J AM COLL CARDIOL, V71, P1094, DOI 10.1016/j.jacc.2018.01.011; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Narula J, 2013, J AM COLL CARDIOL, V61, P1041, DOI 10.1016/j.jacc.2012.10.054; Newby D, 2015, LANCET, V385, P2383, DOI 10.1016/S0140-6736(15)60291-4; Newby DE, 2018, NEW ENGL J MED, V379, P924, DOI 10.1056/NEJMoa1805971; Nicholls SJ, 2020, JAMA-J AM MED ASSOC, V324, P2268, DOI 10.1001/jama.2020.22258; Nidorf SM, 2020, NEW ENGL J MED, V383, P1838, DOI 10.1056/NEJMoa2021372; Norgaard BL, 2018, J AM COLL CARDIOL, V72, P2123, DOI 10.1016/j.jacc.2018.07.043; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Omland T, 2017, CLIN CHEM, V63, P165, DOI 10.1373/clinchem.2016.255190; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Pack QR, 2014, MAYO CLIN PROC, V89, P1368, DOI 10.1016/j.mayocp.2014.04.033; Reeh J, 2019, EUR HEART J, V40, P1426, DOI 10.1093/eurheartj/ehy806; Reynolds HR, 2020, JAMA CARDIOL, V5, P773, DOI 10.1001/jamacardio.2020.0822; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Savarese G, 2015, INT J CARDIOL, V201, P247, DOI 10.1016/j.ijcard.2015.08.103; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Sharma G, 2020, JAMA-J AM MED ASSOC, V324, P2262, DOI 10.1001/jama.2020.22387; Shaw LJ, 2014, JACC-CARDIOVASC IMAG, V7, P593, DOI 10.1016/j.jcmg.2013.10.021; Shaw LJ, 2012, AM HEART J, V164, P243, DOI 10.1016/j.ahj.2012.05.018; Shaw LJ, 2006, J AM COLL CARDIOL, V47, p4S, DOI 10.1016/j.jacc.2005.01.072; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Sorbets E, 2019, EUR HEART J, V40, P1399, DOI 10.1093/eurheartj/ehy811; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Spertus JA, 2020, NEW ENGL J MED, V382, P1408, DOI 10.1056/NEJMoa1916370; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Taskinen MR, 2019, CURR ATHEROSCLER REP, V21, DOI 10.1007/s11883-019-0791-9; Tsimikas S, 2020, NEW ENGL J MED, V382, P244, DOI 10.1056/NEJMoa1905239; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Voros S, 2011, JACC-CARDIOVASC IMAG, V4, P537, DOI 10.1016/j.jcmg.2011.03.006; Walker S, 2016, EUR HEART J-QUAL CAR, V2, P125, DOI 10.1093/ehjqcco/qcw003; Wei J, 2019, JAMA-J AM MED ASSOC, V322, P2334, DOI 10.1001/jama.2019.15736; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Xaplanteris P, 2018, NEW ENGL J MED, V379, P250, DOI 10.1056/NEJMoa1803538; Yang K, 2019, INT J CARDIOL, V293, P278, DOI 10.1016/j.ijcard.2019.06.054; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zelniker TA, 2019, LANCET, V393, P31, DOI 10.1016/S0140-6736(18)32590-X	119	13	13	5	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1765	1778		10.1001/jama.2021.1527	http://dx.doi.org/10.1001/jama.2021.1527			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944871				2022-12-28	WOS:000647831200017
J	Kirschner, J; Hunter, B				Kirschner, Jonathan; Hunter, Benton			In the ED, LUS and CT did not differ for sensitivity or specificity for diagnosing COVID-19 pneumonia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kirschner, Jonathan; Hunter, Benton] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Kirschner, J (corresponding author), Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA.							Carpenter CR, 2020, ACAD EMERG MED, V27, P653, DOI 10.1111/acem.14048; Hussain A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03369-5	2	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC57	JC57		10.7326/ACPJ202105180-057	http://dx.doi.org/10.7326/ACPJ202105180-057			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939488				2022-12-28	WOS:000652604800012
J	St Louis, VL; Schiff, SL; Kelly, CA				St Louis, Vincent L.; Schiff, Sherry L.; Kelly, Carol A.			David William Schindler (1940-2021)	SCIENCE			English	Editorial Material									[St Louis, Vincent L.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Schiff, Sherry L.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada; [Kelly, Carol A.] R&K Res Inc, Salt Spring Isl, BC V8K 2J3, Canada	University of Alberta; University of Waterloo	St Louis, VL (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	vince.stlouis@ualberta.ca		Kelly, Carol/0000-0003-2473-7560					0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					468	468		10.1126/science.abi8814	http://dx.doi.org/10.1126/science.abi8814			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926943				2022-12-28	WOS:000645554100029
J	Abascal, F; Harvey, LMR; Mitchell, E; Lawson, ARJ; Lensing, SV; Ellis, P; Russell, AJC; Alcantara, RE; Baez-Ortega, A; Wang, YC; Kwa, EJ; Lee-Six, H; Cagan, A; Coorens, THH; Chapman, MS; Olafsson, S; Leonard, S; Jones, D; Machado, HE; Davies, M; Obro, NF; Mahubani, KT; Allinson, K; Gerstung, M; Saeb-Parsy, K; Kent, DG; Laurenti, E; Stratton, MR; Rahbari, R; Campbell, PJ; Osborne, RJ; Martincorena, I				Abascal, Federico; Harvey, Luke M. R.; Mitchell, Emily; Lawson, Andrew R. J.; Lensing, Stefanie V.; Ellis, Peter; Russell, Andrew J. C.; Alcantara, Raul E.; Baez-Ortega, Adrian; Wang, Yichen; Kwa, Eugene Jing; Lee-Six, Henry; Cagan, Alex; Coorens, Tim H. H.; Chapman, Michael Spencer; Olafsson, Sigurgeir; Leonard, Steven; Jones, David; Machado, Heather E.; Davies, Megan; Obro, Nina F.; Mahubani, Krishnaa T.; Allinson, Kieren; Gerstung, Moritz; Saeb-Parsy, Kourosh; Kent, David G.; Laurenti, Elisa; Stratton, Michael R.; Rahbari, Raheleh; Campbell, Peter J.; Osborne, Robert J.; Martincorena, Inigo			Somatic mutation landscapes at single-molecule resolution	NATURE			English	Article							STEM-CELLS; CANCER; RARE; EVOLUTION; DISCOVERY; SELECTION; CAPTURE	Somatic mutations drive the development of cancer and may contribute to ageing and other diseases(1,2). Despite their importance, the difficulty of detecting mutations that are only present in single cells or small clones has limited our knowledge of somatic mutagenesis to a minority of tissues. Here, to overcome these limitations, we developed nanorate sequencing (NanoSeq), a duplex sequencing protocol with error rates of less than five errors per billion base pairs in single DNA molecules from cell populations. This rate is two orders of magnitude lower than typical somatic mutation loads, enabling the study of somatic mutations in any tissue independently of clonality. We used this single-molecule sensitivity to study somatic mutations in non-dividing cells across several tissues, comparing stem cells to differentiated cells and studying mutagenesis in the absence of celldivision. Differentiated cells in blood and colon displayed remarkably similar mutation loads and signatures to their corresponding stem cells, despite mature blood cells having undergone considerably more divisions. We then characterized the mutational landscape of post-mitotic neurons and polyclonal smooth muscle, confirming that neurons accumulate somatic mutations at a constant rate throughout life without cell division, with similar rates to mitotically active tissues. Together, our results suggest that mutational processes that are independent of cell division are important contributors to somatic mutagenesis. We anticipate that the ability to reliably detect mutations in single DNA molecules could transform our understanding of somatic mutagenesis and enable non-invasive studies on large-scale cohorts.	[Abascal, Federico; Harvey, Luke M. R.; Mitchell, Emily; Lawson, Andrew R. J.; Lensing, Stefanie V.; Ellis, Peter; Russell, Andrew J. C.; Alcantara, Raul E.; Baez-Ortega, Adrian; Wang, Yichen; Kwa, Eugene Jing; Lee-Six, Henry; Cagan, Alex; Coorens, Tim H. H.; Chapman, Michael Spencer; Olafsson, Sigurgeir; Leonard, Steven; Jones, David; Machado, Heather E.; Stratton, Michael R.; Rahbari, Raheleh; Campbell, Peter J.; Osborne, Robert J.; Martincorena, Inigo] Wellcome Sanger Inst, Hinxton, England; [Mitchell, Emily; Davies, Megan; Obro, Nina F.; Kent, David G.; Laurenti, Elisa] Wellcome MRC Cambridge Stem Cell Inst, Cambridge Biomed Campus, Cambridge, England; [Obro, Nina F.; Mahubani, Krishnaa T.; Laurenti, Elisa; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Mahubani, Krishnaa T.; Saeb-Parsy, Kourosh] Univ Cambridge, Dept Surg, Cambridge, England; [Mahubani, Krishnaa T.; Saeb-Parsy, Kourosh] NIHR Cambridge Biomed Res Ctr, Cambridge Biomed Campus, Cambridge, England; [Allinson, Kieren] Addenbrookes Hosp, Cambridge Brain Bank, Div Human Res Tissue Bank, Cambridge, England; [Gerstung, Moritz] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Hinxton, England; [Kent, David G.] Univ York, York Biomed Res Inst, Dept Biol, York, N Yorkshire, England; [Ellis, Peter] Inivata, Babraham Res Campus, Cambridge, England; [Osborne, Robert J.] Biofidelity, Cambridge Sci Pk, Cambridge, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; European Molecular Biology Laboratory (EMBL); University of York - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Osborne, RJ; Martincorena, I (corresponding author), Wellcome Sanger Inst, Hinxton, England.	r.osborne@biofidelity.com; im3@sanger.ac.uk	Kent, David/AAZ-4916-2021	Kent, David/0000-0001-7871-8811; Spencer Chapman, Michael/0000-0002-5320-8193; Wang, Yichen/0000-0001-5122-7545; Gerstung, Moritz/0000-0001-6709-963X; Abascal, Federico/0000-0002-6201-1587; Friesgaard Obro, Nina/0000-0002-1254-7332; Saeb-Parsy, Kourosh/0000-0002-0633-3696; Martincorena, Inigo/0000-0003-1122-4416; Russell, Andrew/0000-0001-5411-2807; Lawson, Andrew/0000-0003-3592-1005	Cambridge Blood and Stem Cell Biobank; Cambridge NIHR BRC Cell Phenotyping Hub; Cancer Research UK [C57387/A21777]; Wellcome Trust; CRUK Career Development fellowship [C66259/A27114]; Wellcome/Royal Society Sir Henry Dale Fellowship [107630/Z/15/Z]; European Hematology Association; BBSRC; Wellcome [203151/Z/16/Z]; MRC; Bloodwise Bennett Fellowship [15008]; Bill and Melinda Gates Foundation [INV-002189]; ERC Starting Grant [ERC-2016-STG-715371]; European Community's Seventh Framework Programme (FP7/2007-2013); National Institute for Health Research (NIHR); King's College London	Cambridge Blood and Stem Cell Biobank; Cambridge NIHR BRC Cell Phenotyping Hub; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK Career Development fellowship; Wellcome/Royal Society Sir Henry Dale Fellowship; European Hematology Association; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bloodwise Bennett Fellowship; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ERC Starting Grant(European Research Council (ERC)); European Community's Seventh Framework Programme (FP7/2007-2013)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); King's College London(General Electric)	We are grateful to the live donors and the families of the deceased organ transplant donors. We thank L. Anderson, K. Roberts, C. Latimer, Q. Lin, members of the CGP-lab, R. Vicario, F. Geissmann, N. Angelopoulos, G. Tischler, T. Bellerby, M. Abascal and K. Chatterjee for assistance in the development of NanoSeq or with this manuscript; all NIHR BioResource Centre Cambridge volunteers for participation; the NIHR BioResource Centre Cambridge and staff for their contribution; the National Institute for Health Research and NHS Blood and Transplant; the Cambridge Blood and Stem Cell Biobank for sample donation and support of this work; the Cambridge Brain Bank for sample donation; and the participants and local coordinators at the TwinsUK study. This research was supported by the Cambridge NIHR BRC Cell Phenotyping Hub. I.M. is funded by Cancer Research UK (C57387/A21777) and the Wellcome Trust. P.J.C. is a Wellcome Trust Senior Clinical Fellow. R.R. is a recipient of a CRUK Career Development fellowship (C66259/A27114). E.L. is supported by a Wellcome/Royal Society Sir Henry Dale Fellowship (grant number 107630/Z/15/Z), the European Hematology Association, BBSRC and by core funding from Wellcome (grant number 203151/Z/16/Z) and MRC to the Wellcome-MRC Cambridge Stem Cell Institute. D.G.K. is supported by a Bloodwise Bennett Fellowship (15008), the Bill and Melinda Gates Foundation (INV-002189) and an ERC Starting Grant (ERC-2016-STG-715371). The TwinsUK study was funded by the Wellcome Trust and European Community's Seventh Framework Programme (FP7/2007-2013). The TwinsUK study also receives support from the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health & Social Care.	Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; [Anonymous], 2013, PREPRINTS; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Brazhnik K, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax2659; Brunner SF, 2019, NATURE, V574, P538, DOI 10.1038/s41586-019-1670-9; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Hoang DT, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1131-3; Ellis P, 2021, NAT PROTOC, V16, P841, DOI 10.1038/s41596-020-00437-6; Franco I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03244-6; Gabella Giorgio, 2012, Journal of Smooth Muscle Research, V48, P65; Gao ZY, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002355; Gerstung M, 2014, BIOINFORMATICS, V30, P1198, DOI 10.1093/bioinformatics/btt750; Gerstung M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1814; Gori K., 2018, SIGFIT FLEXIBLE BAYE, DOI [10.1101/372896, DOI 10.1101/372896]; Hoang ML, 2016, P NATL ACAD SCI USA, V113, P9846, DOI 10.1073/pnas.1607794113; Jones David, 2016, Curr Protoc Bioinformatics, V56, DOI 10.1002/cpbi.20; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kennedy SR, 2012, MECH AGEING DEV, V133, P118, DOI 10.1016/j.mad.2011.10.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Krishnaswami SR, 2016, NAT PROTOC, V11, P499, DOI 10.1038/nprot.2016.015; Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Lawson ARJ, 2020, SCIENCE, V370, P75, DOI 10.1126/science.aba8347; Lee-Six H, 2019, NATURE, V574, P532, DOI 10.1038/s41586-019-1672-7; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; Lensing S. V., 2021, PROTOCOL EXCHANGE, DOI [10.21203/rs.3.pex-1298/v1, DOI 10.21203/RS.3.PEX-1298/V1]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RY, 2020, SCIENCE, V370, P82, DOI 10.1126/science.aba7300; Lodato MA, 2018, SCIENCE, V359, P555, DOI 10.1126/science.aao4426; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Matsumura S, 2019, ARCH TOXICOL, V93, P2689, DOI 10.1007/s00204-019-02541-3; Nicholson AM, 2018, CELL STEM CELL, V22, P909, DOI 10.1016/j.stem.2018.04.020; Olafsson S, 2020, CELL, V182, P672, DOI 10.1016/j.cell.2020.06.036; Petljak M, 2019, CELL, V176, P1282, DOI 10.1016/j.cell.2019.02.012; Pleguezuelos-Manzano C, 2020, NATURE, V580, P269, DOI 10.1038/s41586-020-2080-8; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Raine Keiran M, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi1507s52; Rheinbay E, 2020, NATURE, V578, P102, DOI 10.1038/s41586-020-1965-x; Robinson PS, 2020, ELEVATED SOMATIC MUT, DOI [DOI 10.1101/2020.06.23.167668, 10.1101/2020.06.23.167668]; Salk JJ, 2018, NAT REV GENET, V19, P269, DOI 10.1038/nrg.2017.117; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Su SL, 2012, J ORTHOP RES, V30, P9, DOI 10.1002/jor.21494; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Wyles SP, 2014, INT J MOL SCI, V15, P20948, DOI 10.3390/ijms151120948; Xing D, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2013106118; Yizhak K, 2019, SCIENCE, V364, P970, DOI 10.1126/science.aaw0726; Yoshida K, 2020, NATURE, V578, P266, DOI 10.1038/s41586-020-1961-1; You XY, 2020, ARCH TOXICOL, V94, P3475, DOI 10.1007/s00204-020-02832-0; Zhang F, 2020, GENOME RES, V30, P185, DOI 10.1101/gr.246934.118	59	89	89	13	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					405	+		10.1038/s41586-021-03477-4	http://dx.doi.org/10.1038/s41586-021-03477-4		APR 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33911282	Green Accepted, Green Submitted			2022-12-28	WOS:000645224800001
J	Kemet, S				Kemet, Shakkaura			I Can't Breathe during Interviews - The Incomplete Penetrance of Antiracism	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kemet, Shakkaura] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Kemet, S (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.			Kemet, Shakkaura/0000-0003-0316-2796				Ellis J, 2020, NEW ENGL J MED, V383, P2401, DOI 10.1056/NEJMp2023999; Guh J, 2019, FAM MED, V51, P37, DOI 10.22454/FamMed.2019.987621; Kemet S, 2019, NEW ENGL J MED, V381, P800, DOI 10.1056/NEJMp1905346; Wooding DJ, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100178	4	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 13	2021	384	19					E72	+		10.1056/NEJMpv2104827	http://dx.doi.org/10.1056/NEJMpv2104827		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD6UF	33909961	Bronze			2022-12-28	WOS:000645678900001
J	Amidei, CB; Fayosse, A; Dumurgier, J; Machado-Fragua, MD; Tabak, AG; van Sloten, T; Kivimaki, M; Dugravot, A; Sabia, S; Singh-Manoux, A				Amidei, Claudio Barbiellini; Fayosse, Aurore; Dumurgier, Julien; Machado-Fragua, Marcos D.; Tabak, Adam G.; van Sloten, Thomas; Kivimaki, Mika; Dugravot, Aline; Sabia, Severine; Singh-Manoux, Archana			Association Between Age at Diabetes Onset and Subsequent Risk of Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CESAREAN DELIVERY RATES; SECTION RATES; QUALITY; SAFETY; PERFORMANCE; IMPROVEMENT; SCALE	Key PointsQuestionWhat is the association between age at onset of type 2 diabetes and subsequent risk of dementia? FindingsIn this prospective cohort study of 10095 participants, younger age at onset of type 2 diabetes was significantly associated with higher risk for incident dementia; at age 70, the hazard ratio for every 5-year earlier age at type 2 diabetes onset was 1.24. MeaningYounger age at diabetes onset was associated with higher risk of subsequent dementia. ImportanceTrends in type 2 diabetes show an increase in prevalence along with younger age of onset. While vascular complications of early-onset type 2 diabetes are known, the associations with dementia remains unclear. ObjectiveTo determine whether younger age at diabetes onset is more strongly associated with incidence of dementia. Design, Setting, and ParticipantsPopulation-based study in the UK, the Whitehall II prospective cohort study, established in 1985-1988, with clinical examinations in 1991-1993, 1997-1999, 2002-2004, 2007-2009, 2012-2013, and 2015-2016, and linkage to electronic health records until March 2019. The date of final follow-up was March 31, 2019. ExposuresType 2 diabetes, defined as a fasting blood glucose level greater than or equal to 126 mg/dL at clinical examination, physician-diagnosed type 2 diabetes, use of diabetes medication, or hospital record of diabetes between 1985 and 2019. Main Outcomes and MeasuresIncident dementia ascertained through linkage to electronic health records. ResultsAmong 10095 participants (67.3% men; aged 35-55 years in 1985-1988), a total of 1710 cases of diabetes and 639 cases of dementia were recorded over a median follow-up of 31.7 years. Dementia rates per 1000 person-years were 8.9 in participants without diabetes at age 70 years, and rates were 10.0 per 1000 person-years for participants with diabetes onset up to 5 years earlier, 13.0 for 6 to 10 years earlier, and 18.3 for more than 10 years earlier. In multivariable-adjusted analyses, compared with participants without diabetes at age 70, the hazard ratio (HR) of dementia in participants with diabetes onset more than 10 years earlier was 2.12 (95% CI, 1.50-3.00), 1.49 (95% CI, 0.95-2.32) for diabetes onset 6 to 10 years earlier, and 1.11 (95% CI, 0.70-1.76) for diabetes onset 5 years earlier or less; linear trend test (P<.001) indicated a graded association between age at onset of type 2 diabetes and dementia. At age 70, every 5-year younger age at onset of type 2 diabetes was significantly associated with an HR of dementia of 1.24 (95% CI, 1.06-1.46) in analyses adjusted for sociodemographic factors, health behaviors, and health-related measures. Conclusions and RelevanceIn this longitudinal cohort study with a median follow-up of 31.7 years, younger age at onset of diabetes was significantly associated with higher risk of subsequent dementia. This cohort study uses UK Whitehall cohort data to examine the association between age at type 2 diabetes onset and incident dementia.	[Amidei, Claudio Barbiellini; Fayosse, Aurore; Dumurgier, Julien; Machado-Fragua, Marcos D.; Dugravot, Aline; Sabia, Severine; Singh-Manoux, Archana] Univ Paris, INSERM, U1153, Epidemiol Ageing & Neurodegenerat Dis, Paris, France; [Amidei, Claudio Barbiellini; Kivimaki, Mika] Univ Padua, Dept Cardiothoracovasc Sci & Publ Hlth, Padua, Italy; [Dumurgier, Julien] Univ Paris, Lariboisiere Fernand Widal Hosp, AP HP, Cognit Neurol Ctr, Paris, France; [Tabak, Adam G.; Kivimaki, Mika; Sabia, Severine; Singh-Manoux, Archana] UCL, Dept Epidemiol & Publ Hlth, London, England; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Internal Med & Oncol, Budapest, Hungary; [Tabak, Adam G.] Semmelweis Univ, Fac Med, Dept Publ Hlth, Budapest, Hungary; [van Sloten, Thomas] Maastricht Univ, Med Ctr, Dept Med, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Padua; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Semmelweis University; Semmelweis University; Maastricht University	Singh-Manoux, A (corresponding author), Univ Paris, INSERM, U1153, EpiAgeing, 10 Ave Verdun, F-75010 Paris, France.	archana.singh-manoux@inserm.fr	Kivimaki, Mika/B-3607-2012; Singh-Manoux, Archana/F-6804-2013; Machado-Fragua, Marcos D/AAG-7303-2021; Sabia, Séverine/G-2966-2017; Dumurgier, Julien/G-2400-2017	Kivimaki, Mika/0000-0002-4699-5627; Singh-Manoux, Archana/0000-0002-1244-5037; Machado-Fragua, Marcos D/0000-0003-2646-1510; Sabia, Séverine/0000-0003-3109-9720; van Sloten, Thomas/0000-0003-2870-482X; Tabak, Adam/0000-0002-6234-3936; Barbiellini Amidei, Claudio/0000-0002-7792-3781; Dumurgier, Julien/0000-0003-2070-9706; FAYOSSE, AURORE/0000-0003-2646-9408				Agency for Healthcare Research and Quality, MODULE 10 ACAD DETAI; Ahern J, 2009, AM J EPIDEMIOL, V169, P1140, DOI 10.1093/aje/kwp015; Alliance for Innovation on Maternal Health, PATIENT SAFETY BUNDL; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; Blackmon L, 2004, PEDIATRICS, V114, P1341, DOI 10.1542/peds.2004-1697; Caceres IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057817; Chaillet N, 2007, BIRTH-ISS PERINAT C, V34, P53, DOI 10.1111/j.1523-536X.2006.00146.x; Chaillet N, 2015, NEW ENGL J MED, V372, P1710, DOI 10.1056/NEJMoa1407120; Covered California, ATTACHMENT 7 COVERED; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Danielsen B., PROBABILISTIC RECORD; Davidoff F, 2005, QUAL SAF HEALTH CARE, V14, P319, DOI 10.1136/qshc.2005.014787; Flamm BL, 1998, BIRTH-ISS PERINAT C, V25, P117, DOI 10.1046/j.1523-536x.1998.00117.x; Getahun D, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.07.062; Gilbert WM, 2013, JT COMM J QUAL PATIE, V39, P258, DOI 10.1016/S1553-7250(13)39035-7; Gude WT, 2019, IMPLEMENT SCI, V14, DOI 10.1186/s13012-019-0887-1; Health Resources and Services Administration. Federal Office of Rural Health Policy, LIST RURAL COUNTIES; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Joint Commission, SPECIFICATIONS MANUA; Kozhimannil KB, 2013, HEALTH AFFAIR, V32, P527, DOI 10.1377/hlthaff.2012.1030; Landry S, 2020, MATERN CHILD HLTH J, V24, P405, DOI 10.1007/s10995-020-02894-7; Lazenbatt AE., 2002, EVALUATION HDB HLTH, DOI [10.4324/9780203994498, DOI 10.4324/9780203994498]; Main E K, 1999, Pediatrics, V103, P374; Main EK, 2019, OBSTET GYNECOL, V133, P613, DOI 10.1097/AOG.0000000000003109; Main EK, 2018, HEALTH AFFAIR, V37, P1484, DOI 10.1377/hlthaff.2018.0463; Main EK, 2018, JT COMM J QUAL PATIE, V44, P250, DOI 10.1016/j.jcjq.2017.11.005; Main EK, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.017; Main EK, 2012, OBSTET GYNECOL, V120, P1194, DOI [10.1097/AOG.0b013e31826fc13d, http://10.1097/AOG.0b013e31826fc13d]; Martin Joyce A, 2019, Natl Vital Stat Rep, V68, P1; National Center for Health Statistics, 2016, HLTH PEOPLE 2020 MID; Nilsen P., 2020, HDB IMPLEMENTATION S; Office of Disease Prevention and Health Promotion, HLTH PEOPLE 2020 TOP; Sebastiao YV, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.08.027; Smith H., 2016, TOOLKIT SUPPORT VAGI; Spong CY, 2012, OBSTET GYNECOL, V120, P1181, DOI [http://10.1097/AOG.0b013e3182704880, 10.1097/AOG.0b013e3182704880]; US Centers for Disease Control and Prevention National Center for Health Statistics, VITAL STAT ONLINE; Valdes EG, 2021, J RACIAL ETHN HEALTH, V8, P844, DOI 10.1007/s40615-020-00842-3; VanGompel EW, 2019, HEALTH SERV RES, V54, P417, DOI 10.1111/1475-6773.13123; VanGompel EW, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1756-7; Warton EM., PAPER 25 2018 OOPS D	40	40	40	9	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1640	1649		10.1001/jama.2021.4001	http://dx.doi.org/10.1001/jama.2021.4001			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV1RL	33904867	Green Published, Bronze			2022-12-28	WOS:000645617800021
J	Esteves, SC				Esteves, Sandro C.			Intracytoplasmic sperm injection versus conventional IVF	LANCET			English	Editorial Material									[Esteves, Sandro C.] ANDROFERT, Androl & Human Reprod Clin, BR-13075460 Campinas, Brazil; [Esteves, Sandro C.] Univ Campinas UNICAMP, Dept Surg, Div Urol, Fac Med Sci, Campinas, Brazil; [Esteves, Sandro C.] Aarhus Univ, Fac Hlth, Aarhus, Denmark	Universidade Estadual de Campinas; Aarhus University	Esteves, SC (corresponding author), Univ Campinas UNICAMP, Dept Surg, Div Urol, Fac Med Sci, Campinas, Brazil.; Esteves, SC (corresponding author), Aarhus Univ, Fac Hlth, Aarhus, Denmark.	s.esteves@androfert.com.br	Esteves, Sandro C./G-4416-2012	Esteves, Sandro C./0000-0002-1313-9680	Merck KGaA, Germany	Merck KGaA, Germany	I report research grants and speaker's fees from Merck KGaA, Germany, outside the area of work commented on here.	Aitken RJ, 2021, HUM REPROD, V36, P1175, DOI 10.1093/humrep/deab004; Atik RB, 2018, HUM REPROD OPEN, V2018, DOI 10.1093/hropen/hoy004; Barratt CLR, 2017, HUM REPROD UPDATE, V23, P660, DOI 10.1093/humupd/dmx021; Bhattacharya S, 2001, LANCET, V357, P2075, DOI 10.1016/S0140-6736(00)05179-5; Dang VQ, 2021, LANCET, V397, P1554, DOI 10.1016/S0140-6736(21)00535-3; de Mouzon J, 2020, HUM REPROD, V35, P1900, DOI 10.1093/humrep/deaa090; Esteves SC, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.630550; Esteves SC, 2021, ANDROLOGIA, V53, DOI 10.1111/and.13874; Esteves SC, 2018, NAT REV UROL, V15, P535, DOI 10.1038/s41585-018-0051-8; Esteves SC, 2014, INT BRAZ J UROL, V40, P443, DOI 10.1590/S1677-5538.IBJU.2014.04.02; Goisis A, 2019, LANCET, V393, P1225, DOI 10.1016/S0140-6736(18)31863-4; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Roque M, 2019, LANCET, V394, P1227, DOI 10.1016/S0140-6736(19)31393-5; Salonia A, 2021, 2020 EUROPEAN ASS UR; Wei DM, 2019, LANCET, V393, P1310, DOI 10.1016/S0140-6736(18)32843-5	15	4	4	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1521	1523						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RR7QA	33894819				2022-12-28	WOS:000643286900003
J	Scaltriti, M				Scaltriti, Maurizio			Jose Manuel Baselga (1959-2021)	SCIENCE			English	Biographical-Item								Transformative oncologist who laid the groundwork for precision medicine	[Scaltriti, Maurizio] AstraZeneca, Cambridge, England		Scaltriti, M (corresponding author), AstraZeneca, Cambridge, England.	maurizio.scaltriti@astrazeneca.com							0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					350	350		10.1126/science.abi7805	http://dx.doi.org/10.1126/science.abi7805			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888631				2022-12-28	WOS:000645009800025
J	Oliver, D				Oliver, David			David Oliver: Renaming government agencies won't improve population health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Bamrah JS, 2021, BMJ OPINION; Buck D., 2021, PUBLIC HLTH REFORM W; Department of Health and Social Care, 2018, PREV IS BETT CUR MAT; Department of Health and Social Care, 2021, NEW OFF HLTH PROM DR; Iacobucci G, 2021, BMJ-BRIT MED J, V373, DOI 10.1136/bmj.n911; Institute for Government, 2020, MAJ PROJ; Oliver D, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4712; Razai MS, 2021, BMJ OPINION; UK Health Security Agency, 2021, HIV TEST NEW HIV DIA; World Health Organization, HLTH PROMOTION	10	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n1004	10.1136/bmj.n1004	http://dx.doi.org/10.1136/bmj.n1004			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883125	Bronze			2022-12-28	WOS:000642452700006
J	Zider, A				Zider, Alexander			Start With All the Little Things	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a pulmonologist learns about process improvement from his father, an engineer, who drew up a list of 50 improvements he noted during his hospitalizations for prostate cancer.	[Zider, Alexander] Mills Peninsula Med Ctr, Burlingame, CA USA; [Zider, Alexander] Pulm Associates, 1750 El Camino Real,Suite 307, Burlingame, CA 94010 USA		Zider, A (corresponding author), Pulm Associates, 1750 El Camino Real,Suite 307, Burlingame, CA 94010 USA.	alexander.zider@gmail.com							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1509	1510		10.1001/jama.2021.4885	http://dx.doi.org/10.1001/jama.2021.4885			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877271				2022-12-28	WOS:000642636500014
J	Tan, T; Wu, J; Si, CY; Dai, SX; Zhang, YY; Sun, NQ; Zhang, E; Shao, HL; Si, W; Yang, PP; Wang, H; Chen, ZZ; Zhu, R; Kang, Y; Hernandez-Benitez, R; Martinez, LM; Delicado, EN; Berggren, WT; Schwarz, M; Ai, ZY; Li, TQ; Esteban, CR; Ji, WZ; Niu, YY; Belmonte, JCI				Tan, Tao; Wu, Jun; Si, Chenyang; Dai, Shaoxing; Zhang, Youyue; Sun, Nianqin; Zhang, E.; Shao, Honglian; Si, Wei; Yang, Pengpeng; Wang, Hong; Chen, Zhenzhen; Zhu, Ran; Kang, Yu; Hernandez-Benitez, Reyna; Martinez, Llanos Martinez; Delicado, Estrella Nunez; Berggren, W. Travis; Schwarz, May; Ai, Zongyong; Li, Tianqing; Esteban, Concepcion Rodriguez; Ji, Weizhi; Niu, Yuyu; Belmonte, Juan Carlos Izpisua			Chimeric contribution of human extended pluripotent stem cells to monkey embryos ex vivo	CELL			English	Article							SELF-ORGANIZATION; FATE DECISIONS; RNA-SEQ; NAIVE; RECONSTRUCTION; GENERATION; DERIVATION; INDUCTION; STATES	Interspecies chimera formation with human pluripotent stem cells (hPSCs) represents a necessary alternative to evaluate hPSC pluripotency in vivo and might constitute a promising strategy for various regenerative medicine applications, including the generation of organs and tissues for transplantation. Studies using mouse and pig embryos suggest that hPSCs do not robustly contribute to chimera formation in species evolutionarily distant to humans. We studied the chimeric competency of human extended pluripotent stem cells (hEPSCs) in cynomolgus monkey (Macaca fascicularis) embryos cultured ex vivo. We demonstrate that hEPSCs survived, proliferated, and generated several pen- and early post-implantation cell lineages inside monkey embryos. We also uncovered signaling events underlying interspecific crosstalk that may help shape the unique developmental trajectories of human and monkey cells within chimeric embryos. These results may help to better understand early human development and primate evolution and develop strategies to improve human chimerism in evolutionarily distant species.	[Tan, Tao; Si, Chenyang; Dai, Shaoxing; Zhang, Youyue; Sun, Nianqin; Zhang, E.; Shao, Honglian; Si, Wei; Yang, Pengpeng; Wang, Hong; Chen, Zhenzhen; Zhu, Ran; Kang, Yu; Ai, Zongyong; Li, Tianqing; Ji, Weizhi; Niu, Yuyu] Kunming Univ Sci & Technol, Inst Primate Translat Med, State Key Lab Primate Biomed Res, Kunming 650500, Yunnan, Peoples R China; [Wu, Jun; Hernandez-Benitez, Reyna; Berggren, W. Travis; Schwarz, May; Esteban, Concepcion Rodriguez; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Martinez, Llanos Martinez; Delicado, Estrella Nunez] Univ Catolica San Antonio Murcia UCAM, Campus Jeronimos 13512, Guadalupe 30107, Spain; [Wu, Jun] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Kunming University of Science & Technology; Salk Institute; Universidad Catolica de Murcia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Tan, T; Ji, WZ; Niu, YY (corresponding author), Kunming Univ Sci & Technol, Inst Primate Translat Med, State Key Lab Primate Biomed Res, Kunming 650500, Yunnan, Peoples R China.; Wu, J; Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA.; Wu, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	tant@lpbr.cn; jun2.wu@utsouthwestern.edu; wji@lpbr.cn; niuyy@lpbr.cn; belmonte@salk.edu	Núñez-Delicado, Estrella/AAR-9438-2021; Wu, Jun/AAF-1830-2019; Martinez Martinez/F-9711-2016	Núñez-Delicado, Estrella/0000-0002-0554-2365; Wu, Jun/0000-0001-9863-1668; Martinez Martinez/0000-0003-3087-1977; Zhu, Ran/0000-0003-0874-9369; Hernandez-Benitez, Reyna/0000-0003-2546-8956	National Key Research and Development Program [2018YFA0801400, 2016YFA0101401]; National Natural Science Foundation of China [81760271, 31660346]; Major Basic Research Project of Science and Technology of Yunnan [2017ZF028, 202001BC070001]; Key Projects of Basic Research Program in Yunnan Province [2017FA010]; High-level Talent Cultivation Support Plan of Yunnan Province and Yunnan Fundamental Research Projects [2019FB050]; UCAM; Moxie Foundation	National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Project of Science and Technology of Yunnan; Key Projects of Basic Research Program in Yunnan Province; High-level Talent Cultivation Support Plan of Yunnan Province and Yunnan Fundamental Research Projects; UCAM; Moxie Foundation	Special thanks to the Stanford University Research Ethics Program for helpful discussions and feedback during the protocol review process. We would like to thank David O'Keefe for his critical reading of this manuscript and invaluable comments. This work was supported by grants from the National Key Research and Development Program (2018YFA0801400 and 2016YFA0101401), the National Natural Science Foundation of China (81760271 and 31660346), Major Basic Research Project of Science and Technology of Yunnan (2017ZF028 and 202001BC070001), Key Projects of Basic Research Program in Yunnan Province (2017FA010), High-level Talent Cultivation Support Plan of Yunnan Province and Yunnan Fundamental Research Projects (2019FB050), UCAM, and The Moxie Foundation.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aksoy I., 2020, BIORXIV; Bayerl J., 2020, BIORXIV; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chen YC, 2015, CELL STEM CELL, V17, P116, DOI 10.1016/j.stem.2015.06.004; Das S, 2020, NAT BIOTECHNOL, V38, P297, DOI 10.1038/s41587-019-0373-y; De Los Angeles Alejandro, 2019, Curr Protoc Stem Cell Biol, V50, pe87, DOI 10.1002/cpsc.87; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948; Fu R, 2020, PROTEIN CELL, V11, P97, DOI 10.1007/s13238-019-00676-8; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gao XF, 2019, NAT CELL BIOL, V21, P687, DOI 10.1038/s41556-019-0333-2; Guo G., 2020, BIORXIV; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Harvey A, 2019, STEM CELL REP, V13, P573, DOI 10.1016/j.stemcr.2019.09.003; Hu ZX, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz0298; Huang K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07098-w; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Ma HX, 2019, SCIENCE, V366, P836, DOI 10.1126/science.aax7890; Martyn I, 2018, NATURE, V558, P132, DOI 10.1038/s41586-018-0150-y; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Morgani S, 2017, BMC DEV BIOL, V17, DOI 10.1186/s12861-017-0150-4; Nakamura T, 2016, NATURE, V537, P57, DOI 10.1038/nature19096; Niu YY, 2019, SCIENCE, V366, P837, DOI 10.1126/science.aaw5754; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Posfai E., 2020, BIORXIV; Riveiro AR, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.189845; Rossant J, 2018, ANNU REV GENET, V52, P185, DOI 10.1146/annurev-genet-120116-024544; Rossant J, 2018, SCIENCE, V360, P1075, DOI 10.1126/science.aas9302; Rossant J, 2017, CELL STEM CELL, V20, P18, DOI 10.1016/j.stem.2016.12.004; Salazar-Roa M, 2020, EMBO J, V39, DOI 10.15252/embj.2019104324; Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347; Shao Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16104; Simunovic M, 2019, NAT CELL BIOL, V21, P900, DOI 10.1038/s41556-019-0349-7; Smith A, 2017, DEVELOPMENT, V144, P365, DOI 10.1242/dev.142679; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suchy F, 2018, CURR OPIN GENET DEV, V52, P36, DOI 10.1016/j.gde.2018.05.007; Theunissen TW, 2016, CELL STEM CELL, V19, P502, DOI 10.1016/j.stem.2016.06.011; Theunissen TW, 2014, CELL STEM CELL, V15, P471, DOI 10.1016/j.stem.2014.07.002; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Wang XP, 2018, CELL RES, V28, P126, DOI 10.1038/cr.2017.138; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Weinberger L, 2016, NAT REV MOL CELL BIO, V17, P155, DOI 10.1038/nrm.2015.28; Weinreb C, 2018, BIOINFORMATICS, V34, P1246, DOI 10.1093/bioinformatics/btx792; Wu J, 2017, CELL, V168, P473, DOI 10.1016/j.cell.2016.12.036; Wu J, 2016, NATURE, V540, P51, DOI 10.1038/nature20573; Wu J, 2016, CELL, V165, P1572, DOI 10.1016/j.cell.2016.05.043; Wu J, 2015, CELL STEM CELL, V17, P509, DOI 10.1016/j.stem.2015.10.009; Xiang LF, 2020, NATURE, V577, P537, DOI 10.1038/s41586-019-1875-y; Xue XF, 2018, NAT MATER, V17, P633, DOI 10.1038/s41563-018-0082-9; Yang J, 2017, NATURE, V550, P393, DOI 10.1038/nature24052; Yang Y, 2017, CELL, V169, P243, DOI 10.1016/j.cell.2017.02.005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang J, 2018, CELL METAB, V27, P332, DOI 10.1016/j.cmet.2018.01.008; Zheng CB, 2021, NATURE, V592, P272, DOI 10.1038/s41586-021-03273-0; Zheng Y, 2019, NATURE, V573, P421, DOI 10.1038/s41586-019-1535-2; Zhou F, 2019, NATURE, V572, P660, DOI 10.1038/s41586-019-1500-0	68	44	46	8	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2021	184	8					2020	+		10.1016/j.cell.2021.03.020	http://dx.doi.org/10.1016/j.cell.2021.03.020		APR 2021	27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RN5JL	33861963	Bronze			2022-12-28	WOS:000640387300014
J	Rockwern, B; Johnson, D; Sulmasy, LS				Rockwern, Brooke; Johnson, Dejaih; Sulmasy, Lois Snyder		Amer Coll Phys	Health Information Privacy, Protection, and Use in the Expanding Digital Health Ecosystem: A Position Paper of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review								Technologic advancements and the evolving digital health landscape have offered innovative solutions to several of our health care system's issues as well as increased the number of digital interactions and type of personal health information that is generated and collected, both within and outside of traditional health care. This American College of Physicians' position paper discusses the state of privacy legislation and regulations, highlights existing gaps in health information privacy protections, and outlines policy principles and recommendations for the development of health information privacy and security protections that are comprehensive, transparent, understandable, adaptable, and enforceable. The principles and recommendations aim to improve on the privacy framework in which physicians have practiced for decades and expand similar privacy guardrails to entities not currently governed by privacy laws and regulations. The expanded privacy framework should protect personal health information from unauthorized, discriminatory, deceptive, or harmful uses and align with the principles of medical ethics, respect individual rights, and support the culture of trust necessary to maintain and improve care delivery.	[Rockwern, Brooke; Johnson, Dejaih] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Sulmasy, Lois Snyder] Amer Coll Physicians, Ctr Eth & Professionalism, 190 N Independence Mall West, Philadelphia, PA 19106 USA	American College of Physicians; American College of Physicians	Rockwern, B (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	brockwern@acponline.org		Johnson, Dejaih/0000-0002-5951-9865	ACP	ACP	Financial support for the development of this position paper came exclusively from the ACP operating budget.	American College of Physicians, HLTH INF TECHN PRIV HLTH INF TECHN PRIV; Board of Governors of the Federal Reserve System, FED TRAD COMM ACT 5 **NON-TRADITIONAL**; Hamel L., 2020, TOP ISSUES 2020 ELEC; Klein DM, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4595; Office of the National Coordinator for Health Information Technology, HLTH IT QUICK STATS; Price WN, 2019, NAT MED, V25, P37, DOI 10.1038/s41591-018-0272-7; Singhal Shubham, 2019, ERA EXPONENTIAL IMPR; Sulmasy LS, 2019, ANN INTERN MED, V170, pS1, DOI 10.7326/M18-2160; Sulmasy LS, 2017, J GEN INTERN MED, V32, P935, DOI 10.1007/s11606-017-4030-1; U.S. Department of Health and Human Services, DOES FERPA HIPAA APP; U.S . Department of Health and Human Services, FED POL PROT HUM SUB; U.S. Department of Health and Human Services, HHS 42 CFR 2 HHS 42 CFR 2; U.S. Department of Health and Human Services, **NON-TRADITIONAL**; U.S. Equal Employment Opportunity Commission, GEN INF NOND ACT 200; U.S. Food and Drug Administration, 2018, US EL HLTH REC DAT C; U.S. Food and Drug Administration, CYBERSECURITY; Watson C., 2020, NATL PLAN ENABLE COM	17	3	3	2	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					994	+		10.7326/M20-7639	http://dx.doi.org/10.7326/M20-7639			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33900797				2022-12-28	WOS:000675809000026
J	Konig, MF; Sathiyakumar, V; Phan, CM; Schulman, SP; Gelber, AC				Konig, Maximilian F.; Sathiyakumar, Vasanth; Phan, Casey M.; Schulman, Steven P.; Gelber, Allan C.			Inside and Out	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEUROFIBROMATOSIS TYPE-1	Inside and Out A 38-year-old woman who walked several hours per day as a mail carrier had sudden substernal chest pain accompanied by shortness of breath on her way home from work. Emergency coronary angiography and transthoracic echocardiography are shown in videos.	[Konig, Maximilian F.; Sathiyakumar, Vasanth; Schulman, Steven P.; Gelber, Allan C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21224 USA; [Konig, Maximilian F.; Gelber, Allan C.] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21224 USA; [Sathiyakumar, Vasanth; Schulman, Steven P.] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21224 USA; [Phan, Casey M.] Johns Hopkins Univ, Sch Med, Div Dermatopathol, Baltimore, MD 21224 USA; [Phan, Casey M.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gelber, AC (corresponding author), Johns Hopkins Univ, Sch Med, 5200 Eastern Ave,Mason F Lord Bldg,Ctr Tower, Baltimore, MD 21224 USA.	agelber@jhmi.edu	Konig, Maximilian F/I-9356-2019	Konig, Maximilian F/0000-0001-5045-5255; Gelber, Allan/0000-0001-8463-311X				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; FUKUSHIGE J, 1994, ACTA PAEDIATR, V83, P1057, DOI 10.1111/j.1651-2227.1994.tb12985.x; Gulati R, 2020, MAYO CLIN PROC, V95, P136, DOI 10.1016/j.mayocp.2019.05.001; Gutmann DH, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.4; Koczkowska M, 2020, HUM MUTAT, V41, P299, DOI 10.1002/humu.23929; Li F, 2014, CIRCULATION, V129, P1213, DOI 10.1161/CIRCULATIONAHA.113.006320; Lie JT, 1998, CARDIOVASC PATHOL, V7, P97, DOI 10.1016/S1054-8807(97)00081-1; NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601; Oderich GS, 2007, J VASC SURG, V46, P475, DOI 10.1016/j.jvs.2007.03.055; Pascual-Tejerina V, 2019, JACC-CARDIOVASC INTE, V12, pE21, DOI 10.1016/j.jcin.2018.11.006; POULLET P, 1994, MOL CELL BIOL, V14, P815, DOI 10.1128/MCB.14.1.815; Stewart DR, 2018, GENET MED, V20, P671, DOI 10.1038/gim.2018.28; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Xu J, 2007, CIRCULATION, V116, P2148, DOI 10.1161/CIRCULATIONAHA.107.707752; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	16	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1753	1760		10.1056/NEJMcps2034360	http://dx.doi.org/10.1056/NEJMcps2034360			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY1SU	33951365	Green Accepted			2022-12-28	WOS:000647698500014
J	Yen, I; Shanahan, F; Lee, J; Hong, YS; Shin, SJ; Moore, AR; Sudhamsu, J; Chang, MT; Bae, I; Dela Cruz, D; Hunsaker, T; Klijn, C; Liau, NPD; Lin, E; Martin, SE; Modrusan, Z; Piskol, R; Segal, E; Venkatanarayan, A; Ye, X; Yin, JP; Zhang, LX; Kim, JS; Lim, HS; Kim, KP; Kim, YJ; Han, HS; Lee, SJ; Kim, ST; Jung, M; Hong, YH; Noh, YS; Choi, M; Han, O; Nowicka, M; Srinivasan, S; Yan, YB; Kim, TW; Malek, S				Yen, Ivana; Shanahan, Frances; Lee, Jeeyun; Hong, Yong Sang; Shin, Sang Joon; Moore, Amanda R.; Sudhamsu, Jawahar; Chang, Matthew T.; Bae, Inhwan; Dela Cruz, Darlene; Hunsaker, Thomas; Klijn, Christiaan; Liau, Nicholas P. D.; Lin, Eva; Martin, Scott E.; Modrusan, Zora; Piskol, Robert; Segal, Ehud; Venkatanarayan, Avinashnarayan; Ye, Xin; Yin, Jianping; Zhang, Liangxuan; Kim, Jin-Soo; Lim, Hyeong-Seok; Kim, Kyu-Pyo; Kim, Yu Jung; Han, Hye Sook; Lee, Soo Jung; Kim, Seung Tae; Jung, Minkyu; Hong, Yoon-hee; Noh, Young Su; Choi, Munjeong; Han, Oakpil; Nowicka, Malgorzata; Srinivasan, Shrividhya; Yan, Yibing; Kim, Tae Won; Malek, Shiva			ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma	NATURE			English	Article								Although RAF monomer inhibitors (type I.5, BRAF(V600)) are clinically approved for the treatment of BRAF(V600)-mutant melanoma, they are ineffective in non-BRAF(V600) mutant cells(1-3). Belvarafenib is a potent and selective RAF dimer (type II) inhibitor that exhibits clinical activity in patients with BRAF(V600E)- and NRAS-mutant melanomas. Here we report the first-in-human phase I study investigating the maximum tolerated dose, and assessing the safety and preliminary efficacy of belvarafenib in BRAF(V600E)- and RAS-mutated advanced solid tumours (NCT02405065, NCT03118817). By generating belvarafenib-resistant NRAS-mutant melanoma cells and analysing circulating tumour DNA from patients treated with belvarafenib, we identified new recurrent mutations in ARAF within the kinase domain. ARAF mutants conferred resistance to belvarafenib in both a dimer- and a kinase activity-dependent manner. Belvarafenib induced ARAF mutant dimers, and dimers containing mutant ARAF were active in the presence of inhibitor. ARAF mutations may serve as a general resistance mechanism for RAF dimer inhibitors as the mutants exhibit reduced sensitivity to a panel of type II RAF inhibitors. The combination of RAF plus MEK inhibition may be used to delay ARAF-driven resistance and suggests a rational combination for clinical use. Together, our findings reveal specific and compensatory functions for the ARAF isoform and implicate ARAF mutations as a driver of resistance to RAF dimer inhibitors.	[Yen, Ivana; Shanahan, Frances; Moore, Amanda R.; Sudhamsu, Jawahar; Lin, Eva; Martin, Scott E.; Venkatanarayan, Avinashnarayan; Ye, Xin; Malek, Shiva] Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA; [Lee, Jeeyun; Kim, Seung Tae] Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea; [Lee, Jeeyun] Sungkyunkwan Univ, Samsung Med Ctr, Dept Intelligence Precis Healthcare Convergence, Sch Med, Suwon, South Korea; [Hong, Yong Sang; Kim, Kyu-Pyo; Kim, Tae Won] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea; [Shin, Sang Joon; Jung, Minkyu] Yonsei Univ, Dept Internal Med, Div Med Oncol, Coll Med, Seoul, South Korea; [Sudhamsu, Jawahar; Liau, Nicholas P. D.; Yin, Jianping] Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA; [Chang, Matthew T.; Klijn, Christiaan; Piskol, Robert] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Bae, Inhwan] Hanmi Pharmaceut Co Ltd, Dept New Chem Ent Discovery, Hanmi Res Ctr, Seoul, South Korea; [Dela Cruz, Darlene; Hunsaker, Thomas; Segal, Ehud] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Modrusan, Zora] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Zhang, Liangxuan; Nowicka, Malgorzata; Srinivasan, Shrividhya; Yan, Yibing] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Kim, Jin-Soo] Seoul Natl Univ, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Lim, Hyeong-Seok] Univ Ulsan, Asan Med Ctr, Dept Clin Pharmacol & Therapeut, Coll Med, Seoul, South Korea; [Kim, Yu Jung] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Hematol & Med Oncol,Coll Med, Seongnam, South Korea; [Han, Hye Sook] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Internal Med, Coll Med, Cheongju, South Korea; [Lee, Soo Jung] Kyungpook Natl Univ, Chilgok Hosp, Dept Oncol Hematol, Daegu, South Korea; [Hong, Yoon-hee; Noh, Young Su; Choi, Munjeong; Han, Oakpil] Hanmi Pharmaceut Co Ltd, Dept Clin Res & Dev, Seoul, South Korea	Roche Holding; Genentech; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Roche Holding; Genentech; Roche Holding; Genentech; Hanmi Pharmaceutical; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Chungbuk National University; Chungbuk National University Hospital; Kyungpook National University; Hanmi Pharmaceutical	Malek, S (corresponding author), Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA.; Kim, TW (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea.	twkimmd@amc.seoul.kr; shivam@gene.com		Bae, InHwan/0000-0001-5390-2401; Shin, Sang Joon/0000-0001-5350-7241; Jung, Minkyu/0000-0001-8281-3387; Sudhamsu, Jawahar/0000-0003-0737-2299				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ascierto PA, 2016, LANCET ONCOL, V17, P1248, DOI 10.1016/S1470-2045(16)30122-X; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Clark TA, 2018, J MOL DIAGN, V20, P686, DOI 10.1016/j.jmoldx.2018.05.004; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Desai J, 2020, J CLIN ONCOL, V38, P2140, DOI 10.1200/JCO.19.02654; Dorard C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15262; Dummer R, 2018, LANCET ONCOL, V19, P603, DOI 10.1016/S1470-2045(18)30142-6; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; Kim TW, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.3000; Lee JW, 2005, APMIS, V113, P54, DOI 10.1111/j.1600-0463.2005.apm1130108.x; Liau NPD, 2020, NAT STRUCT MOL BIOL, V27, P134, DOI 10.1038/s41594-019-0365-0; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Monaco K. A., 2020, CLIN CANCER RES; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Moore AR, 2020, NAT REV DRUG DISCOV, V19, P533, DOI 10.1038/s41573-020-0068-6; Nelson DS, 2014, BLOOD, V123, P3152, DOI 10.1182/blood-2013-06-511139; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Ramurthy S, 2020, J MED CHEM, V63, P2013, DOI 10.1021/acs.jmedchem.9b00161; Rebocho AP, 2013, ONCOGENE, V32, P3207, DOI 10.1038/onc.2012.330; Sekulic A, 2008, MAYO CLIN PROC, V83, P825, DOI 10.4065/83.7.825; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun Y, 2017, NEURO-ONCOLOGY, V19, P774, DOI 10.1093/neuonc/now261; Tang ZY, 2015, MOL CANCER THER, V14, P2187, DOI 10.1158/1535-7163.MCT-15-0262; Treiber DK, 2013, CHEM BIOL, V20, P745, DOI 10.1016/j.chembiol.2013.06.001; US Food & Drug Administration, 2010, S9 NONCL EV ANT PHAR; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Yaeger R, 2017, CANCER RES, V77, P6513, DOI 10.1158/0008-5472.CAN-17-0768; Yuan X, 2020, MOL ONCOL, V14, P1833, DOI 10.1002/1878-0261.12698; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t	58	28	29	2	28	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 17	2021	594	7863					418	+		10.1038/s41586-021-03515-1	http://dx.doi.org/10.1038/s41586-021-03515-1		MAY 2021	27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SU1FZ	33953400				2022-12-28	WOS:000647555000001
J	Kohn, OF				Kohn, Orly F.			SGLT2 inhibitors reduce all-cause mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							KIDNEY-DISEASE		[Kohn, Orly F.] Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Kohn, OF (corresponding author), Univ Chicago, Chicago, IL 60637 USA.							Heerspink HJL, 2020, NEW ENGL J MED, V383, P1436, DOI 10.1056/NEJMoa2024816; Mosenzon O, 2019, LANCET DIABETES ENDO, V7, P606, DOI 10.1016/S2213-8587(19)30180-9; Neuen BL, 2019, LANCET DIABETES ENDO, V7, P845, DOI 10.1016/S2213-8587(19)30256-6; Neuen BL, 2018, CIRCULATION, V138, P1537, DOI 10.1161/CIRCULATIONAHA.118.035901; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Perkovic V, 2018, LANCET DIABETES ENDO, V6, P691, DOI 10.1016/S2213-8587(18)30141-4; Wanner C, 2016, NEW ENGL J MED, V375, P323, DOI [10.1056/NEJMoa1515920, 10.1056/NEJMc1611290]; Wheeler DC, 2020, NEPHROL DIAL TRANSPL, V35, P1700, DOI 10.1093/ndt/gfaa234	8	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC52	JC53		10.7326/ACPJ202105180-052	http://dx.doi.org/10.7326/ACPJ202105180-052			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939484				2022-12-28	WOS:000652604800007
J	Mahase, E				Mahase, Elisabeth			Covid-19: Most people admitted to hospital after vaccination were infected before immunity could develop, research shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Egan C, 2021, ISARIC4C CO CIN HOSP	1	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2021	373								n1127	10.1136/bmj.n1127	http://dx.doi.org/10.1136/bmj.n1127			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QM	33931384	Bronze			2022-12-28	WOS:000649708000003
J	Steed, G; Ramirez, DC; Hannah, MA; Webb, AAR				Steed, Gareth; Ramirez, Dora Cano; Hannah, Matthew A.; Webb, Alex A. R.			Chronoculture, harnessing the circadian clock to improve crop yield and sustainability	SCIENCE			English	Review							POSTHARVEST STORAGE; FLOWERING TIME; ANNUAL WEEDS; GENE; ARABIDOPSIS; PHOTOPERIOD; LOCUS; ADAPTATION; RHYTHMS; GROWTH	Human health is dependent on a plentiful and nutritious supply of food, primarily derived from crop plants. Rhythmic supply of light as a result of the day and night cycle led to the evolution of circadian clocks that modulate most plant physiology, photosynthesis, metabolism, and development. To regulate crop traits and adaptation, breeders have indirectly selected for variation at circadian genes. The pervasive impact of the circadian system on crops suggests that future food production might be improved by modifying circadian rhythms, engineering the timing of transgene expression, and applying agricultural treatments at the most effective time of day. We describe the applied research required to take advantage of circadian biology in agriculture to increase production and reduce inputs.	[Steed, Gareth; Ramirez, Dora Cano; Webb, Alex A. R.] Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England; [Hannah, Matthew A.] BBCC Innovat Ctr Gent, BASF, Technol Pk Zwijnaarde 101, B-9052 Ghent, Belgium	University of Cambridge; BASF	Webb, AAR (corresponding author), Univ Cambridge, Dept Plant Sci, Downing St, Cambridge CB2 3EA, England.	aarw2@cam.ac.uk		Cano Ramirez, Dora Luz/0000-0002-5713-8284; Steed, Gareth/0000-0001-6225-4848; Webb, Alex/0000-0003-0261-4375	URKI BBSRC [BB/S006370/1, BB/S002251/1]	URKI BBSRC	G.S. and D.C.R. are supported by URKI BBSRC grants BB/S006370/1 and BB/S002251/1 awarded to A.A.R.W.	Alvarez MA, 2016, FUNCT INTEGR GENOMIC, V16, P365, DOI 10.1007/s10142-016-0490-3; Asseng S, 2020, P NATL ACAD SCI USA, V117, P19131, DOI 10.1073/pnas.2002655117; Atamian HS, 2016, SCIENCE, V353, P587, DOI 10.1126/science.aaf9793; Belbin FE, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11709-5; Bours R, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-29; Box MS, 2015, CURR BIOL, V25, P194, DOI 10.1016/j.cub.2014.10.076; Caird MA, 2007, PLANT PHYSIOL, V143, P4, DOI 10.1104/pp.106.092940; Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Coupel-Ledru A, 2016, P NATL ACAD SCI USA, V113, P8963, DOI 10.1073/pnas.1600826113; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2014, NEW PHYTOL, V201, P168, DOI 10.1111/nph.12489; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Endo M, 2014, NATURE, V515, P419, DOI 10.1038/nature13919; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Fujimoto R, 2018, BREEDING SCI, V68, P145, DOI 10.1270/jsbbs.17155; Gardner MJ, 2009, J EXP BOT, V60, P213, DOI 10.1093/jxb/ern292; Gawronski P, 2014, GENETICS, V196, P1253, DOI 10.1534/genetics.113.158444; Goodspeed D, 2013, CURR BIOL, V23, P1235, DOI 10.1016/j.cub.2013.05.034; Gottlieb D, 2019, J STORED PROD RES, V82, P9, DOI 10.1016/j.jspr.2019.03.003; Greenham K, 2017, J BIOL RHYTHM, V32, P26, DOI 10.1177/0748730416679307; Hasperue JH, 2013, POSTHARVEST BIOL TEC, V82, P22, DOI 10.1016/j.postharvbio.2013.02.021; Hassidim M, 2017, PLANT PHYSIOL, V175, P1864, DOI 10.1104/pp.17.01214; Hevia MA, 2015, P NATL ACAD SCI USA, V112, P8744, DOI 10.1073/pnas.1508432112; Hubbard CJ, 2018, ISME J, V12, P400, DOI 10.1038/ismej.2017.172; Ingle RA, 2015, PLANT J, V84, P937, DOI 10.1111/tpj.13050; Jones HG, 2018, BIOSYST ENG, V165, P59, DOI 10.1016/j.biosystemseng.2017.09.012; Jung JH, 2020, NATURE, V585, P256, DOI 10.1038/s41586-020-2644-7; Kong YM, 2020, J INTEGR PLANT BIOL, V62, P1880, DOI 10.1111/jipb.12999; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Kusakina J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127449; Liew LC, 2014, PLANT PHYSIOL, V165, P648, DOI 10.1104/pp.114.237008; Liu JD, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0474-9; Lu SJ, 2017, NAT GENET, V49, P773, DOI 10.1038/ng.3819; Martinson KB, 2002, CHRONOBIOL INT, V19, P405, DOI 10.1081/CBI-120002877; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Miller RP, 2003, CHRONOBIOL INT, V20, P299, DOI 10.1081/CBI-120019344; Mishra P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00008; Mizuno N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165618; Muller LM, 2020, PLANT PHYSIOL, V183, P765, DOI 10.1104/pp.19.01411; Muller NA, 2018, P NATL ACAD SCI USA, V115, P7135, DOI 10.1073/pnas.1801862115; Ochagavia H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39201-6; Oldroyd GED, 2020, SCIENCE, V368, P45, DOI 10.1126/science.aba0196; Preuss SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030717; Ramirez DA, 2018, AM J POTATO RES, V95, P139, DOI 10.1007/s12230-017-9618-9; Roenneberg T, 2016, CURR BIOL, V26, pR432, DOI 10.1016/j.cub.2016.04.011; Roman A, 2020, PLANT J, V102, P187, DOI 10.1111/tpj.14603; Ruben MD, 2019, SCIENCE, V365, P547, DOI 10.1126/science.aax7621; Rubenach AJS, 2017, PLANT PHYSIOL, V173, P2253, DOI 10.1104/pp.16.01738; Saito H, 2012, PLANT CELL PHYSIOL, V53, P717, DOI 10.1093/pcp/pcs029; Sartor F, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020041; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schoppach R, 2020, FUNCT PLANT BIOL, V47, P1117, DOI 10.1071/FP20044; Sellers BA, 2003, WEED TECHNOL, V17, P302, DOI 10.1614/0890-037X(2003)017[0302:DFALAR]2.0.CO;2; Shaw LM, 2012, PLANT J, V71, P71, DOI 10.1111/j.1365-313X.2012.04971.x; Shimizu H, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.163, 10.1038/nplants.2015.163]; Silva CS, 2020, P NATL ACAD SCI USA, V117, P6901, DOI 10.1073/pnas.1920972117; Simon NML, 2020, PLANT PHYSIOL, V183, P317, DOI 10.1104/pp.20.00030; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Song YH, 2015, ANNU REV PLANT BIOL, V66, P441, DOI 10.1146/annurev-arplant-043014-115555; Staley C, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0287-1; Stopps GJ, 2013, WEED TECHNOL, V27, P690, DOI 10.1614/WT-D-13-00035.1; Sun H, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00285; Topfer N, 2020, PLANT CELL, V32, P3689, DOI 10.1105/tpc.20.00132; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Velez-Ramirez AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5549; Wani SH, 2016, ADV GENOME SCI, V4, P173, DOI 10.2174/9781681081731116040010; Webb AAR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08398-5; Weller JL, 2012, P NATL ACAD SCI USA, V109, P21158, DOI 10.1073/pnas.1207943110; Yarkhunova Y, 2016, NEW PHYTOL, V210, P133, DOI 10.1111/nph.13758; Yon F, 2016, NEW PHYTOL, V209, P1058, DOI 10.1111/nph.13681; Zhang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10485-6; Zhang ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127723; Zhao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043705; Zikhali M, 2016, J EXP BOT, V67, P287, DOI 10.1093/jxb/erv458	75	34	37	28	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					479	+	eabc9141	10.1126/science.abc9141	http://dx.doi.org/10.1126/science.abc9141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926926				2022-12-28	WOS:000645554100035
J	Tanne, JH				Tanne, Janice Hopkins			Biden administration proposes making opioid addiction treatment more easily available	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Addiction Center, 2021, ADD STAT; Centers for Disease Control and Prevention. National Center for Health Statistics, 2021, VIT STAT RAP REL PRO; Department of Health and Human Services, 2021, HHS REL NEW BUPR PRA; Facher L., 2021, STATNEWS; Federal Register, 2021, PRACTICE GUIDELINES	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2021	373								n1126	10.1136/bmj.n1126	http://dx.doi.org/10.1136/bmj.n1126			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QM	33931433				2022-12-28	WOS:000649708000001
J	Wise, J				Wise, Jacqui			Many more people could benefit from blood pressure lowering drugs, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2019, BMJ BRIT MED J; Blood Pressure Lowering Treatment Trialists' Collaboration, LANCET, V397, P1625; NICE, 2019, HYPERTENSION ADULTS; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]; Williams B, 2018, J HYPERTENS, V36, P1953, DOI 10.1097/HJH.0000000000001940	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2021	373								n1120	10.1136/bmj.n1120	http://dx.doi.org/10.1136/bmj.n1120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0QM	33931395				2022-12-28	WOS:000649708000004
J	Zhang, ZD; Chen, LC; Yao, KX; Chin, C				Zhang, Zhendong; Chen, Liangchao; Yao, Kai-Xuan; Chin, Cheng			Transition from an atomic to a molecular Bose-Einstein condensate	NATURE			English	Article								Molecular quantum gases (that is, ultracold and dense molecular gases) have many potential applications, including quantum control of chemical reactions, precision measurements, quantum simulation and quantum information processing(1-3). For molecules, to reach the quantum regime usually requires efficient cooling at high densities, which is frequently hindered by fast inelastic collisions that heat and deplete the population of molecules(4,5). Here we report the preparation of two-dimensional Bose-Einstein condensates (BECs) of spinning molecules by inducing pairing interactions in an atomic condensate near a g-wave Feshbach resonance(6). The trap geometry and the low temperature of the molecules help to reduce inelastic loss, ensuring thermal equilibrium. From the equation-of-state measurement, we determine the molecular scattering length to be + 220(+/- 30) Bohr radii (95% confidence interval). We also investigate the unpairing dynamics in the strong coupling regime and find that near the Feshbach resonance the dynamical timescale is consistent with the unitarity limit. Our work demonstrates the long-sought transition between atomic and molecular condensates, the bosonic analogue of the crossover from a BEC to a Bardeen-Cooper-Schrieffer (BCS) superfluid in a Fermi gas(7-9). In addition, our experiment may shed light on condensed pairs with orbital angular momentum, where a novel anisotropic superfluid with non-zero surface current is predicted(10,11), such as the A phase of He-3. A Bose-Einstein condensate of molecules is produced by pairing atoms in an atomic condensate; this transition is the bosonic analog of the Bardeen-Cooper-Schrieffer superfluid to BEC crossover in Fermi gases.	[Zhang, Zhendong; Yao, Kai-Xuan; Chin, Cheng] Univ Chicago, James Franck Inst, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA; [Zhang, Zhendong; Yao, Kai-Xuan; Chin, Cheng] Univ Chicago, Dept Phys, Chicago, IL 60637 USA; [Chen, Liangchao] Shanxi Univ, Inst Optoelect, State Key Lab Quantum Opt & Quantum Opt Devices, Taiyuan, Peoples R China	University of Chicago; University of Chicago; Shanxi University; State Key Laboratory of Quantum Optics & Quantum Optics Devices	Chin, C (corresponding author), Univ Chicago, James Franck Inst, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.; Chin, C (corresponding author), Univ Chicago, Dept Phys, Chicago, IL 60637 USA.	cchin@uchicago.edu		Yao, Kai-Xuan/0000-0002-4071-7060; Zhang, Zhendong/0000-0001-7221-1729				ANDERSON PW, 1961, PHYS REV, V123, P1911, DOI 10.1103/PhysRev.123.1911; Bohn JL, 2017, SCIENCE, V357, P1002, DOI 10.1126/science.aam6299; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Chen QJ, 2005, PHYS REP, V412, P1, DOI 10.1016/j.physrep.2005.02.005; Chin C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123201; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Clark LW, 2017, NATURE, V551, P356, DOI 10.1038/nature24272; De Marco L, 2019, SCIENCE, V363, P853, DOI 10.1126/science.aau7230; de Miranda MHG, 2011, NAT PHYS, V7, P502, DOI [10.1038/NPHYS1939, 10.1038/nphys1939]; Duine RA, 2004, PHYS REP, V396, P115, DOI 10.1016/j.physrep.2004.03.003; Eigen C, 2018, NATURE, V563, P221, DOI 10.1038/s41586-018-0674-1; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Ferlaino F, 2010, LASER PHYS, V20, P23, DOI 10.1134/S1054660X0917006X; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Hadzibabic Z, 2011, RIV NUOVO CIMENTO, V34, P389, DOI 10.1393/ncr/i2011-10066-3; Herbig J, 2003, SCIENCE, V301, P1510, DOI 10.1126/science.1088876; Ho T.-L., 2021, PREPRINT; Ho TL, 2010, NAT PHYS, V6, P131, DOI 10.1038/NPHYS1477; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Hung C.-L., 2011, IN SITU PROBING 2 DI; Hung CL, 2011, NATURE, V470, P236, DOI 10.1038/nature09722; Idziaszek Z, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/035007; Idziaszek Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.113202; Kohler T, 2006, REV MOD PHYS, V78, P1311, DOI 10.1103/RevModPhys.78.1311; Kruger P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.040402; Mark M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.113201; Mark MJ, 2018, SCIPOST PHYS, V5, DOI 10.21468/SciPostPhys.5.5.055; Mayle M, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.012709; Micheli A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.073202; Petrov DS, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012706; Prokof'ev N, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043608; Prokof'ev N, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.270402; Quemener G, 2012, CHEM REV, V112, P4949, DOI 10.1021/cr300092g; Radzihovsky L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.160402; Romans MWJ, 2004, PHYS REV LETT, V93, DOI [10.1103/PhysRevLett.93.020405, 10.1103/PhysRevLett.92.020405]; Son H, 2020, NATURE, V580, P197, DOI 10.1038/s41586-020-2141-z; Timmermans E, 2001, PHYS LETT A, V285, P228, DOI 10.1016/S0375-9601(01)00346-2; Tung S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230408	38	12	12	3	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					708	+		10.1038/s41586-021-03443-0	http://dx.doi.org/10.1038/s41586-021-03443-0			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911270	Green Submitted			2022-12-28	WOS:000645368900010
J	Mahase, E				Mahase, Elisabeth			Covid-19: One dose of vaccine cuts risk of passing on infection by as much as 50%, research shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Harris RJ., 2021, IMPACT VACCINATION H	1	9	9	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1112	10.1136/bmj.n1112	http://dx.doi.org/10.1136/bmj.n1112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910890	Bronze			2022-12-28	WOS:000656399900011
J	Aibara, S; Schilbach, S; Cramer, P				Aibara, Shintaro; Schilbach, Sandra; Cramer, Patrick			Structures of mammalian RNA polymerase II pre-initiation complexes	NATURE			English	Article							TRANSCRIPTION INITIATION; MECHANISM; TFIIH; VISUALIZATION; ARCHITECTURE; STEPS	The initiation of transcription is a focal point for the regulation of gene activity during mammalian cell differentiation and development. To initiate transcription, RNA polymerase II (Pol II) assembles with general transcription factors into a pre-initiation complex (PIC) that opens promoter DNA. Previous work provided the molecular architecture of the yeast(1-9) and human(10,11) PIC and a topological model for DNA opening by the general transcription factor TFIIH12-14. Here we report the high-resolution cryo-electron microscopy structure of PIC comprising human general factors and Sus scrofa domesticus Pol II, which is 99.9% identical to human Pol II. We determine the structures of PIC with closed and opened promoter DNA at 2.5-2.8 angstrom resolution, and resolve the structure of TFIIH at 2.9-4.0 angstrom resolution. We capture the TFIIH translocase XPB in the pre- and post-translocation states, and show that XPB induces and propagates a DNA twist to initiate the opening of DNA approximately 30 base pairs downstream of the TATA box. We also provide evidence that DNA opening occurs in two steps and leads to the detachment of TFIIH from the core PIC, which may stop DNA twisting and enable RNA chain initiation.	[Aibara, Shintaro; Schilbach, Sandra; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de		Schilbach, Sandra/0000-0001-9071-8515	H2020 Marie Curie Individual Fellowship [894862]; Deutsche Forschungsgemeinschaft [EXC 2067/1 39072994, SFB860, SPP2191]; ERC Advanced Investigator Grant CHROMATRANS [882357]	H2020 Marie Curie Individual Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC Advanced Investigator Grant CHROMATRANS	We thank members of the Cramer laboratory, in particular C. Dienemann and U. Steuerwald for maintenance of the cryo-EM facility, U. Neef and P. Rus for maintenance of the insect cell facility, and F. Jochheim and M. Klein for maintenance of the computing infrastructure. S.A. was supported by an H2020 Marie Curie Individual Fellowship (894862). P.C. was supported by the Deutsche Forschungsgemeinschaft (EXC 2067/1 39072994, SFB860, SPP2191) and the ERC Advanced Investigator Grant CHROMATRANS (grant agreement no. 882357).	Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Compe E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10131-1; Dienemann C, 2019, MOL CELL, V73, P97, DOI 10.1016/j.molcel.2018.10.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farnung L, 2020, ELIFE, V9, DOI 10.7554/eLife.56178; Fishburn J, 2015, P NATL ACAD SCI USA, V112, P3961, DOI 10.1073/pnas.1417709112; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gradia SD, 2017, METHOD ENZYMOL, V592, P1, DOI 10.1016/bs.mie.2017.03.008; Greber BJ, 2019, ELIFE, V8, DOI 10.7554/eLife.44771; Greber BJ, 2017, NATURE, V549, P414, DOI 10.1038/nature23903; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; Hantsche M, 2017, CURR OPIN STRUC BIOL, V47, P17, DOI 10.1016/j.sbi.2017.03.013; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Holstege FCP, 1996, EMBO J, V15, P1666, DOI 10.1002/j.1460-2075.1996.tb00512.x; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kokic G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10745-5; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Li MJ, 2019, NATURE, V567, P409, DOI 10.1038/s41586-019-1029-2; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Muhlbacher W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5310; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Murakami K, 2015, MOL CELL, V59, P133, DOI 10.1016/j.molcel.2015.05.021; Noe Gonzalez M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05923-w; Nogales E, 2017, ANNU REV BIOPHYS, V46, P59, DOI 10.1146/annurev-biophys-070816-033751; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Qiu CX, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02040-0; Ren DL, 1999, MOL CELL BIOL, V19, P7377; Rengachari S., 2021, NATURE, DOI [10.1038/s41586-021-3555-7, DOI 10.1038/S41586-021-3555-7]; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; Scheres SHW, 2012, J MOL BIOL, V415, P406, DOI 10.1016/j.jmb.2011.11.010; Schilbach S, 2017, NATURE, V551, P204, DOI 10.1038/nature24282; Seizl M, 2011, NUCLEIC ACIDS RES, V39, P6291, DOI 10.1093/nar/gkr229; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tomko EJ, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166813; Tomko EJ, 2017, NAT STRUCT MOL BIOL, V24, P1139, DOI 10.1038/nsmb.3500; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003	47	26	26	3	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					124	+		10.1038/s41586-021-03554-8	http://dx.doi.org/10.1038/s41586-021-03554-8		APR 2021	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	33902107				2022-12-28	WOS:000652171700001
J	Lee, TH				Lee, Thomas H.			Zoom Family Meeting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Thomas H.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Lee, Thomas H.] Press Ganey, Boston, MA 02109 USA	Harvard University; Brigham & Women's Hospital	Lee, TH (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Lee, TH (corresponding author), Press Ganey, Boston, MA 02109 USA.								0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1586	1587		10.1056/NEJMp2035869	http://dx.doi.org/10.1056/NEJMp2035869		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV1ND	33914438				2022-12-28	WOS:000643866000001
J	Ingebretson, AE; Lemos, JC				Ingebretson, Anna E.; Lemos, Julia C.			A spotlight on the elusive striatal cholinergic interneuron	SCIENCE			English	Editorial Material							DOPAMINE	A new role for the ubiquitous integrated stress response pathway in striatal-dependent learning and memory.	[Ingebretson, Anna E.; Lemos, Julia C.] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Lemos, JC (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	jlemos@umn.edu			US National Institute of Mental Health [MH R00109627, MH R01122749]	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors are supported by US National Institute of Mental Health grants MH R00109627 and MH R01122749.	Apicella P, 2017, NEUROSCIENCE, V360, P81, DOI 10.1016/j.neuroscience.2017.07.060; Augustin SM, 2018, CELL REP, V24, P2883, DOI 10.1016/j.celrep.2018.08.042; Chuhma N, 2014, NEURON, V81, P901, DOI 10.1016/j.neuron.2013.12.027; Cox J, 2019, NAT REV NEUROSCI, V20, P482, DOI 10.1038/s41583-019-0189-2; Ding JB, 2010, NEURON, V67, P294, DOI 10.1016/j.neuron.2010.06.017; Gonzales KK, 2015, ANN NY ACAD SCI, V1349, P1, DOI 10.1111/nyas.12762; Helseth A. R., 2021, SCIENCE, V372; Lester DB, 2010, CNS NEUROSCI THER, V16, P137, DOI 10.1111/j.1755-5949.2010.00142.x; Lipton DM, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00028; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Prado VF, 2017, NEUROSCIENCE, V345, P130, DOI 10.1016/j.neuroscience.2016.09.013; Tepper JM, 2007, PROG BRAIN RES, V160, P3, DOI 10.1016/S0079-6123(06)60001-0; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Zhang YF, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00080	15	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					345	346		10.1126/science.abi4907	http://dx.doi.org/10.1126/science.abi4907			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888628	Green Accepted			2022-12-28	WOS:000645009800022
J	Walsh, ED; Jung, W; Lee, GH; Efetov, DK; Wu, BI; Huang, KF; Ohki, TA; Taniguchi, T; Watanabe, K; Kim, P; Englund, D; Fong, KC				Walsh, Evan D.; Jung, Woochan; Lee, Gil-Ho; Efetov, Dmitri K.; Wu, Bae-Ian; Huang, K-F; Ohki, Thomas A.; Taniguchi, Takashi; Watanabe, Kenji; Kim, Philip; Englund, Dirk; Fong, Kin Chung			Josephson junction infrared single-photon detector	SCIENCE			English	Article							ZERO-VOLTAGE STATE; SUPERCONDUCTING QUBIT; DECOHERENCE; RADIATION; LIFETIME; CONTACT; LIGHT	Josephson junctions are superconducting devices used as high-sensitivity magnetometers and voltage amplifiers as well as the basis of high-performance cryogenic computers and superconducting quantum computers. Although device performance can be degraded by the generation of quasiparticles formed from broken Cooper pairs, this phenomenon also opens opportunities to sensitively detect electromagnetic radiation. We demonstrate single near-infrared photon detection by coupling photons to the localized surface plasmons of a graphene-based Josephson junction. Using the photon-induced switching statistics of the current-biased device, we reveal the critical role of quasiparticles generated by the absorbed photon in the detection mechanism. The photon sensitivity will enable a high-speed, low-power optical interconnect for future superconducting computing architectures.	[Walsh, Evan D.; Englund, Dirk] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Walsh, Evan D.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Jung, Woochan; Lee, Gil-Ho] Pohang Univ Sci & Technol, Dept Phys, Pohang 790784, South Korea; [Lee, Gil-Ho; Huang, K-F; Kim, Philip] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Efetov, Dmitri K.] Barcelona Inst Sci & Technol, ICFO Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain; [Wu, Bae-Ian] Air Force Res Lab, Wright Patterson AFB, OH 45433 USA; [Ohki, Thomas A.; Fong, Kin Chung] Raytheon BBN Technol, Quantum Engn & Comp Grp Cambridge, Cambridge, MA 02138 USA; [Taniguchi, Takashi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan; [Watanabe, Kenji] Natl Inst Mat Sci, Res Ctr Funct Mat, Tsukuba, Ibaraki, Japan; [Englund, Dirk] MIT, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Walsh, Evan D.] Syst & Technol Res, Arlington, VA USA	Massachusetts Institute of Technology (MIT); Harvard University; Pohang University of Science & Technology (POSTECH); Harvard University; Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Raytheon Technologies; Raytheon BBN Technologies; National Institute for Materials Science; National Institute for Materials Science; Massachusetts Institute of Technology (MIT)	Fong, KC (corresponding author), Raytheon BBN Technol, Quantum Engn & Comp Grp Cambridge, Cambridge, MA 02138 USA.	kc.fong@rtx.com	Lee, Gil-Ho/AAN-9580-2021; Englund, Dirk Robert/GNH-1681-2022; Kim, Philip/N-1886-2013; Watanabe, Kenji/ABB-2135-2021; Efetov, Dmitri/P-5697-2018	Englund, Dirk Robert/0000-0002-1043-3489; Kim, Philip/0000-0002-8255-0086; Watanabe, Kenji/0000-0003-3701-8119; Jung, Woochan/0000-0002-2677-7219; Ohki, Thomas/0000-0002-9823-3122; Wu, Bae-Ian/0000-0002-8437-3239; Efetov, Dmitri/0000-0001-5862-0462	Army Research Laboratory Institute for Soldier Nanotechnologies program [W911NF-18-2-0048]; U.S. Army Research Laboratory [W911NF-17-1-0435]; AFOSR program "Developing graphene Josephson microwave single-photon detector for quantum information science"; National Research Foundation of Korea (NRF) - Korean Government [2016R1A5A1008184, 2020R1C1C1013241, 2020M3H3A1100839]; Samsung Science and Technology Foundation [SSTF-BA1702-05]; Samsung Electronics Co. [IO20120707801-01]; Ministry of Economy and Competitiveness of Spain through the "Severo Ochoa" program for Centres of Excellence in RD [SE5-0522]; Fundacio Privada Cellex; Fundacio Privada Mir-Puig; Generalitat de Catalunya through the CERCA program; H2020 Programme [820378]; Project: 2D.SIPC; La Caixa Foundation; Air Force Office of Scientific Research [FA9550-16RYCOR290]; Raytheon BBN Technologies; Elemental Strategy Initiative by MEXT, Japan [JPMXP0112101001]; JSPS KAKENHI grant [JP20H00354]; CREST, JST [JPMJCR15F3]; Army Research Office [W911NF-17-1-0574]	Army Research Laboratory Institute for Soldier Nanotechnologies program; U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); AFOSR program "Developing graphene Josephson microwave single-photon detector for quantum information science"; National Research Foundation of Korea (NRF) - Korean Government(National Research Foundation of Korea); Samsung Science and Technology Foundation(Samsung); Samsung Electronics Co.(Samsung); Ministry of Economy and Competitiveness of Spain through the "Severo Ochoa" program for Centres of Excellence in RD; Fundacio Privada Cellex(Foundation CELLEX); Fundacio Privada Mir-Puig; Generalitat de Catalunya through the CERCA program; H2020 Programme; Project: 2D.SIPC; La Caixa Foundation(La Caixa Foundation); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Raytheon BBN Technologies; Elemental Strategy Initiative by MEXT, Japan; JSPS KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Army Research Office	The work of E.D.W. and D.E. was supported in part by the Army Research Laboratory Institute for Soldier Nanotechnologies program W911NF-18-2-0048 and the U.S. Army Research Laboratory (award W911NF-17-1-0435). D.E. was also supported in part by AFOSR program FA2386-20-1-4070 "Developing graphene Josephson microwave single-photon detector for quantum information science." W.J. and G.-H.L. were supported by the National Research Foundation of Korea (NRF) funded by the Korean Government (grants 2016R1A5A1008184, 2020R1C1C1013241, and 2020M3H3A1100839), Samsung Science and Technology Foundation (project SSTF-BA1702-05) and Samsung Electronics Co. (IO20120707801-01). D.K.E. acknowledges support from the Ministry of Economy and Competitiveness of Spain through the "Severo Ochoa" program for Centres of Excellence in R&D (SE5-0522), Fundacio Privada Cellex, Fundacio Privada Mir-Puig, the Generalitat de Catalunya through the CERCA program, the H2020 Programme under grant agreement 820378, Project: 2D center dot SIPC, and the La Caixa Foundation. B.-I.W. was supported by the Air Force Office of Scientific Research under award FA9550-16RYCOR290. T.A.O. and K.C.F. acknowledge support from Raytheon BBN Technologies. K.W. and T.T. acknowledge support from the Elemental Strategy Initiative conducted by MEXT, Japan, grant JPMXP0112101001; JSPS KAKENHI grant JP20H00354; and CREST (JPMJCR15F3), JST. P.K. and K.C.F. were supported in part by the Army Research Office under Cooperative Agreement W911NF-17-1-0574.	Anant V, 2008, OPT EXPRESS, V16, P10750, DOI 10.1364/OE.16.010750; Angers L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165408; Bae MH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.104509; BENJACOB E, 1982, PHYS REV A, V26, P2805, DOI 10.1103/PhysRevA.26.2805; Borzenets IV, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.237002; Calado VE, 2015, NAT NANOTECHNOL, V10, P761, DOI [10.1038/NNANO.2015.156, 10.1038/nnano.2015.156]; Castellanos-Gomez A, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/1/011002; Courtois H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.067002; DEVORET MH, 1985, PHYS REV LETT, V55, P1908, DOI 10.1103/PhysRevLett.55.1908; Driessen EFC, 2009, EUR PHYS J-APPL PHYS, V47, DOI 10.1051/epjap/2009087; Echternach PM, 2018, NAT ASTRON, V2, P90, DOI 10.1038/s41550-017-0294-y; Engheta N, 2007, SCIENCE, V317, P1698, DOI 10.1126/science.1133268; Francesco T., 2019, SPRINGER SERIES MAT, V286; FULTON TA, 1974, PHYS REV B, V9, P4760, DOI 10.1103/PhysRevB.9.4760; Giazotto F, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908922; Gol'tsman GN, 2001, APPL PHYS LETT, V79, P705, DOI 10.1063/1.1388868; Guruswamy T, 2015, SUPERCOND SCI TECH, V28, DOI 10.1088/0953-2048/28/5/054002; Karasik BS, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4739839; Kokkoniemi R, 2020, NATURE, V586, P47, DOI 10.1038/s41586-020-2753-3; Korzh B, 2020, NAT PHOTONICS, V14, P250, DOI 10.1038/s41566-020-0589-x; Krasnov VM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224517; Lee GH, 2020, NATURE, V586, P42, DOI 10.1038/s41586-020-2752-4; Lee GH, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.146605; Mannik J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.220509; Martinis JM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.094510; MCGRATH WR, 1988, J APPL PHYS, V63, P2479, DOI 10.1063/1.341026; Oelsner G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824308; Peacock A, 1996, NATURE, V381, P135, DOI 10.1038/381135a0; Pekola JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.197004; Riste D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2936; Sadleir JE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.047003; Schapers T, 1999, APPL PHYS LETT, V75, P391, DOI 10.1063/1.124385; Semenov A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.054510; Serniak K, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.157701; Stella F, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2931700; Tinkham M., 2004, INTRO SUPERCONDUCTIV, V2nd; Tsumura K, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4940377; Walsh ED, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.024022; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6836; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang YW, 2015, PHYSICA C, V515, P49, DOI 10.1016/j.physc.2015.05.005; Wu B.-I., 2021, **DATA OBJECT**, DOI [10.5281/zenodo.4624530, DOI 10.5281/ZENODO.4624530]	43	26	26	10	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					409	+		10.1126/science.abf5539	http://dx.doi.org/10.1126/science.abf5539			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888641	Green Submitted			2022-12-28	WOS:000645009800042
J	Truong, ME; Bilekova, S; Choksi, SP; Li, W; Bugaj, LJ; Xu, K; Reiter, JF				Truong, Melissa E.; Bilekova, Sara; Choksi, Semil P.; Li, Wan; Bugaj, Lukasz J.; Xu, Ke; Reiter, Jeremy F.			Vertebrate cells differentially interpret ciliary and extraciliary cAMP	CELL			English	Article							PROTEIN-KINASE-A; HEDGEHOG SIGNAL-TRANSDUCTION; COUPLED RECEPTOR GPR161; LEFT-RIGHT ASYMMETRY; CUBITUS-INTERRUPTUS; NEGATIVE REGULATOR; ADENYLATE-CYCLASE; REPRESSOR FORMS; PRIMARY CILIUM; BETA-ARRESTIN	Hedgehog pathway components and select G protein-coupled receptors (GPCRs) localize to the primary cilium, an organelle specialized for signal transduction. We investigated whether cells distinguish between ciliary and extraciliary GPCR signaling. To test whether ciliary and extraciliary cyclic AMP (cAMP) convey different information, we engineered optogenetic and chemogenetic tools to control the subcellular site of cAMP generation. Generating equal amounts of ciliary and cytoplasmic cAMP in zebrafish and mammalian cells revealed that ciliary cAMP, but not cytoplasmic cAMP, inhibited Hedgehog signaling. Modeling suggested that the distinct geometries of the cilium and cell body differentially activate local effectors. The search for effectors identified a ciliary pool of protein kinase A (PKA). Blocking the function of ciliary PKA, but not extraciliary PKA, activated Hedgehog signal transduction and reversed the effects of ciliary cAMP. Therefore, cells distinguish ciliary and extraciliary cAMP using functionally and spatially distinct pools of PKA, and different subcellular pools of cAMP convey different information.	[Truong, Melissa E.; Bilekova, Sara; Choksi, Semil P.; Reiter, Jeremy F.] Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Li, Wan; Xu, Ke] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bugaj, Lukasz J.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bilekova, Sara] Ludwig Maximilians Univ Munchen, D-80539 Munich, Germany; [Xu, Ke; Reiter, Jeremy F.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of Pennsylvania; University of Munich	Reiter, JF (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Cardiovasc Res Inst, San Francisco, CA 94158 USA.; Reiter, JF (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.	jeremy.reiter@ucsf.edu		Truong, Melissa/0000-0003-1526-1521; Bilekova, Sara/0000-0001-6699-1386	UCSF Research Evaluation and Allocation Committee; Gross Fund; Heart Anonymous Fund; Arnold O. Beckman Postdoctoral Fellowship; UCSF Discovery Fellowship; NIH [T32HD007470, DP2GM132681, R01DE029454, R01AR054396]; Packard Fellowships for Science and Engineering	UCSF Research Evaluation and Allocation Committee; Gross Fund; Heart Anonymous Fund; Arnold O. Beckman Postdoctoral Fellowship; UCSF Discovery Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowships for Science and Engineering	We thank members of the Reiter laboratory for discussion and advice; Roshanak Irannejad, Markus Delling, Didier Stainier, and Mark von Zastrow for comments on the manuscript; DeLaine Larsen and Kari Herrington from the UCSF Center for Advanced Light Microscopy for microscope use and imaging assistance; and the UCSF Cardiovascular Building fish facility for zebrafish husbandry. We also thank Aaron Marley, Peng Huang, James Chen, Xiaokun Shu, Maxence Nachury, Roshanak Irannejad, and Mark von Zastrow for providing reagents. The UCSF Center for Advanced Light Microscopy is funded by the UCSF Research Evaluation and Allocation Committee, the Gross Fund, and the Heart Anonymous Fund. L.J.B. was funded by an Arnold O. Beckman Postdoctoral Fellowship. M.E.T. was supported by the UCSF Discovery Fellowship and NIH (T32HD007470). This work was supported by grants from the NIH (DP2GM132681 to K.X. and R01DE029454 and R01AR054396 to J.F.R.). K.X. and J.F.R. acknowledge support by the Packard Fellowships for Science and Engineering. K.X. and J.F.R. are Chan Zuckerberg Biohub Investigators.	Agarwal SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095835; Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bachmann VA, 2016, P NATL ACAD SCI USA, V113, P7786, DOI 10.1073/pnas.1608061113; Bangs F, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028175; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Barresi MJF, 2001, CURR BIOL, V11, P1432, DOI 10.1016/S0960-9822(01)00428-6; Barzi M, 2010, J CELL SCI, V123, P62, DOI 10.1242/jcs.060020; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berg H. C, 1993, RANDOM WALKS BIOL NE; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; BRUNTON LL, 1979, NATURE, V280, P78, DOI 10.1038/280078a0; Bugaj LJ, 2019, NAT PROTOC, V14, P2205, DOI 10.1038/s41596-019-0178-y; BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Calebiro D, 2019, MOL CELL ENDOCRINOL, V483, P24, DOI 10.1016/j.mce.2018.12.020; Carpenter B, 2016, PROTEIN ENG DES SEL, V29, P583, DOI 10.1093/protein/gzw049; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; CLEGG CH, 1987, J BIOL CHEM, V262, P13111; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Evans TM, 2003, TRAFFIC, V4, P869, DOI 10.1046/j.1600-0854.2003.00141.x; FAN CM, 1994, CELL, V79, P1175, DOI 10.1016/0092-8674(94)90009-4; Gigante ED, 2020, ELIFE, V9, DOI 10.7554/eLife.50434; Gigante ED, 2020, WIRES DEV BIOL, V9, DOI 10.1002/wdev.377; Gillingham AK, 2000, EMBO REP, V1, P524; Goncalves J, 2017, MOL CELLS, V40, P243, DOI 10.14348/molcells.2017.0054; Green JA, 2016, MOL CELL BIOL, V36, P223, DOI 10.1128/MCB.00765-15; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Guner B, 2007, GENE EXPR PATTERNS, V7, P596, DOI 10.1016/j.modgep.2007.01.002; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Harada K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07820-6; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Higginbotham H, 2012, DEV CELL, V23, P925, DOI 10.1016/j.devcel.2012.09.019; Hilgendorf KI, 2016, CURR OPIN CELL BIOL, V39, P84, DOI 10.1016/j.ceb.2016.02.008; Hirsinger E, 2004, DEV BIOL, V275, P143, DOI 10.1016/j.ydbio.2004.07.030; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Insel PA, 2005, ANN NY ACAD SCI, V1047, P166, DOI 10.1196/annals.1341.015; Irannejad R, 2017, NAT CHEM BIOL, V13, P799, DOI 10.1038/nchembio.2389; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang JY, 2019, P NATL ACAD SCI USA, V116, P12066, DOI 10.1073/pnas.1819730116; Jullie D, 2020, NEURON, V105, P663, DOI 10.1016/j.neuron.2019.11.016; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KEELY SL, 1979, MOL PHARMACOL, V15, P235; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kong JH, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.166892; Koschinski A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13021-y; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Leaf A, 2015, ELIFE, V4, DOI 10.7554/eLife.06996; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lim YS, 2015, J CELL SCI, V128, P2996, DOI 10.1242/jcs.163964; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Marley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070857; May EA, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202007207; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Mich JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103661; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Moore BS, 2016, P NATL ACAD SCI USA, V113, P13069, DOI 10.1073/pnas.1602393113; MorinKensicki EM, 1997, DEVELOPMENT, V124, P159; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Mykytyn K, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028183; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Odenthal J, 2000, DEV BIOL, V219, P350, DOI 10.1006/dbio.1999.9589; Ohadi D, 2019, BIOPHYS J, V117, P1981, DOI 10.1016/j.bpj.2019.10.004; Pal K, 2016, J CELL BIOL, V212, P861, DOI 10.1083/jcb.201506132; Pazour GJ, 2002, CURR BIOL, V12, pR378, DOI 10.1016/S0960-9822(02)00877-1; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Price MA, 1999, DEVELOPMENT, V126, P4331; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Repina NA, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107737; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Siljee JE, 2018, NAT GENET, V50, P180, DOI 10.1038/s41588-017-0020-9; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Sungkaworn T, 2017, NATURE, V550, P543, DOI 10.1038/nature24264; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3795, DOI 10.1021/bi00611a020; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3811, DOI 10.1021/bi00611a021; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Ungar AR, 1996, DEV BIOL, V178, P186, DOI 10.1006/dbio.1996.0209; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang GL, 1999, GENE DEV, V13, P2828, DOI 10.1101/gad.13.21.2828; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Ye F, 2018, J CELL BIOL, V217, P1847, DOI 10.1083/jcb.201709041; Yoshiba S, 2012, SCIENCE, V338, P226, DOI 10.1126/science.1222538; Yu D, 2015, NAT METHODS, V12, P763, DOI [10.1038/NMETH.3447, 10.1038/nmeth.3447]; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982	107	24	24	4	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2911	+		10.1016/j.cell.2021.04.002	http://dx.doi.org/10.1016/j.cell.2021.04.002		MAY 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33932338	Bronze, Green Accepted			2022-12-28	WOS:000656965600010
J	Brune, WH; McFarland, PJ; Bruning, E; Waugh, S; MacGorman, D; Miller, DO; Jenkins, JM; Ren, X; Mao, J; Peischl, J				Brune, W. H.; McFarland, P. J.; Bruning, E.; Waugh, S.; MacGorman, D.; Miller, D. O.; Jenkins, J. M.; Ren, X.; Mao, J.; Peischl, J.			Extreme oxidant amounts produced by lightning in storm clouds	SCIENCE			English	Article							MASTER CHEMICAL MECHANISM; MCM V3 PART; NITROGEN-OXIDES; TROPOSPHERIC DEGRADATION; ATMOSPHERIC OXIDATION; NOX PRODUCTION; THUNDERSTORM; OZONE; OH; CHEMISTRY	Lightning increases the atmosphere's ability to cleanse itself by producing nitric oxide (NO), leading to atmospheric chemistry that forms ozone (O-3) and the atmosphere's primary oxidant, the hydroxyl radical (OH). Our analysis of a 2012 airborne study of deep convection and chemistry demonstrates that lightning also directly generates the oxidants OH and the hydroperoxyl radical (HO2). Extreme amounts of OH and HO2 were discovered and linked to visible flashes occurring in front of the aircraft and to subvisible discharges in electrified anvil regions. This enhanced OH and HO2 is orders of magnitude greater than any previous atmospheric observation. Lightning-generated OH in all storms happening at the same time globally can be responsible for a highly uncertain, but substantial, 2 to 16% of global atmospheric OH oxidation.	[Brune, W. H.; McFarland, P. J.; Miller, D. O.; Jenkins, J. M.] Penn State Univ, Dept Meteorol & Atmospher Sci, University Pk, PA 16802 USA; [Bruning, E.] Texas Tech Univ, Dept Geosci, Lubbock, TX 79409 USA; [Waugh, S.; MacGorman, D.] Natl Severe Storms Lab, Natl Ocean & Atmospher Adm, Norman, OK USA; [MacGorman, D.] Univ Oklahoma, Cooperat Inst Mesoscale Meteorol Studies, Norman, OK USA; [MacGorman, D.] Univ Oklahoma, Sch Meteorol, Norman, OK USA; [Ren, X.] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD USA; [Ren, X.] Air Resources Lab, Natl Ocean & Atmospher Adm, College Pk, MD USA; [Mao, J.] Univ Alaska, Dept Chem & Biochem, Fairbanks, AK USA; [Mao, J.] Univ Alaska, Geophys Inst, Fairbanks, AK USA; [Peischl, J.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO USA; [Peischl, J.] NOAA, Chem Sci Lab, Boulder, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Texas Tech University System; Texas Tech University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University System of Maryland; University of Maryland College Park; National Oceanic Atmospheric Admin (NOAA) - USA; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA	Brune, WH (corresponding author), Penn State Univ, Dept Meteorol & Atmospher Sci, University Pk, PA 16802 USA.	whb2@psu.edu	Mao, Jingqiu/F-2511-2010; Peischl, Jeff/E-7454-2010; Ren, Xinrong/E-7838-2015; Brune, William/U-7661-2017	Mao, Jingqiu/0000-0002-4774-9751; Peischl, Jeff/0000-0002-9320-7101; Ren, Xinrong/0000-0001-9974-1666; Miller, David/0000-0003-1017-3979; Bruning, Eric/0000-0003-1959-442X; Brune, William/0000-0002-1609-4051; McFarland, Patrick/0000-0002-4540-2324; MacGorman, Donald/0000-0002-2395-8196; Jenkins, Jena/0000-0002-3330-9640	NSF [AGS-1834711, AGS-1063945]; NASA [NNX12AB84G];  [NSF-1063966];  [AGS-1352144]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); ; 	NSF AGS-1834711 supported this work; NASA NNX12AB84G supported the DC3 OH and HO2 measurements; NSF AGS-1063945 supported the Oklahoma LMA work; and NSF-1063966 and AGS-1352144 supported the Colorado LMA work.	Aknan A., 2017, NASA LARC AIRBORNE S; Archibald AT, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046520; Barth MC, 2015, B AM METEOROL SOC, V96, P1281, DOI 10.1175/BAMS-D-13-00290.1; Basarab BM, 2015, J GEOPHYS RES-ATMOS, V120, P9481, DOI 10.1002/2015JD023470; BHETANABHOTLA MN, 1985, ATMOS ENVIRON, V19, P1391, DOI 10.1016/0004-6981(85)90276-8; Bozem H, 2014, ATMOS CHEM PHYS, V14, P8917, DOI 10.5194/acp-14-8917-2014; Brune WH, 2018, ATMOS CHEM PHYS, V18, P14493, DOI 10.5194/acp-18-14493-2018; Bruning E. C, 2013, 12 PYTH SCI C SCIPY; Bruning EC, 2013, J ATMOS SCI, V70, P4012, DOI 10.1175/JAS-D-12-0289.1; CHAMEIDES WL, 1977, J ATMOS SCI, V34, P143, DOI 10.1175/1520-0469(1977)034<0143:NPIL>2.0.CO;2; Chmielewski VC, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2020JD032384; Chmielewski VC, 2016, J GEOPHYS RES-ATMOS, V121, P8600, DOI 10.1002/2016JD025159; Davis TC, 2019, J GEOPHYS RES-ATMOS, V124, P8722, DOI 10.1029/2018JD029979; DeCaria AJ, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005556; DeCaria AJ, 2000, J GEOPHYS RES-ATMOS, V105, P11601, DOI 10.1029/2000JD900033; Dye JE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007550; Faloona IC, 2004, J ATMOS CHEM, V47, P139, DOI 10.1023/B:JOCH.0000021036.53185.0e; Feiner PA, 2016, J ATMOS SCI, V73, P4699, DOI 10.1175/JAS-D-16-0044.1; FRANZBLAU E, 1989, J GEOPHYS RES-ATMOS, V94, P11089, DOI 10.1029/JD094iD08p11089; Fuchs BR, 2016, J GEOPHYS RES-ATMOS, V121, P8625, DOI 10.1002/2015JD024663; HILL RD, 1981, J GEOPHYS RES-OCEANS, V86, P3203, DOI 10.1029/JC086iC04p03203; Huntrieser H, 2016, J GEOPHYS RES-ATMOS, V121, P6638, DOI 10.1002/2015JD024273; Huntrieser H, 2016, J GEOPHYS RES-ATMOS, V121, P6600, DOI 10.1002/2015JD024279; Jenkin ME, 2003, ATMOS CHEM PHYS, V3, P181, DOI 10.5194/acp-3-181-2003; Jenkins JM, 2021, J GEOPHYS RES-ATMOS, V126, DOI 10.1029/2021JD034557; Kostinskiy AY, 2020, J GEOPHYS RES-ATMOS, V125, DOI 10.1029/2020JD033191; Labrador LJ, 2005, ATMOS CHEM PHYS, V5, P1815, DOI 10.5194/acp-5-1815-2005; Lawrence MG, 2001, ATMOS CHEM PHYS, V1, P37, DOI 10.5194/acp-1-37-2001; Lelieveld J, 2016, ATMOS CHEM PHYS, V16, P12477, DOI 10.5194/acp-16-12477-2016; Li MZ, 2018, NPJ CLIM ATMOS SCI, V1, DOI 10.1038/s41612-018-0041-9; MacGorman DR, 2017, J GEOPHYS RES-ATMOS, V122, P2929, DOI 10.1002/2016JD025933; MARSHALL TC, 1995, J GEOPHYS RES-ATMOS, V100, P7097, DOI 10.1029/95JD00020; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; Murray LT, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017934; Nault BA, 2017, GEOPHYS RES LETT, V44, P9479, DOI 10.1002/2017GL074436; ORVILLE RE, 1967, J GEOPHYS RES, V72, P3557, DOI 10.1029/JZ072i014p03557; Ott LE, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD011880; Pan LL, 2014, GEOPHYS RES LETT, V41, P7785, DOI 10.1002/2014GL061921; Petersen D, 2015, Q J ROY METEOR SOC, V141, P1283, DOI 10.1002/qj.2436; Petersen D, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009036; Pollack IB, 2016, J GEOPHYS RES-ATMOS, V121, P2002, DOI 10.1002/2015JD023941; Price C, 1997, J GEOPHYS RES-ATMOS, V102, P5929, DOI 10.1029/96JD03504; PRINN RG, 1995, SCIENCE, V269, P187, DOI 10.1126/science.269.5221.187; Ridley B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004769; Ridley BA, 2006, J ATMOS CHEM, V54, P1, DOI 10.1007/s10874-005-9007-5; Rison W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10721; Ryerson TB, 2000, J GEOPHYS RES-ATMOS, V105, P26447, DOI 10.1029/2000JD900389; Saunders SM, 2003, ATMOS CHEM PHYS, V3, P161, DOI 10.5194/acp-3-161-2003; Schumann U, 2007, ATMOS CHEM PHYS, V7, P3823, DOI 10.5194/acp-7-3823-2007; Stone D, 2012, CHEM SOC REV, V41, P6348, DOI 10.1039/c2cs35140d; Thomas RJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004549; Thomas RJ, 2001, GEOPHYS RES LETT, V28, P143, DOI 10.1029/2000GL011464; TUCK AF, 1976, Q J ROY METEOR SOC, V102, P749, DOI 10.1002/qj.49710243404; von Liebig J., 1827, ANN CHIM PHYS-PARIS, V35, P329; Wang Y, 1998, J GEOPHYS RES-ATMOS, V103, P19149, DOI 10.1029/98JD01356; Weiss SA, 2018, J ATMOS OCEAN TECH, V35, P1273, DOI 10.1175/JTECH-D-17-0213.1; Weiss SA, 2012, MON WEATHER REV, V140, P2064, DOI 10.1175/MWR-D-11-00312.1; Williams E, 2005, ATMOS RES, V76, P288, DOI 10.1016/j.atmosres.2004.11.009; Wolfe G.M., 2017, F0AM BOX MODEL; Wolfe GM, 2016, GEOSCI MODEL DEV, V9, P3309, DOI 10.5194/gmd-9-3309-2016; Zahn A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002345	61	9	9	11	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 14	2021	372	6543					711	+		10.1126/science.abg0492	http://dx.doi.org/10.1126/science.abg0492			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SD1KE	33927054				2022-12-28	WOS:000651125300044
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Two doses of Pfizer vaccine are "highly effective" against infection, hospital admission, and death, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Leshem E, 2021, LANCET, V397, P1783, DOI 10.1016/S0140-6736(21)01018-7	2	3	3	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2021	373								n1164	10.1136/bmj.n1164	http://dx.doi.org/10.1136/bmj.n1164			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YV	33952443	Bronze			2022-12-28	WOS:000651241700011
J	Lundgren, JR; Janus, C; Jensen, SBK; Juhl, CR; Olsen, LM; Christensen, RM; Svane, MS; Bandholm, T; Bojsen-Moller, KN; Blond, MB; Jensen, JEB; Stallknecht, BM; Holst, JJ; Madsbad, S; Torekov, SS				Lundgren, Julie R.; Janus, Charlotte; Jensen, Simon B. K.; Juhl, Christian R.; Olsen, Lisa M.; Christensen, Rasmus M.; Svane, Maria S.; Bandholm, Thomas; Bojsen-Moller, Kirstine N.; Blond, Martin B.; Jensen, Jens-Erik B.; Stallknecht, Bente M.; Holst, Jens J.; Madsbad, Sten; Torekov, Signe S.			Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Weight Loss Maintenance with Exercise and Liraglutide In this trial, adults with obesity without diabetes were randomly assigned, after an 8-week low-calorie diet, to 1 year of placebo, an exercise program, liraglutide, or exercise plus liraglutide. Combined treatment with exercise and liraglutide improved healthy weight loss maintenance more than either treatment alone. Background Weight regain after weight loss is a major problem in the treatment of persons with obesity. Methods In a randomized, head-to-head, placebo-controlled trial, we enrolled adults with obesity (body-mass index [the weight in kilograms divided by the square of the height in meters], 32 to 43) who did not have diabetes. After an 8-week low-calorie diet, participants were randomly assigned for 1 year to one of four strategies: a moderate-to-vigorous-intensity exercise program plus placebo (exercise group); treatment with liraglutide (3.0 mg per day) plus usual activity (liraglutide group); exercise program plus liraglutide therapy (combination group); or placebo plus usual activity (placebo group). End points with prespecified hypotheses were the change in body weight (primary end point) and the change in body-fat percentage (secondary end point) from randomization to the end of the treatment period in the intention-to-treat population. Prespecified metabolic health-related end points and safety were also assessed. Results After the 8-week low-calorie diet, 195 participants had a mean decrease in body weight of 13.1 kg. At 1 year, all the active-treatment strategies led to greater weight loss than placebo: difference in the exercise group, -4.1 kg (95% confidence interval [CI], -7.8 to -0.4; P=0.03); in the liraglutide group, -6.8 kg (95% CI, -10.4 to -3.1; P<0.001); and in the combination group, -9.5 kg (95% CI, -13.1 to -5.9; P<0.001). The combination strategy led to greater weight loss than exercise (difference, -5.4 kg; 95% CI, -9.0 to -1.7; P=0.004) but not liraglutide (-2.7 kg; 95% CI, -6.3 to 0.8; P=0.13). The combination strategy decreased body-fat percentage by 3.9 percentage points, which was approximately twice the decrease in the exercise group (-1.7 percentage points; 95% CI, -3.2 to -0.2; P=0.02) and the liraglutide group (-1.9 percentage points; 95% CI, -3.3 to -0.5; P=0.009). Only the combination strategy was associated with improvements in the glycated hemoglobin level, insulin sensitivity, and cardiorespiratory fitness. Increased heart rate and cholelithiasis were observed more often in the liraglutide group than in the combination group. Conclusions A strategy combining exercise and liraglutide therapy improved healthy weight loss maintenance more than either treatment alone. (Funded by the Novo Nordisk Foundation and others; EudraCT number, ; ClinicalTrials.gov number, .)	[Lundgren, Julie R.; Janus, Charlotte; Jensen, Simon B. K.; Juhl, Christian R.; Olsen, Lisa M.; Christensen, Rasmus M.; Blond, Martin B.; Stallknecht, Bente M.; Holst, Jens J.; Torekov, Signe S.] Univ Copenhagen, Dept Biomed Sci, Panum Rm 12-4-06,Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark; [Lundgren, Julie R.; Janus, Charlotte; Jensen, Simon B. K.; Juhl, Christian R.; Olsen, Lisa M.; Christensen, Rasmus M.; Holst, Jens J.; Torekov, Signe S.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Bandholm, Thomas; Jensen, Jens-Erik B.] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Svane, Maria S.; Bojsen-Moller, Kirstine N.; Jensen, Jens-Erik B.; Madsbad, Sten] Copenhagen Univ Hosp Amager & Hvidovre, Dept Endocrinol, Copenhagen, Denmark; [Bandholm, Thomas] Copenhagen Univ Hosp Amager & Hvidovre, Dept Clin Res, Copenhagen, Denmark; [Blond, Martin B.] Steno Diabet Ctr Copenhagen, Gentofte, Denmark	University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Steno Diabetes Center	Torekov, SS (corresponding author), Univ Copenhagen, Dept Biomed Sci, Panum Rm 12-4-06,Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark.	torekov@sund.ku.dk	Holst, Jens/AAA-8022-2022; Sandsdal, Rasmus Michael/HHS-1465-2022; Janus, Charlotte/P-3593-2018	Sandsdal, Rasmus Michael/0000-0003-0590-6285; Juhl, Christian Rimer/0000-0003-3024-4017; Bandholm, Thomas/0000-0001-6884-1971; Holst, Jens Juul/0000-0001-6853-3805; Stallknecht, Bente Merete/0000-0003-3117-0451; Janus, Charlotte/0000-0001-5111-7047; Jensen, Simon Birk Kjaer/0000-0002-1437-2150; Blond, Martin Baek/0000-0002-2032-1560; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Torekov, Signe/0000-0001-6779-0252				Astbury NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3760; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Bohm M, 2015, AM J MED, V128, P219, DOI 10.1016/j.amjmed.2014.09.016; Borg P, 2002, INT J OBESITY, V26, P676, DOI 10.1038/sj.ijo.0801962; Bull FC, 2020, BRIT J SPORT MED, V54, P1451, DOI 10.1136/bjsports-2020-102955; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Fogelholm M, 2000, ARCH INTERN MED, V160, P2177, DOI 10.1001/archinte.160.14.2177; Foright RM, 2018, PHYSIOL BEHAV, V188, P86, DOI 10.1016/j.physbeh.2018.01.025; Iepsen EW, 2015, INT J OBESITY, V39, P834, DOI 10.1038/ijo.2014.177; Iepsen EW, 2018, CELL METAB, V28, P23, DOI 10.1016/j.cmet.2018.05.008; Iepsen EW, 2016, EUR J ENDOCRINOL, V174, P775, DOI 10.1530/EJE-15-1116; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Jensen SBK, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031431; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Knowler WC, 2015, DIABETES CARE, V38, P51, DOI 10.2337/dc14-0886; Lean MEJ, 2019, LANCET DIABETES ENDO, V7, P344, DOI 10.1016/S2213-8587(19)30068-3; Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Logue J, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c154; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Purcell K, 2014, LANCET DIABETES ENDO, V2, P954, DOI 10.1016/S2213-8587(14)70200-1; Ross R, 2000, ANN INTERN MED, V133, P92, DOI 10.7326/0003-4819-133-2-200007180-00008; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Stringhini S, 2017, LANCET, V389, P1229, DOI 10.1016/S0140-6736(16)32380-7; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Taheri S, 2020, LANCET DIABETES ENDO, V8, P477, DOI 10.1016/S2213-8587(20)30117-0; van Baak MA, 2019, NAT REV ENDOCRINOL, V15, P274, DOI 10.1038/s41574-018-0148-4; van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162; Wadden TA, 2013, INT J OBESITY, V37, P1443, DOI 10.1038/ijo.2013.120; Ward ZJ, 2019, NEW ENGL J MED, V381, P2440, DOI 10.1056/NEJMsa1909301; Wilding JPH, 2021, NEW ENGL J MED, V384, P989, DOI 10.1056/NEJMoa2032183; Willis LH, 2012, J APPL PHYSIOL, V113, P1831, DOI 10.1152/japplphysiol.01370.2011; Wing RR., 2013, NEW ENGL J MED, V369, P145, DOI [DOI 10.1056/NEJMOA1212914, 10.1056/NEJMoa1212914]	35	57	56	10	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1719	1730		10.1056/NEJMoa2028198	http://dx.doi.org/10.1056/NEJMoa2028198			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY1SU	33951361				2022-12-28	WOS:000647698500010
J	Mammen, JSR; Cappola, AR				Mammen, Jennifer S. R.; Cappola, Anne R.			Autoimmune Thyroid Disease in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NATIONAL-HEALTH; OLDER-ADULTS; TSH	This JAMA Insights narrative review discusses the relationship of thyroid autoantibodies to autoimmune thyroid disease and emphasizes the importance of age, fertility, and pregnancy when interpreting thyroid function test results.	[Mammen, Jennifer S. R.] Johns Hopkins Univ Hosp, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD 21287 USA; [Cappola, Anne R.] Univ Penn, Perelman Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine	Cappola, AR (corresponding author), Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Translat Res Ctr, 3400 Civ Ctr Blvd,Bldg 421,12th Floor, Philadelphia, PA 19104 USA.	acappola@pennmedicine.upenn.edu						Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; Biondi B, 2019, JAMA-J AM MED ASSOC, V322, P153, DOI 10.1001/jama.2019.9052; Dhillon-Smith RK, 2019, NEW ENGL J MED, V380, P1316, DOI 10.1056/NEJMoa1812537; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Mammen JS, 2017, THYROID, V27, P1370, DOI 10.1089/thy.2017.0211; Mammen JS, 2015, THYROID, V25, P979, DOI 10.1089/thy.2015.0180; Spencer CA, 2007, J CLIN ENDOCR METAB, V92, P4236, DOI 10.1210/jc.2007-0287; Stott DJ, 2017, NEW ENGL J MED, V376, P2534, DOI 10.1056/NEJMoa1603825; Wang HN, 2017, JAMA-J AM MED ASSOC, V318, P2190, DOI 10.1001/jama.2017.18249	10	7	7	4	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	2021	325	23					2392	2393		10.1001/jama.2020.22196	http://dx.doi.org/10.1001/jama.2020.22196		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SU3BJ	33938930				2022-12-28	WOS:000647843500001
J	Moussa, HF; Angstman, JF; Khalil, AS				Moussa, Hagar F.; Angstman, James F.; Khalil, Ahmad S.			Here to stay: Writing lasting epigenetic memories	CELL			English	Editorial Material								In this issue of Cell, Nunez et al. develop CRISPRoff, a programmable epigenetic memory writer capable of establishing specific gene silencing programs that are stably maintained across cell division and differentiation. The singular dCas9 fusion offers a simple, reliable, and general tool for genome-wide screens, multiplexed editing, and potential therapeutics.	[Moussa, Hagar F.; Angstman, James F.; Khalil, Ahmad S.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Moussa, Hagar F.; Angstman, James F.; Khalil, Ahmad S.] Boston Univ, Biol Design Ctr, Boston, MA 02215 USA; [Khalil, Ahmad S.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Boston University; Boston University; Harvard University	Khalil, AS (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Boston Univ, Biol Design Ctr, Boston, MA 02215 USA.; Khalil, AS (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	khalil@bu.edu						Amabile A, 2016, CELL, V167, P219, DOI 10.1016/j.cell.2016.09.006; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Moreno AM, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aay9056; Nunez JK, 2021, CELL, V184, P2503, DOI 10.1016/j.cell.2021.03.025; O'Geen H., 2019, EZH2 DCAS9 KRAB DCAS, V238; Park M, 2019, CELL, V176, P227, DOI 10.1016/j.cell.2018.11.002; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/nmeth.3733, 10.1038/NMETH.3733]; Wegmann S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe1611	10	0	0	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2021	184	9					2281	2283		10.1016/j.cell.2021.04.007	http://dx.doi.org/10.1016/j.cell.2021.04.007		APR 2021	4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RV7SH	33930295	Bronze			2022-12-28	WOS:000646027900007
J	Da Mesquita, S; Papadopoulos, Z; Dykstra, T; Brase, L; Farias, FG; Wall, M; Jiang, H; Kodira, CD; de Lima, KA; Herz, J; Louveau, A; Goldman, DH; Salvador, AF; Onengut-Gumuscu, S; Farber, E; Dabhi, N; Kennedy, T; Milam, MG; Baker, W; Smirnov, I; Rich, SS; Benitez, BA; Karch, CM; Perrin, RJ; Farlow, M; Chhatwal, JP; Holtzman, DM; Cruchaga, C; Harari, O; Kipnis, J				Da Mesquita, Sandro; Papadopoulos, Zachary; Dykstra, Taitea; Brase, Logan; Farias, Fabiana Geraldo; Wall, Morgan; Jiang, Hong; Kodira, Chinnappa Dilip; de Lima, Kalil Alves; Herz, Jasmin; Louveau, Antoine; Goldman, Dylan H.; Salvador, Andrea Francesca; Onengut-Gumuscu, Suna; Farber, Emily; Dabhi, Nisha; Kennedy, Tatiana; Milam, Mary Grace; Baker, Wendy; Smirnov, Igor; Rich, Stephen S.; Benitez, Bruno A.; Karch, Celeste M.; Perrin, Richard J.; Farlow, Martin; Chhatwal, Jasmeer P.; Holtzman, David M.; Cruchaga, Carlos; Harari, Oscar; Kipnis, Jonathan		Dominantly Inherited Alzheimer Net	Meningeal lymphatics affect microglia responses and anti-A beta immunotherapy	NATURE			English	Article							ALZHEIMERS-DISEASE; R/BIOCONDUCTOR PACKAGE; BRAIN; ONSET; RISK; NORMALIZATION; BIOCONDUCTOR; ASSOCIATION; EXPRESSION; SYSTEM	Alzheimer's disease (AD) is the most prevalent cause of dementia(1). Although there is no effective treatment for AD, passive immunotherapy with monoclonal antibodies against amyloid beta (A beta) is a promising therapeutic strategy(2,3). Meningeal lymphatic drainage has an important role in the accumulation of A beta in the brain(4), but it is not known whether modulation of meningeal lymphatic function can influence the outcome of immunotherapy in AD. Here we show that ablation of meningeal lymphatic vessels in 5xFAD mice (a mouse model of amyloid deposition that expresses five mutations found in familial AD) worsened the outcome of mice treated with anti-A beta passive immunotherapy by exacerbating the deposition of A beta, microgliosis, neurovascular dysfunction, and behavioural deficits. By contrast, therapeutic delivery of vascular endothelial growth factor C improved clearance of A beta by monoclonal antibodies. Notably, there was a substantial overlap between the gene signature of microglia from 5xFAD mice with impaired meningeal lymphatic function and the transcriptional profile of activated microglia from the brains of individuals with AD. Overall, our data demonstrate that impaired meningeal lymphatic drainage exacerbates the microglial inflammatory response in AD and that enhancement of meningeal lymphatic function combined with immunotherapies could lead to better clinical outcomes.	[Da Mesquita, Sandro; Wall, Morgan; Louveau, Antoine; Goldman, Dylan H.; Salvador, Andrea Francesca; Dabhi, Nisha; Kennedy, Tatiana; Milam, Mary Grace; Baker, Wendy; Smirnov, Igor; Kipnis, Jonathan] Univ Virginia, Dept Neurosci, Charlottesville, VA 22903 USA; [Da Mesquita, Sandro] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Papadopoulos, Zachary; Dykstra, Taitea; de Lima, Kalil Alves; Herz, Jasmin; Goldman, Dylan H.; Salvador, Andrea Francesca; Smirnov, Igor; Kipnis, Jonathan] Washington Univ, Ctr Brain Immunol & Glia BIG, St Louis, MO 63110 USA; [Papadopoulos, Zachary; Dykstra, Taitea; de Lima, Kalil Alves; Herz, Jasmin; Goldman, Dylan H.; Salvador, Andrea Francesca; Smirnov, Igor; Perrin, Richard J.; Kipnis, Jonathan] Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Papadopoulos, Zachary; Kipnis, Jonathan] Washington Univ, Neurosci Grad Program, St Louis, MO 63110 USA; [Brase, Logan; Farias, Fabiana Geraldo; Benitez, Bruno A.; Karch, Celeste M.; Cruchaga, Carlos; Harari, Oscar] Washington Univ, Dept Psychiat, St Louis, MO 63110 USA; [Jiang, Hong; Karch, Celeste M.; Perrin, Richard J.; Holtzman, David M.; Cruchaga, Carlos] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Dept Neurol,Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Kodira, Chinnappa Dilip] PureTech Hlth, Boston, MA USA; [Louveau, Antoine] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Goldman, Dylan H.; Salvador, Andrea Francesca; Kipnis, Jonathan] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22903 USA; [Onengut-Gumuscu, Suna; Farber, Emily; Rich, Stephen S.] Univ Virginia, Ctr Publ Hearth Genom, Charlottesville, VA USA; [Benitez, Bruno A.; Cruchaga, Carlos] Washington Univ, Sch Med, NeuroGen & Informat Ctr, St Louis, MO USA; [Farlow, Martin] Indiana Sch Med, Indianapolis, IN USA; [Chhatwal, Jasmeer P.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02115 USA	University of Virginia; Mayo Clinic; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Cleveland Clinic Foundation; University of Virginia; University of Virginia; Washington University (WUSTL); Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Massachusetts General Hospital	Da Mesquita, S; Kipnis, J (corresponding author), Univ Virginia, Dept Neurosci, Charlottesville, VA 22903 USA.; Da Mesquita, S (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.; Kipnis, J (corresponding author), Washington Univ, Ctr Brain Immunol & Glia BIG, St Louis, MO 63110 USA.; Kipnis, J (corresponding author), Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Kipnis, J (corresponding author), Washington Univ, Neurosci Grad Program, St Louis, MO 63110 USA.; Kipnis, J (corresponding author), Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22903 USA.	damesquita@mayo.edu; kipnis@wustl.edu	Kipnis, Jonathan/AGG-9735-2022; Cruchaga, Carlos/ABF-4065-2020; Da Mesquita, Sandro/A-7365-2010; Benitez, Bruno A./E-7116-2014	Kipnis, Jonathan/0000-0002-3714-517X; Cruchaga, Carlos/0000-0002-0276-2899; Da Mesquita, Sandro/0000-0002-0786-5010; Salvador, Andrea Francesca/0000-0002-9197-7575; Rich, Stephen/0000-0003-3872-7793; Benitez, Bruno A./0000-0002-2699-3878	National Institutes of Health/National Institute on Aging [AG034113, AG057496]; PureTech Health; Cure Alzheimer's Fund; Ed Owens Family Foundation [RF1AG053303, RF1AG058501, AG057777, AG067764, AG062734]; Dominantly Inherited Alzheimer's Network (DIAN) - National Institute on Aging (NIA) [UF1AG032438]; German Center for Neurodegenerative Diseases (DZNE); Raul Carrea Institute for Neurological Research (FLENI); Research and Development Grants for Dementia from Japan Agency for Medical Research and Development, AMED; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PureTech Health; Cure Alzheimer's Fund; Ed Owens Family Foundation; Dominantly Inherited Alzheimer's Network (DIAN) - National Institute on Aging (NIA); German Center for Neurodegenerative Diseases (DZNE)(Helmholtz Association); Raul Carrea Institute for Neurological Research (FLENI); Research and Development Grants for Dementia from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI))	We thank S. Smith for editing the manuscript and S. Blackburn and N. Al-Hamadani for animal colony maintenance. This work was supported by grants from the National Institutes of Health/National Institute on Aging (AG034113 and AG057496), PureTech Health, the Cure Alzheimer's Fund and the Ed Owens Family Foundation to J.K.; RF1AG053303 and RF1AG058501 to C.C.; AG057777 and AG067764 to O.H.; and AG062734 to C.M.K. O.H. is an Archer Foundation Research Scientist. We thank all members of the Kipnis laboratory for their comments during discussions of this work. We acknowledge the staff of the Neuropathology Cores and other personnel of the Charles F. and Joanne Knight Alzheimer Disease Research Center (P30 AG066444, P01AG026276, P01AG03991). Data collection and sharing for this project were supported by The Dominantly Inherited Alzheimer's Network (DIAN, UF1AG032438) funded by the National Institute on Aging (NIA), the German Center for Neurodegenerative Diseases (DZNE), Raul Carrea Institute for Neurological Research (FLENI), with partial support by the Research and Development Grants for Dementia from Japan Agency for Medical Research and Development, AMED, and the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI). This manuscript has been reviewed by DIAN Study investigators for scientific content and consistency of data interpretation with previous DIAN Study publications. We acknowledge the altruism of the participants and their families and contributions of the Knight ADRC and DIAN (see full list of DIAN consortium members in Supplementary Notes) research and support staff at each of the participating sites for their contributions to this study.	Abbasi J, 2018, JAMA-J AM MED ASSOC, V320, P965, DOI 10.1001/jama.2018.13027; Buniello A, 2019, NUCLEIC ACIDS RES, V47, pD1005, DOI 10.1093/nar/gky1120; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Da Mesquita S, 2018, NEURON, V100, P375, DOI 10.1016/j.neuron.2018.09.022; Da Mesquita S, 2018, NATURE, V560, P185, DOI 10.1038/s41586-018-0368-8; Darnell G, 2012, BIOINFORMATICS, V28, pI147, DOI 10.1093/bioinformatics/bts235; Del-Aguila JL, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0524-x; Del-Aguila JL, 2018, J ALZHEIMERS DIS, V62, P745, DOI 10.3233/JAD-170834; Deming Y, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau2291; Deming Y, 2017, ACTA NEUROPATHOL, V133, P839, DOI 10.1007/s00401-017-1685-y; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duong D, 2016, BIOINFORMATICS, V32, P156, DOI 10.1093/bioinformatics/btw272; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Eskin E, 2008, GENOME RES, V18, P653, DOI 10.1101/gr.072785.107; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Howard R, 2020, NAT REV NEUROL, V16, P63, DOI 10.1038/s41582-019-0295-9; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Kastanenka KV, 2016, J NEUROSCI, V36, P12549, DOI 10.1523/JNEUROSCI.2080-16.2016; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kunkle BW, 2019, NAT GENET, V51, P414, DOI 10.1038/s41588-019-0358-2; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Logovinsky V, 2016, ALZHEIMERS RES THER, V8, DOI [10.1016/j.trci.2016.01.001, 10.1186/s13195-016-0181-2]; Louveau A, 2018, NAT NEUROSCI, V21, P1380, DOI 10.1038/s41593-018-0227-9; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Merlini M, 2019, NEURON, V101, P1099, DOI 10.1016/j.neuron.2019.01.014; Montagne A, 2020, NATURE, V581, P70, DOI 10.1038/s41586-020-2247-3; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Nettleton D, 2000, BIOMETRICS, V56, P52, DOI 10.1111/j.0006-341X.2000.00052.x; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pliner HA, 2019, NAT METHODS, V16, P983, DOI 10.1038/s41592-019-0535-3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rustenhoven J, 2021, CELL, V184, P1000, DOI 10.1016/j.cell.2020.12.040; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shi Y, 2019, J EXP MED, V216, P2546, DOI 10.1084/jem.20190980; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sul JH, 2015, AM J HUM GENET, V96, P857, DOI 10.1016/j.ajhg.2015.04.012; Sweeney MD, 2018, NAT REV NEUROL, V14, P133, DOI 10.1038/nrneurol.2017.188; Tarasoff-Conway JM, 2016, NAT REV NEUROL, V12, P248, DOI 10.1038/nrneurol.2016.36; Tinevez JY, 2017, METHODS, V115, P80, DOI 10.1016/j.ymeth.2016.09.016; Tucker S, 2015, J ALZHEIMERS DIS, V43, P575, DOI 10.3233/JAD-140741; Uhlmann RE, 2020, NAT NEUROSCI, V23, P1580, DOI 10.1038/s41593-020-00737-w; Van den Berge K, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1406-4; Vanlandewijck M, 2018, NATURE, V554, P475, DOI 10.1038/nature25739; Wang LM, 2019, BRAIN PATHOL, V29, P176, DOI 10.1111/bpa.12656; Won, 2020, PREPRINT, DOI 10.1101/2020.09.25.310722; Xiong M, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd7522; Yamazaki Y, 2019, NAT REV NEUROL, V15, P501, DOI 10.1038/s41582-019-0228-7; Yan Q, 2021, MOL PSYCHIATR, V26, P309, DOI 10.1038/s41380-018-0246-7; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9	70	59	59	14	123	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 13	2021	593	7858					255	+		10.1038/s41586-021-03489-0	http://dx.doi.org/10.1038/s41586-021-03489-0		APR 2021	35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SB2RT	33911285	Green Accepted			2022-12-28	WOS:000645224800002
J	Dawson, J; Liu, CY; Francisco, GE; Cramer, SC; Wolf, SL; Dixit, A; Alexander, J; Ali, R; Brown, BL; Feng, WW; DeMark, L; Hochberg, LR; Kautz, SA; Majid, A; O'Dell, MW; Pierce, D; Prudente, CN; Redgrave, J; Turner, DL; Engineer, ND; Kimberley, TJ				Dawson, Jesse; Liu, Charles Y.; Francisco, Gerard E.; Cramer, Steven C.; Wolf, Steven L.; Dixit, Anand; Alexander, Jen; Ali, Rushna; Brown, Benjamin L.; Feng, Wuwei; DeMark, Louis; Hochberg, Leigh R.; Kautz, Steven A.; Majid, Arshad; O'Dell, Michael W.; Pierce, David; Prudente, Cecilia N.; Redgrave, Jessica; Turner, Duncan L.; Engineer, Navzer D.; Kimberley, Teresa J.			Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial	LANCET			English	Article							UPPER-EXTREMITY; PLASTICITY; RECOVERY; MODULATION	Background Long-term loss of arm function after ischaemic stroke is common and might be improved by vagus nerve stimulation paired with rehabilitation. We aimed to determine whether this strategy is a safe and effective treatment for improving arm function after stroke. Methods In this pivotal, randomised, triple-blind, sham-controlled trial, done in 19 stroke rehabilitation services in the UK and the USA, participants with moderate-to-severe arm weakness, at least 9 months after ischaemic stroke, were randomly assigned (1: 1) to either rehabilitation paired with active vagus nerve stimulation (VNS group) or rehabilitation paired with sham stimulation (control group). Randomisation was done by ResearchPoint Global (Austin, TX, USA) using SAS PROC PLAN (SAS Institute Software, Cary, NC, USA), with stratification by region (USA vs UK), age (<= 30 years vs >30 years), and baseline Fugl-Meyer Assessment-Upper Extremity (FMA-UE) score (20-35 vs 36-50). Participants, outcomes assessors, and treating therapists were masked to group assignment. All participants were implanted with a vagus nerve stimulation device. The VNS group received 0.8 mA, 100 mu s, 30 Hz stimulation pulses, lasting 0.5 s. The control group received 0 mA pulses. Participants received 6 weeks of in-clinic therapy (three times per week; total of 18 sessions) followed by a home exercise programme. The primary outcome was the change in impairment measured by the FMA-UE score on the first day after completion of inclinic therapy. FMA-UE response rates were also assessed at 90 days after in-clinic therapy (secondary endpoint). All analyses were by intention to treat. This trial is registered at ClinicalTrials.gov, NCT03131960. Findings Between Oct 2, 2017, and Sept 12, 2019, 108 participants were randomly assigned to treatment (53 to the VNS group and 55 to the control group). 106 completed the study (one patient for each group did not complete the study). On the first day after completion of in-clinic therapy, the mean FMA-UE score increased by 5.0 points (SD 4.4) in the VNS group and by 2.4 points (3.8) in the control group (between group difference 2.6, 95% CI 1.0-4.2, p=0.0014). 90 days after in-clinic therapy, a clinically meaningful response on the FMA-UE score was achieved in 23 (47%) of 53 patients in the VNS group versus 13 (24%) of 55 patients in the control group (between group difference 24%, 6-41; p=0.0098). There was one serious adverse event related to surgery (vocal cord paresis) in the control group. Interpretation Vagus nerve stimulation paired with rehabilitation is a novel potential treatment option for people with long-term moderate-to-severe arm impairment after ischaemic stroke.Copyright (C) 2021 Elsevier Ltd. All rights reserved.	[Dawson, Jesse; Alexander, Jen] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 9QQ, Lanark, Scotland; [Liu, Charles Y.] USC, Keck Sch Med, USC Neurorestorat Ctr, Los Angeles, CA USA; [Liu, Charles Y.] USC, Keck Sch Med, Dept Neurol Surg, Los Angeles, CA USA; [Liu, Charles Y.] Rancho Los Amigos Natl Rehabil Ctr, Downey, CA USA; [Francisco, Gerard E.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Francisco, Gerard E.] Mem Hermann Hosp, Inst Rehabil & Res TIRR, Houston, TX USA; [Cramer, Steven C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Cramer, Steven C.] Calif Rehabil Inst, Los Angeles, CA USA; [Wolf, Steven L.] Emory Univ, Sch Med, Dept Rehabil Med, Div Phys Therapy, Atlanta, GA USA; [Dixit, Anand] Newcastle Tyne Hosp Natl Hlth Serv Fdn Trust, Stroke Serv, Newcastle, NSW, Australia; [Ali, Rushna] Spectrum Hlth, Dept Neurosci, Grand Rapids, MI USA; [Brown, Benjamin L.] Ochsner Neurosci Inst, Dept Neurosurg, Covington, LA USA; [Feng, Wuwei] Duke Univ, Sch Med, Dept Neurol, Durham, NC USA; [DeMark, Louis] Brooks Rehabil, Jacksonville, FL USA; [Hochberg, Leigh R.; Kimberley, Teresa J.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02115 USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] VA Med Ctr, VA RR&D Ctr Neurorestorat & Neurotechnol, Providence, RI USA; [Kautz, Steven A.] Ralph H Johnson VA Med Ctr, Charleston, SC USA; [Kautz, Steven A.] Med Univ South Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Majid, Arshad; Redgrave, Jessica] Univ Sheffield, Sheffield Inst Neurol Sci SITraN, Sheffield, S Yorkshire, England; [Majid, Arshad] Sheffield Teaching Hosp Natl Hlth Serv Fdn Trust, Sheffield, S Yorkshire, England; [O'Dell, Michael W.] Clin Rehabil Med, Weill Cornell Med, New York, NY USA; [Pierce, David; Prudente, Cecilia N.; Engineer, Navzer D.] MicroTransponder, Austin, TX USA; [Turner, Duncan L.] Univ East London, Sch Hlth Sport & Biosci, London, England; [Kimberley, Teresa J.] MGH Inst Hlth Profess, Dept Phys Therapy, Boston, MA USA	University of Glasgow; University of Southern California; University of Southern California Keck Hospital; University of Southern California; University of Southern California Keck Hospital; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Emory University; Michigan State University; Michigan State University College of Human Medicine; Ochsner Health System; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Brown University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; University of Sheffield; Cornell University; University of East London	Dawson, J (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 9QQ, Lanark, Scotland.	jesse.dawson@glasgow.ac.uk	Kautz, Steven A/I-4164-2012	Kautz, Steven A/0000-0003-3151-8235; Feng, Wuwei/0000-0001-6230-4905; Majid, Arshad/0000-0002-1144-039X; Hochberg, Leigh/0000-0003-0261-2273	MicroTransponder	MicroTransponder	MicroTransponder.	Burger AM, 2018, BRAIN STIMUL, V11, P945, DOI 10.1016/j.brs.2018.03.018; Bushnell C, 2015, CIRC-CARDIOVASC QUAL, V8, pS163, DOI 10.1161/CIRCOUTCOMES.115.002098; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Dawson J, 2020, NEUROREHAB NEURAL RE, V34, P609, DOI 10.1177/1545968320924361; Dawson J, 2016, STROKE, V47, P143, DOI 10.1161/STROKEAHA.115.010477; Dhamoon MS, 2009, STROKE, V40, P2805, DOI 10.1161/STROKEAHA.109.549576; Engineer ND, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00280; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Hankey GJ, 2020, LANCET NEUROL, V19, P651, DOI 10.1016/S1474-4422(20)30207-6; Harvey RL, 2018, STROKE, V49, P2138, DOI 10.1161/STROKEAHA.117.020607; Hayat H, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4232; Hays SA, 2013, PROG BRAIN RES, V207, P275, DOI 10.1016/B978-0-444-63327-9.00010-2; He KW, 2015, NEURON, V88, P528, DOI 10.1016/j.neuron.2015.09.037; Hulsey D, 2018, NEUROMODULATORY PATH, P88; Kahlow H, 2013, SEIZURE-EUR J EPILEP, V22, P827, DOI 10.1016/j.seizure.2013.06.011; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Khodaparast N, 2016, NEUROREHAB NEURAL RE, V30, P676, DOI 10.1177/1545968315616494; Kimberley TJ, 2019, EUR STROKE J, V4, P363, DOI 10.1177/2396987319855306; Kimberley TJ, 2018, STROKE, V49, P2789, DOI 10.1161/STROKEAHA.118.022279; Kwakkel G, 2015, LANCET NEUROL, V14, P224, DOI 10.1016/S1474-4422(14)70160-7; Levy RM, 2016, NEUROREHAB NEURAL RE, V30, P107, DOI 10.1177/1545968315575613; Lin KC, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-5; Lin KC, 2010, NEUROREHAB NEURAL RE, V24, P486, DOI 10.1177/1545968309356295; Lin KC, 2009, NEUROREHAB NEURAL RE, V23, P429, DOI 10.1177/1545968308331144; METHERATE R, 1992, J NEUROSCI, V12, P4701; Meyers EC, 2018, STROKE, V49, P710, DOI 10.1161/STROKEAHA.117.019202; Morrison RA, 2020, BEHAV BRAIN RES, V391, DOI 10.1016/j.bbr.2020.112705; Ni Z, 2014, J NEUROSCI, V34, P7314, DOI 10.1523/JNEUROSCI.4714-13.2014; Page SJ, 2012, PHYS THER, V92, P791, DOI 10.2522/ptj.20110009; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; Porter BA, 2012, CEREB CORTEX, V22, P2365, DOI 10.1093/cercor/bhr316; Pruitt DT, 2021, TRANSL STROKE RES, V12, P65, DOI 10.1007/s12975-020-00829-6; Robinson LC, 2015, J NEUROSURG, V122, P532, DOI 10.3171/2014.10.JNS14640; Rodgers H, 2019, LANCET, V394, P51, DOI 10.1016/S0140-6736(19)31055-4; See J, 2013, NEUROREHAB NEURAL RE, V27, P732, DOI 10.1177/1545968313491000; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Stinear CM, 2020, LANCET NEUROL, V19, P348, DOI 10.1016/S1474-4422(19)30415-6; Townsley RB, 2017, CLIN OTOLARYNGOL, V42, P959, DOI 10.1111/coa.12519; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; Wyller TB, 1997, CLIN REHABIL, V11, P139, DOI 10.1177/026921559701100207; Yap JYY, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00284	42	57	59	23	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1545	1553						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RR7QA	33894832	Green Accepted			2022-12-28	WOS:000643286900020
J	Meyer, S; Nourkami-Tutdibi, N; Poryo, M; Casper, M; Geipel, M; Zemlin, M				Meyer, Sascha; Nourkami-Tutdibi, Nasenien; Poryo, Martin; Casper, Markus; Geipel, Martina; Zemlin, Michael			Pericardial effusion, cardiomegaly, oedema, and IgA deficiency in a child: coeliac disease	LANCET			English	Editorial Material									[Meyer, Sascha; Nourkami-Tutdibi, Nasenien; Geipel, Martina; Zemlin, Michael] Univ Childrens Hosp Saarland, Dept Paediat & Neonatol, D-66421 Homburg, Germany; [Poryo, Martin] Univ Childrens Hosp Saarland, Dept Paediat Cardiol, Homburg, Germany; [Casper, Markus] Saarland Univ, Med Ctr, Dept Med 2, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Meyer, S (corresponding author), Univ Childrens Hosp Saarland, Dept Paediat & Neonatol, D-66421 Homburg, Germany.	sascha.meyer@uks.eu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2021	397	10284					1576	1576						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RR7QA	33894835				2022-12-28	WOS:000643286900023
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: One in five government contracts had signs of possible corruption, report finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Good Law Project, 2021, EXPL EM SHOW GOV VIP; Iacobucci G, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4474; Transparency International UK , 2021, TRACK TRAC ID CORR R	3	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2021	373								n1072	10.1136/bmj.n1072	http://dx.doi.org/10.1136/bmj.n1072			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0KR	33893123	Bronze			2022-12-28	WOS:000708057000013
J	Jasechko, S; Perrone, D				Jasechko, Scott; Perrone, Debra			Global groundwater wells at risk of running dry	SCIENCE			English	Article							WATER; DEPLETION; MANAGEMENT; INDIA	Groundwater wells supply water to billions of people, but they can run dry when water tables decline. Here, we analyzed construction records for similar to 39 million globally distributed wells. We show that 6 to 20% of wells are no more than 5 meters deeper than the water table, implying that millions of wells are at risk of running dry if groundwater levels decline by only a few meters. Further, newer wells are not being constructed deeper than older wells in some of the places experiencing significant groundwater level declines, suggesting that newer wells are at least as likely to run dry as older wells if groundwater levels continue to decline. Poor water quality in deep aquifers and the high costs of well construction limit the effectiveness of tapping deep groundwater to stave off the loss of access to water as wells run dry.	[Jasechko, Scott] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Perrone, Debra] Univ Calif Santa Barbara, Environm Studies Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Jasechko, S (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	jasechko@ucsb.edu		Jasechko, Scott/0000-0001-6470-7708; Perrone, Debra/0000-0002-4268-8478				Alley WM, 2016, GROUNDWATER, V54, P758, DOI [10.1111/gwat.12465, 10.1111/gwat.12466]; Anindita Sarkar, 2011, Economic and Political Weekly, V46, P61; Blakeslee D, 2020, AM ECON REV, V110, P200, DOI 10.1257/aer.20180976; Famiglietti JS, 2014, NAT CLIM CHANGE, V4, P945, DOI 10.1038/nclimate2425; Famiglietti JS, 2013, SCIENCE, V340, P1300, DOI 10.1126/science.1236460; Fan Y, 2013, SCIENCE, V339, P940, DOI 10.1126/science.1229881; Foster S, 2013, CURR OPIN ENV SUST, V5, P685, DOI 10.1016/j.cosust.2013.10.010; Foster T, 2017, J HYDROL, V547, P638, DOI 10.1016/j.jhydrol.2017.02.034; Gleeson T, 2020, ANNU REV EARTH PL SC, V48, P431, DOI 10.1146/annurev-earth-071719-055251; Gleeson T, 2012, NATURE, V488, P197, DOI 10.1038/nature11295; Hora T, 2019, GEOPHYS RES LETT, V46, P9602, DOI 10.1029/2019GL083525; Jasechko S, 2020, EARTHS FUTURE, V8, DOI 10.1029/2019EF001339; Johnston R., 2013, **DROPPED REF**, P12; Kemper KE, 2007, AGRICULTURAL GROUNDWATER REVOLUTION: OPPORTUNITIES AND THREATS TO DEVELOPMENT, P153, DOI 10.1079/9781845931728.0153; Konikow LF, 2005, HYDROGEOL J, V13, P317, DOI 10.1007/s10040-004-0411-8; Limaye SD, 2010, HYDROGEOL J, V18, P543, DOI 10.1007/s10040-009-0566-4; MacAllister DJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14839-3; Margat J, 2013, GROUNDWATER AROUND THE WORLD: A GEOGRAPHIC SYNOPSIS, P1; Moench M., 2007, COMPREHENSIVE ASSESS; Molle F, 2018, WATER ALTERN, V11, P445; Mukherji A, 2005, HYDROGEOL J, V13, P328, DOI 10.1007/s10040-005-0434-9; Murti M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3039-4; Pauloo RA, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab6f10; Perrone D, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8ac0; Perrone D, 2019, NAT SUSTAIN, V2, P773, DOI 10.1038/s41893-019-0325-z; Rodell M, 2018, NATURE, V557, P650, DOI 10.1038/s41586-018-0123-1; Sayre SS, 2019, J ENVIRON ECON MANAG, V93, P85, DOI 10.1016/j.jeem.2018.11.002; Scott CA, 2004, INT J WATER RESOUR D, V20, P149, DOI 10.1080/0790062042000206156; Shah T., 1993, GROUNDWATER MARKETS; Siebert S, 2010, HYDROL EARTH SYST SC, V14, P1863, DOI 10.5194/hess-14-1863-2010; Taylor RG, 2013, NAT CLIM CHANGE, V3, P322, DOI [10.1038/nclimate1744, 10.1038/NCLIMATE1744]; Thomas BF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40155-y; Thorslund J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0562-z; Turner SWD, 2019, EARTHS FUTURE, V7, P123, DOI 10.1029/2018EF001105; Zeng YJ, 2018, J ADV MODEL EARTH SY, V10, P1882, DOI 10.1029/2018MS001304	35	42	42	37	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					418	+		10.1126/science.abc2755	http://dx.doi.org/10.1126/science.abc2755			686	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888642				2022-12-28	WOS:000645009800044
J	Okwudire, CE; Madhyastha, HV				Okwudire, Chinedum E.; Madhyastha, Harsha V.			Distributed manufacturing for and by the masses	SCIENCE			English	Editorial Material							CHALLENGES		[Okwudire, Chinedum E.; Madhyastha, Harsha V.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Okwudire, CE (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	okwudire@umich.edu		Okwudire, Chinedum/0000-0001-6910-8827				[Anonymous], 2013, FACT FUT MULT ROADM; [Anonymous], 2017, DEMOCRATIZING MANUFA; Jiang PY, 2016, P I MECH ENG B-J ENG, V230, P1961, DOI 10.1177/0954405416666903; Lopez-Gomez C., 2013, EMERGING TRENDS GLOB; Meyerson B., 2015, TOP 10 EMERGING TECH; Okwudire CE, 2020, ROBOT CIM-INT MANUF, V62, DOI 10.1016/j.rcim.2019.101880; Okwudire CE, 2018, INVENTIONS-BASEL, V3, DOI 10.3390/inventions3030056; Pearce JM, 2020, J MANUF MATER PROC, V4, DOI 10.3390/jmmp4020049; Pine II BJ, 1993, MASS CUSTOMIZATION N; Ridgway K, 2013, FACTORY FUTURE; Srai JS, 2016, INT J PROD RES, V54, P6917, DOI 10.1080/00207543.2016.1192302; Stewart H., 2015, MAKING FUTURES, V4, P1; Wohlers Associates, 2020, WOHL REP 2020 3D PRI; Wuest T, 2016, PROD MANUF RES, V4, P23, DOI 10.1080/21693277.2016.1192517	14	8	9	16	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					341	342						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888625				2022-12-28	WOS:000645009800019
J	Carville, S; Constanti, M; Kosky, N; Stannard, C; Wilkinson, C				Carville, Serena; Constanti, Margaret; Kosky, Nick; Stannard, Cathy; Wilkinson, Colin		Guideline Comm	Chronic pain (primary and secondary) in over 16s: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Carville, Serena; Constanti, Margaret] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England; [Kosky, Nick] Dorset HealthCare NHS Fdn Trust, Poole, Dorset, England; [Stannard, Cathy] NHS Gloucestershire CCG, Gloucester, England	Royal College of Physicians	Carville, S (corresponding author), Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England.	serena.carville@rcp.ac.uk			NICE	NICE	No authors received specific funding from NICE to write this summary. The guideline referred to in this article was produced by the National Guideline Centre, which received funding from NICE. The views expressed in this article are those of the authors and not necessarily those of NICE.	Fayaz A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010364; National Institute for Health and Care Excellence, 2021, CHRON PAIN PRIM SEC; Nicholas M, 2019, PAIN, V160, P28, DOI 10.1097/j.pain.0000000000001390	3	11	11	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n895	10.1136/bmj.n895	http://dx.doi.org/10.1136/bmj.n895			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883123				2022-12-28	WOS:000642452700009
J	Dyer, C				Dyer, Clare			East Kent trust pleads guilty to criminal offence of unsafe care over baby's death	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, BMJ BRIT MED J; Dyer C, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m610	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n1021	10.1136/bmj.n1021	http://dx.doi.org/10.1136/bmj.n1021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3BI	33879474				2022-12-28	WOS:000643654700011
J	Baldomero, AK; Melzer, AC; Greer, N; Majeski, BN; MacDonald, R; Linskens, EJ; Wilt, TJ				Baldomero, Arianne K.; Melzer, Anne C.; Greer, Nancy; Majeski, Brittany N.; MacDonald, Roderick; Linskens, Eric J.; Wilt, Timothy J.			Effectiveness and Harms of High-Flow Nasal Oxygen for Acute Respiratory Failure: An Evidence Report for a Clinical Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; CANNULA OXYGEN; NONINVASIVE VENTILATION; IMMUNOCOMPROMISED PATIENTS; EMERGENCY-DEPARTMENT; ENDOTRACHEAL INTUBATION; THERAPY; EXTUBATION	Background: Use of high-flow nasal oxygen (HFNO) for treatment of adults with acute respiratory failure (ARF) has increased. Purpose: To assess HFNO versus noninvasive ventilation (NIV) or conventional oxygen therapy (COT) for ARF in hospitalized adults. Data Sources: English-language searches of MEDLINE, Embase, CINAHL, and Cochrane Library from January 2000 to July 2020; systematic review reference lists. Study Selection: 29 randomized controlled trials evaluated HFNO versus NIV (k=11) or COT (k=21). Data Extraction: Data extraction by a single investigator was verified by a second, 2 investigators assessed risk of bias, and evidence certainty was determined by consensus. Data Synthesis: Results are reported separately for HFNO versus NIV, for HFNO versus COT, and by initial or postextubation management. Compared with NIV, HFNO may reduce all-cause mortality, intubation, and hospital-acquired pneumonia and improve patient comfort in initial ARF management (low-certainty evidence) but not in postextubation management. Compared with COT, HFNO may reduce reintubation and improve patient comfort in postextubation ARF management (low-certainty evidence). Limitations: Trials varied in populations enrolled, ARF causes, and treatment protocols. Trial design, sample size, duration of treatment and follow-up, and results reporting were often insufficient to adequately assess many outcomes. Protocols, clinician and health system training, cost, and resource use were poorly characterized. Conclusion: Compared with NIV, HFNO as initial ARF management may improve several clinical outcomes. Compared with COT, HFNO as postextubation management may reduce reintubations and improve patient comfort; HFNO resulted in fewer harms than NIV or COT. Broad applicability, including required clinician and health system experience and resource use, is not well known.	[Baldomero, Arianne K.; Melzer, Anne C.] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Baldomero, Arianne K.; Melzer, Anne C.] Univ Minnesota, Minneapolis, MN USA; [Greer, Nancy; Majeski, Brittany N.; MacDonald, Roderick; Linskens, Eric J.; Wilt, Timothy J.] Minneapolis Vet Affairs Hlth Care Syst, Ctr Care Delivery & Outcomes Res, Minneapolis, MN USA; [Baldomero, Arianne K.; Melzer, Anne C.] 1 Vet Dr,Pulm 111-N, Minneapolis, MN 55417 USA; [Greer, Nancy; Majeski, Brittany N.; MacDonald, Roderick; Linskens, Eric J.; Wilt, Timothy J.] 1 Vet Dr,111-0, Minneapolis, MN 55417 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Baldomero, AK (corresponding author), 1 Vet Dr,Pulm 111-N, Minneapolis, MN 55417 USA.	baldo004@umn.edu	Baldomero, Arianne K/L-6555-2019	Baldomero, Arianne K/0000-0002-8309-0747	National Institutes of Health National Center for Advancing Translational Sciences [KL2TR002492, UL1TR002494]	National Institutes of Health National Center for Advancing Translational Sciences	The evidence review was commissioned by ACP. The material is the result of work supported by and conducted at the Minneapolis VA Health Care System. Dr. Baldomero was also supported, in part, by grants KL2TR002492 and UL1TR002494 from the National Institutes of Health National Center for Advancing Translational Sciences.	Andino R, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620956459; [Anonymous], 2015, GRADEPRO GDT GRADEPR; Apltekinoglu Mendil N, 2021, TURK J MED SCI, V51, P1756, DOI 10.3906/sag-2007-228; Azoulay E, 2018, JAMA-J AM MED ASSOC, V320, P2099, DOI 10.1001/jama.2018.14282; Baldomero AK, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034956; Bell N, 2015, EMERG MED AUSTRALAS, V27, P537, DOI 10.1111/1742-6723.12490; Cheng LC, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100693; Cho JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e194; Cong L, 2019, INT J CLIN EXP MED, V12, P10863; Corley A, 2011, BRIT J ANAESTH, V107, P998, DOI 10.1093/bja/aer265; Corley A, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010172.pub2; Corley A, 2015, INTENS CARE MED, V41, P887, DOI 10.1007/s00134-015-3765-6; Cortegiani A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03409-0; Cortegiani A, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2473-y; Cortegiani A, 2019, J CRIT CARE, V50, P250, DOI 10.1016/j.jcrc.2018.12.015; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; Delorme M, 2017, CRIT CARE MED, V45, P1981, DOI 10.1097/CCM.0000000000002693; Doshi P, 2018, ANN EMERG MED, V72, P73, DOI 10.1016/j.annemergmed.2017.12.006; Doshi PB, 2020, HEART LUNG, V49, P610, DOI 10.1016/j.hrtlng.2020.03.008; Drake MG, 2018, ANN AM THORAC SOC, V15, P145, DOI 10.1513/AnnalsATS.201707-548FR; Frat JP, 2016, LANCET RESP MED, V4, P646, DOI 10.1016/S2213-2600(16)30093-5; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Geng WR, 2020, CAN RESPIR J, V2020, DOI 10.1155/2020/2301712; Grieco DL, 2020, AM J RESP CRIT CARE, V201, P303, DOI 10.1164/rccm.201904-0841OC; Groves Nicole, 2007, Aust Crit Care, V20, P126; Hasani A, 2008, Chron Respir Dis, V5, P81, DOI 10.1177/1479972307087190; Haywood ST, 2019, AM J EMERG MED, V37, P2084, DOI 10.1016/j.ajem.2019.03.002; Helviz Y, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1990-4; Hernandez G, 2016, JAMA-J AM MED ASSOC, V316, P1565, DOI 10.1001/jama.2016.14194; Hernandez G, 2016, JAMA-J AM MED ASSOC, V315, P1354, DOI 10.1001/jama.2016.2711; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Huang CC, 2019, EMERG MED INT, V2019, DOI 10.1155/2019/2130935; Huang HB, 2018, J CRIT CARE, V43, P300, DOI 10.1016/j.jcrc.2017.09.176; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Jing GQ, 2019, RES NURS HEALTH, V42, P217, DOI 10.1002/nur.21942; Jones PG, 2016, RESP CARE, V61, P291, DOI 10.4187/respcare.04252; Kang HYJ, 2020, RESP CARE, V65, P369, DOI 10.4187/respcare.07205; Leeies M, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0593-5; Lemiale V, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1097-0; Lenglet H, 2012, RESP CARE, V57, P1873, DOI 10.4187/respcare.01575; Li XY, 2020, INT J CHRONIC OBSTR, V15, P3051, DOI 10.2147/COPD.S283020; Liesching TN, 2019, J INTENSIVE CARE MED, V34, P140, DOI 10.1177/0885066616689043; Lin SM, 2017, RESP MED, V131, P58, DOI 10.1016/j.rmed.2017.08.005; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Makdee O, 2017, ANN EMERG MED, V70, P465, DOI 10.1016/j.annemergmed.2017.03.028; Matsuda W, 2020, RESP CARE, V65, P610, DOI 10.4187/respcare.07095; Mehta AB, 2017, ANN AM THORAC SOC, V14, P1667, DOI 10.1513/AnnalsATS.201703-208OC; Moller W, 2017, J APPL PHYSIOL, V122, P191, DOI 10.1152/japplphysiol.00584.2016; Monro-Somerville T, 2017, CRIT CARE MED, V45, pE449, DOI 10.1097/CCM.0000000000002091; Ni YN, 2017, CHEST, V151, P764, DOI 10.1016/j.chest.2017.01.004; Ou XF, 2017, CAN MED ASSOC J, V189, pE260, DOI 10.1503/cmaj.160570; Papachatzakis Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165994; Parke R, 2009, BRIT J ANAESTH, V103, P886, DOI 10.1093/bja/aep280; Parke RL, 2013, RESP CARE, V58, P1621, DOI 10.4187/respcare.02358; Parke RL, 2011, RESP CARE, V56, P1151, DOI 10.4187/respcare.01106; Parke RL, 2011, RESP CARE, V56, P265, DOI 10.4187/respcare.00801; Pilcher J, 2017, RESPIROLOGY, V22, P1149, DOI 10.1111/resp.13050; Rezaei A, 2021, CLIN RESPIR J, V15, P420, DOI 10.1111/crj.13315; Ritchie JE, 2011, ANAESTH INTENS CARE, V39, P1103, DOI 10.1177/0310057X1103900620; Rittayamai N, 2015, RESP CARE, V60, P1377, DOI 10.4187/respcare.03837; Rittayamai N, 2014, RESP CARE, V59, P485, DOI 10.4187/respcare.02397; Roca O, 2010, RESP CARE, V55, P408; Rochwerg B, 2019, INTENS CARE MED, V45, P563, DOI 10.1007/s00134-019-05590-5; Rochwerg B, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.02426-2016; Ruangsomboon O, 2020, ANN EMERG MED, V75, P615, DOI 10.1016/j.annemergmed.2019.09.009; Saksitthichok B, 2019, J THORAC DIS, V11, P1929, DOI 10.21037/jtd.2019.05.02; Schunemann H, 2019, GRADE HDB; Schwabbauer N, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-66; Sim MAB, 2008, ANAESTHESIA, V63, P938, DOI 10.1111/j.1365-2044.2008.05536.x; Sklar MC, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0432-4; Song HZ, 2017, CLINICS, V72, P562, DOI 10.6061/clinics/2017(09)07; Spoletini G, 2018, J CRIT CARE, V48, P418, DOI 10.1016/j.jcrc.2018.10.004; Stephan F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI 10.1001/jama.2015.5213; Sztrymf B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.07.075; Sztrymf B, 2011, INTENS CARE MED, V37, P1780, DOI 10.1007/s00134-011-2354-6; Tan DY, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03214-9; Theerawit P, 2021, J CRIT CARE, V63, P117, DOI 10.1016/j.jcrc.2020.09.031; Thille AW, 2011, CRIT CARE MED, V39, P2612, DOI 10.1097/CCM.0b013e3182282a5a; Tinelli V, 2019, J EMERG MED, V57, P322, DOI 10.1016/j.jemermed.2019.06.033; Tiruvoipati R, 2010, J CRIT CARE, V25, P463, DOI 10.1016/j.jcrc.2009.06.050; Vargas F, 2015, RESP CARE, V60, P1369, DOI 10.4187/respcare.03814; Veroniki AA, 2019, RES SYNTH METHODS, V10, P23, DOI 10.1002/jrsm.1319; Vourc'h M, 2020, J CARDIOTHOR VASC AN, V34, P157, DOI 10.1053/j.jvca.2019.05.039; Walkey Allan J, 2013, Ann Am Thorac Soc, V10, P10, DOI 10.1513/AnnalsATS.201206-034OC; Williams R, 1996, CRIT CARE MED, V24, P1920, DOI 10.1097/00003246-199611000-00025; Xu ZH, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0908-7; Zhu YF, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2465-y	88	11	11	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					952	+		10.7326/M20-4675	http://dx.doi.org/10.7326/M20-4675			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33900793	Green Accepted			2022-12-28	WOS:000675809000022
J	Shi, LD; Moser, S				Shi, Linda; Moser, Susanne			Transformative climate adaptation in the United States: Trends and prospects	SCIENCE			English	Review							SEA-LEVEL RISE; FUTURE; INFRASTRUCTURE; PERSPECTIVES; COMPETENCES; RESILIENCE; GOVERNANCE; STRATEGIES; DISASTERS; IMPACTS	As climate change intensifies, civil society is increasingly calling for transformative adaptation that redresses drivers of climate vulnerability. We review trends in how US federal government, private industry, and civil society are planning for climate adaptation. We find growing divergence in their approaches and impacts. This incoherence increases maladaptive investment in climate-blind infrastructure, justice-blind reforms in financial and professional sectors, and greater societal vulnerability to climate impacts. If these actors were to proactively and deliberatively engage in transformative adaptation, they would need to address the material, relational, and normative factors that hold current systems in place. Drawing on a review of transformation and collective impact literatures, we conclude with directions for research and policy engagement to support more transformative adaptation moving forward.	[Shi, Linda] Cornell Univ, Dept City & Reg Planning, 213 West Sibley Hall, Ithaca, NY 14853 USA; [Moser, Susanne] Susanne Moser Res & Consulting, Hadley, MA 01035 USA; [Moser, Susanne] Univ Massachusetts, Dept Landscape Architecture & Reg Planning, Amherst, MA 01002 USA	Cornell University; University of Massachusetts System; University of Massachusetts Amherst	Shi, LD (corresponding author), Cornell Univ, Dept City & Reg Planning, 213 West Sibley Hall, Ithaca, NY 14853 USA.	lindashi@cornell.edu		Moser, Susanne/0000-0001-6375-895X; Shi, Linda/0000-0002-2444-367X				A.S.C.E, 2017, INFRASTRUCTURE REPOR; Algunaibet IM, 2019, ENERG ENVIRON SCI, V12, P1890, DOI 10.1039/c8ee03423k; Andrews S., 2019, P 58 ANN M INV ATT; Anguelovski I, 2019, P NATL ACAD SCI USA, V116, P26139, DOI 10.1073/pnas.1920490117; Anguelovski I, 2016, J PLAN EDUC RES, V36, P333, DOI 10.1177/0739456X16645166; [Anonymous], 2018, UND RIS SEAS CHRON F; Aune KT, 2020, ENVIRON RES, V185, DOI 10.1016/j.envres.2020.109384; Ayyub B, 2018, COMMITTEE ADAPTATION, V140, DOI [10.1061/9780784415191, DOI 10.1061/9780784415191]; Bernstein A, 2019, J FINANC ECON, V134, P253, DOI 10.1016/j.jfineco.2019.03.013; Berzonsky CL, 2017, ANTHROPOCENE, V20, P15, DOI 10.1016/j.ancene.2017.11.002; Bigger P., 2019, ENVIRON PLAN E-NAT, V3, P601, DOI 10.1177/; Boas I, 2019, NAT CLIM CHANGE, V9, P901, DOI 10.1038/s41558-019-0633-3; Boyatzis RE, 2017, J APPL BEHAV SCI, V53, P498, DOI 10.1177/0021886317731575; Bromley-Trujillo R, 2020, PUBLIUS J FEDERALISM, V50, P446, DOI 10.1093/publius/pjaa008; Bronen R, 2013, P NATL ACAD SCI USA, V110, P9320, DOI 10.1073/pnas.1210508110; C.L.F. G.R.C, 2018, CLIMATE ADAPTATION L; C. N. A. Corporation, 2007, NAT SEC THREAT CLIM; C.S.I.W.G, 2018, PAYING IT FORWARD PA; Cabaj M., 2016, COMMUNITY CHANGE SER, P14; Castan Broto V., 2020, CLIMATE URBANISM CRI; Cavallo A, 2014, INT J DISAST RISK RE, V9, P181, DOI 10.1016/j.ijdrr.2014.05.001; Centeno MA, 2015, ANNU REV SOCIOL, V41, P65, DOI 10.1146/annurev-soc-073014-112317; Chu E., 2019, UNLOCKING POTENTIAL; Cianconi P, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00074; Cinner JE, 2018, NAT CLIM CHANGE, V8, P117, DOI 10.1038/s41558-017-0065-x; Conyers ZA, 2019, PROF GEOGR, V71, P278, DOI 10.1080/00330124.2018.1531037; Curtis KJ, 2020, RURAL SOCIOL, V85, P856, DOI 10.1111/ruso.12305; Easterling D., 2018, IMPACTS RISKS ADAPTI, VII, DOI [10.7930/NCA4.2018.RiB, DOI 10.7930/NCA4.2018.RIB]; Eubanks Virginia, 2016, NATION; Fazey I, 2020, ENERGY RES SOC SCI, V70, DOI 10.1016/j.erss.2020.101724; FEMA, 2020, BUILDING COMMUNITY R; Finn D, 2019, J PLAN EDUC RES, DOI 10.1177/0739456X19864145; Fischer J, 2019, PEOPLE NAT, V1, P115, DOI 10.1002/pan3.13; Flavelle C., 2020, NEW YORK TIMES; Fraser N., 1995, J POLIT PHILOS, V3, P166, DOI [DOI 10.1111/j.1467-9760.1995.tb00033.x, https://doi.org/10.1111/j.1467-9760.1995.tb00033.x, DOI 10.1111/J.1467-9760.1995.TB00033.X]; Funk Cary, 2019, PEW RES CTR; G.A.O, 2019, STAT JA GOM DIR NAT; Gallina V, 2016, J ENVIRON MANAGE, V168, P123, DOI 10.1016/j.jenvman.2015.11.011; Galvin R, 2020, ENERGY RES SOC SCI, V67, DOI 10.1016/j.erss.2020.101529; GAO, 2009, REP CHAIRM SEL COMM; Garcia-Lamarca M, 2021, URBAN STUD, V58, P90, DOI 10.1177/0042098019885330; Gilford D., 2019, EOS, V100, P6, DOI 10.1029/; Grayson B., 2018, MOODYS CLIMATE CHANG; Gunn-Wright R., 2019, NEW CONSENSUS FEB; Gustafson A, 2019, NAT CLIM CHANGE, V9, P940, DOI 10.1038/s41558-019-0621-7; Hauer ME, 2017, NAT CLIM CHANGE, V7, P321, DOI [10.1038/nclimate3271, 10.1038/NCLIMATE3271]; Henrique KP, 2021, PROG HUM GEOG, V45, P1169, DOI 10.1177/0309132520962856; Hoover Fushcia-Ann, 2021, Socioecol Pract Res, V3, P55, DOI 10.1007/s42532-020-00070-3; Juhola S, 2016, ENVIRON SCI POLICY, V55, P135, DOI 10.1016/j.envsci.2015.09.014; Kalesnikaite V, 2019, PUBLIC PERFORM MANAG, V42, P864, DOI 10.1080/15309576.2018.1526091; Kallis G, 2018, ANNU REV ENV RESOUR, V43, P291, DOI 10.1146/annurev-environ-102017-025941; Kania J., 2018, WATER SYSTEMS CHANGE; Kaplan-Leiserson E., 2019, PE MAGAZINE; Kates RW, 2012, P NATL ACAD SCI USA, V109, P7156, DOI 10.1073/pnas.1115521109; Keenan JM, 2020, CLIMATIC CHANGE, V162, P2043, DOI 10.1007/s10584-020-02734-1; Keenan JM, 2019, SCIENCE, V365, P1240, DOI 10.1126/science.aay8442; Keenan JM, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aabb32; Keenan JM, 2018, NAT HAZARDS REV, V19, DOI 10.1061/(ASCE)NH.1527-6996.0000273; Klein J, 2018, GLOBAL ENVIRON CHANG, V53, P127, DOI 10.1016/j.gloenvcha.2018.09.012; Klein N., 2007, SHOCK DOCTRINE RISE; Kothari A, 2014, DEVELOPMENT, V57, P362, DOI [10.1057/dev.2015.24, DOI 10.1057/DEV.2015.24]; Kousky C., 2017, FINANCING FLOOD LOSS; MacArthur JL, 2020, ENERGY RES SOC SCI, V65, DOI 10.1016/j.erss.2020.101442; Mach KJ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8995; Magnan AK, 2016, WIRES CLIM CHANGE, V7, P646, DOI 10.1002/wcc.409; Maldonado JK, 2014, CLIMATE CHANGE INDIG, DOI [10.1007/978-3-319-05266-3, DOI 10.1007/978-3-319-05266-3]; Malloy JT, 2020, CLIMATIC CHANGE, V160, P1, DOI 10.1007/s10584-020-02705-6; Marino E, 2018, GLOBAL ENVIRON CHANG, V49, P10, DOI 10.1016/j.gloenvcha.2018.01.002; McAlpine SA, 2018, POPUL RES POLICY REV, V37, P871, DOI 10.1007/s11113-018-9473-5; Miao Q, 2018, NATL TAX J, V71, P11, DOI 10.17310/ntj.2018.1.01; Moftakhari HR, 2017, P NATL ACAD SCI USA, V114, P9785, DOI 10.1073/pnas.1620325114; Mondaine E. D., 2020, THEORY CLIMATE JUSTI; Moser S.C., 2017, TOGETHER REV CRITICA; Moser S. C., 2019, TRANSFORMATION SCI D; Moser S. C., 2019, AGU ANN M; Moser SC, 2015, CLIMATIC CHANGE, V129, P13, DOI 10.1007/s10584-015-1328-z; N.G.F.S, 2019, CALL ACT CLIM CHANG; NAACP, 2015, EQ BUILD RES AD PLAN; Nance E., 2020, ASS COLL SCH PLANN C; O'Brien K., 2009, WHATS WORD CONFLICTI; O'Brien K, 2012, PROG HUM GEOG, V36, P667, DOI 10.1177/0309132511425767; Obama Task Force, 2014, PRES STAT LOC TRIB L; Opperman J., 2014, FLOOD BENEFITS USING; Overland I, 2020, ENERGY RES SOC SCI, V62, DOI 10.1016/j.erss.2019.101349; Owen G, 2020, GLOBAL ENVIRON CHANG, V62, DOI 10.1016/j.gloenvcha.2020.102071; Patterson J, 2017, ENVIRON INNOV SOC TR, V24, P1, DOI 10.1016/j.eist.2016.09.001; Pelling M, 2011, ADAPTATION TO CLIMATE CHANGE: FROM RESILIENCE TO TRANSFORMATION, P1; Pfefferbaum B, 2020, NEW ENGL J MED, V383, P510, DOI 10.1056/NEJMp2008017; Phillips CA, 2020, NAT CLIM CHANGE, V10, P586, DOI 10.1038/s41558-020-0804-2; Pruneau D, 2013, J ENVIRON EDUC, V44, P217, DOI 10.1080/00958964.2012.759521; Ranganathan M, 2021, ANTIPODE, V53, P115, DOI 10.1111/anti.12555; Ratcliffe C., 2019, INSULT INJURY NATURA; Raworth K, 2017, LANCET PLANET HEALTH, V1, pE48, DOI 10.1016/S2542-5196(17)30028-1; Robinson C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227436; Rodin Judith, 2014, RESILIENCE DIVIDEND, P6; Schulz A, 2017, MITIG ADAPT STRAT GL, V22, P175, DOI 10.1007/s11027-015-9672-x; Scoones I, 2020, CURR OPIN ENV SUST, V42, P65, DOI 10.1016/j.cosust.2019.12.004; Shi Linda, 2020, Socioecol Pract Res, V2, P311, DOI 10.1007/s42532-020-00065-0; Shi LD, 2020, CITIES, V100, DOI 10.1016/j.cities.2020.102658; Shi L, 2021, URBAN AFF REV, V57, P1442, DOI 10.1177/1078087419910827; Shi L, 2019, ENVIRON SCI POLICY, V92, P262, DOI 10.1016/j.envsci.2018.11.002; Shokry G, 2020, URBAN CLIM, V31, DOI 10.1016/j.uclim.2019.100539; Siders AR, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.573; Siders AR, 2019, CLIMATIC CHANGE, V152, P239, DOI 10.1007/s10584-018-2272-5; Smith A. B, 2020, 2010 2019 LANDMARK D; Standard's, 2019, GLOB RAT; Straka JW, 2020, POLICY SCI, V53, P779, DOI 10.1007/s11077-020-09383-2; Suckall N, 2019, ENVIRON SCI POLICY, V96, P64, DOI 10.1016/j.envsci.2019.03.003; Taylor ZJ, 2020, CAMB J REG ECON SOC, V13, P405, DOI 10.1093/cjres/rsaa015; Torabi E, 2018, CITIES, V72, P295, DOI 10.1016/j.cities.2017.09.008; Tschakert P, 2013, CLIM DEV, V5, P340, DOI 10.1080/17565529.2013.828583; US Department of Homeland Security (DHS), 2019, NAT PREP REP; Walsh P, 2019, LAND ECON, V95, P19, DOI 10.3368/le.95.1.19; Warner BP, 2017, CURR OPIN ENV SUST, V29, P69, DOI 10.1016/j.cosust.2017.12.012; WFEO, 2015, MOD COD PRACT PRINC; Whyte KP, 2016, SUSTAIN SCI, V11, P25, DOI 10.1007/s11625-015-0296-6; Woodruff Sierra C., 2016, Nature Climate Change, V6, P796, DOI 10.1038/nclimate3012; Woodruff S, 2018, SYST DYNAM REV, V34, P48, DOI 10.1002/sdr.1597; Wretched of the Earth, 2019, RED PEPPER; Zscheischler J, 2018, NAT CLIM CHANGE, V8, P469, DOI 10.1038/s41558-018-0156-3; Zuccaro G, 2018, INT J DISAST RISK RE, V30, P199, DOI 10.1016/j.ijdrr.2018.04.019	121	19	19	16	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2021	372	6549					1408	+	eabc8054	10.1126/science.abc8054	http://dx.doi.org/10.1126/science.abc8054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SY4KW	33927053				2022-12-28	WOS:000665860000037
J	Brugha, R; Spencer, H				Brugha, Rossa; Spencer, Helen			Mycobacterium abscessus in cystic fibrosis	SCIENCE			English	Editorial Material							NONTUBERCULOUS MYCOBACTERIA		[Brugha, Rossa; Spencer, Helen] Great Ormond St Hosp Sick Children, Resp Med & Cardiothorac Transplantat, London, England; [Brugha, Rossa] UCL Great Ormond St Inst Child Hlth, Infect Immun & Inflammat, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Spencer, H (corresponding author), Great Ormond St Hosp Sick Children, Resp Med & Cardiothorac Transplantat, London, England.	helen.spencer@gosh.nhs.uk						Abidin NZ, 2021, J CYST FIBROS, V20, P737, DOI 10.1016/j.jcf.2020.09.007; Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Bryant JM, 2021, SCIENCE, V372, P483, DOI 10.1126/science.abb8699; Bryant JM, 2016, SCIENCE, V354, P751, DOI 10.1126/science.aaf8156; Clark ST, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny026; Dedrick RM, 2019, NAT MED, V25, P730, DOI 10.1038/s41591-019-0437-z; Doyle RM, 2020, CLIN INFECT DIS, V70, P1855, DOI 10.1093/cid/ciz526; Floto RA, 2016, THORAX, V71, P1, DOI 10.1136/thoraxjnl-2015-207360; Gilbert JA, 2017, LANCET RESP MED, V5, P384, DOI 10.1016/S2213-2600(17)30109-1; Hughes DA, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03636-2020; Johansen MD, 2020, NAT REV MICROBIOL, V18, P392, DOI 10.1038/s41579-020-0331-1; Kavaliunaite E, 2020, TRANSPL INFECT DIS, V22, DOI 10.1111/tid.13274; Middleton PG, 2019, NEW ENGL J MED, V381, P1809, DOI 10.1056/NEJMoa1908639; Qvist T, 2016, J CYST FIBROS, V15, P380, DOI 10.1016/j.jcf.2015.09.007; Shaw LP, 2019, CLIN INFECT DIS, V69, P1678, DOI 10.1093/cid/ciz069	15	4	4	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					465	466		10.1126/science.abi5695	http://dx.doi.org/10.1126/science.abi5695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926941				2022-12-28	WOS:000645554100027
J	Baraniuk, C				Baraniuk, Chris			Covid-19: What do we know about airborne transmission of SARS-CoV-2?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chrisbaraniuk@gmail.com						CDC, 2020, COV 19 SPREADS; Centers for Disease Control and Prevention (CDC), HOW FLU SPREADS; de Oliveira PM, 2021, P ROY SOC A-MATH PHY, V477, DOI 10.1098/rspa.2020.0584; Greenhalgh T, 2021, LANCET, V397, P1603, DOI 10.1016/S0140-6736(21)00869-2; Katelaris AL, 2021, EMERG INFECT DIS, V27, P1677, DOI 10.3201/eid2706.210465; Klompas M, 2020, JAMA-J AM MED ASSOC, V324, P441, DOI 10.1001/jama.2020.12458; Li YG, 2021, BUILD ENVIRON, V196, DOI 10.1016/j.buildenv.2021.107788; Ma JX, 2021, CLIN INFECT DIS, V72, pE652, DOI 10.1093/cid/ciaa1283; McGrevy R., IRISH TIMES, V2021; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Public Health England, 2021, STOP SPREAD COR COV; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; Tang JW, 2021, J HOSP INFECT, V110, P89, DOI 10.1016/j.jhin.2020.12.022; Tang JW, 2009, J R SOC INTERFACE, V6, pS737, DOI 10.1098/rsif.2009.0227.focus; WHO,, 2021, ROADM IMPR ENS GOOD; WHO, 2020, MODES TRANSMISSION V; Wilson NM, 2021, ANAESTHESIA, V76, P1465, DOI 10.1111/anae.15475; World Health Organization (WHO), 2014, INF PREV CONTR EP AN; Yan J, 2018, P NATL ACAD SCI USA, V115, P1081, DOI 10.1073/pnas.1716561115	19	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2021	373								n1030	10.1136/bmj.n1030	http://dx.doi.org/10.1136/bmj.n1030			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0MU	33888460	Bronze			2022-12-28	WOS:000708062500002
J	Rejou-Mechain, M; Mortier, F; Bastin, JF; Cornu, G; Barbier, N; Bayol, N; Benedet, F; Bry, X; Dauby, G; Deblauwe, V; Doucet, JL; Doumenge, C; Fayolle, A; Garcia, C; Lubamba, JPK; Loumeto, JJ; Ngomanda, A; Ploton, P; Sonke, B; Trottier, C; Vimal, R; Yongo, O; Pelissier, R; Gourlet-Fleury, S				Rejou-Mechain, Maxime; Mortier, Frederic; Bastin, Jean-Francois; Cornu, Guillaume; Barbier, Nicolas; Bayol, Nicolas; Benedet, Fabrice; Bry, Xavier; Dauby, Gilles; Deblauwe, Vincent; Doucet, Jean-Louis; Doumenge, Charles; Fayolle, Adeline; Garcia, Claude; Lubamba, Jean-Paul Kibambe; Loumeto, Jean-Joel; Ngomanda, Alfred; Ploton, Pierre; Sonke, Bonaventure; Trottier, Catherine; Vimal, Ruppert; Yongo, Olga; Pelissier, Raphael; Gourlet-Fleury, Sylvie			Unveiling African rainforest composition and vulnerability to global change	NATURE			English	Article								Africa is forecasted to experience large and rapid climate change(1) and population growth(2) during the twenty-first century, which threatens the world's second largest rainforest. Protecting and sustainably managing these African forests requires an increased understanding of their compositional heterogeneity, the environmental drivers of forest composition and their vulnerability to ongoing changes. Here, using a very large dataset of 6 million trees in more than 180,000 field plots, we jointly model the distribution in abundance of the most dominant tree taxa in central Africa, and produce continuous maps of the floristic and functional composition of central African forests. Our results show that the uncertainty in taxon-specific distributions averages out at the community level, and reveal highly deterministic assemblages. We uncover contrasting floristic and functional compositions across climates, soil types and anthropogenic gradients, with functional convergence among types of forest that are floristically dissimilar. Combining these spatial predictions with scenarios of climatic and anthropogenic global change suggests a high vulnerability of the northern and southern forest margins, the Atlantic forests and most forests in the Democratic Republic of the Congo, where both climate and anthropogenic threats are expected to increase sharply by 2085. These results constitute key quantitative benchmarks for scientists and policymakers to shape transnational conservation and management strategies that aim to provide a sustainable future for central African forests. A large dataset of 6 million trees from 193 taxa is used to map the floristic and functional composition of central African forests and predict their vulnerability to climate change.	[Rejou-Mechain, Maxime; Bastin, Jean-Francois; Barbier, Nicolas; Dauby, Gilles; Ploton, Pierre; Pelissier, Raphael] Univ Montpellier, INRAE, AMAP, IRD,CNRS,CIRAD, Montpellier, France; [Mortier, Frederic; Bastin, Jean-Francois; Cornu, Guillaume; Benedet, Fabrice; Doumenge, Charles; Garcia, Claude; Gourlet-Fleury, Sylvie] CIRAD, Forets & Soc, Montpellier, France; [Mortier, Frederic; Bastin, Jean-Francois; Cornu, Guillaume; Benedet, Fabrice; Doumenge, Charles; Garcia, Claude; Gourlet-Fleury, Sylvie] Univ Montpellier, CIRAD, Forets & Soc, Montpellier, France; [Bastin, Jean-Francois; Doucet, Jean-Louis; Fayolle, Adeline] Univ Liege, Gembloux Agrobio Tech, TERRA Teaching & Res Ctr, Gembloux, Belgium; [Bayol, Nicolas] FRM Ingn, Mauguio, France; [Bry, Xavier; Trottier, Catherine] Univ Montpellier, CNRS, IMAG, Montpellier, France; [Deblauwe, Vincent] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA; [Deblauwe, Vincent] Int Inst Trop Agr, Yaounde, Cameroon; [Garcia, Claude] Swiss Fed Inst Technol, Dept Environm Syst Sci, Inst Integrat Biol, Forest Management & Dev Team, Zurich, Switzerland; [Lubamba, Jean-Paul Kibambe] Univ Kinshasa, Fac Sci Agron, Dept Gest Ressources Nat, Kinshasa, DEM REP CONGO; [Lubamba, Jean-Paul Kibambe] Wildlife Conservat Soc, Kinshasa, DEM REP CONGO; [Loumeto, Jean-Joel] Univ Marien Ngouabi, Fac Sci & Tech, Brazzaville, Rep Congo; [Ngomanda, Alfred] Inst Rech Ecol Trop IRET CENAREST, Libreville, Gabon; [Sonke, Bonaventure] Univ Yaounde I, Higher Teachers Training Coll, Plant Systemat & Ecol Lab, Yaounde, Cameroon; [Trottier, Catherine] Univ Paul Valery Montpellier 3, AMIS, Montpellier, France; [Vimal, Ruppert] Univ Jean Jaures, CNRS, GEODE UMR 5602, Toulouse, France; [Yongo, Olga] Univ Bangui, Fac Sci, Lab Biodiversite Vegetale & Fong, Bangui, Cent Afr Republ	Centre National de la Recherche Scientifique (CNRS); CIRAD; INRAE; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; CIRAD; Universite de Montpellier; University of Liege; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of California System; University of California Los Angeles; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Kinshasa; University of Yaounde I; CIRAD; Universite Paul-Valery; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Rejou-Mechain, M (corresponding author), Univ Montpellier, INRAE, AMAP, IRD,CNRS,CIRAD, Montpellier, France.	maxime.rejou@ird.fr	Pélissier, Raphaël/C-1224-2008; Barbier, Nicolas/A-5489-2010	Pélissier, Raphaël/0000-0003-4845-5090; Barbier, Nicolas/0000-0002-5323-3866; Gilles, Dauby/0000-0002-9498-413X; Mortier, Frederic/0000-0001-5473-709X	AFD; FFEM; CoForTips project - ERA-NET BiodivERsA [ANR-12-EBID-0002]; ANR; BELSPO; FWF; French National Research Agency [ANR-18-CE02-0025]; project 3DForMod - UE FACCE ERA-GAS consortium [ANR-17-EGAS-0002-01]	AFD; FFEM; CoForTips project - ERA-NET BiodivERsA; ANR(French National Research Agency (ANR)); BELSPO(Belgian Federal Science Policy Office); FWF(Austrian Science Fund (FWF)); French National Research Agency(French National Research Agency (ANR)); project 3DForMod - UE FACCE ERA-GAS consortium	Wethank the 105 forest companies that provided access, albeit restricted,to their inventory data for research purposes and members of the central African plot network (https://central-african-plot-network.netlify.app/),Y.Yalibanda,F.Allah-Barem, F. Baya, F. Boyemba, M.Mbasi Mbula, P. Berenger, M. Mazengue, V. Istace, I. Zombo, E. Forni, Nature+andthe CEB-Precious Woods company for giving access to the scientific inventoriesdescribed in Supplementary Fig. 4, someof which were funded by the AFD and the FFEM (for example, DynAfFor and P3FACprojects). We thank J. Chave, P. Couteron, S. Lewis and M. Tadesse for their comments and discussions on previous versions, B. Sultan for useful discussions on climate projections, O. J. Hardy for advice on phylogenetical analyses, B. Locatelli for advice on vulnerability analyses, G.Vieilledent for discussions on thehuman-induced forest-disturbanceintensity index and A. Stokes for English editing. This work was supportedby the CoForTips project (ANR-12-EBID-0002) funded by the ERA-NET BiodivERsA, with the national funders ANR, BELSPO and FWF, as part of the2012 BiodivERsA call forresearch proposals, the GAMBAS project fundedby theFrench National Research Agency (ANR-18-CE02-0025)andthe project 3DForMod funded by the UE FACCE ERA-GAS consortium (ANR-17-EGAS-0002-01). This study is a contribution tothe research program of LMIDYCOFAC(Dynamique desecosystemes continentaux d'Afrique Centrale en contexte de changements globaux).	Abernethy K, 2016, ANNU REV ENV RESOUR, V41, P1, DOI 10.1146/annurev-environ-110615-085415; Abouheif E, 1999, EVOL ECOL RES, V1, P895; Aguirre-Gutierrez J, 2019, ECOL LETT, V22, P855, DOI 10.1111/ele.13243; [Anonymous], AFRICAN PLANT DATABA; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Benedet F., 2019, COFORTRAITS AFRICAN, DOI [10.18167/DVN1/Y2BIZK, DOI 10.18167/DVN1/Y2BIZK]; Borchert R, 2002, BIOTROPICA, V34, P27, DOI 10.1111/j.1744-7429.2002.tb00239.x; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Boulvert, 1986, CARTE PHYTOGEOGRAPHI; Bry X, 2015, J CHEMOMETR, V29, P637, DOI 10.1002/cem.2759; Bry X, 2013, J MULTIVARIATE ANAL, V119, P47, DOI 10.1016/j.jmva.2013.03.013; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Chao A, 2010, PHILOS T R SOC B, V365, P3599, DOI 10.1098/rstb.2010.0272; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Chessel D, 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087; Claeys F, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aafb81; Clark CJ, 2009, CONSERV BIOL, V23, P1281, DOI 10.1111/j.1523-1739.2009.01243.x; Cornu G., 2016, **DATA OBJECT**; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Curtis PG, 2018, SCIENCE, V361, P1108, DOI 10.1126/science.aau3445; Dauby G, 2016, PHYTOKEYS, P1, DOI 10.3897/phytokeys.74.9723; Davies TJ, 2013, J ECOL, V101, P1520, DOI 10.1111/1365-2745.12154; De Wasseige C., 2015, FORESTS CONGO BASIN; Deblauwe V, 2016, GLOBAL ECOL BIOGEOGR, V25, P443, DOI 10.1111/geb.12426; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Diffenbaugh NS, 2012, CLIMATIC CHANGE, V114, P813, DOI 10.1007/s10584-012-0570-x; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Droissart V, 2018, J BIOGEOGR, V45, P1153, DOI 10.1111/jbi.13190; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fayolle A, 2014, J BIOGEOGR, V41, P2320, DOI 10.1111/jbi.12382; Fayolle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042381; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P1830, DOI 10.1111/j.1365-2486.2009.02085.x; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Fyllas NM, 2012, PERSPECT PLANT ECOL, V14, P97, DOI 10.1016/j.ppees.2011.11.001; Geldmann J, 2014, CONSERV BIOL, V28, P1604, DOI 10.1111/cobi.12332; Gourlet-Fleury S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0302; Gourlet-Fleury S, 2011, J ECOL, V99, P981, DOI 10.1111/j.1365-2745.2011.01829.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hijmans R.J., 2017, RASTER GEOGRAPHIC DA; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hubau W, 2020, NATURE, V579, P80, DOI 10.1038/s41586-020-2035-0; James R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0298; Janssens SB, 2020, BIODIVERS DATA J, V8, DOI 10.3897/BDJ.8.e39677; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Lachenaud O, 2013, PLANT ECOL EVOL, V146, P68, DOI 10.5091/plecevo.2013.744; Lafarge T, 2017, ALPHASHAPE3D IMPLEME; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Letouzey R, 1985, NOTICE CARTE PHYTOGE, V5; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Lloyd CT, 2019, BIG EARTH DATA, V3, P108, DOI 10.1080/20964471.2019.1625151; Maguire KC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2817; Malhi Y, 2013, PHILOS T R SOC B, V368, DOI [10.1098/rstb.2012.0293, 10.1098/rstb.2012.0312]; Marcon E, 2015, J STAT SOFTW, V67, P1; McDowell NG, 2020, SCIENCE, V368, P964, DOI 10.1126/science.aaz9463; Menzel A, 2002, CLIMATIC CHANGE, V54, P379, DOI 10.1023/A:1016125215496; Mitchard ETA, 2014, GLOBAL ECOL BIOGEOGR, V23, P935, DOI 10.1111/geb.12168; Morin-Rivat J, 2017, ELIFE, V6, DOI [10.7554/eLife.20343, 10.7554/elife.20343]; Nachtergaele F., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Symposium 1.2.1 Global soil spatial information systems, P34; Neves DM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-55621-w; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Ouedraogo DY, 2016, J ECOL, V104, P924, DOI 10.1111/1365-2745.12589; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Parmentier I, 2011, J BIOGEOGR, V38, P1164, DOI 10.1111/j.1365-2699.2010.02467.x; Parry ML, 2007, CLIMATE CHANGE 2007; Philippon N, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf5d8; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; Ploton P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18321-y; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Putz FE, 2012, CONSERV LETT, V5, P296, DOI 10.1111/j.1755-263X.2012.00242.x; R Development Core Team, 2009, R LANG ENV STAT COMP; Rejou-Mechain M, 2008, J TROP ECOL, V24, P663, DOI 10.1017/S0266467408005506; Rejou-Mechain M, 2014, GLOBAL ECOL BIOGEOGR, V23, P1440, DOI 10.1111/geb.12222; Rejou-Mechain M, 2011, FOREST ECOL MANAG, V261, P187, DOI 10.1016/j.foreco.2010.10.003; Renard D., 2014, RGEOSTATS MANUAL; Ricklefs RE, 2015, ECOL LETT, V18, P497, DOI 10.1111/ele.12431; Ruger N, 2020, SCIENCE, V368, P165, DOI 10.1126/science.aaz4797; SABATIER R, 1989, MULTIWAY DATA ANAL, P341; Schamp BS, 2009, OIKOS, V118, P564, DOI 10.1111/j.1600-0706.2009.16589.x; Scrucca L, 2016, R J, V8, P289; Shipley B, 2010, PLANT TRAITS VEGETAT; Slik JWF, 2011, P NATL ACAD SCI USA, V108, P12343, DOI 10.1073/pnas.1103353108; Sosef MSM, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0356-8; Stevart T, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9444; Sullivan MJP, 2020, SCIENCE, V368, P869, DOI 10.1126/science.aaw7578; TENENHAUS M., 1998, REGRESSION PLS THEOR; TER BRAAK CJF, 1987, VEGETATIO, V69, P69, DOI 10.1007/BF00038688; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; United Nations Department of Economic and Social Affairs Population Division, 2017, ESAPWP248 UN DEP EC; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Visconti P, 2010, CONSERV LETT, V3, P404, DOI 10.1111/j.1755-263X.2010.00130.x; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woolmer G, 2008, LANDSCAPE URBAN PLAN, V87, P42, DOI 10.1016/j.landurbplan.2008.04.005; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zhou LM, 2014, NATURE, V509, P86, DOI 10.1038/nature13265	99	19	19	11	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					90	+		10.1038/s41586-021-03483-6	http://dx.doi.org/10.1038/s41586-021-03483-6		APR 2021	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RY0YD	33883743	Green Submitted			2022-12-28	WOS:000642083200004
J	Soop, M				Soop, Mattias			Extending infusion set replacement intervals to preserve resources and reduce waste	LANCET			English	Editorial Material							BLOOD-STREAM INFECTIONS; GUIDELINES		[Soop, Mattias] Danderyd Hosp, Karolinska Inst, Ersta Hosp, Dept Surg, Stockholm, Sweden	Danderyds Hospital; Ersta Sjukhus; Karolinska Institutet	Soop, M (corresponding author), Danderyd Hosp, Karolinska Inst, Ersta Hosp, Dept Surg, Stockholm, Sweden.	mattias.soop@ki.se	Soop, Mattias/AAQ-3417-2021	Soop, Mattias/0000-0003-4287-6978				Blot F, 1999, LANCET, V354, P1071, DOI 10.1016/S0140-6736(98)11134-0; Rosenthal VD, 2020, AM J INFECT CONTROL, V48, P281, DOI 10.1016/j.ajic.2019.08.015; ECDC, 2017, HEALTHCARE ASSOCIATE; Flemming HC, 2016, NAT REV MICROBIOL, V14, P563, DOI 10.1038/nrmicro.2016.94; Gorski L, 2021, J INFUS NURS; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Maki DG, 2006, MAYO CLIN PROC, V81, P1159, DOI 10.4065/81.9.1159; Nuckols TK, 2016, JAMA INTERN MED, V176, P1843, DOI 10.1001/jamainternmed.2016.6610; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Rickard CM, 2021, LANCET; Ullman AJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003588.pub3; World Health Organization (WHO), 2018, HLTH CARE WASTE	13	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1420	1421						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33865481				2022-12-28	WOS:000640378100002
J	Qaseem, A; Etxeandia-Ikobaltzeta, I; Fitterman, N; Williams, JW; Kansagara, D				Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar; Fitterman, Nick; Williams, John W., Jr.; Kansagara, Devan			Appropriate Use of High-Flow Nasal Oxygen in Hospitalized Patients for Initial or Postextubation Management of Acute Respiratory Failure: A Clinical Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; NONINVASIVE VENTILATION; CANNULA OXYGEN; EMERGENCY-DEPARTMENT; THERAPY; EXTUBATION; EXACERBATIONS; DYSPNEA	Description: The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of high-flow nasal oxygen (HFNO) in hospitalized patients for initial or postextubation management of acute respiratory failure. It is based on the best available evidence on the benefits and harms of HFNO, taken in the context of costs and patient values and preferences. Methods: The ACP Clinical Guidelines Committee based these recommendations on a systematic review on the efficacy and safety of HFNO. The patient-centered health outcomes evaluated included all-cause mortality, hospital length of stay, 30-day hospital readmissions, hospital-acquired pneumonia, days of intubation or reintubation, intensive care unit (ICU) admission and ICU transfers, patient comfort, dyspnea, delirium, barotrauma, compromised nutrition, gastric dysfunction, functional independence at discharge, discharge disposition, and skin breakdown. This guideline was developed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method. Target Audience and Patient Population: The target audience is all clinicians, and the target patient population is adult patients with acute respiratory failure treated in a hospital setting (including emergency departments, hospital wards, intermediate or step-down units, and ICUs). Recommendation 1a: ACP suggests that clinicians use high-flow nasal oxygen rather than noninvasive ventilation in hospitalized adults for the management of acute hypoxemic respiratory failure (conditional recommendation; low-certainty evidence). Recommendation 1b: ACP suggests that clinicians use highflow nasal oxygen rather than conventional oxygen therapy for hospitalized adults with postextubation acute hypoxemic respiratory failure (conditional recommendation; low-certainty evidence).	[Qaseem, Amir; Etxeandia-Ikobaltzeta, Itziar] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Fitterman, Nick] Northwell Hlth, 270 Pk Ave, Huntington, WV 11743 USA; [Williams, John W., Jr.] Duke Univ, Durham Vet Affairs Med Ctr, Sch Med, 200 Morris St,3rd Floor, Durham, NC 27701 USA; [Kansagara, Devan] Portland VA Med Ctr, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Etxeandia-Ikobaltzeta, Itziar] 1 Santa Margarita Hosp St,Ground Floor 2,Off 1, Irun 20303, Gipuzkoa, Spain	American College of Physicians; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org	ETXEANDIA-IKOBALTZETA, ITZIAR/AAG-3519-2022; ETXEANDIA-IKOBALTZETA, ITZIAR/AFK-4845-2022; Williams, Jr., John/A-3696-2008	ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; ETXEANDIA-IKOBALTZETA, ITZIAR/0000-0001-6606-649X; Williams, Jr., John/0000-0002-5267-5558; Qaseem, Amir/0000-0001-6866-7985	ACP	ACP	Financial support for the development of this guideline comes exclusively fromthe ACP operating budget.	Azoulay E, 2018, JAMA-J AM MED ASSOC, V320, P2099, DOI 10.1001/jama.2018.14282; Baldomero AK, 2021, ANN INTERN MED, V174, P952, DOI 10.7326/M20-4675; Bell N, 2015, EMERG MED AUSTRALAS, V27, P537, DOI 10.1111/1742-6723.12490; Cho JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e194; Cong L, 2019, INT J CLIN EXP MED, V12, P10863; Corley A, 2015, INTENS CARE MED, V41, P887, DOI 10.1007/s00134-015-3765-6; Cuquemelle E, 2012, RESP CARE, V57, P1571, DOI 10.4187/respcare.01681; Delorme M, 2017, CRIT CARE MED, V45, P1981, DOI 10.1097/CCM.0000000000002693; Doshi P, 2018, ANN EMERG MED, V72, P73, DOI 10.1016/j.annemergmed.2017.12.006; Ferreyro BL, 2020, JAMA-J AM MED ASSOC, V324, P57, DOI 10.1001/jama.2020.9524; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; GRADEpro GDT, 2015, GRADEPRO GUID DEV TO; Grieco DL, 2020, AM J RESP CRIT CARE, V201, P303, DOI 10.1164/rccm.201904-0841OC; Hernandez G, 2016, JAMA-J AM MED ASSOC, V316, P1565, DOI 10.1001/jama.2016.14194; Hernandez G, 2016, JAMA-J AM MED ASSOC, V315, P1354, DOI 10.1001/jama.2016.2711; Jackson T, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000730; Jing GQ, 2019, RES NURS HEALTH, V42, P217, DOI 10.1002/nur.21942; Jones PG, 2016, RESP CARE, V61, P291, DOI 10.4187/respcare.04252; Lemiale V, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1097-0; Maggiore SM, 2014, AM J RESP CRIT CARE, V190, P282, DOI 10.1164/rccm.201402-0364OC; Makdee O, 2017, ANN EMERG MED, V70, P465, DOI 10.1016/j.annemergmed.2017.03.028; Matsuda W, 2020, RESP CARE, V65, P610, DOI 10.4187/respcare.07095; Moller W, 2017, J APPL PHYSIOL, V122, P191, DOI 10.1152/japplphysiol.00584.2016; Nishimura M, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0084-5; Papazian L, 2016, INTENS CARE MED, V42, P1336, DOI 10.1007/s00134-016-4277-8; Parke RL, 2013, RESP CARE, V58, P1621, DOI 10.4187/respcare.02358; Parke RL, 2011, RESP CARE, V56, P265, DOI 10.4187/respcare.00801; Pilcher J, 2017, RESPIROLOGY, V22, P1149, DOI 10.1111/resp.13050; Qaseem A, 2019, ANN INTERN MED, V171, P354, DOI 10.7326/M18-3279; Qaseem A, 2019, ANN INTERN MED, V170, P863, DOI 10.7326/M18-3290; Rittayamai N, 2015, RESP CARE, V60, P1377, DOI 10.4187/respcare.03837; Rittayamai N, 2014, RESP CARE, V59, P485, DOI 10.4187/respcare.02397; Ruangsomboon O, 2020, ANN EMERG MED, V75, P615, DOI 10.1016/j.annemergmed.2019.09.009; Saksitthichok B, 2019, J THORAC DIS, V11, P1929, DOI 10.21037/jtd.2019.05.02; Santesso N, 2020, J CLIN EPIDEMIOL, V119, P126, DOI 10.1016/j.jclinepi.2019.10.014; Schunemann H, GRADE HDB; Schwabbauer N, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-66; Sklar MC, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0432-4; Song HZ, 2017, CLINICS, V72, P562, DOI 10.6061/clinics/2017(09)07; Spoletini G, 2018, J CRIT CARE, V48, P418, DOI 10.1016/j.jcrc.2018.10.004; Stephan F, 2015, JAMA-J AM MED ASSOC, V313, P2331, DOI 10.1001/jama.2015.5213; Vargas F, 2015, RESP CARE, V60, P1369, DOI 10.4187/respcare.03814; Vourc'h M, 2020, J CARDIOTHOR VASC AN, V34, P157, DOI 10.1053/j.jvca.2019.05.039	43	7	7	4	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					977	+		10.7326/M20-7533	http://dx.doi.org/10.7326/M20-7533			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33900796				2022-12-28	WOS:000675809000024
J	Yoshino, M; Yoshino, J; Kayser, BD; Patti, GJ; Franczyk, MP; Mills, KF; Sindelar, M; Pietka, T; Patterson, BW; Imai, SI; Klein, S				Yoshino, Mihoko; Yoshino, Jun; Kayser, Brandon D.; Patti, Gary J.; Franczyk, Michael P.; Mills, Kathryn F.; Sindelar, Miriam; Pietka, Terri; Patterson, Bruce W.; Imai, Shin-Ichiro; Klein, Samuel			Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women	SCIENCE			English	Article							INDUCED AKT PHOSPHORYLATION; NAD(+) BIOSYNTHESIS; HOMEOSTASIS; METABOLISM; RESISTANCE; CELLS; BIOLOGY; NMN	In rodents, obesity and aging impair nicotinamide adenine dinucleotide (NAD+) biosynthesis, which contributes to metabolic dysfunction. Nicotinamide mononucleotide (NMN) availability is a rate-limiting factor in mammalian NAD+ biosynthesis. We conducted a 10-week, randomized, placebo-controlled, double-blind trial to evaluate the effect of NMN supplementation on metabolic function in postmenopausal women with prediabetes who were overweight or obese. Insulin-stimulated glucose disposal, assessed by using the hyperinsulinemic-euglycemic clamp, and skeletal muscle insulin signaling [phosphorylation of protein kinase AKT and mechanistic target of rapamycin (mTOR)] increased after NMN supplementation but did not change after placebo treatment. NMN supplementation up-regulated the expression of platelet-derived growth factor receptor beta and other genes related to muscle remodeling. These results demonstrate that NMN increases muscle insulin sensitivity, insulin signaling, and remodeling in women with prediabetes who are overweight or obese (clinicaltrial.gov NCT 03151239).	[Yoshino, Mihoko; Yoshino, Jun; Kayser, Brandon D.; Franczyk, Michael P.; Pietka, Terri; Patterson, Bruce W.; Klein, Samuel] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Patti, Gary J.; Sindelar, Miriam] Washington Univ, Dept Chem, Sch Med, St Louis, MO USA; [Mills, Kathryn F.; Imai, Shin-Ichiro] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Klein, S (corresponding author), Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA.	sklein@wustl.edu		Patterson, Bruce W/0000-0001-9261-0233; Yoshino, Mihoko/0000-0003-4123-7699; Yoshino, Jun/0000-0001-9833-4356; Sindelar, Miriam/0000-0002-1700-6551; Franczyk, Michael/0000-0002-3729-6365	NIH [DK56341, DK104995, AG037457, AG047902]; UC San Diego IGM Genomics Center; NIH SIG [S10 OD026929]; Tanaka Fund; Foundation for Barnes-Jewish Hospital	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC San Diego IGM Genomics Center; NIH SIG; Tanaka Fund; Foundation for Barnes-Jewish Hospital	This study was supported by NIH grants DK56341, DK104995, AG037457, and AG047902; the UC San Diego IGM Genomics Center, which has an Illumina NovaSeq 6000 that was purchased with funding from a NIH SIG grant (#S10 OD026929); the Tanaka Fund; and the Foundation for Barnes-Jewish Hospital.	Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Conte C, 2012, DIABETES CARE, V35, P1316, DOI 10.2337/dc11-1951; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dollerup OL, 2018, AM J CLIN NUTR, V108, P343, DOI 10.1093/ajcn/nqy132; Elhassan YS, 2019, CELL REP, V28, P1717, DOI 10.1016/j.celrep.2019.07.043; Fabbrini E, 2012, J LIPID RES, V53, P321, DOI 10.1194/jlr.D020321; Frederick DW, 2016, CELL METAB, V24, P269, DOI 10.1016/j.cmet.2016.07.005; Gelman SJ, 2018, CELL REP, V22, P512, DOI 10.1016/j.celrep.2017.12.050; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Irie J, 2020, ENDOCR J, V67, P153, DOI 10.1507/endocrj.EJ19-0313; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Magkos F, 2016, CELL METAB, V23, P591, DOI 10.1016/j.cmet.2016.02.005; McReynolds MR, 2020, EXP GERONTOL, V134, DOI 10.1016/j.exger.2020.110888; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Naser FJ, 2018, ANAL BIOANAL CHEM, V410, P1287, DOI 10.1007/s00216-017-0768-x; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Rauch BH, 2000, FEBS LETT, V481, P3, DOI 10.1016/S0014-5793(00)01957-8; Razmara M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-3; Remie CME, 2020, AM J CLIN NUTR, V112, P413, DOI 10.1093/ajcn/nqaa072; Smith GI, 2020, J CLIN INVEST, V130, P3305, DOI 10.1172/JCI136756; Smith GI, 2020, J CLIN INVEST, V130, P1453, DOI 10.1172/JCI134165; Stromsdorfer KL, 2016, CELL REP, V16, P1851, DOI 10.1016/j.celrep.2016.07.027; Uddin GM, 2016, FRONT PHARMACOL, V7, DOI [10.3389/fphar.2016.00258, 10.13389/fphar.2016.00258]; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Yamaguchi S, 2019, P NATL ACAD SCI USA, V116, P23822, DOI 10.1073/pnas.1909917116; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yoshino J, 2013, METHODS MOL BIOL, V1077, P203, DOI 10.1007/978-1-62703-637-5_14; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	34	81	83	34	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2021	372	6547					1224	+		10.1126/science.abe9985	http://dx.doi.org/10.1126/science.abe9985			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SS9QN	33888596	Bronze, Green Accepted			2022-12-28	WOS:000662088000032
J	Lai, KY; Galan, SRG; Zeng, YB; Zhou, TH; He, C; Raj, R; Riedl, J; Liu, S; Chooi, KP; Garg, N; Zeng, M; Jones, LH; Hutchings, GJ; Mohammed, S; Nair, SK; Chen, J; Davis, BG; van der Donk, WA				Lai, Kuan-Yu; Galan, Sebastien R. G.; Zeng, Yibo; Zhou, Tianhui Hina; He, Chang; Raj, Ritu; Riedl, Jitka; Liu, Shi; Chooi, K. Phin; Garg, Neha; Zeng, Min; Jones, Lyn H.; Hutchings, Graham J.; Mohammed, Shabaz; Nair, Satish K.; Chen, Jie; Davis, Benjamin G.; van der Donk, Wilfred A.			LanCLs add glutathione to dehydroamino acids generated at phosphorylated sites in the proteome	CELL			English	Article							SECRETION SYSTEM EFFECTORS; TISSUE-SPECIFIC EXPRESSION; HIGH CATALYTIC EFFICIENCY; C-LIKE PROTEIN-1; CRYSTAL-STRUCTURES; TRANSFERASE A4-4; LANTHIONINE; DEHYDROALANINE; IDENTIFICATION; BIOSYNTHESIS	Enzyme-mediated damage repair or mitigation, while common for nucleic acids, is rare for proteins. Examples of protein damage are elimination of phosphorylated Ser/Thr to dehydroalanine/dehydrobutyrine (Dha/Dhb) in pathogenesis and aging. Bacterial LanC enzymes use Dha/Dhb to form carbon-sulfur linkages in antimicrobial peptides, but the functions of eukaryotic LanC-like (LanCL) counterparts are unknown. We show that LanCLs catalyze the addition of glutathione to Dha/Dhb in proteins, driving irreversible C-glutathionylation. Chemo-enzymatic methods were developed to site-selectively incorporate Dha/Dhb at phospho-regulated sites in kinases. In human MAPK-MEK1, such "elimination damage'' generated aberrantly activated kinases, which were deactivated by LanCL-mediated C-glutathionylation. Surveys of endogenous proteins bearing damage from elimination (the eliminylome) also suggest it is a source of electrophilic reactivity. LanCLs thus remove these reactive electrophiles and their potentially dysregulatory effects from the proteome. As knockout of LanCL in mice can result in premature death, repair of this kind of protein damage appears important physiologically.	[Lai, Kuan-Yu; Zhou, Tianhui Hina; Garg, Neha; Nair, Satish K.; van der Donk, Wilfred A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Galan, Sebastien R. G.; Zeng, Yibo; Raj, Ritu; Riedl, Jitka; Chooi, K. Phin; Mohammed, Shabaz; Davis, Benjamin G.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [He, Chang; Liu, Shi; van der Donk, Wilfred A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [He, Chang; Liu, Shi; van der Donk, Wilfred A.] Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA; [Jones, Lyn H.] Dana Farber Canc Inst, 360 Longwood Ave, Boston, MA 02115 USA; [Zeng, Min; Chen, Jie] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Zeng, Yibo; Hutchings, Graham J.] Rutherford Appleton Lab, UK Catalysis Hub, Res Complex & Harwell, Oxford OX11 0FA, Berks, England; [Hutchings, Graham J.] Cardiff Univ, Sch Chem, Cardiff Catalysis Inst, Cardiff CF10 3AT, Wales; [Zeng, Yibo; Mohammed, Shabaz; Davis, Benjamin G.] Rosalind Franklin Inst, Didcot OX11 0FA, Oxon, England; [Lai, Kuan-Yu] Cytiva, 2780 N 200 W, North Logan, UT 84341 USA; [Galan, Sebastien R. G.] Evotec UK, 114 Innovat Dr,Milton Pk, Abingdon OX14 4RZ, Oxon, England; [He, Chang] 10770 Wateridge Cir Unit 120, San Diego, CA 92121 USA; [Riedl, Jitka; Chooi, K. Phin] QMB Innovat Ctr, AstraZeneca Grp, Spirogen, 42 New Rd, London E1 2AX, England; [Garg, Neha] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Zeng, Min] Facebook, 1 Hacker Way, Menlo Pk, CA 94025 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Oxford; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Dana-Farber Cancer Institute; University of Illinois System; University of Illinois Urbana-Champaign; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Cardiff University; Evotec; University System of Georgia; Georgia Institute of Technology; Facebook Inc	van der Donk, WA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Davis, BG (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.; van der Donk, WA (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.; van der Donk, WA (corresponding author), Univ Illinois, Howard Hughes Med Inst, Urbana, IL 61801 USA.; Chen, J (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA.; Davis, BG (corresponding author), Rosalind Franklin Inst, Didcot OX11 0FA, Oxon, England.	jiechen@life.illinois.edu; ben.davis@chem.ox.ac.uk; vddonk@illinois.edu	Nair, Satish/AAY-2510-2021; Davis, Benjamin G/C-5281-2011; Garg, Neha/L-3120-2018	Davis, Benjamin G/0000-0002-5056-407X; Garg, Neha/0000-0002-2760-7123; Liu, Shi/0000-0002-9113-6207; Galan, Sebastien/0000-0002-6241-0238; Zeng, Yibo/0000-0001-7760-4329; Jones, Lyn/0000-0002-8388-5865; Chen, Jie/0000-0002-7887-3747	Howard Hughes Medical Institute; NIH [GM089771, GM 079038]; BBSRC; AstraZeneca; EPSRC UK Catalysis Hub [EP/R026815/1, EP/R026939/1]; EU Horizon 2020 Programme under the Marie Sklodowska-Curie program [700124]; Felix Foundation; EPSRC; Pfizer; National Institutes of Health [S10 RR027109]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); EPSRC UK Catalysis Hub(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU Horizon 2020 Programme under the Marie Sklodowska-Curie program; Felix Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Howard Hughes Medical Institute (to W.A.V.), NIH GM089771 (to J.C.), NIH GM 079038 (to S.K.N.), the BBSRC with AstraZeneca (S.R.G.G.), the EPSRC UK Catalysis Hub (EP/R026815/1, EP/R026939/1 Y.Z., G.J.H., and B.G.D.), the EU Horizon 2020 Programme under the Marie Sklodowska-Curie program (700124, J.R.), the Felix Foundation (R.R.), and the EPSRC with Pfizer (K.P.C.). A MALDI TOF mass spectrometer was purchased with a grant from the National Institutes of Health (S10 RR027109 A). We thank Dr. Ian R. Bothwell and Dr. Alex V. Ulanov (Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign) for assistance with GC-MS, Elisabete Pires for assistance with MS/MS analysis, Dr. Shih-Hsuan Hsiao (Veterinary Medicine, UIUC) for histopathology of deceased TKO mice, and Drs. J. Read and G. Pairaudeau (AstraZeneca) for useful discussions.	ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Bauer H, 2000, BIOCHEM BIOPH RES CO, V275, P69, DOI 10.1006/bbrc.2000.3260; Bose AK, 2013, MOL CELL PROTEOMICS, V12, P797, DOI 10.1074/mcp.O112.024059; Brennan DF, 2009, TRENDS BIOCHEM SCI, V34, P108, DOI 10.1016/j.tibs.2008.11.005; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Chalker JM, 2011, CHEM SCI, V2, P1666, DOI 10.1039/c1sc00185j; Chambers KA, 2018, BIOCHEMISTRY-US, V57, P3790, DOI 10.1021/acs.biochem.8b00534; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Chung CHY, 2007, BIOCHEMISTRY-US, V46, P3262, DOI 10.1021/bi061888s; Cooper AJL, 2011, EXPERT OPIN DRUG MET, V7, P891, DOI 10.1517/17425255.2011.577738; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dai P, 2016, ACS CENTRAL SCI, V2, P637, DOI 10.1021/acscentsci.6b00180; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dong SH, 2015, ELIFE, V4, DOI 10.7554/eLife.07607; Duan Y, 2019, NATURE, V575, P505, DOI 10.1038/s41586-019-1742-x; Eley GD, 2002, NEURO-ONCOLOGY, V4, P86, DOI 10.1093/neuonc/4.2.86; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Friedman M, 1999, J AGR FOOD CHEM, V47, P1295, DOI 10.1021/jf981000+; Geiger T, 2013, MOL CELL PROTEOMICS, V12, P1709, DOI 10.1074/mcp.M112.024919; Gopalbhai K, 2003, J BIOL CHEM, V278, P8118, DOI 10.1074/jbc.M211870200; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; He C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40980; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Huang C, 2014, DEV CELL, V30, P479, DOI 10.1016/j.devcel.2014.06.011; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Kawaji H, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.113; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Lamoureaux TL, 2011, CHEM COMMUN, V47, P8623, DOI 10.1039/c1cc11745a; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li B, 2007, J BIOL CHEM, V282, P21169, DOI 10.1074/jbc.M701802200; Li B, 2010, P NATL ACAD SCI USA, V107, P10430, DOI 10.1073/pnas.0913677107; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Linetsky M, 2005, MOL CELL BIOCHEM, V272, P133, DOI 10.1007/s11010-005-6908-1; Linetsky M, 2004, EXP EYE RES, V79, P499, DOI 10.1016/j.exer.2004.06.026; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Liu W, 2011, J AM CHEM SOC, V133, P14216, DOI 10.1021/ja206017p; Ma S, 2003, J AM SOC MASS SPECTR, V14, P593, DOI 10.1016/S1044-0305(03)00141-7; Mayer H, 1998, BBA-GENE STRUCT EXPR, V1395, P301, DOI 10.1016/S0167-4781(97)00178-4; Mayer H, 2001, DNA SEQUENCE, V12, P161, DOI 10.3109/10425170109080770; Mayer H, 2001, GENE, V269, P73, DOI 10.1016/S0378-1119(01)00463-2; MCFADDEN PN, 1987, P NATL ACAD SCI USA, V84, P2595, DOI 10.1073/pnas.84.9.2595; Medard G, 2015, J PROTEOME RES, V14, P1574, DOI 10.1021/pr5012608; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mladkova J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-449; Morrison PM, 2015, CHEM COMMUN, V51, P13470, DOI 10.1039/c5cc05469a; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Repka LM, 2017, CHEM REV, V117, P5457, DOI 10.1021/acs.chemrev.6b00591; Rhee SG, 2010, METHOD ENZYMOL, V474, P23, DOI 10.1016/S0076-6879(10)74002-7; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Schmutz C, 2013, MOL CELL PROTEOMICS, V12, P2952, DOI 10.1074/mcp.M113.029918; Tang WX, 2019, J IND MICROBIOL BIOT, V46, P537, DOI 10.1007/s10295-018-2110-9; Tang WX, 2013, NAT CHEM BIOL, V9, P157, DOI [10.1038/NCHEMBIO.1162, 10.1038/nchembio.1162]; Tang WX, 2012, BIOCHEMISTRY-US, V51, P4271, DOI 10.1021/bi300255s; Thibodeaux CJ, 2014, J AM CHEM SOC, V136, P17513, DOI 10.1021/ja5089452; van Kasteren SI, 2007, NATURE, V446, P1105, DOI 10.1038/nature05757; Veuthey AL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-104; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang SK, 2011, FREE RADICAL BIO MED, V51, P197, DOI 10.1016/j.freeradbiomed.2011.03.018; Wang Z, 2014, AGING CELL, V13, P226, DOI 10.1111/acel.12164; Willwacher J, 2016, J AM CHEM SOC, V138, P8678, DOI 10.1021/jacs.6b04043; Wu BJ, 2012, TRENDS PHARMACOL SCI, V33, P656, DOI 10.1016/j.tips.2012.09.007; Xu BE, 1999, J BIOL CHEM, V274, P34029, DOI 10.1074/jbc.274.48.34029; Yang J, 2016, MOL CELL PROTEOMICS, V15, P1, DOI 10.1074/mcp.O115.056051; Yang X, 2018, NAT CHEM BIOL, V14, P375, DOI 10.1038/s41589-018-0008-5; Yang X, 2015, ACS CHEM BIOL, V10, P1234, DOI 10.1021/acschembio.5b00007; Zeng M, 2014, MOL BIOL CELL, V25, P3954, DOI 10.1091/mbc.E14-01-0004; Zhang WC, 2009, GENE DEV, V23, P1387, DOI 10.1101/gad.1789209; Zhao KX, 2014, EMBO REP, V15, P792, DOI 10.1002/embr.201338213; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x; Zhu YQ, 2007, MOL CELL, V28, P899, DOI 10.1016/j.molcel.2007.11.011; Zurawski DV, 2006, INFECT IMMUN, V74, P5964, DOI 10.1128/IAI.00594-06; Zurawski DV, 2009, MOL MICROBIOL, V71, P350, DOI 10.1111/j.1365-2958.2008.06524.x	81	7	7	12	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2680	+		10.1016/j.cell.2021.04.001	http://dx.doi.org/10.1016/j.cell.2021.04.001		MAY 2021	42	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33932340	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000652830800013
J	Tay, A				Tay, Andy			STAND OUT WITH A GREAT PERSONAL STATEMENT	NATURE			English	Editorial Material																			0	0	0	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					153	155		10.1038/d41586-021-01101-z	http://dx.doi.org/10.1038/d41586-021-01101-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RZ1BQ	33893464				2022-12-28	WOS:000648334100009
J	Voelker, R				Voelker, Rebecca			Electrical Stimulator Can Improve MS-Related Walking Problems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1713	1713		10.1001/jama.2021.6402	http://dx.doi.org/10.1001/jama.2021.6402			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944886				2022-12-28	WOS:000647831200006
J	Nogue, S; Santos, AMC; Birks, HJB; Bjorck, S; Castilla-Beltran, A; Connor, S; de Boer, EJ; de Nascimento, L; Felde, VA; Fernandez-Palacios, JM; Froyd, CA; Haberle, SG; Hooghiemstra, H; Ljung, K; Norder, SJ; Penuelas, J; Prebble, M; Stevenson, J; Whittaker, RJ; Willis, KJ; Wilmshurst, JM; Steinbauer, MJ				Nogue, Sandra; Santos, Ana M. C.; Birks, H. John B.; Bjorck, Svante; Castilla-Beltran, Alvaro; Connor, Simon; de Boer, Erik J.; de Nascimento, Lea; Felde, Vivian A.; Maria Fernandez-Palacios, Jose; Froyd, Cynthia A.; Haberle, Simon G.; Hooghiemstra, Henry; Ljung, Karl; Norder, Sietze J.; Penuelas, Josep; Prebble, Matthew; Stevenson, Janelle; Whittaker, Robert J.; Willis, Kathy J.; Wilmshurst, Janet M.; Steinbauer, Manuel J.			The human dimension of biodiversity changes on islands	SCIENCE			English	Article							ENVIRONMENTAL-CHANGE; VEGETATION DYNAMICS; HUMAN IMPACT; HUMAN COLONIZATION; GALAPAGOS-ISLANDS; GLOBAL PATTERNS; SOUTH ATLANTIC; POLLEN RECORD; NEW-ZEALAND; 3 FLAWS	Islands are among the last regions on Earth settled and transformed by human activities, and they provide replicated model systems for analysis of how people affect ecological functions. By analyzing 27 representative fossil pollen sequences encompassing the past 5000 years from islands globally, we quantified the rates of vegetation compositional change before and after human arrival. After human arrival, rates of turnover accelerate by a median factor of 11, with faster rates on islands colonized in the past 1500 years than for those colonized earlier. This global anthropogenic acceleration in turnover suggests that islands are on trajectories of continuing change. Strategies for biodiversity conservation and ecosystem restoration must acknowledge the long duration of human impacts and the degree to which ecological changes today differ from prehuman dynamics.	[Nogue, Sandra; Castilla-Beltran, Alvaro] Univ Southampton, Sch Geog & Environm Sci, Southampton SO17 1BJ, Hants, England; [Santos, Ana M. C.] Univ Lisbon, Ctr Ecol Evolut & Environm Changes cE3c, Fac Ciencias, P-1749016 Lisbon, Portugal; [Santos, Ana M. C.] Azores Biodivers Grp, P-9700042 Angra Do Heroismo, Azores, Portugal; [Santos, Ana M. C.] Univ Acores, P-9700042 Angra Do Heroismo, Azores, Portugal; [Santos, Ana M. C.] Univ Alcala, Dept Life Sci, Global Change Ecol & Evolut Grp GloCEE, Madrid 28805, Spain; [Santos, Ana M. C.] Univ Autonoma Madrid, Dept Ecol, Terr Ecol Grp TEG UAM, Madrid 28049, Spain; [Santos, Ana M. C.] Univ Autonoma Madrid, Ctr Invest Biodiversidad & Cambio Global CIBC UAM, Madrid 28049, Spain; [Birks, H. John B.; Felde, Vivian A.; Steinbauer, Manuel J.] Univ Bergen, Dept Biol Sci, N-5020 Bergen, Norway; [Birks, H. John B.; Felde, Vivian A.] Univ Bergen, Bjerknes Ctr Climate Res, N-5020 Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London WC1E 6BT, England; [Bjorck, Svante; Ljung, Karl] Lund Univ, Dept Geol, SE-22362 Lund, Sweden; [Connor, Simon; Haberle, Simon G.; Prebble, Matthew; Stevenson, Janelle] Australian Natl Univ, Coll Asia & Pacific, Sch Culture Hist & Language, Canberra, ACT 2601, Australia; [Connor, Simon; Haberle, Simon G.; Stevenson, Janelle] Australian Natl Univ, Australian Res Ctr ARC Ctr Excellence Australian, Canberra, ACT 2601, Australia; [de Boer, Erik J.] Univ Barcelona, Fac Ciencies Terra, Dept Estratig Paleontol & Geociencies Marines, Marti i Franques S-N, Barcelona 08028, Spain; [de Nascimento, Lea; Maria Fernandez-Palacios, Jose] Univ La Laguna ULL, Inst Univ Enfermedades Trop & Salud Publ Canarias, Isl Ecol & Biogeog Grp, San Cristobal la Laguna 38200, Canary Islands, Spain; [de Nascimento, Lea; Wilmshurst, Janet M.] Manaaki Whenua Landcare Res, Long Term Ecol Lab, Lincoln 7640, New Zealand; [Froyd, Cynthia A.] Swansea Univ, Dept Biosci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales; [Hooghiemstra, Henry] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam IBED, Dept Ecosyst & Landscape Dynam, NL-1098 XH Amsterdam, Netherlands; [Norder, Sietze J.] Leiden Univ, Ctr Linguist, NL-2300 RA Leiden, Netherlands; [Penuelas, Josep] CSIC, Global Ecol Unit CREAF CSIC UAB, Barcelona 08193, Catalonia, Spain; [Penuelas, Josep] CREAF, Barcelona 08193, Catalonia, Spain; [Prebble, Matthew] Univ Canterbury, Coll Sci, Sch Earth & Environm, Christchurch 8140, New Zealand; [Whittaker, Robert J.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Whittaker, Robert J.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, GLOBE Inst, DK-2100 Copenhagen, Denmark; [Willis, Kathy J.] Univ Oxford, Dept Zool, Oxford Long Term Ecol Lab, Oxford OX1 3PS, England; [Wilmshurst, Janet M.] Univ Auckland, Sch Environm, Auckland 1142, New Zealand; [Steinbauer, Manuel J.] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, D-95447 Bayreuth, Germany; [Steinbauer, Manuel J.] Univ Bayreuth, Dept Sport Sci, D-95447 Bayreuth, Germany	University of Southampton; Universidade de Lisboa; Universidade dos Acores; Universidad de Alcala; Autonomous University of Madrid; Autonomous University of Madrid; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; University of London; University College London; Lund University; Australian National University; Australian National University; University of Barcelona; Universidad de la Laguna; Landcare Research - New Zealand; Swansea University; University of Amsterdam; Leiden University; Leiden University - Excl LUMC; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); University of Canterbury; University of Oxford; University of Copenhagen; University of Oxford; University of Auckland; University of Bayreuth; University of Bayreuth	Nogue, S (corresponding author), Univ Southampton, Sch Geog & Environm Sci, Southampton SO17 1BJ, Hants, England.; Steinbauer, MJ (corresponding author), Univ Bergen, Dept Biol Sci, N-5020 Bergen, Norway.; Steinbauer, MJ (corresponding author), Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, D-95447 Bayreuth, Germany.; Steinbauer, MJ (corresponding author), Univ Bayreuth, Dept Sport Sci, D-95447 Bayreuth, Germany.	s.nogue-bosch@soton.ac.uk; steinbauer@uni-bayreuth.de	Santos, Ana/E-7598-2010; Penuelas, Josep/D-9704-2011; de Nascimento, Lea/ABC-6723-2021; santos, ana/GWV-5678-2022; Castilla-Beltrán, Alvaro/AAS-6169-2021; Fernandez-Palacios, Jose Maria/H-2054-2015; de Nascimento, Lea/F-7349-2012; Birks, H. John B./C-3103-2008; de Boer, Erik/O-3385-2015	Santos, Ana/0000-0002-9197-792X; Penuelas, Josep/0000-0002-7215-0150; Castilla-Beltrán, Alvaro/0000-0002-0540-9062; Fernandez-Palacios, Jose Maria/0000-0001-9741-6878; Bjorck, Svante/0000-0001-8824-9000; Steinbauer, Manuel/0000-0002-7142-9272; de Nascimento, Lea/0000-0003-1085-2605; Connor, Simon/0000-0001-5685-2390; Prebble, Matthew/0000-0001-8577-7190; Birks, H. John B./0000-0002-5891-9859; Stevenson, Janelle/0000-0001-9640-7275; de Boer, Erik/0000-0002-7157-9860	Juan de la Cierva Fellowship - Spanish Ministerio de Ciencia, Innovacion y Universidades [IJCI-2014-19502]; Portuguese Fundacao para a Ciencia e a Tecnologia [CEEIND/03425/2017]; European Research Council under the EU H2020 research and innovation program Humans on Planet Earth-LongTerm Impacts on Biosphere Dynamics (HOPE grant) [741413]; European Research Council [ERC-SyG-2013610028 IMBALANCE-P]; European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant) [700952]; Deutsche Forschungsgemeinschaft [STE 2360/2-1, FOR 2332]; Swedish Research Council (VR); Worldwide Universities Network (WUN) Research Mobility Programme; European Research Council under the EU H2020 and Research and Innovation program (SAPPHIRE grant) [818854]	Juan de la Cierva Fellowship - Spanish Ministerio de Ciencia, Innovacion y Universidades; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); European Research Council under the EU H2020 research and innovation program Humans on Planet Earth-LongTerm Impacts on Biosphere Dynamics (HOPE grant); European Research Council(European Research Council (ERC)European Commission); European Union's Horizon 2020 research and innovation program (Marie Sklodowska-Curie grant); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council (VR)(Swedish Research Council); Worldwide Universities Network (WUN) Research Mobility Programme; European Research Council under the EU H2020 and Research and Innovation program (SAPPHIRE grant)	A.M.C.S. was supported by a Juan de la Cierva Fellowship (IJCI-2014-19502) funded by the Spanish Ministerio de Ciencia, Innovacion y Universidades and by the Portuguese Fundacao para a Ciencia e a Tecnologia (contract CEEIND/03425/2017). H.J.B.B., V.A.F., and M.J.S. were supported by the European Research Council under the EU H2020 research and innovation program Humans on Planet Earth -LongTerm Impacts on Biosphere Dynamics (HOPE grant 741413). J.P. was supported by European Research Council grant ERC-SyG-2013610028 IMBALANCE-P. L.d.N. was supported by the European Union's Horizon 2020 research and innovation program (Marie SklodowskaCurie grant 700952). M.J.S. was supported by the Deutsche Forschungsgemeinschaft (STE 2360/2-1 embedded in the Research Unit TERSANE FOR 2332). S.B. and K.L. were supported by several grants from the Swedish Research Council (VR). S.N was supported by the Worldwide Universities Network (WUN) Research Mobility Programme and a generous sabbatical granted by the School of Geography and Environmental Science (University of Southampton). S.J.N. was supported by the European Research Council under the EU H2020 and Research and Innovation program (SAPPHIRE grant 818854).	Anderson A., 2002, 50 YEARS FIELD ESSAY, V25, P239; Arnay-De-La-Rosa M, 2009, J ARCHAEOL SCI, V36, P1972, DOI 10.1016/j.jas.2009.05.018; Barnosky AD, 2017, SCIENCE, V355, DOI 10.1126/science.aah4787; Birks H.J.B., 2012, TRACKING ENV CHANGE, P355; Birks HJB, 2019, PLANT ECOL DIVERS, V12, P189, DOI 10.1080/17550874.2019.1646831; Bjorck S, 2006, QUATERNARY SCI REV, V25, P9, DOI 10.1016/j.quascirev.2005.08.008; Blaauw M., 2020, CLAM CLASSICAL AGE D; Braje TJ, 2013, ANTHROPOCENE, V4, P14, DOI 10.1016/j.ancene.2013.08.003; Breheny P, 2017, R J, V9, P56, DOI 10.32614/RJ-2017-046; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Camoin GF, 2004, MAR GEOL, V206, P119, DOI 10.1016/j.margeo.2004.02.003; Rando JC, 2014, QUATERNARY SCI REV, V94, P22, DOI 10.1016/j.quascirev.2014.04.013; Castilla-Beltran A, 2020, BIOL CONSERV, V242, DOI 10.1016/j.biocon.2019.108397; Castilla-Beltran A, 2019, PALAEOGEOGR PALAEOCL, V524, P101, DOI 10.1016/j.palaeo.2019.03.033; Cheke A., 2008, LOST LAND DODO ECOLO; Chiarucci A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05114-5; Clark G., 2009, ANU PRESS TERRA AUST, V31, P63; Cochrane E. E., 2017, OXFORD HDB PREHISTOR, P133; COLINVAUX PA, 1976, J ECOL, V64, P989, DOI 10.2307/2258820; Connor SE, 2012, J BIOGEOGR, V39, P1007, DOI 10.1111/j.1365-2699.2011.02671.x; Cooke SB, 2017, ANNU REV ECOL EVOL S, V48, P301, DOI 10.1146/annurev-ecolsys-110316-022754; Crausbay SD, 2015, J ECOL, V103, P891, DOI 10.1111/1365-2745.12423; de Boer EJ, 2015, HOLOCENE, V25, P758, DOI 10.1177/0959683614567886; de Boer EJ, 2013, QUATERNARY SCI REV, V68, P114, DOI 10.1016/j.quascirev.2013.02.005; de Nascimento L, 2009, J BIOGEOGR, V36, P499, DOI 10.1111/j.1365-2699.2008.02012.x; de Nascimento L, 2020, QUATERNARY SCI REV, V239, DOI 10.1016/j.quascirev.2020.106332; de Nascimento L, 2016, HOLOCENE, V26, P113, DOI 10.1177/0959683615596836; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Ellis Erle C., 2013, Elementa-Science of the Anthropocene, V1, P000018, DOI 10.12952/journal.elementa.000018; Froyd CA, 2010, VEG HIST ARCHAEOBOT, V19, P207, DOI 10.1007/s00334-010-0239-1; Fyfe RM, 2009, VEG HIST ARCHAEOBOT, V18, P417, DOI 10.1007/s00334-009-0215-9; Goring Simon, 2015, Open Quaternary, V1, P2, DOI 10.5334/oq.ab; Gosling W. D., 2020, J BIOGEOGR, V47; Gosling WD, 2020, J BIOGEOGR, V47, P600, DOI 10.1111/jbi.13783; Green R.C, 2002, PACIFIC LANDSCAPES A, P125; Grimm EC, 1992, CLIM DYNAM, V6, P179, DOI 10.1007/BF00193530; Haberle S, 2009, ENCY ISLANDS; Haberle SG, 2003, J BIOGEOGR, V30, P239, DOI 10.1046/j.1365-2699.2003.00780.x; Halsdottir M, 1987, LUNDQUA THESIS, V18, P1; Harcourt A., 2012, HUMAN BIOGEOGRAPHY; Haslett J, 2008, J R STAT SOC C-APPL, V57, P399, DOI 10.1111/j.1467-9876.2008.00623.x; Headland J. K, 1989, CHRONOLOGICAL LIST A; Helmus MR, 2014, NATURE, V513, P543, DOI 10.1038/nature13739; HILL MO, 1980, VEGETATIO, V42, P47, DOI 10.1007/BF00048870; Hobbs RJ, 2006, GLOBAL ECOL BIOGEOGR, V15, P1, DOI 10.1111/j.1466-822x.2006.00212.x; Hogg AG, 2003, ANTIQUITY, V77, P116, DOI 10.1017/S0003598X00061408; Holdaway SJ, 2019, ARCHAEOL OCEAN, V54, P17, DOI 10.1002/arco.5173; Hope G, 2009, TERRA AUSTRALIS, V31, P63; Kahn JG, 2017, J POLYNESIAN SOC, V126, P33, DOI 10.15286/jps.126.1.33-60; Kaiser-Bunbury CN, 2010, PERSPECT PLANT ECOL, V12, P131, DOI 10.1016/j.ppees.2009.10.002; Kennett D, 2006, ANTIQUITY, V80, P340, DOI 10.1017/S0003598X00093662; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kreft H, 2008, ECOL LETT, V11, P116, DOI 10.1111/j.1461-0248.2007.01129.x; Li HY, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2459; Ljung K, 2007, QUATERNARY SCI REV, V26, P3150, DOI 10.1016/j.quascirev.2007.08.003; Ljung K, 2006, PALAEOGEOGR PALAEOCL, V241, P539, DOI 10.1016/j.palaeo.2006.05.007; MacArthur R, 1967, THEORY ISLAND BIOGEO; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; Moser D, 2018, P NATL ACAD SCI USA, V115, P9270, DOI 10.1073/pnas.1804179115; Muggeo VMR, 2017, AUST NZ J STAT, V59, P311, DOI 10.1111/anzs.12200; Nogue S, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0181; Nogue S, 2013, J ECOL, V101, P368, DOI 10.1111/1365-2745.12051; Nolan C, 2018, SCIENCE, V361, P920, DOI 10.1126/science.aan5360; Norder SJ, 2020, ANTHROPOCENE, V30, DOI 10.1016/j.ancene.2020.100242; Norder SJ, 2018, GLOBAL ECOL BIOGEOGR, V27, P500, DOI 10.1111/geb.12715; Oksanen J., 2022, R PACKAGE VERSION; Parnell AC, 2008, QUATERNARY SCI REV, V27, P1872, DOI 10.1016/j.quascirev.2008.07.009; PATTERSON KD, 1988, INT J AFR HIST STUD, V21, P291, DOI 10.2307/219938; Pau S, 2012, ANN ASSOC AM GEOGR, V102, P748, DOI 10.1080/00045608.2011.652853; Petchey F, 2011, J ARCHAEOL SCI, V38, P29, DOI 10.1016/j.jas.2010.07.029; Poblamiento P, 2019, ANUARIO ESTUDIOS ATL, V66, P1; Prebble M, 2009, BIOL INVASIONS, V11, P1529, DOI 10.1007/s10530-008-9405-0; Prebble M, 2019, P NATL ACAD SCI USA, V116, P8824, DOI 10.1073/pnas.1821732116; Prebble M, 2013, HOLOCENE, V23, P179, DOI 10.1177/0959683612455551; R Core Team, 2021, R LANG ENV STAT COMP; Restrepo A, 2012, ECOLOGY, V93, P1853, DOI 10.1890/11-1545.1; Rieth TM, 2011, J ARCHAEOL SCI, V38, P2740, DOI 10.1016/j.jas.2011.06.017; Rolett B, 2004, NATURE, V431, P443, DOI 10.1038/nature02801; Ruddiman WF, 2018, PROG PHYS GEOG, V42, P451, DOI 10.1177/0309133318783142; Rull V, 2017, QUATERNARY SCI REV, V159, P155, DOI 10.1016/j.quascirev.2017.01.021; Sear DA, 2020, P NATL ACAD SCI USA, V117, P8813, DOI 10.1073/pnas.1920975117; Shaefer H, 2005, FLORA AZORES; Southern W., 1986, LATE QUATERNARY ENV; Steadman D. W., 2007, EXTINCTION BIOGEOGRA, DOI [10.1016/j.ancene.2013.08.003, DOI 10.1016/J.ANCENE.2013.08.003]; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Steffen W, 2015, ANTHROPOCENE REV, V2, P81, DOI 10.1177/2053019614564785; Steinbauer MJ, 2018, NATURE, V556, P231, DOI 10.1038/s41586-018-0005-6; Stephens L, 2019, SCIENCE, V365, P897, DOI 10.1126/science.aax1192; Stevenson J, 2001, PALAEOGEOGR PALAEOCL, V168, P97, DOI 10.1016/S0031-0182(00)00251-0; Stevenson J, 2017, HOLOCENE, V27, P1963, DOI 10.1177/0959683617715690; Svenning JC, 2018, AM J BOT, V105, P963, DOI 10.1002/ajb2.1117; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Turney CSM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20970-5; van der Plicht J, 2020, RADIOCARBON, V62, P1095, DOI 10.1017/RDC.2020.22; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Weigelt P, 2013, ECOGRAPHY, V36, P417, DOI 10.1111/j.1600-0587.2012.07669.x; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Williams JW, 2018, QUATERNARY RES, V89, P156, DOI 10.1017/qua.2017.105; Willis KJ, 2010, TRENDS ECOL EVOL, V25, P583, DOI 10.1016/j.tree.2010.07.006; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Wilmshurst JM, 2014, CONSERV BIOL, V28, P202, DOI 10.1111/cobi.12150; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Wilmshurst JM, 1997, NEW ZEAL J BOT, V35, P79; Wilmshurst JM, 1996, HOLOCENE, V6, P399, DOI 10.1177/095968369600600402; Wood JR, 2017, ENVIRON CONSERV, V44, P348, DOI 10.1017/S037689291700039X; Wood JR, 2017, FUNCT ECOL, V31, P1012, DOI 10.1111/1365-2435.12773; WRIGHT SJ, 1985, OIKOS, V44, P331, DOI 10.2307/3544708; Zalasiewicz J, 2019, PROG PHYS GEOG, V43, P319, DOI 10.1177/0309133319832607	108	30	30	13	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					488	+		10.1126/science.abd6706	http://dx.doi.org/10.1126/science.abd6706			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926949	Green Submitted, Green Accepted			2022-12-28	WOS:000645554100041
J	Vrinten, C; Aldridge, RW; Adamson, A; Aldridge, RW; Aletta, F; Ashman, A; Briggs, A; Burns, R; Capewell, S; Davies, L; Griffin, T; Haig, C; Hastie, C; Head, A; Katikireddi, SV; Kee, F; Lyons, R; Maguire, A; McKee, M; McMeekin, N; Melendez-Torres, GJ; Luchenski, S; Pineo, H; Rutter, H; Savona, N; van Schalkwyk, M; Thomson, R; Tweed, E; Vrinten, C; Wilson, C; Wulaningsih, W				Vrinten, Charlotte; Aldridge, Robert W.; Adamson, Ashley; Aldridge, Robert W.; Aletta, Francesco; Ashman, Annie; Briggs, Adam; Burns, Rachel; Capewell, Simon; Davies, Llion; Griffin, Tania; Haig, Caroline; Hastie, Claire; Head, Anna; Katikireddi, Srinivasa Vittal; Kee, Frank; Lyons, Ronan; Maguire, Aideen; McKee, Martin; McMeekin, Nicola; Melendez-Torres, G. J.; Luchenski, Serena; Pineo, Helen; Rutter, Harry; Savona, Natalie; van Schalkwyk, May; Thomson, Rachel; Tweed, Emily; Vrinten, Charlotte; Wilson, Claire; Wulaningsih, Wahyu		Uk Public Hlth Sci Conf Organising	UK Public Health Science 2021: a call for abstracts	LANCET			English	Editorial Material									[Vrinten, Charlotte] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England; [Vrinten, Charlotte] Imperial Coll Business Sch, Ctr Hlth Econ & Policy Innovat, London, England; [Aldridge, Robert W.] UCL, Inst Hlth Informat, London, England	Imperial College London; Imperial College London; University of London; University College London	Vrinten, C (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London W6 8RP, England.; Vrinten, C (corresponding author), Imperial Coll Business Sch, Ctr Hlth Econ & Policy Innovat, London, England.	c.vrinten@imperial.ac.uk	Rutter, Harry/HCI-8765-2022; Savona, Natalie/ABB-2397-2021; Aletta, Francesco/U-4821-2017	Savona, Natalie/0000-0002-3006-3681; Aldridge, Robert/0000-0003-0542-0816; Ashman, Annie/0000-0002-3181-4168; Aletta, Francesco/0000-0003-0351-3189				Watts N, 2021, LANCET, V397, P129, DOI 10.1016/S0140-6736(20)32290-X	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1607	1608		10.1016/S0140-6736(21)00942-9	http://dx.doi.org/10.1016/S0140-6736(21)00942-9		APR 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33894144				2022-12-28	WOS:000645510600008
J	Dyer, O				Dyer, Owen			Covid-19: US will send 60 million AstraZeneca doses abroad as domestic demand falls	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2021, WASH POST; Wan W, 2021, WASH POST	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1111	10.1136/bmj.n1111	http://dx.doi.org/10.1136/bmj.n1111			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910922	Bronze			2022-12-28	WOS:000656399900010
J	Mahase, E				Mahase, Elisabeth			Myanmar: Medical organisations unite to condemn attacks on healthcare workers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2021, STAT SOL MYANM; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n704	2	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2021	373								n1097	10.1136/bmj.n1097	http://dx.doi.org/10.1136/bmj.n1097			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RW1QM	33906859				2022-12-28	WOS:000646297900006
J	Rubin, R				Rubin, Rita			Medicare Raises Payment for Administering COVID-19 Vaccines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1601	1601		10.1001/jama.2021.5882	http://dx.doi.org/10.1001/jama.2021.5882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904883	Bronze			2022-12-28	WOS:000645617800003
J	Moulia, B; Douady, S; Hamant, O				Moulia, Bruno; Douady, Stephane; Hamant, Olivier			Fluctuations shape plants through proprioception	SCIENCE			English	Review							GROWTH; SIGNALS; STRESS; TREES; MORPHOGENESIS; MICROTUBULES; VARIABILITY; TERMINATION; FEEDBACK; CELLS	Plants constantly experience fluctuating internal and external mechanical cues, ranging from nanoscale deformation of wall components, cell growth variability, nutating stems, and fluttering leaves to stem flexion under tree weight and wind drag. Developing plants use such fluctuations to monitor and channel their own shape and growth through a form of proprioception. Fluctuations in mechanical cues may also be actively enhanced, producing oscillating behaviors in tissues. For example, proprioception through leaf nastic movements may promote organ flattening. We propose that fluctuation-enhanced proprioception allows plant organs to sense their own shapes and behave like active materials with adaptable outputs to face variable environments, whether internal or external. Because certain shapes are more amenable to fluctuations, proprioception may also help plant shapes to reach self-organized criticality to support such adaptability.	[Moulia, Bruno] Univ Clermont Auvergne, INRAE, PIAF, F-63000 Clermont Ferrand, France; [Douady, Stephane] Univ Paris, CNRS, Lab Matieres & Syst Complexes MSC, F-75205 Paris 13, France; [Hamant, Olivier] Univ Lyon, Lab Reprod & Dev Plantes, ENS Lyon, UCB Lyon 1,CNRS,INRAE, F-69007 Lyon, France	INRAE; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Moulia, B (corresponding author), Univ Clermont Auvergne, INRAE, PIAF, F-63000 Clermont Ferrand, France.; Douady, S (corresponding author), Univ Paris, CNRS, Lab Matieres & Syst Complexes MSC, F-75205 Paris 13, France.; Hamant, O (corresponding author), Univ Lyon, Lab Reprod & Dev Plantes, ENS Lyon, UCB Lyon 1,CNRS,INRAE, F-69007 Lyon, France.	bruno.moulia@inrae.fr; stephane.douady@univ-paris-diderot.fr; olivier.hamant@ens-lyon.fr	DOUADY, Stephane/C-4498-2018	DOUADY, Stephane/0000-0002-3416-886X; Hamant, Olivier/0000-0001-6906-6620; Moulia, Bruno/0000-0002-3099-0207	Human Frontier Science Program grant [RGP0023]; MURINAS [ANR-17-CAPS-0005-01]; ANR IDEXISITE initiative [16-IDEX-0001 (CAP 20-25)]	Human Frontier Science Program grant(Human Frontier Science Program); MURINAS; ANR IDEXISITE initiative(French National Research Agency (ANR))	This work was supported by the Human Frontier Science Program grant RGP0023/2018, ANR-17-CAPS-0005-01 MURINAS, and ANR IDEXISITE initiative 16-IDEX-0001 (CAP 20-25).	Agostinelli D, 2020, J MECH PHYS SOLIDS, V136, DOI 10.1016/j.jmps.2019.103702; Alonso-Serra J, 2020, CURR BIOL, V30, P589, DOI 10.1016/j.cub.2019.12.016; Ashby W.R., 1991, CYBERNETICA, P405, DOI DOI 10.1007/978-1-4899-0718-9_28; Atlan Henri, 1972, COMMUNICATIONS-GER, V18, P21, DOI 10.3406/; Cabrera JBC, 2020, NEW PHYTOL, V227, P1776, DOI 10.1111/nph.16639; Bartholome J, 2020, PLANT J, V103, P338, DOI 10.1111/tpj.14734; Bastien R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194893; Bastien R, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00136; Bastien R, 2013, P NATL ACAD SCI USA, V110, P755, DOI 10.1073/pnas.1214301109; Berut A, 2018, P NATL ACAD SCI USA, V115, P5123, DOI 10.1073/pnas.1801895115; Bonnesoeur V, 2016, NEW PHYTOL, V210, P850, DOI 10.1111/nph.13836; Bose I, 2017, J BIOSCIENCES, V42, P683, DOI 10.1007/s12038-017-9721-6; Busov VB, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01505; Chauvet H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35431; Chelakkot R, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0001; Colin L, 2020, P NATL ACAD SCI USA, V117, P32731, DOI 10.1073/pnas.2008895117; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Coutand C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209973; de Langre E, 2019, J EXP BOT, V70, P3521, DOI 10.1093/jxb/erz209; Derr J, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0595; DOUADY S, 1992, PHYS REV LETT, V68, P2098, DOI 10.1103/PhysRevLett.68.2098; Duchemin L, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0976; Dumais J, 2013, P NATL ACAD SCI USA, V110, P391, DOI 10.1073/pnas.1219974110; Eloy C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00995-6; Fruleux A, 2019, P NATL ACAD SCI USA, V116, P1940, DOI 10.1073/pnas.1815342116; Galvan-Ampudia CS, 2020, ELIFE, V9, DOI 10.7554/eLife.55832; Halle F., 1978, TROPICAL TREES FORES, Vfirst; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hamant O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10207-y; Hamant O, 2016, NEW PHYTOL, V212, P333, DOI 10.1111/nph.14143; Han HB, 2020, PLANT PHYSIOL, V183, P37, DOI 10.1104/pp.20.00212; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Hejnowicz Z, 2000, J PLANT GROWTH REGUL, V19, P31, DOI 10.1007/s003440000005; Hervieux N, 2017, CURR BIOL, V27, P3468, DOI 10.1016/j.cub.2017.10.033; Hervieux N, 2016, CURR BIOL, V26, P1019, DOI 10.1016/j.cub.2016.03.004; Inoue D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12557; Jackson T, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0116; JR JLH, 2019, CURR OPIN PLANT BIOL, V47, P73, DOI DOI 10.1016/J.PBI.2018.09.010; Kothari P, 2019, J CELL SCI, V132, DOI 10.1242/jcs.234476; Kroger S, 2018, CURR OPIN NEUROL, V31, P592, DOI 10.1097/WCO.0000000000000590; Krotov D, 2014, P NATL ACAD SCI USA, V111, P3683, DOI 10.1073/pnas.1324186111; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Landrein B, 2019, J EXP BOT, V70, P3507, DOI 10.1093/jxb/erz103; LOCKHART JA, 1965, J THEOR BIOL, V8, P264, DOI 10.1016/0022-5193(65)90077-9; Long YC, 2020, CURR BIOL, V30, P1504, DOI 10.1016/j.cub.2020.02.027; Massou S, 2020, NAT CELL BIOL, V22, P1011, DOI 10.1038/s41556-020-0548-2; Meroz Y, 2020, J EXP BOT, V71, P6189, DOI 10.1093/jxb/eraa389; Meroz Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00674; Mirabet V, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006011; Moulia B, 2019, J EXP BOT, V70, P3467, DOI 10.1093/jxb/erz278; Moulia B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00052; Nakamura M, 2019, J EXP BOT, V70, P3495, DOI 10.1093/jxb/erz158; Nakamura M, 2015, METHODS MOL BIOL, V1309, P57, DOI 10.1007/978-1-4939-2697-8_6; Nakayama N, 2012, CURR BIOL, V22, P1468, DOI 10.1016/j.cub.2012.06.050; Okamoto Keishi, 2015, Nat Plants, V1, P15031, DOI 10.1038/nplants.2015.31; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peters WS, 1996, ANN BOT-LONDON, V77, P657, DOI 10.1006/anbo.1996.0082; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Rakusova H, 2016, CURR BIOL, V26, P3026, DOI 10.1016/j.cub.2016.08.067; Riviere M, 2020, J EXP BOT, V71, P6408, DOI 10.1093/jxb/eraa378; Riviere M, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa5945; Rue P, 2012, PROG BIOPHYS MOL BIO, V110, P106, DOI 10.1016/j.pbiomolbio.2012.05.003; Sampathkumar A, 2011, PLANT CELL, V23, P2302, DOI 10.1105/tpc.111.087940; Scarpa E, 2018, DEV CELL, V47, P727, DOI 10.1016/j.devcel.2018.10.029; Schopfer P, 2006, AM J BOT, V93, P1415, DOI 10.3732/ajb.93.10.1415; Sherrington CS, 1906, BRAIN, V29, P467; Shih B, 2020, SCI ROBOT, V5, DOI 10.1126/scirobotics.aaz9239; Tadrist L, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0010; Takatani S, 2020, CURR BIOL, V30, P1491, DOI 10.1016/j.cub.2020.02.024; Talts K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01932; Tardieu F, 2018, ANNU REV PLANT BIOL, V69, P733, DOI 10.1146/annurev-arplant-042817-040218; Topham AT, 2017, P NATL ACAD SCI USA, V114, P6629, DOI 10.1073/pnas.1704745114; Traas J, 2002, PHILOS T R SOC B, V357, P737, DOI 10.1098/rstb.2002.1091; Tran D, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.1919402118; Tsugawa S, 2020, J THEOR BIOL, V486, DOI 10.1016/j.jtbi.2019.110092; Tsugawa S, 2017, DEVELOPMENT, V144, P4398, DOI 10.1242/dev.153999; Ueda H, 2015, CURR OPIN PLANT BIOL, V28, P30, DOI 10.1016/j.pbi.2015.08.006; Uyttewaal M, 2012, CELL, V149, P439, DOI 10.1016/j.cell.2012.02.048; Whitewoods CD, 2017, CURR BIOL, V27, pR910, DOI 10.1016/j.cub.2017.05.079; Zandiyeh P, 2019, J BIOMECH, V84, P52, DOI 10.1016/j.jbiomech.2018.12.018; Zhao F, 2020, CURR BIOL, V30, P3972, DOI 10.1016/j.cub.2020.07.076; Zhu MY, 2020, NAT PLANTS, V6, P686, DOI 10.1038/s41477-020-0666-7	82	15	15	11	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					359	+	eabc6868	10.1126/science.abc6868	http://dx.doi.org/10.1126/science.abc6868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888615				2022-12-28	WOS:000645009800031
J	Kebebew, E				Kebebew, Electron			Adrenal Incidentaloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTONOMOUS CORTISOL SECRETION; CARDIOVASCULAR EVENTS; PRIMARY ALDOSTERONISM; INCREASED MORTALITY; MANAGEMENT; SOCIETY; HYPERCORTISOLISM; PHEOCHROMOCYTOMA; DIAGNOSIS	A 42-year-old woman has been in a motor vehicle accident in which her seat belt tightened. She has upper abdominal pain and is evaluated with computed tomography (CT). This imaging shows no evidence of intraabdominal trauma but reveals a well-circumscribed and homogeneous left adrenal mass that is 3.2 cm in diameter. The mass has an attenuation value of 7 Hounsfield units on unenhanced CT. The patient's history is remarkable for obesity and newly diagnosed mild hypertension. On physical examination, the blood pressure is 142/90 mm Hg. There is sternal and upper abdominal bruising but no striae, moon facies, or fat accumulation over the dorsocervical spine ("buffalo hump"). How should this patient be further evaluated and treated?	[Kebebew, Electron] Stanford Univ, Dept Surg, Sch Med, Div Gen Surg, 300 Pasteur Dr,H3642, Stanford, CA 94305 USA	Stanford University	Kebebew, E (corresponding author), Stanford Univ, Dept Surg, Sch Med, Div Gen Surg, 300 Pasteur Dr,H3642, Stanford, CA 94305 USA.	kebebew@stanford.edu						[Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Bancos I, 2016, EUR J ENDOCRINOL, V175, pR65, DOI 10.1530/EJE-16-0297; Barzon L, 2003, EUR J ENDOCRINOL, V149, P273, DOI 10.1530/eje.0.1490273; Bourdeau I, 2018, EUR J ENDOCRINOL, V179, pR57, DOI 10.1530/EJE-18-0296; Buitenwerf E, 2019, MAYO CLIN PROC, V94, P2040, DOI 10.1016/j.mayocp.2019.03.030; Buitenwerf E, 2018, EUR J ENDOCRINOL, V178, P431, DOI 10.1530/EJE-18-0006; Canu L, 2019, J CLIN ENDOCR METAB, V104, P312, DOI 10.1210/jc.2018-01532; Chiodini I, 2001, J CLIN ENDOCR METAB, V86, P5337, DOI 10.1210/jc.86.11.5337; Debono M, 2014, J CLIN ENDOCR METAB, V99, P4462, DOI 10.1210/jc.2014-3007; Dennedy MC, 2017, J CLIN ENDOCR METAB, V102, P786, DOI 10.1210/jc.2016-2718; Di Dalmazi G, 2014, LANCET DIABETES ENDO, V2, P396, DOI 10.1016/S2213-8587(13)70211-0; Dinnes J, 2016, EUR J ENDOCRINOL, V175, pR51, DOI 10.1530/EJE-16-0461; Elhassan YS, 2019, ANN INTERN MED, V171, P107, DOI 10.7326/M18-3630; Falhammar H, 2016, ENDOCR PRACT, V22, P736, DOI 10.4158/EP151085.RA; Fassnacht M, 2016, EUR J ENDOCRINOL, V175, pG1, DOI 10.1530/EJE-16-0467; Ferreira L, 2018, J ENDOCRINOL METAB, V8, P62, DOI 10.14740/jem510w; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Iacobone M, 2012, SURGERY, V152, P991, DOI 10.1016/j.surg.2012.08.054; Kebebew E, 2017, MANAGEMENT ADRENAL M; Kim SJ, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170520; Lam KY, 2002, CLIN ENDOCRINOL, V56, P95, DOI 10.1046/j.0300-0664.2001.01435.x; Lee JM, 2017, ENDOCRINOL METAB, V32, P200, DOI 10.3803/EnM.2017.32.2.200; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Mantero F, 2000, J CLIN ENDOCR METAB, V85, P637, DOI 10.1210/jc.85.2.637; Morelli V, 2017, EUR J ENDOCRINOL, V177, P73, DOI 10.1530/EJE-17-0047; Muth A, 2011, BRIT J SURG, V98, P1383, DOI 10.1002/bjs.7566; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Park J, 2019, J ENDOCR SOC, V3, P996, DOI 10.1210/js.2019-00090; Patrova J, 2017, ENDOCRINE, V58, P267, DOI 10.1007/s12020-017-1400-8; Perysinakis I, 2013, SURG ENDOSC, V27, P2145, DOI 10.1007/s00464-012-2730-5; Platzek I, 2019, EUR RADIOL, V29, P806, DOI 10.1007/s00330-018-5626-5; Reznik Y, 2016, ANN ENDOCRINOL-PARIS, V77, P202, DOI 10.1016/j.ando.2016.01.007; Sbardella E, 2018, EUR J ENDOCRINOL, V178, P501, DOI 10.1530/EJE-17-0986; Sherlock M, 2020, ENDOCR REV, V41, P775, DOI 10.1210/endrev/bnaa008; Sturgeon C, 2006, J AM COLL SURGEONS, V202, P423, DOI 10.1016/j.jamcollsurg.2005.11.005; Tabari A, 2008, ANN ENDOCRINOL-PARIS, V69, P487, DOI 10.1016/j.ando.2008.09.003; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-1147; Toniato A, 2009, ANN SURG, V249, P388, DOI 10.1097/SLA.0b013e31819a47d2; Valli N, 2001, EUR J ENDOCRINOL, V144, P401, DOI 10.1530/eje.0.1440401; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	41	26	26	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1542	1551		10.1056/NEJMcp2031112	http://dx.doi.org/10.1056/NEJMcp2031112			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RQ6OT	33882207				2022-12-28	WOS:000642536700012
J	Anchan, R; Cifu, AS; Paul, J				Anchan, Rajeev; Cifu, Adam S.; Paul, Jonathan			Management of Acute Coronary Syndromes in Patients Without Persistent ST-Segment Elevation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OUTCOMES	This JAMA Clinical Guidelines Synopsis summarizes the European Society of Cardiology's 2020 recommendations for management of patients with non-ST-segment elevation acute coronary syndromes.	[Anchan, Rajeev; Cifu, Adam S.; Paul, Jonathan] Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu			ESC	ESC	ESC	Chew DP, 2019, CIRCULATION, V140, P1543, DOI 10.1161/CIRCULATIONAHA.119.042891; Collet Jean-Philippe, 2021, Eur Heart J, V42, P1289, DOI [10.1093/eurheartj/ehaa575, 10.15829/1560-4071-2021-4418]; Dworeck C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.18735; Gargiulo G, 2019, EUR HEART J, V40, P3757, DOI 10.1093/eurheartj/ehz732; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Puymirat E, 2017, CIRCULATION, V136, P1908, DOI 10.1161/CIRCULATIONAHA.117.030798; Schupke S, 2019, NEW ENGL J MED, V381, P1524, DOI 10.1056/NEJMoa1908973	7	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1556	1557		10.1001/jama.2021.2744	http://dx.doi.org/10.1001/jama.2021.2744			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877282	Green Accepted			2022-12-28	WOS:000642636500021
J	Barbash, IJ; Davis, BS; Yabes, JG; Seymour, CW; Angus, DC; Kahn, JM				Barbash, Ian J.; Davis, Billie S.; Yabes, Jonathan G.; Seymour, Chris W.; Angus, Derek C.; Kahn, Jeremy M.			Treatment Patterns and Clinical Outcomes After the Introduction of the Medicare Sepsis Performance Measure (SEP-1)	ANNALS OF INTERNAL MEDICINE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; HOSPITAL MORTALITY; CARE; PAY	Background: Medicare requires that hospitals report on their adherence to the Severe Sepsis and Septic Shock Early Management Bundle (SEP-1). Objective: To evaluate the effect of SEP-1 on treatment patterns and patient outcomes. Design: Longitudinal study of hospitals using repeated cross-sectional cohorts of patients. Setting: 11 hospitals within an integrated health system. Patients: 54 225 encounters between January 2013 and December 2017 for adults with sepsis who were hospitalized through the emergency department. Intervention: Onset of the SEP-1 reporting requirement in October 2015. Measurements: Changes in SEP-1-targeted processes, including antibiotic administration, lactate measurement, and fluid administration at 3 hours from sepsis onset; repeated lactate and vasopressor administration for hypotension within 6 hours of sepsis onset; and sepsis outcomes, including risk-adjusted intensive care unit (ICU) admission, in-hospital mortality, and home discharge among survivors. Results: Two years after its implementation, SEP-1 was associated with variable changes in process measures, with the greatest effect being an increase in lactate measurement within 3 hours of sepsis onset (absolute increase, 23.7 percentage points [95% CI, 20.7 to 26.7 percentage points]; P < 0.001). There were small increases in antibiotic administration (absolute increase, 4.7 percentage points [CI, 1.9 to 7.6 percentage points]; P = 0.001) and fluid administration of 30 mL/kg of body weight within 3 hours of sepsis onset (absolute increase, 3.4 percentage points [CI, 1.5 to 5.2 percentage points]; P < 0.001). There was no change in vasopressor administration. There was a small increase in ICU admissions (absolute increase, 2.0 percentage points [CI, 0 to 4.0 percentage points]; P = 0.055) and no changes in mortality (absolute change, 0.1 percentage points [CI, -0.9 to 1.1 percentage points]; P = 0.87) or discharge to home. Limitation: Data are from a single health system. Conclusion: Implementation of the SEP-1 mandatory reporting program was associated with variable changes in process measures, without improvements in clinical outcomes. Revising the measure may optimize its future effect.	[Barbash, Ian J.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Barbash, Ian J.; Angus, Derek C.; Kahn, Jeremy M.] UPMC Hlth Syst, Pittsburgh, PA USA; [Davis, Billie S.] Univ Pittsburgh, Sch Med, 602A Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Yabes, Jonathan G.] Ctr Res Hlth Care, 200 Meyran Ave,Suite 300, Pittsburgh, PA 15213 USA; [Seymour, Chris W.] Univ Pittsburgh, Sch Med, 3520 Fifth Ave,Suite 100, Pittsburgh, PA 15261 USA; [Angus, Derek C.] Univ Pittsburgh, Sch Med, 614 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Kahn, Jeremy M.] Univ Pittsburgh, Sch Med, 602B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA; [Barbash, Ian J.] Univ Pittsburgh, Montefiore Hosp 628 NW,3459 Fifth Ave, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Barbash, IJ (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA.; Barbash, IJ (corresponding author), Univ Pittsburgh, Montefiore Hosp 628 NW,3459 Fifth Ave, Pittsburgh, PA 15213 USA.	barbashij@upmc.edu		Barbash, Ian/0000-0002-9840-0576; Angus, Derek/0000-0002-7026-5181; Yabes, Jonathan/0000-0002-9406-2362	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	Afshar M, 2019, CRIT CARE MED, V47, P1371, DOI 10.1097/CCM.0000000000003919; Angus DC, 2016, AM J RESP CRIT CARE, V194, P14, DOI 10.1164/rccm.201604-0879ED; Barbash IJ, 2019, CRIT CARE MED, V47, P1026, DOI 10.1097/CCM.0000000000003613; Barbash IJ, 2017, J HOSP MED, V12, P963, DOI 10.12788/jhm.2929; Barbash IJ, 2016, AM J RESP CRIT CARE, V194, P139, DOI 10.1164/rccm.201604-0723ED; Buchman TG, 2020, CRIT CARE MED, V48, P276, DOI 10.1097/CCM.0000000000004224; Centers for Medicare & Medicaid Services, TECHN EXP PAN COMP M TECHN EXP PAN COMP M; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Kahn JM, 2019, JAMA-J AM MED ASSOC, V322, P240, DOI 10.1001/jama.2019.9021; Kempker JA, 2020, CRIT CARE MED, V48, P1881, DOI 10.1097/CCM.0000000000004577; Klompas M, 2016, ANN INTERN MED, V165, P517, DOI 10.7326/M16-0588; Levy MM, 2018, AM J RESP CRIT CARE, V198, P1406, DOI [10.1164/rccm.201712-2545OC, 10.1164/rccm.201712-2545oc]; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Liu VX, 2017, AM J RESP CRIT CARE, V196, P856, DOI 10.1164/rccm.201609-1848OC; Mendelson A, 2017, ANN INTERN MED, V166, P341, DOI 10.7326/M16-1881; Pepper DJ, 2018, ANN INTERN MED, V168, P558, DOI 10.7326/M17-2947; Rhee C, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa05, DOI 10.1093/CID/CIAA05]; Rhee C, 2020, CRIT CARE MED, V48, P779, DOI 10.1097/CCM.0000000000004305; Rhee C, 2019, CRIT CARE MED, V47, P1169, DOI 10.1097/CCM.0000000000003817; Rhee C, 2018, CRIT CARE MED, V46, P1585, DOI 10.1097/CCM.0000000000003261; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	26	18	18	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					927	+		10.7326/M20-5043	http://dx.doi.org/10.7326/M20-5043			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	33872042	Green Accepted			2022-12-28	WOS:000675809000019
J	Lessler, J; Grabowski, MK; Grantz, KH; Badillo-Goicoechea, E; Metcalf, CJE; Lupton-Smith, C; Azman, AS; Stuart, EA				Lessler, Justin; Grabowski, M. Kate; Grantz, Kyra H.; Badillo-Goicoechea, Elena; Metcalf, C. Jessica E.; Lupton-Smith, Carly; Azman, Andrew S.; Stuart, Elizabeth A.			Household COVID-19 risk and in-person schooling	SCIENCE			English	Article							TRANSMISSION; OUTBREAKS	In-person schooling has proved contentious and difficult to study throughout the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Data from a massive online survey in the United States indicate an increased risk of COVID-19-related outcomes among respondents living with a child attending school in person. School-based mitigation measures are associated with significant reductions in risk, particularly daily symptoms screens, teacher masking, and closure of extracurricular activities. A positive association between in-person schooling and COVID-19 outcomes persists at low levels of mitigation, but when seven or more mitigation measures are reported, a significant relationship is no longer observed. Among teachers, working outside the home was associated with an increase in COVID-19-related outcomes, but this association is similar to that observed in other occupations (e.g., health care or office work). Although in-person schooling is associated with household COVID-19 risk, this risk can likely be controlled with properly implemented school-based mitigation measures.	[Lessler, Justin; Grabowski, M. Kate; Grantz, Kyra H.; Azman, Andrew S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Grabowski, M. Kate] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA; [Badillo-Goicoechea, Elena; Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Metcalf, C. Jessica E.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Lupton-Smith, Carly; Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Azman, Andrew S.] Univ Geneva, Fac Med, Inst Global Hlth, Geneva, Switzerland; [Stuart, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Princeton University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Geneva; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	justin@jhu.edu		Azman, Andrew/0000-0001-8662-9077; Lupton Brantner, Carly/0000-0003-1067-3260; Grantz, Kyra/0000-0002-2319-5010; Goicoechea, Elena/0000-0003-1653-1247; Lessler, Justin/0000-0002-9741-8109; Stuart, Elizabeth/0000-0002-9042-8611	Johns Hopkins University Discovery Award; Johns Hopkins University COVID-19 Modeling and Policy Hub Award; Department of Health and Human Services	Johns Hopkins University Discovery Award; Johns Hopkins University COVID-19 Modeling and Policy Hub Award; Department of Health and Human Services	This work was supported by the Johns Hopkins University Discovery Award (to E.B.-G., C.L.-S., and E.A.S.), the Johns Hopkins University COVID-19 Modeling and Policy Hub Award (to E.B.-G., C.L.-S., and E.A.S.), and the Department of Health and Human Services (to J.L. and M.K.G.).	[Anonymous], 2020, EDUCATION; Barkay N., ARXIV200914675 CSSI; Bi Q., 2021, MEDRXIV2020110420225; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Education Week, 2020, SCH DISTR REOP PLANS; Falk A, 2021, MMWR-MORBID MORTAL W, V70, P136, DOI [10.15585/mmwr.mm7004e3, 10.15585/mmwr.mm7004e3externalicon]; Flasche S, 2021, LANCET INFECT DIS, V21, P298, DOI 10.1016/S1473-3099(20)30927-0; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Harris DN, 2021, EFFECTS SCH REOPENIN; Ismail SA, 2021, LANCET INFECT DIS, V21, P344, DOI 10.1016/S1473-3099(20)30882-3; Kreuter F, 2020, SURV RES METHODS-GER, V14, P159, DOI 10.18148/srm/2020.v14i2.7761; Lessler J., 2020, MEDRXIV2020102920221; Lessler J., 2021, ZENODO; Lessler J, 2021, ZENODO, DOI [10.5281/zenodo.4710757, DOI 10.5281/ZENODO.4710757]; Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4; Lopez AS, 2020, MMWR-MORBID MORTAL W, V69, P1319, DOI 10.15585/mmwr.mm6937e3; Ludvigsson JF, 2021, NEW ENGL J MED, V384, P669, DOI 10.1056/NEJMc2026670; Lupton-Smith C., 2021, ARXIV210313296STATAP; Stein-Zamir C, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.29.2001352; Szablewski CM, 2020, MMWR-MORBID MORTAL W, V69, P1023, DOI 10.15585/mmwr.mm6931e1; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; Vlachos J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020834118; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Yang B., 2020, MEDRXIV2020102920221; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001	25	80	80	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2021	372	6546					1092	+		10.1126/science.abh2939	http://dx.doi.org/10.1126/science.abh2939			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM5NE	33927057	Green Published, Green Submitted			2022-12-28	WOS:000657651200049
J	Mittnenzweig, M; Mayshar, Y; Cheng, SF; Ben-Yair, R; Hadas, R; Rais, Y; Chomsky, E; Reines, N; Uzonyi, A; Lumerman, L; Lifshitz, A; Mukamel, Z; Orenbuch, AH; Tanay, A; Stelzer, Y				Mittnenzweig, Markus; Mayshar, Yoav; Cheng, Saifeng; Ben-Yair, Raz; Hadas, Ron; Rais, Yoach; Chomsky, Elad; Reines, Netta; Uzonyi, Anna; Lumerman, Lior; Lifshitz, Aviezer; Mukamel, Zohar; Orenbuch, Ayelet-Hashahar; Tanay, Amos; Stelzer, Yonatan			A single-embryo, single-cell time-resolved model for mouse gastrulation	CELL			English	Article							EPIBLAST STEM-CELLS; LINEAGE ALLOCATION; RNA-SEQ; DIFFERENTIATION; PROLIFERATION; HETEROGENEITY; COMMITMENT; NOTOCHORD; ENDODERM; DYNAMICS	Mouse embryonic development is a canonical model system for studying mammalian cell fate acquisition. Recently, single-cell atlases comprehensively charted embryonic transcriptional landscapes, yet inference of the coordinated dynamics of cells over such atlases remains challenging. Here, we introduce a temporal model for mouse gastrulation, consisting of data from 153 individually sampled embryos spanning 36 h of molecular diversification. Using algorithms and precise timing, we infer differentiation flows and lineage specification dynamics over the embryonic transcriptional manifold. Rapid transcriptional bifurcations characterize the commitment of early specialized node and blood cells. However, for most lineages, we observe combinatorial multi-furcation dynamics rather than hierarchical transcriptional transitions. In the mesoderm, dozens of transcription factors combinatorially regulate multifurcations, as we exemplify using time-matched chimeric embryos of Foxc1/Foxc2 mutants. Our study rejects the notion of differentiation being governed by a series of binary choices, providing an alternative quantitative model for cell fate acquisition.	[Mittnenzweig, Markus; Chomsky, Elad; Lifshitz, Aviezer; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel; [Mittnenzweig, Markus; Chomsky, Elad; Lifshitz, Aviezer; Mukamel, Zohar; Tanay, Amos] Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot, Israel; [Mayshar, Yoav; Cheng, Saifeng; Ben-Yair, Raz; Hadas, Ron; Rais, Yoach; Reines, Netta; Uzonyi, Anna; Lumerman, Lior; Orenbuch, Ayelet-Hashahar; Stelzer, Yonatan] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [Uzonyi, Anna] Weizmann Inst Sci, Dept Mol Genet, IL-7610001 Rehovot, Israel; [Lumerman, Lior] UPMC Hillman Canc Ctr, Pittsburgh, PA 15213 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-7610001 Rehovot, Israel.; Tanay, A (corresponding author), Weizmann Inst Sci, Dept Biol Regulat, IL-7610001 Rehovot, Israel.; Stelzer, Y (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel.	amos.tanay@weizmann.ac.il; yonatan.stelzer@weizmann.ac.il		Cheng, SaiFeng/0000-0003-2712-3521; Uzonyi, Anna/0000-0001-8303-3219; Mayshar, Yoav/0000-0002-5553-2472	Moross Integrated Cancer Center; Israel Cancer Research Fund (ICRF); Helen and Martin Kimmel Stem Cell Institute; Hadar Impact Fund; Lord Sieff of Brimpton Memorial Fund; Yeda-Sela Center; European Research Council [ERC_StG 852865]; ISF [1610/18]; Minerva Foundation; Human Frontier Science Program [CDA00023/2019-C]; EMBO long term fellowship [ALTF 268-2018]; Walter Benjamin program of the German Research Foundation (DFG); European Research Council (ERC CoG scAssembly); EU BRAINTIME project; Israel Science Foundation; ChenZuckerberg Foundation; Israeli Council for Higher Education (CHE) Data Science program; Madame Olga Klein-Astrachan; Edward Anixter Family	Moross Integrated Cancer Center; Israel Cancer Research Fund (ICRF); Helen and Martin Kimmel Stem Cell Institute; Hadar Impact Fund; Lord Sieff of Brimpton Memorial Fund; Yeda-Sela Center; European Research Council(European Research Council (ERC)European Commission); ISF(Israel Science Foundation); Minerva Foundation; Human Frontier Science Program(Human Frontier Science Program); EMBO long term fellowship(European Molecular Biology Organization (EMBO)); Walter Benjamin program of the German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC CoG scAssembly)(European Research Council (ERC)); EU BRAINTIME project; Israel Science Foundation(Israel Science Foundation); ChenZuckerberg Foundation; Israeli Council for Higher Education (CHE) Data Science program; Madame Olga Klein-Astrachan; Edward Anixter Family	We thank the Tanay and Stelzer group members for discussion and critical reading of the manuscript, and Hernan Rubinstein for graphic work. Y.S. is the incumbent of the Louis and Ida Rich Career Development Chair and is supported by Moross Integrated Cancer Center, the Israel Cancer Research Fund (ICRF), Helen and Martin Kimmel Stem Cell Institute, Hadar Impact Fund, Lord Sieff of Brimpton Memorial Fund, Janet and Steven Anixter, JoAnne Silva and Lester and Edward Anixter Family, Yeda-Sela Center, Barry and Janet Lang, European Research Council (ERC_StG 852865), ISF (1610/18), the Minerva Foundation, and Human Frontier Science Program (CDA00023/2019-C). S.C. was supported by the EMBO long term fellowship (ALTF 268-2018). M.M. was a postdoctoral fellow of the Minerva Stiftung and is supported by the Walter Benjamin program of the German Research Foundation (DFG). A.T. is supported by the European Research Council (ERC CoG scAssembly), the EU BRAINTIME project, the Israel Science Foundation, and the ChenZuckerberg Foundation. This research was further supported Israeli Council for Higher Education (CHE) Data Science program and by a grant from Madame Olga Klein-Astrachan.	Ahuja R. K., 1993, NETWORK FLOWS THEORY; Argelaguet R, 2019, NATURE, V576, P487, DOI 10.1038/s41586-019-1825-8; Arkell RM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120030; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Balmer S, 2016, DEV DYNAM, V245, P547, DOI [10.1002/DVDY.24392, 10.1002/dvdy.24392]; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Bedzhov I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0538; Bellomo D, 1996, DEV DYNAM, V205, P471, DOI 10.1002/(SICI)1097-0177(199604)205:4<471::AID-AJA10>3.0.CO;2-4; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bowling S, 2020, CELL, V181, P1410, DOI 10.1016/j.cell.2020.04.048; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cajal M, 2012, DEVELOPMENT, V139, P423, DOI 10.1242/dev.075499; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chan MM, 2019, NATURE, V570, P77, DOI 10.1038/s41586-019-1184-5; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Cheng SL, 2019, CELL REP, V26, P2593, DOI 10.1016/j.celrep.2019.02.031; Costello I, 2015, GENE DEV, V29, P2108, DOI 10.1101/gad.268979.115; de Soysa TY, 2019, NATURE, V572, P120, DOI 10.1038/s41586-019-1414-x; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Ebisuya M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164368; Ellis B., 2020, FLOWCORE FLOWCORE BA; Fatima A, 2016, J CLIN INVEST, V126, P2437, DOI 10.1172/JCI80465; Fischer DS, 2019, NAT BIOTECHNOL, V37, P461, DOI 10.1038/s41587-019-0088-0; Grosswendt S, 2020, NATURE, V584, P102, DOI 10.1038/s41586-020-2552-x; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Harvey NT, 2010, J CELL SCI, V123, P1796, DOI 10.1242/jcs.047530; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Ibarra-Soria X, 2018, NAT CELL BIOL, V20, P127, DOI 10.1038/s41556-017-0013-z; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kalhor R, 2018, SCIENCE, V361, P893, DOI 10.1126/science.aat9804; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Kojima Y, 2014, CELL STEM CELL, V14, P107, DOI 10.1016/j.stem.2013.09.014; Kume T, 2009, ADV EXP MED BIOL, V665, P63; Kwon GS, 2008, DEV CELL, V15, P509, DOI 10.1016/j.devcel.2008.07.017; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; LAWSON KA, 1992, CIBA F SYMP, V165, P3; Lescroart F, 2018, SCIENCE, V359, P1177, DOI 10.1126/science.aao4174; Li LY, 2013, DEVELOPMENT, V140, P4533, DOI 10.1242/dev.092866; Liu C, 2018, STEM CELL REP, V11, P43, DOI 10.1016/j.stemcr.2018.05.019; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Metzis V, 2018, CELL, V175, P1105, DOI 10.1016/j.cell.2018.09.040; Mohammed H, 2017, CELL REP, V20, P1215, DOI 10.1016/j.celrep.2017.07.009; Nowotschin S, 2019, NATURE, V569, P361, DOI 10.1038/s41586-019-1127-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Peng GD, 2019, NATURE, V572, P528, DOI 10.1038/s41586-019-1469-8; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Raj B, 2018, NAT BIOTECHNOL, V36, P442, DOI 10.1038/nbt.4103; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Schiebinger G, 2019, CELL, V176, P928, DOI 10.1016/j.cell.2019.01.006; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Spagnoli FM, 2006, CURR OPIN GENET DEV, V16, P469, DOI 10.1016/j.gde.2006.08.004; Spanjaard B, 2018, NAT BIOTECHNOL, V36, P469, DOI 10.1038/nbt.4124; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Stern CD, 2006, INT J DEV BIOL, V50, P3, DOI 10.1387/ijdb.052095cs; Tam PPL, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.179788; TAM PPL, 1987, DEVELOPMENT, V99, P109; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tritschler S, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.170506; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016	69	34	34	3	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 27	2021	184	11					2825	+		10.1016/j.cell.2021.04.004	http://dx.doi.org/10.1016/j.cell.2021.04.004		MAY 2021	40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SL5NT	33932341	Green Published, hybrid			2022-12-28	WOS:000656965600005
J	Boyarsky, BJ; Werbel, WA; Avery, RK; Tobian, AAR; Massie, AB; Segev, DL; Garonzik-Wang, JM				Boyarsky, Brian J.; Werbel, William A.; Avery, Robin K.; Tobian, Aaron A. R.; Massie, Allan B.; Segev, Dorry L.; Garonzik-Wang, Jacqueline M.			Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Boyarsky, Brian J.; Massie, Allan B.; Segev, Dorry L.; Garonzik-Wang, Jacqueline M.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Werbel, William A.; Avery, Robin K.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Tobian, Aaron A. R.] Johns Hopkins Sch Med, Dept Pathol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Segev, DL (corresponding author), Johns Hopkins Med Inst, Dept Surg, 2000 E Monument St, Baltimore, MD 21205 USA.	dorry@jhmi.edu		Garonzik Wang, Jacqueline/0000-0002-2789-7503	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [F32DK124941, K01DK101677, K23DK115908]; National Institute of Allergy and Infectious Diseases (NIAID) [K24AI144954]; Transplantation and Immunology Research Network of the American Society of Transplantation [gSAN-201C0WW]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Transplantation and Immunology Research Network of the American Society of Transplantation	This work was supported by the Ben-Dov family; grants F32DK124941 (Dr Boyarsky), K01DK101677 (Dr Massie), and K23DK115908 (Dr Garonzik-Wang) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); grant K24AI144954 (Dr Segev) from the National Institute of Allergy and Infectious Diseases (NIAID); and by grant gSAN-201C0WW from the Transplantation and Immunology Research Network of the American Society of Transplantation (DrWerbel).	Boyarsky BJ, 2021, JAMA-J AM MED ASSOC, V325, P1784, DOI 10.1001/jama.2021.4385; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Klein S, 2020, J CLIN INVEST, V130, P6141, DOI 10.1172/JCI142004; Mueller T, 2021, CLIN CHIM ACTA, V518, P9, DOI 10.1016/j.cca.2021.03.007; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906	5	541	545	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	2021	325	21					2204	2206		10.1001/jama.2021.7489	http://dx.doi.org/10.1001/jama.2021.7489		MAY 2021	3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	UK2NJ	33950155	Bronze, Green Published			2022-12-28	WOS:000647844600003
J	Pottegard, A; Lund, LC; Karlstad, O; Dahl, J; Andersen, M; Hallas, J; Lidegaard, O; Tapia, G; Gulseth, HL; Ruiz, PLD; Watle, SV; Mikkelsen, AP; Pedersen, L; Sorensen, HT; Thomsen, RW; Hviid, A				Pottegard, Anton; Lund, Lars Christian; Karlstad, Oystein; Dahl, Jesper; Andersen, Morten; Hallas, Jesper; Lidegaard, Ojvind; Tapia, German; Gulseth, Hanne Lovdal; Ruiz, Paz Lopez-Doriga; Watle, Sara Viksmoen; Mikkelsen, Anders Pretzmann; Pedersen, Lars; Sorensen, Henrik Toft; Thomsen, Reimar Wernich; Hviid, Anders			Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT REGISTRY; DANISH; SYSTEM	OBJECTIVE To assess rates of cardiovascular and haemostatic events in the first 28 days after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S in Denmark and Norway and to compare them with rates observed in the general populations. DESIGN Population based cohort study. SETTING Nationwide healthcare registers in Denmark and Norway. PARTICIPANTS All people aged 18-65 years who received a first vaccination with ChAdOx1-S from 9 February 2021 to 11 March 2021. The general populations of Denmark (2016-18) and Norway (2018-19) served as comparator cohorts. MAIN OUTCOME MEASURES Observed 28 day rates of hospital contacts for incident arterial events, venous thromboembolism, thrombocytopenia/coagulation disorders, and bleeding among vaccinated people compared with expected rates, based on national age and sex specific background rates from the general populations of the two countries. RESULTS The vaccinated cohorts comprised 148 792 people in Denmark (median age 45 years, 80% women) and 132 472 in Norway (median age 44 years, 78% women), who received their first dose of ChAdOx1-S. Among 281 264 people who received ChAdOx1-S, the standardised morbidity ratio for arterial events was 0.97 (95% confidence interval 0.77 to 1.20). 59 venous thromboembolic events were observed in the vaccinated cohort compared with 30 expected based on the incidence rates in the general population, corresponding to a standardised morbidity ratio of 1.97 (1.50 to 2.54) and 11 (5.6 to 17.0) excess events per 100 000 vaccinations. A higher than expected rate of cerebral venous thrombosis was observed: standardised morbidity ratio 20.25 (8.14 to 41.73); an excess of 2.5 (0.9 to 5.2) events per 100 000 vaccinations. The standardised morbidity ratio for any thrombocytopenia/coagulation disorders was 1.52 (0.97 to 2.25) and for any bleeding was 1.23 (0.97 to 1.55). 15 deaths were observed in the vaccine cohort compared with 44 expected. CONCLUSIONS Among recipients of ChAdOx1-S, increased rates of venous thromboembolic events, including cerebral venous thrombosis, were observed. For the remaining safety outcomes, results were largely reassuring, with slightly higher rates of thrombocytopenia/coagulation disorders and bleeding, which could be influenced by increased surveillance of vaccine recipients. The absolute risks of venous thromboembolic events were, however, small, and the findings should be interpreted in the light of the proven beneficial effects of the vaccine, the context of the given country, and the limitations to the generalisability of the study findings.	[Pottegard, Anton; Lund, Lars Christian; Hallas, Jesper] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol Pharm & Environm Med, Odense, Denmark; [Karlstad, Oystein; Dahl, Jesper; Tapia, German; Gulseth, Hanne Lovdal; Ruiz, Paz Lopez-Doriga; Watle, Sara Viksmoen] Norwegian Inst Publ Hlth, Oslo, Norway; [Andersen, Morten; Hviid, Anders] Univ Copenhagen, Dept Drug Design & Pharmacol, Pharmacovigilance Res Ctr, Copenhagen, Denmark; [Lidegaard, Ojvind; Mikkelsen, Anders Pretzmann] Rigshosp, Dept Gynaecol, Copenhagen, Denmark; [Lidegaard, Ojvind; Mikkelsen, Anders Pretzmann] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Pedersen, Lars; Sorensen, Henrik Toft; Thomsen, Reimar Wernich] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Pedersen, Lars; Sorensen, Henrik Toft; Thomsen, Reimar Wernich] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark	University of Southern Denmark; Norwegian Institute of Public Health (NIPH); University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University; Aarhus University; Statens Serum Institut	Pottegard, A (corresponding author), Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol Pharm & Environm Med, Odense, Denmark.	apottegaard@health.sdu.dk	Andersen, Morten/H-3555-2011; Karlstad, Øystein/AAC-9873-2022	Andersen, Morten/0000-0001-7029-2860; Karlstad, Øystein/0000-0003-1204-787X; Pottegard, Anton/0000-0001-9314-5679; Lund, Lars Christian/0000-0001-8651-6072; Mikkelsen, Anders Pretzmann/0000-0002-7583-9826; Thomsen, Reimar/0000-0001-9135-3474; Toft Sorensen, Henrik/0000-0003-4299-7040				Agency EM, 2021, M HIGHL PHARM RISK A; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bakken IJ, 2020, SCAND J PUBLIC HEALT, V48, P49, DOI 10.1177/1403494819859737; Blauenfeldt RA, 2021, J THROMB HAEMOST, V19, P1771, DOI 10.1111/jth.15347; Breslow N E, 1987, IARC Sci Publ, P1; Cines DB, 2021, NEW ENGL J MED, V384, P2254, DOI 10.1056/NEJMe2106315; Dalager-Pedersen M, 2021, CLIN INFECT DIS, V2021, DOI 10.1093/cid/ciab003; Darby AC, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n771; EMA, COVID 19 VACC ASTRAZ; European Medicines Agency (EMA), EMA1584242021; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Greinacher A, 2021, RES SQ, DOI [DOI 10.7774/cevr.2012.1.1.18, DOI 10.21203/RS.3.RS-362354/V1]; Greinacher A, 2021, NEW ENGL J MED, V384, P2092, DOI 10.1056/NEJMoa2104840; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Krause TG, 2012, EUROSURVEILLANCE, V17, P5; Ludvigsson JF, 2015, CLIN EPIDEMIOL, V7, P491, DOI 10.2147/CLEP.S90589; Norwegian Institute of Public Health, EM PREP REG COVID 19; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Schmidt M, 2019, CLIN EPIDEMIOL, V11, P563, DOI 10.2147/CLEP.S179083; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI 10.1056/NEJMoa2104882; Scully M, 2021, NEW ENGL J MED, V384, P2202, DOI 10.1056/NEJMoa2105385; Thygesen LC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-571; Trogstad L, 2012, EUROSURVEILLANCE, V17, P11; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Voldstedlund M, 2014, EUROSURVEILLANCE, V19, P29, DOI 10.2807/1560-7917.ES2014.19.1.20667; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n699; Wolberg AS, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.6; World Health Organization, COVID 19 WEEKL EPID	32	197	199	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n1114	10.1136/bmj.n1114	http://dx.doi.org/10.1136/bmj.n1114			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952445	Green Published, hybrid			2022-12-28	WOS:000651241900001
J	Grome, MW; Isaacs, FJ				Grome, Michael W.; Isaacs, Farren J.			ZTCG: Viruses expand the genetic alphabet	SCIENCE			English	Editorial Material							BASE; DNA; 2-AMINOADENINE; CLEAVAGE		[Grome, Michael W.; Isaacs, Farren J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Grome, Michael W.; Isaacs, Farren J.] Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA; [Grome, Michael W.; Isaacs, Farren J.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Isaacs, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Isaacs, FJ (corresponding author), Yale Univ, Syst Biol Inst, West Haven, CT 06516 USA.; Isaacs, FJ (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	farren.isaacs@yale.edu			NIH [R01GM140481, R01GM125951, R01GM117230, U54CA209992]; NSF [EF-1935120, IOS1923321]; US Department of Energy (BER)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); US Department of Energy (BER)(United States Department of Energy (DOE))	We are supported by the NIH (R01GM140481, R01GM125951, R01GM117230,U54CA209992), NSF (EF-1935120,IOS1923321), and US Department of Energy (BER).	Callahan MP, 2011, P NATL ACAD SCI USA, V108, P13995, DOI 10.1073/pnas.1106493108; CHEONG C, 1988, NUCLEIC ACIDS RES, V16, P5115, DOI 10.1093/nar/16.11.5115; CHOLLET A, 1988, NUCLEIC ACIDS RES, V16, P305, DOI 10.1093/nar/16.1.305; Cristofalo M, 2019, BIOPHYS J, V116, P760, DOI 10.1016/j.bpj.2019.01.027; KHUDYAKOV IY, 1978, VIROLOGY, V88, P8, DOI 10.1016/0042-6822(78)90104-6; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Pezo V, 2021, SCIENCE, V372, P520, DOI 10.1126/science.abe6542; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Seeman NC, 2018, NAT REV MATER, V3, DOI 10.1038/natrevmats.2017.68; Sleiman D, 2021, SCIENCE, V372, P516, DOI 10.1126/science.abe6494; SZEKERES M, 1987, FEBS LETT, V222, P89, DOI 10.1016/0014-5793(87)80197-7; Yang ZY, 2007, NUCLEIC ACIDS RES, V35, P4238, DOI 10.1093/nar/gkm395; Zhang WM, 2020, ANNU REV BIOCHEM, V89, P77, DOI 10.1146/annurev-biochem-013118-110704; Zhou Y, 2021, SCIENCE, V372, P512, DOI 10.1126/science.abe4882	15	2	2	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					460	561		10.1126/science.abh3571	http://dx.doi.org/10.1126/science.abh3571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926938				2022-12-28	WOS:000645554100024
J	Zhou, Y; Xu, XX; Wei, YF; Cheng, Y; Guo, Y; Khudyakov, I; Liu, FL; He, P; Song, ZY; Li, Z; Gao, Y; Ang, EL; Zhao, HM; Zhang, Y; Zhao, SW				Zhou, Yan; Xu, Xuexia; Wei, Yifeng; Cheng, Yu; Guo, Yu; Khudyakov, Ivan; Liu, Fuli; He, Ping; Song, Zhangyue; Li, Zhi; Gao, Yan; Ang, Ee Lui; Zhao, Huimin; Zhang, Yan; Zhao, Suwen			A widespread pathway for substitution of adenine by diaminopurine in phage genomes	SCIENCE			English	Article							ADENYLOSUCCINATE SYNTHETASE; SEMISYNTHETIC ORGANISM; DNA; BASE; 2-AMINOADENINE; COMPLEXES; CLEAVAGE; RNA	DNA modifications vary in form and function but generally do not alter Watson-Crick base pairing. Diaminopurine (Z) is an exception because it completely replaces adenine and forms three hydrogen bonds with thymine in cyanophage S-2L genomic DNA. However, the biosynthesis, prevalence, and importance of Z genomes remain unexplored. Here, we report a multienzyme system that supports Z-genome synthesis. We identified dozens of globally widespread phages harboring such enzymes, and we further verified the Z genome in one of these phages, Acinetobacter phage SH-Ab 15497, by using liquid chromatography with ultraviolet and mass spectrometry. The Z genome endows phages with evolutionary advantages for evading the attack of host restriction enzymes, and the characterization of its biosynthetic pathway enables Z-DNA production on a large scale for a diverse range of applications.	[Zhou, Yan; Li, Zhi; Gao, Yan; Zhang, Yan] Tianjin Univ, Tianjin Key Lab Modem Drug Delivery & High Effici, Collaborat Innovat Ctr Chem Sci & Engn, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China; [Zhou, Yan; Zhang, Yan] Tianjin Univ, Frontiers Sci Ctr Synthet Biol, Minist Educ, Tianjin 300072, Peoples R China; [Xu, Xuexia; Cheng, Yu; Guo, Yu; Zhao, Suwen] Shanghai Tech Univ, iHuman Inst, Shanghai 201210, Peoples R China; [Xu, Xuexia; Cheng, Yu; Guo, Yu; Zhao, Suwen] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Xu, Xuexia] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Xu, Xuexia] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Shanghai 200061, Peoples R China; [Wei, Yifeng; Ang, Ee Lui; Zhao, Huimin] ASTAR, Singapore Inst Food & Biotechnol Innovat, Singapore, Singapore; [Khudyakov, Ivan] All Russian Res Inst Agr Microbiol, St Petersburg 196608, Russia; [Liu, Fuli; He, Ping] Shanghai Jiao Tong Univ, Dept Med Microbiol & Immunol, Sch Med, Shanghai 200025, Peoples R China; [Song, Zhangyue] Shanghai Tech Univ, SIAIS, Biomed Big Data Platform, Shanghai 201210, Peoples R China; [Zhao, Huimin] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA	Tianjin University; Tianjin University; ShanghaiTech University; ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Agency for Science Technology & Research (A*STAR); Shanghai Jiao Tong University; ShanghaiTech University; University of Illinois System; University of Illinois Urbana-Champaign	Zhang, Y (corresponding author), Tianjin Univ, Tianjin Key Lab Modem Drug Delivery & High Effici, Collaborat Innovat Ctr Chem Sci & Engn, Sch Pharmaceut Sci & Technol, Tianjin 300072, Peoples R China.; Zhang, Y (corresponding author), Tianjin Univ, Frontiers Sci Ctr Synthet Biol, Minist Educ, Tianjin 300072, Peoples R China.; Zhao, SW (corresponding author), Shanghai Tech Univ, iHuman Inst, Shanghai 201210, Peoples R China.; Zhao, SW (corresponding author), Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Zhao, HM (corresponding author), ASTAR, Singapore Inst Food & Biotechnol Innovat, Singapore, Singapore.; Zhao, HM (corresponding author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.	zhao5@illinois.edu; zhang@tju.edu.cn; zhaosw@shanghaitech.edu.cn		Zhang, Yan/0000-0003-2031-0631	National Key R&D Program of China [2019YFA0905700, 2018YFA0507000, 2016YFC0905900]; National Natural Science Foundation of China [31971178, 31870049]; Agency for Science, Research and Technology of Singapore Visiting Investigator Program [1535j00137]; Advanced Manufacturing and Engineering Programmatic Grant [A18A9b0060]; ShanghaiTech University	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agency for Science, Research and Technology of Singapore Visiting Investigator Program(Agency for Science Technology & Research (A*STAR)); Advanced Manufacturing and Engineering Programmatic Grant; ShanghaiTech University	This work was supported by the National Key R&D Program of China 2019YFA0905700 (Y.Zhang), 2018YFA0507000 (S.Z.), 2016YFC0905900 (S.Z.), the National Natural Science Foundation of China grants 31971178 (S.Z.), 31870049 (Y.Zhang), the Agency for Science, Research and Technology of Singapore Visiting Investigator Program Grant 1535j00137 (H.Z.), and Advanced Manufacturing and Engineering Programmatic Grant A18A9b0060 (Y.W., E.L.A., and H.Z.). S.Z. thanks ShanghaiTech University for funding.	Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Bridwell-Rabb J, 2016, P NATL ACAD SCI USA, V113, P13750, DOI 10.1073/pnas.1613610113; Callahan MP, 2011, P NATL ACAD SCI USA, V108, P13995, DOI 10.1073/pnas.1106493108; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Ceze L, 2019, NAT REV GENET, V20, P456, DOI 10.1038/s41576-019-0125-3; CHEONG C, 1988, NUCLEIC ACIDS RES, V16, P5115, DOI 10.1093/nar/16.11.5115; Choe JY, 1999, BIOCHEMISTRY-US, V38, P6953, DOI 10.1021/bi990159s; CHOLLET A, 1988, NUCLEIC ACIDS RES, V16, P305, DOI 10.1093/nar/16.1.305; Cristofalo M, 2019, BIOPHYS J, V116, P760, DOI 10.1016/j.bpj.2019.01.027; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dedrick RM, 2019, NAT MED, V25, P730, DOI 10.1038/s41591-019-0437-z; Gerlt JA, 2017, BIOCHEMISTRY-US, V56, P4293, DOI 10.1021/acs.biochem.7b00614; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gollihar J, 2014, SCIENCE, V343, P259, DOI 10.1126/science.1246704; Greene BL, 2020, ANNU REV BIOCHEM, V89, P45, DOI 10.1146/annurev-biochem-013118-111843; Han RM, 2018, BIOINFORMATICS, V34, P722, DOI 10.1093/bioinformatics/bty555; Honzatko RB, 1999, ARCH BIOCHEM BIOPHYS, V370, P1, DOI 10.1006/abbi.1999.1383; Hoshika S, 2019, SCIENCE, V363, P884, DOI 10.1126/science.aat0971; Hua GQ, 2018, ANAL BIOCHEM, V547, P26, DOI 10.1016/j.ab.2018.02.002; Hua YF, 2019, ACTA BIOCH BIOPH SIN, V51, P1079, DOI 10.1093/abbs/gmz094; Iancu CV, 2002, J BIOL CHEM, V277, P40536, DOI 10.1074/jbc.M204952200; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; KANG C, 1994, J BIOL CHEM, V269, P24046; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KHUDYAKOV IY, 1978, VIROLOGY, V88, P8, DOI 10.1016/0042-6822(78)90104-6; KIRNOS MD, 1977, NATURE, V270, P369, DOI 10.1038/270369a0; Kohn G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043879; Malyshev DA, 2014, NATURE, V509, P385, DOI 10.1038/nature13314; Marliere P., 2003, Patent, Patent No. [WO2003093461, 2003093461]; Mehrotra S, 2007, BIOCHEMISTRY-US, V46, P12821, DOI 10.1021/bi701009y; Moye ZD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040205; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sagi J, 1996, J BIOMOL STRUCT DYN, V13, P1035, DOI 10.1080/07391102.1996.10508918; Schooley RT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00954-17; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stoiber M., 2017, 094672V2 BIORXIV; SZEKERES M, 1987, FEBS LETT, V222, P89, DOI 10.1016/0014-5793(87)80197-7; Weigele P, 2016, CHEM REV, V116, P12655, DOI 10.1021/acs.chemrev.6b00114; Xu L, 2020, J HUM GENET, V65, P25, DOI 10.1038/s10038-019-0679-0; Zhang Y, 2017, NATURE, V551, P644, DOI 10.1038/nature24659; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	43	31	40	22	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					512	+		10.1126/science.abe4882	http://dx.doi.org/10.1126/science.abe4882			50	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926954				2022-12-28	WOS:000645554100047
J	Guirguis-Blake, JM; Evans, CV; Webber, EM; Coppola, EL; Perdue, LA; Weyrich, MS				Guirguis-Blake, Janelle M.; Evans, Corinne V.; Webber, Elizabeth M.; Coppola, Erin L.; Perdue, Leslie A.; Weyrich, Meghan Soulsby			Screening for Hypertension in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CARDIOVASCULAR-DISEASE PREVENTION; WHITE-COAT HYPERTENSION; HIGH BLOOD-PRESSURE; MASKED HYPERTENSION; PHYSICAL-ACTIVITY; HEALTHFUL DIET; PROMOTE	ImportanceHypertension is a major risk factor for cardiovascular disease and can be modified through lifestyle and pharmacological interventions to reduce cardiovascular events and mortality. ObjectiveTo systematically review the benefits and harms of screening and confirmatory blood pressure measurements in adults, to inform the US Preventive Services Task Force. Data SourcesMEDLINE, PubMed, Cochrane Collaboration Central Registry of Controlled Trials, and CINAHL; surveillance through March 26, 2021. Study SelectionRandomized clinical trials (RCTs) and nonrandomized controlled intervention studies for effectiveness of screening; accuracy studies for screening and confirmatory measurements (ambulatory blood pressure monitoring as the reference standard); RCTs and nonrandomized controlled intervention studies and observational studies for harms of screening and confirmation. Data Extraction and SynthesisIndependent critical appraisal and data abstraction; meta-analyses and qualitative syntheses. Main Outcomes and MeasuresMortality; cardiovascular events; quality of life; sensitivity, specificity, positive and negative predictive values; harms of screening. ResultsA total of 52 studies (N=215534) were identified in this systematic review. One cluster RCT (n=140642) of a multicomponent intervention including hypertension screening reported fewer annual cardiovascular-related hospital admissions for cardiovascular disease in the intervention group compared with the control group (difference, 3.02 per 1000 people; rate ratio, 0.91 [95% CI, 0.86-0.97]). Meta-analysis of 15 studies (n=11309) of initial office-based blood pressure screening showed a pooled sensitivity of 0.54 (95% CI, 0.37-0.70) and specificity of 0.90 (95% CI, 0.84-0.95), with considerable clinical and statistical heterogeneity. Eighteen studies (n=57128) of various confirmatory blood pressure measurement modalities were heterogeneous. Meta-analysis of 8 office-based confirmation studies (n=53183) showed a pooled sensitivity of 0.80 (95% CI, 0.68-0.88) and specificity of 0.55 (95% CI, 0.42-0.66). Meta-analysis of 4 home-based confirmation studies (n=1001) showed a pooled sensitivity of 0.84 (95% CI, 0.76-0.90) and a specificity of 0.60 (95% CI, 0.48-0.71). Thirteen studies (n=5150) suggested that screening was associated with no decrement in quality of life or psychological distress; evidence on absenteeism was mixed. Ambulatory blood pressure measurement was associated with temporary sleep disturbance and bruising. Conclusions and RelevanceScreening using office-based blood pressure measurement had major accuracy limitations, including misdiagnosis; however, direct harms of measurement were minimal. Research is needed to determine optimal screening and confirmatory algorithms for clinical practice. This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening for hypertension summarizes published evidence on the benefits and harms of hypertension screening and confirmatory blood pressure measurements in adults 18 years or older without known hypertension.	[Guirguis-Blake, Janelle M.] Univ Washington, Dept Family Med, Tacoma, WA USA; [Guirguis-Blake, Janelle M.; Evans, Corinne V.; Webber, Elizabeth M.; Coppola, Erin L.; Perdue, Leslie A.] Kaiser Permanente, Kaiser Permanente Evidence Based Practice Ctr, Ctr Hlth Res, Portland, OR USA; [Weyrich, Meghan Soulsby] Univ Calif Davis, Ctr Healthcare Policy & Res, Sacramento, CA 95817 USA	University of Washington; University of Washington Tacoma; Kaiser Permanente; University of California System; University of California Davis	Guirguis-Blake, JM (corresponding author), Univ Washington, Dept Family Med, Kaiser Permanente Evidence Based Practice Ctr, 521 Martin Luther King Jr Way, Tacoma, WA 98405 USA.	jguirgui@u.washington.edu						American Academy of Family Physicians, CLIN PREV SERV REC H; American Medical Association, 2021, US BLOOD PRESS VAL D; Asayama K, 2014, HYPERTENSION, V64, P935, DOI 10.1161/HYPERTENSIONAHA.114.03614; Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P1997, DOI 10.1001/jama.2016.15450; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Briasoulis A, 2016, J HYPERTENS, V34, P593, DOI 10.1097/HJH.0000000000000832; Centers for Medicare & Medicaid Services, 2019, DEC MEM AMB BLOOD PR; Cohen JB, 2019, ANN INTERN MED, V170, P853, DOI 10.7326/M19-0223; Conen D, 2014, HYPERTENSION, V64, P1073, DOI 10.1161/HYPERTENSIONAHA.114.03957; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P478, DOI 10.1001/jama.2018.10321; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P272, DOI 10.1001/jama.2018.8359; Flint AC, 2019, NEW ENGL J MED, V381, P243, DOI 10.1056/NEJMoa1803180; Grossman DC, 2017, JAMA-J AM MED ASSOC, V318, P167, DOI 10.1001/jama.2017.7171; Guirguis-Blake JM, 2021, JAMA-J AM MED ASSOC, V325, P1657, DOI 10.1001/jama.2020.21669; Guirguis-Blake JM., 2021, SCREENING HYPERTENSI; Huang YL, 2017, J HYPERTENS, V35, P677, DOI 10.1097/HJH.0000000000001226; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; LeFevre ML, 2014, ANN INTERN MED, V161, P587, DOI 10.7326/M14-1796; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Moyer VA, 2013, ANN INTERN MED, V159, P613, DOI 10.7326/0003-4819-159-9-201311050-00725; Muntner P, 2019, HYPERTENSION, V73, pE35, DOI 10.1161/HYP.0000000000000087; National High Blood Pressure Education Program, 2004, 7 REP JOINT NAT COMM; Ostchega Y., 2020, HYPERTENSION PREVALE; Pierdomenico SD, 2011, AM J HYPERTENS, V24, P52, DOI 10.1038/ajh.2010.203; Procedure Manual, 2018, US PREV SERV TASK FO; Shimbo D, 2020, CIRCULATION, V142, pE42, DOI 10.1161/CIR.0000000000000803; Shimbo D, 2019, ANN INTERN MED, V170, P890, DOI 10.7326/M19-1134; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; Wang YC, 2017, AM J EPIDEMIOL, V185, P194, DOI 10.1093/aje/kww237; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]	32	23	24	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1657	1669		10.1001/jama.2020.21669	http://dx.doi.org/10.1001/jama.2020.21669			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904862	Bronze			2022-12-28	WOS:000645617800023
J	Siskind, SM; Lee, SY; Pearce, EN				Siskind, Samantha M.; Lee, Sun Y.; Pearce, Elizabeth N.			Investigating hypothyroidism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AMERICAN THYROID ASSOCIATION; CLINICAL ENDOCRINOLOGISTS; TASK-FORCE; DYSFUNCTION; GUIDELINES; RECOMMENDATION; ADULTS		[Siskind, Samantha M.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Lee, Sun Y.; Pearce, Elizabeth N.] Boston Univ, Sch Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA	Boston University; Boston University	Pearce, EN (corresponding author), Boston Univ, Sch Med, Sect Endocrinol Diabet Nutr & Weight Management, Boston, MA 02118 USA.	Elizabeth.Pearce@bmc.org		Lee, Sun Young/0000-0002-6928-7471; Pearce, Elizabeth/0000-0003-3799-0354				Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; Birtwhistle R, 2019, CAN MED ASSOC J, V191, pE1274, DOI 10.1503/cmaj.190395; Carle A, 2016, AM J MED, V129, P1082, DOI 10.1016/j.amjmed.2016.06.013; Chaker L, 2017, LANCET, V390, P1550, DOI 10.1016/S0140-6736(17)30703-1; Choosing Wisely Canada, 2020, END MET 5 THINGS PHY; Diez JJ, 2005, J CLIN ENDOCR METAB, V90, P4124, DOI 10.1210/jc.2005-0375; Drui D, 2018, ANN ENDOCRINOL-PARIS, V79, P569, DOI 10.1016/j.ando.2018.07.003; Favresse J, 2018, ENDOCR REV, V39, P830, DOI 10.1210/er.2018-00119; Garber JR, 2012, THYROID, V22, P1200, DOI 10.1089/thy.2012.0205; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Hennessey JV, 2016, ENDOCR PRACT, V22, P262, DOI 10.4158/EP151038.PS; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Karlsson B, 1998, ARCH DIS CHILD, V79, P242, DOI 10.1136/adc.79.3.242; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Muir CA, 2020, THYROID, V30, P1458, DOI 10.1089/thy.2020.0032; National Institute for Health and Care Excellence, 2019, THYR DIS ASS MAN NG1; NHS Clinical Commissioners, 2019, IT WHICH SHOULD NOT; Pasquali R, 2020, EUR J ENDOCRINOL, V182, pG1, DOI 10.1530/EJE-19-0893; Peterson SJ, 2018, THYROID, V28, P707, DOI 10.1089/thy.2017.0681; Schmidt RL, 2018, THYROID, V28, P842, DOI 10.1089/thy.2017.0645; Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18; Umpierrez GE, 2003, DIABETES CARE, V26, P1181, DOI 10.2337/diacare.26.4.1181; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x	23	3	3	2	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2021	373								n993	10.1136/bmj.n993	http://dx.doi.org/10.1136/bmj.n993			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RW1QM	33906834				2022-12-28	WOS:000646297900003
J	Famiglietti, JS; Ferguson, G				Famiglietti, James S.; Ferguson, Grant			The hidden crisis beneath our feet	SCIENCE			English	Editorial Material								Disappearing groundwater requires action to prevent widespread water scarcity	[Famiglietti, James S.; Ferguson, Grant] Univ Saskatchewan, Global Inst Water Secur, Saskatoon, SK S7N 3H5, Canada; [Famiglietti, James S.; Ferguson, Grant] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5C8, Canada; [Ferguson, Grant] Univ Saskatchewan, Dept Civil Geol & Environm Engn, Saskatoon, SK S7N 5A9, Canada; [Ferguson, Grant] Univ Arizona, Dept Hydrol & Atmospher Sci, Tucson, AZ 85721 USA	University of Saskatchewan; Global Institute for Water Security; University of Saskatchewan; University of Saskatchewan; University of Arizona	Famiglietti, JS (corresponding author), Univ Saskatchewan, Global Inst Water Secur, Saskatoon, SK S7N 3H5, Canada.; Famiglietti, JS (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK S7N 5C8, Canada.	jay.famiglietti@usask.ca	Famiglietti, James S/G-7383-2017; Ferguson, Grant/C-3597-2009	Famiglietti, James S/0000-0002-6053-5379; Ferguson, Grant/0000-0001-8519-1771				Butler JJ, 2016, GEOPHYS RES LETT, V43, P2004, DOI 10.1002/2016GL067879; Condon LE, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav4574; Famiglietti JS, 2014, NAT CLIM CHANGE, V4, P945, DOI 10.1038/nclimate2425; Gleeson T, 2020, ANNU REV EARTH PL SC, V48, P431, DOI 10.1146/annurev-earth-071719-055251; Gorelick SM, 2015, WATER RESOUR RES, V51, P3031, DOI 10.1002/2014WR016825; Hoogesteger J, 2015, ENVIRON SCI POLICY, V51, P117, DOI 10.1016/j.envsci.2015.04.004; Jasechko S, 2021, SCIENCE, V372, P418, DOI 10.1126/science.abc2755; Richey AS, 2015, WATER RESOUR RES, V51, P5198, DOI 10.1002/2015WR017351; Rodell M, 2018, NATURE, V557, P650, DOI 10.1038/s41586-018-0123-1; Shiklomanov I., 1993, WATER CRISIS GUIDE W, P504; Villholth K, 2018, ADV GROUNDWATER GOVE	11	9	9	19	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					344	345		10.1126/science.abh2867	http://dx.doi.org/10.1126/science.abh2867			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888627				2022-12-28	WOS:000645009800021
J	Alves, L				Alves, Lise			Brazilian ICUs short of drugs and beds amid COVID-19 surge	LANCET			English	Editorial Material																			0	8	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1431	1432						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33865483	Green Published, Bronze			2022-12-28	WOS:000640378100008
J	Prasad, A				Prasad, Aarathi			Dawn Edge: advancing inclusivity in mental health services	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 17	2021	397	10283					1435	1435						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RN5FX	33865485				2022-12-28	WOS:000640378100010
J	Belbin, GM; Cullina, S; Wenric, S; Soper, ER; Glicksberg, BS; Torre, D; Moscati, A; Wojcik, GL; Shemirani, R; Beckmann, ND; Cohain, A; Sorokin, EP; Park, DS; Ambite, JL; Ellis, S; Auton, A; Bottinger, EP; Cho, JH; Loos, RJF; Abul-Husn, NS; Zaitlen, NA; Gignoux, CR; Kenny, EE				Belbin, Gillian M.; Cullina, Sinead; Wenric, Stephane; Soper, Emily R.; Glicksberg, Benjamin S.; Torre, Denis; Moscati, Arden; Wojcik, Genevieve L.; Shemirani, Ruhollah; Beckmann, Noam D.; Cohain, Ariella; Sorokin, Elena P.; Park, Danny S.; Ambite, Jose-Luis; Ellis, Steve; Auton, Adam; Bottinger, Erwin P.; Cho, Judy H.; Loos, Ruth J. F.; Abul-Husn, Noura S.; Zaitlen, Noah A.; Gignoux, Christopher R.; Kenny, Eimear E.		CBIPM Genomics Team; Regeneron Genetics Ctr	Toward a fine-scale population health monitoring system	CELL			English	Article							PRECISION MEDICINE; PUERTO-RICAN; GAUCHER-DISEASE; RISK; ANCESTRY; APOL1; RACE; IDENTITY; DIVERSE; ASTHMA	Understanding population health disparities is an essential component of equitable precision health efforts. Epidemiology research often relies on definitions of race and ethnicity, but these population labels may not adequately capture disease burdens and environmental factors impacting specific sub-populations. Here, we propose a framework for repurposing data from electronic health records (EHRs) in concert with genomic data to explore the demographic ties that can impact disease burdens. Using data from a diverse biobank in New York City, we identified 17 communities sharing recent genetic ancestry. We observed 1,177 health outcomes that were statistically associated with a specific group and demonstrated significant differences in the segregation of genetic variants contributing to Mendelian diseases. We also demonstrated that fine-scale population structure can impact the prediction of complex disease risk within groups. This work reinforces the utility of linking genomic data to EHRs and provides a framework toward fine-scale monitoring of population health.	[Belbin, Gillian M.; Cullina, Sinead; Wenric, Stephane; Soper, Emily R.; Abul-Husn, Noura S.; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Inst Genom Hlth, New York, NY 10029 USA; [Belbin, Gillian M.; Loos, Ruth J. F.; Abul-Husn, Noura S.; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Belbin, Gillian M.; Cullina, Sinead; Wenric, Stephane; Moscati, Arden; Ellis, Steve; Cho, Judy H.; Loos, Ruth J. F.; CBIPM Genomics Team] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Glicksberg, Benjamin S.; Torre, Denis; Beckmann, Noam D.; Cohain, Ariella; Park, Danny S.; Abul-Husn, Noura S.; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Glicksberg, Benjamin S.; Bottinger, Erwin P.] Icahn Sch Med Mt Sinai, Hasso Plattner Inst Digital Hlth Mt Sinai, New York, NY 10029 USA; [Wojcik, Genevieve L.; Sorokin, Elena P.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Shemirani, Ruhollah; Ambite, Jose-Luis] Univ Southern Calif, Inst Informat Sci, Marina Del Rey, CA 90089 USA; [Park, Danny S.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Auton, Adam] Albert Einstein Coll Med, Dept Genet, New York, NY 10461 USA; [Regeneron Genetics Ctr] Regeneron Genet Ctr, New York, NY 10591 USA; [Zaitlen, Noah A.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90033 USA; [Gignoux, Christopher R.] Univ Colorado, Colorado Ctr Personalized Med, Anschutz Med Campus, Aurora, CO 80045 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; University of Southern California; University of California System; University of California San Francisco; Yeshiva University; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Anschutz Medical Campus	Kenny, EE (corresponding author), Icahn Sch Med Mt Sinai, Inst Genom Hlth, New York, NY 10029 USA.; Kenny, EE (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Kenny, EE (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	eimear.kenny@mssm.edu	Shemirani, Ruhollah/HGV-1472-2022; Loos, Ruth/GON-5877-2022; Loos, Ruth/Q-2862-2016	Shemirani, Ruhollah/0000-0003-1065-7244; Soper, Emily/0000-0002-7289-1418; Loos, Ruth/0000-0002-8532-5087; Cullina, Sinead F/0000-0003-1946-7746; Glicksberg, Benjamin/0000-0003-4515-8090	Office of Research Infrastructure of the National Institutes of Health [S10OD018522, S10OD026880]	Office of Research Infrastructure of the National Institutes of Health	Research reported in this paper was supported by the Office of Research Infrastructure of the National Institutes of Health under award numbers S10OD018522 and S10OD026880. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abul-Husn NS, 2019, GENOME MED, V12, DOI 10.1186/s13073-019-0691-1; Abul-Husn NS, 2019, CELL, V177, P58, DOI 10.1016/j.cell.2019.02.039; Aguayo-Mazzucato C, 2019, DIABETES-METAB RES, V35, DOI 10.1002/dmrr.3097; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; Allison MA, 2015, J VASC SURG, V62, P665, DOI 10.1016/j.jvs.2015.03.065; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amendola LM, 2018, AM J HUM GENET, V103, P319, DOI 10.1016/j.ajhg.2018.08.007; Arnold SE, 2013, J ALZHEIMERS DIS, V33, P1089, DOI 10.3233/JAD-2012-121570; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Auton A., 2015, NATURE, V7571, P68, DOI 10.1038/nature15393; Balwani M, 2010, ARCH INTERN MED, V170, P1463, DOI 10.1001/archinternmed.2010.302; Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Belbin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.25060; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Boursi B, 2013, EUR J CANCER, V49, P3680, DOI 10.1016/j.ejca.2013.06.040; Browning SR, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007385; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Browning SR, 2012, ANNU REV GENET, V46, P617, DOI 10.1146/annurev-genet-110711-155534; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Campos CL, 2019, CURR OPIN CARDIOL, V34, P350, DOI 10.1097/HCO.0000000000000636; Cann HM, 2002, SCIENCE, V296, P261; CARTERPOKRAS OD, 1993, AM J PUBLIC HEALTH, V83, P580, DOI 10.2105/AJPH.83.4.580; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; De La Vega FM, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0610-x; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Deng XL, 2017, TRENDS PHARMACOL SCI, V38, P15, DOI 10.1016/j.tips.2016.10.013; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Durrett R., 2006, RANDOM GRAPH DYNAMIC, P27; Ekrikpo UE, 2020, AM J KIDNEY DIS, V76, P100, DOI 10.1053/j.ajkd.2020.01.006; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Gutierrez OM, 2020, AM J KIDNEY DIS, V75, P54, DOI 10.1053/j.ajkd.2019.05.027; Han EJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14238; Hassan MO, 2020, NEPHRON, V144, P331, DOI 10.1159/000507860; Herrera-Paz EF, 2010, AM J HUM BIOL, V22, P36, DOI 10.1002/ajhb.20922; Homa DM, 2000, AM J RESP CRIT CARE, V161, P504, DOI 10.1164/ajrccm.161.2.9906025; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hui L, 2017, ANNU REV MED, V68, P459, DOI 10.1146/annurev-med-072115-033220; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; King M.C., 2001, PATHOL BIOL PARIS, V286, P384; Klinger EV, 2015, J GEN INTERN MED, V30, P719, DOI 10.1007/s11606-014-3102-8; Kramer HJ, 2017, J AM SOC NEPHROL, V28, P915, DOI 10.1681/ASN.2016030357; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Liang J, 2013, AM J EPIDEMIOL, V177, P1169, DOI 10.1093/aje/kws382; Makani J, 2007, ANN TROP MED PARASIT, V101, P3, DOI 10.1179/136485907X154638; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Maples BK, 2013, AM J HUM GENET, V93, P278, DOI 10.1016/j.ajhg.2013.06.020; Martin AR, 2019, NAT GENET, V51, P584, DOI 10.1038/s41588-019-0379-x; Martin AR, 2018, AM J HUM GENET, V102, P760, DOI 10.1016/j.ajhg.2018.03.003; Martin AR, 2017, AM J HUM GENET, V100, P635, DOI 10.1016/j.ajhg.2017.03.004; Mathias RA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12522; McInnes L., 2018, UMAP UNIFORM MANIFOL, DOI DOI 10.21105/JOSS.00861; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Miller AK, 2020, BMC MED GENET, V21, DOI 10.1186/s12881-020-01048-4; Mooney JA, 2018, AM J HUM GENET, V103, P707, DOI 10.1016/j.ajhg.2018.09.013; Moreno-Estrada A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003925; Nadkarni GN, 2018, NEW ENGL J MED, V379, P2571, DOI 10.1056/NEJMc1800748; Nakatsuka N, 2017, NAT GENET, V49, P1403, DOI 10.1038/ng.3917; Narasimhan V, 2016, BIOINFORMATICS, V32, P1749, DOI 10.1093/bioinformatics/btw044; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Nqebelele NU, 2019, KIDNEY INT REP, V4, P939, DOI 10.1016/j.ekir.2019.05.006; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Oh SS, 2016, AM J RESP CRIT CARE, V193, P348, DOI 10.1164/rccm.201510-2045ED; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Peters DG, 2015, SEMIN PERINATOL, V39, P44, DOI 10.1053/j.semperi.2014.10.009; Prasad P, 2014, ARTHRIT CARE RES, V66, P337, DOI 10.1002/acr.22118; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018209; Shaag A, 2005, HUM MOL GENET, V14, P555, DOI 10.1093/hmg/ddi052; Shemirani R., 2019, BIORXIV, DOI [10.1101/749507, DOI 10.1101/749507]; Smith N, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-316; Staples J, 2018, AM J HUM GENET, V102, P874, DOI 10.1016/j.ajhg.2018.03.012; Stark Z, 2019, AM J HUM GENET, V104, P13, DOI 10.1016/j.ajhg.2018.11.014; Szentpetery SE, 2016, J ALLERGY CLIN IMMUN, V138, P1556, DOI 10.1016/j.jaci.2016.08.047; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thakoordeen-Reddy S, 2020, EUR J OBSTET GYN R B, V246, P129, DOI 10.1016/j.ejogrb.2020.01.034; Thompson EA, 2013, GENETICS, V194, P301, DOI 10.1534/genetics.112.148825; Trivedi BP, 2017, SCIENCE, V358, P436, DOI 10.1126/science.358.6362.436; Umeukeje EM, 2019, AM J KIDNEY DIS, V74, P811, DOI 10.1053/j.ajkd.2019.06.006; Villani C, 2009, GRUNDLEHR MATH WISS, V338, P93; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Williams CD, 2019, J RACIAL ETHN HEALTH, V6, P570, DOI 10.1007/s40615-018-00556-7; Wong SN, 2013, WORLD J HEPATOL, V5, P214, DOI 10.4254/wjh.v5.i4.214; Wu JP, 2019, JMIR MED INF, V7, DOI 10.2196/13476; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zuckerman S, 2007, JAMA-J AM MED ASSOC, V298, P1281, DOI 10.1001/jama.298.11.1281	98	24	24	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2021	184	8					2068	+		10.1016/j.cell.2021.03.034	http://dx.doi.org/10.1016/j.cell.2021.03.034		APR 2021	27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RN5JL	33861964	Bronze, Green Submitted			2022-12-28	WOS:000640387300017
J	Tan, JX; Zhang, X; Wang, XF; Xu, CH; Chang, SH; Wu, HJ; Wang, T; Liang, HH; Gao, HC; Zhou, Y; Zhu, YQ				Tan, Jiaxing; Zhang, Xing; Wang, Xiaofei; Xu, Caihuang; Chang, Shenghai; Wu, Hangjun; Wang, Ting; Liang, Huihui; Gao, Haichun; Zhou, Yan; Zhu, Yongqun			Structural basis of assembly and torque transmission of the bacterial flagellar motor	CELL			English	Article							BASAL-BODY COMPLEX; SALMONELLA-TYPHIMURIUM; L-RING; ESCHERICHIA-COLI; HOOK; PROTEINS; MECHANISM; IDENTIFICATION; VISUALIZATION; PURIFICATION	The bacterial flagellar motor is a supramolecular protein machine that drives rotation of the flagellum for motility, which is essential for bacterial survival in different environments and a key determinant of pathogenicity. The detailed structure of the flagellar motor remains unknown. Here we present an atomic-resolution cryoelectron microscopy (cryo-EM) structure of the bacterial flagellar motor complexed with the hook, consisting of 175 subunits with a molecular mass of approximately 6.3 MDa. The structure reveals that 10 peptides protruding from the MS ring with the FlgB and FliE subunits mediate torque transmission from the MS ring to the rod and overcome the symmetry mismatch between the rotational and helical structures in the motor. The LP ring contacts the distal rod and applies electrostatic forces to support its rotation and torque transmission to the hook. This work provides detailed molecular insights into the structure, assembly, and torque transmission mechanisms of the flagellar motor.	[Tan, Jiaxing; Zhang, Xing; Wang, Xiaofei; Xu, Caihuang; Chang, Shenghai; Wu, Hangjun; Wang, Ting; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Dept Biophys, Sir Run Run Shaw Hosp, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Tan, Jiaxing; Zhang, Xing; Wang, Xiaofei; Xu, Caihuang; Chang, Shenghai; Wu, Hangjun; Wang, Ting; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Dept Pathol, Sir Run Run Shaw Hosp, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Tan, Jiaxing; Zhang, Xing; Wang, Xiaofei; Xu, Caihuang; Chang, Shenghai; Wu, Hangjun; Wang, Ting; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Tan, Jiaxing; Wang, Xiaofei; Wang, Ting; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Tan, Jiaxing; Wang, Xiaofei; Wang, Ting; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Zhejiang Prov Key Lab Canc Mol Cell Biol, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Xiaofei; Zhu, Yongqun] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xing; Xu, Caihuang; Chang, Shenghai; Wu, Hangjun] Zhejiang Univ, Ctr Cryo Electron Microscopy, Hangzhou 310058, Zhejiang, Peoples R China; [Tan, Jiaxing; Wang, Ting; Liang, Huihui; Gao, Haichun; Zhou, Yan; Zhu, Yongqun] Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Xing] Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou 311121, Zhejiang, Peoples R China; [Zhu, Yongqun] Zhejiang Univ, Canc Ctr, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zhang, X; Zhu, YQ (corresponding author), Zhejiang Univ, Dept Biophys, Sir Run Run Shaw Hosp, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, X; Zhu, YQ (corresponding author), Zhejiang Univ, Dept Pathol, Sir Run Run Shaw Hosp, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, X; Zhu, YQ (corresponding author), Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Zhu, YQ (corresponding author), Zhejiang Univ, MOE Key Lab Biosyst Homeostasis & Protect, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China.; Zhu, YQ (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Canc Mol Cell Biol, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China.; Zhu, YQ (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, X (corresponding author), Zhejiang Univ, Ctr Cryo Electron Microscopy, Hangzhou 310058, Zhejiang, Peoples R China.; Zhu, YQ (corresponding author), Zhejiang Univ, Inst Microbiol, Hangzhou 310058, Zhejiang, Peoples R China.; Zhang, X (corresponding author), Zhejiang Univ, Liangzhu Lab, Med Ctr, Hangzhou 311121, Zhejiang, Peoples R China.; Zhu, YQ (corresponding author), Zhejiang Univ, Canc Ctr, Hangzhou 310058, Zhejiang, Peoples R China.	xzhang1999@zju.edu.cn; zhuyongqun@zju.edu.cn	Gao, Haichun/AFU-4588-2022; Gao, Haichun/A-2160-2014	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563; Wang, Xiaofei/0000-0002-4654-1983	National Key Research and Development Program of China [2017YFA0504803, 2018YFA0507700, 2017YFA0503900]; NSFC [81925024, 81530068, 81501717]; Zhejiang NSF [R20H190001]; Fundamental Research Funds for the Central Universities of China; National High-level Talents Special Support Program	National Key Research and Development Program of China; NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang NSF; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National High-level Talents Special Support Program	This work was supported by the National Key Research and Development Program of China (2017YFA0504803 and 2018YFA0507700 to X.Z. and 2017YFA0503900 to Y. Zhu), NSFC (81925024 and 81530068 to Y. Zhu and 81501717 to Y. Zhou), Zhejiang NSF (R20H190001 to Y. Zhou), and the Fundamental Research Funds for the Central Universities of China. Y. Zhu was supported by the National High-level Talents Special Support Program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985; Aizawa SI, 2017, METHODS MOL BIOL, V1593, P87, DOI 10.1007/978-1-4939-6927-2_6; Armitage JP, 2020, ANNU REV MICROBIOL, V74, P181, DOI 10.1146/annurev-micro-090816-093411; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Burrage AM, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00425-18; Carroll BL, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111492; Chang YJ, 2020, NAT STRUCT MOL BIOL, V27, P1041, DOI 10.1038/s41594-020-0497-2; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chevance FFV, 2007, GENE DEV, V21, P2326, DOI 10.1101/gad.1571607; Cohen EJ, 2017, SCIENCE, V356, P197, DOI 10.1126/science.aam6512; Cohen EJ, 2014, J BACTERIOL, V196, P2387, DOI 10.1128/JB.01580-14; Deme JC, 2020, NAT MICROBIOL, V5, P1553, DOI 10.1038/s41564-020-0788-8; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304; FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Hiraoka KD, 2017, SCI REP-UK, V7, DOI 10.1038/srep46723; HOMMA M, 1990, J MOL BIOL, V213, P819, DOI 10.1016/S0022-2836(05)80266-9; HOMMA M, 1990, J MOL BIOL, V211, P465, DOI 10.1016/0022-2836(90)90365-S; Hu JH, 2019, NAT MICROBIOL, V4, P2010, DOI 10.1038/s41564-019-0545-z; Johnson S, 2020, NAT MICROBIOL, V5, P966, DOI 10.1038/s41564-020-0703-3; Johnson S, 2019, MBIO, V10, DOI 10.1128/mBio.00818-19; JONES CJ, 1987, J BACTERIOL, V169, P1489, DOI 10.1128/jb.169.4.1489-1492.1987; JONES CJ, 1990, J MOL BIOL, V212, P377, DOI 10.1016/0022-2836(90)90132-6; JONES CJ, 1989, J BACTERIOL, V171, P3890, DOI 10.1128/jb.171.7.3890-3900.1989; Kaplan M, 2019, EMBO J, V38, DOI 10.15252/embj.2018100957; Kaplan M, 2019, ELIFE, V8, DOI 10.7554/eLife.43487; Kawamoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03369; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; Kuhlen L, 2018, NAT STRUCT MOL BIOL, V25, P583, DOI 10.1038/s41594-018-0086-9; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2019, COMPUT STRUCT BIOTEC, V17, P1075, DOI 10.1016/j.csbj.2019.07.020; Minamino T, 2015, TRENDS MICROBIOL, V23, P267, DOI 10.1016/j.tim.2014.12.011; Moens S, 1996, CRIT REV MICROBIOL, V22, P67, DOI 10.3109/10408419609106456; MULLER V, 1992, J BACTERIOL, V174, P2298; Nakamura S, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9070279; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Santiveri M, 2020, CELL, V183, P244, DOI 10.1016/j.cell.2020.08.016; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schoenhals GJ, 1996, J BACTERIOL, V178, P4200, DOI 10.1128/jb.178.14.4200-4207.1996; Shibata S, 2019, NAT STRUCT MOL BIOL, V26, P941, DOI 10.1038/s41594-019-0301-3; SOSINSKY GE, 1992, J MOL BIOL, V223, P171, DOI 10.1016/0022-2836(92)90724-X; SOSINSKY GE, 1992, P NATL ACAD SCI USA, V89, P4801, DOI 10.1073/pnas.89.11.4801; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Subramanian S, 2019, ANNU REV MICROBIOL, V73, P225, DOI 10.1146/annurev-micro-020518-115725; SUZUKI T, 1981, J BACTERIOL, V145, P1036, DOI 10.1128/JB.145.2.1036-1041.1981; Takekawa N, 2020, TRENDS MICROBIOL, V28, P719, DOI 10.1016/j.tim.2020.03.010; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Worrall LJ, 2016, NATURE, V540, P597, DOI 10.1038/nature20576; Zhao XW, 2013, P NATL ACAD SCI USA, V110, P14390, DOI 10.1073/pnas.1308306110; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	63	21	23	28	97	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2665	+		10.1016/j.cell.2021.03.057	http://dx.doi.org/10.1016/j.cell.2021.03.057		MAY 2021	34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33882274	Bronze			2022-12-28	WOS:000652830800012
J	Dafoe, A; Bachrach, Y; Hadfield, G; Horvitz, E; Larson, K; Graepel, T				Dafoe, Allan; Bachrach, Yoram; Hadfield, Gillian; Horvitz, Eric; Larson, Kate; Graepel, Thore			Cooperative AI: machines must learn to find common ground	NATURE			English	Editorial Material						Machine learning; Computer science; Society; Technology; Sociology; Human behaviour	ARTIFICIAL-INTELLIGENCE	To help humanity solve fundamental problems of cooperation, scientists need to reconceive artificial intelligence as deeply social. To help humanity solve fundamental problems of cooperation, scientists need to reconceive artificial intelligence as deeply social.	[Dafoe, Allan] Univ Oxford, Future Humanity Inst, Ctr Governance AI, Oxford, England; [Bachrach, Yoram; Graepel, Thore] DeepMind, London, England; [Hadfield, Gillian] Univ Toronto, Schwartz Reisman Inst Technol & Soc, Toronto, ON, Canada; [Hadfield, Gillian] OpenAI, San Francisco, CA USA; [Horvitz, Eric] Microsoft, Redmond, WA USA; [Larson, Kate] Univ Waterloo, Comp Sci, Waterloo, ON, Canada; [Larson, Kate] DeepMind, Montreal, PQ, Canada; [Graepel, Thore] UCL, Comp Sci, London, England	University of Oxford; University of Toronto; Microsoft; University of Waterloo; University of London; University College London	Dafoe, A (corresponding author), Univ Oxford, Future Humanity Inst, Ctr Governance AI, Oxford, England.	allan.dafoe@governance.ai; thore@google.com						Adadi A, 2018, IEEE ACCESS, V6, P52138, DOI 10.1109/ACCESS.2018.2870052; Allcott H, 2020, AM ECON REV, V110, P629, DOI 10.1257/aer.20190658; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Buolamwini J., 2018, C FAIRNESS ACCOUNTAB, P77; Campbell M, 2002, ARTIF INTELL, V134, P57, DOI 10.1016/S0004-3702(01)00129-1; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Kitano H, 1997, AI MAG, V18, P73; Moravcik M, 2017, SCIENCE, V356, P508, DOI 10.1126/science.aam6960; Russell S., 2019, HUMAN COMPATIBLE ART; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Villani V, 2018, MECHATRONICS, V55, P248, DOI 10.1016/j.mechatronics.2018.02.009	13	14	14	14	52	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 6	2021	593	7857					33	36		10.1038/d41586-021-01170-0	http://dx.doi.org/10.1038/d41586-021-01170-0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RX5DL	33947992	Green Submitted			2022-12-28	WOS:000647243800012
J	Leshem, E; Lopman, BA				Leshem, Eyal; Lopman, Benjamin Alan			Population immunity and vaccine protection against infection	LANCET			English	Editorial Material							SARS-COV-2 INFECTION; COVID-19; BNT162B2		[Leshem, Eyal] Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Ramat Gan, Israel; [Leshem, Eyal] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Lopman, Benjamin Alan] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Emory University; Rollins School Public Health	Leshem, E (corresponding author), Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Ramat Gan, Israel.; Leshem, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	eyal.leshem@sheba.health.gov.il						Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Gallagher ME, 2021, NAT MED, V27, P4, DOI 10.1038/s41591-020-01172-x; Hall VJ, 2021, LANCET, DOI [10.1016/014847, DOI 10.1016/014847]; Hansen CH, 2021, LANCET, V397, P1204, DOI 10.1016/S0140-6736(21)00575-4; Levine-Tiefenbrun M, 2021, NAT MED, V27, P790, DOI 10.1038/s41591-021-01316-7; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sayampanathan AA, 2021, LANCET, V397, P93, DOI [10.1016/S0140-6736(20)32651-9, 10.1016/S0140-6736(20)326S1-g]; Thompson MG, 2021, MMWR-MORBID MORTAL W, V70, P495, DOI 10.15585/mmwr.mm7013e3; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wallace S, 2020, SIREN PROTOCOL IMPAC, DOI [10.1101/2020.12.15.20247981, DOI 10.1101/2020.12.15.20247981]	10	17	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1685	1687		10.1016/S0140-6736(21)00870-9	http://dx.doi.org/10.1016/S0140-6736(21)00870-9		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33901422	Bronze, Green Published			2022-12-28	WOS:000647813600003
J	Sebastiano, V; Zack, DJ				Sebastiano, Vittorio; Zack, Donald J.			We Shall See?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sebastiano, Vittorio] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Sebastiano, Vittorio] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Human Genet, Baltimore, MD USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Ctr Nanomed, Baltimore, MD USA	Stanford University; Stanford University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sebastiano, V (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Sebastiano, V (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA.							Horvath S, 2018, NAT REV GENET, V19, P371, DOI 10.1038/s41576-018-0004-3; Lu YC, 2020, NATURE, V588, P124, DOI 10.1038/s41586-020-2975-4; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Sarkar TJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15174-3; Williams PR, 2020, ANNU REV VIS SCI, V6, P195, DOI 10.1146/annurev-vision-022720-094953	5	0	0	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1766	1768		10.1056/NEJMcibr2034927	http://dx.doi.org/10.1056/NEJMcibr2034927			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33951368				2022-12-28	WOS:000647698500017
J	Dwivedi, VK; Pardo-Pastor, C; Droste, R; Kong, JN; Tucker, N; Denning, DP; Rosenblatt, J; Horvitz, HR				Dwivedi, Vivek K.; Pardo-Pastor, Carlos; Droste, Rita; Kong, Ji Na; Tucker, Nolan; Denning, Daniel P.; Rosenblatt, Jody; Horvitz, H. Robert			Replication stress promotes cell elimination by extrusion	NATURE			English	Article							C-ELEGANS; DNA-REPLICATION; P53; RNAI; TRANSCRIPTION; PROGRESSION; ACTIVATION; REPLISOME; DIVISION; PATHWAYS	Cell extrusion is a mechanism of cell elimination that is used by organisms as diverse as sponges, nematodes, insects and mammals(1-3). During extrusion, a cell detaches from a layer of surrounding cells while maintaining the continuity of that layer(4). Vertebrate epithelial tissues primarily eliminate cells by extrusion, and the dysregulation of cell extrusion has been linked to epithelial diseases, including cancer(1,5). The mechanisms that drive cell extrusion remain incompletely understood. Here, to analyse cell extrusion by Caenorhabdids elegans embryos(3), we conducted a genome-wide RNA interference screen, identified multiple cell-cycle genes with S-phase-specific function, and performed live-imaging experiments to establish how those genes control extrusion. Extruding cells experience replication stress during S phase and activate a replication-stress response via homologues of ATR and CHK1. Preventing S-phase entry, inhibiting the replication-stress response, or allowing completion of the cell cycle blocked cell extrusion. Hydroxyurea-induced replication stress(6,7) triggered ATR-CHK1- and p53-dependent cell extrusion from a mammalian epithelial monolayer. We conclude that cell extrusion induced by replication stress is conserved among animals and propose that this extrusion process is a primordial mechanism of cell elimination with a tumour-suppressive function in mammals.	[Dwivedi, Vivek K.; Droste, Rita; Kong, Ji Na; Tucker, Nolan; Denning, Daniel P.; Horvitz, H. Robert] MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Pardo-Pastor, Carlos; Rosenblatt, Jody] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Denning, Daniel P.] Novartis Inst BioMed Res, Cambridge, MA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of London; King's College London; Novartis	Horvitz, HR (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	horvitz@mit.edu	Pardo-Pastor, Carlos/AAD-5233-2022	Pardo-Pastor, Carlos/0000-0003-4083-0511; Rosenblatt, Jody/0000-0001-9460-5868; Dwivedi, Vivek/0000-0002-0608-1230; Horvitz, Howard/0000-0002-9964-9613	NIH Office of Research Infrastructure Programs [P40 OD010440]; Howard Hughes Medical Institute; NIH [R01GM024663, T32GM007287]; Human Frontiers Science Program postdoctoral fellowship [LT000654/2019-L]; Damon Runyon Cancer Research Foundation; Charles A. King Trust; King's College London startup funds	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program postdoctoral fellowship; Damon Runyon Cancer Research Foundation; Charles A. King Trust; King's College London startup funds	We thank S. van den Heuvel and the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for providing strains; L. Hufnagel and X. Trepat for providing MDCK-Fucci cells; G. van Meer and the ECACC for providing MDCK-II cells (ECACC 62107); N. An for strain management; S. Luo, S. R. Sando, E. L. Q. Lee, A. Doi, A. Corrionero and other members of the Horvitz laboratory for helpful discussions; and D. Ghosh, C. L. Pender, M. G. Vander Heiden, P. W. Reddien, and R. O. Hynes for suggestions regarding the manuscript. This work was supported by the Howard Hughes Medical Institute and by NIH grant R01GM024663. V.K.D. was a Howard Hughes Medical Institute International Student Research fellow. C.P.-P. was the recipient of Human Frontiers Science Program postdoctoral fellowship LT000654/2019-L. J.N.K. was supported by NIH grant R01GM024663. N.T. was supported by NIH Pre-Doctoral Training Grant T32GM007287. D.P.D. was supported by postdoctoral fellowships from the Damon Runyon Cancer Research Foundation and from the Charles A. King Trust. J.R. and C.P.-P. were funded by King's College London startup funds. H.R.H. is the David H. Koch Professor of Biology at MIT and an Investigator at the Howard Hughes Medical Institute.	Boeck ME, 2011, DEV BIOL, V358, P345, DOI 10.1016/j.ydbio.2011.08.002; Brauchle M, 2003, CURR BIOL, V13, P819, DOI 10.1016/S0960-9822(03)00295-1; BRENNER S, 1974, GENETICS, V77, P71; Brodigan TM, 2003, DEV BIOL, V254, P102, DOI 10.1016/S0012-1606(02)00032-5; De Goeij JM, 2009, J EXP BIOL, V212, P3892, DOI 10.1242/jeb.034561; Denning DP, 2012, NATURE, V488, P226, DOI 10.1038/nature11240; Dewar JM, 2017, GENE DEV, V31, P275, DOI 10.1101/gad.291799.116; Dinant C, 2007, J CELL SCI, V120, P2731, DOI 10.1242/jcs.004523; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Fay DS, 2000, DEVELOPMENT, V127, P4049; Fischer SEJ, 2013, GENE DEV, V27, P2678, DOI 10.1101/gad.233254.113; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Grieve AG, 2014, J CELL SCI, V127, P3331, DOI 10.1242/jcs.147926; Grishok A, 2005, GENE DEV, V19, P683, DOI 10.1101/gad.1247705; Gudipaty SA, 2017, SEMIN CELL DEV BIOL, V67, P132, DOI 10.1016/j.semcdb.2016.05.010; HANSSON GC, 1986, EMBO J, V5, P483, DOI 10.1002/j.1460-2075.1986.tb04237.x; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Jones MC, 2018, J CELL BIOL, V217, P3203, DOI 10.1083/jcb.201802088; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Karagiannis GS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan0026; Kipreos ET, 2000, DEVELOPMENT, V127, P5071; Koc A, 2004, J BIOL CHEM, V279, P223, DOI 10.1074/jbc.M303952200; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Merlet J, 2010, DEVELOPMENT, V137, P3857, DOI 10.1242/dev.054866; Ohsawa S, 2018, DEV CELL, V44, P284, DOI 10.1016/j.devcel.2018.01.009; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Ossareh-Nazari B, 2016, G3-GENES GENOM GENET, V6, P3431, DOI 10.1534/g3.116.033043; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Singh S, 2017, J CLIN INVEST, V127, P1839, DOI 10.1172/JCI87724; Sonneville R, 2017, NAT CELL BIOL, V19, P468, DOI 10.1038/ncb3500; Stergiou L, 2011, CELL DEATH DIFFER, V18, P897, DOI 10.1038/cdd.2010.158; Stevens H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164601; Streichan SJ, 2014, P NATL ACAD SCI USA, V111, P5586, DOI 10.1073/pnas.1323016111; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Takeda DY, 2005, ONCOGENE, V24, P2827, DOI 10.1038/sj.onc.1208616; Teuliere J, 2017, RESULTS PROBL CELL D, V61, P141, DOI 10.1007/978-3-319-53150-2_6; TIMSON J, 1975, MUTAT RES, V32, P115, DOI 10.1016/0165-1110(75)90002-0; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; van Rijnberk LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171600; Wernike D, 2016, DEV BIOL, V412, P261, DOI 10.1016/j.ydbio.2016.02.023; Wu YC, 2000, GENE DEV, V14, P536; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yeo CQX, 2016, CELL REP, V15, P132, DOI 10.1016/j.celrep.2016.03.011; Zerjatke T, 2017, CELL REP, V19, P1953, DOI 10.1016/j.celrep.2017.05.022	51	5	6	5	30	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					591	+		10.1038/s41586-021-03526-y	http://dx.doi.org/10.1038/s41586-021-03526-y		MAY 2021	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IG	33953402	Green Accepted, Green Submitted			2022-12-28	WOS:000647544800005
J	Gillespie, BM; Webster, J; Ellwood, D; Thalib, L; Whitty, JA; Mahomed, K; Clifton, V; Kumar, S; Wagner, A; Kang, E; Chaboyer, W				Gillespie, Brigid M.; Webster, Joan; Ellwood, David; Thalib, Lukman; Whitty, Jennifer A.; Mahomed, Kassam; Clifton, Vicki; Kumar, Sailesh; Wagner, Adam; Kang, Evelyn; Chaboyer, Wendy			Closed incision negative pressure wound therapy versus standard dressings in obese women undergoing caesarean section: multicentre parallel group randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL SITE INFECTION	OBJECTIVE To determine the effectiveness of closed incision negative pressure wound therapy (NPWT) compared with standard dressings in preventing surgical site infection (SSI) in obese women undergoing caesarean section. DESIGN Multicentre, pragmatic, randomised, controlled, parallel group, superiority trial. SETTING Four Australian tertiary hospitals between October 2015 and November 2019. PARTICIPANTS Eligible women had a pre-pregnancy body mass index of 30 or greater and gave birth by elective or semi-urgent caesarean section. INTERVENTION 2035 consenting women were randomised before the caesarean procedure to closed incision NPWT (n=1017) or standard dressing (n=1018). Allocation was concealed until skin closure. MAIN OUTCOME MEASURES The primary outcome was cumulative incidence of SSI. Secondary outcomes included depth of SSI (superficial, deep, or organ/body space), rates of wound complications (dehiscence, haematoma, seroma, bleeding, bruising), length of stay in hospital,	[Gillespie, Brigid M.; Kang, Evelyn; Chaboyer, Wendy] Griffith Univ, Menzies Hlth Inst, Ctr Res Excellence Wiser Wound Care, Natl Hlth & Med Res Council, Gold Coast, Qld, Australia; [Gillespie, Brigid M.; Ellwood, David] Gold Coast Univ Hosp, Gold Coast Hlth, Southport, Qld, Australia; [Webster, Joan] Royal Brisbane & Womens Hosp, Ctr Clin Nursing, Herston, Qld, Australia; [Ellwood, David] Griffith Univ, Sch Med & Dent, Gold Coast, Qld, Australia; [Thalib, Lukman] Griffith Univ, Sch Nursing & Midwifery, Gold Coast, Qld, Australia; [Whitty, Jennifer A.; Kang, Evelyn] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England; [Whitty, Jennifer A.; Wagner, Adam] Natl Inst Hlth Res, Appl Res Collaborat ARC, East England EoE, Norwich, Norfolk, England; [Mahomed, Kassam] Ipswich Hosp, West Moreton Hlth, Ipswich, Qld, Australia; [Clifton, Vicki; Kumar, Sailesh] Univ Queensland, Mater Res Inst, South Brisbane, Qld, Australia; [Kumar, Sailesh] Mater Mothers Hosp, South Brisbane, Qld, Australia	Griffith University; Menzies Health Institute Queensland; Gold Coast University Hospital; Royal Brisbane & Women's Hospital; Griffith University; Griffith University; University of East Anglia; Mater Research; University of Queensland	Gillespie, BM (corresponding author), Griffith Univ, Menzies Hlth Inst, Ctr Res Excellence Wiser Wound Care, Natl Hlth & Med Res Council, Gold Coast, Qld, Australia.; Gillespie, BM (corresponding author), Gold Coast Univ Hosp, Gold Coast Hlth, Southport, Qld, Australia.	b.gillespie@griffith.edu.au	Clifton, Vicki/AAV-2749-2021	Clifton, Vicki/0000-0002-4892-6748; Wagner, Adam/0000-0002-9101-3477; Gillespie, Brigid/0000-0003-3186-5691; Chaboyer, Wendy/0000-0001-9528-7814; Kang, Evelyn/0000-0001-8253-1638	Australian National Health and Medical Research Council [APP1081026]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The trial was funded by a competitive peer reviewed grant (APP1081026) from the Australian National Health and Medical Research Council. The funders had no role in considering the study design or in the collection, analysis, or interpretation of data, the writing of the report, or the decision to submit the article for publication. The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research (NIHR) , or the Department of Health and Social Care.	Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Chaboyer W, 2014, HEALTHCARE, V2, P417, DOI 10.3390/healthcare2040417; Dias M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216157; Ferraro F, 2016, NEW MICROBIOL, V39, P134; Gillespie BM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010287; Gillespie BM, 2015, SURG INNOV, V22, P488, DOI 10.1177/1553350615573583; Glass GE, 2014, BRIT J SURG, V101, P1627, DOI 10.1002/bjs.9636; Hall C, 2019, J AM COLL SURGEONS, V228, P393, DOI 10.1016/j.jamcollsurg.2018.12.006; Heslehurst N, 2008, OBES REV, V9, P635, DOI 10.1111/j.1467-789X.2008.00511.x; Hussamy DJ, 2019, OBSTET GYNECOL, V134, P781, DOI 10.1097/AOG.0000000000003465; Hyldig N, 2019, BJOG-INT J OBSTET GY, V126, P619, DOI 10.1111/1471-0528.15573; Hyldig N, 2019, BJOG-INT J OBSTET GY, V126, P628, DOI 10.1111/1471-0528.15413; Kawakita T, 2021, J MATERN-FETAL NEO M, V34, P634, DOI 10.1080/14767058.2019.1611774; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Norman G, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009261.pub6, 10.1002/14651858.CD009261.pub5]; Queensland Clinical Guidelines, 2018, QUEENSL CLIN GUID MA; Ramirez-Wong FM, 2015, SURG INFECT, V16, P572, DOI 10.1089/sur.2014.201; Ruhstaller K, 2017, AM J PERINAT, V34, P1125, DOI 10.1055/s-0037-1604161; Saeed KBM, 2019, EUR J OBSTET GYN R B, V240, P256, DOI 10.1016/j.ejogrb.2019.07.020; Smyth ETM, 2008, J HOSP INFECT, V69, P230, DOI 10.1016/j.jhin.2008.04.020; Tuuli M, 2019, BJOG-INT J OBSTET GY, V126, P635, DOI 10.1111/1471-0528.15572; Tuuli MG, 2017, AM J OBSTET GYNECOL, V216, pS245, DOI 10.1016/j.ajog.2016.11.670; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Webster J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009261.pub3; Webster J, 2010, ANZ J SURG, V80, P169, DOI 10.1111/j.1445-2197.2009.05200.x; Wells CI, 2019, WORLD J SURG, V43, P2779, DOI 10.1007/s00268-019-05116-6; Yang XJ, 2017, ARCH GYNECOL OBSTET, V296, P503, DOI 10.1007/s00404-017-4445-2	29	8	8	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								bmj	10.1136/bmj.n893	http://dx.doi.org/10.1136/bmj.n893			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952438	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000651241900014
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Female NHS and care staff report deteriorating health because of pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Confederation, 2021, COV 19 FEM HLTH CAR	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n1157	10.1136/bmj.n1157	http://dx.doi.org/10.1136/bmj.n1157			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952446	Bronze			2022-12-28	WOS:000651241900005
J	Shepherd, A				Shepherd, Alison			Covid-19: Photograph collection records historic vaccine rollout	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n1125	10.1136/bmj.n1125	http://dx.doi.org/10.1136/bmj.n1125			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947704	Bronze			2022-12-28	WOS:000649710200005
J	Irfan, N; Chagla, Z				Irfan, Neal; Chagla, Zain			In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant)	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Irfan, Neal; Chagla, Zain] McMaster Univ, Hamilton, ON, Canada	McMaster University	Irfan, N (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Feng LQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18077-5; Food and Drug Administration, 2021, FDA BRIEF DOC JANSS; Oxford Vaccine Group, 2021, COM COV COMP COVID; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179	4	8	9	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY	2021	174	5					JC50	JC50		10.7326/ACPJ202105180-050	http://dx.doi.org/10.7326/ACPJ202105180-050			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SF2QB	33939483				2022-12-28	WOS:000652604800005
J	Lundgren, EJ; Ramp, D; Stromberg, JC; Wu, JG; Nieto, NC; Sluk, M; Moeller, KT; Wallach, AD				Lundgren, Erick J.; Ramp, Daniel; Stromberg, Juliet C.; Wu, Jianguo; Nieto, Nathan C.; Sluk, Martin; Moeller, Karla T.; Wallach, Arian D.			Equids engineer desert water availability	SCIENCE			English	Article							PLEISTOCENE; CLIMATE; ECONOMY; RIVER; RESTORATION; CONSUMPTION; MEGAFAUNA; MORTALITY; SPARROW; FORESTS	Megafauna play important roles in the biosphere, yet little is known about how they shape dryland ecosystems. We report on an overlooked form of ecosystem engineering by donkeys and horses. In the deserts of North America, digging of <= 2-meter wells to groundwater by feral equids increased the density of water features, reduced distances between waters, and, at times, provided the only water present. Vertebrate richness and activity were higher at equid wells than at adjacent dry sites, and, by mimicking flood disturbance, equid wells became nurseries for riparian trees. Our results suggest that equids, even those that are introduced or feral, are able to buffer water availability, which may increase resilience to ongoing human-caused aridification.	[Lundgren, Erick J.; Ramp, Daniel; Wallach, Arian D.] Univ Technol Sydney, Fac Sci, Ctr Compassionate Conservat, Ultimo, NSW, Australia; [Lundgren, Erick J.] Aarhus Univ, Ctr Biodivers Dynam Changing World BIOCHANGE, Dept Biol, Aarhus, Denmark; [Lundgren, Erick J.] Aarhus Univ, Dept Biol, Sect Ecoinformat & Biodivers, Aarhus C, Denmark; [Stromberg, Juliet C.; Wu, Jianguo; Moeller, Karla T.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Wu, Jianguo] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Nieto, Nathan C.] No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA; [Sluk, Martin] Roger Williams Pk Museum Nat Hist, Providence, RI USA	University of Technology Sydney; Aarhus University; Aarhus University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Northern Arizona University	Lundgren, EJ (corresponding author), Univ Technol Sydney, Fac Sci, Ctr Compassionate Conservat, Ultimo, NSW, Australia.; Lundgren, EJ (corresponding author), Aarhus Univ, Ctr Biodivers Dynam Changing World BIOCHANGE, Dept Biol, Aarhus, Denmark.; Lundgren, EJ (corresponding author), Aarhus Univ, Dept Biol, Sect Ecoinformat & Biodivers, Aarhus C, Denmark.	erick.lundgren@gmail.com	Wu, Jianguo/G-6267-2010; Ramp, Daniel/C-3692-2008	Wu, Jianguo/0000-0002-1182-3024; Ramp, Daniel/0000-0003-3202-9898; Moeller, Karla/0000-0003-4785-8162; Sluk, Martin/0000-0003-4360-1650; Lundgren, Erick/0000-0001-9893-3324	Arizona State University	Arizona State University	This work was supported through crowdfunding and two Arizona State University fieldwork grants.	Allen DC, 2014, FRONT ECOL ENVIRON, V12, P156, DOI 10.1890/130160; Atwood TC, 2011, J WILDLIFE MANAGE, V75, P1609, DOI 10.1002/jwmg.225; Baldwin RA, 2004, J MAMMAL, V85, P1068, DOI 10.1644/BWG-207.1; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Bright JL, 2005, WILDLIFE SOC B, V33, P43, DOI 10.2193/0091-7648(2005)33[43:AAFMOS]2.0.CO;2; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; BROWN JH, 1972, ECOLOGY, V53, P310, DOI 10.2307/1934087; Burnham K P, 2003, MODEL SELECT MULTIMO; Burrell AL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17710-7; Chadwick D, 2016, TRACKING GOBI GRIZZL; Cooper DJ, 2012, RIVER RES APPL, V28, P204, DOI 10.1002/rra.1452; Datry T, 2017, INTERMITTENT RIVERS AND EPHEMERAL STREAMS: ECOLOGY AND MANAGEMENT, P1; Doody JS, 2007, ETHOLOGY, V113, P128, DOI 10.1111/j.1439-0310.2006.01298.x; Feh C., 2002, EQUIDS ZEBRAS ASSES; Fox J., 2019, R COMPANION APPL REG, VThird; GOLIGHTLY RT, 1984, J MAMMAL, V65, P51, DOI 10.2307/1381199; Gonzalez E, 2018, J ENVIRON MANAGE, V218, P374, DOI 10.1016/j.jenvman.2018.04.069; Hamilton W. J. III, 1977, Madoqua (Ser 1), V10, P5; Haynes G, 2012, GEOMORPHOLOGY, V157, P99, DOI 10.1016/j.geomorph.2011.04.045; Hyde T., 2011, THESIS U NEW MEXICO; International Union for Conservation of Nature and Natural Resources (IUCN), 2015, IUCN RED LIST THREAT; IUCN, 2013, IUCN RED LIST THREAT; Joshi R, 2009, NAT SCI, V2009, P1; Kiesow AB, 2017, OECOLOGIA, V185, P619, DOI 10.1007/s00442-017-3969-2; KLINGEL H, 1968, Zeitschrift fuer Tierpsychologie, V25, P76; KLINGEL H, 1974, Zeitschrift fuer Tierpsychologie, V36, P37; Lenth Russell V, 2020, CRAN; Lite SJ, 2005, BIOL CONSERV, V125, P153, DOI 10.1016/j.biocon.2005.01.020; Lundgren E. J, 2021, **DROPPED REF**, DOI [10.6084/m9.figshare.13668794, DOI 10.6084/M9.FIGSHARE.13668794]; Lundgren EJ, 2021, SCI DATA, V8, DOI 10.1038/s41597-020-00788-5; Lundgren EJ, 2020, P NATL ACAD SCI USA, V117, P7871, DOI 10.1073/pnas.1915769117; Lundgren EJ, 2018, ECOGRAPHY, V41, P857, DOI 10.1111/ecog.03430; Lynn JC, 2006, WILDLIFE SOC B, V34, P592, DOI 10.2193/0091-7648(2006)34[592:UOWWDB]2.0.CO;2; MACMILLEN RE, 1983, ECOLOGY, V64, P152, DOI 10.2307/1937337; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; McCluney KE, 2012, BIOL REV, V87, P563, DOI 10.1111/j.1469-185X.2011.00209.x; McCluney KE, 2009, ECOLOGY, V90, P1463, DOI 10.1890/08-1626.1; MCKNIGHT TOM L., 1958, JOUR WILDLIFE MANAGEMENT, V22, P163, DOI 10.2307/3797325; Metcalf JL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501682; Millington B., 2020, ABC NEWCASTLE   0206; MOLDENHAUER RR, 1970, CONDOR, V72, P265, DOI 10.2307/1366003; Murphy MS, 2019, PHYSIOL BIOCHEM ZOOL, V92, P381, DOI 10.1086/704081; NAGY KA, 1976, PHYSIOL ZOOL, V49, P351, DOI 10.1086/physzool.49.3.30155693; Oksanen J., 2019, R PACKAGE VERSION; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Payne JC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59969-2; Payne K., 1999, SILENT THUNDER PRESE; Ramey EM, 2013, PACHYDERM, P66; RAUTENSTRAUCH KR, 1989, J MAMMAL, V70, P197, DOI 10.2307/1381689; Reid F. A, 2007, FIELD GUIDE MAMMALS; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Rocklov J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-23; Rogerson JD, 2008, J WILDLIFE DIS, V44, P28, DOI 10.7589/0090-3558-44.1.28; Rolls E., 1969, THEY ALL RAN WILD ST; Rosenstock SS, 1999, J RANGE MANAGE, V52, P302, DOI 10.2307/4003538; Rozen-Rechels D, 2015, OIKOS, V124, P1142, DOI 10.1111/oik.02207; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Shafroth PB, 2017, ECOL ENG, V106, P645, DOI 10.1016/j.ecoleng.2017.02.016; Sibley David Allen, 2000, SIBLEY GUIDE BIRDS; SMYTH M, 1966, CONDOR, V68, P447, DOI 10.2307/1365317; Stella JC, 2006, ECOSYSTEMS, V9, P1200, DOI 10.1007/s10021-005-0138-y; Stromberg JC, 2007, FRESHWATER BIOL, V52, P651, DOI 10.1111/j.1365-2427.2006.01713.x; Stromberg JC, 2016, FRESHWATER BIOL, V61, P1259, DOI 10.1111/fwb.12686; Switalski AB, 2017, PEERJ, V5, DOI 10.7717/peerj.4003; THRASH I, 1995, J ARID ENVIRON, V29, P213, DOI 10.1016/S0140-1963(05)80091-6; Turner DS, 2011, ENVIRON MANAGE, V47, P497, DOI 10.1007/s00267-010-9607-y; Wallach AD, 2020, CONSERV BIOL, V34, P997, DOI 10.1111/cobi.13447; Wallach AD, 2018, CONSERV BIOL, V32, P962, DOI 10.1111/cobi.13116; Whiting JC, 2009, ACTA THERIOL, V54, P127, DOI 10.1007/BF03193168; Wilson DE., 2015, HDB MAMMALS WORLD; ZERVANOS SM, 1977, J WILDLIFE MANAGE, V41, P527, DOI 10.2307/3800527	72	18	18	3	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					491	+		10.1126/science.abd6775	http://dx.doi.org/10.1126/science.abd6775			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926950				2022-12-28	WOS:000645554100042
J	Xue, YH; Xia, Y; Yang, S; Alsaid, Y; Fong, KY; Wang, Y; Zhang, X				Xue, Yahui; Xia, Yang; Yang, Sui; Alsaid, Yousif; Fong, King Yan; Wang, Yuan; Zhang, Xiang			Atomic-scale ion transistor with ultrahigh diffusivity	SCIENCE			English	Article							GRAPHENE; TRANSPORT	Biological ion channels rapidly and selectively gate ion transport through atomic-scale filters to maintain vital life functions. We report an atomic-scale ion transistor exhibiting ultrafast and highly selective ion transport controlled by electrical gating in graphene channels around 3 angstroms in height, made from a single flake of reduced graphene oxide. The ion diffusion coefficient reaches two orders of magnitude higher than the coefficient in bulk water. Atomic-scale ion transport shows a threshold behavior due to the critical energy barrier for hydrated ion insertion. Our in situ optical measurements suggest that ultrafast ion transport likely originates from highly dense packing of ions and their concerted movement inside the graphene channels.	[Xue, Yahui; Xia, Yang; Yang, Sui; Alsaid, Yousif; Fong, King Yan; Wang, Yuan] Univ Calif Berkeley, Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Zhang, Xiang] Univ Hong Kong, Fac Sci, Hong Kong, Peoples R China; [Zhang, Xiang] Univ Hong Kong, Fac Engn, Hong Kong, Peoples R China	University of California System; University of California Berkeley; University of Hong Kong; University of Hong Kong	Zhang, X (corresponding author), Univ Hong Kong, Fac Sci, Hong Kong, Peoples R China.; Zhang, X (corresponding author), Univ Hong Kong, Fac Engn, Hong Kong, Peoples R China.	president@hku.hk	wangwangwang, yuanyaun/HHN-6432-2022; Xue, Yahui/AHA-5549-2022; Wang, Yuan/HHC-1520-2022; Zhang, Xiang/F-6905-2011; Wang, Yuan/F-7211-2011	Xue, Yahui/0000-0002-0313-8182; Wang, Yuan/0000-0001-7892-2812; Zhang, Xiang/0000-0002-3272-894X	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research award [OSR-2016-CRG5-2996]	King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research award(King Abdullah University of Science & Technology)	Supported by King Abdullah University of Science and Technology (KAUST) Office of Sponsored Research award OSR-2016-CRG5-2996.	Abraham J, 2017, NAT NANOTECHNOL, V12, P546, DOI [10.1038/nnano.2017.21, 10.1038/NNANO.2017.21]; Bao WZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5224; Bard A. J., 2001, ELECTROCHEMICAL METH; Byrnes S. J., 2016, ARXIV160302720PHYSIC; Cantley L, 2019, NANOSCALE, V11, P9856, DOI 10.1039/c8nr10360g; Castellanos-Gomez A, 2014, 2D MATER, V1, DOI 10.1088/2053-1583/1/1/011002; Chen CC, 2016, NATURE, V536, P159, DOI 10.1038/nature19078; Chen L, 2017, NATURE, V550, P415, DOI 10.1038/nature24044; Cheng C, 2018, NAT NANOTECHNOL, V13, P685, DOI 10.1038/s41565-018-0181-4; Cho SJ, 2011, NANO LETT, V11, P1925, DOI 10.1021/nl200017f; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Dimiev AM, 2014, ACS NANO, V8, P3060, DOI 10.1021/nn500606a; Duan CH, 2010, NAT NANOTECHNOL, V5, P848, DOI [10.1038/nnano.2010.233, 10.1038/NNANO.2010.233]; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Eisenberg B, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400019; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Falkovsky LA, 2008, J PHYS CONF SER, V129, DOI 10.1088/1742-6596/129/1/012004; Fornasiero F, 2008, P NATL ACAD SCI USA, V105, P17250, DOI 10.1073/pnas.0710437105; Fumagalli L, 2018, SCIENCE, V360, P1339, DOI 10.1126/science.aat4191; Gao WL, 2012, ACS NANO, V6, P7806, DOI 10.1021/nn301888e; Geng J, 2014, NATURE, V514, P612, DOI 10.1038/nature13817; Hanson GW, 2008, J APPL PHYS, V103, DOI 10.1063/1.2891452; Hantel MM, 2011, ELECTROCHEM COMMUN, V13, P90, DOI 10.1016/j.elecom.2010.11.021; He XF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15893; Hille B., 1992, IONIC CHANNELS EXCIT; Horng J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165113; Joshi RK, 2014, SCIENCE, V343, P752, DOI 10.1126/science.1245711; Karnik R, 2005, NANO LETT, V5, P943, DOI 10.1021/nl050493b; Kopfer DA, 2014, SCIENCE, V346, P352, DOI 10.1126/science.1254840; Kondrat S, 2014, NAT MATER, V13, P387, DOI 10.1038/NMAT3916; Kuhne M, 2017, NAT NANOTECHNOL, V12, P895, DOI [10.1038/nnano.2017.108, 10.1038/NNANO.2017.108]; Li H, 2014, ACS NANO, V8, P6563, DOI 10.1021/nn501779y; Luo ZX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7358; Mouterde T, 2019, NATURE, V567, P87, DOI 10.1038/s41586-019-0961-5; Muy S, 2018, ENERG ENVIRON SCI, V11, P850, DOI 10.1039/c7ee03364h; Park HB, 2017, SCIENCE, V356, DOI 10.1126/science.aab0530; Rollings RC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11408; Sigworth FJ, 2003, NATURE, V423, P21, DOI 10.1038/423021a; Skinner B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056102; Wang PF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02941-6; Werber JR, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.18; Wu J, 2012, NAT NANOTECHNOL, V7, P133, DOI [10.1038/NNANO.2011.240, 10.1038/nnano.2011.240]; Xue YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5237; Yu YZ, 2019, NANOSCALE, V11, P8449, DOI 10.1039/c9nr00317g; Zhang HC, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq0066	45	38	38	41	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					501	+		10.1126/science.abb5144	http://dx.doi.org/10.1126/science.abb5144			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926952	Bronze			2022-12-28	WOS:000645554100044
J	Bayas, A; Menacher, M; Christ, M; Behrens, L; Rank, A; Naumann, M				Bayas, Antonios; Menacher, Martina; Christ, Monika; Behrens, Lars; Rank, Andreas; Naumann, Markus			Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination	LANCET			English	Editorial Material									[Bayas, Antonios; Menacher, Martina; Christ, Monika; Naumann, Markus] Univ Hosp Augsburg, Neurol & Clin Neurophysiol, D-86156 Augsburg, Germany; [Behrens, Lars] Univ Hosp Augsburg, Diagnost & Intervent Neuroradiol, Augsburg, Germany; [Rank, Andreas] Univ Hosp Augsburg, Interdisciplinary Canc Ctr Augsburg, Dept Haematol & Oncol, Augsburg, Germany		Bayas, A (corresponding author), Univ Hosp Augsburg, Neurol & Clin Neurophysiol, D-86156 Augsburg, Germany.	antonios.bayas@uk-augsburg.de							0	77	77	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					E11	E11		10.1016/S0140-6736(21)00872-2	http://dx.doi.org/10.1016/S0140-6736(21)00872-2		APR 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33864750	Bronze, Green Published			2022-12-28	WOS:000645510600001
J	LeBlanc, EV; Colpitts, CC				LeBlanc, Emmanuelle V.; Colpitts, Che C.			SARS-CoV-2 RNA: Exclusive friends and common foes	CELL			English	Editorial Material								Infection with SARS-CoV-2 sets off a molecular arms race between virus replication and host cell defense. In this issue of Cell, Flynn, Belk, et al. integrate an advanced large-scale RNA-centered approach with custom CRISPR screens to functionally characterize the interactome of the SARS-CoV-2 RNA genome during infection.	[LeBlanc, Emmanuelle V.; Colpitts, Che C.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Colpitts, CC (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	che.colpitts@queensu.ca						Flynn RA, 2021, CELL, V184, P2394, DOI 10.1016/j.cell.2021.03.012; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Labeau A., 2021, CHARACTERIZATION FUN, DOI [DOI 10.1126/sciimmunol.abc3582, 10.1101/2021.03.23.436611, DOI 10.1101/2021.03.23.436611]; Lee S., 2020, SARS COV 2 RNA INTER, DOI [10.1101/2020.11.02.364497, DOI 10.1101/2020.11.02.364497]; Ooi YS, 2019, NAT MICROBIOL, V4, P2369, DOI 10.1038/s41564-019-0518-2; Schmidt N, 2021, NAT MICROBIOL, V6, P339, DOI 10.1038/s41564-020-00846-z; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4	7	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2021	184	9					2276	2278		10.1016/j.cell.2021.04.009	http://dx.doi.org/10.1016/j.cell.2021.04.009		APR 2021	3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RV7SH	33930293	Bronze, Green Published			2022-12-28	WOS:000646027900005
J	Liu, I; Hack, OA; Filbin, MG				Liu, Ilon; Hack, Olivia A.; Filbin, Mariella G.			The imitation game: How glioblastoma outmaneuvers immune attack	CELL			English	Editorial Material								Immune evasion and resistance to immunotherapy mark major roadblocks in treating glioblastoma, the deadliest form of brain cancer. In this issue of Cell, Gangoso et al. demonstrate that the immune microenvironment drives glioblastoma cells to hijack myeloid-characteristic transcriptional and epigenetic circuits as a mode of immune evasion.	[Liu, Ilon; Hack, Olivia A.; Filbin, Mariella G.] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Filbin, MG (corresponding author), Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA.	mariella.filbin@childrens.harvard.edu	Liu, Ilon/CAG-0703-2022	Liu, Ilon/0000-0002-6186-3630				Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Friebel E, 2020, CELL, V181, P1626, DOI 10.1016/j.cell.2020.04.055; Gangoso E, 2021, CELL, V184, P2454, DOI 10.1016/j.cell.2021.03.023; Gutmann DH, 2019, NEURON, V104, P442, DOI 10.1016/j.neuron.2019.08.028; Jackson CM, 2019, NAT IMMUNOL, V20, P1100, DOI 10.1038/s41590-019-0433-y; Klemm F, 2020, CELL, V181, P1643, DOI 10.1016/j.cell.2020.05.007; Mathewson ND, 2021, CELL, V184, P1281, DOI 10.1016/j.cell.2021.01.022; Neftel C, 2019, CELL, V178, P835, DOI 10.1016/j.cell.2019.06.024; Schmitt MJ, 2021, CANCER DISCOV, V11, P754, DOI 10.1158/2159-8290.CD-20-0219; Wang QH, 2017, CANCER CELL, V32, P42, DOI 10.1016/j.ccell.2017.06.003	10	1	1	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2021	184	9					2278	2281		10.1016/j.cell.2021.04.008	http://dx.doi.org/10.1016/j.cell.2021.04.008		APR 2021	5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RV7SH	33930294	Bronze			2022-12-28	WOS:000646027900006
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Let's talk about sustainability	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk						NHS Digital, 2021, GEN PRACT WORKF 31 D; United Nations General Assembly, 1987, REPORT WORLD COMMISS	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2021	373								n1082	10.1136/bmj.n1082	http://dx.doi.org/10.1136/bmj.n1082			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RW1QM	33906833	Bronze			2022-12-28	WOS:000646297900002
J	Banono, NS				Banono, Nancy Saana			When do I tell my supervisor?	SCIENCE			English	Editorial Material									[Banono, Nancy Saana] Univ Oslo, Oslo, Norway	University of Oslo	Banono, NS (corresponding author), Univ Oslo, Oslo, Norway.	SciCareerEditor@aaas.org		Banono, Nancy Saana/0000-0002-3061-1633					0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					430	430		10.1126/science.372.6540.430	http://dx.doi.org/10.1126/science.372.6540.430			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888643				2022-12-28	WOS:000645009800046
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Infections fell by 65% after first dose of AstraZeneca or Pfizer vaccine, data show	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Matthews PC, IMPACT VACCINATION S; Wei J, IMPACT SARS COV 2 VA	2	7	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2021	373								n1068	10.1136/bmj.n1068	http://dx.doi.org/10.1136/bmj.n1068			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0KR	33893107	Bronze			2022-12-28	WOS:000708057000011
J	Jaklevic, MC				Jaklevic, Mary Chris			Molecular COVID-19 Test Gains First EAU for At-home Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1499	1499		10.1001/jama.2021.5121	http://dx.doi.org/10.1001/jama.2021.5121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877285	Bronze			2022-12-28	WOS:000642636500008
J	Riley, S; Ainslie, KEC; Eales, O; Walters, CE; Wang, HW; Atchison, C; Fronterre, C; Diggle, PJ; Ashby, D; Donnelly, CA; Cooke, G; Barclay, W; Ward, H; Darzi, A; Elliott, P				Riley, Steven; Ainslie, Kylie E. C.; Eales, Oliver; Walters, Caroline E.; Wang, Haowei; Atchison, Christina; Fronterre, Claudio; Diggle, Peter J.; Ashby, Deborah; Donnelly, Christl A.; Cooke, Graham; Barclay, Wendy; Ward, Helen; Darzi, Ara; Elliott, Paul			Resurgence of SARS-CoV-2: Detection by community viral surveillance	SCIENCE			English	Article							TRANSMISSION; COVID-19; CONTACTS	Surveillance of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has mainly relied on case reporting, which is biased by health service performance, test availability, and test-seeking behaviors. We report a community-wide national representative surveillance program in England based on self-administered swab results from -594,000 individuals tested for SARS-CoV-2, regardless of symptoms, between May and the beginning of September 2020. The epidemic declined between May and July 2020 but then increased gradually from mid-August, accelerating into early September 2020 at the start of the second wave. When compared with cases detected through routine surveillance, we report here a longer period of decline and a younger age distribution. Representative community sampling for SARS-CoV-2 can substantially improve situational awareness and feed into the public health response even at low prevalence.	[Riley, Steven; Ainslie, Kylie E. C.; Eales, Oliver; Walters, Caroline E.; Wang, Haowei; Atchison, Christina; Ashby, Deborah; Donnelly, Christl A.; Ward, Helen; Elliott, Paul] Imperial Coll London, Sch Publ Hlth, London, England; [Riley, Steven; Ainslie, Kylie E. C.; Eales, Oliver; Walters, Caroline E.; Wang, Haowei; Donnelly, Christl A.] Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England; [Riley, Steven; Ainslie, Kylie E. C.; Eales, Oliver; Walters, Caroline E.; Wang, Haowei; Donnelly, Christl A.] Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England; [Fronterre, Claudio; Diggle, Peter J.] Univ Lancaster, Ctr Hlth Informat Comp & Stat CHICAS, Lancaster Med Sch, Lancaster, England; [Fronterre, Claudio; Diggle, Peter J.] Hlth Data Res UK, London, England; [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England; [Cooke, Graham; Barclay, Wendy] Imperial Coll London, Dept Infect Dis, London, England; [Cooke, Graham; Ward, Helen; Darzi, Ara; Elliott, Paul] Imperial Coll Healthcare NHS Trust, London, England; [Cooke, Graham; Ward, Helen; Darzi, Ara; Elliott, Paul] Natl Inst Hlth Res, Imperial Biomed Res Ctr, London, England; [Darzi, Ara] Imperial Coll London, Inst Global Hlth Innovat, London, England; [Elliott, Paul] Imperial Coll London, MRC Ctr Environm & Hlth, Sch Publ Hlth, London, England	Imperial College London; Imperial College London; Imperial College London; Lancaster University; University of Oxford; Imperial College London; Imperial College London; Imperial College London; Imperial College London	Riley, S; Elliott, P (corresponding author), Imperial Coll London, Sch Publ Hlth, London, England.; Riley, S (corresponding author), Imperial Coll London, MRC Ctr Global Infect Dis Anal, London, England.; Riley, S (corresponding author), Imperial Coll London, Abdul Latif Jameel Inst Dis & Emergency Analyt, London, England.; Elliott, P (corresponding author), Imperial Coll Healthcare NHS Trust, London, England.; Elliott, P (corresponding author), Natl Inst Hlth Res, Imperial Biomed Res Ctr, London, England.; Elliott, P (corresponding author), Imperial Coll London, MRC Ctr Environm & Hlth, Sch Publ Hlth, London, England.	s.riley@imperial.ac.uk; p.elliott@imperial.ac.uk	Fronterre, Claudio/AGW-2090-2022; Ward, Helen/A-1836-2009	Fronterre, Claudio/0000-0001-6723-9727; Ward, Helen/0000-0001-8238-5036; Ashby, Deborah/0000-0003-3146-7466; WANG, HAOWEI/0000-0003-4753-8783; Atchison, Christina/0000-0001-8304-7389; Barclay, Wendy/0000-0002-3948-0895; Diggle, Peter/0000-0003-3521-5020; Donnelly, Christl/0000-0002-0195-2463	Department of Health and Social Care in England; MRC Centre for Global Infectious Disease Analysis; National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU); Wellcome Trust [200861/Z/16/Z, 200187/Z/15/Z]; US Centers for Disease Control and Prevention [U01CK0005-01-02]; NIHR Professorship; MRC Centre for Environment and Health [MR/L01341X/1, MR/S019669/1]; NIHR Imperial Biomedical Research Centre; NIHR HPRUs in Chemical and Radiation Threats and Hazards and Environmental Exposures and Health; British Heart Foundation Centre for Research Excellence at Imperial College London [RE/18/4/34215]; UK Dementia Research Institute at Imperial [MC_PC_17114]; Huo Family Foundation; Health Data Research UK (HDR UK)	Department of Health and Social Care in England; MRC Centre for Global Infectious Disease Analysis(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU); Wellcome Trust(Wellcome Trust); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIHR Professorship; MRC Centre for Environment and Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Imperial Biomedical Research Centre; NIHR HPRUs in Chemical and Radiation Threats and Hazards and Environmental Exposures and Health; British Heart Foundation Centre for Research Excellence at Imperial College London; UK Dementia Research Institute at Imperial; Huo Family Foundation; Health Data Research UK (HDR UK)	This research was funded by the Department of Health and Social Care in England. S.R. and C.A.D. acknowledge support from the MRC Centre for Global Infectious Disease Analysis, the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU), the Wellcome Trust (200861/Z/16/Z, 200187/Z/15/Z), and the US Centers for Disease Control and Prevention (U01CK0005-01-02). G.C. is supported by an NIHR Professorship. P.E. is director of the MRC Centre for Environment and Health (MR/L01341X/1, MR/S019669/1) and receives support from the NIHR Imperial Biomedical Research Centre and the NIHR HPRUs in Chemical and Radiation Threats and Hazards and Environmental Exposures and Health, the British Heart Foundation Centre for Research Excellence at Imperial College London (RE/18/4/34215), the UK Dementia Research Institute at Imperial (MC_PC_17114), and Health Data Research UK (HDR UK). We thank the Huo Family Foundation for their support of our work on COVID-19.	Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Bar-Or I., 2020, MEDRXIV 202004262007; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Boger B, 2021, AM J INFECT CONTROL, V49, P21, DOI 10.1016/j.ajic.2020.07.011; Cabinet Office, 2020, COR COVID 19 WHAT HA; Cao SY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19802-w; Cao W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13797-9; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Diggle P.J., 2019, MODEL BASED GEOSTATI, V1st ed.; Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110; Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gelman A., 2011, ARXIV11114246STATCO; Giorgi E, 2017, J STAT SOFTW, V78, P1, DOI 10.18637/jss.v078.i08; Graham NSN, 2020, J INFECTION, V81, P411, DOI 10.1016/j.jinf.2020.05.073; Greaney Allison J, 2021, Cell Host Microbe, V29, P463, DOI 10.1016/j.chom.2021.02.003; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Home Office Rt Hon Priti Patel MP, 2020, RULE 6 COMES EFFECT; Jarvis CI, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01597-8; Jeffrey Benjamin, 2020, Wellcome Open Res, V5, P170, DOI 10.12688/wellcomeopenres.15997.1; Jeyanathan M, 2020, NAT REV IMMUNOL, V20, P615, DOI 10.1038/s41577-020-00434-6; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Lang S, 2004, J COMPUT GRAPH STAT, V13, P183, DOI 10.1198/1061860043010; Layard R., 2020, SSRN ELECT J; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Luo SW, 2020, CONTEMP ECON POLICY, V38, P583, DOI 10.1111/coep.12482; Mahase E, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4714; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Moss R, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010012; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Office for National Statistics, 2021, CORONAVIRUS COVID 19; Office for National Statistics, 2020, DEATHS REG WEEKL ENG; Office for National Statistics, ANN POP SURV LAB FOR; Pavelka M, 2021, SCIENCE, V372, P635, DOI 10.1126/science.abf9648; Peretti-Watel P, 2020, LANCET INFECT DIS, V20, P769, DOI 10.1016/S1473-3099(20)30426-6; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Public Health England, NEW SARS COV 2 VAR I; Riley S., 2021, REACTIDD R PACKAGE D; Riley Steven, 2020, Wellcome Open Res, V5, P200, DOI 10.12688/wellcomeopenres.16228.1; Rivett L, 2020, ELIFE, V9, DOI 10.7554/eLife.58728; SHAROT T, 1986, J MARKET RES SOC, V28, P269; UK Government, COR COVID 19 UK DASH; van Leeuwen E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005838; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Ward H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21237-w; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wise J, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4857; Zhang JJ, 2020, LANCET INFECT DIS, V20, P793, DOI 10.1016/S1473-3099(20)30230-9	50	39	39	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2021	372	6545					990	+		10.1126/science.abf0874	http://dx.doi.org/10.1126/science.abf0874			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK7YO	33893241	Green Submitted, Green Published			2022-12-28	WOS:000656432400052
J	Iacobucci, G				Iacobucci, Gareth			GPs are at "breaking point" and in need of respite, leaders warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2021, BMA SURV COV 19 TRAC; NHS Digital, 2021, APP GEN PRACT MARCH; Surgery IG, 2021, OP LETT OUR PAT DEM	3	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n1139	10.1136/bmj.n1139	http://dx.doi.org/10.1136/bmj.n1139			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947713	Bronze			2022-12-28	WOS:000649710200007
J	Phillips, RL; McCauley, LA; Koller, CF				Phillips, Robert L., Jr.; McCauley, Linda A.; Koller, Christopher F.			Implementing High-Quality Primary Care A Report From the National Academies of Sciences, Engineering, and Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses a 2021 National Academies of Sciences, Engineering, and Medicine consensus report proposing patient-centered principles and recommendations to strengthen primary care services and systems, including payment and information technology reform and dedicated funding for primary care research.	[Phillips, Robert L., Jr.] Amer Board Family Med Fdn, Ctr Professionalism & Value Hlth Care, 1016 NW 16th St,Ste 700, Washington, DC 20036 USA; [McCauley, Linda A.] Emory Univ, Neil Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA; [Koller, Christopher F.] Milbank Mem Fund, New York, NY USA	Emory University	Phillips, RL (corresponding author), Amer Board Family Med Fdn, Ctr Professionalism & Value Hlth Care, 1016 NW 16th St,Ste 700, Washington, DC 20036 USA.	bphillips@theabfm.org	Phillips, Robert/GYV-4088-2022		Academic Pediatric Association; Agency for Healthcare Research and Quality; Alliance for Academic Internal Medicine; American Academy of Family Physicians; American Academy of Pediatrics; American Board of Pediatrics; American College of Physicians; American Geriatrics Society Blue Shield of California; Commonwealth Fund; FMA Health; Health Resources and Services Administration; New York State Health Foundation; Patient-Centered Outcomes Research Institute; Samueli Institute Society for General Internal Medicine	Academic Pediatric Association; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Alliance for Academic Internal Medicine; American Academy of Family Physicians; American Academy of Pediatrics; American Board of Pediatrics; American College of Physicians; American Geriatrics Society Blue Shield of California; Commonwealth Fund; FMA Health; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); New York State Health Foundation; Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Samueli Institute Society for General Internal Medicine	The National Academies study was funded by the Academic Pediatric Association, Agency for Healthcare Research and Quality, Alliance for Academic Internal Medicine, American Academy of Family Physicians, American Academy of Pediatrics, American Board of Pediatrics, American College of Physicians, American Geriatrics Society Blue Shield of California, Commonwealth Fund, FMA Health, Health Resources and Services Administration, New York State Health Foundation, Patient-Centered Outcomes Research Institute, and Samueli Institute Society for General Internal Medicine.	Donaldson M, 1996, PRIMARY CARE AM HLTH; Institute of Medicine, 2012, PRIM CAR PUBL HLTH E; Kringos DE, 2015, BUILDING PRIMARY CAR, V38, P172; Martin S, 2020, JAMA INTERN MED, V180, P1019, DOI 10.1001/jamainternmed.2020.1360; National Academies of Sciences Engineering and Medicine, 2021, IMPL HIGHQ QUAL PRIM; Organisation for Economic Co-operation and Development, DER PREL EST PRIM CA	6	11	11	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	2021	325	24					2437	2438		10.1001/jama.2021.7430	http://dx.doi.org/10.1001/jama.2021.7430		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TD7ZK	33944903				2022-12-28	WOS:000647843400001
J	Bryant, JM; Brown, KP; Burbaud, S; Everall, I; Belardinelli, JM; Rodriguez-Rincon, D; Grogono, DM; Peterson, CM; Verma, D; Evans, IE; Ruis, C; Weimann, A; Arora, D; Malhotra, S; Bannerman, B; Passemar, C; Templeton, K; MacGregor, G; Jiwa, K; Fisher, AJ; Blundell, TL; Ordway, DJ; Jackson, M; Parkhill, J; Floto, RA				Bryant, Josephine M.; Brown, Karen P.; Burbaud, Sophie; Everall, Isobel; Belardinelli, Juan M.; Rodriguez-Rincon, Daniela; Grogono, Dorothy M.; Peterson, Chelsea M.; Verma, Deepshikha; Evans, Ieuan E.; Ruis, Christopher; Weimann, Aaron; Arora, Divya; Malhotra, Sony; Bannerman, Bridget; Passemar, Charlotte; Templeton, Kerra; MacGregor, Gordon; Jiwa, Kasim; Fisher, Andrew J.; Blundell, Tom L.; Ordway, Diane J.; Jackson, Mary; Parkhill, Julian; Floto, R. Andres			Stepwise pathogenic evolution of Mycobacterium abscessus	SCIENCE			English	Article							CYSTIC-FIBROSIS; NONTUBERCULOUS MYCOBACTERIA; LUNG-TRANSPLANT; GENOME; TUBERCULOSIS; PROTEIN; VIRULENCE; SUSCEPTIBILITY; TRANSMISSION; RESISTANCE	Although almost all mycobacterial species are saprophytic environmental organisms, a few, such as Mycobacterium tuberculosis, have evolved to cause transmissible human infection. By analyzing the recent emergence and spread of the environmental organism M. abscessus through the global cystic fibrosis population, we have defined key, generalizable steps involved in the pathogenic evolution of mycobacteria. We show that epigenetic modifiers, acquired through horizontal gene transfer, cause saltational increases in the pathogenic potential of specific environmental clones. Allopatric parallel evolution during chronic lung infection then promotes rapid increases in virulence through mutations in a discrete gene network; these mutations enhance growth within macrophages but impair fomite survival. As a consequence, we observe constrained pathogenic evolution while person-to-person transmission remains indirect, but postulate accelerated pathogenic adaptation once direct transmission is possible, as observed for M. tuberculosis. Our findings indicate how key interventions, such as early treatment and cross-infection control, might restrict the spread of existing mycobacterial pathogens and prevent new, emergent ones.	[Bryant, Josephine M.; Brown, Karen P.; Burbaud, Sophie; Everall, Isobel; Rodriguez-Rincon, Daniela; Grogono, Dorothy M.; Evans, Ieuan E.; Ruis, Christopher; Weimann, Aaron; Arora, Divya; Bannerman, Bridget; Passemar, Charlotte; Floto, R. Andres] Univ Cambridge, Mol Immun Unit, MRC Lab Mol Biol, Dept Med, Cambridge, England; [Bryant, Josephine M.; Ruis, Christopher; Weimann, Aaron; Bannerman, Bridget; Floto, R. Andres] Univ Cambridge, Ctr AI Med, Cambridge, England; [Brown, Karen P.; Grogono, Dorothy M.; Evans, Ieuan E.; Floto, R. Andres] Royal Papworth Hosp, Cambridge Ctr Lung Infect, Cambridge, England; [Everall, Isobel; Parkhill, Julian] Wellcome Sanger Inst, Hinxton, England; [Belardinelli, Juan M.; Peterson, Chelsea M.; Verma, Deepshikha; Ordway, Diane J.; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Malhotra, Sony; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Malhotra, Sony] Sci & Technol Facil Council, Sci Comp Dept, Harwell, Berks, England; [Templeton, Kerra; MacGregor, Gordon] NHS Greater Glasgow & Clyde, Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland; [Jiwa, Kasim; Fisher, Andrew J.] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Jiwa, Kasim; Fisher, Andrew J.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Inst Transplantat, Newcastle Upon Tyne, Tyne & Wear, England; [Parkhill, Julian] Univ Cambridge, Dept Vet Med, Cambridge, England	MRC Laboratory Molecular Biology; University of Cambridge; University of Cambridge; Papworth Hospital; Wellcome Trust Sanger Institute; Colorado State University; University of Cambridge; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); Queen Elizabeth University Hospital (QEUH); Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Cambridge	Floto, RA (corresponding author), Univ Cambridge, Mol Immun Unit, MRC Lab Mol Biol, Dept Med, Cambridge, England.; Floto, RA (corresponding author), Univ Cambridge, Ctr AI Med, Cambridge, England.; Floto, RA (corresponding author), Royal Papworth Hosp, Cambridge Ctr Lung Infect, Cambridge, England.; Parkhill, J (corresponding author), Wellcome Sanger Inst, Hinxton, England.; Parkhill, J (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	jp369@cam.ac.uk; arf27@cam.ac.uk	Bannerman, Bridget/AGZ-8550-2022; Parkhill, Julian/G-4703-2011; Bryant, Josephine/ABC-8288-2021; Jackson, Mary/D-5345-2017	Bannerman, Bridget/0000-0002-5746-8283; Parkhill, Julian/0000-0002-7069-5958; Jackson, Mary/0000-0002-9212-0258; Brown, Karen P/0000-0002-0387-5318; Bryant, Josephine/0000-0002-0149-5768; Peterson, Chelsea/0000-0002-7167-5860; Burbaud, Sophie/0000-0003-0013-5565; Belardinelli, Juan Manuel/0000-0003-1336-9141	Wellcome Trust [107032AIA, 10224/Z/15/Z, 098051]; UK Cystic Fibrosis Trust [Innovation Hub grant] [001]; UK Cystic Fibrosis Trust [Strategic Research Centre grants] [002, 010]; NIHR Cambridge Biomedical Research Centre; Botnar Foundation [6063]	Wellcome Trust(Wellcome Trust); UK Cystic Fibrosis Trust [Innovation Hub grant]; UK Cystic Fibrosis Trust [Strategic Research Centre grants]; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Botnar Foundation	Supported by Wellcome Trust grants 107032AIA (R.A.F., D.M.G., and S.B.), 10224/Z/15/Z (J.M.Br.), and 098051 (J.P.); the UK Cystic Fibrosis Trust [Innovation Hub grant 001 (R.A.F., T.L.B., J.P., S.B., and I.E.E.) and Strategic Research Centre grants 002 and 010 (I.E., D.R.-R., T.L.B., D.J.O., J.M.Be., D.V., M.J., D.M.G., I.E., J.P., and R.A.F.)]; the NIHR Cambridge Biomedical Research Centre (R.A.F. and K.P.B.); and Botnar Foundation grant 6063 (R.A.F., A.W., T.L.B., S.M., and J.P.). Author contributions: J.M.Br. and R.A.F. conceived the project;	Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Alexander KA, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00471-16; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andreeva A, 2014, NUCLEIC ACIDS RES, V42, pD310, DOI 10.1093/nar/gkt1242; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Boniotti MB, 2014, J CLIN MICROBIOL, V52, P2834, DOI 10.1128/JCM.00440-14; Bos KI, 2014, NATURE, V514, P494, DOI 10.1038/nature13591; Broeckl S, 2017, VET RES COMMUN, V41, P113, DOI 10.1007/s11259-017-9679-8; Bryant JM, 2016, SCIENCE, V354, P751, DOI 10.1126/science.aaf8156; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Chiner-Oms A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11948-6; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Coscolla M, 2021, MICROB GENOMICS, V7, DOI 10.1099/mgen.0.000477; Coscolla M, 2013, EMERG INFECT DIS, V19, P969, DOI 10.3201/eid1906.121012; COUSINS DV, 1994, VET MICROBIOL, V42, P135, DOI 10.1016/0378-1135(94)90013-2; Crispell J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3569-x; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dippenaar A, 2015, TUBERCULOSIS, V95, P682, DOI 10.1016/j.tube.2015.10.001; Doyle RM, 2020, CLIN INFECT DIS, V70, P1855, DOI 10.1093/cid/ciz526; Dubois V, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008069; Everall I, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000111; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Floto RA, 2016, THORAX, V71, P1, DOI 10.1136/thoraxjnl-2015-207360; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Frohlich H, 2008, BIOINFORMATICS, V24, P2549, DOI 10.1093/bioinformatics/btn446; Gagneux S, 2018, NAT REV MICROBIOL, V16, P202, DOI 10.1038/nrmicro.2018.8; Grandjean L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189838; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hahsler M, 2019, J STAT SOFTW, V91, P1, DOI 10.18637/jss.v091.i01; Hasan NA, 2019, 663559 BIORXIV; Haworth CS, 2017, THORAX, V72, DOI 10.1136/thoraxjnl-2017-210927; Hepburn L, 2014, SCIENCE, V346, P641, DOI 10.1126/science.1258705; Ishikawa SA, 2019, MOL BIOL EVOL, V36, P2069, DOI 10.1093/molbev/msz131; Johansen MD, 2020, NAT REV MICROBIOL, V18, P392, DOI 10.1038/s41579-020-0331-1; Kapnadak SG, 2016, AM J INFECT CONTROL, V44, P154, DOI 10.1016/j.ajic.2015.08.023; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P59, DOI 10.1093/nar/30.1.59; Kudhair BK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02418-y; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li B, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01739; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martiniano SL, 2019, THORAC SURG CLIN, V29, P95, DOI 10.1016/j.thorsurg.2018.09.008; McGuire AM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-120; Medjahed Halima, 2010, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10d02s18; Miller CA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3195-z; NCBI Resource Coordinators, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, DOI 10.1093/NAR/GKX1095]; Nebenzahl-Guimaraes H, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000063; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ngabonziza JCS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16626-6; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Orgeur M, 2018, CURR OPIN MICROBIOL, V41, P68, DOI 10.1016/j.mib.2017.11.021; Page AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000083; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponstingl H., 2011, SMALT V0 5 8; Qvist T, 2016, J CYST FIBROS, V15, P380, DOI 10.1016/j.jcf.2015.09.007; Richards CJ, 2019, SEMIN RESP CRIT CARE, V40, P737, DOI 10.1055/s-0039-1693706; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Rodriguez GM, 2002, INFECT IMMUN, V70, P3371, DOI 10.1128/IAI.70.7.3371-3381.2002; Ryndak M, 2008, TRENDS MICROBIOL, V16, P528, DOI 10.1016/j.tim.2008.08.006; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanz-Garcia F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00046; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shin DM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001230; Silva-Pereira TT, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6407-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taylor JL, 2006, J HEART LUNG TRANSPL, V25, P985, DOI 10.1016/j.healun.2006.04.003; Tonkin-Hill G, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02090-4; Tran PH, 1998, STRUCT FOLD DES, V6, P1563, DOI 10.1016/S0969-2126(98)00154-3; Uchiya K, 2017, SCI REP-UK, V7, DOI 10.1038/srep39750; Vazquez-Torres A, 2016, CURR OPIN MICROBIOL, V29, P1, DOI 10.1016/j.mib.2015.09.002; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; Weller R, 2006, NITRIC OXIDE-BIOL CH, V15, P395, DOI 10.1016/j.niox.2006.04.002; Yan J, 2020, J CYST FIBROS, V19, P219, DOI 10.1016/j.jcf.2019.02.011; Zhou Z, 2011, J CYST FIBROS, V10, pS172, DOI 10.1016/S1569-1993(11)60021-0	87	38	38	6	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					483	+	eabb8699	10.1126/science.abb8699	http://dx.doi.org/10.1126/science.abb8699			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RV0UZ	33926925	Green Accepted, Green Submitted			2022-12-28	WOS:000645554100039
J	Boehm, JS				Boehm, Jesse S.			The power of parent scientists	CELL			English	Editorial Material								Parent scientists lead a journey to bring surveillance severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing to public schools across the state of Massachusetts and beyond.				boehm.jesse@gmail.com							0	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 29	2021	184	9					2263	2270		10.1016/j.cell.2021.03.049	http://dx.doi.org/10.1016/j.cell.2021.03.049		APR 2021	8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	RV7SH	33930292	Bronze, Green Published			2022-12-28	WOS:000646027900003
J	Chertow, GM; Pergola, PE; Farag, YMK; Agarwal, R; Arnold, S; Bako, G; Block, GA; Burke, S; Castillo, FP; Jardine, AG; Khawaja, Z; Koury, MJ; Lewis, EF; Lin, T; Luo, WL; Maroni, BJ; Matsushita, K; McCullough, PA; Parfrey, PS; Roy-Chaudhury, P; Sarnak, MJ; Sharma, A; Spinowitz, B; Tseng, C; Tumlin, J; Vargo, DL; Walters, KA; Winkelmayer, WC; Wittes, J; Eckardt, KU				Chertow, Glenn M.; Pergola, Pablo E.; Farag, Youssef M. K.; Agarwal, Rajiv; Arnold, Susan; Bako, Gabriel; Block, Geoffrey A.; Burke, Steven; Castillo, Fausto P.; Jardine, Alan G.; Khawaja, Zeeshan; Koury, Mark J.; Lewis, Eldrin F.; Lin, Tim; Luo, Wenli; Maroni, Bradley J.; Matsushita, Kunihiro; McCullough, Peter A.; Parfrey, Patrick S.; Roy-Chaudhury, Prabir; Sarnak, Mark J.; Sharma, Amit; Spinowitz, Bruce; Tseng, Carol; Tumlin, James; Vargo, Dennis L.; Walters, Kimberly A.; Winkelmayer, Wolfgang C.; Wittes, Janet; Eckardt, Kai-Uwe		PRO2 TECT Study Grp	Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Vadadustat is an oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor, a class of drugs that stabilize HIF and stimulate erythropoietin and red-cell production. Methods In two phase 3, randomized, open-label, active-controlled, noninferiority trials, we compared vadadustat with the erythropoiesis-stimulating agent (ESA) darbepoetin alfa in patients with non-dialysis-dependent chronic kidney disease (NDD-CKD) not previously treated with an ESA who had a hemoglobin concentration of less than 10 g per deciliter and in patients with ESA-treated NDD-CKD and a hemoglobin concentration of 8 to 11 g per deciliter (in the United States) or 9 to 12 g per deciliter (in other countries). The primary safety end point, assessed in a time-to-event analysis, was the first major adverse cardiovascular event (MACE; a composite of death from any cause, nonfatal myocardial infarction, or nonfatal stroke), pooled across the two trials. Secondary safety end points included expanded MACE (MACE plus hospitalization for either heart failure or a thromboembolic event). The primary and key secondary efficacy end points in each trial were the mean change in hemoglobin concentration from baseline during two evaluation periods: weeks 24 through 36 and weeks 40 through 52. Results A total of 1751 patients with ESA-untreated NDD-CKD and 1725 with ESA-treated NDD-CKD underwent randomization in the two trials. In the pooled analysis, in which 1739 patients received vadadustat and 1732 received darbepoetin alfa, the hazard ratio for MACE was 1.17 (95% confidence interval [CI], 1.01 to 1.36), which did not meet the prespecified noninferiority margin of 1.25. The mean between-group differences in the change in the hemoglobin concentration at weeks 24 through 36 were 0.05 g per deciliter (95% CI, -0.04 to 0.15) in the trial involving ESA-untreated patients and -0.01 g per deciliter (95% CI, -0.09 to 0.07) in the trial involving ESA-treated patients, which met the prespecified noninferiority margin of -0.75 g per deciliter. Conclusions Vadadustat, as compared with darbepoetin alfa, met the prespecified noninferiority criterion for hematologic efficacy but not the prespecified noninferiority criterion for cardiovascular safety in patients with NDD-CKD. (Funded by Akebia Therapeutics and Otsuka Pharmaceutical; PRO2TECT ClinicalTrials.gov numbers, NCT02648347 and NCT02680574.) Vadadustat in Non-Dialysis-Dependent CKD Two randomized, phase 3, open-label noninferiority trials compared vadadustat with darbepoetin alfa in patients with non-dialysis-dependent chronic kidney disease. Vadadustat, as compared with darbepoetin alfa, met the prespecified noninferiority criterion for hematologic efficacy but not for cardiovascular safety.	[Chertow, Glenn M.; Lewis, Eldrin F.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Pergola, Pablo E.] Renal Associates, San Antonio, TX USA; [Block, Geoffrey A.] US Renal Care, Plano, TX USA; [McCullough, Peter A.] Baylor Univ, Med Ctr, Baylor Heart & Vasc Hosp, Baylor Heart & Vasc Inst, Dallas, TX USA; [Winkelmayer, Wolfgang C.] Baylor Coll Med, Sect Nephrol, Houston, TX 77030 USA; [Farag, Youssef M. K.; Burke, Steven; Khawaja, Zeeshan; Luo, Wenli; Maroni, Bradley J.; Sharma, Amit; Vargo, Dennis L.] Akebia Therapeut, Cambridge, MA USA; [Sarnak, Mark J.] Tufts Univ, Sch Med, Div Nephrol, Tufts Med Ctr, Boston, MA 02111 USA; [Agarwal, Rajiv] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Arnold, Susan] Excellentis Clin Trial Consultants, George, South Africa; [Bako, Gabriel] Bihor Cty Hosp Oradea, Oradea, Romania; [Castillo, Fausto P.] Qway Res, Hialeah, FL USA; [Jardine, Alan G.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Koury, Mark J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Lin, Tim] Firma Clin Res, Hunt Valley, MD USA; [Matsushita, Kunihiro] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Parfrey, Patrick S.] Mem Univ Newfoundland, Dept Med, St John, NF, Canada; [Roy-Chaudhury, Prabir] Univ N Carolina, Kidney Ctr, Div Nephrol & Hypertens, Chapel Hill, NC 27515 USA; [Roy-Chaudhury, Prabir] WG Bill Hefner Vet Affairs Med Ctr, Salisbury, NC USA; [Spinowitz, Bruce] New York Presbyterian Queens, Div Nephrol, Flushing, NY USA; [Tseng, Carol] Firma Clin Res, Chicago, IL USA; [Tumlin, James] Emory Univ, Sch Med, Atlanta, GA USA; [Walters, Kimberly A.; Wittes, Janet] Stat Collaborat, Washington, DC USA; [Eckardt, Kai-Uwe] Charite, Dept Nephrol & Med Intens Care, Berlin, Germany	Stanford University; Baylor University; Baylor University Medical Center; Baylor College of Medicine; Tufts Medical Center; Tufts University; Indiana University System; Indiana University Bloomington; University of Glasgow; Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Memorial University Newfoundland; University of North Carolina; University of North Carolina Chapel Hill; Emory University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Chertow, GM (corresponding author), Stanford Univ, Sch Med, Dept Med, 1070 Arastradero Rd,Suite 311, Palo Alto, CA 94304 USA.	gchertow@stanford.edu	Maslovskyi, Valentyn/V-3896-2019; peride, ileana/G-6503-2014; Garibotto, Giacomo/AAB-1190-2019; Matsushita, Kunihiro/AAJ-5817-2020; Maslovskyi, Valentyn/GQO-9125-2022; Block, Geoffrey/AAV-8070-2021; Tesar, Vladimir/O-2312-2017; Reznik, Elena/N-6856-2016	Maslovskyi, Valentyn/0000-0001-5184-1799; Garibotto, Giacomo/0000-0001-6432-2429; Matsushita, Kunihiro/0000-0002-7179-718X; Maslovskyi, Valentyn/0000-0001-5184-1799; Block, Geoffrey/0000-0002-4646-7074; Tesar, Vladimir/0000-0001-6982-0689; da Silva Franco, Roberto Jorge/0000-0001-9787-4393; Jardine, Alan/0000-0001-5815-9370; Chertow, Glenn/0000-0002-7599-0534; NATICCHIA, Alessandro/0000-0003-3260-7926; Reznik, Elena/0000-0001-7479-418X				Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Chertow GM., 2020, AM HEART J, V235, P1; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eckardt KU, 2021, NEW ENGL J MED, V384, P1601, DOI 10.1056/NEJMoa2025956; Fishbane S, 2013, NEW ENGL J MED, V368, P307, DOI 10.1056/NEJMoa1203165; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Luo W., 2020, NEPHROL DIAL TRANSPL; Macdougall IC, 2013, NEW ENGL J MED, V368, P320, DOI 10.1056/NEJMoa1203166; Martin ER, 2017, AM J NEPHROL, V45, P380, DOI 10.1159/000464476; Pergola PE, 2016, KIDNEY INT, V90, P1115, DOI 10.1016/j.kint.2016.07.019; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943	18	64	68	3	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1589	1600		10.1056/NEJMoa2035938	http://dx.doi.org/10.1056/NEJMoa2035938			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1ND	33913637	Bronze			2022-12-28	WOS:000645605800010
J	Tajalli, M; Wambier, CG				Tajalli, Mahroo; Wambier, Carlos G.			Lucio's Phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Lucio's Phenomenon A 48-year-old man presented with fever and blistering skin lesions. Multiple acid-fast bacilli were detected on biopsy of the skin, and a diagnosis of Lucio's phenomenon, a reaction that occurs in patients with diffuse lepromatous leprosy, was made.	[Tajalli, Mahroo; Wambier, Carlos G.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Wambier, CG (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	carlos_wambier@brown.edu	Wambier, Carlos Gustavo/H-4281-2012	Wambier, Carlos Gustavo/0000-0002-4636-4489					0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1646	1646		10.1056/NEJMicm2025081	http://dx.doi.org/10.1056/NEJMicm2025081			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1ND	33913641				2022-12-28	WOS:000645605800015
J	Best, J				Best, Jo			The robot will see you now: how machines could reshape post-pandemic medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jo.best@journalist.com						Boskoski I, 2019, DIGEST ENDOSC, V31, P119, DOI 10.1111/den.13270; Dalsgaard T, 2020, ANN SURG, V271, P106, DOI 10.1097/SLA.0000000000002845; Dyer C, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4791; Engineering and Technology, 2020, ROB FOUND IMPR MENT; Fagogenis G, 2019, SCI ROBOT, V4, DOI 10.1126/scirobotics.aaw1977; Leading Healthcare, 2019, SCOTL 1 NHS ORTH ROB; Murayama Y, 2011, NEUROSURGERY, V68, P1427, DOI 10.1227/NEU.0b013e31820b4f1c; Perez RE, 2019, ANN LAPAROSC ENDOSC, V4, DOI 10.21037/ales.2019.05.02; Tan A, 2016, SURG ENDOSC, V30, P4330, DOI 10.1007/s00464-016-4752-x; The Royal Orthopaedic Hospital, 2018, PION ROB ARM ASS SUR; University Hospitals of Derby and Burton, 2020, STAT OF THE ART ROB; Zheng JL, 2020, SURG ENDOSC, V34, P5172, DOI 10.1007/s00464-020-07823-x	12	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n454	10.1136/bmj.n454	http://dx.doi.org/10.1136/bmj.n454			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910807				2022-12-28	WOS:000656399900003
J	Iacobucci, G				Iacobucci, Gareth			Assisted dying: Hancock asks for more data on suicides of terminally ill people	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royall J., HL13019 UIN	1	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n1107	10.1136/bmj.n1107	http://dx.doi.org/10.1136/bmj.n1107			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910921				2022-12-28	WOS:000656399900013
J	Gerada, C				Gerada, Clare			Clare Gerada: A problem shared	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 27	2021	373								n1074	10.1136/bmj.n1074	http://dx.doi.org/10.1136/bmj.n1074			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RW1QM	33906849	Bronze			2022-12-28	WOS:000646297900005
J	Slomski, A				Slomski, Anita			Bimekizumab Offers Rapid and Durable Psoriasis Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2021	325	16					1602	1602		10.1001/jama.2021.5863	http://dx.doi.org/10.1001/jama.2021.5863			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1RL	33904869				2022-12-28	WOS:000645617800009
J	Mahase, E				Mahase, Elisabeth			Malaria vaccine becomes first to achieve 75% efficacy goal in trial of children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n651; World Health Organization (WHO), MAL VACC IMPL PROGR	2	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 23	2021	373								n1078	10.1136/bmj.n1078	http://dx.doi.org/10.1136/bmj.n1078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0KR	33893146				2022-12-28	WOS:000708057000016
J	Qiao, XD; Midya, B; Gao, ZH; Zhang, ZF; Zhao, HQ; Wu, TW; Yim, J; Agarwal, R; Litchinitser, NM; Feng, L				Qiao, Xingdu; Midya, Bikashkali; Gao, Zihe; Zhang, Zhifeng; Zhao, Haoqi; Wu, Tianwei; Yim, Jieun; Agarwal, Ritesh; Litchinitser, Natalia M.; Feng, Liang			Higher-dimensional supersymmetric microlaser arrays	SCIENCE			English	Article							ANGULAR-MOMENTUM; LASER ARRAYS; LIGHT	The nonlinear scaling of complexity with the increased number of components in integrated photonics is a major obstacle impeding large-scale, phase-locked laser arrays. Here, we develop a higher-dimensional supersymmetry formalism for precise mode control and nonlinear power scaling. Our supersymmetric microlaser arrays feature phase-locked coherence and synchronization of all of the evanescently coupled microring lasers-collectively oscillating in the fundamental transverse supermode-which enables high-radiance, small-divergence, and single-frequency laser emission with a two-orders-of-magnitude enhancement in energy density. We also demonstrate the feasibility of structuring high-radiance vortex laser beams, which enhance the laser performance by taking full advantage of spatial degrees of freedom of light. Our approach provides a route for designing large-scale integrated photonic systems in both classical and quantum regimes.	[Qiao, Xingdu; Zhang, Zhifeng; Zhao, Haoqi; Feng, Liang] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Midya, Bikashkali; Gao, Zihe; Wu, Tianwei; Yim, Jieun; Agarwal, Ritesh; Feng, Liang] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Midya, Bikashkali] Indian Inst Sci Educ & Res, Dept Phys Sci, Berhampur 760010, India; [Litchinitser, Natalia M.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	University of Pennsylvania; University of Pennsylvania; Indian Institute of Science Education & Research (IISER) - Berhampur; Duke University	Feng, L (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.; Feng, L (corresponding author), Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.	fenglia@seas.upenn.edu	Gao, Zihe/I-7205-2015	Gao, Zihe/0000-0003-1844-0541; Zhang, Zhifeng/0000-0001-6847-4876	US Army Research Office (ARO) [W911NF-19-1-0249, W911NF-18-1-0348]; National Science Foundation (NSF) [ECCS-1932803, ECCS1842612, OMA-1936276]; Sloan Research Fellowship; NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC) [DMR-1720530]; NSF National Nanotechnology Coordinated Infrastructure Program [NNCI-1542153]	US Army Research Office (ARO); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Sloan Research Fellowship(Alfred P. Sloan Foundation); NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC)(National Science Foundation (NSF)); NSF National Nanotechnology Coordinated Infrastructure Program	We acknowledge support from the US Army Research Office (ARO) (W911NF-19-1-0249 and W911NF-18-1-0348), the National Science Foundation (NSF) (ECCS-1932803, ECCS1842612, and OMA-1936276), and a Sloan Research Fellowship. This work was partially supported by the NSF through the University of Pennsylvania Materials Research Science and Engineering Center (MRSEC) (DMR-1720530) and was carried out in part at the Singh Center for Nanotechnology, which is supported by the NSF National Nanotechnology Coordinated Infrastructure Program under grant NNCI-1542153.	Alperin SN, 2016, OPT LETT, V41, P5019, DOI 10.1364/OL.41.005019; Bahari B, 2021, NAT PHYS, V17, P700, DOI 10.1038/s41567-021-01165-8; Barkhofen S, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.260501; BOTEZ D, 1988, APPL PHYS LETT, V53, P464, DOI 10.1063/1.99885; Botez D., 2005, DIODE LASER ARRAYS; COOPER F, 1995, PHYS REP, V251, P268; Deka SS, 2017, OPT LETT, V42, P4760, DOI 10.1364/OL.42.004760; Dine M., 2007, SUPERSYMMETRY STRING; El-Ganainy R, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.033818; Feng L, 2017, NAT PHOTONICS, V11, P752, DOI 10.1038/s41566-017-0031-1; Heinrich M, 2014, OPT LETT, V39, P6130, DOI 10.1364/OL.39.006130; Heinrich M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4698; Hokmabadi MP, 2019, SCIENCE, V363, P623, DOI 10.1126/science.aav5103; Kao TY, 2016, NAT PHOTONICS, V10, P541, DOI [10.1038/nphoton.2016.104, 10.1038/NPHOTON.2016.104]; Kodigala A, 2017, NATURE, V541, P196, DOI 10.1038/nature20799; LEGER JR, 1988, APPL PHYS LETT, V52, P1771, DOI 10.1063/1.99621; Longhi S, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.032111; Midya B, 2019, PHOTONICS RES, V7, P363, DOI 10.1364/PRJ.7.000363; Miri MA, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.233902; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Shao ZK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03237-5; Siriani D. F., 2012, ADV SEMICONDUCTOR LA, V86; Siriani DF, 2012, SEMICONDUCT SEMIMET, V86, P227, DOI 10.1016/B978-0-12-391066-0.00006-X; Siriani DF, 2011, IEEE J QUANTUM ELECT, V47, P160, DOI 10.1109/JQE.2010.2068278; SOURLAS N, 1985, PHYSICA D, V15, P115, DOI 10.1016/0167-2789(85)90153-8; Takeda K, 2013, NAT PHOTONICS, V7, P569, DOI [10.1038/NPHOTON.2013.110, 10.1038/nphoton.2013.110]; Walasik W, 2018, OPT LETT, V43, P3758, DOI 10.1364/OL.43.003758; Yoshida M, 2019, NAT MATER, V18, P121, DOI 10.1038/s41563-018-0242-y; Yu S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9269; Zhang ZF, 2020, SCIENCE, V368, P760, DOI 10.1126/science.aba8996	30	22	22	25	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					403	+		10.1126/science.abg3904	http://dx.doi.org/10.1126/science.abg3904			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888640				2022-12-28	WOS:000645009800041
J	Chi, XW; Li, ML; Di, JC; Bai, P; Song, LN; Wang, XX; Li, F; Liang, S; Xu, JJ; Yu, JH				Chi, Xiwen; Li, Malin; Di, Jiancheng; Bai, Pu; Song, Lina; Wang, Xiaoxue; Li, Fei; Liang, Shuang; Xu, Jijing; Yu, Jihong			A highly stable and flexible zeolite electrolyte solid-state Li-air battery	NATURE			English	Article							LONG CYCLE LIFE; IONIC-CONDUCTIVITY; LITHIUM; LI-O-2; CHALLENGES	Solid-state lithium (Li)-air batteries are recognized as a next-generation solution for energy storage to address the safety and electrochemical stability issues that are encountered in liquid battery systems(1-4). However, conventional solid electrolytes are unsuitable for use in solid-state Li-air systems owing to their instability towards lithium metal and/or air, as well as the difficulty in constructing low-resistance interfaces(5). Here we present an integrated solid-state Li-air battery that contains an ultrathin, high-ion-conductive lithium-ion-exchanged zeolite X (LiX) membrane as the sole solid electrolyte. This electrolyte is integrated with cast lithium as the anode and carbon nanotubes as the cathode using an in situ assembly strategy. Owing to the intrinsic chemical stability of the zeolite, degeneration of the electrolyte from the effects of lithium or air is effectively suppressed. The battery has a capacity of 12,020 milliamp hours per gram of carbon nanotubes, and has a cycle life of 149 cycles at a current density of 500 milliamps per gram and at a capacity of 1,000 milliamp hours per gram. This cycle life is greater than those of batteries based on lithium aluminium germanium phosphate (12 cycles) and organic electrolytes (102 cycles) under the same conditions. The electrochemical performance, flexibility and stability of zeolite-based Li-air batteries confer practical applicability that could extend to other energy-storage systems, such as Li-ion, Na-air and Na-ion batteries.	[Chi, Xiwen; Li, Malin; Di, Jiancheng; Bai, Pu; Song, Lina; Wang, Xiaoxue; Li, Fei; Liang, Shuang; Xu, Jijing; Yu, Jihong] Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, P, Changchun, Peoples R China; [Chi, Xiwen; Li, Malin; Xu, Jijing; Yu, Jihong] Jilin Univ, Coll Chem, Int Ctr Future Sci, Changchun, Peoples R China	Jilin University; Jilin University	Xu, JJ; Yu, JH (corresponding author), Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, P, Changchun, Peoples R China.; Xu, JJ; Yu, JH (corresponding author), Jilin Univ, Coll Chem, Int Ctr Future Sci, Changchun, Peoples R China.	jijingxu@jlu.edu.cn; jihong@jlu.edu.cn	Xu, Ji-Jing/AAE-7774-2019; Han, Yu/N-2036-2015; min, guo/F-3813-2014	Han, Yu/0000-0003-1462-1118; Xu, Ji-Jing/0000-0002-6212-8224; Li, Malin/0000-0002-6736-180X	National Natural Science Foundation of China [21621001, 51771177, 51972141, 21835002, 21920102005]; 111 Project [B17020]; Jilin Province Science and Technology Development Program [20190303104SF]; National Postdoctoral Program for Innovative Talents [BX20180119]; China Postdoctoral Science Foundation [2019M651194]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Jilin Province Science and Technology Development Program; National Postdoctoral Program for Innovative Talents; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	J.Y. is supported by the National Natural Science Foundation of China (grants 21621001, 21835002 and 21920102005) and the 111 Project (B17020). J.X. is supported by the National Natural Science Foundation of China (grants 21621001, 51771177 and 51972141) and Jilin Province Science and Technology Development Program (20190303104SF). M. L. is supported by the National Postdoctoral Program for Innovative Talents (BX20180119) and the China Postdoctoral Science Foundation (2019M651194).	ANDERSEN EK, 1988, SOLID STATE IONICS, V28, P249, DOI 10.1016/S0167-2738(88)80044-4; Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Asadi M, 2018, NATURE, V555, P502, DOI 10.1038/nature25984; Bachman JC, 2016, CHEM REV, V116, P140, DOI 10.1021/acs.chemrev.5b00563; Baimpos T, 2011, CHEM MATER, V23, P1347, DOI 10.1021/cm1025206; Bruce PG, 2012, NAT MATER, V11, P19, DOI [10.1038/nmat3191, 10.1038/NMAT3191]; Chen RS, 2020, CHEM REV, V120, P6820, DOI 10.1021/acs.chemrev.9b00268; Famprikis T, 2019, NAT MATER, V18, P1278, DOI 10.1038/s41563-019-0431-3; Feuerstein M, 1999, SOLID STATE IONICS, V118, P135, DOI 10.1016/S0167-2738(98)00435-4; FREEMAN DC, 1961, J CHEM PHYS, V35, P799, DOI 10.1063/1.1701219; Freunberger SA, 2011, J AM CHEM SOC, V133, P8040, DOI 10.1021/ja2021747; GOODENOUGH JB, 1976, MATER RES BULL, V11, P203, DOI 10.1016/0025-5408(76)90077-5; Goodenough JB, 2010, CHEM MATER, V22, P587, DOI 10.1021/cm901452z; Han FD, 2019, NAT ENERGY, V4, P187, DOI 10.1038/s41560-018-0312-z; Kamaya N, 2011, NAT MATER, V10, P682, DOI [10.1038/NMAT3066, 10.1038/nmat3066]; KELEMEN G, 1992, J MATER SCI, V27, P6036, DOI 10.1007/BF01133746; KELEMEN G, 1989, J MATER SCI, V24, P333, DOI 10.1007/BF00660976; Kim BG, 2016, ADV FUNCT MATER, V26, P1747, DOI 10.1002/adfm.201504437; Lai JN, 2020, ANGEW CHEM INT EDIT, V59, P2974, DOI 10.1002/anie.201903459; Li Y, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600751; Li Y, 2017, CHEM-US, V3, P928, DOI 10.1016/j.chempr.2017.10.009; Lin Y, 2017, NANO LETT, V17, P3252, DOI 10.1021/acs.nanolett.7b00872; Liu GZ, 2019, ENERGY STORAGE MATER, V17, P266, DOI 10.1016/j.ensm.2018.07.008; Liu W, 2017, ADV MATER, V29, DOI 10.1002/adma.201603436; Liu YJ, 2018, J POWER SOURCES, V395, P439, DOI 10.1016/j.jpowsour.2018.05.080; Liu YJ, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201702374; Liu YJ, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201701602; Lu YC, 2013, ENERG ENVIRON SCI, V6, P750, DOI 10.1039/c3ee23966g; Manthiram A, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.103; Martinez C, 2011, COORDIN CHEM REV, V255, P1558, DOI 10.1016/j.ccr.2011.03.014; Mo FJ, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201902123; OHGUSHI T, 1990, J SOLID STATE CHEM, V87, P95, DOI 10.1016/0022-4596(90)90069-A; SCHOONHEYDT RA, 1971, ADV CHEM SER, P456; Simon U, 1999, J POROUS MAT, V6, P33, DOI 10.1023/A:1009637102831; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Tekin R, 2015, J CRYST GROWTH, V411, P45, DOI 10.1016/j.jcrysgro.2014.11.017; Vitillo JG, 2005, PHYS CHEM CHEM PHYS, V7, P3948, DOI 10.1039/b510989b; Wan JY, 2019, NAT NANOTECHNOL, V14, P705, DOI 10.1038/s41565-019-0465-3; Wang CW, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201701963; Wang S, 2018, J MATER CHEM A, V6, P21248, DOI 10.1039/c8ta08095j; Wang S, 2018, J MATER CHEM B, V6, P3254, DOI 10.1039/c8tb00328a; Wang ZB, 2009, J AM CHEM SOC, V131, P6910, DOI 10.1021/ja901626d; Wang ZQ, 2018, ADV MATER, V30, DOI 10.1002/adma.201704436; Xu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3438; Yang XY, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201702242; Yoshima K, 2016, J POWER SOURCES, V302, P283, DOI 10.1016/j.jpowsour.2015.10.031; Yu H, 2005, J THERM ANAL CALORIM, V82, P97, DOI 10.1007/s10973-005-0847-7; Zhang T, 2012, ANGEW CHEM INT EDIT, V51, P11062, DOI 10.1002/anie.201204983; Zhu XB, 2015, ENERG ENVIRON SCI, V8, P2782, DOI 10.1039/c5ee01604e	49	126	129	260	875	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					551	+		10.1038/s41586-021-03410-9July2020	http://dx.doi.org/10.1038/s41586-021-03410-9July2020			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6RQ	33883734				2022-12-28	WOS:000687333900007
J	Libby, P				Libby, Peter			The changing landscape of atherosclerosis	NATURE			English	Review							ACUTE CORONARY SYNDROMES; LOW-GRADE INFLAMMATION; SMOOTH-MUSCLE-CELLS; CLINICAL RISK SCORE; CARDIOVASCULAR-DISEASE; CLONAL HEMATOPOIESIS; INDOLEAMINE 2,3-DIOXYGENASE; OXIDIZED PHOSPHOLIPIDS; SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION	Emerging evidence has spurred a considerable evolution of concepts relating to atherosclerosis, and has called into question many previous notions. Here I review this evidence, and discuss its implications for understanding of atherosclerosis. The risk of developing atherosclerosis is no longer concentrated in Western countries, and it is instead involved in the majority of deaths worldwide. Atherosclerosis now affects younger people, and more women and individuals from a diverse range of ethnic backgrounds, than was formerly the case. The risk factor profile has shifted as levels of low-density lipoprotein (LDL) cholesterol, blood pressure and smoking have decreased. Recent research has challenged the protective effects of high-density lipoprotein, and now focuses on triglyceride-rich lipoproteins in addition to low-density lipoprotein as causal in atherosclerosis. Non-traditional drivers of atherosclerosis-such as disturbed sleep, physical inactivity, the microbiome, air pollution and environmental stress-have also gained attention. Inflammatory pathways and leukocytes link traditional and emerging risk factors alike to the altered behaviour of arterial wall cells. Probing the pathogenesis of atherosclerosis has highlighted the role of the bone marrow: somatic mutations in stem cells can cause clonal haematopoiesis, which represents a previously unrecognized but common and potent age-related contributor to the risk of developing cardiovascular disease. Characterizations of the mechanisms that underpin thrombotic complications of atherosclerosis have evolved beyond the `vulnerable plaque' concept. These advances in our understanding of the biology of atherosclerosis have opened avenues to therapeutic interventions that promise to improve the prevention and treatment of now-ubiquitous atherosclerotic diseases.	[Libby, Peter] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Libby, Peter] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Libby, P (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.; Libby, P (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	plibby@bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	National Heart, Lung, and Blood Institute [1R01HL134892]; American Heart Association [18CSA34080399]; RRM Charitable Fund; Simard Fund	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); RRM Charitable Fund; Simard Fund	P.L. receives funding support from the National Heart, Lung, and Blood Institute (1R01HL134892), the American Heart Association (18CSA34080399), the RRM Charitable Fund and the Simard Fund.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Andersson C, 2019, NAT REV CARDIOL, V16, P687, DOI 10.1038/s41569-019-0202-5; Aragam KG, 2020, CIRC RES, V126, P1159, DOI 10.1161/CIRCRESAHA.120.315928; Arbab-Zadeh A, 2015, J AM COLL CARDIOL, V65, P846, DOI 10.1016/j.jacc.2014.11.041; Arora S, 2019, CIRCULATION, V139, P1047, DOI 10.1161/CIRCULATIONAHA.118.037137; Baumgartner R, 2019, CYTOKINE, V122, DOI 10.1016/j.cyto.2017.09.004; Baylis RA, 2017, ARTERIOSCL THROM VAS, V37, pE174, DOI 10.1161/ATVBAHA.117.310097; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Bhatt DL, 2019, J AM COLL CARDIOL, V73, P2791, DOI 10.1016/j.jacc.2019.02.032; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Boren J, 2020, EUR HEART J, V41, P2313, DOI 10.1093/eurheartj/ehz962; Brook RD, 2018, AM J HYPERTENS, V31, P1, DOI 10.1093/ajh/hpx109; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Crea F, 2017, CIRCULATION, V136, P1155, DOI 10.1161/CIRCULATIONAHA.117.029870; Cuffy MC, 2007, J IMMUNOL, V179, P5246, DOI 10.4049/jimmunol.179.8.5246; Dai HJ, 2022, EUR HEART J-QUAL CAR, V8, P50, DOI 10.1093/ehjqcco/qcaa076; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Deliargyris EN, 2010, J AM COLL CARDIOL, V55, P1598, DOI 10.1016/j.jacc.2009.10.069; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Domanski MJ, 2020, J AM COLL CARDIOL, V76, P1507, DOI 10.1016/j.jacc.2020.07.059; Douglas PS, 2015, NEW ENGL J MED, V372, P1291, DOI 10.1056/NEJMoa1415516; Drager LF, 2017, CIRCULATION, V136, P1840, DOI 10.1161/CIRCULATIONAHA.117.029400; Elliott J, 2020, JAMA-J AM MED ASSOC, V323, P636, DOI 10.1001/jama.2019.22241; Feinberg MW, 2016, CIRC RES, V118, P703, DOI 10.1161/CIRCRESAHA.115.306300; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Fernandez-Friera L, 2019, J AM COLL CARDIOL, V73, P1371, DOI 10.1016/j.jacc.2018.12.075; Fidler TP, 2021, NATURE, V592, P296, DOI 10.1038/s41586-021-03341-5; Franck G., 2019, EUR HEART J, V40, P928, DOI [10.1093/eurheartj/ehy822, DOI 10.1093/eurheartj/ehy822]; Fuster JJ, 2017, SCIENCE, V355, P842, DOI 10.1126/science.aag1381; Gaziano T. A., 2018, BRAUNWALDS HEART DIS, P1; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gerstein HC, 2019, LANCET, V394, P131, DOI 10.1016/S0140-6736(19)31150-X; Gistera A, 2018, CIRCULATION, V138, P2513, DOI 10.1161/CIRCULATIONAHA.118.034076; Gistera A, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.51; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Hansen SEJ, 2019, CLIN CHEM, V65, P321, DOI 10.1373/clinchem.2018.294926; Hansson GK, 2017, CIRCULATION, V136, P1875, DOI 10.1161/CIRCULATIONAHA.117.030484; Huang LZ, 2019, NATURE, V569, P565, DOI 10.1038/s41586-019-1140-4; Jae N, 2020, CIRC RES, V126, P1127, DOI 10.1161/CIRCRESAHA.119.315938; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Kalluri AS, 2019, CIRCULATION, V140, P147, DOI 10.1161/CIRCULATIONAHA.118.038362; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Karakikes I, 2015, CIRC RES, V117, P80, DOI 10.1161/CIRCRESAHA.117.305365; Ketelhuth DFJ, 2019, CARDIOVASC RES, V115, P1385, DOI 10.1093/cvr/cvz166; Ketelhuth DFJ, 2016, CIRC RES, V118, P668, DOI 10.1161/CIRCRESAHA.115.306427; Khera AV, 2017, JAMA-J AM MED ASSOC, V317, P937, DOI 10.1001/jama.2017.0972; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kolte D, 2021, JAMA-J AM MED ASSOC, V325, P1043, DOI 10.1001/jama.2021.0069; Kraehling JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13516; Kruth HS, 2002, CURR OPIN LIPIDOL, V13, P483, DOI 10.1097/00041433-200210000-00003; Kubo T, 2010, J AM COLL CARDIOL, V55, P1590, DOI 10.1016/j.jacc.2009.07.078; Kwok CS, 2020, CORONARY ARTERY DIS, V31, P354, DOI 10.1097/MCA.0000000000000844; Lee SR, 2017, CIRCULATION, V135, P251, DOI 10.1161/CIRCULATIONAHA.116.024611; Leibundgut G, 2012, J AM COLL CARDIOL, V59, P1426, DOI 10.1016/j.jacc.2011.12.033; Lewis GF, 2015, ENDOCR REV, V36, P131, DOI 10.1210/er.2014-1062; Libby P, 2002, CIRCULATION, V106, P2760, DOI 10.1161/01.CIR.0000037282.92395.AE; Libby P, 2019, J AM COLL CARDIOL, V74, P1594, DOI 10.1016/j.jacc.2019.07.061; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Libby P, 2019, J AM COLL CARDIOL, V74, P567, DOI 10.1016/j.jacc.2019.06.007; Libby P, 2019, EUR HEART J, V40, P938, DOI 10.1093/eurheartj/ehz081; Libby P, 2019, ARTERIOSCL THROM VAS, V39, P538, DOI 10.1161/ATVBAHA.118.310958; Libby P, 2019, CIRC RES, V124, P150, DOI 10.1161/CIRCRESAHA.118.311098; Libby Peter, 2016, JACC Basic Transl Sci, V1, P428, DOI 10.1016/j.jacbts.2016.08.007; Libby P, 2016, J AM COLL CARDIOL, V67, P1091, DOI 10.1016/j.jacc.2015.12.048; Libby P, 2015, EUR HEART J, V36, P2984, DOI 10.1093/eurheartj/ehv349; Libby P, 2015, EUR HEART J, V36, P774, DOI 10.1093/eurheartj/ehu500; Libby P, 2013, J CLIN INVEST, V123, P3201, DOI 10.1172/JCI67526; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Libby P, 2012, J AM COLL CARDIOL, V59, P1438, DOI 10.1016/j.jacc.2012.01.023; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Lorenzo C, 2021, NATURE, V589, P287, DOI 10.1038/s41586-020-2993-2; Malik VS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081840; Marso SP, 2016, NEW ENGL J MED, V375, P1834, DOI 10.1056/NEJMoa1607141; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mason RP, 2020, ARTERIOSCL THROM VAS, V40, P1135, DOI 10.1161/ATVBAHA.119.313286; Mensah GA, 2019, J AM COLL CARDIOL, V74, P2529, DOI 10.1016/j.jacc.2019.10.009; Molinaro R, 2021, CARDIOVASC RES, DOI DOI 10.1093/cvr/cvab074; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Mosley JD, 2020, JAMA-J AM MED ASSOC, V323, P627, DOI 10.1001/jama.2019.21782; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Munzel T, 2019, CARDIOVASC RES, V115, pE144, DOI 10.1093/cvr/cvz134; Musunuru K, 2016, CIRC RES, V118, P579, DOI 10.1161/CIRCRESAHA.115.306398; Nazir S, 2020, ADV DRUG DELIVER REV, V159, P94, DOI 10.1016/j.addr.2020.10.006; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Neuen BL, 2018, CIRCULATION, V138, P1537, DOI 10.1161/CIRCULATIONAHA.118.035901; Newby DE, 2018, NEW ENGL J MED, V379, P924, DOI 10.1056/NEJMoa1805971; Nidorf SM, 2020, NEW ENGL J MED, V383, P1838, DOI 10.1056/NEJMoa2021372; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Owsiany KM, 2019, ARTERIOSCL THROM VAS, V39, P836, DOI 10.1161/ATVBAHA.119.312557; Pasterkamp G, 2017, NAT REV CARDIOL, V14, P21, DOI 10.1038/nrcardio.2016.166; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Pradhan AD, 2018, AM HEART J, V206, P80, DOI 10.1016/j.ahj.2018.09.011; Preiss D, 2020, J AM COLL CARDIOL, V75, P1945, DOI 10.1016/j.jacc.2019.11.072; Que XC, 2018, NATURE, V558, P301, DOI 10.1038/s41586-018-0198-8; Ramirez CM, 2019, CIRCULATION, V140, P225, DOI 10.1161/CIRCULATIONAHA.118.038571; Ray KK, 2019, NEW ENGL J MED, V380, P1022, DOI 10.1056/NEJMoa1803917; Ray KK, 2017, NEW ENGL J MED, V376, P1430, DOI 10.1056/NEJMoa1615758; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2018, EUR HEART J, V39, P4109, DOI 10.1093/eurheartj/ehy723; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Ridker PM, 2017, CIRC RES, V120, P617, DOI 10.1161/CIRCRESAHA.116.310527; Ridker PM, 2016, J AM COLL CARDIOL, V67, P712, DOI 10.1016/j.jacc.2015.11.037; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Rohlenova K, 2018, TRENDS CELL BIOL, V28, P224, DOI 10.1016/j.tcb.2017.10.010; Ross R, 2020, NAT REV ENDOCRINOL, V16, P177, DOI 10.1038/s41574-019-0310-7; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sage AP, 2019, NAT REV CARDIOL, V16, P180, DOI 10.1038/s41569-018-0106-9; Sakash JB, 2002, INFECT IMMUN, V70, P3959, DOI 10.1128/IAI.70.7.3959-3961.2002; Schloss MJ, 2020, CIRC RES, V126, P1242, DOI 10.1161/CIRCRESAHA.120.315936; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Seeger T, 2017, CIRC RES, V120, P778, DOI 10.1161/CIRCRESAHA.116.310197; Shea S, 2019, ARTERIOSCL THROM VAS, V39, P89, DOI 10.1161/ATVBAHA.118.311366; Siddiqi HK, 2015, CURR OPIN CARDIOL, V30, P536, DOI 10.1097/HCO.0000000000000211; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tabas I, 2020, CIRC RES, V126, P1209, DOI 10.1161/CIRCRESAHA.119.315939; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tardif JC, 2019, NEW ENGL J MED, V381, P2497, DOI 10.1056/NEJMoa1912388; Thanassoulis G, 2013, NEW ENGL J MED, V368, P503, DOI 10.1056/NEJMoa1109034; Thomas DG, 2021, J LIPID RES, V62, DOI 10.1194/jlr.P120001000; Towfighi A, 2011, AM J CARDIOL, V108, P1102, DOI 10.1016/j.amjcard.2011.05.046; Tsimikas S, 2020, NEW ENGL J MED, V382, P244, DOI 10.1056/NEJMoa1905239; Tsimikas S, 2019, CIRC RES, V124, P405, DOI 10.1161/CIRCRESAHA.118.313864; Tsimikas S, 2017, J AM COLL CARDIOL, V69, P692, DOI 10.1016/j.jacc.2016.11.042; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Tuzcu EM, 2001, CIRCULATION, V103, P2705; Varbo A, 2013, CIRCULATION, V128, P1298, DOI 10.1161/CIRCULATIONAHA.113.003008; Vergallo R, 2020, NEW ENGL J MED, V383, P846, DOI 10.1056/NEJMra2000317; VIRMANI R, 1987, ARCH PATHOL LAB MED, V111, P972; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Waksman R, 2017, AM HEART J, V192, P98, DOI 10.1016/j.ahj.2017.02.010; Williams JW, 2020, CIRC RES, V126, P1112, DOI 10.1161/CIRCRESAHA.119.315940; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Xiao L, 2020, CAN J CARDIOL, V36, P635, DOI 10.1016/j.cjca.2020.01.013; Yurdagul A, 2018, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00086; Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827	146	275	284	134	309	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					524	533		10.1038/s41586-021-03392-8	http://dx.doi.org/10.1038/s41586-021-03392-8			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6RQ	33883728				2022-12-28	WOS:000687333900002
J	Torjesen, I				Torjesen, Ingrid			Antidepressants: Evidence on safe discontinuation is lacking, concludes Cochrane review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence, 2009, DEPR AD REC MAN; The Royal College of Psychiatrists, 2020, STOPP ANT; Van Leeuwen E, 2021, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013495.pub2	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 22	2021	373								n1065	10.1136/bmj.n1065	http://dx.doi.org/10.1136/bmj.n1065			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WI0MU	33888551				2022-12-28	WOS:000708062500008
J	Emile, JF; Cohen-Aubart, F; Collin, M; Fraitag, S; Idbaih, A; Abdel-Wahab, O; Rollins, BJ; Donadieu, J; Haroche, J				Emile, Jean-Francois; Cohen-Aubart, Fleur; Collin, Matthew; Fraitag, Sylvie; Idbaih, Ahmed; Abdel-Wahab, Omar; Rollins, Barrett J.; Donadieu, Jean; Haroche, Julien			Histiocytosis	LANCET			English	Review							ERDHEIM-CHESTER DISEASE; LANGERHANS CELL HISTIOCYTOSIS; ROSAI-DORFMAN-DISEASE; CENTRAL-NERVOUS-SYSTEM; BRAF V600E; MASSIVE LYMPHADENOPATHY; SINUS HISTIOCYTOSIS; CARDIAC INVOLVEMENT; MONOCENTRIC SERIES; MUTATIONS	Histiocytoses constitute a heterogeneous group of rare disorders, characterised by infiltration of almost any organ by myeloid cells with diverse macrophage or dendritic cell phenotypes. Histiocytoses can start at any age. Diagnosis is based on histology in combination with appropriate clinical and radiological findings. The low incidence and broad spectrum of clinical manifestations often leads to diagnostic delay, especially for adults. In most cases, biopsy specimens infiltrated by histiocytes have somatic mutations in genes activating the MAP kinase cell-signalling pathway. These mutations might also be present in blood cells and haematopoietic progenitors of patients with multisystem disease. A comprehensive range of investigations and molecular typing are essential to accurately predict prognosis, which can vary from spontaneous resolution to life-threatening disseminated disease. Targeted therapies with BRAF or MEK inhibitors have revolutionised salvage treatment. However, the type and duration of treatment are still debated, and the prevention of neurological sequelae remains a crucial issue.	[Emile, Jean-Francois; Donadieu, Jean] Univ Versailles SQY, Hop Ambroise Pare, AP HP, EA4340 BECCOH,Serv Pathol, Boulogne, France; [Donadieu, Jean] Hop Armand Trousseau, AP HP, Serv Hematol Oncol Pediat, Ctr Reference Histiocytoses, Paris, France; [Cohen-Aubart, Fleur; Haroche, Julien] Hop La Pitie Salpetriere, AP HP, Internal Med Dept 2, French Natl Referral Ctr Rare Syst Dis & Histiocy, Paris, France; [Cohen-Aubart, Fleur; Idbaih, Ahmed; Haroche, Julien] Sorbonne Univ, Paris, France; [Collin, Matthew] Newcastle Univ, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Fraitag, Sylvie] Necker Enfants Malad Hosp, AP HP, Pathol Dept, Paris, France; [Idbaih, Ahmed] Hop Univ La Pitie Salpetriere Charles Foix, AP HP, UMR S 1127, CNRS,INSERM,Inst Cerveau & Moelle Epiniere, Paris, France; [Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Rollins, Barrett J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Rollins, Barrett J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Newcastle University - UK; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Emile, JF (corresponding author), Hop Ambroise Pare, Serv Pathol, EA4340 BECCOH, F-92104 Boulogne, France.	jean-francois.emile@uvsq.fr			Programme de Recherche Translationnelle en Cancerologie [19-143]; Association pour le Recherche et l'Enseignement en Pathologie	Programme de Recherche Translationnelle en Cancerologie; Association pour le Recherche et l'Enseignement en Pathologie	We thank the physicians who provided clinical or metabolic pictures of histiocytoses (A Aouba, D Bessis, C Bodemer, F Cambazard, P Maksud, V Pallure, and O Sangueza), as well as Janet Jacobson for editorial assistance. This work was supported by grants from the Programme de Recherche Translationnelle en Cancerologie (grant reference 19-143) and from the Association pour le Recherche et l'Enseignement en Pathologie. This Seminar is dedicated to the memory of our dear friend and colleague, Johannes Visser.	Abdallah M, 2011, CLIN RES HEPATOL GAS, V35, P475, DOI 10.1016/j.clinre.2011.03.012; Abla O, 2018, BLOOD, V131, P2877, DOI 10.1182/blood-2018-03-839753; Allen CE, 2020, NAT IMMUNOL, V21, P1, DOI 10.1038/s41590-019-0558-z; Andriko JAW, 2001, MODERN PATHOL, V14, P172, DOI 10.1038/modpathol.3880278; [Anonymous], 1987, Lancet, V1, P208; Arnaud L, 2011, BLOOD, V117, P2778, DOI 10.1182/blood-2010-06-294108; Arnaud L, 2010, ARTHRITIS RHEUM-US, V62, P3504, DOI 10.1002/art.27672; Arnaud L, 2009, ARTHRITIS RHEUM-US, V60, P3128, DOI 10.1002/art.24848; Aubart FC, 2017, BLOOD, V130, P1377, DOI 10.1182/blood-2017-03-771873; Aubart FC, 2018, BRIT J HAEMATOL, V180, P150, DOI 10.1111/bjh.14284; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; Barkaoui MA, 2020, BRIT J HAEMATOL, V191, P825, DOI 10.1111/bjh.16944; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Berti A, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1318237; Braier Jorge, 2014, J Pediatr Hematol Oncol, V36, pe280, DOI 10.1097/MPH.0000000000000165001; Cao XX, 2020, AM J HEMATOL, V95, pE235, DOI 10.1002/ajh.25864; Chakraborty R, 2016, BLOOD, V128, P2533, DOI 10.1182/blood-2016-08-733790; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Chang KTE, 2019, MODERN PATHOL, V32, P598, DOI 10.1038/s41379-018-0168-6; Chasset F, 2016, J AM ACAD DERMATOL, V74, P513, DOI 10.1016/j.jaad.2015.11.007; Cohen-Aubart F, 2018, ANN RHEUM DIS, V77, P1387, DOI 10.1136/annrheumdis-2017-212678; Cohen-Aubart F, 2018, AM J HEMATOL, V93, pE114, DOI 10.1002/ajh.25055; Cohen-Aubart F, 2016, BLOOD, V127, P1509, DOI 10.1182/blood-2015-09-672667; Cohen-Aubart F, 2014, NEUROLOGY, V83, P1294, DOI 10.1212/WNL.0000000000000832; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Collin MP, 2006, J EXP MED, V203, P27, DOI 10.1084/jem.20051787; Courtillot C, 2016, J CLIN ENDOCR METAB, V101, P304, DOI 10.1210/jc.2015-3357; Cui L, 2020, HAEMATOLOGICA, V105, pE444, DOI 10.3324/haematol.2019.229187; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dehner LP, 2003, AM J SURG PATHOL, V27, P579, DOI 10.1097/00000478-200305000-00003; Diamond EL, 2019, NATURE, V567, P521, DOI 10.1038/s41586-019-1012-y; Diamond EL, 2018, JAMA ONCOL, V4, P384, DOI 10.1001/jamaoncol.2017.5029; Diamond EL, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0490-3; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Donadieu J, 2004, PEDIATR BLOOD CANCER, V43, P770, DOI 10.1002/pbc.20160; Donadieu J, 2019, J CLIN ONCOL, V37, P2857, DOI 10.1200/JCO.19.00456; Donadieu J, 2015, BLOOD, V126, P1415, DOI 10.1182/blood-2015-03-635151; Drier A, 2010, RADIOLOGY, V255, P586, DOI 10.1148/radiol.10090320; Dupeux M, 2019, AM J DERMATOPATH, V41, P29, DOI 10.1097/DAD.0000000000001255; Durham BH, 2019, NAT MED, V25, P1839, DOI 10.1038/s41591-019-0653-6; Durham BH, 2017, BLOOD, V130, P176, DOI 10.1182/blood-2016-12-757377; Egan C, 2020, HAEMATOLOGICA, V105, P951, DOI 10.3324/haematol.2019.230375; Emile JF, 2016, BLOOD, V127, P2672, DOI [10.1182/blood-2016-01690636, 10.1182/blood-2016-01-690636]; Emile JF, 2014, BLOOD, V124, P3016, DOI 10.1182/blood-2014-04-570937; Emile JF, 1997, BRIT J HAEMATOL, V98, P480, DOI 10.1046/j.1365-2141.1997.2293046.x; Euskirchen P, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000078; Farris M, 2019, CL LYMPH MYELOM LEUK, V19, pE1, DOI 10.1016/j.clml.2018.10.004; Fatobene G, 2018, HAEMATOLOGICA, V103, pE377, DOI 10.3324/haematol.2018.190934; Feldman AL, 2008, BLOOD, V111, P5433, DOI 10.1182/blood-2007-11-124792; FOUCAR E, 1990, SEMIN DIAGN PATHOL, V7, P19; Gadner H, 2013, BLOOD, V121, P5006, DOI 10.1182/blood-2012-09-455774; Garces S, 2017, MODERN PATHOL, V30, P1367, DOI 10.1038/modpathol.2017.55; Ghobadi A, 2019, HAEMATOLOGICA, V104, pE373, DOI 10.3324/haematol.2019.217794; Gianfreda D, 2016, BLOOD, V128, P2468, DOI 10.1182/blood-2016-07-724815; Gianfreda D, 2015, BLOOD, V126, P1163, DOI 10.1182/blood-2015-01-620377; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Girschikofsky M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-72; Go H, 2014, HISTOPATHOLOGY, V65, P261, DOI 10.1111/his.12416; Gounder MM, 2018, NEW ENGL J MED, V378, P1945, DOI 10.1056/NEJMc1511490; Goyal G, 2020, BLOOD, V135, P1929, DOI 10.1182/blood.2019003507; Goyal G, 2018, BRIT J HAEMATOL, V182, P579, DOI 10.1111/bjh.14818; Goyal G, 2017, JAMA ONCOL, V3, P1253, DOI 10.1001/jamaoncol.2017.0041; Guyot-Goubin A, 2008, PEDIATR BLOOD CANCER, V51, P71, DOI 10.1002/pbc.21498; Halbritter F, 2019, CANCER DISCOV, V9, P1406, DOI 10.1158/2159-8290.CD-19-0138; Haroche J, 2017, LANCET ONCOL, V18, pE113, DOI 10.1016/S1470-2045(17)30031-1; Haroche J, 2015, J CLIN ONCOL, V33, P411, DOI 10.1200/JCO.2014.57.1950; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Haroche J, 2009, CIRCULATION, V119, pE597, DOI 10.1161/CIRCULATIONAHA.108.825075; Haupt R, 2013, PEDIATR BLOOD CANCER, V60, P175, DOI 10.1002/pbc.24367; Heritier S, 2018, BRIT J HAEMATOL, V183, P608, DOI 10.1111/bjh.15577; Heritier S, 2017, BRIT J HAEMATOL, V178, P457, DOI 10.1111/bjh.14695; Heritier S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0690-z; Heritier S, 2016, J CLIN ONCOL, V34, P3023, DOI 10.1200/JCO.2015.65.9508; Heritier S, 2015, JAMA ONCOL, V1, P836, DOI 10.1001/jamaoncol.2015.0736; Hervier B, 2014, BLOOD, V124, P1119, DOI 10.1182/blood-2013-12-543793; Hunt D, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000299; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Idbaih A, 2014, NEUROLOGY, V83, P1478, DOI 10.1212/WNL.0000000000000880; Jacobsen E, 2017, NEW ENGL J MED, V377, P2398, DOI 10.1056/NEJMc1713676; Janku F, 2014, ONCOTARGET, V5, P3607, DOI 10.18632/oncotarget.1964; Johnson RL, 2014, INT J CLIN EXP PATHO, V7, P378; Le Guen P, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1203-5; Lee LH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89473; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Maric I, 2005, AM J SURG PATHOL, V29, P903, DOI 10.1097/01.pas.0000157997.61177.08; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Mass E, 2017, NATURE, V549, P389, DOI 10.1038/nature23672; McClain KL, 2018, CANCER-AM CANCER SOC, V124, P2607, DOI 10.1002/cncr.31348; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Melloul S, 2019, HAEMATOLOGICA, V104, pE97, DOI 10.3324/haematol.2018.201194; Menon MP, 2014, HISTOPATHOLOGY, V64, P455, DOI 10.1111/his.12274; Milne P, 2017, BLOOD, V130, P167, DOI 10.1182/blood-2016-12-757823; Molho-Pessach V, 2014, J AM ACAD DERMATOL, V70, P80, DOI 10.1016/j.jaad.2013.09.019; Moyon Q, 2020, CHEST, V157, P323, DOI 10.1016/j.chest.2019.09.036; Muma S, 2020, LANCET, V395, pE1, DOI 10.1016/S0140-6736(19)33006-5; Nelson DS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222400; Nelson DS, 2015, GENE CHROMOSOME CANC, V54, P361, DOI 10.1002/gcc.22247; Nelson DS, 2014, BLOOD, V123, P3152, DOI 10.1182/blood-2013-06-511139; Nicolini FE, 2019, CLIN CANCER RES, V25, P6606, DOI 10.1158/1078-0432.CCR-18-3373; Papo M, 2017, BLOOD, V130, P1007, DOI 10.1182/blood-2017-01-761718; Pardanani A, 2019, AM J HEMATOL, V94, P363, DOI 10.1002/ajh.25371; Peckham-Gregory EC, 2017, BLOOD, V130, P2229, DOI 10.1182/blood-2017-08-800565; Picarsic J, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0811-6; Nanduri VR, 2006, EUR J CANCER, V42, P2563, DOI 10.1016/j.ejca.2006.05.031; Razanamahery J, 2020, HAEMATOLOGICA, V105, pE5, DOI 10.3324/haematol.2019.216937; Richardson TE, 2018, ANN NEUROL, V84, P147, DOI 10.1002/ana.25281; Rigaud C, 2016, BRIT J HAEMATOL, V174, P887, DOI 10.1111/bjh.14140; Rodriguez-Galindo C, 2020, BLOOD, V135, P1319, DOI 10.1182/blood.2019000934; Roeser A, 2019, HAEMATOLOGICA, V104, pE502, DOI 10.3324/haematol.2018.214007; Sagna Y, 2019, EUR J ENDOCRINOL, V181, P275, DOI 10.1530/EJE-19-0177; Sahm F, 2012, BLOOD, V120, pE28, DOI 10.1182/blood-2012-06-429597; Sandoval-Sus JD, 2014, MEDICINE, V93, P165, DOI 10.1097/MD.0000000000000030; Satoh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033891; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwentner R, 2019, PEDIATR RES, V85, P856, DOI 10.1038/s41390-018-0238-y; Singhi AD, 2011, AM J SURG PATHOL, V35, P305, DOI 10.1097/PAS.0b013e31820654e4; Stinco G, 2013, INT J DERMATOL, V52, P849, DOI 10.1111/j.1365-4632.2011.05358.x; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Vassallo R, 2000, NEW ENGL J MED, V342, P1969, DOI 10.1056/NEJM200006293422607; Weitzman S, 2009, PEDIATR BLOOD CANCER, V53, P1271, DOI 10.1002/pbc.22229; Yasmin N, 2013, J EXP MED, V210, P2597, DOI 10.1084/jem.20130275; YU RC, 1994, LANCET, V343, P767, DOI 10.1016/S0140-6736(94)91842-2	123	22	22	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2021	398	10295					157	170		10.1016/S0140-6736(21)00311-1	http://dx.doi.org/10.1016/S0140-6736(21)00311-1		JUL 2021	14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TG0BQ	33901419	Green Accepted			2022-12-28	WOS:000671078800027
J	Zhu, JJ; Schworer, S; Berisa, M; Kyung, YJ; Ryu, KW; Yi, JM; Jiang, XJ; Cross, JR; Thompson, CB				Zhu, Jiajun; Schworer, Simon; Berisa, Mirela; Kyung, Yeon Ju; Ryu, Keun Woo; Yi, Junmei; Jiang, Xuejun; Cross, Justin R.; Thompson, Craig B.			Mitochondrial NADP(H) generation is essential for proline biosynthesis	SCIENCE			English	Article							METABOLISM; 2-HYDROXYGLUTARATE; MUTATIONS; BIOLOGY	The coenzyme nicotinamide adenine dinucleotide phosphate (NADP(+)) and its reduced form (NADPH) regulate reductive metabolism in a subcellularly compartmentalized manner. Mitochondrial NADP(H) production depends on the phosphorylation of NAD(H) by NAD kinase 2 (NADK2). Deletion of NADK2 in human cell lines did not alter mitochondrial folate pathway activity, tricarboxylic acid cycle activity, or mitochondrial oxidative stress, but rather led to impaired cell proliferation in minimal medium. This growth defect was rescued by proline supplementation. NADK2-mediated mitochondrial NADP(H) generation was required for the reduction of glutamate and hence proline biosynthesis. Furthermore, mitochondrial NADP(H) availability determined the production of collagen proteins by cells of mesenchymal lineage. Thus, a primary function of the mitochondrial NADP(H) pool is to support proline biosynthesis for use in cytosolic protein synthesis.	[Zhu, Jiajun; Schworer, Simon; Kyung, Yeon Ju; Ryu, Keun Woo; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Berisa, Mirela; Cross, Justin R.] Mem Sloan Kettering Canc Ctr, Donald B & Catherine C Marron Canc Metab Ctr, New York, NY 10065 USA; [Yi, Junmei; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Thompson, CB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.	thompsonc@mskcc.org	Zhu, Jiajun/GQP-3551-2022; Zhu, Jiajun/R-6196-2016	/0000-0002-2972-9917; Kyung, Yeon Ju/0000-0003-4434-8124; Berisa, Mirela/0000-0001-7347-9823; Zhu, Jiajun/0000-0002-1760-3081	Leukemia and Lymphoma Society [5460-18]; NCI [1K99CA248711]; Human Frontier Science Program [LT000854/2018-L]; European Molecular Biology Organization [ALTF 467-2018]; Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; Hunter Douglas Fellowship in Breast Cancer Research [13459]; NIAID [AI140472-01A1]; Donald B. and Catherine C. Marron Cancer Metabolism Center; NIH [R01CA204232, R01CA166413]; BRIA Postdoctoral Researcher Innovation Grant [18057]; NCI; cancer center support grant [P30 CA008748]	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Human Frontier Science Program(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center; Hunter Douglas Fellowship in Breast Cancer Research; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Donald B. and Catherine C. Marron Cancer Metabolism Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRIA Postdoctoral Researcher Innovation Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); cancer center support grant	J.Z. is supported by the Leukemia and Lymphoma Society (5460-18) and the NCI (1K99CA248711). S.S. is supported by the Human Frontier Science Program (LT000854/2018-L), the European Molecular Biology Organization (ALTF 467-2018), and the Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center. K.W.R. is supported by the Hunter Douglas Fellowship in Breast Cancer Research (13459) and the BRIA Postdoctoral Researcher Innovation Grant (18057). J.R.C. is supported by grants from the NIAID (R25 training grant AI140472-01A1) and the Donald B. and Catherine C. Marron Cancer Metabolism Center. X.J. is supported by grants from the NIH (R01CA204232 and R01CA166413). This work is supported by grants from the NCI (to C.B.T.) and by the cancer center support grant (P30 CA008748) to Memorial Sloan Kettering Cancer Center.	Baghirova S, 2015, METHODSX, V2, P440, DOI 10.1016/j.mex.2015.11.001; Chen WW, 2017, NAT PROTOC, V12, P2215, DOI 10.1038/nprot.2017.104; Chen WW, 2016, CELL, V166, P1324, DOI 10.1016/j.cell.2016.07.040; Cracan V, 2017, NAT CHEM BIOL, V13, P1088, DOI [10.1038/NCHEMBIO.2454, 10.1038/nchembio.2454]; De Ingeniis J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045190; Ding CKC, 2020, NAT METAB, V2, P270, DOI 10.1038/s42255-020-0181-1; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Gao MH, 2019, MOL CELL, V73, P354, DOI 10.1016/j.molcel.2018.10.042; Goodman RP, 2018, J BIOL CHEM, V293, P7508, DOI 10.1074/jbc.TM117.000258; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hoxhaj G, 2019, SCIENCE, V363, P1088, DOI 10.1126/science.aau3903; Kong H, 2018, J BIOL CHEM, V293, P7499, DOI 10.1074/jbc.TM117.000257; Kory N, 2018, SCIENCE, V362, P791, DOI 10.1126/science.aat9528; KRAMER JJ, 1988, ANAL BIOCHEM, V168, P380, DOI 10.1016/0003-2697(88)90333-8; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Loayza-Puch F, 2016, NATURE, V530, P490, DOI 10.1038/nature16982; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Outten CE, 2003, EMBO J, V22, P2015, DOI 10.1093/emboj/cdg211; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Phang JM, 2019, ANTIOXID REDOX SIGN, V30, P635, DOI 10.1089/ars.2017.7350; Robb EL, 2015, FREE RADICAL BIO MED, V89, P883, DOI 10.1016/j.freeradbiomed.2015.08.021; Salamanca-Cardona L, 2017, CELL METAB, V26, P830, DOI 10.1016/j.cmet.2017.10.001; Schworer S, 2020, EMBO J, V39, DOI 10.15252/embj.2019103334; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Ward PS, 2013, J BIOL CHEM, V288, P3804, DOI 10.1074/jbc.M112.435495; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943	28	32	32	12	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 28	2021	372	6545					968	+		10.1126/science.abd5491	http://dx.doi.org/10.1126/science.abd5491			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SK7YO	33888598	Bronze, Green Accepted			2022-12-28	WOS:000656432400047
J	Morales, DR; Ali, SN				Morales, Daniel R.; Ali, Sarah N.			COVID-19 and disparities affecting ethnic minorities	LANCET			English	Editorial Material									[Morales, Daniel R.] Univ Dundee, Div Populat Hlth & Genom, Dundee DD2 4BF, Scotland; [Morales, Daniel R.] Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark; [Ali, Sarah N.] Royal Free London NHS Fdn Trust, Diabet & Endocrinol, London, England; [Ali, Sarah N.] South Asian Hlth Fdn, Birmingham, W Midlands, England	University of Dundee; University of Southern Denmark; University of London; University College London; Royal Free London NHS Foundation Trust	Morales, DR (corresponding author), Univ Dundee, Div Populat Hlth & Genom, Dundee DD2 4BF, Scotland.; Morales, DR (corresponding author), Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark.	d.r.z.morales@dundee.ac.uk						Hills AP, 2018, LANCET DIABETES ENDO, V6, P966, DOI [10.1016/S2213-8587(18)30204-3, 10.1016/s2213-8587(18)30204-3]; Intensive Care National Audit and Research Centre, 2020, ICNARC REPORT COVID; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2503; Morales DR, 2021, LANCET DIGIT HEALTH, V3, pe98, DOI 10.1016/S2589-7500(20)30289-2; Nguyen LH, 2020, LANCET PUBLIC HEALTH, V5, pE475, DOI 10.1016/S2468-2667(20)30164-X; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Public Health England, 2020, UNDERSTANDING IMPACT; Public Health England, 2020, NFDA NEWS 0401; Robinson E, 2021, VACCINE, V39, P2024, DOI 10.1016/j.vaccine.2021.02.005; Shah ASV, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3582; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	11	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 8	2021	397	10286					1684	1685		10.1016/S0140-6736(21)00949-1	http://dx.doi.org/10.1016/S0140-6736(21)00949-1		MAY 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY3KF	33939952	Green Published, Bronze			2022-12-28	WOS:000647813600002
J	Shinde, V; Bhikha, S; Hoosain, Z; Archary, M; Bhorat, Q; Fairlie, L; Lalloo, U; Masilela, MSL; Moodley, D; Hanley, S; Fouche, L; Louw, C; Tameris, M; Singh, N; Goga, A; Dheda, K; Grobbelaar, C; Kruger, G; Carrim-Ganey, N; Baillie, V; de Oliveira, T; Koen, AL; Lombaard, JJ; Mngqibisa, R; Bhorat, AE; Benade, G; Lalloo, N; Pitsi, A; Vollgraaff, PL; Luabeya, A; Esmail, A; Petrick, FG; Oommen-Jose, A; Foulkes, S; Ahmed, K; Thombrayil, A; Fries, L; Cloney-Clark, S; Zhu, M; Bennett, C; Albert, G; Faust, E; Plested, JS; Robertson, A; Neal, S; Cho, I; Glenn, GM; Dubovsky, F; Madhi, SA				Shinde, V.; Bhikha, S.; Hoosain, Z.; Archary, M.; Bhorat, Q.; Fairlie, L.; Lalloo, U.; Masilela, M. S. L.; Moodley, D.; Hanley, S.; Fouche, L.; Louw, C.; Tameris, M.; Singh, N.; Goga, A.; Dheda, K.; Grobbelaar, C.; Kruger, G.; Carrim-Ganey, N.; Baillie, V.; de Oliveira, T.; Koen, A. Lombard; Lombaard, J. J.; Mngqibisa, R.; Bhorat, A. E.; Benade, G.; Lalloo, N.; Pitsi, A.; Vollgraaff, P. -L.; Luabeya, A.; Esmail, A.; Petrick, F. G.; Oommen-Jose, A.; Foulkes, S.; Ahmed, K.; Thombrayil, A.; Fries, L.; Cloney-Clark, S.; Zhu, M.; Bennett, C.; Albert, G.; Faust, E.; Plested, J. S.; Robertson, A.; Neal, S.; Cho, I.; Glenn, G. M.; Dubovsky, F.; Madhi, S. A.		2019nCoV-501 Study Grp	Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR-BINDING DOMAIN	BACKGROUND The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants threatens progress toward control of the coronavirus disease 2019 (Covid-19) pandemic. In a phase 1-2 trial involving healthy adults, the NVXCoV2373 nanoparticle vaccine had an acceptable safety profile and was associated with strong neutralizing-antibody and antigen-specific polyfunctional CD4+T-cell responses. Evaluation of vaccine efficacy was needed in a setting of ongoing SARSCoV-2 transmission. METHODS In this phase 2a-b trial in South Africa, we randomly assigned human immunodeficiency virus (HIV)-negative adults between the ages of 18 and 84 years or medically stable HIV-positive participants between the ages of 18 and 64 years in a 1:1 ratio to receive two doses of either the NVX-CoV2373 vaccine (5 mu g of recombinant spike protein with 50 mu g of Matrix-M1 adjuvant) or placebo. The primary end points were safety and vaccine efficacy against laboratory-confirmed symptomatic Covid-19 at 7 days or more after the second dose among participants without previous SARS-CoV-2 infection. RESULTS Of 6324 participants who underwent screening, 4387 received at least one injection of vaccine or placebo. Approximately 30% of the participants were seropositive for SARS-CoV-2 at baseline. Among 2684 baseline seronegative participants (94% HIV-negative and 6% HIV-positive), predominantly mild-to-moderate Covid-19 developed in 15 participants in the vaccine group and in 29 in the placebo group (vaccine efficacy, 49.4%; 95% confidence interval [CI], 6.1 to 72.8). Vaccine efficacy among HIV-negative participants was 60.1% (95% CI, 19.9 to 80.1). Of 41 sequenced isolates, 38 (92.7%) were the B.1.351 variant. Post hoc vaccine efficacy against B.1.351 was 51.0% (95% CI, -0.6 to 76.2) among the HIV-negative participants. Preliminary local and systemic reactogenicity events were more common in the vaccine group; serious adverse events were rare in both groups. CONCLUSIONS The NVX-CoV2373 vaccine was efficacious in preventing Covid-19, with higher vaccine efficacy observed among HIV-negative participants. Most infections were caused by the B.1.351 variant.	[Shinde, V.; Fairlie, L.; Cloney-Clark, S.; Zhu, M.; Albert, G.; Faust, E.; Plested, J. S.; Robertson, A.; Neal, S.; Cho, I.; Glenn, G. M.; Dubovsky, F.] Novavax, 21 Firstfield Rd, Gaithersburg, MD 20878 USA; [Bhikha, S.; Baillie, V.; Koen, A. Lombard; Oommen-Jose, A.; Thombrayil, A.; Madhi, S. A.] Univ Witwatersrand, Fac Hlth Sci, South African Med Res Council, Vaccines & Infect Dis Analyt Res Unit, Johannesburg, South Africa; [Fairlie, L.; Benade, G.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Bhorat, Q.; Bhorat, A. E.] Soweto Clin Trials Ctr, Johannesburg, South Africa; [Hoosain, Z.; Lombaard, J. J.; Foulkes, S.] Josha Res Ctr, Bloemfontein, South Africa; [Archary, M.; Mngqibisa, R.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Paediat Infect Dis Unit, Durban, South Africa; [Lalloo, U.; Lalloo, N.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Resp & Crit Care Unit, Durban, South Africa; [Moodley, D.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Obstet & Gynaecol, Durban, South Africa; [Hanley, S.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Ctr AIDS Programme Res South Africa, Durban, South Africa; [de Oliveira, T.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Kwazulu Natal Res Innovat & Sequencing Platform, Durban, South Africa; [Fouche, L.; Vollgraaff, P. -L.] Limpopo Clin Res Initiat, Rustenburg, South Africa; [Louw, C.] Univ Pretoria, Sch Hlth, Dept Family Med, Madibeng Ctr Res, Pretoria, South Africa; [Grobbelaar, C.] Aurum Inst, Pretoria, South Africa; [Tameris, M.; Singh, N.; Luabeya, A.] Univ Cape Town, South African TB Vaccine Initiat, Cape Town, South Africa; [Dheda, K.; Esmail, A.] Univ Cape Town, Ctr Lung Infect & Immun, Dept Med, Div Pulmonol, Cape Town, South Africa; [Dheda, K.; Esmail, A.] Univ Cape Town, UCT Lung Inst, Cape Town, South Africa; [Singh, N.; Goga, A.] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Singh, N.; Goga, A.] South African Med Res Council, HIV Prevent Res Unit, Cape Town, South Africa; [Kruger, G.; Petrick, F. G.] Mzansi Eth Res Ctr, Middelburg, South Africa; [Carrim-Ganey, N.] Peermed Clin Trial Ctr, Kempton Pk, South Africa	South African Medical Research Council; University of Witwatersrand; University of Witwatersrand; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal; University of Pretoria; University of Cape Town; University of Cape Town; University of Cape Town; South African Medical Research Council; South African Medical Research Council	Shinde, V (corresponding author), Novavax, 21 Firstfield Rd, Gaithersburg, MD 20878 USA.	vshinde@novavax.-com	Tameris, Michele/AAR-6663-2021; Hanley, Sherika/AHA-7014-2022	Tameris, Michele/0000-0002-7983-7203; Hanley, Sherika/0000-0002-4343-7646; Blacow, Rachel/0000-0002-0946-5539; de Oliveira, Tulio/0000-0002-3027-5254; Dheda, Keertan/0000-0001-7709-5341; Baillie, Vicky Lynne/0000-0003-1327-9090; Bhorat, Qasim Ebrahim/0000-0002-4102-8750; Archary, Moherndran/0000-0003-3082-9234; Madhi, Shabir/0000-0002-7629-0636	Novavax; Bill and Melinda Gates Foundation; Coalition for Epidemic Preparedness Innovations	Novavax; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Coalition for Epidemic Preparedness Innovations	Supported by Novavax and the Bill and Melinda Gates Foundation. Investigational vaccine manufacturing support was provided by the Coalition for Epidemic Preparedness Innovations.	[Anonymous], 2021, JOHNSON JOHNSON ANNO; [Anonymous], 2021, NOVAVAX COVID 19 VAC; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bangaru S, 2020, SCIENCE, V370, P1089, DOI 10.1126/science.abe1502; Cele S., 2021, ESCAPE SARS COV 2 50, DOI [10.1101/2021.01.26.21250224v2, DOI 10.1101/2021.01.26.21250224V2]; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Food and Drug Administration, 2021, VACCINES RELATED BIO; Greaney AJ, 2021, CELL HOST MICROBE, V29, P463, DOI 10.1016/j.chom.2021.02.003; Kalk E., COVID 19 SPECIAL PUB, V18; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Logunov DY, 2021, LANCET, V397, P671, DOI 10.1016/S0140-6736(21)00234-8; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Organization WH, 2020, NAMING CORONAVIRUS D; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Starr Tyler N, 2020, Cell, V182, P1295, DOI [10.1101/2020.06.17.157982, 10.1016/j.cell.2020.08.012]; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Le TT, 2020, NAT REV DRUG DISCOV, V19, P305, DOI 10.1038/d41573-020-00073-5; Tian JH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20653-8; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wang Pengfei, 2021, bioRxiv, DOI 10.1101/2021.01.25.428137; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; who, WHO CORONAVIRUS COVI; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Williams TC, 2021, LANCET RESP MED, V9, P333, DOI 10.1016/S2213-2600(21)00075-8	25	224	229	4	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 20	2021	384	20					1899	1909		10.1056/NEJMoa2103055	http://dx.doi.org/10.1056/NEJMoa2103055		MAY 2021	11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SJ4AW	33951374	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000647808400001
J	Voelker, R				Voelker, Rebecca			Pioneering Heart Valve Approved for Patients With CHD	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 4	2021	325	17					1713	1713		10.1001/jama.2021.6103	http://dx.doi.org/10.1001/jama.2021.6103			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RY3QZ	33944888				2022-12-28	WOS:000647831200005
J	Arcodia, R; Merloni, A; Nandra, K; Buchner, J; Salvato, M; Pasham, D; Remillard, R; Comparat, J; Lamer, G; Ponti, G; Malyali, A; Wolf, J; Arzoumanian, Z; Bogensberger, D; Buckley, DAH; Gendreau, K; Gromadzki, M; Kara, E; Krumpe, M; Markwardt, C; Ramos-Ceja, ME; Rau, A; Schramm, M; Schwope, A				Arcodia, R.; Merloni, A.; Nandra, K.; Buchner, J.; Salvato, M.; Pasham, D.; Remillard, R.; Comparat, J.; Lamer, G.; Ponti, G.; Malyali, A.; Wolf, J.; Arzoumanian, Z.; Bogensberger, D.; Buckley, D. A. H.; Gendreau, K.; Gromadzki, M.; Kara, E.; Krumpe, M.; Markwardt, C.; Ramos-Ceja, M. E.; Rau, A.; Schramm, M.; Schwope, A.			X-ray quasi-periodic eruptions from two previously quiescent galaxies	NATURE			English	Article								Quasi-periodic eruptions (QPEs) are very-high-amplitude bursts of X-ray radiation recurring every few hours and originating near the central supermassive black holes of galactic nuclei(1,2). It is currently unknown what triggers these events, how long they last and how they are connected to the physical properties of the inner accretion flows. Previously, only two such sources were known, found either serendipitously or in archival data(1,2), with emission lines in their optical spectra classifying their nuclei as hosting an actively accreting supermassive black hole(3,4). Here we report observations of QPEs in two further galaxies, obtained with a blind and systematic search of half of the X-ray sky. The optical spectra of these galaxies show no signature of black hole activity, indicating that a pre-existing accretion flow that is typical of active galactic nuclei is not required to trigger these events. Indeed, the periods, amplitudes and profiles of the QPEs reported here are inconsistent with current models that invoke radiation-pressure-driven instabilities in the accretion disk(5-9). Instead, QPEs might be driven by an orbiting compact object. Furthermore, their observed properties require the mass of the secondary object to be much smaller than that of the main body(10), and future X-ray observations may constrain possible changes in their period owing to orbital evolution. This model could make QPEs a viable candidate for the electromagnetic counterparts of so-called extreme-mass-ratio inspirals(11-13), with considerable implications for multi-messenger astrophysics and cosmology(14,15). X-ray quasi-periodic eruptions are detected from two previously inactive galaxies, with observations suggesting that the very-high-amplitude X-ray bursts may arise from an orbiting compact object.	[Arcodia, R.; Merloni, A.; Nandra, K.; Buchner, J.; Salvato, M.; Comparat, J.; Ponti, G.; Malyali, A.; Wolf, J.; Bogensberger, D.; Ramos-Ceja, M. E.; Rau, A.] Max Planck Inst Extraterr Phys, Garching, Germany; [Pasham, D.; Remillard, R.; Kara, E.] MIT, Kavli Inst Astrophys & Space Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lamer, G.; Krumpe, M.; Schwope, A.] Leibniz Inst Astrophys Potsdam AIP, Potsdam, Germany; [Ponti, G.] INAF Osservatorio Astron Brera, Merate, Italy; [Arzoumanian, Z.; Gendreau, K.; Markwardt, C.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD USA; [Buckley, D. A. H.] South African Astron Observ, Cape Town, South Africa; [Gromadzki, M.] Univ Warsaw, Astron Observ, Warsaw, Poland; [Schramm, M.] Saitama Univ, Grad Sch Sci & Engn, Saitama, Japan	Max Planck Society; Massachusetts Institute of Technology (MIT); Leibniz Institut fur Astrophysik Potsdam (AIP); Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Research Foundation - South Africa; South African Astronomical Observatory; University of Warsaw; Saitama University	Arcodia, R (corresponding author), Max Planck Inst Extraterr Phys, Garching, Germany.	arcodia@mpe.mpg.de	Schwope, Axel/AAX-9701-2021; Wolf, Julien/GWV-2743-2022; Salvato, Mara/AAD-7397-2019	Salvato, Mara/0000-0001-7116-9303; Arcodia, Riccardo/0000-0003-4054-7978; Nandra, Kirpal/0000-0002-7150-9192; Merloni, Andrea/0000-0002-0761-0130; Wolf, Julien/0000-0003-0643-7935; Ramos Ceja, Miriam Elizabeth/0000-0002-9117-3251; Remillard, Ronald/0000-0003-4815-0481; Buchner, Johannes/0000-0003-0426-6634; Gromadzki, Mariusz/0000-0002-1650-1518				Abbott TMC, 2018, ASTROPHYS J SUPPL S, V239, DOI 10.3847/1538-4365/aae9f0; Altamirano D, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L17; Amaro-Seoane P, 2007, CLASSICAL QUANT GRAV, V24, pR113, DOI 10.1088/0264-9381/24/17/R01; Arcavi I, 2014, ASTROPHYS J, V793, DOI 10.1088/0004-637X/793/1/38; Arcodia R, 2019, ASTRON ASTROPHYS, V628, DOI 10.1051/0004-6361/201935874; Arnaud KA, 1996, ASTR SOC P, V101, P17; Arzoumanian Z, 2014, PROC SPIE, V9144, DOI 10.1117/12.2056811; Babak S, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.103012; Belloni T, 2000, ASTRON ASTROPHYS, V355, P271; Ben Bekhti N, 2016, ASTRON ASTROPHYS, V594, DOI 10.1051/0004-6361/201629178; Bloom J. S., 2009, PREPRINT; Bowen DB, 2018, ASTROPHYS J LETT, V853, DOI 10.3847/2041-8213/aaa756; Brinchmann J, 2004, MON NOT R ASTRON SOC, V351, P1151, DOI 10.1111/j.1365-2966.2004.07881.x; Buchner J, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322971; Buchner J, 2019, PUBL ASTRON SOC PAC, V131, DOI 10.1088/1538-3873/aae7fc; Buckley DAH, 2018, MON NOT R ASTRON SOC, V474, pL71, DOI 10.1093/mnrasl/slx196; Buckley DAH, 2006, PROC SPIE, V6267, DOI 10.1117/12.673750; Burgh EB, 2003, P SOC PHOTO-OPT INS, V4841, P1463, DOI 10.1117/12.460312; CASH W, 1979, ASTROPHYS J, V228, P939, DOI 10.1086/156922; Charisi M, 2016, MON NOT R ASTRON SOC, V463, P2145, DOI 10.1093/mnras/stw1838; Chen JH, 2019, MON NOT R ASTRON SOC, V489, P855, DOI 10.1093/mnras/stz2183; Comparat J, 2013, MON NOT R ASTRON SOC, V428, P1498, DOI 10.1093/mnras/sts127; Czerny B, 2009, ASTROPHYS J, V698, P840, DOI 10.1088/0004-637X/698/1/840; D'Orazio DJ, 2018, MON NOT R ASTRON SOC, V474, P2975, DOI 10.1093/mnras/stx2936; D'Orazio DJ, 2015, NATURE, V525, P351, DOI 10.1038/nature15262; De Rosa A, 2019, NEW ASTRON REV, V86, DOI 10.1016/j.newar.2020.101525; Dey A, 2019, ASTRON J, V157, DOI 10.3847/1538-3881/ab089d; Dodd SA, 2021, ASTROPHYS J LETT, V907, DOI 10.3847/2041-8213/abd852; Eracleous M., 2019, B AM ASTRON SOC, V51, P10; Eracleous M, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/23; Farris BD, 2015, MON NOT R ASTRON SOC, V446, pL36, DOI 10.1093/mnrasl/slu160; Farris BD, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/134; Franchini A, 2016, MON NOT R ASTRON SOC, V455, P1946, DOI 10.1093/mnras/stv2417; French KD, 2016, ASTROPHYS J LETT, V818, DOI 10.3847/2041-8205/818/1/L21; Gendreau KC, 2012, PROC SPIE, V8443, DOI 10.1117/12.926396; Giustini M, 2020, ASTRON ASTROPHYS, V636, DOI 10.1051/0004-6361/202037610; Graham MJ, 2015, MON NOT R ASTRON SOC, V453, P1562, DOI 10.1093/mnras/stv1726; Graham MJ, 2015, NATURE, V518, P74, DOI 10.1038/nature14143; Grzedzielski M, 2017, ASTRON ASTROPHYS, V603, DOI 10.1051/0004-6361/201629672; Hameury JM, 2020, ADV SPACE RES, V66, P1004, DOI 10.1016/j.asr.2019.10.022; Hameury JM, 2009, ASTRON ASTROPHYS, V496, P413, DOI 10.1051/0004-6361/200810928; Hammerstein E, 2021, ASTROPHYS J LETT, V908, DOI 10.3847/2041-8213/abdcb4; Heckman TM, 2014, ANNU REV ASTRON ASTR, V52, P589, DOI 10.1146/annurev-astro-081913-035722; Janiuk A, 2004, ASTROPHYS J, V602, P595, DOI 10.1086/381159; Janiuk A, 2002, ASTROPHYS J, V576, P908, DOI 10.1086/341804; Janiuk A, 2011, MON NOT R ASTRON SOC, V414, P2186, DOI 10.1111/j.1365-2966.2011.18544.x; Kelley LZ, 2017, MON NOT R ASTRON SOC, V464, P3131, DOI 10.1093/mnras/stw2452; Kelly BC, 2012, ADV ASTRON, V2012, DOI 10.1155/2012/970858; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Kewley LJ, 2004, ASTRON J, V127, P2002, DOI 10.1086/382723; Khan FM, 2016, ASTROPHYS J, V828, DOI 10.3847/0004-637X/828/2/73; King A, 2020, MON NOT R ASTRON SOC, V493, pL120, DOI 10.1093/mnrasl/slaa020; Lasota JP, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/89; Law-Smith J, 2017, ASTROPHYS J, V850, DOI 10.3847/1538-4357/aa94c7; LIGHTMAN AP, 1974, ASTROPHYS J, V187, pL1, DOI 10.1086/181377; LIN DNC, 1986, ASTROPHYS J, V305, P28, DOI 10.1086/164225; MacLeod CL, 2016, MON NOT R ASTRON SOC, V457, P389, DOI 10.1093/mnras/stv2997; Maraston C, 2020, MON NOT R ASTRON SOC, V496, P2962, DOI 10.1093/mnras/staa1489; Maraston C, 2011, MON NOT R ASTRON SOC, V418, P2785, DOI 10.1111/j.1365-2966.2011.19738.x; Mason KO, 2001, ASTRON ASTROPHYS, V365, pL36, DOI 10.1051/0004-6361:20000044; McHardy IM, 2006, NATURE, V444, P730, DOI 10.1038/nature05389; Merloni A, 2008, MON NOT R ASTRON SOC, V388, P1011, DOI 10.1111/j.1365-2966.2008.13472.x; Merloni A, 2006, MON NOT R ASTRON SOC, V372, P728, DOI 10.1111/j.1365-2966.2006.10889.x; Miniutti G, 2019, NATURE, V573, P381, DOI 10.1038/s41586-019-1556-x; Miniutti G, 2013, MON NOT R ASTRON SOC, V433, P1764, DOI 10.1093/mnras/stt850; MITSUDA K, 1984, PUBL ASTRON SOC JPN, V36, P741; Motta SE, 2020, ASTROPHYS J, V898, DOI 10.3847/1538-4357/ab9b81; Neilsen J, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/69; Netzer H, 2015, ANNU REV ASTRON ASTR, V53, P365, DOI 10.1146/annurev-astro-082214-122302; Nixon C, 2012, ASTROPHYS J LETT, V757, DOI 10.1088/2041-8205/757/2/L24; Payne A. V., 2020, PREPRINT; Pfeifle RW, 2019, ASTROPHYS J, V875, DOI 10.3847/1538-4357/ab07bc; Raj A, 2021, ASTROPHYS J, V909, DOI 10.3847/1538-4357/abdc24; Raj A, 2021, ASTROPHYS J, V909, DOI 10.3847/1538-4357/abdc25; Reines AE, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/2/82; Salvato M, 2018, MON NOT R ASTRON SOC, V473, P4937, DOI 10.1093/mnras/stx2651; Saxton RD, 2008, ASTRON ASTROPHYS, V480, P611, DOI 10.1051/0004-6361:20079193; Sesana A, 2008, MON NOT R ASTRON SOC, V391, P718, DOI 10.1111/j.1365-2966.2008.13904.x; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Shu XW, 2017, ASTROPHYS J, V837, DOI 10.3847/1538-4357/aa5eb3; Silverman JD, 2009, ASTROPHYS J, V696, P396, DOI 10.1088/0004-637X/696/1/396; Simmonds C, 2018, ASTRON ASTROPHYS, V618, DOI 10.1051/0004-6361/201833412; Smith KL, 2010, ASTROPHYS J, V716, P866, DOI 10.1088/0004-637X/716/1/866; Sniegowska M, 2020, ASTRON ASTROPHYS, V641, DOI 10.1051/0004-6361/202038575; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Sun LM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/167; Taam RE, 1997, ASTROPHYS J, V485, pL83, DOI 10.1086/310812; Tamanini N, 2017, J PHYS CONF SER, V840, DOI 10.1088/1742-6596/840/1/012029; Tang YK, 2018, MON NOT R ASTRON SOC, V476, P2249, DOI 10.1093/mnras/sty423; Trumper J., 1982, Advances in Space Research, V2, P241, DOI 10.1016/0273-1177(82)90070-9; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; Valtonen MJ, 2008, NATURE, V452, P851, DOI 10.1038/nature06896; van Velzen S, 2021, ASTROPHYS J, V908, DOI 10.3847/1538-4357/abc258; van Velzen S, 2019, ASTROPHYS J, V872, DOI 10.3847/1538-4357/aafe0c; Wang JM, 2009, ASTROPHYS J LETT, V705, pL76, DOI 10.1088/0004-637X/705/1/L76; Wang YY, 2019, ASTROPHYS J LETT, V886, DOI 10.3847/2041-8213/ab55e2; Wilkinson DM, 2017, MON NOT R ASTRON SOC, V472, P4297, DOI 10.1093/mnras/stx2215; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; Wu QW, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/79; Yan Z, 2018, MON NOT R ASTRON SOC, V475, P1190, DOI 10.1093/mnras/stx3259; Zabludoff AI, 1996, ASTROPHYS J, V466, P104, DOI 10.1086/177495; Zalamea I, 2010, MON NOT R ASTRON SOC, V409, pL25, DOI 10.1111/j.1745-3933.2010.00930.x	107	30	30	2	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					704	+		10.1038/s41586-021-03394-6	http://dx.doi.org/10.1038/s41586-021-03394-6			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU8CH	33911275	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000645368900009
J	Fox, D; Cole, E				Fox, Dov; Cole, Erin			The Supreme Court's Abortion Exceptionalism - Judicial Deference, Medical Science, and Mifepristone Access	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cole, Erin] Univ San Diego, Sch Law, San Diego, CA 92110 USA; [Fox, Dov] Univ San Diego, Ctr Hlth Law Policy & Bioeth, Sch Law, San Diego, CA 92110 USA	University of San Diego; University of San Diego	Fox, D (corresponding author), Univ San Diego, Ctr Hlth Law Policy & Bioeth, Sch Law, San Diego, CA 92110 USA.			Cole, Erin/0000-0002-2019-0433				Grossman D, 2021, OBSTET GYNECOL, V137, P613, DOI 10.1097/AOG.0000000000004312; Jones RK, 2017, PERSPECT SEX REPRO H, V49, P17, DOI 10.1363/psrh.12015; Ziegler M., 2016, SUPREME COURT REV, V1, P77	3	0	0	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2021	384	24								10.1056/NEJMp2104461	http://dx.doi.org/10.1056/NEJMp2104461		APR 2021	2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SV2KH	33909959				2022-12-28	WOS:000645679000001
J	Rengachari, S; Schilbach, S; Aibara, S; Dienemann, C; Cramer, P				Rengachari, Srinivasan; Schilbach, Sandra; Aibara, Shintaro; Dienemann, Christian; Cramer, Patrick			Structure of the human Mediator-RNA polymerase II pre-initiation complex	NATURE			English	Article							CRYO-EM; TRANSCRIPTION; ARCHITECTURE; REARRANGEMENTS; ACTIVATION; MECHANISM; DOMAIN; ROBUST; TFIIH; CDK7	Mediator is a conserved coactivator complex that enables the regulated initiation of transcription at eukaryotic genes(1-3). Mediator is recruited by transcriptional activators and binds the pre-initiation complex (PIC) to stimulate the phosphorylation of RNA polymerase II (Pol II) and promoter escape(1-6). Here we prepare a recombinant version of human Mediator, reconstitute a 50-subunit Mediator-PIC complex and determine the structure of the complex by cryo-electron microscopy. The head module of Mediator contacts the stalk of Pol II and the general transcription factors TFIIB and TFIIE, resembling the Mediator-PIC interactions observed in the corresponding complex in yeast(7-9). The metazoan subunits MED27-MED30 associate with exposed regions in MED14 and MED17 to form the proximal part of the Mediator tail module that binds activators. Mediator positions the flexibly linked cyclin-dependent kinase (CDK)-activating kinase of the general transcription factor TFIIH near the linker to the C-terminal repeat domain of Pol II. The Mediator shoulder domain holds the CDK-activating kinase subunit CDK7, whereas the hook domain contacts a CDK7 element that flanks the kinase active site. The shoulder and hook domains reside in the Mediator head and middle modules, respectively, which can move relative to each other and may induce an active conformation of the CDK7 kinase to allosterically stimulate phosphorylation of the C-terminal domain.	[Rengachari, Srinivasan; Schilbach, Sandra; Aibara, Shintaro; Dienemann, Christian; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de		Rengachari, Srinivasan/0000-0003-4237-8258; Schilbach, Sandra/0000-0001-9071-8515; Dienemann, Christian/0000-0002-2172-5110	Peter-and-Traudl-Engelhorn postdoctoral fellowship; H2020 Marie Curie Individual Fellowship [894862]; Deutsche Forschungsgemeinschaft [EXC 2067/1 39072994, SFB860, SPP2191]; ERC Advanced Investigator Grant CHROMATRANS [882357]	Peter-and-Traudl-Engelhorn postdoctoral fellowship; H2020 Marie Curie Individual Fellowship; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC Advanced Investigator Grant CHROMATRANS	We thank past and present members of the P.C. laboratory, particularly U. Neef, P. Rus and F. Grabbe for maintenance of the insect cell culture and purification of the recombinant human initiation factors; and we thank C. Dienemann and U. Steuerwald for maintenance of the cryo-EM facility. S.R. was supported by a Peter-and-Traudl-Engelhorn postdoctoral fellowship; S.A. was supported by an H2020 Marie Curie Individual Fellowship (894862); and P.C. was supported by the Deutsche Forschungsgemeinschaft (EXC 2067/1 39072994, SFB860 and SPP2191) and the ERC Advanced Investigator Grant CHROMATRANS (grant agreement no. 882357).	Abdella R, 2021, SCIENCE, V372, P52, DOI 10.1126/science.abg3074; Aibara S, 2021, NATURE, V594, P124, DOI 10.1038/s41586-021-03554-8; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Cevher MA, 2014, NAT STRUCT MOL BIOL, V21, P1028, DOI 10.1038/nsmb.2914; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Egly JM, 2011, DNA REPAIR, V10, P714, DOI 10.1016/j.dnarep.2011.04.021; El Khattabi L, 2019, CELL, V178, P1145, DOI 10.1016/j.cell.2019.07.011; Elmlund H, 2006, P NATL ACAD SCI USA, V103, P15788, DOI 10.1073/pnas.0607483103; Farnung L, 2017, NATURE, V550, P539, DOI 10.1038/nature24046; Gradia SD, 2017, METHOD ENZYMOL, V592, P1, DOI 10.1016/bs.mie.2017.03.008; Greber BJ, 2020, P NATL ACAD SCI USA, V117, P22849, DOI 10.1073/pnas.2009627117; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kokic G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10745-5; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Lariviere L, 2012, CURR OPIN CELL BIOL, V24, P305, DOI 10.1016/j.ceb.2012.01.007; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nozawa K, 2017, NATURE, V545, P248, DOI 10.1038/nature22328; Peissert S, 2020, P NATL ACAD SCI USA, V117, P26739, DOI 10.1073/pnas.2010885117; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Plaschka C, 2016, J MOL BIOL, V428, P2569, DOI 10.1016/j.jmb.2016.01.028; Prisant MG, 2020, PROTEIN SCI, V29, P315, DOI 10.1002/pro.3786; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; Robinson PJJ, 2012, P NATL ACAD SCI USA, V109, P17931, DOI 10.1073/pnas.1215241109; Schier AC, 2020, GENE DEV, V34, P465, DOI 10.1101/gad.335679.119; Schilbach S, 2017, NATURE, V551, P204, DOI 10.1038/nature24282; Tsai KL, 2017, NATURE, V544, P196, DOI 10.1038/nature21393; Tsai KL, 2014, CELL, V157, P1430, DOI 10.1016/j.cell.2014.05.015; Tsai KL, 2013, NAT STRUCT MOL BIOL, V20, P611, DOI 10.1038/nsmb.2549; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Wang XJ, 2014, CELL RES, V24, P796, DOI 10.1038/cr.2014.64; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weissmann F, 2016, P NATL ACAD SCI USA, V113, pE2564, DOI 10.1073/pnas.1604935113; Wood DJ, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180112; Zhao HY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21601-w; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	53	40	41	3	19	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 3	2021	594	7861					129	+		10.1038/s41586-021-03555-7	http://dx.doi.org/10.1038/s41586-021-03555-7		APR 2021	14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SM2RM	33902108				2022-12-28	WOS:000652171700002
J	Helseth, AR; Hernandez-Martinez, R; Hall, VL; Oliver, ML; Turner, BD; Caffall, ZF; Rittiner, JE; Shipman, MK; King, CS; Gradinaru, V; Gerfen, C; Costa-Mattioli, M; Calakos, N				Helseth, Ashley R.; Hernandez-Martinez, Ricardo; Hall, Victoria L.; Oliver, Matthew L.; Turner, Brandon D.; Caffall, Zachary F.; Rittiner, Joseph E.; Shipman, Miranda K.; King, Connor S.; Gradinaru, Viviana; Gerfen, Charles; Costa-Mattioli, Mauro; Calakos, Nicole			Cholinergic neurons constitutively engage the ISR for dopamine modulation and skill learning in mice	SCIENCE			English	Article							LASTING SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; CORTICOSTRIATAL PLASTICITY; INTERNEURONS; TERM; STRESS; ACETYLCHOLINE; DEPRESSION; STRIATUM; BALANCE	The integrated stress response (ISR) maintains proteostasis by modulating protein synthesis and is important in synaptic plasticity, learning, and memory. We developed a reporter, SPOTlight, for brainwide imaging of ISR state with cellular resolution. Unexpectedly, we found a class of neurons in mouse brain, striatal cholinergic interneurons (CINs), in which the ISR was activated at steady state. Genetic and pharmacological manipulations revealed that ISR signaling was necessary in CINs for normal type 2 dopamine receptor (D2R) modulation. Inhibiting the ISR inverted the sign of D2R modulation of CIN firing and evoked dopamine release and altered skill learning. Thus, a noncanonical, steady-state mode of ISR activation is found in CINs, revealing a neuromodulatory role for the ISR in learning.	[Helseth, Ashley R.; Hernandez-Martinez, Ricardo; Turner, Brandon D.; Caffall, Zachary F.; Rittiner, Joseph E.; Shipman, Miranda K.; King, Connor S.; Calakos, Nicole] Duke Univ, Dept Neurol, Med Ctr, Durham, NC 27715 USA; [Hall, Victoria L.; Calakos, Nicole] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27715 USA; [Oliver, Matthew L.; Calakos, Nicole] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27715 USA; [Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Gerfen, Charles] NIMH, Sect Neuroanat, Bethesda, MD 20892 USA; [Costa-Mattioli, Mauro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Calakos, Nicole] Duke Univ, Duke Inst Brain Sci, Durham, NC 27715 USA	Duke University; Duke University; Duke University; California Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Baylor College of Medicine; Duke University	Calakos, N (corresponding author), Duke Univ, Dept Neurol, Med Ctr, Durham, NC 27715 USA.; Calakos, N (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27715 USA.; Calakos, N (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27715 USA.; Calakos, N (corresponding author), Duke Univ, Duke Inst Brain Sci, Durham, NC 27715 USA.	nicole.calakos@duke.edu	Hernández-Martínez, Ricardo/T-4163-2019	Hernández-Martínez, Ricardo/0000-0002-9376-8363; Oliver, Matthew/0000-0002-8474-4589; Helseth, Ashley/0000-0002-7383-823X; Turner, Brandon/0000-0002-2887-1719; King, Connor/0000-0002-3740-9817; Shipman, Miranda/0000-0002-4418-8717; Caffall, Zachary/0000-0003-4601-6799	NIH BRAIN initiative [NS110059, MH123017]; NIH [NS07670806, NS051156, NS095653]; NSF [DGE-1644868]; Dystonia Medical Research Foundation; Tyler's Hope for a Dystonia Cure; Holland-Trice Scholar award	NIH BRAIN initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Dystonia Medical Research Foundation; Tyler's Hope for a Dystonia Cure; Holland-Trice Scholar award	Research was supported by funding from the following sources: NIH BRAIN initiative (NS110059, N.C.; MH123017, B.D.T.), NIH (NS07670806, M.C.-M.; NS051156 and NS095653, J.E.R.), NSF (DGE-1644868, V.L.H.), Dystonia Medical Research Foundation (N.C., A.R.H.), Tyler's Hope for a Dystonia Cure (N.C.), and a Holland-Trice Scholar award (N.C.).	Aosaki T, 2010, GERIATR GERONTOL INT, V10, pS148, DOI 10.1111/j.1447-0594.2010.00588.x; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Augustin SM, 2018, CELL REP, V24, P2883, DOI 10.1016/j.celrep.2018.08.042; Beierholm U, 2013, NEUROPSYCHOPHARMACOL, V38, P1495, DOI 10.1038/npp.2013.48; Belleau ML, 2000, J NEUROPHYSIOL, V84, P2204, DOI 10.1152/jn.2000.84.5.2204; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Cagnetta R, 2019, MOL CELL, V73, P474, DOI 10.1016/j.molcel.2018.11.013; Chan KY, 2017, NAT NEUROSCI, V20, P1172, DOI 10.1038/nn.4593; Cheng J, 2019, NEURON, V101, P662, DOI 10.1016/j.neuron.2018.12.018; Colla E, 2012, J NEUROSCI, V32, P3306, DOI 10.1523/JNEUROSCI.5367-11.2012; Conner JM, 2003, NEURON, V38, P819, DOI 10.1016/S0896-6273(03)00288-5; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Di Prisco GV, 2014, NAT NEUROSCI, V17, P1073, DOI 10.1038/nn.3754; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Goldberg JA, 2009, J NEUROSCI, V29, P8396, DOI 10.1523/JNEUROSCI.5582-08.2009; Halliday M, 2017, BRAIN, V140, P1768, DOI 10.1093/brain/awx074; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07/006.2007, 10.3389/neuro.07.006.2007]; Huang W, 2016, ELIFE, V5, DOI 10.7554/eLife.12052; Kabir ZD, 2017, MOL PSYCHIATR, V22, P1096, DOI 10.1038/mp.2017.124; KAWAGUCHI Y, 1992, J NEUROPHYSIOL, V67, P1669, DOI 10.1152/jn.1992.67.6.1669; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Kheirbek MA, 2009, J NEUROSCI, V29, P12115, DOI 10.1523/JNEUROSCI.3343-09.2009; Kim SY, 2015, P NATL ACAD SCI USA, V112, pE6274, DOI 10.1073/pnas.1510133112; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mao DX, 2020, AM J HUM GENET, V106, P570, DOI 10.1016/j.ajhg.2020.02.016; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Munoz-Manchado AB, 2018, CELL REP, V24, P2179, DOI 10.1016/j.celrep.2018.07.053; Murray E, 2015, CELL, V163, P1500, DOI 10.1016/j.cell.2015.11.025; Nguyen HG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2036; O'Hare JK, 2017, ELIFE, V6, DOI 10.7554/eLife.26231; O'Hare JK, 2016, NEURON, V89, P472, DOI 10.1016/j.neuron.2015.12.032; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Panigrahi B, 2015, CELL, V162, P1418, DOI 10.1016/j.cell.2015.08.014; Park YG, 2019, NAT BIOTECHNOL, V37, P73, DOI 10.1038/nbt.4281; Pathak SS, 2019, NEURON, V104, P724, DOI 10.1016/j.neuron.2019.08.007; Patriarchi T, 2018, SCIENCE, V360, P1420, DOI 10.1126/science.aat4422; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Rittiner JE, 2016, NEURON, V92, P1238, DOI 10.1016/j.neuron.2016.11.012; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Segev Y, 2015, J NEUROSCI, V35, P12986, DOI 10.1523/JNEUROSCI.5241-14.2015; Shin JH, 2017, J NEUROSCI, V37, P11166, DOI 10.1523/JNEUROSCI.0596-17.2017; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Threlfell S, 2012, NEURON, V75, P58, DOI 10.1016/j.neuron.2012.04.038; Trinh MA, 2013, NEUROBIOL LEARN MEM, V105, P93, DOI 10.1016/j.nlm.2013.04.013; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Warner-Schmidt JL, 2012, P NATL ACAD SCI USA, V109, P11360, DOI 10.1073/pnas.1209293109; Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870; Witten IB, 2010, SCIENCE, V330, P1677, DOI 10.1126/science.1193771; Wong YL, 2018, ELIFE, V7, DOI 10.7554/eLife.32733; Zhu PJ, 2011, CELL, V147, P1384, DOI 10.1016/j.cell.2011.11.029; Zyryanova AF, 2021, MOL CELL, V81, P88, DOI 10.1016/j.molcel.2020.10.031	64	8	8	5	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					361	+	eabe1931	10.1126/science.abe1931	http://dx.doi.org/10.1126/science.abe1931			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888613	Green Accepted			2022-12-28	WOS:000645009800033
J	Conroy, C; Naidu, RP; Garavito-Camargo, N; Besla, G; Zaritsky, D; Bonaca, A; Johnson, BD				Conroy, Charlie; Naidu, Rohan P.; Garavito-Camargo, Nicolas; Besla, Gurtina; Zaritsky, Dennis; Bonaca, Ana; Johnson, Benjamin D.			All-sky dynamical response of the Galactic halo to the Large Magellanic Cloud	NATURE			English	Article							MILKY; FRICTION; MODELS; GALAXY; DISC	Gravitational interactions between the Large Magellanic Cloud (LMC) and the stellar and dark matter halo of the Milky Way are expected to give rise to disequilibrium phenomena in the outer Milky Way1-7. A local wake is predicted to trail the orbit of the LMC, and a large-scale overdensity is predicted to exist across a large area of the northern Galactic hemisphere. Here we report the detection of both the local wake and northern overdensity (hereafter the `collective response') in a map of the Galaxy based on 1,301 stars at Galactocentric distances between 60 and 100 kiloparsecs. The location of the wake is in good agreement with an N-body simulation that includes the dynamical effect of the LMC on the Milky Way halo. The density contrast of the wake and collective response are stronger in the data than in the simulation. The detection of a strong local wake is independent evidence that the Magellanic clouds are on their first orbit around the Milky Way. The wake traces the path of the LMC, which will provide insight into the orbit of the LMC, which in turn is a sensitive probe of the mass of the LMC and the Milky Way. These data demonstrate that the outer halo is not in dynamical equilibrium, as is often assumed. The morphology and strength of the wake could be used to test the nature of dark matter and gravity.	[Conroy, Charlie; Naidu, Rohan P.; Bonaca, Ana; Johnson, Benjamin D.] Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA 02138 USA; [Garavito-Camargo, Nicolas; Besla, Gurtina; Zaritsky, Dennis] Univ Arizona, Steward Observ, Tucson, AZ USA	Smithsonian Institution; University of Arizona	Conroy, C (corresponding author), Harvard & Smithsonian, Ctr Astrophys, Cambridge, MA 02138 USA.	cconroy@cfa.harvard.edu		Naidu, Rohan/0000-0003-3997-5705	Packard Foundation; Harvard University; HST [AR 15004]; NASA ATP [17-ATP17-0006]; NSF CAREER [AST-1941096]; NASA through HST [HST-GO-15930]; National Science Foundation [1228509]; National Aeronautics and Space Administration	Packard Foundation(The David & Lucile Packard Foundation); Harvard University; HST; NASA ATP(National Aeronautics & Space Administration (NASA)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NASA through HST; National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	C.C. is partially supported by the Packard Foundation. R.P.N. acknowledges an Ashford Fellowship and Peirce Fellowship granted by Harvard University. G.B. and N.G.-C. are supported by HST grant AR 15004, NASA ATP grant 17-ATP17-0006, NSF CAREER AST-1941096. A.B. acknowledges support from NASA through HST grant HST-GO-15930. All the simulations were run on El-Gato supercomputer, which was supported by the National Science Foundation under grant no. 1228509. We have made use of data from the European Space Agency mission Gaia (http://www.cosmos.esa.int/gaia), processed by the Gaia Data Processing and Analysis Consortium (DPAC; see http://www.cosmos.esa.int/web/gaia/dpac/consortium).Funding for DPAC has been provided by national institutions, in particular the institutions participating in the Gaia Multilateral Agreement. This publication makes use of data products from the Wide-field Infrared Survey Explorer, which is a joint project of the University of California, Los Angeles, and the Jet Propulsion Laboratory/California Institute of Technology, and NEOWISE, which is a project of the Jet Propulsion Laboratory/California Institute of Technology. WISE and NEOWISE are funded by the National Aeronautics and Space Administration.	Abuter R, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201935656; Belokurov V, 2014, MON NOT R ASTRON SOC, V437, P116, DOI 10.1093/mnras/stt1862; Belokurov V, 2019, MON NOT R ASTRON SOC, V488, pL47, DOI 10.1093/mnrasl/slz101; Bennett M, 2019, MON NOT R ASTRON SOC, V482, P1417, DOI 10.1093/mnras/sty2813; Besla G, 2007, ASTROPHYS J, V668, P949, DOI 10.1086/521385; Besla G, 2013, MON NOT R ASTRON SOC, V428, P2342, DOI 10.1093/mnras/sts192; Chandrasekhar S, 1943, ASTROPHYS J, V97, P255, DOI 10.1086/144517; Ciotti L, 2004, MON NOT R ASTRON SOC, V351, P285, DOI 10.1111/j.1365-2966.2004.07779.x; Clementini G, 2019, ASTRON ASTROPHYS, V622, DOI 10.1051/0004-6361/201833374; Conroy C, 2019, ASTROPHYS J, V887, DOI 10.3847/1538-4357/ab5710; Conroy C, 2018, ASTROPHYS J LETT, V861, DOI 10.3847/2041-8213/aacdf1; Cunningham EC, 2020, ASTROPHYS J, V898, DOI 10.3847/1538-4357/ab9b88; D'Onghia E, 2016, ANNU REV ASTRON ASTR, V54, P363, DOI 10.1146/annurev-astro-081915-023251; Deason AJ, 2019, MON NOT R ASTRON SOC, V485, P3514, DOI 10.1093/mnras/stz623; Deason AJ, 2018, ASTROPHYS J, V852, DOI 10.3847/1538-4357/aa9d19; Diaz JD, 2012, ASTROPHYS J, V750, DOI 10.1088/0004-637X/750/1/36; Drimmel R., 2018, RNAAS, V2, P210, DOI 10.3847/2515-5172/aaef8b; Erkal D., 2020, DETECTION LMC INDUCE; Erkal D., 2020, MON NOT R ASTRON SOC, V498, P5574, DOI DOI 10.1093/MNRAS/STAA2840; Furlanetto SR, 2002, ASTROPHYS J, V565, P854, DOI 10.1086/324693; Garavito-Camargo N., 2020, QUANTIFYING IMPACT L; Garavito-Camargo N, 2019, ASTROPHYS J, V884, DOI 10.3847/1538-4357/ab32eb; Gardiner LT, 1996, MON NOT R ASTRON SOC, V278, P191, DOI 10.1093/mnras/278.1.191; Gomez FA, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/128; Gorski KM, 2005, ASTROPHYS J, V622, P759, DOI 10.1086/427976; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; Hui L, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.043541; Kallivayalil N, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/161; Koposov SE, 2015, MON NOT R ASTRON SOC, V446, P3110, DOI 10.1093/mnras/stu2263; Lancaster L, 2020, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2020/01/001; Laporte CFP, 2018, MON NOT R ASTRON SOC, V473, P1218, DOI 10.1093/mnras/stx2146; Lindegren L., 2020, GAIA EARLY DATA RELE; Lindegren L., 2020, GAIA EARLY DATA RELE; Lucchini S, 2020, NATURE, V585, P203, DOI 10.1038/s41586-020-2663-4; Majewski SR, 2003, ASTROPHYS J, V599, P1082, DOI 10.1086/379504; Mateu C, 2020, MON NOT R ASTRON SOC, V496, P3291, DOI 10.1093/mnras/staa1676; Nipoti C, 2008, MON NOT R ASTRON SOC, V386, P2194, DOI 10.1111/j.1365-2966.2008.13192.x; Petersen MS, 2021, NAT ASTRON, V5, P251, DOI 10.1038/s41550-020-01254-3; Price-Whelan A.M., 2017, JOSS, V2, P388, DOI [10.21105/joss.00388, DOI 10.21105/JOSS.00388]; Riello M., 2020, GAIA EARLY DATA RELE; Rimoldini L, 2019, ASTRON ASTROPHYS, V625, DOI 10.1051/0004-6361/201834616; Robitaille TP, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201322068; Rybizki J, 2018, PUBL ASTRON SOC PAC, V130, DOI 10.1088/1538-3873/aabd70; Schlafly EF, 2019, ASTROPHYS J SUPPL S, V240, DOI 10.3847/1538-4365/aafbea; Schlafly EF, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/103; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Sesar B, 2017, ASTRON J, V153, DOI 10.3847/1538-3881/aa661b; Tamfal T., 2020, REVISITING DYNAMICAL; Weinberg MD, 1998, MON NOT R ASTRON SOC, V299, P499, DOI 10.1046/j.1365-8711.1998.01790.x; Williams AA, 2017, MON NOT R ASTRON SOC, V468, P2359, DOI 10.1093/mnras/stx508; Yurin D, 2014, MON NOT R ASTRON SOC, V444, P62, DOI 10.1093/mnras/stu1421; Zaritsky D, 2020, ASTROPHYS J LETT, V905, DOI 10.3847/2041-8213/abcb83	56	28	30	2	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 22	2021	592	7855					534	+		10.1038/s41586-021-03385-7	http://dx.doi.org/10.1038/s41586-021-03385-7			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	UD6RQ	33883729	Green Submitted			2022-12-28	WOS:000687333900003
J	Evans, CD; Peacock, M; Baird, AJ; Artz, RRE; Burden, A; Callaghan, N; Chapman, PJ; Cooper, HM; Coyle, M; Craig, E; Cumming, A; Dixon, S; Gauci, V; Grayson, RP; Helfter, C; Heppell, CM; Holden, J; Jones, DL; Kaduk, J; Levy, P; Matthews, R; McNamara, NP; Misselbrook, T; Oakley, S; Page, SE; Rayment, M; Ridley, LM; Stanley, KM; Williamson, JL; Worrall, F; Morrison, R				Evans, C. D.; Peacock, M.; Baird, A. J.; Artz, R. R. E.; Burden, A.; Callaghan, N.; Chapman, P. J.; Cooper, H. M.; Coyle, M.; Craig, E.; Cumming, A.; Dixon, S.; Gauci, V.; Grayson, R. P.; Helfter, C.; Heppell, C. M.; Holden, J.; Jones, D. L.; Kaduk, J.; Levy, P.; Matthews, R.; McNamara, N. P.; Misselbrook, T.; Oakley, S.; Page, S. E.; Rayment, M.; Ridley, L. M.; Stanley, K. M.; Williamson, J. L.; Worrall, F.; Morrison, R.			Overriding water table control on managed peatland greenhouse gas emissions	NATURE			English	Article							CARBON-DIOXIDE EXCHANGE; NET ECOSYSTEM EXCHANGE; LAND-USE CHANGE; INTERANNUAL VARIABILITY; CO2 EXCHANGE; METHANE EMISSIONS; EDDY COVARIANCE; BOREAL PEATLAND; ORGANIC SOIL; CH4 FLUXES	Global peatlands store more carbon than is naturally present in the atmosphere(1,2). However, many peatlands are under pressure from drainage-based agriculture, plantation development and fire, with the equivalent of around 3 per cent of all anthropogenic greenhouse gases emitted from drained peatland(3-5). Efforts to curb such emissions are intensifying through the conservation of undrained peatlands and re-wetting of drained systems(6). Here we report eddy covariance data for carbon dioxide from 16 locations and static chamber measurements for methane from 41 locations in the UK and Ireland. We combine these with published data from sites across all major peatland biomes. We find that the mean annual effective water table depth (WTDe; that is, the average depth of the aerated peat layer) overrides all other ecosystem- and management-related controls on greenhouse gas fluxes. We estimate that every 10 centimetres of reduction in WTDe could reduce the net warming impact of CO2 and CH4 emissions (100-year global warming potentials) by the equivalent of at least 3 tonnes of CO2 per hectare per year, until WTDe is less than 30 centimetres. Raising water levels further would continue to have a net cooling effect until WTDe is within 10 centimetres of the surface. Our results suggest that greenhouse gas emissions from peatlands drained for agriculture could be greatly reduced without necessarily halting their productive use. Halving WTDe in all drained agricultural peatlands, for example, could reduce emissions by the equivalent of over 1 per cent of global anthropogenic emissions.	[Evans, C. D.; Burden, A.; Callaghan, N.; Craig, E.; Williamson, J. L.] UK Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales; [Evans, C. D.; Peacock, M.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Baird, A. J.; Chapman, P. J.; Grayson, R. P.; Holden, J.] Univ Leeds, Sch Geog, Leeds, W Yorkshire, England; [Artz, R. R. E.; Coyle, M.] James Hutton Inst, Aberdeen, Scotland; [Cooper, H. M.; Cumming, A.; Morrison, R.] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Coyle, M.; Helfter, C.; Levy, P.] UK Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Craig, E.; Jones, D. L.; Rayment, M.; Ridley, L. M.] Bangor Univ, Sch Nat Sci, Bangor, Gwynedd, Wales; [Dixon, S.; Worrall, F.] Univ Durham, Dept Earth Sci, Durham, England; [Gauci, V.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Heppell, C. M.] Queen Mary Univ London, Sch Geog, London, England; [Jones, D. L.] Murdoch Univ, Food Futures Inst, Ctr Sustainable Farming Syst, SoilsWest, Murdoch, WA, Australia; [Jones, D. L.] Univ Western Australia, UWA Sch Agr & Environm, Perth, WA, Australia; [Kaduk, J.] Univ Leicester, Sch Geog Geol & Environm, Leicester, Leics, England; [Misselbrook, T.] North Wyke, Rothamsted Res, Okehampton, England; [McNamara, N. P.; Oakley, S.] UK Ctr Ecol & Hydrol, Lancaster, England; [Stanley, K. M.] Goethe Univ Frankfurt, Inst Atmosphare & Umwelt, Frankfurt, Germany	UK Centre for Ecology & Hydrology (UKCEH); Swedish University of Agricultural Sciences; University of Leeds; James Hutton Institute; UK Centre for Ecology & Hydrology (UKCEH); UK Centre for Ecology & Hydrology (UKCEH); Bangor University; Durham University; University of Birmingham; University of London; Queen Mary University London; Murdoch University; University of Western Australia; University of Leicester; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; UK Centre for Ecology & Hydrology (UKCEH); Goethe University Frankfurt	Evans, CD (corresponding author), UK Ctr Ecol & Hydrol, Bangor, Gwynedd, Wales.; Evans, CD (corresponding author), Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden.	cev@ceh.ac.uk	jones, davey/AAN-5606-2020; Kaduk, Jörg/I-3276-2019; Burden, Annette/G-4443-2011; Jones, Davey L/C-7411-2011; Burden, Annette/J-2228-2019; Cooper, Hollie M/F-6369-2019; McNamara, Niall P/B-4907-2008; Artz, Rebekka/G-6384-2013; Evans, Christopher/F-2087-2010; Helfter, Carole/A-1835-2010; Misselbrook, Tom/N-2385-2014	Kaduk, Jörg/0000-0003-4051-3081; Burden, Annette/0000-0002-7694-1638; Jones, Davey L/0000-0002-1482-4209; Burden, Annette/0000-0002-7694-1638; Cooper, Hollie M/0000-0002-1382-3407; McNamara, Niall P/0000-0002-5143-5819; Artz, Rebekka/0000-0002-8462-6558; Chapman, Pippa/0000-0003-0438-6855; Dixon, Simon/0000-0002-6801-6098; Peacock, Mike/0000-0002-3086-2854; Evans, Christopher/0000-0002-7052-354X; Helfter, Carole/0000-0001-5773-4652; Holden, Joseph/0000-0002-1108-4831; Misselbrook, Tom/0000-0002-4594-3606; Baird, Andy/0000-0001-8198-3229	UK Department for Environment, Food and Rural Affairs [SP1210, SP1218]; UK Natural Environment Research Council [NE/P0140971/1, NE/R016429/1]; Scottish Government; Natural Resources Wales (NRW)	UK Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Natural Resources Wales (NRW)	This study was supported by the UK Department for Environment, Food and Rural Affairs (projects SP1210 and SP1218), with additional data provided from projects funded by the UK Natural Environment Research Council (SEFLOS, NE/P0140971/1 and UKSCAPE, NE/R016429/1), Scottish Government and Natural Resources Wales (NRW). UK flux sites were hosted by a range of organizations including G's Fresh, the National Trust, NRW and the Balmoral Estate. We thank all those responsible for collecting the published data used in the study, in particular M. Strack, D. Holl, H. Keck and C. Deshmukh for providing additional data and information on individual studies, L. Menichetti for sharing peat mapping data and L. Barber at the University of Leicester for preparing the site maps.	Adkinson AC, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001512; Andrew RM, 2018, EARTH SYST SCI DATA, V10, P195, DOI 10.5194/essd-10-195-2018; [Anonymous], 2014, MITIGATION CLIMATE C, V9; Aslan-Sungur G, 2016, SCI TOTAL ENVIRON, V554, P192, DOI 10.1016/j.scitotenv.2016.02.153; Aurela M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020315; Aurela M, 2007, TELLUS B, V59, P826, DOI 10.1111/j.1600-0889.2007.00309.x; Aurela M, 2015, BOREAL ENVIRON RES, V20, P455; Aurela M, 2009, BOREAL ENVIRON RES, V14, P699; Baird A, 2009, SP0574 U LEEDS; Brown E. L., 2017, THESIS BANGOR U; Brown P., 2019, UK GREENHOUSE GAS IN; Bubier J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002351; Byrne KE, 2004, EU PEATLANDS CURRENT; Campbell DI, 2015, AGR ECOSYST ENVIRON, V202, P68, DOI 10.1016/j.agee.2014.12.019; Carlson KM, 2017, NAT CLIM CHANGE, V7, P63, DOI [10.1038/nclimate3158, 10.1038/NCLIMATE3158]; Cooper MDA, 2014, ECOSYSTEMS, V17, P1227, DOI 10.1007/s10021-014-9791-3; Couwenberg J, 2011, HYDROBIOLOGIA, V674, P67, DOI 10.1007/s10750-011-0729-x; D'Acunha B, 2019, J GEOPHYS RES-BIOGEO, V124, P884, DOI 10.1029/2019JG005123; Dargie GC, 2017, NATURE, V542, P86, DOI 10.1038/nature21048; Denmead OT, 2008, PLANT SOIL, V309, P5, DOI 10.1007/s11104-008-9599-z; Dias ATC, 2010, ECOSYSTEMS, V13, P526, DOI 10.1007/s10021-010-9338-1; Drewer J, 2010, EUR J SOIL SCI, V61, P640, DOI 10.1111/j.1365-2389.2010.01267.x; Drollinger S, 2019, AGR FOREST METEOROL, V275, P69, DOI 10.1016/j.agrformet.2019.05.015; Evans C., 2017, IMPLEMENTATION EMISS; Evans C., 2016, LOWLAND PEATLAND SYS; Evans CD, 2016, AQUAT SCI, V78, P573, DOI [10.1007/s00027-016-0470-7, 10.1007/s00027-015-0447-y]; Evans CD, 2019, GEODERMA, V338, P410, DOI 10.1016/j.geoderma.2018.12.028; Ferre M, 2019, LAND USE POLICY, V87, DOI 10.1016/j.landusepol.2019.05.038; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Finkelstein PL, 2001, J GEOPHYS RES-ATMOS, V106, P3503, DOI 10.1029/2000JD900731; Flanagan LB, 2011, GLOBAL CHANGE BIOL, V17, P2271, DOI 10.1111/j.1365-2486.2010.02378.x; Fleischer E, 2016, SCI TOTAL ENVIRON, V545, P424, DOI 10.1016/j.scitotenv.2015.12.073; Foken T., 2004, HDB MICROMETEOROLOGY, P181, DOI DOI 10.1007/1-4020-2265-4_9; Friborg T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017797; Frolking S, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000091; Gasser T, 2017, EARTH SYST DYNAM, V8, P235, DOI 10.5194/esd-8-235-2017; Gauci V, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001370; Gong JN, 2014, AGR FOREST METEOROL, V198, P232, DOI 10.1016/j.agrformet.2014.08.011; Granath G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28498; Green SM, 2017, MIRES PEAT, V19, DOI 10.19189/MaP.2016.OMB.254; Green SM, 2012, PLANT SOIL, V351, P207, DOI 10.1007/s11104-011-0945-1; Griffis TJ, 2020, AGR FOREST METEOROL, V295, DOI 10.1016/j.agrformet.2020.108167; Gunther A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15499-z; Hadden D, 2017, AGR FOREST METEOROL, V243, P1, DOI 10.1016/j.agrformet.2017.05.002; Hambley G, 2019, MIRES PEAT, V23, DOI 10.19189/MaP.2018.DW.346; Hao YB, 2011, WETLANDS, V31, P413, DOI 10.1007/s13157-011-0151-1; Hatala JA, 2012, AGR ECOSYST ENVIRON, V150, P1, DOI 10.1016/j.agee.2012.01.009; Helbig M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8c85; Helbig M, 2017, GLOBAL CHANGE BIOL, V23, P3231, DOI 10.1111/gcb.13638; Helfter C, 2015, BIOGEOSCIENCES, V12, P1799, DOI 10.5194/bg-12-1799-2015; Hendriks DMD, 2007, BIOGEOSCIENCES, V4, P411, DOI 10.5194/bg-4-411-2007; Hirano T, 2012, GLOBAL CHANGE BIOL, V18, P3410, DOI 10.1111/j.1365-2486.2012.02793.x; Holl D, 2019, BIOGEOSCIENCES, V16, P3397, DOI 10.5194/bg-16-3397-2019; Hommeltenberg J, 2014, AGR FOREST METEOROL, V198, P273, DOI 10.1016/j.agrformet.2014.08.017; Hooijer A, 2012, BIOGEOSCIENCES, V9, P1053, DOI 10.5194/bg-9-1053-2012; Humphreys ER, 2014, ARCT ANTARCT ALP RES, V46, P103, DOI 10.1657/1938-4246.46.1.103; HUTCHINSON JN, 1980, J ECOL, V68, P229, DOI 10.2307/2259253; I.P.O.C. Change, 2006, 2006 IPCC GUIDELINES; IPCC Task Force on National Greenhouse Gas Inventories, 2014, TASK FORC NAT GREENH; Joiner DW, 1999, J GEOPHYS RES-ATMOS, V104, P27663, DOI 10.1029/1999JD900136; Joosten H, 2012, MITIGATION CLIMATE C, V5; Kiew F, 2018, AGR FOREST METEOROL, V248, P494, DOI 10.1016/j.agrformet.2017.10.022; Knox SH, 2015, GLOBAL CHANGE BIOL, V21, P750, DOI 10.1111/gcb.12745; Kormann R, 2001, BOUND-LAY METEOROL, V99, P207, DOI 10.1023/A:1018991015119; Laine A, 2007, PLANT SOIL, V299, P181, DOI 10.1007/s11104-007-9374-6; Langeveld CA, 1997, EUR J AGRON, V7, P35, DOI 10.1016/S1161-0301(97)00036-1; Lee SC, 2017, BIOGEOSCIENCES, V14, P2799, DOI 10.5194/bg-14-2799-2017; Leifeld J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03406-6; Levy PE, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/094019; Levy PE, 2012, GLOBAL CHANGE BIOL, V18, P1657, DOI 10.1111/j.1365-2486.2011.02616.x; Liu LJ, 2019, GEODERMA, V352, P138, DOI 10.1016/j.geoderma.2019.06.008; Lohila A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004715; Lund M, 2007, TELLUS B, V59, P804, DOI 10.1111/j.1600-0889.2007.00303.x; McVeigh P, 2014, AGR FOREST METEOROL, V194, P8, DOI 10.1016/j.agrformet.2014.01.017; Miao Y, 2012, BIOGEOSCIENCES, V9, P4455, DOI 10.5194/bg-9-4455-2012; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Neubauer SC, 2015, ECOSYSTEMS, V18, P1000, DOI 10.1007/s10021-015-9879-4; Nieveen JP, 1998, GLOBAL CHANGE BIOL, V4, P823, DOI 10.1046/j.1365-2486.1998.00189.x; Nilsson M, 2008, GLOBAL CHANGE BIOL, V14, P2317, DOI 10.1111/j.1365-2486.2008.01654.x; Nugent KA, 2018, GLOBAL CHANGE BIOL, V24, P5751, DOI 10.1111/gcb.14449; Olefeldt D, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050355; Olson DM, 2013, J GEOPHYS RES-BIOGEO, V118, P226, DOI 10.1002/jgrg.20031; Papale D, 2006, BIOGEOSCIENCES, V3, P571, DOI 10.5194/bg-3-571-2006; Paustian K, 2016, NATURE, V532, P49, DOI 10.1038/nature17174; Peacock M, 2019, AGR ECOSYST ENVIRON, V269, P1, DOI 10.1016/j.agee.2018.09.020; Pohl M, 2015, BIOGEOSCIENCES, V12, P2737, DOI 10.5194/bg-12-2737-2015; Pullens JWM, 2016, AGR FOREST METEOROL, V220, P69, DOI 10.1016/j.agrformet.2016.01.012; Rankin T, 2018, ECOL ENG, V122, P241, DOI 10.1016/j.ecoleng.2018.06.021; Ratcliffe JL, 2019, SCI TOTAL ENVIRON, V655, P1037, DOI 10.1016/j.scitotenv.2018.11.151; Regina K, 2007, AGR ECOSYST ENVIRON, V119, P346, DOI 10.1016/j.agee.2006.08.002; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2016, REDDYPROC DATA PROCE; Renou-Wilson F, 2016, AGR ECOSYST ENVIRON, V222, P156, DOI 10.1016/j.agee.2016.02.011; Rigney C, 2018, MIRES PEAT, V21, DOI 10.19189/MaP.2017.OMB.314; Roulet NT, 2007, GLOBAL CHANGE BIOL, V13, P397, DOI 10.1111/j.1365-2486.2006.01292.x; Schrier-Uijl AP, 2014, BIOGEOSCIENCES, V11, P4559, DOI 10.5194/bg-11-4559-2014; Schulze ED, 2002, TELLUS B, V54, P531, DOI 10.1034/j.1600-0889.2002.01386.x; Shurpali NJ, 2009, GCB BIOENERGY, V1, P35, DOI 10.1111/j.1757-1707.2009.01003.x; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Sonnentag O, 2010, GLOBAL CHANGE BIOL, V16, P1762, DOI 10.1111/j.1365-2486.2009.02032.x; Stanley KM, 2019, J GEOPHYS RES-BIOGEO, V124, P1750, DOI 10.1029/2018JG004902; Sterner EO, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa61dc; Strachan IB, 2016, BIOGEOCHEMISTRY, V127, P99, DOI 10.1007/s10533-015-0170-8; Tiemeyer B, 2020, ECOL INDIC, V109, DOI 10.1016/j.ecolind.2019.105838; Tiemeyer B, 2016, GLOBAL CHANGE BIOL, V22, P4134, DOI 10.1111/gcb.13303; Turetsky MR, 2015, NAT GEOSCI, V8, P11, DOI [10.1038/NGEO2325, 10.1038/ngeo2325]; Turetsky MR, 2014, GLOBAL CHANGE BIOL, V20, P2183, DOI 10.1111/gcb.12580; Valdes-Barrera A, 2019, WETL ECOL MANAG, V27, P635, DOI 10.1007/s11273-019-09682-3; Wang M, 2018, AGR FOREST METEOROL, V248, P91, DOI 10.1016/j.agrformet.2017.09.010; Wijedasa LS, 2018, GLOBAL CHANGE BIOL, V24, P4598, DOI 10.1111/gcb.14340; Wilson D, 2016, GLOBAL CHANGE BIOL, V22, P4080, DOI 10.1111/gcb.13325; Wilson D, 2009, RESTOR ECOL, V17, P796, DOI 10.1111/j.1526-100X.2008.00416.x; Yamulki S, 2013, BIOGEOSCIENCES, V10, P1051, DOI 10.5194/bg-10-1051-2013; Yu XY, 2020, ECOL INDIC, V115, DOI 10.1016/j.ecolind.2020.106427; Yu ZC, 2012, BIOGEOSCIENCES, V9, P4071, DOI 10.5194/bg-9-4071-2012	115	67	68	53	212	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 27	2021	593	7860					548	+		10.1038/s41586-021-03523-1	http://dx.doi.org/10.1038/s41586-021-03523-1		APR 2021	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YT9IB	33882562	Green Submitted, Green Accepted			2022-12-28	WOS:000652171900001
J	Ghanim, GE; Fountain, AJ; van Roon, AMM; Rangan, R; Das, R; Collins, K; Nguyen, THD				Ghanim, George E.; Fountain, Adam J.; van Roon, Anne-Marie M.; Rangan, Ramya; Das, Rhiju; Collins, Kathleen; Thi Hoang Duong Nguyen			Structure of human telomerase holoenzyme with bound telomeric DNA	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; CAJAL BODY LOCALIZATION; MOLECULAR-REPLACEMENT; REVERSE-TRANSCRIPTASE; STRUCTURE REFINEMENT; RNA STRUCTURE; REPLICATION; BINDING; VISUALIZATION; PROCESSIVITY	Telomerase adds telomeric repeats at chromosome ends to compensate for the telomere loss that is caused by incomplete genome end replication(1). In humans, telomerase is upregulated during embryogenesis and in cancers, and mutations that compromise the function of telomerase result in disease(2). A previous structure of human telomerase at a resolution of 8 A revealed a vertebrate-specific composition and architecture(3), comprising a catalytic core that is flexibly tethered to an H and ACA (hereafter, H/ACA) box ribonucleoprotein (RNP) lobe by telomerase RNA. High-resolution structural information is necessary to develop treatments that can effectively modulate telomerase activity as a therapeutic approach against cancers and disease. Here we used cryo-electron microscopy to determine the structure of human telomerase holoenzyme bound to telomeric DNA at sub-4 angstrom resolution, which reveals crucial DNA- and RNA-binding interfaces in the active site of telomerase as well as the locations of mutations that alter telomerase activity. We identified a histone H2A-H2B dimer within the holoenzyme that was bound to an essential telomerase RNA motif, which suggests a role for histones in the folding and function of telomerase RNA. Furthermore, this structure of a eukaryotic H/ACA RNP reveals the molecular recognition of conserved RNA and protein motifs, as well as interactions that are crucial for understanding the molecular pathology of many mutations that cause disease. Our findings provide the structural details of the assembly and active site of human telomerase, which paves the way for the development of therapeutic agents that target this enzyme.	[Ghanim, George E.; Fountain, Adam J.; van Roon, Anne-Marie M.; Thi Hoang Duong Nguyen] MRC, Lab Mol Biol, Cambridge, England; [Rangan, Ramya; Das, Rhiju] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Collins, Kathleen] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Collins, Kathleen] Univ Calif Berkeley, Calif Inst Quantitat Biol QB3, Berkeley, CA 94720 USA	MRC Laboratory Molecular Biology; Stanford University; Stanford University; Stanford University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Nguyen, THD (corresponding author), MRC, Lab Mol Biol, Cambridge, England.	knguyen@mrc-lmb.cam.ac.uk		Nguyen, Thi Hoang Duong/0000-0002-2180-3430; Rangan, Ramya/0000-0002-0960-0825; Das, Rhiju/0000-0001-7497-0972	National Science Foundation Graduate Fellowship; UKRI-Medical Research Council [MC_UP_1201/19]; NIH [GM054198, GM122579, GM121487]	National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); UKRI-Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the MRC-LMB EM facility staff for access and support of electron microscopy sample preparation and data collection; J. Grimmett and T. Darling for maintaining the computing facility; the LMB mass spectrometry facility for running mass spectrometry experiments; S. Scotcher and the LMB workshop team for making our electrophoresis gel systems; K. Muir and D. Barford for sharing human histone expression constructs; K. Kappel for advice on DRRAFTER modelling; the K. Nagai, J. Lowe and L. Passmore laboratories for sharing reagents and equipment; members of the laboratories of K.C. and E. Nogales for past technical support; and D. Barford, A. Carter, E. Nogales, L. Passmore and S. Scheres for critical reading of the manuscript. R.R. is supported by a National Science Foundation Graduate Fellowship. This work was funded by a UKRI-Medical Research Council grant to T.H.D.N. (MC_UP_1201/19), an NIH grant to K.C. (GM054198) and NIH grants to R.D. (GM122579 and GM121487).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Blackburn EH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003558; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Bryan TM, 2000, J BIOL CHEM, V275, P24199, DOI 10.1074/jbc.M003246200; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen JL, 2002, NUCLEIC ACIDS RES, V30, P592, DOI 10.1093/nar/30.2.592; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chou FC, 2016, METHODS MOL BIOL, V1320, P269, DOI 10.1007/978-1-4939-2763-0_17; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goodrich J., 2007, BINDING KINETICS MOL; Greider CW, 2016, GENE DEV, V30, P1483, DOI 10.1101/gad.280578.116; Jady BE, 2004, J CELL BIOL, V164, P647, DOI 10.1083/jcb.200310138; Jiang JS, 2018, CELL, V173, P1179, DOI 10.1016/j.cell.2018.04.038; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Kappel K, 2018, NAT METHODS, V15, P947, DOI 10.1038/s41592-018-0172-2; Kim NK, 2010, NUCLEIC ACIDS RES, V38, P6746, DOI 10.1093/nar/gkq525; Latrick CM, 2010, EMBO J, V29, P924, DOI 10.1038/emboj.2009.409; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; Li S, 2011, GENE DEV, V25, P2409, DOI 10.1101/gad.175299.111; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luger K, 1999, METHOD ENZYMOL, V304, P3; MacNeil DE, 2016, GENES-BASEL, V7, DOI 10.3390/genes7090064; Margalef P, 2018, CELL, V172, P439, DOI 10.1016/j.cell.2017.11.047; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miller MC, 2000, EMBO J, V19, P4412, DOI 10.1093/emboj/19.16.4412; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Nguyen T. H. D, 2014, STRUCTURAL BIOCHEMIC; Nicholls RA, 2014, ACTA CRYSTALLOGR D, V70, P2487, DOI 10.1107/S1399004714016241; Palka C, 2020, RNA, V26, P1787, DOI 10.1261/rna.077255.120; Parks JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5146; Patrick EM, 2020, NAT CHEM BIOL, V16, P801, DOI 10.1038/s41589-020-0478-0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Podlevsky JD, 2016, RNA BIOL, V13, P720, DOI 10.1080/15476286.2016.1205768; Qi XD, 2012, EMBO J, V31, P150, DOI 10.1038/emboj.2011.363; Robart AR, 2010, J BIOL CHEM, V285, P4375, DOI 10.1074/jbc.M109.088575; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sarek G, 2015, NAT STRUCT MOL BIOL, V22, P867, DOI 10.1038/nsmb.3093; Sauer PV, 2018, NUCLEIC ACIDS RES, V46, P9907, DOI 10.1093/nar/gky823; Schaich MA, 2020, ELIFE, V9, DOI 10.7554/eLife.55438; Schnapp G, 1998, NUCLEIC ACIDS RES, V26, P3311, DOI 10.1093/nar/26.13.3311; Sexton AN, 2012, J BIOL CHEM, V287, P34455, DOI 10.1074/jbc.M112.394767; Shay JW, 2016, CANCER DISCOV, V6, P584, DOI 10.1158/2159-8290.CD-16-0062; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tesmer VM, 2019, P NATL ACAD SCI USA, V116, P26505, DOI 10.1073/pnas.1911912116; Theimer CA, 2007, MOL CELL, V27, P869, DOI 10.1016/j.molcel.2007.07.017; Nguyen THD, 2018, NATURE, V557, P190, DOI 10.1038/s41586-018-0062-x; Tycowski KT, 2009, MOL CELL, V34, P47, DOI 10.1016/j.molcel.2009.02.020; Upton HE, 2014, MOL CELL BIOL, V34, P4200, DOI 10.1128/MCB.01030-14; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Witkin KL, 2004, GENE DEV, V18, P1107, DOI 10.1101/gad.1201704; Wu RA, 2017, ANNU REV BIOCHEM, V86, P439, DOI 10.1146/annurev-biochem-061516-045019; Wu RA, 2017, EMBO J, V36, P1908, DOI 10.15252/embj.201796887; Wu RA, 2015, ELIFE, V4, DOI 10.7554/eLife.08363; Yu YT, 2014, RNA BIOL, V11, P1483, DOI 10.4161/15476286.2014.972855; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	71	46	46	5	37	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					449	+		10.1038/s41586-021-03415-4	http://dx.doi.org/10.1038/s41586-021-03415-4		APR 2021	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SE2PC	33883742	Green Accepted			2022-12-28	WOS:000642083200005
J	Reinert, S; Hubener, M; Bonhoeffer, T; Goltstein, PM				Reinert, Sandra; Huebener, Mark; Bonhoeffer, Tobias; Goltstein, Pieter M.			Mouse prefrontal cortex represents learned rules for categorization	NATURE			English	Article							BEHAVIORAL FLEXIBILITY; VISUAL CATEGORIZATION; CELLULAR RESOLUTION; MIXED SELECTIVITY; NEURAL ACTIVITY; RATS; DECONVOLUTION; SOFTWARE; IMPLICIT	The ability to categorize sensory stimuli is crucial for an animal's survival in a complex environment. Memorizing categories instead of individual exemplars enables greater behavioural flexibility and is computationally advantageous. Neurons that show category selectivity have been found in several areas of the mammalian neocortex(1-4), but the prefrontal cortex seems to have a prominent role(4,5) in this context. Specifically, in primates that are extensively trained on a categorization task, neurons in the prefrontal cortex rapidly and flexibly represent learned categories(6,7). However, how these representations first emerge in naive animals remains unexplored, leaving it unclear whether flexible representations are gradually built up as part of semantic memory or assigned more or less instantly during task execution(8,9). Here we investigate the formation of a neuronal category representation throughout the entire learning process by repeatedly imaging individual cells in the mouse medial prefrontal cortex. We show that mice readily learn rule-based categorization and generalize to novel stimuli. Over the course of learning, neurons in the prefrontal cortex display distinct dynamics in acquiring category selectivity and are differentially engaged during a later switch in rules. A subset of neurons selectively and uniquely respond to categories and reflect generalization behaviour. Thus, a category representation in the mouse prefrontal cortex is gradually acquired during learning rather than recruited ad hoc. This gradual process suggests that neurons in the medial prefrontal cortex are part of a specific semantic memory for visual categories.	[Reinert, Sandra; Huebener, Mark; Bonhoeffer, Tobias; Goltstein, Pieter M.] Max Planck Inst Neurobiol, Martinsried, Germany; [Reinert, Sandra] Ludwig Maximilians Univ Munchen, Grad Sch Syst Neurosci, Martinsried, Germany	Max Planck Society; University of Munich	Goltstein, PM (corresponding author), Max Planck Inst Neurobiol, Martinsried, Germany.	goltstein@neuro.mpg.de	Goltstein, Pieter/GVU-3883-2022; Bonhoeffer, Tobias/B-9481-2009	Reinert, Sandra/0000-0003-4302-7433; Bonhoeffer, Tobias/0000-0001-7897-6634	Max Planck Society; Collaborative Research Center of the German Research Association (DFG) [SFB870]; German Research Association (DFG) [RTG 2175]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Collaborative Research Center of the German Research Association (DFG)(German Research Foundation (DFG)); German Research Association (DFG)(German Research Foundation (DFG))	We thank C. Leibold for discussions contributing to the study design; V. Staiger, C. Huber, F. Voss and M. Sperling for technical assistance; A. Glas for help with the implant method and discussions; J. Bauer, D. Mearns and T. Mrsic-Flogel for discussions and comments on the manuscript; T. Rose for the viral construct; J. Kuhl for illustrations. This project was funded by the Max Planck Society and the Collaborative Research Center SFB870 (project numbers A07, A08) of the German Research Association (DFG) to T.B. and M.H. and the German Research Association (DFG) via the RTG 2175 `Perception in context and its neural basis' to M.H. and C. Leibold.	Antzoulatos EG, 2011, NEURON, V71, P243, DOI 10.1016/j.neuron.2011.05.040; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Ashby F Gregory, 2004, Behav Cogn Neurosci Rev, V3, P101, DOI 10.1177/1534582304270782; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brigman JL, 2008, BEHAV BRAIN RES, V187, P405, DOI 10.1016/j.bbr.2007.10.004; Brincat SL, 2018, P NATL ACAD SCI USA, V115, pE7202, DOI 10.1073/pnas.1717075115; Broschard MB, 2019, LEARN MEMORY, V26, P84, DOI 10.1101/lm.048942.118; Carlen M, 2017, SCIENCE, V358, P478, DOI 10.1126/science.aan8868; Chang JY, 2002, EXP BRAIN RES, V142, P67, DOI 10.1007/s00221-001-0918-3; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; DEBRUIN JPC, 1994, BRAIN RES, V652, P323, DOI 10.1016/0006-8993(94)90243-7; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Fitzgerald JK, 2013, NEURON, V77, P180, DOI 10.1016/j.neuron.2012.11.014; Franklin K.B, 2007, MOUSE BRAIN STEREOTA, V3, DOI [10.1038/s41586-021-03452-z, DOI 10.1038/S41586-021-03452-Z]; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2016, ANNU REV NEUROSCI, V39, P129, DOI 10.1146/annurev-neuro-071714-033919; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2002, J NEUROPHYSIOL, V88, P929, DOI 10.1152/jn.2002.88.2.929; Giovannucci A, 2019, ELIFE, V8, DOI 10.7554/eLife.38173; Goltstein PM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204066; Goodwin SJ, 2012, J NEUROSCI, V32, P3499, DOI 10.1523/JNEUROSCI.3585-11.2012; Grunfeld IS, 2018, CURR OPIN NEUROBIOL, V49, P108, DOI 10.1016/j.conb.2018.01.008; Guizar-Sicairos M, 2008, OPT LETT, V33, P156, DOI 10.1364/OL.33.000156; Guo ZCV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088678; Holscher C, 2005, J EXP BIOL, V208, P561, DOI 10.1242/jeb.01371; Huda R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19772-z; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; Karlsson MP, 2012, SCIENCE, V338, P135, DOI 10.1126/science.1226518; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kesner RP, 2000, PSYCHOBIOLOGY, V28, P219; Kleiner M, 2007, PERCEPTION, V36, P14; Laubach M, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0315-18.2018; Leinweber M, 2014, JOVE-J VIS EXP, DOI 10.3791/50885; Li B, 2020, P NATL ACAD SCI USA, V117, P17278, DOI 10.1073/pnas.2000523117; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Musall S, 2019, NAT NEUROSCI, V22, P1677, DOI 10.1038/s41593-019-0502-4; Nath T, 2019, NAT PROTOC, V14, P2152, DOI 10.1038/s41596-019-0176-0; Otis JM, 2017, NATURE, V543, P103, DOI 10.1038/nature21376; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pinto L, 2015, NEURON, V87, P437, DOI 10.1016/j.neuron.2015.06.021; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rikhye RV, 2018, NAT NEUROSCI, V21, P1753, DOI 10.1038/s41593-018-0269-z; Roy JE, 2010, J NEUROSCI, V30, P8519, DOI 10.1523/JNEUROSCI.4837-09.2010; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Smith JD, 2012, NEUROSCI BIOBEHAV R, V36, P2355, DOI 10.1016/j.neubiorev.2012.09.003; Smith JD, 2011, PSYCHON B REV, V18, P414, DOI 10.3758/s13423-010-0047-8; Smith JD, 2010, J EXP PSYCHOL-ANIM B, V36, P54, DOI 10.1037/a0015892; Tonegawa S, 2018, NAT REV NEUROSCI, V19, P485, DOI 10.1038/s41583-018-0031-2; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Villagrasa F, 2018, J NEUROSCI, V38, P9551, DOI 10.1523/JNEUROSCI.0874-18.2018; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Xin Y, 2019, NEURON, V103, P909, DOI 10.1016/j.neuron.2019.06.004; Zhong L, 2019, NAT NEUROSCI, V22, P963, DOI 10.1038/s41593-019-0383-6	64	20	21	5	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 20	2021	593	7859					411	+		10.1038/s41586-021-03452-z	http://dx.doi.org/10.1038/s41586-021-03452-z		APR 2021	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SE2PC	33883745	hybrid, Green Published			2022-12-28	WOS:000642083200003
J	Iacobucci, G				Iacobucci, Gareth			All intensive care patients must have access to community rehabilitation, leaders urge	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n1037	10.1136/bmj.n1037	http://dx.doi.org/10.1136/bmj.n1037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3BI	33879455				2022-12-28	WOS:000643654700010
J	Shepherd, A				Shepherd, Alison			Thailand tightens covid-19 rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 20	2021	373								n1016	10.1136/bmj.n1016	http://dx.doi.org/10.1136/bmj.n1016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RS3BI	33879447	Bronze			2022-12-28	WOS:000643654700006
J	Alpert, T; Brito, AF; Lasek-Nesselquist, E; Rothman, J; Valesano, AL; MacKay, MJ; Petrone, ME; Breban, MI; Watkins, AE; Vogels, CBF; Kalinich, CC; Dellicour, S; Russell, A; Kelly, JP; Shudt, M; Plitnick, J; Schneider, E; Fitzsimmons, WJ; Khullar, G; Metti, J; Dudley, JT; Nash, M; Beaubier, N; Wang, JH; Liu, C; Hui, P; Muyombwe, A; Downing, R; Razeq, J; Bart, SM; Grills, A; Morrison, SM; Murphy, S; Neal, C; Laszlo, E; Rennert, H; Cushing, M; Westblade, L; Velu, P; Craney, A; Cong, L; Peaper, DR; Landry, ML; Cook, PW; Fauver, JR; Mason, CE; Lauring, AS; St George, K; MacCannell, DR; Grubaugh, ND				Alpert, Tara; Brito, Anderson F.; Lasek-Nesselquist, Erica; Rothman, Jessica; Valesano, Andrew L.; MacKay, Matthew J.; Petrone, Mary E.; Breban, Mallery, I; Watkins, Anne E.; Vogels, Chantal B. F.; Kalinich, Chaney C.; Dellicour, Simon; Russell, Alexis; Kelly, John P.; Shudt, Matthew; Plitnick, Jonathan; Schneider, Erasmus; Fitzsimmons, William J.; Khullar, Gaurav; Metti, Jessica; Dudley, Joel T.; Nash, Megan; Beaubier, Nike; Wang, Jianhui; Liu, Chen; Hui, Pei; Muyombwe, Anthony; Downing, Randy; Razeq, Jafar; Bart, Stephen M.; Grills, Ardath; Morrison, Stephanie M.; Murphy, Steven; Neal, Caleb; Laszlo, Eva; Rennert, Hanna; Cushing, Melissa; Westblade, Lars; Velu, Priya; Craney, Arryn; Cong, Lin; Peaper, David R.; Landry, Marie L.; Cook, Peter W.; Fauver, Joseph R.; Mason, Christopher E.; Lauring, Adam S.; St George, Kirsten; MacCannell, Duncan R.; Grubaugh, Nathan D.			Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States	CELL			English	Article							READ ALIGNMENT; SPREAD	The emergence and spread of SARS-CoV-2 lineage B.1.1.7, first detected in the United Kingdom, has become a global public health concern because of its increased transmissibility. Over 2,500 COVID-19 cases associated with this variant have been detected in the United States (US) since December 2020, but the extent of establishment is relatively unknown. Using travel, genomic, and diagnostic data, we highlight that the primary ports of entry for B.1.1.7 in the US were in New York, California, and Florida. Furthermore, we found evidence for many independent B.1.1.7 establishments starting in early December 2020, followed by interstate spread by the end of the month. Finally, we project that B.1.1.7 will be the dominant lineage in many states by mid- to late March. Thus, genomic surveillance for B.1.1.7 and other variants urgently needs to be enhanced to better inform the public health response.	[Alpert, Tara; Brito, Anderson F.; Rothman, Jessica; Petrone, Mary E.; Breban, Mallery, I; Watkins, Anne E.; Vogels, Chantal B. F.; Kalinich, Chaney C.; Fauver, Joseph R.; Grubaugh, Nathan D.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA; [Lasek-Nesselquist, Erica; Russell, Alexis; Kelly, John P.; Shudt, Matthew; Plitnick, Jonathan; Schneider, Erasmus; St George, Kirsten] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA; [Lasek-Nesselquist, Erica; Shudt, Matthew; Plitnick, Jonathan; Schneider, Erasmus; St George, Kirsten] SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA; [Valesano, Andrew L.; Fitzsimmons, William J.; Lauring, Adam S.] Univ Michigan, Dept Internal Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [MacKay, Matthew J.; Khullar, Gaurav; Metti, Jessica; Dudley, Joel T.; Nash, Megan; Beaubier, Nike; Mason, Christopher E.] Tempus Labs, Chicago, IL 60654 USA; [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium; [Dellicour, Simon] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol Immunol & Transplantat, Lab Clin & Epidemiol Virol, Leuven, Belgium; [Wang, Jianhui; Liu, Chen; Hui, Pei] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Muyombwe, Anthony; Downing, Randy; Razeq, Jafar; Bart, Stephen M.] Connecticut State Dept Publ Hlth, Rocky Hill, CT 06067 USA; [Bart, Stephen M.; Grills, Ardath; Morrison, Stephanie M.; Cook, Peter W.; MacCannell, Duncan R.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Murphy, Steven; Neal, Caleb; Laszlo, Eva] Murphy Med Associates, Greenwich, CT 06830 USA; [Rennert, Hanna; Cushing, Melissa; Westblade, Lars; Velu, Priya; Craney, Arryn; Cong, Lin; Mason, Christopher E.] New York Presbyterian Hosp Weill Cornell Med, Dept Pathol & Lab Med, New York, NY 10021 USA; [Peaper, David R.; Landry, Marie L.] Yale Sch Med, Dept Lab Med, New Haven, CT 06510 USA; [Peaper, David R.; Landry, Marie L.] Yale Sch Med, Dept Med, New Haven, CT 06510 USA; [Grubaugh, Nathan D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06510 USA	Yale University; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Michigan System; University of Michigan; Universite Libre de Bruxelles; KU Leuven; Yale University; Centers for Disease Control & Prevention - USA; NewYork-Presbyterian Hospital; Yale University; Yale University; Yale University	Grubaugh, ND (corresponding author), Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06510 USA.; St George, K (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA.; St George, K (corresponding author), SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA.; MacCannell, DR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30329 USA.; Grubaugh, ND (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06510 USA.	kirsten.st.george@health.ny.gov; fms2@cdc.gov; nathan.grubaugh@yale.edu	Mason, Christopher/HCH-3977-2022	Alpert, Tara/0000-0003-3582-1047; Valesano, Andrew/0000-0002-3649-8352; Bart, Stephen/0000-0001-5501-6286; Watkins, Anne/0000-0002-0399-8238; Khullar, Gaurav/0000-0002-7641-669X; Vogels, Chantal/0000-0003-0027-6480; Neal, Caleb/0000-0001-5595-2867; wang, jianhui/0000-0002-6261-4863	CTSA grant [TL1 TR001864]; Emergent Ventures at the Mercatus Center at George Mason University; Centers for Disease Control and Prevention (CDC) [75D30120C09570, 75D30120C09870]; New York Community Trust	CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Emergent Ventures at the Mercatus Center at George Mason University; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); New York Community Trust	We thank K. Fauntleroy and P. Ruggiero for laboratory support, K. Gangavarapu and K. Anderson for making their phylogenetic analysis openly available, the frontline and essential workers for their continued service during the pandemic, and our friends and family, particularly V. Parsons, P. Jack, and S. Taylor, for their support. This work was funded by CTSA grant no. TL1 TR001864 (T.A. and M.E.P.), a fast grant from Emergent Ventures at the Mercatus Center at George Mason University (N.D.G.), and Centers for Disease Control and Prevention (CDC) contracts 75D30120C09570 (N.D.G.) and 75D30120C09870 (A.S.L.). Initial funding for sequencing at the Wadsworth Center was provided by the New York Community Trust. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC. Use of trade names is for identification only and does not imply endorsement by the CDC.	[Anonymous], 2003, ARCUSER ANN GIS; Becker R.A., 2018, MAPS DRAW GEOGRAPHIC; Borges V., 2021, EURO SURVEILL, V26; Brito A., 2021, DETECTION NON B 1 1; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; CDC, 2021, CAS COVID 19 RESOURC; CDC, 2021, GEN SURV SARS COV 2; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; De Maio D., 2020, MASKING STRATEGIES S; Dellicour S, 2021, MOL BIOL EVOL, V38, P1608, DOI 10.1093/molbev/msaa284; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644Article, 10.1126/science.abh2644, 10.1101/2021.02.26.21252554]; Fauver JR, 2020, CELL, V181, P990, DOI 10.1016/j.cell.2020.04.021; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Gonzalez-Reiche AS, 2020, SCIENCE, V369, P297, DOI 10.1126/science.abc1917; Grubaugh ND, 2021, CELL, V184, P1127, DOI 10.1016/j.cell.2021.01.044; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Huber C, 2020, LECT NOTES GEOINF CA, P263, DOI 10.1007/978-3-030-14745-7_15; HUFF DL, 1963, LAND ECON, V39, P81, DOI 10.2307/3144521; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Larsen B.B., 2020, IDENTIFICATION NOVEL; Lauring AS, 2021, JAMA-J AM MED ASSOC, V325, P529, DOI 10.1001/jama.2020.27124; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Maurano MT, 2020, GENOME RES, V30, DOI 10.1101/gr.266676.120; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Quick J., 2020, NCOV 2019 SEQUENCING; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rambaut A., 2020, COVID 19 GENOMICS CO; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007; Sagulenko P, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vex042; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; Trulia Inc, 2020, CHOROPLETHR SIMPLIFY; Vavrek D., 2021, GENOMIC SURV SCAL IS, DOI [10.1101/2021.01.12.21249613, DOI 10.1101/2021.01.12.21249613]; Vogels Chantal B F, 2021, medRxiv, DOI 10.1101/2021.01.28.21250486; Washington Nicole L, 2021, medRxiv, DOI 10.1101/2021.02.06.21251159; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wise J, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n359; Zimmer C., 2020, NEW YORK TIMES, pA7	45	46	47	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2595	+	e13	10.1016/j.cell.2021.03.061	http://dx.doi.org/10.1016/j.cell.2021.03.061		MAY 2021	23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33891875	Bronze, Green Published			2022-12-28	WOS:000652830800007
J	Oliver, D				Oliver, David			David Oliver: A vision for transparent post-covid government	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Calman B., 2020, MAIL ONLINE; Healthcare Safety Investigation Branch, 2020, COVID 19 TRANSM HOSP; Kenber B, 2020, TIMES; National Audit Office, 2020, INV GOV PROC COVID 1; Warren S, 2021, ASSESSING ENGLANDS R	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 5	2021	373								n1123	10.1136/bmj.n1123	http://dx.doi.org/10.1136/bmj.n1123			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SD2YX	33952440	hybrid			2022-12-28	WOS:000651241900006
J	Nasir, K; Cainzos-Achirica, M				Nasir, Khurram; Cainzos-Achirica, Miguel			Role of coronary artery calcium score in the primary prevention of cardiovascular disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ALL-CAUSE MORTALITY; C-REACTIVE PROTEIN; BEAM COMPUTED-TOMOGRAPHY; IMAGING SUBCLINICAL ATHEROSCLEROSIS; CHOLESTEROL MANAGEMENT GUIDELINES; CARDIAC RISK-FACTORS; HEART-DISEASE; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; WARRANTY PERIOD	First developed in 1990, the Agatston coronary artery calcium (CAC) score is an international guideline-endorsed decision aid for further risk assessment and personalized management in the primary prevention of atherosclerotic cardiovascular disease. This review discusses key international studies that have informed this 30 year journey, from an initial coronary plaque screening paradigm to its current role informing personalized shared decision making. Special attention is paid to the prognostic value of a CAC score of zero (the so called "power of zero"), which, in a context of low estimated risk thresholds for the consideration of preventive therapy with statins in current guidelines, may be used to de-risk individuals and thereby inform the safe delay or avoidance of certain preventive therapies. We also evaluate current recommendations for CAC scoring in clinical practice guidelines around the world, and past and prevailing barriers for its use in routine patient care. Finally, we discuss emerging approaches in this field, with a focus on the potential role of CAC informing not only the personalized allocation of statins and aspirin in the general population, but also of other risk-reduction therapies in special populations, such as individuals with diabetes and people with severe hypercholesterolemia.	[Nasir, Khurram; Cainzos-Achirica, Miguel] Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Div Cardiovasc Prevent & Wellness, Houston, TX 77030 USA; [Nasir, Khurram; Cainzos-Achirica, Miguel] Houston Methodist, Ctr Outcomes Res, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; The Methodist Hospital System; The Methodist Hospital - Houston	Nasir, K (corresponding author), Houston Methodist DeBakey Heart & Vasc Ctr, Dept Cardiol, Div Cardiovasc Prevent & Wellness, Houston, TX 77030 USA.; Nasir, K (corresponding author), Houston Methodist, Ctr Outcomes Res, Houston, TX 77030 USA.	knasir@houstonmethodist.org			Jerold B. Katz Academy of Translational Research	Jerold B. Katz Academy of Translational Research	We have read and understood the BMJ policy on declaration of interests and declare the following interests: Khurram Nasir is on the advisory board of Amgen, Novartis, Medicine Company, and his research is partly supported by the Jerold B. Katz Academy of Translational Research. Miguel Cainzos-Achirica is fully supported by the Jerold B Katz Academy of Translational Research and has no other disclosures to report.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ajufo E, 2021, JAMA CARDIOL, V6, P179, DOI 10.1001/jamacardio.2020.4939; Akosah KO, 2003, J AM COLL CARDIOL, V41, P1475, DOI 10.1016/S0735-1097(03)00187-6; Al Rifai M, 2020, AM J CARDIOL, V125, P835, DOI 10.1016/j.amjcard.2019.12.031; Al-Kindi SG, 2020, J AM COLL CARDIOL, V76, P1259, DOI 10.1016/j.jacc.2020.06.077; American College of Cardiology, COR ART CALC SCOR; Amin NP, 2014, J AM COLL CARDIOL, V63, P2789, DOI 10.1016/j.jacc.2014.04.010; Anand DV, 2006, EUR HEART J, V27, P713, DOI 10.1093/eurheartj/ehi808; Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000678, 10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.009, 10.1016/j.jacc.2019.03.010]; Arps K, 2019, AM J CARDIOL, V124, P1198, DOI 10.1016/j.amjcard.2019.07.016; Baron KB, 2016, CURR CARDIOVASC IMAG, V9, DOI 10.1007/s12410-016-9373-1; BARTEL AG, 1974, CIRCULATION, V49, P1247, DOI 10.1161/01.CIR.49.6.1247; Baum SJ, 2017, CLIN CARDIOL, V40, P243, DOI 10.1002/clc.22713; Becker A, 2008, AM HEART J, V155, P154, DOI 10.1016/j.ahj.2007.08.024; Berman AN, 2019, JAMA CARDIOL, V4, P965, DOI 10.1001/jamacardio.2019.2963; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Bittencourt MS, 2015, EUR J PREV CARDIOL, V22, P931, DOI 10.1177/2047487314568022; Bittencourt MS, 2020, ATHEROSCLEROSIS, V292, P207, DOI 10.1016/j.atherosclerosis.2019.11.019; Bittencourt MS, 2014, J AM COLL CARDIOL, V63, P434, DOI 10.1016/j.jacc.2013.08.1640; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI 10.1016/j.jcmg.2009.03.009; Blaha MJ, 2018, J AM COLL CARDIOL, V71, P2487, DOI 10.1016/j.jacc.2018.03.478; Blaha MJ, 2017, JACC-CARDIOVASC IMAG, V10, P924, DOI 10.1016/j.jcmg.2017.05.007; Blaha MJ, 2016, CIRCULATION, V133, P849, DOI 10.1161/CIRCULATIONAHA.115.018524; Blaha MJ, 2014, CIRC-CARDIOVASC IMAG, V7, P398, DOI 10.1161/CIRCIMAGING.113.000341; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Blankstein R, 2020, J AM COLL CARDIOL, V76, P665, DOI 10.1016/j.jacc.2020.06.055; Budoff M, 2019, JACC-CARDIOVASC IMAG, V12, P1341, DOI 10.1016/j.jcmg.2019.01.014; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2018, EUR HEART J, V39, P2401, DOI 10.1093/eurheartj/ehy217; Cainzos-Achirica M, 2021, JACC-CARDIOVASC IMAG, V14, P1005, DOI 10.1016/j.jcmg.2020.10.016; Cainzos-Achirica M, 2021, JACC-CARDIOVASC IMAG, V14, P1470, DOI 10.1016/j.jcmg.2020.12.024; Cainzos-Achirica M, 2021, JACC-CARDIOVASC IMAG, V14, P243, DOI 10.1016/j.jcmg.2020.09.015; Cainzos-Achirica M, 2021, JAMA CARDIOL, V6, P187, DOI 10.1001/jamacardio.2020.4961; Cardoso R, 2020, CIRC-CARDIOVASC IMAG, V13, DOI 10.1161/CIRCIMAGING.120.011365; Carr JJ, 2017, JAMA CARDIOL, V2, P391, DOI 10.1001/jamacardio.2016.5493; Chamberlain AM, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011246; Chen NX, 2006, NEPHROL DIAL TRANSPL, V21, P3435, DOI 10.1093/ndt/gfl429; Cho I, 2012, CIRCULATION, V126, P304, DOI 10.1161/CIRCULATIONAHA.111.081380; Choi EK, 2008, J AM COLL CARDIOL, V52, P357, DOI 10.1016/j.jacc.2008.02.086; ClinicalTrials.gov, 2020, EFF EV PAT HIGH CARD; ClinicalTrials.gov, 2020, MIAM HEART STUD BAPT; Criqui MH, 2020, JAMA CARDIOL, V5, P290, DOI 10.1001/jamacardio.2019.5745; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Dzaye O, 2021, JACC-CARDIOVASC IMAG, V14, P990, DOI 10.1016/j.jcmg.2020.06.048; Elamin AFM, 2019, POSTGRAD MED J, V95, P61, DOI 10.1136/postgradmedj-2018-136171; Erbel R, 2012, EUR HEART J, V33, P1201, DOI 10.1093/eurheartj/ehs076; Erbel R, 2010, J AM COLL CARDIOL, V56, P1397, DOI 10.1016/j.jacc.2010.06.030; European Heart Network, 2017, EUROPEAN CARDIOVASCU; Ferencik M, 2019, EUR HEART J-CARD IMG, V20, P1305, DOI 10.1093/ehjci/jez043; Gerstein HC, 2019, LANCET, V394, P121, DOI 10.1016/S0140-6736(19)31149-3; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2018, J AM COLL CARDIOL, V72, P434, DOI 10.1016/j.jacc.2018.05.027; Grundy SM, 2019, CIRCULATION, V139, pE1082, DOI 10.1161/CIR.0000000000000625; Hamilton-Craig CR, 2017, MED J AUSTRALIA, V207, P357, DOI 10.5694/mja16.01134; He ZX, 2000, CIRCULATION, V101, P244, DOI 10.1161/01.CIR.101.3.244; Hecht H, 2017, J CARDIOVASC COMPUT, V11, P157, DOI 10.1016/j.jcct.2017.02.010; Hecht HS, 2010, J AM COLL CARDIOL, V55, P1118, DOI 10.1016/j.jacc.2009.09.064; Hoffmann U, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003144; Hong JC, 2017, JACC-CARDIOVASC IMAG, V10, P938, DOI 10.1016/j.jcmg.2017.04.014; Hussain A, 2020, CIRCULATION, V142, P917, DOI 10.1161/CIRCULATIONAHA.119.045026; Jin HY, 2021, JACC-CARDIOVASC IMAG, V14, P233, DOI 10.1016/j.jcmg.2020.08.036; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Karmali KN, 2014, J AM COLL CARDIOL, V64, P959, DOI 10.1016/j.jacc.2014.06.1186; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kim J, 2017, ATHEROSCLEROSIS, V257, P1, DOI 10.1016/j.atherosclerosis.2016.12.012; Kinoshita M, 2018, J ATHEROSCLER THROMB, V25, P846, DOI 10.5551/jat.GL2017; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; LaMonte MJ, 2005, AM J EPIDEMIOL, V162, P421, DOI 10.1093/aje/kwi228; Lee JH, 2016, CIRC J, V80, P2356, DOI 10.1253/circj.CJ-16-0731; Li HY, 2010, BLOOD, V116, P210, DOI 10.1182/blood-2009-11-255026; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Mahabadi AA, 2017, JACC-CARDIOVASC IMAG, V10, P143, DOI 10.1016/j.jcmg.2016.03.022; Malik S, 2017, JAMA CARDIOL, V2, P1332, DOI 10.1001/jamacardio.2017.4191; Malik S, 2011, DIABETES CARE, V34, P2285, DOI 10.2337/dc11-0816; Marsico F, 2020, EUR HEART J, V41, P3346, DOI 10.1093/eurheartj/ehaa082; Martin SS, 2014, CIRCULATION, V129, P77, DOI 10.1161/CIRCULATIONAHA.113.003625; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; McEvoy JW, 2017, CIRCULATION, V135, P153, DOI 10.1161/CIRCULATIONAHA.116.025471; McEvoy JW, 2016, JACC-CARDIOVASC IMAG, V9, P994, DOI 10.1016/j.jcmg.2016.03.012; McEvoy JW, 2015, ARTERIOSCL THROM VAS, V35, P700, DOI 10.1161/ATVBAHA.114.304562; Mensah GA, 2019, J AM COLL CARDIOL, V74, P2529, DOI 10.1016/j.jacc.2019.10.009; Michos ED, 2006, ATHEROSCLEROSIS, V184, P201, DOI 10.1016/j.atherosclerosis.2005.04.004; Miedema MD, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7440; Miedema MD, 2014, CIRC-CARDIOVASC QUAL, V7, P453, DOI 10.1161/CIRCOUTCOMES.113.000690; Min JK, 2010, J AM COLL CARDIOL, V55, P1110, DOI 10.1016/j.jacc.2009.08.088; Miname MH, 2019, JACC-CARDIOVASC IMAG, V12, P1797, DOI 10.1016/j.jcmg.2018.09.019; Mitchell JD, 2018, J AM COLL CARDIOL, V72, P3233, DOI 10.1016/j.jacc.2018.09.051; Mortensen MB, 2020, JAMA CARDIOL, V5, P209, DOI 10.1001/jamacardio.2019.4759; Mortensen MB, 2019, J AM COLL CARDIOL, V74, P1, DOI 10.1016/j.jacc.2019.04.049; Mortensen MB, 2016, J AM COLL CARDIOL, V68, P881, DOI 10.1016/j.jacc.2016.05.084; Moss AJ, 2017, CURR CARDIOVASC IMAG, V10, DOI 10.1007/s12410-017-9412-6; Mszar R, 2020, CIRCULATION, V142, P1405, DOI 10.1161/CIRCULATIONAHA.120.049057; Mszar R, 2020, JACC-CARDIOVASC IMAG, V13, P1090, DOI 10.1016/j.jcmg.2019.11.001; Nasir K, 2005, J AM COLL CARDIOL, V46, P1931, DOI 10.1016/j.jacc.2005.07.052; Nasir K, 2018, J AM COLL CARDIOL, V72, P3243, DOI 10.1016/j.jacc.2018.10.006; Nasir K, 2015, J AM COLL CARDIOL, V66, P1657, DOI 10.1016/j.jacc.2015.07.066; Nasir K, 2015, CIRC-CARDIOVASC QUAL, V8, P466, DOI 10.1161/CIRCOUTCOMES.115.002207; Nasir K, 2012, RADIOLOGY, V264, P637, DOI 10.1148/radiol.12110810; Nasir K, 2012, CIRC-CARDIOVASC IMAG, V5, P467, DOI 10.1161/CIRCIMAGING.111.964528; Nasir K, 2012, JACC-CARDIOVASC IMAG, V5, P111, DOI 10.1016/j.jcmg.2011.11.007; Nasir K, 2007, J AM COLL CARDIOL, V50, P953, DOI 10.1016/j.jacc.2007.03.066; Osei AD, 2020, ATHEROSCLEROSIS, V301, P65, DOI 10.1016/j.atherosclerosis.2020.04.006; Packard CJ, 1998, CIRCULATION, V97, P1440; Paixao ARM, 2015, JACC-CARDIOVASC IMAG, V8, P1285, DOI 10.1016/j.jcmg.2015.06.015; Parhami F, 2001, CIRC RES, V88, P954, DOI 10.1161/hh0901.090975; Patel J, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003186; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Piepoli MF, 2020, EUR J PREV CARDIOL, V27, P181, DOI 10.1177/2047487319893035; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Qazi AH, 2016, PROG CARDIOVASC DIS, V58, P529, DOI 10.1016/j.pcad.2016.01.007; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rozanski A, 2011, J AM COLL CARDIOL, V57, P1622, DOI 10.1016/j.jacc.2011.01.019; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Sandesara PB, 2020, ATHEROSCLEROSIS, V292, P224, DOI 10.1016/j.atherosclerosis.2019.09.014; Sandoval Y, 2020, J AM COLL CARDIOL, V76, P357, DOI 10.1016/j.jacc.2020.05.057; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Schmermund A, 1999, J AM COLL CARDIOL, V34, P777, DOI 10.1016/S0735-1097(99)00265-X; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Shah RV, 2017, JAMA CARDIOL, V2, P644, DOI 10.1001/jamacardio.2017.0944; Shapiro MD, 2019, JACC-CARDIOVASC IMAG, V12, P1805, DOI 10.1016/j.jcmg.2018.10.010; Shareghi Shahrzad, 2007, J Cardiovasc Comput Tomogr, V1, P155, DOI 10.1016/j.jcct.2007.10.001; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Silverman MG, 2014, EUR HEART J, V35, P2232, DOI 10.1093/eurheartj/eht508; Spahillari A, 2020, JAMA CARDIOL, V5, P871, DOI 10.1001/jamacardio.2020.1240; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Taylor Allen J, 2007, J Cardiovasc Comput Tomogr, V1, P160, DOI 10.1016/j.jcct.2007.10.004; Tintut Y, 2004, ARTERIOSCL THROM VAS, V24, pE6, DOI 10.1161/01.ATV.0000112023.62695.7f; Tota-Maharaj R, 2012, EUR HEART J, V33, P2955, DOI 10.1093/eurheartj/ehs230; Valenti V, 2015, JACC-CARDIOVASC IMAG, V8, P900, DOI 10.1016/j.jcmg.2015.01.025; van der Aalst CM, 2020, EUR HEART J-CARD IMG, V21, P1216, DOI 10.1093/ehjci/jeaa168; van Rosendael AR, 2020, ATHEROSCLEROSIS, V311, P100, DOI 10.1016/j.atherosclerosis.2020.08.022; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Wang Cecilia C Low, 2007, Atherosclerosis, V195, pe65, DOI 10.1016/j.atherosclerosis.2007.02.032; Williams MC, 2020, CIRCULATION, V141, P1452, DOI 10.1161/CIRCULATIONAHA.119.044720; Won KB, 2020, CARDIOVASC DIABETOL, V19, DOI 10.1186/s12933-020-01008-5; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6; World Health Organization, 2017, CARDIOVASC DIS; Yeboah J, 2016, J AM COLL CARDIOL, V67, P139, DOI 10.1016/j.jacc.2015.10.058; Yeboah J, 2014, EUR J PREV CARDIOL, V21, P1233, DOI 10.1177/2047487313492065; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Zeitouni M, 2020, J AM COLL CARDIOL, V76, P653, DOI 10.1016/j.jacc.2020.06.030; Zheng SL, 2019, JAMA-J AM MED ASSOC, V321, P277, DOI 10.1001/jama.2018.20578	157	29	29	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n776	10.1136/bmj.n776	http://dx.doi.org/10.1136/bmj.n776			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947652				2022-12-28	WOS:000649710200002
J	Song, MY; Emilsson, L; Roelstraete, B; Ludvigsson, JF				Song, Mingyang; Emilsson, Louise; Roelstraete, Bjorn; Ludvigsson, Jonas F.			Risk of colorectal cancer in first degree relatives of patients with colorectal polyps: nationwide case-control study in Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAMILY-HISTORY; 1ST-DEGREE RELATIVES; ADENOMATOUS POLYPS; MORTALITY; RECOMMENDATIONS; POLYPECTOMY; US	OBJECTIVE To assess the risk of colorectal cancer (CRC) in first degree relatives (parents and full siblings) of patients with precursor lesions (polyps) for CRC. DESIGN Case-control study. SETTING Linkage to the multi-generation register and gastrointestinal ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden) histopathology cohort in Sweden. PARTICIPANTS 68 060 patients with CRC and 333 753 matched controls. MAIN OUTCOME MEAsURES Multivariable adjusted odds ratios of CRC according to the number of first degree relatives with a colorectal polyp and the histology of polyps and age at diagnosis in first degree relatives. Subgroup analysis was also performed according to age at CRC diagnosis and evaluated the joint association of family history of colorectal polyps and family history of CRC. RESULTS After adjusting for family history of CRC and other covariates, having a first degree relative with a colorectal polyp (8.4% (5742/68 060) in cases and 5.7% (18 860/333 753) in controls) was associated with a higher risk of CRC (odds ratio 1.40, 95% confidence interval 1.35 to 1.45). The odds ratios ranged from 1.23 for those with hyperplastic polyps to 1.44 for those with tubulovillous adenomas. To better put this risk in perspective, the age specific absolute risk of colon and rectal cancers was estimated according to family history of polyps based on the 2018 national CRC incidence in Sweden. For example, the absolute risk of colon cancer in individuals aged 60-64 years with and without a family history of colorectal polyp was, respectively, 94.3 and 67.9 per 100 000 for men and 89.1 and 64.1 per 100 000 for women. The association between family history of polyps and CRC risk was strengthened by the increasing number of first degree relatives with polyps (s2 first degree relatives: 1.70, 1.52 to 1.90, P < 0.001 for trend) and decreasing age at polyp diagnosis (< 50 years: 1.77, 1.57 to 1.99, P < 0.001 for trend). A particularly strong association was found for early onset CRC diagnosed before age 50 years (s2 first degree relatives: 3.34, 2.05 to 5.43, P=0.002 for heterogeneity by age of CRC diagnosis). In the joint analysis, the odds ratio of CRC for individuals with two or more first degree relatives with polyps but no CRC was 1.79 (1.52 to 2.10), with one first degree relative with CRC but no polyps was 1.70 (1.65 to 1.76), and with two or more first degree relatives with both polyps and CRC was 5.00 (3.77 to 6.63) (P < 0.001 for interaction). CONCLUSIONS After adjusting for family history of CRC, the siblings and children of patients with colorectal polyps are still at higher risk of CRC, particularly early onset CRC. Early screening for CRC might be considered for first degree relatives of patients with polyps.	[Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Song, Mingyang] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA; [Song, Mingyang] Harvard Med Sch, Boston, MA 02115 USA; [Song, Mingyang] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Emilsson, Louise] Univ Oslo, Inst Hlth & Soc, Dept Gen Med, Oslo, Norway; [Emilsson, Louise] Cty Council Varmland, Vardctr Nysater, Varmland, Sweden; [Emilsson, Louise] Cty Council Varmland, Clin Res Ctr, Varmland, Sweden; [Emilsson, Louise; Roelstraete, Bjorn; Ludvigsson, Jonas F.] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Emilsson, Louise] Orebro Univ, Fac Med & Hlth, Orebro, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, Orebro, Sweden; [Ludvigsson, Jonas F.] Columbia Univ, Dept Med, Med Ctr, Div Digest & Liver Dis, New York, NY 10027 USA; [Ludvigsson, Jonas F.] Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Oslo; Karolinska Institutet; Orebro University; Orebro University; Columbia University; University of Nottingham	Ludvigsson, JF (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden.; Ludvigsson, JF (corresponding author), Orebro Univ Hosp, Dept Pediat, Orebro, Sweden.; Ludvigsson, JF (corresponding author), Columbia Univ, Dept Med, Med Ctr, Div Digest & Liver Dis, New York, NY 10027 USA.; Ludvigsson, JF (corresponding author), Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Nottingham, England.	jonas.ludvigsson@ki.se	Emilsson, Louise/K-4589-2013; Ludvigsson, Jonas F/A-8560-2012	Emilsson, Louise/0000-0001-9137-2800; Ludvigsson, Jonas F/0000-0003-1024-5602	National Institutes of Health [R00 CA215314]; American Cancer Society [MRSG-17-220-01-NEC]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society)	This work was supported by the National Institutes of Health (R00 CA215314 to MS) and American Cancer Society (MRSG-17-220-01-NEC to MS). The funders had no role in considering the study design or in the collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.	Ahsan H, 1998, ANN INTERN MED, V128, P900, DOI 10.7326/0003-4819-128-11-199806010-00006; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bozorg SR, 2019, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-019-1134-6; Braillon A, 2019, GASTROENTEROLOGY, V156, P1532, DOI 10.1053/j.gastro.2018.12.034; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bretthauer M, 2018, ANN INTERN MED, V169, P405, DOI 10.7326/M18-1720; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Corley DA, 2018, GASTROENTEROLOGY, V155, P947, DOI 10.1053/j.gastro.2018.08.040; Cottet V, 2007, GASTROENTEROLOGY, V133, P1086, DOI 10.1053/j.gastro.2007.07.023; Ekbom A, 2011, METHODS MOL BIOL, V675, P215, DOI 10.1007/978-1-59745-423-0_10; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; GREENLAND S, 1981, J CHRON DIS, V34, P445, DOI 10.1016/0021-9681(81)90004-7; Holme O, 2018, ANN INTERN MED, V168, P775, DOI 10.7326/M17-1441; Imperiale TF, 2018, CLIN GASTROENTEROL H, V16, P1541, DOI 10.1016/j.cgh.2018.08.023; Ladabaum U, 2019, GASTROENTEROLOGY, V157, P137, DOI 10.1053/j.gastro.2019.03.023; Liang PS, 2018, GASTROENTEROLOGY, V155, P950, DOI 10.1053/j.gastro.2018.08.019; Lowery JT, 2016, CANCER-AM CANCER SOC, V122, P2633, DOI 10.1002/cncr.30080; Ludvigsson JF, 2019, CLIN EPIDEMIOL, V11, P101, DOI 10.2147/CLEP.S191914; Ludvigsson JF, 2015, CLIN EPIDEMIOL, V7, P491, DOI 10.2147/CLEP.S90589; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Lui RN, 2019, CANCER EPIDEM BIOMAR, V28, P1275, DOI [10.1158/1055-9965.EPI-18-1111, 10.1158/1055-9965.epi-18-1111]; Lynch KL, 2003, CLIN GASTROENTEROL H, V1, P96, DOI 10.1053/cgh.2003.50018; Meester RGS, 2020, GASTROENTEROLOGY, V159, P105, DOI 10.1053/j.gastro.2020.03.025; Nakama H, 2000, EUR J CANCER, V36, P2111, DOI 10.1016/S0959-8049(00)00293-8; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Niv Y, 2017, EUR J GASTROEN HEPAT, V29, P1327, DOI 10.1097/MEG.0000000000000994; Rex DK, 2017, GASTROINTEST ENDOSC, V86, P18, DOI 10.1016/j.gie.2017.04.003; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Robertson DJ, 2019, GASTROENTEROLOGY, V156, P904, DOI 10.1053/j.gastro.2018.12.012; Senore C, 2019, GUT, V68, P1232, DOI 10.1136/gutjnl-2018-317293; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Song MY, 2020, LANCET GASTROENTEROL, V5, P537, DOI 10.1016/S2468-1253(20)30009-1; The National Board of Health and Welfare, STAT CANC INC 2018 T; Tuohy TMF, 2014, CANCER-AM CANCER SOC, V120, P35, DOI 10.1002/cncr.28227; Vogelaar I, 2006, CANCER-AM CANCER SOC, V107, P1624, DOI 10.1002/cncr.22115; Wang ML, 2016, STAT MED, V35, P782, DOI 10.1002/sim.6793; Winawer SJ, 1996, NEW ENGL J MED, V334, P82, DOI 10.1056/NEJM199601113340204; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457; Wong MCS, 2016, AM J GASTROENTEROL, V111, P1621, DOI 10.1038/ajg.2016.52; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	40	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2021	373								n877	10.1136/bmj.n877	http://dx.doi.org/10.1136/bmj.n877			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SB0RI	33947661	Green Published, hybrid			2022-12-28	WOS:000649710200003
J	Gupta, S; Leaf, DE				Gupta, Shruti; Leaf, David E.			Tocilizumab in COVID-19: some clarity amid controversy	LANCET			English	Editorial Material									[Gupta, Shruti; Leaf, David E.] Brigham & Womens Hosp, Div Renal Med, 75 Francis St, Boston, MA 02115 USA; [Gupta, Shruti; Leaf, David E.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Gupta, S (corresponding author), Brigham & Womens Hosp, Div Renal Med, 75 Francis St, Boston, MA 02115 USA.; Gupta, S (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	sgupta21@bwh.harvard.edu	Leaf, David/AAO-8977-2021	Leaf, David/0000-0001-7875-090X				Aitken AE, 2007, DRUG METAB DISPOS, V35, P1687, DOI 10.1124/dmd.107.015511; Del Valle D.M., 2020, NAT MED, V26, P1636, DOI DOI 10.1038/s41591-020-1051-9; Goligher EC, 2021, NEW ENGL J MED, V385, P777, DOI [10.1056/NEJMoa2103417, 10.1056/NEJMoa2100433]; Gupta S, 2021, JAMA INTERN MED, V181, P41, DOI 10.1001/jamainternmed.2020.6252; Hermine O, 2021, JAMA INTERN MED, V181, P1020, DOI 10.1001/jamainternmed.2021.0407; Horby PW, 2021, LANCET, V397, P2049, DOI 10.1016/S0140-6736(21)00897-7; Leaf DE, 2021, NEW ENGL J MED, V384, P86, DOI 10.1056/NEJMc2032911; Rosas IO, 2021, NEW ENGL J MED, V384, P1503, DOI 10.1056/NEJMoa2028700; Salvarani C, 2021, JAMA INTERN MED, V181, P1019, DOI 10.1001/jamainternmed.2021.0404; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; Wang CD, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00527-1; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117	12	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1599	1601						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33933194	Bronze, Green Published			2022-12-28	WOS:000645510600004
J	Kahan, T				Kahan, Thomas			Decisions about antihypertensive treatment should focus on reducing cardiovascular risk	LANCET			English	Editorial Material							BLOOD-PRESSURE; TASK-FORCE; MANAGEMENT; ADULTS		[Kahan, Thomas] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Kahan, Thomas] Danderyd Univ Hosp Corp, Dept Cardiol, SE-18288 Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Danderyds Hospital	Kahan, T (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden.; Kahan, T (corresponding author), Danderyd Univ Hosp Corp, Dept Cardiol, SE-18288 Stockholm, Sweden.	thomas.kahan@sll.se	Kahan, Thomas/CAE-8515-2022					Blood Pressure Lowering Treatment Trialists' Collaboration, 2021, LANCET, V397, P1625; Brandberg H, 2021, J MED INTERNET RES, V23, DOI 10.2196/25493; Brunstrom M, 2018, JAMA INTERN MED, V178, P28, DOI 10.1001/jamainternmed.2017.6015; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Herrett E, 2019, LANCET, V394, P663, DOI 10.1016/S0140-6736(19)31359-5; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; National Institute for Health and Care Excellence, 2019, HYP AD DIAGN MAN NIC; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Thomopoulos C, 2014, J HYPERTENS, V32, P2285, DOI 10.1097/HJH.0000000000000378; Whelton PK, 2018, J AM COLL CARDIOL, V71, P2275, DOI 10.1016/j.jacc.2018.03.016; Williams B, 2018, BLOOD PRESSURE, V27, P314, DOI [10.1080/08037051.2018.1527177, 10.1097/HJH.0000000000001961]	11	1	1	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 1	2021	397	10285					1598	1599						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RV0EH	33933193				2022-12-28	WOS:000645510600003
J	Buritica, LM; Karduss Urueta, AJ				Mejia Buritica, Leonardo; Karduss Urueta, Amado J.			Pulmonary Mucormycosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Mucormycosis (formerly zygomycosis) is a life-threatening opportunistic mycosis that infects a broad range of hosts with qualitative or quantitative defects in innate immunity, including patients with severe neutropenia, recipients of corticosteroids or other immunosuppressive medications, poorly controlled diabetes mellitus, and those with iron overload states. Mucormycosis has recently emerged as breakthrough sinopulmonary infection in hematologic patients and recipients of transplantation being on antifungal prophylaxis with Aspergillus-active antifungals that lack activity against Mucorales. Unlike pulmonary aspergillosis, the prognosis and outcome of pulmonary mucormycosis have not improved significantly over the last decade, mainly because of difficulties in early diagnosis and the limited activity of current antifungal agents against Mucorales. Recent evidence suggests a critical role for iron metabolism and fungal-endothelial cell interactions in pathogenesis of mucormycosis, and holds promise for development of novel therapeutic strategies. Currently, prompt initiation of antifungal therapy with a lipid amphotericin B-based regimen, reversal of underlying host factors, and aggressive surgical approach offers the best chances for survival of patients infected with this devastating mycosis.	[Mejia Buritica, Leonardo] Univ Antioquia, Medellin, Colombia; [Karduss Urueta, Amado J.] Clin Amer, Medellin, Colombia	Universidad de Antioquia	Buritica, LM (corresponding author), Univ Antioquia, Medellin, Colombia.	leonardo.mejiab@udea.edu.co							0	1	1	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18								10.1056/NEJMicm2030205	http://dx.doi.org/10.1056/NEJMicm2030205		MAY 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33951358				2022-12-28	WOS:000646649100001
J	Morris, DB; Gruppuso, PA; McGee, HA; Murillo, AL; Grover, A; Adashi, EY				Morris, Devin B.; Gruppuso, Philip A.; McGee, Heather A.; Murillo, Anarina L.; Grover, Atul; Adashi, Eli Y.			Diversity of the National Medical Student Body - Four Decades of Inequities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								A racially and ethnically diverse health care workforce remains a distant goal, the attainment of which is contingent on the inclusivity of the national medical student body. We examined the diversity of medical school applicants and enrollees over the past four decades with an eye toward assessing the progress made. Data on the gender and race or ethnic group of enrollees in all medical doctorate degree-granting U.S. medical schools from 1978 through 2019 were examined. The percentage of female enrollees doubled during this period, and women now constitute more than half the national medical student body. This upturn has been attributed largely to an increase by a factor of 12 in the enrollment of Asian women. The corresponding decrease in the percentage of male enrollees, most notably White men, was offset by an increase by a factor of approximately 5 in the enrollment of Asian men. The percentages of enrollees from Black, Hispanic, and other racial and ethnic groups that are underrepresented in medicine remain well below the percentages of these groups in the national Census. Diversity of the National Medical Student Body The percentage of women enrolled in U.S. medical schools doubled during the past four decades; now, more than half the students are women. The percentage of Asian enrollees increased substantially. The percentages of enrollees from Black, Hispanic, and other underrepresented racial and ethnic groups remain well below the respective percentages of these groups in U.S. Census data.	[Morris, Devin B.; Gruppuso, Philip A.; McGee, Heather A.; Murillo, Anarina L.; Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, 222 Richmond St, Providence, RI 02903 USA; [Grover, Atul] Assoc Amer Med Coll, Washington, DC USA	Brown University; Association of American Medical Colleges	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 222 Richmond St, Providence, RI 02903 USA.	eli_adashi@brown.edu		Adashi, Eli/0000-0001-7730-1192				Adashi EY, 2010, ACAD MED, V85, P763, DOI 10.1097/ACM.0b013e3181d5cff7; Addams A., 2010, ROADMAP DIVERSITY IN; American Medical Association, 2016, INCREASING MINORITIE; [Anonymous], 1995, STAT ABSTRACT US 199, V115; [Anonymous], 2014, ROADM DIV ED EXC KEY, V2; [Anonymous], 2019, DIVERSITY MED FACTS; [Anonymous], 2001, CENSUS 2000 SUMMARY; [Anonymous], 2015, ALT COURS BLACK MAL; [Anonymous], 2020, P4 PHYS PIPELINE PRE; [Anonymous], 2019, FACTS GLOSSARY; Asch DA, 2020, NEW ENGL J MED, V383, P6, DOI 10.1056/NEJMp1916528; Bristow LR., 2004, NATIONS COMPELLING I; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; Glazer G., 2014, HOL ADM HLTH PROF FI; Institute of Medicine, 2001, RIGHT THING SMART TH; Jaschik S., 2019, INSIDE HIGHER ED; Komaromy M, 1996, NEW ENGL J MED, V334, P1305, DOI 10.1056/NEJM199605163342006; Lucey CR, 2020, ACAD MED, V95, P351, DOI 10.1097/ACM.0000000000002939; Marrast LM, 2014, JAMA INTERN MED, V174, P289, DOI 10.1001/jamainternmed.2013.12756; MOY E, 1995, JAMA-J AM MED ASSOC, V273, P1515, DOI 10.1001/jama.273.19.1515; National Academies of Sciences E Medicine, 2018, P JOINT WORKSHOP; Population Division, 2020, NATL POPULATION CHAR; Rodriguez JE, 2017, J HEALTH CARE POOR U, V28, P266, DOI 10.1353/hpu.2017.0022; Silver JK, 2019, HEALTH EQUITY, V3, P360, DOI 10.1089/heq.2019.0040; Talamantes E, 2019, NEW ENGL J MED, V380, P803, DOI 10.1056/NEJMp1808582; Terregino CA, 2020, ACAD MED, V95, P344, DOI 10.1097/ACM.0000000000002941; Thomas B, 2019, JAMA-J AM MED ASSOC, V321, P143, DOI 10.1001/jama.2018.19457; U.S. Bureau of the Census, 1980, CENSUS POPULATION VO, V1; Witzburg RA, 2013, NEW ENGL J MED, V368, P1565, DOI 10.1056/NEJMp1300411	29	48	48	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 29	2021	384	17					1661	1668		10.1056/NEJMsr2028487	http://dx.doi.org/10.1056/NEJMsr2028487			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RV1ND	33913645	Bronze			2022-12-28	WOS:000645605800019
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Government will consider call to allow GPs to vaccinate in their own surgeries	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], COVID 19 UPDATE HOUS; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n548; NHS England, DEAR COLL COV 19 VAC DEAR COLL COV 19 VAC	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2021	373								n1084	10.1136/bmj.n1084	http://dx.doi.org/10.1136/bmj.n1084			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TQ8OY	33903098	Bronze			2022-12-28	WOS:000678538700006
J	Clark, IC; Gutierrez-Vazquez, C; Wheeler, MA; Li, ZR; Rothhammer, V; Linnerbauer, M; Sanmarco, LM; Guo, L; Blain, M; Zandee, SEJ; Chao, CC; Batterman, KV; Schwabenland, M; Lotfy, P; Tejeda-Velarde, A; Hewson, P; Polonio, CM; Shultis, MW; Salem, Y; Tjon, EC; Fonseca-Castro, PH; Borucki, DM; de Lima, KA; Plasencia, A; Abate, AR; Rosene, DL; Hodgetts, KJ; Prinz, M; Antel, JP; Prat, A; Quintana, FJ				Clark, Iain C.; Gutierrez-Vazquez, Cristina; Wheeler, Michael A.; Li, Zhaorong; Rothhammer, Veit; Linnerbauer, Mathias; Sanmarco, Liliana M.; Guo, Lydia; Blain, Manon; Zandee, Stephanie E. J.; Chao, Chun-Cheih; Batterman, Katelyn, V; Schwabenland, Marius; Lotfy, Peter; Tejeda-Velarde, Amalia; Hewson, Patrick; Polonio, Carolina Manganeli; Shultis, Michael W.; Salem, Yasmin; Tjon, Emily C.; Fonseca-Castro, Pedro H.; Borucki, Davis M.; de Lima, Kalil Alves; Plasencia, Agustin; Abate, Adam R.; Rosene, Douglas L.; Hodgetts, Kevin J.; Prinz, Marco; Antel, Jack P.; Prat, Alexandre; Quintana, Francisco J.			Barcoded viral tracing of single-cell interactions in central nervous system inflammation	SCIENCE			English	Article							DENDRITIC SPINE MORPHOLOGY; SET ENRICHMENT ANALYSIS; GENOME-WIDE EXPRESSION; GENE-EXPRESSION; ASTROCYTE ACTIVATION; MULTIPLE-SCLEROSIS; IN-VIVO; T-CELLS; SEMAPHORIN; RECEPTORS	Cell-cell interactions control the physiology and pathology of the central nervous system (CNS). To study astrocyte cell interactions in vivo, we developed rabies barcode interaction detection followed by sequencing (RABID-seq), which combines barcoded viral tracing and single-cell RNA sequencing (scRNA-seq). Using RABID-seq, we identified axon guidance molecules as candidate mediators of microgliaastrocyte interactions that promote CNS pathology in experimental autoimmune encephalomyelitis (EAE) and, potentially, multiple sclerosis (MS). In vivo cell- specific genetic perturbation EAE studies, in vitro systems, and the analysis of MS scRNA-seq datasets and CNS tissue established that Sema4D and Ephrin-B3 expressed in microglia control astrocyte responses via PlexinB2 and EphB3, respectively. Furthermore, a CNS-penetrant EphB3 inhibitor suppressed astrocyte and microglia proinflammatory responses and ameliorated EAE. In summary, RABID-seq identified microgliaastrocyte interactions and candidate therapeutic targets.	[Clark, Iain C.; Gutierrez-Vazquez, Cristina; Wheeler, Michael A.; Li, Zhaorong; Rothhammer, Veit; Linnerbauer, Mathias; Sanmarco, Liliana M.; Guo, Lydia; Chao, Chun-Cheih; Lotfy, Peter; Tejeda-Velarde, Amalia; Hewson, Patrick; Polonio, Carolina Manganeli; Shultis, Michael W.; Salem, Yasmin; Tjon, Emily C.; Fonseca-Castro, Pedro H.; Borucki, Davis M.; de Lima, Kalil Alves; Plasencia, Agustin; Hodgetts, Kevin J.; Quintana, Francisco J.] Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA; [Clark, Iain C.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Dept Bioengn, Berkeley, CA 94720 USA; [Wheeler, Michael A.; Li, Zhaorong; Lotfy, Peter; Quintana, Francisco J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Rothhammer, Veit; Linnerbauer, Mathias] Friedrich Alexander Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neurol, D-91054 Erlangen, Germany; [Blain, Manon; Antel, Jack P.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Neuroimmunol Unit, Montreal, PQ H3A 2B4, Canada; [Zandee, Stephanie E. J.; Prat, Alexandre] Univ Montreal CRCHUM, Neuroimmunol Res Lab, Ctr Rech, Ctr Hosp, Montreal, PQ H2X 0A9, Canada; [Batterman, Katelyn, V; Rosene, Douglas L.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Schwabenland, Marius; Prinz, Marco] Univ Freiburg, Inst Neuropathol, D-79106 Freiburg, Germany; [Abate, Adam R.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Abate, Adam R.] Chan Zuckerberg Biohub, San Francisco, CA USA; [Prinz, Marco] Univ Freiburg, Signaling Res Ctr BIOSS, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Signaling Res Ctr CIBSS, D-79106 Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBas, D-79106 Freiburg, Germany; [Tejeda-Velarde, Amalia] Hosp Univ Ramon y Cajal, Immunol Dept, Madrid, Spain; [Tejeda-Velarde, Amalia] Inst Ramon y Cajal Invest Sanitaria IRYCIS, Madrid, Spain	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Berkeley; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Erlangen Nuremberg; McGill University; Universite de Montreal; Boston University; University of Freiburg; University of California System; University of California San Francisco; University of Freiburg; University of Freiburg; University of Freiburg; Hospital Universitario Ramon y Cajal	Quintana, FJ (corresponding author), Harvard Med Sch, Ann Romney Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA.; Quintana, FJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	fquintana@bwh.harvard.edu	Schwabenland, Marius/AAF-4348-2021; Zandee, Stephanie/GQQ-3078-2022	Schwabenland, Marius/0000-0003-2205-5427; Guo, Lydia/0000-0002-6702-1223; Lotfy, Peter/0000-0003-0809-7073; Zandee, Stephanie/0000-0003-0812-676X; Linnerbauer, Mathias/0000-0002-5528-5141; Plasencia, Agustin/0000-0002-7415-0947; Li, Zhaorong/0000-0002-5268-6986; Tejeda Velarde, Amalia/0000-0002-7061-8725; Alves de Lima, Kalil/0000-0002-9149-168X; Trecartin, Katelyn/0000-0001-7912-7028	NIH [NS102807, ES02530, ES029136, AI126880, 1K99NS114111, F30AG063463, F32NS101790, 5T32AG000222, R21AG061678]; National Multiple Sclerosis Society [RG4111A1, JF2161-A-5]; American Cancer Society [RSG-14198-01-LIB]; International Progressive MS Alliance [PA-160408459]; DFG [CRC/TRR167]; Alfonso Martin Escudero Foundation; European Molecular Biology Organization [ALTF 610-2017]; Dana-Farber Cancer Institute [T32CA207201]; Program in Interdisciplinary Neuroscience at Brigham and Women's Hospital; Women's Brain Initiative at Brigham and Women's Hospital; Mallinkrodt Pharmaceuticals [A219074]; German Research Foundation [DFG RO4866 1/1]; joint FRQS-EndMS postdoctoral fellowship; Ministry of Science and Technology, Taiwan [104-2917-I-564024]; FAPESP BEPE [2019/13731-0]; senior Canada Research Chair in Multiple Sclerosis; NCI Cancer Center support grant [2P30CA006516-48]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Cancer Society(American Cancer Society); International Progressive MS Alliance; DFG(German Research Foundation (DFG)); Alfonso Martin Escudero Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Dana-Farber Cancer Institute; Program in Interdisciplinary Neuroscience at Brigham and Women's Hospital; Women's Brain Initiative at Brigham and Women's Hospital; Mallinkrodt Pharmaceuticals; German Research Foundation(German Research Foundation (DFG)); joint FRQS-EndMS postdoctoral fellowship; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); FAPESP BEPE(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); senior Canada Research Chair in Multiple Sclerosis; NCI Cancer Center support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants NS102807, ES02530, ES029136, and AI126880 from the NIH; RG4111A1 and JF2161-A-5 from the National Multiple Sclerosis Society; RSG-14198-01-LIB from the American Cancer Society; and PA-160408459 from the International Progressive MS Alliance (to F.J.Q.). F.J.Q. and M.P. were supported by the DFG-funded CRC/TRR167 "NeuroMac." C.G.-V. was supported by an Alfonso Martin Escudero Foundation postdoctoral fellowship and by a postdoctoral fellowship (ALTF 610-2017) from the European Molecular Biology Organization. M.A.W. was supported by NIH (1K99NS114111 and F32NS101790), a training grant from the NIH and Dana-Farber Cancer Institute (T32CA207201), and a traveling neuroscience fellowship from the Program in Interdisciplinary Neuroscience at Brigham and Women's Hospital. I.C.C. and M.A.W. received support from the Women's Brain Initiative at Brigham and Women's Hospital. V.R. received support from an educational grant from Mallinkrodt Pharmaceuticals (A219074) and a fellowship from the German Research Foundation (DFG RO4866 1/1). S.E.J.Z. was supported by a joint FRQS-EndMS postdoctoral fellowship. C.-C.C. received support from a postdoctoral research abroad program (104-2917-I-564024) from the Ministry of Science and Technology, Taiwan. K.V.B. was supported by F30AG063463 from the NIH. P. L. was supported by 5T32AG000222 from the NIH. C.M.P. was supported by a fellowship from FAPESP BEPE (2019/13731-0). D.L.R. was supported by R21AG061678 from the NIH. A.Pr. holds a senior Canada Research Chair in Multiple Sclerosis. Sanger sequencing was carried out at the DNA Resource Core of Dana-Farber/Harvard Cancer Center (funded in part by NCI Cancer Center support grant 2P30CA006516-48).	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Carmona MA, 2009, P NATL ACAD SCI USA, V106, P12524, DOI 10.1073/pnas.0903328106; Chao CC, 2019, CELL, V179, P1483, DOI 10.1016/j.cell.2019.11.016; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Cowan CA, 2001, NATURE, V413, P174, DOI 10.1038/35093123; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dhaeze T, 2019, CELL MOL IMMUNOL, V16, P652, DOI 10.1038/s41423-018-0198-5; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Fazzari P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-55; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; FONTANA A, 1984, NATURE, V307, P273, DOI 10.1038/307273a0; Foo Lynette C, 2013, Cold Spring Harb Protoc, V2013, P421, DOI 10.1101/pdb.prot074211; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Ghanem A, 2016, VIRUS RES, V216, P41, DOI 10.1016/j.virusres.2015.05.023; Giladi A, 2020, NAT BIOTECHNOL, V38, P629, DOI 10.1038/s41587-020-0442-2; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Greenhalgh AD, 2020, NAT REV NEUROSCI, V21, P139, DOI 10.1038/s41583-020-0263-9; Hagendorf Nadin, 2015, Cold Spring Harb Protoc, V2015, DOI 10.1101/pdb.prot089417; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HEWETT SJ, 1994, NEURON, V13, P487, DOI 10.1016/0896-6273(94)90362-X; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Huang KW, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00065; Imondi R, 2000, DEVELOPMENT, V127, P1397; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; Jakel S, 2019, NATURE, V566, P543, DOI 10.1038/s41586-019-0903-2; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Kuhlmann T, 2017, ACTA NEUROPATHOL, V133, P13, DOI 10.1007/s00401-016-1653-y; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Kung A, 2016, J AM CHEM SOC, V138, P10554, DOI 10.1021/jacs.6b05483; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2014.191; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Linnerbauer M, 2020, NEURON, V108, P608, DOI 10.1016/j.neuron.2020.08.012; Locatelli G, 2018, NAT NEUROSCI, V21, P1196, DOI 10.1038/s41593-018-0212-3; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Mayo L, 2015, J IMMUNOL, V194; Mayo L, 2016, BRAIN, V139, P1939, DOI 10.1093/brain/aww113; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; Mendiola AS, 2020, NAT IMMUNOL, V21, P513, DOI 10.1038/s41590-020-0654-0; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Moffitt JR, 2018, SCIENCE, V362, P792, DOI 10.1126/science.aau5324; Motori E, 2013, CELL METAB, V18, P844, DOI 10.1016/j.cmet.2013.11.005; Mount CW, 2019, ELIFE, V8, DOI 10.7554/eLife.49291; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Nishide M, 2018, NAT REV RHEUMATOL, V14, P19, DOI 10.1038/nrrheum.2017.201; Nkiliza A, 2016, NEUROBIOL DIS, V96, P312, DOI 10.1016/j.nbd.2016.09.014; Okuno T, 2010, J IMMUNOL, V184, P1499, DOI 10.4049/jimmunol.0903302; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Paldy E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00341-w; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pasqual G, 2018, NATURE, V553, P496, DOI 10.1038/nature25442; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Perez EJ, 2017, J CLIN INVEST, V127, P3114, DOI 10.1172/JCI92300; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Qiao LX, 2009, BIOORG MED CHEM LETT, V19, P6122, DOI 10.1016/j.bmcl.2009.09.010; Reardon TR, 2016, NEURON, V89, P711, DOI 10.1016/j.neuron.2016.01.004; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rothhammer V, 2017, P NATL ACAD SCI USA, V114, P2012, DOI 10.1073/pnas.1615413114; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanmarco LM, 2021, NATURE, V590, P473, DOI 10.1038/s41586-020-03116-4; Sarafian TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009532; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schirmer L, 2019, NATURE, V573, P75, DOI 10.1038/s41586-019-1404-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Simmons SB, 2013, TRENDS IMMUNOL, V34, P410, DOI 10.1016/j.it.2013.04.006; Sobel RA, 2005, BRAIN PATHOL, V15, P35; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stanley G, 2020, NEURON, V105, P688, DOI 10.1016/j.neuron.2019.11.004; Stevens B., 2020, 202012034085 BIORXIV; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/nmeth.4380, 10.1038/NMETH.4380]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUN D, 1986, NATURE, V320, P70, DOI 10.1038/320070a0; Syed YA, 2016, ACTA NEUROPATHOL, V131, P281, DOI 10.1007/s00401-015-1521-1; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Turczyk Brian M, 2020, J Biomol Tech, V31, P44, DOI 10.7171/jbt.20-3102-003; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Vainchtein ID, 2020, TRENDS NEUROSCI, V43, P144, DOI 10.1016/j.tins.2020.01.003; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Waller F., 2005, P NATL ACAD SCI USA; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132638; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wang X, 2018, SCIENCE, V361, DOI 10.1126/science.aat5691; Weiss JM, 1998, J NEUROIMMUNOL, V91, P190, DOI 10.1016/S0165-5728(98)00183-0; Werneburg S, 2020, IMMUNITY, V52, P167, DOI 10.1016/j.immuni.2019.12.004; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Wheeler MA, 2019, CELL, V176, P581, DOI 10.1016/j.cell.2018.12.012; Wheeler MA, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a029009; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Worzfeld T, 2014, NAT REV DRUG DISCOV, V13, P603, DOI 10.1038/nrd4337; Xie LK, 2015, EUR J IMMUNOL, V45, P180, DOI 10.1002/eji.201444823; Ye L, 2013, J NEUROCHEM, V125, P897, DOI 10.1111/jnc.12263; Zador AM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001411; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154; Zorita E, 2015, BIOINFORMATICS, V31, P1913, DOI 10.1093/bioinformatics/btv053	154	62	62	17	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					360	+	eabf1230	10.1126/science.abf1230	http://dx.doi.org/10.1126/science.abf1230			113	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888612	Green Published, Green Accepted			2022-12-28	WOS:000645009800032
J	Bardia, A; Hurvitz, SA; Tolaney, SM; Loirat, D; Punie, K; Oliveira, M; Brufsky, A; Sardesai, SD; Kalinsky, K; Zelnak, AB; Weaver, R; Traina, T; Dalenc, F; Aftimos, P; Lynce, F; Diab, S; Cortes, J; O'Shaughnessy, J; Dieras, V; Ferrario, C; Schmid, P; Carey, LA; Gianni, L; Piccart, MJ; Loibl, S; Goldenberg, DM; Hong, Q; Olivo, MS; Itri, LM; Rugo, HS				Bardia, A.; Hurvitz, S. A.; Tolaney, S. M.; Loirat, D.; Punie, K.; Oliveira, M.; Brufsky, A.; Sardesai, S. D.; Kalinsky, K.; Zelnak, A. B.; Weaver, R.; Traina, T.; Dalenc, F.; Aftimos, P.; Lynce, F.; Diab, S.; Cortes, J.; O'Shaughnessy, J.; Dieras, V; Ferrario, C.; Schmid, P.; Carey, L. A.; Gianni, L.; Piccart, M. J.; Loibl, S.; Goldenberg, D. M.; Hong, Q.; Olivo, M. S.; Itri, L. M.; Rugo, H. S.		ASCENT Clinical Trial	Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background Patients with metastatic triple-negative breast cancer have a poor prognosis. Sacituzumab govitecan is an antibody-drug conjugate composed of an antibody targeting the human trophoblast cell-surface antigen 2 (Trop-2), which is expressed in the majority of breast cancers, coupled to SN-38 (topoisomerase I inhibitor) through a proprietary hydrolyzable linker. Methods In this randomized, phase 3 trial, we evaluated sacituzumab govitecan as compared with single-agent chemotherapy of the physician's choice (eribulin, vinorelbine, capecitabine, or gemcitabine) in patients with relapsed or refractory metastatic triple-negative breast cancer. The primary end point was progression-free survival (as determined by blinded independent central review) among patients without brain metastases. Results A total of 468 patients without brain metastases were randomly assigned to receive sacituzumab govitecan (235 patients) or chemotherapy (233 patients). The median age was 54 years; all the patients had previous use of taxanes. The median progression-free survival was 5.6 months (95% confidence interval [CI], 4.3 to 6.3; 166 events) with sacituzumab govitecan and 1.7 months (95% CI, 1.5 to 2.6; 150 events) with chemotherapy (hazard ratio for disease progression or death, 0.41; 95% CI, 0.32 to 0.52; P<0.001). The median overall survival was 12.1 months (95% CI, 10.7 to 14.0) with sacituzumab govitecan and 6.7 months (95% CI, 5.8 to 7.7) with chemotherapy (hazard ratio for death, 0.48; 95% CI, 0.38 to 0.59; P<0.001). The percentage of patients with an objective response was 35% with sacituzumab govitecan and 5% with chemotherapy. The incidences of key treatment-related adverse events of grade 3 or higher were neutropenia (51% with sacituzumab govitecan and 33% with chemotherapy), leukopenia (10% and 5%), diarrhea (10% and <1%), anemia (8% and 5%), and febrile neutropenia (6% and 2%). There were three deaths owing to adverse events in each group; no deaths were considered to be related to sacituzumab govitecan treatment. Conclusions Progression-free and overall survival were significantly longer with sacituzumab govitecan than with single-agent chemotherapy among patients with metastatic triple-negative breast cancer. Myelosuppression and diarrhea were more frequent with sacituzumab govitecan. (Funded by Immunomedics; ASCENT ClinicalTrials.gov number, ; EudraCT number, .) Sacituzumab Govitecan in Triple-Negative Breast Cancer Patients with metastatic triple-negative breast cancer were treated with standard chemotherapy or the anti-Trop-2 antibody-drug conjugate sacituzumab govitecan. Patients receiving the drug conjugate had significantly longer progression-free and overall survival as well as more frequent myelotoxic effects and diarrhea.	[Bardia, A.] Massachusetts Gen Hosp, Canc Ctr, Div Med Oncol, Boston, MA 02114 USA; [Tolaney, S. M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hurvitz, S. A.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Loirat, D.] Inst Curie, Med Oncol Dept, Paris, France; [Loirat, D.] Inst Curie, Dept Drug Dev & Innovat, Paris, France; [Dalenc, F.] Inst Univ Canc Toulouse Oncopole, Inst Claudius Regaud, Toulouse, France; [Dieras, V] Ctr Eugene Marquis, Dept Med Oncol, Rennes, France; [Punie, K.] Univ Hosp Leuven, Leuven Canc Inst, Dept Gen Med Oncol, Leuven, Belgium; [Punie, K.] Univ Hosp Leuven, Leuven Canc Inst, Multidisciplinary Breast Ctr, Leuven, Belgium; [Aftimos, P.; Piccart, M. J.] Univ Libre Bruxelles, Inst Jules Bordet, Clin Trials Conduct Unit, Brussels, Belgium; [Oliveira, M.] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain; [Oliveira, M.] Vall dHebron Univ Hosp, Breast Canc Grp, Barcelona, Spain; [Cortes, J.] Quiron Grp, Int Breast Canc Ctr, Barcelona, Spain; [Brufsky, A.] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Pittsburgh, PA USA; [Brufsky, A.] Univ Pittsburgh, Med Ctr, Hillman Canc Ctr, Pittsburgh, PA USA; [Sardesai, S. D.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Kalinsky, K.] Columbia Univ, Irving Med Ctr, New York, NY USA; [Traina, T.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Zelnak, A. B.] Northside Hosp, Atlanta, GA USA; [Weaver, R.] Florida Canc Specialists, Tampa, FL USA; [Lynce, F.] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA; [Diab, S.] Rocky Mt Canc Ctr, Greenwood Village, CO USA; [O'Shaughnessy, J.] Baylor Univ, Med Ctr, Dallas, TX USA; [O'Shaughnessy, J.] Texas Oncol, Dallas, TX USA; [Ferrario, C.] Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ, Canada; [Schmid, P.] Queen Mary Univ London, Barts Canc Inst, London, England; [Carey, L. A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Gianni, L.] Gianni Bonadonna Fdn, Milan, Italy; [Loibl, S.] Hamatol Onkol Gemeinschaftspraxis Bethanien Krank, Dept Med & Res, Frankfurt, Germany; [Goldenberg, D. M.; Hong, Q.; Olivo, M. S.; Itri, L. M.] Immunomedics, Morris Plains, NJ USA; [Rugo, H. S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UNICANCER; Institut Claudius Regaud; UNICANCER; Centre Eugene Marquis; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Institut Jules Bordet; Universite Libre de Bruxelles; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; Columbia University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Florida Cancer Specialists; Rocky Mountain Cancer Centers; Baylor University; Baylor University Medical Center; Texas Oncology; McGill University; University of London; Queen Mary University London; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Bardia, A (corresponding author), Massachusetts Gen Hosp, Canc Ctr, BHX 237,55 Fruit St, Boston, MA 02114 USA.	bardia.aditya@mgh.harvard.edu	Punie, Kevin/AAP-9729-2021; Punie, Kevin/AAL-9232-2020	Punie, Kevin/0000-0002-1162-7963; Armstrong, Anne/0000-0002-0774-7006; Martinez Garcia, Maria/0000-0001-5891-3935; Diamond, Jennifer/0000-0002-0703-2772				Anders CK, 2013, HEMATOL ONCOL CLIN N, V27, P737, DOI 10.1016/j.hoc.2013.05.003; [Anonymous], 2019, KADCYLA ADO TRASTUZU; [Anonymous], 2019, ENHERTU FAM TRASTUZU; Bardia A, 2019, NEW ENGL J MED, V380, P741, DOI 10.1056/NEJMoa1814213; Bardia A., 2021, ANNAL ONCOL; Bardia A, 2017, J CLIN ONCOL, V35, P2141, DOI 10.1200/JCO.2016.70.8297; BASU A, 1995, INT J CANCER, V62, P472, DOI 10.1002/ijc.2910620419; Brufsky A, 2012, BREAST CANCER RES TR, V133, P1067, DOI 10.1007/s10549-012-2008-6; Cardillo TM, 2015, BIOCONJUGATE CHEM, V26, P919, DOI 10.1021/acs.bioconjchem.5b00223; Cardillo TM, 2011, CLIN CANCER RES, V17, P3157, DOI 10.1158/1078-0432.CCR-10-2939; Cardoso F, 2017, BREAST, V31, P244, DOI 10.1016/j.breast.2016.10.001; Cortes J, 2019, ANN ONCOL, V30, P859; Criscitiello C, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01035-z; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Food and Drug Administration , 2020, FDA GRANTS ACCELERAT; Goldenberg DM, 2019, MABS-AUSTIN, V11, P987, DOI 10.1080/19420862.2019.1632115; Goldenberg DM, 2015, ONCOTARGET, V6, P22496, DOI 10.18632/oncotarget.4318; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Mathijssen RHJ, 2001, CLIN CANCER RES, V7, P2182; Moon SJ, 2008, J MED CHEM, V51, P6916, DOI 10.1021/jm800719t; Nagayama A, 2020, THER ADV MED ONCOL, V12, DOI 10.1177/1758835920915980; National Comprehensive Cancer Network, 2020, NCCN CLIN PRACTICE G; Ogitani Y, 2016, CLIN CANCER RES, V22, P5097, DOI 10.1158/1078-0432.CCR-15-2822; Park IH, 2019, CANCER RES TREAT, V51, P43, DOI 10.4143/crt.2017.562; Perez EA, 2010, BREAST CANCER RES TR, V121, P261, DOI 10.1007/s10549-010-0824-0; Pivot X, 2016, ANN ONCOL, V27, P1525, DOI 10.1093/annonc/mdw203; Ripani E, 1998, INT J CANCER, V76, P671; Sharkey RM, 2015, CLIN CANCER RES, V21, P5131, DOI 10.1158/1078-0432.CCR-15-0670; Twelves C, 2014, BREAST CANCER RES TR, V148, P553, DOI 10.1007/s10549-014-3144-y; Zaman S, 2019, ONCOTARGETS THER, V12, P1781, DOI 10.2147/OTT.S162447; Zeichner SB, 2016, BREAST CANCER-BASIC, V10, DOI 10.4137/BCBCR.S32783	31	203	211	23	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1529	1541		10.1056/NEJMoa2028485	http://dx.doi.org/10.1056/NEJMoa2028485			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ6OT	33882206	Green Published, Bronze			2022-12-28	WOS:000642536700011
J	Yoon, MK; Kelly, HR; Freitag, SK; Marneros, AG; Barshak, MB; Brackett, DG				Yoon, Michael K.; Kelly, Hillary R.; Freitag, Suzanne K.; Marneros, Alexander G.; Barshak, Miriam B.; Brackett, Diane G.			Case 12-2021: A 78-Year-Old Man with a Rash on the Scalp and Face	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HERPES-ZOSTER		[Yoon, Michael K.; Freitag, Suzanne K.] Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA 02114 USA; [Kelly, Hillary R.] Massachusetts Eye & Ear, Dept Radiol, Boston, MA USA; [Kelly, Hillary R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Marneros, Alexander G.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Barshak, Miriam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Brackett, Diane G.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kelly, Hillary R.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Marneros, Alexander G.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Barshak, Miriam B.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Brackett, Diane G.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yoon, MK (corresponding author), Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA 02114 USA.							Centers for Disease Control and Prevention, 2020, SHINGL HERP ZOST CLI; Dudenhoefer EJ, 1998, OPHTHALMOLOGY, V105, P1875, DOI 10.1016/S0161-6420(98)91033-8; Dworkin RH, 2007, CLIN INFECT DIS, V44, pS1, DOI 10.1086/510206; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; Johnson RW, 2014, NEW ENGL J MED, V371, P1526, DOI 10.1056/NEJMcp1403062; Kost RG, 1996, NEW ENGL J MED, V335, P32, DOI 10.1056/NEJM199607043350107; Liesegang TJ, 2008, OPHTHALMOLOGY, V115, pS3, DOI 10.1016/j.ophtha.2007.10.009; Menon GJ, 2003, SURV OPHTHALMOL, V48, P58, DOI 10.1016/S0039-6257(02)00414-9; Szeto SKH, 2017, CORNEA, V36, P338, DOI 10.1097/ICO.0000000000001046; Tsirouki T, 2018, SURV OPHTHALMOL, V63, P534, DOI 10.1016/j.survophthal.2017.12.001; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	11	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 22	2021	384	16					1553	1562		10.1056/NEJMcpc2100276	http://dx.doi.org/10.1056/NEJMcpc2100276			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RQ6OT	33882209				2022-12-28	WOS:000642536700014
J	Arkell, P; Florindo, TE; Baird, R; Babua, C				Arkell, Paul; Florindo, Tanizio E.; Baird, Rob; Babua, Christopher			Chronic suppurative skin lesions in a young woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Arkell, Paul; Florindo, Tanizio E.; Babua, Christopher] Hosp Nacl Guido Valadares, Dept Internal Med, Dili, Timor-Leste; Menzies Sch Hlth Res, STONG TL Project, Darwin, NT, Australia; [Arkell, Paul] Imperial Coll London, Dept Infect Dis, London, England; [Baird, Rob] Terr Pathol, Darwin, NT, Australia; [Babua, Christopher] Royal Australasian Coll Surg, Melbourne, Australia	Charles Darwin University; Menzies School of Health Research; Imperial College London	Arkell, P (corresponding author), Hosp Nacl Guido Valadares, Dept Internal Med, Dili, Timor-Leste.; Arkell, P (corresponding author), Imperial Coll London, Dept Infect Dis, London, England.	paularkell@doctors.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 21	2021	373								n797	10.1136/bmj.n797	http://dx.doi.org/10.1136/bmj.n797			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IT	33883148				2022-12-28	WOS:000642452700004
J	Sadoff, J; Gray, G; Vandebosch, A; Cardenas, V; Shukarev, G; Grinsztejn, B; Goepfert, PA; Truyers, C; Fennema, H; Spiessens, B; Offergeld, K; Scheper, G; Taylor, KL; Robb, ML; Treanor, J; Barouch, DH; Stoddard, J; Ryser, MF; Marovich, MA; Neuzil, KM; Corey, L; Cauwenberghs, N; Tanner, T; Hardt, K; Ruiz-Guinazu, J; Le Gars, M; Schuitemaker, H; Van Hoof, J; Struyf, F; Douoguih, M				Sadoff, Jerald; Gray, Glenda; Vandebosch, An; Cardenas, Vicky; Shukarev, Georgi; Grinsztejn, Beatriz; Goepfert, Paul A.; Truyers, Carla; Fennema, Hein; Spiessens, Bart; Offergeld, Kim; Scheper, Gert; Taylor, Kimberly L.; Robb, Merlin L.; Treanor, John; Barouch, Dan H.; Stoddard, Jeffrey; Ryser, Martin F.; Marovich, Mary A.; Neuzil, Kathleen M.; Corey, Lawrence; Cauwenberghs, Nancy; Tanner, Tamzin; Hardt, Karin; Ruiz-Guinazu, Javier; Le Gars, Mathieu; Schuitemaker, Hanneke; Van Hoof, Johan; Struyf, Frank; Douoguih, Macaya		ENSEMBLE Study Grp	Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLUENZA; IMMUNOGENICITY; SEVERITY	Background The Ad26.COV2.S vaccine is a recombinant, replication-incompetent human adenovirus type 26 vector encoding full-length severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein in a prefusion-stabilized conformation. Methods In an international, randomized, double-blind, placebo-controlled, phase 3 trial, we randomly assigned adult participants in a 1:1 ratio to receive a single dose of Ad26.COV2.S (5x10(10) viral particles) or placebo. The primary end points were vaccine efficacy against moderate to severe-critical coronavirus disease 2019 (Covid-19) with an onset at least 14 days and at least 28 days after administration among participants in the per-protocol population who had tested negative for SARS-CoV-2. Safety was also assessed. Results The per-protocol population included 19,630 SARS-CoV-2-negative participants who received Ad26.COV2.S and 19,691 who received placebo. Ad26.COV2.S protected against moderate to severe-critical Covid-19 with onset at least 14 days after administration (116 cases in the vaccine group vs. 348 in the placebo group; efficacy, 66.9%; adjusted 95% confidence interval [CI], 59.0 to 73.4) and at least 28 days after administration (66 vs. 193 cases; efficacy, 66.1%; adjusted 95% CI, 55.0 to 74.8). Vaccine efficacy was higher against severe-critical Covid-19 (76.7% [adjusted 95% CI, 54.6 to 89.1] for onset at >= 14 days and 85.4% [adjusted 95% CI, 54.2 to 96.9] for onset at >= 28 days). Despite 86 of 91 cases (94.5%) in South Africa with sequenced virus having the 20H/501Y.V2 variant, vaccine efficacy was 52.0% and 64.0% against moderate to severe-critical Covid-19 with onset at least 14 days and at least 28 days after administration, respectively, and efficacy against severe-critical Covid-19 was 73.1% and 81.7%, respectively. Reactogenicity was higher with Ad26.COV2.S than with placebo but was generally mild to moderate and transient. The incidence of serious adverse events was balanced between the two groups. Three deaths occurred in the vaccine group (none were Covid-19-related), and 16 in the placebo group (5 were Covid-19-related). Conclusions A single dose of Ad26.COV2.S protected against symptomatic Covid-19 and asymptomatic SARS-CoV-2 infection and was effective against severe-critical disease, including hospitalization and death. Safety appeared to be similar to that in other phase 3 trials of Covid-19 vaccines. (Funded by Janssen Research and Development and others; ENSEMBLE ClinicalTrials.gov number, NCT04505722.) Ad26.COV2.S Vaccine Efficacy against Covid-19 Ad26.COV2.S vaccine is a replication-incompetent human adenovirus type 26 vector containing the gene sequence that produces SARS-CoV-2 spike protein in a prefusion-stabilized conformation. In a randomized trial involving nearly 40,000 persons, vaccine efficacy was 66% against moderate to severe-critical Covid-19 and 85% against severe-critical Covid-19. Efficacy against the variant first identified in South Africa was 64% against moderate disease and 82% against severe-critical disease.	[Sadoff, Jerald; Shukarev, Georgi; Scheper, Gert; Le Gars, Mathieu; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya] Janssen Vaccines & Prevent, Newtonweg 1, NL-2333 CP Leiden, Netherlands; [Gray, Glenda] South African Res Council, Cape Town, South Africa; [Vandebosch, An; Truyers, Carla; Fennema, Hein; Spiessens, Bart; Offergeld, Kim; Ryser, Martin F.; Cauwenberghs, Nancy; Tanner, Tamzin; Hardt, Karin; Ruiz-Guinazu, Javier; Struyf, Frank] Janssen Res & Dev, Beerse, Belgium; [Cardenas, Vicky] Janssen Res & Dev, Spring House, PA USA; [Grinsztejn, Beatriz] Fiocruz MS, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil; [Goepfert, Paul A.] Univ Alabama Birmingham, Birmingham, AL USA; [Taylor, Kimberly L.; Marovich, Mary A.] NIAID, Rockville, MD USA; [Robb, Merlin L.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Neuzil, Kathleen M.] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA; [Treanor, John] Biomed Adv Res & Dev Author, Washington, DC USA; [Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Stoddard, Jeffrey] Janssen Res & Dev, Raritan, NJ USA; [Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Fundacao Oswaldo Cruz; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University System of Maryland; University of Maryland Baltimore; Harvard University; Beth Israel Deaconess Medical Center; Johnson & Johnson; Janssen Pharmaceuticals; Fred Hutchinson Cancer Center	Douoguih, M (corresponding author), Janssen Vaccines & Prevent, Newtonweg 1, NL-2333 CP Leiden, Netherlands.	mdouogui@its.jnj.com	Kilgore, Paul E/L-1462-2013; Pilotto, Jose Henrique/AAD-9773-2019; Gottlieb, Robert/AAM-8310-2020; Kilgore, Paul/AAD-2869-2019	Kilgore, Paul E/0000-0003-3214-4482; Pilotto, Jose Henrique/0000-0003-0521-8597; Gottlieb, Robert/0000-0001-8376-8709; Kilgore, Paul/0000-0003-3214-4482; Greninger, Alexander/0000-0002-7443-0527; da Silva, Cesar Mauricio/0000-0003-0361-2283; Shukarev, Georgi/0000-0001-5154-7047; Struyf, Frank/0000-0001-9988-0260; Brumskine, William/0000-0002-1092-9919; Gompf, Sandra/0000-0001-6533-7577; Kotze, Philip/0000-0003-1346-7833; Gray, Glenda E./0000-0003-4649-1477				Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Arriola C, 2017, CLIN INFECT DIS, V65, P1289, DOI 10.1093/cid/cix468; Barouch DH, 2018, LANCET, V392, P232, DOI [10.1016/s0140-6736(18)31364-3, 10.1016/S0140-6736(18)31364-3]; Beran J, 2021, LANCET INFECT DIS, V21, P1027, DOI 10.1016/S1473-3099(20)30694-0; Bos R, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-00243-x; Castilla J, 2013, CLIN INFECT DIS, V57, P167, DOI 10.1093/cid/cit194; Claeys C, 2018, LANCET CHILD ADOLESC, V2, P338, DOI 10.1016/S2352-4642(18)30062-2; Custers J, 2021, VACCINE, V39, P3081, DOI 10.1016/j.vaccine.2020.09.018; Deiss RG, 2015, VACCINE, V33, P7160, DOI 10.1016/j.vaccine.2015.11.004; Dragalin V, 2006, J BIOPHARM STAT, V16, P539, DOI 10.1080/10543400600721554; Dragalin V, 2002, STAT MED, V21, P877, DOI 10.1002/sim.1039; GISAID, 2021, MAP TRACKED VARIANT; Gomes MGM, 2016, VACCINE, V34, P3007, DOI 10.1016/j.vaccine.2016.04.065; Hodgson SH, 2021, LANCET INFECT DIS, V21, pE26, DOI 10.1016/S1473-3099(20)30773-8; Jain VK, 2013, NEW ENGL J MED, V369, P2481, DOI 10.1056/NEJMoa1215817; Johns Hopkins University Coronavirus Resource Center, 2021, COVID 19 DASHBOARD C; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Langwig KE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39698-x; Lee CH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.579480; Lee EO, 2021, J VIROL, V95, DOI 10.1128/JVI.02002-20; Liu, 2021, NAT MED; Margheri A, 2017, DYNAM SYST, V32, P148, DOI 10.1080/14689367.2016.1187115; Mehrotra DV, 2021, ANN INTERN MED, V174, P221, DOI 10.7326/M20-6169; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Moliva, 2021, PREPRINT, DOI 10.1101/2021.01.25.427948v1; Nauta J., 2011, STAT CLIN VACCINE TR, P95; Prakash S., 2020, PREPRINT, DOI 10.1101/2020.09.27.316018v1.full; Public Health England, 2021, INVESTIGATION NOVEL; SADOFF J, NEW ENGL J MED; Salisch NC, 2021, ANN INTERN MED, V174, P585, DOI 10.7326/M20-5306; Stephenson KE, 2021, JAMA-J AM MED ASSOC, V325, P1535, DOI 10.1001/jama.2021.3645; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Voloch CM, 2021, J VIROL, V95, DOI 10.1128/JVI.00119-21; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Williams K, 2020, J INFECT DIS, V222, P979, DOI 10.1093/infdis/jiaa193; World Health Organization, 2021, DRAFT LANDSCAPE TRAC; Zhou DB, 2021, HUM CELL, V34, P1478, DOI 10.1007/s13577-021-00572-6	39	1109	1125	17	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2021	384	23					2187	2201		10.1056/NEJMoa2101544	http://dx.doi.org/10.1056/NEJMoa2101544		APR 2021	15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SU1MX	33882225	Green Published, Bronze			2022-12-28	WOS:000642260000001
J	Jaklevic, MC				Jaklevic, Mary Chris			Pathway Eased for Serial COVID-19 Screening Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2021	325	15					1499	1499		10.1001/jama.2021.5391	http://dx.doi.org/10.1001/jama.2021.5391			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ8AS	33877284	Bronze			2022-12-28	WOS:000642636500007
J	Rimmer, A				Rimmer, Abi			How can I succeed in a virtual consultant interview?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2021	372								n990	10.1136/bmj.n990	http://dx.doi.org/10.1136/bmj.n990			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IH	33875490	Bronze			2022-12-28	WOS:000642451400009
J	Muster, V; Gary, T; Raggam, RB; Wolfler, A; Brodmann, M				Muster, Viktoria; Gary, Thomas; Raggam, Reinhard B.; Woelfler, Albert; Brodmann, Marianne			Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination	LANCET			English	Editorial Material									[Muster, Viktoria; Gary, Thomas; Raggam, Reinhard B.; Brodmann, Marianne] Med Univ Graz, Dept Internal Med, Div Angiol, A-8036 Graz, Austria; [Woelfler, Albert] Med Univ Graz, Dept Internal Med, Dept Haematol, A-8036 Graz, Austria	Medical University of Graz; Medical University of Graz	Gary, T (corresponding author), Med Univ Graz, Dept Internal Med, Div Angiol, A-8036 Graz, Austria.	thomas.gary@medunigraz.at							0	19	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 15	2021	397	10287					1842	1842		10.1016/S0140-6736(21)00871-0	http://dx.doi.org/10.1016/S0140-6736(21)00871-0		MAY 2021	1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	SD0HD	33864749	Bronze			2022-12-28	WOS:000651041900030
J	Washington, NL; Gangavarapu, K; Zeller, M; Bolze, A; Cirulli, ET; Barrett, KMS; Larsen, BB; Anderson, C; White, S; Cassens, T; Jacobs, S; Levan, G; Nguyen, J; Ramirez, JM; Rivera-Garcia, C; Sandoval, E; Wang, XQ; Wong, D; Spencer, E; Robles-Sikisaka, R; Kurzban, E; Hughes, LD; Deng, XD; Wang, CDC; Servellita, V; Valentine, H; De Hoff, P; Seaver, P; Sathe, S; Gietzen, K; Sickler, B; Antico, J; Hoon, K; Liu, JT; Harding, A; Bakhtar, O; Basler, T; Austin, B; MacCannell, D; Isaksson, M; Febbo, PG; Becker, D; Laurent, M; McDonald, E; Yeo, GW; Knight, R; Laurent, LC; de Feo, E; Worobey, M; Chiu, CY; Suchard, MA; Lu, JT; Lee, W; Andersen, KG				Washington, Nicole L.; Gangavarapu, Karthik; Zeller, Mark; Bolze, Alexandre; Cirulli, Elizabeth T.; Barrett, Kelly M. Schiabor; Larsen, Brendan B.; Anderson, Catelyn; White, Simon; Cassens, Tyler; Jacobs, Sharoni; Levan, Geraint; Nguyen, Jason; Ramirez, Jimmy M., III; Rivera-Garcia, Charlotte; Sandoval, Efren; Wang, Xueqing; Wong, David; Spencer, Emily; Robles-Sikisaka, Refugio; Kurzban, Ezra; Hughes, Laura D.; Deng, Xianding; Wang, Candace; Servellita, Venice; Valentine, Holly; De Hoff, Peter; Seaver, Phoebe; Sathe, Shashank; Gietzen, Kimberly; Sickler, Brad; Antico, Jay; Hoon, Kelly; Liu, Jingtao; Harding, Aaron; Bakhtar, Omid; Basler, Tracy; Austin, Brett; MacCannell, Duncan; Isaksson, Magnus; Febbo, Phillip G.; Becker, David; Laurent, Marc; McDonald, Eric; Yeo, Gene W.; Knight, Rob; Laurent, Louise C.; de Feo, Eileen; Worobey, Michael; Chiu, Charles Y.; Suchard, Marc A.; Lu, James T.; Lee, William; Andersen, Kristian G.			Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States	CELL			English	Article								The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom, has gained a foothold across the world. Using S gene target failure (SGTF) and SARS-CoV-2 genomic sequencing, we investigated the prevalence and dynamics of this variant in the United States (US), tracking it back to its early emergence. We found that, while the fraction of B.1.1.7 varied by state, the variant increased at a logistic rate with a roughly weekly doubling rate and an increased transmission of 40%-50%. We revealed several independent introductions of B.1.1.7 into the US as early as late November 2020, with community transmission spreading it to most states within months. We show that the US is on a similar trajectory as other countries where B.1.1.7 became dominant, requiring immediate and decisive action to minimize COVID-19 morbidity and mortality.	[Washington, Nicole L.; Bolze, Alexandre; Cirulli, Elizabeth T.; Barrett, Kelly M. Schiabor; White, Simon; Cassens, Tyler; Jacobs, Sharoni; Levan, Geraint; Nguyen, Jason; Ramirez, Jimmy M., III; Rivera-Garcia, Charlotte; Sandoval, Efren; Wang, Xueqing; Wong, David; Isaksson, Magnus; Becker, David; Laurent, Marc; Lu, James T.; Lee, William] Helix, San Mateo, CA 94401 USA; [Gangavarapu, Karthik; Zeller, Mark; Anderson, Catelyn; Spencer, Emily; Robles-Sikisaka, Refugio; Kurzban, Ezra; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Larsen, Brendan B.; Worobey, Michael] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Hughes, Laura D.; Andersen, Kristian G.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92122 USA; [Deng, Xianding; Wang, Candace; Servellita, Venice; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94158 USA; [Valentine, Holly; De Hoff, Peter; Seaver, Phoebe; Sathe, Shashank; Yeo, Gene W.; Knight, Rob; Laurent, Louise C.] Univ Calif San Diego, San Diego, CA 92093 USA; [Gietzen, Kimberly; Sickler, Brad; Antico, Jay; Hoon, Kelly; Liu, Jingtao; Febbo, Phillip G.; de Feo, Eileen] Illumina, San Diego, CA 92122 USA; [Harding, Aaron; Bakhtar, Omid] Sharp Healthcare, San Diego, CA 92111 USA; [Basler, Tracy; Austin, Brett; McDonald, Eric] San Diego Cty Hlth & Human Serv Agcy, San Diego, CA 92101 USA; [MacCannell, Duncan] Ctr Dis Control & Prevent, Off Adv Mol Detect, Atlanta, GA 30329 USA; [Chiu, Charles Y.] Innovat Genom Inst, Berkeley, CA 94720 USA; [Suchard, Marc A.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomath, Los Angeles, CA 90095 USA; [Suchard, Marc A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Andersen, Kristian G.] Scripps Res Translat Inst, La Jolla, CA 92037 USA	Scripps Research Institute; University of Arizona; Scripps Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Diego; Illumina; Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Washington, NL (corresponding author), Helix, San Mateo, CA 94401 USA.; Gangavarapu, K; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92122 USA.; Andersen, KG (corresponding author), Scripps Res Translat Inst, La Jolla, CA 92037 USA.	nicole.washington@helix.com; gkarthik@scripps.edu; andersen@scripps.edu	Yeo, Gene/AAE-7676-2019	Yeo, Gene/0000-0002-0799-6037; Anderson, Catelyn/0000-0002-2023-5814; Schiabor Barrett, Kelly/0000-0001-6194-787X; Washington, Nicole/0000-0001-8936-9143; White, Simon/0000-0001-6375-2363; Spencer, Emily/0000-0003-2650-4357; Bolze, Alexandre/0000-0001-7399-2766; Knight, Rob/0000-0002-0975-9019	CDC BAA [75D30121P10258, 75D30120C09795]; NIH NIAID [3U19AI135995-03S2, U19AI135995, U01AI151812]; Innovative Genomics Institute; New Frontiers in Research Fund by the Canadian Institutes of Health Research; NIH NCATS [UL1TR002550]	CDC BAA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Innovative Genomics Institute; New Frontiers in Research Fund by the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the employees of Helix, employees of Illumina, members of the CDC SPHERES consortium and California CovidNET, and members of the Andersen Lab for discussion and help with logistics. We thank the healthcare workers, frontline workers, and patients who made the collection of this SARS-CoV-2 dataset possible and all those who made genomic data available for analysis via GISAID (Data S2). This work has been funded by CDC BAA contracts 75D30121P10258 (Illumina, Helix) and 75D30120C09795 (G.W.Y., R.K., L.C.L., and K.G.A.), NIH NIAID 3U19AI135995-03S2 (M.A.S. and K.G.A.), U19AI135995 (M.A.S. and K.G.A.), U01AI151812 (K.G.A.), NIH NCATS UL1TR002550 (K.G.A.), the Innovative Genomics Institute (C.Y.C.), and the New Frontiers in Research Fund provided by the Canadian Institutes of Health Research (C.Y.C.). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the Centers for Disease Control and Prevention.	Ayres DL, 2019, SYST BIOL, V68, P1052, DOI 10.1093/sysbio/syz020; Bal A., 2020, 2 STEP STRATEGY IDEN, DOI [10.1101/2020.11.10.20228528, DOI 10.1101/2020.11.10.20228528]; Borges B., 2021, TRACKING SARS COV 2; CDC, 2021, CAS COVID 19 RESOURC; Chand M., 2020, INVESTIGATION NOVEL; Chand M., 2021, INVESTIGATION NOVEL; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Cyranoski D, 2021, NATURE, V589, P337, DOI 10.1038/d41586-021-00065-4; Davies NG, 2020, ESTIMATED TRANSMISSI; Davis C., 2020, BUSINESS INSIDER; Deng XD, 2020, SCIENCE, V369, P582, DOI 10.1126/science.abb9263; ECDC, 2021, RISK REL SPREAD NEW; Faria N., 2021, GENOMIC CHARACTERISA, DOI 10.1093/cid/ciaa1864; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Galloway SE, 2021, MMWR-MORBID MORTAL W, V70, P95, DOI [10.15585/mmwr.mm7003e2externalicon, 10.15585/mmwr.mm7003e2]; Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Iacobucci G, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n230; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Li H., 2013, ARXIV13033997 Q BIO; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; O'Toole A., 2021, TRACKING INT SPREAD; O'Toole A., 2021, PHYLOGENETIC ASSIGNM; PHE, 2020, INV NOV SARS COV 2 V, P1; Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066; Rambaut A., 2020, COVID 19 GENOMICS CO; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; RIFM (Research Institute for Fragrance Materials Inc), 2021, EXP SURV 30; Romo V., 2020, NPR; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Statens Serums Institute, 2021, EST SCEN UDV CLUST B; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640]; TSA, 2021, TSA CHECKP TRAV NUMB; Washington NL, 2020, MEDRXIV, DOI [10.1101/2020.12.24.20248814, DOI 10.1101/2020.12.24.20248814]	35	130	131	3	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 13	2021	184	10					2587	+	e7	10.1016/j.cell.2021.03.052	http://dx.doi.org/10.1016/j.cell.2021.03.052		MAY 2021	15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	SF5YM	33861950	Bronze, Green Published			2022-12-28	WOS:000652830800006
J	Lavizzo-Mourey, RJ; Besser, RE; Williams, DR				Lavizzo-Mourey, Risa J.; Besser, Richard E.; Williams, David R.			Understanding and Mitigating Health Inequities - Past, Current, and Future Directions	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISPARITIES	Understanding and Mitigating Health Inequities Eliminating racial health inequities requires a movement away from disparities as the focus of research and toward a research agenda centered on achieving equity by dismantling structural racism.	[Lavizzo-Mourey, Risa J.] Univ Penn, Philadelphia, PA 19104 USA; [Besser, Richard E.] Robert Wood Johnson Fdn, Princeton, NJ USA; [Williams, David R.] Harvard Univ, Cambridge, MA 02138 USA	University of Pennsylvania; Robert Wood Johnson Foundation (RWJF); Harvard University	Lavizzo-Mourey, RJ (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.							Chen J, 2016, MED CARE, V54, P140, DOI 10.1097/MLR.0000000000000467; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Roberts D, 2012, CAMB Q HEALTHC ETHIC, V21, P332, DOI 10.1017/S0963180112000059; Williams DR, 2010, ANN NY ACAD SCI, V1186, P69, DOI 10.1111/j.1749-6632.2009.05339.x	5	32	32	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 6	2021	384	18					1681	1684		10.1056/NEJMp2008628	http://dx.doi.org/10.1056/NEJMp2008628		MAY 2021	4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	RY1SU	33951376	Bronze			2022-12-28	WOS:000646648300001
J	Fatemi, V; Devoret, MH				Fatemi, Valla; Devoret, Michel H.			Going with the grains	SCIENCE			English	Editorial Material							EPITAXY		[Fatemi, Valla; Devoret, Michel H.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Yale University	Fatemi, V (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	valla.fatemi@yale.edu						Chang W, 2015, NAT NANOTECHNOL, V10, P232, DOI [10.1038/NNANO.2014.306, 10.1038/nnano.2014.306]; Clerk AA, 2010, REV MOD PHYS, V82, P1155, DOI 10.1103/RevModPhys.82.1155; Gazibegovic S, 2017, NATURE, V548, P434, DOI 10.1038/nature23468; Gu I., 2017, NANO LETT, V17, P2690; Hays M, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.047001; Houzet M, 2019, PHYS REV LETT, V123, DOI 10.1103/PhysRevLett.123.107704; Krogstrup P, 2015, NAT MATER, V14, P400, DOI [10.1038/nmat4176, 10.1038/NMAT4176]; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Pendharkar M., 2020, SCIENCE, V372, P508; Tosi L, 2019, PHYS REV X, V9, DOI 10.1103/PhysRevX.9.011010	14	0	0	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	2021	372	6541					464	464		10.1126/science.abd8556	http://dx.doi.org/10.1126/science.abd8556			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RV0UZ	33926940				2022-12-28	WOS:000645554100026
J	Hotez, P				Hotez, Peter			COVID vaccines: time to confront anti-vax aggression	NATURE			English	Editorial Material						SARS-CoV-2; Vaccines; Society		Halting the spread of the coronavirus will require a high-level counteroffensive against new destructive forces. Halting the spread of the coronavirus will require a high-level counteroffensive against new destructive forces.	[Hotez, Peter] Baylor Coll Med, Houston, TX 77030 USA; [Hotez, Peter] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Hotez, P (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.; Hotez, P (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	hotez@bcm.edu							0	18	19	1	14	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2021	592	7856					661	661		10.1038/d41586-021-01084-x	http://dx.doi.org/10.1038/d41586-021-01084-x			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU0WM	33907330				2022-12-28	WOS:000644873400001
J	Chia, A				Chia, Audrey			Why is dying not seen as a diagnosis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Chia, Audrey/0000-0001-6098-2526					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 28	2021	373								n920	10.1136/bmj.n920	http://dx.doi.org/10.1136/bmj.n920			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SK7MH	33910919	Bronze			2022-12-28	WOS:000656399900006
J	Cornwall, W				Cornwall, Warren			UNLEASHING BIG MUDDY	SCIENCE			English	Editorial Material																			0	2	2	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					334	337						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	RU2WE	33888623				2022-12-28	WOS:000645009800017
J	Vasilopoulos, A; Krska, SW; Stahl, SS				Vasilopoulos, Aristidis; Krska, Shane W.; Stahl, Shannon S.			C(sp(3))-H methylation enabled by peroxide photosensitization and Ni-mediated radical coupling	SCIENCE			English	Article							LATE-STAGE FUNCTIONALIZATION; POSITIVE HALOGEN COMPOUNDS; TRANSITION-METAL; DIALKYL PEROXIDES; ALKOXY RADICALS; DISCOVERY; OXIDATION; POTENT; ABSTRACTION; ANTAGONIST	The "magic methyl" effect describes the change in potency, selectivity, and/or metabolic stability of a drug candidate associated with addition of a single methyl group. We report a synthetic method that enables direct methylation of C(sp(3))-H bonds in diverse drug-like molecules and pharmaceutical building blocks. Visible light-initiated triplet energy transfer promotes homolysis of the O-O bond in di-tert-butyl or dicumyl peroxide under mild conditions. The resulting alkoxyl radicals undergo divergent reactivity, either hydrogen-atom transfer from a substrate C-H bond or generation of a methyl radical via beta-methyl scission. The relative rates of these steps may be tuned by varying the reaction conditions or peroxide substituents to optimize the yield of methylated product arising from nickel-mediated cross-coupling of substrate and methyl radicals.	[Vasilopoulos, Aristidis; Stahl, Shannon S.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Krska, Shane W.] Merck & Co Inc, Kenilworth, NJ 07033 USA	University of Wisconsin System; University of Wisconsin Madison; Merck & Company	Stahl, SS (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	stahl@chem.wisc.edu		Krska, Shane/0000-0001-9757-9036; VASILOPOULOS, ARISTIDIS/0000-0001-7494-7801	NIH [R01 GM126832, R35 GM134929, 1S10 OD020022-1]; NSF [CHE-1048642]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	Supported by NIH grants R01 GM126832 and R35 GM134929. Spectroscopic instrumentation was partially supported by NIH grant 1S10 OD020022-1 and NSF grant CHE-1048642.	AVILA DV, 1993, J AM CHEM SOC, V115, P466, DOI 10.1021/ja00055a015; Aynetdinova D, 2021, CHEM SOC REV, V50, P5517, DOI 10.1039/d0cs00973c; Barreiro EJ, 2011, CHEM REV, V111, P5215, DOI 10.1021/cr200060g; BEAK P, 1969, J AM CHEM SOC, V91, P5073, DOI 10.1021/ja01046a023; Benowitz AB, 2018, BIOORG MED CHEM LETT, V28, P3676, DOI 10.1016/j.bmcl.2018.10.032; Berthiol F, 2006, TETRAHEDRON, V62, P4372, DOI 10.1016/j.tet.2006.02.061; Bietti M, 2018, ANGEW CHEM INT EDIT, V57, P16618, DOI 10.1002/anie.201804929; Cao XY, 2010, TETRAHEDRON, V66, P9703, DOI 10.1016/j.tet.2010.10.038; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Chen YT, 2020, ADV SYNTH CATAL, V362, P998, DOI 10.1002/adsc.201901240; Chen YT, 2019, CHEM-EUR J, V25, P3405, DOI 10.1002/chem.201803642; Coleman PJ, 2012, CHEMMEDCHEM, V7, P415, DOI 10.1002/cmdc.201200025; Costa BZ, 2018, CHEMCATCHEM, V10, P4733, DOI 10.1002/cctc.201801166; DiRocco DA, 2014, ANGEW CHEM INT EDIT, V53, P4802, DOI 10.1002/anie.201402023; Donkers RL, 1999, J AM CHEM SOC, V121, P7239, DOI 10.1021/ja9906148; ENCINAS MV, 1982, J PHOTOCHEM, V20, P153, DOI 10.1016/0047-2670(82)85030-2; ENGEL PS, 1983, J PHYS CHEM-US, V87, P10, DOI 10.1021/j100224a004; Feng KB, 2020, NATURE, V580, P621, DOI 10.1038/s41586-020-2137-8; Friis SD, 2020, NAT CHEM, V12, P511, DOI 10.1038/s41557-020-0475-7; Gephart RT, 2012, J AM CHEM SOC, V134, P17350, DOI 10.1021/ja3053688; Hanson K, 2010, J AM CHEM SOC, V132, P16247, DOI 10.1021/ja1075162; Howell JM, 2015, J AM CHEM SOC, V137, P14590, DOI 10.1021/jacs.5b10299; Jia H, 2014, J MED CHEM, V57, P7577, DOI 10.1021/jm500510f; Jones GD, 2005, CHEM COMMUN, P4211, DOI 10.1039/b504996b; KHARASCH MS, 1958, J AM CHEM SOC, V80, P756, DOI 10.1021/ja01536a062; Lee M, 2015, J AM CHEM SOC, V137, P12796, DOI 10.1021/jacs.5b09099; Leeman M, 2008, ANGEW CHEM INT EDIT, V47, P1287, DOI 10.1002/anie.200704021; Liang ZY, 2014, ORG LETT, V16, P5620, DOI 10.1021/ol502682q; Liu C, 2007, ORG LETT, V9, P5601, DOI 10.1021/ol702456z; Luo J, 2016, ACS CATAL, V6, P873, DOI 10.1021/acscatal.5b02204; Mortenson PN, 2019, J MED CHEM, V62, P3857, DOI 10.1021/acs.jmedchem.8b01472; Pelletier G, 2006, ORG LETT, V8, P6031, DOI 10.1021/ol062514u; PINES H, 1969, J ORG CHEM, V34, P2113, DOI 10.1021/jo01259a018; Pipal RW, 2021, NATURE, V589, P542, DOI 10.1038/s41586-020-3015-0; Piszel PE, 2019, ANGEW CHEM INT EDIT, V58, P12211, DOI 10.1002/anie.201906130; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Romero NA, 2016, CHEM REV, V116, P10075, DOI 10.1021/acs.chemrev.6b00057; SCAIANO JC, 1981, J AM CHEM SOC, V103, P640, DOI 10.1021/ja00393a024; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Skubi KL, 2016, CHEM REV, V116, P10035, DOI 10.1021/acs.chemrev.6b00018; SMALL RD, 1978, J AM CHEM SOC, V100, P296, DOI 10.1021/ja00469a058; Sun SY, 2018, BIOORG MED CHEM LETT, V28, P3283, DOI 10.1016/j.bmcl.2018.09.016; Tran BL, 2014, J AM CHEM SOC, V136, P2555, DOI 10.1021/ja411912p; Twilton J, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0052; Varela A, 2017, ANGEW CHEM INT EDIT, V56, P2127, DOI 10.1002/anie.201611273; Vasilopoulos A, 2017, J AM CHEM SOC, V139, P7705, DOI 10.1021/jacs.7b03387; WAGNER P, 1965, J AM CHEM SOC, V87, P5179, DOI 10.1021/ja00950a035; WALLING C, 1964, J AM CHEM SOC, V86, P3368, DOI 10.1021/ja01070a032; Wang SC, 2018, SCI BULL, V63, P1006, DOI 10.1016/j.scib.2018.06.004; Wang SL, 2012, ORG LETT, V14, P3352, DOI 10.1021/ol3013342; Wang Y, 2014, ORG LETT, V16, P5960, DOI 10.1021/ol502987f; Xiang M, 2017, ORG LETT, V19, P3009, DOI 10.1021/acs.orglett.7b01270; Yan GB, 2015, ADV SYNTH CATAL, V357, P1333, DOI 10.1002/adsc.201400984; Yi H, 2017, CHEM REV, V117, P9016, DOI 10.1021/acs.chemrev.6b00620	55	50	50	20	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					398	+		10.1126/science.abh2623	http://dx.doi.org/10.1126/science.abh2623			139	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888639	Green Accepted			2022-12-28	WOS:000645009800040
J	Xu, J; Mandal, J; Raman, AP				Xu, Jin; Mandal, Jyotirmoy; Raman, Aaswath P.			Broadband directional control of thermal emission	SCIENCE			English	Article							PERIODIC MICROMACHINED SURFACES; POLARIZED SPECTRAL EMITTANCE; PERFECT ABSORPTION; SILICON; RADIATION; MODES; OXIDE	Controlling the directionality of emitted far-field thermal radiation is a fundamental challenge. Photonic strategies enable angular selectivity of thermal emission over narrow bandwidths, but thermal radiation is a broadband phenomenon. The ability to constrain emitted thermal radiation to fixed narrow angular ranges over broad bandwidths is an important, but lacking, capability. We introduce gradient epsilon-near-zero (ENZ) materials that enable broad-spectrum directional control of thermal emission. We demonstrate two emitters consisting of multiple oxides that exhibit high (>0.7, >0.6) directional emissivity (60 degrees to 75 degrees, 70 degrees to 85 degrees) in the p-polarization for a range of wavelengths (10.0 to 14.3 micrometers, 7.7 to 11.5 micrometers). This broadband directional emission enables meaningful radiative heat transfer primarily in the high emissivity directions. Decoupling the conventional limitations on angular and spectral response improves performance for applications such as thermal camouflaging, solar heating, radiative cooling, and waste heat recovery.	[Xu, Jin; Mandal, Jyotirmoy; Raman, Aaswath P.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Raman, AP (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA.	aaswath@ucla.edu	Raman, Aaswath/H-4245-2013	Raman, Aaswath/0000-0003-0106-8341; Xu, Jin/0000-0002-6147-6550; Mandal, Jyotirmoy/0000-0001-8124-5234	Sloan Research Fellowship in Physics from the Alfred P. Sloan Foundation; Schmidt Science Fellows; Rhodes Trust	Sloan Research Fellowship in Physics from the Alfred P. Sloan Foundation; Schmidt Science Fellows; Rhodes Trust	Supported by the Sloan Research Fellowship in Physics from the Alfred P. Sloan Foundation (A.P.R. and J.X.) and by the Schmidt Science Fellows, in partnership with the Rhodes Trust (J.M.).	ANE JM, 1986, INT J THERMOPHYS, V7, P1191, DOI 10.1007/BF00503975; Argyropoulos C, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205112; Badsha MA, 2014, OPT COMMUN, V332, P206, DOI 10.1016/j.optcom.2014.07.004; Barbillon G, 2017, OPT EXPRESS, V25, P23356, DOI 10.1364/OE.25.023356; Beenakker CWJ, 1998, PHYS REV LETT, V81, P1829, DOI 10.1103/PhysRevLett.81.1829; Bright TJ, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819325; Coppens ZJ, 2017, ADV MATER, V29, DOI 10.1002/adma.201701275; Costantini D, 2015, PHYS REV APPL, V4, DOI 10.1103/PhysRevApplied.4.014023; Davids PS, 2020, SCIENCE, V367, P1341, DOI 10.1126/science.aba2089; Gong Y., 2018, FRONTIERS OPTICS LAS; Greffet JJ, 2002, NATURE, V416, P61, DOI 10.1038/416061a; Guo YF, 2019, APPL PHYS EXPRESS, V12, DOI 10.7567/1882-0786/ab29e4; HASS G, 1954, J OPT SOC AM, V44, P181, DOI 10.1364/JOSA.44.000181; HESKETH PJ, 1986, NATURE, V324, P549, DOI 10.1038/324549a0; HESKETH PJ, 1988, PHYS REV B, V37, P10803, DOI 10.1103/PhysRevB.37.10803; Hofmeister AM, 2003, MON NOT R ASTRON SOC, V345, P16, DOI 10.1046/j.1365-8711.2003.06899.x; Horiuchi N, 2020, NAT PHOTONICS, V14, P66, DOI 10.1038/s41566-020-0585-1; Hulley GC, 2016, ATMOS MEAS TECH, V9, P2393, DOI 10.5194/amt-9-2393-2016; Inoue T, 2014, NAT MATER, V13, P928, DOI [10.1038/NMAT4043, 10.1038/nmat4043]; Jung D, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/aa939b; Kischkat J, 2012, APPL OPTICS, V51, P6789, DOI 10.1364/AO.51.006789; Krayer LJ, 2019, ACS PHOTONICS, V6, P2238, DOI 10.1021/acsphotonics.9b00449; Laroche M, 2005, OPT LETT, V30, P2623, DOI 10.1364/OL.30.002623; Liberal I, 2017, SCIENCE, V358, P1540, DOI 10.1126/science.aaq0459; Liberal I, 2017, SCIENCE, V355, DOI 10.1126/science.aal2672; Liberal I, 2017, NAT PHOTONICS, V11, P149, DOI [10.1038/NPHOTON.2017.13, 10.1038/nphoton.2017.13]; Lucchi E, 2018, RENEW SUST ENERG REV, V82, P3077, DOI 10.1016/j.rser.2017.10.031; Luo CY, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.213905; Mason JA, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3600779; Newman WD, 2015, ACS PHOTONICS, V2, P2, DOI 10.1021/ph5003297; Palchetti L, 2016, J GEOPHYS RES-ATMOS, V121, P10804, DOI 10.1002/2016JD025162; Pan ZG, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17030473; Qu YR, 2018, ACS PHOTONICS, V5, P4125, DOI 10.1021/acsphotonics.8b00862; Raman AP, 2019, JOULE, V3, P2679, DOI 10.1016/j.joule.2019.08.009; Raman AP, 2014, NATURE, V515, P540, DOI 10.1038/nature13883; Rensberg J, 2017, PHYS REV APPL, V8, DOI 10.1103/PhysRevApplied.8.014009; Sakakibara R, 2019, J PHOTON ENERGY, V9, DOI 10.1117/1.JPE.9.032713; Sakr E, 2017, OPT EXPRESS, V25, pA880, DOI 10.1364/OE.25.00A880; Shaykhutdinov T, 2017, OPT MATER EXPRESS, V7, P3706, DOI 10.1364/OME.7.003706; Shen YC, 2016, APPL PHYS REV, V3, DOI 10.1063/1.4941257; Shen YC, 2014, SCIENCE, V343, P1499, DOI 10.1126/science.1249799; Streyer W, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4870255; Vollmer M., 2017, INFRARED THERMAL IMA, DOI [10.1002/9783527693306, DOI 10.1002/9783527693306]; Vulis DI, 2019, REP PROG PHYS, V82, DOI 10.1088/1361-6633/aad3e5; WANG TK, 1991, INFRARED PHYS, V32, P477, DOI 10.1016/0020-0891(91)90137-5; Wang ZT, 2019, RESULTS PHYS, V14, DOI 10.1016/j.rinp.2019.102376; Yin XB, 2020, SCIENCE, V370, P786, DOI 10.1126/science.abb0971; Yoon J, 2015, SCI REP-UK, V5, DOI 10.1038/srep12788	48	31	32	34	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 23	2021	372	6540					393	+		10.1126/science.abc5381	http://dx.doi.org/10.1126/science.abc5381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RU2WE	33888638	Green Submitted			2022-12-28	WOS:000645009800039
J	Mahase, E				Mahase, Elisabeth			Covid-19: Pregnant women should be offered Pfizer or Moderna vaccine, says UK advisory committee	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2021	372								n1013	10.1136/bmj.n1013	http://dx.doi.org/10.1136/bmj.n1013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	RQ5IH	33875518	Bronze			2022-12-28	WOS:000642451400002
J	Shepperd, S; Butler, C; Cradduck-Bamford, A; Ellis, G; Gray, A; Hemsley, A; Khanna, P; Langhorne, P; Mort, S; Ramsay, S; Schiff, R; Stott, DJ; Wilkinson, A; Yu, LM; Young, J				Shepperd, Sasha; Butler, Chris; Cradduck-Bamford, Andrea; Ellis, Graham; Gray, Alastair; Hemsley, Anthony; Khanna, Pradeep; Langhorne, Peter; Mort, Sam; Ramsay, Scott; Schiff, Rebekah; Stott, David J.; Wilkinson, Angela; Yu, Ly-Mee; Young, John			Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons? A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CARE; PEOPLE	Background: Delivering hospital-level care with comprehensive geriatric assessment (CGA) in the home is one approach to deal with the increased demand for bed-based hospital care, but clinical effectiveness is uncertain. Objective: To assess the clinical effectiveness of admission avoidance hospital at home (HAH) with CGA for older persons. Design: Multisite randomized trial. (ISRCTN registry number: ISRCTN60477865) Setting: 9 hospital and community sites in the United Kingdom. Patients: 1055 older persons who were medically unwell, were physiologically stable, and were referred for a hospital admission. Intervention: Admission avoidance HAH with CGA versus hospital admission with CGA when available using 2:1 randomization. Measurements: The primary outcome of living at home was measured at 6 months. Secondary outcomes were new admission to long-term residential care, death, health status, delirium, and patient satisfaction. Results: Participants had a mean age of 83.3 years (SD, 7.0). At 6-month follow-up, 528 of 672 (78.6%) participants in the CGA HAH group versus 247 of 328 (75.3%) participants in the hospital group were living at home (relative risk [RR], 1.05 [95% CI, 0.95 to 1.15]; P = 0.36); 114 of 673 (16.9%) versus 58 of 328 (17.7%) had died (RR, 0.98 [CI, 0.65 to 1.47]; P = 0.92); and 37 of 646 (5.7%) versus 27 of 311 (8.7%) were in long-term residential care (RR, 0.58 [CI, 0.45 to 0.76]; P < 0.001). Limitation: The findings are most applicable to older persons referred from a hospital short-stay acute medical assessment unit; episodes of delirium may have been undetected. Conclusion: Admission avoidance HAH with CGA led to similar outcomes as hospital admission in the proportion of older persons living at home as well as a decrease in admissions to long-term residential care at 6 months. This type of service can provide an alternative to hospitalization for selected older persons.	[Shepperd, Sasha; Cradduck-Bamford, Andrea] Univ Oxford, Nuffield Dept Populat Hlth Sci, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England; [Butler, Chris; Mort, Sam; Yu, Ly-Mee] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Woodstock Rd, Oxford OX2 6GG, England; [Ellis, Graham] NHS Lanarkshire, Univ Hosp Monklands, Monkscourt Ave, Airdrie ML6 0JS, Scotland; [Gray, Alastair] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Richard Doll Bldg, Oxford OX3 7LF, England; [Hemsley, Anthony] Royal Devon & Exeter NHS Fdn Trust, Exeter EX2 5DW, Devon, England; [Khanna, Pradeep] Aneurin Bevan Univ Hlth Board, Newport NP20 45Z, Gwent, Wales; [Langhorne, Peter; Stott, David J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Ramsay, Scott] NHS Lothian, St Johns Hosp, Livingston EH54 6PP, Scotland; [Schiff, Rebekah] Guys & St ThomasNHS Fdn Trust, Westminster Bridge Rd, London SE1 7EH, England; [Wilkinson, Angela] NHS Fife, Victoria Hosp, Hayfield Rd, Kirkcaldy KY2 5AH, Scotland; [Young, John] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of Oxford; University of Oxford; University of Oxford; University of Exeter; University of Glasgow; University of Dundee; University of Leeds	Shepperd, S (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth Sci, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	sasha.shepperd@ndph.ox.ac.uk		Mort, Sam James/0000-0001-6332-4641; Butler, Christopher/0000-0002-0102-3453; Gray, Alastair/0000-0003-0239-7278; Shepperd, Sasha/0000-0001-6384-8322; Yu, Ly-Mee/0000-0003-0331-7364; Hemsley, Anthony/0000-0002-5595-4528; Cradduck-Bamford, Andrea/0000-0002-5772-9666; Ramsay, Scott/0000-0001-9048-1562; Schiff, Rebekah/0000-0001-6687-3726	National Institute for Health Research Health Services and Delivery Research Programme [12/209/66]	National Institute for Health Research Health Services and Delivery Research Programme	The National Institute for Health Research Health Services and Delivery Research Programme (12/209/66).	Beswick AD, 2008, LANCET, V371, P725, DOI 10.1016/S0140-6736(08)60342-6; Bibbins-Domingo K, 2019, JAMA-J AM MED ASSOC, V322, P1763, DOI 10.1001/jama.2019.15603; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarke F., 1984, HOSP HOME ALTERNATIV; Conley J, 2016, JAMA INTERN MED, V176, P1693, DOI 10.1001/jamainternmed.2016.5974; Ellis G, 2012, EUR GERIATR MED, V3, P261, DOI 10.1016/j.eurger.2012.03.004; Ellis G, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub3; Federman AD, 2018, JAMA INTERN MED, V178, P1033, DOI 10.1001/jamainternmed.2018.2562; Fried TR, 2000, ARCH INTERN MED, V160, P1501, DOI 10.1001/archinte.160.10.1501; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Levine DM, 2020, ANN INTERN MED, V172, P77, DOI 10.7326/M19-0600; Liao JM, 2020, ANN FRESH LOOK; Makela P, 2020, AGE AGEING, V49, P856, DOI 10.1093/ageing/afaa085; MISLEVY RJ, 1991, J EDUC STAT, V16, P150; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; NHS Health Research Authority, SAF REP SAF REP; Powers BW, 2016, JAMA-J AM MED ASSOC, V315, P23, DOI 10.1001/jama.2015.17029; Prince MJ, 2015, LANCET, V385, P549, DOI 10.1016/S0140-6736(14)61347-7; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Shenkin SD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1367-9; Shepperd S, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2214-y; Shepperd S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007491; Strini Veronica, 2020, Acta Biomed, V91, P19, DOI 10.23750/abm.v91i2-S.9226; Teale EA, 2015, AGE AGEING, V44, P667, DOI 10.1093/ageing/afv014; Thiyagarajan JA, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002948; Thomson R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-467; Wade D T, 1988, Int Disabil Stud, V10, P64; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Young J, 2009, ARCH GERONTOL GERIAT, V49, pS21, DOI 10.1016/S0167-4943(09)70008-1; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	34	25	25	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL	2021	174	7					889	+		10.7326/M20-5688	http://dx.doi.org/10.7326/M20-5688			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TM8QB	34781721	Green Accepted			2022-12-28	WOS:000675809000015
J	Hacisuleyman, E; Hale, C; Saito, Y; Blachere, NE; Bergh, M; Conlon, EG; Schaefer-Babajew, DJ; DaSilva, J; Muecksch, F; Gaebler, C; Lifton, R; Nussenzweig, MC; Hatziioannou, T; Bieniasz, PD; Darnell, RB				Hacisuleyman, Ezgi; Hale, Caryn; Saito, Yuhki; Blachere, Nathalie E.; Bergh, Marissa; Conlon, Erin G.; Schaefer-Babajew, Dennis J.; DaSilva, Justin; Muecksch, Frauke; Gaebler, Christian; Lifton, Richard; Nussenzweig, Michel C.; Hatziioannou, Theodora; Bieniasz, Paul D.; Darnell, Robert B.			Vaccine Breakthrough Infections with SARS-CoV-2 Variants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of clinical concern. In a cohort of 417 persons who had received the second dose of BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) vaccine at least 2 weeks previously, we identified 2 women with vaccine breakthrough infection. Despite evidence of vaccine efficacy in both women, symptoms of coronavirus disease 2019 developed, and they tested positive for SARS-CoV-2 by polymerase-chain-reaction testing. Viral sequencing revealed variants of likely clinical importance, including E484K in 1 woman and three mutations (T95I, del142-144, and D614G) in both. These observations indicate a potential risk of illness after successful vaccination and subsequent infection with variant virus, and they provide support for continued efforts to prevent and diagnose infection and to characterize variants in vaccinated persons. (Funded by the National Institutes of Health and others.) Variant SARS-CoV-2 Infection after Vaccination Mild Covid-19 symptoms developed in two fully vaccinated persons. Serum tests showed high titers of antibodies capable of neutralizing the wild-type strain of SARS-CoV-2 first identified in Wuhan, China, but sequencing of the virus isolates revealed novel variants. Some mutations in the receptor-binding domain of the spike protein were shared by the two variant strains.	[Hacisuleyman, Ezgi; Hale, Caryn; Saito, Yuhki; Blachere, Nathalie E.; Bergh, Marissa; Conlon, Erin G.; Darnell, Robert B.] Rockefeller Univ, Lab Mol Neurooncol, 1230 York Ave, New York, NY 10065 USA; [Schaefer-Babajew, Dennis J.; Gaebler, Christian; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA; [Lifton, Richard] Rockefeller Univ, Lab Human Genet & Genom, 1230 York Ave, New York, NY 10021 USA; [DaSilva, Justin; Muecksch, Frauke; Hatziioannou, Theodora; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, 1230 York Ave, New York, NY 10021 USA; [Nussenzweig, Michel C.; Bieniasz, Paul D.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	Darnell, RB (corresponding author), Rockefeller Univ, Lab Mol Neurooncol, 1230 York Ave, New York, NY 10065 USA.	darnelr@rockefeller.edu	Gaebler, Christian/GWZ-2628-2022; Darnell, Robert/B-9022-2008	Gaebler, Christian/0000-0001-7295-8128; Schaefer-Babajew, Dennis/0000-0002-5380-2950; Darnell, Robert/0000-0002-5134-8088	National Institutes of Health [R01AI50111, R35NS097404, R01AI78788]; Kavli Neural Systems Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Neural Systems Institute	Supported by grants (R01AI50111, to Dr. Bieniasz, R35NS097404, to Dr. Darnell, and R01AI78788, to Dr. Hatziioannou) from the National Institutes of Health; a grant (to Dr. Hacisuleyman) from the Kavli Neural Systems Institute; and funding to Drs. Nussenzweig, Bieniasz, and Darnell from the Howard Hughes Medical Institute for being investigators.	CDC, 2021, SARS COV 2 VARIANT C; Centers for Disease Control and Prevention, 2021, COVID 19 VACCINE EFF; Frank MO., 2021, DRUL SCH OPENING PRE, DOI [10.1101/2021.04.03.21254873v1, DOI 10.1101/2021.04.03.21254873V1]; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Jackson B, VIROLOGICAL; Kemp SA, 2021, NATURE, V592, P277, DOI 10.1038/s41586-021-03291-y; Luchsinger LL, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02005-20; NYC Health, 2021, New York City COVID-19 cases caused by SARS-CoV-2 variants report; Planas D, 2021, NAT MED, V27, P917, DOI [DOI 10.1038/s41591-021-01318-5, 10.1038/s41591-021- 01318-5]; Rambaut A, 2020, NAT MICROBIOL, V5, P1403, DOI 10.1038/s41564-020-0770-5; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Schmidt F, 2020, J EXP MED, V217, DOI 10.1084/jem.20201181; Stamatatos L., SCIENCE, V25; Wang Zijun, 2021, Nature, V592, P616, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weisblum Y, 2020, ELIFE, V9, DOI 10.7554/eLife.61312	15	356	363	9	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2021	384	23					2212	2218		10.1056/NEJMoa2105000	http://dx.doi.org/10.1056/NEJMoa2105000		APR 2021	7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	SU1MX	33882219	Bronze, Green Published			2022-12-28	WOS:000642260700001
J	Shepperd, S; Ellis, G; Schiff, R; Stott, DJ; Young, J				Shepperd, Sasha; Ellis, Graham; Schiff, Rebekah; Stott, David J.; Young, John			Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons? RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							PRAGMATIC TRIALS		[Shepperd, Sasha] Univ Oxford, Oxford, England; [Ellis, Graham] Univ Hosp Monklands, Airdrie, Scotland; [Schiff, Rebekah] Guys & St Thomas NHS Fdn Trust, London, England; [Stott, David J.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Young, John] Univ Leeds, Leeds, W Yorkshire, England	University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of Glasgow; University of Leeds	Shepperd, S (corresponding author), Univ Oxford, Oxford, England.			Mort, Sam James/0000-0001-6332-4641; Butler, Christopher/0000-0002-0102-3453; Gray, Alastair/0000-0003-0239-7278; Shepperd, Sasha/0000-0001-6384-8322; Yu, Ly-Mee/0000-0003-0331-7364; Hemsley, Anthony/0000-0002-5595-4528; Cradduck-Bamford, Andrea/0000-0002-5772-9666; Ramsay, Scott/0000-0001-9048-1562; Schiff, Rebekah/0000-0001-6687-3726				Sox HC, 2016, JAMA-J AM MED ASSOC, V316, P1205, DOI 10.1001/jama.2016.11409; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	2	25	25	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV	2021	174	11					1633	1634						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	YI2OV	34781721				2022-12-28	WOS:000743694300037
J	Shimabukuro, TT; Kim, SY; Myers, TR; Moro, PL; Oduyebo, T; Panagiotakopoulos, L; Marquez, PL; Olson, CK; Liu, RL; Chang, KT; Ellington, SR; Burkel, VK; Smoots, AN; Green, CJ; Licata, C; Zhang, BCC; Alimchandani, M; Mba-Jonas, A; Martin, SW; Gee, JM; Meaney-Delman, DM				Shimabukuro, Tom T.; Kim, Shin Y.; Myers, Tanya R.; Moro, Pedro L.; Oduyebo, Titilope; Panagiotakopoulos, Lakshmi; Marquez, Paige L.; Olson, Christine K.; Liu, Ruiling; Chang, Karen T.; Ellington, Sascha R.; Burkel, Veronica K.; Smoots, Ashley N.; Green, Caitlin J.; Licata, Charles; Zhang, Bicheng C.; Alimchandani, Meghna; Mba-Jonas, Adamma; Martin, Stacey W.; Gee, Julianne M.; Meaney-Delman, Dana M.		CDC V-Safe COVID-19 Pregnancy Regi	Preliminary Findings of mRNA COVID-19 Vaccine Safety in Pregnant Persons	OBSTETRICAL & GYNECOLOGICAL SURVEY			English	Editorial Material								The first coronavirus disease (COVID-19) vaccines in the United States were the messenger RNA (mRNA) vaccines BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna). Pregnant persons were excluded from the original Emergency Use Authorization (EUA) issued by the Federal Drug Administration (FDA) in December 2020. Pregnant persons with COVID-19 are at increased risk for adverse pregnancy outcomes compared with pregnant persons without COVID-19. This study presents preliminary findings of mRNA COVID-19 vaccine safety in pregnant persons from the United States. To conduct this study, the researchers extracted data from 3 different US vaccine safety monitoring systems: the "v-safe after vaccination health checker" surveillance system, the v-safe pregnancy registry, and the Vaccine Adverse Event Reporting System (VAERS). V-safe asks participants to report local and systemic signs and symptoms as mild, moderate, or severe during daily surveys. Women were eligible if they received their mRNA vaccination during pregnancy or during the preconception period, defined as 30 days before the last menstrual period through 14 days after, and were 18 years of age or older. Participant-reported pregnancy outcomes were spontaneous pregnancy loss (defined as spontaneous abortion and stillbirth) and neonatal outcomes (such as preterm birth, congenital anomalies, small size for gestational age, and neonatal death). Data were obtained through December 14, 2020, to February 28, 2021. In all, 35,691 v-safe participants ages 16 to 54 years identified themselves as pregnant. The majority of enrolled participants were between the ages of 25 and 44 years (98.8%), non-Hispanic White (79.0%), and did not report a COVID-19 diagnosis during pregnancy (97.6%). Overall, 92 (2.3%) of participants received their first vaccination dose during the preconception period, 1132 (28.6%) in the first trimester, 1714 (43.3%) in the second trimester, and 1019 (25.7%) in the third trimester. In terms of adverse effects, injection site pain was described more among pregnant persons compared with nonpregnant women. Headache, myalgia, chills, and fever were reported less often among pregnant persons compared with nonpregnant people. Of the 3958 participants enrolled in the v-safe pregnancy registry, 827 had a completed pregnancy. Of these, 827 completed pregnancies, 115 (13.9%) resulted in a pregnancy loss, and 712 (86.1%) resulted in a live birth (mainly among participants with vaccination in the third trimester). Adverse neonatal outcomes included preterm birth (in 9.4%) and small size for gestational age (in 3.2%); no neonatal deaths were reported. There were 221 pregnancy-related adverse events reported to VAERS, of which the most frequently reported event was spontaneous abortion (46 cases). No congenital anomalies were reported. Of note, the proportions of adverse pregnancy and neonatal outcomes in the v-safe pregnancy database were similar to those published before the COVID-19 pandemic. The findings from this study did not show obvious safety concerns among pregnant persons who received mRNA COVID-19 vaccines. More longitudinal follow-up and studies including larger numbers of women vaccinated earlier in pregnancy are needed to better inform outcomes. Further, new evidence has shown transplacental transfer of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies after maternal COVID-19 vaccination during the third trimester. This evidence suggests that maternal vaccination might provide some protection to the neonate. However, more data are needed to make evaluations on the level of protection.	[Shimabukuro, Tom T.; Myers, Tanya R.; Moro, Pedro L.; Panagiotakopoulos, Lakshmi; Marquez, Paige L.; Olson, Christine K.; Licata, Charles; Zhang, Bicheng C.; Gee, Julianne M.] Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; [Martin, Stacey W.] Ctr Dis Control & Prevent, Arboviral Dis Branch, Div Vector Borne Dis, Atlanta, GA USA; [Kim, Shin Y.; Burkel, Veronica K.; Green, Caitlin J.; Meaney-Delman, Dana M.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Birth Defects & Infant Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Oduyebo, Titilope; Chang, Karen T.; Ellington, Sascha R.; Smoots, Ashley N.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Liu, Ruiling] Ctr Dis Control & Prevent, World Trade Ctr Hlth Program, Natl Inst Occupat Safety & Hlth, Atlanta, GA USA; [Chang, Karen T.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Alimchandani, Meghna; Mba-Jonas, Adamma] US FDA, Div Epidemiol, Off Biostat & Epidemiol, Ctr Biol Evaluat & Res, Silver Spring, MD USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Shimabukuro, TT (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Off, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.			Judge, Ashley/0000-0003-4501-9744					0	296	312	3	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0029-7828	1533-9866		OBSTET GYNECOL SURV	Obstet. Gynecol. Surv.	DEC	2021	76	12					729	731		10.1097/01.ogx.0000802676.57373.17	http://dx.doi.org/10.1097/01.ogx.0000802676.57373.17			3	Obstetrics & Gynecology	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology	XU8MG	34496171				2022-12-28	WOS:000734511500007
